PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Olympia, RP; Brady, J; Rupp, V; Lansenderfer, C				Olympia, Robert P.; Brady, Jodi; Rupp, Valerie; Lansenderfer, Cheryl			EMERGENCY DEPARTMENT VISITS FROM A LOCAL AMUSEMENT PARK	JOURNAL OF EMERGENCY MEDICINE			English	Article						amusement park; roller coaster rides; injuries; Emergency Department	ROLLER-COASTER RIDE; SUBDURAL-HEMATOMA; HEADACHE; INJURIES	Background: There are limited published data examining Emergency Department (ED) presentations associated with amusement parks, and even fewer data on presentations not associated with roller coaster rides. Study Objectives: To determine the spectrum of medical and traumatic presentations to two EDs from nearby amusement parks. Methods: A retrospective chart review of prospectively identified, enrolled, and surveyed patients was conducted at two EDs in Pennsylvania during the summer of 2006. Any patient presenting with a medical or traumatic complaint that occurred within 12 h of ED presentation and was associated with a visit to the local amusement park was prospectively identified and details of the visit were retrospectively reviewed. Results: There were a total of 325 discharge diagnoses for the 296 ED visits identified; 74% of discharge diagnoses were trauma related. The most common traumatic diagnoses were laceration (27%) and head injury or concussion (14%). The most common non-traumatic diagnosis was heat-related illness (24%). Twenty-nine percent of discharge diagnoses were directly associated with amusement park rides. Eighty-nine percent of patients were discharged home. There were no mortalities reported. Conclusion: The majority of ED visits from nearby amusement parks were benign and did not require hospitalization. (C) 2011 Elsevier Inc.	[Olympia, Robert P.] Penn State Milton S Hershey Med Ctr, Dept Emergency Med & Pediat, Hershey, PA 17033 USA; [Brady, Jodi] Penn State Milton S Hershey Med Ctr, Div Adolescent Med, Dept Pediat, Hershey, PA 17033 USA; [Rupp, Valerie; Lansenderfer, Cheryl] Lehigh Valley Hosp, Dept Emergency Med, Allentown, PA USA		Olympia, RP (corresponding author), Penn State Milton S Hershey Med Ctr, Dept Emergency Med & Pediat, 500 Univ Dr, Hershey, PA 17033 USA.						Bateman DE, 1998, LANCET, V352, P1902, DOI 10.1016/S0140-6736(98)08248-8; BIOUSSE V, 1995, LANCET, V346, P767, DOI 10.1016/S0140-6736(95)91525-7; BOABBAS Y, 1995, NEW ENGL J MED, V332, P1585, DOI 10.1056/NEJM199506083322317; Bosch MM, 2003, NEW ENGL J MED, V349, P1094, DOI 10.1056/NEJM200309113491122; Braksiek RJ, 2002, ANN EMERG MED, V39, P65, DOI 10.1067/mem.2002.120127; FERNANDES CMB, 1994, J TRAUMA, V37, P1007, DOI 10.1097/00005373-199412000-00024; Freeman MD, 2005, ARCH PHYS MED REHAB, V86, P2126, DOI 10.1016/j.apmr.2005.05.017; Fukutake T, 2000, NEUROLOGY, V54, P264, DOI 10.1212/WNL.54.1.264; Holtzman DK, 1997, PEDIATR EMERG CARE, V13, P218, DOI 10.1097/00006565-199706000-00011; Jones CH, 1996, PERITON DIALYSIS INT, V16, P329; Kettaneh A, 1998, NEUROLOGY, V51, P637, DOI 10.1212/WNL.51.2.637; Levenson MS, 2005, AMUSEMENT RIDE RELAT; LEVENSON MS, 2001, AMUSEMENT RIDE RELAT; Nencini P, 2000, JAMA-J AM MED ASSOC, V284, P832, DOI 10.1001/jama.284.7.832; Nichols M, 1986, JAMA-J AM MED ASSOC, V256, P833; Pelletier AR, 2005, INJURY PREV, V11, P309, DOI 10.1136/ip.2005.008425; PREBLE MR, 1974, NEW ENGL J MED, V290, P616, DOI 10.1056/NEJM197403142901110; Roldan-Valadeza E, 2006, EUR J PAEDIATR NEURO, V10, P194, DOI 10.1016/j.ejpn.2006.07.001; SCHEER MS, 1979, JAMA-J AM MED ASSOC, V242, P1769, DOI 10.1001/jama.242.16.1769; SENEGOR M, 1991, J NEUROSURG, V75, P475, DOI 10.3171/jns.1991.75.3.0475; Snyder RW, 1997, AM J MED, V102, P488, DOI 10.1016/S0002-9343(97)89445-4; Thakur D, 2006, ARCH DIS CHILD, V91, P421, DOI 10.1136/adc.2005.088864; Yamakami I, 2005, J CLIN NEUROSCI, V12, P81, DOI 10.1016/j.jocn.2004.02.018	23	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679			J EMERG MED	J. Emerg. Med.	JUL	2011	41	1					14	20		10.1016/j.jemermed.2008.04.052			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	798KB	WOS:000293203500003	19022606				2022-02-06	
J	Wang, HE; Balasubramani, GK; Cook, LJ; Yealy, DM; Lave, JR				Wang, Henry E.; Balasubramani, G. K.; Cook, Lawrence J.; Yealy, Donald M.; Lave, Judith R.			Medical Conditions Associated with Out-of-Hospital Endotracheal Intubation	PREHOSPITAL EMERGENCY CARE			English	Article						emergency medical services; paramedics; intubation; intratracheal; comorbidities	RAPID-SEQUENCE INTUBATION; POSITIVE AIRWAY PRESSURE; RECORD LINKAGE; PROBABILISTIC LINKAGE; CARDIAC-ARREST; EMERGENCY; CARE; RESUSCITATION; EXPERIENCE; MANAGEMENT	Background. While prior studies describe the clinical presentation of patients requiring paramedic out-of-hospital endotracheal intubation (ETI), limited data characterize the underlying medical conditions or comorbidities. Objective. To characterize the medical conditions and comorbidities of patients receiving successful paramedic out-of-hospital ETI. Methods. We used Pennsylvania statewide emergency medical services (EMS) clinical data, including all successful ETIs performed during 2003--2005. Using multiple imputation triple-match algorithms, we probabilistically linked EMS ETI to statewide death and hospital admission data. Each hospitalization record contained one primary and up to eight secondary diagnoses, classified according to the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). We determined the proportion of patients in each major ICD-9-CM diagnostic group and subgroup. We calculated the Charlson Comorbidity Index score for each patient. Using binomial proportions with confidence intervals (CIs), we analyzed the data and combined imputed results using Rubin's method. Results. Across the imputed sets, we linked 25,733 (77.7%% linkage) successful ETIs to death or hospital records; 56.3%% patients died before and 43.7%% survived to hospital admission. Of the 14,478 patients who died before hospital admission, most (92.7%%; 95%% CI: 92.5--93.3%%) had presented to EMS in cardiac arrest. Of the 11,255 hospitalized patents, the leading primary diagnoses were circulatory diseases (32.0%%; 95%% CI: 30.2--33.7%%), respiratory diseases (22.8%%; 95%% CI: 21.9--23.7%%), and injury or poisoning (25.2%%; 95%% CI: 22.7--27.8%%). Prominent primary diagnosis subgroups included asphyxia and respiratory failure (15.2%%), traumatic brain injury and skull fractures (11.3%%), acute myocardial infarction and ischemic heart disease (10.9%%), poisonings and drug and alcohol disorders (6.7%%), dysrhythmias (6.7%%), hemorrhagic and nonhemorrhagic stroke (5.9%%), acute heart failure and cardiomyopathies (5.6%%), pneumonia and aspiration (4.9%%), and sepsis, septicemia, and septic shock (3.2%%). Most of the admitted ETI patients had a secondary circulatory (70.8%%), respiratory (61.4%%), or endocrine, nutritional, or metabolic (51.4%%) secondary diagnosis. The mean Charlson Index score was 1.6 (95%% CI: 1.5--1.7). Conclusions. The majority of successful paramedic ETIs occur on patients with cardiac arrest and circulatory and respiratory conditions. Injuries, poisonings, and other conditions compromise smaller but important portions of the paramedic ETI pool. Patients undergoing ETI have multiple comorbidities. These findings may guide the systemic planning of paramedic airway management care and education.	[Wang, Henry E.] Univ Alabama Birmingham, Dept Emergency Med, Birmingham, AL 35249 USA; [Balasubramani, G. K.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Yealy, Donald M.] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA USA; [Lave, Judith R.] Univ Pittsburgh, Dept Hlth Policy & Management, Pittsburgh, PA USA; [Cook, Lawrence J.] Univ Utah, Dept Pediat, Intermt Injury Control & Res Ctr, Salt Lake City, UT USA		Wang, HE (corresponding author), Univ Alabama Birmingham, Dept Emergency Med, 619 19th St S,OHB 251, Birmingham, AL 35249 USA.	hwang@uabmc.edu		Goundappa K, Balasubramani/0000-0001-7221-1825	National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R21-HL084528]; Agency for Health Care Research and Quality, Rockville, MarylandUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08-HS013628]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08HS013628] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R21HL084528] Funding Source: NIH RePORTER	Supported by the National Heart, Lung and Blood Institute grant R21-HL084528. Dr. Wang received support from Clinical Scientist Development Award K08-HS013628 from the Agency for Health Care Research and Quality, Rockville, Maryland. The funders had no direct role in the design or execution of the study or the composition of the resulting manuscript. The authors declare no financial or other conflicts of interest.	Bobrow BJ, 2008, JAMA-J AM MED ASSOC, V299, P1158, DOI 10.1001/jama.299.10.1158; Boyle MJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-52; Cercarelli LR, 1996, J TRAUMA, V40, P805, DOI 10.1097/00005373-199605000-00021; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cook LJ, 2000, ANN EMERG MED, V35, P585, DOI 10.1016/S0196-0644(00)70032-1; Cook LJ, 2001, METHOD INFORM MED, V40, P196; Coutinho Renata Gutierrez da Matta, 2008, Rev. Saúde Pública, V42, P1097, DOI 10.1590/S0034-89102008005000053; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Egly J, 2011, PREHOSP EMERG CARE, V15, P44, DOI 10.3109/10903127.2010.514090; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; Garza AG, 2003, J EMERG MED, V25, P251, DOI 10.1016/S0736-4679(03)00198-7; Garza AG, 2009, CIRCULATION, V119, P2597, DOI 10.1161/CIRCULATIONAHA.108.815621; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; GOLDACRE MJ, 1988, BRIT MED J, V296, P583, DOI 10.1136/bmj.296.6621.583; Grasner JT, 2009, RESUSCITATION, V80, P199, DOI 10.1016/j.resuscitation.2008.10.008; Guenther E, 2009, J PEDIATR-US, V154, P272, DOI 10.1016/j.jpeds.2008.07.047; Hanif MA, 2010, ACAD EMERG MED, V17, P926, DOI 10.1111/j.1553-2712.2010.00829.x; HENDERSON J, 1990, BRIT MED J, V301, P17, DOI 10.1136/bmj.301.6742.17; HENDERSON J, 1989, BRIT MED J, V299, P709, DOI 10.1136/bmj.299.6701.709; Hubble MW, 2006, PREHOSP EMERG CARE, V10, P430, DOI 10.1080/10903120600884848; Hubble MW, 2010, PREHOSP EMERG CARE, V14, P377, DOI 10.3109/10903121003790173; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Little R. J., 2019, STAT ANAL MISSING DA, V793; McGlincy MH, 2004, ASA P JOINT STAT M, P4001; NEWCOMBE HB, 1962, COMMUN ACM, V5, P563, DOI 10.1145/368996.369026; Newgard CD, 2006, ACAD EMERG MED, V13, P69, DOI 10.1197/j.aem.2005.07.029; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Ochs M, 2002, ANN EMERG MED, V40, P159, DOI 10.1067/mem.2002.126397; OVERPECK MD, 1992, AM J PUBLIC HEALTH, V82, P441, DOI 10.2105/AJPH.82.3.441; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; *SOAPNOTE, CHARLS COM IND; SPAITE D, 1995, ANN EMERG MED, V25, P525, DOI 10.1016/S0196-0644(95)70271-7; Studnek JR, 2010, ACAD EMERG MED, V17, P918, DOI 10.1111/j.1553-2712.2010.00827.x; Thomas S, 2010, PREHOSP EMERG CARE, V14, P283, DOI 10.3109/10903127.2010.481758; Thompson J, 2008, ANN EMERG MED, V52, P232, DOI 10.1016/j.annemergmed.2008.01.006; Walls RM, 2008, ANN EMERG MED, V52, P13, DOI 10.1016/j.annemergmed.2008.01.001; Wang H E, 2001, Prehosp Emerg Care, V5, P10, DOI 10.1080/10903120190940254; Wang HE, 2006, HEALTH AFFAIR, V25, P501, DOI 10.1377/hlthaff.25.2.501; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2003, RESUSCITATION, V58, P49, DOI 10.1016/S0300-9572(03)00058-3; Wang HE, 2006, PREHOSP EMERG CARE, V10, P261, DOI 10.1080/10903120500541506; Wang HE, 2006, ANN EMERG MED, V47, P532, DOI 10.1016/j.annemergmed.2006.01.016; Wang HE, 2010, ACAD EMERG MED, V17, P987, DOI 10.1111/j.1553-2712.2010.00864.x; Wang HE, 2010, ANN EMERG MED, V55, P527, DOI 10.1016/j.annemergmed.2009.12.020; Wang HE, 2009, RESUSCITATION, V80, P50, DOI 10.1016/j.resuscitation.2008.08.016	50	6	6	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	JUL-SEP	2011	15	3					338	346		10.3109/10903127.2011.569850			9	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	768VX	WOS:000290967800006	21612386	Green Accepted			2022-02-06	
J	Catale, C; Germain, S; Meulemans, T				Catale, Corinne; Germain, Sophie; Meulemans, Thierry			EXPLORATION OF PERCEPTUAL AND MOTOR INHIBITION IN CHILDREN WITH TRAUMATIC BRAIN INJURY	PERCEPTUAL AND MOTOR SKILLS			English	Article							RESPONSE-INHIBITION; EXECUTIVE FUNCTIONS; FUNCTIONAL-ANATOMY; ATTENTION; TBI; DISSOCIATION; INTERFERENCE; IMPAIRMENT; COGNITION; DISORDER	Perceptual and motor inhibition were examined using conflict resolution tasks for 12 children with traumatic brain injury and 24 matched controls. Direct comparisons of inhibition performances between the two groups showed a specific and disproportionate impairment of motor inhibition (compared with perceptual inhibition) for the children with traumatic brain injury, which suggests that inhibition processes might be differentially impaired in children after traumatic brain injury.	[Catale, Corinne; Germain, Sophie; Meulemans, Thierry] Univ Liege, Neuropsychol Unit, B-4000 Liege, Belgium		Catale, C (corresponding author), Univ Liege, Neuropsychol Unit, Blvd Rectorat B33, B-4000 Liege, Belgium.	corinne.catale@ulg.ac.be					Amieva H, 2004, BRAIN, V127, P949, DOI 10.1093/brain/awh045; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 1999, MENT RETARD DEV D R, V5, P177, DOI 10.1002/(SICI)1098-2779(1999)5:3<177::AID-MRDD3>3.3.CO;2-7; BENCH CJ, 1993, NEUROPSYCHOLOGIA, V31, P907, DOI 10.1016/0028-3932(93)90147-R; Chee MWL, 2000, NEUROREPORT, V11, P135; Dempster FN, 1999, ACTA PSYCHOL, V101, P395, DOI 10.1016/S0001-6918(99)00013-X; Dempster FN, 1999, EDUC PSYCHOL REV, V11, P1, DOI 10.1023/A:1021992632168; Friedman NP, 2004, J MEM LANG, V51, P136, DOI 10.1016/j.jml.2004.03.008; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Germain S, 2008, J INT NEUROPSYCH SOC, V14, P1014, DOI 10.1017/S135561770808123X; Gioia GA IP, 2000, BEHAV RATING INVENTO; Konrad KN, 2000, BRAIN INJURY, V14, P859; LARRUE V, 1994, J CEREBR BLOOD F MET, V14, P958, DOI 10.1038/jcbfm.1994.128; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nassauer KW, 2003, J INT NEUROPSYCH SOC, V9, P25, DOI 10.1017/S1355617703910034; Passolunghi MC, 2001, J EXP CHILD PSYCHOL, V80, P44, DOI 10.1006/jecp.2000.2626; Raven J.C., 1998, PROGR MATRICES COULE; Romine CB, 2005, APPL NEUROPSYCHOL, V12, P190, DOI 10.1207/s15324826an1204_2; Sergeant J., 1996, ATTENTION MEMORY EXE, P57; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; von Hippel W, 2005, PSYCHOL AGING, V20, P519, DOI 10.1037/0882-7974.20.3.519; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	25	6	6	0	3	AMMONS SCIENTIFIC, LTD	MISSOULA	PO BOX 9229, MISSOULA, MT 59807-9229 USA	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	JUN	2011	112	3					667	679		10.2466/04.15.22.25.PMS.112.3.667-679			13	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	793WY	WOS:000292855800001	21853756				2022-02-06	
J	Schulz, C; Mauer, UM				Schulz, C.; Mauer, U. M.			Postoperative course after acute traumatic subdural hematoma in the elderly	ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE			German	Article						Hematoma subdural, acute; Brain injuries; Craniotomy; Prospective studies; Elderly	BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; PRACTICAL SCALE; MANAGEMENT	The goal of the study was to analyze the short-term outcome after surgical treatment of acute subdural hematomas in two treatment groups in a patient population > 65 years. Whether there are disadvantages from invasive treatment or whether advantages can be achieved with the less invasive treatment has not been previously examined in a prospective study. A prospective, nonrandomized study of 50 patients > 65 years with acute traumatic subdural hematoma was performed, comparing the short-term outcome after two different primary surgical procedures: limited craniotomy (group A, n=25) and large decompressive craniectomy (group B, n=25). There were no differences of hematoma volume, degree of midline structure shift, and time from trauma to operation between the two groups. Initial Glasgow coma scale and short-term outcome after 4 weeks measured by the Glasgow outcome score in both groups showed no significant differences. No significant differences between short-term outcome after limited craniotomy versus large decompressive craniectomy were found for patients > 65 years, and the results indicate that decompressive craniectomy can be accepted as a surgical treatment option for acute traumatic subdural hematoma even in elderly patients.	[Schulz, C.; Mauer, U. M.] Bundeswehrkrankenhaus Ulm, Neurochirurg Klin, D-89081 Ulm, Germany		Schulz, C (corresponding author), Bundeswehrkrankenhaus Ulm, Neurochirurg Klin, Oberer Eselsberg 40, D-89081 Ulm, Germany.	chr74@gmx.de					Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Aruga T, 1984, No To Shinkei, V36, P709; BRITT RH, 1978, NEUROSURGERY, V2, P195, DOI 10.1227/00006123-197805000-00001; CROCE MA, 1994, J TRAUMA, V36, P820, DOI 10.1097/00005373-199406000-00012; GAAB MR, 1990, ACT NEUR S, V51, P326; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; HAUX D, 2004, NEUROCHIRURGIE, pS740; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P67, DOI 10.1007/BF01809175; Huang Qiang, 2003, Chin J Traumatol, V6, P305; JAMJOOM A, 1992, INJURY, V23, P518, DOI 10.1016/0020-1383(92)90149-M; JENNETT B, 1975, LANCET, V1, P480; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; Marshall LF, 1991, J NEUROSURG S, V75, P14; Messing-Junger AM, 2003, ZBL NEUROCHIR, V64, P171; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096; Regel JP, 2004, NEUROCHIRURGIE, P231; Sawauchi S, 2003, J NEUROTRAUM, V20, P613, DOI 10.1089/089771503322144536; SCHAAN M, 1999, MANUAL NEUROCHIRURGI, P299; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; SHIGEMORI M, 1987, Neurological Surgery, V15, P1305; TEASDALE G, 1974, LANCET, V2, P81; UNTERBERG AW, 1999, GRUNDLAGEN NEUROCHIR, P321; Vollmer DG, 1991, J NEUROSURG S, V75, P37; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	27	6	6	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0948-6704			Z GERONTOL GERIATR	Z. Gerontol. Geriatr.	JUN	2011	44	3					177	180		10.1007/s00391-011-0168-3			4	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	778FA	WOS:000291686300007	21505941				2022-02-06	
J	Keshavarzi, Z; Hadad, MK; Zahedi, MJ; Bahrami, A				Keshavarzi, Zakieh; Hadad, Mohammad Khaksari; Zahedi, Mohammad Javad; Bahrami, Abbas			The Effects of Female Sex Steroids on Gastric Secretory Responses of Rat Following Traumatic Brain Injury	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Brain injury; Estrogen; Gastric acid; Pepsin; Progesterone	ACID-SECRETION; GASTROINTESTINAL-TRACT; HORMONES; PEPSIN; STRESS; ESTRADIOL; ESTROGEN; RECEPTOR; PATHOPHYSIOLOGY; INFLAMMATION	Objective(s) Gastric ulceration is induced by various forms of stress like surgery, ischemia and trauma. The female sex has more resistance to stress and the gastrointestinal lesions happen fewer than male sex. The purpose of this study was to evaluate the role of estradiol and progesterone on the gastric acid and pepsin levels following traumatic brain injury (TB!) induction. Materials and Methods Diffuse TBI was induced by Marmarou method in female rats. Rats randomly assigned into 9 groups: intact, OVX (ovarectomized rat), Sham+OVX, TBI (intact rats under TBI), TBI+OVX (ovarectomized rats under TBI) and treated OVX rats with vehicle (sesame oil), E2 (estradiol), P4 (progesterone) or E2+P4 combination. The acid content and pepsin levels of each gastric washout sample were measured 5 days after the TB! induction. Results There was no significant difference in gastric acid output between groups either after TBI induction or after treatment with E2 or P4 or E2+P4. Gastric pepsin levels were increased in Sham+OVX, TBI (P<0.001) and TBI+OVX (P<0.05) compared to intact group. Gastric pepsin levels were significantly lower in E2 and E2+P4 treated rats than vehicle treated group (P<0.01). P4 treatment increased gastric pepsin level compared to TBI+OVX group (P<0.05) and this increment was higher than rats that were treated with the E2 and E2+P4 (P<0.01). Conclusion These results suggest that protective effect of estradiol and E2+P4 combination against mucosal damage after TBI, might be mediated by inhibition of pepsin secretion.	[Hadad, Mohammad Khaksari; Bahrami, Abbas] Kerman Univ Med Sci, Physiol Res Ctr, Kerman, Iran; [Keshavarzi, Zakieh] Kerman Univ Med Sci, Neurosci Res Ctr, Kerman, Iran; [Bahrami, Abbas] Kerman Univ Med Sci, Neurosci Ctr, Kerman, Iran		Hadad, MK (corresponding author), Kerman Univ Med Sci, Physiol Res Ctr, Kerman, Iran.	khaksar38@yahoo.co.uk	zahedi, mohammad javad/AAP-2631-2020; Keshavarzi, Zakieh/ABG-4268-2020	zahedi, mohammad javad/0000-0001-7576-6658; Khaksari, Mohammad/0000-0003-0770-4281; Zahedi, Mohammad Javad/0000-0002-4580-9562	Neuroscience and Physiology Research Centers of Kerman University of Medical Sciences, Kerman, Iran	The present study was financially supported by the Neuroscience and Physiology Research Centers of Kerman University of Medical Sciences, Kerman, Iran. The authors declare that they have no conflict of interests.	AGUWA CN, 1984, EUR J PHARMACOL, V104, P79, DOI 10.1016/0014-2999(84)90371-6; AMURE BO, 1970, GUT, V11, P641, DOI 10.1136/gut.11.8.641; ANDERS S, 2008, ENDOCRINOLOGY, V149, P4554; Angele MK, 1998, J TRAUMA, V44, P78, DOI 10.1097/00005373-199801000-00007; Anson ML, 1938, J GEN PHYSIOL, V22, P79, DOI 10.1085/jgp.22.1.79; Baron JH, 1997, INFLAMM RES, V46, P260, DOI 10.1007/s000110050184; BLACK HE, 1988, TOXICOL PATHOL, V16, P213, DOI 10.1177/019262338801600214; Blandizzi C, 1999, EUR J PHARMACOL, V373, P71, DOI 10.1016/S0014-2999(99)00212-5; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Bradesi S, 2002, GUT, V50, P349, DOI 10.1136/gut.50.3.349; Bubenik GA, 1998, BIOL SIGNAL RECEPT, V7, P195; Campbell-Thompson M, 2001, J ENDOCRINOL, V171, P65, DOI 10.1677/joe.0.1710065; Chen G, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/93431; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Drago F, 1999, LIFE SCI, V64, P2341, DOI 10.1016/S0024-3205(99)00187-3; Du DS, 2010, LIFE SCI, V86, P30, DOI 10.1016/j.lfs.2009.11.001; Esplugues JV, 1996, P NATL ACAD SCI USA, V93, P14839, DOI 10.1073/pnas.93.25.14839; Girma K, 1997, SCAND J GASTROENTERO, V32, P669, DOI 10.3109/00365529708996516; GIROUD M, 1991, INT J EPIDEMIOL, V20, P892, DOI 10.1093/ije/20.4.892; Gritti I, 2000, PHARMACOL RES, V41, P265, DOI 10.1006/phrs.1999.0586; Gunel O, 2003, INFLAMMATION, V27, P351; Harbrecht BG, 2002, J TRAUMA, V53, P517, DOI 10.1097/00005373-200209000-00020; Hogan AM, 2009, INT J COLORECTAL DIS, V24, P1367, DOI 10.1007/s00384-009-0785-0; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; HUNT JN, 1958, J OBSTET GYNAECOL, V65, P78; Isomoto H, 2007, SCAND J GASTROENTERO, V42, P410, DOI 10.1080/00365520600931469; JACKSON MD, 1989, ARCH PHYS MED REHAB, V70, P553; Kao CH, 1998, AM J GASTROENTEROL, V93, P1108; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kawakubo Keishi, 2002, Nihon Rinsho, V60, P1573; KITAGAWA H, 1979, GASTROENTEROLOGY, V77, P298; Kotani T, 2007, LIFE SCI, V80, P1984, DOI 10.1016/j.lfs.2007.02.041; Lehmann FS, 1998, EUR J CLIN INVEST, V28, P511; LINDH A, 1992, ACTA ANAESTH SCAND, V36, P119, DOI 10.1111/j.1399-6576.1992.tb03436.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mathias JR, 1998, DIGEST DIS, V16, P3, DOI 10.1159/000016844; MODLIN IM, 1990, SCAND J GASTROENTERO, V25, P865; Moore FA, 1999, POSTINJURY MULTIPLE, P1427; NORTON JA, 1988, J NEUROSURG, V68, P62, DOI 10.3171/jns.1988.68.1.0062; OHJA KN, 1950, BRIT J PHARMACOL, V5, P389; OKUMURA T, 1990, BIOCHEM BIOPH RES CO, V167, P956, DOI 10.1016/0006-291X(90)90616-U; OLSON ME, 1986, CAN VET J, V27, P523; OLUWOLE F S, 1990, African Journal of Medicine and Medical Sciences, V19, P139; PEDOTO MJ, 1995, ARCH PHYS MED REHAB, V76, P871, DOI 10.1016/S0003-9993(95)80555-9; Pfaffl MW, 2003, J STEROID BIOCHEM, V84, P159, DOI 10.1016/S0960-0760(03)00025-6; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; PIYACHATURAWAT P, 1983, RES COMMUN CHEM PATH, V42, P81; Rafsanjani FN, 2007, PHYTOTHER RES, V21, P1036, DOI 10.1002/ptr.2203; Rotstein OD, 2003, J TRAUMA, V54, pS203, DOI 10.1097/01.TA.0000064512.62949.92; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Samuels TL, 2009, OTOLARYNG HEAD NECK, V141, P559, DOI 10.1016/j.otohns.2009.08.022; SAXE JM, 1994, J TRAUMA, V37, P581, DOI 10.1097/00005373-199410000-00010; SAYEGH M, 1995, GUT, V36, P558, DOI 10.1136/gut.36.4.558; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; SHAN J, 1994, AM J PHYSIOL, V266, pH967, DOI 10.1152/ajpheart.1994.266.3.H967; Shimozawa N, 2007, AM J PHYSIOL-GASTR L, V292, pG615, DOI 10.1152/ajpgi.00117.2006; Smith A, 2008, ENDOCRINOLOGY, V149, P4554, DOI 10.1210/en.2007-1597; SOLTANI Z, 2010, IRAN J ENDOCRINOL ME, V10, P629; Wichmann MW, 1996, CYTOKINE, V8, P853, DOI 10.1006/cyto.1996.0114; Yang W, 2008, CHINESE MED J-PEKING, V121, P268, DOI 10.1097/00029330-200802010-00018; Yang Xia, 2006, Shengli Xuebao, V58, P275; Zhou ML, 2007, J SURG RES, V137, P103, DOI 10.1016/j.jss.2006.06.023	62	6	6	0	3	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	MAY-JUN	2011	14	3					231	239					9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	768XE	WOS:000290971300006					2022-02-06	
J	Shackford, SR				Shackford, Steven R.			Prehospital Fluid Resuscitation of Known or Suspected Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	US Army-Institute-of-Surgical-Research Prehospital Fluid Conference	JAN 08-09, 2010	Ft Worth, TX	USArmy Inst Surg Res & Casual Care Res, US Army Med Res Mat Command			7.5-PERCENT SODIUM-CHLORIDE; HYPERTONIC SALINE RESUSCITATION; INTRACRANIAL HYPERTENSION; MULTICENTER TRIAL; HEAD-INJURY; MANNITOL; DEXTRAN; HYPOTENSION; PRESSURE; THERAPY		[Shackford, Steven R.] Scripps Mercy Med Ctr, Dept Surg, Div Trauma, San Diego, CA USA		Shackford, SR (corresponding author), Trauma Team Med Grp, 550 Washington St,Suite 641, San Diego, CA 92103 USA.	shackford.steven@scrippshealth.org					Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cotton BA, 2009, J TRAUMA, V67, P389, DOI 10.1097/TA.0b013e3181a8b26f; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Holcomb JB, 2003, J TRAUMA, V54, pS46, DOI 10.1097/01.TA.0000051936.91915.A2; Luh EH, 1996, J SURG RES, V60, P122, DOI 10.1006/jsre.1996.0020; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; SHACKFORD SR, 1983, SURGERY, V94, P41; SHACKFORD SR, 1987, SURG GYNECOL OBSTET, V164, P127; Tyagi R, 2007, NEUROSURG REV, V30, P277, DOI 10.1007/s10143-007-0091-7; VASSAR MJ, 1990, ARCH SURG-CHICAGO, V125, P1309; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, J TRAUMA, V34, P622, DOI 10.1097/00005373-199305000-00003; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Vincent JL, 2005, CRIT CARE MED, V33, P1392, DOI 10.1097/01.CCM.0000166890.93559.2D; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O	25	6	6	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2011	70	5		S			S32	S33		10.1097/TA.0b013e31821a5858			2	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	762RU	WOS:000290499200012	21841567				2022-02-06	
J	Zaidi, HA; Pendleton, C; Cohen-Gadol, AA; Quinones-Hinojosa, A				Zaidi, Hasan A.; Pendleton, Courtney; Cohen-Gadol, Aaron A.; Quinones-Hinojosa, Alfredo			Harvey Cushing's Repair of a Dural Defect After a Traumatic Brain Injury: Novel Use of a Fat Graft	WORLD NEUROSURGERY			English	Article						Dural repair; Fat; Graft; Harvey Cushing	MESENCHYMAL STEM-CELLS; CEREBROSPINAL-FLUID RHINORRHEA; ADIPOSE-TISSUE; STROMAL CELLS; LEAKS	OBJECTIVE: A review of Harvey Cushing's surgical cases at Johns Hopkins Hospital revealed new information about his early work with the use of fat grafts to close dural defects. METHODS: The Johns Hopkins Hospital surgical records from 1896 to 1912 were reviewed. A single case in which Cushing used an autologous fat graft to repair a dural defect in 1912 after a traumatic brain injury was selected for further study. RESULTS: An 18-year-old white female patient presented with recurring seizures in her sleep approximately 12 years after a traumatic brain injury. A depressed skull fracture as a result of this injury was explored by Cushing, and a dural defect was found. Fat was harvested from the thigh of the patient and was sutured in layers to cover the defect. Cushing noted that this was the first of its kind of operation and "probably of very little use." The patient was discharged within 2 weeks after the operation despite recurrence of her seizure episodes. CONCLUSIONS: Despite its questionable functional success, we report herein a previously unpublished operative case by Harvey Cushing's in which an autologous fat graft was used to close a traumatic wound resulting in a dural defect. This report predates currently known published reports of the use of fat to seal dural defects. Cushing recognized that a factor found in fat tissue may aid in wound healing. Contemporary studies indicate the presence of mesenchymal stem cells in fat tissue may be responsible for the accelerated healing and reduced incidence of cerebral spinal fluid leaks after cranial surgery.	[Zaidi, Hasan A.; Pendleton, Courtney; Quinones-Hinojosa, Alfredo] Johns Hopkins Sch Med, Dept Neurosurg & Oncol, Baltimore, MD USA; [Cohen-Gadol, Aaron A.] Indiana Univ, Dept Neurosurg, Indianapolis, IN 46204 USA; [Cohen-Gadol, Aaron A.] Goodman Campbell Brain & Spine, Clarian Neurosci Inst, Indianapolis, IN USA		Quinones-Hinojosa, A (corresponding author), Johns Hopkins Sch Med, Dept Neurosurg & Oncol, Baltimore, MD USA.	aquinon2@jhmi.edu		Cohen-Gadol, Aaron/0000-0002-4946-1524			AARABI B, 1992, Ear Nose and Throat Journal, V71, P300; ADAMS CBT, 1995, BRIT J NEUROSURG, V9, P201, DOI 10.1080/02688699550041557; BECKHARDT RN, 1991, OTOLARYNG HEAD NECK, V104, P425, DOI 10.1177/019459989110400402; BROECKAERT TJ, 1919, B ACAD ROY MED BELG, V28, P440; Cosgrove GR, 2007, J NEUROSURG, V106, P52, DOI 10.3171/jns.2007.106.1.52; DALY D T, 1992, Ear Nose and Throat Journal, V71, P311; Dandy WE, 1926, ARCH SURG-CHICAGO, V12, P949, DOI 10.1001/archsurg.1926.01130050003001; Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270; FERGUSON BJ, 1986, LARYNGOSCOPE, V96, P635; Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681; Har-El G, 1999, ANN OTO RHINOL LARYN, V108, P323, DOI 10.1177/000348949910800401; Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X; Kosztowski T, 2009, EXPERT REV ANTICANC, V9, P597, DOI 10.1586/ERA.09.22; KUO JS, 2009, J NEUROSURG     1204; Lanza DC, 1996, LARYNGOSCOPE, V106, P1119, DOI 10.1097/00005537-199609000-00015; Liu YN, 2007, STEM CELLS DEV, V16, P695, DOI 10.1089/scd.2006.0118; NEUBER GA, 1993, VERH DTSCH GES CHIR, V22, P66; Nistor RF, 1997, SKULL BASE SURG, V7, P23, DOI 10.1055/s-2008-1058620; Nuss DW, 1995, OTOLARYNGOL HEAD NEC, V8, P79; Nutik S, 1995, SURG NEUROL, V44, P192, DOI 10.1016/0090-3019(95)90401-8; Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234; Savva A, 2003, LARYNGOSCOPE, V113, P50, DOI 10.1097/00005537-200301000-00010; Sommer B, 2000, DERMATOL SURG, V26, P1159, DOI 10.1046/j.1524-4725.2000.t01-1-00278.x; Thompson S., 1899, CEREBROSPINAL FLUID; WOLFF E, 1914, WCHNSCHR, V16, P899; ZLAB M K, 1992, Ear Nose and Throat Journal, V71, P314	26	6	6	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750			WORLD NEUROSURG	World Neurosurg.	MAY-JUN	2011	75	5-6					696	699		10.1016/j.wneu.2010.11.014			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	792VX	WOS:000292779600033	21704938				2022-02-06	
J	D'Aleo, G; Rifici, C; Kofler, M; Sessa, E; Saltuari, L; Bramanti, P				D'Aleo, Giangaetano; Rifici, Carmela; Kofler, Markus; Sessa, Edoardo; Saltuari, Leopold; Bramanti, Placido			Seizure after intrathecal baclofen bolus in a multiple sclerosis patient treated with oxcarbazepine	NEUROLOGICAL SCIENCES			English	Article						Epileptic seizure; Intrathecal baclofen; Multiple sclerosis	STATUS EPILEPTICUS; OLANZAPINE	Epileptic seizures associated with intrathecal baclofen (ITB) application have been observed in patients with traumatic brain injury. A higher incidence of seizures has also been reported in patients with multiple sclerosis (MS) receiving ITB. To our knowledge, no case of a first epileptic seizure has been reported in the context of ITB bolus testing in MS. We report a 41-year-old female patient with primary progressive MS receiving olanzapine and oxcarbazepine for psychotic disorder. Five years prior she began to develop severe spastic quadriparesis, rendering her a candidate for ITB treatment. After ITB test bolus application, however, she experienced a first epileptic seizure. Our observation indicates that ITB may trigger seizures in patients with MS. The observed seizure occurred during ITB bolus testing despite antiepileptic co-medication, which concurs with previous reports suggesting that rapid changes in the dose of ITB may carry a higher risk of seizure induction.	[D'Aleo, Giangaetano; Rifici, Carmela; Sessa, Edoardo; Bramanti, Placido] IRCCS, Ctr Neurolesi Bonino Pulejo, I-98124 Messina, Italy; [Kofler, Markus; Saltuari, Leopold] Hosp Hochzirl, Dept Neurol, A-6170 Zirl, Austria		D'Aleo, G (corresponding author), IRCCS, Ctr Neurolesi Bonino Pulejo, Via Prov Palermo, I-98124 Messina, Italy.	gngdaleo@alice.it	Kofler, Markus/P-5585-2019; Rifici, Carmela/ABH-4398-2020; Sessa, Edoardo/AAB-8544-2020; Bramanti, Placido/K-5117-2016	Kofler, Markus/0000-0002-2962-0903			Camacho A, 2005, CLIN NEUROPHARMACOL, V28, P145, DOI 10.1097/01.wnf.0000165351.10841.fa; DRALLE D, 1989, LANCET, V2, P916; KOFLER M, 1994, NEUROLOGY, V44, P25, DOI 10.1212/WNL.44.1.25; MOTT DD, 1989, J PHARMACOL EXP THER, V249, P721; Nyquist PA, 2001, MAYO CLIN PROC, V76, P983, DOI 10.4065/76.10.983; SALTUARI L, 1992, LANCET, V339, P373, DOI 10.1016/0140-6736(92)91697-7; Schuele SU, 2006, NEUROLOGY, V66, P784; Schuele SU, 2005, NEUROLOGY, V64, P1086, DOI 10.1212/01.WNL.0000154639.35941.21; Spyridi S, 2009, INT J CLIN PHARM TH, V47, P120	9	6	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1590-1874			NEUROL SCI	Neurol. Sci.	APR	2011	32	2					293	295		10.1007/s10072-010-0364-8			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	735EY	WOS:000288397400013	20607336				2022-02-06	
J	Farahvar, A; Huang, JH; Papadakos, PJ				Farahvar, Arash; Huang, Jason H.; Papadakos, Peter J.			Intracranial monitoring in traumatic brain injury	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						brain monitoring; intracranial pressure; neurocritical care; traumatic brain injury	SEVERE HEAD-INJURY; TISSUE OXYGENATION; PRESSURE; HYPERTENSION; MANAGEMENT; OUTCOMES; GUIDELINES; MORTALITY; CHILDREN; ADULTS	Purpose of review This review focuses on the role of various intracranial monitoring technologies in the diagnosis and therapy of traumatic brain injury injury. Recent findings There exist many controversial points as to the utility of different intracranial monitoring with regard to improvement of outcomes from severe traumatic brain injury. Most recent studies are confirming that the use of multiple modalities in the neurological ICU setting may offer promising results. Summary Increased adherence to guideline-based and protocol-driven neurointensive care utilizing multimodality in monitoring technology for patients with severe traumatic brain injury is likely to give clinicians increased insight into the elusive mechanisms underlying the complex pathophysiology of this disease process and may further improve outcomes in this patient population.	[Farahvar, Arash; Huang, Jason H.; Papadakos, Peter J.] Univ Rochester, Dept Neurosurg, Med Ctr, Rochester, NY 14534 USA; [Papadakos, Peter J.] Univ Rochester, Dept Surg, Med Ctr, Rochester, NY 14534 USA; [Papadakos, Peter J.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14534 USA		Farahvar, A (corresponding author), Univ Rochester, Dept Neurosurg, Med Ctr, 601 Elmwood Ave,Box 670, Rochester, NY 14534 USA.	Arash_Farahvar@URMC.Rochester.edu	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS45; Akopian G, 2007, AM SURGEON, V73, P447; Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brown JB, 2010, J TRAUMA, V69, P263, DOI 10.1097/TA.0b013e3181e5d72e; Carrera E, 2010, J NEUROTRAUM, V27, P317, DOI 10.1089/neu.2009.0951; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Citerio G, 2008, INTENS CARE MED, V34, P1173, DOI 10.1007/s00134-008-1080-1; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Diedler J, 2010, J NEUROL SCI, V295, P16, DOI 10.1016/j.jns.2010.05.027; Diedler J, 2010, NEUROCRIT CARE, V12, P313, DOI 10.1007/s12028-010-9350-5; Drummond JC, 2010, J NEUROSURG ANESTH, V22, P336, DOI 10.1097/ANA.0b013e3181e4b7e3; EXO J, 2010, PEDIAT CRIT CARE MED; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Figaji AA, 2010, NEUROCRIT CARE, V12, P430, DOI 10.1007/s12028-010-9344-3; Firsching RJ, 2010, CENT EUR NEUROSURG, V71, P134, DOI 10.1055/s-0030-1248256; Fletcher JJ, 2010, NEUROCRIT CARE, V13, P47, DOI 10.1007/s12028-010-9345-2; Geeraerts T, 2010, Ann Fr Anesth Reanim, V29, pe171, DOI 10.1016/j.annfar.2010.06.006; Griesdale DEG, 2010, CAN J NEUROL SCI, V37, P43, DOI 10.1017/S031716710000963X; Guerguerian AM, 2009, CURR OPIN PEDIATR, V21, P737, DOI 10.1097/MOP.0b013e328332d11c; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hu X, 2010, IEEE T BIO-MED ENG, V57, P1070, DOI 10.1109/TBME.2009.2037607; Hu X, 2010, PHYSIOL MEAS, V31, P679, DOI 10.1088/0967-3334/31/5/006; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Kahraman S, 2010, J NEUROSURG ANESTH, V22, P296, DOI 10.1097/ANA.0b013e3181e25fc3; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Lakshmanan R, 2010, NEUROCRIT CARE, V12, P324, DOI 10.1007/s12028-010-9342-5; Lane JL, 2000, PEDIATRICS, V105, P973; Liew B S, 2009, Med J Malaysia, V64, P280; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AI, 2008, J TRAUMA, V65, P966, DOI 10.1097/TA.0b013e318184ee7b; Madikians A, 2009, CURR TREAT OPTION NE, V11, P393, DOI 10.1007/s11940-009-0044-2; Maloney-Wilensky E, 2010, CHILD NERV SYST, V26, P419, DOI 10.1007/s00381-009-1037-x; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; MEHTA A, 2010, DEV NEUROSCI; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P58; Oddo M, 2010, NEUROCRIT CARE, V12, P10, DOI 10.1007/s12028-009-9280-2; Olivecrona M, 2010, J NEUROSURG, V112, P1113, DOI 10.3171/2009.8.JNS09636; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Procaccio F, 2000, J Neurosurg Sci, V44, P1; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; ROSENTHAL G, 2010, J NEUROSURG; Sample PL, 2004, BRAIN INJURY, V18, P1177, DOI 10.1080/02699050410001719925; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stocchetti N, 2009, ANESTH ANALG, V109, P1726, DOI 10.1213/ANE.0b013e3181bdca25; Stover JF, 2006, CRIT CARE MED, V34, P1582, DOI 10.1097/01.CCM.0000216697.37348.FC; STUART GG, 1983, J NEUROSURG, V59, P601, DOI 10.3171/jns.1983.59.4.0601; Swanson EW, 2010, NEUROSURGERY, V66, P925, DOI 10.1227/01.NEU.0000368543.59446.A4; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Zuluaga MT, 2010, PEDIATR CRIT CARE ME, V11, P514, DOI 10.1097/PCC.0b013e3181c51cf1; Zweifel C, 2010, STROKE, V41, P1963, DOI 10.1161/STROKEAHA.109.577320	55	6	7	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	APR	2011	24	2					209	213		10.1097/ACO.0b013e328344016d			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	732AS	WOS:000288154100015	21293266				2022-02-06	
J	Hannold, EM; Freytes, IM; Uphold, CR				Hannold, Elizabeth M.; Freytes, I. Magaly; Uphold, Constance R.			Unmet Health Services Needs Experienced by Puerto Rican OEF/OIF Veterans and Families Post Deployment	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; MILITARY SERVICE; IRAQ; AFGHANISTAN; COMBAT; CARE; POLYTRAUMA; BARRIERS; SUPPORT; MEMBERS	Objective: This study examined perceptions of unmet health services needs among native Puerto Rican Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF) Veterans and family members (FMs) post deployment. Methods: Investigators used qualitative methods to collect and analyze data from 8 veterans and 8 FMs (N = 16). All participants were native-born residents of Puerto Rico. Investigators conducted single, in-depth interviews with participants. They conducted 13/16 interviews in Spanish. Puerto Rican Spanish speakers transcribed audio-taped interviews verbatim and then translated them into English for coding. Results: Veterans' unmet needs included psychological evaluations, mental health services, support groups, medical evaluations, and pain treatment. Denial and stigma emerged as factors that deter Veterans from seeking mental health treatment. The need for family support groups also emerged from the data. Conclusions: Native Puerto Rican Veterans and FMs identified several gaps in health services. Findings suggest the need for studies comparing the health services needs of Puerto Rican versus mainland OEF/OIF Veterans and families.	[Hannold, Elizabeth M.; Freytes, I. Magaly; Uphold, Constance R.] NF SG VA Med Ctr, Rehabil Outcomes Res Ctr, REAP, Gainesville, FL 32608 USA; [Uphold, Constance R.] VA Med Ctr 182, GRECC, Gainesville, FL 32608 USA; [Uphold, Constance R.] Univ Florida, Coll Med, Dept Aging & Geriatr, Gainesville, FL 32610 USA		Hannold, EM (corresponding author), NF SG VA Med Ctr, Rehabil Outcomes Res Ctr, REAP, 151-B,1601 SW Archer Rd, Gainesville, FL 32608 USA.			Freytes, Ivette Magaly/0000-0002-5928-3098	Disabled American Veterans/Nurses Organization of Veterans Affairs (NOVA) Foundation; VA Rehabilitation Research and Disability (RR&D) Disability Supplement [O3795U]	We thank our research participants and Meggan Jordan, MA, Doctoral Candidate, for their assistance with this manuscript. We also thank Eric R. Litt, GIS Analyst. The Disabled American Veterans/Nurses Organization of Veterans Affairs (NOVA) Foundation provided grant support for this research (No grant number; C. Uphold, Principal Investigator; M. Rittman, Co-Principal Investigator; February 1, 2006 to January 31,2007). Dr. Hannold's work was supported through a VA Rehabilitation Research and Disability (RR&D) Disability Supplement (O3795U).	Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; ANGAPAK NN, 2005, REPORT ADVISORY COMM, P1; Barrio C, 2008, COMMUNITY MENT HLT J, V44, P57, DOI 10.1007/s10597-007-9112-9; *BOARD HLTH SEL PO, 2010, COMM IN ASS READJ NE, P1; Brown ND, 2008, AAOHN J, V56, P343, DOI 10.3928/08910162-20080801-01; *BUR USC, 2008, POP EST PUERT RIC CO; Charmaz Kathy, 2006, CONSTRUCTING GROUND; CHRISTENSEN EW, 1977, PERS GUID J, V55, P412, DOI 10.1002/j.2164-4918.1977.tb05277.x; Clark ME, 2009, PAIN MED, V10, P456, DOI 10.1111/j.1526-4637.2009.00589.x; Collins RC, 2008, J CLIN PSYCHOL, V64, P993, DOI 10.1002/jclp.20515; Daniron-Rodriguez J, 2004, MIL MED, V169, P243, DOI 10.7205/MILMED.169.3.243; *DEF UDO, 2009, DEM 2009 PROF MIL CO, P188; Eaton KM, 2008, MIL MED, V173, P1051, DOI 10.7205/MILMED.173.11.1051; Gifford B, 2005, ARMED FORCES SOC, V31, P201, DOI 10.1177/0095327X0503100203; Helman C., 2007, CULTURE HLTH ILLNESS; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Johnson SJ, 2007, PAIN TREATMENT TOPIC, V6, P1; *LAB USDO, 2009, PUERT RIC EC GLANC; Lehman C, 2008, REHABIL NURS, V33, P192, DOI 10.1002/j.2048-7940.2008.tb00227.x; Lincoln A, 2008, J CLIN PSYCHOL, V64, P984, DOI 10.1002/jclp.20520; McCracken G., 1988, LONG INTERVIEW; McNulty PAF, 2005, MIL MED, V170, P530, DOI 10.7205/MILMED.170.6.530; Miles MB, 1994, EXPANDED SOURCEBOOK; Patton M.Q., 1990, QUALITATIVE EVALUATI; Perez GM, 2006, IDENTITIES-GLOB STUD, V13, P53, DOI 10.1080/10702890500534346; Sammons MT, 2008, J CLIN PSYCHOL, V64, P921, DOI 10.1002/jclp.20519; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Sayer NA, 2009, PSYCHIATRY, V72, P238, DOI 10.1521/psyc.2009.72.3.238; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; STRAUSS AL, 1998, HDB QUALITATIVE RES, P1; Tanielian T., 2008, INVISIBLE WOUNDS WAR; *VET HLTH ADM, 2009, VHA HDB 1010 01 CAR; Wehman P, 2009, J REHABIL RES DEV, V46, P909, DOI 10.1682/JRRD.2008.08.0105	36	6	6	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	APR	2011	176	4					381	388		10.7205/MILMED-D-10-00334			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825BO	WOS:000295246100007	21539159	Bronze			2022-02-06	
J	Hicks, EJ; Larkins, BM; Purdy, SC				Hicks, Emma J.; Larkins, Brigette M.; Purdy, Suzanne C.			Fatigue management by speech-language pathologists for adults with traumatic brain injury	INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article						Traumatic brain injury; fatigue; speech language therapy; communication; intervention; interview; fatigue-management-focused	MULTIPLE-SCLEROSIS; OBJECTIVE MEASURES; SLEEP DISTURBANCE; INSOMNIA; SCALE; REHABILITATION; RELIABILITY; ATTENTION; AWARENESS; SEVERITY	This study uses a qualitative approach to examine common techniques used by speech-language pathologists (SLPs) to manage fatigue in communication intervention following traumatic brain injury (TBI). Thirteen SLPs from New Zealand hospital and rehabilitation services completed semi-structured interviews in which they discussed their current management strategies. A number of management-related themes recurred throughout the interviews, highlighting the basis of fatigue-management-focused (FMF) communication intervention. The four fatigue-related themes were: intervention structure, client and family strategies, monitoring by both the client and therapist, and lifestyle and daily activities. From these four themes, a model of current SLP practice was developed for clients with TBI. This model will provide the basis for future studies evaluating the effectiveness of FMF communication intervention.	[Purdy, Suzanne C.] Univ Auckland, Dept Psychol, Discipline Speech Sci, Auckland, New Zealand; [Larkins, Brigette M.] Univ Queensland, Brisbane, Qld, Australia		Purdy, SC (corresponding author), Univ Auckland, Dept Psychol, Discipline Speech Sci, Tamaki Campus,Private Bag 92019, Auckland, New Zealand.	sc.purdy@auckland.ac.nz	Purdy, Suzanne C/F-2050-2010	Purdy, Suzanne C/0000-0001-9978-8173			Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chan A., 1999, INT J MS CARE, V1, P13; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; EVANS RL, 1988, STROKE, V19, P1243, DOI 10.1161/01.STR.19.10.1243; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; FISK JD, 1994, CAN J NEUROL SCI, V21, P9, DOI 10.1017/S0317167100048691; Gourgey AF, 1998, INSTR SCI, V26, P81, DOI 10.1023/A:1003092414893; Gutstein HB, 2001, CANCER-AM CANCER SOC, V92, P1678, DOI 10.1002/1097-0142(20010915)92:6+<1678::AID-CNCR1496>3.0.CO;2-R; Hicks E., 2007, COCHRANE DB SYST REV, V3, P1; Jay G W, 1996, J Insur Med, V27, P262; Khateb A, 2005, EUR NEUROL, V54, P39, DOI 10.1159/000087718; Krupp LB, 1996, CURR OPIN NEUROL, V9, P456, DOI 10.1097/00019052-199612000-00011; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Lucas SE, 2005, AUSTR OCCUPATIONAL T, V52, P160, DOI DOI 10.1111/J.1440-1630.2005.00485.X; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Man DWK, 2002, BRAIN INJURY, V16, P1025, DOI 10.1080/0269905021000010087; Mock V, 2001, CANCER-AM CANCER SOC, V92, P1699, DOI 10.1002/1097-0142(20010915)92:6+<1699::AID-CNCR1500>3.0.CO;2-9; Musiek Frank E, 2004, J Am Acad Audiol, V15, P117, DOI 10.3766/jaaa.15.2.3; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Rieger PT, 2001, CANCER-AM CANCER SOC, V92, P1733; Seyone C., 2006, SLEEP SLEEP DISORDER, P210; SIMPSON G, 2004, BRAIN IMPAIR, V5, DOI DOI 10.1375/BRIM.5.1.67.35401; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Swain MG, 2000, CLIN SCI, V99, P1, DOI 10.1042/CS19990372; Wedcliffe T, 2001, S Afr J Commun Disord, V48, P77; Zafonte RD, 1996, NEUROREHABILITATION, V7, P189, DOI 10.3233/NRE-1996-7304; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	48	6	6	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1754-9507	1754-9515		INT J SPEECH-LANG PA	Int. J. Speech-Lang. Pathol.	APR	2011	13	2					145	155		10.3109/17549507.2011.485329			11	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	738GL	WOS:000288628200005	20586529				2022-02-06	
J	Intiso, D; Lombardi, T; Grimaldi, G; Iarossi, A; Tolfa, V; Russo, M; Di Rienzo, F				Intiso, Domenico; Lombardi, Teresa; Grimaldi, Giuseppina; Iarossi, Andrea; Tolfa, Viaurizio; Russo, Mario; Di Rienzo, Filomena			Long-term outcome and health status in decompressive craniectomized patients with intractable intracranial pressure after severe brain injury	BRAIN INJURY			English	Article						Decompressive craniectomy; traumatic brain injury; outcome; rehabilitation; health status	ANEURYSMAL SUBARACHNOID HEMORRHAGE; SEVERE HEAD-INJURY; SURGICAL DECOMPRESSION; CEREBRAL EDEMA; HEMICRANIECTOMY; MANAGEMENT; HYPERTENSION; MULTICENTER; EXPERIENCE	Objective: Decompressive craniectomy (DC) in severe traumatic brain injury (TBI) remains a controversial therapeutic strategy. The long-term functional recovery and health status in a sample of decompressive craniectomized TBI are reported. Methods: Patients with TBI who underwent DC were retrospectively investigated. Patients with cerebral haemorrhage (CH) and DC were considered as control group. In all survival patients admitted to a neuro-rehabilitation setting, the modified Rankin (mRS), Glasgow Outcome scale (GOS) and Barthel Scales (BS) were administered at admission, discharge, 1 year and follow-up. The quality-of-life was evaluated with the SF-36 questionnaire at follow-up (41.1 +/- 16.6 months). Results: Seventy (33 F, 37 M, mean age = 46.8, SD = 18.8) patients were enrolled: 46 (20 F, 26 M) subjects with TBI and 24 (13 F, 11 M) with CH. After surgery, 11 (23.9%) and 10 (41.6%) subjects in the TBI and CH group, respectively, died. The mean Barthel scores were 4.0 (SD = 5.9), 60.9 (SD = 37.5), 63.7 (SD = 35.1) and 67.3 (SD = 38.2) (p < 0.001) and median GOS was 3, 4, 4 and 4 at admission, discharge, 1 year and follow-up, respectively, in TBI patients. Seventeen (36.9%) patients with TBI and four (16.6%) with CH made a full recovery. The SF-36 questionnaire showed significant abnormalities in all domains of health status in both groups. Conclusion: Craniectomized patients with TBI achieved good long-term outcome, although they experienced significant difficulties in health status.	[Intiso, Domenico; Iarossi, Andrea; Tolfa, Viaurizio; Russo, Mario; Di Rienzo, Filomena] Hosp Sci Inst Casa Sollievo della Sofferenza, Neurorehabil Unit, I-71013 San Giovanni Rotondo, FG, Italy; [Lombardi, Teresa; Grimaldi, Giuseppina] Univ Foggia, Rehabil Med Unit, Foggia, Italy		Intiso, D (corresponding author), Hosp Sci Inst Casa Sollievo della Sofferenza, Neurorehabil Unit, Viale Cappuccini 1, I-71013 San Giovanni Rotondo, FG, Italy.	d.intiso@operapadrepio.it	Intiso, Domenico/H-2414-2016	Intiso, Domenico/0000-0002-6564-5956; Di Rienzo, Filomena/0000-0001-8297-9002			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Apolone G., 1997, QUESTIONARIO STATO S; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Buschmann U, 2007, ACTA NEUROCHIR, V149, P59, DOI 10.1007/s00701-006-1069-x; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; D'Ambrosio AL, 2005, NEUROSURGERY, V56, P12, DOI 10.1227/01.NEU.0000144820.38439.63; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Lemcke J, 2010, ACTA NEUROCHIR SUPPL, V106, P231, DOI 10.1007/978-3-211-98811-4_43; MAHONEY F I, 1965, Md State Med J, V14, P61; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Otani N, 2008, CEREBROVASC DIS, V26, P612, DOI 10.1159/000165115; Peng R, 1998, AM SURGEON, V64, P950; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; SAHUQUILLO J, 2009, COCHRANE DB SYST REV, V1, P1; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Ziai WC, 2003, J NEUROSURG ANESTH, V15, P25, DOI 10.1097/00008506-200301000-00005	29	6	6	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2011	25	4					379	386		10.3109/02699052.2011.558046			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	739RL	WOS:000288735600007	21323416				2022-02-06	
J	LaRoche, SM				LaRoche, Suzette M.			Seizures and Encephalopathy	SEMINARS IN NEUROLOGY			English	Article						Seizure; encephalopathy; nonconvulsive status epilepticus; electroencephalogram; EEG monitoring	NONCONVULSIVE STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; ELECTROGRAPHIC SEIZURES; ABSENCE STATUS; INTRACEREBRAL HEMORRHAGE; CLINICAL-FEATURES; DISCHARGES; ENCEPHALITIS	There is a complex relationship between seizures and encephalopathy. Seizures alone without any underlying neurologic or medical illness can be the sole cause of encephalopathy. Often these patients have a history of epilepsy, in which case accurate diagnosis is straightforward. Acute neurologic conditions often contribute to encephalopathy, but also increase the risk of seizures-many of which are subclinical. In these scenarios, it can be difficult to determine whether the encephalopathy is caused by seizures, the underlying neurologic disorder, or both. In addition, systemic diseases are commonly associated with encephalopathy; they may also increase the risk of seizures, although less commonly than acute neurologic conditions, and therefore may go unrecognized. This review will examine common and uncommon causes of seizures in encephalopathic patients, typical clinical presentations as well as diagnosis and treatment.	Emory Univ, Sch Med, Atlanta, GA 30322 USA		LaRoche, SM (corresponding author), Emory Univ, Sch Med, 1365 Clifton Rd NE, Atlanta, GA 30322 USA.	slaroch@emory.org					Agathonikou A, 1998, EPILEPSIA, V39, P1265, DOI 10.1111/j.1528-1157.1998.tb01324.x; ANDERMANN F, 1972, EPILEPSIA, V13, P177, DOI 10.1111/j.1528-1157.1972.tb04565.x; BALLENGER CE, 1983, NEUROLOGY, V33, P1545; BICKFORD RG, 1955, J CLIN INVEST, V34, P790, DOI 10.1172/JCI103134; BOLTON CF, 1993, ANN NEUROL, V33, P94, DOI 10.1002/ana.410330115; Carrera E, 2008, ARCH NEUROL-CHICAGO, V65, P1612, DOI 10.1001/archneur.65.12.1612; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2006, NEUROCRIT CARE, V4, P103, DOI 10.1385/NCC:4:2:103; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; COCKERELL OC, 1994, J NEUROL NEUROSUR PS, V57, P835, DOI 10.1136/jnnp.57.7.835; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; DeLorenzo RJ, 2009, SEIZURE-EUR J EPILEP, V18, P405, DOI 10.1016/j.seizure.2009.02.005; Drislane FW, 2005, CUR CLIN NEUROL, P245; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Gultekin SH, 2000, BRAIN, V123, P1481, DOI 10.1093/brain/123.7.1481; HANDFORTH A, 1994, EPILEPSIA, V35, P876, DOI 10.1111/j.1528-1157.1994.tb02526.x; Husain AM, 1999, J CLIN NEUROPHYSIOL, V16, P51, DOI 10.1097/00004691-199901000-00005; JORDAN KG, 1995, NEUROL CLIN, V13, P579, DOI 10.1016/S0733-8619(18)30035-5; Kaya D, 2007, EPILEPSY BEHAV, V11, P567, DOI 10.1016/j.yebeh.2007.07.014; Lawn ND, 2003, MAYO CLIN PROC, V78, P1363, DOI 10.4065/78.11.1363; Litt B, 1998, EPILEPSIA, V39, P1194, DOI 10.1111/j.1528-1157.1998.tb01311.x; McKnight K, 2005, NEUROLOGY, V65, P1730, DOI 10.1212/01.wnl.0000187129.66353.13; Meador KJ, 2000, J INT NEUROPSYCH SOC, V6, P731, DOI 10.1017/S1355617700666122; NIEDERMEYER E, 1981, CLIN ELECTROENCEPHAL, V12, P113, DOI 10.1177/155005948101200304; Niedermeyer E, 1965, Epilepsia, V6, P250, DOI 10.1111/j.1528-1157.1965.tb03793.x; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; Pandian JD, 2004, ARCH NEUROL-CHICAGO, V61, P1090, DOI 10.1001/archneur.61.7.1090; PohlmannEden B, 1996, J CLIN NEUROPHYSIOL, V13, P519, DOI 10.1097/00004691-199611000-00007; PRIVITERA M, 1994, EPILEPSY RES, V18, P155, DOI 10.1016/0920-1211(94)90008-6; Servillo G, 2007, INTENS CARE MED, V33, P230, DOI 10.1007/s00134-006-0459-0; Shneker BF, 2003, NEUROLOGY, V61, P1066, DOI 10.1212/01.WNL.0000082653.40257.0B; THOMAS P, 1992, NEUROLOGY, V42, P104, DOI 10.1212/WNL.42.1.104; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; TREIMAN DM, 1984, EPILEPSIA, V25, P653; TREIMAN DM, 1983, STATUS EPILEPTICUS M, P69; Tyler K. L., 2004, HERPES J IHMF, V11, P57; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; Vernino S, 2007, NEUROLOGIST, V13, P140, DOI 10.1097/01.nrl.0000259483.70041.55; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Yemisci M, 2003, SEIZURE-EUR J EPILEP, V12, P465, DOI 10.1016/S1059-1311(02)00351-5; Young GB, 1996, NEUROLOGY, V47, P83	46	6	6	0	1	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	APR	2011	31	2					194	201		10.1055/s-0031-1277987			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	765OH	WOS:000290717400009	21590624				2022-02-06	
J	Solomon, D; Kim, B; Scultetus, A; Arnaud, F; Auker, C; Freilich, D; McCarron, R				Solomon, Daniel; Kim, Bobby; Scultetus, Anke; Arnaud, Francoise; Auker, Charles; Freilich, Daniel; McCarron, Richard			The effect of rFVIIa on pro- and anti-inflamatory cytokines in serum and cerebrospinal fluid in a swine model of traumatic brain injury	CYTOKINE			English	Article						Tumor necrosis factor-alpha; Interleukin-1 beta; Interleukin-10; rFVIIa; TBI	RECOMBINANT-FACTOR-VIIA; ACTIVATED FACTOR-VII; INTERLEUKIN-10; EXPRESSION; COAGULOPATHY; COAGULATION; THERAPY	Traumatic brain injury (TBI) is associated with significant infectious and inflammatory complications. Though increasing evidence suggests that rFVIla administration may be efficacious for the pre-hospital treatment of TBI, the FVIIa-tissue factor complex has beets shown to be immunologically active. To date the cytokine response to rFVIIa administration for the treatment of TBI has not been evaluated. Twenty anesthetized immature Yorkshire swine underwent fluid percussion TBI. At 15 min following injury, animals were randomized to receive either 90 mu g/kg rFVIla (rFVIIa) or nothing. Animals were observed for 6 h and then euthanized. Plasma and cerebrospinal (CSF) samples were collected at 0 min and 360 min. and ELISA analysis of TNF-alpha, IL-1 beta and IL-10 was performed. Survival in both groups was 100%. Baseline cytokine concentrations were not statistically different between rFVIIa and control animals in plasma or CSF. Animals in both groups did not have significant changes in plasma cytokine concentrations following TBI. Control animals did not demonstrate significant changes from baseline of CSF cytokine concentrations following TBI. The administration of rFVIla however, resulted in significant increases in CSF TNF-alpha concentration (232.0 pg/ml +/- 75.9 vs 36.4 pg/ml +/- 10.4, p = 0.036) and IL-10 concentration (10.7 pg/ml +/- 0.6 vs 8.8 pg/ml +/- 0.1, p = 0.015). IL-10 concentrations were not significantly changed over the experimental time course. These results suggest that rEVIIa administration for the treatment of TBI is not immunologically inert, and is associated with increased CSF concentrations of TNF-alpha and IL-10. (C) 2010 Elsevier Ltd. All rights reserved.	[Solomon, Daniel; Kim, Bobby; Scultetus, Anke; Arnaud, Francoise; Auker, Charles; Freilich, Daniel; McCarron, Richard] USN, NeuroTrauma Dept, Operat & Undersea Med Directorate, Med Res Ctr, Silver Spring, MD 20910 USA; [Solomon, Daniel] Yale Univ, Sch Med, Sect Trauma Crit Care & Surg Emergencies, New Haven, CT 06520 USA; [Scultetus, Anke; Auker, Charles; McCarron, Richard] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Solomon, D (corresponding author), USN, NeuroTrauma Dept, Operat & Undersea Med Directorate, Med Res Ctr, 503 Robert Grant Ave,2N81, Silver Spring, MD 20910 USA.	D.Solomon@Yale.edu			 [202236N.M04426.826.A0241]	This work was supported and funded by work unit number 202236N.M04426.826.A0241.	Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; de Jonge E, 2003, CLIN DIAGN LAB IMMUN, V10, P495, DOI 10.1128/CDLI.10.3.495-497.2003; De Pont ACJM, 2004, J THROMB HAEMOST, V2, P65, DOI 10.1111/j.1538-7836.2004.00526.x; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Muth H, 2005, THROMB HAEMOSTASIS, V94, P1028, DOI 10.1160/TH05-01-0002; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Spinella PC, 2008, J TRAUMA, V64, P286, DOI 10.1097/TA.0b013e318162759f; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Zaaroor M, 2008, ACTA NEUROCHIR, V150, P663, DOI 10.1007/s00701-008-1593-y; Zhang J, 2008, EXP NEUROL, V210, P645, DOI 10.1016/j.expneurol.2007.12.019	18	6	6	0	7	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	APR	2011	54	1					20	23		10.1016/j.cyto.2010.12.013			4	Biochemistry & Molecular Biology; Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Immunology	743LO	WOS:000289020000003	21251848				2022-02-06	
J	Svatos, F; Bartoska, R; Skala-Rosenbaum, J; Dousa, P; Pacovsky, V; Krbec, M				Svatos, F.; Bartoska, R.; Skala-Rosenbaum, J.; Dousa, P.; Pacovsky, V.; Krbec, M.			Calcaneal Fractures Treated by Open Reduction and Internal Fixation with a Locking Compression Plate (LCP). A Prospective Study. Part I: Basic Analysis of the Group	ACTA CHIRURGIAE ORTHOPAEDICAE ET TRAUMATOLOGIAE CECHOSLOVACA			Czech	Article						calcaneal fracture; LCP; open reduction; epidemiology; demography	INTRAARTICULAR FRACTURES; NONOPERATIVE MANAGEMENT; TENDON; TRIAL	PURPOSE OF THE STUDY In a prospective study of patients with calcaneal fractures treated by open reduction from an extensile lateral approach and LOP osteosynthesis, the authors evaluated the basic epidemiological data, mechanism of injury, type of fracture, essential data on surgery, days of hospital stay and the number of complications. MATERIAL AND METHODS In the period from September 1, 2006 to July 31, 2010, a total of 230 patients with 243 calcaneal fractures were treated. The fractures were classified as either open or closed and according to the Essex-Lopresti system. Of the total number of patients, 135 (55.6% of all fractures) were indicated for conservative treatment and 108 (44.4% of all fractures) for surgical intervention. Indications for surgery based on the generally accepted criteria enabled us to select 77 patients with 82 fractures (33.7% of all fractures) for treatment by the method of open reduction and LOP osteosynthesis. These patients constituted the group evaluated here. The other patients were treated using other techniques (21 fractures, i.e., 8.6% of all fractures, by the Stehlik-Stulik transfixation method and further five [2.1%] by screw osteosynthesis). Six surgeons were involved in the treatment of this group. For the diagnosis of fractures, plain radiographs in lateral and axial projection and axial and coronal CT images were used. All fractures were treated after subsidence of oedema by the method of open reduction and LOP fixation from an extensile lateral approach, with the use of a tourniquet. The follow-up period for the evaluation of functional outcome and bone union was 3 to 48 months. Fifty patients were followed up for over one year. RESULTS The group evaluated comprised 58 men (75.3%) with 63 fractures (76.8%) and 19 women (24.7%) with 19 fractures (23.2%). The average age of the group was 42 years, with 41 years (range, 22-61 years) in men and 47 years (range, 30-70 years) in women. The most frequent cause of injury was a fall from a height below 1 metre and this was recorded in 38 patients (49.4%); 18 patients (24.3%) had a fall from a height below 3 metres. Eight fractures were caused by a fall from the window, seven calcaneal fractures, as part of polytrauma, were sustained in road accidents (9.1%) and six calcaneal bones were injured due to ankle sprain in walking on a flat surface (7.8%). Bilateral fractures occurred in five (6.5%) patients, the right and left heel bones were injured in 31 (40.3%) and 41 (53.2%) fracture cases, respectively. An open fracture was recorded on three occasions (3.7%). Of the 82 evaluated fractures, 23 were type IIa fractures (28%) and 59 were type IIb fractures (72%) according to the Essex-Lopresti classification system. The average injury-surgery interval was 10 days (range, 1 23 days). The average operative time was 77 minutes (range, 45-175 min) and the average duration of tourniquet application was 61 minutes (range, 20-130 min). The average length of hospital stay was 18 days (range, 7-61 days). In 15 patients (18.3% of osteosynthesis cases) wound healing was delayed. Deep wound infection developed in three cases (3.7%); these required revision surgery which involved implant removal before bone union in two cases and healing of the wound after revision without implant removal in one case. A necrotic lesion in one case (1.2%) was treated by muscle flap transfer. Complications which varied in type and severity were recorded in 22% of the patients. The Rowe score was used to evaluate functional outcomes, which were excellent in 44%, good in 46%, satisfactory in 4% and poor in 6% of the surgically treated patients. DISCUSSION Only about one-third of the patients with calcaneal fractures were indicated for open LOP osteosynthesis. This is in agreement with the strict indication criteria established by the foreign authors with Professors Zwipp and Sanders at the head. It appears that this fracture chiefly occurs in the population of young active men (Kocis reported only men and no woman with this fracture in his study). The authors focus on exact radiographic diagnosis including CT examination, as recommended by Stehlik and Stulik in their book. They recommend to use the Essex-Lopresti system for primary classification and, because of the frequency of LOP osteosynthesis procedures performed, also recommend to carry out this treatment in specialised institutions. The rate of serious complications in this study was relatively low and in accordance with the findings of Zwipp, Zeman and others. CONCLUSIONS The analysis of basic data on the group of patients with calcaneal fractures treated by open reduction and LCP fixation showed the following: chiefly young active men sustained this fracture; calcaneal fracture was usually due to a fall or jump from a level not too high; X-ray examination (lateral and axial projection) was sufficient to make a diagnosis; for a decision to operate it was useful to complete the diagnosis by CT examination; the prerequisite for minimising post-operative complications was strict adherence to the established indication criteria, surgery only after oedema had subsided and use of the correct surgical technique. The number of complications and their nature did not differ from the data reported by other authors.	[Svatos, F.] Ortopedicko Traumatologicka Klin 3 LF UK, Prague 10034 10, Czech Republic; FNKV, Prague 10034 10, Czech Republic		Svatos, F (corresponding author), Ortopedicko Traumatologicka Klin 3 LF UK, Srobarova 50, Prague 10034 10, Czech Republic.	svatos@fnkv.cz		Dousa, Pavel/0000-0002-2499-421X			BERRY G, 2004, TRAUMA, V18, P206; Brauer CA, 2005, J BONE JOINT SURG AM, V87A, P2741, DOI 10.2106/JBJS.E.00166; Buckley R, 2002, J BONE JOINT SURG AM, V84A, P1733, DOI 10.2106/00004623-200210000-00001; Buckley RE, 2010, ACTA CHIR ORTHOP TR, V77, P179; Coughlin MJ, 2007, SURG FOOT ANKLE, V8th; ESSEXLOPRESTI P, 1952, BRIT J SURG, V39, P395, DOI 10.1002/bjs.18003915704; Fridrich F, 2009, ACTA CHIR ORTHOP TR, V76, P212; Howard JL, 2003, J ORTHOP TRAUMA, V17, P241, DOI 10.1097/00005131-200304000-00001; Hromadka R, 2009, ACTA CHIR ORTHOP TR, V76, P104; Kachlik D, 2010, ACTA CHIR BELG, V110, P255, DOI 10.1080/00015458.2010.11680613; Kachlik D, 2008, ANN ANAT, V190, P284, DOI 10.1016/j.aanat.2008.02.001; Kocis J, 2006, Acta Chir Orthop Traumatol Cech, V73, P164; KRAMER K. L., 1993, SCORES BEWERTUNGSSCH, P431; Langova K, 2010, ACTA CHIR ORTHOP TR, V77, P118; PARMAR HV, 1993, J BONE JOINT SURG BR, V75, P932, DOI 10.1302/0301-620X.75B6.8245085; Richards PJ, 2001, INJURY, V32, P633, DOI 10.1016/S0020-1383(01)00053-5; Sanders R, 1992, J Orthop Trauma, V6, P252, DOI 10.1097/00005131-199206000-00022; Stehlik J, 1998, Rozhl Chir, V77, P389; Stehlik J, 2002, Acta Chir Orthop Traumatol Cech, V69, P209; STEHLIK J., 2005, ZLOMENINY PATNI KOST; Tornetta P, 1998, J ORTHOP TRAUMA, V12, P469, DOI 10.1097/00005131-199809000-00007; Vanecek L, 2003, Acta Chir Orthop Traumatol Cech, V70, P100; WONDRAK E, 1964, ZLOMENINY PATNI KOST; Zeman P, 2008, ACTA CHIR ORTHOP TR, V75, P457; ZWIPP H, 1993, CLIN ORTHOP RELAT R, P76; ZWIPP H, 2004, INJURY, V36, P46	26	6	6	0	3	GALEN SRO	PRAGUE 5	NA BELIDLE 34, PRAGUE 5, 150 00, CZECH REPUBLIC	0001-5415			ACTA CHIR ORTHOP TR	Acta Chir. Orthop. Traumatol. Cechoslov.	APR	2011	78	2					126	130					5	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	764OL	WOS:000290641200006	21575555				2022-02-06	
J	Dutton, RP; Prior, K; Cohen, R; Wade, C; Sewell, J; Fouche, Y; Stein, D; Aarabi, B; Scalea, TM				Dutton, Richard P.; Prior, Kate; Cohen, Robin; Wade, Christine; Sewell, John; Fouche, Yvette; Stein, Deborah; Aarabi, Bizhan; Scalea, Thomas M.			Diagnosing Mild Traumatic Brain Injury: Where Are We Now?	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	23rd Annual Meeting of the Eastern-Association-for-the-Surgery-of-Trauma69th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	JAN 19-23, 2010SEP 22-25, 2010	Phoenix, AZBoston, MA	Eastern Assoc Surg TraumaAmer Assoc Surg Trauma (AAST)		Traumatic brain injury; Brain acoustic monitor; Diagnosis	QUESTIONNAIRE	Background: The brain acoustic monitor (BAM), an indicator of cerebral autoregulation, has previously shown high sensitivity but low specificity for computed tomographic (CT) abnormality in patients following the clinical diagnosis of traumatic brain injury. We assessed the utility of the BAM in diagnosing mild TBI (mTBI) in patients with and without normal findings of CT scan, a population for which there are a few objective markers of disease. Methods: We prospectively studied 369 patients with mechanism of injury consistent with TBI. The diagnosis was evaluated by five methods: (a) study enrollment (i.e., mechanism of injury), (b) signs of head trauma, (c) expert physician assessment, (d) presence of initial symptoms (loss of consciousness [LOC]; amnesia), and (e) BAM. All patients had a head CT scan. We compared the BAM screen results with the diagnosis of mTBI and BAM data from 50 normal volunteers and 49 trauma control patients not thought to have TBI. Results: None of the diagnostic methods correlated well with the others. Correlation between the methods ranged from 21% to 71%. BAM discriminated between patients with mTBI versus without TBI (p < 0.01) and patients with mTBI versus normal subjects (p < 0.001). There were 14 patients with new abnormal findings of CT scans. A history of LOC and physical signs of head injury were associated with a new abnormality on head CT (p < 0.05 and p < 0.01, respectively), whereas an abnormal BAM signal was suggestive (p = 0.08). The sensitivity of BAM abnormality for head CT abnormality was 100%, with a specificity of 30.14%. Conclusion: There is no gold standard for the diagnosis of mTBI. BAM screening is a useful diagnostic adjunct in patients with mTBI and may facilitate decision making. An abnormal BAM reading adds significance to LOC as a predictor of a new abnormality on head CT. In our study, opting not to CT scan patients with a normal BAM signal would have missed no new CT findings and no patients who required medical intervention for TBI, at a cost savings of $202,950.	[Dutton, Richard P.; Prior, Kate; Cohen, Robin; Wade, Christine; Sewell, John; Fouche, Yvette; Stein, Deborah; Aarabi, Bizhan; Scalea, Thomas M.] Univ Maryland, Sch Med, Div Trauma Anesthesiol & Trauma Gen Surg, Baltimore, MD 21201 USA		Dutton, RP (corresponding author), R Adams Cowley Shock Trauma Ctr, Baltimore, MD USA.	r.dutton@asahq.org		Stein, Deborah/0000-0003-3683-3963			Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Dutton RP, 2002, J TRAUMA, V53, P857, DOI 10.1097/00005373-200211000-00009; DUTTON RP, 2004, 2004 YB INTENSIVE CA, P576; Dutton RP., 2005, CLIN INTENSIVE CARE, V16, P97, DOI DOI 10.3109/09563070500116911; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558	7	6	7	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2011	70	3					554	558		10.1097/TA.0b013e31820d1062			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	732PU	WOS:000288201200013	21610342				2022-02-06	
J	Silva, DD; Brito, JNPD; Ibiapina, JO; Lima, MFMB; Medeiros, ARGD; Queiroz, BHCE; Guedes, VOD				Silva, Danilo dos Santos; Pearce de Oliveira Brito, Jose Nazareno; Ibiapina, Jerusia Oliveira; Miranda Batista Lima, Marcel Fernando; Goncalves de Vasconcelos Medeiros, Andrea Ribeiro; Carvalho e Queiroz, Barbara Hamedy; de Melo Guedes, Vanessa Olimpio			Traumatic brain injury. Clinical and pathological parameters in an experimental weight-drop model	ACTA CIRURGICA BRASILEIRA			English	Article						Models, Animal; Brain Injuries; Parameters; Rats	CONTROLLED CORTICAL IMPACT; RATS	Purpose: To investigate the function of an experimental cranium trauma model in rats. Methods: The equipment, already described in the literature and under discreet adaptations, is composed by a platform that produces closed head impact controlled by weight drop with pre-defined and known energy. 25 Wistar male rats (Rattus norvegicus albinus) were divided into five equal groups that received different quantities of cranial impact energy: G1, G2, G3 and G4 with 0,234J, 0,5J, 0,762J and 1J respectively and G5 (Sham). Under intense analgesia, each group was evaluated clinically in a sequence of intervals and had their encephalon removed for pathologic analysis. Results: Important clinical alterations (convulsions, bradycardia, bradypnea and abnormal postures) and focal pathologic (hematomas and hemorrhages) kept proportion with the intensity of the impact. No fracture was observed and the group 4 had 80% mortality rate. Conclusion: The experimental cranium trauma animal model by weight drop is an alternative of low cost and easy reproduction that allows evaluating clinical and pathological alterations in accordance with studies in experimental surgery aims for new traumatic brain injury approach in rats.	[Silva, Danilo dos Santos; Miranda Batista Lima, Marcel Fernando; Goncalves de Vasconcelos Medeiros, Andrea Ribeiro; Carvalho e Queiroz, Barbara Hamedy; de Melo Guedes, Vanessa Olimpio] Piaui State Univ UESPI, Fac Med, Dept Expt Surg, Teresina, PI, Brazil; [Silva, Danilo dos Santos; Miranda Batista Lima, Marcel Fernando; Goncalves de Vasconcelos Medeiros, Andrea Ribeiro; Carvalho e Queiroz, Barbara Hamedy; de Melo Guedes, Vanessa Olimpio] Piaui Assoc Canc Care, Sao Marcos Hosp, Dept Pathol, Teresina, PI, Brazil; [Pearce de Oliveira Brito, Jose Nazareno] Univ Estadual Piaui, Fac Med, Dept Neurol & Neurosurg, Teresina, Piaui, Brazil; [Silva, Danilo dos Santos; Miranda Batista Lima, Marcel Fernando; Goncalves de Vasconcelos Medeiros, Andrea Ribeiro; Carvalho e Queiroz, Barbara Hamedy; de Melo Guedes, Vanessa Olimpio] Univ Estadual Piaui, Fac Med, Teresina, Piaui, Brazil; [Ibiapina, Jerusia Oliveira] Sao Marcos Hosp, Dept Pathol, Teresina, Piaui, Brazil		Brito, JNPD (corresponding author), Rua Desembargador Cesar do Rego Monteiro 1220, BR-64049580 Teresina, PI, Brazil.	nazapearce@uol.com.br					Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; CARVALHO LFA, 2007, REV BRAS TER INTENSI, V19; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dvilevicius AE, 2008, ARQ BRAS NEUROCIR, V27, P42; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARQUES R.G., 2005, TECNICA OPERATORIA C; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Park HK, 1999, CRIT REV NEUROSURG, V9, P44, DOI 10.1007/s003290050108; SCHOSSLER JE, 1993, ACTA CIR BRAS, V8, P32; SEPPELT I, 2004, INDIAN J CRIT CARE M, V8, P120; SHALIT MN, 1974, J NEUROSURG, V40, P594, DOI 10.3171/jns.1974.40.5.0594; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Melo JRT, 2009, ARQ NEURO-PSIQUIAT, V67, P804, DOI 10.1590/S0004-282X2009000500004; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007	18	6	6	0	1	ACTA CIRURGICA BRASILEIRA	SAO PAULO	ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL	0102-8650	1678-2674		ACTA CIR BRAS	Acta Cir. Bras.	MAR-APR	2011	26	2					94	100					7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	741MC	WOS:000288866800004	21445470	gold			2022-02-06	
J	Bai, Y; Yao, HX; Hu, ML; Wang, LR; Jin, LD; Wang, WT; Lin, LN				Bai Yu; Yao Hai-xia; Hu Ming-lun; Wang Liang-rong; Jin Li-da; Wang Wan-tie; Lin Li-na			Effects of shenmai injection on pulmonary aquaporin 1 in rats following traumatic brain injury	CHINESE MEDICAL JOURNAL			English	Article						pulmonary aquaporin 1; traumatic brain injury; shenmai injection	DECREASED EXPRESSION; WATER CHANNELS; LUNG; AQP5; EDEMA	Background Aquaporin-1 (AQP1) has involved in fluid transport in diverse pulmonary edema diseases. Our study aimed to explore the dynamic changes of AQP1 in pulmonary water metabolism in rats following traumatic brain injury (TBI) and the protective effect provided by shenmai injection. Methods Sixty male Sprague Dawley rats weighting 280-300 g were randomly divided into three groups: the normal control group, the model group and the shenmai injection (SMI) group. One piece skull was taken away without injuring cerebral tissue in normal control group, while rats in model group and SMI group were subject to free fall injury in the cerebral hemisphere. Rats in model group received intraperitoneal normal sodium (15 ml/kg) at one hour post-injury and the same dose of shenmai injection instead in SMI group, respectively. The expression of AQP1 was detected by immunohistochemical analysis and semi-quantitative RT-PCR at 0 hour, 10 hours, 72 hours and 120 hours after TBI. Arterial blood gas analysis and lung wet to dry were also measured. Results AQP1 was mainly presented in the capillary endothelium and slightly alveolar epithelial cells in three groups, but the expression of AQP1 in the normal control group was positive and tenuous, weakly positive in the model and SMI groups, respectively. Compared with normal control group, AQP1 mRNA levels were down regulated in the model and SMI groups at 10 hours, 72 hours and 120 hours (P < 0.05). While AQP1 mRNA levels in the SMI group was up-regulated than that in the model group (P < 0.05). Lung wet to dry weight ratio (W/D) in the model and SMI groups at 10 hours were higher than that in normal control group (P < 0.05). Compared with normal control group, PaO2 was markedly lower in the model and SMI groups (P < 0.05), but there were no statistically significant differences between model and SMI groups (P > 0.05). Conclusions The decreased AQP1 expression may be involved in the increased lung water content and dysfunction of pulmonary water metabolism following TBI. The treatment with SMI could improve water metabolism by promoting AQP1 expression. Chin Med J 2011;124(3):457-460	[Bai Yu; Yao Hai-xia; Hu Ming-lun; Wang Liang-rong; Jin Li-da; Wang Wan-tie; Lin Li-na] Wenzhou Med Coll, Affiliated Hosp 1, Dept Anesthesiol, Wenzhou 325000, Zhejiang, Peoples R China; [Wang Wan-tie] Wenzhou Med Coll, Dept Pathophysiol, Wenzhou 325000, Zhejiang, Peoples R China		Lin, LN (corresponding author), Wenzhou Med Coll, Affiliated Hosp 1, Dept Anesthesiol, Wenzhou 325000, Zhejiang, Peoples R China.	wzlinlina@tom.com			Administration of Traditional Chinese Medicine Science of Zhejiang Province [2007CA086]	The work was supported by a grant from the Administration of Traditional Chinese Medicine Science of Zhejiang Province (No. 2007CA086).	Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; Anderson Michael R, 2003, Respir Care, V48, P261; Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276.x; Chen Fei-Fei, 2009, Zhongguo Zhong Xi Yi Jie He Za Zhi, V29, P414; Huang DH, 2005, CHIN J CURR TRAD W M, V3, P625; Jiao GY, 2002, CHINESE MED J-PEKING, V115, P963; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Law RJ, 2002, CURR BIOL, V12, pR250, DOI 10.1016/S0960-9822(02)00784-4; Matthay MA, 2002, J APPL PHYSIOL, V93, P1533, DOI 10.1152/japplphysiol.01210.2001; Sartori C, 2002, EUR RESPIR J, V20, P1299, DOI 10.1183/09031936.02.00401602; Towne JE, 2000, AM J RESP CELL MOL, V22, P34, DOI 10.1165/ajrcmb.22.1.3818; Wei YL, 2001, CHIN J INTEGR TRAD W, V21, P47; Woo J, 2008, BIOCHEM BIOPH RES CO, V366, P321, DOI 10.1016/j.bbrc.2007.11.078; Xie YB, 2008, CHINA J MOD MED, V10, P316; Zhao Wei-xian, 2009, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V21, P282; Zhao Y LJ, 2001, CHIN CLIN ONCOL, V2, P81	17	6	6	0	7	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	FEB 5	2011	124	3					457	460		10.3760/cma.j.issn.0366-6999.2011.03.024			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729ZE	WOS:000287992400024	21362350				2022-02-06	
J	Natarajan, MS; Prabhu, K; Braganza, A; Chacko, AG				Natarajan, Manikandan S.; Prabhu, Krishna; Braganza, Andrew; Chacko, Ari G.			Posttraumatic subgaleal and orbital hematoma due to factor XIII deficiency	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						subgaleal hematoma; orbital hematoma; factor XIII deficiency	OF-THE-LITERATURE; SUBPERIOSTEAL HEMATOMA; BILATERAL PROPTOSIS; EXTRADURAL HEMATOMA; EXTENSION	The authors report on a 6-year-old boy who presented with a tense subgaleal hematoma and proptosis 2 weeks after a minor head injury that were successfully managed by continuous closed-system drainage and blood transfusion. At evaluation he was found to have a transient mild factor XIII deficiency. (DOI: 10.3171/2010.11.PEDS10486)	[Natarajan, Manikandan S.; Prabhu, Krishna; Chacko, Ari G.] Christian Med Coll & Hosp, Dept Neurol Sci, Vellore 6320004, Tamil Nadu, India; [Braganza, Andrew] Christian Med Coll & Hosp, Dept Ophthalmol, Vellore 6320004, Tamil Nadu, India		Chacko, AG (corresponding author), Christian Med Coll & Hosp, Dept Neurol Sci, Vellore 6320004, Tamil Nadu, India.	agchacko@cmcvellore.ac.in	Chacko, Ari/AAA-3720-2022	Braganza, Andrew/0000-0003-0475-1920			Agrawal A, 2007, NEUROL INDIA, V55, P423, DOI 10.4103/0028-3886.33302; Anton J, 1999, PEDIATR EMERG CARE, V15, P347, DOI 10.1097/00006565-199910000-00013; Chotirmall SH, 2007, J AM GERIATR SOC, V55, P135, DOI 10.1111/j.1532-5415.2006.01008.x; Dragu A, 2009, MED SCI MONITOR, V15, pCS1; Gerlach R, 2002, STROKE, V33, P1618, DOI 10.1161/01.STR.0000017219.83330.FF; GIOIA VM, 1987, ARCH OPHTHALMOL-CHIC, V105, P529; Gregory Thomas F, 2006, Proc (Bayl Univ Med Cent), V19, P221; Hsieh L, 2008, HAEMOPHILIA, V14, P1190, DOI 10.1111/j.1365-2516.2008.01857.x; Kakizaki H, 2010, OPHTHAL PLAST RECONS, V26, P265, DOI 10.1097/IOP.0b013e3181be3097; Kim D, 2009, PEDIATR RADIOL, V39, P622, DOI 10.1007/s00247-009-1176-y; KOTHANDARAM P, 1970, POSTGRAD MED J, V46, P109, DOI 10.1136/pgmj.46.532.109; LAKI K, 1948, SCIENCE, V108, P280, DOI 10.1126/science.108.2802.280; LEE K S, 1991, Journal of Korean Medical Science, V6, P251; LEE KS, 1988, J NEUROSURG, V69, P770, DOI 10.3171/jns.1988.69.5.0770; Nayak N, 2010, NEUROL INDIA, V58, P637, DOI 10.4103/0028-3886.68685; POMERANZ AJ, 1995, ANN EMERG MED, V26, P752, DOI 10.1016/S0196-0644(95)70051-X; POPEPEGRAM LD, 1986, SURV OPHTHALMOL, V30, P258, DOI 10.1016/0039-6257(86)90122-0; PRAKASH S, 1990, J NEUROSURG, V72, P835; Procianoy F, 2008, ARQ BRAS OFTALMOL, V71, P262, DOI 10.1590/S0004-27492008000200024; Robbins KC, 1944, AM J PHYSIOL, V142, P0581; STEWART CR, 1993, BRIT J OPHTHALMOL, V77, P179, DOI 10.1136/bjo.77.3.179; Wolter J R, 1979, Trans Am Ophthalmol Soc, V77, P104	22	6	6	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	FEB	2011	7	2					213	217		10.3171/2010.11.PEDS10486			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	710WV	WOS:000286548600016	21284470				2022-02-06	
J	Abd-El-Basset, EM; Abd-El-Barr, MM				Abd-El-Basset, E. M.; Abd-El-Barr, Muhammad M.			Effect of Interleukin-1 beta on the Expression of Actin Isoforms in Cultured Mouse Astroglia	ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY			English	Article						astroglia; cytoskeleton; actin isoforms; cytokines; GFAP	FIBRILLARY ACIDIC PROTEIN; TUMOR-NECROSIS-FACTOR; CENTRAL-NERVOUS-SYSTEM; SMOOTH-MUSCLE ACTIN; CYCLIC-AMP; REACTIVE ASTROCYTES; GROWTH-FACTORS; ALPHA-ISOFORM; UP-REGULATION; BRAIN	Cytokines are soluble mediators that are thought to act as communication signals between astroglia and neighboring neural cells. They are both released by, and act on, astroglia. It is hypothesized that it is this effect on astroglia that may be important in widespread phenomena including traumatic brain injury, inflammation, and scar formation. In this article, we examine the effect of mouse recombinant interleukin-1 beta (IL-1 beta) on the morphology, organization, and expression of glial fibrillary acidic protein (GFAP) and actin isoforms in cultured mouse astroglia. This study shows that the majority of the astroglia treated with IL-1 beta acquire long processes. Immunofluorescence staining shows that there are no remarkable changes in the organization of GFAP, F-actin, alpha-smooth muscle (alpha-sm) actin, and beta-actin isoforms. In fluorescent microplate assay, the short-term treated astroglia (range, 1-2 days) show an increase in the intensity of GFAP and beta-actin isoform over the level observed in untreated control, whereas no remarkable changes are observed in the intensity of alpha-sm actin isoform. In the case of long-term treatment (range, 4-8 days), the intensity of GFAP and alpha-sm actin isoform progressively decreases below the level of untreated control. In addition, the intensity of beta-actin isoform increases above the control level. These results have been confirmed by immunoblotting experiments. The upregulation of beta-actin isoform may be important in limiting the noxious effects of an inflammatory reaction. This gives credence to the hypothesis that it might be possible to modulate astroglial effects on neuronal inflammation and scar formation with appropriate therapies. Anat Rec, 294:16-23, 2011. (C) 2010 Wiley-Liss, Inc.	[Abd-El-Basset, E. M.] Kuwait Univ, Fac Med, Dept Anat, Safat 13100, Kuwait; [Abd-El-Barr, Muhammad M.] Univ Florida, Dept Neurosurg, Gainesville, FL USA		Abd-El-Basset, EM (corresponding author), Kuwait Univ, Fac Med, Dept Anat, POB 24923, Safat 13100, Kuwait.	ebtesam@hsc.edu.kw		Abd-El-Barr, Muhammad/0000-0001-7151-2861	Kuwait University Research Adminstration [MA037]	This work was supported by Kuwait University Research Adminstration grant # MA037. The authors would like to thank Dr. Ananth Lakshmi KVV and Mrs. Jeena Prashanth for technical assistance.	Abd-El-Basset EM, 2004, MED PRIN PRACT, V13, P325, DOI 10.1159/000080469; Abd-El-Basset EM, 2000, HISTOCHEM J, V32, P581, DOI 10.1023/A:1026738600838; AbdElBasset EM, 1997, J NEUROSCI RES, V49, P608, DOI 10.1002/(SICI)1097-4547(19970901)49:5<608::AID-JNR11>3.0.CO;2-R; ABDELBASSET EM, 1991, J NEUROSCI RES, V30, P1, DOI 10.1002/jnr.490300103; ABDELBASSET EM, 1994, J CHEM NEUROANAT, V7, P113, DOI 10.1016/0891-0618(94)90012-4; ABDELBASSET EM, 1991, NEUROSCI LETT, V125, P117, DOI 10.1016/0304-3940(91)90005-E; Abe K, 1999, BRAIN RES, V837, P306, DOI 10.1016/S0006-8993(99)01658-3; ALOISI F, 1995, INT J DEV NEUROSCI, V13, P265, DOI 10.1016/0736-5748(94)00071-A; ALOISI F, 1992, J IMMUNOL, V149, P2358; BALASINGAM V, 1994, J NEUROSCI, V14, P846; BENVENISTE EN, 1992, AM J PHYSIOL, V263, pC1, DOI 10.1152/ajpcell.1992.263.1.C1; BENVENISTE EN, 1990, J NEUROIMMUNOL, V30, P201, DOI 10.1016/0165-5728(90)90104-U; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; Bignami Amico, 1995, P843; Blanco VM, 2008, AM J PHYSIOL-HEART C, V294, pH2855, DOI 10.1152/ajpheart.91451.2007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaponnier C, 2004, J PATHOL, V204, P386, DOI 10.1002/path.1635; CHIU FC, 1985, J NEUROIMMUNOL, V8, P283, DOI 10.1016/S0165-5728(85)80067-9; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; FONTANA A, 1982, J IMMUNOL, V129, P2413; FREI K, 1989, EUR J IMMUNOL, V19, P689, DOI 10.1002/eji.1830190418; GIULIAN D, 1988, J NEUROSCI, V8, P709; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; GIULIAN D, 1988, J NEUROSCI, V8, P2485; Gomes FCA, 1999, BRAZ J MED BIOL RES, V32, P619, DOI 10.1590/S0100-879X1999000500016; Gordon GR, 2008, NATURE, V456, P729; Gordon GRJ, 2007, GLIA, V55, P1214, DOI 10.1002/glia.20543; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; Khaitlina SY, 2001, INT REV CYTOL, V202, P35, DOI 10.1016/S0074-7696(01)02003-4; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; Koehler RC, 2006, J APPL PHYSIOL, V100, P307, DOI 10.1152/japplphysiol.00938.2005; LACHMAN LB, 1987, J IMMUNOL, V138, P2913; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPING NJ, 1994, BRAIN PATHOL, V4, P259, DOI 10.1111/j.1750-3639.1994.tb00841.x; LECAIN E, 1991, J NEUROSCI RES, V28, P601, DOI 10.1002/jnr.490280417; LIU W, 1994, J NEUROCHEM, V63, P1625; MERRILL JE, 1992, DEV NEUROSCI-BASEL, V14, P1, DOI 10.1159/000111642; MORRISON RS, 1985, J NEUROSCI RES, V14, P167, DOI 10.1002/jnr.490140202; OH YJ, 1993, GLIA, V8, P77, DOI 10.1002/glia.440080203; Pascale A, 2004, GLIA, V46, P169, DOI 10.1002/glia.10354; Pawlinski R, 2000, FOLIA HISTOCHEM CYTO, V38, P151; Reisler E, 2007, J BIOL CHEM, V282, P36133, DOI 10.1074/jbc.R700030200; SHAFITZAGARDO B, 1988, GLIA, V1, P346, DOI 10.1002/glia.440010507; SHIRAKAWA F, 1988, P NATL ACAD SCI USA, V85, P8201, DOI 10.1073/pnas.85.21.8201; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Woiciechowsky C, 2004, MED SCI MONITOR, V10, pBR325; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4	50	6	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8486	1932-8494		ANAT REC	Anat. Rec.	JAN	2011	294	1					16	23		10.1002/ar.21303			8	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	820FO	WOS:000294891200003	21157913	Bronze			2022-02-06	
J	Barney, SJ; Allen, DN; Thaler, NS; Park, BS; Strauss, GP; Mayfield, J				Barney, Sally J.; Allen, Daniel N.; Thaler, Nicholas S.; Park, Brandon S.; Strauss, Gregory P.; Mayfield, Joan			Neuropsychological and Behavioral Measures of Attention Assess Different Constructs in Children With Traumatic Brain Injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Children; Traumatic brain injury; Attention; Test of Memory and Learning; TOMAL; Wisconsin Card Sorting Test; WCST; Comprehensive Trail Making Test; CTMT; Behavioral Assessment System for Children; BASC; Continuous Performance Test-II; Conners' CPT	INDEX SCORE PATTERNS; SUSTAINED ATTENTION; EXECUTIVE FUNCTION; HEAD-INJURY; COMPREHENSIVE TRAIL; RATING INVENTORY; WISC-III; ADOLESCENTS; DISORDER; DEFICITS	Neuropsychological and behavioral measures are used to assess attention, but little convergence has been found between these two assessment methods. However, many prior studies have not considered attention as a multicomponent system, which may contribute to this lack of agreement between neuropsychological and behavioral measures. To address this the current study examined the relationship between the neuropsychological measures that comprise a four-component model of attention and parent-report behavioral ratings of attention problems and hyperactivity. A total of 65 children and adolescents who had sustained a traumatic brain injury (TBI) were included in the study. Principal components analysis identified the four attention components in this sample, which accounted for 80.9% of the variance. However, correlations between the neuropsychological measures of attention and behavioral ratings of attention and hyperactivity were low and nonsignificant. This minimal correspondence suggests that neuropsychological and behavioral measures assess different aspects of attentional disturbances in children with TBI.	[Allen, Daniel N.] Univ Nevada Las Vegas, Neuropsychol Res Program, Dept Psychol, Las Vegas, NV 89154 USA; [Mayfield, Joan] Our Childrens House Baylor, Dallas, TX USA		Allen, DN (corresponding author), Univ Nevada Las Vegas, Neuropsychol Res Program, Dept Psychol, 4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			Allen D. N., 2011, COMPREHENSIVE UNPUB; Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Allen DN, 2009, CHILD NEUROPSYCHOL, V15, P543, DOI 10.1080/09297040902748234; Allen DN, 1997, SCHIZOPHR RES, V25, P53, DOI 10.1016/S0920-9964(97)00006-6; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Armstrong CM, 2008, ARCH CLIN NEUROPSYCH, V23, P351, DOI 10.1016/j.acn.2007.11.004; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barker-Collo S., 2007, BRAIN IMPAIR, V8, DOI [DOI 10.1375/BRIM.8.1.22, https://doi.org/10.1375/brim.8.1.22]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bodnar LE, 2007, CHILD NEUROPSYCHOL, V13, P345, DOI 10.1080/09297040600899867; Catroppa C, 1999, CHILD NEUROPSYCHOL, V5, P251, DOI 10.1076/0929-7049(199912)05:04;1-R;FT251; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Centers for Disease Control and Prevention: United States Department of Health and Human Services/National Center for Injury Prevention and Control (NCIPC), 2004, TBI GEN FACT SHEET T; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Chan RCK, 2003, BRAIN INJURY, V17, P131, DOI 10.1080/0269905021000010168; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Conners C. K., 2000, CONNERS CONTINUOUS P; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Gioia GA, 2009, TOP LANG DISORD, V29, P266, DOI 10.1097/TLD.0b013e3181b5322b; Goldstein G, 2001, J AUTISM DEV DISORD, V31, P433, DOI 10.1023/A:1010620820786; Gross D, 2004, RES NURS HEALTH, V27, P413, DOI 10.1002/nur.20040; Heaton RK, 1981, WISCONSIN CARD SORT; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Lee S. W., 1994, BEHAV DISORDERS, V19, P87; Lowther JL, 2004, ARCH CLIN NEUROPSYCH, V19, P105, DOI 10.1016/S0887-6177(02)00222-6; Luria A.R., 1973, WORKING BRAIN; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McAuley C, 2000, BRIT J SOC WORK, V30, P91, DOI 10.1093/bjsw/30.1.91; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; Mesulam M., 1985, PRINCIPLES BEHAV NEU; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Mirsky A.F., 1996, ATTENTION MEMORY EXE, P71; MIRSKY AF, 1987, ENVIRON HEALTH PERSP, V74, P191, DOI 10.2307/3430449; Mirsky AF, 1999, MENT RETARD DEV D R, V5, P169, DOI 10.1002/(SICI)1098-2779(1999)5:3<169::AID-MRDD2>3.3.CO;2-B; Mottram L, 2006, DEV NEUROPSYCHOL, V30, P865, DOI 10.1207/s15326942dn3003_6; Naglieri JA, 2005, ARCH CLIN NEUROPSYCH, V20, P385, DOI 10.1016/j.acn.2004.09.008; *NAT INF CTR CHILD, 2004, TRAUM BRAIN INJ FACT; Park BS, 2009, APPL NEUROPSYCHOL, V16, P1, DOI 10.1080/09084280802636371; POGGE DL, 1994, J CLIN EXP NEUROPSYC, V16, P344, DOI 10.1080/01688639408402645; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Reynolds C.R., 1994, TEST MEMORY LEARNING; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Reynolds CR., 1992, BEHAV ASSESSMENT SYS; Roberts MA, 1997, ARCH CLIN NEUROPSYCH, V12, P449, DOI 10.1016/S0887-6177(96)00039-X; Sohlberg M., 2001, COGNITIVE REHABILITA; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; TEASDALE G, 1974, LANCET, V2, P81; Thaler NS, 2010, ARCH CLIN NEUROPSYCH, V25, P781, DOI 10.1093/arclin/acq073; Thaler NS, 2010, J CLIN EXP NEUROPSYC, V32, P929, DOI 10.1080/13803391003596488; Toplak ME, 2009, CHILD NEUROPSYCHOL, V15, P53, DOI 10.1080/09297040802070929; van der Heijden P, 2003, ASSESSMENT, V10, P115, DOI 10.1177/1073191103010002001; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Vriezen ER, 2000, BRAIN COGNITION, V44, P67; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Whyte J, 2006, NEUROPSYCHOLOGIA, V44, P2007, DOI 10.1016/j.neuropsychologia.2006.02.012; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Young S, 2005, BRIT J CLIN PSYCHOL, V44, P47, DOI 10.1348/014466504X197769; Zubin J, 1975, EXPT APPROACHES PSYC, P139; [No title captured]	68	6	6	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2011	25	7					1145	1157		10.1080/13854046.2011.595956			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	882JJ	WOS:000299559600004	21902568				2022-02-06	
B	Carmichael, JD		Melmed, S		Carmichael, John D.			Anterior Pituitary Failure	PITUITARY, 3RD EDITION			English	Article; Book Chapter							GROWTH-HORMONE GH; BONE-MINERAL DENSITY; HUMAN CHORIONIC-GONADOTROPIN; SURGICALLY MENOPAUSAL WOMEN; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; ADULT HYPOPITUITARY PATIENTS; INSULIN-INDUCED HYPOGLYCEMIA; GLUCAGON STIMULATION TEST; ADRENAL AXIS SUPPRESSION		Cedars Sinai Med Ctr, Pituitary Ctr, Los Angeles, CA 90048 USA		Carmichael, JD (corresponding author), Cedars Sinai Med Ctr, Pituitary Ctr, Los Angeles, CA 90048 USA.						Agarwal G, 2000, J CLIN ENDOCR METAB, V85, P4556, DOI 10.1210/jc.85.12.4556; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 1998, J CLIN ENDOCR METAB, V83, P1615, DOI 10.1210/jc.83.5.1615; Aimaretti G, 2000, EUR J ENDOCRINOL, V142, P347, DOI 10.1530/eje.0.1420347; Alatzoglou KS, 2009, EARLY HUM DEV, V85, P705, DOI 10.1016/j.earlhumdev.2009.08.057; Alexopoulou O, 2004, EUR J ENDOCRINOL, V150, P1, DOI 10.1530/eje.0.1500001; AlShoumer KAS, 1996, CLIN ENDOCRINOL, V45, P171, DOI 10.1046/j.1365-2265.1996.d01-1552.x; Ammari F, 1996, CLIN ENDOCRINOL, V44, P473, DOI 10.1046/j.1365-2265.1996.712533.x; Andersen B, 2001, ENDOCR REV, V22, P2, DOI 10.1210/er.22.1.2; Andrioli Massimiliano, 2006, Pituitary, V9, P289, DOI 10.1007/s11102-006-0408-5; [Anonymous], 2005, NATURE, V435, P1003, DOI 10.1038/4351003a; Appelhof BC, 2005, J CLIN ENDOCR METAB, V90, P2666, DOI 10.1210/jc.2004-2111; Arafah BM, 2006, J CLIN ENDOCR METAB, V91, P3725, DOI 10.1210/jc.2006-0674; ARAFAH BM, 1994, J CLIN ENDOCR METAB, V79, P348, DOI 10.1210/jc.79.2.348; ARAFAH BM, 1982, CLIN ENDOCRINOL, V17, P213, DOI 10.1111/j.1365-2265.1982.tb01583.x; Arafah BM, 2000, J CLIN ENDOCR METAB, V85, P1789, DOI 10.1210/jc.85.5.1789; ARAFAH PM, 1986, J CLIN ENDOCR METAB, V62, P1173, DOI 10.1210/jcem-62-6-1173; Arlt W, 2006, CLIN ENDOCRINOL, V64, P384, DOI 10.1111/j.1365-2265.2006.02473.x; Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; Arlt W, 1999, NEW ENGL J MED, V341, P1013, DOI 10.1056/NEJM199909303411401; Arlt W, 2009, J CLIN ENDOCR METAB, V94, P1059, DOI 10.1210/jc.2009-0032; Atmaca H, 2007, THYROID, V17, P529, DOI 10.1089/thy.2006.0311; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Attanasio AF, 1997, J CLIN ENDOCR METAB, V82, P82, DOI 10.1210/jc.82.1.82; Attanasio AF, 2002, J CLIN ENDOCR METAB, V87, P1600, DOI 10.1210/jc.87.4.1600; Bachmann G, 2002, FERTIL STERIL, V77, P660, DOI 10.1016/S0015-0282(02)02969-2; Barrande G, 2000, J CLIN ENDOCR METAB, V85, P3779, DOI 10.1210/jc.85.10.3779; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; Beems T, 1999, NEUROSURGERY, V45, P1474, DOI 10.1097/00006123-199912000-00042; Beishuizen A, 2001, INTENS CARE MED, V27, P1584, DOI 10.1007/s001340101073; Bellastella A, 2003, EUR J ENDOCRINOL, V149, P363, DOI 10.1530/eje.0.1490363; BENGTSSON BA, 1993, J CLIN ENDOCR METAB, V76, P309, DOI 10.1210/jc.76.2.309; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Beressi N, 1999, ANN MED INTERNE, V150, P327; Beshyah SA, 1999, CLIN ENDOCRINOL, V50, P1, DOI 10.1046/j.1365-2265.1999.00682.x; BESHYAH SA, 1995, HORM RES, V44, P69, DOI 10.1159/000184596; Bex M, 2002, J BONE MINER RES, V17, P1081, DOI 10.1359/jbmr.2002.17.6.1081; Bhasin S, 2001, ENDOCRIN METAB CLIN, V30, P749, DOI 10.1016/S0889-8529(05)70210-3; Bhasin S, 2006, J CLIN ENDOCR METAB, V91, P1995, DOI 10.1210/jc.2005-2847; Biermasz NR, 2000, J CLIN ENDOCR METAB, V85, P2476, DOI 10.1210/jc.85.7.2476; Bihan H, 2007, MEDICINE, V86, P259, DOI 10.1097/MD.0b013e31815585aa; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Bin-Abbas B, 1999, J PEDIATR-US, V134, P579, DOI 10.1016/S0022-3476(99)70244-1; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2008, PITUITARY, V11, P187, DOI 10.1007/s11102-008-0112-8; Borson-Chazot F, 1999, J CLIN ENDOCR METAB, V84, P1329, DOI 10.1210/jc.84.4.1329; Borst SE, 2007, CLIN INTERV AGING, V2, P561; Braunstein GD, 2005, ARCH INTERN MED, V165, P1582, DOI 10.1001/archinte.165.14.1582; Bravenboer N, 1996, BONE, V18, P551, DOI 10.1016/8756-3282(96)00069-5; Brooke AM, 2006, J CLIN ENDOCR METAB, V91, P3773, DOI 10.1210/jc.2006-0316; Bunevicius R, 1999, NEW ENGL J MED, V340, P424, DOI 10.1056/NEJM199902113400603; Burman P, 1997, J CLIN ENDOCR METAB, V82, P550, DOI 10.1210/jc.82.2.550; Buster JE, 2005, OBSTET GYNECOL, V105, P944, DOI 10.1097/01.AOG.0000158103.27672.0d; Carpinteri R, 2009, BEST PRACT RES CL EN, V23, P639, DOI 10.1016/j.beem.2009.05.009; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Castinetti F, 2009, J CLIN ENDOCR METAB, V94, P3400, DOI 10.1210/jc.2008-2772; Castle D, 1988, Br J Neurosurg, V2, P401, DOI 10.3109/02688698809001013; Caturegli P, 2005, ENDOCR REV, V26, P599, DOI 10.1210/er.2004-0011; Chrisoulidou A, 2000, J CLIN ENDOCR METAB, V85, P3762, DOI 10.1210/jc.85.10.3762; Clayton PE, 2005, EUR J ENDOCRINOL, V152, P165, DOI 10.1530/eje.1.01829; Clement K, 2008, J CLIN ENDOCR METAB, V93, P4955, DOI 10.1210/jc.2008-1164; Clyde PW, 2003, JAMA-J AM MED ASSOC, V290, P2952, DOI 10.1001/jama.290.22.2952; Cohen J, 2006, INTENS CARE MED, V32, P1901, DOI 10.1007/s00134-006-0389-x; COHEN LE, 1995, J CLIN ENDOCR METAB, V80, P679, DOI 10.1210/jc.80.2.679; Colao A, 2004, J CLIN ENDOCR METAB, V89, P5998, DOI 10.1210/jc.2004-1042; Colao A, 2002, J CLIN ENDOCR METAB, V87, P3650, DOI 10.1210/jc.87.8.3650; Colao A, 1999, J CLIN ENDOCR METAB, V84, P1919, DOI 10.1210/jc.84.6.1919; Colao A, 2006, GROWTH HORM IGF RES, V16, pS41, DOI 10.1016/j.ghir.2006.03.006; Conceicao FL, 2003, J ENDOCRINOL INVEST, V26, P1065, DOI 10.1007/BF03345251; Cook DM, 1999, J CLIN ENDOCR METAB, V84, P3956, DOI 10.1210/jc.84.11.3956; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Corneli G, 2007, PITUITARY, V10, P141, DOI 10.1007/s11102-007-0031-0; Courtney CH, 2000, CLIN ENDOCRINOL, V53, P431, DOI 10.1046/j.1365-2265.2000.01106.x; Courtney CH, 2000, CLIN ENDOCRINOL, V53, P309; CUNEO RC, 1991, J APPL PHYSIOL, V70, P695, DOI 10.1152/jappl.1991.70.2.695; Danaher PJ, 2009, ORTHOPEDICS, V32, P450, DOI 10.3928/01477447-20090511-28; De Marinis L, 2005, J CLIN ENDOCR METAB, V90, P5471, DOI 10.1210/jc.2005-0288; DEBOER H, 1994, METABOLISM, V43, P199, DOI 10.1016/0026-0495(94)90245-3; DEBOER H, 1995, ENDOCR REV, V16, P63, DOI 10.1210/er.16.1.63; Degros V, 2003, EUR J ENDOCRINOL, V149, P23, DOI 10.1530/eje.0.1490023; Deladoey J, 1999, J CLIN ENDOCR METAB, V84, P1645, DOI 10.1210/jc.84.5.1645; Delemarre EM, 2008, EUR J ENDOCRINOL, V159, pS9, DOI 10.1530/EJE-08-0314; Diaczok D, 2008, J CLIN ENDOCR METAB, V93, P4351, DOI 10.1210/jc.2008-1189; Donaubauer J, 2003, CLIN ENDOCRINOL, V58, P456, DOI 10.1046/j.1365-2265.2003.01739.x; Dorin RI, 2003, ANN INTERN MED, V139, P194, DOI 10.7326/0003-4819-139-3-200308050-00009; Drake WM, 2003, J CLIN ENDOCR METAB, V88, P1658, DOI 10.1210/jc.2002-021541; Drake WM, 2001, ENDOCR REV, V22, P425, DOI 10.1210/er.22.4.425; Drake WM, 2001, CLIN ENDOCRINOL, V54, P525, DOI 10.1046/j.1365-2265.2001.01246.x; Dullaart RPF, 1999, CLIN ENDOCRINOL, V50, P465, DOI 10.1046/j.1365-2265.1999.00679.x; DUNKEL L, 1985, J CLIN ENDOCR METAB, V60, P333, DOI 10.1210/jcem-60-2-333; Dutta Pinaki, 2006, Pituitary, V9, P267, DOI 10.1007/s11102-006-8327-z; Elgzyri T, 2004, CLIN ENDOCRINOL, V61, P113, DOI 10.1111/j.1365-2265.2004.02080.x; Escobar-Morreale HF, 2005, J CLIN ENDOCR METAB, V90, P4946, DOI 10.1210/jc.2005-0184; Escobar-Morreale HF, 2005, ANN INTERN MED, V142, P412, DOI 10.7326/0003-4819-142-6-200503150-00007; Farquhar C, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003139.pub2, 10.1002/14651858.CD004143.pub2, 10.1002/14651858.CD003142.pub2, 10.1002/14651858.CD001122.pub2]; Fatemi N, 2008, NEUROSURGERY, V63, P244, DOI 10.1227/01.NEU.0000327025.03975.BA; Fernandez A, 2009, ENDOCR-RELAT CANCER, V16, P733, DOI 10.1677/ERC-08-0231; Ferretti E, 1999, J CLIN ENDOCR METAB, V84, P924, DOI 10.1210/jc.84.3.924; FINKEL DM, 1985, NEW ENGL J MED, V313, P651, DOI 10.1056/NEJM198509123131102; FINKELSTEIN JS, 1989, J CLIN ENDOCR METAB, V69, P776, DOI 10.1210/jcem-69-4-776; FLORKOWSKI CM, 1994, NEW ZEAL MED J, V107, P52; FOREST MG, 1985, ACTA NEUROCHIR, V75, P23, DOI 10.1007/BF01406321; Gasco V, 2008, EUR J ENDOCRINOL, V159, pS45, DOI 10.1530/EJE-08-0293; Germain RMS, 2007, AIDS PATIENT CARE ST, V21, P373, DOI 10.1089/apc.2006.0117; GHIGO E, 1990, J CLIN ENDOCR METAB, V71, P1481, DOI 10.1210/jcem-71-6-1481; Ghigo E, 1996, EUR J ENDOCRINOL, V134, P352, DOI 10.1530/eje.0.1340352; Gibney J, 1999, J CLIN ENDOCR METAB, V84, P2596, DOI 10.1210/jc.84.8.2596; Gleeson HK, 2003, J CLIN ENDOCR METAB, V88, P2106, DOI 10.1210/jc.2002-020969; Gnanalingham KK, 2002, J NEUROSURG, V96, P960, DOI 10.3171/jns.2002.96.5.0960; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; GRINSPOON SK, 1994, J CLIN ENDOCR METAB, V79, P923, DOI 10.1210/jc.79.4.923; Grumbach MM, 2005, J CLIN ENDOCR METAB, V90, P3122, DOI 10.1210/jc.2004-2465; Gurnell EM, 2001, EUR J ENDOCRINOL, V145, P103, DOI 10.1530/eje.0.1450103; Gutenberg A, 2005, AM J SURG PATHOL, V29, P329, DOI 10.1097/01.pas.0000149707.12335.8e; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; HARRISON MJ, 1994, J NEUROSURG, V80, P1018, DOI 10.3171/jns.1994.80.6.1018; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Hartoft-Nielsen ML, 2004, HORM RES, V61, P53, DOI 10.1159/000075239; Hernandez LM, 2007, PITUITARY, V10, P351, DOI 10.1007/s11102-007-0073-3; Heshmati HM, 2001, MAYO CLIN PROC, V76, P789; Hickey M, 2005, LANCET, V366, P409, DOI 10.1016/S0140-6736(05)66519-1; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Hoffman AR, 2004, J CLIN ENDOCR METAB, V89, P3224, DOI 10.1210/jc.2003-032082; Hoffman AR, 2004, J CLIN ENDOCR METAB, V89, P2048, DOI 10.1210/jc.2003-030346; HOFFMAN DM, 1995, J CLIN ENDOCR METAB, V80, P72, DOI 10.1210/jc.80.1.72; Howlett TA, 1997, CLIN ENDOCRINOL, V46, P263, DOI 10.1046/j.1365-2265.1997.1340955.x; Hoybye C, 2009, PITUITARY, V12, P211, DOI 10.1007/s11102-008-0163-x; Hunt PJ, 2000, J CLIN ENDOCR METAB, V85, P4650, DOI 10.1210/jc.85.12.4650; Hurel SJ, 1996, CLIN ENDOCRINOL, V44, P141, DOI 10.1046/j.1365-2265.1996.555381.x; Iqbal J, 1999, ACTA NEUROCHIR, V141, P389, DOI 10.1007/s007010050315; Ishihara T, 1996, ENDOCR J, V43, P433, DOI 10.1507/endocrj.43.433; Isidori AM, 2008, PITUITARY, V11, P171, DOI 10.1007/s11102-008-0111-9; Jodar E, 2003, CLIN ENDOCRINOL, V58, P617, DOI 10.1046/j.1365-2265.2003.01761.x; Johannsson G, 1997, CLIN ENDOCRINOL, V47, P571, DOI 10.1046/j.1365-2265.1997.3271123.x; Johannsson G, 1996, J CLIN ENDOCR METAB, V81, P2865, DOI 10.1210/jc.81.8.2865; Johannsson G, 2002, J CLIN ENDOCR METAB, V87, P2046, DOI 10.1210/jc.87.5.2046; Johannsson G, 1997, J CLIN ENDOCR METAB, V82, P2877, DOI 10.1210/jc.82.9.2877; Johannsson G, 1997, J CLIN ENDOCR METAB, V82, P727, DOI 10.1210/jc.82.3.727; Johannsson G, 1999, J CLIN ENDOCR METAB, V84, P4516, DOI 10.1210/jc.84.12.4516; Johnson MS, 2005, ANN INTERN MED, V142, P855, DOI 10.7326/0003-4819-142-10-200505170-00011; Jonklaas J, 2008, JAMA-J AM MED ASSOC, V299, P769, DOI 10.1001/jama.299.7.769; JORGENSEN JOL, 1994, CLIN ENDOCRINOL, V41, P609, DOI 10.1111/j.1365-2265.1994.tb01826.x; Karavitaki N, 2007, CLIN ENDOCRINOL, V67, P938, DOI 10.1111/j.1365-2265.2007.02990.x; Karavitaki N, 2006, ENDOCR REV, V27, P371, DOI 10.1210/er.2006-0002; Kearney T, 2003, METABOLISM, V52, P50, DOI 10.1053/meta.2003.50061; Kelberman D, 2007, PITUITARY, V10, P393, DOI 10.1007/s11102-007-0055-5; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kristrom B, 2009, J CLIN ENDOCR METAB, V94, P1154, DOI 10.1210/jc.2008-0325; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lania A, 2008, PITUITARY, V11, P181, DOI 10.1007/s11102-008-0122-6; Layman LC, 2007, ENDOCRIN METAB CLIN, V36, P283, DOI 10.1016/j.ecl.2007.03.010; Le Moli R, 1999, NETH J MED, V55, P71, DOI 10.1016/S0300-2977(99)00040-6; LEIBA S, 1986, JAMA-J AM MED ASSOC, V255, P230, DOI 10.1001/jama.255.2.230; Leong KS, 2001, CLIN ENDOCRINOL, V54, P463, DOI 10.1046/j.1365-2265.2001.01169.x; Leung KC, 2004, ENDOCR REV, V25, P693, DOI 10.1210/er.2003-0035; Lewis AS, 2009, PITUITARY, V12, P273, DOI 10.1007/s11102-008-0090-x; Lindholm J, 2001, CLIN ENDOCRINOL, V54, P283, DOI 10.1046/j.1365-2265.2001.01163.x; LITTLEY MD, 1989, Q J MED, V70, P145; Lury Kenneth M, 2005, Top Magn Reson Imaging, V16, P301, DOI 10.1097/01.rmr.0000224686.21748.ea; Machinis K, 2005, J CLIN ENDOCR METAB, V90, P5456, DOI 10.1210/jc.2004-2332; Mah PM, 2005, J CLIN ENDOCR METAB, V90, P5964, DOI 10.1210/jc.2005-1207; Maison P, 2003, CIRCULATION, V108, P2648, DOI 10.1161/01.CIR.0000100720.01867.1D; Maison P, 2004, J CLIN ENDOCR METAB, V89, P2192, DOI 10.1210/jc.2003-030840; Makras P, 2007, TRENDS ENDOCRIN MET, V18, P252, DOI 10.1016/j.tem.2007.06.003; Marik PE, 2002, CHEST, V122, P1784, DOI 10.1378/chest.122.5.1784; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Martins MRA, 2007, J CLIN ENDOCR METAB, V92, P4144, DOI 10.1210/jc.2007-0941; Massier A, 2007, ENDOCR PATHOL, V18, P233, DOI 10.1007/s12022-007-9010-2; Mauras N, 2005, J CLIN ENDOCR METAB, V90, P3946, DOI 10.1210/jc.2005-0208; Mayenknecht J, 1998, J CLIN ENDOCR METAB, V83, P1558, DOI 10.1210/jc.83.5.1558; McCord MW, 1997, INT J RADIAT ONCOL, V39, P437, DOI 10.1016/S0360-3016(97)00335-0; McDermott JH, 2005, J CLIN ENDOCR METAB, V90, P2451, DOI 10.1210/jc.2004-0980; Mehta A, 2008, BEST PRACT RES CL EN, V22, P191, DOI 10.1016/j.beem.2007.07.007; Menon Dileep V, 2006, Treat Endocrinol, V5, P37, DOI 10.2165/00024677-200605010-00005; Miller KK, 2006, J CLIN ENDOCR METAB, V91, P1683, DOI 10.1210/jc.2005-2596; Miller KK, 2001, J CLIN ENDOCR METAB, V86, P2395, DOI 10.1210/jc.86.6.2395; Miller KK, 2001, J CLIN ENDOCR METAB, V86, P561, DOI 10.1210/jc.86.2.561; Minniti G, 2005, CLIN ENDOCRINOL, V62, P210, DOI 10.1111/j.1365-2265.2005.02199.x; Minniti G, 2009, REV ENDOCR METAB DIS, V10, P135, DOI 10.1007/s11154-008-9106-0; Mirocha S, 2009, CLIN EXP IMMUNOL, V155, P403, DOI 10.1111/j.1365-2249.2008.03828.x; Molitch ME, 2007, HORM RES, V68, P145, DOI 10.1159/000110611; MOLITCH ME, 1990, ANN INTERN MED, V112, P925, DOI 10.7326/0003-4819-112-12-925; Molitch ME, 2006, J CLIN ENDOCR METAB, V91, P1621, DOI 10.1210/jc.2005-2227; Mullis PE, 2005, EUR J ENDOCRINOL, V152, P11, DOI 10.1530/eje.1.01797; Murray RD, 2002, J CLIN ENDOCR METAB, V87, P4427, DOI 10.1210/jc.2002-020430; Murray RD, 1999, CLIN ENDOCRINOL, V51, P565, DOI 10.1046/j.1365-2265.1999.00838.x; Nawar Rita N, 2008, J Intensive Care Med, V23, P75, DOI 10.1177/0885066607312992; Netchine I, 2000, NAT GENET, V25, P182, DOI 10.1038/76041; Nieman L K, 2003, J Endocrinol Invest, V26, P74; Nomikos P, 2004, ACTA NEUROCHIR, V146, P27, DOI 10.1007/s00701-003-0174-3; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607; OKADA Y, 1989, ENDOCRINOL JAPON, V36, P695; Orme SM, 1998, CLIN ENDOCRINOL, V49, P773, DOI 10.1046/j.1365-2265.1998.00610.x; Parasrampuria J, 1998, JAMA-J AM MED ASSOC, V280, P1565, DOI 10.1001/jama.280.18.1565; Pelin S, 2009, EUR J DERMATOL, V19, P169, DOI 10.1684/ejd.2008.0584; Pfeifer M, 1999, J CLIN ENDOCR METAB, V84, P453, DOI 10.1210/jc.84.2.453; PLUMPTON FS, 1968, BRIT J SURG, V55, P857; Pokrajac A, 2007, CLIN ENDOCRINOL, V67, P65, DOI 10.1111/j.1365-2265.2007.02836.x; PRESSMAN EK, 1995, J REPROD MED, V40, P251; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; Rasmussen MH, 2010, MOL CELL ENDOCRINOL, V316, P147, DOI 10.1016/j.mce.2009.08.017; Reimondo G, 2008, PITUITARY, V11, P147, DOI 10.1007/s11102-008-0108-4; Reiter EO, 2006, J CLIN ENDOCR METAB, V91, P2047, DOI 10.1210/jc.2005-2284; Reynolds RM, 2006, CLIN ENDOCRINOL, V64, P82, DOI 10.1111/j.1365-2265.2005.02421.x; Richmond EJ, 2008, PITUITARY, V11, P115, DOI 10.1007/s11102-008-0105-7; Rivera Juan-Andres, 2006, Pituitary, V9, P35, DOI 10.1007/s11102-006-6598-z; Roberts CGP, 2004, LANCET, V363, P793, DOI 10.1016/S0140-6736(04)15696-1; Romero CJ, 2009, TRENDS ENDOCRIN MET, V20, P506, DOI 10.1016/j.tem.2009.06.005; Rosen T, 1997, EUR J ENDOCRINOL, V137, P240, DOI 10.1530/eje.0.1370240; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Rosenbloom AL, 1999, J CLIN ENDOCR METAB, V84, P50, DOI 10.1210/jc.84.1.50; ROSENFELD RG, 1995, J CLIN ENDOCR METAB, V80, P1532, DOI 10.1210/jc.80.5.1532; Rosilio M, 2004, J CLIN ENDOCR METAB, V89, P1684, DOI 10.1210/jc.2003-030134; Salvatori R, 2005, JAMA-J AM MED ASSOC, V294, P2481, DOI 10.1001/jama.294.19.2481; Sanmarti A, 1999, EUR J ENDOCRINOL, V141, P481, DOI 10.1530/eje.0.1410481; Sawka AM, 2003, J CLIN ENDOCR METAB, V88, P4551, DOI 10.1210/jc.2003-030139; Schmidt IL, 2003, J CLIN ENDOCR METAB, V88, P4193, DOI 10.1210/jc.2002-021897; Schmiegelow M, 2003, J CLIN ENDOCR METAB, V88, P3149, DOI 10.1210/jc.2002-021994; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Selva KA, 2002, J PEDIATR-US, V141, P786, DOI 10.1067/mpd.2002.128887; Sesmilo G, 2001, J CLIN ENDOCR METAB, V86, P1518, DOI 10.1210/jc.86.4.1518; Sesmilo G, 2000, ANN INTERN MED, V133, P111, DOI 10.7326/0003-4819-133-2-200007180-00010; Shalet SM, 2003, J CLIN ENDOCR METAB, V88, P4124, DOI 10.1210/jc.2003-030126; Siegmund W, 2004, CLIN ENDOCRINOL, V60, P750, DOI 10.1111/j.1365-2265.2004.02050.x; Simon J, 2005, J CLIN ENDOCR METAB, V90, P5226, DOI 10.1210/jc.2004-1747; Skouby SO, 2005, MATURITAS, V51, P8, DOI 10.1016/j.maturitas.2005.02.019; Smith JC, 2002, CLIN ENDOCRINOL, V56, P493, DOI 10.1046/j.1365-2265.2002.01514.x; Snead FE, 2008, INT J RADIAT ONCOL, V71, P994, DOI 10.1016/j.ijrobp.2007.11.057; Stanworth RD, 2009, FRONT HORM RES, V37, P74, DOI 10.1159/000176046; Suliman AM, 2002, CLIN ENDOCRINOL, V56, P533, DOI 10.1046/j.1365-2265.2002.01509.x; Svensson J, 2004, J CLIN ENDOCR METAB, V89, P3306, DOI 10.1210/jc.2003-031601; Svensson J, 2003, J CLIN ENDOCR METAB, V88, P2061, DOI 10.1210/jc.2002-020901; Tabaee A, 2009, J NEUROSURG, V111, P545, DOI 10.3171/2007.12.17635; TANNER JM, 1985, J PEDIATR-US, V107, P317, DOI 10.1016/S0022-3476(85)80501-1; Thaler LM, 1998, J CLIN ENDOCR METAB, V83, P2726, DOI 10.1210/jc.83.8.2726; THODOU E, 1995, J CLIN ENDOCR METAB, V80, P2302, DOI 10.1210/jc.80.8.2302; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Tordjman K, 2000, CLIN ENDOCRINOL, V52, P633, DOI 10.1046/j.1365-2265.2000.00984.x; Turton JPG, 2005, J CLIN ENDOCR METAB, V90, P4762, DOI 10.1210/jc.2005-0570; Underwood LE, 2003, J CLIN ENDOCR METAB, V88, P5273, DOI 10.1210/jc.2003-030204; Vahl N, 2000, J CLIN ENDOCR METAB, V85, P1874, DOI 10.1210/jc.85.5.1874; Valdez R, 2002, HUM PATHOL, V33, P1044, DOI 10.1053/hupa.2002.128063; Verhelst J, 2009, EUR J ENDOCRINOL, V161, pS41, DOI 10.1530/EJE-09-0291; Verrees Meg, 2004, Neurosurg Focus, V16, pE6; Vestergaard P, 2002, CLIN ENDOCRINOL, V56, P159, DOI 10.1046/j.0300-0664.2001.01464.x; Wallace I, 2009, ANN CLIN BIOCHEM, V46, P351, DOI 10.1258/acb.2009.009101; Walsh JP, 2003, J CLIN ENDOCR METAB, V88, P4543, DOI 10.1210/jc.2003-030249; Webb EA, 2010, EUR J HUM GENET, V18, P393, DOI 10.1038/ejhg.2009.125; Webb SM, 1999, J CLIN ENDOCR METAB, V84, P3696, DOI 10.1210/jc.84.10.3696; Wierman ME, 2006, J CLIN ENDOCR METAB, V91, P3697, DOI 10.1210/jc.2006-1121; Wiersinga WM, 2001, HORM RES, V56, P74, DOI 10.1159/000048140; Wolie SQ, 2008, NEUROSURGERY, V63, P173, DOI 10.1227/01.NEU.0000319520.30043.27; Wood L, 2008, ANN CLIN BIOCHEM, V45, P380, DOI 10.1258/acb.2007.007119; Woodhouse LJ, 1999, J CLIN ENDOCR METAB, V84, P4570, DOI 10.1210/jc.84.12.4570; WU FCW, 1993, J CLIN ENDOCR METAB, V76, P26, DOI 10.1210/jc.76.1.26; Wuster C, 2001, J BONE MINER RES, V16, P398, DOI 10.1359/jbmr.2001.16.2.398; Wyatt A, 2008, HUM MUTAT, V29, pE278, DOI 10.1002/humu.20869; Yong TY, 2008, PITUITARY, V11, P77, DOI 10.1007/s11102-007-0021-2; Yuen KCJ, 2009, J CLIN ENDOCR METAB, V94, P2702, DOI 10.1210/jc.2009-0299; Zayour DH, 2004, J CLIN ENDOCR METAB, V89, P5649, DOI 10.1210/jc.2004-0884; ZELISSEN PMJ, 1994, ANN INTERN MED, V120, P207, DOI 10.7326/0003-4819-120-3-199402010-00005; Zhang FL, 2009, J CLIN NEUROSCI, V16, P1273, DOI 10.1016/j.jocn.2009.01.003; Zhong J, 2007, SURG NEUROL, V68, P29, DOI 10.1016/j.surneu.2007.01.079; Zollner EW, 2007, PEDIAT ALLERG IMM-UK, V18, P401, DOI 10.1111/j.1399-3038.2007.00540.x; Zollner EW, 2007, PEDIATR ALLERGY IMMU, V18, P469, DOI 10.1111/j.1399-3038.2007.00539.x	268	6	6	0	1	ELSEVIER ACADEMIC PRESS INC	SAN DIEGO	525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA			978-0-12-380927-8; 978-0-12-380926-1				2011							343	381		10.1016/B978-0-12-380926-1.10010-0			39	Endocrinology & Metabolism	Book Citation Index – Science (BKCI-S)	Endocrinology & Metabolism	BHM84	WOS:000325935700011					2022-02-06	
J	Chesire, DJ; Canto, AI; Buckley, VA				Chesire, David; Canto, Angela; Buckley, Valerie			Hospital-School Collaboration to Serve the Needs of Children With Traumatic Brain Injury	JOURNAL OF APPLIED SCHOOL PSYCHOLOGY			English	Article						traumatic brain injury; school reentry; reintegration	ADOLESCENTS; REINTEGRATION	Traumatic brain injuries are the leading cause of death and disability for children and adolescents each year in the United States. Children who survive these injuries often suffer from a range of impairments including intellectual, academic, behavioral, affective, and social problems, but they often become mired in a slow-moving process while waiting for educational resources. This case study explores one school district's attempts to implement a best practices model of service delivery for students with a traumatic brain injury, focusing on the role of a school psychologist in the multidisciplinary team, candidly discussing and problem-solving several key challenges, and improving the service delivery model overall.	[Chesire, David] Univ Florida, Coll Med, Dept Surg, 655 West 8th St, Jacksonville, FL 32209 USA; [Canto, Angela] Florida State Univ, Tallahassee, FL 32306 USA; [Buckley, Valerie] Duval Cty Publ Sch, Jacksonville, FL 32209 USA		Chesire, DJ (corresponding author), Univ Florida, Coll Med, Dept Surg, 655 West 8th St, Jacksonville, FL 32209 USA.	david.chesire@jax.ufl.edu					Arroyos-Jurado E., 2006, EXCEPTIONALITY, V14, P125, DOI [10.1207/s15327035ex1403_2, DOI 10.1207/S15327035EX1403_2]; Berbaum C., 2008, DISS ABSTR INT A, V68, P3798; Canto A. I., 2010, FLORIDA STATE U 1 YE; Centers for Disease Control, 2000, TRAUM BRAIN INJ US; Curtis M. J., 2008, BEST PRACTICES SCH P, P887; DONDERS J, 1994, J SCHOOL PSYCHOL, V32, P53, DOI 10.1016/0022-4405(94)90028-0; Eagle J. W., 2008, BEST PRACTICES SCH P, VV, P953; Ewing-Cobbs L, 2004, HANDBOOK OF PEDIATRIC PSYCHOLOGY IN SCHOOL SETTINGS, P313; FARMER JE, 1995, SCHOOL PSYCHOL REV, V24, P230; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gopinath S. P., 1992, CLIN TREATMENT HEAD; Grimes J, 1996, SCHOOL PSYCHOL REV, V25, P465; Haider AH, 2004, J PEDIATR SURG, V39, P976, DOI 10.1016/j.jpedsurg.2004.02.028; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; HANSON SL, 1992, PHYSICAL MED REHABIL, V6, P483; Harris MS, 2009, PSYCHOL SCHOOLS, V46, P579, DOI 10.1002/pits.20399; Havey M. J., 2002, BEST PRACTICES SCH P, VIV, P1433; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Jantz PB, 2007, SUPPORT LEARN, V22, P84, DOI 10.1111/j.1467-9604.2007.00452.x; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Madan-Swain A, 2004, HANDBOOK OF PEDIATRIC PSYCHOLOGY IN SCHOOL SETTINGS, P637; McDougall J, 2006, BRAIN INJURY, V20, P1189, DOI 10.1080/02699050600975541; O'Malley D., 2008, DISS ABSTR INT A, V68, P3734; Prevatt FF, 2000, J SCHOOL PSYCHOL, V38, P447, DOI 10.1016/S0022-4405(00)00046-7; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Shaw S. R., 2008, BEST PRACTICES SCH P, P1707; Shaw S. R., 2002, BEST PRACTICES SCH P, VIV, P1473; Shaw SR, 2008, PSYCHOL SCHOOLS, V45, P74, DOI 10.1002/pits.20280; Sheridan S. M., 2002, BEST PRACTICES SCH P, P321; SHIELDS JD, 1995, EDUC TREAT CHILD, V18, P184; Souza Ligia Maria Do N, 2007, Dev Neurorehabil, V10, P35, DOI 10.1080/13638490600822239; THARP RG, 1969, BEHAV MODIFICATION N; Yeates KO., 2006, EXCEPTIONALITY, V14, P141, DOI DOI 10.1207/S15327035EX1403_; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, P369; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	43	6	6	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1537-7903	1537-7911		J APPL SCH PSYCHOL	J. Appl. Sch. Psychol.		2011	27	1					60	76		10.1080/15377903.2011.540513			17	Psychology, Educational	Emerging Sources Citation Index (ESCI)	Psychology	V81BD	WOS:000212224800004					2022-02-06	
J	Demerjian, GG; Sims, AB; Stack, BC				Demerjian, Garabed Gary; Sims, Anothony Benjamin; Stack, Brendan Curran			Proteomic signature of Temporomandibular Joint Disorders (TMD): Toward diagnostically predictive biomarkers	BIOINFORMATION			English	Article								The temporomandibular joint (TMJ) articulates the mandible with the maxilla. Temporomandibular joint disorders (TMD) are dysfunctions of this joint, which range from acute to chronic inflammation, trauma and dislocations, developmental anomalies and neoplasia. TMD manifest as signs and symptoms that involve the surrounding muscles, ligaments, bones, synovial capsule, connective tissue, teeth and innervations proximal and distal to this joint. TMD induce proximal and distal, chronic and acute, dull or intense pain and discomfort, muscle spasm, clicking/popping sounds upon opening and closing of the mouth, and chewing or speaking difficulties. The trigeminal cranial nerve V, and its branches provide the primary sensory innervation to the TMJ. Our clinical work suggests that the auriculotemporal (AT) nerve, a branch of the mandibular nerve, the largest of the three divisions of the trigeminal nerve, plays a critical role in TMD sequelae. The AT nerve provides the somatosensory fibers that supply the joint, the middle ear, and the temporal region. By projecting fibers toward the otic ganglion, the AT nerve establishes an important bridge to the sympathetic system. As it courses posteriorly to the condylar head of the TMJ, compression, injury or irritation of the AT nerve can lead to significant neurologic and neuro-muscular disorders, including Tourette's syndrome, Torticolli, gait or balance disorders and Parkinson's disease. Here, we propose that a proteomic signature of TMD can be obtained by assessing certain biomarkers in local (e.g., synovial fluid at the joint) and distal body fluids (e.g., saliva, cerebrospinal fluid), which can aid TMD diagnosis and prognosis.				drdemerjian@yahoo.com	Stack, Brendan C./AAQ-5580-2020	Stack, Brendan C./0000-0003-2896-1615			Aramideh M, 2002, MUSCLE NERVE, V26, P14, DOI 10.1002/mus.10120; Arasho B, 2009, NEUROL INDIA, V57, P375, DOI 10.4103/0028-3886.55577; Bartolo M, 2008, MOVEMENT DISORD, V23, P1475, DOI 10.1002/mds.22039; Chiappelli F, 2006, BIOINFORMATION, V1, P331, DOI 10.6026/97320630001331; Fernandes PRB, 2003, CRANIO, V21, P165, DOI 10.1080/08869634.2003.11746246; Fricton J, 2010, J OROFAC PAIN, V24, P237; Greene CS, 2010, AM J ORTHOD DENTOFAC, V138, P3, DOI 10.1016/j.ajodo.2010.04.015; Janis JE, 2010, PLAST RECONSTR SURG, V125, P1422, DOI 10.1097/PRS.0b013e3181d4fb05; JOHANSSON AS, 1990, J ORAL MAXIL SURG, V48, P953, DOI 10.1016/0278-2391(90)90008-P; Kaneyama K, 2010, J ORAL MAXIL SURG, V68, P1088, DOI 10.1016/j.joms.2009.10.027; Ogura N, 2010, J DENT RES; Oluwadara O, 2009, BIOINFORMATION, V3, P332, DOI 10.6026/97320630003332; Schaller B, 2009, J NEUROSURG ANESTH, V21, P187, DOI 10.1097/ANA.0b013e3181a2bf22; Schmidt BL, 1998, ORAL SURG ORAL MED O, V86, P165, DOI 10.1016/S1079-2104(98)90119-6; Sims A, 2009, CRANIO, V27, P11, DOI 10.1179/crn.2009.003; Stack B, 2009, CRANIO, V27, P248, DOI 10.1179/crn.2009.036; Van Uum SHM, 2008, STRESS, V11, P483, DOI 10.1080/10253890801887388; Wei LL, 2010, J ORAL MAXIL SURG, V68, P2478, DOI 10.1016/j.joms.2010.01.018	18	6	7	0	2	BIOMEDICAL INFORMATICS	TAMIL NADU	NO 42, 2ND MAIN RD, CHENNAI, TAMIL NADU, 600 020, INDIA	0973-8894	0973-2063		BIOINFORMATION	Bioinformation		2011	5	7					282	284		10.6026/97320630005282			3	Mathematical & Computational Biology	Emerging Sources Citation Index (ESCI)	Mathematical & Computational Biology	VG9HE	WOS:000449328200003	21364835	Green Published, Green Submitted, hybrid			2022-02-06	
J	Kim, S; Park, MH; Han, SH; Na, HR; Cho, S; Choi, MS; Lee, JH; Na, DL; Kim, JE; Park, KW				Kim, SangYun; Park, Moon Ho; Han, Seol-Heui; Na, Hae Ri; Cho, SungJin; Choi, Mun Seong; Lee, Jae-Hong; Na, Duk L.; Kim, Jung Eun; Park, Kun Woo			Validation Analysis of the Attention Questionnaire Scale	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; attention; dementia; questionnaire	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; BRIEF INFORMANT; PERFORMANCE; AWARENESS; DEMENTIA; RATINGS	Screening tests that briefly measure early signs of cognitive dysfunction in Alzheimer's disease (AD) are lacking. We devised a newscale focused on early detecting cognitive dysfunction: the Attention Questionnaire Scale (AQS). We prospectively studied the AQS in 268 subjects with varying degrees of cognitive dysfunction and compared it with the Mini-Mental Status Examination (MMSE), digit span test, trail making test part B, letter cancellation test, Instrumental ADL, Geriatric Depression Scale, and Clinical Dementia Rating Scale. The internal consistency was excellent with the AQS (Cronbach's alpha = 0.945). There were significant differences in the overall AQS scores across varying degree of cognitive dysfunction (26.80 +/- 3.43 in normal elderly, 20.78 +/- 4.83 in patients with mild cognitive impairment (MCI), 19.01 +/- 4.49 in early AD, 16.00 +/- 5.03 in mild AD, and 12.02 +/- 6.28 in moderate AD), and subjects with the early stage of cognitive dysfunction could be further distinguished using the AQS than MMSE. The area under the receiver operating characteristic curve was estimated to be 0.93 (95% confidence interval 0.89-0.97) in screening for normal elderly versus patients with MCI or various stages of AD. The AQS provides greater screening ability for early stage cognitive dysfunction, used not only as a screening tool but also an appropriate simple questionnaire.	[Kim, SangYun] Seoul Natl Univ, Coll Med, Dept Neurol, Songnam, South Korea; [Kim, SangYun] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea; [Park, Moon Ho; Park, Kun Woo] Korea Univ, Coll Med, Dept Neurol, Ansan, South Korea; [Park, Moon Ho] Korea Univ, Ansan Hosp, Ansan, South Korea; [Han, Seol-Heui] Konkuk Univ, Sch Med, Dept Neurol, Seoul, South Korea; [Han, Seol-Heui] Konkuk Univ, Med Ctr, Seoul, South Korea; [Na, Hae Ri] Bobath Mem Hosp, Dept Neurol, Songnam, South Korea; [Cho, SungJin] SungAe Gen Hosp, Dept Neurol, Seoul, South Korea; [Choi, Mun Seong] Maryknoll Hosp, Dept Neurol, Pusan, South Korea; [Lee, Jae-Hong] Univ Ulsan, Coll Med, Dept Neurol, Seoul, South Korea; [Lee, Jae-Hong] Asan Med Ctr, Seoul, South Korea; [Na, Duk L.] Sungkyunkwan Univ, Sch Med, Dept Neurol, Seoul, South Korea; [Kim, Jung Eun] Ewha Womans Univ, Dept Neurol, Ctr Cognit & Neurodegenerat Disorders, Mokdong Hosp, Seoul, South Korea; [Kim, Jung Eun] Ewha Womans Univ, Sch Med, Seoul, South Korea; [Park, Kun Woo] Korea Univ, Anam Hosp, Seoul, South Korea		Kim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Neurol, 166 Gumi Ro, Songnam 463707, Gyeonggi Do, South Korea.	neuroksy@snu.ac.kr	Kim, Sang Yun/J-5400-2012; Na, Duk Lyul/C-9598-2011		Janssen, Korea, Ltd., a Johnson & Johnson companyJohnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc	The authors thank the members of the Attention Questionnaire Investigators Group. The authors thank the Medical Research Collaborating Center, Seoul National University for statistical support. This investigation was supported by Janssen, Korea, Ltd., a Johnson & Johnson company.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Ashford J W, 2001, Curr Psychiatry Rep, V3, P20, DOI 10.1007/s11920-001-0067-1; Baddeley AD, 2001, BRAIN, V124, P1492, DOI 10.1093/brain/124.8.1492; Buckley T, 2010, INT J GERIATR PSYCH, V25, P739, DOI 10.1002/gps.2416; Burgess P, 1996, BEHAV ASSESSMENT DYS; Choi S.H., 2001, J KOREAN NEUROL ASS, V19, P585; Clare L, 2005, AGING MENT HEALTH, V9, P394, DOI 10.1080/13607860500142903; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dywan J, 1996, J HEAD TRAUMA REHAB, V11, P79, DOI 10.1097/00001199-199604000-00008; Galvin JE, 2007, ARCH NEUROL-CHICAGO, V64, P718, DOI 10.1001/archneur.64.5.718; Galvin JE, 2005, NEUROLOGY, V65, P559, DOI 10.1212/01.wnl.0000172958.95282.2a; Graham DP, 2005, COGNITIVE BRAIN RES, V25, P144, DOI 10.1016/j.cogbrainres.2005.05.001; Han C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-10; Hart T, 2006, ARCH PHYS MED REHAB, V87, P647, DOI 10.1016/j.apmr.2006.01.016; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; Jung IK, 1997, J KOREAN GERIATR PSY, V1, P61; Kang S.J., 2002, J KOREAN NEUROL ASS, V20, P8; Kang Y., 1997, J KOREAN NEUROL ASS, V15, P300; Kang Y.W., 2003, SEOUL NEUROPSYCHOLOG; Kang Yeonwook, 2002, Korean Journal of Clinical Psychology, V21, P911; Kim JE, 2007, J CLIN NEUROL, V3, P9, DOI 10.3988/jcn.2007.3.1.9; MORRIS JC, 1991, NEUROLOGY, V41, P469, DOI 10.1212/WNL.41.4.469; Onor M L, 2006, Am J Alzheimers Dis Other Demen, V21, P333, DOI 10.1177/1533317506292454; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; RAY C, 1993, BRIT J CLIN PSYCHOL, V32, P357, DOI 10.1111/j.2044-8260.1993.tb01068.x; Ready RE, 2004, ALZ DIS ASSOC DIS, V18, P11, DOI 10.1097/00002093-200401000-00003; Sliwinski M, 1996, J GERONTOL B-PSYCHOL, V51, pP217, DOI 10.1093/geronb/51B.4.P217; Yoon SM, 2008, J KOREAN NEUROSURG S, V44, P308, DOI 10.3340/jkns.2008.44.5.308	28	6	6	0	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2011	24	2					393	402		10.3233/JAD-2011-100660			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	747WS	WOS:000289352400018	21297275				2022-02-06	
J	Lippert-Gruner, M; Magele, M; Svestkova, O; Angerova, Y; Ester-Bode, T; Angelov, DN				Lippert-Gruener, M.; Maegele, M.; Svestkova, O.; Angerova, Y.; Ester-Bode, T.; Angelov, D. N.			Rehabilitation Intervention in Animal Model Can Improve Neuromotor and Cognitive Functions After Traumatic Brain Injury: Pilot Study	PHYSIOLOGICAL RESEARCH			English	Article						Brain trauma recovery; Multisensory rehabilitation model; Enriched environment	USE-DEPENDENT EXAGGERATION; ENVIRONMENTAL ENRICHMENT; NEUROTROPHIC FACTOR; CEREBRAL INFARCTION; PHYSICAL-ACTIVITY; AFFECTED FORELIMB; NEURONAL INJURY; RAT; EXPRESSION; ISCHEMIA	The aim of the present study was to quantify the effect of multisensory rehabilitation on rats' cognition after an experimental brain trauma and to assess its possible clinical implications. The complex intermittent multisensory rehabilitation consisted of currently used major therapeutic procedures targeted at the improvement of cognitive functions; including multisensory and motor stimulation and enriched environment. We have confirmed this positive effect of early multisensory rehabilitation on the recovery of motor functions after traumatic brain injury. However, we have been able to prove a positive effect on the recovery of cognitive functions only with respect to the frequency of efficient search strategies in a Barnes maze test, while results for search time and travelled distance were not significantly different between study groups. We have concluded that the positive effects of an early treatment of functional deficits are comparable with the clinical results in early neurorehabilitation in human patients after brain trauma. It might therefore be reasonable to apply these experimental results to human medical neurorehabilitation care.	[Lippert-Gruener, M.; Svestkova, O.; Angerova, Y.] Charles Univ Prague, Dept Rehabil Med, Fac Med 1, Albertov 7, Prague 12800, Czech Republic; [Lippert-Gruener, M.] Univ Cologne, Dept Neurosurg, Fac Med, D-5000 Cologne 41, Germany; [Maegele, M.] Univ Witten Herdecke, Merheim Med Ctr, Dept Surg, Cologne, Germany; [Lippert-Gruener, M.; Svestkova, O.; Angerova, Y.] Gen Teaching Hosp Prague, Prague, Czech Republic; [Ester-Bode, T.] Univ Witten Herdecke, Dept Neurol, Merheim Med Ctr, Cologne, Germany; [Angelov, D. N.] Univ Cologne, Inst Anat 1, D-5000 Cologne, Germany		Svestkova, O (corresponding author), Charles Univ Prague, Dept Rehabil Med, Fac Med 1, Albertov 7, Prague 12800, Czech Republic.	olga.svestkova@lf1.cuni.cz	Svetkova, Olga/O-1062-2017; Angerova, Yvona/AAL-8925-2021	Svetkova, Olga/0000-0002-4271-4795; 			BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BENNETT EL, 1964, SCIENCE, V146, P610, DOI 10.1126/science.146.3644.610; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Bland ST, 2001, BEHAV BRAIN RES, V126, P33, DOI 10.1016/S0166-4328(01)00243-1; Bland ST, 2000, STROKE, V31, P1144, DOI 10.1161/01.STR.31.5.1144; Czeh B, 1998, HIPPOCAMPUS, V8, P647, DOI 10.1002/(SICI)1098-1063(1998)8:6<647::AID-HIPO7>3.0.CO;2-L; DALY M, 1973, BRIT J PSYCHOL, V64, P435, DOI 10.1111/j.2044-8295.1973.tb01370.x; DENENBERG VH, 1971, EARLY CHILDHOOD DEV, P39; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; GENTILE AM, 1987, BEHAV NEURAL BIOL, V47, P321, DOI 10.1016/S0163-1047(87)90435-3; GRABOWSKI M, 1995, EXP NEUROL, V133, P96, DOI 10.1006/exnr.1995.1011; GREENOUGH WT, 1973, EXP NEUROL, V40, P491, DOI 10.1016/0014-4886(73)90090-3; Gruner ML, 2000, BRAIN INJURY, V14, P585; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Humm JL, 1999, EXP NEUROL, V157, P349, DOI 10.1006/exnr.1999.7061; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Johansson BB, 1996, EXP NEUROL, V139, P322, DOI 10.1006/exnr.1996.0106; Johansson BB, 2002, J CEREBR BLOOD F MET, V22, P89, DOI 10.1097/00004647-200201000-00011; Kolb B., 1995, BRAIN PLASTICITY BEH; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Lauterborn JC, 1996, J NEUROSCI, V16, P7428; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359, DOI 10.33549/physiolres.930971; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Lippert-Gruner M, 2002, ACT NEUR S, V79, P21; MAEGELE M, 2002, LANGENBECK ARCH SURG, V387, P266; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; NAKAYAMA M, 1994, MOL BRAIN RES, V21, P206, DOI 10.1016/0169-328X(94)90251-8; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/0006-8993(96)00273-9; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Risedal A, 1999, J CEREBR BLOOD F MET, V19, P997, DOI 10.1097/00004647-199909000-00007; ROSENZWE.MR, 1966, AM PSYCHOL, V21, P321, DOI 10.1037/h0023555; Saatman KE, 2001, J NEUROPATH EXP NEUR, V60, P183, DOI 10.1093/jnen/60.2.183; SINSON G, 1995, J NEUROCHEM, V65, P2209; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Zeng JS, 2000, EXP NEUROL, V164, P176, DOI 10.1006/exnr.2000.7423; Zhao LR, 2001, NEUROSCI LETT, V305, P169, DOI 10.1016/S0304-3940(01)01837-7	42	6	8	0	8	ACAD SCIENCES CZECH REPUBLIC, INST PHYSIOLOGY	PRAGUE 4	VIDENSKA 1083, PRAGUE 4 142 20, CZECH REPUBLIC	0862-8408	1802-9973		PHYSIOL RES	Physiol. Res.		2011	60	2					367	375		10.33549/physiolres.931816			9	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	771KF	WOS:000291154900020	21114367	gold			2022-02-06	
J	Martin-Saez, M; Deakins, J; Winson, R; Watson, P; Wilson, BA				Martin-Saez, Maria; Deakins, Joe; Winson, Rachel; Watson, Peter; Wilson, Barbara A.			A 10-year follow up of a paging service for people with memory and planning problems within a healthcare system: How do recent users differ from the original users?	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Memory; Planning problems; Independence; Traumatic brain injury; Paging system	NEUROPAGE; REHABILITATION	In 2003 Wilson, Scott, Evans, and Emslie published a report of a new healthcare resource; a paging system designed to reduce the everyday problems of people with neurological deficits who experience memory and/or planning problems. The system was established following several research studies carried out to evaluate its effectiveness. Information was collected on the first 40 clients recruited to the service. The purpose of the present study is to determine how the service might have changed over a 10-year period. The most recent users of the service (N = 40) have been compared with the original cohort of 40 clients. In addition, in 2007 clients were given the opportunity to use their mobile telephones to receive messages; 17 chose to do so. There was no difference in age between the telephone users compared to the pager users, but those using a pager were less likely to have sustained a traumatic brain injury (TBI) and were more likely to be longer post-insult. There were no significant differences in the gender or ages of the people using the pager compared with those using the telephone service. However, the mean overall time since injury for the last 40 referrals was 9.48 years compared to 4.56 years for the original cohort. Both cohorts comprised several diagnostic groups; clients with TBI formed the largest subgroup, followed by those with stroke. This is typical of patients seen for rehabilitation, with other diagnostic groups forming a smaller percentage. We wanted to determine whether the range of diagnoses was similar over the 10-year period. Despite slight differences, we found a similar range of patients referred. In both cohorts the most frequent messages sent each week related to medication (27.9% in the first compared to 28.6% in the second). More messages were sent regarding mood management in the second cohort. No such messages were sent to the first 40 clients, whereas over 27 per week were sent to the last 40. Fewer health authorities (N = 21) were referring after 10 years in comparison with 26 referrers for the first cohort.	[Watson, Peter; Wilson, Barbara A.] MRC Cognit & Brain Sci Unit, Cambridge CB2 7EF, England; [Martin-Saez, Maria; Deakins, Joe; Winson, Rachel; Wilson, Barbara A.] Oliver Zangwill Ctr Neuropsychol Rehabil, Ely, Cambs, England		Wilson, BA (corresponding author), MRC Cognit & Brain Sci Unit, 14 Chaucer Rd, Cambridge CB2 7EF, England.	barbara.wilson00@gmail.com		Martin Saez, Maria Mar/0000-0003-1926-3583; Watson, Peter/0000-0002-9436-0693	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U105579212] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U105579212] Funding Source: Medline		Daisley A, 2009, HEAD INJURY FACTS; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; Emslie H, 2007, NEUROPSYCHOL REHABIL, V17, P567, DOI 10.1080/09602010701381933; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Fish J, 2008, J NEUROL NEUROSUR PS, V79, P930, DOI 10.1136/jnnp.2007.125203; Hersch N., 1999, NEUROREHABILITATION, V4, P187; Kapur N., 2009, MEMORY REHABILITATIO, P52; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Wilson B, 2009, MEMORY REHABILITATIO; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Wilson BA, 2003, NEUROREHABILITATION, V18, P3; Wilson BA, 2003, NEURO S B C, P329; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 1999, REHABIL PSYCHOL, V44, P284, DOI 10.1037/0090-5550.44.3.284; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wilson BA, 2009, DEV NEUROREHABIL, V12, P421, DOI 10.3109/17518420903200573; Wright P, 2001, INT J REHABIL RES, V24, P299, DOI 10.1097/00004356-200112000-00006	18	6	6	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2011	21	6					769	783		10.1080/09602011.2011.614378			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	885OT	WOS:000299789200001	22026441				2022-02-06	
J	McElligott, J; Carroll, A; Morgan, J; Macdonnell, C; Neumann, V; Gutenbrunner, C; Fialka-Moser, V; Christodoulou, N; Varela, E; Giustini, A; Delarque, A; Assucena, A; Lukmann, A; Tuulik-Leisi, V; Zoltan, D				McElligott, Jacinta; Carroll, A.; Morgan, J.; Macdonnell, C.; Neumann, V.; Gutenbrunner, C.; Fialka-Moser, V.; Christodoulou, N.; Varela, E.; Giustini, A.; Delarque, A.; Assucena, A.; Lukmann, A.; Tuulik-Leisi, V.; Zoltan, D.			European Models of Multidisciplinary Rehabilitation Services for Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Traumatic Brain Injury; Interdisciplinary Health Team; Rehabilitation; Europe	EPIDEMIOLOGY		[McElligott, Jacinta; Carroll, A.; Morgan, J.] Natl Rehabil Hosp, Dublin, Ireland		McElligott, J (corresponding author), Natl Rehabil Hosp, Rochestown Ave, Dublin, Ireland.		Carroll, Aine/ABG-2309-2020	Carroll, Aine/0000-0002-4383-8650; Gutenbrunner, Christoph/0000-0002-6522-1942			Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Neumann V, 2010, J REHABIL MED, V42, P4, DOI 10.2340/16501977-0483; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y	7	6	6	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JAN	2011	90	1					74	78		10.1097/PHM.0b013e318201744e			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	695ZW	WOS:000285412700010	21169747				2022-02-06	
B	Murphy, GC; O'Hare, MA		Geisen, T; Harder, H		Murphy, Gregory C.; O'Hare, Mary A.			The Role of Workplace Social Support in Disability Management	DISABILITY MANAGEMENT AND WORKPLACE INTEGRATION: INTERNATIONAL RESEARCH FINDINGS			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; WORK DISABILITY; BACK-PAIN; REHABILITATION; OUTCOMES; STRESS; HEALTH; PREVENTION; DISORDERS; SERVICE		[Murphy, Gregory C.] La Trobe Univ, Sch Publ Hlth, Bundoora, Vic, Australia; [O'Hare, Mary A.] Massey Univ, Palmerston North, New Zealand								Amick BC, 2000, J OCCUP REHABIL, V10, P21, DOI 10.1023/A:1009437728024; Andersen LP, 2007, J OCCUP REHABIL, V17, P107, DOI 10.1007/s10926-007-9064-5; Anema JR, 2007, SPINE, V32, P291, DOI 10.1097/01.brs.0000253604.90039.ad; Armengol CG, 1999, J HEAD TRAUMA REHAB, V14, P233, DOI 10.1097/00001199-199906000-00004; Babin BJ, 1996, J RETAILING, V72, P57, DOI 10.1016/S0022-4359(96)90005-6; Beaudway D., 1986, J APPLIED REHABILITA, V17, P20; Borja SE, 2009, PSYCHOL TRAUMA-US, V1, P118, DOI 10.1037/a0016011; COBB S, 1976, PSYCHOSOM MED, V38, P300, DOI 10.1097/00006842-197609000-00003; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Currier KF, 2001, REHABIL COUNS BULL, V44, P133, DOI 10.1177/003435520104400303; Eisenberger NI, 2007, NEUROIMAGE, V35, P1601, DOI 10.1016/j.neuroimage.2007.01.038; Esselman PC, 2007, ARCH PHYS MED REHAB, V88, pS50, DOI 10.1016/j.apmr.2007.09.009; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Galvin D., 1986, ANN REV REHABILITATI; GOTTLIEB BH, 1983, SOCIAL SUPPORT STRAT; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; Habeck R., 1991, REHABILITATION COUNS, V34, P211; Homans GL, 1974, SOCIAL BEHAV; HOUSE JS, 1988, ANNU REV SOCIOL, V14, P293, DOI 10.1146/annurev.so.14.080188.001453; Jarvikoski A., 1980, EARLY REHABILITATION; Kaplan RM., 1990, SOCIAL SUPPORT INTER, P427; Karrholm J, 2008, J REHABIL MED, V40, P628, DOI 10.2340/16501977-0233; Katz JN, 2005, AM J IND MED, V47, P120, DOI 10.1002/ajim.20127; Klonoff PS, 2007, BRAIN INJURY, V21, P1097, DOI 10.1080/02699050701687342; Kuoppala J, 2008, J REHABIL MED, V40, P796, DOI 10.2340/16501977-0270; Loisel P, 1997, SPINE, V22, P2911, DOI 10.1097/00007632-199712150-00014; Loisel P, 2005, J OCCUP REHABIL, V15, P507, DOI 10.1007/s10926-005-8031-2; Mayer T, 1998, SPINE, V23, P598, DOI 10.1097/00007632-199803010-00013; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; MILLER KI, 1986, ACAD MANAGE J, V29, P727, DOI 10.2307/255942; MILLSTEIN S, 1985, PROSTHET ORTHOT INT, V9, P69; Munrowd D., 1986, J APPLIED REHABILITA, V17, P23; Murphy G C, 1993, J Occup Rehabil, V3, P51, DOI 10.1007/BF01076742; Murphy G. C., 2009, C P AUSTR PSYCH SOC; Murphy G. C., 2008, ANAL HLTH POLICY; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; Petrie K. J., 2004, INT ENCY SOCIAL BEHA, P14458; PIERCE GR, 1991, J PERS SOC PSYCHOL, V61, P1028, DOI 10.1037/0022-3514.61.6.1028; Pransky GS, 2005, AM J IND MED, V47, P104, DOI 10.1002/ajim.20122; ROOK KS, 1992, SER CLIN C, P157; ROOK KS, 1984, J PERS SOC PSYCHOL, V46, P1097, DOI 10.1037/0022-3514.46.5.1097; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; Schwarzer R, 1992, LIFE CRISES EXPERIEN, P435; Selye H., 1950, STRESS; Shrey D E, 1994, J Occup Rehabil, V4, P39, DOI 10.1007/BF02109995; Shrey DE, 1999, J OCCUP REHABIL, V9, P45, DOI 10.1023/A:1021393432243; SHREY DE, 1995, PRINCIPLES PRACTICES; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; VEIEL HOF, 1992, MEANING MEASUREMENT; Wallis L., 2010, THESIS LA TROBE U ME; West M, 1990, Int J Rehabil Res, V13, P291, DOI 10.1097/00004356-199012000-00002; Williams RM, 2007, J OCCUP REHABIL, V17, P153, DOI 10.1007/s10926-006-9045-0; [No title captured]; [No title captured]	56	6	6	0	1	GOWER PUBL CO	NEW YORK	1185 AVE OF THE AMERICAS, NEW YORK, NY 10036 USA			978-1-4094-1889-4; 978-1-4094-1888-7				2011							43	58					16	Public, Environmental & Occupational Health; Management	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Public, Environmental & Occupational Health; Business & Economics	BA7LU	WOS:000337631500004					2022-02-06	
J	Parente, R; DeMott, E; Johnson, C; Jennings, P; Silver, R				Parente, Rick; DeMott, Ellen; Johnson, Craig; Jennings, Peter; Silver, Rebecca			Measuring and manipulating subjective organization after traumatic brain injury	NEUROREHABILITATION			English	Article						Subjective organization; memory; transfer of learning; traumatic brain injury; part-whole learning	FREE-RECALL	This study presents a method for assessing subjective organization (SO) after brain injury and techniques for planning cognitive rehabilitation therapy based on the survivor's SO ability. Eighty-seven college students, 50 persons with traumatic brain injury (TBI), and 30 participants with specific learning disability (SLD) learned two overlapping lists of unrelated nouns in which half of the second list were words that the person had learned on the first list. The study assessed whether different patterns of recall for the overlapping words versus the new words on the second list would discriminate persons with brain injury relative to college students and persons with SLD. The results indicated that college students and the SLD participants showed significantly diminished recall of overlapping words on the second list. However, the TBI participants showed significantly improved recall of the overlapping words. The results indicated that this task provides a simple diagnostic assessment of a participant's SO ability. The results also suggested that a TBI survivor's level of SO may moderate the success of prevocational cognitive rehabilitation therapies.	[Parente, Rick; DeMott, Ellen; Johnson, Craig; Jennings, Peter] Towson Univ, Towson, MD USA; [Silver, Rebecca] Syracuse Univ, Syracuse, NY USA		Parente, R (corresponding author), 1212 Brookview Rd, Towson, MD 21286 USA.	rparente10@yahoo.com	Parente, Frederick/W-2570-2019	Parente, Frederick/0000-0002-2784-3433			DEMATT E, 2009, THESIS TOWSON U; Ellis H.C., 1965, TRANSFER LEARNING; HARTZLER B, 2007, THESIS TOWSON U; Howard MW, 2002, J MEM LANG, V46, P85, DOI 10.1006/jmla.2001.2798; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; PARENTE R, 2003, RETRAINING COGNITION; TULVING E, 1966, J VERB LEARN VERB BE, V5, P193, DOI 10.1016/S0022-5371(66)80016-6; Twum M, 1994, NeuroRehabilitation, V4, P157, DOI 10.3233/NRE-1994-4306; UNDERWOO.BJ, 1969, PSYCHOL REV, V76, P559, DOI 10.1037/h0028143; WAUGH NC, 1967, J EXP PSYCHOL, V73, P39, DOI 10.1037/h0024125; WESCHSLER D, 1955, WECHSLER ADULT INTEL; Wilbur R, 2007, J CLIN EXP NEUROPSYC, V29, P682, DOI 10.1080/13803390600932120	13	6	6	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2011	29	2					117	124		10.3233/NRE-2011-0685			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	842IB	WOS:000296589600001	22027072				2022-02-06	
J	Smith, A; Stuart, M; Greenwald, R; Benson, B; Dodick, D; Emery, C; Finnoff, J; Mihalik, J; Roberts, W; Sullivan, CA; Meeuwisse, W; Ashare, A; Aubry, M; Tator, C; Echemendia, R; Fraser, K; Johnson, J; Krause, D; Lovell, M; Mariconda, J; Mariconda, T; Whitehead, J; Wiese-Bjornstal, D; Babson, T; Bazarian, J; Bishop, P; Brooks, A; Dick, R; Echlin, P; Forbes, S; Gill, K; Gioia, G; Guskiewicz, K; Halstead, PD; Herring, S; Hoshizaki, B; LaPrade, R; Lavoi, N; Macpherson, A; McKee, A; Moore, D; Moore, H; Montelpare, W; Putukian, M; Sarmiento, K; Stacey, D; Szalkowski, R				Smith, A.; Stuart, M.; Greenwald, R.; Benson, B.; Dodick, D.; Emery, C.; Finnoff, J.; Mihalik, J.; Roberts, W.; Sullivan, C. A.; Meeuwisse, W.; Ashare, A.; Aubry, M.; Tator, C.; Echemendia, R.; Fraser, K.; Johnson, J.; Krause, D.; Lovell, M.; Mariconda, J.; Mariconda, T.; Whitehead, J.; Wiese-Bjornstal, D.; Babson, T.; Bazarian, J.; Bishop, P.; Brooks, A.; Dick, R.; Echlin, P.; Forbes, S.; Gill, K.; Gioia, G.; Guskiewicz, K.; Halstead, P. David; Herring, S.; Hoshizaki, B.; LaPrade, R.; Lavoi, N.; Macpherson, A.; McKee, A.; Moore, D.; Moore, H.; Montelpare, W.; Putukian, M.; Sarmiento, K.; Stacey, D.; Szalkowski, R.			Proceedings From the Ice Hockey Summit on Concussion: A Call to Action	CLINICAL NEUROPSYCHOLOGIST			English	Article						Concussion; Hockey	SPORTS-RELATED CONCUSSION; NEURON-SPECIFIC ENOLASE; RETURN-TO-PLAY; HIGH-SCHOOL; INJURY PREVENTION; BODY-CHECKING; RECURRENT CONCUSSION; NORTH-AMERICAN; HEAD-INJURIES; ASSOCIATION	The objective of this proceedings is to integrate the concussion in sport literature and sport science research on safety in ice hockey to develop an action plan to reduce the risk, incidence, severity, and consequences of concussion in ice hockey. A rationale paper outlining a collaborative action plan to address concussions in hockey was posted for review two months prior to the Ice Hockey Summit: Action on Concussion. Focused presentations devoted specifically to concussion in ice hockey were presented during the Summit and breakout sessions were used to develop strategies to reduce concussion in the sport. This proceedings and a detailed scientific review (a matrix of solutions) were written to disseminate the evidence-based information and resulting concussion reduction strategies. The manuscripts were reviewed by the authors, advisors and contributors to ensure that the opinions and recommendations reflect the current level of knowledge on concussion in hockey. Six components of a potential solution were articulated in the Rationale paper and became the topics for breakout groups that followed the professional, scientific lectures. Topics that formed the core of the action plan were: metrics and databases; recognizing, managing and return to play; hockey equipment and ice arenas; prevention and education; rules and regulations; and expedient communication of the outcomes. The attendees in breakout sessions identified action items for each section. The most highly ranked action items were brought to a vote in the open assembly, using an Audience Response System (ARS). The strategic planning process was conducted to assess: Where are we at?; Where must we get to?; and What strategies are necessary to make progress on the prioritized action items? Three prioritized action items for each component of the solution and the percentage of the votes received are listed in the body of this proceedings.					Emery, Carolyn/AAI-2761-2020; Wiese-Bjornstal, Diane M./L-1408-2019; Echemendia, Ruben/R-6939-2019	Wiese-Bjornstal, Diane M./0000-0003-4824-3311; Mihalik, Jason/0000-0001-6085-8322; Roberts, William O/0000-0003-4517-4330	Hockey Equipment Certification Council; International Ice Hockey Federation; Ontario Neurotrauma Foundation; USA Hockey	Hockey Equipment Certification Council, International Ice Hockey Federation, Ontario Neurotrauma Foundation, and USA Hockey.	Ackery A, 2009, CAN J NEUROL SCI, V36, P207, DOI 10.1017/S0317167100120281; Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; [Anonymous], HEADS CONC YOUTH SPO, V2010; [Anonymous], FACTS PREV TIPS, V2010; [Anonymous], 2010, STOP SPORTS INJURIES, V2010; Ashare A., 2009, SAFETY ICE HOCKEY, V5, P336; Ashare A. B., 2000, SAFETY ICE HOCKEY, V3, P313; Asplund C, 2009, BRIT J SPORT MED, V43, P993, DOI 10.1136/bjsm.2009.060152; Aubry M, 2001, BRIT J SPORT MED, V36, P6, DOI DOI 10.1136/BJSM.36.1.6; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bazarian J., 2009, SCIENCEDAILY    0402, V2010; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Bernard D, 2004, AM SOC TEST MATER, V1446, P152, DOI 10.1520/STP11616S; Bernstein R., 2006, CODE UNWRITTEN RULES; Bishop PJ, 2009, AM SOC TEST MATER, V1516, P3, DOI 10.1520/JAI101900; Bishop PJ, 2008, SAFETY ICE HOCKEY, V5, P171; Bloom GA, 2004, AM SOC TEST MATER, V1446, P12, DOI 10.1520/STP11605S; Brunelle JP, 2005, J SCI MED SPORT, V8, P294, DOI 10.1016/S1440-2440(05)80040-4; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Castaldi C. R., 1993, SAFETY ICE HOCKEY, V2, P217; Castaldi C. R., 1989, SAFETY ICE HOCKEY, V1, P284; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Ciavarro C, 2008, COMPUT HUM BEHAV, V24, P2862, DOI 10.1016/j.chb.2008.04.011; Collins CL, 2008, INJURY PREV, V14, P34, DOI 10.1136/ip.2007.017277; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Committee on Quality of Health Care in America, 1999, TO ERR HUM BUILD SAF, V2010; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Coulson N. R., 2009, J ASTM INT JAI, V6; Crawford BJ, 2004, AM SOC TEST MATER, V1446, P26, DOI 10.1520/STP11606S; Creighton DW, 2010, CLIN J SPORT MED, V20, P379, DOI 10.1097/JSM.0b013e3181f3c0fe; CUSIMANO M, 2002, CAN J NEUROL SCI, V29, pS23; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dick RW, 2008, MED SCI SPORT EXER, V40, pS231, DOI 10.1249/01.mss.0000322493.95532.98; Dorsch KD, 2007, PSYCHOL SPORT EXERC, V8, P585, DOI 10.1016/j.psychsport.2006.06.003; Echemendia R., 2006, SPORTS NEUROPSYCHOLO; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Faught B. E., 2009, J ASTM INT JAI, V6; Ferrara Michael S., 2001, J Athl Train, V36, P145; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fraser K, 2010, FINAL CALL; Gee CJ, 2007, PSYCHOL SPORT EXERC, V8, P567, DOI 10.1016/j.psychsport.2006.06.006; Gilbert WD, 2000, AM SOC TEST MATER, V1341, P291, DOI 10.1520/STP15246S; Gioia G., 2008, BRAIN INJURY PROFESS, V4, P14; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gladwell M., 2000, TIPPING POINT LITTLE, Vviii, P279; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Goodman D, 2006, J ADOLESCENCE, V29, P351, DOI 10.1016/j.adolescence.2005.07.004; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Goodman D, 2004, ASTM SAFETY ICE HOCK, V4, P11; Gordon KE, 2010, CLIN J SPORT MED, V20, P405, DOI 10.1097/JSM.0b013e318202de6b; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead PD, 2000, AM SOC TEST MATER, V1341, P93, DOI 10.1520/STP15230S; Heads Up Hockey, 2010, HEADS HOCK, V2010; Hockey Education Program, 2010, MINN HOCK HEP, V2010; John A., 2009, POPULAR MECH, V2010; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Klugl M, 2010, CLIN J SPORT MED, V20, P407, DOI 10.1097/JSM.0b013e3181f4a99c; LaPrade RF, 2000, AM SOC TEST MATER, V1341, P124, DOI 10.1520/STP15234S; Leape LL, 2000, JAMA-J AM MED ASSOC, V284, P95, DOI 10.1001/jama.284.1.95; LINK A, 2008, RYHA NEWSLETTER; LINK A, 2007, HEP NEWSLETTER; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Makdissi M, 2009, BRIT J SPORT MED, V43, pI23, DOI 10.1136/bjsm.2009.058206; Marcotte G, 1993, SAFETY ICE HOCKEY, V2, P100; Mariconda J, 2004, AM SOC TEST MATER, V1446, P135, DOI 10.1520/STP11614S; Matheson GO, 2010, CLIN J SPORT MED, V20, P399, DOI 10.1097/JSM.0b013e318203114c; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M., 1997, STANDARDIZED ASSESSM; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McPherson MN, 2009, J ASTM INT JAI, V6, P7; Middleton K, 2010, CLIN J SPORT MED, V20, P491, DOI 10.1097/JSM.0b013e3181fac088; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Montelpare W, 2010, INT J SPORTS SCI COA, V5, P61; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; MUELLER FO, 2002, 19 NAT CTR CAT SPORT; Pearsall D. J., 2004, SAFETY ICE HOCKEY, V4, P300; Pocket SCAT2, 2009, BRIT J SPORTS MED, V43, pi89; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Roberts William O, 2010, Clin J Sport Med, V20, P500, DOI 10.1097/JSM.0b013e3181fc94e6; Roberts WO, 1996, ARCH PEDIAT ADOL MED, V150, P140, DOI 10.1001/archpedi.1996.02170270022003; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; Rousseau P., 2008, J ASTM INT JAI, V6; Rudolph H, 1989, SAFETY ICE HOCKEY, V1, P35; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; SCAPINELLO R, 2006, LINES NOT SO TALL TA; SCAT2 Sport Concussion Assesment Tool 2, 2009, BRIT J SPORTS MED, V3, pi85; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Smith A.C., 2010, P 2 ANN WORKSH SEC P, P1; Smith AM, 2000, AM SOC TEST MATER, V1341, P199, DOI 10.1520/STP15240S; Smith AM., 2009, J ASTM INT, V6, P1; SMITH AM, 1999, POWER PLAY MENTAL TO; SMITH MD, 1975, CAN REV SOC ANTHROP, V12, P72; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Stuart MJ, 2009, AM SOC TEST MATER, V1516, P11, DOI 10.1520/JAI101778; Stuart MJ, 2009, CLIN J SPORT MED, V19, P494, DOI 10.1097/JSM.0b013e3181c0aaa4; Stuart MJ, 2004, AM SOC TEST MATER, V1446, P52, DOI 10.1520/STP11608S; Stuart MJ, 2002, AM J SPORT MED, V30, P39, DOI 10.1177/03635465020300012001; Stuart MJ, 2000, AM SOC TEST MATER, V1341, P19, DOI 10.1520/STP15224S; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tator CH, 2000, AM SOC TEST MATER, V1341, P150, DOI 10.1520/STP15236S; Tegner Y, 2000, AM SOC TEST MATER, V1341, P165, DOI 10.1520/STP15237S; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Visek A, 2005, SPORT PSYCHOL, V19, P178, DOI 10.1123/tsp.19.2.178; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Watson RC, 1996, CLIN J SPORT MED, V6, P108, DOI 10.1097/00042752-199604000-00008; Watson RC, 1997, CLIN J SPORT MED, V7, P192, DOI 10.1097/00042752-199707000-00007; Wennberg R, 2004, CAN J NEUROL SCI, V31, P373, DOI 10.1017/S0317167100003474; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Williamson IJS, 2009, AM SOC TEST MATER, V1516, P211, DOI 10.1520/JAI101851; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	137	6	6	5	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2011	25	5					689	701		10.1080/13854046.2011.586561			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	882JE	WOS:000299559000001	21756209				2022-02-06	
J	Thaler, NS; Barney, SJ; Reynolds, CR; Mayfield, J; Allen, DN				Thaler, Nicholas S.; Barney, Sally J.; Reynolds, Cecil R.; Mayfield, Joan; Allen, Daniel N.			Differential Sensitivity of TOMAL Subtests and Index Scores to Pediatric Traumatic Brain Injury	APPLIED NEUROPSYCHOLOGY			English	Article						memory; pediatric; ROC; TBI; TOMAL	WECHSLER INTELLIGENCE SCALE; CRITERION VALIDITY; CVLT-C; CHILDREN; MEMORY; ATTENTION; RECOVERY; PERFORMANCE; PROFILES; SIMILARITIES	The objective of the present study was to examine and compare the subtest, index, and factor scores of the Test of Memory and Learning (TOMAL), using receiver-operating characteristic curves, to investigate their sensitivity and specificity to traumatic brain injury (TBI) in children and adolescents. One hundred and fifty participants who had sustained TBI were compared to 150 controls matched on age and gender from the TOMAL's standardization sample. Results indicated that the greatest area under the curve (AUC) was for the Object Recall (OR) subtest score, the Composite Memory Index (CMI), and the attention factor score. The optimal CMI cutoff score for a TBI diagnosis was 83. When factor scores were compared, the attention factor and two verbal factors had significantly larger AUCs than the three nonverbal factors. These findings suggest that the OR subtest and CMI are most sensitive to TBI, and that when components were broken into factors with no overlapping subtests, attention and verbal memory were optimal for classifying TBI.	[Allen, Daniel N.] Univ Nevada, Dept Psychol, Neuropsychol Res Program, Las Vegas, NV 89154 USA; [Reynolds, Cecil R.] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA; [Mayfield, Joan] Baylor Univ, Dallas, TX USA		Allen, DN (corresponding author), Univ Nevada, Dept Psychol, Neuropsychol Res Program, 4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			Alexander AI, 2005, ARCH CLIN NEUROPSYCH, V20, P587, DOI 10.1016/j.acn.2004.12.005; Allen DN, 2007, NEUROPSYCHOLOGY, V21, P713, DOI 10.1037/0894-4105.21.6.713; Allen DN, 2006, ARCH CLIN NEUROPSYCH, V21, P711, DOI 10.1016/j.acn.2006.08.003; Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Basic D, 2009, AUST PSYCHOL, V44, P40, DOI 10.1080/00050060802593593; Calhoun SL, 2005, PSYCHOL SCHOOLS, V42, P333, DOI 10.1002/pits.20067; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Delis DC., 1994, CALIFORNIA VERBAL LE; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Farmer JE, 1999, DEV NEUROPSYCHOL, V15, P269, DOI 10.1080/87565649909540749; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Horwitz JE, 2008, ARCH CLIN NEUROPSYCH, V23, P393, DOI 10.1016/j.acn.2008.01.009; Howes NL, 1999, ARCH CLIN NEUROPSYCH, V14, P317, DOI 10.1016/S0887-6177(98)00025-0; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Lajiness-O'Neill RR, 2005, CHILD NEUROPSYCHOL, V11, P55, DOI 10.1080/09297040590911202; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lowther JL, 2004, ARCH CLIN NEUROPSYCH, V19, P105, DOI 10.1016/S0887-6177(02)00222-6; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Mayes SD, 2004, CLIN NEUROPSYCHOL, V18, P559, DOI 10.1080/13854040490888530; REYNOLDS C. R., 2007, TEST MEMORY LEARNING; Reynolds C.R., 1994, TEST MEMORY LEARNING; Reynolds CR, 1996, ARCH CLIN NEUROPSYCH, V11, P29, DOI 10.1016/0887-6177(95)00027-5; Roberts MA, 1997, ARCH CLIN NEUROPSYCH, V12, P449, DOI 10.1016/S0887-6177(96)00039-X; Sagen U, 2009, J PSYCHOSOM RES, V67, P325, DOI 10.1016/j.jpsychores.2009.03.007; Salorio CF, 2005, J INT NEUROPSYCH SOC, V11, P686, DOI 10.1017/S1355617705050885; Schmitt A., 2009, J PSYCHOEDUCATIONAL, V27, P157; Sheslow DA, 2003, WIDE RANGE ASSESSMEN; Shum DHK, 2000, J CLIN EXP NEUROPSYC, V22, P25, DOI 10.1076/1380-3395(200002)22:1;1-8;FT025; Strong CAH, 2008, J CLIN EXP NEUROPSYC, V30, P885, DOI 10.1080/13803390701858224; SWETS J, 1996, SCI PSYCHOL SERIES; Thaler NS, 2010, J CLIN EXP NEUROPSYC, V32, P929, DOI 10.1080/13803391003596488; Thaler NS, 2010, CLIN NEUROPSYCHOL, V24, P246, DOI 10.1080/13854040903277305; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; WECHSLER D, 1995, CHILDRENS MEMORY SCA; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; [No title captured]	49	6	6	0	4	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2011	18	3					168	178		10.1080/09084282.2011.595443			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	884YJ	WOS:000299744500003	21846216				2022-02-06	
J	Walker, WC; McDonald, SD				Walker, William C.; McDonald, Scott D.			Does Neurologic Examination During Inpatient Rehabilitation Help Predict Global Outcome After Nonpenetrating Traumatic Brain Injury?	PM&R			English	Article							DISABILITY STATUS SCALE; CLOSED-HEAD INJURY; GLASGOW COMA SCALE; POSTTRAUMATIC AMNESIA; MULTICENTER ANALYSIS; MULTIPLE-SCLEROSIS; PRACTICAL SCALE; BALANCE; IMPAIRMENT; RECOVERY	Objective: To determine whether combining basic neurologic examination measurements with posttraumatic amnesia (PTA) duration can enhance prediction accuracy in moderate-to-severe traumatic brain injury (TBI). Design: A descriptive between-subjects study. Setting: Multicenter: 4 Veterans Affairs Brain Injury Rehabilitation Centers within the Defense and Veterans Brain Injury Center network. Participants: A total of 210 patients (active duty, veteran, or military dependent) with moderate-to-severe nonpenetrating TBI who consented during acute rehabilitation for data collection and completed relevant baseline and 12-month follow-up evaluations. Methods: Multivariate analysis on neurologic examination predictor variables (upper extremity paresis, lower extremity paresis, Romberg test, and Kurtzke Expanded Disability Status Scale [EDSS]) was performed with block logistic regression modeling that controlled for duration of PTA. Main Outcome Measure: Glasgow Outcome Score at 1 year. Results: Glasgow Outcome Score prediction accuracy by using PTA duration was modestly improved with the included neurologic examination measurements. The most influential predictor among them was EDSS, a composite measurement of neurologic impairment. When EDSS was excluded, the simple measurements of upper limb paresis and the Romberg test also provided independent prognostic value. Conclusions: This study demonstrated that simple clinical measurements of neurologic impairment (limb paresis, imbalance, other neurologic deficits) are of value in refining the prediction of long-term global outcome from TBI. These measurements may serve as markers of focal injury not captured by PTA duration, a severity marker weighted toward diffuse injury. PM R 2011;3:6-12	[Walker, William C.] Hunter Holmes McGuire Vet Affairs Med Ctr VAMC, Div Res, Richmond, VA USA; [Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Def & Vet Brain Injury Ctr, Richmond, VA 23284 USA; [McDonald, Scott D.] Hunter Holmes McGuire VAMC, Div Res, Richmond, VA USA		Walker, WC (corresponding author), MCV Box 677, Richmond, VA 23298 USA.	wwalker@mcvh-vcu.edu	Walker, William C/N-3162-2014		CDMRPUnited States Department of Defense	8A, co-investigator on a CDMRP-funded study of the effects of blast exposure on health	Annoni J M, 1992, Disabil Rehabil, V14, P23; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Association, 2008, GUIDES EVALUATION PE; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Black K, 2000, BRAIN INJURY, V14, P141, DOI 10.1080/026990500120808; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CONDELUCI A, 1992, Brain Injury, V6, P543, DOI 10.3109/02699059209008151; Duong TT, 2004, ARCH PHYS MED REHAB, V85, P1291, DOI 10.1016/j.apmr.2003.11.032; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Englander JS, 1996, J HEAD TRAUMA REHAB, V11, P15, DOI 10.1097/00001199-199610000-00003; EVANS RL, 1992, AM J PHYS MED REHAB, V71, P140, DOI 10.1097/00002060-199206000-00003; Gokula K, 2003, J POSTGRAD MED, V49, P169; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; Juneja G, 1998, AM J PHYS MED REHAB, V77, P388, DOI 10.1097/00002060-199809000-00005; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kothari S., 2007, BRAIN INJURY MED PRI, P169; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kurtzke JF, 2008, NEUROEPIDEMIOLOGY, V31, P1, DOI 10.1159/000136645; Lanska DJ, 2000, NEUROLOGY, V55, P1201, DOI 10.1212/WNL.55.8.1201; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Muir KW, 1996, STROKE, V27, P1817, DOI 10.1161/01.STR.27.10.1817; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Salazar AM, 2000, J HEAD TRAUMA REHAB, V15, P1081, DOI 10.1097/00001199-200010000-00002; Schaan M, 2002, J TRAUMA, V52, P667, DOI 10.1097/00005373-200204000-00009; Sharrack B, 1999, BRAIN, V122, P141, DOI 10.1093/brain/122.1.141; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; TATE RL, 1989, ACTA NEUROL SCAND, V79, P97, DOI 10.1111/j.1600-0404.1989.tb03719.x; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Watanabe TK, 2003, ARCH PHYS MED REHAB, V84, pS23, DOI 10.1053/apmr.2003.50054; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091; Wilson JTL, 2001, CURR PHARM DESIGN, V7, P1537, DOI 10.2174/1381612013397276; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	38	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482			PM&R	PM&R	JAN	2011	3	1					6	12		10.1016/j.pmrj.2010.11.001			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	960AS	WOS:000305361000003	21257127				2022-02-06	
J	Yeniceri, N; Altan-Atalay, A				Yeniceri, Nur; Altan-Atalay, Ayse			Age-Related Changes in the Wisconsin Card Sorting Test Performances of 8- to 11-Year-Old Turkish Children	CLINICAL NEUROPSYCHOLOGIST			English	Article						Executive functions; Wisconsin Card Sorting Test; WCST; Developmental changes	TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTIONS; LATENT STRUCTURE; VALIDITY; ADOLESCENTS; ATTENTION; NORMS; WCST; RELIABILITY; DEFICITS	The leading aim of the present study was to examine developmental trends in performance on a computerized version of the Wisconsin Card Sorting Test (WCST) in Turkish children. Participants were 449 children aged between 8 and 11. Findings suggested that children's WCST scores improve with age, and developmental changes in executive functions follow distinct processes as assessed by different components of the WCST. The most striking improvement was noted in perseverative tendencies around age 10. This study also explored the effects of parental education on WCST performances of children, and maternal education emerged as the most important predictor.	[Yeniceri, Nur] Bogazici Univ, Dept Psychol, TR-34342 Istanbul, Turkey; [Altan-Atalay, Ayse] Middle E Tech Univ, Dept Psychol, TR-06531 Ankara, Turkey		Yeniceri, N (corresponding author), Bogazici Univ, Dept Psychol, TR-34342 Istanbul, Turkey.	yenicern@boun.edu.tr	Altan-Atalay, Ayse/AAV-5413-2020; Altan-Atalay, Ayse/AAI-8812-2021	Altan-Atalay, Ayse/0000-0001-9748-2517	Bogazici UniversityBogazici University [BAP-02B702]	This research was supported by Bogazici University Research Fund (BAP-02B702). We would like to thank all students for their help in data collection. We are also grateful to all children and families who participated in this study.	Ardila A, 2005, DEV NEUROPSYCHOL, V28, P539, DOI 10.1207/s15326942dn2801_5; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Barcelo F, 2002, NEUROPSYCHOLOGIA, V40, P349, DOI 10.1016/S0028-3932(01)00110-5; Barcelo F, 1999, NEUROREPORT, V10, P1299, DOI 10.1097/00001756-199904260-00027; Bourdieu P., 1986, HDB THEORY RES SOCIO, P241; Bowden SC, 1998, NEUROPSYCHOL REHABIL, V8, P243, DOI 10.1080/713755573; Bujoreanu IS, 2008, DEV NEUROPSYCHOL, V33, P584, DOI 10.1080/87565640802254364; Bundak R, 2006, ACTA PAEDIATR, V95, P194, DOI 10.1080/08035250500334738; CHELUNE GJ, 1986, J CLIN EXP NEUROPSYC, V8, P219, DOI 10.1080/01688638608401314; Cinan S, 2006, COGNITIVE DEV, V21, P377, DOI 10.1016/j.cogdev.2006.03.002; Cirino PT, 2000, J CLIN EXP NEUROPSYC, V22, P245, DOI 10.1076/1380-3395(200004)22:2;1-1;FT245; Crone EA, 2004, DEVELOPMENTAL SCI, V7, P443, DOI 10.1111/j.1467-7687.2004.00365.x; Donders J, 2004, CLIN NEUROPSYCHOL, V18, P521, DOI 10.1080/11385404049052411; Erginoz E, 2004, EUR J PEDIATR, V163, P485, DOI 10.1007/s00431-004-1446-5; Goncu A., 2008, WORLD YB ED 2009 CHI; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Greve KW, 1999, ARCH CLIN NEUROPSYCH, V14, P497; Greve KW, 1998, ARCH CLIN NEUROPSYCH, V13, P597; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton R.K., 1981, WISCONSIN CARD SORTI; Helland T, 2000, CHILD NEUROPSYCHOL, V6, P37, DOI 10.1076/0929-7049(200003)6:1;1-B;FT037; HORTACSU N, 1990, J PSYCHOL, V124, P535, DOI 10.1080/00223980.1990.10543246; HORTACSU N, 1989, J ADOLESCENCE, V12, P253, DOI 10.1016/0140-1971(89)90076-6; Huizinga M, 2007, DEV NEUROPSYCHOL, V31, P193, DOI 10.1080/87565640701190817; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Inc, 1994, REVIEW, V17, P383; Kagitcibasi C., 1995, COORDINATORS NOTEBOO, P24; Kagitcibasi C., 1996, FAMILY HUMAN DEV CUL; Karaka S, 2007, COCUK GENCLIK RUH SA, V14, P24; Karakas S., 2004, BILNOT BATARYASI KIT; Kizilbash A, 1999, CHILD NEUROPSYCHOL, V5, P224, DOI 10.1076/0929-7049(199912)05:04;1-R;FT224; Klenberg L, 2001, DEV NEUROPSYCHOL, V20, P407, DOI 10.1207/S15326942DN2001_6; Kohli Adarsh, 2006, Indian J Psychiatry, V48, P181, DOI 10.4103/0019-5545.31582; Koren D, 1998, NEUROPSYCHOLOGY, V12, P289, DOI 10.1037/0894-4105.12.2.289; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; Lin CCH, 2000, J CLIN EXP NEUROPSYC, V22, P69, DOI 10.1076/1380-3395(200002)22:1;1-8;FT069; Liss M, 2001, J CHILD PSYCHOL PSYC, V42, P261, DOI 10.1017/S0021963001006679; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; OZONOFF S, 1995, NEUROPSYCHOLOGY, V9, P491, DOI 10.1037/0894-4105.9.4.491; PANIAK C, 1996, CANADIAN J REHABILIT, V9, P233; PAOLO AM, 1995, ARCH CLIN NEUROPSYCH, V10, P463, DOI 10.1016/0887-6177(95)00052-6; PENNINGTON BF, 1993, DEV PSYCHOL, V29, P511, DOI 10.1037/0012-1649.29.3.511; Perry W, 1998, SCHIZOPHR RES, V33, P69, DOI 10.1016/S0920-9964(98)00061-9; Romine CB, 2004, ARCH CLIN NEUROPSYCH, V19, P1027, DOI 10.1016/j.acn.2003.12.009; ROSSELLI M, 1993, CLIN NEUROPSYCHOL, V7, P145, DOI 10.1080/13854049308401516; Samuelson KW, 2010, CHILD NEUROPSYCHOL, V16, P119, DOI 10.1080/09297040903190782; Shu BC, 2000, CLIN NEUROPSYCHOL, V14, P275, DOI 10.1076/1385-4046(200008)14:3;1-P;FT275; Somsen RJM, 2007, DEVELOPMENTAL SCI, V10, P664, DOI 10.1111/j.1467-7687.2007.00613.x; Somsen RJM, 2000, ACTA PSYCHOL, V104, P227, DOI 10.1016/S0001-6918(00)00030-5; Sunar D., 2005, FAMILIES GLOBAL PERS, P169; Toren P, 2000, J ANXIETY DISORD, V14, P239, DOI 10.1016/S0887-6185(99)00036-5; Turkish Statistical Institute, 2010, TURK STAT YB; Welsh MC, 2002, DEVELOPMENTAL VARIATIONS IN LEARNING, P139; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483	54	6	6	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2011	25	7					1179	1192		10.1080/13854046.2011.613855			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	882JJ	WOS:000299559600006	21985078				2022-02-06	
J	Kraemer, P; Lee, MB; Englehardt, H; Chapman, JR; Bransford, RJ				Kraemer, Paul; Lee, Michael B.; Englehardt, Hillary; Chapman, Jens R.; Bransford, Richard J.			Infectious Pin Complication Rates in Halo Vest Fixators Using Ceramic Versus Metallic Pins	JOURNAL OF SPINAL DISORDERS & TECHNIQUES			English	Article						halo; cervical spine; spine trauma; pin tract infection; ceramics	BRAIN-ABSCESS; NERVE INJURY; FIXATION; FRACTURES; ORTHOSIS; TRACTION; CARE	Study Design: Retrospective review of database patients. Objective: To compare infectious pin complication rates utilizing ceramic pins, an emerging technology, with a large database of complications in halo's using metallic pins. Summary of Background Data: The halo/vest fixator remains a useful modality of treatment for cervical spine trauma but has been described as having a high incidence of complications, foremost pin-related complications. Ceramic pins and vest modifications have been introduced under the premise of (1) decreasing pin-tract infections compared with metallic pins manufactured from stainless steel or titanium and with the advent of 3T MRI, (2) decreasing brain MRI artifact, and (3) lowering MRI intolerance owing to material overheating. Material and Methods: We retrospectively reviewed a prospectively collected patient data set of the Harborview Medical Center spine trauma registry. A historic control group exclusively utilizing metallic halo pins over a 10-year period was compared with patients who were treated with halo's exclusively utilizing ceramic pins over a recent 14-month period. Complications investigated included aseptic, loosening, and infections graded on a novel 3-tier system adapted from external fixation in long bone and periarticular trauma. Inclusion criteria were the patients with traumatic cervical spine injuries treated with a halo for a period of at least 14 days. Results: Forty-four patients were available for analysis in the ceramic pin group versus 263 in the metallic pin group. Overall pin complications amounted to 40.9% ceramic (C) versus 21.7% metal (M) pins (P<0.05), aseptic loosening rates 13.7% (C) compared with 8.3%(M), and pin site infections 27.3% (C) compared with 13.3 %(M) (P<0.05). A grading system for halo pin tract infections was developed. In assessing overall complications and infections specifically, ceramic pins seemed to be associated with a higher incidence of adverse events or complications compared with titanium pins. Conclusion: Despite the imbalance of size of our cohort groups, there seems to be a strong trend toward the newer ceramic pin technology not meeting expected minimum performance standards set by the earlier metallic material. Causes for the higher failure rate likely lay in the necessary changes made to the halo vest and specifically the pin design owing to the inherent mechanical property limitations of MRI compatible materials.	[Kraemer, Paul; Lee, Michael B.; Englehardt, Hillary; Chapman, Jens R.; Bransford, Richard J.] Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA		Kraemer, P (corresponding author), Univ Washington, Harborview Med Ctr, 325 9Th Ave, Seattle, WA 98104 USA.	pkraemer@indianaspinegroup.com					Brown R, 2006, J ORAL MAXIL SURG, V64, P130, DOI 10.1016/j.joms.2005.09.021; Chapman JR, 2000, NEUROSURG FOCUS, V8, P1; Davies R, 2005, J BONE JOINT SURG BR, V87B, P716, DOI 10.1302/0301-620X.87B5.15623; Frangen TM, 2007, J TRAUMA, V63, P83, DOI 10.1097/TA.0b013e318060d2b9; GARFIN SR, 1986, J BONE JOINT SURG AM, V68A, P320, DOI 10.2106/00004623-198668030-00002; Ginsburg GM, 1998, SPINE, V23, P1490, DOI 10.1097/00007632-199807010-00011; Henley MB, 1998, J ORTHOP TRAUMA, V12, P1, DOI 10.1097/00005131-199801000-00001; Horn EM, 2006, J NEUROSURG-SPINE, V5, P46, DOI 10.3171/spi.2006.5.1.46; KOCH R A, 1978, Spine, V3, P103, DOI 10.1097/00007632-197806000-00002; Koivikko MP, 2000, ARCH ORTHOP TRAUM SU, V120, P448, DOI 10.1007/s004029900129; Nemeth JA, 2001, J BONE JOINT SURG AM, V83A, P377, DOI 10.2106/00004623-200103000-00009; Nottmeier EW, 2000, J NEUROSURG, V92, P233, DOI 10.3171/spi.2000.92.2.0233; Park P, 2005, SPINAL CORD, V43, P684, DOI 10.1038/sj.sc.3101773; Patterson MM, 2005, ORTHOP NURS, V24, P349; Pinches E, 2004, J AAPOS, V8, P580, DOI 10.1016/j.jaapos.2004.08.002; ROSENBLUM D, 1995, ARCH PHYS MED REHAB, V76, P865, DOI 10.1016/S0003-9993(95)80553-2; Saeed MU, 2007, SPINE, V32, pE271, DOI 10.1097/01.brs.0000259976.46403.8a	17	6	6	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1536-0652			J SPINAL DISORD TECH	J. Spinal Disord. Tech.	DEC	2010	23	8					E59	E62		10.1097/BSD.0b013e3181d1e14c			4	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	689QG	WOS:000284942700004	20890224				2022-02-06	
J	Moon, ES; Kim, MS; Kong, IK				Moon, Eun-Sun; Kim, Myung-Sun; Kong, Il-Kyu			Traumatic isolated closed rupture of the short head of the biceps brachii in military paratrooper	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Biceps brachii; Short head; Rupture; Primary repair; Paratrooper		Isolated closed rupture of the short head of the biceps brachii is rare and has been reported infrequently. We experienced a case of traumatic isolated closed rupture of the short head of the biceps brachii in a healthy 21-year-old military paratrooper and report this case. At the surgery, the distal portion of short head of biceps brachii was sutured to the proximal stump and long head of biceps. At the last follow-up, elbow flexion strength was revealed 79% of normal and medial depression in the mid-portion of the upper arm was improved. Isolated rupture of the short head of the biceps brachii is a rare injury and early intervention is recommended if a sulcus or gap in musculotendinous unit is palpable or considerable weakness is present.	[Moon, Eun-Sun; Kim, Myung-Sun; Kong, Il-Kyu] Chonnam Natl Univ Hosp, Dept Orthopaed Surg, Kwangju 501757, South Korea		Kim, MS (corresponding author), Chonnam Natl Univ Hosp, Dept Orthopaed Surg, 8 Hak Dong, Kwangju 501757, South Korea.	rhamses@chol.com					DICHRISTINA DG, 1992, CLIN ORTHOP RELAT R, P139; Gilcreest EL, 1934, SURG GYNECOL OBSTET, V58, P322; HECKMAN JD, 1978, J BONE JOINT SURG AM, V60, P369, DOI 10.2106/00004623-197860030-00019; Shah AK, 2004, J SHOULDER ELB SURG, V13, P562, DOI 10.1016/j.jse.2004.02.005	4	6	6	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	DEC	2010	18	12					1759	1761		10.1007/s00167-010-1108-2			3	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	682BV	WOS:000284375000022					2022-02-06	
J	Rangel-Castilla, L; Ahmed, O; Goodman, JC; Gopinath, S; Valadka, A; Robertson, C				Rangel-Castilla, Leonardo; Ahmed, Osama; Goodman, J. Clay; Gopinath, Shankar; Valadka, Alex; Robertson, Claudia			L-arginine reactivity in cerebral vessels after severe traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Cerebral autoregulation; Endothelial dysfunction; L-arginine; Nitric oxide; Traumatic brain injury	CONTROLLED CORTICAL IMPACT; NITRIC-OXIDE SYNTHASE; FLOW-MEDIATED DILATATION; BLOOD-FLOW; CEREBROVASCULAR REACTIVITY; HEAD-INJURY; CEREBROSPINAL-FLUID; CO2 REACTIVITY; CAROTID-ARTERY; AUTOREGULATION	Objectives: Traumatic brain injury (TBI) causes an early reduction of cerebral blood flow (CBF). The purpose was to study cerebrovascular endothelial function by examining the reactivity of cerebral vessels to L-arginine. Methods: Fifty-one patients with severe TBI were prospectively studied by measuring cerebral hemodynamics before and after the administration of L-arginine, 300 mg/kg at 12 hours and at 48 hours after injury. These hemodynamic measurements, using transcranial Doppler techniques, included internal carotid flow volume as an estimate of hemispheric CBF, flow velocity in intracranial vessels, CO2 reactivity, and dynamic pressure autoregulation using thigh cuff deflation and carotid compression methods. Changes in the hemodynamics with L-arginine administration were analyzed using a general linear mixed model. Results: L-arginine produced no change in mean arterial pressure, intracranial pressure, or brain oxygenation. Overall, L-arginine induced an 11.3% increase in internal carotid artery flow volume (P=0.0190). This increase was larger at 48 hours than at 12 hours (P=0.0045), and tended to be larger in the less injured hemisphere at both time periods. The response of flow velocity in the intracranial vessels was similar, but smaller differences with administration of L-arginine were observed. There was a significant improvement in CO2 reactivity with L-arginine, but no change in dynamic pressure autoregulation. Discussion: The low response of the cerebral vessels to L-arginine at 12 hours post-injury with improvement at 48 hours suggests that dysfunction of cerebrovascular endothelium plays a role in the reduced CBF observed after TBI.	[Gopinath, Shankar; Robertson, Claudia] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Rangel-Castilla, Leonardo] Methodist Hosp, Dept Neurosurg, Methodist Neurol Inst, Houston, TX 77030 USA; [Ahmed, Osama] LSU Hlth Sci Ctr, Dept Neurosurg, Shreveport, LA USA; [Goodman, J. Clay] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Valadka, Alex] Seton Brain & Spine Inst, Austin, TX USA		Robertson, C (corresponding author), Baylor Coll Med, Dept Neurosurg, 1709 Dryden,Suite 750,Mail Stop BCM650, Houston, TX 77030 USA.	claudiar@bcm.tmc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS 048428]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048428] Funding Source: NIH RePORTER	The work was supported by NIH grant no. R01-NS 048428.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BUCHANAN JE, 1993, BRAIN RES, V610, P248, DOI 10.1016/0006-8993(93)91408-K; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Clark RSB, 1997, NEUROSURGERY, V41, P1284, DOI 10.1097/00006123-199712000-00010; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; Golding EM, 2000, J CEREBR BLOOD F MET, V20, P820, DOI 10.1097/00004647-200005000-00008; Hlatky R, 2006, NEUROCRIT CARE, V4, P127, DOI 10.1385/NCC:4:2:127; Hlatky R, 2005, NEUROSURGERY, V57, P917, DOI 10.1227/01.NEU.0000180025.43747.fc; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Lundblad C, 2007, MICROVASC RES, V74, P1, DOI 10.1016/j.mvr.2007.03.001; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Micieli G, 1997, J NEUROL SCI, V150, P71, DOI 10.1016/S0022-510X(97)05380-X; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; Okamoto M, 2001, GERONTOLOGY, V47, P131, DOI 10.1159/000052786; Preckel MP, 1996, INT J MICROCIRC, V16, P277, DOI 10.1159/000179186; Pretnar-Oblak J, 2006, CEREBROVASC DIS, V21, P180, DOI 10.1159/000090530; Pretnar-Oblak J, 2008, AM J HYPERTENS, V21, P674, DOI 10.1038/ajh.2008.153; Pretnar-Oblak J, 2007, ULTRASOUND MED BIOL, V33, P1546, DOI 10.1016/j.ultrasmedbio.2007.04.011; Pretnar-Oblak J, 2007, ENDOTHELIUM-J ENDOTH, V14, P73, DOI 10.1080/10623320701346692; Prettlar-Oblak J, 2006, STROKE, V37, P2540, DOI 10.1161/01.STR.0000239659.99112.fb; Schulman SP, 2006, JAMA-J AM MED ASSOC, V295, P58, DOI 10.1001/jama.295.1.58; Smielewski P, 1996, STROKE, V27, P2197, DOI 10.1161/01.STR.27.12.2197; Soustiel JF, 2003, STROKE, V34, P1876, DOI 10.1161/01.STR.0000080942.32331.39; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; White RP, 2000, CLIN SCI, V99, P555, DOI 10.1042/CS20000064; Wilson AM, 2007, CIRCULATION, V116, P188, DOI 10.1161/CIRCULATIONAHA.106.683656; Zhang FY, 1996, STROKE, V27, P317, DOI 10.1161/01.STR.27.2.317; Zhang FY, 2002, J NEUROSURG, V97, P963, DOI 10.3171/jns.2002.97.4.0963; Zimmermann C, 2004, CEREBROVASC DIS, V17, P128, DOI 10.1159/000075781; Zimmermann C, 2003, STROKE, V34, P643, DOI 10.1161/01.STR.0000056526.35630.47; Zvan B, 2002, INT ANGIOL, V21, P256	45	6	7	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	DEC	2010	32	10					1033	1040		10.1179/016164110X12767786356598			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	670LD	WOS:000283422300004	20712924	Green Accepted			2022-02-06	
J	Thone-Otto, A; George, S; Hildebrandt, H; Reuther, P; Schoof-Tams, K; Sturm, W; Wallesch, CW				Thoene-Otto, Angelika; George, Sabine; Hildebrandt, Helmut; Reuther, Paul; Schoof-Tams, Karin; Sturm, Walter; Wallesch, Claus-Werner			Diagnosis and therapy by memory disorders	ZEITSCHRIFT FUR NEUROPSYCHOLOGIE			German	Article							BRAIN-INJURY REHABILITATION; CLOSED-HEAD INJURY; REALITY ORIENTATION; COGNITIVE REHABILITATION; ELECTRONIC MEMORY; IMPAIRED PATIENTS; SEVERE AMNESIA; REMEDIATION; EFFICACY; PROGRAM		[Thoene-Otto, Angelika] Univ Klinikum Leipzig, Tagesklin Kognit Neurol, DE-04103 Leipzig, Germany; [George, Sabine] Deutsch Verband Ergotherapeuten eV, Karlsbad, Germany; [Hildebrandt, Helmut] Klinikum Bremen Ost, Zentrum Neurol, Oldenburg, Germany; [Hildebrandt, Helmut] Carl von Ossietzky Univ Oldenburg, Inst Psychol, D-2900 Oldenburg, Germany; [Reuther, Paul] Ambulantes Neurol Rehabil Ctr Ahrweiler, Bad Neuenahr Ahrweiler, Germany; [Schoof-Tams, Karin] Neurol Klin Westend, Bad Wildungen, Germany; [Sturm, Walter] Univ Klinikum RWTH Aachen, Sekt Klin Neuropsychol, Neurol Klin, Aachen, Germany; [Wallesch, Claus-Werner] Otto VonGuericke Univ Magdegurg, Neurol Klin, Magdeburg, Germany		Thone-Otto, A (corresponding author), Univ Klinikum Leipzig, Tagesklin Kognit Neurol, Liebigstr 16, DE-04103 Leipzig, Germany.	angelika.thoene@medizin.uni-leipzig.de					BEBLO T, 2006, FORTSCHRITTE NEUROPS, V6; BENEDICT RHB, 1992, J HEAD TRAUMA REHAB, V7, P84; BENEDICT RHB, 1993, NEUROPSYCHOL REHABIL, V3, P37; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; BURKE JM, 1994, BRAIN INJURY, V8, P71, DOI 10.3109/02699059409150960; BUSSMANNMORK BA, 2000, NEUROL REHABIL, V6, P195; CANCELLIERE AEB, 1991, ARCH PHYS MED REHAB, V72, P148; CARDENAS DD, 1994, BRAIN INJURY, V8, P579, DOI 10.3109/02699059409151010; Christodoulou C, 2003, NEUROLOGY, V60, P1793, DOI 10.1212/01.WNL.0000072264.75989.B8; Christodoulou C, 2006, J NEUROL SCI, V245, P127, DOI 10.1016/j.jns.2005.08.021; Chute DL, 1988, NEUROPSYCHOLOGY, V2, P41, DOI 10.1037//0894-4105.2.1.41; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; CROSSON B, 1984, J CLIN NEUROPSYCHOL, V6, P287, DOI 10.1080/01688638408401219; Dayus B, 2000, NEUROPSYCHOL REHABIL, V10, P415, DOI 10.1080/096020100411998; Diamond BJ, 1997, BRAIN, V120, P1015, DOI 10.1093/brain/120.6.1015; Donaghy S, 1998, BRAIN INJURY, V12, P1061, DOI 10.1080/026990598121963; Doornhein K, 1998, NEUROPSYCHOL REHABIL, V8, P393, DOI 10.1080/713755579; Evans J, 1996, CLIN REHABIL, V6, P75; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; FINSET A, 1995, BRAIN INJURY, V9, P495, DOI 10.3109/02699059509008209; FOWLER P, 1972, REHABIL COUNS BULL, V16, P80; FREEMAN M R, 1992, Brain Injury, V6, P65, DOI 10.3109/02699059209008124; FURST C, 1994, J COGNITIVE REHABILI, P24; GIANUTSOS R, 1979, Journal of Clinical Neuropsychology, V1, P117, DOI 10.1080/01688637908414446; GLASGOW RE, 1977, J CLIN PSYCHOL, V33, P1049, DOI 10.1002/1097-4679(197710)33:4<1049::AID-JCLP2270330429>3.0.CO;2-V; GODFREY HPD, 1988, ARCH PHYS MED REHAB, V69, P458; Goldstein G, 1996, CLIN NEUROPSYCHOL, V10, P66, DOI 10.1080/13854049608406664; GOLDSTEIN G, 1988, CLIN NEUROPSYCHOL, V2, P251; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; HANLEY IG, 1981, BRIT J PSYCHIAT, V138, P10, DOI 10.1192/bjp.138.1.10; HANLEY IG, 1984, BEHAV RES THER, V22, P709, DOI 10.1016/0005-7967(84)90134-7; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309; Hildebrandt H, 2006, J NEUROL, V253, P512, DOI 10.1007/s00415-006-0013-6; HILDEBRANDT H, 2007, NEUROLOGIE REHABILIT, V13, P135; Hildebrandt H., 2004, NEUROL REHABIL, V10, P57; Hux K, 2000, BRAIN INJURY, V14, P907; KASCHEL R, 1995, BRAIN INJURY, V9, P619, DOI 10.3109/02699059509008220; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; KASCHEL R, 1992, Z GERONTOPSYCHOL PSY, V5, P223; KERNER MJ, 1985, J COGNITIVE REHA NOV, P26; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; Kessels RPC, 2000, J INT NEUROPSYCH SOC, V6, P271, DOI 10.1017/S1355617700633027; Kessels RPC, 2002, J CLIN EXP NEUROPSYC, V24, P115, DOI 10.1076/jcen.24.1.115.967; Kime SK, 1996, BRAIN INJURY, V10, P17; KIRNE S, 1996, BRAIN INJURY, V10, P17; KIRSCH NL, 1987, J HEAD TRAUMA REHAB, V2, P77; KIRSCH NL, 1992, J HEAD TRAUMA REHAB, V7, P13, DOI DOI 10.1097/00001199-199209000-00004; KISSELS A, 2002, PRAXIS KLIN VERHALTE, V60, P306; Kopelman MD, 2002, BRAIN, V125, P2152, DOI 10.1093/brain/awf229; Kroll NEA, 1997, BRAIN, V120, P1377, DOI 10.1093/brain/120.8.1377; LAATSCH L, 1983, J COGNITIVE REHABILI, V1, P15; LENG NRC, 1991, BEHAV PSYCHOTHER, V19, P173, DOI 10.1017/S0141347300012209; MALEC FA, 1991, NEUROPSYCHOLOGY, V5, P29; MALEC J, 1983, ARCH PHYS MED REHAB, V64, P436; MALLOY M, 1984, AUST OCCUP THER J, V31, P20; Markowitsch, 2002, GEDACHTNIS SPUR ERIN; MAYEUX R, 1982, MOVEMENT DISORD, P75; Milders M, 1998, MEMORY, V6, P21, DOI 10.1080/741941597; Nair RD, 2007, COCHRANE DB SYST REV, V3; Ownsworth TL, 1999, BRAIN INJURY, V13, P605, DOI 10.1080/026990599121340; PARENTE FJ, 1983, J COGNITIVE REHABILI, V1, P20; Parente R, 1999, NEUROREHABILITATION, V13, P13; Parente R, 1994, NeuroRehabilitation, V4, P198, DOI 10.3233/NRE-1994-4310; Raskin SA, 1996, J HEAD TRAUMA REHAB, V11, P32, DOI 10.1097/00001199-199606000-00007; Requena C, 2004, DEMENT GERIATR COGN, V18, P50, DOI 10.1159/000077735; Ribot Theodule-Armand, 1882, MALADIES MEMOIRE; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; SCHACTER DL, 1985, J CLIN EXP NEUROPSYC, V7, P79, DOI 10.1080/01688638508401243; Schellig D., 2009, HDB NEUROPSYCHOLOGIS, V1; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; SOHLBERG M M, 1992, Brain Injury, V6, P129, DOI 10.3109/02699059209029651; SOHLBERG M M, 1992, Brain Injury, V6, P139, DOI 10.3109/02699059209029652; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Spector A, 2003, BRIT J PSYCHIAT, V183, P248, DOI 10.1192/bjp.183.3.248; Squires EJ, 1996, NEUROPSYCHOL REHABIL, V6, P55, DOI 10.1080/713755494; SQUIRES EJ, 1997, CASE STUDIES NEUROPS, P191; Sturm W, 2009, Z NEUROPSYCHOL, V20, P59, DOI 10.1024/1016-264X.20.1.59; Thoene A I, 1995, J Int Neuropsychol Soc, V1, P29; THONE AIT, 1995, J INT NEUROPSYCH SOC, V1, P29; Thone-Otto AIT, 2003, INT J PSYCHOL, V38, P236, DOI 10.1080/00207590344000169; THONEOTTO A, 2000, LEHRBUCH KLIN NEUROP; THONEOTTO AIT, 2004, FORTSCHRITTE NEUROPS, V2; van den Broek MD, 2000, BRAIN INJURY, V14, P455; WADE TK, 2000, BRAIN INJURY, V14, P455; WALTHER K, 2005, THESIS U LEIPZIG; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; WERHEID K, 2001, MPI SERIES COGNITIVE; WILSON B, 1992, J NEUROL NEUROSUR PS, V55, P177, DOI 10.1136/jnnp.55.3.177; WILSON B, 1982, CORTEX, V18, P581, DOI 10.1016/S0010-9452(82)80055-5; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 1999, REHABIL PSYCHOL, V44, P284, DOI 10.1037/0090-5550.44.3.284; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161; Yasuda K, 2002, NEUROPSYCHOL REHABIL, V12, P155, DOI 10.1080/09602010143000239; ZENCIUS A, 1990, Brain Injury, V4, P33, DOI 10.3109/02699059009026146; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	100	6	6	0	7	VERLAG HANS HUBER	BERN 9	LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND	1016-264X	1664-2902		Z NEUROPSYCHOL	Z. Neuropsychol.	DEC	2010	21	4					271	281		10.1024/1016-264X/a000020			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	691ID	WOS:000285072600005					2022-02-06	
J	Zaveri, A; Cofiel, L; Shah, J; Pradhan, S; Chan, E; Dameron, O; Pietrobon, R; Ang, BT				Zaveri, Amrapali; Cofiel, Luciana; Shah, Jatin; Pradhan, Shreyasee; Chan, Edwin; Dameron, Olivier; Pietrobon, Ricardo; Ang, Beng Ti			Achieving High Research Reporting Quality Through the Use of Computational Ontologies	NEUROINFORMATICS			English	Article						Systematic review; Meta-analyses; Evidence-based medicine; Reporting; RCT; Neurosurgery; Standardized; Ontology; Kappa coefficient	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIALS; ANEURYSMAL SUBARACHNOID HEMORRHAGE; PSYCHIATRIC RATING-SCALE; CLINICAL-TRIALS; SYSTEMATIC REVIEWS; DOUBLE-BLIND; DIAGNOSTIC-ACCURACY; RECEPTOR ANTAGONIST; CONSORT STATEMENT	Systematic reviews and meta-analyses constitute one of the central pillars of evidence-based medicine. However, clinical trials are poorly reported which delays meta-analyses and consequently the translation of clinical research findings to clinical practice. We propose a Center of Excellence in Research Reporting in Neurosurgery (CERR-N) and the creation of a clinically significant computational ontology to encode Randomized Controlled Trials (RCT) studies in neurosurgery. A 128 element strong computational ontology was derived from the Trial Bank ontology by omitting classes which were not required to perform meta-analysis. Three researchers from our team tagged five randomly selected RCT's each, published in the last 5 years (2004-2008), in the Journal of Neurosurgery (JoN), Neurosurgery Journal (NJ) and Journal of Neuro-trauma (JoNT). We evaluated inter and intra observer reliability for the ontology using percent agreement and kappa coefficient. The inter-observer agreement was 76.4%, 75.97% and 74.9% and intra-observer agreement was 89.8%, 80.8% and 86.56% for JoN, NJ and JoNT respectively. The inter-observer kappa coefficient was 0.60, 0.54 and 0.53 and the intra-observer kappa coefficient was 0.79, 0.82 and 0.79 for JoN, NJ and JoNT journals respectively. The high degree of inter and intra-observer agreement confirms tagging consistency in sections of a given scientific manuscript. Standardizing reporting for neurosurgery articles can be reliably achieved through the integration of a computational ontology within the context of a CERR-N. This approach holds potential for the overall improvement in the quality of reporting of RCTs in neurosurgery, ultimately streamlining the translation of clinical research findings to improvement in patient care.	[Zaveri, Amrapali; Ang, Beng Ti] Natl Inst Neurosci, Singapore, Singapore; [Zaveri, Amrapali; Shah, Jatin; Pradhan, Shreyasee; Pietrobon, Ricardo] Duke NUS Grad Med Sch, Singapore, Singapore; [Chan, Edwin] Australasian Cochrane Ctr, Singapore, Singapore; [Dameron, Olivier] Univ Rennes 1, INSERM, U936, Rennes, France; [Cofiel, Luciana] Res Res Grp, Sao Paulo, Brazil		Zaveri, A (corresponding author), Natl Inst Neurosci, Singapore, Singapore.	Amrapali_Jyotindra_ZAVERI@ttsh.com.sg	Shah, Jatin/B-6039-2011	Shah, Jatin/0000-0002-2457-491X; Pietrobon, Ricardo/0000-0003-2996-2193; Zaveri, Amrapali/0000-0003-3239-4588			Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; ANDERSEN J, 1989, PSYCHOPATHOLOGY, V22, P168, DOI 10.1159/000284591; BIESEN WV, 2008, NEPHROL DIAL TRANSPL, V23, P2729; Bossuyt PM, 2004, FAM PRACT, V21, P4, DOI 10.1093/fampra/cmh103; Bossuyt PMM, 2004, CLIN CHEM, V50, P465, DOI 10.1373/clinchem.2003.029736; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Choi G, 2005, NEUROSURGERY, V57, P764, DOI 10.1227/01.NEU.0000175858.80925.38; CLARKE MJ, 1994, BRIT MED J, V309, P1007, DOI 10.1136/bmj.309.6960.1007; Cook Chad, 2007, Account Res, V14, P1, DOI 10.1080/08989620601003471; Cook DJ, 1997, ANN INTERN MED, V127, P210, DOI 10.7326/0003-4819-127-3-199708010-00006; Crippa JAS, 2002, BRAZ J MED BIOL RES, V35, P1209, DOI 10.1590/S0100-879X2002001000014; Fergusen S, 2007, NEUROSURGERY, V60, P658, DOI 10.1227/01.NEU.0000255396.23280.31; Fonseca F, 2007, J ASSOC INF SYST, V8, P129, DOI 10.17705/1jais.00114; Fung AE, 2009, OPHTHALMOLOGY, V116, P286, DOI 10.1016/j.ophtha.2008.09.014; Groves Trish, 2008, BMJ, V337, pa718, DOI 10.1136/bmj.a718; GRUBER T, 2008, IN PRESS; GRUBER TR, 1993, PRINCIPLES DESIGN ON; HAINES SJ, 1983, NEUROSURGERY, V12, P259, DOI 10.1227/00006123-198303000-00001; Han C, 2009, CONTEMP CLIN TRIALS, V30, P116, DOI 10.1016/j.cct.2008.11.004; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; Hripcsak G, 2002, J BIOMED INFORM, V35, P99, DOI 10.1016/S1532-0464(02)00500-2; JARLAIS DC, 2004, PUBLIC HLTH, V94, P361; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kane RL, 2007, J CLIN EPIDEMIOL, V60, P241, DOI 10.1016/j.jclinepi.2006.06.016; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Manchikanti L, 2008, PAIN PHYSICIAN, V11, P161; Manser R, 2001, Monaldi Arch Chest Dis, V56, P33; Marmarou A, 2005, J NEUROTRAUM, V22, P1444, DOI 10.1089/neu.2005.22.1444; Mazzeo AT, 2006, J NEUROTRAUM, V23, P962, DOI 10.1089/neu.2006.23.962; Meinert CL, 1998, JAMA-J AM MED ASSOC, V279, P1487, DOI 10.1001/jama.279.18.1487; MEINERT CL, 1984, CONTROL CLIN TRIALS, V5, P328, DOI 10.1016/S0197-2456(84)80013-6; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher D, 2000, BRIT J SURG, V87, P1448, DOI 10.1046/j.1365-2168.2000.01610.x; Moher D, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-13; Mummaneni PV, 2007, J NEUROSURG-SPINE, V6, P198, DOI 10.3171/spi.2007.6.3.198; Naff NJ, 2004, NEUROSURGERY, V54, P577, DOI 10.1227/01.NEU.0000108422.10842.60; North RB, 2005, NEUROSURGERY, V56, P98, DOI 10.1227/01NEU.0000144839.65524.E0; Noy N., 2001, ONTOLOGY DEV; Petersson H, 2002, J BIOMED INFORM, V35, P331, DOI 10.1016/S1532-0464(03)00036-4; Phadtare A, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-27; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; *RAC, RAC PRO 2 0; Righesso O, 2007, NEUROSURGERY, V61, P545, DOI 10.1227/01.NEU.0000290901.00320.F5; Rogers JE, 2006, METHOD INFORM MED, V45, P267; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Schulz EB, 1998, J AM MED INFORM ASSN, V5, P337, DOI 10.1136/jamia.1998.0050337; Shankar Ravi D, 2007, AMIA Annu Symp Proc, P661; Sim I, 2005, PLOS MED, V2, P1090, DOI 10.1371/journal.pmed.0020365; Sim I, 2004, J BIOMED INFORM, V37, P108, DOI 10.1016/j.jbi.2004.03.001; Sim I, 2001, J AM MED INFORM ASSN, V8, P527, DOI 10.1136/jamia.2001.0080527; Sim I, 2000, MED DECIS MAKING, V20, P440, DOI 10.1177/0272989X0002000408; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; TENDAL B, 2008, 16 COCHR COLL FREIB; Tseng MY, 2007, J NEUROSURG, V107, P1092, DOI 10.3171/JNS-07/12/1092; Vajkoczy P, 2005, J NEUROSURG, V103, P9, DOI 10.3171/jns.2005.103.1.0009; Vranos G, 2004, NEUROSURGERY, V55, P18, DOI 10.1227/01.NEU.0000126873.00845.A7; Wilczynski NL, 2008, RADIOLOGY, V248, P817, DOI 10.1148/radiol.2483072067; Willems PWA, 2006, J NEUROSURG, V104, P360, DOI 10.3171/jns.2006.104.3.360; Xu L, 2008, CONTEMP CLIN TRIALS, V29, P727, DOI 10.1016/j.cct.2008.05.003	62	6	6	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1539-2791	1559-0089		NEUROINFORMATICS	Neuroinformatics	DEC	2010	8	4			SI		261	271		10.1007/s12021-010-9079-5			11	Computer Science, Interdisciplinary Applications; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Neurosciences & Neurology	679XP	WOS:000284194400005	20953737				2022-02-06	
J	Prabhu, SP; Young-Poussaint, T				Prabhu, Sanjay P.; Young-Poussaint, Tina			Pediatric Central Nervous System Emergencies	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article						Pediatric; Neurologic; Emergencies; MRI; CT; Brain	TRAUMATIC BRAIN-INJURY; REVERSIBLE ENCEPHALOPATHY SYNDROME; ACUTE DISSEMINATED ENCEPHALOMYELITIS; COMPUTED-TOMOGRAPHY; VENTRICULOPERITONEAL SHUNT; INFLAMMATORY DEMYELINATION; OUTCOME PREDICTION; ABNORMAL FINDINGS; CT ANGIOGRAPHY; NEW-ONSET	This article summarizes current state-of-the-art techniques used in the management of pediatric neurologic emergencies. Solutions to challenges faced by the radiologist, including the selection of an appropriate modality for an individual patient, are discussed. Imaging appearances of specific entities are described with an emphasis on conditions unique to the pediatric population.	[Prabhu, Sanjay P.; Young-Poussaint, Tina] Childrens Hosp Boston, Dept Radiol, Boston, MA 02115 USA; [Prabhu, Sanjay P.; Young-Poussaint, Tina] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA		Young-Poussaint, T (corresponding author), Childrens Hosp Boston, Dept Radiol, 300 Longwood Ave, Boston, MA 02115 USA.	tina.poussaint@childrens.harvard.edu	PRABHU, SANJAY/A-9947-2013	PRABHU, SANJAY/0000-0003-0871-115X			Antunes NL, 1999, PEDIATR NEUROL, V20, P121, DOI 10.1016/S0887-8994(98)00114-3; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Baker C, 1999, AM J EMERG MED, V17, P230, DOI 10.1016/S0735-6757(99)90111-0; Banwell B, 2007, NEUROLOGY, V68, pS46, DOI 10.1212/01.wnl.0000259406.09052.75; Barkovich A.J., 2005, PEDIAT NEUROIMAGING; Barnes SRS, 2009, MAGN RESON IMAGING C, V17, P47, DOI 10.1016/j.mric.2008.12.002; Bartynski WS, 2008, AM J NEURORADIOL, V29, P1043, DOI 10.3174/ajnr.A0929; Baskin HJ, 2007, PEDIATR RADIOL, V37, P949, DOI 10.1007/s00247-007-0506-1; BLAHD W H JR, 1985, Journal of Emergency Medicine, V2, P243, DOI 10.1016/0736-4679(85)90102-7; Blaser S, 2004, NEUROIMAG CLIN N AM, V14, P307, DOI 10.1016/j.nic.2004.03.013; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Browd SR, 2006, PEDIATR NEUROL, V34, P83, DOI 10.1016/j.pediatrneurol.2005.05.020; Callen DJA, 2009, NEUROLOGY, V72, P961, DOI 10.1212/01.wnl.0000338629.01627.54; Chen J, 2009, J MAGN RESON IMAGING, V29, P282, DOI 10.1002/jmri.21641; Cianfoni A, 2007, AM J NEURORADIOL, V28, P272; Covarrubias DJ, 2002, AM J NEURORADIOL, V23, P1038; Dale RC, 2000, BRAIN, V123, P2407, DOI 10.1093/brain/123.12.2407; Dale RC, 2009, CURR OPIN NEUROL, V22, P233, DOI 10.1097/WCO.0b013e32832b4c47; De Bruecker Y, 2004, EUR RADIOL, V14, P1478, DOI 10.1007/s00330-004-2247-y; Deresiewicz RL, 1997, NEW ENGL J MED, V336, P1867, DOI 10.1056/NEJM199706263362604; Desai KR, 2007, PEDIATR RADIOL, V37, P452, DOI 10.1007/s00247-007-0431-3; Du YPP, 2009, J MAGN RESON IMAGING, V30, P449, DOI 10.1002/jmri.21833; Foerster BR, 2009, J PEDIATR-US, V154, P573, DOI 10.1016/j.jpeds.2008.09.051; Frush DP, 2008, PEDIATR RADIOL, V38, pS259, DOI 10.1007/s00247-008-0795-z; Gaillard WD, 2009, EPILEPSIA, V50, P2147, DOI 10.1111/j.1528-1167.2009.02075.x; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Garg M, 2004, RADIOLOGY, V230, P519, DOI 10.1148/radiol.2302021317; Garvey MA, 1998, J PEDIATR-US, V133, P664, DOI 10.1016/S0022-3476(98)70109-X; Greer DM, 2009, CRIT CARE MED, V37, P1523, DOI 10.1097/CCM.0b013e31819d2df2; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; Hutchings L, 2009, J TRAUMA, V67, P681, DOI 10.1097/TA.0b013e3181a5f0ed; Jan W, 2003, NEURORADIOLOGY, V45, P634, DOI 10.1007/s00234-003-1035-8; Kastrup O, 2008, SEMIN NEUROL, V28, P511, DOI 10.1055/s-0028-1083688; Kemp AM, 2009, CLIN RADIOL, V64, P473, DOI 10.1016/j.crad.2008.11.011; Kleinman PK, 1998, DIAGNOSTIC IMAGING C; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Kuppermann N, 2008, PEDIATR RADIOL, V38, pS670, DOI 10.1007/s00247-008-0996-5; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Lucchini G, 2008, PEDIATR BLOOD CANCER, V51, P629, DOI 10.1002/pbc.21688; Lum C, 2009, AM J NEURORADIOL, V30, P787, DOI 10.3174/ajnr.A1455; Luthra G, 2007, AM J NEURORADIOL, V28, P1332, DOI 10.3174/ajnr.A0548; Makoroff KL, 2005, PEDIATR RADIOL, V35, P668, DOI 10.1007/s00247-005-1441-7; Mater A, 2008, CAN J EMERG MED, V10, P131; Matsukuma E, 2008, EUR J PEDIATR, V167, P829, DOI 10.1007/s00431-007-0574-0; Maytal J, 2000, EPILEPSIA, V41, P950, DOI 10.1111/j.1528-1157.2000.tb00277.x; MCABEE GN, 1989, PEDIATR NEUROL, V5, P102, DOI 10.1016/0887-8994(89)90034-9; McKinney AM, 2008, PEDIATR RADIOL, V38, P164, DOI 10.1007/s00247-007-0673-0; McKinney AM, 2007, AM J ROENTGENOL, V189, P904, DOI 10.2214/AJR.07.2024; Mikaeloff Y, 2004, BRAIN, V127, P1942, DOI 10.1093/brain/awh218; Morris EB, 2007, PEDIATR BLOOD CANCER, V48, P152, DOI 10.1002/pbc.20703; Proctor MR, 2002, CRIT CARE MED, V30, pS489, DOI 10.1097/00003246-200211001-00014; Rekate HL, 2009, SEMIN PEDIATR NEUROL, V16, P9, DOI 10.1016/j.spen.2009.01.002; Rybka Krzysztof, 2007, Med Sci Monit, V13 Suppl 1, P147; Sharma S, 2003, PEDIATRICS, V111, P1, DOI 10.1542/peds.111.1.1; Suh DY, 2001, NEUROSURGERY, V49, P309, DOI 10.1097/00006123-200108000-00011; Swischuk LE, 2000, PEDIATR RADIOL, V30, P186, DOI 10.1007/s002470050043; Tan MA, 2009, J CHILD NEUROL, V24, P1250, DOI 10.1177/0883073809333539; Teksam M, 2008, AM J NEURORADIOL, V29, P1961, DOI 10.3174/ajnr.A1246; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Udayasankar UK, 2008, AM J NEURORADIOL, V29, P802, DOI 10.3174/ajnr.A0923; Vertinsky AT, 2008, AM J NEURORADIOL, V29, P1753, DOI 10.3174/ajnr.A1189; Visocchi M, 2007, ACTA NEUROCHIR, V149, P347, DOI 10.1007/s00701-006-1102-0; Warden CR, 1997, ANN EMERG MED, V29, P518, DOI 10.1016/S0196-0644(97)70226-9; Wasay M, 2005, EUR J NEUROL, V12, P475, DOI 10.1111/j.1468-1331.2005.00999.x; Widjaja E, 2006, AM J NEURORADIOL, V27, P1913; Wintermark P, 2008, J MAGN RESON IMAGING, V28, P1019, DOI 10.1002/jmri.21525; Wintermark P, 2008, J MAGN RESON IMAGING, V27, P1229, DOI 10.1002/jmri.21379; YNGVE DA, 1988, J PEDIATR ORTHOPED, V8, P153; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698; Zimmerman RA, 2006, NEUROIMAG CLIN N AM, V16, P229, DOI 10.1016/j.nic.2006.02.009	73	6	6	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	NOV	2010	20	4					663	+		10.1016/j.nic.2010.07.008			22	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	683VE	WOS:000284504300014	20974382				2022-02-06	
J	Zhao, XD; Zhou, YT; Zhang, X; Wang, XL; Qi, W; Zhuang, Z; Su, XF; Shi, JX				Zhao, Xu-Dong; Zhou, Yi-Ting; Zhang, Xing; Wang, Xiao-Liang; Qi, Wu; Zhuang, Zong; Su, Xing-Fen; Shi, Ji-Xin			Expression of NF-E2-related factor 2 (Nrf2) in the basilar artery after experimental subarachnoid hemorrhage in rabbits: A preliminary study	BRAIN RESEARCH			English	Article						NF-E2-related factor 2; Cerebral vasospasm; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; CEREBRAL VASOSPASM; OXIDATIVE STRESS; RESPONSIVE ELEMENT; KAPPA-B; ACTIVATION; PATHWAY; ANTIOXIDANTS; INDUCTION; OXIDANTS	It has been suggested that the pathogenesis of vasospasm is complex including endothelial damage, oxidative stress, inflammatory damage, and the accumulation of toxic metabolites. Recently, a growing body of evidence indicates that nuclear factor erythroid 2-related factor 2 (Nrf2) plays a unique role in many physiological stress processes. In this study, a total of 48 rabbits were assigned randomly to four groups: control group, SAH day 3, day 5, and day 7 groups. The animals in SAH day 3, day 5, and day 7 groups were subjected to injection of autologous blood into cistema magna twice on day 0 and day 2 and were killed on days 3, 5, and 7, respectively. Cross-sectional area of basilar artery was measured and the Nrf2 expression was assessed by immunohistochemistry and Western blot analysis. The mRNA levels of Nrf2 were also determined by RT-PCR. The basilar arteries exhibited vasospasm after SAH and became more severe on days 3 and 5. The elevated expression of Nrf2 was detected after SAH and peaked on days 3 and 5. Nrf2 is increasingly expressed in a parallel time course to the development of cerebral vasospasm in a rabbit experimental model of SAH. (C) 2010 Elsevier B.V. All rights reserved.	[Zhang, Xing; Wang, Xiao-Liang; Qi, Wu; Zhuang, Zong; Su, Xing-Fen; Shi, Ji-Xin] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu Prov, Peoples R China; [Zhao, Xu-Dong] Nanjing Med Univ, Wuxi Hosp 2, Dept Neurosurg, Wuxi 214002, Jiangsu Prov, Peoples R China; [Zhou, Yi-Ting] Wuxi Integrated Tradit Chinese & Western Med Hosp, Dept Radiol, Wuxi 214041, Jiangsu Prov, Peoples R China		Shi, JX (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu Prov, Peoples R China.	jxshi@yahoo.cn			Jinling Hospital; China Scholarship Council (CSC)China Scholarship Council	We thank Dr Yin Hong Lin for his technical assistance. This work was supported by grants from Jinling Hospital and China Scholarship Council (CSC).	Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Calabrese V, 2005, J NEUROSCI RES, V79, P509, DOI 10.1002/jnr.20386; Chen G, 2008, BRAIN RES, V1214, P136, DOI 10.1016/j.brainres.2008.03.085; Crowley RW, 2008, DRUG DISCOV TODAY, V13, P254, DOI 10.1016/j.drudis.2007.11.010; Dinkova-Kostova AT, 2005, BIOCHEMISTRY-US, V44, P6889, DOI 10.1021/bi047434h; Diringer MN, 2009, CRIT CARE MED, V37, P432, DOI 10.1097/CCM.0b013e318195865a; Fassbender K, 2001, J NEUROL NEUROSUR PS, V70, P534, DOI 10.1136/jnnp.70.4.534; Grasso G, 2004, BRAIN RES REV, V44, P49, DOI 10.1016/j.brainresrev.2003.10.003; Ishii T, 2004, CIRC RES, V94, P609, DOI 10.1161/01.RES.0000119171.44657.45; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Kang KW, 2002, NITRIC OXIDE-BIOL CH, V7, P244, DOI 10.1016/S1089-8603(02)00117-9; Kim YC, 2001, J BIOL CHEM, V276, P18399, DOI 10.1074/jbc.M100103200; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Numazawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC334, DOI 10.1152/ajpcell.00043.2003; Osburn WO, 2006, ARCH BIOCHEM BIOPHYS, V454, P7, DOI 10.1016/j.abb.2006.08.005; Osuka K, 2006, BRAIN RES, V1072, P1, DOI 10.1016/j.brainres.2005.12.003; Osuka K, 2010, BRAIN RES, V1332, P12, DOI 10.1016/j.brainres.2010.03.046; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Polin RS, 1998, J NEUROSURG, V89, P559, DOI 10.3171/jns.1998.89.4.0559; Radjendirane V, 1998, J BIOL CHEM, V273, P7382, DOI 10.1074/jbc.273.13.7382; Ramsey CP, 2007, J NEUROPATH EXP NEUR, V66, P75, DOI 10.1097/nen.0b013e31802d6da9; Shah ZA, 2007, NEUROSCIENCE, V147, P53, DOI 10.1016/j.neuroscience.2007.02.066; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Tanito M, 2007, FREE RADICAL BIO MED, V42, P1838, DOI 10.1016/j.freeradbiomed.2007.03.018; van Muiswinkel FL, 2005, CNS NEUROL DISORD-DR, V4, P267, DOI 10.2174/1568007054038238; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang JA, 2007, FREE RADICAL BIO MED, V43, P408, DOI 10.1016/j.freeradbiomed.2007.04.020; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Yan W, 2009, J TRAUMA, V66, P1431, DOI 10.1097/TA.0b013e318180f5c7; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Zhou ML, 2007, J CEREBR BLOOD F MET, V27, P1583, DOI 10.1038/sj.jcbfm.9600456; Zhou ML, 2007, BRAIN RES, V1173, P110, DOI 10.1016/j.brainres.2007.07.059; Zhou ML, 2007, J NEUROSCI METH, V159, P318, DOI 10.1016/j.jneumeth.2006.07.026	37	6	10	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	OCT 28	2010	1358						221	227		10.1016/j.brainres.2010.08.035			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	675GL	WOS:000283814800023	20727861				2022-02-06	
J	Hup, CK; Tharakan, J; Pal, HK; Khan, N; Chin, TY				Hup, Chan Kin; Tharakan, John; Pal, Hillol Kanti; Khan, Naeem; Chin, Tan Yew			Risk Factors and Phenytoin Prophylaxis for Early Post-Traumatic Seizures among Patients with Traumatic Brain Injury	MALAYSIAN JOURNAL OF MEDICAL SCIENCES			English	Article						post-traumatic epilepsy; traumatic brain injury; head injuries; incidence; risk factors; phenytoin		Background: Post-traumatic seizure is a well-known and serious complication of traumatic brain injury (TBI). The incidence and risk factors vary among study populations. Very little data have been published concerning this in the Malaysian population. The aim of this study was to ascertain the risk factors for the development of early post-traumatic seizures among patients with TBI. Methods: This was a prospective observational study, carried out in Hospital Universiti Sains Malaysia, Kubang Kerian, Kelantan, under the Department of Neurosciences. A total of 157 patients, from all age groups, who were diagnosed with TBI were enrolled from June 2007 to December 2007. They were followed-up for 12 months until death or their first post-traumatic seizure. Survival analysis with Kaplan-Meier curves and Cox proportional hazards regression was performed. Results: A total of 11 (7.0%) of the patients developed early post-traumatic seizures. The risk factors for early post-traumatic seizures were young age (P = 0.021, 95% CI 0.806 to 0.982) and intubated patients (P = 0.029, 95% CI 1.194 to 25.913). The incidence of early post-traumatic seizures in the local population was 7.0%. Conclusion: The incidence of early post-traumatic seizures in the local population of Kelantan and Terengganu is comparable to the incidences reported elsewhere. Younger as well as intubated patients were at a higher risk of developing this condition. It may be necessary to give antiepileptic prophylaxis because any seizure could adversely affect morbidity and mortality. However, the study showed that antiepileptic drug was not beneficial in preventing late post-traumatic seizures, but may have a role in preventing early seizures.	[Hup, Chan Kin] Int Islamic Univ Malaysia, Jalan Istana Bandar Indera Mahkota, Dept Surg Kulliyyah Med, Kuantan 25200, Pahang, Malaysia; [Tharakan, John; Pal, Hillol Kanti; Chin, Tan Yew] Hosp Univ Sains Malaysia, Dept Neurosci, Kubang Kerian 16150, Kelantan, Malaysia; [Khan, Naeem] Univ Sains Malaysia, Sch Med Sci, Unit Biostat & Res Methodol, Kubang Kerian 16150, Kelantan, Malaysia		Hup, CK (corresponding author), Int Islamic Univ Malaysia, Jalan Istana Bandar Indera Mahkota, Dept Surg Kulliyyah Med, Kuantan 25200, Pahang, Malaysia.	khchan@hotmail.com					[Anonymous], 2010, MEDICAL RECORDS DATA; Ates O, 2006, CHILD NERV SYST, V22, P279, DOI 10.1007/s00381-005-1177-6; Black P, 1975, Ciba Found Symp, P215; Burcet DJ, 1992, NEUROLOGIA, V7, P49; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; De Santis A, 1979, J Neurosurg Sci, V23, P207; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; JACOBI G, 1992, MONATSSCHR KINDERH, V140, P619; Kareem Abdul, 2003, Malays J Med Sci, V10, P31; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MURRI L, 1980, ITAL J NEUROL SCI, V1, P225; Ong LC, 1996, J PAEDIATR CHILD H, V32, P173, DOI 10.1111/j.1440-1754.1996.tb00917.x; Pagni CA, 2005, ACT NEUR S, V93, P27; PECHADRE JC, 1991, PRESSE MED, V20, P841; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; Temkin N R, 1995, New Horiz, V3, P518; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC	20	6	6	0	0	UNIV SAINS MALAYSIA, SCH MEDICAL SCIENCES	KELANTAN	HEALTH CAMPUS, 16150 KUBANG KERIAN, KELANTAN, 00000, MALAYSIA	1394-195X	2180-4303		MALAYS J MED SCI	Malays. J. Med. Sci.	OCT-DEC	2010	17	4					36	43					8	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	V6M8L	WOS:000420427400006	22135559				2022-02-06	
J	Clifford, M; Hunt, RW				Clifford, Michael; Hunt, Rodney W.			Neonatal resuscitation	BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY			English	Article						neonatal resuscitation; therapeutic hypothermia; ILCOR guidelines	MECONIUM ASPIRATION SYNDROME; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; DELIVERY ROOM RESUSCITATION; STANDARD-DOSE EPINEPHRINE; LARYNGEAL MASK AIRWAY; CUFFED TRACHEAL TUBES; CARDIOPULMONARY-RESUSCITATION; 100-PERCENT OXYGEN; UMBILICAL-CORD	Neonatal resuscitation techniques are evolving. More sophisticated methods of monitoring have emerged and current practices have been challenged. It is recognised that most newborns will require only gentle assistance to facilitate the transition from intrauterine life. The routine use of suction and oxygen supplementation is no longer recommended and the effectiveness of current methods of delivering ventilatory support has been questioned. The importance of effective use of masks and optimising tidal ventilation rather than pressure generation is emphasised. Newer oximetry technologies and the routine use of capnography may facilitate clinical assessment even during active resuscitation. Methods of warming infants have become increasingly effective and the use of servo- control is emphasised to prevent overheating. Evidence to support therapeutic hypothermia for the birth- asphyxiated baby is solid and cooling should be considered a standard of care. The next revision of the International Liason Committee on Resuscitation (ILCOR) Guidelines is eagerly awaited in 2010. (C) 2010 Elsevier Ltd. All rights reserved.	[Clifford, Michael] Royal Childrens Hosp, Dept Anaesthesia & Pain Management, Paediat Intens Care Unit, Melbourne, Vic, Australia; [Hunt, Rodney W.] Royal Childrens Hosp, Dept Neonatal Med, Murdoch Childrens Res Inst, Crit Care & Neurosci Theme, Melbourne, Vic, Australia		Clifford, M (corresponding author), Royal Childrens Hosp, Dept Anaesthesia & Pain Management, Paediat Intens Care Unit, Melbourne, Vic, Australia.	michael.clifford@rch.org.au		Hunt, Rodney/0000-0002-2446-1739			Abe KK, 2000, AM J EMERG MED, V18, P126, DOI 10.1016/S0735-6757(00)90001-9; AIZAD T, 1984, J APPL PHYSIOL, V57, P1531, DOI 10.1152/jappl.1984.57.5.1531; Aziz H F, 1999, J Perinatol, V19, P110; AZZOPARI DV, 2009, THE NEW ENGLAND JOUR, V361, P1349; Barber CA, 2006, PEDIATRICS, V118, P1028, DOI 10.1542/peds.2006-0416; Berg RA, 1996, CRIT CARE MED, V24, P1695, DOI 10.1097/00003246-199610000-00016; Berg RA, 2001, CIRCULATION, V104, P2465, DOI 10.1161/hc4501.098926; Berglund S, 2008, ACTA PAEDIATR, V97, P714, DOI 10.1111/j.1651-2227.2008.00803.x; Bergman NJ, 2004, ACTA PAEDIATR, V93, P779, DOI 10.1111/j.1651-2227.2004.tb03018.x; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BHENDE MS, 1992, PEDIATRICS, V89, P1042; Biarent D, 2005, RESUSCITATION, V67, pS97, DOI 10.1016/j.resuscitation.2005.10.010; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Bjorklund LJ, 1997, PEDIATR RES, V42, P348; Bjorklund LJ, 2001, ACTA ANAESTH SCAND, V45, P986, DOI 10.1034/j.1399-6576.2001.450811.x; Boyle DW, 2008, SEMIN FETAL NEONAT M, V13, P392, DOI 10.1016/j.siny.2008.04.026; Carrasco M, 1997, J PEDIATR-US, V130, P832, DOI 10.1016/S0022-3476(97)80031-5; Cernadas JMC, 2006, PEDIATRICS, V117, pE779, DOI 10.1542/peds.2005-1156; Chaparro CM, 2006, LANCET, V367, P1997, DOI 10.1016/S0140-6736(06)68889-2; Chaput de Saintongue DM, 1979, BMJ CLIN RES ED, V6190, P570; Copnell B, LAVAGE EXOGENOUS SUR; CORDERO L, 1971, J PEDIATR-US, V78, P441, DOI 10.1016/S0022-3476(71)80224-X; DAHM LS, 1972, PEDIATRICS, V49, P504; Dargaville PA, 2005, DRUGS, V65, P2569, DOI 10.2165/00003495-200565180-00003; Dargaville PA, 2007, J PAEDIATR CHILD H, V43, P539, DOI 10.1111/j.1440-1754.2007.01130.x; Davis PG, 2004, LANCET, V364, P1329, DOI 10.1016/S0140-6736(04)17189-4; Dawson JA, 2007, ARCH DIS CHILD-FETAL, V92, pF4, DOI 10.1136/adc.2006.102749; DEAKERS TW, 1994, THE JOURNAL OF PEDIA, V125, P57; DeBoer S, 2008, NEONATAL NETW, V27, P25, DOI 10.1891/0730-0832.27.1.25; Dullenkopf A, 2004, PEDIATR ANESTH, V14, P825, DOI 10.1111/j.1460-9592.2004.01316.x; Edelson DP, 2006, RESUSCITATION, V71, P137, DOI 10.1016/j.resuscitation.2006.04.008; EMERY EF, 1992, ARCH DIS CHILD-FETAL, V67, P1185, DOI 10.1136/adc.67.10_Spec_No.1185; Escrig R, 2008, PEDIATRICS, V121, P875, DOI 10.1542/peds.2007-1984; Esmail N., 2002, EG J ANESTH, V18, P115; FALCIGLIA HS, 1992, AM J OBSTET GYNECOL, V167, P1243, DOI 10.1016/S0002-9378(11)91695-0; Fardig J A, 1980, J Nurse Midwifery, V25, P19, DOI 10.1016/0091-2182(80)90005-1; FILAN PM, 2006, THE JOURNAL OF PEDIA, V148, P552, DOI DOI 10.1016/J.JPEDS.2005.11.015; Finer NN, 2004, CURR OPIN PEDIATR, V16, P157, DOI 10.1097/00008480-200404000-00007; Finer NN, 2001, RESUSCITATION, V49, P299, DOI 10.1016/S0300-9572(01)00311-2; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Flynn PE, 2008, EUR J ANAESTH, V25, P685, DOI 10.1017/S0265021508003839; Gandini D, 1999, ANESTH ANALG, V89, P642, DOI 10.1097/00000539-199909000-00018; Gerstmann Dale, 2003, J Perinatol, V23, P378, DOI 10.1038/sj.jp.7210944; Ghidini A, 2001, AM J OBSTET GYNECOL, V185, P931, DOI 10.1067/mob.2001.116828; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gungor S, 2006, GYNECOL OBSTET INVES, V61, P9, DOI 10.1159/000087604; Gungor S, 2005, AUST NZ J OBSTET GYN, V45, P453, DOI 10.1111/j.1479-828X.2005.00452.x; Halamek LP, 2008, SEMIN FETAL NEONAT M, V13, P448, DOI 10.1016/j.siny.2008.04.015; Halamek LP, 2006, CLIN PERINATOL, V33, P83, DOI 10.1016/j.clp.2005.11.010; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hosono S, 2008, ARCH DIS CHILD-FETAL, V93, pF14, DOI 10.1136/adc.2006.108902; Houri P K, 1997, Prehosp Emerg Care, V1, P65, DOI 10.1080/10903129708958789; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Hutton EK, 2007, JAMA-J AM MED ASSOC, V297, P1241, DOI 10.1001/jama.297.11.1241; ILCOR C, 2010, WORKSH NRP 007A; ILCOR C, 2010, WORKSH NRP 020A; ILCOR C, 2010, WORKSH PEDS 029; ILCOR C, 2010, WORKSH PEDS 023B R4; Jankov RP, 2000, J PAEDIATR CHILD H, V36, P19, DOI 10.1046/j.1440-1754.2000.00434.x; Kamlin COF, 2006, RESUSCITATION, V71, P319, DOI 10.1016/j.resuscitation.2006.04.015; KAMLIN CO, 2008, THE JOURNAL OF PEDIA, V152, P756, DOI DOI 10.1016/J.JPEDS.2008.01.002; KAMLIN COF, 2006, THE JOURNAL OF PEDIA, V148, P585, DOI DOI 10.1016/J.JPEDS.2005.12.050; Kattwinkel J, 2006, PEDIATRICS, V117, pE1029, DOI 10.1542/peds.2006-0349; Khine HH, 1997, ANESTHESIOLOGY, V86, P627, DOI 10.1097/00000542-199703000-00015; Kinsella JP, 2003, AM J RESP CRIT CARE, V168, P413, DOI 10.1164/rccm.2306002; Laptook AR, 2008, SEMIN FETAL NEONAT M, V13, P383, DOI 10.1016/j.siny.2008.04.003; Laptook AR, 2002, CLIN PERINATOL, V29, P623, DOI 10.1016/S0095-5108(02)00057-X; Leone TA, 2006, PEDIATRICS, V117, pE164, DOI 10.1542/peds.2005-0936; Linder N, 1998, J PEDIAT, V112, P613; Litman RS, 2003, ANESTHESIOLOGY, V98, P41, DOI 10.1097/00000542-200301000-00010; Liu WF, 1998, AM J PERINAT, V15, P675, DOI 10.1055/s-2007-999301; LUNDSTROM KE, 1995, ARCH DIS CHILD-FETAL, V73, pF81, DOI 10.1136/fn.73.2.F81; MARIANI G, 2007, THE JOURNAL OF PEDIA, V150, P418, DOI DOI 10.1016/J.JPEDS.2006.12.015; MAYFIELD SR, 1984, THE JOURNAL OF PEDIA, V104, P271; McCall EM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004210.pub2; McGowan JE, 2006, CLIN PERINATOL, V33, P183, DOI 10.1016/j.clp.2005.11.007; MENEGAZZI JJ, 1993, ANN EMERG MED, V22, P240, DOI 10.1016/S0196-0644(05)80212-4; Mercer JS, 2006, PEDIATRICS, V117, P1235, DOI 10.1542/peds.2005-1706; Moehrlen U, 2007, PAEDIATR ANAESTH, V17, P1; Moeller-Bartram T, 2007, INTERNET J ANESTHESI, V12; Mora EU, 2006, CLIN PERINATOL, V33, P99, DOI 10.1016/j.clp.2005.11.011; Morley CJ, 2008, ARCH DIS CHILD-FETAL, V93, pF334, DOI 10.1136/adc.2007.128827; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; Murase M, 2005, ACTA PAEDIATR, V94, P85, DOI 10.1080/08035250410033015; NEWTH CJ, 2004, THE JOURNAL OF PEDIA, V144, P333; Newton T, 2003, ARCH DIS CHILD-FETAL, V88, P256; Niermeyer S, 2006, CLIN PERINATOL, V33, P133, DOI 10.1016/j.clp.2005.12.002; O'Donnell C, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/L4651858.CD00434L.PUB2; O'Donnell CPF, 2008, SEMIN FETAL NEONAT M, V13, P401, DOI 10.1016/j.siny.2008.04.010; O'Donnell CPF, 2007, ARCH DIS CHILD-FETAL, V92, P465, DOI 10.1136/adc.2007.120634; O'Donnell CPF, 2008, ARCH DIS CHILD-FETAL, V93, pF82, DOI 10.1136/adc.2007.118505; O'Donnell CPF, 2005, J PEDIATR-US, V147, P698, DOI 10.1016/j.jpeds.2005.07.025; O'Donnell CPF, 2005, ACTA PAEDIATR, V94, P1261, DOI 10.1080/08035250510036471; O'Donnell CPF, 2005, ARCH DIS CHILD-FETAL, V90, pF392, DOI 10.1136/adc.2004.064691; O'Donnell CPF, 2005, ARCH DIS CHILD-FETAL, V90, pF397, DOI 10.1136/adc.2004.064709; Oca Melisa J, 2003, J Perinatol, V23, P473, DOI 10.1038/sj.jp.7210971; PALME C, 1985, LANCET, V1, P207; PALMEKILANDER C, 1993, ARCH DIS CHILD-FETAL, V68, P6, DOI 10.1136/adc.68.1_Spec_No.6; PASTERNAK JF, 1983, NEUROLOGY, V33, P559; PATERSON SJ, 1994, ANESTHESIOLOGY, V80, P1248, DOI 10.1097/00000542-199406000-00012; Perlman JM, 2006, CLIN PERINATOL, V33, P55, DOI 10.1016/j.clp.2005.11.002; PERLMAN JM, 1995, ARCH PEDIAT ADOL MED, V149, P20, DOI 10.1001/archpedi.1995.02170130022005; PERONDI MB, 2004, THE NEW ENGLAND JOUR, V350, P1722; Rabi Y, 2009, J PERINATOL, V29, P101, DOI 10.1038/jp.2008.186; Rabi Y, 2006, J PEDIATR-US, V148, P590, DOI 10.1016/j.jpeds.2005.12.047; Radford MJ, 2005, CIRCULATION, V112, P1888, DOI 10.1161/CIRCULATIONAHA.105.170073; Richmond S, 2006, CLIN PERINATOL, V33, P11, DOI 10.1016/j.clp.2005.11.003; Richmond S, 2008, SEMIN FETAL NEONAT M, V13, P368, DOI 10.1016/j.siny.2008.04.002; ROSSI EM, 1989, AM J OBSTET GYNECOL, V161, P1106, DOI 10.1016/0002-9378(89)90643-1; Salhab WA, 2004, PEDIATRICS, V114, P361, DOI 10.1542/peds.114.2.361; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shann F, 2003, LANCET, V362, P1950, DOI 10.1016/S0140-6736(03)15083-0; Singhal N, ADDENDUM 2006 NRP PR; Sinha SK, 2008, SEMIN FETAL NEONAT M, V13, P24, DOI 10.1016/j.siny.2007.09.006; So KW, 1997, ARCH DIS CHILD-FETAL, V76, pF43, DOI 10.1136/fn.76.1.F43; Stola A, 2008, SEMIN FETAL NEONAT M, V13, P424, DOI 10.1016/j.siny.2008.04.011; Tibballs J, PEDIAT CRIT IN PRESS; Topjian AA, 2009, CURR OPIN CRIT CARE, V15, P203, DOI 10.1097/MCC.0b013e32832931e1; Tracy M, 2004, ARCH DIS CHILD-FETAL, V89, pF84, DOI 10.1136/fn.89.1.F84; Trevisanuto D, 2004, RESUSCITATION, V60, P291, DOI 10.1016/j.resuscitation.2003.11.001; Udassi JP, 2009, PEDIATR CRIT CARE ME, V10, P328, DOI 10.1097/PCC.0b013e31819886ab; Vain NE, 2004, LANCET, V364, P597, DOI 10.1016/S0140-6736(04)16852-9; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Vandycke C, 2000, RESUSCITATION, V45, P161, DOI 10.1016/S0300-9572(00)00188-X; Velaphi S, 2008, SEMIN FETAL NEONAT M, V13, P375, DOI 10.1016/j.siny.2008.04.001; Vento M, 2001, PEDIATRICS, V107, P642, DOI 10.1542/peds.107.4.642; Vento M, 2008, PEDIATRICS, V122, P1113, DOI 10.1542/peds.2008-1422; Vento M, 2009, PEDIATRICS, V124, pE439, DOI 10.1542/peds.2009-0434; Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1; VOHRA S, 1999, THE JOURNAL OF PEDIA, V134, P547; VYAS H, 1986, PEDIATR PULM, V2, P189, DOI 10.1002/ppul.1950020403; Waltman PA, 2004, J MIDWIFERY WOM HEAL, V49, P32, DOI 10.1016/j.jmwh.2003.10.003; Wang CL, 2008, PEDIATRICS, V121, P1083, DOI 10.1542/peds.2007-1460; Weiss M, 2006, PEDIATR ANESTH, V16, P1005, DOI 10.1111/j.1460-9592.2006.02071.x; White MC, 2009, PEDIATR ANESTH, V19, P55, DOI 10.1111/j.1460-9592.2009.02997.x; Wiswell TE, 2000, PEDIATRICS, V105, P1, DOI 10.1542/peds.105.1.1; Wood FE, 2008, ARCH DIS CHILD-FETAL, V93, pF235, DOI 10.1136/adc.2007.117713; Wyckoff MH, 2006, CLIN PERINATOL, V33, P153, DOI 10.1016/j.clp.2005.11.013; Wyckoff MH, 2005, PEDIATRICS, V115, P950, DOI 10.1542/peds.2004-0913; Wyckoff MH, 2003, PEDIATR RES, V53, p1123A; Wyckoff MH, 2008, SEMIN FETAL NEONAT M, V13, P410, DOI 10.1016/j.siny.2008.04.012; Wyllie J, 2006, CLIN PERINATOL, V33, P111, DOI 10.1016/j.clp.2005.12.001; Wyllie J, 2008, SEMIN FETAL NEONAT M, V13, P416, DOI 10.1016/j.siny.2008.04.017	143	6	7	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1521-6896	1878-1608		BEST PRACT RES-CLIN	Best Pract. Res.-Clin Anaesth.	SEP	2010	24	3					461	474		10.1016/j.bpa.2010.02.011			14	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	V27YO	WOS:000215395300014	21033020				2022-02-06	
J	Kemp, S; Agostinis, A; House, A; Coughlan, AK				Kemp, Steven; Agostinis, Alessio; House, Allan; Coughlan, Anthony K.			Analgesia and other causes of amnesia that mimic post-traumatic amnesia (PTA): A cohort study	JOURNAL OF NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; STRESS-DISORDER; METHODOLOGIC ISSUES; MEMORY; SCALE; DRUGS; IRAQ	Objective. This study explores the possibility that a post-traumatic amnesia (PTA) like phenomenon is caused by the administration of drugs in hospital following injury and that this may be observed in patients who have not suffered a traumatic brain injury (TBI). This work also explored the possibility for an additional contribution to this phenomenon of demographic and psychological variables. Method. Sixty-three orthopaedic patients with no evidence of brain injury were recruited to a two-phase study. Medication records, demographic, and psychological data were obtained at the phase 1. At follow-up interviews (phase 2), psychological data (mood and post-traumatic stress disorder, PTSD) were again obtained and retrospective assessment of PTA using the Rivermead PTA protocol was carried out in 47 patients. Results. Thirty-eight per cent (N = 18) of the total sample (N = 47) reported a PTA-like phenomenon despite not having suffered TBI. A logistic regression model including the receipt of opioids, surgery, and anxiety-related variables, was significant in predicting this phenomenon (chi(2) = 22.054, df = 4, p <= .01) and accounted for up to 57.5% of variation in the data. Age, either alone or in interaction with opioid use, depression, and PTSD symptoms were not significant predictors. PTA-like phenomenon did not occur without at least one predictive factor. Conclusion. Receiving opioids, undergoing surgery, and suffering clinical levels of anxiety at an early stage following injury, can lead patients who have not suffered a TBI to report a PTA-like phenomenon at follow-up. This suggests that retrospective PTA assessment on actual brain injury patients may also be influenced by these factors.	[Kemp, Steven; Agostinis, Alessio; Coughlan, Anthony K.] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [House, Allan] Univ Leeds, Acad Unit Psychiat & Behav Sci, Inst Hlth Sci & Publ Hlth Res, Leeds LS2 9JT, W Yorkshire, England		Kemp, S (corresponding author), St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England.	steven.kemp@leedsth.nhs.uk		House, Allan/0000-0001-8721-8026			Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Ghoneim MM, 2004, ANESTHESIOLOGY, V100, P1277, DOI 10.1097/00000542-200405000-00033; Ghoneim MM, 2004, ANESTHESIOLOGY, V100, P987, DOI 10.1097/00000542-200404000-00033; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kamboj SK, 2005, PAIN, V117, P388, DOI 10.1016/j.pain.2005.06.022; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; McCarter RJ, 2007, BRAIN INJURY, V21, P1393, DOI 10.1080/02699050701793793; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; McNally RJ, 2005, CAN J PSYCHIAT, V50, P817, DOI 10.1177/070674370505001302; Rohde P, 1997, AM J PSYCHIAT, V154, P1593, DOI 10.1176/ajp.154.11.1593; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423; Wagner B K, 1997, Am J Crit Care, V6, P192; Weiss D.S., 2004, ASSESSING PSYCHOL TR, V2, P168, DOI DOI 10.1007/978-0-387-70990-1_10; Zigmond AS, 1983, HOSP ANXIETY DEPRESS	18	6	6	0	6	BRITISH PSYCHOLOGICAL SOC	LEICESTER	ST ANDREWS HOUSE, 48 PRINCESS RD EAST, LEICESTER LE1 7DR, LEICS, ENGLAND	1748-6645			J NEUROPSYCHOL	J. Neuropsychol.	SEP	2010	4		2				231	236		10.1348/174866409X482614			6	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	670DO	WOS:000283401600007	20122307				2022-02-06	
J	Rijkers, K; Mescheriakova, J; Majoie, M; Lemmens, E; van Wijk, X; Philippens, M; Van Kranen-Mastenbroek, V; Schijns, O; Vles, J; Hoogland, G				Rijkers, Kim; Mescheriakova, Julia; Majoie, Marian; Lemmens, Evi; van Wijk, Xander; Philippens, Marjan; Van Kranen-Mastenbroek, Vivianne; Schijns, Olaf; Vles, Johannes; Hoogland, Govert			Polymorphisms in CACNA1 E and Camk2d are associated with seizure susceptibility of Sprague-Dawley rats	EPILEPSY RESEARCH			English	Article						Polymorphisms; Kindling; Hyperthermia; Seizures	KINASE-II ACTIVITY; PROLONGED FEBRILE SEIZURES; ELECTRICAL-STIMULATION; STATUS EPILEPTICUS; MODEL; EPILEPSY; INHIBITION; EXPRESSION; INDUCTION; CALCIUM	Seizures are associated with high intracellular calcium levels. However, conditions characterized by high intracellular calcium levels, such as stroke or traumatic brain injury, do not always evoke epilepsy. We hypothesized that polymorphisms in calcium-related genes CACNA1E and Camk2d contribute to the individual variability in seizure susceptibility. The distribution of one single nucleotide polymorphism (SNP) in the CACNA1E and one in the Camk2d gene was determined in Sprague-Dawley rats that were subjected to amygdala kindling or hyperthermia-induced seizures. The pre-kindling afterdischarge threshold was significantly lower in rats with the CACNA1E GG genotype (45.2 +/- 6.7 mu A) than in the GT genotyped animals (79.3 +/- 53.7 mu A). Among hyperthermia treated rats, the Camk2d G allele was more frequent among rats that did not display behavioral seizures during hyperthermia (67%) than in animals that did show behavioral seizures during hyperthermia (52%, chi(2)(1) = 3.847, p = 0.05). SNPs in CACNA1E and Camk2d genes are associated with the individual variability in seizure susceptibility in two experimental seizure models. (C) 2010 Elsevier B.V. All rights reserved.	[Rijkers, Kim; Mescheriakova, Julia; Lemmens, Evi; van Wijk, Xander; Philippens, Marjan; Schijns, Olaf; Hoogland, Govert] Univ Med Ctr Maastricht, Dept Neurosurg, NL-6202 AZ Maastricht, Netherlands; [Rijkers, Kim; Lemmens, Evi; Hoogland, Govert] European Grad Sch Neurosci EURON, Heeze, Netherlands; [Majoie, Marian] Univ Med Ctr Maastricht, Dept Neurol, NL-6202 AZ Maastricht, Netherlands; [Majoie, Marian] Epilepsy Ctr Kempenhaeghe, Heeze, Netherlands; [Lemmens, Evi] Hasselt Univ, Diepenbeek, Belgium; [Van Kranen-Mastenbroek, Vivianne] Univ Med Ctr Maastricht, Dept Clin Neurophysiol, NL-6202 AZ Maastricht, Netherlands; [Vles, Johannes] Univ Med Ctr Maastricht, Dept Child Neurol, NL-6202 AZ Maastricht, Netherlands		Rijkers, K (corresponding author), Univ Med Ctr Maastricht, Dept Neurosurg, POB 5800, NL-6202 AZ Maastricht, Netherlands.	kimrijkers@gmail.com	Majoie, HJM/A-8065-2012	Lemmens, Evi/0000-0001-6044-5659; Majoie, Marian/0000-0003-0579-8122	Dutch Scientific OrganisationNetherlands Organization for Scientific Research (NWO) [92003453]	K. Rijkers is supported by grant #92003453 from the Dutch Scientific Organisation. All authors state that there are no conflicts of interest.	Baram TZ, 1997, DEV BRAIN RES, V98, P265, DOI 10.1016/S0165-3806(96)00190-3; Blair RE, 2008, EUR J PHARMACOL, V588, P64, DOI 10.1016/j.ejphar.2008.04.021; Brandt C, 2004, EPILEPSY RES, V62, P135, DOI 10.1016/j.eplepsyres.2004.08.008; BRONSTEIN JM, 1992, BRAIN RES, V584, P257, DOI 10.1016/0006-8993(92)90903-M; Churn SB, 2000, BRAIN RES, V875, P66, DOI 10.1016/S0006-8993(00)02623-8; de Borman B, 1999, NEUROREPORT, V10, P569, DOI 10.1097/00001756-199902250-00023; DeLorenzo RJ, 2005, PHARMACOL THERAPEUT, V105, P229, DOI 10.1016/j.pharmthera.2004.10.004; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Dube C, 2000, ANN NEUROL, V47, P336, DOI 10.1002/1531-8249(200003)47:3<336::AID-ANA9>3.3.CO;2-N; Gloyn AL, 2002, DIABETOLOGIA, V45, P580, DOI 10.1007/s00125-002-0779-8; Gurd JW, 2008, BRAIN RES, V1218, P158, DOI 10.1016/j.brainres.2008.04.040; Guryev V, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-10; Holmkvist J, 2007, DIABETOLOGIA, V50, P2467, DOI 10.1007/s00125-007-0846-2; Jansen JFA, 2008, NEUROBIOL DIS, V32, P293, DOI 10.1016/j.nbd.2008.07.010; Kochan LD, 2000, NEUROSCIENCE, V95, P735; Lemmens EMP, 2005, EPILEPSIA, V46, P1603, DOI 10.1111/j.1528-1167.2005.00252.x; Lemmens EMP, 2008, EPILEPSIA, V49, P853, DOI 10.1111/j.1528-1167.2007.01476.x; Lemmens EMP, 2009, EPILEPSY BEHAV, V14, P309, DOI 10.1016/j.yebeh.2008.11.005; Loscher W, 1998, EXP NEUROL, V154, P551, DOI 10.1006/exnr.1998.6948; N'Gouemo P, 2010, BRAIN RES, V1308, P153, DOI 10.1016/j.brainres.2009.10.019; Ng MSM, 2006, EPILEPSY RES, V72, P97, DOI 10.1016/j.eplepsyres.2006.06.007; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P269, DOI 10.1016/0013-4694(72)90176-9; Rakhade SN, 2008, J NEUROSCI, V28, P7979, DOI 10.1523/JNEUROSCI.1734-08.2008; Rijkers K, 2010, BRAIN RES, V1319, P155, DOI 10.1016/j.brainres.2010.01.014; Singleton MW, 2005, EPILEPSIA, V46, P1389, DOI 10.1111/j.1528-1167.2005.19205.x; Smits BMG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-170; Temel Y, 2004, NEUROSCI LETT, V367, P92, DOI 10.1016/j.neulet.2004.05.087	29	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	SEP	2010	91	1					28	34		10.1016/j.eplepsyres.2010.06.006			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660DH	WOS:000282619100004	20638246				2022-02-06	
J	Rolius, R; Antoniou, C; Nazarova, LA; Kim, SH; Cobb, G; Gala, P; Rajaram, P; Li, QF; Fung, LWM				Rolius, Ramunas; Antoniou, Chloe; Nazarova, Lidia A.; Kim, Stephen H.; Cobb, Garrett; Gala, Pooja; Rajaram, Priyanka; Li, Qufei; Fung, Leslie W. -M.			Inhibition of calpain but not caspase activity by spectrin fragments	CELLULAR & MOLECULAR BIOLOGY LETTERS			English	Article						Spectrin; Calpain; Caspase; Calpain inhibition; Cysteine protease	TRAUMATIC BRAIN-INJURY; ALPHA-II-SPECTRIN; TETRAMERIZATION SITE; PARAMAGNETIC-RESONANCE; BETA-SPECTRIN; CELL-DEATH; CALPASTATIN; CLEAVAGE; DEGRADATION; GLUTATHIONE	Calpains and caspases are ubiquitous cysteine proteases that are associated with a variety of cellular pathways. Calpains are involved in processes such as long term potentiation, cell motility and apoptosis, and have been shown to cleave non-erythroid (brain) alpha- and beta-spectrin and erythroid beta-spectrin. The cleavage of erythroid alpha-spectrin by calpain has not been reported. Caspases play an important role in the initiation and execution of apoptosis, and have been shown to cleave non-erythroid but not erythroid spectrin. We have studied the effect of spectrin fragments on calpain and caspase activities. The erythroid and non-erythroid spectrin fragments used were from the N-terminal region of alpha-spectrin, and C-terminal region of beta-spectrin, both consisting of regions involved in spectrin tetramer formation. We observed that the all spectrin fragments exhibited a concentration-dependent inhibitory effect on calpain, but not caspase activity. It is clear that additional studies are warranted to determine the physiological significance of calpain inhibition by spectrin fragments. Our findings suggest that calpain activity is modulated by the presence of spectrin partial domains at the tetramerization site. It is not clear whether the inhibitory effect is substrate specific or is a general effect. Further studies of this inhibitory effect may lead to the identification and development of new therapeutic agents specifically for calpains, but not for caspases. Proteins/peptides with a coiled coil helical conformation should be studied for potential inhibitory effects on calpain activity.	[Rolius, Ramunas; Antoniou, Chloe; Nazarova, Lidia A.; Kim, Stephen H.; Cobb, Garrett; Gala, Pooja; Rajaram, Priyanka; Li, Qufei; Fung, Leslie W. -M.] Univ Illinois, Dept Chem, Chicago, IL 60607 USA		Fung, LWM (corresponding author), Univ Illinois, Dept Chem, 845 W Taylor St,M-C 111, Chicago, IL 60607 USA.	lfung@uic.edu	Nazarova, Lidia/C-5818-2013	Nazarova, Lidia/0000-0001-8010-1167	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM68621]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM068621] Funding Source: NIH RePORTER	This work was supported by a grant from NIH (GM68621) to LWMF.	Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Antoniou C, 2008, BIOCHEMISTRY-US, V47, P10765, DOI 10.1021/bi800840p; Antoniou C, 2008, ANAL BIOCHEM, V376, P160, DOI 10.1016/j.ab.2008.02.001; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1989, BIOCHIM BIOPHYS ACTA, V988, P107, DOI 10.1016/0304-4157(89)90006-3; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; ETO A, 1995, J BIOL CHEM, V270, P25115, DOI 10.1074/jbc.270.42.25115; Glantz SB, 2007, BIOCHEMISTRY-US, V46, P502, DOI 10.1021/bi061504y; Janossy J, 2004, BIOCHEM PHARMACOL, V67, P1513, DOI 10.1016/j.bcp.2003.12.021; Kiss R, 2008, BIOCHEMISTRY-US, V47, P6936, DOI 10.1021/bi800201a; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Li QF, 2009, BIOCHEMISTRY-US, V48, P206, DOI 10.1021/bi8013032; Lofvenberg L, 1999, FEBS LETT, V443, P89, DOI 10.1016/S0014-5793(98)01697-4; Lynch DR, 2007, NEURON, V53, P317, DOI 10.1016/j.neuron.2007.01.014; Meary F, 2007, J BIOL CHEM, V282, P14226, DOI 10.1074/jbc.M700028200; Mehboob S, 2005, BIOCHEMISTRY-US, V44, P15898, DOI 10.1021/bi051009m; Mehboob S, 2001, BIOCHEMISTRY-US, V40, P12457, DOI 10.1021/bi010984k; Mehboob S, 2010, J BIOL CHEM, V285, P14572, DOI 10.1074/jbc.M109.080028; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Mucsi Z, 2003, PROTEIN SCI, V12, P2327, DOI 10.1110/ps.03138803; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Park S, 2003, J BIOL CHEM, V278, P21837, DOI 10.1074/jbc.M300617200; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Rackoff J, 2001, NEUROSCI LETT, V311, P129, DOI 10.1016/S0304-3940(01)02161-9; Rutledge TW, 2002, J BIOL CHEM, V277, P37009, DOI 10.1074/jbc.M204526200; Saez ME, 2006, DRUG DISCOV TODAY, V11, P917, DOI 10.1016/j.drudis.2006.08.009; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Spira ME, 2001, CELL MOL NEUROBIOL, V21, P591, DOI 10.1023/A:1015135617557; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wronski R, 2000, J NEURAL TRANSM, V107, P145, DOI 10.1007/s007020050013; Yuen Po-Wai, 1998, Drugs of the Future, V23, P741, DOI 10.1358/dof.1998.023.07.858362	35	6	6	0	3	VERSITA	WARSAW	SOLIPSKA 14A-1, 02-482 WARSAW, POLAND	1425-8153			CELL MOL BIOL LETT	Cell. Mol. Biol. Lett.	SEP	2010	15	3					395	405		10.2478/s11658-010-0015-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	612US	WOS:000278930100003	20467904	Green Accepted, Green Published			2022-02-06	
J	Bajcetic, M; Brajovic, M; Korkut-Tesic, R				Bajcetic, Milica; Brajovic, Milan; Korkut-Tesic, Radojka			DIAGNOSTIC AND THERAPEUTIC SIGNIFICANCE OF THE OXIDATIVE STRESS PARAMETERS IN CHILDREN	JOURNAL OF MEDICAL BIOCHEMISTRY			English	Article						oxidative stress parameters; antioxidants; children	ANTIOXIDANT ENZYME-ACTIVITIES; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE LEVELS; LIPID-PEROXIDATION; PEDIATRIC-PATIENTS; VITAMIN-E; PROTEIN OXIDATION; HEME OXYGENASE-1; CYSTIC-FIBROSIS; OBESE CHILDREN	Pharmacotherapy of pediatric diseases represents a major challenge considering that the majority of medicines in everyday practice have not been pediatrically evaluated. The efficacy of therapy depends to a large extent on the knowledge of pathophysiological processes in the children organism at different ages. Therefore, research in that direction is of the utmost importance. An imbalance in the production of free oxygen/nitrogen species and parameters of antioxidative protection is a significant factor in many diseases (e. g. heart failure, pulmonary hypertension, asthma, neonatal sepsis, cancer etc.) in children of different age groups. Reactive oxygen/nitrogen species serve as cell signaling molecules for normal biologic processes. An increase in their generation can cause damages which can disrupt normal physiological cellular processes and eventually cause cell death. This review outlines the previous assessments of oxidative stress parameters in children of different ages for some diseases. Also, the potential diagnostic and therapeutic possibilities for the oxydative stress parameters in children have been considered.	[Bajcetic, Milica] Univ Belgrade, Sch Med, Inst Pharmacol Clin Pharmacol & Toxicol, Belgrade, Serbia; [Brajovic, Milan] Clin Hosp Ctr Zvezdara, Dept Cardiol, Belgrade, Serbia; [Korkut-Tesic, Radojka] Childrens Hosp Korkut Tesic, Indjija, Serbia; [Bajcetic, Milica] Univ Childrens Hosp, Clin Pharmacol Unit, Belgrade, Serbia		Bajcetic, M (corresponding author), POB 840, Belgrade 11000, Serbia.	mbajcetic@doctor.com					Andreadis AA, 2003, FREE RADICAL BIO MED, V35, P213, DOI 10.1016/S0891-5849(03)00278-8; Atabek ME, 2004, J PEDIATR ENDOCR MET, V17, P1063; Back EI, 2004, AM J CLIN NUTR, V80, P374, DOI 10.1093/ajcn/80.2.374; Bajcetic M, 2005, EUR J CLIN PHARMACOL, V61, P775, DOI 10.1007/s00228-005-0981-y; BAJCETIC M, 2002, NOVA ISKUSTVA SA NEZ, P72; BAJCETIC M, 2008, KLIN SEM, P128; BAJCETIC M, 2007, KLIN SEM, P128; Bajcetic M, 2008, CLIN THER, V30, P702, DOI 10.1016/j.clinthera.2008.04.007; Bajcetic Milica, 2006, Exp Clin Cardiol, V11, P89; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; BEAN JP, 1996, SANTE, V6, P209; Becker K, 2005, REDOX REP, V10, P215, DOI 10.1179/135100005X70161; Bloomer J, 2005, J CLIN GASTROENTEROL, V39, pS167, DOI 10.1097/01.mcg.0000155518.96629.ea; Bockowski L, 2008, PHARMACOL REP, V60, P542; Buonocore G, 2003, BRAIN, V126, P1224, DOI 10.1093/brain/awg116; Cabre E, 2003, CURR OPIN CLIN NUTR, V6, P569, DOI 10.1097/01.mco.000087977.83880.8f; Cardin R, 2001, J HEPATOL, V34, P587, DOI 10.1016/S0168-8278(00)00098-2; Caron JE, 2009, PEDIATR BLOOD CANCER, V53, P551, DOI 10.1002/pbc.22128; Cemek M, 2005, INT J PEDIATR OTORHI, V69, P823, DOI 10.1016/j.ijporl.2005.01.016; Chariot P, 2003, MUSCLE NERVE, V27, P662, DOI 10.1002/mus.10304; Chiarelli F, 2005, DIABETES CARE, V28, P1690, DOI 10.2337/diacare.28.7.1690; Conklin Kenneth A, 2005, Integr Cancer Ther, V4, P110, DOI 10.1177/1534735405276191; Corradi M, 2003, AM J RESP CRIT CARE, V167, P395, DOI 10.1164/rccm.200206-507OC; Denicola A, 2005, TOXICOLOGY, V208, P273, DOI 10.1016/j.tox.2004.11.023; DORDEVIC VB, 2004, CLIN CHEM LAB MED, V42, P1117; Elshamaa MF, 2009, ANN NUTR METAB, V55, P309, DOI 10.1159/000245938; Engler MM, 2003, CIRCULATION, V108, P1059, DOI 10.1161/01.CIR.0000086345.09861.A0; Erdogan O, 2003, ACTA PAEDIATR, V92, P546, DOI [10.1080/08035320310000000, 10.1080/08035350310011461]; Facorro G, 2004, BONE MARROW TRANSPL, V33, P793, DOI 10.1038/sj.bmt.1704427; Fulia F, 2001, J PINEAL RES, V31, P343, DOI 10.1034/j.1600-079X.2001.310409.x; Gangemi S, 2004, INFLAMM RES, V53, P601, DOI 10.1007/s00011-004-1306-9; Ghosh S, 2005, ANN HEMATOL, V84, P76, DOI 10.1007/s00277-004-0933-0; Giray B, 2002, FREE RADICAL RES, V36, P55, DOI 10.1080/10715760210162; Gualandri W, 2003, INT J CLIN PHARM RES, V23, P23; Gupta M, 2004, EPILEPSIA, V45, P1636, DOI 10.1111/j.0013-9580.2004.17604.x; Gurkan F, 2004, BIOL TRACE ELEM RES, V100, P97, DOI 10.1385/BTER:100:2:097; Hamed SA, 2004, J PHARMACOL SCI, V96, P465, DOI 10.1254/jphs.FPJ04032X; Hargreaves IP, 2005, J INHERIT METAB DIS, V28, P81, DOI 10.1007/s10545-005-4160-1; HARINARAYANAN S, 2002, CLIN CHIM ACTA, V325, P147; Hart PE, 2005, ARCH NEUROL-CHICAGO, V62, P621, DOI 10.1001/archneur.62.4.621; Hata I, 2006, PEDIATR INT, V48, P58, DOI 10.1111/j.1442-200X.2006.02156.x; Hayashi M, 2002, J CHILD NEUROL, V17, P725, DOI 10.1177/08830738020170101101; Hayashi M, 2002, BRAIN DEV-JPN, V24, P770, DOI 10.1016/S0387-7604(02)00103-1; Jacob R. A., 2000, PANEL DIETARY ANTIOX; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Jareno EJ, 2002, FREE RADICAL RES, V36, P341, DOI 10.1080/10715760290019363; Kassab-Chekir A, 2003, CLIN CHIM ACTA, V338, P79, DOI 10.1016/j.cccn.2003.07.010; Kaygusuz I, 2003, OTOLARYNG HEAD NECK, V129, P265, DOI 10.1016/S0194-5998(03)00630-2; Kennedy DD, 2005, PEDIATR BLOOD CANCER, V44, P378, DOI 10.1002/pbc.20307; Kettle AJ, 2004, AM J RESP CRIT CARE, V170, P1317, DOI 10.1164/rccm.200311-1516OC; Kojic S, 2010, J MED BIOCHEM, V29, P157, DOI 10.2478/v10011-010-0024-9; Kolker S, 2002, NEUROPEDIATRICS, V33, P225, DOI 10.1055/s-2002-36741; Kosecik M, 2005, INT J CARDIOL, V100, P61, DOI 10.1016/j.ijcard.2004.05.069; Kulak W, 2005, LIFE SCI, V77, P3031, DOI 10.1016/j.lfs.2005.02.031; Lavine Joel E, 2004, Clin Liver Dis, V8, P549, DOI 10.1016/j.cld.2004.04.010; Lim DS, 2004, AM J CARDIOL, V94, P828, DOI 10.1016/j.amjcard.2004.05.073; Lotito APN, 2004, J RHEUMATOL, V31, P992; Lull ME, 2008, PEDIATR RES, V63, P638, DOI 10.1203/PDR.0b013e31816e391f; Malila N, 1999, CANCER EPIDEM BIOMAR, V8, P489; Manary MJ, 2000, J PEDIATR-US, V137, P421, DOI 10.1067/mpd.2000.107512; Mandato C, 2005, J PEDIATR-US, V147, P62, DOI 10.1016/j.jpeds.2005.02.028; Martin-Gallan P, 2005, FREE RADICAL RES, V39, P933, DOI 10.1080/10715760500156751; Matsubasa T, 2002, FREE RADICAL RES, V36, P189, DOI 10.1080/10715760290006510; Medina J, 2003, ALIMENT PHARM THER, V17, P1, DOI 10.1046/j.1365-2036.2003.01389.x; Menke T, 2004, HORM RES, V61, P153, DOI 10.1159/000075670; Ming X, 2005, PROSTAG LEUKOTR ESS, V73, P379, DOI 10.1016/j.plefa.2005.06.002; Miric D, 2010, CLIN BIOCHEM, V43, P246, DOI 10.1016/j.clinbiochem.2009.09.023; Misaki K, 2003, FREE RADICAL RES, V37, P1037, DOI 10.1080/10715760310001600426; Mohn A, 2005, J CLIN ENDOCR METAB, V90, P2653, DOI 10.1210/jc.2004-2178; Molnar D, 2004, INT J OBESITY, V28, P1197, DOI 10.1038/sj.ijo.0802719; Monici MC, 2003, NEUROLOGY, V60, P993, DOI 10.1212/01.WNL.0000049913.27181.51; Muller T, 2004, HEPATOLOGY, V39, P963, DOI 10.1002/hep.20108; Nagano T, 2002, CHEM REV, V102, P1235, DOI 10.1021/cr010152s; Nemeth I, 2001, INTENS CARE MED, V27, P216, DOI 10.1007/s001340000791; Nikoli-Kokic A, 2010, J MED BIOCHEM, V29, P189, DOI 10.2478/v10011-010-0018-7; Noiri E, 2005, J INVEST MED, V53, P167, DOI 10.2310/6650.2005.00403; Omata N, 2001, LIFE SCI, V69, P223, DOI 10.1016/S0024-3205(01)01124-9; Pagano G, 2004, CARCINOGENESIS, V25, P1899, DOI 10.1093/carcin/bgh194; PARRA CT, 2003, TOXICOLOGY, V189, P99; Pastore A, 2003, J PEDIATR-US, V142, P583, DOI 10.1067/mpd.2003.203; Patel MN, 2002, FREE RADICAL RES, V36, P1139, DOI 10.1080/1071576021000016391; Pavlova EL, 2005, PEDIATR NEPHROL, V20, P1599, DOI 10.1007/s00467-005-1990-x; PORTAL B, 1995, CLIN CHIM ACTA, V234, P137, DOI 10.1016/0009-8981(94)05991-Z; Posadas-Romero C, 2004, ARTHRITIS RHEUM-US, V50, P160, DOI 10.1002/art.11472; Reichenbach J, 2002, ANTIOXID REDOX SIGN, V4, P465, DOI 10.1089/15230860260196254; Renke J, 2000, FREE RADICAL BIO MED, V29, P101, DOI 10.1016/S0891-5849(00)00288-4; Ristoff E, 2002, J INHERIT METAB DIS, V25, P577, DOI 10.1023/A:1022095324407; Rodriguez MC, 2003, FREE RADICAL BIO MED, V34, P1217, DOI 10.1016/S0891-5849(03)00141-2; Ross BM, 2003, NUTR NEUROSCI, V6, P277, DOI 10.1080/10284150310001612203; Saugstad OD, 2005, BIOL NEONATE, V88, P228, DOI 10.1159/000087586; Serarslan G, 2005, CLIN EXP DERMATOL, V30, P267, DOI 10.1111/j.1365-2230.2005.01758.x; Shimizu T, 2002, FREE RADICAL RES, V36, P1067, DOI 10.1080/1071576021000006734; Sienra-Monge JJ, 2004, CLIN EXP IMMUNOL, V138, P317, DOI 10.1111/j.1365-2249.2004.02606.x; Sigurdsson L, 1998, J PEDIATR GASTR NUTR, V26, P85, DOI 10.1097/00005176-199801000-00015; Simbre Valeriano C, 2005, Paediatr Drugs, V7, P187, DOI 10.2165/00148581-200507030-00005; Sirtori LR, 2005, BBA-MOL BASIS DIS, V1740, P68, DOI 10.1016/j.bbadis.2005.02.005; Sogut S, 2003, CLIN CHIM ACTA, V331, P111, DOI 10.1016/S0009-8981(03)00119-0; Somjee SS, 2005, BRIT J HAEMATOL, V128, P112, DOI 10.1111/j.1365-2141.2004.05274.x; Starosta V, 2006, PEDIATR PULM, V41, P67, DOI 10.1002/ppul.20289; Stephensen CB, 2005, FREE RADICAL RES, V39, P859, DOI 10.1080/10715760500164136; Stolarska M, 2006, PHARMACOL REP, V58, P30; Stringer DM, 2009, PEDIATR DIABETES, V10, P269, DOI 10.1111/j.1399-5448.2008.00473.x; Surdacki A, 2003, CLIN CHIM ACTA, V334, P111, DOI 10.1016/S0009-8981(03)00230-4; Takeuchi M, 2003, J INT MED RES, V31, P413, DOI 10.1177/147323000303100509; Tondel M, 2005, ARCH ENVIRON CON TOX, V48, P515, DOI 10.1007/s00244-004-0079-z; Tsukahara H, 2000, REDOX REP, V5, P295, DOI 10.1179/135100000101535834; Tsukahara H, 2005, PEDIATR INT, V47, P528, DOI 10.1111/j.1442-200x.2005.02123.x; Tsukahara H, 2005, EARLY HUM DEV, V81, P643, DOI 10.1016/j.earlhumdev.2005.03.012; Tsukahara H, 2004, LIFE SCI, V75, P933, DOI 10.1016/j.lfs.2004.01.025; Tsukahara H, 2004, FREE RADICAL RES, V38, P691, DOI 10.1080/1071576042000220256; Tsukahara H, 2003, PEDIATR RES, V54, P419, DOI 10.1203/01.PDR.0000076662.72100.74; Tsukahara H, 2003, LIFE SCI, V72, P2509, DOI 10.1016/S0024-3205(03)00145-0; Tuo JS, 2003, FASEB J, V17, P668, DOI 10.1096/fj.02-0851com; Turi S, 2003, J HYPERTENS, V21, P145, DOI 10.1097/00004872-200301000-00024; Uchida K, 1999, TRENDS CARDIOVAS MED, V9, P109, DOI 10.1016/S1050-1738(99)00016-X; Vargas CR, 2004, BBA-MOL BASIS DIS, V1688, P26, DOI 10.1016/j.bbadis.2003.10.004; Wang XD, 1999, NUTR REV, V57, P263; Wong RH, 2005, ENVIRON HEALTH PERSP, V113, P1386, DOI 10.1289/ehp.7401; Yachie A, 2003, EXP BIOL MED, V228, P550, DOI 10.1177/15353702-0322805-26; Yamamoto T, 2002, J CHILD NEUROL, V17, P793, DOI 10.1177/08830738020170110701; Yilmaz T, 2004, OTOLARYNG HEAD NECK, V131, P797, DOI 10.1016/j.otohns.2004.07.001; Yilmaz T, 2004, INT J PEDIATR OTORHI, V68, P1053, DOI 10.1016/j.ijporl.2004.04.003; Zhou JF, 2005, WORLD J GASTROENTERO, V11, P368, DOI 10.3748/wjg.v11.i3.368; Zwolinska D, 2006, NEPHRON CLIN PRACT, V103, pC12, DOI 10.1159/000090506	125	6	6	1	3	SOC MEDICAL BIOCHEMISTS SERBIA	BELGRADE	VOJISLAVA ILICA 94B, I SPRAT, STAN 7, BELGRADE, VOZDOVAC, SERBIA	1452-8258	1452-8266		J MED BIOCHEM	J. Med. Biochem.	JUL-SEP	2010	29	3					196	203		10.2478/v10011-010-0019-6			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633CT	WOS:000280477800009		gold			2022-02-06	
J	Nowinski, D; Di Rocco, F; Roujeau, T; Meyer, P; Renier, D; Arnaud, E				Nowinski, Daniel; Di Rocco, Frederico; Roujeau, Thomas; Meyer, Philippe; Renier, Dominique; Arnaud, Eric			Complex Pediatric Orbital Fractures Combined With Traumatic Brain Injury: Treatment and Follow-Up	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Orbit; facial fracture; pediatrics; head trauma	COMPUTED-TOMOGRAPHY; POSTTRAUMATIC ENOPHTHALMOS; FACIAL FRACTURES; NERVE PALSY; CRANIOFACIAL TRAUMA; BLOWOUT FRACTURE; FIXATION; PATTERNS; CHILDREN; OUTCOMES	The treatment of orbital fractures aims at the restoration of orbital anatomy and prevention of posttraumatic sequels. The treatment of facial fractures in patients with traumatic brain injury may necessitate a postponement of fracture surgery to allow for brain recovery. However, such delay of reconstruction in complex orbital fractures may lead to inferior results. Fourteen pediatric patients with complex orbital fractures were retrospectively reviewed. Eleven patients (79%) had brain injury, with a mean Glasgow Coma Scale score of 8.6 at initial evaluation. Fracture patterns were highly complex with many bilateral and multiple orbital wall fractures. Six patients (43%) had injuries to the medial canthal tendon, as part of a naso-orbito-ethmoid fracture. Mean follow-up time was 4.7 years (range, 1.2-13.1 years). Eleven patients (79%) had reconstructive surgery early (within 3 weeks), and 3 (29%) patients had the surgery postponed. Four patients had secondary surgeries for enophthalmos and medial canthal dislocation. Eighty-two percent of patients with brain injury had a good overall neurologic outcome (Glasgow Outcome Scale score of 1 or 2). Sixty-seven percent of patients had a good aesthetic outcome without any need for revisional surgery. Medial canthal injury and late surgery both correlated with an inferior aesthetic result. In conclusion, good results with respect to mental outcome and aesthetics can be achieved in highly complex orbital fractures combined with brain injury. Delayed surgery and medial canthal tendon injury predispose for posttraumatic sequels and secondary surgery.	[Nowinski, Daniel] Hop Necker Enfants Malad, Dept Pediat Neurosurg, F-75015 Paris, France; [Nowinski, Daniel; Di Rocco, Frederico; Roujeau, Thomas; Meyer, Philippe; Renier, Dominique; Arnaud, Eric] Univ Uppsala Hosp, Dept Plast Surg, Uppsala, Sweden		Arnaud, E (corresponding author), Hop Necker Enfants Malad, Unite Chirurg Craniofaciale, Dept Neurochirurg, 149 Rue Sevres, F-75015 Paris, France.	drericarnaud@hotmail.com	Meyer, Philippe/ABE-4242-2020; DI ROCCO, Federico/C-6343-2015	Meyer, Philippe/0000-0002-3829-6631; 			ANTONYSHYN O, 1989, PLAST RECONSTR SURG, V84, P10, DOI 10.1097/00006534-198907000-00002; Arnaud E, 2002, PLAST RECONSTR SURG, V110, P6, DOI 10.1097/00006534-200207000-00002; Chapman VM, 2009, J COMPUT ASSIST TOMO, V33, P70, DOI 10.1097/RCT.0b013e318169bfdc; Cook T, 2002, J AM COLL SURGEONS, V195, P831, DOI 10.1016/S1072-7515(02)01479-5; DERDYN C, 1990, PLAST RECONSTR SURG, V86, P238, DOI 10.1097/00006534-199008000-00005; Dolynchuk K N, 1996, J Craniomaxillofac Trauma, V2, P56; Gassner R, 2004, J ORAL MAXIL SURG, V62, P399, DOI 10.1016/j.joms.2003.05.013; Girotto JA, 2001, PLAST RECONSTR SURG, V108, P312, DOI 10.1097/00006534-200108000-00005; GRUSS JS, 1985, PLAST RECONSTR SURG, V75, P303; Harris GJ, 2000, OPHTHALMIC PLAST REC, V16, P179, DOI 10.1097/00002341-200005000-00004; Hosal Banu M, 2002, Orbit, V21, P27; Imahara SD, 2008, J AM COLL SURGEONS, V207, P710, DOI 10.1016/j.jamcollsurg.2008.06.333; Jaicks RR, 1997, J TRAUMA, V42, P1, DOI 10.1097/00005373-199701000-00001; Jamal BT, 2009, J ORAL MAXIL SURG, V67, P986, DOI 10.1016/j.joms.2008.12.035; Kolk A, 2007, J ORAL MAXIL SURG, V65, P1926, DOI 10.1016/j.joms.2006.06.269; Kontio RK, 2006, PLAST RECONSTR SURG, V118, P1365, DOI 10.1097/01.prs.0000244519.26368.4c; MANSON PN, 1986, PLAST RECONSTR SURG, V77, P193, DOI 10.1097/00006534-198602000-00004; MANSON PN, 1986, PLAST RECONSTR SURG, V77, P203, DOI 10.1097/00006534-198602000-00005; MERKX MAW, 1995, INT J ORAL MAX SURG, V24, P344, DOI 10.1016/S0901-5027(05)80488-6; PASKERT JP, 1988, CLIN PLAST SURG, V15, P209; Raskin EM, 1998, OPHTHALMIC PLAST REC, V14, P19, DOI 10.1097/00002341-199801000-00006; RONCEVIC R, 1994, ANN PLAS SURG, V32, P288; RUBIN MM, 1992, J ORAL MAXIL SURG, V50, P1238, DOI 10.1016/0278-2391(92)90164-U; RUTTUM MS, 1985, AM J OPHTHALMOL, V100, P343, DOI 10.1016/0002-9394(85)90816-5; Sargent LA, 2007, PLAST RECONSTR SURG, V120, p16S, DOI 10.1097/01.prs.0000260731.01178.18; Soparkar CNS, 2007, PLAST RECONSTR SURG, V120, p49S, DOI 10.1097/01.prs.0000260733.61389.0b; Velmahos GC, 1998, AM J SURG, V176, P324, DOI 10.1016/S0002-9610(98)00208-6; Wang MC, 2007, J TRAUMA, V62, P1250, DOI 10.1097/01.ta.0000215581.50234.56; WOJNO TH, 1987, OPHTHALMOLOGY, V94, P682; Wymann NME, 2008, J ORAL MAXIL SURG, V66, P58, DOI 10.1016/j.joms.2007.04.023; Zimmermann CE, 2006, INT J ORAL MAX SURG, V35, P1, DOI 10.1016/j.ijom.2005.06.015	31	6	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUL	2010	21	4					1054	1059		10.1097/SCS.0b013e3181e573be			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	628UV	WOS:000280149100026	20613557				2022-02-06	
J	Thomas, S; Judge, T; Lowell, MJ; MacDonald, RD; Madden, J; Pickett, K; Werman, HA; Shear, ML; Patel, P; Starr, G; Chesney, M; Domeier, R; Frantz, P; Funk, D; Greenberg, RD				Thomas, Stephen; Judge, Tom; Lowell, Mark J.; MacDonald, Russell D.; Madden, John; Pickett, Kimberly; Werman, Howard A.; Shear, Melissa L.; Patel, Pina; Starr, Greg; Chesney, Michael; Domeier, Robert; Frantz, Pam; Funk, Deb; Greenberg, Robert D.			AIRWAY MANAGEMENT SUCCESS AND HYPOXEMIA RATES IN AIR AND GROUND CRITICAL CARE TRANSPORT: A PROSPECTIVE MULTICENTER STUDY	PREHOSPITAL EMERGENCY CARE			English	Article						airway management; critical care transport; intubation; air medical; helicopter	RAPID-SEQUENCE INTUBATION; HOSPITAL ENDOTRACHEAL INTUBATION; TRAUMATIC BRAIN-INJURY; IMPACT; MODERATE; HYPOXIA; US	Objective. To assess critical care transport (CCT) crews' endotracheal intubation (ETI) attempts, success rates, and peri-ETI oxygenation. Methods. Participants were adult and pediatric patients undergoing attempted advanced airway management during the period from July 2007 to December 2008 by crews from 11 CCT programs varying in geography, crew configuration, and casemix; all crews had access to neuromuscular-blocking agents. Data collected included airway management variables defined per national consensus criteria. Descriptive analysis focused on ETI success rates (reported with exact binomial 95% confidence intervals [CIs]) and occurrence of new hypoxemia (oxygen saturation [SpO(2)] dropping below 90% during or after ETI); to assess categorical variables, Fisher's exact test, Pearson chi(2), and logistic regression were employed to explore associations between predictor variables and ETI failure or new hypoxemia. For all tests, p < 0.05 defined significance. Results. There were 603 total attempts at airway management, with successful oral or nasal ETI in 582 cases, or 96.5% (95% CI 94.7-97.8%). In 182 cases (30.2%, 95% CI 26.5-34.0%), there were failed ETI attempts prior to CCT crew arrival; CCT crew ETI success on these patients (96.2%, 95% CI 92.2-98.4%) was just as high as in the patients in whom there was no pre-CCT ETI attempt (p = 0.81). New hypoxemia occurred in only six cases (1.6% of the 365 cases with ongoing SpO2 monitoring; 95% CI 0.6-3.5%); the only predictor of new hypoxemia was pre-ETI hypotension (p < 0.001). A requirement for multiple ETI attempts by CCT crews was not associated with new hypoxemia (Fisher's exact p = 0.13). Conclusions. CCT crews' ETI success rates were very high, and even when ETI required multiple attempts, airway management was rarely associated with SpO2 derangement. CCT crews' ETI success rates were equally high in the subset of patients in whom ground emergency medical services (EMS) ETI failed prior to arrival of transport crews.	[Thomas, Stephen] Univ Oklahoma, Sch Community Med, OU Schusterman Ctr, Dept Emergency Med, Tulsa, OK 74135 USA; [Judge, Tom] LifeFlight Maine, Bangor, ME USA; [Lowell, Mark J.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [MacDonald, Russell D.] Orange Transport Med, Toronto, ON, Canada; [MacDonald, Russell D.] Univ Toronto, Dept Med, Div Emergency Med, Toronto, ON, Canada; [Madden, John] Christiana Care Hlth Syst, LifeNet, Wilmington, DE USA; [Madden, John] Christiana Care Hlth Syst, Dept Emergency Med, Wilmington, DE USA; [Pickett, Kimberly] Sunstar Crit Care Transport, Largo, FL USA; [Werman, Howard A.] Ohio State Univ, Dept Emergency Med, Columbus, OH 43210 USA; [Shear, Melissa L.; Patel, Pina] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Emergency Med, Boston, MA USA; [Chesney, Michael] Univ Michigan Survival Flight, Ann Arbor, MI USA; [Domeier, Robert] Washtenaw Livingston Cty Med Control Author, Ann Arbor, MI USA; [Frantz, Pam] Flight Life Colorado, Denver, CO USA; [Funk, Deb] City San Diego EMS, San Diego, CA USA; [Greenberg, Robert D.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Emergency Med, Temple, TX USA; [Greenberg, Robert D.] Scott & White Hosp & Clin, Temple, TX USA		Thomas, S (corresponding author), Univ Oklahoma, Sch Community Med, OU Schusterman Ctr, Dept Emergency Med, 4502 E 41st St, Tulsa, OK 74135 USA.	stephen-thomas@ouhsc.edu			MedEvac Foundation International	The study's multicenter collaborative research group (the Critical Care Transport Collaborative Outcomes Research Effort, CCT CORE) is supported by an unrestricted grant from the MedEvac Foundation International. There are no conflicts of interest or financial disclosures, and the authors are responsible for all of the content in the manuscript.	Alpern ER, 2006, PEDIATR EMERG CARE, V22, P689, DOI 10.1097/01.pec.0000236830.39194.c0; Davis DP, 2007, PREHOSP EMERG CARE, V11, P1, DOI 10.1080/10903120601021093; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Gausche-Hill Marianne, 2003, Curr Opin Anaesthesiol, V16, P173, DOI 10.1097/00001503-200304000-00011; Hankins DG, 2006, PREHOSP EMERG CARE, V10, P324, DOI 10.1080/10903120600728748; Harrison TH, 2004, PEDIATR EMERG CARE, V20, P101, DOI 10.1097/01.pec.0000113879.10140.7f; Haukoos JS, 2005, ACAD EMERG MED, V12, P360, DOI 10.1197/j.aem.2004.11.018; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lindsell CJ, 2006, ANN EMERG MED, V48, P666, DOI 10.1016/j.annemergmed.2006.08.005; Newton A, 2008, J TRAUMA, V64, P487, DOI 10.1097/TA.0b013e31802e7476; Sagarin MJ, 2005, ANN EMERG MED, V46, P328, DOI 10.1016/j.annemergmed.2005.01.009; Slater EA, 1998, J TRAUMA, V45, P588, DOI 10.1097/00005373-199809000-00031; Tam RK, 2009, PREHOSP EMERG CARE, V13, P311, DOI 10.1080/10903120902935231; Thomas S H, 1999, Prehosp Emerg Care, V3, P310, DOI 10.1080/10903129908958960; Tiamfook-Morgan TO, 2006, PREHOSP EMERG CARE, V10, P363, DOI 10.1080/10903120600725835; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang Henry E, 2004, Prehosp Emerg Care, V8, P366; Wang Henry E, 2004, Prehosp Emerg Care, V8, P58; Zink BJ, 2004, ANN EMERG MED, V44, P451, DOI 10.1016/j.annemergmed.2004.05.001; 2009, PREHOSP EMERG CARE, V13, P304	25	6	6	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	JUL-SEP	2010	14	3					283	291		10.3109/10903127.2010.481758			9	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	666MC	WOS:000283118400001	20507218				2022-02-06	
J	Jamuna, N; Pillai, S				Jamuna, N.; Pillai, Shibu			Home based cognitive retraining in traumatic brain injury	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						brain injury; cognitive impairment		Traumatic brain injury is a complex injury with a broad spectrum of symptoms and disabilities. The impact on a person and his or her family can be devastating. Cognitive difficulties are very common in people with traumatic brain injury. Studies have shown neuropsychological rehabilitation to be usefulness in improving the cognitive functions and day-to-day functioning. The purpose of the study was to examine the efficacy of home based cognitive retraining in traumatic brain injury. Single case-study was adopted. The neuropsychological profile of the patient was compared pre and post home based cognitive retraining. A 32-year-old male was referred for post head-injury neuropsychological assessment and rehabilitation. He was given 6 months package of home based cognitive retraining. The training was given by patient's wife. The preassessment showed impairment in frontal and temporal functions. Results indicated improvement in cognitive functions, occupational functions and social functioning.	[Jamuna, N.] Natl Inst Mental Hlth & Neurosci, Dept Mental Hlth & Social Psychol, Hosur Rd, Bangalore 560029, Karnataka, India; [Pillai, Shibu] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India		Jamuna, N (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Mental Hlth & Social Psychol, Hosur Rd, Bangalore 560029, Karnataka, India.	jamunarajan@nimhans.kar.nic.in					[Anonymous], 1975, CIBA F SYMP, V34, P141; Assmus A, 2005, NEUROSCIENCE, V132, P923, DOI 10.1016/j.neuroscience.2005.01.047; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Maull KL, 1989, HEAD INJURY, P67; Nag S, 1999, NEUROL INDIA, V47, P32; Rao, 2004, 2 WORKSH CONT ED NEU; Rao SL, 2004, NIMHANS PUBLICATION; Robertson IH, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P631	10	6	6	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2010	7	1					93	95					3	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M1N	WOS:000218381400020					2022-02-06	
J	Ragbetli, MC; Aydinlioglu, A; Koyun, N; Yayici, R; Arslan, K				Ragbetli, Murat Cetin; Aydinlioglu, Atif; Koyun, Necat; Yayici, Recep; Arslan, Kadir			Total neuron numbers in CA1-4 sectors of the dog hippocampus	INDIAN JOURNAL OF MEDICAL RESEARCH			English	Article						Cornu ammonis; hippocampus; sex differences; sterelogy; subiculum	TRAUMATIC BRAIN-INJURY; RIGHT-LEFT ASYMMETRIES; RAT HIPPOCAMPUS; STEREOLOGICAL ESTIMATION; PRENATAL EXPOSURE; SEX-DIFFERENCES; PAW PREFERENCE; DENSITY	Background & objectives: Early reports addressed morphological asymmetry in the cross-sectional width of the rat hippocampus. The present study was aimed at counting total number of neurons in CA1-4 sectors and the subiculum of the dog hippocampus as well as investigating possible left/right and male/female asymmetry. Methods: Adult mongrel dogs (8 female and 5 male) were assessed by the right and left pawedness and sacrificed by exsanguinations. In each hippocampus dissected, the total neuron numbers of CAs and subiculum were estimated by the physical fractioning method. Results: Significant hemispheric asymmetries were found in the number of pyramidal cells of CA1, CA3/2, CA4 and the subiculum. Sex difference was also found in the subiculum, in favour of the males. Interpretation & conclusion: Our study indicated a left dominant asymmetry in males and right dominancy in females as well as no functional asymmetry in specific regions of the dog hippocampus. Further investigations are necessary to verify the hypothesis that hippocampal morphological asymmetries in normal subjects are functionally related in memory or in cognitive skills.	[Ragbetli, Murat Cetin; Yayici, Recep] Yuzuncu Yil Univ, Fac Med, Dept Histol & Embryol, TR-65300 Van, Turkey; [Aydinlioglu, Atif; Koyun, Necat] Yuzuncu Yil Univ, Fac Med, Dept Anat, TR-65300 Van, Turkey; [Arslan, Kadir] Kafkas Univ, Fac Vet, Dept Anat, Kars, Turkey		Ragbetli, MC (corresponding author), Yuzuncu Yil Univ, Fac Med, Dept Histol & Embryol, TR-65300 Van, Turkey.	ragbetli@hotmail.com	Koyun, Necat/AAF-1844-2019; Ragbetli, Murat/Q-5060-2017; Ragbetli, Murat Cetin/ABG-5631-2021	Ragbetli, Murat/0000-0002-8189-264X; Ragbetli, Murat Cetin/0000-0002-8189-264X	Yuzuncu Yil UniversityYuzuncu Yil University [2008-SBE-YL 037]	This study has been supported by a grant from the Yuzuncu Yil University research fund (2008-SBE-YL 037). The authors thank to Dr Aydin Him for language correction.	AMARAL DG, 1984, J COMP NEUROL, V224, P307, DOI 10.1002/cne.902240302; Aydinlioglu A, 2006, INT J NEUROSCI, V116, P77, DOI 10.1080/00207450690962433; Aydinlioglu A, 2000, EUR J MORPHOL, V38, P128, DOI 10.1076/0924-3860(200004)38:2;1-F;FT128; Aydinlioglu A, 2000, EUR J MORPHOL, V38, P63, DOI 10.1076/0924-3860(200002)38:01;1-#;FT063; Chilingarian L I, 2002, Zh Vyssh Nerv Deiat Im I P Pavlova, V52, P47; DAM AM, 1979, NEUROPATH APPL NEURO, V5, P249, DOI 10.1111/j.1365-2990.1979.tb00624.x; DIAMOND MC, 1983, EXP NEUROL, V8, P1; Dombrowski SM, 2008, NEUROSCIENCE, V152, P346, DOI 10.1016/j.neuroscience.2007.11.049; FLORHENRY P, 1976, ANN NY ACAD SCI, V280, P777, DOI 10.1111/j.1749-6632.1976.tb25541.x; Gokcimen A, 2007, BRAIN RES, V1127, P185, DOI 10.1016/j.brainres.2006.10.026; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; GUNDERSEN HJG, 1980, MICROSC ACTA, V83, P409; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; HOWARD CV, 1998, UNBIASED STEREOLOGY, P69; KAHLE W, 1984, TASCHENATLAS ANATOMI, V3; Kaplan S, 2001, J MICROSC-OXFORD, V203, P321, DOI 10.1046/j.1365-2818.2001.00931.x; Kowalska DM, 2000, PROG NEURO-PSYCHOPH, V24, P855, DOI 10.1016/S0278-5846(00)00110-X; Lister JP, 2006, HIPPOCAMPUS, V16, P946, DOI 10.1002/hipo.20221; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; McNaughton N, 2006, BEHAV BRAIN RES, V174, P232, DOI 10.1016/j.bbr.2006.05.037; NIGLIO T, 1990, ACTA ANAT, V139, P283; Ragbetli MC, 2002, INT J NEUROSCI, V112, P81, DOI 10.1080/00207450212016; Ragbetli MC, 2007, BRAIN RES, V1174, P130, DOI 10.1016/j.brainres.2007.08.025; ROSENE DL, 1987, CEREB CORTEX, P231; Sarac-Hadzhalilovic A, 2007, BOSNIAN J BASIC MED, V7, P162; Shi F, 2009, HIPPOCAMPUS, V19, P1055, DOI 10.1002/hipo.20573; SLOMIANKA L, 1987, BRAIN RES, V436, P69, DOI 10.1016/0006-8993(87)91557-5; STOKES KA, 1981, PHYSIOL BEHAV, V26, P163, DOI 10.1016/0031-9384(81)90005-6; VANEDEN CG, 1984, DEV BRAIN RES, V12, P146, DOI 10.1016/0165-3806(84)90186-X; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zaidel DW, 1999, ANAT REC, V254, P87, DOI 10.1002/(SICI)1097-0185(19990101)254:1<87::AID-AR11>3.0.CO;2-T; ZAIDEL DW, 1994, J NEUROL, V141, P620	34	6	6	0	4	INDIAN COUNCIL MEDICAL RES	NEW DELHI	PO BOX 4911 ANSARI NAGAR, NEW DELHI 110029, INDIA	0971-5916			INDIAN J MED RES	Indian J. Med. Res.	JUN	2010	131	6					780	785					6	Immunology; Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; General & Internal Medicine; Research & Experimental Medicine	612RP	WOS:000278920500008	20571166				2022-02-06	
J	Zhao, Z; Zhao, S; Xu, N; Yu, C; Guan, S; Liu, X; Huang, L; Liao, W; Jia, W				Zhao, Z.; Zhao, S.; Xu, N.; Yu, C.; Guan, S.; Liu, X.; Huang, L.; Liao, W.; Jia, W.			LOVASTATIN IMPROVES NEUROLOGICAL OUTCOME AFTER NUCLEUS BASALIS MAGNOCELLULARIS LESION IN RATS	NEUROSCIENCE			English	Article						lovastatin; Morris Water Maze; nucleus basalis magnocellularis; neuroprotection; muscarinic/NMDA receptor; signaling pathway	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; ENDOTHELIAL-CELLS; KINASE PATHWAY; UP-REGULATION; CHOLINE-ACETYLTRANSFERASE; SYNAPTIC PLASTICITY; SIGNALING PATHWAYS; RECEPTOR-BINDING; SPATIAL MEMORY	Increasing evidence indicates that statins, specific inhibitors of 3-hydroxy-3-methylglutaryl (HMG)-coenzyme A (CoA) reductase, exerts neuroprotective actions rather than simply lowering cholesterol. However, the underlying mechanism has not been elucidated clearly. Here, the effect of lovastatin on the neurological outcomes of nucleus basalis magnocellularis (NBM)-lesioned rats and the pathophysiological mechanisms were investigated. Sprague-Dawley rats were divided into three groups: (i) a sham group; (ii) a model group: bilateral NBM of rats were injured by infusion of ibotenic acid; and (iii) a lovastatin-treated group: lovastatin was administrated orally for 4 weeks before treated by ibotenic acid. We show that lovastatin significantly improves the neurological outcomes as well as the choline acetyltransferase (ChAT) activity and muscarinic/NMDA receptor binding activity impaired by NBM lesion, and that lovastatin prevents neuron loss and induces Akt whereas inhibits p38 phosphorylation. Overall, the neuro-restorative and -protective effect of lovastatin may be attributed to the regulation of Akt- and p38-mediated signaling pathway together with improvement of muscarinic/NMDA receptor functions. Statins may be useful in the treatment of neurological disorders. (C) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.	[Yu, C.; Huang, L.; Liao, W.] China Japan Friendship Hosp, Natl Integrat Med Ctr Cardiovasc Dis, Beijing, Peoples R China; [Zhao, Z.] Hebei Med Univ, Coll Tradit Chinese Med, Shijiazhuang, Peoples R China; [Zhao, S.; Jia, W.] PepMetr & Pegasus Pharmaceut Grp Inc, Unit 110 116, Richmond, BC V6X 1Z7, Canada; [Xu, N.; Liu, X.] Peking Univ, Dept Rheumatol & Immunol, Hosp 3, Beijing 100029, Peoples R China; [Guan, S.] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Peoples R China; [Jia, W.] Univ British Columbia, Dept Surg, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada		Liao, W (corresponding author), China Japan Friendship Hosp, Natl Integrat Med Ctr Cardiovasc Dis, Beijing, Peoples R China.	lwqxy@hotmail.com	JIA, WILLIAM/AAE-4322-2020		Chinese Medical Association [09010580213]; National Health Ministry	This work was supported partly by grants of the Chinese Medical Association (No. 09010580213) and by grants from the National Health Ministry for Ph.D. Research Project in China.	BOIS TM, 2009, PROG NEUROPSYCHOPHAR, V33, P37; BOTTI RE, 1991, CLIN NEUROPHARMACOL, V14, P256, DOI 10.1097/00002826-199106000-00010; Burke JP, 2009, BRIT J SURG, V96, P541, DOI 10.1002/bjs.6577; Caccamo A, 2009, CURR ALZHEIMER RES, V6, P112, DOI 10.2174/156720509787602915; Cerezo-Guisado MI, 2007, BBA-MOL CELL BIOL L, V1771, P164, DOI 10.1016/j.bbalip.2006.12.002; Cerezo-Guisado MI, 2007, BIOCHEM J, V401, P175, DOI 10.1042/BJ20060731; Chen B, 2009, BRAIN RES, V1273, P129, DOI 10.1016/j.brainres.2009.04.002; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen LY, 1997, J AM COLL CARDIOL, V30, P569, DOI 10.1016/S0735-1097(97)00158-7; Contestabile A, 2008, NEUROCHEM RES, V33, P318, DOI 10.1007/s11064-007-9497-4; Davignon J, 2001, ANN ENDOCRINOL-PARIS, V62, P101; Dembowski E, 2009, J CARDIOPULM REHABIL, V29, P2, DOI 10.1097/HCR.0b013e318192754e; Dolga AM, 2008, J ALZHEIMERS DIS, V13, P111; Evans BA, 2009, DEMENT GERIATR COGN, V27, P519, DOI 10.1159/000221835; FONNUM F, 1975, J NEUROCHEM, V24, P407, DOI 10.1111/j.1471-4159.1975.tb11895.x; Fujii T, 2008, J PHARMACOL SCI, V106, P186, DOI 10.1254/jphs.FM0070109; Fujii T, 2007, LIFE SCI, V80, P2320, DOI 10.1016/j.lfs.2007.01.012; Fujii T, 2006, J NEUROIMMUNOL, V179, P101, DOI 10.1016/j.jneuroim.2006.05.029; Gluhovschi G, 2008, ACTA CLIN BELG, V63, P152, DOI 10.1179/acb.2008.026; GOMIS M, 2009, EUR J NEUROL; GUILLOT F, 1993, J CARDIOVASC PHARM, V21, P339, DOI 10.1097/00005344-199302000-00022; Haendeler J, 2004, CIRCULATION, V110, P856, DOI 10.1161/01.CIR.0000138743.09012.93; Handattu SP, 2009, NEUROBIOL DIS, V34, P525, DOI 10.1016/j.nbd.2009.03.007; Ho NF, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-57; Jiang JL, 2007, BIOCHEM CELL BIOL, V85, P66, DOI 10.1139/O06-146; Kandiah N, 2009, J NEUROL SCI, V283, P230, DOI 10.1016/j.jns.2009.02.352; KITA T, 1980, J CLIN INVEST, V66, P1094, DOI 10.1172/JCI109938; Li WD, 2005, CURR BIOL, V15, P1961, DOI 10.1016/j.cub.2005.09.043; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lutjohann D, 2003, PHARMACOPSYCHIATRY, V36, pS102; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Meyer-Ter-Vehn T, 2008, INVEST OPHTH VIS SCI, V49, P3955, DOI 10.1167/iovs.07-1610; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Mufson Elliott J, 2008, Expert Rev Neurother, V8, P1703, DOI 10.1586/14737175.8.11.1703; Paintlia AS, 2009, GLIA, V57, P182, DOI 10.1002/glia.20745; Park CS, 2009, J NEUROSCI RES, V87, P3107, DOI 10.1002/jnr.22134; Qu CS, 2005, J NEUROSURG, V103, P695, DOI 10.3171/jns.2005.103.4.0695; Reiss AB, 2009, THESCIENTIFICWORLDJO, V9, P1242, DOI 10.1100/tsw.2009.141; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Ruperez M, 2007, HYPERTENSION, V50, P377, DOI 10.1161/HYPERTENSIONAHA.107.091264; SAHEKI A, 1994, PHARMACEUT RES, V11, P305, DOI 10.1023/A:1018975928974; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Sironi L, 2006, NEUROBIOL DIS, V22, P445, DOI 10.1016/j.nbd.2005.12.004; Song CY, 2008, TRANSL RES, V151, P27, DOI 10.1016/j.trsl.2007.09.008; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tobin G, 2009, J PHYSIOL PHARMACOL, V60, P3; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; von Bardeleben R, 2003, BIOCHEM BIOPH RES CO, V307, P401, DOI 10.1016/S0006-291X(03)01205-1; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang Q, 2008, NEUROSCIENCE, V154, P1100, DOI 10.1016/j.neuroscience.2008.04.026; Wang Q, 2009, EXP NEUROL, V216, P132, DOI 10.1016/j.expneurol.2008.11.016; Weitberg AB, 2007, J EXP CLIN CANC RES, V26, P583; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xiu J, 2005, J NEUROSCI RES, V82, P531, DOI 10.1002/jnr.20658; Yamashita M, 2008, J ENDOCRINOL, V196, P601, DOI 10.1677/JOE-07-0532; Yamin G, 2009, J NEUROSCI RES, V87, P1729, DOI 10.1002/jnr.21998; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; YONEDA Y, 1989, BRAIN RES, V499, P305, DOI 10.1016/0006-8993(89)90779-8; Zhao S, 2009, NEUROSCIENCE, V164, P398, DOI 10.1016/j.neuroscience.2009.08.027; Zhou Q, 2002, J NUTR BIOCHEM, V13, P200, DOI 10.1016/S0955-2863(01)00213-3	60	6	7	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAY 19	2010	167	3					954	963		10.1016/j.neuroscience.2010.02.054			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587IY	WOS:000276985800039	20219644				2022-02-06	
J	Cherney, LR; Gardner, P; Logemann, JA; Newman, LA; O'Neil-Pirozzi, T; Roth, CR; Solomon, NP				Cherney, Leora R.; Gardner, Patricia; Logemann, Jeri A.; Newman, Lisa A.; O'Neil-Pirozzi, Therese; Roth, Carole R.; Solomon, Nancy Pearl			The Role of Speech-Language Pathology and Audiology in the Optimal Management of the Service Member Returning From Iraq or Afghanistan With a Blast-Related Head Injury: Position of the Communication Sciences and Disorders Clinical Trials Research Group	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						audiology; blast injuries; speech-language pathology; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; TYMPANIC-MEMBRANE PERFORATION; POSTTRAUMATIC-STRESS-DISORDER; OPERATION ENDURING FREEDOM; HEARING-LOSS; GLOBAL WAR; EXPERIENCE; REHABILITATION; SYMPTOMS; POLYTRAUMA	This position paper, prepared by the Communication Sciences and Disorders Clinical Trails Research Group, describes communication and swallowing disorders associated with blast injuries and delineates the roles of speech-language pathologists (SLPs) and audiologists in the management of these deficits. Recovery of individuals with mild, moderate, or severe swallowing, speech, hearing, and cognitive-communication impairments is best facilitated by a team of multidisciplinary specialists including SLPs and audiologists. Speech-language pathologists and audiologists have the knowledge and skills to evaluate, treat, and research swallowing, speech, hearing, and cognitive-communication functions, and they should have a primary role in determining the clinical management of, research agenda for, and public health policies regarding individuals with blast-related head injuries from the time of injury to their return to maximized life participation and quality of life.	[Cherney, Leora R.; Gardner, Patricia; Logemann, Jeri A.; Newman, Lisa A.; O'Neil-Pirozzi, Therese; Roth, Carole R.; Solomon, Nancy Pearl] CSDRG, CBIC, Evanston, IL USA		Cherney, LR (corresponding author), Commun Sci & Disorders Clin Trials Res Grp Jeri A, 1720 Maple Ave,Unit 2251, Evanston, IL 60201 USA.			Solomon, Nancy/0000-0002-5018-7569			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; *AM SPEECH LANG HE, KNOWL SKILLS NEED SP; American Speech-Language Hearing Association, 2017, ROL SPEECH LANG PATH; Belanger HG, 2005, J REHABIL RES DEV, V42, P403, DOI 10.1682/JRRD.2004.08.0095; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Centers for Disease Control and Prevention (CDC), MAN PEOPL HAV TBI; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Eckert MJ, 2006, ARCH SURG-CHICAGO, V141, P806, DOI 10.1001/archsurg.141.8.806; ESHEL D, DEFENSE UPDATE INT O; Fager S, 2006, AUGMENT ALTERN COMM, V22, P37, DOI 10.1080/07434610500243990; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Finkelstein E., 2006, INCIDENCE EC BURDEN; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Hare SS, 2007, CLIN RADIOL, V62, P1, DOI 10.1016/j.crad.2006.09.013; Helfer Thomas M, 2005, Am J Audiol, V14, P161, DOI 10.1044/1059-0889(2005/018); HENRY LL, 2009, J REHABIL RES DEV, V46, P697; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Moore DF, 2008, FUTUR NEUROL, V3, P243, DOI 10.2217/14796708.3.3.243; Morgan AT, 2010, CHILD CARE HLTH DEV, V36, P44, DOI 10.1111/j.1365-2214.2009.00961.x; Nageris Ben I., 2008, Journal of Basic and Clinical Physiology and Pharmacology, V19, P185; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Orji FT, 2009, CLIN OTOLARYNGOL, V34, P526, DOI 10.1111/j.1749-4486.2009.02035.x; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Patel TH, 2004, J TRAUMA, V57, P201, DOI 10.1097/01.TA.0000133638.30269.38; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Preskorn Sheldon H, 2007, J Psychiatr Pract, V13, P5, DOI 10.1097/00131746-200701000-00002; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Ritenour AE, 2008, J TRAUMA, V64, pS174, DOI 10.1097/TA.0b013e318160773e; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shahzadi S, 2007, SURG NEUROL, V68, P464, DOI 10.1016/j.surneu.2006.10.064; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TRUDEL TM, 2007, BRAIN INJ PROF, V4, P22; Tungsinmunkong Sunee, 2007, Journal of the Medical Association of Thailand, V90, P2662; *US DEP DEF, CAS REP OP IR FREED; *US DEP VET AFF, POL; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071	48	6	6	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2010	25	3					219	224		10.1097/HTR.0b013e3181dc82c1			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	606KG	WOS:000278423300008	20473095				2022-02-06	
J	Brindle, TJ; Lebiedowska, MK; Miller, JL; Stanhope, SJ				Brindle, T. J.; Lebiedowska, M. K.; Miller, J. L.; Stanhope, S. J.			The influence of ankle joint movement on knee joint kinesthesia at various movement velocities	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						proprioception; muscle; lower extremity; somatosensory	ANTERIOR CRUCIATE LIGAMENT; DEFICIENT KNEE; PROPRIOCEPTION; AGE; RECONSTRUCTION; CONCUSSION; STABILITY; POSITION; FINGER; ADULTS	The purpose of this study was to determine if gastrocnemius elongation or shortening and direction and velocity of knee movement influenced knee kinesthesia. Healthy volunteers sat with their knee flexed (20 degrees) and was then passively rotated (flexion or extension) at three velocities (0.5, 2, or 10 degrees/s) while the ankle was either fixed or rotated (dorsiflexed or plantar flexed at 0.17, 0.65, or 3.3 degrees/s) creating gastrocnemius elongation or shortening. Subjects activated a thumb switch, stopping motion once they detected onset and direction of the motion. Detection of passive movement sense (DPMS) was the angular movement before activation of a thumb-switch. Significant differences (P=0.003) in the rate of change in DPMS across a variety of movement velocities was observed but shortening or elongation of the gastrocnemius did not affect DPMS. Gastrocnemius elongation/shortening did not affect knee DPMS, simple reaction time plays an important role in testing kinesthesia especially at faster movements. While feedback from the gastrocnemius muscle plays a limited role in healthy subjects, differences in testing velocities may incorporate higher levels of central nervous system processing. Clinical measures of kinesthesia can be affected by both movement direction and movement velocity that are speed dependent.	[Brindle, T. J.] NIH, Biomech Lab, Funct & Appl Biomech Sect, Bethesda, MD 20892 USA		Brindle, TJ (corresponding author), NIH, Biomech Lab, Funct & Appl Biomech Sect, Room 1-1469,Bldg 10 CRC,10 Ctr Dr,MCS 1604, Bethesda, MD 20892 USA.	tbrindle@cc.nih.gov					Ageberg E, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-57; BARRACK RL, 1984, J SPORT MED PHYS FIT, V24, P18; BARRACK RL, 1989, AM J SPORT MED, V17, P1, DOI 10.1177/036354658901700101; BARRETT DS, 1991, J BONE JOINT SURG BR, V73, P53, DOI 10.1302/0301-620X.73B1.1991775; BASTAIN HC, 1886, BRAIN, V10, P1; Borsa PA, 1997, AM J SPORT MED, V25, P336, DOI 10.1177/036354659702500311; Bosco G, 2001, PHYSIOL REV, V81, P539, DOI 10.1152/physrev.2001.81.2.539; Brindle TJ, 2008, J APPL BIOMECH, V24, P252, DOI 10.1123/jab.24.3.252; CLARK FJ, 1979, J NEUROPHYSIOL, V42, P877, DOI 10.1152/jn.1979.42.3.877; CO FH, 1993, J ORTHOP RES, V11, P696, DOI 10.1002/jor.1100110512; Friden T, 1996, Knee Surg Sports Traumatol Arthrosc, V4, P217, DOI 10.1007/BF01567966; GANDEVIA SC, 1983, J PHYSIOL-LONDON, V335, P507, DOI 10.1113/jphysiol.1983.sp014547; Grob KR, 2002, J BONE JOINT SURG BR, V84B, P614, DOI 10.1302/0301-620X.84B4.11241; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; HALL LA, 1983, J PHYSIOL-LONDON, V335, P519, DOI 10.1113/jphysiol.1983.sp014548; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Koralewicz LM, 2000, J BONE JOINT SURG AM, V82A, P1582, DOI 10.2106/00004623-200011000-00011; LATASH ML, 1998, NEUROPHYSIOLOGICAL B; Pai YC, 1997, ARTHRITIS RHEUM, V40, P2260, DOI 10.1002/art.1780401223; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; REFSHAUGE KM, 1995, J PHYSIOL-LONDON, V488, P231, DOI 10.1113/jphysiol.1995.sp020961; Risberg MA, 1999, KNEE SURG SPORT TR A, V7, P303, DOI 10.1007/s001670050168; Rozzi SL, 1999, AM J SPORT MED, V27, P312, DOI 10.1177/03635465990270030801; Safran MR, 1999, KNEE SURG SPORT TR A, V7, P310, DOI 10.1007/s001670050169; Shields RK, 2005, CLIN NEUROPHYSIOL, V116, P87, DOI 10.1016/j.clinph.2004.07.019; SKINNER HB, 1984, CLIN ORTHOP RELAT R, P208; Swanik CB, 2004, J BONE JOINT SURG AM, V86A, P328, DOI 10.2106/00004623-200402000-00016	27	6	6	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	APR	2010	20	2					262	267		10.1111/j.1600-0838.2009.00887.x			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	566TF	WOS:000275395400013	19486484				2022-02-06	
J	Levine, Z				Levine, Zachary			Mild traumatic brain injury Part 1: Determining the need to scan	CANADIAN FAMILY PHYSICIAN			English	Article							CT HEAD RULE; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; VALIDATION; RISK		McGill Univ, Ctr Hlth, Dept Emergency Med, Montreal, PQ, Canada		Levine, Z (corresponding author), McGill Univ, Ctr Hlth, Dept Emergency Med, Montreal, PQ, Canada.						Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; MEAGHER R, 2009, SUBDURAL HEMATOMA; PRICE D, 2009, EPIDURAL HEMATOMA; Saboori M, 2007, CLIN NEUROL NEUROSUR, V109, P399, DOI 10.1016/j.clineuro.2007.01.013; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	18	6	6	0	1	COLL FAMILY PHYSICIANS CANADA	MISSISSAUGA	2630 SKYMARK AVE, MISSISSAUGA, ONTARIO L4W 5A4, CANADA	0008-350X	1715-5258		CAN FAM PHYSICIAN	Can. Fam. Phys.	APR	2010	56	4					346	349					4	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	584CT	WOS:000276728300013	20393093				2022-02-06	
J	Loizou, E; Bouamra, O; Dark, P; Martin, B; Lecky, F				Loizou, Eleana; Bouamra, Omar; Dark, Paul; Martin, Bruce; Lecky, Fiona			Comparing the systolic blood pressure (SBP) and pulse rate (PR) in injured children with and without traumatic brain injury	RESUSCITATION			English	Article						Cardiovascular physiology; Injured children; TBI		Aims: Following evidence that injured children have higher systolic blood pressures (SBP) than similar-aged resting uninjured children, we investigate whether the initial cardiovascular physiology differs between forms of injury. Methods: Analysis of prospectively recorded data from the Trauma Audit and Research Network (TARN) database of injured children aged <= 15, presenting with blunt trauma from March 1988 to February 2009. We compared the ED arrival SBP and pulse rate (PR) in children with and without TBI. The analysis was stratified by age and injury severity (ISS <= 8 = mild, ISS 9-14 = moderate, ISS >= 15 = severe) through medians, graphs and compared through analysis of covariance. Results: Data for 18,135 children were analysed. Those with TBI had a higher mortality rate (17.2%) and were more severely injured. No difference was seen between the two groups in the SBP of severely injured children (p = 0.09) who were almost all hypertensive compared to APLS "norms". Further analysis revealed a significant difference in the PR of severely injured children (p < 0.001), attributed to children <9 years of age with brain injuries showing lower heart rates than those with extracranial injuries, though all still within the normal range for their age. Conclusions: Although injured children remain hypertensive as compared to resting norms, we have seen no difference in the initial systolic blood pressure of moderately and severely injured children with and without traumatic brain injury. The relative bradycardia in the younger children appears to be an early sign of a severe traumatic brain injury. (C) 2010 Elsevier Ireland Ltd. All rights reserved.	[Loizou, Eleana; Bouamra, Omar; Dark, Paul; Martin, Bruce; Lecky, Fiona] Trauma Audit & Res Network, Manchester M6 8HD, Lancs, England		Loizou, E (corresponding author), Trauma Audit & Res Network, Clin Sci Bldg, Manchester M6 8HD, Lancs, England.	eleana.loizou@gmail.com		Dark, Paul/0000-0003-3309-0164	Academic Foundation; TARN NHS Trusts	This project was funded by an Academic Foundation post by the North Western Deanery and by the TARN NHS Trusts.	Advanced Life Support Group, 2001, ADV PAED LIF SUPP PR; ANDERSON ID, 1990, J TRAUMA, V30, P974, DOI 10.1097/00005373-199008000-00005; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BAKER WA, 1976, INORG CHIM ACTA, V16, P5, DOI 10.1016/S0020-1693(00)91684-0; Bayreuther J, 2009, ARCH DIS CHILDHOOD-E, V94, P37, DOI 10.1136/adc.2007.132787; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; Dark P, 2002, RESUSCITATION, V54, P245, DOI 10.1016/S0300-9572(02)00154-5; Dawodu S, 2009, TRAUMATIC BRAIN INJU; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; LITTLE RA, 1995, J ACCID EMERG MED, V12, P1; LITTLE RJA, 1989, SOCIOL METHOD RES, V18, P292, DOI 10.1177/0049124189018002004; McMahon CG, 2008, CRIT CARE MED, V36, P216, DOI 10.1097/01.CCM.0000295425.41831.85; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; *TRAUM AUD RES NET, 2009, PROC MAN; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3	16	6	6	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	APR	2010	81	4					418	421		10.1016/j.resuscitation.2009.12.017			4	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	583VE	WOS:000276707200010	20117873				2022-02-06	
J	Ma, JF; Liu, RG; Peng, HM; Zhou, JP; Li, HP				Ma, Junfang; Liu, Rengang; Peng, Huiming; Zhou, Jieping; Li, Haipeng			CD81 Inhibits the Proliferation of Astrocytes by Inducing G(0)/G(1) Arrest In Vitro	JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES			English	Article						CD81; astrocytes; proliferation; inhibition; cell cycle; tetraspanins	ANTIPROLIFERATIVE ANTIBODY TAPA; CELL-CYCLE; PROTEINS; TARGET; RAT; TETRASPANINS; EXPRESSION; GROWTH; BRAIN; HIV-1	Astrocytes play a major role in the reactive processes in response to neuronal injuries in the brain. Excessive gliosis is detrimental and can contribute to neuronal damage. CD81 (TAPA), a member of the tetraspanin family of proteins, is upregulated by astrocytes after traumatic injury to the rat central nervous system (CNS). To further understand the role of CD81 in the inhibition of astrocytes, we analyzed the effects of a CD81 antibody, on cultured rat astrocytes. The results indicated that the effect worked in a dose-dependent manner with certain dosage range. It, however, reached a dosage equilibrium at a high dosage. Furthermore, anti-CD81 antibody remarkably inhibited the proliferation of astrocytes after incubation with astrocytes for different periods of time and the effect presented a time-dependent fashion. However, anti-CD81 antibody substantially inhibited the proliferation of astrocytes at low density and middle density but slightly inhibited the proliferation of astrocytes at high density, suggesting that the effect was positively correlated with the proliferative ability of astrocytes. Finally, the cell cycle of astrocytes exposured to anti-CD81 antibody was arrested in S phase at the initial stage and at G(0)/G(1) phase over time. These findings indicated that CD81 exert significant inhibitory effect, dose-dependently and time-dependently, on the proliferation of astrocytes and the effect is positively correlated with the proliferative capability of astrocytes.	[Liu, Rengang; Peng, Huiming; Zhou, Jieping; Li, Haipeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Anat, Wuhan 430030, Peoples R China; [Ma, Junfang] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Neurol, Wuhan 430030, Peoples R China		Liu, RG (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Anat, Wuhan 430030, Peoples R China.	treemjf@163.com; rglpaul@hotmail.com			National Natural Sciences Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30570568]	This project was supported by a grant from the National Natural Sciences Foundation of China (No. 30570568).	Balfe Peter, 2009, J Hepatol, V51, P609, DOI 10.1016/j.jhep.2009.06.014; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Delandre C, 2009, EXP CELL RES, V315, P1953, DOI 10.1016/j.yexcr.2009.03.013; Dijkstra S, 2001, J NEUROIMMUNOL, V114, P151, DOI 10.1016/S0165-5728(01)00240-5; Dreux M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000310; Geisert EE, 2002, J COMP NEUROL, V453, P22, DOI 10.1002/cne.10364; Geisert EE, 2002, INVEST OPHTH VIS SCI, V43, P274; Geisert EE, 1996, J NEUROSCI, V16, P5478; Gensert JM, 2007, NEUROBIOL DIS, V26, P671, DOI 10.1016/j.nbd.2007.03.008; Grigorov B, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-28; Kato H, 2003, BRAIN RES BULL, V60, P215, DOI 10.1016/S0361-9230(03)00036-4; Kelic S, 2001, MOL CELL NEUROSCI, V17, P551, DOI 10.1006/mcne.2000.0955; Krementsov DN, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-64; MAECKER HT, 2003, BMC IMMUNOL, V19, P1; Mordica WJ, 2009, IN VITRO CELL DEV-AN, V45, P213, DOI 10.1007/s11626-008-9167-0; OREN R, 1990, MOL CELL BIOL, V10, P4007, DOI 10.1128/MCB.10.8.4007; Pan Y, 2007, MOL VIS, V13, P181; Rohlena J, 2009, CARDIOVASC RES, V81, P187, DOI 10.1093/cvr/cvn256; SCHWARTZ JP, 1992, GLIA, V5, P75, DOI 10.1002/glia.440050111; Staflin K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-206; Sullivan CD, 1998, J COMP NEUROL, V396, P366; Yamamoto T, 2000, EUR J PHARMACOL, V397, P25, DOI 10.1016/S0014-2999(00)00244-2	25	6	6	2	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1672-0733			J HUAZHONG U SCI-MED	J. Huazhong Univ. Sci. Tech.-Med.	APR	2010	30	2					201	205		10.1007/s11596-010-0214-1			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638GH	WOS:000280881000014	20407874				2022-02-06	
J	Peschel, O; Rothschild, MA; Mutzel, E				Peschel, O.; Rothschild, M. A.; Muetzel, E.			Bloodstains from gunshot injuries	RECHTSMEDIZIN			German	Article						Bloodstain pattern analysis; Gunshot injuries; Forward spatter; Backspatter	CLOSE-RANGE SHOTS; SUICIDAL GUNSHOTS; BACKSPATTER; HEAD; PATTERNS; WOUNDS; HAND	The type and extent of bloodstains which can be found at the scene of crime after gunshot injuries are extremely variable. Bloodstains which are primarily indicative of gunshot wounds are those which originate from the entrance wound (forward spatter) and retrograde from the exit wound (backspatter) and found on adjacent surfaces. The formation and morphology of these stains and their importance for the medico-legal reconstruction will be described. Backspatter bloodstains are a criterium which when positive concerning the victim give an indication of suicide but when they are lacking must be interpreted with caution, especially if the conditions for securing evidential material were sub-optimal. A critical causal assessment in this area cannot be substituted by a statistical categorization.	[Peschel, O.; Muetzel, E.] Univ Munich, Inst Rechtsmed, D-80336 Munich, Germany; [Rothschild, M. A.] Univ Klinikum Koln, Inst Rechtsmed, Cologne, Germany		Peschel, O (corresponding author), Univ Munich, Inst Rechtsmed, Nussbaumstr 26, D-80336 Munich, Germany.	oliver.peschel@med.uni-muenchen.de					Benecke M, 2003, FORENSIC SCI INT, V137, P152, DOI 10.1016/j.forsciint.2003.07.012; Betz P, 1995, FORENSIC SCI INT, V76, P47, DOI 10.1016/0379-0738(95)01793-3; Bevel T., 2002, BLOODSTAIN PATTERN A; Di Maio VJM, 1999, GUNSHOT WOUNDS PRACT; Fackler ML, 1996, ANN EMERG MED, V28, P194, DOI 10.1016/S0196-0644(96)70062-8; FACKLER ML, 1988, JAMA-J AM MED ASSOC, V259, P2730, DOI 10.1001/jama.259.18.2730; FRATINI P, 2006, INT C SERIES, V1288, P538; Hausmann R, 2002, FORENSIC SCI INT, V129, P191, DOI 10.1016/S0379-0738(02)00273-6; Karger B, 1996, INT J LEGAL MED, V109, P66, DOI 10.1007/BF01355519; Karger B, 2002, AM J FOREN MED PATH, V23, P211, DOI 10.1097/00000433-200209000-00001; Karger B, 1997, INT J LEGAL MED, V110, P27; KARGER B, 2008, FORENSIC PATHOLOGY R, V5, P141; KARGER B, 2004, HDB GERICHTLICHE MED, V1, P660; Kleiber M, 2001, FORENSIC SCI INT, V119, P260, DOI 10.1016/S0379-0738(00)00363-7; KNEUBUEHL BP, 2008, WUNDBALLISTIK; MacDonell H.L., 1993, BLOODSTAIN PATTERNS; Padosch SA, 2006, FORENSIC SCI INT, V158, P224, DOI 10.1016/j.forsciint.2005.05.024; Peschel O, 2008, RECHTSMEDIZIN, V18, P131, DOI 10.1007/s00194-008-0512-0; PESCHEL O, 2009, RECHTSMEDIZINSICHE B; Pollak S, 2004, FORENSIC SCI INT, V144, P201, DOI 10.1016/j.forsciint.2004.04.054; REED GE, 1990, J FORENSIC SCI, V35, P62; Rothschild MA, 2010, RECHTSMEDIZIN, V20, P85, DOI 10.1007/s00194-010-0659-3; Rothschild MA, 2008, WUNDBALLISTIK; Schyma C, 2000, J FORENSIC SCI, V45, P1303; STONE IC, 1992, AM J FOREN MED PATH, V13, P275, DOI 10.1097/00000433-199212000-00001; Verhoff MA, 2003, INT J LEGAL MED, V117, P229, DOI 10.1007/s00414-003-0383-6; Yen K, 2003, AM J FOREN MED PATH, V24, P132, DOI 10.1097/01.paf.0000065164.92878.2f; Zwingli M, 1941, ARCH KRIMINOL, V108, P1	28	6	6	0	14	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0937-9819	1434-5196		RECHTSMEDIZIN	Rechtsmedizin	APR	2010	20	2					91	97		10.1007/s00194-010-0663-7			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	573IT	WOS:000275906800005					2022-02-06	
J	Beretta, L; Anzalone, N; Dell'Acqua, A; Calvi, MR; Gemma, M				Beretta, Luigi; Anzalone, Nicoletta; Dell'Acqua, Antonio; Calvi, Maria Rosa; Gemma, Marco			Post-Traumatic Interpeduncular Cistern Hemorrhage as a Marker for Brainstem Lesions	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; axonal injury; clinical management of central nervous system injury; computed tomography scanning; magnetic resonance imaging	DIFFUSE AXONAL INJURY; CLOSED-HEAD TRAUMA; IMAGING FINDINGS; CORPUS-CALLOSUM; WHITE-MATTER; MR; DAMAGE; COMA; CT; CLASSIFICATION	We retrospectively reviewed a prospectively collected database of our diffuse axonal injury (DAI) patients to evaluate the accuracy of the evidence of interpeduncular cistern (IPC) blood on computed tomography (CT) scan when diagnosing brainstem lesions (BSL) early after trauma. From December 1989 to December 2008 we prospectively maintained a clinical and radiological database of head injured patients admitted to our neurosurgical intensive care unit (ICU) that met the following criteria: coma (Glasgow Coma Scale [GCS] score<9) following the traumatic event; neurological derangement not ascribable to hypoxia, hypotension, or long-acting drugs able to alter state of consciousness; absence of lesions accounting for the severity of coma either on the admission CT scan or on subsequent CT scans; and no contraindications to magnetic resonance imaging (MRI; e. g., indwelling metallic implants). Patients with MRI evidence of BSL exhibited a significantly higher incidence of IPC blood on CT scan than patients without such evidence (77.92% versus 20.00%; p<0.0001). However, these same patients showed a similar incidence of lesions not associated with IPC blood (68.83% versus 56%; p = 0.2459). The evidence of IPC blood on CT scan as an indicator of BSL had a sensitivity of 0.78 (95% CI: 0.70, 0.86), and a specificity of 0.80 (95% CI: 0.72, 0.88), with a 3.90 likelihood ratio for a positive CT scan, and a 0.28 likelihood ratio for a negative CT scan. Our data suggest that the finding of IPC blood on CT scan early after trauma in patients with otherwise unexplained coma is a good marker for possible brainstem lesions.	[Beretta, Luigi; Dell'Acqua, Antonio; Calvi, Maria Rosa; Gemma, Marco] Ist Sci San Raffaele, Head & Neck Dept, I-20132 Milan, Italy; [Anzalone, Nicoletta] Ist Sci San Raffaele, Dept Neuroradiol, I-20132 Milan, Italy		Calvi, MR (corresponding author), Ist Sci San Raffaele, Head & Neck Dept, Via Olgettina 60, I-20132 Milan, Italy.	calvi.mariarosa@hsr.it	anzalone, nicoletta/I-8752-2018	anzalone, nicoletta/0000-0002-4249-2723; Gemma, Marco/0000-0002-9543-3831			ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; BERETTA L, 1994, INTRACRANIAL PRESSUR, V9, P284; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; Firsching R, 2002, NEUROL RES, V24, P145, DOI 10.1179/016164102101199684; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; GEAN AD, 1994, IMAGING HEAD TRAUMA, P236; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GODERSKY JC, 1990, ACT NEUR S, V51, P311; HUME JH, 2000, BRAIN, V123, P1327; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Kawamoto H, 1997, ACTA NEUROCHIR, V139, P566, DOI 10.1007/BF02751001; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; Lu J, 2005, J NEUROSURG, V103, P337, DOI 10.3171/jns.2005.103.2.0337; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; SAHUQUILLO J, 1989, ACTA NEUROCHIR, V101, P149, DOI 10.1007/BF01410531; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; SELLADURAI BM, 1995, J CLIN NEUROSCI, V2, P216, DOI 10.1016/S0967-5868(95)80005-0; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Takaoka M, 2002, J NEUROL NEUROSUR PS, V73, P289, DOI 10.1136/jnnp.73.3.289; Wada T, 2005, NEUROL MED-CHIR, V45, P614, DOI 10.2176/nmc.45.614; WONG CW, 1993, SURG NEUROL, V39, P37, DOI 10.1016/0090-3019(93)90107-C; YEAKLEY JW, 1986, RADIOLOGY, V158, P699, DOI 10.1148/radiology.158.3.3945742	37	6	7	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2010	27	3					509	514		10.1089/neu.2009.1054			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	575PJ	WOS:000276079100005	19938944				2022-02-06	
J	Grabinger, S				Grabinger, Scott			A Framework for Supporting Postsecondary Learners with Psychiatric Disabilities in Online Environments	ELECTRONIC JOURNAL OF E-LEARNING			English	Article						cognitive impairments; online education; universal design for learning		Elena has a psychiatric disability: bipolar (manic/depressive) disorder. Daniele suffers from depression. Both are serious cognitive disorders that have significant effects on learning, especially learning online. One of the problems students with psychiatric disabilities encounter is finding support in online environments, especially when 10, 50, 100, or even 6000 kilometers from the originating university. Students with disabilities represent a growing number of students in postsecondary education. As the opportunities for online education continue to grow exponentially, so does the number of students with cognitive disabilities, like Elena and Daniele. Unfortunately, this is often a forgotten group because of ignorance and fear in society. Taking online courses is an important option for all students. As we will see, at the same time an online course can be difficult for students with disabilities; it also has advantages. Access to online instruction needs to be made available to students with cognitive disabilities just as it is for students with learning, mobility, PTSD, and traumatic brain injury disorders. The fundamental question, then, of this paper is "what can be done to improve access, retention, and success for the 14% of postsecondary students with cognitive impairments taking online classes?" Targeting specific types of impairments are not an efficient option, given that even the same kinds of impairments often present themselves in different ways. Rather, this paper develops a conceptual framework around work done by the Center of Applied Special Technology in the application of recognition, strategic, and affective brain networks to improve instruction related to cognitive impairments including attention and memory, language, executive function, problem solving, and social interaction. Additionally, I recommend turning the locus of support for students with cognitive impairments 180 degrees, addressing support for students at the instructional level instead of the institutional level, which usually takes the learner out of the classroom. This has the negative effect of making the students feel as if they are not part of the class, and it delays support until the disabilities office has time to help the learners. This just-in-time approach based on instructional strategies personalizes instruction, minimizes frustration, and encourages persistence-leading to better learning and success. [Caveat: Statistics and the nature of the problems here describe the situation in the United States of America and are not meant to make assumptions of the postsecondary situation in Western Europe.]	[Grabinger, Scott] Univ Colorado Denver, Denver, CO 80217 USA		Grabinger, S (corresponding author), Univ Colorado Denver, Denver, CO 80217 USA.	Scott.Grabinger@gmail.com					ALLEN IE, 2005, GROWING DEGREES ONLI; [Anonymous], 2003, COGNITIVE FUNCTION; Blalock B, 2004, DISABILITIES OFFICE; Bushnell J, 2005, FAM PRACT, V22, P631, DOI 10.1093/fampra/cmi080; Carlton P, 2004, DISABILITIES OFFICES; Center for Applied Special Technology, 2009, CAST MISS STAT; Center for Applied Special Technology, 2003, UND PREM UN DES LEAR; Center for Applied Special Technology, 2009, DIFF INSTR IMPL UDL; Center for Applied Special Technology, 2009, UN DES LEARN; Center for Applied Special Technology, 2009, UN DES LEARN UDL GUI; Healthyplace. Com Depression Community, 2002, CAMP DOCT AR; Ito A, 2004, DISABILITIES OFFICES; Leake D, 2004, DISABILITIES OFFICES; Marano H.E, 2002, PSYCHOL TODAY; Martinez-Aran A, 2004, AM J PSYCHIAT, V161, P262, DOI 10.1176/appi.ajp.161.2.262; Martinez-Aran A, 2004, BIPOLAR DISORD, V6, P224, DOI 10.1111/j.1399-5618.2004.00111.x; Martinez-Aran A, 2000, PSYCHOTHER PSYCHOSOM, V69, P2, DOI 10.1159/000012361; McCandless M, 2005, DISABILITIES SERVICE; Mccandless M., 2005, DISABILITIES SERVICE; Mcgill L., 2004, DISABILITIES OFFICE; Oblinger D., 2004, BOOMERS GEN XERS MIL; Scientific Brain Training, 2004, BRAIN; Silva J, 2004, DISABILITIES OFFICES; Tollefson J, 2003, PUTTING SPECIAL SPEC; Tolsma R., 2009, GROWING USE ONLINE I; University of Colorado at Denver Disabilities Office, 2004, DISC MAK STUD POP SE; Zarate CA, 2000, PSYCHIAT QUART, V71, P309; Zemke R., 1984, INNOVATION ABSTRACTS, V6; Zull J.E., 2002, ART CHANGING BRAIN E	29	6	7	0	0	ACAD CONFERENCES & PUBL INT LTD	NR READING	CURTIS FARM, KIDMORE END, NR READING, RG4 9AY, ENGLAND	1479-4403			ELECTRON J E-LEARN	Electron. J. E-Learn.	MAR	2010	8	2					101	109					9	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	V54ZP	WOS:000210463200006					2022-02-06	
J	Munjal, SK; Panda, NK; Pathak, A				Munjal, Sanjay Kumar; Panda, Naresh K.; Pathak, Ashis			Dynamics of Hearing Status in Closed Head Injury	JOURNAL OF NEUROTRAUMA			English	Article						auditory brainstem response; closed head injury; hearing impairment; middle latency response	TRAUMA	Hearing impairment can be one of the more subtle deficits seen after closed head injury (CHI), and it may not be diagnosed until late in the recovery phase if at all. Most studies have assessed patients immediately after CHI. Repeated assessments at regular intervals were not performed in the majority of studies done to assess whether any initial hearing loss regressed or progressed. Follow-up at later stages will shed more light on the audiological consequences of CHI. The aim of this study was to analyze the long-term audiological consequences of CHI. A total of 290 subjects with CHI were chosen and followed-up at 3, 6, and 12 months. The audiological test battery comprised pure tone audiometry (PTA), speech audiometry, tympanometry, auditory brainstem response (ABR), and middle latency response (MLR), and was administered to all subjects. The data from 96 subjects who completed all three follow-ups were analyzed for tympanometry, ABR, and MLR. However, for PTA and speech audiometry, data from only 76 subjects were analyzed, as unconscious and disoriented subjects could not undergo these tests at initial testing. The results revealed that hearing status after CHI varies, and that at follow-up significant changes in hearing were seen. Hearing of low frequencies improved, due primarily to improvements in middle ear function. Significant changes in ABR latencies and MLR amplitudes were also observed. This reflects the unequal rates of recovery observed in the different parts of the central auditory nervous system.	[Munjal, Sanjay Kumar] Post Grad Inst Med Educ Res, Speech & Hearing Unit, Ear Nose & Throat Out Patient Dept, Chandigarh 160012, India; [Panda, Naresh K.] Post Grad Inst Med Educ Res, Dept Otolaryngol, Chandigarh 160012, India; [Pathak, Ashis] Post Grad Inst Med Educ Res, Dept Neurosurg, Chandigarh 160012, India		Munjal, SK (corresponding author), Post Grad Inst Med Educ Res, Speech & Hearing Unit, Ear Nose & Throat Out Patient Dept, Room 441,4th Floor,A Block,New OPD Block, Chandigarh 160012, India.	sanjaymunjal1@hotmail.com					ALHADY MRA, 1990, J LARYNGOL OTOL, V104, P927, DOI 10.1017/S0022215100114410; BARBER HO, 1969, ANN OTO RHINOL LARYN, V78, P239, DOI 10.1177/000348946907800204; Bergemalm PO, 2001, ACTA OTO-LARYNGOL, V121, P724, DOI 10.1080/00016480152583674; BHARTI P, 1993, NEUROL INDIA, V41, P49; COLLET L, 1986, INT J NEUROSCI, V30, P145, DOI 10.3109/00207458608985663; Drake M E Jr, 1996, Electromyogr Clin Neurophysiol, V36, P457; Fligor BJ, 2002, ARCH PHYS MED REHAB, V83, P141, DOI 10.1053/apmr.2002.26813; GURURAJ G, 1993, WHO SCI WORKSH NEUR; KOCHHAR L K, 1990, Ear Nose and Throat Journal, V69, P537; Lancaster JL, 1999, J ROY COLL SURG EDIN, V44, P87; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; PEARSON BW, 1973, ARCH OTOLARYNGOL, V97, P81; PODOSHIN L, 1975, ARCH OTOLARYNGOL, V101, P15; SCHUKNECHT HF, 1956, ARCHIV OTOLARYNGOL, V63, P513; Segal S, 2002, OTOL NEUROTOL, V23, P312, DOI 10.1097/00129492-200205000-00014; SOUSTIEL JF, 1995, BRAIN INJURY, V9, P805, DOI 10.3109/02699059509008236; Tos M, 1971, J Laryngol Otol, V85, P1147, DOI 10.1017/S0022215100074569; ZIMMERMAN WD, 1993, LARYNGOSCOPE, V103, P87	18	6	7	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2010	27	2					309	316		10.1089/neu.2009.0957			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	557JG	WOS:000274664800003	20136520				2022-02-06	
J	Blaha, M; Schwab, J; Vajnerova, O; Bednar, M; Vajner, L; Michal, T				Blaha, Martin; Schwab, Juraj; Vajnerova, Olga; Bednar, Michal; Vajner, Ludek; Michal, Tichy			Intracranial Pressure and Experimental Model of Diffuse Brain Injury in Rats	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Traumatic brain injury; Experimental model; Rat; Intracranial pressure	CONTROLLED CORTICAL IMPACT; FLUID PERCUSSION	Objective : In this study, we present a simple closed head injury model as a two-stage experiment. The height of the weight drop enables gradation of head trauma severity. Methods : The head injury device consists of three parts and there are three adjustable parameters-weight (100-600 g), height of fall (5-100 cm) and elasticity of the springs. Thirty male Wistar rats underwent monitoring of intracranial pressure with and without induction of the head injury. Results : The weight drop from 45 to 100 cm led to immediate seizure activity and early death of the experimental animals. Severe head injury was induced from 40 cm weight drop. There was 50% mortality and all surviving rats had behavioral deterioration. Intracranial pressure was 9.3 +/- 3.76 mmHg. Moderate head injury was induced from 35 cm, mortality decreased to 20-40%, only half of the animals showed behavioral pathology and intracranial pressure was 7.6 +/- 3.54 mmHg. Weight drop from 30 cm caused mild head injury without mortality and neurological deterioration. Intracranial pressure was slightly higher compared to sham group- 5.5 +/- 0.74 mmHg and 2.9 +/- 0.81 mmHg respectively. Conclusion : This model is an eligible tool to create graded brain injury with stepwise intracranial pressure elevation.	[Blaha, Martin; Schwab, Juraj] Univ Hosp Motol, Dept Neurol Surg, Prague 15006 5, Czech Republic; [Blaha, Martin; Schwab, Juraj; Vajnerova, Olga; Michal, Tichy] Charles Univ Prague, Fac Med 2, Dept Physiol, Prague, Czech Republic; [Vajner, Ludek] Charles Univ Prague, Fac Med 2, Dept Histol & Embryol, Prague, Czech Republic; [Bednar, Michal] Clinicum, Dept Anaesthesiol, Prague, Czech Republic		Blaha, M (corresponding author), Univ Hosp Motol, Dept Neurol Surg, V Uvalu 84, Prague 15006 5, Czech Republic.	drmartinblaha@yahoo.com	Vajner, Ludek/C-5823-2014	Vajner, Ludek/0000-0002-2414-7571; Blaha, Martin/0000-0002-9611-498X	Grant Agency of the Ministry of Health of the Czech Republic [IGA MZ NR/9514-3/2007]	This work was supported by the Grant Agency of the Ministry of Health of the Czech Republic: IGA MZ NR/9514-3/2007.	CESAK T, 2001, PORANENI MOZKU, P19; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; JAMES HE, 1990, ACTA NEUROCHIR WIE S, P5179; Jeon IC, 2008, J KOREAN NEUROSURG S, V44, P295, DOI 10.3340/jkns.2008.44.5.295; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Rooker S, 2003, J NEUROSCI METH, V131, P75, DOI 10.1016/S0165-0270(03)00233-4; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; TODD MM, 1993, ANESTHESIOLOGY, V79, P139, DOI 10.1097/00000542-199307000-00020; Tsai MS, 2001, J CLIN NEUROSCI, V8, P157, DOI 10.1054/jocn.2000.0842	13	6	9	0	13	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	JAN	2010	47	1					7	10		10.3340/jkns.2010.47.1.7			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	554OQ	WOS:000274444700002	20157371	Green Published, Green Submitted, gold			2022-02-06	
S	Elliott, TR; Hurst, M		Walsh, WB		Elliott, Timothy R.; Hurst, Morgan			Social Problem Solving and Health	BIENNIAL REVIEW OF COUNSELING PSYCHOLOGY, VOL 1	Biennial Review of Counseling Psychology		English	Article; Book Chapter							LOW-BACK-PAIN; FAMILY-MEMBER ADJUSTMENT; TRAUMATIC BRAIN-INJURY; PSYCHOLOGICAL ADJUSTMENT; AFRICAN-AMERICANS; STROKE SURVIVORS; ABILITIES; THERAPY; CAREGIVERS; APPRAISAL		[Elliott, Timothy R.; Hurst, Morgan] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA		Elliott, TR (corresponding author), Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA.		Elliott, Timothy R./I-5301-2012	Elliott, Timothy R./0000-0002-6608-7714			Bandura A, 1986, SOCIAL FDN THOUGHT A; CALIFF RM, 2002, PRINCIPLES PRACTICE, P225; D'Zurilla T.J., 2002, SOCIAL PROBLEM SOLVI; D'Zurilla T.J., 1999, PROBLEM SOLVING THER, V2nd edn; D'Zurilla T.J., 1990, PSYCHOL ASSESSMENT, V2, P156, DOI DOI 10.1037/1040-3590.2.2.156; D'Zurilla TJ., 2004, SOCIAL PROBLEM SOLVI, P11, DOI [10.1037/10805-001, DOI 10.1037/10805-001]; De Vlieger P, 2006, PAIN, V120, P138, DOI 10.1016/j.pain.2005.10.022; DREER L, 2007, EFFICIENT ASSE UNPUB; Dreer LE, 2007, REHABIL PSYCHOL, V52, P351, DOI 10.1037/0090-5550.52.3.351; Dreer LE, 2005, REHABIL PSYCHOL, V50, P232, DOI 10.1037/0090-5550.50.3.232; Dreer LE, 2004, J CLIN PSYCHOL MED S, V11, P7, DOI 10.1023/B:JOCS.0000016265.62022.82; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; DZURILLA TJ, 2007, PROBLEM SOLVING THER, P33; ELLIOTT T, 2007, BRIEF PROBLEM UNPUB; ELLIOTT T, PROBLEM SOLVIN UNPUB; Elliott TR, 2006, REHABIL PSYCHOL, V51, P69, DOI 10.1037/0090-5550.51.1.69; Elliott TR, 1999, REHABIL PSYCHOL, V44, P104, DOI 10.1037/0090-5550.44.1.104; ELLIOTT TR, 1991, COGNITIVE THER RES, V15, P387, DOI 10.1007/BF01173033; Elliott TR, 2001, J COUNS PSYCHOL, V48, P223, DOI 10.1037//0022-0167.48.2.223; Elliott TR, 1999, REHABIL PSYCHOL, V44, P315, DOI 10.1037/0090-5550.44.4.315; Elliott TR, 2001, J CLIN PSYCHOL MED S, V8, P283, DOI 10.1023/A:1011920914079; ELLIOTT TR, 1994, J COUNS DEV, V72, P531, DOI 10.1002/j.1556-6676.1994.tb00987.x; Elliott TR, 2004, SOCIAL PROBLEM SOLVI, V11, P7, DOI DOI 10.1037/10805-007; Godshall FJ, 1997, J APPL SOC PSYCHOL, V27, P929, DOI 10.1111/j.1559-1816.1997.tb00279.x; Gore-Felton C, 2005, AIDS EDUC PREV, V17, P21, DOI 10.1521/aeap.17.2.21.58691; Grant JS, 2006, ARCH PHYS MED REHAB, V87, P343, DOI 10.1016/j.apmr.2005.09.019; Grant JS, 2004, REHABIL PSYCHOL, V49, P172, DOI 10.1037/0090-5550.49.2.172; Grant JS, 2002, STROKE, V33, P2060, DOI 10.1161/01.STR.0000020711.38824.E3; Heppner PP, 2003, POSITIVE PSYCHOLOGICAL ASSESSMENT: HANDBOOK OF MODELS AND MEASURES, P127; Heppner PP, 2004, COUNS PSYCHOL, V32, P344, DOI 10.1177/0011000003262793; HEPPNER PP, 1987, COUNS PSYCHOL, V15, P371, DOI 10.1177/0011000087153001; HEPPNER PP, 1982, J COUNS PSYCHOL, V29, P580, DOI 10.1037/0022-0167.29.6.580; Heppner PP, 1997, MEAS EVAL COUNS DEV, V29, P229, DOI 10.1080/07481756.1997.12068907; HEPPNER PP, 1978, J COUNS PSYCHOL, V25, P366; Herrick SM, 2001, J CLIN PSYCHOL, V57, P75, DOI 10.1002/1097-4679(200101)57:1<75::AID-JCLP9>3.0.CO;2-6; Hill-Briggs F, 2006, J BEHAV MED, V29, P69, DOI 10.1007/s10865-005-9037-0; Hill-Briggs F, 2003, DIABETES EDUCATOR, V29, P1018; Hill-Briggs F, 2003, ANN BEHAV MED, V25, P182, DOI 10.1207/S15324796ABM2503_04; Johnson MO, 2006, HEALTH PSYCHOL, V25, P355, DOI 10.1037/0278-6133.25.3.355; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Kurylo M, 2004, J CLIN PSYCHOL MED S, V11, P151, DOI 10.1023/B:JOCS.0000037609.23007.24; Latimer WW, 2003, DRUG ALCOHOL DEPEN, V71, P303, DOI 10.1016/S0376-8716(03)00171-6; Lesley ML, 2007, PATIENT EDUC COUNS, V65, P137, DOI 10.1016/j.pec.2006.07.001; Lui MHL, 2005, STROKE, V36, P2514, DOI 10.1161/01.STR.0000185743.41231.85; Malouff JM, 2007, CLIN PSYCHOL REV, V27, P46, DOI 10.1016/j.cpr.2005.12.005; MYNORSWALLIS LM, 1995, BMJ-BRIT MED J, V310, P441, DOI 10.1136/bmj.310.6977.441; NEAL GW, 1986, J COUNS PSYCHOL, V33, P39, DOI 10.1037/0022-0167.33.1.39; Nezu A, 1989, ANXIETY DEPRESSION D, P285; Nezu AM, 2004, BEHAV THER, V35, P1, DOI 10.1016/S0005-7894(04)80002-9; Nezu AM, 2003, J CONSULT CLIN PSYCH, V71, P1036, DOI 10.1037/0022-006X.71.6.1036; NEZU AM, 1989, J CONSULT CLIN PSYCH, V57, P408, DOI 10.1037/0022-006X.57.3.408; Nezu AM, 1998, HELPING CANC PATIENT; *PARTN SOL, 2004, CHRON COND MAK CAS O; Perri MG, 2001, J CONSULT CLIN PSYCH, V69, P722, DOI 10.1037/0022-006X.69.4.722; Rath JF, 2004, ARCH CLIN NEUROPSYCH, V19, P613, DOI 10.1016/j.acn.2003.08.006; Rath JF, 2003, REHABIL PSYCHOL, V48, P137, DOI 10.1037/0090-5550.48.3.137; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; RICHARDS CS, 1978, J COUNS PSYCHOL, V25, P376, DOI 10.1037/0022-0167.25.5.376; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVERA P, ARCH PHYS M IN PRESS; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rivera PA, 2006, J CLIN PSYCHOL MED S, V13, P431, DOI 10.1007/s10880-006-9043-6; ROB JEM, 2008, PAIN, V134, P263; Sahler OJZ, 2005, J CONSULT CLIN PSYCH, V73, P272, DOI 10.1037/0022-006X.73.2.272; Shanmugham K, 2004, NEUROREHABILITATION, V19, P259; SHANMUGHAM K, SOCIAL PROBLEM UNPUB; Shaw WS, 2001, PAIN, V93, P129, DOI 10.1016/S0304-3959(01)00304-9; Siu AMH, 2005, SOC INDIC RES, V71, P517, DOI 10.1007/s11205-004-8034-y; Smeets RJEM, 2008, PAIN, V134, P263, DOI 10.1016/j.pain.2007.04.021; van den Hout JHC, 2003, CLIN J PAIN, V19, P87, DOI 10.1097/00002508-200303000-00003; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wisniewski SR, 2003, PSYCHOL AGING, V18, P375, DOI 10.1037/0882-7974.18.3.375; Witty TE, 2001, J CLIN PSYCHOL MED S, V8, P149, DOI 10.1023/A:1011361418436	74	6	6	1	6	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND	1941-4250		978-0-8058-6279-9	BIENN REV COUNS PSYC			2010							295	314					20	Psychology, Clinical; Psychology, Applied	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Psychology	BUX31	WOS:000290563700013					2022-02-06	
J	Hassan, NA; El Kelany, RS; Emara, AM; Amer, M				Hassan, Neven Ahmed; El Kelany, Rabab Sayed; Emara, Ashraf Mahmoud; Amer, Mohamed			Pattern of craniofacial injuries in patients admitted to Tanta University Hospital - Egypt	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Craniofacial injuries; Soft tissues; Skull; Brain; Egypt	MAXILLOFACIAL INJURIES; BRAIN-INJURY; ACCIDENTS; TRAUMA	The goal of this work was to determine the craniofacial injury patterns in hospitalized patients to facilitate the awareness, by identifying, describing and quantifying trauma for use in planning and evaluation of preventive programs. Two-hundred and fifty five patients with craniofacial injuries were registered at the department of neurosurgery in Tanta University Hospital. Data were collected including age, gender, medical history, cause of injury and type of injury, location and frequency of soft tissue injuries, skull fractures, facial bone fractures, brain injuries and concomitant injuries, patient symptoms, clinical signs and the radiological findings. The most common causes of craniofacial injuries were road traffic accidents, followed by activity of daily life and assaults. Gender distribution showed that, males were at higher risk than females with a ratio of 5.5/1. In total of skull fractures, 47.84% were fissure fracture and 24.31% were depressed fractures. In total of brain injuries, 7.06% for concussion, 4.71% for contusion, 10.98% for brain laceration, 14.12% for pneumocephalus and 36.47% for brain edema. Regression analysis revealed increased risk for skull fractures and brain injuries in traffic accidents were 84.78%, 94.20%, respectively, and 59.14%, 50.54% in activity of daily life, but the probability of soft tissue injuries increase in traffic accident and violence. (C) 2009 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.	[Emara, Ashraf Mahmoud] Tanta Univ, Fac Med, Tanta Poison Ctr, Tanta, Egypt		Emara, AM (corresponding author), Tanta Univ, Fac Med, Tanta Poison Ctr, Tanta, Egypt.	ashrafemara99@hotmail.com	Hassan, Neveen/AAA-1803-2021; Emara, Ashraf Mahmoud/AAE-5314-2019; Amer, Mohamed/AAK-4023-2020; N.A, Hassan/AAU-2112-2020	Emara, Ashraf Mahmoud/0000-0002-1114-7580; Amer, Mohamed/0000-0002-0478-8689; hassan, neven/0000-0003-0042-2994; sokar, neven/0000-0003-1051-7030			Adams CD, 2000, AUST NZ J SURG, V70, P401, DOI 10.1046/j.1440-1622.2000.01836.x; Anwar BB, 1998, J ORAL SURG ORAL MED, V86, P31; Ardekian L, 1998, INJURY, V29, P253, DOI 10.1016/S0020-1383(97)00209-X; Caroli M, 2001, SURG NEUROL, V56, P82, DOI 10.1016/S0090-3019(01)00540-7; Cheung PSY, 2007, INJURY, V38, P76, DOI 10.1016/j.injury.2006.08.059; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; COOK HE, 1990, J ORAL MAXIL SURG, V48, P574, DOI 10.1016/S0278-2391(10)80469-0; Girotto JA, 2001, PLAST RECONSTR SURG, V108, P312, DOI 10.1097/00006534-200108000-00005; Gopalakrishna G, 1998, ANN EMERG MED, V32, P425, DOI 10.1016/S0196-0644(98)70170-2; Haug RH, 2000, ORAL SURG ORAL MED O, V90, P126, DOI 10.1067/moe.2000.107974; Hogg NJV, 2000, J TRAUMA, V49, P425, DOI 10.1097/00005373-200009000-00007; HUSSAIN K, 1994, J TRAUMA, V36, P34, DOI 10.1097/00005373-199401000-00006; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iida S, 2001, INT J ORAL MAX SURG, V30, P286, DOI 10.1054/ijom.2001.0056; Israr M, 2001, PAK ORAL DENT J, V21, P50; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Knight B, 1996, FORENSIC PATHOLOGY, P156; Le BT, 2001, J ORAL MAXIL SURG, V59, P1277, DOI 10.1053/joms.2001.27490; Lin JW, 2006, SURG NEUROL, V66, pS20, DOI 10.1016/j.surneu.2006.04.005; Lin S, 2008, DENT TRAUMATOL, V24, P53, DOI 10.1111/j.1600-9657.2006.00510.x; Manson PN, 1999, PLASTIC SURG, V2, P867; Mouzakes J, 2001, ARCH OTOLARYNGOL, V127, P1189, DOI 10.1001/archotol.127.10.1189; Oji C, 1995, J CRANIOMAXILLOFAC S, V26, P322; Roccia F, 1999, J CRANIO MAXILL SURG, V27, P335, DOI 10.1054/jcms.1999.0082; Tadj A, 2003, ANZ J SURG, V73, P49, DOI 10.1046/j.1445-2197.2003.02595.x; TORGERSEN S, 1992, INT J ORAL MAX SURG, V21, P335, DOI 10.1016/S0901-5027(05)80756-8; Viano D, 1997, ACCIDENT ANAL PREV, V29, P811, DOI 10.1016/S0001-4575(97)00050-X; Yoffe Tal, 2008, Harefuah, V147, P192; ZACHARIADES N, 1990, J CRANIO MAXILL SURG, V18, P251, DOI 10.1016/S1010-5182(05)80425-1; Zerfowski M, 1998, Clin Oral Investig, V2, P120, DOI 10.1007/s007840050056	30	6	6	1	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	JAN	2010	17	1					26	32		10.1016/j.jflm.2009.07.008			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	V23AT	WOS:000208316400005	20083047				2022-02-06	
J	Katsaragakis, S; Drimousis, PG; Toutouzas, K; Stefanatou, M; Larentzakis, A; Theodoraki, ME; Stergiopoulos, S; Theodorou, D				Katsaragakis, Stylianos; Drimousis, Panagiotis G.; Toutouzas, Konstantinos; Stefanatou, Maria; Larentzakis, Antreas; Theodoraki, Maria E.; Stergiopoulos, Spyros; Theodorou, Dimitrios			Traumatic brain injury in Greece: Report of a countrywide registry	BRAIN INJURY			English	Article						Traumatic brain injury (TBI); trauma; trauma registry	MAJOR TRAUMA; HEAD-INJURY; UNITED-STATES; EPIDEMIOLOGY; DEATH; CARE	Introduction: The purpose of this study was to evaluate the incidence of TBI in Greece and to provide evidence on the epidemiologic characteristics of the disease. Patients and methods: This is a prospective observational study initiated by the Hellenic Society of Trauma and Emergency Surgery. Thirty hospitals participated in the registry. All trauma patients requiring admission transfer to a higher level centre and those who arrived dead were included in the study. This report evaluated the epidemiologic characteristics of patients with brain trauma, the cause and the severity of the injury and the final outcome. Results: Eight thousand eight hundred and sixty-two patients were included in the registry. Of them, 3383 had at least one brain injury. There were 2451 males and 932 females. Traffic accidents were the leading cause of TBI (54.1%), followed by falls (27.7%). The most affected age group was the 15-44 year olds (48.0%), but TBIs were more lethal in the 45-64 age group (17.8%). Interestingly, a 3.4% mortality was recorded if a TBI was present, even if ISS was relatively low (0-9 ISS group). Conclusion: TBI is a major element of trauma. Knowledge of the epidemiologic characteristics of the disease is imperative for adequate planning and future quality assessment.	[Katsaragakis, Stylianos; Drimousis, Panagiotis G.; Toutouzas, Konstantinos; Stefanatou, Maria; Larentzakis, Antreas; Theodorou, Dimitrios] Univ Athens, Sch Med, Dept Propeudeut Surg 1, Surg Intens Care Unit, GR-11527 Athens, Greece; [Stergiopoulos, Spyros] Univ Athens, Sch Med, Dept Surg 4, GR-11527 Athens, Greece		Stefanatou, M (corresponding author), 8 Ar Oikonomou St, Athens 10445, Greece.	marwstef@gmail.com	Larentzakis, Andreas/AAF-5291-2021; Dimitrios, Theodorou/W-1918-2019	Larentzakis, Andreas/0000-0002-8286-531X; 			BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Dick WF, 1999, RESUSCITATION, V42, P81, DOI 10.1016/S0300-9572(99)00102-1; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Jurkovich GJ, 1999, J TRAUMA, V47, pS46, DOI 10.1097/00005373-199909001-00011; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Meyer AA, 1998, J TRAUMA, V44, P1, DOI 10.1097/00005373-199801000-00001; Siegel JH, 2001, J TRAUMA, V51, P975, DOI 10.1097/00005373-200111000-00024; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Spaite D, 1998, ANN EMERG MED, V32, P480, DOI 10.1016/S0196-0644(98)70178-7; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; [No title captured]; 1999, JAMA J AM MED ASS, V282, P974	20	6	7	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	6					871	876		10.3109/02699051003789237			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	620MT	WOS:000279504700009	20433285				2022-02-06	
J	Katz-Leurer, M; Rotem, H; Keren, O; Meyer, S				Katz-Leurer, Michal; Rotem, Hemda; Keren, Ofer; Meyer, Shirley			The immediate effect of treadmill walking on step variability in boys with a history of severe traumatic brain injury and typically-developed controls	DEVELOPMENTAL NEUROREHABILITATION			English	Article						gait; traumatic brain injury; step variability; treadmill	GAIT CHARACTERISTICS; CHILDREN; LOCOMOTION; MOTOR; RECOVERY; MOBILITY; PATTERN; LENGTH	Objective: To examine the immediate effect of treadmill walking (i.e. enforced walking at a fixed gait velocity) on gait variability among children post-severe traumatic brain injury (TBI) and typically-developing (TD) age-matched controls. Methods: Twelve boys post-severe TBI and 18 TD boys participated in this study. Ages were 7-13 years. Step time and length variability were assessed by an electronic walkway prior to and after treadmill walking for 6 minutes. Results: Significantly reduced walking velocity and step length, with significantly increased step length variability were noted among children post-TBI compared to the TD subjects when walking on level ground prior to the treadmill. Treadmill walking reduced step length variability in TD children, while there was a slight increase in variability in children post-TBI (p < 0.05). Conclusion: Walking on a treadmill at a fixed gait velocity has a different effect on boys post-severe TBI and TD controls.	[Katz-Leurer, Michal] Tel Aviv Univ, Michal Sackler Fac Med, Sch Hlth Profess, Phys Therapy Dept, IL-69978 Tel Aviv, Israel; [Rotem, Hemda; Keren, Ofer; Meyer, Shirley] Alyn Pediat & Adolescent Rehabil Ctr, Jerusalem, Israel		Katz-Leurer, M (corresponding author), Tel Aviv Univ, Michal Sackler Fac Med, Sch Hlth Profess, Phys Therapy Dept, IL-69978 Tel Aviv, Israel.	michalkz@post.tau.ac.il					Alton F, 1998, CLIN BIOMECH, V13, P434, DOI 10.1016/S0268-0033(98)00012-6; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; Brisswalter J, 1996, Can J Appl Physiol, V21, P471; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Choi JT, 2007, NAT NEUROSCI, V10, P1055, DOI 10.1038/nn1930; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Danion F, 2003, GAIT POSTURE, V18, P69, DOI 10.1016/S0966-6362(03)00030-4; Frenkel-Toledo S, 2005, MOVEMENT DISORD, V20, P1109, DOI 10.1002/mds.20507; Harley C, 2009, GAIT POSTURE, V29, P428, DOI 10.1016/j.gaitpost.2008.10.063; Helbostad JL, 2007, J GERONTOL A-BIOL, V62, P1010, DOI 10.1093/gerona/62.9.1010; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Katz-Leurer M, 2009, GAIT POSTURE, V29, P154, DOI 10.1016/j.gaitpost.2008.06.013; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; LEE RD, 2003, NUTR ASSESSMENT; Leitner Y, 2007, J NEUROL, V254, P1330, DOI 10.1007/s00415-006-0522-3; MATHIOWETZ V, 1994, AM J OCCUP THER, V48, P733, DOI 10.5014/ajot.48.8.733; McDonough AL, 2001, ARCH PHYS MED REHAB, V82, P419, DOI 10.1053/apmr.2001.19778; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; PROKOP T, 1995, EXP BRAIN RES, V106, P449; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Scherer M, 2007, BRAIN INJURY, V21, P93, DOI 10.1080/02699050601149104; Sekiya N, 1997, J ORTHOP SPORT PHYS, V26, P266, DOI 10.2519/jospt.1997.26.5.266; Thorpe DE, 2005, ARCH PHYS MED REHAB, V86, P2342, DOI 10.1016/j.apmr.2005.07.301; Van de Crommert HWAA, 1998, GAIT POSTURE, V7, P251, DOI 10.1016/S0966-6362(98)00010-1; VanderSchaaf PJ, 1997, PEDIATR NEUROL, V16, P306, DOI 10.1016/S0887-8994(97)00025-8; Wilson DJ, 2006, AM J PHYS MED REHAB, V85, P68, DOI 10.1097/01.phm.0000193507.28759.37; YAMASAKI M, 1991, EUR J APPL PHYSIOL O, V62, P99, DOI 10.1007/BF00626763	28	6	6	0	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1751-8423			DEV NEUROREHABIL	Dev. Neurorehabil.		2010	13	3					170	174		10.3109/17518420903512873			5	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Rehabilitation	686LM	WOS:000284697800004	20450466				2022-02-06	
J	Large, M; Nielssen, O; Elliott, G				Large, Matthew; Nielssen, Olav; Elliott, Gordon			The Reliability of Evidence About Psychiatric Diagnosis After Serious Crime: Part II. Agreement Between Experts and Treating Practitioners	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							CONFLICT; WITNESS; INJURY	In this second part of our study, we examined the extent of agreement between treating practitioners and expert witnesses on psychiatric diagnoses in evidence presented in criminal proceedings. We found good agreement on diagnoses of acquired brain injury, schizophrenia-spectrum psychoses, depressive disorders, intellectual disability, substance abuse, and personality disorders; fair agreement on substance-induced psychotic disorder; and poor agreement on the presence of anxiety disorders. A proportion of defendants with diagnosis by experts of substance-induced psychotic disorder also had a diagnosis of schizophrenia-spectrum psychosis by treating practitioners. Treating practitioners and experts engaged by the prosecution rarely made the diagnosis of post-traumatic stress disorder. Overall, there was moderate agreement between experts and treating practitioners on the principal Axis I disorder, and the evidence for psychiatric diagnoses presented by treating practitioners in criminal cases was found to be generally reliable.	[Large, Matthew; Nielssen, Olav] Univ New S Wales, Sydney, NSW, Australia; [Large, Matthew] Prince Wales Hosp, Sydney, NSW, Australia; [Nielssen, Olav; Elliott, Gordon] St Vincents Hosp, Sydney, NSW 2010, Australia; [Elliott, Gordon] New S Wales Justice Hlth, Sydney, NSW, Australia		Large, M (corresponding author), Prince Wales Hosp, Euroa Ctr, Randwick, NSW 2031, Australia.	mmbl@bigpond.com		Nielssen, Olav/0000-0001-5172-2781			*AC MED ROYAL COLL, MED EXP WITN GUID; American Academy of Psychiatry and the Law, 2005, ETH GUID PRACT FOR P; American Psychiatric Association, PRINC MED ETH ANN ES; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; American Psychological Association, ETH PRINC PSYCH COD; Dattilio FM, 2006, J AM ACAD PSYCHIATRY, V34, P482; Fleiss J.L., 1981, STAT METHODS RATES P; Freckelton I., 1999, AUSTR JUDICIAL PERSP; Greenberg SA, 1997, PROF PSYCHOL-RES PR, V28, P50, DOI 10.1037/0735-7028.28.1.50; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Large M, 2001, AUST NZ J PSYCHIAT, V35, P535, DOI 10.1046/j.1440-1614.2001.00939.x; Large M, 2009, AUST NZ J PSYCHIAT, V43, P446, DOI 10.1080/00048670902817745; Large MM, 2008, J AM ACAD PSYCHIATRY, V36, P515; LEVINE SV, 1983, CAN J PSYCHIAT, V28, P255, DOI 10.1177/070674378302800403; MILLER RD, 1984, J FORENSIC SCI, V29, P825; Mossman D, 1999, J AM ACAD PSYCHIATRY, V27, P414; Nielssen O, 2010, J AM ACAD PSYCHIATRY, V38, P516; *ROYAL AUSTR NZ CO, 2009, ETH GUID ROYAL AUSTR, V9; Shuman DW, 1998, BEHAV SCI LAW, V16, P509, DOI 10.1002/(SICI)1099-0798(199823)16:4<509::AID-BSL324>3.0.CO;2-Y; Strasburger LH, 1997, AM J PSYCHIAT, V154, P448	20	6	6	0	2	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793			J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law		2010	38	4					524	530					7	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	712WL	WOS:000286696900011	21156912				2022-02-06	
J	Lippert-Gruner, M				Lippert-Gruener, Marcela			Early rehabilitation of comatose patients after traumatic brain injury	NEUROLOGIA I NEUROCHIRURGIA POLSKA			English	Article						rehabilitation; coma; outcome; brain injury	FUNCTIONAL OUTCOMES; HEAD-INJURY; CONSCIOUSNESS; INTERVENTION; ADULTS; LIFE	Background and purpose: As a result of improvements in the rescue system and progress in intensive care therapy, an increasing number of patients have survived severe traumatic brain injury in recent years. Early and consistent administration of the correct rehabilitation programme is of crucial importance for the restoration and improvement of cerebral function, as well as social reintegration. This prospective study was conducted at the neurosurgical department of a university hospital to assess the one-year outcome of comatose patients after severe traumatic brain injury. Material and methods: Twenty-seven patients were included. Patients received multimodal early-onset stimulation and continuous inpatient and outpatient rehabilitation therapy. One-year outcome was assessed by means of the Glasgow Outcome Scale, Barthel Index, Functional Independence Measure (FIM) and need of care. Results: Seven patients died, 4 remained in a vegetative state, 7 were severely disabled, 6 were moderately disabled, and 3 achieved a good recovery 12 months after injury Median Barthel Index was 65 and median FIM score was 84. The majority of patients were still at least intermittently dependent on care. Conclusions: Despite intensive rehabilitation treatment, severe traumatic brain injury is still burdened with significant mortality and morbidity	[Lippert-Gruener, Marcela] Univ Cologne, Fac Med, ANR Bonn, Dept Neurol Rehabil, D-5000 Cologne 41, Germany; [Lippert-Gruener, Marcela] ILF Univ Karlova, Dept Rehabil Med, Prague, Czech Republic		Lippert-Gruner, M (corresponding author), Graurheindorfer Str 149A,50, Bonn, Germany.	marcela.lippert-gruener@uk-koeln.de					Anderson SI, 1996, BRAIN INJURY, V10, P115, DOI 10.1080/026990596124601; Chua KSG, 1999, INT J REHABIL RES, V22, P189, DOI 10.1097/00004356-199909000-00005; Grossman P, 1996, DISABIL REHABIL, V18, P57, DOI 10.3109/09638289609166019; Gruner ML, 2000, BRAIN INJURY, V14, P585; HALL M E, 1992, Brain Injury, V6, P435, DOI 10.3109/02699059209008139; Hawkins ML, 1996, J TRAUMA, V41, P257, DOI 10.1097/00005373-199608000-00010; HELLWICK LD, 1994, CRITICAL CARE NURSE, V8, P47; Jeon IC, 2008, J KOREAN NEUROSURG S, V44, P295, DOI 10.3340/jkns.2008.44.5.295; Kater K M, 1989, West J Nurs Res, V11, P20, DOI 10.1177/019394598901100103; KIRCHBERGER S, 1993, SPEKTRUM NEUROREHABI, P91; Lancioni GE, 2008, EUR J PHYS REHAB MED, V44, P449; LAPUMA J, 1988, ARCH NEUROL-CHICAGO, V45, P20; LEWINN EB, 1978, LANCET, V2, P156; Lippert-Gruner M, 1997, Rehabilitation (Stuttg), V36, P111; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; Niedzwecki CM, 2008, J HEAD TRAUMA REHAB, V23, P209, DOI 10.1097/01.HTR.0000327253.61751.29; PFURTSCHELLER G, 1985, ELECTROEN CLIN NEURO, V62, P88, DOI 10.1016/0168-5597(85)90020-6; PIERCE J P, 1990, Brain Injury, V4, P191, DOI 10.3109/02699059009026165; Reuter B M, 1989, Arch Psychol (Frankf), V141, P155; RHODES M, 1988, J TRAUMA, V28, P931, DOI 10.1097/00005373-198807000-00005; Rosenzwelg M., 1980, RECOVERY FUNCTION TH, P127; Schreiber P, 1990, Rehabilitation (Stuttg), V29, P238; Sorbo AK, 2009, INT J REHABIL RES, V32, P139, DOI 10.1097/MRR.0b013e328325a5d1; TALBOT LR, 1994, BRAIN INJURY, V8, P689, DOI 10.3109/02699059409151023; TEASDALE G, 1974, LANCET, V2, P81; Wilson FC, 2007, DISABIL REHABIL, V29, P1751, DOI 10.1080/09638280601118432; Wood R L, 1992, Brain Inj, V6, P411, DOI 10.3109/02699059209008137; Zieger A, 1992, Zentralbl Neurochir, V53, P92; [No title captured]	29	6	6	0	3	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	WENEDOW ST 9-1, POZNAN, 61-614, POLAND	0028-3843			NEUROL NEUROCHIR POL	Neurol. Neurochir. Pol.		2010	44	5					475	480					6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	708JE	WOS:000286357300006	21082492				2022-02-06	
J	Mantell, A				Mantell, Andy			Traumatic brain injury and potential safeguarding concerns	JOURNAL OF ADULT PROTECTION			English	Article						Traumatic brain injury; safeguarding; social work; carers		Safeguarding people who have sustained a traumatic brain injury (TBI) requires not only knowledge of safeguarding practice and procedures, but also the implications of a brain injury. This paper provides an introduction to the nature and impact of TBI upon individuals and their families. Drawing on anonymised case material and practice experience, it explores how the sequelae of TBI, in particular cognitive, emotional and behavioural changes can produce potential safeguarding issues. The person with TBI's potential vulnerability to different forms of abuse is then considered and the relevance of the legislative framework explored. The paper then summarises key points for safeguarding practice in this complex field. It concludes by emphasising that gaining knowledge of how TBI impacts on individuals and their families is essential to understand their risk of abuse. In doing so, it also highlights that simplistic dichotomies between victim and perpetrator can ignore the complexity of the interactions in which safeguarding occurs.	[Mantell, Andy] Univ Chichester, Chichester, England		Mantell, A (corresponding author), Univ Chichester, Dept Social Work, New Hall Bishop Otter Campus,Coll Lane, Chichester PO19 6PE, England.	A.Mantell@chi.ac.uk					Albert SM, 2002, J HEAD TRAUMA REHAB, V17, P175, DOI 10.1097/00001199-200204000-00007; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Avison WR, 1996, CURR OPIN PSYCHIATR, V9, P149, DOI 10.1097/00001504-199603000-00012; BAUBY JD, 1997, DIVING BELL BUTTERFL; Bennett J, 2010, SOCIAL CARE NEURODIS, V1, P44; CARLTON TO, 1990, SOC SCI MED, V31, P5, DOI 10.1016/0277-9536(90)90003-B; Concannon N, 2010, 6 INT C SOC WORK HLT; Daisley A., 2009, HEAD INJURY; Department of Health & Social Services Inspectorate, 1996, HIDD DIS REP SSI TRA; DoH, 2005, NAT SERV FRAM LONG T; Forssmann-Falck R, 1989, Psychiatr Med, V7, P43; FORSSMANN-FALCK R, 1989, Health and Social Work, V14, P235; Gill-Thwaites G, 2010, BRAIN INJ SOC WORK G; Higham PE, 2001, BRIT J SOC WORK, V31, P197, DOI 10.1093/bjsw/31.2.197; HM Government, 2007, MENT HLTH 2007; Illich Ivan, 1977, DISABLING PROFESSION; Jones R, 2007, MENTAL HLTH ACT MANU; Kelly G., 2004, BRAIN IMPAIR, V5, DOI [10.1375/brim.5.1.42.35398, DOI 10.1375/brim.5.1.42.35398]; Kinsella G, 1989, Int Disabil Stud, V11, P9; Kolakowski-Hayner S, 2001, J HEAD TRAUMA REHAB, V16, P1; Langfield I, 2009, COMMISIONIN IN PRESS; Leslie S, 2008, GOOD PRACTICE SAFEGU; Lewis Jason, 2009, DAILY MAIL; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; Mantell A, 2008, SAFEGUARDING ADULTS; Mantell A, 2006, HUNTINGTONS DI UNPUB; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Mowlam A., 2007, UK STUDY ABUSE NEGLE; Murray C, 1996, GLOBAL BURDEN DIS IN; Naven L, 2008, GOOD PRACTICE SAFEGU; O'Keeffe M., 2007, UK STUDY ABUSE NEGLE; Price M, 2009, SOCIAL WORK SKILLS A; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; Rotondi AJ, 2005, J HEAD TRAUMA REHAB, V20, P173, DOI 10.1097/00001199-200503000-00005; Rowlands A., 2000, BRAIN IMPAIR, V1, P151, DOI [10.1375/brim.1.2.151, DOI 10.1375/BRIM.1.2.151]; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Simpson G, 2001, BRAIN IMPAIR, V2, P97, DOI DOI 10.1375/BRIM.2.2.97; Simpson G., 2002, AUST SOC WORK, V55, P24, DOI [10.1080/03124070208411669, DOI 10.1080/03124070208411669]; Simpson GK, 2009, FAMILY OUTCOME MEASU; TATE RL, 1989, ACTA NEUROL SCAND, V79, P97, DOI 10.1111/j.1600-0404.1989.tb03719.x; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; TEASDALE G, 1974, LANCET, V2, P81; Williams SJ, 2000, SOCIOL HEALTH ILL, V22, P40, DOI 10.1111/1467-9566.00191	44	6	6	0	0	EMERALD GROUP PUBLISHING LTD	BINGLEY	HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND	1466-8203	2042-8669		J ADULT PROT	J. Adult Prot.		2010	12	4					31	42		10.5042/jap.2010.0642			12	Social Work	Emerging Sources Citation Index (ESCI)	Social Work	V5I6H	WOS:000219641800004					2022-02-06	
J	Miller, JB; Fichtenberg, NL; Millis, SR				Miller, Justin B.; Fichtenberg, Norman L.; Millis, Scott R.			[image omitted] Diagnostic Efficiency of an Ability-Focused Battery	CLINICAL NEUROPSYCHOLOGIST			English	Article						Neuropsychology; Psychometrics; Ability focused; Flexible battery; Validation	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; NEUROPSYCHOLOGISTS; VALIDATION; SEVERITY	An ability-focused battery (AFB) is a selected group of well-validated neuropsychological measures that assess the conventional range of cognitive domains. This study examined the diagnostic efficiency of an AFB for use in clinical decision making with a mixed sample composed of individuals with neurological brain dysfunction and individuals referred for cognitive assessment without evidence of neurological disorders. Using logistic regression analyses and ROC curve analysis, a five-domain model composed of attention, processing speed, visual-spatial reasoning, language/verbal reasoning, and memory domain scores was fitted that had an AUC of.89 (95% CI =.84-.95). A more parsimonious two-domain model using processing speed and memory was also fitted that had an AUC of.90 (95% confidence interval =.84-.95). A model composed of a global ability score calculated from the mean of the individual domain scores was also fitted with an AUC of.88 (95% CI =.82-.94).	[Miller, Justin B.; Fichtenberg, Norman L.; Millis, Scott R.] Wayne State Univ, Detroit, MI 48202 USA		Miller, JB (corresponding author), Wayne State Univ, 5057 Woodward Ave,7th Floor, Detroit, MI 48202 USA.	Justin.b.miller@gmail.com		Miller, Justin B./0000-0002-4439-6604			Bauer RM, 2000, CLIN GUIDE NEUROPSYC, P419; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Hardin JW., 2007, GEN LINEAR MODELS EX; Heaton R. K., 2004, REVISED COMPREHENSIV; Hosmer D.W., 2000, APPL LOGISITIC REGRE; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P139, DOI 10.1076/1385-4046(200002)14:1;1-8;FT139; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P813, DOI 10.1080/13854040701625846; Meyers JE, 2004, ARCH CLIN NEUROPSYCH, V19, P637, DOI 10.1016/j.acn.2003.08.007; MILLER ME, 1991, STAT MED, V10, P1213, DOI 10.1002/sim.4780100805; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Russell EW, 2005, ARCH CLIN NEUROPSYCH, V20, P785, DOI 10.1016/j.acn.2005.05.001; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Steyerberg, 2019, CLIN PREDICTION MODE; Sweet JJ, 2006, CLIN NEUROPSYCHOL, V20, P325, DOI 10.1080/13854040600760488; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Volbrecht ME, 2000, ARCH CLIN NEUROPSYCH, V15, P251, DOI 10.1016/S0887-6177(99)00016-5	24	6	7	2	4	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2010	24	4					678	688	PII 919836293	10.1080/13854041003601493			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	597LR	WOS:000277759300173	20229434				2022-02-06	
J	Oluwole, KE; Faniran, EA				Oluwole, Komolafe Edward; Faniran, E. A.			TENSION PNEUMOCEPHALUS - A RARE BUT TREATABLE CAUSE OF RAPID NEUROLOGICAL DETERIORATION IN TRAUMATIC BRAIN INJURY. A CASE REPORT	AFRICAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article								Pneumocephalus is a frequent complication following head injury and craniotomies. It can become an acute neurosurgical emergency when associated with raised intracranial pressure and neurological deterioration. Early diagnosis and timely appropriate intervention will reduce morbidity and unnecessary mortality from a case as this.	[Oluwole, Komolafe Edward; Faniran, E. A.] Obafemi Awolowo Univ Teaching Hosp Complex, Dept Surg & Med, Ife, Osun State, Nigeria		Oluwole, KE (corresponding author), Obafemi Awolowo Univ Teaching Hosp Complex, Dept Surg & Med, Ife, Osun State, Nigeria.	eokomolafe@hotmail.com					Clark DW, 2010, OTOLARYNG HEAD NECK, V142, P820, DOI 10.1016/j.otohns.2009.12.041; Dandy WE, 1926, ARCH SURG-CHICAGO, V12, P949, DOI 10.1001/archsurg.1926.01130050003001; HOROWITZ M, 1964, J Laryngol Otol, V78, P128, DOI 10.1017/S0022215100061910; ISHIWATA Y, 1988, J NEUROSURG, V68, P58, DOI 10.3171/jns.1988.68.1.0058; Keskil S, 1998, NEUROSURG REV, V21, P10, DOI 10.1007/BF01111479; Lee CH, 2009, AM J EMERG MED, V27, p257e1; LEE SEUNG HWAN, 2009, J KOREAN NEUROSURG S, V45, P318; Mirza S, 2003, ORL J OTO-RHINO-LARY, V65, P215, DOI 10.1159/000073118; Nicholson B, 2010, PREHOSP EMERG CARE, V14, P499, DOI 10.3109/10903120903564522; Schirmer CM, 2010, NEUROCRIT CARE, V13, P152, DOI 10.1007/s12028-010-9363-0; STEUDEL WI, 1986, ACTA NEUROCHIR, V80, P93, DOI 10.1007/BF01812281; Zeba I, 2010, AVIAT SPACE ENVIR MD, V81, P511, DOI 10.3357/ASEM.2686.2010	12	6	7	0	0	PAN AMER ASSOC NEUROLOGICAL SCIENCES	BOULOGNE	CMCO COTE D OPALE, ROUTE DESVRES, ST MARTIN, BOULOGNE, 62280, FRANCE	1015-8618	1992-2647		AFR J NEUROL SCI	Afr. J. Neurol. Sci.		2010	29	2					88	91					4	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V5X3K	WOS:000420024300012					2022-02-06	
J	Ripley, DL; Politzer, T; Berryman, A; Rasavage, K; Weintraub, A				Ripley, David L.; Politzer, Tom; Berryman, Amy; Rasavage, Karen; Weintraub, Alan			The Vision Clinic: An interdisciplinary method for assessment and treatment of visual problems after Traumatic Brain Injury	NEUROREHABILITATION			English	Article							PAIN		[Ripley, David L.; Politzer, Tom; Berryman, Amy; Rasavage, Karen; Weintraub, Alan] Craig Hosp, Englewood, CO 80113 USA		Ripley, DL (corresponding author), Craig Hosp, 3425 S Clarkson St, Englewood, CO 80113 USA.	DRipley@CraigHospital.org		Ripley, David/0000-0002-5349-1830			Angst F, 2009, J REHABIL MED, V41, P569, DOI 10.2340/16501977-0381; Cima Rilana, 2009, BMC Health Serv Res, V9, P29, DOI 10.1186/1472-6963-9-29; Cohen A H, 1992, J Am Optom Assoc, V63, P530; Dewa CS, 2009, CAN J PSYCHIAT, V54, P428; Flavell HA, 1996, MED J AUSTRALIA, V165, P253, DOI 10.5694/j.1326-5377.1996.tb124958.x; GIANUTSOS R, 1988, ARCH PHYS MED REHAB, V69, P573; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kitahara M, 2006, CLIN J PAIN, V22, P647, DOI 10.1097/01.ajp.0000210909.49923.df; MCDOWELL BJ, 1992, J AM GERIATR SOC, V40, P370, DOI 10.1111/j.1532-5415.1992.tb02137.x; McGonnell M, 2009, J CAN ACAD CHILD ADO, V18, P283; Poitras S, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-54; RAMMAGE LA, 1983, J OTOLARYNGOL, V12, P315; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; Sonino N, 2009, PSYCHOTHER PSYCHOSOM, V78, P346, DOI 10.1159/000235738; Stelmack J A, 1987, J Am Optom Assoc, V58, P382; THURMAN D, 2001, HEAD TRAUMA BASIC PR; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tierney D W, 1988, J Am Optom Assoc, V59, P614; Walker P H, 1994, Nurs Adm Q, V19, P1; Williams BC, 2005, GERONTOL GERIATR EDU, V26, P29, DOI 10.1300/J021v26n03_03; Williams Brent C, 2002, Acad Med, V77, P935, DOI 10.1097/00001888-200209000-00040; ZELINSKY D, 2007, PHYS MED REH CLIN N, V18, pR6; Zelinsky Deborah, 2007, Phys Med Rehabil Clin N Am, V18, P87, DOI 10.1016/j.pmr.2006.11.005	23	6	6	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2010	27	3					231	235		10.3233/NRE-2010-0602			5	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	684FM	WOS:000284535800005	21098991				2022-02-06	
J	Simmons, CD; Griswold, LA				Simmons, C. Douglas; Griswold, Lou Ann			Using the Evaluation of Social Interaction in a community-based program for persons with traumatic brain injury	SCANDINAVIAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Assessment and intervention planning; OTIPM; outcomes; social interaction	PARTICIPATION	The purpose of this study was to examine the utility of the Evaluation of Social Interaction (ESI) in a community-based program for persons with traumatic brain injury (TBI), as well as its effectiveness in measuring occupational therapy intervention. Ten people who experienced a TBI and were participating in a community-based program were a convenience sample for this study. The Occupational Therapy Intervention Process Model (OTIPM) provided the theoretical framework. The ESI provided a pre-test performance measure and also served as a guide for an eight-week occupational therapy intervention program, and as a post-test to measure intervention effectiveness. This study showed that the ESI was effective in guiding therapist intervention related to social skill performance of participants during their participation in a community-based program. As a group, the difference between pre and post ESI logit measures was also significant (t=4.977, p=0.001). The study provides initial considerations for the utility of the ESI to guide intervention related to social skill performance during daily occupations. It further documents the effectiveness of the ESI in measuring occupational therapy intervention, based on OTIPM, and supports occupational therapy services provided in a community-based program context for those living with TBI.	[Simmons, C. Douglas; Griswold, Lou Ann] Univ New Hampshire, Coll Hlth & Human Serv, Dept Occupat Therapy, Durham, NH 03824 USA		Simmons, CD (corresponding author), Univ New Hampshire, Coll Hlth & Human Serv, Dept Occupat Therapy, 119 Hewitt Hall,4 Lib Way, Durham, NH 03824 USA.	dsimmons@cisunix.unh.edu					Bond T. G., 2007, APPL RASCH MODEL FUN, V2; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; CASESMITH J, 2005, EVALUATION OBTAINING, P101; CLARK F, 1993, AM J OCCUP THER, V47, P1067, DOI 10.5014/ajot.47.12.1067; Coster WJ, 2008, AM J OCCUP THER, V62, P743, DOI 10.5014/ajot.62.6.743; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DOBLE SE, 1991, CAN J OCCUP THER, V5, P241; DOBLE SE, 1992, CAN J OCCUP THER, V3, P141; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Englund B, 1995, SCAND J OCCUP THER, V2, P17, DOI DOI 10.3109/11038129509106794; Fisher A. G., 1995, MODEL HUMAN OCCUPATI, P113; Fisher A. G, 2006, ASSESSMENT MOTOR PRO, V6th; Fisher AG, 2009, EVALUATION SOCIAL IN; Fisher AG, 2009, OCCUPATIONAL THERAPY; FISHER AG, 1994, INT J EDUC RES, V21, P579; Law M, 2002, AM J OCCUP THER, V56, P640, DOI 10.5014/ajot.56.6.640; Linacre, 1989, MANY FACETED RASCH M; Linacre J., 1987, FACETS WINDOWS 3 63; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; SIMMONS CD, AM J OCCUP IN PRESS	20	6	6	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1103-8128	1651-2014		SCAND J OCCUP THER	Scand. J. Occup. Ther.		2010	17	1					49	56		10.3109/11038120903350303			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	600XO	WOS:000278022400007	20170411				2022-02-06	
J	Tung, JN; Tsao, TY; Chen, SL; Tai, CJ; Shen, SC; Cheng, YW; Jiang, MC				Tung, Jai-Nien; Tsao, Tang-Yi; Chen, Shun-Liang; Tai, Cheng-Jeng; Shen, Shing-Chuan; Cheng, Ya-Wen; Jiang, Ming-Chung			Presence of secretory cellular apoptosis susceptibility protein in cerebrospinal fluids of patients with intracerebral hemorrhage caused by stroke and neurotrauma	NEUROENDOCRINOLOGY LETTERS			English	Article						blood-brain barrier; cerebrospinal fluids; interferon-gamma;; microglia; matrix metalloproteinase-2	INTERFERON-GAMMA; MATRIX-METALLOPROTEINASE; NERVOUS-SYSTEM; TAU-PROTEIN; CELLS; MICROGLIA; BRAIN; EXPRESSION; CSE1L/CAS; CANCER	OBJECTIVE: The blood-brain barrier (BBB) is a specialized structure that separates blood vessels from the central nervous system (CNS) and restricts the entry of biomolecules and cells into the brain. Matrix metalloproteinase-2 (MMP-2) produced by interferon-gamma-activated microglia (brain macrophages) is essential for disrupting the glia limitans of BBB, which is critical for lymphocytes penetration into brain capillaries in various CNS disorders. The cellular apoptosis susceptibility (CSE1L/CAS) protein has been shown to regulate MMP-2 secretion. METHODS: We examined if CSE1L played a role in regulating the progression of intracerebral brain hemorrhage disorders. RESULTS: CSE1L was detected by immunoblotting in cerebrospinal fluids (CSFs) of patients with intracerebral hemorrhage brain disorders, including stroke and neurotrauma. Interferon-gamma treatment induced CSE1L expression and increased the secretions of CSE1L and MMP-2 by U937 macrophages. Moreover, tranfection of U937 macrophages with siRNA that targeted CSE1L inhibited interferon-gamma-induced CSE1L and MMP-2 secretion by U937 macrophages. The numbers of lymphocytes in CSF were correlated with the levels of CSE1L and MMP-2 in patients' CSF. CONCLUSIONS: Our results suggest that CSE1L plays a role in regulating MMP-2-mediated BBB breakdown and it may be a target for control of BBB permeability in intracerebral brain hemorrhage disorders.	[Tai, Cheng-Jeng; Jiang, Ming-Chung] Taipei Med Univ & Hosp, Hematol Oncol Sect, Dept Med, Taipei 110, Taiwan; [Shen, Shing-Chuan] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Tung, Jai-Nien; Cheng, Ya-Wen] Chung Shan Med Univ, Inst Med, Taichung 40203, Taiwan; [Tung, Jai-Nien] Tungs Taichung MetroHarbor Hosp, Dept Surg, Taichung, Taiwan; [Tsao, Tang-Yi] Tungs Taichung MetroHarbor Hosp, Dept Pathol, Taichung, Taiwan; [Chen, Shun-Liang] Tungs Taichung MetroHarbor Hosp, Div Clin Pathol, Taichung, Taiwan		Jiang, MC (corresponding author), Taipei Med Univ & Hosp, Hematol Oncol Sect, Dept Med, 252 Wu Hsing St, Taipei 110, Taiwan.	yawen@csmu.edu.tw; jiangmwd@gmail.com			Tungs' Taichung Metro Harbor Hospital, Taichung, Taiwan [TTMHH-R980623]	We thank Sin-Lin Sin for assistance with immunohistochemistry. This work was supported by a grant (TTMHH-R980623) from Tungs' Taichung Metro Harbor Hospital, Taichung, Taiwan.	Aschner M, 1998, TOXICOL LETT, V103, P283, DOI 10.1016/S0378-4274(98)00324-5; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bik W, 2008, NEUROENDOCRINOL LETT, V29, P359; Bougoin S, 2008, NEUROENDOCRINOL LETT, V29, P438; BRINKMANN U, 1995, P NATL ACAD SCI USA, V92, P10427, DOI 10.1073/pnas.92.22.10427; BURNHAM DB, 1982, CELL TISSUE RES, V222, P201; Chabot S, 2001, J NEUROSCI METH, V105, P111, DOI 10.1016/S0165-0270(00)00346-0; Chew LJ, 2006, MENT RETARD DEV D R, V12, P105, DOI 10.1002/mrdd.20102; del Zoppo GJ, 2007, STROKE, V38, P646, DOI 10.1161/01.STR.0000254477.34231.cb; Folkerth RD, 2004, BRAIN PATHOL, V14, P265; Gottschall PE, 1996, NEUROIMMUNOMODULAT, V3, P69, DOI 10.1159/000097229; Grau V, 1997, GLIA, V19, P181, DOI 10.1002/(SICI)1098-1136(199703)19:3<181::AID-GLIA1>3.0.CO;2-2; Hartung HP, 2000, J NEUROIMMUNOL, V107, P140, DOI 10.1016/S0165-5728(00)00225-3; Jiang MC, 2007, J EXP CLIN CANC RES, V26, P91; Jiang Ming-Chung, 2001, Molecular Cell Biology Research Communications, V4, P353, DOI 10.1006/mcbr.2001.0303; Jiang Yi-feng, 2009, Huanjing Kexue, V30, P85; Kawanokuchi J, 2006, MULT SCLER J, V12, P558, DOI 10.1177/1352458506070763; Lee SR, 2007, NEUROSCI LETT, V417, P1, DOI 10.1016/j.neulet.2007.01.017; Liao CF, 2008, BMB REP, V41, P210, DOI 10.5483/BMBRep.2008.41.3.210; Liao CF, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-15; Liao CF, 2008, TOXICOL MECH METHOD, V18, P771, DOI 10.1080/15376510802428609; Millward JM, 2007, J IMMUNOL, V178, P8175, DOI 10.4049/jimmunol.178.12.8175; Moran LB, 2007, J NEUROIMMUNOL, V183, P1, DOI 10.1016/j.jneuroim.2006.10.023; Qureshi GA, 2000, NEUROENDOCRINOL LETT, V21, P409; Raedler TJ, 2006, NEUROENDOCRINOL LETT, V27, P297; Rock RB, 2005, GENES IMMUN, V6, P712, DOI 10.1038/sj.gene.6364246; Starka L, 2009, NEUROENDOCRINOL LETT, V30, P368; Streit WJ, 2005, NEUROL RES, V27, P685, DOI 10.1179/016164105X49463; Stuerenburg HJ, 2005, NEUROENDOCRINOL LETT, V26, P696; Talab R, 2009, NEUROENDOCRINOL LETT, V30, P647; Tsai CSS, 2010, AM J PATHOL, V176, P1619, DOI 10.2353/ajpath.2010.090467; Tsai CSS, 2009, BIOMED PHARMACOTHER, V63, P522, DOI 10.1016/j.biopha.2008.07.094; Tsao TY, 2009, MOL CELL BIOCHEM, V327, P163, DOI 10.1007/s11010-009-0054-0; Tung MC, 2009, CANCER EPIDEM BIOMAR, V18, P1570, DOI 10.1158/1055-9965.EPI-08-0948; Valis M, 2008, NEUROENDOCRINOL LETT, V29, P971; Walski M, 2001, NEUROENDOCRINOL LETT, V22, P19; Xue Ai-min, 2007, Chinese Journal of Pathology, V36, P405	37	6	8	0	1	MAGHIRA & MAAS PUBLICATIONS	MUNSBACH	MAGHIRA & MAAS S A R L, 6C, RUE GABRIEL LIPPMANN, L-5365 MUNSBACH, LUXEMBOURG	0172-780X			NEUROENDOCRINOL LETT	Neuroendocrinol. Lett.		2010	31	3					390	398					9	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	632XG	WOS:000280462300021	20588233				2022-02-06	
J	Writer, BW; Schillerstrom, JE; Regwan, HK; Harlan, BS				Writer, Brian W.; Schillerstrom, Jason E.; Regwan, Heather K.; Harlan, Brent S.			Executive clock drawing correlates with performance-based functional status in people with combat-related mild traumatic brain injury and comorbid posttraumatic stress disorder	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						activities of daily living; cognitive disorder; concussion; executive functioning; functional status; head injury; mild traumatic brain injury; military combat injury; neuropsychological impairment; traumatic brain injury	PROCESSING SPEED; VETERANS; TBI; SEQUELAE; MEMORY; IMPAIRMENT; PTSD; CARE	Executive Clock Drawing Tasks (CLOX parts 1 and 2) can predict functional impairment. This study determined the correlation between CLOX and other psychometric screening instruments with the Structured Assessment of Independent Living Skills (SAILS)-defined performance-based functional status in people with combat-related mild traumatic brain injury (TBI) and comorbid posttraumatic stress disorder (PTSD). We hypothesized that CLOX would correlate significantly with functional performance. This prospective, cross-sectional study design determined the correlation between a structured neuropsychological battery and functional status assessment. We calculated Pearson correlation coefficients between neuropsychological instruments and functional status scores. We entered neuropsychological measures correlating p < 0.1 with functional status into a linear regression model to determine independent contributions. Fifteen Operation Iraqi Freedom veterans participated. Only CLOX I correlated significantly with functional competency and efficiency. Only mean CLOX I scores were significantly lower in those scoring below the median for SAILS competency and in those scoring above the median for SAILS efficiency. CLOX I contributed significant variance to functional status independent of mood or anxiety symptoms and was not affected by age or time since injury. Executive dysfunction per the brief, easily administered CLOXI is sensitive to functional status following combatrelated mild TBI, independent of PTSD anxiety with or without depression.	[Writer, Brian W.] San Antonio Mil Med Ctr, Dept Psychiat, Lackland AFB, TX 78236 USA; [Schillerstrom, Jason E.; Regwan, Heather K.] Univ Texas Hlth Sci Ctr San Antonio, Sch Med, Dept Psychiat, San Antonio, TX 78229 USA; [Harlan, Brent S.] 1st Special Operat Med Grp, Dept Psychiat, Hurlburt Field AFB, FL USA		Writer, BW (corresponding author), San Antonio Mil Med Ctr, Dept Psychiat, 59 MHS SGOWV1,2200 Bergquist Dr,Suite 1, Lackland AFB, TX 78236 USA.	brian.writer@us.af.mil					Buschke H, 1999, NEUROLOGY, V52, P231, DOI 10.1212/WNL.52.2.231; Campbell TA, 2009, PSYCHIAT ANN, V39, P796, DOI 10.3928/00485713-20090728-01; Erez ABH, 2009, AM J OCCUP THER, V63, P634; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Jefferson AL, 2006, ARCH CLIN NEUROPSYCH, V21, P311, DOI 10.1016/j.acn.2006.03.007; KAUFMAN DM, 2007, CLIN NEUROLOGY PSYCH, P537; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Lavery LL, 2005, J GERONTOL A-BIOL, V60, P928, DOI 10.1093/gerona/60.7.928; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; *NAT I NEUR DIS, 2002, TRAUM BRAIN INJ HOP; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Royall DR, 2007, J NEUROPSYCH CLIN N, V19, P249, DOI 10.1176/appi.neuropsych.19.3.249; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221, DOI 10.1111/j.1532-5415.1992.tb03646.x; Royall DR, 1999, J GERONTOL B-PSYCHOL, V54, pP328, DOI 10.1093/geronb/54B.5.P328; SADOCK BJ, 2007, KAPLAN SADOCKS SYNOP, P363; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; STERN TA, 2008, MASSACHUSETTS GEN HO, P1107; *U TX HLTH SCI CTR, 1999, SAN ANT LONG STUD AG; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Weathers F.W., 1993, ANN CONV INT SOC TRA	38	6	6	1	1	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2010	47	9					841	849		10.1682/JRRD.2009.10.0162			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	707PX	WOS:000286299600005	21174249	Bronze			2022-02-06	
J	Sahin, A; Dane, S; Seven, B; Akar, S; Yildirim, S				Sahin, Ali; Dane, Senol; Seven, Bedri; Akar, Sedat; Yildirim, Serap			DIFFERENCES BY SEX AND HANDEDNESS IN RIGHT AND LEFT FEMUR BONE MINERAL DENSITIES	PERCEPTUAL AND MOTOR SKILLS			English	Article							HAND PREFERENCE; INJURY RISK; WOMEN; MEN; AGE; EYE; ADOLESCENTS; PREVALENCE; CRICKETERS; LONGEVITY	Left-handedness was reported to be a risk factor for accident-related injuries, head injuries, traumatic brain injuries, sport-related injuries, and bone breaks and fractures. As decreased bone mineral density is a good marker of bone fractures, the femoral bone mineral densities of normal left-handed university students were compared with those of right-handed students. Hand preference of 66 men and 47 women was assessed using the Edinburgh Handedness Inventory. Measures of bone mineral density with a Hologic QDR-4500W (S/N 48403) densitometer showed bone mineral densities of both right and left proximal femur regions were higher in right-handed than in left-handed students. These results are consistent with the claim that left-handed participants had higher trauma and injury risk. Also, these results may explain the sex-related differences by handedness for susceptibility in accident-related injuries such as bone fractures.	[Dane, Senol] Fatih Univ, Dept Physiol, Sch Med, TR-06510 Ankara, Turkey; Ataturk Univ, Erzurum, Turkey		Dane, S (corresponding author), Fatih Univ, Dept Physiol, Sch Med, TR-06510 Ankara, Turkey.	senoldane@fatih.edu.tr	Dane, Senol/Q-7745-2019; DANE, SENOL/N-2743-2019; seven, bedri/K-1029-2015; DANE, SENOL/R-1005-2018	DANE, SENOL/0000-0001-5572-9454; DANE, SENOL/0000-0001-5572-9454; Seven, Bedri/0000-0002-2645-7661			AGGLETON JP, 1994, BRIT MED J, V309, P1681, DOI 10.1136/bmj.309.6970.1681; AGGLETON JP, 1993, J EPIDEMIOL COMMUN H, V47, P206, DOI 10.1136/jech.47.3.206; Akar S, 2002, INT J NEUROSCI, V112, P301, DOI 10.1080/00207450212034; Aydin N, 2001, PERCEPT MOTOR SKILL, V93, P230, DOI 10.2466/pms.2001.93.1.230; Bhushan B, 2006, LATERALITY, V11, P395, DOI 10.1080/13576500500457458; Boote C, 2006, INVEST OPHTH VIS SCI, V47, P901, DOI 10.1167/iovs.05-0893; Canakci V, 2003, DENT TRAUMATOL, V19, P248, DOI 10.1034/j.1600-9657.2003.00199.x; COREN S, 1989, AM J PUBLIC HEALTH, V79, P1040, DOI 10.2105/AJPH.79.8.1040; Coren S, 1996, Laterality, V1, P139, DOI 10.1080/713754232; Dagistan S, 2009, TURK J MED SCI, V39, P803, DOI 10.3906/sag-0809-37; Dane S, 2004, INT J NEUROSCI, V114, P651, DOI 10.1080/00207450490430516; Dane S, 2003, INT J NEUROSCI, V113, P923, DOI 10.1080/00207450390220367; Dane S, 2003, VISION RES, V43, P405, DOI 10.1016/S0042-6989(02)00568-0; Dane S, 1998, PERCEPT MOTOR SKILL, V86, P667, DOI 10.2466/pms.1998.86.2.667; Dane S, 1999, PERCEPT MOTOR SKILL, V89, P846, DOI 10.2466/PMS.89.7.846-848; Dane S, 2002, INT J NEUROSCI, V112, P1141, DOI 10.1080/00207450290026111; Dane S, 2001, INT J NEUROSCI, V111, P187, DOI 10.3109/00207450108994230; Dane S, 2007, INT J DEV NEUROSCI, V25, P223, DOI 10.1016/j.ijdevneu.2007.03.005; Dane S, 2007, LATERALITY, V12, P167, DOI 10.1080/13576500600939082; Dane S, 2006, PERCEPT MOTOR SKILL, V103, P89, DOI 10.2466/PMS.103.5.89-90; Dane Senol, 1999, Journal of Basic and Clinical Physiology and Pharmacology, V10, P147; GRAHAM CJ, 1995, J ADOLESCENT HEALTH, V16, P50, DOI 10.1016/1054-139X(94)00061-I; GRAHAM CJ, 1993, PEDIATRICS, V92, P823; Gumustekin K, 2004, INT J NEUROSCI, V114, P1533, DOI 10.1080/00207450490509186; HALPERN DF, 1991, NEW ENGL J MED, V324, P998; HICKS RA, 1993, PERCEPT MOTOR SKILL, V77, P1119, DOI 10.2466/pms.1993.77.3f.1119; LEIDY LE, 1990, OBSTET GYNECOL, V76, P1111; MACNIVEN E, 1994, BRAIN INJURY, V8, P457, DOI 10.3109/02699059409150997; Nikolova P, 1996, INT J NEUROSCI, V86, P143, DOI 10.3109/00207459608986705; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pekkarinen A, 2003, LATERALITY, V8, P339, DOI 10.1080/13576500244000283; PETERS M, 1991, NEUROPSYCHOLOGIA, V29, P1257, DOI 10.1016/0028-3932(91)90039-B; PORAC C, 1993, NEUROPSYCHOLOGIA, V31, P355, DOI 10.1016/0028-3932(93)90159-W; Searleman A, 2005, LATERALITY, V10, P111, DOI 10.1080/13576500342000329; Stellman SD, 1997, ANN EPIDEMIOL, V7, P167, DOI 10.1016/S1047-2797(96)00158-5; TAN U, 1988, INT J NEUROSCI, V41, P35, DOI 10.3109/00207458808985740; Wright P, 1996, PERCEPT MOTOR SKILL, V82, P855, DOI 10.2466/pms.1996.82.3.855	38	6	6	0	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0031-5125	1558-688X		PERCEPT MOTOR SKILL	Percept. Mot. Skills	DEC	2009	109	3					824	830		10.2466/PMS.109.3.824-830			7	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	544HV	WOS:000273646200022	20178282				2022-02-06	
J	Stevenson, CB; Leach, JL; Gupta, A; Crone, KR				Stevenson, Charles B.; Leach, James L.; Gupta, Anita; Crone, Kerry R.			Cystic degeneration of the cerebellar tonsils in pediatric patients with Chiari Type I malformation Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						Chiari I malformation; cerebellar tonsils; cyst; ischemia	TRAUMATIC BRAIN-INJURY; FOSSA; DECOMPRESSION; ISCHEMIA	Object. The operative indications and treatment algorithms for pediatric patients with Chiari Type I malformation (CM-I) vary widely. When an intradural approach and duraplasty are thought necessary at the time of surgery. neurosurgeons may elect to fulgurate or resect a portion of the cerebellar tonsils. Histological analyses of cerebellar tonsils resected during decompression in pediatric patients with CM-I have revealed multiple abnormal findings including extensive ischemic and degenerative changes. The authors describe an interesting phenomenon of cystic degeneration in the distal ends of the cerebellar tonsils in children undergoing operative treatment of CM-I. Methods. The authors reviewed the clinical database of 440 pediatric patients who underwent surgical decompression for CM-I performed by a single surgeon. The clinical course, preoperative MR imaging and intraoperative ultrasound characteristics, and histological findings in 3 children found to have tonsillar cystic degeneration were analyzed and detailed. Results. Cystic changes were subtle but uniformly evident on preoperative MR imaging and were more readily apparent on intraoperative ultrasonography. In each patient, the tonsillar cyst was resected. Histological examination revealed areas of cystic degenerative change characterized by distortion of the normal cerebellar architecture with absent Purkinje and internal granular cell layers. All children experienced improvement in their symptoms, without complication, postoperatively. Conclusions. Cystic degeneration of the tonsils in pediatric patients with CM-I is an uncommon pathological process most likely resulting from long-standing and excessive compression. Based on their experience, the authors advocate expeditious surgical treatment, including intradural exploration and capacious duraplasty, for patients in whom there is evidence of this phenomenon on preoperative imaging. (DOI: 10.3171/2009.7.PEDS09174)	[Stevenson, Charles B.; Crone, Kerry R.] Cincinnati Childrens Hosp, Med Ctr, Div Pediat Neurosurg, Cincinnati, OH 45229 USA; [Leach, James L.] Cincinnati Childrens Hosp, Med Ctr, Dept Radiol, Cincinnati, OH 45229 USA; [Gupta, Anita] Cincinnati Childrens Hosp, Med Ctr, Dept Pathol, Cincinnati, OH 45229 USA; [Leach, James L.] Inst Neurosci, Cincinnati, OH USA		Crone, KR (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Pediat Neurosurg, 3333 Burnet Ave,ML 2016, Cincinnati, OH 45229 USA.	kerry.crone@cchmc.org					Allen GV, 2001, NEUROSCIENCE, V102, P603, DOI 10.1016/S0306-4522(00)00519-4; BADIE B, 1995, NEUROSURGERY, V37, P214, DOI 10.1227/00006123-199508000-00004; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Koga H, 1995, No To Shinkei, V47, P1075; MARINPADILLA M, 1981, J NEUROL SCI, V50, P29, DOI 10.1016/0022-510X(81)90040-X; Martin LJ, 2000, J CEREBR BLOOD F MET, V20, P153, DOI 10.1097/00004647-200001000-00020; Mautes AEM, 1996, NEUROSCI LETT, V214, P95, DOI 10.1016/0304-3940(96)12916-5; Milhorat TH, 1999, NEUROSURGERY, V44, P1005, DOI 10.1097/00006123-199905000-00042; Nishikawa M, 1997, J NEUROSURG, V86, P40, DOI 10.3171/jns.1997.86.1.0040; Pueyrredon F, 2007, CHILD NERV SYST, V23, P427, DOI 10.1007/s00381-006-0252-y; Welsh JP, 2002, ADV NEUROL, V89, P331; Yeh DD, 2006, J NEUROSURG, V105, P26, DOI 10.3171/ped.2006.105.1.26	12	6	6	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2009	4	6					557	563		10.3171/2009.7.PEDS09174			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	528WN	WOS:000272477800011	19951044				2022-02-06	
J	Stutts, LA; McCulloch, RC; Chung, K; Robinson, ME				Stutts, Lauren A.; McCulloch, Robert C.; Chung, Karen; Robinson, Michael E.			Sex Differences in Prior Pain Experience	JOURNAL OF PAIN			English	Article						Pain experience; sex differences; pain ratings; questionnaire; common pain events	GENDER-ROLE EXPECTATIONS; POPULATION; ANCHORS; FIBROMYALGIA; PERCEPTION; TOLERANCE; EVENTS	Sex differences in clinical and experimental pain experiences are well documented. However, there has been little work investigating men's and women's experiences with common painful events. This study examined sex differences in the nature and intensity of common pain experiences. Participants (102 women and 85 men) completed the Prior Pain Experience Questionnaire, which is a 79-item assessment of an individual's pain experience, recalled pain ratings, and imagined pain ratings. Analyses of variance were conducted to assess for sex differences in overall pain experience and pain ratings. Men and women did not have significant differences in the overall number of reported pain experiences or in the overall mean pain rating of those experiences. However, they differed in specific pain events experienced (eg, men experienced concussions more than women) and pain ratings (eg, women rated minor surgery as significantly more painful than men). Individuals who imagined pain events tended to rate them as equally or more painful than individuals who experienced those pain events. Perspective: Results of this study demonstrate that men and women have varying types of pain experiences without evidence that the overall pain experience differs between sexes. It was also found that imagined pain ratings are often worse than experienced pain ratings, lending support for the tendency of individuals to catastrophize. (C) 2009 by the American Pain Society	[Stutts, Lauren A.; McCulloch, Robert C.; Chung, Karen; Robinson, Michael E.] Univ Florida, Ctr Pain Res & Behav Hlth, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA		Stutts, LA (corresponding author), Univ Florida, Ctr Pain Res & Behav Hlth, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA.	lstutts@phhp.ufl.edu	Robinson, Michael E/B-9765-2014				Dannecker EA, 2007, J PAIN, V8, P476, DOI 10.1016/j.jpain.2007.01.003; Dionne RA, 2005, TRENDS PHARMACOL SCI, V26, P125, DOI 10.1016/j.tips.2005.01.009; Edwards RR, 2004, PAIN, V111, P335, DOI 10.1016/j.pain.2004.07.012; Fillingim RB, 1999, PAIN, V83, P419, DOI 10.1016/S0304-3959(99)00128-1; Forseth KO, 1999, CLIN RHEUMATOL, V18, P114, DOI 10.1007/s100670050067; Hirsh AT, 2008, J PAIN, V9, P806, DOI 10.1016/j.jpain.2008.03.012; Myers CD, 2003, CLIN J PAIN, V19, P225, DOI 10.1097/00002508-200307000-00005; National Centers for Health Statistics US, 2006, 2006 CHARTB TRENDS H; Papageorgiou AC, 2002, ANN RHEUM DIS, V61, P1071, DOI 10.1136/ard.61.12.1071; Robinson ME, 2001, J PAIN, V2, P251, DOI 10.1054/jpai.2001.24551; Robinson ME, 2004, J PAIN, V5, P264, DOI 10.1016/j.jpain.2004.04.003; Robinson ME, 2004, EUR J PAIN, V8, P299, DOI 10.1016/j.ejpain.2003.10.003; Robinson ME, 2004, J PAIN, V5, P77, DOI 10.1016/j.jpain.2003.11.004; Robinson ME, 2003, J PAIN, V4, P284, DOI 10.1016/S1526-5900(03)00559-5; Robinson ME, 2003, J PAIN, V4, P40, DOI 10.1054/jpai.2003.4; SKOOTSKY SA, 1989, WESTERN J MED, V151, P157; Vallerand A H, 2000, Pain Manag Nurs, V1, P8; Weir PT, 2006, JCR-J CLIN RHEUMATOL, V12, P124, DOI 10.1097/01.rhu.0000221817.46231.18; Wise EA, 2002, PAIN, V96, P335, DOI 10.1016/S0304-3959(01)00473-0	19	6	6	1	7	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1526-5900			J PAIN	J. Pain	DEC	2009	10	12					1226	1230		10.1016/j.jpain.2009.04.016			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588RP	WOS:000277091600004	19560976				2022-02-06	
J	Viswanathan, V; Eugster, EA				Viswanathan, Vidhya; Eugster, Erica A.			Etiology and Treatment of Hypogonadism in Adolescents	ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA			English	Article						Hypergonadotropic hypogonadism; Hypogonadotropic hypogonadism; Adolescents; Delayed puberty; Treatment	ADRENAL HYPOPLASIA CONGENITA; TRAUMATIC BRAIN-INJURY; GENOTYPE-PHENOTYPE CORRELATIONS; COMPLETE ANDROGEN INSENSITIVITY; TESTICULAR REGRESSION SYNDROME; PREMATURE OVARIAN FAILURE; ACUTE-REGULATORY-PROTEIN; PRADER-WILLI-SYNDROME; LONG-TERM SURVIVORS; DISEASE TYPE-I	Adequate functioning at all levels of the hypothalamic-pituitary-gonadal axis is necessary for normal gonadal development and subsequent sex steroid production. Deficiencies at any level of the axis can lead to a hypogonadal state. The causes of hypogonadism are heterogeneous and may involve any level of the reproductive system. This review discusses various causes of hypogonadism, describes the evaluation of hypogonadal states, and outlines treatment options for the induction of puberty in affected adolescents. Whereas some conditions are clearly delineated, the exact etiology and underlying pathogenesis of many disorders is unknown.	[Viswanathan, Vidhya; Eugster, Erica A.] Indiana Univ, Sch Med, Dept Pediat, Sect Pediat Endocrinol,Riley Hosp Children, Indianapolis, IN 46202 USA		Viswanathan, V (corresponding author), Indiana Univ, Sch Med, Dept Pediat, Sect Pediat Endocrinol,Riley Hosp Children, Room 5960,702 Barnhill Dr, Indianapolis, IN 46202 USA.	vviswana@iupui.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T32DK065549] Funding Source: NIH RePORTER; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T32 DK065549] Funding Source: Medline		Abulhasan SJ, 1999, ANN HUM GENET, V63, P199, DOI 10.1046/j.1469-1809.1999.6330199.x; Achermann JC, 2001, MOL CELL ENDOCRINOL, V179, P89, DOI 10.1016/S0303-7207(01)00474-9; AHONEN P, 1987, J CLIN ENDOCR METAB, V64, P494, DOI 10.1210/jcem-64-3-494; AITTOMAKI K, 1994, AM J HUM GENET, V54, P844; Akefeldt A, 1999, DEV MED CHILD NEUROL, V41, P789, DOI 10.1017/S0012162299221573; al Kandari Hessa, 2006, J Clin Endocrinol Metab, V91, P2821, DOI 10.1210/jc.2005-2230; Andreu JAL, 2000, PEDIATR HEMAT ONCOL, V17, P21, DOI 10.1080/088800100276631; Ankarberg-Lindgren C, 2001, J CLIN ENDOCR METAB, V86, P3039, DOI 10.1210/jc.86.7.3039; APTER D, 1993, J CLIN ENDOCR METAB, V76, P940, DOI 10.1210/jc.76.4.940; Arnhold IJP, 1999, CLIN ENDOCRINOL, V51, P701, DOI 10.1046/j.1365-2265.1999.00863.x; Arslanian S, 1997, J CLIN ENDOCR METAB, V82, P3213, DOI 10.1210/jc.82.10.3213; Baker BY, 2006, J CLIN ENDOCR METAB, V91, P4781, DOI 10.1210/jc.2006-1565; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BERGADA I, 1995, J PEDIATR ENDOCR MET, V8, P117; Biason-Lauber A, 2000, AM J HUM GENET, V67, P1563, DOI 10.1086/316893; Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491; Bondy CA, 2007, J CLIN ENDOCR METAB, V92, P10, DOI 10.1210/jc.2006-1374; BOYAR R, 1972, NEW ENGL J MED, V287, P582, DOI 10.1056/NEJM197209212871203; Buzi F, 2003, J CLIN ENDOCR METAB, V88, P3146, DOI 10.1210/jc.2002-021495; Chan JL, 2005, LANCET, V366, P74, DOI 10.1016/S0140-6736(05)66830-4; CHETKOWSKI RJ, 1986, NEW ENGL J MED, V314, P1615, DOI 10.1056/NEJM198606193142505; CONSTINE LS, 1993, NEW ENGL J MED, V328, P87, DOI 10.1056/NEJM199301143280203; Costa-Santos M, 2004, J CLIN ENDOCR METAB, V89, P49, DOI 10.1210/jc.2003-031021; Crino A, 2003, EUR J PEDIATR, V162, P327, DOI 10.1007/s00431-002-1132-4; Dasen JS, 2001, GENE DEV, V15, P3193, DOI 10.1101/gad.932601; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; de Roux N, 2001, MOL CELL ENDOCRINOL, V179, P83, DOI 10.1016/S0303-7207(01)00471-3; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; DEZEGHER F, 1995, PEDIATR RES, V37, P395; Donaldson MDC, 2006, ARCH DIS CHILD, V91, P513, DOI 10.1136/adc.2003.035907; Eiholzer U, 2007, HORM RES, V68, P178, DOI 10.1159/000100925; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fechner PY, 2006, J CLIN ENDOCR METAB, V91, P4896, DOI 10.1210/jc.2006-1157; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; Fujieda K, 1997, J CLIN INVEST, V99, P1265, DOI 10.1172/JCI119284; FURUI K, 1994, J CLIN ENDOCR METAB, V78, P107, DOI 10.1210/jc.78.1.107; Gelfand IM, 2006, J PEDIATR-US, V149, P877, DOI 10.1016/j.jpeds.2006.08.050; Gonc EN, 2004, PEDIATR NEUROSURG, V40, P112, DOI 10.1159/000079852; GOODPASTURE JC, 1993, CLIN OBSTET GYNECOL, V36, P773, DOI 10.1097/00003081-199309000-00034; Habiby RL, 1996, J CLIN INVEST, V98, P1055, DOI 10.1172/JCI118866; Haddad NG, 2005, J PEDIATR ENDOCR MET, V18, P853; Hoek A, 1997, ENDOCR REV, V18, P107, DOI 10.1210/er.18.1.107; Holland C M, 2001, J Pediatr Adolesc Gynecol, V14, P77, DOI 10.1016/S1083-3188(01)00075-4; Hovatta O, 1999, ANN MED, V31, P106, DOI 10.3109/07853899708998785; IMBEAUD S, 1995, EUR J PEDIATR, V154, P187, DOI 10.1007/BF01954268; JEFFCOATE WJ, 1980, CLIN ENDOCRINOL, V12, P81, DOI 10.1111/j.1365-2265.1980.tb03136.x; KASSMANN K, 1992, CLIN NEPHROL, V37, P148; KAUFMAN FR, 1981, NEW ENGL J MED, V304, P994, DOI 10.1056/NEJM198104233041702; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kohler B, 2008, HUM MUTAT, V29, P59, DOI 10.1002/humu.20588; KREMER H, 1995, NAT GENET, V9, P160, DOI 10.1038/ng0295-160; Larsen EC, 2003, J CLIN ENDOCR METAB, V88, P5307, DOI 10.1210/jc.2003-030352; Latronico AC, 1996, NEW ENGL J MED, V334, P507, DOI 10.1056/NEJM199602223340805; Law H, 2006, FETAL PEDIATR PATHOL, V25, P119, DOI 10.1080/15513810600788806; Layman LC, 1997, NEW ENGL J MED, V337, P607, DOI 10.1056/NEJM199708283370905; Lazar L, 2003, HORM RES, V60, P227, DOI 10.1159/000074036; Lee PA, 2006, PEDIATRICS, V118, pE488, DOI 10.1542/peds.2006-0738; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LIN HJ, 1993, AM J MED GENET, V45, P761, DOI 10.1002/ajmg.1320450619; LINDEN MG, 1988, PEDIATRICS, V82, P619; Lindstedt G, 1998, CLIN CHEM LAB MED, V36, P663, DOI 10.1515/CCLM.1998.118; Mantovani G, 2006, EUR J ENDOCRINOL, V154, P685, DOI 10.1530/eje.1.02132; MATTHEWS CH, 1993, NAT GENET, V5, P83, DOI 10.1038/ng0993-83; Mauras N, 2007, J CLIN ENDOCR METAB, V92, P4154, DOI 10.1210/jc.2007-0671; Mayo A, 2004, J CLIN ENDOCR METAB, V89, P681, DOI 10.1210/jc.2003-031086; Meacham LR, 1997, MED PEDIATR ONCOL, V29, P86, DOI 10.1002/(SICI)1096-911X(199708)29:2<86::AID-MPO4>3.0.CO;2-N; Merchant TE, 2002, INT J RADIAT ONCOL, V54, P45, DOI 10.1016/S0360-3016(02)02888-2; Michala L, 2008, BJOG-INT J OBSTET GY, V115, P737, DOI 10.1111/j.1471-0528.2008.01703.x; Mills JL, 1997, J PEDIATR-US, V131, P598, DOI 10.1016/S0022-3476(97)70069-6; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; Nabhan ZM, 2009, J CLIN ENDOCR METAB, V94, P2009, DOI 10.1210/jc.2008-2123; Nandagopal R, 2008, HORM RES, V69, P65, DOI 10.1159/000111809; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; Oakes MB, 2008, J PEDIATR ADOL GYNEC, V21, P305, DOI 10.1016/j.jpag.2007.09.006; Oliveira LMB, 2001, J CLIN ENDOCR METAB, V86, P1532, DOI 10.1210/jc.86.4.1532; Pasquino AM, 1997, J CLIN ENDOCR METAB, V82, P1810, DOI 10.1210/jc.82.6.1810; Perniola R, 2000, EUR J ENDOCRINOL, V143, P497, DOI 10.1530/eje.0.1430497; Pfaeffle RW, 2008, J CLIN ENDOCR METAB, V93, P1062, DOI 10.1210/jc.2007-1525; Pfaffle RW, 1999, ACTA PAEDIATR, V88, P33, DOI 10.1111/j.1651-2227.1999.tb14401.x; Piippo S, 2004, J CLIN ENDOCR METAB, V89, P3241, DOI 10.1210/jc.2003-032069; Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104; Prestoz LLC, 1997, EUR J PEDIATR, V156, P116, DOI 10.1007/s004310050568; Priebe C, 2005, J PEDIATR SURG, V40, P136; Rahhal SN, 2008, J PEDIATR-US, V152, P289, DOI 10.1016/j.jpeds.2007.10.052; Raivio T, 2007, NEW ENGL J MED, V357, P863, DOI 10.1056/NEJMoa066494; RAPPAPORT R, 1982, J CLIN ENDOCR METAB, V54, P1164, DOI 10.1210/jcem-54-6-1164; RICHMAN RA, 1988, NEW ENGL J MED, V319, P1563, DOI 10.1056/NEJM198812153192402; Rizzolio F, 2006, HUM REPROD, V21, P1477, DOI 10.1093/humrep/dei495; Rogol Alan D, 2005, Pediatr Endocrinol Rev, V2, P383; Rosenfield RL, 1998, PEDIATRICS, V102, P486; Sarpel U, 2005, J PEDIATR SURG, V40, P133, DOI 10.1016/j.jpedsurg.2004.09.012; Sato N, 2004, J CLIN ENDOCR METAB, V89, P1079, DOI 10.1210/jc.2003-030476; Schatz DA, 2002, ENDOCRIN METAB CLIN, V31, P339, DOI 10.1016/S0889-8529(01)00012-3; Schulze A, 2001, ACTA PAEDIATR, V90, P455, DOI 10.1080/080352501750126474; Sedlmeyer IL, 2002, J CLIN ENDOCR METAB, V87, P1613, DOI 10.1210/jc.87.4.1613; SHALET SM, 1989, J ENDOCRINOL, V120, P161, DOI 10.1677/joe.0.1200161; Sinisi AA, 1997, INT J ANDROL, V20, P23, DOI 10.1046/j.1365-2605.1997.00101.x; SMITH NM, 1991, HISTOPATHOLOGY, V19, P269, DOI 10.1111/j.1365-2559.1991.tb00033.x; SOLIMAN AT, 1995, METABOLISM, V44, P1013, DOI 10.1016/0026-0495(95)90098-5; Steffens M, 2008, CLIN ENDOCRINOL, V69, P819, DOI 10.1111/j.1365-2265.2008.03283.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; UIBO R, 1994, J CLIN ENDOCR METAB, V78, P323, DOI 10.1210/jc.78.2.323; Vinci G, 2004, J CLIN ENDOCR METAB, V89, P6282, DOI 10.1210/jc.2004-0891; VOGL TJ, 1994, RADIOLOGY, V191, P53, DOI 10.1148/radiology.191.1.8134597; VONKALCKREUTH G, 1991, HORM RES, V35, P222; Wallace WHB, 2003, HUM REPROD, V18, P117, DOI 10.1093/humrep/deg016; WEISS J, 1992, NEW ENGL J MED, V326, P179, DOI 10.1056/NEJM199201163260306; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Wharton Robert H., 1996, Current Opinion in Pediatrics, V8, P618, DOI 10.1097/00008480-199612000-00013; Wolff ASB, 2007, J CLIN ENDOCR METAB, V92, P595, DOI 10.1210/jc.2006-1873; Yang F, 2009, EUR J PEDIATR, V168, P329, DOI 10.1007/s00431-008-0779-x; Yang J, 2006, J CLIN ENDOCR METAB, V91, P3619, DOI 10.1210/jc.2005-2283; Zielinska D, 2007, J PEDIATR SURG, V42, P1721, DOI 10.1016/j.jpedsurg.2007.05.029	117	6	8	1	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0889-8529	1558-4410		ENDOCRIN METAB CLIN	Endocrinol. Metabol. Clin. North Amer.	DEC	2009	38	4					719	+		10.1016/j.ecl.2009.08.004			21	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	627JQ	WOS:000280035700006	19944289	Green Accepted			2022-02-06	
J	Woischneck, D; Kapapa, T; Heissler, HE; Reissberg, S; Skalej, M; Firsching, R				Woischneck, Dieter; Kapapa, Thomas; Heissler, Hans E.; Reissberg, Steffen; Skalej, Martin; Firsching, Raimund			Respiratory function after lesions in medulla oblongata	NEUROLOGICAL RESEARCH			English	Article						Medulla oblongata; respiration; magnetic resonance imaging; brain injuries; cerebral hemorrhage	BRAIN-STEM LESIONS; CLASSIFICATION; INJURY	Objectives: To evaluate the correlation of lesions of the brain as visualized in cranial magnetic resonance imaging (MRI) and the ability of spontaneous respiration. Methods: In a prospective concept, cranial MRI after traumatic brain injury or spontaneous intracerebral hemorrhage was performed in 250 subjects at an early stage. All MRI findings were correlated with respiratory conditions on the day of examination. Sedation was performed only to facilitate toleration of the artificial ventilation, as and when necessary. Spontaneous respiration could hence be registered clinically. Results: Thirteen subjects (5.2%) had no spontaneous respiration. In these cases, a bilateral lesion of the distal medulla oblongata could be displayed. In four of these cases, no additional injuries of the brainstem were detected. These subjects awoke 2 days after the impact with tetraparesis and apnea. Combined lesions of the medulla oblongata and other brainstem regions were found in nine subjects. All these patients died without awakening. In the absence of a bilateral lesion of the caudal medulla oblongata, spontaneous respiration was always possible. A unilateral lesion of the caudal medulla oblongata was visualized in one patient who had the ability of spontaneous respiration. Conclusions: This work confirms the presence of autonomous respiratory centers within the caudal medulla oblongata that allows sufficient adequate respiration in coma. Respiration ceases in the presence of a bilateral lesion of this area. [Neurol Res 2009; 31: 1019-1022]	[Woischneck, Dieter] Univ Hosp, Neurochirurg Klin, D-89075 Ulm, Germany; [Heissler, Hans E.] Hannover Med Sch, D-3000 Hannover, Germany; [Reissberg, Steffen] Bonhoeffer Klinikum Neubrandenburg, Neubrandenburg, Germany; [Skalej, Martin; Firsching, Raimund] Otto VonGuericke Univ Magdegurg, D-39016 Magdeburg, Germany		Woischneck, D (corresponding author), Univ Hosp, Neurochirurg Klin, Steinhovelstr 9, D-89075 Ulm, Germany.	dieter-heinrich.woischneck@uniklinik-ulm.de	Skalej, Martin/G-2122-2013	Skalej, Martin/0000-0001-9506-619X	Bundesministerium fur Forschung und Technologie (German Federal Ministry for Research and Technology)	The authors are grateful to the Bundesministerium fur Forschung und Technologie (German Federal Ministry for Research and Technology) for its support to this work.	Abbott R, 1996, PEDIATR NEUROSURG, V25, P41, DOI 10.1159/000121095; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Firsching R, 2002, NEUROL RES, V24, P145, DOI 10.1179/016164102101199684; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; FROWEIN RA, 1976, ACTA NEUROCHIR, V34, P5, DOI 10.1007/BF01405858; Horne Rosemary S C, 2004, Paediatr Respir Rev, V5, P190, DOI 10.1016/j.prrv.2004.04.011; NORTH JB, 1974, ARCH NEUROL-CHICAGO, V31, P338, DOI 10.1001/archneur.1974.00490410086010; PATON JFR, 1994, NEUROSCI LETT, V170, P167, DOI 10.1016/0304-3940(94)90265-8; Shukla D, 2007, CLIN NEUROPATHOL, V26, P197; Teasell R, 2002, ARCH PHYS MED REHAB, V83, P1013, DOI 10.1053/apmr.2002.33102; Wijdicks EFM, 2001, J NEUROL NEUROSUR PS, V70, P127, DOI 10.1136/jnnp.70.1.127; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woischneck D, 1997, NEUROL RES, V19, P305, DOI 10.1080/01616412.1997.11740817; Woischneck D, 2003, CHILD NERV SYST, V19, P174, DOI 10.1007/s00381-002-0703-z; ZHOU D, J APPL PHYSL, V70, P1265	16	6	6	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	DEC	2009	31	10					1019	1022		10.1179/174313209X385608			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530XR	WOS:000272626800003	19215659				2022-02-06	
J	Lamb, L; Hoshizaki, TB				Lamb, L.; Hoshizaki, T. B.			Deformation mechanisms and impact attenuation characteristics of thin-walled collapsible air chambers used in head protection	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE			English	Article						energy absorber; air chamber; helmet; head protection; mild traumatic brain injury	PLASTIC COLLAPSE; ENERGY ABSORBERS; POLYURETHANE; FRUSTA	Head injuries are a major cause of morbidity and mortality worldwide, many resulting from sporting activities. There is a constant need in the head protection industry for improved methods to manage impacts and to reduce the risk of mild and severe head injuries. Contemporary head protection primarily consists of foam with several inherent disadvantages, including a limited ability to provide effective energy absorption under both low and high impact velocities. Recently, thin-walled collapsible chambers were engineered to address this problem and have been implemented into sport helmets. The chambers consist of four engineering elements which define their dynamic performance: geometry, air volume, material, and venting system. This research analysed the contribution of air flow through an orifice to the chamber's management of impact energy. The objective of this study was to determine the effect of the chamber's vent diameter and material stiffness on peak force and venting rate during an impact. Two material stiffnesses (thermoplastic polyurethane 45D and thermoplastic polyurethane 90A) and five vent diameters (1 mm, 2 mm, 3 mm, 4 mm, and 5 mm) were tested at three inbound velocities (1.3 m/s, 2.3 m/s, and 3.0 m/s). Each chamber was impacted ten times using a monorail drop system. Analysis of the results revealed that the material stiffness, vent diameter, and inbound velocity all had a significant effect on peak force and venting rate (p < 0.001). Under low inbound velocities the largest vent diameters transmitted a lower force than the smallest vent, while this relationship reversed at high inbound velocities. Under low velocities the air flowrate was negatively correlated and the flow duration was positively correlated to the peak force. Under high velocities, the air flowrate was positively correlated and the duration was negatively correlated to the peak force. This suggested that, under low velocities, chambers performed optimally when air was dissipated quickly, for a short duration; however, as the chamber approached a critical failure region, the increased duration and decreased velocity of air released prevented higher peak forces. This research confirmed that the differences in vent diameter and material stiffness significantly affected the impact force characteristics of engineered thin-walled collapsible chambers.	[Lamb, L.; Hoshizaki, T. B.] Univ Ottawa, Neurotrauma Impact Lab, Ottawa, ON K1N 6N5, Canada		Lamb, L (corresponding author), Univ Ottawa, Neurotrauma Impact Lab, 200 Lees Ave, Ottawa, ON K1N 6N5, Canada.	llamb007@uottawa.ca			Xenith, LLC	This study was in part supported by Xenith, LLC.	Abdul-Latif A, 2003, J ENG MATER-T ASME, V125, P215, DOI 10.1115/1.1543970; AIJAWI AAN, 2005, THIN WALLED STRUCTS, V43, P647; Alghamdi AAA, 2001, THIN WALL STRUCT, V39, P189, DOI 10.1016/S0263-8231(00)00048-3; Atkins A.G., 1985, ELASTIC PLASTIC FRAC; *CAD INC, 2007, IMP MACH UN MACH; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; Coban O, 2009, MATER DESIGN, V30, P628, DOI 10.1016/j.matdes.2008.05.042; GILCHRIST A, 1994, INT J IMPACT ENG, V15, P201, DOI 10.1016/S0734-743X(05)80013-2; GIMBEL G, 2008, P 5 INT S SAF IC HOC; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; HOSHIZAKI TB, 2009, J ASTM INT, V6; Hwang IK, 2006, J BIOMECH ENG-T ASME, V128, P229, DOI 10.1115/1.2165695; Kim KJ, 2006, AM J SPORT MED, V34, P637, DOI 10.1177/0363546505281800; MAMALIS AG, 1986, INT J MECH SCI, V28, P219, DOI 10.1016/0020-7403(86)90070-6; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; Naganathan P, 1999, PACKAG TECHNOL SCI, V12, P81, DOI 10.1002/(SICI)1099-1522(199903/04)12:2<81::AID-PTS456>3.0.CO;2-7; NARDO NR, 1987, J ELASTOM PLAST, V19, P59, DOI 10.1177/009524438701900106; ROBERTSON DGE, 2008, BIOPROC DATA PROCESS; Sasaki H, 1999, PACKAG TECHNOL SCI, V12, P143, DOI 10.1002/(SICI)1099-1522(199905/06)12:3<143::AID-PTS462>3.0.CO;2-P; Singace AA, 2001, THIN WALL STRUCT, V39, P415, DOI 10.1016/S0263-8231(01)00008-8; WOLSTENHOLME WE, 1962, J APPL POLYM SCI, V1, P332; Yu-Hallada LC, 1998, J CELL PLAST, V34, P272, DOI 10.1177/0021955X9803400306; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang ZY, 2007, COMPOS STRUCT, V81, P195, DOI 10.1016/j.compstruct.2006.08.019	24	6	6	0	7	PROFESSIONAL ENGINEERING PUBLISHING LTD	WESTMINISTER	1 BIRDCAGE WALK, WESTMINISTER SW1H 9JJ, ENGLAND	0954-4119			P I MECH ENG H	Proc. Inst. Mech. Eng. Part H-J. Eng. Med.	NOV	2009	223	H8					1021	1031		10.1243/09544119JEIM573			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	528WR	WOS:000272478200008	20092098				2022-02-06	
J	Saunders, LL; Selassie, AW; Hill, EG; Horner, MD; Nicholas, JS; Lackland, DT; Corrigan, JD				Saunders, Lee L.; Selassie, Anbesaw W.; Hill, Elizabeth G.; Horner, Michael D.; Nicholas, Joyce S.; Lackland, Daniel T.; Corrigan, John D.			Pre-existing Health Conditions and Repeat Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Epilepsy; Rehabilitation; Seizures	PROFESSIONAL FOOTBALL PLAYERS; RECURRENT CONCUSSION; SOCIOECONOMIC-STATUS; UNITED-STATES; HEAD-INJURY; ALCOHOL-USE; POPULATION; EPILEPSY; SEIZURES; PREVALENCE	Objective: To assess and compare the effect of Pre-existing epilepsy/seizure disorder and drug/alcohol problem on the hazard of repeat traumatic brain injury (TBI) in persons with TBI who participated in a follow-up study. Design: Retrospective cohort. Setting: Acute care hospitals in South Carolina. Participants: Participants were from the South Carolina Traumatic Brain Injury Follow-up Registry cohort of persons (N=2118) who were discharged from an acute care hospital in South Carolina and who participated in a year-1 follow-up interview. Interventions: Not applicable. Main Outcome Measures: Repeat TBI was defined by 2 isolated events of TBI in the same person at least 72 hours apart and recorded in hospital discharge or emergency department records from 1999 through 2005. Results: A Cox proportional hazards model was used to assess the associations of Pre-existing epilepsy/seizure disorder and drug/alcohol problem with time to repeat TBI, controlling for other confounding factors. There were 2099 persons with information on both Pre-existing conditions. There were 147 (7%) persons who sustained repeat TBI after recruitment to the follow-up study, and 82 (3.9%) had a previous TBI before recruitment for which they were seen in the hospital discharge or emergency department since 1996. The hazard of repeat TBI for persons with Pre-existing epilepsy/seizure disorder was 2.3 times the hazard for those without (hazard ratio, 2.3; 95% confidence interval, 1.2-4.4; P=.011). Pre-existing drug/alcohol problem was not associated with repeat TBI. Other variables significantly associated with repeat TBI were having a prior TBI. being insured under Medicaid, and having no insurance. Conclusions: Pre-existing epilepsy/seizure disorder predisposes to repeat TBI. Appropriate management of seizure control may be an important strategy to allay the occurrence of repeat TBI.	[Saunders, Lee L.] Med Univ S Carolina, Dept Hlth Sci & Res, Charleston, SC 29425 USA; [Selassie, Anbesaw W.; Hill, Elizabeth G.; Nicholas, Joyce S.; Lackland, Daniel T.] Med Univ S Carolina, Dept Biostat Bioinformat & Epidemiol, Charleston, SC 29425 USA; [Horner, Michael D.] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; [Horner, Michael D.] Ralph H Johnson Dept Vet Affairs, Med Ctr, Mental Hlth Serv, Charleston, SC USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Saunders, LL (corresponding author), Med Univ S Carolina, Dept Rehabil Sci, 77 President St,Ste 117,MSC 700, Charleston, SC 29425 USA.	saundel@musc.edu			Division of Injury Response [U17/CCU421926]; National Center for Injury Prevention and Control (NCIPC); Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; Social Security Administration (SSA); Office of Disability Income and Support Programs	Supported by the Division of Injury Response (grant no. U17/CCU421926), National Center for Injury Prevention and Control (NCIPC), Centers for Disease Control and Prevention (CDC). The study was performed pursuant to a jointly financed cooperative arrangement between the NCIPC, the National Center for Chronic Discase Prevention and Health Promotion, CDC, and the Social Security Administration (SSA), Office of Disability Income and Support Programs.	ALBRIGHT JP, 1985, AM J SPORT MED, V13, P147, DOI 10.1177/036354658501300301; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; BERAN R G, 1985, Neuroepidemiology, V4, P82, DOI 10.1159/000110218; Birken CS, 2006, CAN MED ASSOC J, V175, P867, DOI 10.1503/cmaj.051207; BUTLER JA, 2001, CENTRAL NERVOUS SYST; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; d'Errico A, 2007, OCCUP ENVIRON MED, V64, P325, DOI 10.1136/oem.2006.027839; Drubach D A, 1993, Md Med J, V42, P989; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; KRUETZER JS, 1996, J HEAD TRAUMA REHAB, V11, P58; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lawn ND, 2004, NEUROLOGY, V63, P1565, DOI 10.1212/01.WNL.0000142991.14507.B5; LIN D, 1993, J AM STAT ASSOC, V84, P1074; Lucas RH, 1998, ANN EMERG MED, V32, P563, DOI 10.1016/S0196-0644(98)70033-2; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Neufeld MY, 2000, SEIZURE-EUR J EPILEP, V9, P595, DOI 10.1053/seiz.2000.0469; Neufeld MY, 1999, EPILEPSY RES, V34, P123, DOI 10.1016/S0920-1211(98)00105-3; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; *SC OFF RES STAT, 2006, S CAR POP REP; SELASSIE A, 2007, S CAROLINA EPIDEMIOL; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Suruda A, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-29; Tai PC, 2004, CAN J NEUROL SCI, V31, P394, DOI 10.1017/S0317167100003516; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017; Walker R, 2007, J HEAD TRAUMA REHAB, V22, P360, DOI 10.1097/01.HTR.0000300231.90619.50; Wirrell EC, 2006, EPILEPSIA, V47, P79, DOI 10.1111/j.1528-1167.2006.00666.x; Wong Pauline P., 1993, Brain Injury, V7, P283, DOI 10.3109/02699059309034955	39	6	6	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2009	90	11					1853	1859		10.1016/j.apmr.2009.05.020			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	520XC	WOS:000271881900006	19887208				2022-02-06	
J	Tang, YL; Zhu, GQ; Zhou, H; Zheng, M; Tang, XF; Wang, XY; Liang, XH				Tang, Ya-ling; Zhu, Gui-quan; Zhou, Hao; Zheng, Min; Tang, Xiu-fa; Wang, Xiao-yi; Liang, Xin-hua			Analysis of 46 maxillofacial fracture victims in the 2008 Wenchuan, China earthquake	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY			English	Article							FACIAL FRACTURES; NEW-ZEALAND; INJURIES; SEVERITY	Purpose. At 14:28 hours on May 12, 2008, a massive earthquake wracked most areas of Sichuan, China, causing catastrophic human loss. The aim of this study was to delineate the characteristics of victims with maxillofacial fractures in this disaster. Patients and methods. A descriptive analysis was conducted based on the medical records of earthquake maxillofacial injuries casualties transferred to West China Hospital of Stomatology, Sichuan University, after the earthquake. Data regarding demographic details, psychological status, patterns, anatomic sites, etiology, concomitant injuries, and management of earthquake maxillofacial fractures were evaluated. Results. A total of 46 maxillofacial fracture patients' records of 28 (60.9%) males and 18 (39.1%) females were included in this study, with peak incidence (32.6%) in the elderly age group (older than 50 years). The most common etiology of earthquake maxillofacial fractures was building collapse (71.7%). The mandible (65.2%) was the most frequent site of the maxillofacial fracture, followed by the zygomatic complex (21.7%) and maxilla (13.0%). The most prevalent of maxillofacial fracture pattern was multiple and/or comminuted fractures (56.5%), which accounted for 72.7% (24/33) in building collapse injury group. There were 9 (19.6%) patients with significant concomitant injuries and the most common site of concomitant injuries was the head (4 cases) and extremity (4 cases). Four (8.7%) patients' maxillofacial fractures were treated conservatively, 16 (34.8%) underwent closed reduction and fixation, and 26 (56.5%) underwent open reduction and rigid internal fixation (RIF). Apart from 3 patients (6.5%) who showed infection, all patients with facial fractures achieved successful bony union with an acceptable occlusion and facial form. Additionally, it is noteworthy that all patients in our study presented the symptoms of posttraumatic stress disorder (PTSD). Conclusion. There is a variation of mechanism of injuries, age group, severity, patterns, concomitant injuries, and management of earthquake maxillofacial fractures. Knowledge of these characteristics provides useful strategies for patient care and prevention of further complications. A multidisciplinary and coordinated approach is important for optimum stabilization and ongoing treatment of victims of building collapse injury. The high percentage of PTSD confirms that psychologists should form an integral part of this multidisciplinary team. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:673-678)	[Tang, Xiu-fa; Wang, Xiao-yi; Liang, Xin-hua] Sichuan Univ, Dept Oral & Maxillofacial Surg, W China Hosp Stomatol, Chengdu 610041, Sichuan, Peoples R China		Liang, XH (corresponding author), Sichuan Univ, Dept Oral & Maxillofacial Surg, W China Hosp Stomatol, 14 Sec 3,Renminnan Rd, Chengdu 610041, Sichuan, Peoples R China.	lxh88866@yahoo.com.cn		Liang, Xinhua/0000-0003-0718-3658			Adeyemo Wasiu Lanre, 2005, Head Face Med, V1, P7, DOI 10.1186/1746-160X-1-7; Alvi A, 2003, LARYNGOSCOPE, V113, P102, DOI 10.1097/00005537-200301000-00019; Andreasen JO, 2008, DENT TRAUMATOL, V24, P17, DOI 10.1111/j.1600-9657.2006.00498.x; Armenian HK, 1997, INT J EPIDEMIOL, V26, P806, DOI 10.1093/ije/26.4.806; Bakardjiev A, 2007, J CRANIO MAXILL SURG, V35, P147, DOI 10.1016/j.jcms.2007.01.005; Bataineh AB, 1998, ORAL SURG ORAL MED O, V86, P31, DOI 10.1016/S1079-2104(98)90146-9; Down KE, 1995, INT J ORAL MAX SURG, V24, P409, DOI 10.1016/S0901-5027(05)80469-2; EDWARDS TJC, 1994, BRIT J PLAST SURG, V47, P310, DOI 10.1016/0007-1226(94)90088-4; Emami MJ, 2005, PREHOSP DISASTER MED, V20, P327, DOI 10.1017/S1049023X0000279X; Brasileiro BF, 2006, ORAL SURG ORAL MED O, V102, P28, DOI 10.1016/j.tripleo.2005.07.023; Hogg NJV, 2000, J TRAUMA, V49, P425, DOI 10.1097/00005373-200009000-00007; Joos U, 1999, J ORAL MAXIL SURG, V57, P2, DOI 10.1016/S0278-2391(99)90619-5; Kieser J, 2002, INT J ORAL MAX SURG, V31, P206, DOI 10.1054/ijom.2002.0208; Levin L, 2008, J ORAL MAXIL SURG, V66, P1630, DOI 10.1016/j.joms.2007.11.028; LIM LH, 1993, BRIT J PLAST SURG, V46, P635, DOI 10.1016/0007-1226(93)90191-D; Love RM, 2008, DENT TRAUMATOL, V24, P170, DOI 10.1111/j.1600-9657.2007.00520.x; Naghi TM, 2005, INJURY, V36, P27, DOI 10.1016/j.injury.2004.06.021; Oji C, 1999, BRIT J ORAL MAX SURG, V37, P106, DOI 10.1054/bjom.1997.0083; Papakosta V, 2008, DENT TRAUMATOL, V24, P193, DOI 10.1111/j.1600-9657.2007.00536.x; PERIN P, 1996, WAR PUBLIC HLTH, P227; Roy N, 2005, INJURY, V36, P927, DOI 10.1016/j.injury.2005.02.017; Roy Nobhojit, 2002, Prehosp Disaster Med, V17, P186; Sarisozen B, 2003, J PEDIATR ORTHOP B, V12, P288, DOI 10.1097/01.bpb.0000049581.53117.65; SINCLAIR D, 1988, Journal of Emergency Medicine, V6, P109, DOI 10.1016/0736-4679(88)90148-5; State Council Information Office of the People's Republic of China, 2008, LAT DEV WENCH EARTHQ; Tanida N, 1996, BRIT MED J, V313, P1133, DOI 10.1136/bmj.313.7065.1133	26	6	6	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1079-2104	1528-395X		ORAL SURG ORAL MED O	Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.	NOV	2009	108	5					673	678		10.1016/j.tripleo.2009.05.031			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	508BY	WOS:000270903000010	19716718				2022-02-06	
J	Woodman, R; Lockette, W				Woodman, Ryan; Lockette, Warren			Alpha-methyltyrosine inhibits formation of reactive oxygen species and diminishes apoptosis in PC12 cells	BRAIN RESEARCH			English	Article						Traumatic brain injury; Chloride channel; Diuretics; Carbonic anhydrase; Allopregnanolone	TYROSINE-HYDROXYLASE GENE; SPINAL-CORD-INJURY; DOPAMINE-BETA-HYDROXYLASE; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; CATECHOLAMINE SYNTHESIS; IN-VITRO; MITOCHONDRIAL DYSFUNCTION; HEMORRHAGIC NECROSIS; SUPEROXIDE-DISMUTASE	Objective. Circulating catecholamines; and adrenal steroids are significantly increased following traumatic brain injury, and elevations in plasma catecholamines and cortisol portend a poor outcome. We hypothesize that an increase in the generation of reactive oxygen species from the synthesis of adrenal steroids and catecholamines is responsible for neuronal injury following traumatic brain injury. As a first step in testing this hypothesis, we sought to determine whether or not inhibition of catecholamine synthesis would decrease neuronal damage. Methods and Results. Using PC12 cells as a model of catecholamine synthesizing neurons, and serum deprivation as a method to induce neuronal damage, we show (1) adrenal corticosteroids increase reactive oxygen species formation and apoptosis induced by serum deprivation; (2) the inhibitor of catecholamine synthesis, alpha-methyltyrosine, reduces reactive oxygen species formation and apoptosis in PC12 cells; and (3) that acetazolamide, chlorthalidone, and the neurosteroid, allopregnanolone, which inhibits chloride transport, protect. PC12 cells from apoptosis. Conclusions. it may be possible to protect catecholaminergic neurons from reactive oxygen species-induced apoptotic death by not only blocking catecholamine synthesis, but also, by inhibiting carbonic anhydrase-dependent chloride/bicarbonate exchange with acetazolamide or chlorthalidone. These agents may prove salutary in reducing cell death in patients with traumatic brain injury or stroke. Published by Elsevier B.V.	[Lockette, Warren] USN, Med Ctr, Dept Clin Invest, San Diego, CA 92134 USA		Lockette, W (corresponding author), USN, Med Ctr, Dept Clin Invest, 34800 Bob Wilson Dr,Mail Code KCA, San Diego, CA 92134 USA.	Warren.Lockette@med.navy.mil			Naval Medical Center, San DiegoUnited States Department of Defense	These studies were supported by the Naval Medical Center, San Diego. A preliminary report of these findings was presented at the Federation of Societies for Experimental Biology Annual Meeting, 2008, San Diego, CA. The opinions expressed are those of the authors and do not necessarily reflect the views of the U.S. Navy or Department of Defense.	ABREU P, 1988, NEUROSCI LETT, V95, P213, DOI 10.1016/0304-3940(88)90659-3; ALDERMAN JL, 1980, NEUROSURGERY, V6, P412, DOI 10.1227/00006123-198004000-00009; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bornstein SR, 2000, P NATL ACAD SCI USA, V97, P14742, DOI 10.1073/pnas.97.26.14742; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; COHEN G, 1974, J BIOL CHEM, V249, P2447; DIBNER MD, 1976, J NEUROCHEM, V27, P323, DOI 10.1111/j.1471-4159.1976.tb01591.x; Edwards P, 2005, LANCET, V365, P1957; ENGELMAN K, 1968, J CLIN INVEST, V47, P577, DOI 10.1172/JCI105754; EVINGER MJ, 1992, CELL MOL NEUROBIOL, V12, P193, DOI 10.1007/BF00712926; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; FOSSOM LH, 1992, MOL PHARMACOL, V42, P898; FRANCIOSA JA, 1989, J AM COLL CARDIOL, V14, P624, DOI 10.1016/0735-1097(89)90103-4; Goldshmit Y, 2001, J BIOL CHEM, V276, P46379, DOI 10.1074/jbc.M105637200; GOLDSTEIN LB, 1990, BRAIN RES, V508, P305, DOI 10.1016/0006-8993(90)90413-6; GOLDSTEIN ME, 1992, MOL BRAIN RES, V14, P79, DOI 10.1016/0169-328X(92)90013-2; GUSEBEHLING H, 1992, J ENDOCRINOL, V135, P229, DOI 10.1677/joe.0.1350229; Haidan A, 1998, ENDOCRINOLOGY, V139, P772, DOI 10.1210/en.139.2.772; HALES TG, 1994, J NEUROSCI, V14, P5429; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HANNA CALVIN, 1965, INVEST OPHTHALMOL, V4, P1095; Heck S, 1997, DEV BRAIN RES, V98, P211, DOI 10.1016/S0165-3806(96)00181-2; HEIKKILA R, 1971, SCIENCE, V172, P1257, DOI 10.1126/science.172.3989.1257; Hentze H, 2001, BIOCHEM BIOPH RES CO, V283, P1111, DOI 10.1006/bbrc.2001.4918; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huang NK, 2003, NEUROSCI LETT, V350, P127, DOI 10.1016/S0304-3940(03)00860-7; INOUE M, 1991, J CEREBR BLOOD F MET, V11, P242, DOI 10.1038/jcbfm.1991.56; Iuchi T, 2003, CIRC RES, V92, P81, DOI 10.1161/01.RES.0000050588.35034.3C; Jeong H, 2006, NEUROSCI LETT, V396, P57, DOI 10.1016/j.neulet.2005.11.011; KALDERSON P, 2005, COCHRANE DB SYST REV, V25; KAROBATH K, 1971, PNAS, V69, P2370; Kaufer D, 2004, NAT NEUROSCI, V7, P947, DOI 10.1038/nn1296; Kim J, 2006, J BIOL CHEM, V281, P20349, DOI 10.1074/jbc.M512740200; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; KOIKE T, 1984, J NEUROCHEM, V42, P1472, DOI 10.1111/j.1471-4159.1984.tb02812.x; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; LEWIS EJ, 1987, P NATL ACAD SCI USA, V84, P3550, DOI 10.1073/pnas.84.11.3550; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Liu HL, 2003, J NEUROCHEM, V86, P1553, DOI 10.1046/j.1471-4159.2003.01978.x; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; LUCAS CA, 1977, NEUROSCIENCE, V2, P1095, DOI 10.1016/0306-4522(77)90132-4; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Mendez DR, 2004, J TRAUMA, V56, P1235, DOI 10.1097/01.TA.0000130759.62286.0E; Musso NR, 1996, J CLIN ENDOCR METAB, V81, P3553, DOI 10.1210/jc.81.10.3553; Oshima Y, 2004, MUSCLE NERVE, V30, P49, DOI 10.1002/mus.20036; OSTERHOLM JL, 1972, J NEUROSURG, V36, P386, DOI 10.3171/jns.1972.36.4.0386; OSTERHOLM JL, 1972, J NEUROSURG, V36, P395, DOI 10.3171/jns.1972.36.4.0395; OTTEN U, 1976, MOL PHARMACOL, V12, P353; Pong K, 2001, EXP NEUROL, V171, P84, DOI 10.1006/exnr.2001.7747; Porcelli AM, 2004, CELL DEATH DIFFER, V11, P655, DOI 10.1038/sj.cdd.4401396; Prasad K, 1996, J MOL CELL CARDIOL, V28, P375, DOI 10.1006/jmcc.1996.0035; ROSS ME, 1990, J NEUROSCI, V10, P520; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1228; Shimizu T, 2004, P NATL ACAD SCI USA, V101, P6770, DOI 10.1073/pnas.0401604101; Son GH, 2005, BIOCHEM BIOPH RES CO, V338, P1751, DOI 10.1016/j.bbrc.2005.10.152; Tafani M, 2002, J BIOL CHEM, V277, P49569, DOI 10.1074/jbc.M208915200; TISCHLER AS, 1983, J NEUROCHEM, V40, P364, DOI 10.1111/j.1471-4159.1983.tb11291.x; Tonomura N, 2003, J IMMUNOL, V170, P2469, DOI 10.4049/jimmunol.170.5.2469; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; Vaitkevicius H, 2002, AM J HYPERTENS, V15, P492, DOI 10.1016/S0895-7061(02)02276-8; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; WURTMAN RJ, 1966, J BIOL CHEM, V241, P2301; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Zhang K, 2003, NEUROCHEM RES, V28, P893, DOI 10.1023/A:1023275426637; 2007, J NEUROTRAUMA S1, V24, pS91, DOI DOI 10.1089/NEU.2007.9981	70	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 16	2009	1296						137	147		10.1016/j.brainres.2009.07.084			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511ME	WOS:000271168600015	19647721				2022-02-06	
J	McEwen, J; Huttunen, KTH				McEwen, Jonathan; Huttunen, K. T. Henrik			Transfusion practice in neuroanesthesia	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						blood transfusion; neurosurgery; perioperative; transfusion threshold	TRAUMATIC BRAIN-INJURY; DISSEMINATED INTRAVASCULAR COAGULATION; ANEURYSMAL SUBARACHNOID HEMORRHAGE; PROTHROMBIN COMPLEX CONCENTRATE; SEVERE ISOVOLEMIC ANEMIA; BLOOD-CELL TRANSFUSION; VITAMIN-K ANTAGONISTS; INTRACEREBRAL HEMORRHAGE; HEMOGLOBIN CONCENTRATION; CEREBRAL OXYGENATION	Purpose of review Perioperative transfusion thresholds in the neurosurgical patient are undefined. Many neurosurgical procedures are associated with significant risk of bleeding. This review will summarize the current understanding of blood transfusion in the neurosurgical patient, as well as other blood component therapies and blood conservation strategies. Recent findings Transfusion of red blood cells has been demonstrated to improve cerebral oxygen delivery. Clinical studies on transfusion-related morbidity and mortality in the neurosurgical patient are limited. Recent findings in both subarachnoid hemorrhage and traumatic brain injured patients have shown worse outcomes in patients with anemia (Hb <9.0 g/dl) yet transfusion of red blood cells may not be associated with improved outcome. Summary Perioperative transfusion management for intracranial neurosurgical procedures presents the clinician with multiple challenges. Clinical evidence is sparse with view to an optimal hemoglobin level, yet anemia is known to be a predictor of poor outcome in many neurosurgical patients. Transfusion thresholds from other patient populations may not apply to this group and further prospective investigations are desperately needed. Until then, clinicians should focus on an individualized assessment of anemia tolerance, consider blood conservation strategies and understand the potential risks and benefits of blood transfusion.	[Huttunen, K. T. Henrik] Univ British Columbia, Dept Anesthesiol, Vancouver Hosp, Vancouver, BC V5Z 1M9, Canada; [McEwen, Jonathan] Univ Washington, Harborview Med Ctr, Dept Anesthesiol, Seattle, WA 98104 USA		Huttunen, KTH (corresponding author), Univ British Columbia, Dept Anesthesiol, Vancouver Hosp, Rm 2449 JPP,899 W 12th Ave, Vancouver, BC V5Z 1M9, Canada.	Henrik.Huttunen@vch.ca					Aiyagari V, 2009, CURR OPIN CRIT CARE, V15, P87, DOI 10.1097/MCC.0b013e3283269e4d; Allport LE, 2005, NEUROLOGY, V65, P1382, DOI 10.1212/01.wnl.0000183057.96792.a8; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Asplund K., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000103; Atzil S, 2008, ANESTHESIOLOGY, V109, P989, DOI 10.1097/ALN.0b013e31818ddb72; Beattie WS, 2009, ANESTHESIOLOGY, V110, P574, DOI 10.1097/ALN.0b013e31819878d3; Brecknell JE, 2006, BRIT J NEUROSURG, V20, P239, DOI 10.1080/02688690600852647; CARDONE D, 2009, EUR J ANAESTHESIOL; Cataldi S, 1997, NEUROSURGERY, V40, P765, DOI 10.1097/00006123-199704000-00021; Chwajol M, 2008, NEUROCRIT CARE, V8, P418, DOI 10.1007/s12028-008-9088-5; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Couture DE, 2002, STROKE, V33, P994, DOI 10.1161/hs0402.105296; De Georgia MA, 2007, STROKE, V38, P544; Dickneite G, 2007, THROMB RES, V119, P643, DOI 10.1016/j.thromres.2006.05.011; Ekelund A, 2002, ACTA NEUROCHIR, V144, P703, DOI 10.1007/s00701-002-0959-9; Eom KS, 2008, J KOREAN NEUROSURG S, V44, P341, DOI 10.3340/jkns.2008.44.5.341; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Goodnough L T, 2000, Curr Opin Anaesthesiol, V13, P365, DOI 10.1097/00001503-200006000-00023; Goodnough LT, 1999, NEW ENGL J MED, V340, P525, DOI 10.1056/NEJM199902183400706; Hare GMT, 2008, ANESTH ANALG, V107, P1356, DOI 10.1213/ane.0b013e318184cfe9; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hendrickson JE, 2009, ANESTH ANALG, V108, P759, DOI 10.1213/ane.0b013e3181930a6e; Hillman J, 2002, J NEUROSURG, V97, P771, DOI 10.3171/jns.2002.97.4.0771; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holland L, 2009, TRANSFUSION, V49, P1171, DOI 10.1111/j.1537-2995.2008.02080.x; Hopf HW, 2000, ARCH SURG-CHICAGO, V135, P1443, DOI 10.1001/archsurg.135.12.1443; Ityas C, 2008, J CLIN ANESTH, V20, P276, DOI 10.1016/j.jclinane.2007.12.012; Komotar RJ, 2008, NEUROSURGERY, V62, P396, DOI 10.1227/01.neu.0000316006.26635.b0; Leal-Noval SR, 2008, CURR OPIN CRIT CARE, V14, P156, DOI 10.1097/MCC.0b013e3282f57577; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; Lee SB, 2006, NEUROLOGY, V67, P1272, DOI 10.1212/01.wnl.0000238104.75563.2f; Levy JH, 2008, ANESTHESIOLOGY, V109, P918, DOI 10.1097/ALN.0b013e3181895bd8; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Naidech AM, 2007, CRIT CARE MED, V35, P2383, DOI 10.1097/01.CCM.0000284516.17580.2C; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Nogueira RG, 2009, STROKE, V40, P516, DOI 10.1161/STROKEAHA.108.525089; Oddo M, 2009, STROKE, V40, P1275, DOI 10.1161/STROKEAHA.108.527911; Pasternak JJ, 2008, J NEUROSURG ANESTH, V20, P15, DOI 10.1097/ANA.0b013e318155b1c4; SAGGAR V, 2009, J NEUROTRAUMA; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Schrieber M, 2007, J TRAUMA, V63, P1261; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Shander A, 2006, CURR OPIN HEMATOL, V13, P462, DOI 10.1097/01.moh.0000245692.32085.bd; Smith MJ, 2004, J NEUROSURG, V101, P1, DOI 10.3171/jns.2004.101.1.0001; Starke RM, 2008, NEUROSURGERY, V62, P1405, DOI 10.1227/01.neu.0000333471.90507.f8; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; Treggiari MM, 2009, CURR OPIN CRIT CARE, V15, P83, DOI 10.1097/MCC.0b013e32832922d1; Weiskopf RB, 2006, ANESTHESIOLOGY, V104, P911, DOI 10.1097/00000542-200605000-00005; Weiskopf RB, 2002, ANESTHESIOLOGY, V96, P871, DOI 10.1097/00000542-200204000-00014; Weiskopf RB, 2000, ANESTHESIOLOGY, V92, P1646, DOI 10.1097/00000542-200006000-00023; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	53	6	7	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	OCT	2009	22	5					566	571		10.1097/ACO.0b013e32832ff4a2			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	497ID	WOS:000270051500004	19606023				2022-02-06	
J	Abdoli, A; Amirjamshidi, A				Abdoli, Ali; Amirjamshidi, Abbass			Work-Related Penetrating Head Trauma Caused by Industrial Grinder Tool	ARCHIVES OF IRANIAN MEDICINE			English	Article						Industrial grinder tool; penetrating head injuries; traumatic brain injury	GUN PELLET INJURIES; CRANIOCEREBRAL INJURY; BRAIN-INJURY; CHILDREN; NECK; CHILDHOOD	Nonmissile low-velocity penetrating brain injuries are unusual among civilian population. Work-related penetrating head wounds are rarer among this group. Here, we report two rare cases of penetrating head wounds caused by industrial grinder tool. The patients (both men) were struck to the head by detached blades of the grinder tool. Depressed fractures, penetrated bone fragments, and dural lacerations were all treated by the routine fashion. Paranasal sinus damage and further cerebrospinal fluid leakage were also treated conservatively. The reported cases are unexpected variants of injuries that neurosurgeons may come across and their management is still beyond the scope of textbooks. Skill and experience of the general neurosurgeons can handle the cases properly but prevention of such incidents using safer and guarded instruments should be stressed to manufacturers.	[Abdoli, Ali; Amirjamshidi, Abbass] Univ Tehran Med Sci, Dept Neurosurg, Sina Hosp, Tehran, Iran		Amirjamshidi, A (corresponding author), Univ Tehran Med Sci, Dept Neurosurg, Sina Hosp, POB 19585-678, Tehran, Iran.	abamirjamshidi@yahoo.com	ABDOLI, ALI/F-3570-2018	ABDOLI, ALI/0000-0002-2173-5343			Amirjamshidi A, 1997, SURG NEUROL, V47, P331, DOI 10.1016/S0090-3019(96)00357-6; Amirjamshidi A, 2003, SURG NEUROL, V60, P105, DOI 10.1016/S0090-3019(03)00358-6; Bhatjiwale MG, 2001, BRIT J NEUROSURG, V15, P256, DOI 10.1080/02688690120057709; Corzillius M, 2007, ANASTH INTENSIV NOTF, V42, P102, DOI 10.1055/s-2007-971160; *CTR DIS CONTR PRE, 1994, JAMA-J AM MED ASSOC, V271, P495; DOMINGO Z, 1994, PEDIATR NEUROSURG, V21, P45, DOI 10.1159/000120813; DUJOVNY M, 1975, J TRAUMA, V15, P981, DOI 10.1097/00005373-197511000-00007; Geller E, 1997, PEDIATR RADIOL, V27, P790, DOI 10.1007/s002470050234; George M, 2006, ARCH DIS CHILD, V91, P416, DOI 10.1136/adc.2004.068056; Gutierrez-Gonzalez R, 2008, CLIN NEUROL NEUROSUR, V110, P207, DOI 10.1016/j.clineuro.2007.09.014; Kim H, 2006, NEUROREHABILITATION, V21, P269; LEVY ML, 1993, NEUROSURGERY, V33, P1018; Lopez F, 2000, CHILD NERV SYST, V16, P117, DOI 10.1007/s003810050025; Martinez-Lage JF, 2001, PEDIATR SURG INT, V17, P657, DOI 10.1007/s003830100018; REGEV E, 1990, INJURY, V21, P414, DOI 10.1016/0020-1383(90)90138-K; SCHLEP L, 1992, ACCID ANALPREV, V24, P161; SOTIROPOULOS SV, 1990, AM J DIS CHILD, V144, P980, DOI 10.1001/archpedi.1990.02150330040018; Tan MH, 2003, INJURY, V34, P950, DOI 10.1016/S0020-1383(02)00167-5; TAY JS, 1987, PEDIATRICS, V79, P261; Taylor AG, 1997, J NEUROSURG, V87, P512, DOI 10.3171/jns.1997.87.4.0512; Tricco AC, 2006, BRAIN INJURY, V20, P719, DOI 10.1080/02699050600664640	21	6	6	0	0	ACAD MEDICAL SCIENCES I R IRAN	TEHRAN	PO BOX 19395-5655, TEHRAN, 00000, IRAN	1029-2977	1735-3947		ARCH IRAN MED	Arch. Iran. Med.	SEP	2009	12	5					496	498					3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506SN	WOS:000270796400011	19722774				2022-02-06	
J	Nenopoulos, SR; Beslikas, TA; Gigis, JR				Nenopoulos, Savvas R.; Beslikas, Theodoros A.; Gigis, Jhon R.			Long-term follow-up of combined fractures of the proximal radius and ulna during childhood	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						childhood; fractures; proximal radius and ulna	OLECRANON FRACTURES; CHILDREN; NECK; DISPLACEMENT	Forty-five children with combined fractures of the proximal end of the radius and ulna were treated in our orthopedic department over a period of 16 years (1984-1999). The age of the patients ranged from 5 to 12 years (mean 8 years) with a peak of 7-8 years. The mechanism of injury was a fall on the outstretched hand with the elbow extended and with a valgus force being applied to the elbow. In 35 patients, closed reduction or immobilization in plaster, or both, were performed. In the other 10 patients, a surgical treatment was followed either for fractures of the radius (4) or for both the radius and ulna (6). The follow-up period ranged from 4 to 20 years (mean 12 years 3 months). The functional results were satisfactory in most cases despite the poor radiological appearance of some of them. In three patients we found a notable restriction, mainly in forearm pronation-supination and less in elbow flexion-extension, because of upper radioulnar joint synostosis. Poor results related with initial damages at the time of injury and the age of the patient (> 10 years) rather than with the way of treatment. Valgus deformity, restriction in flection-extension, and pronation-supination were related with the extent of the initial injury but not related with the way of treatment. Overgrowth of the radial head, which had minor impact mainly on the pronation-supination, was found in the majority of cases that underwent surgical treatment. Minor residual abnormalities of the radius, ulna, or both were present without having marked functional influence. J Pediatr Orthop B 18:252-260 (C) 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins.	[Nenopoulos, Savvas R.; Beslikas, Theodoros A.; Gigis, Jhon R.] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece		Nenopoulos, SR (corresponding author), Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece.	savanen42@hotmail.com					CANALE ST, 1991, OPERATIVE PEDIAT ORT, P981; DORMANS JP, 1990, ORTHOP CLIN N AM, V21, P257; Evans MC, 1999, J PEDIATR ORTHOPED, V19, P559, DOI 10.1097/00004694-199909000-00001; FIELDING JW, 1964, J BONE JOINT SURG AM, V46, P1277, DOI 10.2106/00004623-196446060-00014; Gaddy BC, 1997, J PEDIATR ORTHOPED, V17, P321, DOI 10.1097/00004694-199705000-00010; Gicquel P, 2001, J PEDIATR ORTHOPED, V21, P141, DOI 10.1097/00004694-200103000-00001; GREEN NE, 1994, SKELETAL TRAUMA CHIL, P244; HERRING JA, 2002, TACHDJIANS PEDIAT OR, P2194; Jeffery C C, 1972, J Bone Joint Surg Br, V54, P717; KAUFMAN B, 1989, J BONE JOINT SURG BR, V71, P66, DOI 10.1302/0301-620X.71B1.2915009; Leung AG, 2000, J PEDIATR ORTHOPED, V20, P7; OGDEN JA, 2000, SKELETAL INJURY CHIL; PAPAVASILIOU VA, 1987, INJURY, V18, P100, DOI 10.1016/0020-1383(87)90182-3; Patterson RF, 1934, J BONE JOINT SURG, V16, P695; PETERSON HA, 2000, ELBOW ITS DISORDERS, P229; R ang M, 1983, CHILDRENS FRACTURES; REIDY JA, 1963, J BONE JOINT SURG AM, V45, P1355, DOI 10.2106/00004623-196345070-00002; STANS AA, 2000, ELBOW ITS DISORDERS, P236; VITALE MG, 2002, ORTHOPAEDIC KNOWLEDG, V7, P303; WILKINS KE, 1984, FRACTURES CHILDREN, P501	20	6	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	SEP	2009	18	5					252	260		10.1097/BPB.0b013e3283153f7e			9	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	479ZR	WOS:000268701500010	19634209				2022-02-06	
J	Fenton, A				Fenton, Andrew			BUDDHISM AND NEUROETHICS: THE ETHICS OF PHARMACEUTICAL COGNITIVE ENHANCEMENT	DEVELOPING WORLD BIOETHICS			English	Article						neuroethics; bioethics; Buddhist ethics; comparative ethics; cognitive enhancement	TRAUMATIC BRAIN-INJURY	This paper integrates some Buddhist moral values, attitudes and self-cultivation techniques into a discussion of the ethics of cognitive enhancement technologies - in particular, pharmaceutical enhancements. Many Buddhists utilize meditation techniques that are both integral to their practice and are believed to enhance the cognitive and affective states of experienced practitioners. Additionally, Mahyna Buddhism's teaching on skillful means permits a liberal use of methods or techniques in Buddhist practice that yield insight into our selfnature or aid in alleviating or eliminating duhkha (i.e. dissatisfaction). These features of many, if not most, Buddhist traditions will inform much of the Buddhist assessment of pharmaceutical enhancements offered in this paper. Some Buddhist concerns about the effects and context of the use of pharmaceutical enhancements will be canvassed in the discussion. Also, the author will consider Buddhist views of the possible harms that may befall human and nonhuman research subjects, interference with a recipient's karma, the artificiality of pharmaceutical enhancements, and the possible motivations or intentions of healthy individuals pursuing pharmacological enhancement. Perhaps surprisingly, none of these concerns will adequately ground a reflective Buddhist opposition to the further development and continued use of pharmaceutical enhancements, either in principle or in practice. The author argues that Buddhists, from at least certain traditions - particularly Mahyna Buddhist traditions - should advocate the development or use of pharmaceutical enhancements if a consequence of their use is further insight into our self-nature or the reduction or alleviation of duhkha.				atf@dal.ca		Fenton, Andrew/0000-0002-8811-2917	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	The research for this paper was funded in part by a grant from the Canadian Institutes of Health Research. Sincere thanks are owed to Francoise Baylis, the members of the Novel Tech Ethics research team, Sylvia Burrow and an audience at Cape Breton University for helpful comments on earlier drafts of this paper.; Andrew Fenton completed his PhD in the Department of Philosophy at the University of Calgary, Calgary, Alberta. He is currently a postdoctoral fellow and member of the Novel Tech Ethics research team at Dalhousie University and Assistant Professor in the Department of Comparative Religion at Dalhousie. Dr Fenton's research interests include models of nonhuman animal cognition; conceptual and ethical problems arising from current work in neuroscience or its clinical and nonclinical applications; and what non-Western religious traditions like Buddhism can contribute to discussions of the moral status of neurocognitive enhancement technologies.	Babcock Q, 2000, J AM COLL HEALTH, V49, P143, DOI 10.1080/07448480009596296; BERCHOLZ S, 2003, BUDDHA HIS TEACHINGS; BODHI B, DHAMMAPADA PATH DHAM; Bodhi B, 2005, BUDDHAS WORDS ANTHOL; BOUCHER S, 1997, OPENING LOTUS WOMANS; *BUDDH DHARM ED AS, 2007, BUDDH ART ARCH; Conze Edward., 1959, BUDDHIST SCRIPTURES; deBary William Theodore, 1972, BUDDHIST TRADITION I; Farah MJ, 2005, TRENDS COGN SCI, V9, P34, DOI 10.1016/j.tics.2004.12.001; Farah MJ, 2004, NAT REV NEUROSCI, V5, P421, DOI 10.1038/nrn1390; FRANKFURT HG, 1984, PHILOS PHENOMEN RES, V45, P1, DOI 10.2307/2107323; Fuchs T, 2006, CURR OPIN PSYCHIATR, V19, P600, DOI 10.1097/01.yco.0000245752.75879.26; GAZZANIGA MS, 2005, ETHICAL BRAIN SCI OU, P72; Gethin Rupert., 1998, FDN BUDDHISM; Glannon W, 2006, J MED ETHICS, V32, P74, DOI 10.1136/jme.2005.012575; Glannon W, 2006, BIOETHICS, V20, P37, DOI 10.1111/j.1467-8519.2006.00474.x; GOENKA SN, 1993, BUDDHA HIS TEACHINGS, P101; Goldstein J., 1987, SEEKING HEART WISDOM; Grimes JohnA., 1996, CONCISE DICT INDIAN; GUNARATANA B, 2001, VOICES INSIGHT, P133; GYATSO T, 1999, HEART BUDDHAS PATH; GYATSO T, 2005, ESSENCE HEART SUTRA; Hall SS, 2003, SCI AM, V289, P54, DOI 10.1038/scientificamerican0903-54; Hanh T. N., 1998, INTERBEING 14 GUIDEL; Hanh T. N, 1999, HEART BUDDHAS TEACHI; Harvey P., 2000, INTRO BUDDHIST ETHIC; Harvey Peter, 1990, INTRO BUDDHISM TEACH; Hoag H, 2003, NATURE, V423, P796, DOI 10.1038/423796a; KAPLEAU RP, 1980, ZEN DAWN W; KEOWN D, 1996, BUDDHISM VERY SHORT; KEOWN D, 2004, OXFORD DICT BUDDHISM; Keown Damien, 1995, BUDDHISM BIOETHICS; Keown Damien, 2005, BUDDHIST ETHICS VERY; Khema A, 1987, BEING NOBODY GOING N; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; Mitchell DonaldWilliam., 2002, BUDDHISM INTRO BUDDH; *NAL TRANSL COMM, 2003, BUDDH HIS TEACH, P155; *NYU MED CTR NYU S, 2005, AG ASS MEM IMP; *PAC AS MUS, 2007, VIS ENL UND ART BUDD; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Rahula W., 1974, WHAT BUDDHA TAUGHT; RAY RA, 2002, INDESTRUCTIBLE TRUTH; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; THERA N, 2003, BUDDHA IS TEACHINGS, P84; Thera Nyanaponika, 1998, ABHIDHAMMA STUDIES B; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; VARELA FJ, 2003, BUDDHISM SCI BREAKIN, P217; WILLIAMS P, 2001, MAHAYANA BUDDHISM DO; Wolpe PR, 2002, BRAIN COGNITION, V50, P387, DOI 10.1016/S0278-2626(02)00534-1	51	6	6	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1471-8731	1471-8847		DEV WORLD BIOETH	Dev. World Bioeth.	AUG	2009	9	2					47	56		10.1111/j.1471-8847.2007.00226.x			10	Ethics; Medical Ethics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics	471JG	WOS:000268052800002	18312602	Green Submitted			2022-02-06	
J	Gezici, AR; Ergun, R; Karakas, A; Gunduz, B				Gezici, Ali Riza; Ergun, Ruchan; Karakas, Alper; Gunduz, Bulent			Serum Leptin Levels Following Acute Experimental Spinal Cord Injury	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Spinal cord injuries; Neuroprotection		Background/Objective: Spinal cord injury influences many hormones that are known to be involved in the modulation of neurotrophic, neurogenic, and neuroprotective events. Recent studies showed that leptin could be neuroprotective, enhancing neuronal survival in vitro and in vivo. The objective of this study was to evaluate the pattern of the serum leptin levels in rats during acute traumatic SCI. Methods: Forty male Sprague-Dawley rats were divided randomly into 4 groups. In the control group, neither laminectomy nor SCI was performed; only laminectomy was performed without SCI in the sham group. In the cervical and thoracic spinal trauma groups, laminectomies were performed following the same trauma procedure. Blood samples were drawn 2, 6, 12, and 24 hours after the procedures and assayed immediately. Results: In the first 2 hours, levels of leptin were similar in control and sham-operated groups and higher in neurotrauma groups (P < 0.05). At the sixth hour, leptin levels increased in the sham-operated group, decreased in the neurotrauma groups (P < 0.05), and did not change in the control group (P > 0.05). At the 12th hour, the levels of leptin increased in all groups (P > 0.05). At the 24th hour, they decreased in the control, sham-operated, and cervical groups (P < 0.05); levels did not change in the thoracic group (P > 0.05). The decrease was higher in the control group than in the other groups (P < 0.05). Conclusions: Activation of endogenous leptin secretion started immediately after the SCI. The level of neurologic lesion (either cervical or thoracic regions) affected the levels of serum leptin differently, but with the exception of the first 12-hour period, this difference did not reach a statistically significant level.	[Gezici, Ali Riza; Ergun, Ruchan] Abant Izzet Baysal Univ, Dept Neurosurg, Fac Med, Golkoy, Bolu, Turkey; [Karakas, Alper] Abant Izzet Baysal Univ, Dept Biol, Fac Arts & Sci, Golkoy, Bolu, Turkey; [Gunduz, Bulent] Canakkale Onsekiv Mart Univ, Dept Biol, Fac Arts & Sci, Canakkale, Turkey		Gezici, AR (corresponding author), Abant Izzet Baysal Univ, Dept Neurosurg, Fac Med, Golkoy, Bolu, Turkey.	geziciar@gmail.com	Gunduz, Bulent/AAA-5763-2019				Bauman WA, 1996, HORM METAB RES, V28, P732, DOI 10.1055/s-2007-979889; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Commins SP, 1999, ENDOCRINOLOGY, V140, P4772, DOI 10.1210/en.140.10.4772; Correia MLG, 2001, HYPERTENSION, V38, P384, DOI 10.1161/01.HYP.38.3.384; Desborough JP, 1993, ANAESTHESIA REV, V10, P131; Dicou E, 2001, NEUROREPORT, V12, P3947, DOI 10.1097/00001756-200112210-00019; Dunbar JC, 1997, DIABETES, V46, P2040, DOI 10.2337/diabetes.46.12.2040; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Huang TS, 2000, ARCH PHYS MED REHAB, V81, P1582, DOI 10.1053/apmr.2000.9173; Jeon JY, 2003, AM J PHYSIOL-ENDOC M, V284, pE634, DOI 10.1152/ajpendo.00302.2002; Jeon JY, 2003, J CLIN ENDOCR METAB, V88, P402, DOI 10.1210/jc.2002-020939; Kalsbeek A, 2001, ENDOCRINOLOGY, V142, P2677, DOI 10.1210/en.142.6.2677; Krassioukov AV, 1999, SPINAL CORD, V37, P6, DOI 10.1038/sj.sc.3100718; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lu JN, 2006, NEUROSCI LETT, V407, P240, DOI 10.1016/j.neulet.2006.08.053; Maimoun L, 2004, METABOLISM, V53, P989, DOI 10.1016/j.metabol.2004.03.005; Minokoshi Y, 1999, DIABETES, V48, P287, DOI 10.2337/diabetes.48.2.287; Mizuno A, 1998, ENDOCRINOLOGY, V139, P3863, DOI 10.1210/en.139.9.3863; Pinkney JH, 1998, CLIN ENDOCRINOL, V48, P407, DOI 10.1046/j.1365-2265.1998.00480.x; RIVLIN AS, 1978, SURG NEUROL, V10, P39; Russo VC, 2004, ENDOCRINOLOGY, V145, P4103, DOI 10.1210/en.2003-1767; Satoh N, 1999, DIABETES, V48, P1787, DOI 10.2337/diabetes.48.9.1787; SCARBOROUGH DE, 1990, ANN NY ACAD SCI, V594, P169; Scarpace PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE226, DOI 10.1152/ajpendo.1997.273.1.E226; Schramm LP, 2006, PROG BRAIN RES, V152, P27, DOI 10.1016/S0079-6123(05)52002-8; Sinha MK, 1996, J CLIN INVEST, V97, P1344, DOI 10.1172/JCI118551; Sivitz WI, 1999, AM J PHYSIOL-ENDOC M, V277, pE668, DOI 10.1152/ajpendo.1999.277.4.E668; Tang-Christensen M, 1999, J CLIN ENDOCR METAB, V84, P711, DOI 10.1210/jc.84.2.711; Wang YH, 2005, ARCH PHYS MED REHAB, V86, P1964, DOI 10.1016/j.apmr.2005.04.017; Weng Z, 2007, J BIOL CHEM, V282, P34479, DOI 10.1074/jbc.M705426200; Yan Guang-tao, 2006, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V18, P172; Yoo KY, 2006, ANESTH ANALG, V102, P1223, DOI 10.1213/01.ane.0000198429.09694.d3; Zhang F, 2007, STROKE, V38, P2329, DOI 10.1161/STROKEAHA.107.482786; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	34	6	6	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	AUG	2009	32	4					416	421		10.1080/10790268.2009.11753205			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V16HX	WOS:000207861800008	19777863	Green Published			2022-02-06	
J	Stawicki, SP; Holmes, JH; Kallan, MJ; Nance, ML				Stawicki, S. Peter; Holmes, John H.; Kallan, Michael J.; Nance, Michael L.			Fatal child cervical spine injuries in motor vehicle collisions: Analysis using unique linked national datasets	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Cervical spine injury; Paediatric population; Motor vehicular collision fatalities; Injury-mechanism correlation	FRACTURES	Aim: To improve insight into fatal child cervical spine injuries (CSI) caused by motor vehicle collisions. Method: Two large national mortality datasets were linked at the level of the individual decedent to analyse and compare anatomical injuries and vehicle crash characteristics for fatally injured child occupants. Results: Cervical spine injury was identified among 176 of 6065 child (age 0-15 years) motor vehicle occupant fatalities. Presence compared with absence of CSI had significant association with female gender, traumatic brain injury and seat restraint, but not with age, vehicle model, year or type, exposure to airbag, severe vehicle intrusion, collision speed or direction, drivability of the vehicle or seating position. Conclusions: Cervical spine injury, which was uncommon in the studied subset of child decedents, was associated with female gender, the use of passenger restraints and the presence of traumatic brain injury. (C) 2009 Published by Elsevier Ltd.	[Stawicki, S. Peter] Ohio State Univ, Med Ctr, Dept Surg, Div Crit Care Trauma & Burn, Columbus, OH 43210 USA; [Holmes, John H.; Kallan, Michael J.] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Nance, Michael L.] Childrens Hosp Philadelphia, Dept Surg, Philadelphia, PA 19104 USA		Stawicki, SP (corresponding author), Ohio State Univ, Med Ctr, Dept Surg, Div Crit Care Trauma & Burn, Suite 634,395 W 12th Ave, Columbus, OH 43210 USA.	stanislaw.stawicki@osumc.edu		Stawicki, Stanislaw/0000-0002-8893-6668			ANDERSON PA, 1988, SPINE, V13, P731, DOI 10.1097/00007632-198807000-00004; AUFDERMAUR M, 1974, J BONE JOINT SURG BR, VB 56, P513, DOI 10.1302/0301-620X.56B3.513; Augutis M, 2003, SPINAL CORD, V41, P328, DOI 10.1038/sj.sc.3101478; Brown RL, 2001, J PEDIATR SURG, V36, P1107, DOI 10.1053/jpsu.2001.25665; KIRK AJ, 2005, KTC0539TA19051F U KE; MCGRORY BJ, 1993, J BONE JOINT SURG AM, V75A, P988, DOI 10.2106/00004623-199307000-00004; Platzer P, 2007, J TRAUMA, V62, P389, DOI 10.1097/01.ta.0000221802.83549.46; Reddy SP, 2003, PEDIATR RADIOL, V33, P776, DOI 10.1007/s00247-003-1046-y; Vialle LR, 2005, INJURY, V36, P104, DOI 10.1016/j.injury.2005.06.021; WINSTON FK, 2007, AIR BAGS CHILDREN RE	10	6	6	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	AUG	2009	40	8					864	867		10.1016/j.injury.2008.11.011			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	483FU	WOS:000268948800015	19375697				2022-02-06	
J	Vannemreddy, P; Bryan, K; Nanda, A				Vannemreddy, Prasad; Bryan, Kris; Nanda, Anil			Influence of Prayer and Prayer Habits on Outcome in Patients With Severe Head Injury	AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE			English	Article						coma; head injury; prayer; religion	INTERCESSORY PRAYER; RELIGION; CANCER; ATTENDANCE; BELIEFS; HEALTH; SPIRITUALITY; IMMIGRANTS; MEDICINE; SERVICES	Objectives. The objective of the study is to evaluate the effect of prayers on the recovery of the unconscious patients admitted after traumatic brain injury. Material and Results. A retrospective study of patients with severe head injury was conducted. The Glasgow Coma Scale and Glasgow Outcome Scale scores were examined along with age, gender, smoking, and alcohol intake. There were 13 patients who received prayer and 13 who did not receive prayer during the hospital stay with almost identical mean Glasgow Coma Scale score. The prayer group stayed in the hospital for more days (P = .03). On multivariate analysis, patients' age (P = .01), admission Glasgow Coma Scale score (P = .009), and prayer habits (P = .007) were significant factors. Conclusion. Patients with prayers habits recovered better following severe head injury. The role of intercessory prayer needs further studies in larger groups.	[Vannemreddy, Prasad; Bryan, Kris; Nanda, Anil] LSU Hlth Sci Ctr, Dept Neurosurg, Shreveport, LA 71130 USA		Vannemreddy, P (corresponding author), LSU Hlth Sci Ctr, Dept Neurosurg, 1501 Kings Highway, Shreveport, LA 71130 USA.	pvanne@lsuhsc.edu					Braam AW, 1997, ACTA PSYCHIAT SCAND, V96, P199, DOI 10.1111/j.1600-0447.1997.tb10152.x; Bussing Arndt, 2005, Health Qual Life Outcomes, V3, P10, DOI 10.1186/1477-7525-3-10; BYRD RC, 1988, SOUTHERN MED J, V81, P826, DOI 10.1097/00007611-198807000-00005; CARTWRIGHT A, 1991, PUBLIC HEALTH, V105, P79, DOI 10.1016/S0033-3506(05)80320-8; Eisenberg MJ, 2003, CAN J CARDIOL, V19, P1009; FRIEDLANDER Y, 1986, INT J CARDIOL, V10, P33, DOI 10.1016/0167-5273(86)90163-4; GALLUP G, 1990, RELIG AM; GARDNER JW, 1982, AM J EPIDEMIOL, V116, P258, DOI 10.1093/oxfordjournals.aje.a113410; GOLDBOURT U, 1993, CARDIOLOGY, V82, P100, DOI 10.1159/000175862; Hixson KA, 1998, PREV MED, V27, P545, DOI 10.1006/pmed.1998.0321; Hovey JD, 1999, PSYCHOL REP, V85, P171, DOI 10.2466/PR0.85.5.171-177; Idler EL, 1997, J GERONTOL B-PSYCHOL, V52, pS306, DOI 10.1093/geronb/52B.6.S306; Kaczorowski J M, 1989, Hosp J, V5, P105; KING DE, 1994, J FAM PRACTICE, V39, P349; Koenig H G, 1998, New Dir Ment Health Serv, P81; Koenig HG, 2004, SOUTH MED J, V97, P1194, DOI 10.1097/01.SMJ.0000146489.21837.CE; Koenig HG, 1998, SOUTHERN MED J, V91, P925, DOI 10.1097/00007611-199810000-00006; Koenig HG, 2001, ANN PHARMACOTHER, V35, P352, DOI 10.1345/aph.10215; Kristeller JL, 1999, PSYCHO-ONCOLOGY, V8, P451, DOI 10.1002/(SICI)1099-1611(199909/10)8:5<451::AID-PON422>3.0.CO;2-3; Larson R, 1998, Nebr Symp Motiv, V45, P25; Lesniak KT, 2006, ALTERN THER HEALTH M, V12, P42; Levin JS, 1996, SOC SCI MED, V43, P849, DOI 10.1016/0277-9536(96)00150-5; Maugans TA, 1996, ARCH FAM MED, V5, P11, DOI 10.1001/archfami.5.1.11; Murray SA, 2004, PALLIATIVE MED, V18, P39, DOI 10.1191/0269216304pm837oa; OSLER W, 1910, BMJ-BRIT MED J, V2, P1470; Oyama O, 1998, ARCH FAM MED, V7, P431, DOI 10.1001/archfami.7.5.431; Palmer RF, 2004, J ALTERN COMPLEM MED, V10, P438, DOI 10.1089/1075553041323803; Peterman AH, 2002, ANN BEHAV MED, V24, P49, DOI 10.1207/S15324796ABM2401_06; POWELL T, 1995, J CLIN ETHIC, V6, P73; Roberts D, 1997, BRIT J PSYCHIAT, V171, P188, DOI 10.1192/bjp.171.2.188a; ROBERTS L, 2000, COCHRANE DB SYST REV, V1; Seybold KS, 2001, CURR DIR PSYCHOL SCI, V10, P21, DOI 10.1111/1467-8721.00106; Siegrist M, 1996, J SOC PSYCHOL, V136, P559, DOI 10.1080/00224545.1996.9714040; Timio Mario, 1997, Blood Pressure, V6, P81, DOI 10.3109/08037059709061804; Walsh A, 1998, BEHAV MED, V24, P122, DOI 10.1080/08964289809596390	35	6	6	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-9091	1938-2715		AM J HOSP PALLIAT ME	Am. J. Hosp. Palliat. Med.	AUG-SEP	2009	26	4					264	269		10.1177/1049909109331885			6	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	483NP	WOS:000268974000006	19229065				2022-02-06	
J	Hora, EC; de Sousa, RMC				Hora, Edilene Curvelo; Cardoso de Sousa, Regina Marcia			CROSS-CULTURAL ADAPTATION OF THE INSTRUMENT "FAMILY NEEDS QUESTIONNAIRE"	REVISTA LATINO-AMERICANA DE ENFERMAGEM			English	Article						validation studies; translating; brain injuries; family; family nursing	TRAUMATIC BRAIN-INJURY; MEMBERS	This is a quantitative methodological development study on the cross-cultural adaptation of the "Family Needs Questionnaire" (FNQ), which is a structured instrument developed in the United States to measure the perceived needs of family members after the Traumatic Brain Injury (TBI) of a relative. This instrument aims to identify important needs presented by family members, whether met or not. The FNQ translation and adaptation followed a particular method, which permitted to achieve semantic, idiomatic, cultural and conceptual equivalence of the instrument version labeled in Portuguese as "Questionario de Necessidades da Familia". The results of the questionnaire application to 161 family members showed that the instrument content is valid to measure the needs of families of patients with TBI in the Brazilian context.	[Hora, Edilene Curvelo] Univ Fed Sergipe, Sergipe, Brazil; [Cardoso de Sousa, Regina Marcia] Univ Sao Paulo, Escola Enfermagem, BR-05508 Sao Paulo, Brazil		Hora, EC (corresponding author), Univ Fed Sergipe, Sergipe, Brazil.	edilene@ufs.br; vian@usp.br	Sousa, Regina M/H-1108-2012	Sousa, Regina M/0000-0002-2575-7937			Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Freitas KS, 2007, REV LAT-AM ENFERM, V15, P84, DOI 10.1590/S0104-11692007000100013; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; KREUTZER JS, 1998, FAMILY NEEDS QUESTIN; Kreutzer JS, 1989, FAMILY NEEDS QUESTIO; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; SANDER AM, 1999, REHABILITATION ADULT, P1999; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; Serna Edilene Curvelo Hora, 2006, Rev. Latino-Am. Enfermagem, V14, P183; Serna Edilene Curvelo Hora, 2005, Acta paul. enferm., V18, P131, DOI 10.1590/S0103-21002005000200003; SOUSA RMC, 1995, THESIS USP SAO PAULO; Tyerman A, 2001, NEUROREHABILITATION, V16, P59; Waltz CF, 1991, MEASUREMENT NURSING, P161; Watanabe Y, 2000, CLIN REHABIL, V14, P172, DOI 10.1191/026921500666833742	16	6	7	0	6	UNIV SAO PAULO, ESCOLA DE ENFERMAGEM DE RIBEIRAO PRETO	RIBEIRAO PRETO	AV BANDEIRANTES, 3900, RIBEIRAO PRETO, SP 14040-902  A, BRAZIL	1518-8345			REV LAT-AM ENFERM	Rev. Latino-Am. Enfermagem	JUL-AUG	2009	17	4					541	547		10.1590/S0104-11692009000400017			7	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	504FT	WOS:000270602000017	19820863	Green Submitted, gold, Green Published			2022-02-06	
J	Senathi-Raja, D; Ponsford, J; Schonberger, M				Senathi-Raja, Dawn; Ponsford, Jennie; Schoenberger, Michael			ASSOCIATION OF AGE WITH LONG-TERM PSYCHOSOCIAL OUTCOME FOLLOWING TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						brain injuries; traumatic; psychosocial aspects; ageing; employment status; independent living; family relationships; interpersonal relations; leisure activities	HOSPITAL ANXIETY; DEPRESSION SCALE; PREDICTORS; RECOVERY; VALIDITY; RETURN	Objective: To examine the association of age with long-term psychosocial outcome following traumatic brain injury. Participants: One hundred and twelve participants with mild to very severe traumatic brain injury, aged 26-89 years at 5-22 years post-injury, 112 significant others and 112 healthy controls matched for current age, gender, education and estimated IQ. Methods: Changes in occupational activity, interpersonal relationships and independent living skills were assessed in participants with traumatic brain injury using the Sydney Psychosocial Reintegration Scale (SPRS). Employment status of participants with traumatic brain injury and con trol participants was compared at the time of assessment. Results: No age effects were demonstrated on the 3 SPRS domains. However, compared with healthy individuals, older participants with traumatic brain injury showed greater likelihood of unemployment relative to younger participants with traumatic brain injury. Conclusion: By using matched controls this study has demonstrated that older individuals with traumatic brain injury are less likely to return to the workforce than younger individuals with traumatic brain injury. Other aspects of psychosocial outcome appeared to be less affected by age, although specific domains require closer examination in relation to healthy age-matched controls.	[Ponsford, Jennie] Monash Univ, Dept Psychol, Sch Psychol Psychiat & Psychol Med, Clayton, Vic AU3800, Australia; [Ponsford, Jennie; Schoenberger, Michael] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia		Ponsford, J (corresponding author), Monash Univ, Dept Psychol, Sch Psychol Psychiat & Psychol Med, Clayton, Vic AU3800, Australia.	jennie.ponsford@med.monash.edu.au					Australian Bureau of Statistics, 2006, 41530 AUSTR BUR STAT; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; CHAPMAN B, 2003, TRANSFORMATION AUSTR; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Espeland MA, 2007, J GERONTOL A-BIOL, V62, P1237, DOI 10.1093/gerona/62.11.1237; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Kuipers F, 2004, IEEE NETWORK, V18, P16, DOI 10.1109/MNET.2004.1337731; Lang FR, 2002, PSYCHOL AGING, V17, P125, DOI 10.1037//0882-7974.17.1.125; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; O'Connell MJ, 2000, REHABIL PSYCHOL, V45, P212, DOI 10.1037/0090-5550.45.2.212; OCONNOR P, 1999, TRAUMATIC BRAIN INJU; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; PONSFORD J, 1995, BRAIN INJURY, V17, P453; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; REITAN RM, 1988, HALTEAD REITAN NEURO; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Saltapidas H, 2008, BRAIN IMPAIR, V9, P1, DOI 10.1375/brim.9.1.1; SENATHIRAJA DR, 2008, THESIS MONASH U CLAY; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Smith, 1973, SYMBOL DIGIT MODALIT; Soo CA, 2007, BRAIN IMPAIR, V8, P101, DOI DOI 10.1375/BRIM.8.2.101; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; van Tilburg T, 1998, J GERONTOL B-PSYCHOL, V53, pS313, DOI 10.1093/geronb/53B.6.S313; WechslerD, 2001, WECHSLER TEST ADULT; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	33	6	6	0	0	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	JUL	2009	41	8					666	673		10.2340/16501977-0396			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	474WY	WOS:000268316700011					2022-02-06	
J	Xu, ZY; Liu, HD; Lau, LT; Yingge, Z; Zhao, R; Tong, GL; Chan, PH; Yu, ACH				Xu, Zhen Yu; Liu, Hua Dong; Lau, Lok Ting; Yingge, Zhang; Zhao, Rui; Tong, Geng Lei; Chan, Pak Hoo; Yu, Albert Cheung Hoi			Responses of astrocyte to simultaneous glutamate and arachidonic acid treatment	NEUROCHEMISTRY INTERNATIONAL			English	Article; Proceedings Paper	Conference on Glutamate in the Tripartite Synapse - Functional and Metabolic Relations in Norm and Pathology (Wierzba IV)	AUG 23-27, 2008	Wierzba, POLAND	Polish Acad Sci		Astrocyte; Caspase-3; Bcl-2; Hsp70; Synergistic effect; AFM	MITOCHONDRIAL PERMEABILITY TRANSITION; ATOMIC-FORCE MICROSCOPY; TRAUMATIC BRAIN-INJURY; IN-VITRO ISCHEMIA; CELL-DEATH; CORTICAL-NEURONS; PRIMARY CULTURES; ION HOMEOSTASIS; APOPTOSIS; NEURODEGENERATION	After cellular injury many endogenous toxins are released from injured cells and result in secondary injury. To elucidate mechanisms of such injury many of these toxins have been studied individually. However, the data obtained is only useful for reference and does not accurately represent the multifactorial situation under pathophysiological conditions. Primary astrocytic cultures were treated individually and simultaneously with two well-studied toxins, glutamate (Glu) and arachidonic acid (AA). Both are simultaneously released from neural cells during injury. Measurements of cellular protein content, intracellular water space, lactate dehydrogenase release, and malondialdehyde formation indicated that Glu and AA act through different mechanisms. Glu + AA applied together had a synergistic effect on the levels of Caspase-3 gene expression, and Bcl-2 and Hsp70 protein. Atomic force microscopy observed that Glu caused cell membrane roughness and nuclear swelling, while AA induced pores in the cell membrane and nuclear shrinkage. Glu + AA accelerated nuclear shrinkage and resulted in more serious cell damage. This study not only distinguishes the different responses of astrocytes to Glu and AA, but also provides a new view into the synergistic effect of these biochemicals; highlighting the need to be cautious in applying single factor experimental data to interpret complex physiological and pathological conditions in animals. Two or more factors may act not only on different targets but also on the same target synergistically. (C) 2009 Elsevier Ltd. All rights reserved.	[Xu, Zhen Yu; Liu, Hua Dong; Lau, Lok Ting; Zhao, Rui; Yu, Albert Cheung Hoi] Peking Univ, Neurosci Res Inst, Beijing 100191, Peoples R China; [Xu, Zhen Yu; Liu, Hua Dong; Lau, Lok Ting; Zhao, Rui; Yu, Albert Cheung Hoi] Peking Univ, Key Lab Neurosci, Minist Educ, Beijing 100191, Peoples R China; [Xu, Zhen Yu; Liu, Hua Dong; Lau, Lok Ting; Zhao, Rui; Yu, Albert Cheung Hoi] Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Sch Basic Med Sci, Beijing 100191, Peoples R China; [Xu, Zhen Yu; Tong, Geng Lei] Shanghai Jiao Tong Univ, Inst Life Sci & Technol, Shanghai 200240, Peoples R China; [Yingge, Zhang] Beijing Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China; [Chan, Pak Hoo] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA		Yu, ACH (corresponding author), Peking Univ, Neurosci Res Inst, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	achy@haikanglife.com	Lau, Lok Ting/C-3866-2013	Lau, Lok Ting/0000-0001-7517-1486			Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Basselin M, 2006, NEUROPSYCHOPHARMACOL, V31, P1659, DOI 10.1038/sj.npp.1300920; Blomgren K, 2006, FREE RADICAL BIO MED, V40, P388, DOI 10.1016/j.freeradbiomed.2005.08.040; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Chen XQ, 2005, J NEUROSCI RES, V79, P114, DOI 10.1002/jnr.20323; Chen XQ, 2003, GLIA, V42, P315, DOI 10.1002/glia.10185; Chen XQ, 2002, BIOCHEM BIOPH RES CO, V296, P657; Chung TS, 2002, J MEMBRANE SCI, V196, P251, DOI 10.1016/S0376-7388(01)00609-3; Fairman WA, 1998, NAT NEUROSCI, V1, P105, DOI 10.1038/355; Farooqui AA, 1998, CELL MOL NEUROBIOL, V18, P599, DOI 10.1023/A:1020261600498; Farooqui AA, 2004, PROSTAG LEUKOTR ESS, V71, P161, DOI 10.1016/j.plefa.2004.03.004; Ferl RJ, 2002, GENOME BIOL, V3; Friberg H, 2002, BIOCHIMIE, V84, P241, DOI 10.1016/S0300-9084(02)01381-0; Giffard RG, 2008, ANESTHESIOLOGY, V109, P339, DOI 10.1097/ALN.0b013e31817f4ce0; Haag M, 2003, CAN J PSYCHIAT, V48, P195, DOI 10.1177/070674370304800308; Had-Aissouni L, 2002, J PHYSIOLOGY-PARIS, V96, P317, DOI 10.1016/S0928-4257(02)00022-0; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Herbert SP, 2005, MOL BIOL CELL, V16, P3800, DOI 10.1091/mbc.E05-02-0164; Higuchi Y, 2007, LIFE SCI, V80, P1856, DOI 10.1016/j.lfs.2007.02.031; Izumi Y, 2003, VISUAL NEUROSCI, V20, P97, DOI 10.1017/S0952523803202017; Jiang ZJ, 2002, BIOCHEM BIOPH RES CO, V294, P726, DOI 10.1016/S0006-291X(02)00540-5; KLETZIEN RF, 1975, ANAL BIOCHEM, V68, P537, DOI 10.1016/0003-2697(75)90649-1; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATSUBARA C, 1983, ANAL BIOCHEM, V130, P128, DOI 10.1016/0003-2697(83)90659-0; Miyawaki T, 2008, P NATL ACAD SCI USA, V105, P4892, DOI 10.1073/pnas.0800628105; Nowakowski R, 2001, BBA-BIOMEMBRANES, V1514, P170, DOI 10.1016/S0005-2736(01)00365-0; Peng L, 2003, BRAIN RES, V978, P65, DOI 10.1016/S0006-8993(03)02766-5; Penzo D, 2004, J BIOL CHEM, V279, P25219, DOI 10.1074/jbc.M310381200; Schubert D, 2001, J NEUROSCI, V21, P7455, DOI 10.1523/JNEUROSCI.21-19-07455.2001; Scorrano L, 2001, J BIOL CHEM, V276, P12035, DOI 10.1074/jbc.M010603200; Setroikromo R, 2007, CELL STRESS CHAPERON, V12, P320, DOI 10.1379/CSC-279.1; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Soane L, 2005, J BIOENERG BIOMEMBR, V37, P179, DOI 10.1007/s10863-005-6590-8; Spehr M, 2002, J NEUROSCI, V22, P8429; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Taylor AL, 2002, J BIOL CHEM, V277, P43881, DOI 10.1074/jbc.M205872200; von Engelhardt J, 2007, NEUROPHARMACOLOGY, V53, P10, DOI 10.1016/j.neuropharm.2007.04.015; Weissmuller G, 2000, NEUROSCI RES, V38, P217, DOI 10.1016/S0168-0102(00)00159-0; Xu JF, 2003, FREE RADICAL BIO MED, V34, P1531, DOI 10.1016/S0891-5849(03)00152-7; Yang CZ, 2008, NEUROCHEM RES, V33, P2480, DOI 10.1007/s11064-008-9758-x; YU ACH, 1986, J NEUROCHEM, V47, P1181; Yu ACH, 2003, J NEUROSCI RES, V74, P318, DOI 10.1002/jnr.10742; YU ACH, 1989, J CEREBR BLOOD F MET, V9, P20, DOI 10.1038/jcbfm.1989.3; Yu ACH, 2007, J NEUROSCI RES, V85, P3457, DOI 10.1002/jnr.21345; Yu M, 2004, BIOMATERIALS, V25, P3655, DOI 10.1010/j.biomaterials.2003.10.061; ZERANGUE N, 1995, J BIOL CHEM, V270, P6433, DOI 10.1074/jbc.270.12.6433; Zhang YG, 2003, J STRUCT BIOL, V144, P327, DOI 10.1016/j.jsb.2003.09.022	49	6	6	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JUL-SEP	2009	55	1-3					143	150		10.1016/j.neuint.2009.02.016			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	448ST	WOS:000266283000022	19428819				2022-02-06	
J	Al-Holou, WN; O'Hara, EA; Cohen-Gadol, AA; Maher, CO				Al-Holou, Wajd N.; O'Hara, Edward A.; Cohen-Gadol, Aaron A.; Maher, Cormac O.			Nonaccidental head injury in children Historical vignette	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						nonaccidental trauma; child abuse; history; Auguste Ambroise Tardieu; Wilfred Trotter	CHRONIC SUBDURAL-HEMATOMA; PERMANENT BRAIN-DAMAGE; SHAKEN BABY SYNDROME; WHIPLASH; PACHYMENINGITIS; INFANTS; TRAUMA; MANIFESTATIONS; SHAKING; INTERNA	Our current understanding of nonaccidental head injury in children is the result of decades of effort and the tireless work of numerous physicians. In 1860 Auguste Ambroise Tardieu, a French forensics expert, recognized important patterns of: injury in children and identified nonaccidental trauma as the cause of these injuries. His work was ignored. In the years that followed. physicians continued to report these patterns of injury but were unable to identify the etiology. A fundamental misunderstanding of the usual cause of subdural hematoma (SDH) contributed to the confusion at that time. Early in the 20th century, neurosurgeons Such as Wilfred Trotter recognized that SDHs were traumatic in origin. However, even Trotter's efforts to expose faults in the theories that SDHs primarily resulted from inflammatory or infectious processes were not accepted immediately. Eventually, the pattern of injuries in children was again recognized both by neurosurgeons, who began to identify an association between trauma-induced SDHs and retinal hemorrhages, and by radiologists, who began to note SDHs in conjunction with osseous lesions. Not until the 1950s and 1960s. however. did physicians begin to routinely identify nonaccidental trauma as the cause of these injuries. Following the recognition of child abuse, a pattern Of injuries in conjunction with shaking was identified and is Currently known as shaken baby syndrome. Since its identification. our Understanding of this syndrome has been modified its a result of new medical research. legal challenges. and popular media forces. (DOI: 10.3171/2009.1.PEDS08365)	[Al-Holou, Wajd N.; Maher, Cormac O.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [O'Hara, Edward A.; Cohen-Gadol, Aaron A.] Indiana Univ, Sch Med, Indianapolis, IN USA; [O'Hara, Edward A.; Cohen-Gadol, Aaron A.] Indianapolis Neurosurg Grp, Indianapolis, IN USA		Maher, CO (corresponding author), Univ Michigan Hlth Syst, Dept Neurosurg, 1500 E Med Ctr Dr,Room 3552 TC, Ann Arbor, MI 48109 USA.	cmaher@umich.edu		Cohen-Gadol, Aaron/0000-0002-4946-1524			ADAMS JH, 1986, ARCH PATHOL LAB MED, V110, P485; Bandak FA, 2005, FORENSIC SCI INT, V151, P71, DOI 10.1016/j.forsciint.2005.02.033; BLACK SPW, 1983, SURG NEUROL, V19, P199, DOI 10.1016/S0090-3019(83)80001-9; BOWEN WH, 1905, GUYS HOSP REP, V59, P21; Burhans CW, 1923, J AMER MED ASSOC, V80, P0604, DOI 10.1001/jama.1923.02640360012005; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAFFEY J, 1946, AM J ROENTGENOL, V56, P163; CAFFEY J, 1972, AM J ROENTGENOL, V114, P217; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; CLARK M, 1956, NEWSWEEK, V48, P90; Cushing H, 1905, AM J MED SCI, V130, P563, DOI 10.1097/00000441-190510000-00001; DEBRE R, 1926, JAMA-J AM MED ASSOC, V86, P1488; DOEHLE, 1890, VERH 10 INT MED C GE, V5, P40; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; ELLIOTT TR, 1941, OBIT NOT FELL R SOC, V3, P325; FERRIER PE, 1985, CHILD ABUSE NEGLECT, V9, P133, DOI 10.1016/0145-2134(85)90001-8; FINKELSTEIN H, 1905, LEHRBUCH SAUGLINGSKR, P226; FISHER S H, 1958, South Med J, V51, P956, DOI 10.1097/00007611-195808000-00003; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; George KS, 2005, BRIT J ORAL MAX SURG, V43, P500, DOI 10.1016/j.bjoms.2005.01.021; Girdany B R, 1979, AJR Am J Roentgenol, V132, P149; GRISCOM NT, 1995, RADIOLOGY, V194, P513, DOI 10.1148/radiology.194.2.7824734; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; GWINN JL, 1961, JAMA-J AM MED ASSOC, V176, P926, DOI 10.1001/jama.1961.03040240032011; Hada B, 1913, VIRCHOWS ARCH A, V215, P206; Hahn H, 1911, DEUT MED WOCHENSCHR, V37, P1518, DOI 10.1055/s-0028-1130876; HARCOURT B, 1971, BMJ-BRIT MED J, V3, P398, DOI 10.1136/bmj.3.5771.398; HELFER RE, 1968, BATTERED CHILD; HENSCHEN K, 1912, ARCH KLIN CHIR, V99, P67; HERTER CA, 1898, AM J M SC, V116, P202; Ingalls TH, 1936, NEW ENGL J MED, V215, P1279, DOI 10.1056/NEJM193612312152704; Ingraham FD, 1944, J PEDIATR-US, V24, P1, DOI 10.1016/S0022-3476(44)80138-X; Ingraham FD, 1939, J AMER MED ASSOC, V112, P198, DOI 10.1001/jama.1939.02800030008003; Kairys SW, 2001, PEDIATRICS, V108, P206; KALTER H, 2007, MORTALITY MALDEVEL 1; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004; KIFFNEY GT, 1964, ARCH OPHTHALMOL-CHIC, V72, P231; Kowitz HL, 1914, VIRCHOWS ARCH A, V215, P233, DOI 10.1007/BF01993352; Labbe J, 2005, CHILD ABUSE NEGLECT, V29, P311, DOI 10.1016/j.chiabu.2005.03.002; LINDENBERG R, 1969, ARCH PATHOL, V87, P298; LIS EF, 1950, PEDIATRICS, V6, P890; MALT R A, 1957, N Engl J Med, V257, P933, DOI 10.1056/NEJM195711072571908; MEIGS G, 1913, JAMA-J AM MED ASSOC, V61, P2186; *NAT CTR SHAK BAB, 2008, HIST MISS; *NY SOC PREV CRUEL, 2008, NYSPCC PROGR; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1969, LANCET, V2, P237; PARKINSON J, 1800, VILLAGERS FRIEND PHY; Peet MM, 1932, J AMER MED ASSOC, V98, P1851, DOI 10.1001/jama.1932.02730480001001; Pilcher R S, 1973, Ann R Coll Surg Engl, V53, P71; Putnam TJ, 1925, ARCH SURG-CHICAGO, V11, P329, DOI 10.1001/archsurg.1925.01120150002001; RADBILL SX, 1968, BATTERED CHILD, V1, P3; Roche AJ, 2005, CHILD ABUSE NEGLECT, V29, P325, DOI 10.1016/j.chiabu.2004.04.007; Rosen IB, 2006, CAN J SURG, V49, P278; ROSENBERG D, 1921, ERGEBNUSSE INNEREN M, P549; ROSENBERG O, 1920, DEUT MED WOCHENSCHR, V46, P1348; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; Shedd DP, 1996, HEAD NECK-J SCI SPEC, V18, P366, DOI 10.1002/1097-0347(199607/08)18:4<366::AID-HED2880180403>3.0.CO;2-F; SHEPHERD JR, 1987, BATTERED CHILD, P392; Sherwood D, 1930, AM J DIS CHILD, V39, P980; SILVERMAN FN, 1953, AM J ROENTGENOL, V69, P413; SILVERMAN FN, 1972, RADIOLOGY, V104, P337, DOI 10.1148/104.2.337; SILVERMAN FN, 1965, J PEDIATR-US, V67, P1000, DOI 10.1016/S0022-3476(65)82097-2; SMITH MJ, 1950, AM J ROENTGENOL, V63, P342; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; *SOC BRIT NEUR SUR, 2008, PREV SBNS PRES; Sutherland G. A., 1894, BRAIN, V17, P27; TARDIEU A, 1868, ETUDE MED LEGALE INF; TARDIEU A, 1879, ETUDE MED LEGALE INF; TARDIEU A, 1860, ANN HYG PUBLIQUE MED, V13, P361, DOI DOI 10.3917/EP.039.0174; Trotter W, 1914, BRIT J SURG, V2, P271, DOI 10.1002/bjs.1800020608; Trotter W., 1941, COLLECTED PAPERS W T; TROTTER W, 1920, INSTINCTS HERD PEACE; United Nations Department of Economic and Social Affairs, 2007, WORLD POP PROSP 2006; Virchow R., 1857, VERH PHYS MED GES WU, V7, P134; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185; WEST S, 1888, BRIT MED J, V1, P856; Wiglesworth J., 1892, BRAIN, V15, P431; Willman KY, 1997, CHILD ABUSE NEGLECT, V21, P929, DOI 10.1016/S0145-2134(97)00054-9; Wohlwill F, 1913, VIRCHOWS ARCH A, V214, P388, DOI 10.1007/BF01994120; WOOLLEY PV, 1955, JAMA-J AM MED ASSOC, V158, P539, DOI 10.1001/jama.1955.02960070015005; ZACCHIAS P, 1951, QUAESTIONES MED LEGA; 1940, BR J SURG, V27, P625	86	6	6	2	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUN	2009	3	6					474	483		10.3171/2009.1.PEDS08365			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	451HK	WOS:000266461100008	19485731				2022-02-06	
J	Soliva-Vila, JC; Vilarroya-Oliver, O				Soliva-Vila, J. C.; Vilarroya-Oliver, O.			STRUCTURAL MAGNETIC RESONANCE IMAGING FINDINGS AS AN AID TO EXPLAIN THE NEUROBIOLOGY OF ATTENTION DEFICIT HYPERACTIVITY DISORDER: TOWARDS THE IDENTIFICATION OF A NEUROANATOMICAL PHENOTYPE	REVISTA DE NEUROLOGIA			Spanish	Article						ADHD; Anatomy; Attention deficit hyperactivity disorder; Magnetic resonance imaging; Review; sMRI; Structural magnetic resonance imaging	CORPUS-CALLOSUM MORPHOLOGY; CLOSED-HEAD INJURY; DEFICIT/HYPERACTIVITY DISORDER; CAUDATE-NUCLEUS; BASAL GANGLIA; QUANTITATIVE MORPHOLOGY; DEVELOPMENTAL DYSLEXIA; MORPHOMETRIC ANALYSIS; RESPONSE-INHIBITION; CHILDREN	Introduction. Attention deficit hyperactivity disorder (ADHD) is a highly prevalent mental disorder in childhood. From the nineties, structural MRI has been used in the study of the neurobiological bases of ADHD. Aims. To summarize and to analyze the main findings reported in the structural MRI studies of ADHD. Development. A Medline search of MRI studies e,examining ADHD neuroanatomy from 1990 until 2006 was conducted. Most of the reviewed articles carried out morphometric analysis of selected regions of interest. The more thoroughly examined regions of interest were the frontal lobes and the caudate nuclei. The most replicated positive finding was the decreased volume of the right prefrontal region (5 studies). The most replicated negative finding (5 studies) was the not-mal volume of the left prefrontal region. The right caudate nucleus was reported to be diminished in almost all the studies (4 out of 5) with a sample size equal or greater than 30. Among the regions of interest not pertaining to the fronto-striatal circuits. the total brain volume (9 out of 17) mid morphometric variables associated to corpus callosum and cerebellum encompass most of the positive findings. Conclusion. These findings support tire involvement of the right fronto-striatal circuit in the neurobiology of ADHD. The diminished right caudate nucleus volume could be a fenotypical trait of pediatric ADHD. The intrinsic heterogeneity of ADHD and methodological issues are the main factors accounting for the observed discrepancies. [REV NEUROL 2009; 48: 592-8]	[Soliva-Vila, J. C.; Vilarroya-Oliver, O.] Univ Autonoma Barcelona, Dept Psiquiatria & Med Legal, URNC, E-08193 Barcelona, Spain		Soliva-Vila, JC (corresponding author), Hosp del Mar, Ctr Forum, Llull 410, E-08019 Barcelona, Spain.	24744jsv@comb.es	vilarroya, oscar/K-7021-2013; Vilarroya, Oscar/AAH-3283-2021	Vilarroya, Oscar/0000-0001-8285-5624			ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; American Psychiatric Association, 2002, DSM 4 TR MAN DIAGN E; Ashtari M, 2005, BIOL PSYCHIAT, V57, P448, DOI 10.1016/j.biopsych.2004.11.047; Aylward EH, 1996, J CHILD NEUROL, V11, P112, DOI 10.1177/088307389601100210; BARKLEY RA, 1997, TDAH NATURE SELF CON; Baumgardner TL, 1996, NEUROLOGY, V47, P477, DOI 10.1212/WNL.47.2.477; Berquin PC, 1998, NEUROLOGY, V50, P1087, DOI 10.1212/WNL.50.4.1087; Biederman J, 2005, BIOL PSYCHIAT, V57, P1215, DOI 10.1016/j.biopsych.2004.10.020; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Booth JR, 2005, J CHILD PSYCHOL PSYC, V46, P94, DOI 10.1111/j.1469-7610.2004.00337.x; Bussing Regina, 2002, World J Biol Psychiatry, V3, P216, DOI 10.3109/15622970209150624; Cardo E, 2008, Rev Neurol, V46 Suppl 1, pS51; Carmona S, 2005, NEUROSCI LETT, V389, P88, DOI 10.1016/j.neulet.2005.07.020; Casey BJ, 1997, J AM ACAD CHILD PSY, V36, P374, DOI 10.1097/00004583-199703000-00016; Castellanos FX, 2001, ARCH GEN PSYCHIAT, V58, P289, DOI 10.1001/archpsyc.58.3.289; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; CASTELLANOS FX, 1994, AM J PSYCHIAT, V151, P1791; Castellanos FX, 2003, AM J PSYCHIAT, V160, P1693, DOI 10.1176/appi.ajp.160.9.1693; Castellanos FX, 2002, REV NEUROLOGIA, V35, P1; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; Castellanos FX, 1996, NEUROLOGY, V47, P1581, DOI 10.1212/WNL.47.6.1581; Desmond JE, 1998, NEUROIMAGE, V7, P368, DOI 10.1006/nimg.1998.0340; Durston S, 2004, J AM ACAD CHILD PSY, V43, P332, DOI 10.1097/00004583-200403000-00016; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Filipek PA, 1997, NEUROLOGY, V48, P589, DOI 10.1212/WNL.48.3.589; Foster LM, 2002, J INT NEUROPSYCH SOC, V8, P22, DOI 10.1017/S1355617701020033; Gerring J, 2000, BRAIN INJURY, V14, P205; GIEDD JN, 1994, AM J PSYCHIAT, V151, P665; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; Hesslinger B, 2002, NEUROSCI LETT, V328, P319, DOI 10.1016/S0304-3940(02)00554-2; Hill DE, 2003, NEUROPSYCHOLOGY, V17, P496, DOI 10.1037/0894-4105.17.3.496; HYND GW, 1991, J LEARN DISABIL, V24, P141, DOI 10.1177/002221949102400302; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; HYND GW, 1993, J CHILD NEUROL, V8, P339, DOI 10.1177/088307389300800409; Jucaite A, 2005, BIOL PSYCHIAT, V57, P229, DOI 10.1016/j.biopsych.2004.11.009; Kates WR, 2002, PSYCHIAT RES-NEUROIM, V116, P63, DOI 10.1016/S0925-4927(02)00066-5; Lyoo IK, 1996, BIOL PSYCHIAT, V40, P1060; Mataro M, 1997, ARCH NEUROL-CHICAGO, V54, P963, DOI 10.1001/archneur.1997.00550200027006; Max JE, 2002, J AM ACAD CHILD PSY, V41, P563, DOI 10.1097/00004583-200205000-00014; Max JE, 2005, J AM ACAD CHILD PSY, V44, P443, DOI 10.1097/01.chi.0000156661.38576.0f; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Mostofsky SH, 1998, J CHILD NEUROL, V13, P434, DOI 10.1177/088307389801300904; Mostofsky SH, 2002, BIOL PSYCHIAT, V52, P785, DOI 10.1016/S0006-3223(02)01412-9; Mulas F, 2007, Rev Neurol, V44 Suppl 3, pS47; Nopoulos P, 2000, J CHILD NEUROL, V15, P102, DOI 10.1177/088307380001500208; OKUSKY J, 1988, ANN NEUROL, V24, P379, DOI 10.1002/ana.410240305; Overmeyer S, 2001, PSYCHOL MED, V31, P1425, DOI 10.1017/S0033291701004706; Overmeyer S, 2000, DEV MED CHILD NEUROL, V42, P8, DOI 10.1017/S0012162200000037; PETERSON BS, 1994, PSYCHIAT RES-NEUROIM, V55, P85, DOI 10.1016/0925-4927(94)90003-5; Pineda DA, 2002, J CHILD NEUROL, V17, P97, DOI 10.1177/088307380201700202; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Pueyo R, 2000, REV NEUROLOGIA, V30, P920, DOI 10.33588/rn.3010.2000026; Pueyo R, 2003, COGN BEHAV NEUROL, V16, P75, DOI 10.1097/00146965-200303000-00009; Rubia K, 2007, BIOL PSYCHIAT, V62, P999, DOI 10.1016/j.biopsych.2007.02.024; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Semrud-Clikeman M, 2000, J AM ACAD CHILD PSY, V39, P477, DOI 10.1097/00004583-200004000-00017; SEMRUDCLIKEMAN M, 1994, J AM ACAD CHILD PSY, V33, P875, DOI 10.1097/00004583-199407000-00014; Shafritz KM, 2004, AM J PSYCHIAT, V161, P1990, DOI 10.1176/appi.ajp.161.11.1990; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Sowell ER, 2003, LANCET, V362, P1699, DOI 10.1016/S0140-6736(03)14842-8; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799	61	6	7	0	6	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	JUN 1	2009	48	11					592	598		10.33588/rn.4811.2008337			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	454ZO	WOS:000266724100007	19472158				2022-02-06	
J	Jiang, H; Stein, BE; McHaffie, JG				Jiang, Huai; Stein, Barry E.; McHaffie, John G.			Cortical Lesion-Induced Visual Hemineglect Is Prevented by NMDA Antagonist Pretreatment	JOURNAL OF NEUROSCIENCE			English	Article							NIGRA PARS RETICULATA; LATERAL SUPRASYLVIAN CORTEX; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN INJURY; ANTERIOR ECTOSYLVIAN CORTEX; IBOTENIC ACID LESIONS; EARLY GENE-EXPRESSION; SUPERIOR COLLICULUS; SUBSTANTIA-NIGRA; BASAL GANGLIA	Large unilateral visual cortex lesions produce enduring contralesional visual orientation deficits. To examine whether glutamate excitotoxicity is involved in establishing these deficits, cats were pretreated with the NMDA receptor antagonist dizocilpine (MK-801) 30 min before unilateral visual cortex ablation. Pretreated MK-801 animals were trained first in an orientation task in which they were required to fixate directly ahead and then orient to stimuli introduced at various eccentricities throughout the visual field. They did not display the characteristic ipsilesional head and neck asymmetries and/or spontaneous ipsiversive rotational behaviors or show the profound contralesional visual neglect seen postoperatively in nonpretreated control animals. Rather, pretreated animals were able to orient to visual stimuli in the contralesional hemifield immediately following surgical recovery. Postmortem histology revealed severe retrograde degeneration of the ipsilesional lateral geniculate nucleus in both experimental groups, suggesting that postlesion visuomotor behavioral competencies in pretreated animals are attributable to preserved function in nongeniculocortical visual pathways. These observations are consistent with the hypothesis that visual cortex lesions normally induce secondary alterations via NMDA-mediated excitotoxicity in these other pathways that prevents them from supporting visuomotor behaviors. The similar behavioral competencies of MK-801-pretreated animals and those whose lesion-induced deficits are ameliorated by removing basal ganglia afferents to the ipsilesional superior colliculus are consistent with this hypothesis and highlight the normal functional capabilities of this circuit. It is likely that MK-801 pretreatment acts, at least in part, by preserving the normal interhemispheric control dynamics with which the basal ganglia influence superior colliculus-mediated orientation behaviors.	[Jiang, Huai; Stein, Barry E.; McHaffie, John G.] Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27157 USA		McHaffie, JG (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	mchaffie@wfubmc.edu		Stein, Barry/0000-0001-8089-1779	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS35008, NS36916, EY016716]; Harry O. Parker Neurosciences Research Fund; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY016716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035008, R01NS036916] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (Grant NS35008 to J.G.M. and Grants NS36916 and EY016716 to B.E.S.) and a grant from the Harry O. Parker Neurosciences Research Fund.	Albin Roger L., 1995, Trends in Neurosciences, V18, P63, DOI 10.1016/0166-2236(95)93872-U; ANDERSON M, 1977, BRAIN RES, V137, P361, DOI 10.1016/0006-8993(77)90347-X; ANDERSON ME, 1980, J NEUROPHYSIOL, V43, P883, DOI 10.1152/jn.1980.43.4.883; BARTH TM, 1990, STROKE, V21, P153; BECKSTEAD RM, 1983, EXP BRAIN RES, V52, P261; BECKSTEAD RM, 1981, J NEUROSCI, V1, P121; Berretta S, 1997, J NEUROSCI, V17, P4752; BERSON DM, 1982, J NEUROPHYSIOL, V47, P700, DOI 10.1152/jn.1982.47.4.700; BULLOCK R, 1992, J NEUROTRAUM, V9, pS443; Calabresi P, 1996, TRENDS NEUROSCI, V19, P19, DOI 10.1016/0166-2236(96)81862-5; CHEN M, 1991, ANN NEUROL, V30, P62, DOI 10.1002/ana.410300112; CHEVALIER G, 1985, BRAIN RES, V334, P215, DOI 10.1016/0006-8993(85)90213-6; CHEVALIER G, 1984, EXP BRAIN RES, V53, P320; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; CHOI DW, 1987, J NEUROSCI, V7, P357; Ciaramitaro VM, 1997, J COMP NEUROL, V377, P596; Ciaramitaro VM, 1997, J COMP NEUROL, V387, P568, DOI 10.1002/(SICI)1096-9861(19971103)387:4<568::AID-CNE7>3.0.CO;2-0; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Doubell TP, 2003, J NEUROSCI, V23, P6596; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; Gabriele ML, 2007, BRAIN RES, V1173, P66, DOI 10.1016/j.brainres.2007.07.055; GERFEN CR, 1982, J COMP NEUROL, V207, P283, DOI 10.1002/cne.902070308; GILL R, 1987, J NEUROSCI, V7, P3343; Girman SV, 2007, J NEUROPHYSIOL, V98, P161, DOI 10.1152/jn.00059.2007; GLICK SD, 1988, BRAIN RES, V455, P43, DOI 10.1016/0006-8993(88)90112-6; HARA H, 1993, BRAIN RES, V618, P251, DOI 10.1016/0006-8993(93)91273-U; HARDY SC, 1988, J COMP NEUROL, V273, P527, DOI 10.1002/cne.902730408; HARTING JK, 1992, J COMP NEUROL, V324, P379, DOI 10.1002/cne.903240308; HARTING JK, 1976, J COMP NEUROL, V166, P133, DOI 10.1002/cne.901660202; Harting JK, 2001, EXP BRAIN RES, V136, P138, DOI 10.1007/s002210000606; Harting JK, 2001, EUR J NEUROSCI, V14, P893, DOI 10.1046/j.0953-816x.2001.01712.x; HARTING JK, 1988, J COMP NEUROL, V278, P615, DOI 10.1002/cne.902780412; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1285, DOI 10.1152/jn.1983.49.5.1285; Hoane MR, 1998, BRAIN RES BULL, V45, P45, DOI 10.1016/S0361-9230(97)00288-8; Hoane MR, 1997, RESTOR NEUROL NEUROS, V11, P71, DOI 10.3233/RNN-1997-111208; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; JASPERS RMA, 1989, NEUROSCIENCE, V28, P159, DOI 10.1016/0306-4522(89)90240-6; JIANG H, 1994, EXP BRAIN RES, V101, P385; Jiang H, 2003, NATURE, V423, P982, DOI 10.1038/nature01698; JIANG H, 1994, EXP BRAIN RES, V97, P404; JONES TA, 1992, BEHAV BRAIN RES, V51, P1, DOI 10.1016/S0166-4328(05)80306-7; JOSEPH JP, 1985, EXP BRAIN RES, V57, P286; KANASEKI T, 1974, J COMP NEUROL, V158, P319, DOI 10.1002/cne.901580307; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lee PH, 1997, P NATL ACAD SCI USA, V94, P13299, DOI 10.1073/pnas.94.24.13299; LOOP MS, 1977, J COMP NEUROL, V174, P79, DOI 10.1002/cne.901740106; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; MAY PJ, 1986, NEUROSCIENCE, V19, P159, DOI 10.1016/0306-4522(86)90013-8; MAY PJ, 1984, J COMP NEUROL, V226, P357, DOI 10.1002/cne.902260306; McHaffie JG, 2005, TRENDS NEUROSCI, V28, P401, DOI 10.1016/j.tins.2005.06.006; MCHAFFIE JG, 1993, PROG BRAIN RES, V95, P139, DOI 10.1016/S0079-6123(08)60364-7; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; McIntosh TK, 1996, EUR J ANAESTH, V13, P291, DOI 10.1046/j.1365-2346.1996.00981.x; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Miyabe M, 1997, CRIT CARE MED, V25, P1037, DOI 10.1097/00003246-199706000-00022; MORGAN S, 1983, BRAIN RES BULL, V11, P721, DOI 10.1016/0361-9230(83)90014-X; MUCKE L, 1982, EXP BRAIN RES, V46, P1; NEUMANN S, 1982, BEHAV BRAIN RES, V4, P377, DOI 10.1016/0166-4328(82)90062-6; Niida T, 1997, J NEUROSCI, V17, P8550; NORITA M, 1991, NEUROSCI RES, V10, P149, DOI 10.1016/0168-0102(91)90037-Y; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; OGASAWARA K, 1984, J NEUROPHYSIOL, V52, P1226, DOI 10.1152/jn.1984.52.6.1226; OZYURT E, 1988, J CEREBR BLOOD F MET, V8, P138, DOI 10.1038/jcbfm.1988.18; Parthasarathy HB, 1997, J NEUROSCI, V17, P2477; Payne BR, 1996, P NATL ACAD SCI USA, V93, P290, DOI 10.1073/pnas.93.1.290; PRITZEL M, 1981, BEHAV BRAIN RES, V3, P43, DOI 10.1016/0166-4328(81)90027-9; Ptito A, 2001, PROG BRAIN RES, V134, P367; Rohlfs A, 1997, BRAIN RES, V761, P352, DOI 10.1016/S0006-8993(97)00475-7; ROSENQUIST AC, 1971, EXP NEUROL, V33, P629, DOI 10.1016/0014-4886(71)90133-6; ROSENQUIST AC, 1985, CEREB CORTEX, P81; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SCHALLERT T, 1990, STROKE, V21, P143; SHERMAN SM, 1974, SCIENCE, V185, P355, DOI 10.1126/science.185.4148.355; SHERMAN SM, 1977, J COMP NEUROL, V172, P211, DOI 10.1002/cne.901720203; SPRAGUE JM, 1966, SCIENCE, V153, P1544, DOI 10.1126/science.153.3743.1544; SPRAGUE JM, 1965, EXP NEUROL, V11, P115, DOI 10.1016/0014-4886(65)90026-9; Stein BE., 1993, MERGING SENSES; Stoerig P, 1997, BRAIN, V120, P535, DOI 10.1093/brain/120.3.535; VEZZANI A, 1989, J PHARMACOL EXP THER, V249, P278; VONMONAKOW C, 1914, LOKALISATION GROBHIR; WALLACE MC, 1992, J NEUROSURG, V76, P127, DOI 10.3171/jns.1992.76.1.0127; WALLACE SF, 1990, J COMP NEUROL, V296, P222, DOI 10.1002/cne.902960204; WALLACE SF, 1989, J COMP NEUROL, V284, P429, DOI 10.1002/cne.902840309; WEICK BG, 1987, BRAIN RES, V405, P234, DOI 10.1016/0006-8993(87)90293-9; WICKELGREN BG, 1969, J NEUROPHYSIOL, V32, P16, DOI 10.1152/jn.1969.32.1.16	90	6	6	0	2	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	MAY 27	2009	29	21					6917	6925		10.1523/JNEUROSCI.3125-08.2009			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	450YV	WOS:000266438800017	19474318	Bronze, Green Published, Green Accepted			2022-02-06	
J	Noppens, R; Mobus, S; Werner, C; Piepho, T				Noppens, R. R.; Moebus, S.; Werner, C.; Piepho, T.			Airway management in a patient with immobilized cervical spine	ANAESTHESIST			German	Article						Videolaryngoscope; Laryngoscope; Intubation; Airway management; Cervical spine injury	BONFILS INTUBATION FIBERSCOPE; TRACHEAL INTUBATION; MACINTOSH LARYNGOSCOPE; MCGRATH(R) VIDEOLARYNGOSCOPE; GLIDESCOPE(R); DIFFICULT; AIRTRAQ(R); MOVEMENT	The McGrathA (R) videolaryngoscope was used in a patient with immobilized cervical spine and suspected difficult airway after a high level fall with traumatic brain injury and suspected cervical spine trauma. The airway was successfully secured in the preclinical setting using an oral endotracheal tube with full view of the glottis. Because videolaryngoscopy offers potential advantages compared to established airway management techniques, further studies are required to evaluate the significance of videolaryngoscopy in prehospital emergency medicine.	[Noppens, R. R.; Moebus, S.; Werner, C.; Piepho, T.] Johannes Gutenberg Univ Mainz, Anasthesiol Klin, D-55131 Mainz, Germany		Noppens, R (corresponding author), Johannes Gutenberg Univ Mainz, Anasthesiol Klin, Langenbeckstr 1, D-55131 Mainz, Germany.	noppens@uni-mainz.de					Agro F, 2003, BRIT J ANAESTH, V90, P705, DOI 10.1093/bja/aeg560; Beck A, 2002, NOTFALL RETTUNGSMED, V5, P57; Byhahn C, 2008, CAN J ANAESTH, V55, P232, DOI 10.1007/BF03021507; CORMACK RS, 1984, ANAESTHESIA, V39, P1105, DOI 10.1111/j.1365-2044.1984.tb08932.x; Cross P, 2007, CAN J ANAESTH, V54, P588, DOI 10.1007/BF03022329; Enomoto Y, 2008, BRIT J ANAESTH, V100, P544, DOI 10.1093/bja/aen002; Goutcher CM, 2005, BRIT J ANAESTH, V95, P344, DOI 10.1093/bja/aei190; Halligan M, 2003, ANAESTHESIA, V58, P1087, DOI 10.1046/j.1365-2044.2003.03407.x; Hapgood A, 2008, ANAESTHESIA, V63, P889, DOI 10.1111/j.1365-2044.2008.05620.x; HEATH KJ, 1994, ANAESTHESIA, V49, P843, DOI 10.1111/j.1365-2044.1994.tb04254.x; Hirabayashi Y, 2008, ANAESTHESIA, V63, P635, DOI 10.1111/j.1365-2044.2008.05480.x; Jones PM, 2007, CAN J ANAESTH, V54, P21, DOI 10.1007/BF03021895; Kill C, 2007, ANASTH INTENSIV NOTF, V42, P708, DOI 10.1055/s-2007-993020; Kim HJ, 2008, EMERG MED J, V25, P279, DOI 10.1136/emj.2007.052803; Koyama JI, 2006, J NEUROSURG ANESTH, V18, P247, DOI 10.1097/00008506-200610000-00005; Maharaj CH, 2008, ANAESTHESIA, V63, P182, DOI 10.1111/j.1365-2044.2007.05316.x; Maharaj CH, 2006, ANAESTHESIA, V61, P671, DOI 10.1111/j.1365-2044.2006.04653.x; Maharaj CH, 2007, ANESTHESIOLOGY, V107, P53, DOI 10.1097/01.anes.0000267529.71756.f0; Malik MA, 2008, BRIT J ANAESTH, V101, P723, DOI 10.1093/bja/aen231; Rai MR, 2005, ANAESTHESIA, V60, P60, DOI 10.1111/j.1365-2044.2004.04013.x; Robitaille A, 2008, ANESTH ANALG, V106, P935, DOI 10.1213/ane.0b013e318161769e; Rudolph C, 2005, ANAESTHESIA, V60, P668, DOI 10.1111/j.1365-2044.2005.04224.x; Savoldelli GL, 2008, ANAESTHESIA, V63, P1358, DOI 10.1111/j.1365-2044.2008.05653.x; Shippey B, 2008, BRIT J ANAESTH, V100, P116, DOI 10.1093/bja/aem303; Shippey B, 2007, CAN J ANAESTH, V54, P307, DOI 10.1007/BF03022777; Thierbach A, 2004, ANAESTHESIST, V53, P543, DOI 10.1007/s00101-004-0679-z; Timmermann A, 2006, RESUSCITATION, V70, P179, DOI 10.1016/j.resuscitation.2006.01.010; Wick M, 1997, CHIRURG, V68, P1053, DOI 10.1007/s001040050322	28	6	6	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	MAY	2009	58	5					469	473		10.1007/s00101-009-1528-x			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	448KF	WOS:000266260800005	19384457				2022-02-06	
J	Studahl, M; Gunther, G; Rosengren, L				Studahl, Marie; Gunther, Goran; Rosengren, Lars			Serum S-100B protein levels in patients with herpes simplex encephalitis and tick-borne encephalitis - A marker of CNS damage during the initial stage of disease	JOURNAL OF NEUROLOGY			English	Article						serum S-100B protein; herpes simplex encephalitis; tick-borne encephalitis	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; ACUTE STROKE; VIRUS; MULTICENTER; ACYCLOVIR; DIAGNOSIS; RELEASE; ENOLASE	This study was mainly aimed at the comparative analysis of serum S-100B protein in patients with herpes simplex encephalitis (HSE) and tick-borne encephalitis (TBE). S-100B protein is an established biochemical marker of astroglial damage in central nervous system (CNS) injury. Serum levels of S-100B were measured using a commercial immunolumino-metric assay (LIA). Patients with HSE (n = 17) had significantly higher levels of S-100B with median 0.351 mu g/l (range 0.017-0.636) compared to patients with TBE (n = 15), who had 0.04 mu g/l (range 0.001-0.542) (p < 0.001), as well as controls (n = 17) 0.054 (range 0.004-0.214) (p < 0.001). 11/17 patients with HSE had serum S-100B levels above 0.2 mu g/l, in contrast to 1/15 patients with TBE and 1/17 of the control patients. The patients with HSE with serum levels below 0.2 mu g/l had a mean 3.2 days disease duration, while patients with levels above 0.2 mu g/l had 6 days disease duration. The serum levels of S-100B in the acute stage of disease were significantly higher in patients with HSE than in patients with TBE or controls. A role for the use of serum S-100B in monitoring CNS damage during initial stage of disease in HSE is suggested.	[Studahl, Marie] Gothenburg Univ, Dept Infect Dis, Sahlgrenska Acad, Gothenburg, Sweden; [Gunther, Goran] Uppsala Univ, Akad Hosp, Dept Infect Dis, Uppsala, Sweden; [Rosengren, Lars] Gothenburg Univ, Dept Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden		Studahl, M (corresponding author), Gothenburg Univ, Dept Infect Dis, Sahlgrenska Acad, Gothenburg, Sweden.	marie.studahl@infect.gu.se	Studahl, Marie/AAC-2045-2019	Rosengren, Lars/0000-0003-0505-8896	Goteborg LUA Foundation	This work was supported by Goteborg LUA Foundation.	Abraha HD, 1997, ANN CLIN BIOCHEM, V34, P546, DOI 10.1177/000456329703400510; AURELIUS E, 1991, LANCET, V337, P189, DOI 10.1016/0140-6736(91)92155-U; Elting JW, 2000, J NEUROL SCI, V181, P104, DOI 10.1016/S0022-510X(00)00442-1; Gunther G, 1997, J NEUROL, V244, P230, DOI 10.1007/s004150050077; HEINZ FX, 1981, J CLIN MICROBIOL, V14, P141, DOI 10.1128/JCM.14.2.141-146.1981; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; JENNETT B, 1975, LANCET, V7905, P480; McGrath N, 1997, J NEUROL NEUROSUR PS, V63, P321, DOI 10.1136/jnnp.63.3.321; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Raschilas F, 2002, CLIN INFECT DIS, V35, P254, DOI 10.1086/341405; REEVES RH, 1994, P NATL ACAD SCI USA, V91, P5359, DOI 10.1073/pnas.91.12.5359; Rosen H, 2001, RESUSCITATION, V49, P183, DOI 10.1016/S0300-9572(00)00348-8; SKOLDENBERG B, 1984, LANCET, V2, P707; Studahl M, 2000, J NEUROL, V247, P636, DOI 10.1007/s004150070134; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; WHITLEY RJ, 1995, CLIN INFECT DIS, V20, P414, DOI 10.1093/clinids/20.2.414	18	6	7	0	1	DR DIETRICH STEINKOPFF VERLAG	HEIDELBERG	TIERGARTENSTRASSE 17, 69121 HEIDELBERG, GERMANY	0340-5354			J NEUROL	J. Neurol.	APR	2009	256	4					586	590		10.1007/s00415-009-0124-y			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	445ZZ	WOS:000266091300008	19367359				2022-02-06	
J	Scalzo, PL; Ikuta, N; Cardoso, F; Regner, A; Teixeira, AL				Scalzo, Paula Luciana; Ikuta, Nilo; Cardoso, Francisco; Regner, Andrea; Teixeira, Antonio Lucio			Quantitative plasma DNA analysis in Parkinson's disease	NEUROSCIENCE LETTERS			English	Article						Parkinson's disease; Biomarker; Free DNA	TRAUMATIC BRAIN-INJURY; CLINICAL-DIAGNOSIS; FEATURES IMPROVE; NUCLEIC-ACIDS; SERUM; ACCURACY; MARKER; BIOMARKERS; DAMAGE; MALES	Parkinson disease (PD) is a neurodegenerative disease resulting from the loss of the dopaminergic neurons from the substantia nigra pars compacta (SNpc). It is characterized by bradykinesia, rigidity, resting tremor and/or postural instability. The diagnosis of PD is essentially clinical and there is no reliable biological marker to assess its progression. Recently, investigations have been performed on the potential use of circulating cell-free deoxyribonucleic acid (DNA) in the plasma for clinical diagnosis, prognosis and monitoring of human diseases. The aim of this work was to assess the role of free DNA as a biological marker of PD. Forty-two patients with PD (19 men, 23 women) and 20 healthy (7 men, 13 women) subjects were enrolled in this study. Mean +/- SD plasma DNA concentration in PD patients and control subjects were, respectively, 16,487 +/- 16,378 (range: 100-62,034) kilogenomes-equivalents/L and 37,975 +/- 17.832 (range: 15,143-78,783) kilogenomes-equivalents/L There was a significant difference between control and PD groups (p < 0.001). There was no correlation between plasma DNA levels and demographic or clinical parameters in PD patients. Free DNA does not seem to be a reliable marker of PD progression. Further research is warranted to confirm the present results to have some value as biomarkers in other neurodegenerative diseases.	[Scalzo, Paula Luciana] Univ Fed Minas Gerais, Dept Bioquim & Imunol ICB, Lab Imunofarmacol, Inst Biol Sci, BR-31270901 Belo Horizonte, MG, Brazil; [Ikuta, Nilo; Regner, Andrea] Luteran Univ Brasil, Med Sci Res Ctr, Genet & Mol Diag Postgrad Program, Canoas, Brazil; [Cardoso, Francisco] Univ Fed Minas Gerais, Movement Disorders Clin, Sch Med, BR-31270901 Belo Horizonte, MG, Brazil; [Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Sch Med, Dept Internal Med, Neuropsychiat Branch,Neurol Div, BR-31270901 Belo Horizonte, MG, Brazil		Teixeira, AL (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol ICB, Lab Imunofarmacol, Inst Biol Sci, Bloco O4,Sala 202,Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.	altexr@gmail.com	Regner, Andrea/M-2596-2014; Cardoso, Francisco EC/A-2285-2014; Cardoso, Francisco/R-8542-2019; Teixeira, Antonio L/N-3315-2014	Regner, Andrea/0000-0002-6657-7991; Cardoso, Francisco EC/0000-0003-0808-0116; Teixeira, Antonio L/0000-0002-9621-5422	Rede Instituto Brasileiro de Neurociencia (IBN Net/Finep)Financiadora de Inovacao e Pesquisa (Finep); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	This work was partly funded by grants from Rede Instituto Brasileiro de Neurociencia (IBN Net/Finep) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Calne D, 2005, PARKINSONISM RELAT D, V11, pS39, DOI 10.1016/j.parkreldis.2005.01.008; Catarino R, 2008, DNA CELL BIOL, V27, P415, DOI 10.1089/dna.2008.0744; Da Rocha AB, 2005, J NEUROTRAUM, V22, P966, DOI 10.1089/neu.2005.22.966; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Eriksen JL, 2005, ARCH NEUROL-CHICAGO, V62, P353, DOI 10.1001/archneur.62.3.353; Fahn S., 1987, RECENT DEV PARKINSON, P153; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Henley SMD, 2005, CURR OPIN NEUROL, V18, P698, DOI 10.1097/01.wco.0000186842.51129.cb; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Hughes AJ, 2001, NEUROLOGY, V57, pS34; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kim SW, 2005, DRUG DISCOV TODAY DI, V2, P427, DOI DOI 10.1016/J.DDMEC.2005.11.015; KUMMER A, PARKINSONIS IN PRESS; Lam NYL, 2003, CLIN CHEM, V49, P1286, DOI 10.1373/49.8.1286; Lo YMD, 2000, CLIN CHEM, V46, P319; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Michell AW, 2004, BRAIN, V127, P1693, DOI 10.1093/brain/awh198; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schaf DV, 2005, PARKINSONISM RELAT D, V11, P39, DOI 10.1016/j.parkreldis.2004.07.002; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Yurgel VC, 2007, J NEUROTRAUM, V24, P1172, DOI 10.1089/neu.2006.0160; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zhong XY, 2007, ANN HEMATOL, V86, P139, DOI 10.1007/s00277-006-0182-5	29	6	6	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAR 6	2009	452	1					5	7		10.1016/j.neulet.2009.01.031			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	417QT	WOS:000264092100002	19444939	hybrid			2022-02-06	
J	Humar, M; Graetz, C; Roesslein, M; Goebel, U; Geiger, KK; Heimrich, B; Pannen, BHJ				Humar, Matjaz; Graetz, Christine; Roesslein, Martin; Goebel, Ulrich; Geiger, Klaus K.; Heimrich, Bernd; Pannen, Benedikt H. J.			Heterocyclic Thioureylenes Protect from Calcium-Dependent Neuronal Cell Death	MOLECULAR PHARMACOLOGY			English	Article							NMDA-GLUTAMATE-RECEPTOR; ACTIVATED T-CELLS; FACTOR-KAPPA-B; NUCLEAR-FACTOR; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISMS; HIPPOCAMPAL SLICES; APOPTOSIS; CALCINEURIN; INHIBITION	Calcium-dependent cell death occurs in neurodegenerative diseases and ischemic or traumatic brain injury. We analyzed whether thioureylenes can act in a neuroprotective manner by pharmacological suppression of calcium-dependent pathological pathways. In human neuroblastoma (SK-N-SH) cells, thioureylenes (thiopental, carbimazole) inhibited the calcium-dependent neuronal protein phosphatase (PP)-2B, the activation of the proapoptotic transcription factor nuclear factor of activated T-cells, BAD-induced initiation of caspase-3, and poly(ADP-ribose)-polymerase cleavage. Caspase-3-independent cell death was attenuated by carbimazole and the protein kinase C (PKC) delta inhibitor rottlerin by a PP-2B-independent mechanism. Neuroprotective effects were mediated by the redoxactive sulfur of thioureylenes. Furthermore, we observed that the route of calcium mobilization was differentially linked to caspase-dependent or independent cell death and that BAD dephosphorylation did not necessarily induce intrinsic caspase activation. In addition, a new 30- to 35-kDa caspase-3 fragment with an unknown function was identified. In organotypic hippocampal slice cultures, thioureylenes inhibited caspase-3 activation or reduced N-methyl-D-aspartate and kainic acid receptor-mediated cell death that was independent of caspase-3. Because prolonged inhibition of caspase-3 resulted in caspase-independent cellular damage, different types of cell death must be taken under therapeutic consideration. Here we show that thioureylenes in combination with PKC delta inhibitors might represent a promising therapeutic approach to attenuate neuronal damage.	[Humar, Matjaz; Graetz, Christine; Goebel, Ulrich; Geiger, Klaus K.] Univ Hosp Freiburg, Dept Anesthesiol & Crit Care Med, Clin Res Ctr, D-79106 Freiburg, Germany; [Roesslein, Martin] Univ Munich, Anesthesiol Clin, Munich, Germany; [Heimrich, Bernd] Univ Freiburg, Inst Anat & Cell Biol, Freiburg, Germany; [Pannen, Benedikt H. J.] Univ Hosp Duesseldorf, Dept Anesthesiol, Dusseldorf, Germany		Humar, M (corresponding author), Univ Hosp Freiburg, Dept Anesthesiol & Crit Care Med, Clin Res Ctr, Breisacherstr 66, D-79106 Freiburg, Germany.	humar@ana1.ukl.uni-freiburg.de	Gobel, Ulrich/Q-7613-2016	Gobel, Ulrich/0000-0002-9991-3226			Asai A, 1999, J BIOL CHEM, V274, P34450, DOI 10.1074/jbc.274.48.34450; Bahr BA, 1995, HIPPOCAMPUS, V5, P425, DOI 10.1002/hipo.450050505; Bartalena L, 2005, EXPERT OPIN PHARMACO, V6, P851, DOI 10.1517/14656566.6.6.851; Choi Dennis W., 1995, Trends in Neurosciences, V18, P58, DOI 10.1016/0166-2236(95)93870-4; Ferreiro E, 2006, NEUROBIOL DIS, V23, P669, DOI 10.1016/j.nbd.2006.05.011; Hara MR, 2007, ANNU REV PHARMACOL, V47, P117, DOI 10.1146/annurev.pharmtox.47.120505.105311; Hardiman O, 1997, NEUROLOGY, V48, P339, DOI 10.1212/WNL.48.2.339; Holtz-Heppelmann CJ, 1998, J BIOL CHEM, V273, P4416, DOI 10.1074/jbc.273.8.4416; Humar M, 2004, MOL PHARMACOL, V65, P350, DOI 10.1124/mol.65.2.350; Humar M, 2008, J PHARMACOL EXP THER, V324, P1037, DOI 10.1124/jpet.107.132407; Humar M, 2007, MOL PHARMACOL, V72, P1647, DOI 10.1124/mol.107.038141; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kaminska B, 2004, J CELL MOL MED, V8, P45, DOI 10.1111/j.1582-4934.2004.tb00259.x; KING MM, 1986, J BIOL CHEM, V261, P4081; Kristensen BW, 2001, BRAIN RES, V917, P21, DOI 10.1016/S0006-8993(01)02900-6; Loop T, 2002, ANESTHESIOLOGY, V96, P1202, DOI 10.1097/00000542-200205000-00025; MARTI V, 1995, EUR HEART J, V16, P1014, DOI 10.1093/oxfordjournals.eurheartj.a061014; Matthews CC, 2003, BRAIN RES, V978, P59, DOI 10.1016/S0006-8993(03)02765-3; Mattson MP, 2006, ANTIOXID REDOX SIGN, V8, P1997, DOI 10.1089/ars.2006.8.1997; MODY I, 1995, TRENDS PHARMACOL SCI, V16, P356, DOI 10.1016/S0165-6147(00)89070-7; Molkentin JD, 2000, CIRC RES, V87, P731, DOI 10.1161/01.RES.87.9.731; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Pulsinelli WA, 1997, ANN NY ACAD SCI, V835, P187, DOI 10.1111/j.1749-6632.1997.tb48629.x; Rizzuto R, 2003, ONCOGENE, V22, P8619, DOI 10.1038/sj.onc.1207105; Rodnitzky RL, 1999, DRUGS, V57, P845, DOI 10.2165/00003495-199957060-00001; Roesslein M, 2008, J PHARMACOL EXP THER, V325, P217, DOI 10.1124/jpet.107.133108; Russo H, 1997, CLIN PHARMACOL THER, V62, P15, DOI 10.1016/S0009-9236(97)90147-8; Scheller C, 2006, J CELL BIOCHEM, V97, P1350, DOI 10.1002/jcb.20670; Stemmer P, 1991, Curr Opin Neurobiol, V1, P53, DOI 10.1016/0959-4388(91)90010-5; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Tan RY, 1996, J BIOL CHEM, V271, P7479, DOI 10.1074/jbc.271.13.7479; Tanovic A, 2006, REV NEUROLOGIA, V42, P607, DOI 10.33588/rn.4210.2005252; Turner Brian Keith, 2005, AANA J, V73, P297; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; YASUDA T, 1993, INT J LEGAL MED, V105, P239, DOI 10.1007/BF01642801; Yoshioka A, 1996, J NEUROSCI RES, V46, P164	40	6	6	0	3	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0026-895X	1521-0111		MOL PHARMACOL	Mol. Pharmacol.	MAR	2009	75	3					667	676		10.1124/mol.108.052183			10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	410EE	WOS:000263559500024	19103761				2022-02-06	
J	Claudet, I; Marechal, C				Claudet, Isabelle; Marechal, Celine			Status Epilepticus in a Pediatric Patient With Amantadine Overdose	PEDIATRIC NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; MEMANTINE; PHYSOSTIGMINE; INTOXICATION; TOXICITY; DEATH	A 2-year-old boy who ingested 0.8-1.5 g of amantadine developed status epilepticus. One hour later, the child presented with agitation, diaphoresis, and vomiting. He was admitted to the pediatric emergency department 2 hours later. Generalized seizures evolved to status epilepticus, with alternating generalized tonic-clonic and partial seizures, over a period of 7 hours. Other initial clinical signs were sinusal tachycardia and reactive bilateral mydriasis. All symptoms resolved within 20 hours, with a good recovery; the child was released from the hospital on day 3. (C) 2009 by Elsevier Inc. All rights reserved.	[Claudet, Isabelle; Marechal, Celine] Childrens Hosp, Pediat Emergency Care Unit, Pediat Emergency Dept, F-31059 Toulouse, France		Claudet, I (corresponding author), Childrens Hosp, Pediat Emergency Care Unit, Pediat Emergency Dept, 330 Ave Grande Bretagne,TSA 70034, F-31059 Toulouse, France.	claudet.i@chu-toulouse.fr	Claudet, Isabelle/G-9457-2016; CLAUDET, ISABELLE/N-4195-2019	Claudet, Isabelle/0000-0002-3868-8483; CLAUDET, ISABELLE/0000-0002-3868-8483			BERKOWITZ CD, 1979, J PEDIATR-US, V95, P144, DOI 10.1016/S0022-3476(79)80111-0; Bronstein AC, 2007, CLIN TOXICOL, V45, P815, DOI 10.1080/15563650701754763; CASEY DE, 1978, NEW ENGL J MED, V298, P516; Chen HSV, 2006, J NEUROCHEM, V97, P1611, DOI 10.1111/j.1471-4159.2006.03991.x; CHENG PL, 2008, AM J EMERG MED, V112, pE5; DAVIES WL, 1964, SCIENCE, V144, P862, DOI 10.1126/science.144.3620.862; Green LB, 2004, AM J PHYS MED REHAB, V83, P893, DOI 10.1097/01.PHM.0000143400.15346.C8; HARTSHORNE NJ, 1995, AM J FOREN MED PATH, V16, P340, DOI 10.1097/00000433-199512000-00009; Hayes Benjamin B, 2006, J Drugs Dermatol, V5, P288; *IMM PRACT ADV COM, 1986, ANN INTERN MED, V105, P199; Ito T, 2001, EUR J PEDIATR, V160, P401, DOI 10.1007/s004310100743; MILLER KS, 1994, CHEST, V105, P1630, DOI 10.1378/chest.105.5.1630a; Patrick PD, 2006, J CHILD NEUROL, V21, P879, DOI 10.1177/08830738060210100901; PIMENTEL L, 1991, Pediatric Emergency Care, V7, P89, DOI 10.1097/00006565-199104000-00007; Reisberg B, 2006, ARCH NEUROL-CHICAGO, V63, P49, DOI 10.1001/archneur.63.1.49; SARTORI M, 1984, AM J MED, V77, P388, DOI 10.1016/0002-9343(84)90728-9; Scholtissek C, 1998, ANTIVIR RES, V38, P213, DOI 10.1016/S0166-3542(98)00015-1; SIMPSON DM, 1988, AM J PSYCHIAT, V145, P267; SNOEY ER, 1990, ANN EMERG MED, V19, P668, DOI 10.1016/S0196-0644(05)82473-4; STRONG DK, 1991, DICP ANN PHARMAC, V25, P1175, DOI 10.1177/106002809102501103; Wang RG, 2005, EUR J NEUROSCI, V22, P2376, DOI 10.1111/j.1460-9568.2005.04431.x; WELLER M, 1993, BRAIN RES, V613, P143, DOI 10.1016/0006-8993(93)90464-X	22	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994			PEDIATR NEUROL	Pediatr. Neurol.	FEB	2009	40	2					120	122		10.1016/j.pediatrneurol.2008.10.011			3	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	396EH	WOS:000262574500011	19135627				2022-02-06	
J	Matis, GK; Birbilis, TA				Matis, Georgios K.; Birbilis, Theodossios A.			Poor relation between Glasgow coma scale and survival after head injury	MEDICAL SCIENCE MONITOR			English	Article						Glasgow coma scale; head injuries; intensive care units; outcome assessment	TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE; SCORE; PREDICTION; MORTALITY; EPIDEMIOLOGY; IMPACT	Background: Early indicators or predictors of outcome after head injury can affect clinical decision making and the choice of case-specific approaches to rehabilitation. Materials/Methods: A retrospective study of 60 patients with a head injury who had been admitted to a tertiary care hospital intensive care unit was undertaken to explore the possible correlations between the Glasgow Coma Scale (GCS) and outcome. The correlation among the GCS, GCS eye (GCS-E), GCS verbal (GCS-V), and GCS motor (GCS-M) components and outcome (survival or death) was assessed by constructing contingency Tables and performing the Pearson chi 2 and likelihood ratio tests. The statistical significance was set at a P value of 0.05. Results: The mean total GCS score was 6.39 +/- 0.554 (6.81 +/- 0.983 for survivors and 5.55 +/- 0.706 for nonsurvivors). The most frequent GCS score, which was 3 (61.67%), was followed by scores of 15 and 14 (10% and 6.7%, respectively). No correlation was found between outcome and the GCS, GCS-E, GCS-V or GCS-M components. Conclusions: Our results suggest that the CGS has a limited predictive value of outcome in patients with a head injury, particularly if used as sole predictor or in patients with a mild-to-moderately severe injury.	[Matis, Georgios K.; Birbilis, Theodossios A.] Democritus Univ Thrace, Dept Neurosurg, Sch Med, Univ Hosp Alexandroupolis, GR-68100 Dragana, Alexandroupolis, Greece		Birbilis, TA (corresponding author), Democritus Univ Thrace, Dept Neurosurg, Sch Med, Univ Hosp Alexandroupolis, GR-68100 Dragana, Alexandroupolis, Greece.	mpirmpil@otenet.gr					Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; BASTOS PG, 1993, CRIT CARE MED, V21, P1459, DOI 10.1097/00003246-199310000-00012; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Cho DY, 1997, INTENS CARE MED, V23, P77, DOI 10.1007/s001340050294; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fischer J, 2001, Crit Care Nurs Q, V23, P52; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Ko DY, 2002, NEUROIMAG CLIN N AM, V12, P165, DOI 10.1016/S1052-5149(02)00010-2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Lenfant F, 1997, ANN FR ANESTH, V16, P239, DOI 10.1016/S0750-7658(97)86408-8; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Moore L, 2006, J TRAUMA, V60, P1238, DOI 10.1097/01.ta.0000195593.60245.80; OH HS, 2006, DAEHAN GANHO HAGHOEJ, V36, P621; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Prasad K, 1998, CEREBROVASC DIS, V8, P79, DOI 10.1159/000015822; Rutledge R, 1996, J TRAUMA, V41, P514, DOI 10.1097/00005373-199609000-00022; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 2000, INTENS CARE MED, V26, P153, DOI 10.1007/s001340050037; Zhang J, 2001, Chin J Traumatol, V4, P152; Zimmerman JE, 2000, CRIT CARE MED, V28, P258, DOI 10.1097/00003246-200001000-00048	27	6	7	0	2	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	FEB	2009	15	2					CR62	CR65					4	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	420PD	WOS:000264300800013	19179969				2022-02-06	
J	Subbaswamy, A; Hsu, AA; Weinstein, S; Bell, MJ				Subbaswamy, Anjali; Hsu, Angela A.; Weinstein, Steven; Bell, Michael J.			Correlation of Cerebral Near-Infrared Spectroscopy (cNIRS) and Neurological Markers in Critically Ill Children	NEUROCRITICAL CARE			English	Article						Regional oxygen saturations; Near-infrared spectroscopy; S100 beta; NSE; Neurological markers; Pediatric neurocritical care	NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; HYPOXIC-ISCHEMIC ENCEPHALOPATHY; CONGENITAL HEART-SURGERY; CEREBROSPINAL-FLUID; CARDIAC-SURGERY; OXYGEN-SATURATION; RESPIRATORY-FAILURE; ORGAN FAILURE; CRITICAL-CARE	To correlate regional brain saturations (RSO2) measured by cerebral Near-infrared spectroscopy (cNIRS) with serological markers indicative of neurological injury (neuron-specific enolase (NSE) and S100 beta). Children with at least one organ failure who were undergoing cNIRS monitoring were eligible for enrollment, while children with hyperbilirubinemia and cyanotic heart disease were excluded. Children were further analyzed based on the presence of an acute neurological injury (defined as hypoxic/ischemic injury after cardiac arrest, status epilepticus, meningitis, encephalopathy) as well as survival. RSO2 was measured continuously (every 30 s) and averages were obtained at 6 h and 24 h epochs prior to serum collection (E6 and E24, respectively). Serum was collected for NSE and S100 beta, which were both determined by ELISA. Serum from children undergoing evaluation for fever in the Emergency department served as serological controls. Correlations were determined using the Pearson Product Moment Correlations. A total of 26 children underwent cNIRS monitoring for a total of 47 days. Overall NSE was greater in critically ill children compared to controls, as well as in all subsets of children analyzed (acute CNS injuries, no acute CNS injuries, survivors and non-survivors). S100 beta tended to be greater in critically ill children, but this did not reach statistical significance. Average RSO2 in E6 and E24 was 68.0% +/- A 1.5 and 68.6% +/- A 1.6, respectively, in a total of 131,036 measurements and E6 RSO2 was strongly, negatively correlated with S100 beta in children with acute neurological injuries. This is the first study to correlate averaged RSO2 measured by cNIRS with neurological injury markers in critically ill children. We believe that this data can be used to establish thresholds for RSO2 that can be tested in future trials to determine if this technology is predictive of long-term neurological outcome.	[Bell, Michael J.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Div Pediat Crit Care Med, Pittsburgh, PA 15213 USA; [Subbaswamy, Anjali; Hsu, Angela A.; Weinstein, Steven; Bell, Michael J.] Childrens Natl Med Ctr, Div Crit Care Med, Washington, DC 20010 USA		Bell, MJ (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Div Pediat Crit Care Med, 3705 5th Ave,6th Floor,Main Tower, Pittsburgh, PA 15213 USA.	bellmj4@upmc.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD 044716] Funding Source: Medline		Abdul-Khaliq H, 2003, RESTOR NEUROL NEUROS, V21, P141; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Berens RJ, 2006, PEDIATR ANESTH, V16, P777, DOI 10.1111/j.1460-9592.2006.01956.x; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bhutta AT, 2007, PEDIATR CARDIOL, V28, P34, DOI 10.1007/s00246-006-1379-z; BONE RC, 1992, CRIT CARE MED, V20, P724, DOI 10.1097/00003246-199206000-00002; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Gazzolo D, 2003, ARCH PEDIAT ADOL MED, V157, P1163, DOI 10.1001/archpedi.157.12.1163; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Gopinath SP, 1996, ANESTH ANALG, V83, P1014, DOI 10.1097/00000539-199611000-00020; Gottlieb EA, 2006, PEDIATR ANESTH, V16, P787, DOI 10.1111/j.1460-9592.2006.01989.x; Hayashida M, 2004, BRIT J ANAESTH, V92, P662, DOI 10.1093/bja/aeh120; Hsu AA, 2008, PEDIATR CRIT CARE ME, V9, P245, DOI 10.1097/PCC.0b013e3181727b22; Huang L, 2004, PHYSIOL MEAS, V25, P749, DOI 10.1088/0967-3334/25/3/014; Kirshbom PM, 2007, PEDIATR CARDIOL, V28, P42, DOI 10.1007/s00246-006-1389-x; Kurth CD, 2001, ANN THORAC SURG, V72, P187, DOI 10.1016/S0003-4975(01)02632-7; Leteurtre S, 2003, LANCET, V362, P192, DOI 10.1016/S0140-6736(03)13908-6; Nguyen DN, 2006, CRIT CARE MED, V34, P1967, DOI 10.1097/01.CCM.0000217218.51381.49; Osterlundh G, 2008, PEDIATR BLOOD CANCER, V50, P793, DOI 10.1002/pbc.21378; Pelinka LE, 2003, SHOCK, V19, P422, DOI 10.1097/01.shk.0000055345.58165.52; Petrova A, 2006, PEDIATR CRIT CARE ME, V7, P449, DOI 10.1097/01.PCC.0000235248.70482.14; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; RIVERA RA, 1990, ANAESTH INTENS CARE, V18, P385, DOI 10.1177/0310057X9001800316; Schmitt B, 1998, BRAIN DEV-JPN, V20, P536, DOI 10.1016/S0387-7604(98)00046-1; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; Soul J S, 1999, Semin Pediatr Neurol, V6, P101, DOI 10.1016/S1071-9091(99)80036-9; Tanabe T, 2001, EPILEPSIA, V42, P504, DOI 10.1046/j.1528-1157.2001.30100.x; Thorngren-Jerneck K, 2004, PEDIATR RES, V55, P406, DOI 10.1203/01.PDR.0000106806.75086.D3; Tiainen M, 2003, STROKE, V34, P2881, DOI 10.1161/01.STR.0000103320.90706.35; Tortoriello TA, 2005, PEDIATR ANESTH, V15, P495, DOI 10.1111/j.1460-9592.2005.01488.x; Trachsel D, 2005, AM J RESP CRIT CARE, V172, P206, DOI 10.1164/rccm.200405-625OC; YOXALL CW, 1995, PEDIATR RES, V38, P319, DOI 10.1203/00006450-199509000-00008; ZELTZER PM, 1983, LANCET, V2, P361	41	6	7	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2009	10	1					129	135		10.1007/s12028-008-9122-7			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	397GZ	WOS:000262652200020	18592418				2022-02-06	
J	Todd, SR; Kao, LS; Catania, A; Mercer, DW; Adams, SD; Moore, FA				Todd, S. Rob; Kao, Lillian S.; Catania, Anna; Mercer, David W.; Adams, Sisha D.; Moore, Frederick A.			alpha-Melanocyte Stimulating Hormone in Critically Injured Trauma Patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	2nd Annual Academic Surgical Congress of the Association-for-Academic-Surgery	FEB 09-12, 2007	Phoenix, AZ	Assoc Acad Surg, Soc Univ Surg		Alpha-melanocyte stimulating hormone; alpha-MSH; Critically injured trauma patients	MULTIPLE ORGAN FAILURE; PLASMA-CONCENTRATIONS; CYTOKINE ANTAGONISTS; SHOCK RESUSCITATION; HIV-INFECTION; INTERLEUKIN-10; MSH; SIRS	Background. a-Melanocyte stimulating hormone (alpha-MSH) is a neuropeptide which modulates inflammation. Prior studies have documented decreased alpha-MSH concentrations in patients with acute traumatic brain injury and subarachnoid hemorrhage. We hypothesized that a-MSH levels would be decreased in critically injured patients and that this would correlate with poor outcome. Methods. We performed a retrospective review of prospectively collected data more than 12 months ending December 2005. alpha-MSH concentrations were measured in major torso trauma patients (excluding severe head injuries) who underwent standardized shock resuscitation. alpha-MSH concentrations were measured every 4 hours for the first 24 hours of intensive care unit admission and daily thereafter for hospital days 2 to 5. Controls were similarly aged, healthy volunteers. Outcomes measured included lengths of stay, infectious morbidity, and the incidence of multiple organ failure (MOF) and mortality. Results: Fifty-one trauma patients were studied with a median age of 33 (2254) years. Seventy-five percent were male and 82% sustained blunt trauma. The median Injury Severity Score was 25 (16-34). Eighteen percent of the patients developed MOF, 18% died, and 24% developed MOF and died. The mean initial (first value on the first day) alpha-MSH concentration was significantly lower than in controls (15.9 pg/mL +/- 7.6 pg/mL vs. 26.1 pg/mL +/- 7.4pg/mL, rho = 0.0008) and did not change significantly during the 5-day study period. On univariate and adjusted multivariate analyses, initial alpha-MSH concentrations did not predict either MOF or mortality. Conclusions. The current study is the first to document significantly decreased alpha-MSH concentrations in critically injured trauma patients as compared with controls. Furthermore, alpha-MSH concentrations remained so throughout the	[Todd, S. Rob; Moore, Frederick A.] Cornell Univ, Dept Surg, Weill Med Coll, Houston, TX 77030 USA; [Kao, Lillian S.; Mercer, David W.; Adams, Sisha D.] Univ Texas Houston, Sch Med, Dept Surg, Houston, TX USA; [Catania, Anna] Osped Maggiore Policlin, Fdn IRCCS, Ctr Preclin Res, Mangiagalli E, Regina Elena, Italy		Todd, SR (corresponding author), Cornell Univ, Methodist Hosp, Weill Med Coll, Dept Surg, 6550 Fannin St,Smith Tower 1661, Houston, TX 77030 USA.	srtodd@tmh.tmc.edu		Catania, Anna/0000-0002-8261-7973	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR002558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792, P50GM038529] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR002558, M01RR002558] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50 GM 38529, T32 GM08792, P50 GM038529, T32 GM008792] Funding Source: Medline		AIRAGHI L, 1995, AM HEART J, V130, P204, DOI 10.1016/0002-8703(95)90430-1; Airaghi L, 2000, NEPHROL DIAL TRANSPL, V15, P1212, DOI 10.1093/ndt/15.8.1212; BELL RC, 1987, BRAIN RES BULL, V18, P577, DOI 10.1016/0361-9230(87)90123-7; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Catania A, 1998, ANN NY ACAD SCI, V840, P848, DOI 10.1111/j.1749-6632.1998.tb09622.x; CATANIA A, 1993, CLIN IMMUNOL IMMUNOP, V66, P73, DOI 10.1006/clin.1993.1010; Catania A, 2000, TRENDS ENDOCRIN MET, V11, P304, DOI 10.1016/S1043-2760(00)00296-4; Catania A, 2000, CRIT CARE MED, V28, P1403, DOI 10.1097/00003246-200005000-00024; CATANIA A, 1977, 1856 ISTISAN; Catania Anna, 1994, Neuroimmunomodulation, V1, P321, DOI 10.1159/000097183; Catania Anna, 1994, Neuroimmunomodulation, V1, P42, DOI 10.1159/000097089; Ichiyama T, 2000, ANN NY ACAD SCI, V917, P221; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Lyons A, 1997, ANN SURG, V226, P450, DOI 10.1097/00000658-199710000-00006; Magnoni S, 2003, J NEUROTRAUM, V20, P251, DOI 10.1089/089771503321532833; Malone DL, 2001, J TRAUMA, V51, P458, DOI 10.1097/00005373-200109000-00006; Marr AB, 2004, SHOCK, V21, P300, DOI 10.1097/00024382-200404000-00002; McKinley B, 2001, SHOCK S, V15, P46, DOI 10.1097/00024382-200106001-00137; McKinley BA, 2002, J TRAUMA, V53, P825, DOI 10.1097/00005373-200211000-00004; Neidhardt R, 1997, J TRAUMA, V42, P863, DOI 10.1097/00005373-199705000-00017; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; SAUAIA A, 1994, ARCH SURG-CHICAGO, V129, P39; Schroder O, 2004, SHOCK, V21, P306, DOI 10.1097/01.shk.0000119239.88805.50; van Griensven M, 2003, EUR J TRAUMA, V29, P181, DOI DOI 10.1007/S00068-001-1324-Z; Yao YM, 1998, INFLAMM RES, V47, P201, DOI 10.1007/s000110050318	25	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2009	66	2					465	469		10.1097/TA.0b013e31818b1e04			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	408NX	WOS:000263442800026	19204522	Green Accepted			2022-02-06	
J	Uren, B; Lowell, MJ; Silbergleit, R				Uren, Bradley; Lowell, Mark. J.; Silbergleit, Robert			Critical Care Transport of Patients Who Have Acute Neurological Emergencies	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article						Transport; Critical care; Ambulance; Helicopter; Stroke; Brain injury	HOSPITAL CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; COMATOSE SURVIVORS; RAPID INFUSION; LARGE-VOLUME; COLD; IMPACT; HYPERVENTILATION; 4-DEGREES-C; MODERATE	This article reviews the special questions and issues in critical care transport related specifically to the care of patients who have neurologic emergencies. It first considers potential indications for transport and reviews attempts to create a hierarchical stroke center system akin to that developed for trauma care. It then discusses therapeutic: concerns relating to the transport environment and the use of specific interventions, including the effects of end-tidal CO2 monitoring on intracranial pressure, patient outcomes after traumatic brain injury, and opportunities to initiate therapeutic hypothermia in comatose survivors of cardiac arrest during transport. Finally, the cost of critical care transport of patients who have neurologic emergencies is considered.	[Uren, Bradley; Lowell, Mark. J.; Silbergleit, Robert] Univ Michigan, Dept Emergency Med & Survival Flight, Ann Arbor, MI 48109 USA		Uren, B (corresponding author), Univ Michigan, Dept Emergency Med & Survival Flight, Ann Arbor, MI 48109 USA.	bguren@umich.edu					Alberts MJ, 2000, JAMA-J AM MED ASSOC, V283, P3102, DOI 10.1001/jama.283.23.3102; Badjatia N, 2006, NEUROLOGY, V66, P1739, DOI 10.1212/01.wnl.0000218166.54150.0a; Bernard S, 2003, RESUSCITATION, V56, P9, DOI 10.1016/S0300-9572(02)00276-9; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bernard SA, 2008, RESUSCITATION, V76, P311, DOI 10.1016/j.resuscitation.2007.07.017; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; Hacke W, 2004, LANCET, V363, P768; Holzer M, 2002, NEW ENGL J MED, V346, P549; Kim F, 2007, CIRCULATION, V115, P3064, DOI 10.1161/CIRCULATIONAHA.106.655480; Majersik JJ, 2008, RESUSCITATION, V77, P189, DOI 10.1016/j.resuscitation.2007.11.023; Moore TM, 2008, ANN EMERG MED, V51, P153, DOI 10.1016/j.annemergmed.2007.07.012; Price Daniel D, 2007, Air Med J, V26, P55, DOI 10.1016/j.amj.2006.10.004; Rosenberg BL, 2003, J TRAUMA, V54, P681, DOI 10.1097/01.TA.0000054684.83538.45; Silbergleit R, 1994, Prehosp Disaster Med, V9, P252; Silbergleit R, 2003, ACAD EMERG MED, V10, P966, DOI 10.1197/S1069-6563(03)00316-6; SILBERGLEIT R, 1991, ANN EMERG MED, V20, P875, DOI 10.1016/S0196-0644(05)81429-5; Silbergleit Robert, 2003, Prehosp Emerg Care, V7, P195, DOI 10.1080/10903120390936761; Stradling D, 2007, NEUROLOGY, V68, P469, DOI 10.1212/01.wnl.0000252930.82140.65	21	6	6	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	FEB	2009	27	1					17	+		10.1016/j.emc.2008.09.001			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	420MC	WOS:000264292900004	19218016				2022-02-06	
J	Ryu, J; Cheong, IY; Do, SH; Zuo, ZY				Ryu, Junghee; Cheong, Il-Young; Do, Sang-Hwan; Zuo, Zhiyi			Alphaxalone, a neurosteroid anaesthetic, increases the activity of the glutamate transporter type 3 expressed in Xenopus oocytes	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Alphaxalone; Glutamate transporter; Excitatory amino acid transporter type 3; Protein kinase C; Phosphatidylinositol 3-kinase; Xenopus oocyte	PROTEIN-KINASE-C; TRAUMATIC BRAIN-INJURY; INTRAVENOUS ANESTHETICS; MODULATION; RECEPTORS; INHIBITOR; PROPOFOL; EAAT3; MICE	Glutamate transporters may be important targets for anaesthetic action in the central nervous system. The authors investigated the effects of alphaxalone, an intravenous neurosteroid anaesthetic, on the activity of glutamate transporter type 3 (EAAT3). EAAT3 was expressed in Xenopus oocytes by injecting its mRNA. Two-electrode voltage clamping was used to record membrane currents before, during, and after applying L-glutamate (30 mu M) in the presence or absence of alphaxalone. Responses were quantified by integrating current traces and are reported in microCoulombs (mu C). Results are presented as means +/- S.E.M. L-Glutamate induced inward currents in EAAT3 expressing oocytes, and these currents were dose-dependently increased by alphaxalone. Alphaxalone at 0.01 to 3 W significantly increased the inward currents. In addition, the treatment of oocytes with phorbol-12-myristate-13-acetate (PMA), a protein kinase C (PKC) activator, significantly increased the transporter currents (1.0 +/- 0.2 to 1.4 +/- 0.2 mu C; P<0.05). However, treatment with PMA plus alphaxalone did not increase responses further as compared with PMA or alphaxalone alone. Furthermore, pretreatment of oocytes with chelerythrine or staurosporine, two PKC inhibitors, did not affect basal transporter currents, but did significantly reduce alphaxalone-enhanced EAAT3 activity; whereas oocytes pretreated with wortmannin, a phosphatidylinositol 3-kinase (PI3K) inhibitor, showed significant reductions in basal and alphaxalone-enhanced EAAT3 activities. The above results suggest that alphaxalone enhances EAAT3 activity and that PKC and PI3K are involved in this effect. (C) 2008 Elsevier B.V. All rights reserved.	[Ryu, Junghee; Do, Sang-Hwan] Seoul Natl Univ, Bundang Hosp, Dept Anesthesiol, Songnam 463707, Gyeonggi Do, South Korea; [Cheong, Il-Young] Kangwon Natl Univ, Dept Anesthesiol, Chunchon, South Korea; [Zuo, Zhiyi] Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA USA; [Do, Sang-Hwan] Seoul Natl Univ, Coll Med, Dept Anesthesiol, Seoul, South Korea		Do, SH (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Anesthesiol, 166 Gumi Ro, Songnam 463707, Gyeonggi Do, South Korea.	shdo@snu.ac.kr	Zuo, Zhiyi/F-3950-2010; Do, Sang Hwan/J-5461-2012	Zuo, Zhiyi/0000-0002-3542-5047; 	Seoul National University Hospital Research Fund [04-2006-065]	This study was supported by a grant (No. 04-2006-065) from the Seoul National University Hospital Research Fund (to Dr. Do).	Baker MT, 2005, ANESTHESIOLOGY, V103, P860, DOI 10.1097/00000542-200510000-00026; Cantrell DA, 2001, J CELL SCI, V114, P1439; CASADO M, 1993, J BIOL CHEM, V268, P27313; CHILD KJ, 1971, BRIT J ANAESTH, V43, P2, DOI 10.1093/bja/43.1.2-a; CHOI DW, 1987, J NEUROSCI, V7, P357; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; COTTRELL GA, 1987, BRIT J PHARMACOL, V90, P491, DOI 10.1111/j.1476-5381.1987.tb11198.x; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Danbolt NC, 1998, PROG BRAIN RES, V116, P23, DOI 10.1016/S0079-6123(08)60428-8; Davis KE, 1998, J NEUROSCI, V18, P2475; Deutsch SI, 1996, PHARMACOL BIOCHEM BE, V55, P323, DOI 10.1016/S0091-3057(96)00100-1; Do SH, 2003, NEUROSCI LETT, V343, P113, DOI 10.1016/S0304-3940(03)00358-6; Do SH, 2002, ANESTH ANALG, V95, P1263, DOI 10.1097/00000539-200211000-00030; Do SH, 2002, ANESTHESIOLOGY, V96, P1492, DOI 10.1097/00000542-200206000-00032; Gorter JA, 2002, J COMP NEUROL, V442, P365, DOI 10.1002/cne.10101; Greene JG, 1996, J NEUROCHEM, V66, P637; Hansen SL, 2004, PROG NEURO-PSYCHOPH, V28, P105, DOI 10.1016/j.pnpbp.2003.09.026; HARRISON NL, 1987, J NEUROSCI, V7, P604; HARRISON NL, 1984, BRAIN RES, V323, P287, DOI 10.1016/0006-8993(84)90299-3; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; HOLZBAUER M, 1976, MED BIOL, V54, P227; Horishita T, 2002, ANESTH ANALG, V95, P1661, DOI 10.1097/00000539-200212000-00034; Huang YM, 2005, MOL PHARMACOL, V67, P1522, DOI 10.1124/mol.104.007443; Larsen M, 1997, BRIT J ANAESTH, V78, P55, DOI 10.1093/bja/78.1.55; MATSUMOTO H, 1989, BIOCHEM BIOPH RES CO, V158, P105, DOI 10.1016/S0006-291X(89)80183-4; Minami K, 1997, EUR J PHARMACOL, V339, P237, DOI 10.1016/S0014-2999(97)01354-X; Miyazaki H, 1997, ANESTHESIOLOGY, V86, P1359, DOI 10.1097/00000542-199706000-00018; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Shiraishi M, 2003, ANESTH ANALG, V97, P449, DOI 10.1213/01.ANE.0000068985.78588.E1; Shiraishi M, 2002, ANESTH ANALG, V95, P900, DOI 10.1097/00000539-200210000-00020; Simantov R, 1999, MOL BRAIN RES, V65, P112, DOI 10.1016/S0169-328X(98)00349-0; STOCK JP, 1973, POSTGRAD MED J, V4, P495; SUMIKAWA K, 1983, ANESTHESIOLOGY, V59, P412, DOI 10.1097/00000542-198311000-00008; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Winter L, 2003, ANESTH ANALG, V97, P798, DOI 10.1213/01.ANE.0000075835.73967.F3; Yun JY, 2006, EUR J PHARMACOL, V531, P133, DOI 10.1016/j.ejphar.2005.11.052	40	6	6	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	JAN 5	2009	602	1					23	27		10.1016/j.ejphar.2008.10.063			5	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	401WD	WOS:000262972300004	19041863				2022-02-06	
J	Al-Jarrah, MD; Nazzal, ME; Jamous, MA; Azab, MA; Maayah, MF				Al-Jarrah, Muhammed D.; Nazzal, Mahmoud E.; Jamous, Mohammed A.; Azab, Mohammed A.; Maayah, Mikhled F.			Association between the functional independence measure and Glasgow coma scale regarding the rehabilitation outcomes of traumatic brain injury	NEUROSCIENCES			English	Article							INPATIENT REHABILITATION; MORTALITY; AGE; SEVERITY; LENGTH; STAY	Objectives: To evaluate the outcomes of early comprehensive rehabilitation protocols for traumatic brain injury (TBI) using the functional independence measure (FIM), and to study the relationship between FIM and Glasgow coma scale (GCS) variables to determine which patients will be best served by rehabilitation therapies. Methods: Fifty-one subjects with diagnosed TBI receiving treatment at a single inpatient rehabilitation facility at Jordan University of Science and Technology, Teaching Hospital, Irbid, Jordan were enrolled in this experimental study between August 2006 and February 2008. Of the enrolled subjects, 47 completed the study. The mean age of the participants was 33 years (8 females and 39 males). Glasgow coma scale was measured on admission. Functional independence measure score was measured on admission and on discharge. According to the GCS, the participants were divided into 3 groups as severe injury (GCS: 3-8 [n=24]), moderate injury (GCS: 9-12 [n=12]), and mild or no injury (GCS: 13-15 [n= 11]). The FIM score and CGS and their relation were evaluated. Results: Evaluation outcomes revealed a significant improvement in FIM scores after rehabilitation compared to the FIM admission (p=0.00006) in severe TBI. In moderate TBI, the FIM scores were significantly improved (p=0.0004) after rehabilitation. However, with minimal injury, the FIM scores were not significantly improved (p=0.15). Conclusion: Early rehabilitation interventions significantly improved the FIM scores in moderate and severe TBI patients.	[Al-Jarrah, Muhammed D.; Nazzal, Mahmoud E.; Maayah, Mikhled F.] Jordan Univ Sci & Technol, Dept Physiotherapy & Rehabil Sci, Irbid 22110, Jordan; [Jamous, Mohammed A.] Jordan Univ Sci & Technol, Dept Neurosurg, Irbid 22110, Jordan; [Azab, Mohammed A.] Jordan Univ Sci & Technol, Dept Forens Med & Toxicol, Irbid 22110, Jordan; [Al-Jarrah, Muhammed D.] Univ Kansas, Med Ctr, Phys Therapy & Rehabil Sci Dept, Kansas City, KS 66103 USA		Al-Jarrah, MD (corresponding author), Jordan Univ Sci & Technol, Dept Physiotherapy & Rehabil Sci, POB 3030, Irbid 22110, Jordan.	jarrahm@just.edu.jo		Al-Jarrah, Muhammed/0000-0003-2948-6932			Blicher JU, 2008, NEUROREHABILITATION, V23, P175; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hart T, 2008, NEUROPSYCHOL REHABIL, V18, P1, DOI 10.1080/09602010601082359; Heinemann AW, 1997, ARCH PHYS MED REHAB, V78, P143, DOI 10.1016/S0003-9993(97)90255-0; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Toschlog EA, 2003, AM SURGEON, V69, P491; von Wild KRH, 2008, ACT NEUR S, V101, P55; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Woo J, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-86; Worsowicz GM, 2004, ARCH PHYS MED REHAB, V85, pS3, DOI 10.1016/j.apmr.2004.03.005; Yap SGM, 2008, J HEAD TRAUMA REHAB, V23, P158, DOI 10.1097/01.HTR.0000319932.15085.fe	23	6	6	0	0	RIYADH ARMED FORCES HOSPITAL	RIYADH	PO BOX 7897, RIYADH, KSA 11159, SAUDI ARABIA	1319-6138			NEUROSCIENCES	Neurosciences	JAN	2009	14	1					41	44					4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	408AN	WOS:000263405500008	21048572				2022-02-06	
J	Andriessen, TMJC; de Jong, B; Jacobs, B; van der Werf, SP; Vos, PE				Andriessen, Teuntje M. J. C.; de Jong, Ben; Jacobs, Bram; van der Werf, Sieberen P.; Vos, Pieter E.			Sensitivity and specificity of the 3-item memory test in the assessment of post traumatic amnesia	BRAIN INJURY			English	Article						Post traumatic amnesia; memory test; traumatic brain injury	CLOSED-HEAD INJURY; BRAIN-INJURY; POSTTRAUMATIC AMNESIA; COMPUTED-TOMOGRAPHY; RECOVERY; MULTICENTER; PREDICTION; DURATION; SCALE	Primary objective: To investigate how the type of stimulus (pictures or words) and the method of reproduction (free recall or recognition after a short or a long delay) affect the sensitivity and specificity of a 3-item memory test in the assessment of post traumatic amnesia (PTA). Methods: Daily testing was performed in 64 consecutively admitted traumatic brain injured patients, 22 orthopedically injured patients and 26 healthy controls until criteria for resolution of PTA were reached. Subjects were randomly assigned to a test with visual or verbal stimuli. Short delay reproduction was tested after an interval of 3-5 minutes, long delay reproduction was tested after 24 hours. Sensitivity and specificity were calculated over the first 4 test days. Results: The 3-word test showed higher sensitivity than the 3-picture test, while specificity of the two tests was equally high. Free recall was a more effortful task than recognition for both patients and controls. In patients, a longer delay between registration and recall resulted in a significant decrease in the number of items reproduced. Conclusions: Presence of PTA is best assessed with a memory test that incorporates the free recall of words after a long delay.	[Andriessen, Teuntje M. J. C.; de Jong, Ben; Jacobs, Bram; Vos, Pieter E.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [van der Werf, Sieberen P.] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6500 HB Nijmegen, Netherlands		Andriessen, TMJC (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	tmjc.andriessen@neuro.umcn.nl	Vos, Pieter/A-6043-2012				Ahmed S, 2000, BRAIN INJURY, V14, P765; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Caplain S., 2008, J REHABILITATION M S, V22, P528; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; de Guise E, 2006, J HEAD TRAUMA REHAB, V21, P527, DOI 10.1097/00001199-200611000-00007; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; McFarland K, 2001, CLIN NEUROPSYCHOL, V15, P59, DOI 10.1076/clin.15.1.59.1916; Schwartz ML, 1998, CAN J NEUROL SCI, V25, P108, DOI 10.1017/S0317167100033709; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Stuss DT, 2000, NEUROLOGY, V54, P1337, DOI 10.1212/WNL.54.6.1337; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; Tate R.L., 2000, BRAIN IMPAIR, V1, P116, DOI [10.1375/brim.1.2.116, DOI 10.1375/BRIM.1.2.116]; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247	28	6	6	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	4					345	352	PII 909958930	10.1080/02699050902791414			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	425MY	WOS:000264643000009	19330596				2022-02-06	
B	Geracioti, TD; Strawn, JR; Ekhator, NN; Wortman, M; Kasckow, J		Pfaff, DW; Arnold, AP; Etgen, AM; Fahrbach, SE; Rubin, RT		Geracioti, T. D., Jr.; Strawn, J. R.; Ekhator, N. N.; Wortman, M.; Kasckow, J.			Neuroregulatory Peptides of Central Nervous System Origin: From Laboratory to Clinic	HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION			English	Article; Book Chapter							CORTICOTROPIN-RELEASING HORMONE; MELANOCYTE-STIMULATING HORMONE; TRAUMATIC BRAIN-INJURY; PITUITARY-ADRENAL AXIS; PLASMA NEUROPEPTIDE-Y; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MESSENGER-RIBONUCLEIC-ACID; PLACEBO-CONTROLLED TRIAL; RAT SPINAL-CORD; OPIOMELANOCORTIN-DERIVED PEPTIDES		[Geracioti, T. D., Jr.; Strawn, J. R.; Ekhator, N. N.] Cincinnati VAMC, Cincinnati, OH 45220 USA; [Geracioti, T. D., Jr.; Strawn, J. R.; Ekhator, N. N.] Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA; [Kasckow, J.] VA Pittsburgh Hlth Care Syst Behav Hlth, Pittsburgh, PA USA; [Kasckow, J.] MIRECC, Pittsburgh, PA USA		Geracioti, TD (corresponding author), Cincinnati VAMC, Cincinnati, OH 45220 USA.						Abelson JL, 2007, DEPRESS ANXIETY, V24, P66, DOI 10.1002/da.20220; Adan RAH, 1997, PEPTIDES, V18, P1279, DOI 10.1016/S0196-9781(97)00078-8; Adan Roger A. H., 2006, CNS & Neurological Disorders-Drug Targets, V5, P251, DOI 10.2174/187152706777452290; ADRIAN TE, 1983, NATURE, V306, P584, DOI 10.1038/306584a0; AGMO A, 1994, PHARMACOL BIOCHEM BE, V47, P771, DOI 10.1016/0091-3057(94)90276-3; AGNATI LF, 1995, NEUROSCIENCE, V69, P711, DOI 10.1016/0306-4522(95)00308-6; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Alkemade A, 2005, J CLIN ENDOCR METAB, V90, P323, DOI 10.1210/jc.2004-1430; ALMAY BGL, 1978, PAIN, V5, P153, DOI 10.1016/0304-3959(78)90037-4; Altemus M, 1999, BIOL PSYCHIAT, V45, P931, DOI 10.1016/S0006-3223(98)00263-7; ALTEMUS M, 1992, ARCH GEN PSYCHIAT, V49, P9; Alvaro G, 2007, CURR OPIN DRUG DISC, V10, P613; ALVES SE, 1993, PEPTIDES, V14, P379, DOI 10.1016/0196-9781(93)90056-M; AMIR S, 1980, EUR J PHARMACOL, V66, P307, DOI 10.1016/0014-2999(80)90463-X; AMOSS M, 1971, BIOCHEM BIOPH RES CO, V44, P205, DOI 10.1016/S0006-291X(71)80179-1; ANDERSONHUNT M, 1995, GYNECOL OBSTET INVES, V40, P217, DOI 10.1159/000292340; Anselmino K J, 1966, Ger Med Mon, V11, P177; ANTONAWICH FJ, 1994, ANN NY ACAD SCI, V739, P60, DOI 10.1111/j.1749-6632.1994.tb19807.x; ANTONI FA, 1993, FRONT NEUROENDOCRIN, V14, P76, DOI 10.1006/frne.1993.1004; ARATO M, 1989, BIOL PSYCHIAT, V25, P355, DOI 10.1016/0006-3223(89)90183-2; ARGENTE J, 1991, ENDOCRINOLOGY, V128, P2369, DOI 10.1210/endo-128-5-2369; Arnold LM, 2007, PAIN MED, V8, P633, DOI 10.1111/j.1526-4637.2007.00332.x; Arvanitis AG, 1999, J MED CHEM, V42, P805, DOI 10.1021/jm980222w; ATWEH SF, 1983, BRIT MED BULL, V39, P47, DOI 10.1093/oxfordjournals.bmb.a071789; Bachus SE, 1997, J PSYCHIATR RES, V31, P233, DOI 10.1016/S0022-3956(96)00041-6; Badoer E, 1998, BRAIN RES, V791, P317, DOI 10.1016/S0006-8993(98)00140-1; Baerwald CGO, 2000, Z RHEUMATOL, V59, P29, DOI 10.1007/s003930050002; Bajoria R, 1998, J CLIN ENDOCR METAB, V83, P4148, DOI 10.1210/jc.83.11.4148; Baker DG, 1997, PSYCHONEUROENDOCRINO, V22, P517, DOI 10.1016/S0306-4530(97)00053-X; Baker DG, 1999, AM J PSYCHIAT, V156, P585; Baker J T, 1997, Lippincotts Prim Care Pract, V1, P527; BALE TL, 1995, ENDOCRINOLOGY, V136, P5135, DOI 10.1210/en.136.11.5135; BANKI CM, 1992, J AFFECT DISORDERS, V25, P39, DOI 10.1016/0165-0327(92)90091-J; BANKI CM, 1987, AM J PSYCHIAT, V144, P873; BANKS WA, 1988, AM J MED SCI, V295, P459, DOI 10.1097/00000441-198805000-00008; Bao AM, 2006, MOL PSYCHIATR, V11, P567, DOI 10.1038/sj.mp.4001800; Baranowska B, 2003, NEUROENDOCRINOL LETT, V24, P431; BASTIAS MC, 1993, FERTIL STERIL, V59, P1261; Bauer K, 1999, Results Probl Cell Differ, V26, P13; Bauer K, 1995, METABOLISM BRAIN PEP, P1; Bayatti N, 2005, AGEING RES REV, V4, P258, DOI 10.1016/j.arr.2005.02.004; BEAUDET A, 1995, NEUROSCIENCE, V65, P551, DOI 10.1016/0306-4522(94)00486-O; BECKPECCOZ P, 1985, NEW ENGL J MED, V312, P1085, DOI 10.1056/NEJM198504253121703; BECKWITH BE, 1984, PEPTIDES, V5, P819, DOI 10.1016/0196-9781(84)90028-7; BECKWITH BE, 1983, PEPTIDES, V4, P707, DOI 10.1016/0196-9781(83)90022-0; BECKWITH BE, 1977, PHYSIOL BEHAV, V18, P63, DOI 10.1016/0031-9384(77)90095-6; Beckwith BE, 1988, MELANOTROPIC PEPTIDE, V2, P43; BEGLINGER C, 1992, GASTROENTEROLOGY, V103, P490, DOI 10.1016/0016-5085(92)90838-P; BEHRE HM, 1992, J CLIN ENDOCR METAB, V75, P393, DOI 10.1210/jc.75.2.393; Bellier B, 2000, J MED CHEM, V43, P3614, DOI 10.1021/jm0000416; BENNETT GW, 1986, J NEUROCHEM, V46, P1718; BERKENBOSCH F, 1983, NATURE, V305, P237, DOI 10.1038/305237a0; BERTHERAT J, 1995, EUR J ENDOCRINOL, V132, P12, DOI 10.1530/eje.0.1320012; BerzeteiGurske IP, 1996, EUR J PHARMACOL, V302, pR1, DOI 10.1016/0014-2999(96)00238-5; BESSON JM, 1987, PHYSIOL REV, V67, P67, DOI 10.1152/physrev.1987.67.1.67; Binneman B, 2008, AM J PSYCHIAT, V165, P617, DOI 10.1176/appi.ajp.2008.07071199; Bissette G, 1997, ANN NY ACAD SCI, V814, P17, DOI 10.1111/j.1749-6632.1997.tb46141.x; BLOOM F, 1976, SCIENCE, V194, P630, DOI 10.1126/science.185694; Bohus B, 1998, PROG BRAIN RES, V119, P555; Bohus B, 1993, BRAIN FUNCTIONS NEUR, P15; Bonavera JJ, 1996, ENDOCRINOLOGY, V137, P1956, DOI 10.1210/en.137.5.1956; Bond C, 1998, P NATL ACAD SCI USA, V95, P9608, DOI 10.1073/pnas.95.16.9608; BOURAS C, 1986, NEUROSCI LETT, V69, P31, DOI 10.1016/0304-3940(86)90409-X; BOURQUE CW, 1990, FRONT NEUROENDOCRIN, V11, P183; Bowen T, 1998, MOL PSYCHIATR, V3, P67, DOI 10.1038/sj.mp.4000293; BRADWEJN J, 1990, CAN J PSYCHIAT, V35, P83, DOI 10.1177/070674379003500115; Brambilla F, 1995, PSYCHIAT RES, V59, P51, DOI 10.1016/0165-1781(95)02674-6; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; Bremner JD, 1997, AM J PSYCHIAT, V154, P624; BREMNER WJ, 1991, J CLIN ENDOCR METAB, V73, P465, DOI 10.1210/jcem-73-3-465; Brenner LA, 1996, PHARMACOL BIOCHEM BE, V54, P625, DOI 10.1016/0091-3057(95)02210-4; BROWN JD, 1978, JAMA-J AM MED ASSOC, V240, P1273, DOI 10.1001/jama.240.12.1273; Brugos B, 2004, PHARMAZIE, V59, P339; Buijs RM, 1987, VASOPRESSIN PRINCIPL, P91; BURBACH JPH, 1992, ANN NY ACAD SCI, V652, P1, DOI 10.1111/j.1749-6632.1992.tb34341.x; Burbach JPH, 1995, ADV EXP MED BIOL, V395, P9; Burbach JPH, 1988, VASOPRESSIN CELLULAR, P295; BURGUS R, 1970, NATURE, V226, P321, DOI 10.1038/226321a0; Burri A, 2008, PSYCHONEUROENDOCRINO, V33, P591, DOI 10.1016/j.psyneuen.2008.01.014; Bush DEA, 1999, PSYCHOPHARMACOLOGY, V147, P331, DOI 10.1007/s002130051176; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; CALDWELL JD, 1992, ANN NY ACAD SCI, V652, P166, DOI 10.1111/j.1749-6632.1992.tb34353.x; CALVET MC, 1992, BRAIN RES, V571, P218, DOI 10.1016/0006-8993(92)90658-V; Cameron Oliver G, 2006, Essent Psychopharmacol, V7, P24; Carel JC, 2008, NEW ENGL J MED, V358, P2366, DOI 10.1056/NEJMcp0800459; Carr KD, 1996, NEUROCHEM RES, V21, P1455, DOI 10.1007/BF02532386; CARTER DA, 1991, NEUROENDOCRINOLOGY, V53, P1, DOI 10.1159/000125689; Carter DA, 1985, POSTERIOR PITUITARY, P53; Castro MG, 1997, CRIT REV NEUROBIOL, V11, P35; Chaki S, 2005, PEPTIDES, V26, P1952, DOI 10.1016/j.peptides.2004.11.029; Chen JC, 2000, J COMP NEUROL, V420, P305, DOI 10.1002/(SICI)1096-9861(20000508)420:3<305::AID-CNE3>3.0.CO;2-8; Cherny N, 2000, J Oncol Manag, V9, P8; CHESSELET MF, 1995, CIBA F SYMP, V190, P51; CHHAJLANI V, 1993, BIOCHEM BIOPH RES CO, V195, P866, DOI 10.1006/bbrc.1993.2125; CHHAJLANI V, 1992, FEBS LETT, V309, P417, DOI 10.1016/0014-5793(92)80820-7; CHIHARA K, 1978, ENDOCRINOLOGY, V102, P281, DOI 10.1210/endo-102-1-281; Chini B, 1995, ADV EXP MED BIOL, V395, P321; Chou WY, 2006, ACTA ANAESTH SCAND, V50, P787, DOI 10.1111/j.1399-6576.2006.01058.x; CHRONWALL BM, 1985, PEPTIDES, V6, P1, DOI 10.1016/0196-9781(85)90128-7; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; CIVELLI O, 1982, J BIOL CHEM, V257, P6783; Clasadonte J, 2008, ENDOCRINOLOGY, V149, P587, DOI 10.1210/en.2007-1260; CLEMENTJONES V, 1982, ADV BIOCHEM PSYCHOPH, V33, P379; Clemmons DR, 2007, HORM RES, V68, P178, DOI 10.1159/000110620; Coll AP, 2007, CLIN SCI, V113, P171, DOI 10.1042/CS20070105; CONE RD, 1993, ANN NY ACAD SCI, V680, P342, DOI 10.1111/j.1749-6632.1993.tb19694.x; CONN PM, 1985, ENDOCRINOLOGY, V116, P1324, DOI 10.1210/endo-116-4-1324; Conn PM, 1996, SCIENCE, V273, P923, DOI 10.1126/science.273.5277.923; COX BM, 1994, REGUL PEPTIDES, V54, P71, DOI 10.1016/0167-0115(94)90394-8; CRAWLEY JN, 1985, ANN NY ACAD SCI, V448, P1, DOI 10.1111/j.1749-6632.1985.tb29900.x; CRAWLEY JN, 1991, TRENDS PHARMACOL SCI, V12, P232, DOI 10.1016/0165-6147(91)90558-A; CROISET G, 1992, EUR J PHARMACOL, V229, P211, DOI 10.1016/0014-2999(92)90557-K; CSIFFARY A, 1992, NEUROENDOCRINOLOGY, V56, P429, DOI 10.1159/000126259; CUELLO AC, 1983, BRIT MED BULL, V39, P11, DOI 10.1093/oxfordjournals.bmb.a071784; CUELLO AC, 1976, LANCET, V2, P1054; Cummings DE, 1999, SEMIN REPROD ENDOCR, V17, P311; Dauge V, 1998, NEUROSCI BIOBEHAV R, V22, P815, DOI 10.1016/S0149-7634(98)00011-6; Dawood MY, 1995, ADV EXP MED BIOL, V395, P585; De Kloet ER, 1990, NEUROPEPTIDES BASICS, P105; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; De Rensis F, 1999, J REPROD FERTIL, V116, P243, DOI 10.1530/jrf.0.1160243; De Wied D, 1969, FRONT NEUROENDOCRIN, V1, P97; De Wied D, 1988, PHYSIOL REV, V62, P976; DEBELLIS MD, 1993, AM J PSYCHIAT, V150, P656; DELITALA G, 1991, BRAIN ENDOCRINOLOGY, P217; DEMITRACK MA, 1989, PSYCHOPHARMACOL BULL, V25, P439; Demitrack MA, 1998, ANN NY ACAD SCI, V840, P684, DOI 10.1111/j.1749-6632.1998.tb09607.x; DEMITRACK MA, 1991, J CLIN ENDOCR METAB, V73, P1224, DOI 10.1210/jcem-73-6-1224; DEMITRACK MA, 1992, J CLIN ENDOCR METAB, V74, P1277, DOI 10.1210/jc.74.6.1277; DEMONTIGNY C, 1989, ARCH GEN PSYCHIAT, V46, P511; DESCHENES RJ, 1985, J BIOL CHEM, V260, P1280; DEVESA J, 1995, J STEROID BIOCHEM, V53, P277, DOI 10.1016/0960-0760(95)00065-8; Devlin MJ, 1997, AM J CLIN NUTR, V65, P114, DOI 10.1093/ajcn/65.1.114; DEVRIES GJ, 1994, ANN NY ACAD SCI, V743, P95; DEWIED D, 1987, J PHARMACOL EXP THER, V241, P268; DEWIED D, 1983, PROG BRAIN RES, V60, P155; Dinan TG, 1998, PSYCHIAT CLIN N AM, V21, P325, DOI 10.1016/S0193-953X(05)70008-3; Ding YQ, 1999, NEUROSCI LETT, V266, P133, DOI 10.1016/S0304-3940(99)00283-9; Ding YQ, 1996, J COMP NEUROL, V367, P375; DOCKRAY GJ, 1976, NATURE, V264, P568, DOI 10.1038/264568a0; Dohi K, 2008, REGUL PEPTIDES, V145, P60, DOI 10.1016/j.regpep.2007.08.005; DORES RM, 1990, BRAIN BEHAV EVOLUT, V36, P80, DOI 10.1159/000115300; DORES RM, 1993, ANN NY ACAD SCI, V680, P161, DOI 10.1111/j.1749-6632.1993.tb19682.x; Dotsch J, 1997, J NEUROL SCI, V151, P185, DOI 10.1016/S0022-510X(97)00116-0; DRAKE CT, 1994, J NEUROSCI, V14, P3736; Dubois M P, 1980, Acta Histochem Suppl, V22, P141; DUDLEY CA, 1988, BRAIN RES, V441, P161, DOI 10.1016/0006-8993(88)91394-7; DUVIGNEAUD V, 1953, J AM CHEM SOC, V75, P4879, DOI 10.1021/ja01115a553; Eberle AN, 1988, CHEM PHYSL MECH ACTI, P210; EDWARDS GL, 1981, BRAIN RES, V216, P265, DOI 10.1016/0006-8993(81)90129-3; Ehrnborg C, 2000, BEST PRACT RES CL EN, V14, P71, DOI 10.1053/beem.2000.0054; Eijsbouts AMM, 1999, BEST PRACT RES CL RH, V13, P599, DOI 10.1053/berh.1999.0048; ELDE R, 1979, ANNU REV PHYSIOL, V41, P587, DOI 10.1146/annurev.ph.41.030179.003103; ENG J, 1990, REGUL PEPTIDES, V30, P15, DOI 10.1016/0167-0115(90)90131-F; Ensom MHH, 2000, PHARMACOTHERAPY, V20, P523, DOI 10.1592/phco.20.6.523.35161; EPELBAUM J, 1994, CRIT REV NEUROBIOL, V8, P25; EPELBAUM J, 1986, PROG NEUROBIOL, V27, P63, DOI 10.1016/0301-0082(86)90012-2; Erb K, 2000, CLIN PHARMACOL THER, V67, P660, DOI 10.1067/mcp.2000.106894; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; Evengard B, 1998, PAIN, V78, P153, DOI 10.1016/S0304-3959(98)00134-1; Faglia G, 1998, THYROID, V8, P903, DOI 10.1089/thy.1998.8.903; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fehrenbacher JC, 2003, PAIN, V105, P133, DOI 10.1016/S0304-3959(03)00173-8; Feifel D, 1999, NEUROPSYCHOPHARMACOL, V20, P141, DOI 10.1016/S0893-133X(98)00041-4; Fekete C, 2002, ENDOCRINOLOGY, V143, P3846, DOI 10.1210/en.2002-220338; Felberbaum RF, 2000, MOL CELL ENDOCRINOL, V166, P9, DOI 10.1016/S0303-7207(00)00291-4; FERRARI W, 1958, NATURE, V181, P925, DOI 10.1038/181925a0; Feund-Mercier MJ, 1995, OXYTOCIN, P1; FILE SE, 1978, J PHARM PHARMACOL, V30, P105, DOI 10.1111/j.2042-7158.1978.tb13172.x; Fink G., 1988, P1349; FISHER LA, 1993, PSYCHOTHER PSYCHOSOM, V60, P39, DOI 10.1159/000288678; Fodor M, 2006, NEUROCHEM RES, V31, P137, DOI 10.1007/s11064-005-9017-3; FRANCE RD, 1988, BIOL PSYCHIAT, V23, P86, DOI 10.1016/0006-3223(88)90108-4; Freeman EW, 1997, PSYCHOPHARMACOL BULL, V33, P303; FRIEBOES RM, 1995, NEUROENDOCRINOLOGY, V61, P584, DOI 10.1159/000126883; FRITZ MA, 1982, FERTIL STERIL, V38, P509; FROHMAN LA, 1989, J CLIN INVEST, V83, P1533, DOI 10.1172/JCI114049; Furmark T, 2005, BIOL PSYCHIAT, V58, P132, DOI 10.1016/j.biopsych.2005.03.029; GAFFORI O, 1982, EUR J PHARMACOL, V85, P115, DOI 10.1016/0014-2999(82)90432-0; Gallai V, 2003, CEPHALALGIA, V23, P166, DOI 10.1046/j.1468-2982.2003.00552.x; GANTZ I, 1993, J BIOL CHEM, V268, P15174; GANTZ I, 1994, BIOCHEM BIOPH RES CO, V200, P1214, DOI 10.1006/bbrc.1994.1580; Garbutt JC, 2005, JAMA-J AM MED ASSOC, V293, P1617, DOI 10.1001/jama.293.13.1617; GARDNER JD, 1984, AM J PHYSIOL, V246, pG471, DOI 10.1152/ajpgi.1984.246.5.G471; GARFINKEL PE, 1975, ARCH GEN PSYCHIAT, V32, P739; GARVER DL, 1990, PSYCHOPHARMACOL BULL, V26, P377; Genazzani AR, 2000, ANN NY ACAD SCI, V900, P1; Geracioti TD, 2006, AM J PSYCHIAT, V163, P637, DOI 10.1176/appi.ajp.163.4.637; GERACIOTI TD, 1988, NEW ENGL J MED, V319, P683, DOI 10.1056/NEJM198809153191105; GERACIOTI TD, 1993, BRAIN RES, V629, P260, DOI 10.1016/0006-8993(93)91329-Q; Geracioti TD, 1999, DEPRESS ANXIETY, V10, P77, DOI 10.1002/(SICI)1520-6394(1999)10:2<77::AID-DA7>3.0.CO;2-W; Geracioti TD, 1997, BIOL PSYCHIAT, V42, P165, DOI 10.1016/S0006-3223(96)00312-5; GERACIOTI TD, 1992, J CLIN ENDOCR METAB, V74, P1325, DOI 10.1210/jc.74.6.1325; Geracioti TD, 2008, PSYCHONEUROENDOCRINO, V33, P416, DOI 10.1016/j.psyneuen.2007.12.012; Ghigo E, 1998, ANN MED, V30, P159, DOI 10.3109/07853899808999399; Gianotti L, 2000, J CLIN ENDOCR METAB, V85, P2805, DOI 10.1210/jc.85.8.2805; GIBBS J, 1977, AM J CLIN NUTR, V30, P758, DOI 10.1093/ajcn/30.5.758; GIBBS J, 1973, NATURE, V245, P323, DOI 10.1038/245323a0; GINSBERG SD, 1994, J COMP NEUROL, V341, P476, DOI 10.1002/cne.903410405; Giuliani S, 1996, BRIT J PHARMACOL, V118, P1567, DOI 10.1111/j.1476-5381.1996.tb15576.x; Glazener C.M., 2000, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858, DOI 10.1002/14651858]; Goddard AW, 1999, PSYCHIAT RES, V85, P225, DOI 10.1016/S0165-1781(99)00015-3; Goffin V, 1999, GENET ANAL-BIOMOL E, V15, P189, DOI 10.1016/S1050-3862(99)00025-X; Gold PE, 1981, ENDOGENOUS PEPTIDES, P79; GOLD PW, 1983, NEW ENGL J MED, V308, P1117, DOI 10.1056/NEJM198305123081902; GOLD PW, 1986, NEW ENGL J MED, V314, P1329, DOI 10.1056/NEJM198605223142101; GOLD PW, 1984, AM J PSYCHIAT, V141, P619; GOLD PW, 1988, NEW ENGL J MED, V319, P413, DOI 10.1056/NEJM198808183190706; Gold PW, 1995, ANN NY ACAD SCI, V771, P716, DOI 10.1111/j.1749-6632.1995.tb44723.x; Goodwin TM, 1998, CLIN PERINATOL, V25, P859, DOI 10.1016/S0095-5108(18)30087-3; Greven H M, 1973, Prog Brain Res, V39, P429; GRIFFON N, 1994, BIOCHEM BIOPH RES CO, V200, P1007, DOI 10.1006/bbrc.1994.1550; Gross P, 2000, EXP PHYSIOL, V85, p253S, DOI 10.1111/j.1469-445X.2000.tb00030.x; GROSSMAN A, 1981, CLIN ENDOCRINOL, V14, P381, DOI 10.1111/j.1365-2265.1981.tb00624.x; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; GUBLER U, 1984, P NATL ACAD SCI-BIOL, V81, P4307, DOI 10.1073/pnas.81.14.4307; GUILLEMIN R, 1982, SCIENCE, V218, P585, DOI 10.1126/science.6812220; Guillemin R, 2004, ANN NY ACAD SCI, V1038, P131, DOI 10.1196/annals.1315.021; GUILOFF RJ, 1987, NEUROL CLIN, V5, P171, DOI 10.1016/S0733-8619(18)30941-1; GULDENAAR SEF, 1995, BRAIN RES, V700, P107, DOI 10.1016/0006-8993(95)00939-N; Gyetvai K, 1999, OBSTET GYNECOL, V94, P869, DOI 10.1016/S0029-7844(99)00329-4; Habib KE, 2000, P NATL ACAD SCI USA, V97, P6079, DOI 10.1073/pnas.97.11.6079; Hadley ME, 2005, PEPTIDES, V26, P1687, DOI 10.1016/j.peptides.2005.01.023; Hadley ME, 1999, ANN NY ACAD SCI, V885, P1; Hallschmid M, 2004, PHYSIOL BEHAV, V83, P55, DOI 10.1016/j.physbeh.2004.07.023; HAN JS, 1982, ANNU REV PHARMACOL, V22, P193, DOI 10.1146/annurev.pa.22.040182.001205; HAN JS, 1986, PAIN, V27, P101, DOI 10.1016/0304-3959(86)90227-7; Hargreaves R, 2002, J CLIN PSYCHIAT, V63, P18; Harvey S, 1995, GROWTH HORMONE, P87; HATTON GI, 1992, ANN NY ACAD SCI, V652, P142, DOI 10.1111/j.1749-6632.1992.tb34351.x; Hauser KF, 2005, FRONT BIOSCI-LANDMRK, V10, P216, DOI 10.2741/1522; Hayashida CY, 2000, EUR J ENDOCRINOL, V142, P557, DOI 10.1530/eje.0.1420557; Healy ML, 2003, J CLIN ENDOCR METAB, V88, P5221, DOI 10.1210/jc.2002-021872; HEILIG M, 1995, BIOL PSYCHIAT, V38, P210, DOI 10.1016/0006-3223(94)00239-Y; Heinemann A, 1996, AM J PHYSIOL-GASTR L, V270, pG253, DOI 10.1152/ajpgi.1996.270.2.G253; Heinonen MV, 2008, ACTA PHYSIOL, V192, P471, DOI 10.1111/j.1748-1716.2008.01836.x; Hendry S.H., 1993, BIOL NEUROPEPTIDE Y, P65; Herbison AE, 2007, HORM RES, V68, P75, DOI 10.1159/000110583; HERKENHAM M, 1987, NEUROSCIENCE, V23, P1, DOI 10.1016/0306-4522(87)90268-5; Herman JP, 1996, CRIT REV NEUROBIOL, V10, P371, DOI 10.1615/CritRevNeurobiol.v10.i3-4.50; HERMES MLHJ, 1993, BRAIN RES, V631, P313, DOI 10.1016/0006-8993(93)91550-C; Herpfer I, 2005, CNS DRUGS, V19, P275, DOI 10.2165/00023210-200519040-00001; Herz A, 1997, PSYCHOPHARMACOLOGY, V129, P99, DOI 10.1007/s002130050169; Heuser I, 1998, Depress Anxiety, V8, P71, DOI 10.1002/(SICI)1520-6394(1998)8:2<71::AID-DA5>3.0.CO;2-N; Higuchi H, 2005, J PHARMACOL SCI, V98, P225, DOI 10.1254/jphs.FMJ05001X6; Hilal L, 2008, MOL MED, V14, P286, DOI 10.2119/2007-00128.Hilal; Hill K, 2000, J CHILD ADOL PSYCHOP, V10, P3, DOI 10.1089/cap.2000.10.3; Hillier SG, 1999, ANN ENDOCRINOL-PARIS, V60, P111; Hinkle PM, 1989, ANN NY ACAD SCI, V553, P176; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; HOFFMAN AR, 1982, NEW ENGL J MED, V307, P1237, DOI 10.1056/NEJM198211113072003; Hoffmann P, 1996, NEWS PHYSIOL SCI, V11, P223; HOKFELT T, 1991, NEUROPEPTIDES, V19, P31, DOI 10.1016/0143-4179(91)90081-S; HOKFELT T, 1989, ANN NY ACAD SCI, V553, P76; HOKFELT T, 1994, TRENDS NEUROSCI, V17, P22, DOI 10.1016/0166-2236(94)90031-0; HOLSBOER F, 1984, NEW ENGL J MED, V311, P1127; HOMMER DW, 1985, ANN NY ACAD SCI, V448, P542, DOI 10.1111/j.1749-6632.1985.tb29947.x; Insel TR, 1995, ADV EXP MED BIOL, V395, P227; Inui A, 2000, PHARMACOL REV, V52, P35; Ishak WW, 2008, J SEX MED, V5, P1022, DOI 10.1111/j.1743-6109.2007.00691.x; ISHIBASHI H, 1995, J NEUROPHYSIOL, V74, P1028, DOI 10.1152/jn.1995.74.3.1028; Janecka A, 2007, CURR MED CHEM, V14, P3201, DOI 10.2174/092986707782793880; Janson ET, 1999, CURR PHARM DESIGN, V5, P693; Jard S, 1998, ADV EXP MED BIOL, V449, P1; Jolles J, 1987, VASOPRESSIN PRINCIPL, P549; Jordan J, 2008, CLIN PHARMACOL THER, V83, P281, DOI 10.1038/sj.clpt.6100272; KAMILARIS TC, 1992, ENDOCRINOLOGY, V130, P1764, DOI 10.1210/en.130.4.1764; KARALIS K, 1994, J CLIN INVEST, V93, P2000, DOI 10.1172/JCI117193; Kasckow JW, 2001, PEPTIDES, V22, P845, DOI 10.1016/S0196-9781(01)00399-0; KASTIN AJ, 1971, PHYSIOL BEHAV, V7, P893, DOI 10.1016/0031-9384(71)90060-6; KASTIN AJ, 1968, ACTA ENDOCRINOL-COP, V58, P6, DOI 10.1530/acta.0.0580006; Katschinski M, 1996, EUR J CLIN INVEST, V26, P574, DOI 10.1046/j.1365-2362.1996.1790522.x; Kawai N, 1997, PHARMACOL BIOCHEM BE, V58, P517, DOI 10.1016/S0091-3057(97)00289-X; Keck ME, 2008, AM J MED GENET B, V147B, P1196, DOI 10.1002/ajmg.b.30750; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KENDRICK KM, 1992, ANN NY ACAD SCI, V652, P102, DOI 10.1111/j.1749-6632.1992.tb34349.x; Kennedy JL, 1999, MOL PSYCHIATR, V4, P284, DOI 10.1038/sj.mp.4000507; Khawaja AM, 1996, INT J BIOCHEM CELL B, V28, P721, DOI 10.1016/1357-2725(96)00017-9; KING JA, 1988, ENDOCRINOLOGY, V122, P2742, DOI 10.1210/endo-122-6-2742; Kirk LF, 2000, AM FAM PHYSICIAN, V62, P1119; KISS JZ, 1985, BRAIN RES, V329, P169, DOI 10.1016/0006-8993(85)90522-0; KISS JZ, 1983, BRAIN RES, V265, P11, DOI 10.1016/0006-8993(83)91328-8; KLING MA, 1991, J CLIN ENDOCR METAB, V72, P260, DOI 10.1210/jcem-72-2-260; KLING MA, 1993, NEUROENDOCRINOLOGY, V57, P79, DOI 10.1159/000126345; KLING MA, 1994, PSYCHOPHARMACOL BULL, V30, P489; KLING MA, 1994, J CLIN ENDOCR METAB, V79, P233, DOI 10.1210/jc.79.1.233; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; KNOBIL E, 1989, J STEROID BIOCHEM, V33, P669, DOI 10.1016/0022-4731(89)90476-7; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; Koob GF, 1999, BRAIN RES, V848, P141, DOI 10.1016/S0006-8993(99)01991-5; Koob GF, 1989, NEUROPHARMACOLOGICAL, P214; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Kovacs M, 2008, CURR MED CHEM, V15, P314, DOI 10.2174/092986708783497355; Kow LM, 1996, PEPTIDES, V17, P131, DOI 10.1016/0196-9781(95)02053-5; Kramer MS, 2004, NEUROPSYCHOPHARMACOL, V29, P385, DOI 10.1038/sj.npp.1300260; KRAMER MS, 1995, BIOL PSYCHIAT, V37, P462, DOI 10.1016/0006-3223(94)00190-E; Kramer MS, 1998, SCIENCE, V281, P1640, DOI 10.1126/science.281.5383.1640; Kreek MJ, 2000, ANN NY ACAD SCI, V909, P186; Krieger D T, 1980, Recent Prog Horm Res, V36, P277; Krishnan KRR, 2002, J CLIN PSYCHIAT, V63, P25; KRITZER MF, 1987, J COMP NEUROL, V263, P418, DOI 10.1002/cne.902630308; KRIVOY WA, 1961, ENDOCRINOLOGY, V69, P170, DOI 10.1210/endo-69-1-170; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Kruger THC, 2006, EUR J NEUROSCI, V24, P3445, DOI 10.1111/j.1460-9568.2006.05215.x; KRULICH L, 1968, ENDOCRINOLOGY, V83, P783, DOI 10.1210/endo-83-4-783; Lam KSL, 1996, NEUROENDOCRINOLOGY, V63, P475, DOI 10.1159/000127075; LAMBERT PD, 1994, PEPTIDES, V15, P657, DOI 10.1016/0196-9781(94)90091-4; LAMBERTS SWJ, 1993, FRONT NEUROENDOCRIN, V14, P27, DOI 10.1006/frne.1993.1002; Lanca AJ, 1998, PEPTIDES, V19, P859, DOI 10.1016/S0196-9781(98)00032-1; LANDGRAF R, 1995, EUR J NEUROSCI, V7, P592, DOI 10.1111/j.1460-9568.1995.tb00663.x; Laron Z, 2002, NOVART FDN SYMP, V242, P125; Laszlo F, 1998, SCAND J GASTROENTERO, V33, P62, DOI 10.1080/003655298750026589; LAUFER MR, 1993, CLIN OBSTET GYNECOL, V36, P668, DOI 10.1097/00003081-199309000-00023; Lazarus JH, 1998, THYROID, V8, P909, DOI 10.1089/thy.1998.8.909; LECHAN RM, 1986, SCIENCE, V231, P159, DOI 10.1126/science.3079917; Lee R, 2005, AM J PSYCHIAT, V162, P995, DOI 10.1176/appi.ajp.162.5.995; Legros JJ, 1996, HORM RES, V45, P182, DOI 10.1159/000184784; Lena I, 1999, NEUROPHARMACOLOGY, V38, P543, DOI 10.1016/S0028-3908(98)00223-8; Leng G, 2005, VITAM HORM, V71, P27, DOI 10.1016/S0083-6729(05)71002-5; LENG G, 1993, ANN NY ACAD SCI, V689, P133, DOI 10.1111/j.1749-6632.1993.tb55543.x; Lethagen S, 1999, HAEMOPHILIA, V5, P233; Levin N, 1991, FRONTIERS ENDOCRINOL, V12, P210; LEWIS RV, 1980, SCIENCE, V208, P1459, DOI 10.1126/science.7384787; LIDDLE RA, 1989, J CLIN INVEST, V84, P1220, DOI 10.1172/JCI114288; LIDDLE RA, 1994, ANN NY ACAD SCI, V713, P22, DOI 10.1111/j.1749-6632.1994.tb44048.x; LIDDLE RA, 1994, GUT PEPTIDES BIOCH P, P175; Liddle RA, 1985, J CLIN INVEST, V69, P218; LIEBOWITZ MR, 1984, ARCH GEN PSYCHIAT, V41, P669; Lin XW, 1998, COMP BIOCHEM PHYS C, V119, P375, DOI 10.1016/S0742-8413(98)00025-5; Lindh C, 1997, SCAND J RHEUMATOL, V26, P468, DOI 10.3109/03009749709065721; LINES C, 1995, BRIT J CLIN PHARMACO, V39, P235, DOI 10.1111/j.1365-2125.1995.tb04442.x; Liu H, 2008, ANN INTERN MED, V148, P747, DOI 10.7326/0003-4819-148-10-200805200-00215; LLOYD KCK, 1994, BAILLIERE CLIN ENDOC, V8, P111, DOI 10.1016/S0950-351X(05)80228-9; LOLAIT SJ, 1995, P NATL ACAD SCI USA, V92, P6783, DOI 10.1073/pnas.92.15.6783; LOOSEN PT, 1992, PHARMACOPSYCHIATRY, V25, P192, DOI 10.1055/s-2007-1014405; Lovejoy DA, 1999, GEN COMP ENDOCR, V115, P1, DOI 10.1006/gcen.1999.7298; Low CMR, 2000, J MED CHEM, V43, P3505, DOI 10.1021/jm000937a; LU L, 1989, AM J PHYSIOL, V256, pG430, DOI 10.1152/ajpgi.1989.256.2.G430; LUCKMAN SM, 1995, BRAIN RES, V669, P115, DOI 10.1016/0006-8993(94)01271-I; Ma XM, 1999, ENDOCRINOLOGY, V140, P5642, DOI 10.1210/en.140.12.5642; MACALUSO A, 1994, J NEUROSCI, V14, P2377; MacNeil DJ, 2007, CURR TOP MED CHEM, V7, P1721, DOI 10.2174/156802607782341028; MAEDA K, 1995, NEUROSCI BIOBEHAV R, V19, P427, DOI 10.1016/0149-7634(94)00069-D; Maggi CA, 1997, TRENDS PHARMACOL SCI, V18, P351, DOI 10.1016/S0165-6147(97)01107-3; MAGGI CA, 1995, GEN PHARMACOL-VASC S, V26, P911, DOI 10.1016/0306-3623(94)00292-U; Maheshwari HG, 1998, J CLIN ENDOCR METAB, V83, P4065, DOI 10.1210/jc.83.11.4065; Mansi JA, 1996, ENDOCRINOLOGY, V137, P4619, DOI 10.1210/en.137.11.4619; MANSOUR A, 1987, J NEUROSCI, V7, P2445; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; Mansour A, 1996, NEUROSCIENCE, V71, P671, DOI 10.1016/0306-4522(95)00464-5; Mantyh PW, 2002, J CLIN PSYCHIAT, V63, P6; Marangell LB, 1997, ARCH GEN PSYCHIAT, V54, P214; MARGULES DL, 1978, SCIENCE, V202, P988, DOI 10.1126/science.715455; MARTIGNONI E, 1990, ACTA NEUROL SCAND, V81, P452; MARTIN LW, 1990, AM J PHYSIOL, V259, pR768, DOI 10.1152/ajpregu.1990.259.4.R768; Martin-Martinez M, 2000, J MED CHEM, V43, P3770, DOI 10.1021/jm000959x; Marumo K, 1999, INT J UROL, V6, P19, DOI 10.1046/j.1442-2042.1999.06128.x; MASON AJ, 1986, SCIENCE, V234, P1372, DOI 10.1126/science.3097822; Mathias S, 2007, PSYCHONEUROENDOCRINO, V32, P1021, DOI 10.1016/j.psyneuen.2007.07.008; MATTES JA, 1985, BIOL PSYCHIAT, V20, P533, DOI 10.1016/0006-3223(85)90024-1; MAY C, 1987, NEUROLOGY, V37, P535, DOI 10.1212/WNL.37.3.535; Mayinger B, 1999, EXP CLIN ENDOCR DIAB, V107, P157, DOI 10.1055/s-0029-1212091; MCCARTHY MM, 1994, NEUROENDOCRINOLOGY, V59, P432, DOI 10.1159/000126689; McCarthy MM, 1997, MOL MED TODAY, V3, P269, DOI 10.1016/S1357-4310(97)01058-7; McCleane GJ, 1998, ANESTH ANALG, V87, P1117, DOI 10.1097/00000539-199811000-00025; Mease PJ, 2008, J RHEUMATOL, V35, P502; Melis MR, 1995, EUR J PHARMACOL, V294, P1, DOI 10.1016/0014-2999(95)00508-0; Meurs A, 2007, EUR J NEUROSCI, V26, P3079, DOI 10.1111/j.1460-9568.2007.05911.x; MEZEY E, 1985, ANN NY ACAD SCI, V448, P152, DOI 10.1111/j.1749-6632.1985.tb29915.x; MIACHON S, 1995, BRAIN RES BULL, V36, P119, DOI 10.1016/0361-9230(94)00175-Z; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; MISAKI N, 1992, NEUROCHEM INT, V21, P185, DOI 10.1016/0197-0186(92)90145-H; MIYASAKA K, 1989, AM J PHYSIOL, V257, pG175, DOI 10.1152/ajpgi.1989.257.2.G175; MIZUI K, 1994, 1994 VEHICLE NAVIGATION & INFORMATION SYSTEMS CONFERENCE PROCEEDINGS, pA153; Mizushige T, 2006, BIOMED RES-TOKYO, V27, P227, DOI 10.2220/biomedres.27.227; MOLCHAN SE, 1991, BIOL PSYCHIAT, V29, P1110, DOI 10.1016/0006-3223(91)90253-I; MOLCHAN SE, 1993, PSYCHONEUROENDOCRINO, V18, P509, DOI 10.1016/0306-4530(93)90044-L; Mollereau C, 1996, P NATL ACAD SCI USA, V93, P8666, DOI 10.1073/pnas.93.16.8666; MORAN TH, 1993, AM J PHYSIOL, V265, pR620, DOI 10.1152/ajpregu.1993.265.3.R620; Morgan CA, 2000, BIOL PSYCHIAT, V47, P902, DOI 10.1016/S0006-3223(99)00239-5; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; MOURADIAN MM, 1986, NEUROPEPTIDES, V8, P393, DOI 10.1016/0143-4179(86)90010-7; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; Muller J, 1988, CENTRAL NERVOUS SYST, V2, P336; MUNSAT TL, 1989, ANN NY ACAD SCI, V553, P388; MUTT V, 1968, EUR J BIOCHEM, V6, P156, DOI 10.1111/j.1432-1033.1968.tb00433.x; MYERS BM, 1980, PHARMACOL BIOCHEM BE, V12, P365, DOI 10.1016/0091-3057(80)90038-6; NAIR NPV, 1982, PROG NEURO-PSYCHOPH, V6, P509; Nair RM, 1970, CURRENT THERAPEUTIC, V12, P394; NAKAZAWA T, 1985, PEPTIDES, V6, P75, DOI 10.1016/0196-9781(85)90079-8; Nam SY, 2001, J CLIN ENDOCR METAB, V86, P4849, DOI 10.1210/jc.86.10.4849; NEMEROFF CB, 1992, NEUROPSYCHOPHARMACOL, V6, P69; NEMEROFF CB, 1991, BRIT J PSYCHIAT, V158, P59, DOI 10.1192/bjp.158.1.59; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; Netchine I, 1998, J CLIN ENDOCR METAB, V83, P432, DOI 10.1210/jc.83.2.432; Newman CB, 1999, ENDOCRIN METAB CLIN, V28, P171, DOI 10.1016/S0889-8529(05)70062-1; Nikisch G, 2005, INT J NEUROPSYCHOPH, V8, P403, DOI 10.1017/S1461145705005158; Nikisch G, 2008, EUR PSYCHIAT, V23, P356, DOI 10.1016/j.eurpsy.2008.03.003; NIKOLICS K, 1985, NATURE, V316, P511, DOI 10.1038/316511a0; Nishino S, 2003, BIOL PSYCHIAT, V54, P87, DOI 10.1016/S0006-3223(03)00349-4; ODONOHUE TL, 1982, PEPTIDES, V3, P353, DOI 10.1016/0196-9781(82)90098-5; OLSON GA, 1995, PEPTIDES, V16, P1517, DOI 10.1016/0196-9781(95)02063-2; Olszewski PK, 2004, ENDOCRINOLOGY, V145, P2627, DOI 10.1210/en.2004-0016; OMALLEY SS, 1995, DRUG ALCOHOL DEPEN, V39, pS3, DOI 10.1016/0376-8716(95)01167-W; ORTH DN, 1995, NEW ENGL J MED, V332, P791, DOI 10.1056/NEJM199503233321207; Ortmann O, 1999, HUM REPROD, V14, P194, DOI 10.1093/humrep/14.suppl_1.194; OWENS MJ, 1991, PHARMACOL REV, V43, P425; Owyang C, 1996, AM J PHYSIOL-GASTR L, V271, pG1, DOI 10.1152/ajpgi.1996.271.1.G1; OWYANG C, 1986, J CLIN INVEST, V77, P2042, DOI 10.1172/JCI112534; Pande AC, 1999, BIOL PSYCHIAT, V46, P860, DOI 10.1016/S0006-3223(99)00090-6; PAPADOUKA V, 1994, BRAIN RES, V639, P42, DOI 10.1016/0006-8993(94)91762-0; PASTERNAK GW, 1988, JAMA-J AM MED ASSOC, V259, P1362, DOI 10.1001/jama.259.9.1362; Patel L, 2003, EXPERT OPIN PHARMACO, V4, P2279; PATEL YC, 1995, CIBA F SYMP, V190, P26; Patel YC, 1987, GROWTH HORMONE GROWT, P21; PEDERSEN CA, 1985, NEUROPEPTIDES, V6, P175, DOI 10.1016/0143-4179(85)90108-8; PEDERSEN CA, 1992, ANN NY ACAD SCI, V652, P58, DOI 10.1111/j.1749-6632.1992.tb34346.x; PEDERSEN CA, 1988, ANN NY ACAD SCI, V525, P245, DOI 10.1111/j.1749-6632.1988.tb38610.x; PENG C, 1994, ENDOCRINOLOGY, V134, P1095, DOI 10.1210/en.134.3.1095; PERLMUTTER LS, 1984, NEUROSCIENCE, V13, P769, DOI 10.1016/0306-4522(84)90095-2; Perone MJ, 1998, MOL CELL ENDOCRINOL, V142, P191, DOI 10.1016/S0303-7207(98)00104-X; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; PERT CB, 1973, SCIENCE, V179, P1011, DOI 10.1126/science.179.4077.1011; PESELOW E, 1987, PSYCHOPHARMACOLOGY, V91, P80, DOI 10.1007/BF00690931; PITTS AF, 1995, BIOL PSYCHIAT, V38, P330, DOI 10.1016/0006-3223(95)00229-A; PLOTNIKOFF NP, 1976, LIFE SCI, V18, P1217, DOI 10.1016/0024-3205(76)90197-1; Plotsky PM, 1998, PSYCHIAT CLIN N AM, V21, P293, DOI 10.1016/S0193-953X(05)70006-X; Prange AJ, 1996, THYROID, V6, P537, DOI 10.1089/thy.1996.6.537; Prange AJ, 1979, NEW FRONTIERS PSYCHO, P3; Prange Jr AJ, 1984, NEUROBIOLOGY MOOD DI, P311; Qian A, 1998, CELL SIGNAL, V10, P101, DOI 10.1016/S0898-6568(97)00097-1; Rasmusson AM, 2000, BIOL PSYCHIAT, V47, P526, DOI 10.1016/S0006-3223(99)00185-7; REEVE JR, 1994, ANN NY ACAD SCI, V713, P11, DOI 10.1111/j.1749-6632.1994.tb44047.x; REGOLI D, 1994, PHARMACOL REV, V46, P551; REHFELD JF, 1978, BRAIN RES, V155, P19, DOI 10.1016/0006-8993(78)90301-3; Rehfeld JF, 2000, REGUL PEPTIDES, V93, P79, DOI 10.1016/S0167-0115(00)00179-8; REHFELD JF, 1985, ANN NY ACAD SCI, V448, P11, DOI 10.1111/j.1749-6632.1985.tb29902.x; Reinscheid RK, 1996, J BIOL CHEM, V271, P14163, DOI 10.1074/jbc.271.24.14163; Reiser LW, 1985, COMPREHENSIVE TXB PS, P1171; REISINE T, 1993, TRENDS NEUROSCI, V16, P506, DOI 10.1016/0166-2236(93)90194-Q; REISINE T, 1994, REGUL PEPTIDES, V54, P241, DOI 10.1016/0167-0115(94)90479-0; Reum T, 1997, NEUROPEPTIDES, V31, P82, DOI 10.1016/S0143-4179(97)90025-1; RICHARDSON SB, 1986, ENDOCRINOLOGY, V118, P2076, DOI 10.1210/endo-118-5-2076; Ripley B, 2001, NEUROLOGY, V57, P2253, DOI 10.1212/WNL.57.12.2253; RISTIC H, 1994, J PHARMACOL EXP THER, V270, P534; RIVIER J, 1982, NATURE, V300, P276, DOI 10.1038/300276a0; Roca CA, 1999, BIOL PSYCHIAT, V46, P551, DOI 10.1016/S0006-3223(99)00006-2; Rodgers RJ, 1995, CRIT REV NEUROBIOL, V9, P345; ROOT A W, 1970, Journal of Pediatrics, V76, P422, DOI 10.1016/S0022-3476(70)80483-8; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; Rosler A, 1998, NEW ENGL J MED, V338, P416, DOI 10.1056/nejm199802123380702; Rubin RT, 2003, LIFE SCI, V72, P1209, DOI 10.1016/S0024-3205(02)02369-X; Rubin RT, 1999, NEUROPSYCHOPHARMACOL, V20, P434, DOI 10.1016/S0893-133X(98)00077-3; Rubinow DR, 2005, NEUROPSYCHOPHARMACOL, V30, P1906, DOI 10.1038/sj.npp.1300742; Rupniak NMJ, 2002, CAN J PHYSIOL PHARM, V80, P489, DOI 10.1139/y02-048; RUSSELL IJ, 1994, ARTHRITIS RHEUM-US, V37, P1593, DOI 10.1002/art.1780371106; Safarinejad MR, 2008, J SEX MED, V5, P887, DOI 10.1111/j.1743-6109.2007.00698.x; Safarinejad MR, 2008, J UROLOGY, V179, P1066, DOI 10.1016/j.juro.2007.10.063; Saffroy M, 2003, NEUROSCIENCE, V116, P761, DOI 10.1016/S0306-4522(02)00748-0; Sah R, LOW CEREBRO IN PRESS; SAITO A, 1980, SCIENCE, V208, P1155, DOI 10.1126/science.6246582; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2006, CONTEMPORARY CLIN NE, P13; Salomon RM, 2003, BIOL PSYCHIAT, V54, P96, DOI 10.1016/S0006-3223(02)01740-7; SALOMON Y, 1990, MOL CELL ENDOCRINOL, V70, P139, DOI 10.1016/0303-7207(90)90153-Y; Salvatori R, 1999, J CLIN ENDOCR METAB, V84, P917, DOI 10.1210/jc.84.3.917; SANDMAN CA, 1972, J COMP PHYSIOL PSYCH, V80, P54, DOI 10.1037/h0032827; Sandman CA, 1977, NEUROBIOLOGY SLEEP M, P347; SARKAR DK, 1976, NATURE, V264, P461, DOI 10.1038/264461a0; Sato M, 1997, ENDOCR J, V44, P765, DOI 10.1507/endocrj.44.765; Sattin A, 1998, THYROID, V8, P957, DOI 10.1089/thy.1998.8.957; Scacchi M, 1997, J CLIN ENDOCR METAB, V82, P3225, DOI 10.1210/jc.82.10.3225; Schafer M, 1991, NEUROBIOLOGY OPIOIDS, P53, DOI DOI 10.1007/978-3-642-46660-1_3; SCHALLY AV, 1971, BIOCHEM BIOPH RES CO, V43, P393, DOI 10.1016/0006-291X(71)90766-2; Schally AV, 1999, TRENDS ENDOCRIN MET, V10, P383, DOI 10.1016/S1043-2760(99)00209-X; SCHIFFMANN SN, 1991, NEUROSCI LETT, V123, P123, DOI 10.1016/0304-3940(91)90173-Q; SCHMALE H, 1987, KIDNEY INT, V32, pS8; Schober JM, 2005, ARCH SEX BEHAV, V34, P691, DOI 10.1007/s10508-005-7929-2; SCHOENEN J, 1985, NEUROLOGY, V35, P881, DOI 10.1212/WNL.35.6.881; Schwartz JP, 1998, PERSPECT DEV NEUROBI, V5, P427; Seeley RJ, 2004, ANNU REV NUTR, V24, P133, DOI 10.1146/annurev.nutr.24.012003.132428; SENARIS RM, 1995, MOL BRAIN RES, V29, P185, DOI 10.1016/0169-328X(94)00275-J; SEVARINO KA, 1989, J BIOL CHEM, V264, P21529; Shadiack AM, 2007, CURR TOP MED CHEM, V7, P1137; SHARP FR, 1991, J NEUROSCI, V11, P2321, DOI 10.1523/jneurosci.11-08-02321.1991; SHERWOOD NM, 1990, J EXP ZOOL, P63, DOI 10.1002/jez.1402560412; SHERWOOD NM, 1993, ENDOCR REV, V14, P241, DOI 10.1210/er.14.2.241; SHIBAHARA S, 1983, EMBO J, V2, P775, DOI 10.1002/j.1460-2075.1983.tb01499.x; Shippenberg TS, 1998, CRIT REV NEUROBIOL, V12, P267, DOI 10.1615/CritRevNeurobiol.v12.i4.10; SHIVERS BD, 1983, NATURE, V304, P345, DOI 10.1038/304345a0; Shvartzman P, 2000, ISRAEL MED ASSOC J, V2, P536; Silva AP, 2005, CNS NEUROL DISORD-DR, V4, P331, DOI 10.2174/1568007054546153; Silverman A.-J., 1988, P1283; Singh L, 1996, EUR J PHARMACOL, V307, P283, DOI 10.1016/0014-2999(96)00281-6; SMITH GP, 1985, ANN NY ACAD SCI, V448, P417, DOI 10.1111/j.1749-6632.1985.tb29936.x; Smith RG, 2005, ENDOCR REV, V26, P346, DOI 10.1210/er.2004-0019; Solomon S, 1999, ANN NY ACAD SCI, V885, P22; Steckler T, 1999, BIOL PSYCHIAT, V46, P1480, DOI 10.1016/S0006-3223(99)00170-5; Stefano GB, 1996, CRIT REV IMMUNOL, V16, P109, DOI 10.1615/CritRevImmunol.v16.i2.10; Stein MB, 1996, PSYCHIAT RES, V59, P183, DOI 10.1016/0165-1781(95)02776-9; STINUS L, 1986, BIOL PSYCHIAT, V21, P34, DOI 10.1016/0006-3223(86)90006-5; Stockmeier CA, 2002, NEUROREPORT, V13, P1223, DOI 10.1097/00001756-200207020-00031; Stonesifer LD, 2008, NEW ENGL J MED, V358, P2178; Stout SC, 2001, ANNU REV PHARMACOL, V41, P877, DOI 10.1146/annurev.pharmtox.41.1.877; Strand FL, 2000, EUR J PHARMACOL, V405, P3, DOI 10.1016/S0014-2999(00)00536-7; Strand FL., 1999, NEUROPEPTIDES REGULA; Stratakis CA, 1995, ANN NY ACAD SCI, V771, P1, DOI 10.1111/j.1749-6632.1995.tb44666.x; Strawn JR, 2008, J CLIN PSYCHOPHARM, V28, P596, DOI 10.1097/JCP.0b013e318184c8f2; Strawn Jeffrey R, 2007, Neuropsychiatr Dis Treat, V3, P237; SUEMARU S, 1995, LIFE SCI, V57, P2231, DOI 10.1016/0024-3205(95)02215-5; Sundler F, 1993, BIOL NEUROPEPTIDE Y, P170; Swaab DF, 1987, PROG BRAIN RES <D>, V72, P301; Swaab D F, 1977, Front Horm Res, V4, P170; SWIFT RM, 1995, J CLIN PSYCHIAT, V56, P24; Szuba MP, 2005, J CLIN PSYCHOPHARM, V25, P325, DOI 10.1097/01.jcp.0000169037.17884.79; Tachikawa H, 1999, AM J MED GENET, V88, P700, DOI 10.1002/(SICI)1096-8628(19991215)88:6<700::AID-AJMG21>3.3.CO;2-O; Tachikawa H, 2000, AM J MED GENET, V96, P141, DOI 10.1002/(SICI)1096-8628(20000403)96:2<141::AID-AJMG3>3.0.CO;2-R; Taghzouti K, 1999, PSYCHOPHARMACOLOGY, V143, P141, DOI 10.1007/s002130050929; TAKEUCHI T, 1986, J CLIN INVEST, V77, P1038, DOI 10.1172/JCI112357; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; TAPANAINEN P, 1989, PEDIATR RES, V26, P404, DOI 10.1203/00006450-198911000-00003; TATEMOTO K, 1982, NATURE, V296, P659, DOI 10.1038/296659a0; TATRO JB, 1990, BRAIN RES, V536, P124, DOI 10.1016/0006-8993(90)90016-5; Tatro JB, 1996, NEUROIMMUNOMODULAT, V3, P259, DOI 10.1159/000097281; Thibaut F, 1996, PSYCHONEUROENDOCRINO, V21, P411, DOI 10.1016/0306-4530(96)00004-2; THODY AJ, 1980, PEPTIDES, V1, P125, DOI 10.1016/0196-9781(80)90075-3; Thody AJ, 1999, ANN NY ACAD SCI, V885, P217, DOI 10.1111/j.1749-6632.1999.tb08679.x; THORNER MO, 1988, J CLIN INVEST, V82, P745, DOI 10.1172/JCI113673; TONI R, 1990, NEUROENDOCRINOLOGY, V52, P422, DOI 10.1159/000125623; Toppila J, 1996, J SLEEP RES, V5, P115, DOI 10.1046/j.1365-2869.1996.d01-66.x; Torda C, 1952, AM J PHYSIOL, V169, P133; Trainer PJ, 2000, NEW ENGL J MED, V342, P1171, DOI 10.1056/NEJM200004203421604; TRIBOLLET E, 1992, ANN NY ACAD SCI, V652, P29, DOI 10.1111/j.1749-6632.1992.tb34343.x; TSOU K, 1986, BRAIN RES, V378, P28, DOI 10.1016/0006-8993(86)90283-0; Turner RA, 1999, PSYCHIATRY, V62, P97, DOI 10.1080/00332747.1999.11024859; UHDE TW, 1992, NEUROPSYCHOPHARMACOL, V6, P101; UHL GR, 1994, TRENDS NEUROSCI, V17, P89, DOI 10.1016/0166-2236(94)90110-4; ULM RR, 1995, J CLIN PSYCHIAT, V56, P5; Ursini A, 2000, J MED CHEM, V43, P3596, DOI 10.1021/jm990967h; VACCARINO FJ, 1995, PEPTIDES, V16, P595, DOI 10.1016/0196-9781(95)00018-F; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Vale W, 1997, ENDOCRINOLOGIST, V7, pS3, DOI 10.1097/00019616-199707011-00002; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VALENTIJN JA, 1994, J PHYSIOL-LONDON, V475, P185, DOI 10.1113/jphysiol.1994.sp020060; Van Nispen JW, 1990, NEUROPEPTIDES BASICS, P213; van Poppel H, 2008, UROLOGY, V71, P1001, DOI 10.1016/j.urology.2007.12.070; van Tijn DA, 2007, J CLIN ENDOCR METAB, V92, P104, DOI 10.1210/jc.2006-0689; VANCE ML, 1988, FRONT NEUROENDOCRIN, V10, P279; VANDERHELMHYLKEMA H, 1976, LIFE SCI, V18, P1099, DOI 10.1016/0024-3205(76)90144-2; VANECEK J, 1995, AM J PHYSIOL-ENDOC M, V269, pE85, DOI 10.1152/ajpendo.1995.269.1.E85; VANMEGAN HJGM, 1994, PROG NEURO-PSYCHOPH, V18, P1235, DOI 10.1016/0278-5846(94)90090-6; VANREE JM, 1985, PROG NEURO-PSYCHOPH, V9, P551, DOI 10.1016/0278-5846(85)90016-8; VANREE JM, 1981, LIFE SCI, V28, P2875, DOI 10.1016/0024-3205(81)90104-1; Vaughan CW, 1997, J NEUROSCI, V17, P996; VECSEI L, 1990, PROG NEURO-PSYCHOPH, V14, P835; VECSEI L, 1990, NEUROPEPTIDES, V16, P181, DOI 10.1016/0143-4179(90)90060-C; Veldhuis JD, 1997, ENDOCRINE, V7, P41, DOI 10.1007/BF02778061; Vitiello MV, 2006, NEUROBIOL AGING, V27, P318, DOI 10.1016/j.neurobiolaging.2005.01.010; Volpicelli JR, 1995, ALCOHOL ALCOHOLISM, V30, P789; von Euler US, 1931, J PHYSIOL-LONDON, V72, P74, DOI 10.1113/jphysiol.1931.sp002763; Vythilingam M, 2000, J CLIN ENDOCR METAB, V85, P4138, DOI 10.1210/jc.85.11.4138; Walsh D, 2000, SEMIN ONCOL, V27, P45; WALTER E, 1994, PHARMACEUT RES, V11, P1575, DOI 10.1023/A:1018953603301; WANG JB, 1993, P NATL ACAD SCI USA, V90, P10230, DOI 10.1073/pnas.90.21.10230; WANG PS, 1994, NEUROENDOCRINOLOGY, V59, P202, DOI 10.1159/000126660; Wang SS, 2008, MOL PSYCHIATR, V13, P786, DOI 10.1038/mp.2008.38; Wang XM, 1996, J NEUROPHYSIOL, V76, P3568, DOI 10.1152/jn.1996.76.5.3568; WANK SA, 1995, AM J PHYSIOL-GASTR L, V269, pG628, DOI 10.1152/ajpgi.1995.269.5.G628; WANK SA, 1992, P NATL ACAD SCI USA, V89, P8691, DOI 10.1073/pnas.89.18.8691; Warnock JK, 1997, PSYCHOPHARMACOL BULL, V33, P311; WATSON SJ, 1982, SCIENCE, V216, P85, DOI 10.1126/science.6121376; Webster EL, 1998, ANN NY ACAD SCI, V840, P21, DOI 10.1111/j.1749-6632.1998.tb09545.x; Wei J, 1999, EUR PSYCHIAT, V14, P67, DOI 10.1016/S0924-9338(99)80719-6; Westrin A, 1999, EUR NEUROPSYCHOPHARM, V9, P205, DOI 10.1016/S0924-977X(98)00026-1; White JM, 1999, ADDICTION, V94, P961, DOI 10.1046/j.1360-0443.1999.9479612.x; WIEMER G, 1988, PEPTIDES, V9, P1081, DOI 10.1016/0196-9781(88)90093-9; WITT DM, 1995, NEUROSCI BIOBEHAV R, V19, P315; WOLKOWITZ OM, 1990, BIOL PSYCHIAT, V28, P169, DOI 10.1016/0006-3223(90)90635-F; WOLTERINK G, 1988, PEPTIDES, V9, P277, DOI 10.1016/0196-9781(88)90260-4; Wong ML, 2000, P NATL ACAD SCI USA, V97, P325, DOI 10.1073/pnas.97.1.325; Wunderlich GR, 2000, PSYCHOPHARMACOLOGY, V151, P283, DOI 10.1007/s002130000445; Xia Y, 1986, ACUPUNCTURE ELECTRO, V11; Yamada H, 2005, NEUROSCI LETT, V376, P137, DOI 10.1016/j.neulet.2004.11.043; YAMAGUCHI M, 1986, P SOC EXP BIOL MED, V183, P368; YASUDA K, 1993, P NATL ACAD SCI USA, V90, P6736, DOI 10.1073/pnas.90.14.6736; Yehuda R, 2006, BIOL PSYCHIAT, V59, P660, DOI 10.1016/j.biopsych.2005.08.027; Zachrisson O, 1999, NEUROREPORT, V10, P3265, DOI 10.1097/00001756-199911080-00003; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0; Zadina JE, 1999, ANN NY ACAD SCI, V897, P136, DOI 10.1111/j.1749-6632.1999.tb07885.x; Zeng NX, 1998, YALE J BIOL MED, V71, P233; Zingg HH, 1998, ADV EXP MED BIOL, V449, P287; Zingg HH, 1995, ADV EXP MED BIOL, V395, P395; Zobel AW, 2000, J PSYCHIATR RES, V34, P171, DOI 10.1016/S0022-3956(00)00016-9; Zoli M, 1999, TRENDS PHARMACOL SCI, V20, P142, DOI 10.1016/S0165-6147(99)01343-7	595	6	6	0	3	ELSEVIER ACADEMIC PRESS INC	SAN DIEGO	525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA			978-0-08-088783-8				2009							2541	2596					56	Behavioral Sciences; Neurosciences	Book Citation Index – Science (BKCI-S)	Behavioral Sciences; Neurosciences & Neurology	BCV83	WOS:000311627103019					2022-02-06	
B	Giacino, JT; Schiff, ND		Laureys, S; Tononi, G		Giacino, Joseph T.; Schiff, Nicholas D.			The Minimally Conscious State: Clinical Features, Pathophysiology and Therapeutic Implications	NEUROLOGY OF CONSCIOUSNESS: COGNITIVE NEUROSCIENCE AND NEUROPATHOLOGY			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; PERSISTENT VEGETATIVE STATE; DELAY-PERIOD ACTIVITY; CM-PF COMPLEX; INTRALAMINAR NUCLEI; CORTICAL FUNCTION; HEAD-INJURY; RECOVERY; COMA; SCALE	The minimally conscious state (MCS) is a condition of severely altered consciousness that is distinguished from the vegetative state (VS) by the presence of minimal but clearly discernible behavioural evidence of self or environmental awareness. There is increasing evidence from neurobehavioural and neuroimaging studies that important differences in clinical presentation, neuropathology and functional outcome exist between MCS and VS. This chapter describes the characteristic features of MCS, discusses specialized assessment techniques required for accurate diagnosis and outlines potential pathophysiological mechanisms underlying MCS which may provide important clues for the development of effective treatment interventions.	[Giacino, Joseph T.] JFK Johnson Rehabil Inst, Edison, NJ USA; [Giacino, Joseph T.] New Jersey Neurosci Inst, Edison, NJ USA; [Schiff, Nicholas D.] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA		Giacino, JT (corresponding author), JFK Johnson Rehabil Inst, Edison, NJ USA.	jgiacomo@solarishs.org; nds2001@med.cornell.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698			Adams JH, 2001, J NEUROL NEUROSUR PS, V71, P521, DOI 10.1136/jnnp.71.4.521; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bekinschtein T, 2004, J NEUROL NEUROSUR PS, V75, P788, DOI 10.1136/jnnp.2003.034876; Berthier ML, 2001, NEUROPSY NEUROPSY BE, V14, P23; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Brefel-Courbon C, 2007, ANN NEUROL, V62, P102, DOI 10.1002/ana.21110; Burruss JW, 1999, J NEUROPSYCH CLIN N, V11, P100, DOI 10.1176/jnp.11.1.100; CASELLI RJ, 1991, NEUROPSY NEUROPSY BE, V4, P193; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Clauss P, 2001, SAMJ S AFR MED J, V91, P788; Danielsen ER, 2003, NEURORADIOLOGY, V45, P722, DOI 10.1007/s00234-003-1068-z; Davey MP, 2000, CLIN NEUROPHYSIOL, V111, P1949, DOI 10.1016/S1388-2457(00)00435-1; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2007, CURR OPIN NEUROL, V20, P614, DOI 10.1097/WCO.0b013e3282f189ef; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2004, J HEAD TRAUMA REHAB, V19, P254, DOI 10.1097/00001199-200405000-00006; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, J HEAD TRAUMA REHAB, V10, P40; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; GIACINO JT, 1992, JFK COMA RECOVERY SC, P1; Gold L, 2002, P NATL ACAD SCI USA, V99, P7699, DOI 10.1073/pnas.112012499; GROENEWEGEN HJ, 1994, TRENDS NEUROSCI, V17, P52, DOI 10.1016/0166-2236(94)90074-4; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hirsch J, 2000, NEUROSURGERY, V47, P711, DOI 10.1097/00006123-200009000-00037; HIRSCH J, 2001, ABST SOC NEUR, V271, P1397; JENNETT B, 1972, LANCET, V1, P734; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; Kakigi R, 1986, Rinsho Shinkeigaku, V26, P1100; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Kobylarz E., 2003, ASSC M; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Laureys S, 2006, CURR OPIN NEUROL, V19, P520, DOI 10.1097/WCO.0b013e3280106ba9; LEIGH RJ, 1987, ANN NEUROL, V22, P13; LLINAS R, 1994, TEMPORAL CODING BRAI, P252; Llinas RR, 2002, P NATL ACAD SCI USA, V99, P449, DOI 10.1073/pnas.012604899; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Macniven JA, 2003, BRAIN INJURY, V17, P525, DOI 10.1080/0269905031000086254; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; McMillan T.M., 1996, BRAIN INJURY, V11, P313; McMillan TM, 2004, BRAIN INJURY, V18, P935, DOI 10.1080/02699050410001675915; McMillan TM, 1997, BRAIN INJURY, V11, P483, DOI 10.1080/713802184; MEISSNER I, 1987, STROKE, V18, P380, DOI 10.1161/01.STR.18.2.380; Mennemeier M, 1997, NEUROPSYCHOLOGIA, V35, P183, DOI 10.1016/S0028-3932(96)00062-0; Menon DK, 1998, LANCET, V352, P1148, DOI 10.1016/S0140-6736(05)79795-6; Menon DK, 1999, TRENDS COGN SCI, V3, P44, DOI 10.1016/S1364-6613(98)01269-8; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Minamimoto T, 2002, J NEUROPHYSIOL, V87, P3090, DOI 10.1152/jn.2002.87.6.3090; Nagai Y, 2004, NEUROIMAGE, V21, P1232, DOI 10.1016/j.neuroimage.2003.10.036; Nguyen DK, 1998, CAN J NEUROL SCI, V25, P5, DOI 10.1017/S0317167100033424; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; PLUM F, 1991, CEREBRAL CORTEX, V9; Plum F., 1982, DIAGNOSIS STUPOR COM, V3rd; Purpura KP, 1997, NEUROSCIENTIST, V3, P8, DOI 10.1177/107385849700300110; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Robinson PA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041924; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Schiff N, 1999, J COGNITIVE NEUROSCI, V11, P650, DOI 10.1162/089892999563715; Schiff ND, 2000, J CLIN NEUROPHYSIOL, V17, P438, DOI 10.1097/00004691-200009000-00002; Schiff ND, 1999, TRENDS COGN SCI, V3, P43, DOI 10.1016/S1364-6613(98)01268-6; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2000, NEUROL RES, V22, P267; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; SCHIFF ND, 2002, THALAMUS RELAT SYST, V2, P51; Schiff ND, 2007, ANN NEUROL, V62, P5, DOI 10.1002/ana.21158; Schiff ND, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1121; SCHLAGREY M, 1984, J NEUROPHYSIOL, V51, P1149, DOI 10.1152/jn.1984.51.6.1149; Schneider WN, 1999, BRAIN INJURY, V13, P863; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Shiel A, 1998, BRAIN INJURY, V12, P809, DOI 10.1080/026990598122043; Slobounov SM, 2000, COGNITIVE BRAIN RES, V9, P287, DOI 10.1016/S0926-6410(00)00009-4; STERIADE M, 1982, J NEUROPHYSIOL, V48, P352, DOI 10.1152/jn.1982.48.2.352; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Steriade M, 1996, J NEUROSCI, V16, P2788; Steriade M, 2004, NAT REV NEUROSCI, V5, P121, DOI 10.1038/nrn1325; Steriade M., 1997, THALAMES; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; SZELIES B, 1991, ARCH NEUROL-CHICAGO, V48, P178, DOI 10.1001/archneur.1991.00530140072019; Taylor CM, 2007, ARCH PHYS MED REHAB, V88, P521, DOI 10.1016/j.apmr.2007.01.013; TEASDALE G, 1974, LANCET, V2, P81; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; TRESCH DD, 1991, ARCH INTERN MED, V151, P930, DOI 10.1001/archinte.151.5.930; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; Van der Werf YD, 1999, J NEUROL NEUROSUR PS, V66, P36; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842; Whyte J, 1999, ARCH PHYS MED REHAB, V80, P653, DOI 10.1016/S0003-9993(99)90168-5; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; WHYTE J, 1995, ARCH PHYS MED REHAB, V76, P804, DOI 10.1016/S0003-9993(95)80543-5; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; WILLIAMS D, 1951, BRAIN, V74, P377, DOI 10.1093/brain/74.4.377; Wilson SL, 2000, BRAIN INJURY, V14, P319; Wyder MT, 2004, J NEUROPHYSIOL, V91, P2628, DOI 10.1152/jn.01221.2003; Wyder MT, 2003, J NEUROPHYSIOL, V90, P2029, DOI 10.1152/jn.00064.2003	112	6	6	0	2	ELSEVIER ACADEMIC PRESS INC	SAN DIEGO	525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA			978-0-08-092102-0; 978-0-12-374168-4				2009							173	190		10.1016/B978-0-12-374168-4.00014-9			18	Clinical Neurology; Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BEI12	WOS:000316668600016					2022-02-06	
J	Grinkeviciute, D; Kevalas, R				Grinkeviciute, Dovile; Kevalas, Rimantas			Induced Mild Hypothermia in Children after Brain Injury	REVIEWS IN THE NEUROSCIENCES			English	Article; Proceedings Paper	5th International Symposium of the Definition of Death Network	MAY 20-23, 2008	Varadero Beach, CUBA			traumatic brain injury; posthypoxic brain injury; children; hypothermia; outcome; Pediatric Index of Mortality	HOSPITAL CARDIAC-ARREST; SEVERE HEAD-INJURY; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; HYPOPHOSPHATEMIA; ACTIVATION; TRIAL; PHASE	Aim: To determine the safety and effectiveness of mild induced hypothermia in children after traumatic or posthypoxic brain injury. Thirteen patients after traumatic or poshypoxic brain injury were involved in the study. Mean age was 11.1 +/- 5.7 years. Median GCS 6 (3-8), PIM2 20.3 +/- 28.2%. Results: GOS 5 was assigned for six (46%) patients and GOS 4 for seven (54%) patients. Average GOS in patients after severe head trauma was 4.1 points; in patients with posthypoxic brain injury 5 points (p <0.05). No life threatening complications occurred. Conclusion: Mild induced hypothermia can be safely used in pediatric patients after severe traumatic or posthypoxic brain injury. This method may he of benefit while improving outcomes in children.	[Grinkeviciute, Dovile; Kevalas, Rimantas] Kaunas Univ, Hosp Med, Clin Children Dis, LT-50009 Kaunas, Lithuania		Grinkeviciute, D (corresponding author), Kaunas Univ, Hosp Med, Clin Children Dis, Eiveniu 2, LT-50009 Kaunas, Lithuania.	dovilgrin@hotmail.com					Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Aibiki M, 2001, CRIT CARE MED, V29, P1726, DOI 10.1097/00003246-200109000-00012; Atkins CM, 2007, EUR J NEUROSCI, V26, P810, DOI 10.1111/j.1460-9568.2007.05720.x; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bruel C, 2008, CRIT CARE, V12, DOI 10.1186/cc6809; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Felberg RA, 2001, CIRCULATION, V104, P1799, DOI 10.1161/hc4001.097037; Hay AW, 2008, ANAESTHESIA, V63, P15, DOI 10.1111/j.1365-2044.2007.05262.x; Hein OV, 2004, CRIT CARE, V8, pR353, DOI 10.1186/cc2926; Holzer M, 2002, NEW ENGL J MED, V346, P549; HUGCHINSON JS, 2008, NEW ENGL J MED, V358, P2447; Hutchison J, 2006, DEV NEUROSCI-BASEL, V28, P291, DOI 10.1159/000094155; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; SINGH J, 2006, HEAD TRAUMA; VERIVE M, 2007, NEAR DROWNING; VINCENT A, 2004, ANAESTHESIA, V6, P116; Wang H, 2006, ACTA NEUROCHIR, V148, P565, DOI 10.1007/s00701-006-0747-z	24	6	7	0	2	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.		2009	20	3-4			SI		261	266		10.1515/REVNEURO.2009.20.3-4.261			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	539DE	WOS:000273232900011	20157995				2022-02-06	
J	Hilger, T; Baglaj, M				Hilger, Tomasz; Baglaj, Maciej			Late Sequelae of Minor Head Injury in Children - Is Routine Follow-Up Necessary?	ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						minor head trauma; children; late effects	BRAIN-INJURY; TRAUMA; ADOLESCENTS; MANAGEMENT; MORBIDITY	Background. Late sequelae of minor head injury in children has received little attention in the literature. Authors presenting their experience use different criteria of MHI, hence a comparative analysis is very difficult. Objectives. This is a prospective study of late effects of MHI in a consecutive group of children treated in a regional pediatric surgical center, with a particular emphasis on whether routine follow-up review of children with MHI is necessary and what role a pediatric surgeon might have in long-term management. Material and Methods. The medical notes of all patients with MHI sustained within 24 hours prior to admission were reviewed with emphasis on their previous medical history, circumstances of the injury, clinical signs and symptoms noted in the period immediately following trauma, the results of diagnostic studies, mode of management, potential complications, and final outcome. Six months following the primary review, a questionnaire was sent to all the parents. It included 17 questions referring to potential late effects of head injury specifically aimed at detecting any physical, neurological, psychological, or behavioral symptoms occurring after the event. All children whose parents answered the second questionnaire and noted such symptoms were invited for a follow-up review and were examined by a pediatric surgeon and a pediatric neurologist. Results. Of the 946 patients enrolled in the study, 613 were boys and 333 girls. The mean age was 9.29 years. Five hundred twelve (54.1%) were hospitalized, including all those with loss of consciousness and/or posttraumatic amnesia, while 434 (45.9%) were discharged after initial examination from the hospital under the care of their care-givers. The parents of 353 children (37.31%) responded to the questionnaire. In 151 cases (42.8% of all responders) they noted symptoms they related to the head trauma. The most common symptoms reported were headache (37.4%), irritability/hyperactivity (26%), and sleep disturbances (20.4%). Only 46 of the 151 positively responding to the second questionnaire attended a follow-up review. In all of them, physical and neurological examinations were unremarkable. Conclusions. Physical, neurobehavioral, and cognitive disturbances as a result of MHI in children, although difficult to assess precisely on follow-up clinical examination, affect a significant group of them in the first months after injury. Their recovery from the traumatic event seems to be multifactorial and might be influenced by the family and school environment. A special supportive care program for patients with MHI and their parents aimed at decreasing functional morbidity should be explored. In view of the lack of precise definition and the paucity of data on children, a prospective multicenter study on the late effects of MHI in the pediatric population should be undertaken (Adv Clin Exp Med 2009, 18, 2, 169-176).	[Baglaj, Maciej] Wroclaw Med Univ, Dept Pediat Surg & Urol, PL-50367 Wroclaw, Poland; [Hilger, Tomasz] Reg Specialist Hosp, Dept Pediat Surg, Grudziadz, Poland		Baglaj, M (corresponding author), Wroclaw Med Univ, Dept Pediat Surg & Urol, Sklodowskiej Curie 52, PL-50367 Wroclaw, Poland.	baglaj@chdz.am.wroc.pl					Beattie TF, 1997, ARCH DIS CHILD, V77, P82, DOI 10.1136/adc.77.1.82; Bergman DA, 1999, PEDIATRICS, V104, P1407; BIJUR PE, 1990, PEDIATRICS, V86, P337; CASEY R, 1986, PEDIATRICS, V78, P497; CASEY R, 1987, PEDIATRICS, V80, P159; CULLOTA VP, 1996, NEUROSURGERY, V38, P245; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; LEMKA M, 1999, NEUROL NEUROCHIR POL, V5, P37; Overweg-Plandsoen WCG, 1999, EUR J PEDIATR, V158, P249, DOI 10.1007/s004310051061; PARKER RS, 1994, SEMIN NEUROL, V14, P67, DOI 10.1055/s-2008-1041061; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Schreier H, 2005, J TRAUMA, V58, P353, DOI 10.1097/01.TA.0000152537.15672.B7; STEIN SC, 1995, PEDIATR SURG INT, V10, P465; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105	16	6	6	0	8	WROCLAW MEDICAL UNIV	WROCLAW	UL K MARCINKOWSKIEGO 2-6, WROCLAW, 50-368, POLAND	1899-5276	2451-2680		ADV CLIN EXP MED	Adv. Clin. Exp. Med.		2009	18	2					169	176					8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	497EN	WOS:000270038700011					2022-02-06	
J	Kramer, ME; Chiu, CYP; Shear, PK; Wade, SL				Kramer, Megan E.; Chiu, C. -Y. Peter; Shear, Paula K.; Wade, Shari L.			Neural correlates of verbal associative memory and mnemonic strategy use following childhood traumatic brain injury	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Traumatic brain injury; children; functional magnetic resonance imaging (fMRI); associative memory	CLOSED-HEAD-INJURY; WORKING-MEMORY; EPISODIC MEMORY; HIPPOCAMPAL CONTRIBUTIONS; DECLARATIVE MEMORY; CHILDREN; FMRI; ACTIVATION; RECOVERY; TBI	Children with traumatic brain injury (TBI) often experience memory deficits, although the nature, functional implication, and recovery trajectory of such difficulties are poorly understood. The present fMRI study examined the neural activation patterns in a group of young children who sustained moderate TBI in early childhood (n = 7), and a group of healthy control children (n = 13) during a verbal paired associate learning (PAL) task that promoted the use of two mnemonic strategies differing in efficacy. The children with TBI demonstrated intact memory performance and were able to successfully utilize the mnemonic strategies. However, the TBI group also demonstrated altered brain activation patterns during the task compared to the control children. These findings suggest early childhood TBI may alter activation within the network of brain regions supporting associative memory even in children who show good behavioral performance.	[Kramer, Megan E.; Chiu, C. -Y. Peter; Shear, Paula K.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Chiu, C. -Y. Peter] Univ Cincinnati, Dept Commun Sci & Disorders, Cincinnati, OH USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Childrens Hosp Res Fdn, Cincinnati, OH 45229 USA		Kramer, ME (corresponding author), Kennedy Krieger Inst, Dept Neuropsychol, 1850 East Fairmount Ave, Baltimore, MD 21231 USA.	kramerm2@gmail.com		Kramer, Megan/0000-0002-8813-7217	University Dean's Distinguished Dissertation Award - University of Cincinnati; NIH from the National Center for Medical Rehabilitation Research in the National Institute of Child Health and Human Development [RO1-HD044279]; UPHS GCRC from the National Center for Research Resources, NIH [M01RR08084]; NIH grant from the U.S. National Institute of Child Health and Human Development [RO1-HD38578]; Association of Volunteers of the Convalescent Hospital for Children, Cincinnati Children's Hospital Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R43HD044279, R01HD038578] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR008084] Funding Source: NIH RePORTER	The first author was supported by a University Dean's Distinguished Dissertation Award sponsored by the University of Cincinnati, and she would like to thank M. Douglas Ris for serving on her dissertation committee. The authors would like to acknowledge Lori Bernard and Karen Oberjohn for recruiting assistance.; This work was supported in part by 1) NIH grant RO1-HD044279 from the National Center for Medical Rehabilitation Research in the National Institute of Child Health and Human Development; 2) UPHS GCRC Grant #M01RR08084 from the National Center for Research Resources, NIH; and 3) NIH grant RO1-HD38578 from the U.S. National Institute of Child Health and Human Development. Funding for the fMRI scans was provided by the Association of Volunteers of the Convalescent Hospital for Children, Cincinnati Children's Hospital Medical Center.	Achim AM, 2005, J COGNITIVE NEUROSCI, V17, P652, DOI 10.1162/0898929053467578; Addis DR, 2006, NEUROIMAGE, V33, P1194, DOI 10.1016/j.neuroimage.2006.07.039; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2000, BRAIN INJURY, V14, P679; Arroyos-Jurado E., 2006, EXCEPTIONALITY, V14, P125, DOI [10.1207/s15327035ex1403_2, DOI 10.1207/S15327035EX1403_2]; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Bor D, 2004, EUR J NEUROSCI, V19, P3365, DOI 10.1111/j.1460-9568.2004.03438.x; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Carroll J.B., 1971, AM HERITAGE WORD FRE; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Chiu CYP, 2006, DEV NEUROPSYCHOL, V29, P321, DOI 10.1207/s15326942dn2902_3; Chiu CYP, 2005, NEUROREPORT, V16, P883, DOI 10.1097/00001756-200506210-00002; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cohen M., 1997, CMS CHILDRENS MEMORY; Cohen NJ, 1997, MEMORY, V5, P131, DOI 10.1080/741941149; Cycowicz YM, 2001, NEUROPSYCHOLOGIA, V39, P255, DOI 10.1016/S0028-3932(00)00108-1; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Ensminger ME, 2003, MON PARENT, P13; FERRO SC, 1991, LEARN DISABILITY Q, V14, P231, DOI 10.2307/1510852; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Fletcher PC, 2000, NEUROIMAGE, V12, P404, DOI 10.1006/nimg.2000.0633; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Harris JR, 1996, J COMMUN DISORD, V29, P79, DOI 10.1016/0021-9924(94)00035-2; Hoffman N, 2000, ARCH CLIN NEUROPSYCH, V15, P47, DOI 10.1016/S0887-6177(98)00156-5; Jackson O, 2004, NEUROIMAGE, V21, P456, DOI 10.1016/j.neuroimage.2003.09.050; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; KAPUR S, 1994, P NATL ACAD SCI USA, V91, P2008, DOI 10.1073/pnas.91.6.2008; Karunanayaka PR, 2007, NEUROREHABILITATION, V22, P355; Kramer M. E., NEURAL BEHAV C UNPUB; Kramer ME, 2008, J INT NEUROPSYCH SOC, V14, P424, DOI 10.1017/S1355617708080545; Lepage M, 2000, COGNITIVE BRAIN RES, V9, P271, DOI 10.1016/S0926-6410(00)00005-7; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McGrew K.S., 2001, WOODCOCK JOHNSON 3 T; Menon V, 2005, COGNITIVE BRAIN RES, V25, P379, DOI 10.1016/j.cogbrainres.2005.07.007; Murray LJ, 2007, J NEUROSCI, V27, P5515, DOI 10.1523/JNEUROSCI.0406-07.2007; Muzik O, 2000, NEUROIMAGE, V12, P538, DOI 10.1006/nimg.2000.0651; National Institute of Neurological Disorders and Stroke, 2002, NIH PUBLICATION, V02-2478; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; Newsome MR, 2007, NEUROCASE, V13, P16, DOI 10.1080/13554790601186629; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Noble KG, 2006, DEVELOPMENTAL SCI, V9, P642; Ofen N, 2007, NAT NEUROSCI, V10, P1198, DOI 10.1038/nn1950; Paz-Alonso PM, 2008, CEREB CORTEX, V18, P2208, DOI 10.1093/cercor/bhm246; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PRESSLEY M, 1977, J EXP CHILD PSYCHOL, V24, P53, DOI 10.1016/0022-0965(77)90019-4; PRESSLEY M, 1982, CHILD DEV, V53, P296, DOI 10.1111/j.1467-8624.1982.tb01319.x; RICHARDSON JTE, 1995, NEUROPSYCHOLOGIA, V33, P1345, DOI 10.1016/0028-3932(95)00068-E; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; Salorio CF, 2005, J INT NEUROPSYCH SOC, V11, P686, DOI 10.1017/S1355617705050885; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Schlagmuller M, 2002, J EXP CHILD PSYCHOL, V81, P298, DOI 10.1006/jecp.2002.2655; Schmithorst VJ, 2001, IEEE T MED IMAGING, V20, P535, DOI 10.1109/42.929619; Schneider W, 2004, J EXP CHILD PSYCHOL, V88, P193, DOI 10.1016/j.jecp.2004.02.004; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Sperling R, 2003, NEUROIMAGE, V20, P1400, DOI 10.1016/S1053-8119(03)00391-4; Talairach J., 1988, COPLANAR STEREOTACTI; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wechsler D., 1999, WASI MANUAL; Wechsler D., 2001, WISC 3 ADM SCORING M; Wilke M, 2002, HUM BRAIN MAPP, V17, P48, DOI 10.1002/hbm.10053; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	75	6	6	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2009	2	4					255	271		10.3233/PRM-2009-0091			17	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	GY1ER	WOS:000448267700003	21188286	Green Accepted, Green Submitted			2022-02-06	
J	Kuwabara, T; Fukushima, T; Makino, K; Kondo, H				Kuwabara, Takeo; Fukushima, Takao; Makino, Kunihiko; Kondo, Hiroshi			Epileptic Seizure, Cataract, and Tongue Atrophy during the 8 Years after Electrical Brain Injury	INTERNAL MEDICINE			English	Article						electrical brain injury; delayed neurologic complication; symptomatic epilepsy; motor neuron disease; traumatic cataract	NEUROLOGICAL SEQUELAE	As a delayed neurologic complication following a high-voltage electrical injury, motor neuron disease-like spinal cord injury has often been reported. However, epileptic seizure as a delayed complication of electrical brain injury has not been reported. We report a 32-year-old man, who developed epilepsy 8 years after electrical brain injury. His electroencephalogram (EEG) recordings showed focus on the right side, in which the electrical current passed during the accident eight years earlier. He experienced cataract during these 8 years. On examination, the right side of his tongue was found to be atrophic, and he was unaware when it had started. Systemic EMG examination revealed neuropathic changes in both (interossei dorsalis) IODs, the right biceps, right tongue, and right masseter muscles.	[Kuwabara, Takeo; Fukushima, Takao; Makino, Kunihiko] Niigata Prefectural Shibata Hosp, Dept Neurol, Shibata, Japan; [Kondo, Hiroshi] Brain Dis Ctr Agano Hosp, Agano City, Japan		Kuwabara, T (corresponding author), Niigata Prefectural Shibata Hosp, Dept Neurol, Shibata, Japan.	kuwabara@sbthp.jp					Breugem CC, 1999, ANN NY ACAD SCI, V888, P131, DOI 10.1111/j.1749-6632.1999.tb07950.x; Chaudhuri Z, 2002, OPHTHALMIC SURG LAS, V33, P166; CHERINGTON M, 1995, SEMIN NEUROL, V15, P233, DOI 10.1055/s-2008-1041028; FARRELL DF, 1968, NEUROLOGY, V18, P601, DOI 10.1212/WNL.18.6.601; GALLAGHER JP, 1991, ACTA NEUROL SCAND, V83, P79, DOI 10.1111/j.1600-0404.1991.tb04653.x; Grewal DS, 2007, J CATARACT REFR SURG, V33, P1116, DOI 10.1016/j.jcrs.2007.01.041; GRUBE BJ, 1990, J TRAUMA, V30, P254, DOI 10.1097/00005373-199003000-00002; Jafari H, 2001, J NEUROL NEUROSUR PS, V71, P265, DOI 10.1136/jnnp.71.2.265; Ko SH, 2004, BURNS, V30, P691, DOI 10.1016/j.burns.2004.03.007; Lamy C, 2003, NEUROLOGY, V60, P400, DOI 10.1212/WNL.60.3.400; Liao WC, 2008, J TRAUMA, V64, P843, DOI 10.1097/01.ta.0000234739.14621.3e; SILVERSIDES J, 1964, CAN MED ASSOC J, V91, P195; Tashiro K, 2000, Rinsho Shinkeigaku, V40, P732; 2006, ANN REPORT JAPANESE	14	6	7	0	2	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2009	48	13					1179	1182		10.2169/internalmedicine.48.2008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464MJ	WOS:000267508900013	19571455	Bronze			2022-02-06	
S	Lescot, T; Galanaud, D; Puybasset, L		Schiff, ND; Laureys, S		Lescot, Thomas; Galanaud, Damien; Puybasset, Louis			Exploring Altered Consciousness States by Magnetic Resonance Imaging in Brain Injury	DISORDERS OF CONSCIOUSNESS	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	87th Annual Conference of the Association-for-Reseach-in-Nervous-and-Mental-Disease	DEC 07-08, 2007	New York Acad Med, New York, NY	Assoc Res Nervous & Mental Dis	New York Acad Med	magnetic resonance imaging; brain injury; consciousness	DIFFUSE AXONAL INJURY; PROTON MR SPECTROSCOPY; HEAD-INJURY; PROGNOSTIC VALUE; SEVERITY; LESIONS; CHILDREN; IMAGES; DAMAGE; EDEMA	Traumatic brain injury (TBI) occurs abruptly, involves multiple specialized teams, calls on the health-care system in its emergency dimension, and engages the well-being of the patient and his relatives for a lifetime period. Clinicians in charge of these patients are faced with issues of uppermost importance: medical issues such as predicting the long-term neurological outcome of the comatose patient; ethical issues because of the influence of intensive care on the long-term survival of patients in a vegetative and minimally conscious state; legal issues because of the law that has set the concept of proportionality of care as the legal rule; and social issues as the result of the very high cost of these pathologies. Today's larger availability of magnetic resonance imaging (MRI) in ventilated patients and the recent improvements in hardware and in imaging techniques that have made the last-developed imaging techniques such as diffusion tensor imaging and magnetic resonance spectroscopy available in brain-trauma patients, are changing the paradigm in neurointensive care regarding outcome prediction. The old paradigm that no individual prognosis could be made at the subacute phase in TBI patients does not hold true anymore. This major change opens new challenging ethical questions. This review focuses on the brain explorations that are required, such as MRI, magnetic resonance spectroscopy, and diffusion tensor imaging, to provide the clinician with a multimodal assessment of the brain state to predict outcome of coma. Such an assessment will become mandatory in the near future to answer the crucial question of proportionality of care in these patients.	[Lescot, Thomas; Puybasset, Louis] Hop La Pitie Salpetriere, Dept Anesthesiol & Crit Care, Paris, France; [Galanaud, Damien] Hop La Pitie Salpetriere, Dept Neuroradiol, Paris, France; [Galanaud, Damien] Univ Paris 06, Paris, France		Puybasset, L (corresponding author), Hop La Pitie Salpetriere, Dept Anesthesie Reanimat, 47-83 Blvd Hop, F-75013 Paris, France.	louis.puybasset@psl.ap-hop-paris.fr					Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; ATLAS SW, 1988, RADIOLOGY, V169, P455, DOI 10.1148/radiology.169.2.3174993; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Cecil KM, 1998, J NEUROCHEM, V70, P2038; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; CHOE BY, 1995, INVEST RADIOL, V30, P502, DOI 10.1097/00004424-199508000-00008; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2001, CURR OPIN NEUROL, V14, P753, DOI 10.1097/00019052-200112000-00012; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Hoelper BM, 2000, ACTA NEUROCHIR SUPPL, V76, P21; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hunter JV, 2005, AM J NEURORADIOL, V26, P482; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jones DK, 2000, NEUROSURGERY, V47, P306, DOI 10.1097/00006123-200008000-00008; Kuroiwa T, 1999, J NEUROSURG, V90, P499, DOI 10.3171/jns.1999.90.3.0499; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Ricci B, 1997, NEURORADIOLOGY, V39, P313, DOI 10.1007/s002340050415; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33; Wedekind C, 1999, J TRAUMA, V47, P44, DOI 10.1097/00005373-199907000-00010; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013	30	6	7	1	10	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA	0077-8923		978-1-57331-743-6	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2009	1157						71	80		10.1111/j.1749-6632.2008.04120.x			10	Multidisciplinary Sciences; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Neurosciences & Neurology	BJH38	WOS:000265826300007	19351357				2022-02-06	
J	Liu, WC; Doong, JL; Tsai, SL; Lai, CH; Jeng, MC				Liu, Wei-Chung; Doong, Ji-Liang; Tsai, Sing-Ling; Lai, Ching-Huei; Jeng, Ming-Chang			Integrated model of simulated occupant injury risk and real medical costs	JOURNAL OF SAFETY RESEARCH			English	Article						integrated model; modified kinematics simulation model; injury risk; medical cost	UNITED-STATES; CRASH COSTS; CAR SIZE; GEOMETRY; IMPACT	Introduction: The purpose of this study was to develop an integrated methodology that links occupant injury risk functions, estimated in the laboratory, with real world medical treatment costs by using the abbreviated injury score (AIS). Using our model, the expected medical treatment costs for crash injuries to various body regions and of different severities can be investigated. Methods: First, the simulation results are compared with NHTSA crash data. We used a modified kinematics simulation model that incorporates an F=E-b function as a supplement to the previous Steffan's model to obtain a more accurate acceleration history a(t). Second, head injury criteria HIC36 can be calculated from a(t), and we use the injury probability P as a function of HIC36, as proposed by Kuppa, to obtain the injury risk function for various AIS values. Third, medical treatment cost models for various AIS values can be calculated by using a regression cost model with real world data. Finally, the injury risk function and medical treatment cost models are linked through AIS values. We establish an integrated methodology and predict medical costs and car safety data using real world police reports, medical treatment costs, and laboratory simulation results. Results: Using head injuries in frontal crashes as an example, we focus on simulation parameters for different vehicle models, with and without airbags. We specifically examine impact closing speed, Delta-V, and impact directions. Conclusion: Simulation results can be used to supplement insufficient real crash data, in particular Delta V, and injury risk results from police crash reports. Impact on industry: The proposed integrated methodology may provide the vehicle industry with a new safety assessment method. Real crash data coupling provides consumers with more realistic and applicable information. (C) 2009 National Safety Council and Elsevier Ltd. All rights reserved.	[Doong, Ji-Liang] Tatung Univ, Dept Ind Design, Taipei 104, Taiwan; [Liu, Wei-Chung; Jeng, Ming-Chang] Natl Cent Univ, Dept Mech Engn, Tao Yuan, Taiwan; [Tsai, Sing-Ling] Mackay Med Coll, Dept Nursing, Taipei, Taiwan; [Lai, Ching-Huei] Minist Transportat & Commun, Safety Div, Inst Transportat, Taipei, Taiwan		Doong, JL (corresponding author), Tatung Univ, Dept Ind Design, 40 ChungShan N Rd,3rd Sect, Taipei 104, Taiwan.	jldo@mail2000.com.tw					AUGENSTEIN J, 2005, P 19 ENH SAF VEH C W; BAILEY M, 2000, 2000010849 SAE; CLIFF WE, 2001, P SAE 2001 WORLD C D; CLIFF WE, 1996, 960885 SAE; DATENTECHNIK S, 2004, SIMULATION PROGRAM V; Dawson JM, 1999, ACCIDENT ANAL PREV, V31, P109, DOI 10.1016/S0001-4575(98)00052-9; Gong SW, 2008, COMPUT STRUCT, V86, P758, DOI 10.1016/j.compstruc.2007.06.003; HENDRIE D, 2001, P MEAS BURD INJ 3 IN; *J HOPK U TRIAN IN, 1998, ICDMAP 90 US GUID; Kuppa S., 2004, INJURY CRITERIA SIDE; Lai CH, 2006, ACCIDENT ANAL PREV, V38, P696, DOI 10.1016/j.aap.2005.12.015; LEMMEN P, 2003, P 18 ENH SAF VEH C W; MARTIN PG, 2005, P 19 ENH SAF VEH C W; MCCULLOUGH CA, 2004, P 18 ENH SAF VEH C W; Miller T, 1997, ACCIDENT ANAL PREV, V29, P343, DOI 10.1016/S0001-4575(96)00087-5; Miller TR, 1998, ACCIDENT ANAL PREV, V30, P137, DOI 10.1016/S0001-4575(97)00093-6; NEWMAN JA, 1994, ACCIDENT ANAL PREV, V26, P305, DOI 10.1016/0001-4575(94)90004-3; ROSMAN D, 2002, P S HLTH DAT LINK N, P188; STEFFAN H, 1999, 1999010444 SAE; STEFFAN H, 2000, 2000010471 SAE; TAMURA A, 2005, P 19 ENH SAF VEH C W; WALKER B, 1993, 932910 SAE; Walz F., 2004, TRAUMA BIOMECHANICS; Weaver CS, 2004, ANN EMERG MED, V44, pS127, DOI 10.1016/j.annemergmed.2004.07.408; Wood DP, 2002, ACCIDENT ANAL PREV, V34, P93, DOI 10.1016/S0001-4575(01)00003-3; Wood DP, 1997, ACCIDENT ANAL PREV, V29, P139, DOI 10.1016/S0001-4575(96)00067-X; World Health Organisation (WHO), 1977, MAN INT STAT CLASS D; Zaloshnja E, 2004, ACCIDENT ANAL PREV, V36, P415, DOI 10.1016/S0001-4575(03)00035-6; Zaloshnja E, 2006, ACCIDENT ANAL PREV, V38, P644, DOI 10.1016/j.aap.2005.12.008	29	6	6	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.		2009	40	6					461	468		10.1016/j.jsr.2009.09.006			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	534LT	WOS:000272899300009	19945560				2022-02-06	
J	MacKay, DG; Hadley, C				MacKay, Donald G.; Hadley, Christopher			Supra-Normal Age-Linked Retrograde Amnesia: Lessons From an Older Amnesic (HM)	HIPPOCAMPUS			English	Article						retrograde; amnesia; HM; aging	MEDIAL TEMPORAL-LOBE; CLOSED-HEAD-INJURY; THEORETICAL IMPLICATIONS; MEMORY CONSOLIDATION; HIPPOCAMPAL COMPLEX; PARALLEL DEFICITS; BINDING PROBLEM; WORD RETRIEVAL; REMOTE MEMORY; OUTPUT SIDE	MacKay and James (2001) demonstrated greater-than-normal retrograde amnesia (RA) for lexical-semantic information in amnesic H.M., a deficit that worsened with aging or represented supranormal age-linked RA (SARA). The present experiments extend these earlier observations to new types of information. Experiment 1 participants (H.M. and carefully matched memory-normal controls) named pictures on the Boston Naming Test and H.M. correctly named reliably fewer pictures with low frequency names, he produced unusual naming errors, and he benefited reliably less than the controls from phonological cues to the target word. Experiment 2 participants recalled irregularly-spelled aspects of familiar words in a two-choice recognition memory task and H.M. chose the correct spelling reliably less often than the controls. Experiment 3 participants read low frequency words aloud at age 73 and H.M. produced reliably more reading errors than the controls. Results of all three experiments indicate supranormal RA (SRA) for information once familiar to H.M. and comparisons with earlier studies using similar or identical stimuli indicated that H.M.'s SRA has worsened with aging from 1980 to 1999. In short, H.M. exhibits SARA for phonological and orthographic information, consistent with the MacKay and James results and with interactions between aging and amnesia predicted under binding theory. (C) 2008 Wiley-Liss, Inc.	[MacKay, Donald G.; Hadley, Christopher] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA		MacKay, DG (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	mackay@ucla.edu			The Samuel A. MacKay Memorial Research Fund; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AG 09755]	Grant sponsor: The Samuel A. MacKay Memorial Research Fund and NIH; Grant number: R01 AG 09755.	ALBERT MS, 1979, ARCH NEUROL-CHICAGO, V36, P211, DOI 10.1001/archneur.1979.00500400065010; Barresi BA, 2000, AGING NEUROPSYCHOL C, V7, P169, DOI 10.1076/1382-5585(200009)7:3;1-Q;FT169; Bright P, 2006, LEARN MEMORY, V13, P545, DOI 10.1101/lm.265906; Brown AS, 2002, PSYCHON B REV, V9, P403, DOI 10.3758/BF03196300; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; Burke DM, 2004, PSYCHOL SCI, V15, P164, DOI 10.1111/j.0956-7976.2004.01503004.x; Burke DM., 2008, HDB AGING COGNITION, P373; Burke DM, 2006, LIFESPAN COGNITION M, P193; COHEN NJ, 1981, NEUROPSYCHOLOGIA, V19, P337, DOI 10.1016/0028-3932(81)90064-6; Corkin S, 1997, J NEUROSCI, V17, P3964; CORKIN S, 1984, SEMIN NEUROL, V4, P249, DOI 10.1055/s-2008-1041556; GILHOOLY KJ, 1980, BEHAV RES METH INSTR, V12, P395, DOI 10.3758/BF03201693; GLENBERG AM, 1977, J EXP PSYCHOL-HUM L, V3, P282, DOI 10.1037/0278-7393.3.3.282; HUGHES RA, 1970, PHYSIOL BEHAV, V5, P27, DOI 10.1016/0031-9384(70)90008-9; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P509, DOI 10.1016/0028-3932(94)00136-D; James LE, 2000, J EXP PSYCHOL LEARN, V26, P1378, DOI 10.1037//0278-7393.26.6.1378; James LE, 2001, PSYCHOL SCI, V12, P485, DOI 10.1111/1467-9280.00390; James LE, 2007, PSYCHOL AGING, V22, P94, DOI 10.1037/0882-7974.22.1.94; Kaplan E, 1983, BOSTON NAMING TEST; KAPUR N, 1993, CORTEX, V29, P217, DOI 10.1016/S0010-9452(13)80177-3; Kapur N, 1999, HIPPOCAMPUS, V9, P247, DOI 10.1002/(SICI)1098-1063(1999)9:3<247::AID-HIPO5>3.0.CO;2-W; Kensinger EA, 2001, HIPPOCAMPUS, V11, P347, DOI 10.1002/hipo.1049; Kopelman MD, 1999, NEUROPSYCHOLOGIA, V37, P939, DOI 10.1016/S0028-3932(98)00143-2; Kucera H, 1982, FREQUENCY ANAL ENGLI; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; MacKay DG, 1998, J MEM LANG, V38, P28, DOI 10.1006/jmla.1997.2544; MacKay DG, 2006, HIPPOCAMPUS, V16, P491, DOI 10.1002/hipo.20176; MACKAY DG, 1982, PSYCHOL REV, V89, P483, DOI 10.1037/0033-295X.89.5.483; MacKay DG, 1998, J COGNITIVE NEUROSCI, V10, P377, DOI 10.1162/089892998562807; MacKay DG, 2002, AGING NEUROPSYCHOL C, V9, P298, DOI 10.1076/anec.9.4.298.8774; MacKay DG, 1998, PSYCHOL AGING, V13, P647, DOI 10.1037/0882-7974.13.4.647; MacKay DG, 2001, LANG COGNITIVE PROC, V16, P419, DOI 10.1080/01690960042000102; MacKay DG, 1999, PSYCHOL AGING, V14, P3, DOI 10.1037/0882-7974.14.1.3; MACKAY DG, 1992, CONSCIOUS COGN, V1, P199, DOI 10.1016/1053-8100(92)90061-E; MACKAY DG, 1990, AGING COGNITION KNOW, P281, DOI DOI 10.1016/S0166-4115(08)60159-4; MACKAY DG, 2000, COGN NEUR SOC SAN FR; MacKay DG, 2008, J CLIN EXP NEUROPSYC, V30, P280, DOI 10.1080/13803390701380609; MacKay DG, 2007, LANG COGNITIVE PROC, V22, P377, DOI 10.1080/01690960600652596; MARSLENWILSON WD, 1975, NEUROPSYCHOLOGIA, V13, P353, DOI 10.1016/0028-3932(75)90013-5; Moscovitch M, 1998, CURR OPIN NEUROBIOL, V8, P297, DOI 10.1016/S0959-4388(98)80155-4; Murre JMJ, 1996, HIPPOCAMPUS, V6, P675, DOI 10.1002/(SICI)1098-1063(1996)6:6<675::AID-HIPO10>3.0.CO;2-Y; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; PALFAI T, 1973, Pharmacology Biochemistry and Behavior, V1, P55, DOI 10.1016/0091-3057(73)90055-5; Postle BR, 1998, NEUROPSYCHOLOGIA, V36, P421, DOI 10.1016/S0028-3932(97)00155-3; Rastle KG, 1996, J MEM LANG, V35, P586, DOI 10.1006/jmla.1996.0031; Ribot T., 1882, DIS MEMORY; Salat DH, 2006, HIPPOCAMPUS, V16, P936, DOI 10.1002/hipo.20222; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SCOVILLE WB, 1968, NEUROPSYCHOLOGIA, V6, P211, DOI 10.1016/0028-3932(68)90020-1; Skotko BG, 2005, J MEM LANG, V53, P397, DOI 10.1016/j.jml.2005.05.003; Skotko BG, 2004, NEUROPSYCHOLOGY, V18, P756, DOI 10.1037/0894-4105.18.4.756; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; VANGORP WG, 1986, J CLIN EXP NEUROPSYC, V8, P702, DOI 10.1080/01688638608405189; WICKELGREN WA, 1979, PSYCHOL REV, V86, P44, DOI 10.1037/0033-295X.86.1.44; 1949, WEBSTERS NEW COLL DI; [No title captured]	56	6	6	0	1	WILEY-LISS	HOBOKEN	DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA	1050-9631			HIPPOCAMPUS	Hippocampus		2009	19	5					424	445		10.1002/hipo.20531			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	440VJ	WOS:000265727500002	19115388	Green Submitted			2022-02-06	
J	Ranger, A; Szymczak, A; Fraser, D; Salvadori, M; Jardine, L				Ranger, Adrianna; Szymczak, Artur; Fraser, Douglas; Salvadori, Marina; Jardine, Lawrence			Bilateral Decompressive Craniectomy for Refractory Intracranial Hypertension in a Child with Severe ITP-Related Intracerebral Haemorrhage	PEDIATRIC NEUROSURGERY			English	Article						Decompressive craniectomy; Idiopathic thrombocytopenic purpura; Intracerebral haemorrhage; Intracranial pressure, infant	TRAUMATIC BRAIN-INJURY; IDIOPATHIC-THROMBOCYTOPENIC-PURPURA; ANEURYSMAL SUBARACHNOID HEMORRHAGE; SEVERE HEAD-INJURY; CEREBRAL EDEMA; BIFRONTAL CRANIECTOMY; AXONAL INJURY; MECHANISMS; MANAGEMENT; ENCEPHALITIS	We report a 13-month-old infant who developed acutely elevated intracranial pressure (ICP) as a result of a spontaneous intracerebral haemorrhage (ICH), secondary to idiopathic thrombocytopenic purpura (ITP). Her ICP remained severely elevated despite aggressive medical measures, with persistent obtundation, right hemiparesis and a dilated left pupil. Bilateral decompressive craniectomies (DCs) were performed, which resulted in a rapid decline in ICP. Ultimately, the patient regained consciousness and went on to complete neurological recovery. Tragically, she died of non-neurological, ITP-related complications 9 months later. In our review, we identified no other instances of bilateral DCs reported in the management of an infant with ITP and/or an ICH. We addressed three central questions: (1) Is there any value of DCs in children, and especially in infants, with elevated ICP? (2) Is there any value of DCs in the setting of nontraumatic ICH? And (3) is there any rationale for the use of bilateral versus unilateral DCs? Copyright (C) 2009 S. Karger AG, Basel	[Ranger, Adrianna; Szymczak, Artur] Childrens Hosp, London Hlth Sci Ctr, Dept Pediat Neurosurg, London, ON N6A 5W9, Canada; [Fraser, Douglas] London Hlth Sci Ctr, Dept Pediat Intens Care, London, ON N6A 5W9, Canada; [Salvadori, Marina] London Hlth Sci Ctr, Dept Pediat Infect Dis, London, ON N6A 5W9, Canada; [Jardine, Lawrence] London Hlth Sci Ctr, Div Pediat Oncol, London, ON N6A 5W9, Canada		Ranger, A (corresponding author), Childrens Hosp, London Hlth Sci Ctr, Dept Pediat Neurosurg, 800 Commissioners Rd E,Room E6-315, London, ON N6A 5W9, Canada.	aranger@uwo.ca					Adamo MA, 2008, J NEUROSURG, V108, P174, DOI 10.3171/JNS/2008/108/01/0174; Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Bayram N, 2008, EUR J PEDIATR, V167, P821, DOI 10.1007/s00431-007-0566-0; Belletrutti M, 2007, J PEDIAT HEMATOL ONC, V29, P95, DOI 10.1097/MPH.0b013e3180320b36; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Coles Jonathan P, 2004, Curr Opin Crit Care, V10, P120, DOI 10.1097/00075198-200404000-00008; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; CORDOBES F, 1987, CHILD NERV SYST, V3, P235, DOI 10.1007/BF00274055; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; Di Rienzo A, 2008, ACTA NEUROCHIR, V150, P1057, DOI 10.1007/s00701-008-0019-1; DIERSSEN G, 1983, ACTA NEUROCHIR, V69, P53, DOI 10.1007/BF02055853; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Hieu PD, 1996, CHILD NERV SYST, V12, P270; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; Iyori H, 2000, ANN HEMATOL, V79, P691, DOI 10.1007/s002770000219; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Keller E, 2005, ACTA NEUROCHIR SUPPL, V94, P177; Kermer P, 1999, CELL TISSUE RES, V298, P383, DOI 10.1007/s004410050061; Kim KT, 2009, ACTA NEUROCHIR, V151, P21, DOI 10.1007/s00701-008-0164-6; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; Kuhne T, 2003, J PEDIATR-US, V143, P605, DOI 10.1067/S0022-3476(03)00535-3; Lafuente JV, 1999, J NEUROTRAUM, V16, P425, DOI 10.1089/neu.1999.16.425; Lee MS, 1998, NEUROLOGY, V50, P1160, DOI 10.1212/WNL.50.4.1160; LILLEYMAN JS, 1994, ARCH DIS CHILD, V71, P251, DOI 10.1136/adc.71.3.251; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; Mazzeo AT, 2006, J NEUROSURG ANESTH, V18, P170, DOI 10.1097/01.ana.0000210999.18033.f6; Mussack T, 2005, J TRAUMA, V58, P1061, DOI 10.1097/01.TA.0000171989.63817.8c; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Otani N, 2008, CEREBROVASC DIS, V26, P612, DOI 10.1159/000165115; Paling A, 2008, HEMATOLOGY, V13, P175, DOI 10.1179/102453308X316167; Perin A, 2008, ACTA NEUROCHIR, V150, P837, DOI 10.1007/s00701-008-1596-8; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Rabelino GAG, 2008, PEDIATR NEUROL, V39, P201, DOI 10.1016/j.pediatrneurol.2008.06.006; Reithmeier T, 2005, CHILD NERV SYST, V21, P249, DOI 10.1007/s00381-004-1044-x; Ruppel RA, 2002, NEUROSURG CLIN N AM, V13, P169, DOI 10.1016/S1042-3680(01)00005-5; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Scozzafava J, 2007, NEUROCRIT CARE, V6, P49, DOI 10.1385/NCC:6:1:49; Sehba FA, 2006, NEUROL RES, V28, P381, DOI 10.1179/016164106X114991; Spiller WG, 1906, J AMER MED ASSOC, V47, P679; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; Visocchi M, 2007, ACTA NEUROCHIR, V149, P347, DOI 10.1007/s00701-006-1102-0; Watts RG, 2004, CLIN PEDIATR, V43, P691, DOI 10.1177/000992280404300802; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Ziai WC, 2003, J NEUROSURG ANESTH, V15, P25, DOI 10.1097/00008506-200301000-00005	56	6	6	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2009	45	5					390	395		10.1159/000260910			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	556LQ	WOS:000274593000011	19940538				2022-02-06	
J	Scaturo, DJ; Huszonek, JJ				Scaturo, Douglas J.; Huszonek, John J.			Collaborative Academic Training of Psychiatrists and Psychologists in VA and Medical School Settings	ACADEMIC PSYCHIATRY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SEXUAL ASSAULT; HEALTH-SERVICES; PTSD RISK; VETERANS; COMBAT; PSYCHOTHERAPY; PREVALENCE; DEPRESSION; PRINCIPLES	Objective: The authors review the background and contemporary strengths of Dean's Committee Veterans Affairs Medical Centers in the collaborative academic training of psychiatrists and psychologists. Methods: The authors discuss the problems and prospects of the current health care environment as it impacts the behavioral health treatment of returning veterans from the wars in Iraq and Afghanistan and the educational agenda for psychiatry and psychology. The medical education program in psychiatry and the internship program in psychology at the Syracuse Veterans Affairs Medical Center and the SUNY Upstate Medical University provide an exemplar of academic collaboration in clinical training. Results: Within this combined educational environment, opportunities and challenges abound for interns and residents to receive advanced training in the state-of-the-art assessment and treatment of disorders related to psychological trauma, posttraumatic stress disorder, sexual trauma, traumatic brain injury, polytrauma, behavioral health in primary care, and telepsychiatry. Conclusion: There is tremendous mutual benefit from academic collaboration for both institutions as they grapple with their respective treatment and educational missions.	[Scaturo, Douglas J.; Huszonek, John J.] SUNY Upstate Med Ctr, Dept Psychiat, Syracuse, NY USA; [Scaturo, Douglas J.; Huszonek, John J.] Syracuse VA Med Ctr, Syracuse, NY USA; [Scaturo, Douglas J.] SUNY Upstate Med Ctr, Dept Family Med, Syracuse, NY USA; [Scaturo, Douglas J.] Syracuse Univ, Dept Psychol, Syracuse, NY 13244 USA; [Huszonek, John J.] Hutchings Psychiat Ctr Syracuse, Syracuse, NY USA		Scaturo, DJ (corresponding author), VA Med Ctr, Syracuse Vet Ctr 131, 800 Irving Ave, Syracuse, NY 13210 USA.	douglas.scaturo@va.gov					ARCHARTTREICHEL J, 2004, PSYCHIAT NEWS, V39, P14; BAKER RR, 2006, PSYCHOL DEP VETERANS; BEITMAN BD, 1991, INTEGRATING PHARMACO; Benjamin LT, 2000, AM PSYCHOL, V55, P233, DOI 10.1037/h0087859; Benson H., 2000, RELAXATION RESPONSE; Blanchard E. B., 2003, CRASH PSYCHOL ASSESS; BRENDEL David H., 2006, HEALING PSYCHIAT BRI; Burton M., 1998, PSYCHOTHERAPY COUNSE; CORNISPOP M, 2006, AM SPEECH LANG HEAR; COULEHAN JL, 2001, MEDICAL INTERVIEW MA; Davidson J, 2005, PSYCHIAT ANN, V35, P887; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Dobscha SK, 2001, PSYCHIATR SERV, V52, P1651, DOI 10.1176/appi.ps.52.12.1651; Foa E.B., 2000, EFFECTIVE TREATMENTS; Freud S, 1896, STANDARD EDITION COM, VIII, P187; Friedman MJ, 2000, EFFECTIVE TREATMENTS FOR PTSD, P326; Friedman MJ, 2000, EFFECTIVE TREATMENTS FOR PTSD, P84; Fullerton CS, 2004, AM J PSYCHIAT, V161, P1370, DOI 10.1176/appi.ajp.161.8.1370; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; GLASSER RJ, 2006, WOUNDED VIETNAM IRAQ, P102; Hansen Nathan B, 2003, Ment Health Serv Res, V5, P1, DOI 10.1023/A:1021751307358; HAYMAN PM, 1993, J SOC BEHAV PERS, V8, P117; HERMAN JL, 1992, J TRAUMA STRESS, V5, P377, DOI 10.1002/jts.2490050305; HERMAN JL, 1992, TRAUMA RECOVERY, P61; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hopko DR, 2003, CLIN PSYCHOL REV, V23, P699, DOI 10.1016/S0272-7358(03)00070-9; HOWARD KI, 1986, AM PSYCHOL, V41, P159, DOI 10.1037/0003-066X.41.2.159; HUSZONEK JJ, 1987, AM J PSYCHOTHER, V41, P185, DOI 10.1176/appi.psychotherapy.1987.41.2.185; Janoff-Bulman R., 1992, SHATTERED ASSUMPTION; KAPLAN E, 1995, MANAGED CARE CASE DE; KELLY HO, 2007, PSYCHOL SCI AGENDA, V21, P1; KENTSMITH DK, 1986, MIL MED, V151, P89, DOI 10.1093/milmed/151.2.89; Khuri SF, 2001, ANN SURG, V234, P370, DOI 10.1097/00000658-200109000-00011; Klerman GL., 1984, INTERPERSONAL PSYCHO; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Lambert MJ, 2001, PSYCHOTHERAPY, V38, P357, DOI 10.1037/0033-3204.38.4.357; Lambert MT, 1996, ACAD PSYCHIATR, V20, P56, DOI 10.1007/BF03341961; Launer J, 2005, QJM-INT J MED, V98, P465, DOI 10.1093/qjmed/hci068; Lukens E.P., 2004, BRIEF TREATMENT CRIS, V4, P205, DOI [DOI 10.1093/BRIEF-TREATMENT/MHH019, https://doi.org/10.1093/brief-treatment/mhh019]; Luxenberg T., 2001, DIRECTIONS PSYCHIAT, V21, P373, DOI DOI 10.3325/CMJ.2011.52.505; MOORE DL, 1992, HIST PSYCHOTHERAPY C; Murdoch M, 2004, MIL MED, V169, P392, DOI 10.7205/MILMED.169.5.392; Norcross, 2002, PSYCHOTHERAPY RELATI; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; PALAZZOLI MS, 1980, DIMENSIONS FAMILY TH; POLUSNY MA, 2005, PSYCHIAT TIMES, V22, P4; RAHE RH, 1983, MIL MED, V148, P577; Raimy V., 1950, TRAINING CLIN PSYCHO; Ruskin PE, 2004, AM J PSYCHIAT, V161, P1471, DOI 10.1176/appi.ajp.161.8.1471; Scaturo D.J., 2005, CLIN DILEMMAS PSYCHO; SCATURO DJ, 1992, J TRAUMA STRESS, V5, P273, DOI 10.1002/jts.2490050212; SCATURO DJ, 1988, MIL MED, V153, P262; Schwartz G E, 1978, J Behav Med, V1, P249, DOI 10.1007/BF00846677; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Shore JH, 2005, PSYCHIAT SERV, V56, P976, DOI 10.1176/appi.ps.56.8.976; Skinner KM, 2000, J INTERPERS VIOLENCE, V15, P291, DOI 10.1177/088626000015003005; Solms M., 2000, CLIN STUDIES NEUROPS, V2nd; SONNENBERG SM, 1985, TRAUMA WAR STRESS RE; SPANIER C, 1998, INTERPERSONAL PSYCHO; Spinazzola J., 2001, DIRECTIONS PSYCHIAT, V21, P395; Stevens DP, 2001, JAMA-J AM MED ASSOC, V286, P1061, DOI 10.1001/jama.286.9.1061; STROSAHL K, 2001, INTEGRATED BEHAV HEA; STRUPP HH, 1979, ARCH GEN PSYCHIAT, V36, P1125; Sullivan H. S., 1953, INTERPERSONAL THEORY; Suris A, 2004, PSYCHOSOM MED, V66, P749, DOI 10.1097/01.psy.0000138117.58559.7b; Valente S, 2007, MIL MED, V172, P259, DOI 10.7205/MILMED.172.3.259; van der Kolk BA, 2001, HUM PSYCHOPHARM CLIN, V16, pS49, DOI 10.1002/hup.270; *VHA, 2005, VET HLTH ADM HDB, P3; WEISS TW, 1995, WOMEN HEALTH, V23, P1, DOI 10.1300/J013v23n02_01; Weissman M. M., 1998, INTERPERSONAL PSYCHO	70	6	6	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1042-9670	1545-7230		ACAD PSYCHIATR	Acad. Psych.	JAN-FEB	2009	33	1					4	12		10.1176/appi.ap.33.1.4			9	Education & Educational Research; Psychiatry	Social Science Citation Index (SSCI)	Education & Educational Research; Psychiatry	429NF	WOS:000264926700002	19349434				2022-02-06	
J	Schuh, A; Doleschal, S; Schmickal, T				Schuh, Alexander; Doleschal, Sylvia; Schmickal, Thomas			Anterior Hip Dislocation in a Football Player: A Case Report	CASE REPORTS IN MEDICINE			English	Article							TRAUMATIC DISLOCATION; RUGBY-UNION; INJURIES	Hip dislocations during sporting activities represent only 2%-5% of all hip dislocations. Most hip dislocations in sports can be categorised as "less complicated traumatic hip dislocations" by the Stewart-Milford classification due to the fact that minimal force is involved. The incidence of avascular necrosis of the femoral head greatly increases if the time to reduction is more than six hours. We report the case of a 38-year-old football player who suffered hip dislocation while kicking the ball with the medial aspect of the right foot in an external rotated manner of the right hip. Closed reduction was performed within 2 hours; postoperative follow-up was uneventful. Six months later the patient is out of any complaints; there is no sign of AVN of the femoral head. Copyright (C) 2009 Alexander Schuh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.	[Schuh, Alexander] Neumarkt Clin, Res Unit Orthoped & Gen Surg, D-92318 Neumarkt, Germany; [Schuh, Alexander] Univ Erlangen Nurnberg, Teaching Hosp, Res Unit, D-92318 Neumarkt, Germany; [Doleschal, Sylvia; Schmickal, Thomas] Neumarkt Clin, Inst Dept Trauma Surg, D-92318 Neumarkt, Germany		Schuh, A (corresponding author), Neumarkt Clin, Res Unit Orthoped & Gen Surg, D-92318 Neumarkt, Germany.	alexander.schuh@klinikum.neumarkt.de					Brooks JHM, 2005, BRIT J SPORT MED, V39, P767, DOI 10.1136/bjsm.2005.018408; Chudik SC, 2002, SPORTS MED ARTHROSC, V10, P123, DOI 10.1097/00132585-200210020-00004; Croft SJ, 2006, EMERG MED J, V23, DOI 10.1136/emj.2005.031013; Dahan R, 1997, SPORTS MED ARTHROSC, V5, P326; Giza E, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.005736; Goga IE, 2003, BRIT J SPORT MED, V37, P498, DOI 10.1136/bjsm.37.6.498; Hawkins RD, 2001, BRIT J SPORT MED, V35, P43, DOI 10.1136/bjsm.35.1.43; LAMKE LO, 1970, ACTA ORTHOP SCAND, V41, P188, DOI 10.3109/17453677008991506; Mohanty K, 2000, J ACCID EMERG MED, V17, P429; OLEARY C, 1987, IRISH MED J, V80, P291; Pallia Chris S, 2002, Curr Sports Med Rep, V1, P338; Soderman K, 2001, SCAND J MED SCI SPOR, V11, P299, DOI 10.1034/j.1600-0838.2001.110508.x; STEWART MJ, 1954, J BONE JOINT SURG AM, V36-A, P315, DOI 10.2106/00004623-195436020-00010; Stiris MG, 2000, ACTA RADIOL, V41, P300, DOI 10.1034/j.1600-0455.2000.041003300.x; SULLIVAN JA, 1980, AM J SPORT MED, V8, P325, DOI 10.1177/036354658000800505; Yates C, 2008, PHYS THER, V88, P780, DOI 10.2522/ptj.20070298	16	6	6	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-9627	1687-9635		CASE REP MED	Case Rep. Med.		2009	2009								363461	10.1155/2009/363461			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V24ZV	WOS:000215195800039	20168985	Green Published, Green Submitted, gold			2022-02-06	
J	Stein, DM; Dutton, RP; Alexander, C; Miller, J; Scalea, TM				Stein, Deborah M.; Dutton, Richard P.; Alexander, Charlie; Miller, John; Scalea, Thomas M.			Use of Recombinant Factor VIIa to Facilitate Organ Donation in Trauma Patients with Devastating Neurologic Injury	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							ACTIVATED FACTOR-VII; ORTHOTOPIC LIVER-TRANSPLANTATION; CENTRAL-NERVOUS-SYSTEM; BRAIN-INJURY; COAGULOPATHY; COAGULATION; WARFARIN; THERAPY; ANTICOAGULATION; COMPLICATIONS	BACKGROUND: Organ donation serves a public health function but is also an important part of end-of-life care. Nearly 40% of organ donors are the victims of traumatic brain injury (TBI). We report on a series of patients with nonsurvivable TBI and severe coagulopathy or active hemorrhage who went on to successful organ donation with the use of recombinant factor VIIa (rFVIIa). STUDY DESIGN: Organ donors from a 6-year period were identified from the local Organ Procurement Organization (OPO). Medical records were reviewed, and demographics, injury-specific data, coagulation profiles, and medications administered were abstracted. Outcomes data on early graft function after transplantation were obtained. RESULTS: One hundred forty-eight patients had organ recovery after either brain death or withdrawal of care. Twenty-nine patients received rFVIIa and 119 patients did not. rFVIIa was administered before determination of nonsurvivability or brain death in 21 patients. In eight patients, rFVIIa was administered as a specific salvage therapy to allow donation. Mean Injury Severity Score in the rFVIIa group was 43.4 (+/- 14.8) versus 34.0 (+/- 13.3) in the group that did not receive rFVIIa (p = 0.001). Organs transplanted per donor were no different in the 2 groups (3.5 versus 3.6; P = 0.7). There were nearly twice as many successfully recovered lungs from the donors who received rFVIIa (44.1% versus 26.2%; p = 0.04). There was no difference in early graft function in the two groups when recipient outcomes were compared. CONCLUSIONS: Use of rFVIIa facilitated donation in patients with multisystem injuries who otherwise might have been ineligible for organ donation. Use of rFVIIa did not affect early graft function, although longterm outcomes are unknown. Recombinant factor VIIa is expensive, but its use is justified if the donor organ supply can be increased. (J Am Coll Surg 2009;208:120-125. (C) 2008 by the American College of Surgeons)	[Stein, Deborah M.; Dutton, Richard P.; Scalea, Thomas M.] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Alexander, Charlie; Miller, John] Living Legacy Fdn, Baltimore, MD USA		Stein, DM (corresponding author), Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, 22 S Greene St, Baltimore, MD 21201 USA.	dstein@umm.edu		Stein, Deborah/0000-0003-3683-3963	NovoNordiskNovo Nordisk	The following disclosures have been reported by the authors: Drs Stein and Scalea have received research funding from NovoNordisk. Dr Dutton has worked as a paid consultant to NovoNordisk. None of the authors has any financial interest in the company.	Aiyagari V, 2005, J CRIT CARE, V20, P176, DOI 10.1016/j.jcrc.2005.02.004; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Brody DL, 2005, NEUROCRIT CARE, V2, P263, DOI 10.1385/NCC:2:3:263; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cortiana M, 1986, J Neurosurg Sci, V30, P133; Croezen DH, 2001, CLIN TRANSPLANT, V15, P11, DOI 10.1034/j.1399-0012.2001.00002.x; De Gasperi A, 2005, INTENS CARE MED, V31, P315, DOI 10.1007/s00134-004-2525-9; Dunkley S M, 2003, Hematology, V8, P263, DOI 10.1080/10245330310001594252; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Freeman WD, 2004, MAYO CLIN PROC, V79, P1495, DOI 10.4065/79.12.1495; GORE SM, 1991, BRIT MED J, V302, P149, DOI 10.1136/bmj.302.6769.149; Harrison TD, 2005, J TRAUMA, V59, P150, DOI 10.1097/01.TA.0000171470.39742.8E; Hedner U, 2006, SEMIN THROMB HEMOST, V32, P77, DOI 10.1055/s-2006-939557; Hendriks HGD, 2001, TRANSPLANTATION, V71, P402, DOI 10.1097/00007890-200102150-00011; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Jenkins DH, 1999, WORLD J SURG, V23, P644, DOI 10.1007/PL00012362; Karadimov D, 2003, J NEUROSURG ANESTH, V15, P330, DOI 10.1097/00008506-200310000-00008; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Levy JH, 2006, TRANSFUSION, V46, P919, DOI 10.1111/j.1537-2995.2006.00824.x; Lin J, 2003, J NEUROSURG, V98, P737, DOI 10.3171/jns.2003.98.4.0737; Lisman T, 2002, HEPATOLOGY, V35, P616, DOI 10.1053/jhep.2002.31771; May AK, 1997, AM SURGEON, V63, P233; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Meijer K, 2003, BLOOD COAGUL FIBRIN, V14, P169, DOI 10.1097/00001721-200302000-00008; O'Connell NM, 2003, TRANSFUSION, V43, P1711, DOI 10.1046/j.0041-1132.2003.00577.x; Park P, 2003, NEUROSURGERY, V53, P34, DOI 10.1227/01.NEU.0000068830.54968.A8; Pavese P, 2005, CAN J ANAESTH, V52, P26, DOI 10.1007/BF03018576; Perkins JG, 2007, J TRAUMA, V62, P1095, DOI 10.1097/TA.0b013e31804798a4; POWER BM, 1995, ANAESTH INTENS CARE, V23, P26, DOI 10.1177/0310057X9502300107; Powner DJ, 2005, NEUROSURGERY, V57, P823, DOI 10.1227/01.NEU.0000179915.74429.b2; Pugliese F, 2007, TRANSPL P, V39, P1883, DOI 10.1016/j.transproceed.2007.05.062; Rizoli SB, 2006, J TRAUMA, V61, P1419, DOI 10.1097/01.ta.0000243045.56579.74; Roitberg B, 2005, NEUROSURGERY, V57, P832, DOI 10.1227/01.NEU.0000180816.80626.C2; Salim A, 2006, J TRAUMA, V61, P429, DOI 10.1097/01.ta.0000228968.63652.c1; Salim A, 2006, AM SURGEON, V72, P377; Schreiber MA, 2003, J AM COLL SURGEONS, V196, P691, DOI 10.1016/S1072-7515(02)01835-5; Shafer TJ, 2006, CRIT CARE NURSE, V26, P33; Siegel LJ, 2004, ANESTHESIOLOGY, V100, P441, DOI 10.1097/00000542-200402000-00037; Sorensen B, 2003, BLOOD COAGUL FIBRIN, V14, P469, DOI 10.1097/00001721-200307000-00007; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Thomas GOR, 2007, J TRAUMA, V62, P564, DOI 10.1097/TA.0b013e318031afc2; Valdivia M, 2007, TRANSPL P, V39, P2427, DOI 10.1016/j.transproceed.2007.07.052; White Christopher E, 2006, Curr Surg, V63, P310, DOI 10.1016/j.cursur.2006.04.013; Yusim Y, 2006, J CLIN ANESTH, V18, P545, DOI 10.1016/j.jclinane.2006.02.012; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54; UNDERSTANDING DONATI; DECEASED DONORS RECO	49	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	JAN	2009	208	1					120	125		10.1016/j.jamcollsurg.2008.09.027			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	392VO	WOS:000262330500018	19228513				2022-02-06	
J	Ruzsics, B; Suranyi, P; Kiss, P; Brott, BC; Elgavish, A; Simor, T; Elgavish, GA				Ruzsics, Balazs; Suranyi, Pal; Kiss, Pal; Brott, Brigitta C.; Elgavish, Ada; Simor, Tamas; Elgavish, Gabriel A.			Head-to-Head Comparison Between Delayed Enhancement and Percent Infarct Mapping for Assessment of Myocardial Infarct Size in a Canine Model	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						contrast enhanced cardiac MRI; myocardial viability; percent infarct mapping	CONTRAST ENHANCEMENT; GD-DTPA; IRREVERSIBLE INJURY; VIABILITY; TIME; GD(ABE-DTTA); IMPROVEMENT; RECOVERY; AGENT; RISK	Purpose: To compare a novel method, percent-infarct-mapping (PIM), with conventional delayed enhancement (DE) of contrast for accurate myocardial viability assessment. Contrary to signal intensity (SI), the longitudinal relaxation-rate enhancement (Delta R1) is an intrinsic parameter linearly proportional to the concentration of contrast agent (CA). Determining Delta R1 voxel-by-voxel, after administering an infarct-avid CA, allows determination of pervoxel percentage of infarcted tissue. The feasibility of generating PIM is demonstrated in canine reperfused infarction using an infarct-avid, persistent-CA (PCA), (Gd)(ABE-DTTA). PIM is compared to the DE method using Gd(DTPA), and both to triphenyltetrazolium chloride (TTC) staining histochemistry. Materials and Methods: In six dogs, 48 hours following closed-chest, 180-minute coronary occlusion, DE imaging was carried out. PCA was administered immediately thereafter. Pixel-by-pixel R1 maps of the entire left ventricle (LV) were generated 48 hours after PCA using inversion-recovery with multiple inversion times. R1, Delta R1, and percent-infarct values were calculated voxel-by-voxel. Results: Significant correlations (P < 0.01, R >= 0.8) were obtained for percent-infarct-per-slice (PIS) determined by DE or PIM vs. those from corresponding TTC-stained slices. Compared to TTC, DE overestimated PIS by 32 +/- 18%. PIM underestimated PIS by 2.5 +/- 4.9%. Infarction fraction overestimation was 29 +/- 6% of LV by DE, but only 1.0 +/- 2.3% by PIM. Errors with PIM were significantly smaller than those with DE. Infarct area determined by signal intensity was similarly overestimated whether using Gd(DTPA) or Gd(ABE-DTTA). Conclusion: The Delta R1-based PIM method Is highly reproducible and more accurate than DE for quantifying myocardial viability in vivo.	[Ruzsics, Balazs; Suranyi, Pal; Kiss, Pal; Simor, Tamas; Elgavish, Gabriel A.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Ruzsics, Balazs; Suranyi, Pal; Kiss, Pal; Elgavish, Ada; Simor, Tamas; Elgavish, Gabriel A.] Elgavish Paramagnet Inc, Birmingham, AL USA; [Brott, Brigitta C.; Elgavish, Gabriel A.] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Elgavish, Ada] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA		Elgavish, GA (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet MCLM 556, Birmingham, AL 35294 USA.	gabi@uab.edu		Brott, Brigitta/0000-0002-9707-7500; Elgavish, Ada/0000-0002-9446-1777; Elgavish, Gabriel A./0000-0001-6699-4659	NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [1R41 HL080886]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R41HL080886] Funding Source: NIH RePORTER	Contract grant number: NHLBI 1R41 HL080886.	Amado LC, 2004, J AM COLL CARDIOL, V44, P2383, DOI 10.1016/j.jacc.2004.09.020; Balcells E, 2003, J AM COLL CARDIOL, V41, P827, DOI 10.1016/S0735-1097(02)02962-5; Beller GA, 2000, NEW ENGL J MED, V343, P1488, DOI 10.1056/NEJM200011163432011; Choi KA, 2001, CIRCULATION, V104, P1101, DOI 10.1161/hc3501.096798; Choi SH, 2001, RADIOLOGY, V220, P436, DOI 10.1148/radiology.220.2.r01au04436; Fallon J, 1982, MYOCARDIAL INFARCTIO, P373; Fieno DS, 2000, J AM COLL CARDIOL, V36, P1985, DOI 10.1016/S0735-1097(00)00958-X; Fieno DS, 2004, J AM COLL CARDIOL, V43, P2124, DOI 10.1016/j.jacc.2004.01.043; FISHBEIN MC, 1981, AM HEART J, V101, P593, DOI 10.1016/0002-8703(81)90226-X; Gerber BL, 2002, CIRCULATION, V106, P1083, DOI 10.1161/01.CIR.0000027818.15792.1E; Gerber BL, 2001, CIRCULATION, V104, P998, DOI 10.1161/hc3401.095113; Haas F, 1997, J AM COLL CARDIOL, V30, P1693, DOI 10.1016/S0735-1097(97)00375-6; Hillenbrand HB, 2000, CIRCULATION, V102, P1678, DOI 10.1161/01.CIR.102.14.1678; Ibrahim T, 2005, J AM COLL CARDIOL, V45, P544, DOI 10.1016/j.jacc.2004.10.058; JUDD RM, 1995, CIRCULATION, V92, P1902, DOI 10.1161/01.CIR.92.7.1902; KALDOUDI E, 1993, CONCEPT MAGNETIC RES, V0005, P00217, DOI DOI 10.1002/CMR.1820050303; Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Klein C, 2002, CIRCULATION, V105, P162, DOI 10.1161/hc0202.102123; Kramer CM, 2000, J AM COLL CARDIOL, V36, P1835, DOI 10.1016/S0735-1097(00)00945-1; Kuhl HP, 2003, J AM COLL CARDIOL, V41, P1341, DOI 10.1016/S0735-1097(03)00158-X; LIMA JAC, 1995, CIRCULATION, V92, P1117, DOI 10.1161/01.CIR.92.5.1117; Messroghli DR, 2003, J CARDIOV MAGN RESON, V5, P353, DOI 10.1081/JCMR-120019418; NEKOLLA S, 1992, J COMPUT ASSIST TOMO, V16, P327, DOI 10.1097/00004728-199203000-00031; Oshinski JN, 2001, CIRCULATION, V104, P2838, DOI 10.1161/hc4801.100351; PESHOCK RM, 1986, CIRCULATION, V74, P1434, DOI 10.1161/01.CIR.74.6.1434; REHR RB, 1986, AM J CARDIOL, V57, P864, DOI 10.1016/0002-9149(86)90628-4; Rochitte CE, 1998, CIRCULATION, V98, P1006, DOI 10.1161/01.CIR.98.10.1006; Ruzsics B, 2006, PHARMACOLOGY, V77, P188, DOI 10.1159/000094864; Saab-Ismail NH, 1999, J MED CHEM, V42, P2852, DOI 10.1021/jm980454v; Saeed M, 1999, RADIOLOGY, V213, P247, DOI 10.1148/radiology.213.1.r99se30247; Saeed M, 2001, CIRCULATION, V103, P871, DOI 10.1161/01.CIR.103.6.871; Setser RM, 2003, J MAGN RESON IMAGING, V18, P434, DOI 10.1002/jmri.10391; Simonetti OP, 2001, RADIOLOGY, V218, P215, DOI 10.1148/radiology.218.1.r01ja50215; SIMOR T, 1998, GD ABE DTTA ENHANCED, V10, P132; Suranyi P, 2007, MAGN RESON MED, V58, P55, DOI 10.1002/mrm.21249; Suranyi P, 2006, MAGN RESON MED, V56, P535, DOI 10.1002/mrm.20979; TSCHOLAKOFF D, 1986, RADIOLOGY, V160, P515, DOI 10.1148/radiology.160.2.3726135; Wagner A, 2006, J AM COLL CARDIOL, V47, P2027, DOI 10.1016/j.jacc.2006.01.059; Watzinger N, 2002, J MAGN RESON IMAGING, V16, P633, DOI 10.1002/jmri.10206	40	6	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	DEC	2008	28	6					1386	1392		10.1002/jmri.21571			7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	377SI	WOS:000261270500009	19025946	Bronze			2022-02-06	
J	Benneker, LM; Leitner, C; Martinolli, L; Robert, K; Zimmermann, H; Exadaktylos, AK				Benneker, Lorin M.; Leitner, Christoph; Martinolli, Luca; Robert, Kretschmer; Zimmermann, Heinz; Exadaktylos, Aristomenis K.			Isolated vertebral fractures give elevated serum protein S-100B levels	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article								Background: Serum protein S-100B determinations have been widely proposed in the past as markers of traumatic brain injury and used as a predictor of injury severity and outcome. The purpose of this prospective observational case series was therefore to determine S-100B serum levels in patients with isolated injuries to the back. Methods: Between 1 February and 1 May 2008, serum samples for S-100B analysis were obtained within 1 hour of injury from 285 trauma patients. All patients with a head injury, polytrauma, and intoxicated patients were excluded to select isolated injuries to the spine. 19 patients with isolated injury of the back were included. Serum samples for S-100B analysis and CT spine were obtained within 1 hours of injury. Results: CT scans showed vertebral fractures in 12 of the 19 patients (63%). All patients with fractures had elevated S-100B levels. Amongst the remaining 7 patients without a fracture, only one patient with a severe spinal contusion had an S-100B concentration above the reference limit. The mean S-100B value of the group with fractures was more than 4 times higher than in the group without fractures (0.385 vs 0.087 mu g/L, p = 0.0097). Conclusion: Our data, although limited due to a very small sample size, suggest that S-100B serum levels might be useful for the diagnosis of acute vertebral body and spinal cord injury with a high negative predictive power. According to the literature, the highest levels of serum S-100B are found when large bones are fractured. If a large prospective study confirms our findings, determining the S-100B level may contribute to more selective use of CT and MRI in spinal trauma.	[Leitner, Christoph; Martinolli, Luca; Zimmermann, Heinz; Exadaktylos, Aristomenis K.] Univ Hosp Bern, Dept Emergency Med, Bern, Switzerland; [Benneker, Lorin M.] Univ Hosp Bern, Dept Orthopaed & Trauma Surg, Bern, Switzerland; [Robert, Kretschmer] Univ Hosp Bern, Dept Analyt Chem, Bern, Switzerland		Exadaktylos, AK (corresponding author), Univ Hosp Bern, Dept Emergency Med, Bern, Switzerland.	lorin.benneker@insel.ch; christoph.leitner@insel.ch; luca.martinolli@inselspital.ch; robert.kretschmer@inselspital.ch; heinz.zimmermann@insel.ch; aristomenis@exadaktylos.ch					Cao F, 2008, J CLIN NEUROSCI, V15, P541, DOI 10.1016/j.jocn.2007.05.014; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; DIMOPOULOU I, 2003, RESTOR NEUROL NEUROS, V21, P159; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Loy DN, 2005, NEUROSURGERY, V56, P391, DOI 10.1227/01.NEU.0000148906.83616.D2; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Pickering A, 2008, EMERG MED J, V25, P88, DOI 10.1136/emj.2007.046631; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72	9	6	6	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	NOV	2008	16								13	10.1186/1757-7241-16-13			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	V13KH	WOS:000207665200001	18992158	gold, Green Published			2022-02-06	
J	Pedre, LL; Suarez, SO; Chacon, LM; Maeso, IG; Diaz, BE; del Busto, JEB; Fuentes, NP; Pinero, BP; Arrieta, LR				Lorigados Pedre, L.; Orozco Suarez, S.; Morales Chacon, L.; Garcia Maeso, I.; Estupinan Diaz, B.; Bender del Busto, J. E.; Pavon Fuentes, N.; Paula Pinero, B.; Rocha Arrieta, L.			Neuronal death in the neocortex of drug resistant temporal lobe epilepsy patients	NEUROLOGIA			Spanish	Article						Drug resistant temporal lobe epilepsy; Apoptosis; Necrosis; Neuronal loss	INTERNUCLEOSOMAL DNA CLEAVAGE; TRAUMATIC BRAIN-INJURY; APOPTOTIC CELL-DEATH; STATUS EPILEPTICUS; KAINIC ACID; HIPPOCAMPAL-NEURONS; RAT-BRAIN; CASPASE-3-LIKE PROTEASE; SURGICAL-TREATMENT; TIME-COURSE	Introduction. Participation of apoptotic death mechanisms in drug resistant temporal lobe epilepsy (DRTLE) is currently under great debate. We have investigated if there is neuronal loss and the immunodetection to different markers in neocortical tissue death in eigth patients with DRTLE. The neocortexes of five patients deceased due to non-neurological causes, paired in age and gender were evaluated as control tissue. Methods. The evaluation of neuronal loss was made by means of a stereological study and with immunohistochemical techniques with the synaptophysin marker. Immunopositivity to different apoptotic markers (annexin V, caspase 3 and 8, bcl-2 and p53) and detection of deoxyribonucleic acid (DNA) fragmentation (TUNEL) were analyzed and double labeling with synaptophysin was performed in every case. The results were evaluated with confocal microscope and analyzed with the Zeiss LSM 5 Image Browser Program, 2.80.1113 (Germany). Results. A statistically significant decrease in the total number of cells (p < 0.05) and the synaptophysin cells+ (p < 0.01) in the neocortex (layer IV) of the patients with DRTLE when compared with the control tissue was found. No significant differences were found in the apoptotic markers bcl-2, p53, caspase 3 and 8 for any of the neocortex layers while there was a statistically significant increase in the number of TUNEL cells+ (p < 0.05) and annexin V+ (p < 0.05) in the neocortical layer IV of the patients. Conclusions. This group of evidence speaks in favor of the existence of an effect on the neuronal number in the neocortex layer IV that may be associated with non-caspase dependent apoptotic death process, without being able to rule out death by necrosis.	[Lorigados Pedre, L.; Pavon Fuentes, N.] CIREN, Lab Neuroimmunol, Havana 11300, Cuba; [Rocha Arrieta, L.] CINVESTAV, Lab Farmacobiol, Sede Sur, DF, Mexico		Pedre, LL (corresponding author), CIREN, Lab Neuroimmunol, Av 25,15805 E 158 & 160 Playa,11300 Ciudad Habana, Havana 11300, Cuba.	lourdes.lorigados@infomed.sld.cu		Orozco-Suarez, Sandra/0000-0001-5289-8500			Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Alarcon G, 1997, BRAIN, V120, P2259, DOI 10.1093/brain/120.12.2259; Ananth C, 2001, J NEUROSCI RES, V66, P177, DOI 10.1002/jnr.1210; Babb Thomas L., 1993, P55; Babb TL, 1987, SURGICAL TREATMENT E, P511; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Bengzon J, 2002, PROG BRAIN RES, V135, P111; Bi XN, 1996, BRAIN RES, V726, P98, DOI 10.1016/0006-8993(95)01360-1; Campagne MV, 1996, NEUROSCI LETT, V213, P111, DOI 10.1016/0304-3940(96)12839-1; Cascino GD, 2004, EPILEPSY RES, V60, P179, DOI 10.1016/j.eplepsyres.2004.07.003; CharriautMarlangue C, 1995, NEUROREPORT, V7, P61, DOI 10.1097/00001756-199512000-00014; Chen J, 1998, J NEUROSCI, V18, P4914; DeFelipe-Oroquieta J, 2002, REV NEUROLOGIA, V34, P401, DOI 10.33588/rn.3405.2001403; Dong Z, 1997, AM J PATHOL, V151, P1205; Ebert U, 2002, EPILEPSIA, V43, P86, DOI 10.1046/j.1528-1157.43.s.5.39.x; Engel Jr J, 1993, SURG TREATMENT EPILE, V2nd; Faherty CJ, 1999, MOL BRAIN RES, V70, P159, DOI 10.1016/S0169-328X(99)00143-6; FALCONER MA, 1974, LANCET, V2, P767; FILIPKOWSKI RK, 1994, NEUROREPORT, V5, P1538, DOI 10.1097/00001756-199407000-00032; Fujikawa DG, 2007, BRAIN RES, V1135, P206, DOI 10.1016/j.brainres.2006.12.029; Fujikawa DG, 2000, NEUROSCIENCE, V98, P41, DOI 10.1016/S0306-4522(00)00085-3; Fujikawa DG, 2000, TRENDS NEUROSCI, V23, P410, DOI 10.1016/S0166-2236(00)01601-5; Fujikawa DG, 1999, EUR J NEUROSCI, V11, P1605, DOI 10.1046/j.1460-9568.1999.00573.x; Fujikawa DG, 2002, J NEUROCHEM, V83, P229, DOI 10.1046/j.1471-4159.2002.01152.x; Fujikawa DG, 2000, EPILEPSIA, V41, pS9, DOI 10.1111/j.1528-1157.2000.tb01549.x; FUJIKAWA DG, 1998, SOC NEUR ABSTR, V23, P757; GILLARDON F, 1995, NEUROSCI LETT, V192, P85, DOI 10.1016/0304-3940(95)11619-8; Gillardon F, 1997, MOL BRAIN RES, V50, P16, DOI 10.1016/S0169-328X(97)00162-9; Graham SH, 1996, RESTOR NEUROL NEUROS, V9, P243, DOI 10.3233/RNN-1996-9407; Gwag BJ, 1997, NEUROSCIENCE, V77, P393, DOI 10.1016/S0306-4522(96)00473-3; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Henshall DC, 2002, J NEUROSCI, V22, P8458; Henshall DC, 2000, NEUROLOGY, V55, P250, DOI 10.1212/WNL.55.2.250; Henshall DC, 2000, J NEUROCHEM, V74, P1215; Henshall DC, 2001, NEUROSCI LETT, V305, P153, DOI 10.1016/S0304-3940(01)01849-3; Ishimaru MJ, 1999, J COMP NEUROL, V408, P461; Jeffreys JGR, 1999, BRAIN, V122, P1007, DOI 10.1093/brain/122.6.1007; Kitao Y, 2001, J CLIN INVEST, V108, P1439, DOI 10.1172/JCI12978; Kubova H, 2001, J NEUROSCI, V21, P3593, DOI 10.1523/JNEUROSCI.21-10-03593.2001; Kuida K, 2000, INT J BIOCHEM CELL B, V32, P121, DOI 10.1016/S1357-2725(99)00024-2; LEE JM, 2001, INT J NUCL MED, V7, P455; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Liu W, 1996, NEUROREPORT, V7, P2785, DOI 10.1097/00001756-199611040-00076; Lopez J, 2007, CLIN BIOCHEM, V40, P292, DOI 10.1016/j.clinbiochem.2006.11.019; MARGERISON JH, 1966, BRAIN, V89, P499, DOI 10.1093/brain/89.3.499; Mayanagi Y, 1996, EPILEPSIA, V37, P57, DOI 10.1111/j.1528-1157.1996.tb01823.x; MELDRUM BS, 1993, BRAIN PATHOL, V3, P405, DOI 10.1111/j.1750-3639.1993.tb00768.x; Morrison RS, 1996, J NEUROSCI, V16, P1337; Namura S, 1998, J NEUROSCI, V18, P3659; Narkilahti S, 2003, NEUROPHARMACOLOGY, V44, P1068, DOI 10.1016/S0028-3908(03)00115-1; Ong WY, 1997, EXP BRAIN RES, V113, P117, DOI 10.1007/BF02454147; Palmini A, 2004, NEUROLOGY, V62, pS2, DOI 10.1212/01.WNL.0000114507.30388.7E; Petito CK, 1997, J CEREBR BLOOD F MET, V17, P967, DOI 10.1097/00004647-199709000-00006; POLLARD H, 1994, NEUROSCIENCE, V63, P7, DOI 10.1016/0306-4522(94)90003-5; PorteraCailliau C, 1997, J COMP NEUROL, V378, P70; Puig B, 2002, NEUROSCI LETT, V321, P182, DOI 10.1016/S0304-3940(01)02518-6; Regesta G, 1999, EPILEPSY RES, V34, P109, DOI 10.1016/S0920-1211(98)00106-5; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Roy M, 2002, GENE THER, V9, P214, DOI 10.1038/sj.gt.3301642; SAKHI S, 1994, P NATL ACAD SCI USA, V91, P7525, DOI 10.1073/pnas.91.16.7525; Sakhi S, 1996, NEUROREPORT, V7, P493, DOI 10.1097/00001756-199601310-00028; SCHACHTER SC, 1993, EPILEPSIA, V34, pS24, DOI 10.1111/j.1528-1157.1993.tb05920.x; Schielke GP, 1998, J CEREBR BLOOD F MET, V18, P180, DOI 10.1097/00004647-199802000-00009; SCHMECHEL DE, 1999, CRC METH NEUROSCI S, P23; Shinoda S, 2003, EUR J NEUROSCI, V17, P2065, DOI 10.1046/j.1460-9568.2003.02655.x; Sloviter RS, 1996, J COMP NEUROL, V366, P516, DOI 10.1002/(SICI)1096-9861(19960311)366:3<516::AID-CNE10>3.0.CO;2-N; Sohn S, 1998, NEUROSCI LETT, V240, P147, DOI 10.1016/S0304-3940(97)00936-1; Tuunanen J, 1999, NEUROSCIENCE, V94, P473, DOI 10.1016/S0306-4522(99)00251-1; Uysal H, 2003, EPILEPSIA, V44, P778, DOI 10.1046/j.1528-1157.2003.37402.x; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Wieser HG, 1996, BAILLIERE CLIN NEUR, V5, P849; WIESER HG, 1991, REV NEUROL, V34, P401; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Zhang LX, 1998, MOL BRAIN RES, V55, P198, DOI 10.1016/S0169-328X(97)00316-1; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x	76	6	10	0	0	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0213-4853	1578-1968		NEUROLOGIA	Neurologia	NOV	2008	23	9					555	565					11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	380QY	WOS:000261481500003	18247188				2022-02-06	
J	Payen, JF; Vinclair, M; Broux, C; Faure, P; Chabre, O				Payen, J. -F.; Vinclair, M.; Broux, C.; Faure, P.; Chabre, O.			Should etomidate still be used?	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						Etomidate; Cortisol; Adrenal inhibition; ICU	TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL PATIENTS; SEPTIC SHOCK; ADRENAL INSUFFICIENCY; ENDOTRACHEAL INTUBATION; MENINGOCOCCAL SEPSIS; CORTISOL RESPONSE; RISK-FACTORS; INDUCTION; ANESTHESIA	Etomidate blocks the cortisol synthesis by specifically inhibiting the activity of 11 beta-hydroxylase, resulting in a primary adrenal insufficiency. Therefore, a serum accumulation of I 1,p-deoxycortisol and a low secretion of serum cortisol must be required as diagnostic criteria to assign that adrenal impairment to the drug. These requirements have been rarely fulfilled in studies exploring the contribution of etomidate to the adrenal insufficiency despite numerous causes of adrenal derangement. In critically ill-patients without sepsis, a single dose of etomidate results in a wide. adrenal inhibition, reversible in 48 h after etomidate administration. Although there are still uncertainties as to whether etomidate directly affects mortality and morbidity, it seems preferable to avoid the use of etomidate in patients with severe sepsis and septic shock. In patients with severe traumatic brain injury, arterial hypotension is one of major factors of poor outcome-and can be prevented with the use of etomidate for facilitating tracheal intubation. Substitutive opotherapy with low doses of hydrocortisone should be assessed after a single dose of etomidate for critically ill patients. (c) 2008 Elsevier Masson SAS.	[Payen, J. -F.; Faure, P.] Hop Michallon, Dept Biol Integree, F-38043 Grenoble, France; [Chabre, O.] Hop Michallon, Unite Endocrinol, Pole DIGE DUNE, F-38043 Grenoble, France		Payen, JF (corresponding author), Hop Michallon, Dept Biol Integree, BP 217, F-38043 Grenoble, France.	jfpayen@ujf-grenoble.fr	Payen, Jean-Francois/L-6667-2014	CHABRE, Olivier/0000-0001-8756-7218			Absalom A, 1999, ANAESTHESIA, V54, P861; Adnet F, 1998, ANN FR ANESTH, V17, P688, DOI 10.1016/S0750-7658(98)80106-8; Aihara R, 2001, J TRAUMA, V50, P1027, DOI 10.1097/00005373-200106000-00009; Annane D, 2005, INTENS CARE MED, V31, P325, DOI 10.1007/s00134-005-2560-1; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2006, AM J RESP CRIT CARE, V174, P1319, DOI 10.1164/rccm.200509-1369OC; Arbous MS, 2001, ANAESTHESIA, V56, P1141, DOI 10.1046/j.1365-2044.2001.02051.x; Bergen Joseph M., 1997, Journal of Emergency Medicine, V15, P221, DOI 10.1016/S0736-4679(96)00350-2; Bernard F, 2006, BRIT J ANAESTH, V96, P72, DOI 10.1093/bja/aei277; Bloomfield R, 2006, BRIT J ANAESTH, V97, P116, DOI 10.1093/bja/ael124; Bramwell KJ, 2006, PEDIATR EMERG CARE, V22, P90, DOI 10.1097/01.pec.0000199563.64264.3a; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; den Brinker M, 2005, J CLIN ENDOCR METAB, V90, P5110, DOI 10.1210/jc.2005-1107; den Brinker M, 2008, INTENS CARE MED, V34, P163, DOI 10.1007/s00134-007-0836-3; DUTHIE DJR, 1985, BRIT J ANAESTH, V57, P156, DOI 10.1093/bja/57.2.156; GOODING JM, 1979, ANESTH ANALG, V58, P40; Himmelseher S, 2005, ANESTH ANALG, V101, P524, DOI 10.1213/01.ANE.0000160585.43587.5B; Hoen S, 2002, ANESTHESIOLOGY, V97, P807, DOI 10.1097/00000542-200210000-00010; Jackson WL, 2005, CHEST, V127, P1031, DOI 10.1378/chest.127.3.1031; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Liouber-Friedman D, 2007, CRIT CARE MED, V35, P1012, DOI 10.1097/01.CCM.0000259465.92018.6E; Malerba G, 2005, INTENS CARE MED, V31, P388, DOI 10.1007/s00134-004-2550-8; Mohammad Z, 2006, CRIT CARE, V10, DOI 10.1186/cc4979; Morris C, 2005, ANAESTHESIA, V60, P737, DOI 10.1111/j.1365-2044.2005.04325.x; Murray H, 2005, CHEST, V127, P707, DOI 10.1378/chest.127.3.707; Nieman Lynnette K, 2002, Pituitary, V5, P77, DOI 10.1023/A:1022308429992; Prigent H, 2004, CRIT CARE, V8, P243, DOI 10.1186/cc2878; Ray DC, 2007, CRIT CARE, V11, DOI 10.1186/cc5916; Reich DL, 2005, ANESTH ANALG, V101, P622, DOI 10.1213/01.ANE.0000175214.38450.91; RITTMASTER RS, 1985, J CLIN ENDOCR METAB, V60, P891, DOI 10.1210/jcem-60-5-891; Schenarts CL, 2001, ACAD EMERG MED, V8, P1, DOI 10.1111/j.1553-2712.2001.tb00537.x; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Vinclair M, 2008, INTENS CARE MED, V34, P714, DOI 10.1007/s00134-007-0970-y; WAGNER RL, 1984, NEW ENGL J MED, V310, P1415, DOI 10.1056/NEJM198405313102202	37	6	7	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	NOV	2008	27	11					915	919		10.1016/j.annfar.2008.09.016			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	384VO	WOS:000261772500006	18980826				2022-02-06	
J	Raab, H; Lindner, KH; Wenzel, V				Raab, Helmut; Lindner, Karl H.; Wenzel, Volker			Preventing cardiac arrest during hemorrhagic shock with vasopressin	CRITICAL CARE MEDICINE			English	Article; Proceedings Paper	9th Wolf Creek Conference on Cardiopulmonary	JUN 21-24, 2007	Weil Inst Critical Care Med, Indian Wells, CA		Weil Inst Critical Care Med	advanced trauma life support; survival; multiple trauma; hemorrhage; vasopressor; VITRIS.at	ORGAN BLOOD-FLOW; HYPERTONIC SALINE RESUSCITATION; PULSELESS ELECTRICAL-ACTIVITY; TRAUMA CENTER DESIGNATION; FLUID RESUSCITATION; ARGININE-VASOPRESSIN; LIVER TRAUMA; BRAIN-INJURY; DOUBLE-BLIND; CARDIOVASCULAR-SYSTEM	The optimal strategy of stabilizing hemodynamic function in uncontrolled traumatic hemorrhagic shock states is unclear. Although fluid replacement is established in controlled hemorrhagic shock, its use in uncontrolled hemorrhagic shock is controversial, because it may worsen bleeding. In the refractory phase of severe hemorrhagic shock, arginine vasopressin has been shown to be beneficial in selected cases due to an increase in arterial blood pressure, shift of blood away from a subdiaphragmatic bleeding site toward the heart and brain, and decrease in fluid-resuscitation requirements. Especially in patients with severe traumatic brain injury, rapid stabilization of cardiocirculatory function is essential to ensure adequate brain perfusion, thus, to prevent neurologic damage and to improve outcome. In addition, despite wide distribution of highly developed and professional emergency medical systems in western industrialized countries, survival chances of patients with uncontrolled traumatic hemorrhagic shock in the preclinical setting are still poor. (Crit Care Med 2008; 36[Suppl.]:S474-S480)	[Raab, Helmut; Lindner, Karl H.; Wenzel, Volker] Innsbruck Med Univ, Dept Anesthesiol & Crit Care Med, Innsbruck, Austria		Wenzel, V (corresponding author), Innsbruck Med Univ, Dept Anesthesiol & Crit Care Med, Innsbruck, Austria.	volker.wenzel@uki.at					Alam HB, 2007, SURG CLIN N AM, V87, P55, DOI 10.1016/j.suc.2006.09.015; Alsweiler W, 1970, Z Prakt Anasth, V5, P91; Antonenko DR, 1999, ARCH SURG-CHICAGO, V134, P745; Asfar P, 2004, CRIT CARE, V8, P170, DOI 10.1186/cc2418; Balogh Z, 2003, ARCH SURG-CHICAGO, V138, P637, DOI 10.1001/archsurg.138.6.637; Barak Michal, 2004, Curr Surg, V61, P459, DOI 10.1016/j.cursur.2004.02.002; Battistella FD, 1999, ARCH SURG-CHICAGO, V134, P742, DOI 10.1001/archsurg.134.7.742; BENEDICT CR, 1978, Q J MED, V47, P1; BICKELL WH, 1991, SURGERY, V110, P529; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BISHOP MH, 1991, AM SURGEON, V57, P785; Brandstrup B, 2003, ANN SURG, V238, P641, DOI 10.1097/01.sla.0000094387.50865.23; Cannon WB, 1918, J AMER MED ASSOC, V70, P618; CHRISTENSEN O, 1987, NATURE, V330, P66, DOI 10.1038/330066a0; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; David JS, 2007, CRIT CARE MED, V35, P2251, DOI 10.1097/01.CCM.0000281859.61545.22; DEAKIN CD, 1994, J ACCID EMERG MED, V11, P154; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Dick W F, 2000, Acta Anaesthesiol Belg, V51, P18; DRIES DJ, 1994, ARCH SURG-CHICAGO, V129, P1031; Dunser M, 2002, ANAESTHESIST, V51, P650, DOI 10.1007/s00101-002-0349-y; Dunser MW, 2006, CRIT CARE MED, V34, P562, DOI 10.1097/01.CCM.0000196093.42087.5D; Dunser MW, 2003, DRUGS, V63, P237, DOI 10.2165/00003495-200363030-00001; Dunser MW, 2001, ANESTH ANALG, V93, P7; Dutton RP, 2002, J TRAUMA, V52, P1141, DOI 10.1097/00005373-200206000-00020; Ericsson B F, 1971, Acta Chir Scand Suppl, V414, P1; ERICSSON BF, 1971, ACTA CHIR SCAND, V137, P729; Feinstein AJ, 2005, J TRAUMA, V59, P876, DOI 10.1097/01.ta.0000187654.24146.22; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; Feinstein AJ, 2005, J TRAUMA, V59, P882; Flaherty S, 2003, J TRAUMA, V54, P70; GROSS D, 1988, J TRAUMA, V28, P751, DOI 10.1097/00005373-198806000-00005; Guyton AC, 2000, TXB MED PHYSL, P253; Haas T, 2004, J TRAUMA, V57, P177, DOI 10.1097/01.TA.0000044357.25191.1B; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; HAMMOND JMJ, 1994, CRIT CARE MED, V22, P33, DOI 10.1097/00003246-199401000-00010; Haussinger D, 1997, CELL BIOL TOXICOL, V13, P275, DOI 10.1023/A:1007483324138; Haussinger D, 1997, DIGESTION, V58, P21, DOI 10.1159/000201518; Heckbert SR, 1998, J TRAUMA, V45, P545, DOI 10.1097/00005373-199809000-00022; Holmes CL, 2004, CRIT CARE, V8, P15, DOI 10.1186/cc2338; Holmes CL, 2003, CRIT CARE, V7, P427, DOI 10.1186/cc2337; Hopson LR, 2003, J AM COLL SURGEONS, V196, P106, DOI 10.1016/S1072-7515(02)01668-X; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Joshi GP, 2005, ANESTH ANALG, V101, P601, DOI 10.1213/01.ANE.0000159171.26521.31; KLEEMANN PP, 1988, ANAESTHESIST, V37, P551; Klinzing S, 2003, CRIT CARE MED, V31, P2646, DOI 10.1097/01.CCM.0000094260.05266.F4; Krausz MM, 2003, J TRAUMA, V54, pS39, DOI 10.1097/01.TA.0000064506.47688.51; Krismer AC, 2005, ANAESTHESIST, V54, P220, DOI 10.1007/s00101-004-0793-y; Kwan I, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002245; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lienhart HG, 2007, ANAESTHESIST, V56, P145, DOI 10.1007/s00101-006-1114-4; LINDNER KH, 1995, CIRCULATION, V91, P215, DOI 10.1161/01.CIR.91.1.215; Lobo DN, 2002, LANCET, V359, P1812, DOI 10.1016/S0140-6736(02)08711-1; Lopez A, 2004, CRIT CARE MED, V32, P21, DOI 10.1097/01.CCM.0000105581.01815.C6; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Martin SK, 2002, J TRAUMA, V53, P876, DOI 10.1097/00005373-200211000-00011; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Mayr VD, 2001, CIRCULATION, V104, P1651, DOI 10.1161/hc3901.095896; Meier-Hellmann A, 2003, ANASTH INTENSIV NOTF, V38, P107, DOI 10.1055/s-2003-36994; MEIERHELLMANN A, 2003, ANASTH INTENSIVMED, V38, P134; MILLES G, 1966, SURGERY, V60, P434; Minino A, 2004, NATL VITAL STAT REP, V54, P1; MITCHELL JP, 1992, AM REV RESPIR DIS, V145, P990, DOI 10.1164/ajrccm/145.5.990; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Moore FA, 2004, LANCET, V363, P1988, DOI 10.1016/S0140-6736(04)16415-5; Morales D, 1999, CIRCULATION, V100, P226, DOI 10.1161/01.CIR.100.3.226; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Ng KFJ, 2002, BRIT J ANAESTH, V88, P475, DOI 10.1093/bja/88.4.475; Raedler C, 2004, ANESTH ANALG, V98, P1759, DOI 10.1213/01.ANE.0000117150.29361.5A; Riou B, 2001, ANESTHESIOLOGY, V95, P56, DOI 10.1097/00000542-200107000-00014; Roberts I, 2001, LANCET, V357, P385, DOI 10.1016/S0140-6736(00)03653-9; ROSEMURGY AS, 1993, J TRAUMA, V35, P468, DOI 10.1097/00005373-199309000-00022; Ruchholtz S, 1997, LANGENG ARC, VSUPPL, P1265; Sanui M, 2006, CRIT CARE MED, V34, P433, DOI 10.1097/01.CCM.0000196206.83534.39; Seamon MJ, 2007, J TRAUMA, V63, P113, DOI 10.1097/TA.0b013e31806842a1; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; SHAFTAN GW, 1964, J CARDIOVASC SURG, V5, P251; Shapiro MB, 2002, J TRAUMA, V53, P236; Sharma RM, 2005, ANESTH ANALG, V101, P833, DOI 10.1213/01.ANE.0000175209.61051.7F; SHELLY MP, 1988, INTENS CARE MED, V14, P526, DOI 10.1007/BF00263525; SHIMAZU S, 1983, J TRAUMA, V23, P213, DOI 10.1097/00005373-198303000-00006; SHIRES T, 1964, ARCH SURG-CHICAGO, V88, P688; Shoemaker WC, 1996, CRIT CARE MED, V24, pS12; Sloan EP, 1999, JAMA-J AM MED ASSOC, V282, P1857, DOI 10.1001/jama.282.19.1857; Stadlbauer KH, 2003, ANESTHESIOLOGY, V98, P699, DOI 10.1097/00000542-200303000-00018; STERN SA, 1993, ANN EMERG MED, V22, P155, DOI 10.1016/S0196-0644(05)80195-7; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Thomas A, 2000, ANASTH INTENSIV NOTF, V35, P91, DOI 10.1055/s-2000-13006; Voelckel WG, 2003, CRIT CARE MED, V31, P1160, DOI 10.1097/01.CCM.0000060014.75282.69; Voelckel WG, 2004, ANAESTHESIST, V53, P1151, DOI 10.1007/s00101-004-0771-4; Voelckel WG, 2000, ANESTH ANALG, V91, P627, DOI 10.1213/00000539-200009000-00024; Watters JM, 2006, J TRAUMA, V61, P300, DOI 10.1097/01.ta.0000224211.36154.44; Wenzel V, 1999, CRIT CARE MED, V27, P486, DOI 10.1097/00003246-199903000-00022; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431; Wenzel V, 2002, PHARMACOL RES, V46, P371, DOI 10.1016/S1043661802002116; Yeh CC, 2003, ANESTH ANALG, V97, P577, DOI 10.1213/01.ANE.0000070231.16378.A6; Zenati MS, 2002, J TRAUMA, V53, P232, DOI 10.1097/00005373-200208000-00007	101	6	6	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	NOV	2008	36	11		S			S474	S480		10.1097/CCM.0b013e31818a8d7e			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	369KX	WOS:000260694500015	20449913				2022-02-06	
J	Tappenden, KA				Tappenden, Kelly A.			Inflammation and Intestinal Function. Where Does It Start and What Does It Mean?	JOURNAL OF PARENTERAL AND ENTERAL NUTRITION			English	Article; Proceedings Paper	Intersociety Research Workshop on Nutrition and Inflammation	FEB 08-09, 2008	Chicago, IL	Amer Dietet Assoc, Amer Soc Nutr, Amer Soc Parenteral & Enteral Nutr, Obes Soc		inflammation; mucosa; nutrients; digestion; intestinal barrier function; entrocyte	TRAUMATIC BRAIN-INJURY; BARRIER FUNCTION; MUCOSA STRUCTURE; RATS; TRANSPORT; APOPTOSIS; RABBIT	Various key elements of intestinal function, such as digestion, absorption, and barrier function, are impaired during inflammation. Although intestinal damage associated with inflammation originating within the intestine is well-known, inflammation in distant organs can impair intestinal function, despite normal histological appearance of the impacted intestinal mucosa. Widespread clinical dogma indicating that intestinal dysfunction drives inflammation should be reconsidered based on data indicating that, in many situations, inflammation precedes intestinal damage and appears to be the injurious factor. Finally, various nutrients have been shown to protect and/or repair the intestinal mucosa from the effects of inflammation; therefore, strategies for optimizing the nutrients provided during inflammatory states should be considered. (JPEN J Parenter Enteral Nutr. 2008;32:648-650)	[Tappenden, Kelly A.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA; [Tappenden, Kelly A.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA		Tappenden, KA (corresponding author), Univ Illinois, Dept Food Sci & Human Nutr, 443 Bevier Hall,905 S Goodwin Ave, Urbana, IL 61801 USA.	tappende@uiuc.edu		Tappenden, Kelly/0000-0001-8412-6476			Amador P, 2007, J MEMBRANE BIOL, V215, P125, DOI 10.1007/s00232-007-9012-5; Bartholome AL, 2004, JPEN-PARENTER ENTER, V28, P210, DOI 10.1177/0148607104028004210; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Feng D, 2007, J INT MED RES, V35, P644, DOI 10.1177/147323000703500509; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2007, J SURG RES, V137, P53, DOI 10.1016/j.jss.2006.06.026; Hardin J, 2000, GUT, V47, P184, DOI 10.1136/gut.47.2.184; Jurjus A, 2006, CAN J PHYSIOL PHARM, V84, P1191, DOI 10.1139/Y06-069; Sandek A, 2007, J AM COLL CARDIOL, V50, P1561, DOI 10.1016/j.jacc.2007.07.016; Seidler U, 2006, ANN NY ACAD SCI, V1072, P262, DOI 10.1196/annals.1326.024; Sigalet DL, 2007, AM J PHYSIOL-GASTR L, V293, pG211, DOI 10.1152/ajpgi.00530.2006; Sundaram U, 1999, AM J PHYSIOL-GASTR L, V276, pG211, DOI 10.1152/ajpgi.1999.276.1.G211; Thibault R, 2007, GASTROENTEROLOGY, V133, P1916, DOI 10.1053/j.gastro.2007.08.041	14	6	6	8	20	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0148-6071			JPEN-PARENTER ENTER	J. Parenter. Enter. Nutr.	NOV-DEC	2008	32	6					648	650		10.1177/0148607108325177			3	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Nutrition & Dietetics	365YU	WOS:000260446800011	18974246				2022-02-06	
J	Atalay, B; Bavbek, M; Oezen, O; Nacar, A; Gulsen, S; Yigitkanli, K; Caner, H; Altinors, N				Atalay, Basar; Bavbek, Murad; Oezen, Oezlem; Nacar, Ahmet; Gulsen, Salih; Yigitkanli, Kazim; Caner, Hakan; Altinors, Nur			Nogo-A Inhibitory Peptide (NEP1-40) Increases Pan-Cadherin Expression Following Mild Cortical Contusion Injury in Rats	TURKISH NEUROSURGERY			English	Article						Mild cortical contusion injury; Motor recovery; NCAM; Neuroregeneration; Nogo-A; Pan-cadherin	CENTRAL-NERVOUS-SYSTEM; MESSENGER-RNA EXPRESSION; MONOCLONAL-ANTIBODY IN-1; TRAUMATIC BRAIN-INJURY; AXON REGENERATION; NEURITE OUTGROWTH; SYNAPTIC CONTACT; SPINAL-CORD; ADULT-RAT; RECEPTOR	BACKGROUND: Nogo-A is a myelin-associated neurite outgrowth inhibitory protein that limits elongation of central nerve fibers, neuronal regeneration and plasticity. We investigated the effect of delivering an inhibitory peptide that neutralizes Nogo-A on neuronal recovery following mild cortical contusion injury METHODS: 41 rats were allocated into the control and NEP1-40 treatment groups. PBS was applied following trauma over the parietal cortex after opening the dura in the control group. NEP1-40 solution was immediately applied following trauma after opening the dura in the treatment group. Each group was further divided into 3 subgroups and sacrificed on the third, eighth, and 21st days after injury. The brains were removed for analysis RESULTS: Immunohistochemical staining of the injured cortex for pan-cadherin revealed a significant increase in staining in the NEP 1-40 treatment group at the 8th and 21st days after injury. Electron microscopic evaluation revealed better cytoarchitectural preservation in the axons of the animals treated with NEP 1-40 CONCLUSION: We observed improved preservation of injured neurons after topical application of NEP 1-40 following mild cortical injury. Pan-cadherin expression may correlate with the recovery of neurons and axonal bodies. Electron microscopical findings confirmed better preservation of neuronal structures after NEP1-40 treatment. Pan-cadherin is a good marker for neuronal recovery after cortical injury.	[Atalay, Basar] Yeditepe Univ, Istanbul, Turkey; [Oezen, Oezlem; Nacar, Ahmet; Gulsen, Salih; Caner, Hakan; Altinors, Nur] Baskent Univ, TR-06490 Ankara, Turkey; [Bavbek, Murad; Yigitkanli, Kazim] Ankara Diskapi Educ & Res Hosp, Minist Hlth, Ankara, Turkey		Atalay, B (corresponding author), Yeditepe Univ, Istanbul, Turkey.	batalay@yeditepe.edu.t	Ozen, Ozlem/AAK-4468-2021; nacar, ahmet/H-9122-2015; 谭, 德华 德/D-1910-2009; Gulsen, Salih/AAJ-5746-2021; yigitkanli, kazim/AAK-6184-2021	Ozen, Ozlem/0000-0002-9082-1317; nacar, ahmet/0000-0001-6274-5700; Gulsen, Salih/0000-0002-7535-1804; 	Baskent UniversityBaskent University [DA0211, DA0213]	This study was supported by a Baskent University Research Fund (#: DA0211 and DA0213).	Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Bandtlow CE, 2003, EXP GERONTOL, V38, P79, DOI 10.1016/S0531-5565(02)00165-1; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; Brosamle C, 2000, J NEUROSCI, V20, P8061; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; CIFUENTESDIAZ C, 1994, DEVELOPMENT, V120, P1; Csordas A, 2003, ACTA NEUROPATHOL, V106, P37, DOI 10.1007/s00401-003-0694-1; Emerick AJ, 2003, J NEUROSCI, V23, P4826; Ferretti P, 2003, DEV DYNAM, V226, P245, DOI 10.1002/dvdy.10226; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Gallyas F, 2002, ACTA NEUROPATHOL, V103, P36, DOI 10.1007/s004010100424; Gianola S, 2003, J NEUROSCI, V23, P4613; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Huber AB, 2002, J NEUROSCI, V22, P3553; Huber AB, 2000, BIOL CHEM, V381, P407, DOI 10.1515/BC.2000.053; Hunt D, 2002, MOL CELL NEUROSCI, V20, P537, DOI 10.1006/mcne.2002.1153; Josephson A, 2001, EXP NEUROL, V169, P319, DOI 10.1006/exnr.2001.7659; Kim JE, 2003, MOL CELL NEUROSCI, V23, P451, DOI 10.1016/S1044-7431(03)00076-9; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; LASALLE GL, 1992, J NEUROSCI, V12, P872; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Li Q, 2001, ONCOGENE, V20, P3929, DOI 10.1038/sj.onc.1204536; Magnusson C, 2003, MOL CELL NEUROSCI, V22, P298, DOI 10.1016/S1044-7431(02)00036-2; Marklund N, 2001, ACTA NEUROCHIR, V143, P73, DOI 10.1007/s007010170141; Massaro AR, 2002, NEUROL SCI, V22, P429, DOI 10.1007/s100720200001; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; Niederost B, 2002, J NEUROSCI, V22, P10368; Nilsson P, 1996, J NEUROTRAUM, V13, P201, DOI 10.1089/neu.1996.13.201; Oertle T, 2003, J NEUROSCI, V23, P5393; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Oertle T, 2003, ONCOGENE, V22, P1390, DOI 10.1038/sj.onc.1206278; Oertle T, 2003, J MOL BIOL, V325, P299, DOI 10.1016/S0022-2836(02)01179-8; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Pignot V, 2003, J NEUROCHEM, V85, P717, DOI 10.1046/j.1471-4159.2003.01710.x; RICHARDSON PM, 1982, J NEUROCYTOL, V11, P949, DOI 10.1007/BF01148310; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; Sironen RK, 2004, INT J BIOCHEM CELL B, V36, P1521, DOI 10.1016/j.biocel.2004.01.001; Skaper SD, 2001, PROG NEUROBIOL, V65, P593, DOI 10.1016/S0301-0082(01)00017-X; Stichel CC, 1998, PROG NEUROBIOL, V56, P119, DOI 10.1016/S0301-0082(98)00033-1; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Wang XX, 2002, J NEUROSCI, V22, P5505; Watkins TA, 2002, CURR BIOL, V12, pR654, DOI 10.1016/S0960-9822(02)01159-4; Wiessner C, 2003, J CEREBR BLOOD F MET, V23, P154, DOI 10.1097/01.WCB.0000040400.30600.AF; Woolf CJ, 2003, NEURON, V38, P153, DOI 10.1016/S0896-6273(03)00233-2; Zhou CM, 2003, BIOCHEM BIOPH RES CO, V309, P368, DOI 10.1016/j.bbrc.2003.08.006; Zsombok A, 2005, J NEUROSCI METH, V142, P145, DOI 10.1016/j.jneumeth.2004.08.005	53	6	8	0	3	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	OCT	2008	18	4					356	365					10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	395SY	WOS:000262545000004	19107681				2022-02-06	
J	Fuhrman, SI; Karg, PE; Bertocci, GE				Fuhrman, Susan I.; Karg, Patricia E.; Bertocci, Gina E.			Effect of wheelchair headrest use on pediatric head and neck injury risk outcomes during rear impact	ACCIDENT ANALYSIS AND PREVENTION			English	Article						wheelchair transportation safety; rear impact; pediatric injury risk; neck injury risk; head injury risk; headrest	BIOMECHANICS; WHIPLASH; ADULT; MODEL	Comparative risks or benefits to wheelchair-seated pediatric occupants in motor vehicles associated with wheelchair headrest use during rear impact were evaluated using pediatric head and neck injury outcome measures. A Hybrid III 6-year-old anthropomorphic test device (ATD), seated in identical WC19-compliant pediatric manual wheelchairs, was used to measure head and neck response during a 25 km/h (16 mph), 11g rear impact. ATD responses were evaluated across two test scenarios: three sled tests conducted without headrests, and three with slightly modified commercial headrests. Head and neck injury outcomes measures included: linear head acceleration, head injury criteria (HIC) values, neck injury criteria (N-ij) values, and combined rotational head velocity and acceleration. Neck and head injury outcome measures improved by 34-70% in sled tests conducted with headrests compared to tests without headrests. Headrest use reduced N-ij values and the likelihood of concussion from values above established injury thresholds to values below injury thresholds. Injury measure outcome reductions suggest lower head and neck injury risks for wheelchair-seated children using wheelchair-mounted headrests as compared to non-headrest users in rear impact. Use of relative comparisons across two test scenarios served to minimize effects of ATD biofidelity limitations. (c) 2008 Elsevier Ltd. All rights reserved.	[Fuhrman, Susan I.; Karg, Patricia E.] Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA 15203 USA; [Bertocci, Gina E.] Univ Louisville, Dept Mech Engn, Louisville, KY 40292 USA; [Bertocci, Gina E.] Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA; [Bertocci, Gina E.] Univ Louisville, Dept Pediat, Louisville, KY 40292 USA		Fuhrman, SI (corresponding author), Univ Pittsburgh, Dept Rehabil Sci & Technol, 2310 Jane St,Suite 1300, Pittsburgh, PA 15203 USA.	sif3@pitt.edu					*1 TECHN SAF SYST, 2005, 1 TECHN INN SOL; *ANSI RESNA, 2000, WC19 ANSI RESNA; Association for the Advancement of Automotive Medicine, 2005, ABBR INJ SCAL; Chawda MN, 2004, INJURY, V35, P347, DOI 10.1016/S0020-1383(03)00140-2; *DEP TRANSP, 2000, 202 DEP TRANSP FMVSS; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Eppinger R., 1999, DEV IMPROVED INJURY; Farmer Charles M, 2003, Traffic Inj Prev, V4, P83, DOI 10.1080/15389580309867; FUHRMAN SI, 2005, PRESCRIPTION PATTERN; HA D, 2004, REHABILITATION SCI T, P230; Ha D, 2007, ASSIST TECHNOL, V19, P223, DOI 10.1080/10400435.2007.10131879; HOUSTON DJ, 2001, POLICY STUDIES REV, V18, P163; Irwin A., 1997, BIOMECHANICAL BASIS; *JAP TRAFF SAF ASS, 1997, TRAFFIC GREENPAP NOV, P115; Kaye H.S., 2000, MOBILITY DEVICE USE, P14; King AI, 2000, ANNU REV BIOMED ENG, V2, P55, DOI 10.1146/annurev.bioeng.2.1.55; KLEINBERGER M, 1998, DEV IMPROVED INJURY, P114; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Klinich K.D., 1996, TECHNIQUES DEV CHILD; LOWENHIELM P, 1978, J BIOENG, V2, P501; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Mari-Gowda, 2004, SAE TECHNICAL PAPER; Mchenry B.G., 2004, HEAD INJURY CRITERIO; McLean A. J., 1997, HEAD INJURY; Nahum A.M., 1993, ACCIDENTAL INJURY BI; *NAT HIGHW TRAFF S, 1993, 208 NAT HIGHW TRAFF; *NAT HIGHW TRAFF S, 1999, 213 NAT HIGHW TRAFF; *NHTSA, 1997, PREL ASS NASS CDS DA; Ommaya A.K., 1985, BIOMECHANICS TRAUMA; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; OSTER J, 1996, COMP 6 YEAR OLD HY 1, V3, P371; Pounder DJ, 1997, AM J FOREN MED PATH, V18, P321, DOI 10.1097/00000433-199712000-00001; *REH ENG RES CTR W, 2005, RERC WHEEL TRANSP SA; *RERC WHEELCH TRAN, 2007, GUID US SEC POST SUP; Rivara FP, 1999, AM J PREV MED, V16, P30, DOI 10.1016/S0749-3797(98)00113-5; SCHNEIDER LW, 1999, 8 U PITTSB, P67; Sherwood C P, 2003, Traffic Inj Prev, V4, P206, DOI 10.1080/15389580309885; *SOC AUT ENG, 2003, DUMM TEST EQ SUBC, P50; *SOC AUT ENG, 1996, J2249 SAE; Society of Automotive Engineers, 1995, J211 1 INSTR IMP T 1; Sturtz G, 1980, 24 STAPP CAR CRASH C; *U MICH, 2007, RIS SAF; *US BUR CENS PUBL, 2006, US CENS BUR NEWS NAT; VANRENSBURG L, 2004, ABBREVIATED INJURY S; Viano DC, 2001, J TRAUMA, V51, P959, DOI 10.1097/00005373-200111000-00022; YOUNG JW, 1976, DEV EVALUATION MASTE	47	6	6	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JUL	2008	40	4					1595	1603		10.1016/j.aap.2008.04.007			9	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	333QI	WOS:000258166800042	18606295				2022-02-06	
J	Larson, EB; Leahy, B; Duff, KM; Wilde, MC				Larson, Eric B.; Leahy, Brian; Duff, Kevin M.; Wilde, Mark C.			Assessing executive functions in traumatic brain injury: An exploratory study of the executive interview	PERCEPTUAL AND MOTOR SKILLS			English	Article							DYSCONTROL SCALE DEFICITS; MENTAL-STATE-EXAMINATION; BEDSIDE ASSESSMENT; MEMORY COMPLAINTS; VALIDITY; INDIVIDUALS; PERFORMANCE; STABILITY; DEMENTIA; TASK	Executive dysfunction is a frequent sequela of traumatic brain injury. Two correlational studies using samples of inpatients and outpatients diagnosed with traumatic brain injury were undertaken to evaluate the validity of a bedside screening test of executive functioning, the 1992 Executive Interview EXIT 25 by Royall, Mahurin, and Gray. In the first study of 23 inpatients receiving rehabilitation, the EXIT 25 was strongly related to both the Mini-Mental State Examination and the Modified Mini-Mental State Examination. In the second study of 20 outpatients, the EXIT 25 correlated with other executive function measures and with ratings of functional disability at discharge, although a ceiling effect raised questions about its utility for patients with mild to moderate disability. Further study of the EXIT 25 is justified with a larger sample of inpatients, although caution should be exercised when using the EXIT 25 in mildly impaired outpatients.	[Larson, Eric B.] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA; [Duff, Kevin M.] Univ Iowa, Iowa City, IA 52242 USA		Larson, EB (corresponding author), Rehabil Inst Chicago, 345 E Super St, Chicago, IL 60611 USA.	elarson@ric.org	Larson, Eric/AAD-9567-2021; Schultz, Susan K./M-3516-2019				Berghuis JP, 1999, J ACQ IMMUN DEF SYND, V21, P134; BERNARD LC, 1990, J CLIN PSYCHOL, V46, P432, DOI 10.1002/1097-4679(199007)46:4<432::AID-JCLP2270460410>3.0.CO;2-0; Bond M. R., 1990, REHABILITATION ADULT, P179; Demakis GJ, 1997, PSYCHOL REP, V81, P443; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Gladsjo JA, 1999, NORMS LETT CATEGORY; GOLDBERG JO, 1986, J CLIN PSYCHOL, V42, P792, DOI 10.1002/1097-4679(198609)42:5<792::AID-JCLP2270420519>3.0.CO;2-8; Golden CJ, 1978, STROOP COLOR WORD TE; GRACE J, 1995, ARCH NEUROL-CHICAGO, V52, P477, DOI 10.1001/archneur.1995.00540290067019; Grigsby J, 1996, BEHAV DYSCONTROL SCA; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Heaton RK, 1991, COMPREHENSIVE NORMS; Kelly C, 2000, BRIT J PSYCHIAT, V177, P348, DOI 10.1192/bjp.177.4.348; Laforce R, 2001, PERCEPT MOTOR SKILL, V93, P281, DOI 10.2466/PMS.93.5.281-288; LARSON EB, 2002, ANN M MIDW NEUR GROU; Leahy B, 2003, CLIN NEUROPSYCHOL, V17, P474, DOI 10.1076/clin.17.4.474.27941; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; MATTHEWS CG, 1964, INSTRUCTION MANUAL A; Rasch Georg, 1980, PROBABILISTIC MODELS; Rey A., 1964, EXAMEN CLIN PSYCHOL; Royall D R, 1999, Semin Clin Neuropsychiatry, V4, P13; Royall DR, 2005, J INT NEUROPSYCH SOC, V11, P899, DOI 10.1017/S135561770505109X; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221, DOI 10.1111/j.1532-5415.1992.tb03646.x; ROYALL DR, 1994, EXP AGING RES, V20, P95, DOI 10.1080/03610739408253956; Spreen O, 1991, COMPENDIUM NEUROPSYC; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Suchy Y, 2003, CLIN NEUROPSYCHOL, V17, P492, DOI 10.1076/clin.17.4.492.27949; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; *WAR DEP ADJ GEN O, 1944, ARM IND TEST BATT	32	6	6	1	4	AMMONS SCIENTIFIC, LTD	MISSOULA	PO BOX 9229, MISSOULA, MT 59807-9229 USA	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	JUN	2008	106	3					725	736		10.2466/PMS.106.3.725-736			12	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	333TV	WOS:000258176300008	18712193				2022-02-06	
J	Rocca, A; Wallen, M; Batchelor, J				Rocca, Antonella; Wallen, Margaret; Batchelor, Jennifer			The westmead post-traumatic amnesia scale for children (WPTAS-C) aged 4 and 5 years old	BRAIN IMPAIRMENT			English	Article						brain injuries; posttraumatic amnesia; child; preschool; clinical assessment tools	BLUNT HEAD-INJURY; PTA SCALE; ORIENTATION; SEVERITY	Assessment of posttraumatic amnesia (PTA) in young children remains problematic. This article details a version of the Westmead PTA Scale, which was adapted for use with children aged 4 and 5 years, and an evaluation of this scale with typically developing children. The Westmead PTA Scale for Children (WPTAS-C) comprises 2 orientation and 4 memory questions, including 2 items involving remembering pictures of familiar objects. Participants included 55 preschool and kindergarten children aged 4 and 5 years. The scale was administered for 4 consecutive days. Ninety-three per cent of the children achieved a score of 6 out 6 for the final 3 days of the 4-day test period. It is concluded that the WPTAS-C is an appropriate measure of orientation and continuous memory in 4- and 5-year-old typically developing children. Validation of the scale in clinical populations is recommended.	[Rocca, Antonella] Childrens Hosp, Rehabil Dept, Westmead, NSW, Australia; [Wallen, Margaret] Childrens Hosp, Occupat Therapy Dept, Westmead, NSW, Australia; [Batchelor, Jennifer] Macquarie Univ, Dept Psychol, N Ryde, NSW 2109, Australia		Rocca, A (corresponding author), Thomas Walker Hosp, Adolescent & Family Mental Hlth Serv, Hosp Rd, Concord W, NSW 2138, Australia.	antonella.rocca@sswahs.nsw.gov.au		Wallen, Margaret/0000-0002-8040-5053; Batchelor, Jennifer/0000-0003-4438-4993			ARTIOLA I, 1980, J NEUROL NEUROSUR PS, V43, P377; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; Daniel A., 1983, POWER PRIVILEGE PRES; EVANS CD, 1977, INJURY, V8, P80; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Fernando K., 2002, BRAIN IMPAIR, V3, P34, DOI [10.1375/brim.3.1.34, DOI 10.1375/BRIM.3.1.34]; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; HASLAM C, 1994, BRAIN INJURY, V8, P517; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MAROSSZEKY NEV, 1993, CLIN NEUROPSYCHOL, V7, P85, DOI 10.1080/13854049308401890; Marosszeky NEV, 1998, PTA PROTOCOL GUIDELI; ROCCA A, 2001, THESIS MACQUARIE U A; RUIJS MBM, 1992, DEV MED CHILD NEUROL, V34, P882; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SHORES EA, 1989, J NEUROL NEUROSUR PS, V52, P126, DOI 10.1136/jnnp.52.1.126-a; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Symonds CP, 1943, LANCET, V1, P7; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; [No title captured]	19	6	6	0	3	AUSTRALIAN ACAD PRESS	BOWEN HILLS	32 JEAYS ST, BOWEN HILLS, QLD 4006, AUSTRALIA	1443-9646			BRAIN IMPAIR	Brain Impair.	MAY	2008	9	1					14	21		10.1375/brim.9.1.14			8	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	325OP	WOS:000257598500002					2022-02-06	
J	Sarmiento, K; Langlois, JA; Mitchko, J				Sarmiento, Kelly; Langlois, Jean A.; Mitchko, Jane			"Help Seniors Live Better, Longer: Prevent Brain Injury": An overview of CDC's education initiative to prevent fall-related TBI among older adults	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						falls; older adult; prevention; traumatic brain injury		Background: Falls are the leading cause of traumatic brain injury (TBI) among older adults aged 75 and older. Despite this burden, many older adults, their caregivers, and professionals are not aware of the importance of TBI as an outcome of falls among older adults. Methods: To address this important public health problem, the Centers for Disease Control and Prevention (CDC) developed the "Help Seniors Live Better, Longer: Prevent Brain Injury" initiative to help raise awareness about methods to prevent, recognize and respond to fall-related TBIs among older adults aged 75 and older. Results: The initiative was launched in March 2008, in collaboration with 26 participating organizations, and included a multipronged outreach strategy to help blanket the country with the messages of the initiative at the national, state, and local levels. Conclusion: Adherence to a logical, comprehensive health-education approach has proven to be highly effective in furthering the initial goals of the project.	[Sarmiento, Kelly] CDC, Natl Ctr Injury Prevent & Control, DIR, Ctr Dis Control & Prevent, Atlanta, GA 30341 USA		Sarmiento, K (corresponding author), CDC, Natl Ctr Injury Prevent & Control, DIR, Ctr Dis Control & Prevent, MSF-62,4770 Buford Hwy,NE, Atlanta, GA 30341 USA.	KSarmiento@cdc.gov					*CDCP NAT CTR INJ, 2006, WEB BAS INJ STAT QUE; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; HORNBROOK MC, 1994, GERONTOLOGIST, V34, P16, DOI 10.1093/geront/34.1.16; Langlois JA, 2006, TRAUMATIC BRAIN INJU	4	6	6	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2008	23	3					164	167		10.1097/01.HTR.0000319933.22709.61			4	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	309XN	WOS:000256493600005	18520429				2022-02-06	
J	Taylor, S; Asmundson, GJG				Taylor, Steven; Asmundson, Gordon J. G.			Posttraumatic Stress Disorder: Current Concepts and Controversies	PSYCHOLOGICAL INJURY & LAW			English	Article						PTSD; Trauma; Malingering; Recovered memories		The diagnosis of posttraumatic stress disorder (PTSD) sometimes is raised in compensation claims, in tort settings, and in other medical-legal settings. Accordingly, health-care and legal professionals working in these areas need to be familiar with the current findings and controversies concerning the disorder. The purpose of this article is twofold. First, we review the most important findings concerning the clinical features, etiology, and treatment of PTSD. Second, we examine six major controversies concerning the disorder that are relevant to psychologists and other medical-legal practitioners: (a) the issue of what qualifies as a traumatic stressor, (b) the question of whether traumatic stress causes brain damage, (c) the validity of the concept of delayed-onset PTSD, (d) the recovered memory controversy, (e) the question of whether PTSD can arise when the person has nomemory of the trauma (e. g., due to concussion), and (f) issues concerning PTSD malingering. Throughout this article we offer recommendations for psychological and other medical-legal practice in relation to the evaluation of PTSD claims.	[Taylor, Steven] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada; [Asmundson, Gordon J. G.] Univ Regina, Fac Kinesiol & Hlth Studies, Regina, SK S4S 0A2, Canada		Taylor, S (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada.	taylor@unixg.ubc.ca					Adams RE, 2006, J NERV MENT DIS, V194, P485, DOI 10.1097/01.nmd.0000228503.95503.e9; Adetunji B., 2006, PRIMARY PSYCHIAT, V13, P61; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; Arbisi P. A., 2006, PSYCHOL SERV, V3, P249, DOI DOI 10.1037/1541-1559.3.4.249; Asmundson GJG, 2004, J TRAUMA STRESS, V17, P467, DOI 10.1007/s10960-004-5795-7; Avina C, 2002, J TRAUMA STRESS, V15, P69, DOI 10.1023/A:1014387429057; Baker DG, 1997, PSYCHONEUROENDOCRINO, V22, P517, DOI 10.1016/S0306-4530(97)00053-X; Ballenger JC, 2000, J CLIN PSYCHIAT, V61, P60; Basoglu M, 2003, PSYCHOL MED, V33, P647, DOI 10.1017/S0033291703007360; Beckham J. C., 2003, PSYCHIATRY, P1281; Bisson JI, 2007, BRIT J PSYCHIAT, V190, P97, DOI 10.1192/bjp.bp.106.021402; BOZZUTO JC, 1975, J NERV MENT DIS, V161, P43, DOI 10.1097/00005053-197507000-00005; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Bremner J.D., 2002, DOES STRESS DAMAGE B; Bremner JD, 2001, HIPPOCAMPUS, V11, P75, DOI 10.1002/hipo.1023; BRESLAU N, 1992, AM J PSYCHIAT, V149, P671; Breslau N, 2002, CAN J PSYCHIAT, V47, P923, DOI 10.1177/070674370204701003; Breslau N, 2001, BIOL PSYCHIAT, V50, P699, DOI 10.1016/S0006-3223(01)01167-2; Brewin C. R., 2003, POSTTRAUMATIC STRESS; Brewin Chris R., 2004, Cognitive Behaviour Therapy, V33, P102, DOI 10.1080/16506070410027326; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; BROOKS N, 1992, J TRAUMA STRESS, V5, P527, DOI 10.1007/BF00979222; BROWN D, 1998, MEMORY TRAUMA TREATM; Bryant RA, 2003, J NERV MENT DIS, V191, P191, DOI 10.1097/00005053-200303000-00009; Bryant RA, 2002, AUST NZ J PSYCHIAT, V36, P205, DOI 10.1046/j.1440-1614.2002.01009.x; Caffo E, 2003, CHILD ADOL PSYCH CL, V12, P493, DOI 10.1016/S1056-4993(03)00004-X; Carty J, 2006, J AFFECT DISORDERS, V90, P257, DOI 10.1016/j.jad.2005.11.011; Caspi Y, 2005, J LOSS TRAUMA, V10, P319, DOI 10.1080/15325020590956756; Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001; Dalenberg C, 2006, TRAUMA VIOLENCE ABUS, V7, P274, DOI 10.1177/1524838006294572; Daviss WB, 2000, J AM ACAD CHILD PSY, V39, P576, DOI 10.1097/00004583-200005000-00011; Delahanty DL, 2000, BIOL PSYCHIAT, V48, P940, DOI 10.1016/S0006-3223(00)00896-9; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; Elhai J. D., 2008, J CLIN PSYCHIAT; Elhai JD, 2005, BRIT J PSYCHIAT, V187, P189, DOI 10.1192/bjp.187.2.189-a; Elhai JD, 2002, J PERS ASSESS, V79, P531, DOI 10.1207/S15327752JPA7903_08; Elliott DM, 1997, J CONSULT CLIN PSYCH, V65, P811, DOI 10.1037/0022-006X.65.5.811; Foa EB, 2000, J CLIN PSYCHIAT, V61, P43; Forbes D, 2003, J NERV MENT DIS, V191, P93, DOI 10.1097/01.NMD.0000051903.60517.98; Freeman T., 2005, UNPUB; Frueh BC, 2000, CLIN PSYCHOL REV, V20, P853, DOI 10.1016/S0272-7358(99)00015-X; Frueh BC, 2005, BRIT J PSYCHIAT, V186, P467, DOI 10.1192/bjp.186.6.467; Fulcher G., 2004, PSYCHIAT PSYCHOL LAW, V11, P79, DOI 10.1375/pplt.2004.11.1.79; Geracioti TD, 2001, AM J PSYCHIAT, V158, P1227, DOI 10.1176/appi.ajp.158.8.1227; Geraerts E, 2006, PSYCHOL SCI, V17, P1002, DOI 10.1111/j.1467-9280.2006.01819.x; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Gilbertson MW, 2006, J ABNORM PSYCHOL, V115, P484, DOI 10.1037/0021-843X.115.3.484; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Gray MJ, 2004, J CONSULT CLIN PSYCH, V72, P909, DOI 10.1037/0022-006X.72.5.909; GREEN BL, 1990, AM J ORTHOPSYCHIAT, V60, P43, DOI 10.1037/h0079168; Grossman R, 2002, PSYCHIAT CLIN N AM, V25, P317, DOI 10.1016/S0193-953X(01)00011-9; Guriel Jennifer, 2003, Clin Psychol Rev, V23, P881; Hall RCW, 2006, GEN HOSP PSYCHIAT, V28, P525, DOI 10.1016/j.genhosppsych.2006.08.011; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Harvey AG, 2002, PSYCHOL BULL, V128, P886, DOI 10.1037//0033-2909.128.6.886; Hembree EA, 2003, J TRAUMA STRESS, V16, P555, DOI 10.1023/B:JOTS.0000004078.93012.7d; Herman J., 1997, TRAUMA RECOVERY; HICKLING EJ, 2002, J FORENSIC PSYCHOL P, V0002, P00033, DOI [DOI 10.1300/J158v02n01_02, DOI 10.1300/J158V02N01_]; Horowitz M. J., 2001, STRESS RESPONSE SYND; *I MED, 2007, TREATM POSTR STRESS; Jang KL, 2003, PSYCHIAT RES, V120, P61, DOI 10.1016/S0165-1781(03)00172-0; Johnston D, 2000, J AM GERIATR SOC, V48, P70, DOI 10.1111/j.1532-5415.2000.tb03032.x; Kaemmer, 1989, MINNESOTA MULTIPHASI; Karon BP, 1998, PROF PSYCHOL-RES PR, V29, P482; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; KILPATRICK DG, 1989, BEHAV THER, V20, P199, DOI 10.1016/S0005-7894(89)80069-3; KOCH WJ, 1995, COGN BEHAV PRACT, V2, P327, DOI 10.1016/S1077-7229(95)80016-6; LAYTON BS, 1995, CLIN NEUROPSYCHOL, V9, P2, DOI 10.1080/13854049508402050; LeesHaley PR, 1997, J CLIN PSYCHOL, V53, P745, DOI 10.1002/(SICI)1097-4679(199711)53:7<745::AID-JCLP13>3.3.CO;2-7; Lindsay DS, 1997, J INTERPERS VIOLENCE, V12, P631, DOI 10.1177/088626097012005002; Livanou M, 2002, PSYCHOL MED, V32, P157, DOI 10.1017/S0033291701004767; Loftus EF, 2006, ANNU REV CLIN PSYCHO, V2, P469, DOI 10.1146/annurev.clinpsy.2.022305.095315; Joca SRL, 2007, STRESS, V10, P227, DOI 10.1080/10253890701223130; LYONS MJ, 1993, AM J MED GENET, V48, P22, DOI 10.1002/ajmg.1320480107; MacDonald HA, 2003, J OCCUP REHABIL, V13, P63, DOI 10.1023/A:1022563930482; Maercker A, 2006, EUR PSYCHOL, V11, P137, DOI 10.1027/1016-9040.11.2.137; Matthews LR, 2005, BEHAV RES THER, V43, P475, DOI 10.1016/j.brat.2004.03.008; McFarlane AC, 1997, ANN NY ACAD SCI, V821, P437, DOI 10.1111/j.1749-6632.1997.tb48299.x; McFarlane AC, 2002, PSYCHIAT CLIN N AM, V25, P253, DOI 10.1016/S0193-953X(01)00008-9; MCMILLAN TM, 1991, BRIT J PSYCHIAT, V159, P431, DOI 10.1192/bjp.159.3.431; McNally, 2003, REMEMBERING TRAUMA; McNally Richard J., 2004, Cognitive Behaviour Therapy, V33, P97, DOI 10.1080/16506070410021683; McNally RJ, 2005, J ABNORM PSYCHOL, V114, P147, DOI 10.1037/0021-843X.114.1.147; Miller H.A., 2001, MILLER FORENSIC ASSE; Mittal D, 2001, J GERIATR PSYCH NEUR, V14, P17, DOI 10.1177/089198870101400105; Mol SSL, 2005, BRIT J PSYCHIAT, V186, P494, DOI 10.1192/bjp.186.6.494; Murdoch M, 2006, MIL MED, V171, P166, DOI 10.7205/MILMED.171.2.166; Nemeroff CB, 2004, J CLIN PSYCHIAT, V65, P18; Nicholson K., 2007, CAUSALITY PSYCHOL IN, P501; Nutt DJ, 2004, J CLIN PSYCHIAT, V65, P11; O'Brien M, 1998, BRIT J PSYCHIAT, V173, P102, DOI 10.1192/bjp.173.2.102; Olff M, 2005, BRIT J PSYCHIAT, V186, P165, DOI 10.1192/bjp.186.2.165; Ozer EJ, 2004, CURR DIR PSYCHOL SCI, V13, P169, DOI 10.1111/j.0963-7214.2004.00300.x; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Pankratz L, 1998, PATIENTS WHO DECEIVE; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Parry J. W., 2006, MENTAL PHYS DISABILI, V30, P168; PITMAN RK, 1990, ARCH GEN PSYCHIAT, V47, P541; PITMAN RK, 1989, BIOL PSYCHIAT, V26, P645; Raphael, 1993, INT HDB TRAUMATIC ST, P535, DOI 10.1007/978-1-4615-2820-3_46; Raphael B., 1993, INT HDB TRAUMATIC ST, P441; Resnick PJ, 1997, CLIN ASSESSMENT MALI, P130; Rind B, 1998, PSYCHOL BULL, V124, P22, DOI 10.1037/0033-2909.124.1.22; Rind B, 2001, PSYCHOL BULL, V127, P734, DOI 10.1037//0033-2909.127.6.734; Rogers R., 1992, STRUCTURED INTERVIEW; Rosen, 2004, SCI REV MENTAL HLTH, V3, P39; Rosen G. M., 2004, POSTTRAUMATIC STRESS, P85, DOI 10.1002/9780470713570.ch5.; Rosen GM, 2006, J ANXIETY DISORD, V20, P530, DOI 10.1016/j.janxdis.2005.03.004; Rossman BBR, 2000, CHILDREN EXPOSED TO DOMESTIC VIOLENCE: CURRENT ISSUES IN RESEARCH, INTERVENTION, PREVENTION, AND POLICY DEVELOPMENT, P85, DOI 10.1300/J146v03n01_07; Ruscio AM, 2002, J ABNORM PSYCHOL, V111, P290, DOI 10.1037//0021-843X.111.2.290; Ruzich MJ, 2005, AM J GERIAT PSYCHIAT, V13, P424, DOI 10.1176/appi.ajgp.13.5.424; Sala M, 2004, EUR NEUROPSYCHOPHARM, V14, P393, DOI 10.1016/j.euroneuro.2003.12.005; Sapolsky R.M., 2004, WHY ZEBRAS DONT GET, V3; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SBORDONE RJ, 1991, NEUROPSYCHOLOGY ATTO; Simeon D., 2006, FEELING UNREAL DEPER; Simon R, 2003, POSTTRAUMATIC STRESS; Slovenko R., 2004, J PSYCHIAT LAW, V32, P411, DOI DOI 10.1037/A0018404; Southwick SM, 1997, AM J PSYCHIAT, V154, P173; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Stowe R., 2003, POSTTRAUMATIC STRESS; Tarrier N, 1999, PSYCHOL MED, V29, P801, DOI 10.1017/S0033291799008569; Tarrier N, 1999, J CONSULT CLIN PSYCH, V67, P13, DOI 10.1037/0022-006X.67.1.13; Taylor S, 1995, CLIN PSYCHOL REV, V15, P721, DOI 10.1016/0272-7358(95)00043-7; Taylor S, 2001, J CONSULT CLIN PSYCH, V69, P541, DOI 10.1037//0022-006X.69.3.541; Taylor S., 2004, ADV TREATMENT POSTTR; Taylor S., 2006, CLIN GUID TREATING P; Taylor S., 2006, CANADIAN J COMMUNITY, V25, P289, DOI [DOI 10.7870/CJCMH-2006-0026, 10.7870/cjcmh-2006-0026]; Taylor S, 2007, J ANXIETY DISORD, V21, P22, DOI 10.1016/j.janxdis.2006.03.016; Taylor Steven, 2004, Cognitive Behaviour Therapy, V33, P105, DOI 10.1080/16506070410029586; TRUE WR, 1993, ARCH GEN PSYCHIAT, V50, P257, DOI 10.1001/archpsyc.1993.01820160019002; van Achterberg ME, 2001, J CLIN PSYCHIAT, V62, P206, DOI 10.4088/JCP.v62n0312c; Van Etten ML, 1998, CLIN PSYCHOL PSYCHOT, V5, P126, DOI 10.1002/(SICI)1099-0879(199809)5:3<126::AID-CPP153>3.0.CO;2-H; van Minnen A, 2002, J TRAUMA STRESS, V15, P359, DOI 10.1023/A:1020177023209; van Minnen A, 2002, BEHAV RES THER, V40, P439, DOI 10.1016/S0005-7967(01)00024-9; VANDERKOLK BA, 1989, PSYCHOPHARMACOL BULL, V25, P417; Vernberg EM, 1996, J ABNORM PSYCHOL, V105, P237, DOI 10.1037/0021-843X.105.2.237; Whitley, 1998, STOLEN VALOR VIETNAM; Yehuda R, 1998, BIOL PSYCHIAT, V44, P1305, DOI 10.1016/S0006-3223(98)00276-5; Yehuda R, 2004, J CLIN PSYCHIAT, V65, P29; Yehuda R, 2002, PSYCHIAT CLIN N AM, V25, P341, DOI 10.1016/S0193-953X(02)00002-3; Yehuda R, 2002, PSYCHIAT QUART, V73, P123, DOI 10.1023/A:1015055711424; Yehuda R, 2006, PSYCHOBIOLOGY POSTTR; Young EA, 2004, ARCH GEN PSYCHIAT, V61, P394, DOI 10.1001/archpsyc.61.4.394	146	6	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	APR	2008	1	1					59	74		10.1007/s12207-008-9009-0			16	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	VB3UM	WOS:000415439000006					2022-02-06	
J	Chai, CL; Tu, YK; Huang, SJ				Chai, Chung Liang; Tu, Yong-Kwang; Huang, Sheng-Jean			Can cerebral hypoperfusion after sympathetic used to diagnose brain death? A retrospective traumatic brain injury patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						brain death; sympathetic storm; irreversible apneic coma; traumatic brain injury	HEART-RATE-VARIABILITY; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; DIENCEPHALIC SEIZURES; CONSENSUS; PRESSURE; STORM	Background: The aim of this study was to identify the precise time of occurrence of irreversible coma from brain stem dysfunction that precedes brain death. Sympathetic storm, which is a cardiovascular hyperdynamic state manifested by brain stem ischemia, is known to be related to brain stem failure in animal models. We studied sympathetic storm in the clinical setting and compared the clinical findings observed before and after sympathetic storm to identify the precise time of occurrence of irreversible apneic coma. Methods: We conducted a retrospective study of 15 comatose traumatic brain injury adult patients at the National Taiwan University Hospital's Neurosurgical Intensive Care Unit. Data on arterial blood pressure, heart rate, intracranial pressure, and clinical findings such as cerebral blood flow pattern, Glasgow Coma Scale, brain stem reflexes, utilizations of catecholamines, and occurrence of central diabetes insipidus throughout the course in the intensive care unit were collected retrospectively from medical records. Results: Prolonged uncorrectable cerebral hypoperfusion was found after a characteristic irreversible apneic coma-associated sympathetic storm (IACASS) in all 15 patients. A mean cerebral perfusion pressure of 11.9 mm Hg +/- 10.3 mm Hg and 13 mm Hg +/- 3.5 mm Hg remained at 12 hours and 24 hours, respectively, after IACASS. Differences in clinical findings before and after IACASS that were statistically significant were cerebral circulation pattern (p = 0.0455), Glasgow Coma Scale (p = 0.0143), brain stem reflexes (p = 0.0143), utilization of catecholamines (p = 0.0254), and occurrence of central diabetes insipidus (p = 0.00468). Conclusions: Coma might have become irreversible immediately after IACASS because the prolonged duration of cerebral hypoperfusion could have caused irreversible cerebral tissue injury. Our study provides some preliminary findings suggesting that IACASS may be a predictor of impending brain death. A prospective study is the next step to understanding whether this phenomenon can be applied clinically to diagnose irreversible apneic coma.	[Chai, Chung Liang; Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Dept Surg, Sch Med, Coll Med, Taipei 100, Taiwan; [Chai, Chung Liang] Buddhist Tzu Chi Gen Hosp, Dept Surg, Div Neurosurg, Taipei Branch, Taipei, Taiwan; [Tu, Yong-Kwang; Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Div Neurosurg, Dept Surg, Taipei, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan		Huang, SJ (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Sch Med, Coll Med, 7 Chung Shan S Rd, Taipei 100, Taiwan.	sjhuang@ntu.edu.tw		Chai, Chung Liang/0000-0001-7775-4052; Tu, Yong-kwang/0000-0003-2113-1176			[Anonymous], 1995, Neurology, V45, P1012; Audibert G, 2006, TRANSPLANTATION, V82, P1031, DOI 10.1097/01.tp.0000235825.97538.d5; Baillard C, 2002, CRIT CARE MED, V30, P306, DOI 10.1097/00003246-200202000-00007; BENARROCH E, 2003, TXB CLIN NEUROLOGY, P371; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; BULLOCK MR, 2000, BRAIN TRAUMA FDN GUI; Chen EP, 1996, CRIT CARE MED, V24, P1352, DOI 10.1097/00003246-199608000-00014; Conci F, 2001, J NEUROL NEUROSUR PS, V71, P621, DOI 10.1136/jnnp.71.5.621; Dosemeci L, 2004, TRANSPLANTATION, V77, P71, DOI 10.1097/01.TP.0000092305.00155.72; Ducrocq X, 1998, J NEUROL SCI, V160, P41, DOI 10.1016/S0022-510X(98)00188-9; Ducrocq X, 1998, J NEUROL SCI, V159, P145, DOI 10.1016/S0022-510X(98)00158-0; GANONG WF, 2005, REV MED PHYSL, pCH1; Hadani M, 1999, INTENS CARE MED, V25, P822, DOI 10.1007/s001340050958; HAINES DE, 2002, FUNDAMENTAL NEUROSCI, P159; HUNG TP, 1995, J NEUROL NEUROSUR PS, V58, P75, DOI 10.1136/jnnp.58.1.75; KENJIRO M, 2005, MILLERS ANESTHESIA, P2955; KISHNER S, 2006, POST HEAD INJURY AUT; Lemke Denise M, 2004, J Neurosci Nurs, V36, P4; LYCETTE CA, 2003, CURRENT CRITICAL CAR, pCH31; POWER BM, 1995, ANAESTH INTENS CARE, V23, P26, DOI 10.1177/0310057X9502300107; POWNER DJ, 1992, J HEART LUNG TRANSPL, V11, P1046; Rapenne T, 2001, J NEUROSURG ANESTH, V13, P260, DOI 10.1097/00008506-200107000-00016; Rapenne T, 2000, ANESTH ANALG, V91, P329, DOI 10.1097/00000539-200008000-00018; Ryan JB, 2003, J HEART LUNG TRANSPL, V22, P922, DOI 10.1016/S1053-2498(02)00558-2; SHIVALKAR B, 1993, CIRCULATION, V87, P230, DOI 10.1161/01.CIR.87.1.230; Smith M, 2004, J HEART LUNG TRANSPL, V23, pS217, DOI 10.1016/j.healun.2004.06.017; Swash M, 2002, NEUROLOGY, V58, P9, DOI 10.1212/WNL.58.1.9; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606; Wijdicks EFM, 2002, NEUROLOGY, V58, P20, DOI 10.1212/WNL.58.1.20; Wood KE, 2004, NEW ENGL J MED, V351, P2730, DOI 10.1056/NEJMra013103; Zamperetti N, 2004, INTENS CARE MED, V30, P1715, DOI 10.1007/s00134-003-2106-3	34	6	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2008	64	3					688	697		10.1097/TA.0b013e31815ede12			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	274JE	WOS:000253996800027	18332809				2022-02-06	
J	Huang, HH; Fang, TJ; Li, HY; Chin, SC				Huang, Hsueh-Hsin; Fang, Tuan-Jen; Li, Hsueh-Yi; Chin, Shy-Chyi			Vagus nerve paralysis due to skull base fracture	AURIS NASUS LARYNX			English	Article						vagus nerve paralysis; skull base fracture; closed head injury	OCCIPITAL CONDYLE FRACTURE	Lower cranial nerve paralysis originating from skull base fracture is rare and isolated vagus nerve paralysis after close head injury is extremely rare. We, in this study, present the case of a 49-year-old man sustained a right vocal cord paralysis and dysphagia in a fighting accident. Initial examination, including flexible laryngoscope, esophagogram and fine-cut neck computed tomography scan, failed to find out the cause of isolated vagus paralysis. Until high resolution computed tomography of skull base revealed the jugular foramen bony disruption. One individual cranial nerve paralysis may be a significant sign for skull base fracture in closed head injury. Considering the serious consequences of the disease, thorough neurologic and radiologic examination are needed to evaluate the condition of skull base, and to develop reliable effective management for the neurologic sequalae, result from it. (c) 2007 Elsevier Ireland Ltd. All rights reserved.	[Huang, Hsueh-Hsin; Li, Hsueh-Yi] Chang Gung Univ, Chang Gung Mem Hosp, Dept Otolaryngol, Taipei, Taiwan; [Fang, Tuan-Jen] Dept Otolaryngol, Chilung, Taiwan; [Chin, Shy-Chyi] Chang Gung Mem Hosp, Dept Med Imaging & Intervent, Linkou, Taiwan; [Fang, Tuan-Jen; Chin, Shy-Chyi] Chang Gung Univ, Tao Yuan, Taiwan		Fang, TJ (corresponding author), Chang Gung Mem Hosp, Dept Otolaryngol, 5 Fu Shin St, Tao Yuan 333, Taiwan.	fang3109@cgmh.org.tw		Fang, TuanJen/0000-0002-7805-3458			BRAWLEY BW, 1967, J NEUROSURG, V26, P57, DOI 10.3171/jns.1967.26.1part1.0057; BRIDGMAN SA, 1992, SURG NEUROL, V38, P152, DOI 10.1016/0090-3019(92)90094-4; SPENCER JA, 1984, NEUROSURGERY, V15, P101, DOI 10.1227/00006123-198407000-00019; TIMOTHY JK, 2003, J TRAUMA, V54, P1026; Urculo E, 1996, J NEUROSURG, V84, P522, DOI 10.3171/jns.1996.84.3.0522	5	6	6	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146			AURIS NASUS LARYNX	Auris Nasus Larynx	MAR	2008	35	1					153	155		10.1016/j.anl.2007.05.004			3	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	263VM	WOS:000253244600024	17855032				2022-02-06	
J	Martino, C; Krysko, M; Petrides, G; Tobias, KG; Kellner, CH				Martino, Celena; Krysko, Michael; Petrides, Georgios; Tobias, Kristen G.; Kellner, Charles H.			Cognitive tolerability of electroconvulsive therapy in a patient with a history of traumatic brain injury	JOURNAL OF ECT			English	Article						ECT; traumatic brain injury; depression; cognition	MENTAL-STATE-EXAMINATION; ECT; DEPRESSION; PRESSURE	We present the case of a 28-year-old male with a history of a severe closed head injury who successfully underwent electroconvulsive therapy for treatment of his depression. A detailed neuropsychological evaluation demonstrated the cognitive tolerability of the treatment. We review the literature on electroconvulsive therapy and brain injury.	[Martino, Celena; Krysko, Michael; Petrides, Georgios; Tobias, Kristen G.; Kellner, Charles H.] Univ Med & Dent New Jersey, Dept Psychiat, Newark, NJ 07101 USA		Martino, C (corresponding author), Univ Med & Dent New Jersey, Dept Psychiat, Behav Hlth Sci Bldg,183 S Orange Ave, Newark, NJ 07101 USA.	martince@umdnj.edu	Kellner, Charles/ABC-3434-2020	Kellner, Charles/0000-0001-9663-3571			Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Baker M, 2000, J ECT, V16, P421, DOI 10.1097/00124509-200012000-00014; Crow S, 1996, CONVULSIVE THER, V12, P113; Delis D.C., 2000, CALIFORNIA VERBAL LE; DRESSLER DM, 1975, AM J PSYCHIAT, V132, P1320; Kant R, 1999, J NEUROPSYCH CLIN N, V11, P32, DOI 10.1176/jnp.11.1.32; Kellner CH, 1996, CONVULSIVE THER, V12, P79; KELLNER CH, 1993, CLIN SCI ELECTROCONV, P183; Krystal AD, 1997, J NEUROPSYCH CLIN N, V9, P283; MALEKAHMADI P, 1989, CONVULSIVE THER, V5, P168; Nys GMS, 2005, ARCH CLIN NEUROPSYCH, V20, P623, DOI 10.1016/j.acn.2005.04.001; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Patkar AA, 2000, J ECT, V16, P189, DOI 10.1097/00124509-200006000-00011; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A., 1964, EXAMEN CLIN PSYCHOL; RUEDRICH SL, 1983, AM J PSYCHIAT, V140, P928; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; TSUANG MT, 1979, AM J PSYCHIAT, V136, P1205; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wijeratne C, 1999, J ECT, V15, P275	24	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1095-0680	1533-4112		J ECT	J. ECT	MAR	2008	24	1					92	95		10.1097/YCT.0b013e31814faae5			4	Behavioral Sciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Psychiatry	286SU	WOS:000254867100016	18379342				2022-02-06	
J	Ryu, SR; Kim, JH; Choi, IS; Han, JY; Lee, SG				Ryu, Su-Ra; Kim, Jae-Hyung; Choi, In-Sung; Han, Jae-Young; Lee, Sam-Gyu			Heterotopic ossification as an unusual complication after Guillain-Barre syndrome: A case report	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						case report; Guillain-Barre syndrome; ossification; heterotopic; rehabilitation	BONE-FORMATION	Heterotopic ossification (HO) is the abnormal development of bone within soft tissue. It is frequently encountered after traumatic brain injury or spinal cord injury, rather than lower motoneuron disease. It has been reported as a rare complication in Guillain-Barre syndrome (GBS). We present the case of a 31-year-old woman who suffered from pain and swelling wit limitation of the passive range of motion on right hip joint, and who had been diagnosed with GBS about I year previously. She was wheelchair-bound and had incomplete tetraplegia with flaccidity. She was diagnosed as HO based on the radiologic imaging study. She did not reveal any encephalopathy-related symptoms or signs, and hypercalcemia, and/or related metabolic derangement during 1.5-year follow-up period. Owing to the paucity of other causative factors, we presumed that the long-time hypomobility, even though not accompanied by hypercalcemia, played a major role for the development of HO. Early active rehabilitative management was initiated. The outcome is not promising because of her long-standing paralyzed state; however, it was possible to prevent the aggravation of HO.	[Ryu, Su-Ra; Kim, Jae-Hyung; Choi, In-Sung; Han, Jae-Young; Lee, Sam-Gyu] Chonnam Natl Univ, Med Sch Hosp, Dept Phys & Rehabil Med,Res Inst Med Sci, Cardiovasc Res Inst, Gwangju City 501757, South Korea		Lee, SG (corresponding author), Chonnam Natl Univ, Med Sch Hosp, Dept Phys & Rehabil Med,Res Inst Med Sci, Cardiovasc Res Inst, 8 Hak Dong, Gwangju City 501757, South Korea.	sam91@chonnam.ac.kr					BROOKE MM, 1991, ARCH PHYS MED REHAB, V72, P425; Crawford C M, 1986, J Burn Care Rehabil, V7, P323, DOI 10.1097/00004630-198607000-00005; FINERMAN GAM, 1981, METAB BONE DIS RELAT, V3, P337, DOI 10.1016/0221-8747(81)90050-3; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P133; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Guo Y, 2002, ARCH PHYS MED REHAB, V83, P855, DOI 10.1053/apmr.2002.32440; HU HP, 1991, CLIN ORTHOP RELAT R, P259; KANG SY, 1990, J KOREAN ACAD REHABI, V14, P70; McCarthy EF, 2005, SKELETAL RADIOL, V34, P609, DOI 10.1007/s00256-005-0958-z; MENDELSON L, 1975, SCAND J REHABIL MED, V7, P141; MEYTHALER JM, 1986, ARCH INTERN MED, V146, P1567, DOI 10.1001/archinte.146.8.1567; MICHELSSON JE, 1983, CLIN ORTHOP RELAT R, P265; MICHELSSON JE, 1990, APMIS, V98, P336, DOI 10.1111/j.1699-0463.1990.tb01041.x; MIELANTS H, 1975, ACTA ORTHOP SCAND, V46, P190, DOI 10.3109/17453677508989207; Mukhi PK, 1996, AM J PHYS MED REHABI, V75, P155; ORZEL JA, 1985, J NUCL MED, V26, P125; RIEGLER HF, 1976, CLIN ORTHOP RELAT R, P209; STOVER SL, 1975, ARCH PHYS MED REHAB, V56, P199; Sugita A, 2005, J BONE MINER METAB, V23, P329, DOI 10.1007/s00774-005-0608-5; WHARTON GW, 1975, CLIN ORTHOP RELAT R, P142; Zeilig G, 2006, ARCH PHYS MED REHAB, V87, P92, DOI 10.1016/j.apmr.2005.07.308	21	6	7	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2008	89	3					564	567		10.1016/j.apmr.2007.11.004			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	273UU	WOS:000253958100026	18295638				2022-02-06	
J	Su, CY; Lin, YH; Kwan, AL; Guo, NW				Su, Chwen-Yng; Lin, Yueh-Hsieh; Kwan, Aij-Lie; Guo, Nai-Wen			Construct validity of the Wisconsin card sorting test-64 in patients with stroke	CLINICAL NEUROPSYCHOLOGIST			English	Article						factor structure; stroke; validity; Wisconsin card sorting test-64	VASCULAR COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; LATENT STRUCTURE; TEST DIMENSIONS; DEMENTIA; WCST; SCHIZOPHRENIA; PERFORMANCE; DYSFUNCTION	This study examined the factor structure and contrasted-group validity of the Wisconsin Card Sorting Test-64 (WCST-64) in a stroke sample (n = 112). Confirmatory factor analyses were used to compare fire different models suggested by prior factor analyses. The results indicated that the WCST-64 was best represented by a three-dimensional model comprising response inflexibility (factor 1), ineffective hypothesis-testing strategy (factor 2), and set maintenance (factor 3). A significant overall multivariate effect for group (F = 2.87, df = 18,495.46, p <.001) was found in a multivariate analysis of covariance with WCST scores as dependent variables and four different groups (three stroke subgroups with different levels of cognitive function and a normal control group) as independent variable, after controlling for gender. The results of discriminant analysis supported the use of the WCST-64 in stroke patients with cognitive impairment.	[Guo, Nai-Wen] Kaohsiung Med Univ, Sch Psychol, Kaohsiung, Taiwan; [Kwan, Aij-Lie] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan		Su, CY (corresponding author), Kaohsiung Med Univ, Sch Psychol, 100 Shi-Chuan 1st Rd, Kaohsiung, Taiwan.	cysu@cc.kmu.edu.tw	Kwan, Aij-Lie/D-5505-2009; Su, Chwen-Yng/C-1496-2010; Su, Chwen-Ying/D-2378-2009				ALMKVIST O, 1993, CORTEX, V29, P661, DOI 10.1016/S0010-9452(13)80289-4; Arbuckle J. L., 1999, AMOS 4 0 USERS GUIDE; Axelrod Bradley N, 1992, Clin Neuropsychol, V6, P143, DOI 10.1080/13854049208401851; Ballard C, 2003, DEMENT GERIATR COGN, V16, P52, DOI 10.1159/000069994; Bell MD, 1997, J CLIN EXP NEUROPSYC, V19, P933, DOI 10.1080/01688639708403774; Boyle PA, 2004, CLIN NEUROPSYCHOL, V18, P75, DOI 10.1080/13854040490507172; CUESTA MJ, 1995, PSYCHIAT RES, V58, P45, DOI 10.1016/0165-1781(95)02649-H; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Desmond DW, 2004, J NEUROL SCI, V226, P3, DOI 10.1016/j.jns.2004.09.002; EBRAHIM S, 1985, AGE AGEING, V14, P345, DOI 10.1093/ageing/14.6.345; Ferguson E, 1993, INT J SELECT ASSESS, V1, P84, DOI DOI 10.1111/J.1468-2389.1993.TB00092.X; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOULKES MA, 1988, STROKE, V19, P547, DOI 10.1161/01.STR.19.5.547; Gaffett KD, 2004, ARCH CLIN NEUROPSYCH, V19, P745, DOI 10.1016/j.acn.2003.09.008; Garson GD., 2006, STRUCTURAL EQUATION; Greve KW, 2005, ARCH CLIN NEUROPSYCH, V20, P355, DOI 10.1016/j.acn.2004.09.004; Greve KW, 1997, BRIT J CLIN PSYCHOL, V36, P283, DOI 10.1111/j.2044-8260.1997.tb01414.x; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Greve KW, 1999, ARCH CLIN NEUROPSYCH, V14, P497; Greve KW, 1998, ARCH CLIN NEUROPSYCH, V13, P597; GUO NW, 1988, J CHIN REHABIL MED, V0016, P00052; Heaton SK, 1993, WISCONSIN CARD SORTI; Hu L.T., 1995, STRUCTURAL EQUATION, P76, DOI DOI 10.1080/10705519909540118; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Joreskog K, 1996, LISREL 8 USERS REFER; Kilada S, 2005, ALZ DIS ASSOC DIS, V19, P8, DOI 10.1097/01.wad.0000155381.01350.bf; Kongs S. K., 2000, WCST 64 WISCONSIN CA; Love JM, 2003, APPL NEUROPSYCHOL, V10, P246, DOI 10.1207/s15324826an1004_7; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201; Madureira S, 2001, EUR J NEUROL, V8, P621, DOI 10.1046/j.1468-1331.2001.00332.x; MARSH HW, 1988, PSYCHOL BULL, V103, P391, DOI 10.1037/0033-2909.103.3.391; Mok VCT, 2004, J NEUROL NEUROSUR PS, V75, P560, DOI 10.1136/jnnp.2003.015107; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Osmon DC, 1996, ARCH CLIN NEUROPSYCH, V11, P541, DOI 10.1016/0887-6177(95)00048-8; PAOLO AM, 1995, ARCH CLIN NEUROPSYCH, V10, P463, DOI 10.1016/0887-6177(95)00052-6; Paolo AM, 1996, J CLIN EXP NEUROPSYC, V18, P892, DOI 10.1080/01688639608408310; PEARSON J L, 1989, Clinical Gerontologist, V8, P31, DOI 10.1300/J018v08n04_04; Pohjasvaara T, 2002, EUR J NEUROL, V9, P269, DOI 10.1046/j.1468-1331.2002.00396.x; ROBINSON LJ, 1999, ARCH CLIN NEUROPSYCH, V6, P27; Royall Donald R., 2000, Neurology, V55, P604; Royall DR, 2000, NEUROEPIDEMIOLOGY, V19, P293, DOI 10.1159/000026268; SANDSON TA, 1991, ARCH NEUROL-CHICAGO, V48, P1300, DOI 10.1001/archneur.1991.00530240106031; Sherer M, 2003, J CLIN EXP NEUROPSYC, V25, P512, DOI 10.1076/jcen.25.4.512.13877; Smith-Seemiller L, 1997, CLIN NEUROPSYCHOL, V11, P421, DOI 10.1080/13854049708400472; Stephens S, 2004, INT J GERIATR PSYCH, V19, P1053, DOI 10.1002/gps.1209; SULLIVAN EV, 1993, PSYCHIAT RES, V46, P175, DOI 10.1016/0165-1781(93)90019-D; TATEMICHI TK, 1993, ANN NEUROL, V33, P568, DOI 10.1002/ana.410330603; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Thibault JM, 2004, AM FAM PHYSICIAN, V70, P1101; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Zhou DHD, 2005, NEUROEPIDEMIOLOGY, V24, P87, DOI 10.1159/000081055; [No title captured], DOI DOI 10.1177/107319119600300108	53	6	7	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	MAR	2008	22	2					273	287		10.1080/13854040701220036			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	279ZA	WOS:000254393500007	17853145				2022-02-06	
J	Chaze, B; McDonald, P				Chaze, Brian; McDonald, Patrick			Head injuries in winter sports: Downhill skiing, snowboarding, sledding, snowmobiling, ice skating and ice hockey	NEUROLOGIC CLINICS			English	Article							RISK-FACTORS; CHILDREN; SKIERS; EMERGENCY; CONCUSSIONS; HELMETS; DEATHS; RATES; ADOLESCENTS; MECHANISMS	Winter sports are often associated with high speed, which carries with it the potential for collision. As such, head injuries are among the more commonly encountered injuries in winter-related sporting activities. This article focuses on popular winter sports such as downhill skiing and snowboarding, sledding, snowmobiling, ice skating, and hockey In virtually all of these activities, the incidence and severity of head injuries can be reduced by the use of appropriate protective headgear.	[Chaze, Brian; McDonald, Patrick] Univ Manitoba, Neurosurg Sect, Winnipeg, MB R3A 1R9, Canada; [McDonald, Patrick] Winnipeg Childrens Hosp, Winnipeg, MB R3A 1R9, Canada		McDonald, P (corresponding author), Univ Manitoba, Neurosurg Sect, GB126-820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada.	pmcdonald@hsc.mb.ca		Chaze, Brian/0000-0003-2898-2117			Beilman GJ, 1999, WILD ENVIRON MED, V10, P226, DOI 10.1580/1080-6032(1999)010[0226:RFAPOI]2.3.CO;2; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; DeCou JM, 2003, J PEDIATR SURG, V38, P784, DOI 10.1016/jpsu.2003.50167; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Diamond PT, 2001, BRAIN INJURY, V15, P429, DOI 10.1080/02699050010005922; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Federiuk CS, 2002, WILD ENVIRON MED, V13, P245, DOI 10.1580/1080-6032(2002)013[0245:SSASII]2.0.CO;2; Ferrera PC, 1999, AM J EMERG MED, V17, P575, DOI 10.1016/S0735-6757(99)90199-7; FILK K, 2005, AM J SPORTS MED, V33, P183; Fukuda O, 2001, AM J SPORT MED, V29, P437, DOI 10.1177/03635465010290040901; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Hackam DJ, 1999, J PEDIATR SURG, V34, P65, DOI 10.1016/S0022-3468(99)90230-0; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Hagel BE, 2004, EPIDEMIOLOGY, V15, P279, DOI 10.1097/01.ede.0000120044.62029.b4; Hagel BE, 2003, CAN J PUBLIC HEALTH, V94, P458, DOI 10.1007/BF03405085; Hennessey T, 2002, AM J PREV MED, V22, P110, DOI 10.1016/S0749-3797(01)00411-1; Hentschel S, 2001, CAN J NEUROL SCI, V28, P42; KIM PCW, 1995, J PEDIATR SURG, V30, P1135, DOI 10.1016/0022-3468(95)90005-5; Knox CL, 2006, PEDIATRICS, V118, P549, DOI 10.1542/peds.2005-2913; Knox CL, 2006, BRIT J SPORT MED, V40, P268, DOI 10.1136/bjsm.2005.022855; Landen MG, 1999, PUBLIC HEALTH REP, V114, P48, DOI 10.1093/phr/114.1.48; Lee F, 1999, Inj Prev, V5, P198; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; McCrory P, 2002, BRIT J SPORT MED, V36, P314, DOI 10.1136/bjsm.36.5.314; McGeehan J, 2004, PEDIATRICS, V114, P124, DOI 10.1542/peds.114.1.124; Nakaguchi H, 1999, J TRAUMA, V46, P1066, DOI 10.1097/00005373-199906000-00017; Nayci A, 2006, MAYO CLIN PROC, V81, P39, DOI 10.4065/81.1.39; Ortega HW, 2005, PEDIATR EMERG CARE, V21, P839, DOI 10.1097/01.pec.0000190233.27857.6a; Pierz JJ, 2003, CLIN ORTHOP RELAT R, P29, DOI 10.1097/01.blo.0000057781.10364.c9; Rajan GP, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2004.011882; Rice MR, 2000, PEDIATRICS, V105, P615, DOI 10.1542/peds.105.3.615; ROWE BH, 1994, CAN FAM PHYSICIAN, V40, P68; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Shorter NA, 1999, AM J EMERG MED, V17, P32, DOI 10.1016/S0735-6757(99)90010-4; Skokan EG, 2003, AM J EMERG MED, V21, P95, DOI 10.1053/ajem.2003.50032; Stewart RL, 2004, CAN J SURG, V47, P90; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Sy Mary L, 2005, WMJ, V104, P32; Toth C, 2005, SPORTS MED, V35, P685, DOI 10.2165/00007256-200535080-00003; Uzura M, 2003, BRIT J SPORT MED, V37, P82, DOI 10.1136/bjsm.37.1.82; Voaklander DC, 2001, ACAD EMERG MED, V8, P629, DOI 10.1111/j.1553-2712.2001.tb00176.x; Wennberg R, 2005, CLIN J SPORT MED, V15, P67, DOI 10.1097/01.jsm.0000152712.27968.fe; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; WYNNE AD, 1994, J TRAUMA, V37, P820, DOI 10.1097/00005373-199411000-00019; Xiang H, 2004, INJURY PREV, V10, P99, DOI 10.1136/ip.2003.004655; Xiang HY, 2003, INJURY, V34, P892, DOI 10.1016/S0020-1383(03)00055-X; Yamagami T, 2004, J ORTHOP SCI, V9, P225, DOI 10.1007/s00776-004-0776-5	49	6	6	4	25	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619			NEUROL CLIN	Neurol. Clin.	FEB	2008	26	1					325	+		10.1016/j.ncl.2007.11.009			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281ID	WOS:000254489200020	18295099				2022-02-06	
J	Dicianno, BE; Aguila, ED; Cooper, RA; Pasquina, PF; Clark, MJ; Collins, DM; Fitzgerald, SG; Wichman, TA				Dicianno, Brad E.; Aguila, Eric D.; Cooper, Rory A.; Pasquina, Paul F.; Clark, Mary J.; Collins, Diane M.; Fitzgerald, Shirley G.; Wichman, Todd A.			Acute mountain sickness in disability and adaptive sports: Preliminary data	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						altitude sickness; brain injuries; headache; military; multiple sclerosis; rehabilitation; spinal cord injuries; sports; veterans; visual impairment	ALTITUDE ILLNESS	Acute mountain sickness (AMS) is a frequent complication for military personnel, veterans, athletes, and travelers at high altitudes. Symptoms may occur in individuals with less cerebrospinal fluid volume and less ability to accommodate increased brain volume. No studies on AMS exist in individuals with neurological impairments. We studied 64 subjects, including active and sedentary controls and those with tetraplegia, paraplegia, multiple sclerosis, and traumatic brain injury at the 2007 National Veterans Winter Sports Clinic in Snowmass, Colorado. Subjects completed three Lake Louise Score surveys to quantify symptoms. We found a higher than expected occurrence of AMS overall (51.6%) but no differences among groups, and few participants sought treatment. Fatigue and weakness were common symptoms. High subject activity levels may explain these findings. More research is warranted on larger sample sizes and on preventative medications and treatments for AMS, especially since many military personnel with neurological impairments are returning to full active service.	[Dicianno, Brad E.; Cooper, Rory A.; Collins, Diane M.] Univ Pittsburgh, Human Engn Res Labs, VA Pittsburgh Healthcare Syst, Pittsburgh, PA 15206 USA; [Dicianno, Brad E.; Cooper, Rory A.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15206 USA; [Dicianno, Brad E.; Cooper, Rory A.; Collins, Diane M.] Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA 15206 USA; [Dicianno, Brad E.; Cooper, Rory A.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15206 USA; [Dicianno, Brad E.; Cooper, Rory A.; Collins, Diane M.] Ctr Excellence Wheelchairs & Related Technol, Dept Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Aguila, Eric D.; Pasquina, Paul F.; Wichman, Todd A.] Walter Reed Army Med Ctr, Dept Phys Med & Rehabil, Washington, DC 20307 USA; [Clark, Mary J.] Grand Junct VA Med Ctr, Grand Junction, CO USA; [Fitzgerald, Shirley G.] James A Haley Tampa VA Med Ctr, Patient Safety Ctr Inquiry, Tampa, FL USA		Dicianno, BE (corresponding author), Univ Pittsburgh, Human Engn Res Labs, VA Pittsburgh Healthcare Syst, 7180 Highland Dr,Bldg 4,2nd Floor E,151R1-H, Pittsburgh, PA 15206 USA.	diciannob@herlpitt.org	Rodriguez, Ferran A. A/H-4892-2011; Dicanno, Brad/AAC-5918-2019	Rodriguez, Ferran A. A/0000-0002-2280-8962; Dicanno, Brad/0000-0003-0738-0192; Collins, Diane/0000-0003-0646-0457			Barry PW, 2003, BRIT MED J, V326, P915, DOI 10.1136/bmj.326.7395.915; Bartsch P, 2004, HIGH ALT MED BIOL, V5, P110, DOI 10.1089/1527029041352108; *DEP VET AFF, 2008, 2008 NAT VET WINT SP; HACKETT PH, 1987, ANN EMERG MED, V16, P980, DOI 10.1016/S0196-0644(87)80744-8; Hackett PH, 1999, ADV EXP MED BIOL, V474, P23; Hossmann KA, 1999, ADV EXP MED BIOL, V474, P155; Kinsman TA, 2005, J SCI MED SPORT, V8, P222, DOI 10.1016/S1440-2440(05)80013-1; MACMILLAN AJF, 2003, AVIATION MED, P19; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; SAMPSON JB, 1983, AVIAT SPACE ENVIR MD, V54, P1063; Schneider M, 2002, MED SCI SPORT EXER, V34, P1886, DOI 10.1097/00005768-200212000-00005; West JB, 2004, ANN INTERN MED, V141, P789, DOI 10.7326/0003-4819-141-10-200411160-00010	12	6	6	0	9	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2008	45	4					479	487		10.1682/JRRD.2007.08.0136			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	331KX	WOS:000258012200002	18712635	Bronze			2022-02-06	
J	Hashimoto, K; Uruma, G; Abo, M				Hashimoto, Keiji; Uruma, Go; Abo, Masahiro			Activation of the prefrontal cortex during the Wisconsin Card Sorting Test (Keio Version) as measured by two-channel near-infrared spectroscopy in patients with traumatic brain injury	EUROPEAN NEUROLOGY			English	Article						traumatic brain injury; near-infrared spectroscopy; frontal lobe function; Wisconsin Card Sorting Test (Keio Version)	DIFFUSE AXONAL INJURY; NONINVASIVE ASSESSMENT; FUNCTIONAL MRI; NIRS	To investigate brain activation in the prefrontal cortex (PFC) during the Wisconsin Card Sorting Test (Keio Version) (KWCST), we examined changes in total hemoglobin volume (THV) in 8 patients with traumatic brain injury (TBI) and 20 healthy control subjects using two-channel near-infrared spectroscopy. As a result, average THV in the right PFC during KWCST in TBI patients (-0.131 +/- 0.127) was significantly lower than in control subjects (0.016 +/- 0.135) (2 x 3 ANOVA; p < 0.05). These results demonstrated that the TBI patients had lower circulation of hemoglobin in the right PFC during the KWCST than the control subjects. Copyright (C) 2007 S. Karger AG, Basel.	Jikei Univ, Sch Med, Dept Rehabil Med, Tokyo, Japan		Hashimoto, K (corresponding author), Jikei Univ, Sch Med, Dept Rehabil Med, Minato Ku, 3-25-8 Nishishinbashi, Tokyo 1058461, Japan.	keiman@jikei.ac.jp		Hashimoto, Keiji/0000-0003-2412-860X; Abo, Masahiro/0000-0001-6701-4974			ABO M, 2006, J APPL RES, V6, P36; Adelson PD, 1998, ACT NEUR S, V71, P250; Al-Rawi PG, 2005, ACT NEUR S, V95, P453; BayHansen J, 1997, STROKE, V28, P1009, DOI 10.1161/01.STR.28.5.1009; Braun AR, 1997, BRAIN, V120, P761, DOI 10.1093/brain/120.5.761; Cannestra AF, 2003, NEUROREPORT, V14, P1961, DOI 10.1097/00001756-200310270-00016; Cao Y, 1998, STROKE, V29, P112, DOI 10.1161/01.STR.29.1.112; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Duncan A, 1996, PEDIATR RES, V39, P889, DOI 10.1203/00006450-199605000-00025; Fallgatter AJ, 1998, EUR ARCH PSY CLIN N, V248, P245, DOI 10.1007/s004060050045; Hashimoto K, 2006, EUR NEUROL, V55, P16, DOI 10.1159/000091138; HASHIMOTO K, 2004, SHINKEI, V56, P389; Heekeren HR, 1999, J CEREBR BLOOD F MET, V19, P592, DOI 10.1097/00004647-199906000-00002; ITO H, 1995, J NUCL MED, V36, P531; Madsen PL, 1999, PROG NEUROBIOL, V58, P541, DOI 10.1016/S0301-0082(98)00093-8; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miyazawa N, 1997, STROKE, V28, P984, DOI 10.1161/01.STR.28.5.984; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schroeter ML, 2004, NEUROIMAGE, V23, P1317, DOI 10.1016/j.neuroimage.2004.08.001; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Sumitani S, 2006, NEUROPSYCHOBIOLOGY, V53, P70, DOI 10.1159/000091722; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Watanabe E, 1998, NEUROSCI LETT, V256, P49, DOI 10.1016/S0304-3940(98)00754-X	25	6	7	1	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0014-3022	1421-9913		EUR NEUROL	Eur. Neurol.		2008	59	1-2					24	30		10.1159/000109257			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	238GV	WOS:000251436400004	17917454				2022-02-06	
J	Kuruvilla, MS; Murdoch, BE; Goozee, JV				Kuruvilla, Mili S.; Murdoch, Bruce E.; Goozee, Justine V.			Electropalatographic (EPG) assessment of tongue-to-palate contacts in dysarthric speakers following TBI	CLINICAL LINGUISTICS & PHONETICS			English	Article						dysarthria; traumatic brain injury; electropalatography; speech production measurement; tongue; spatial and temporal measures; articulation	TRAUMATIC BRAIN-INJURY; LINGUAL ACTIVITY; DATA REDUCTION; SPEECH; DISORDERS; PATTERNS	The aim of the investigation was to compare EPG-derived spatial and timing measures between a group of 11 dysarthric individuals post-severe TBI and 10 age- and sex-matched neurologically non-impaired individuals. Participants of the TBI group were diagnosed with dysarthria ranging from mild-to-moderate-severe dysarthria. Each participant from the TBI and comparison group was fitted with a custom-made artificial acrylic palate that recorded lingual palatal contact during target consonant production in sentence- and syllable-repetition tasks at a habitual rate and loudness level. Analysis of temporal parameters between the comparison and TBI groups revealed prolonged durations of the various phases of consonant production, which were attributed to articulatory slowness, impaired speech motor control, impaired accuracy, and impaired coordination of articulatory movements in the dysarthric speakers post-TBI. For the spatial measurements, quantitative analysis, as well as visual inspection of the tongue-to-palate contact diagrams, indicated spatial aberrations in dysarthric speech post-TBI. Both the spatial and temporal aberrations may have at least partially caused the perceptual judgement of articulatory impairments in the dysarthric speakers.	[Kuruvilla, Mili S.; Murdoch, Bruce E.; Goozee, Justine V.] Univ Queensland, Div Speech Pathol, Motor Speech Res Unit, Brisbane, Qld, Australia		Kuruvilla, MS (corresponding author), Univ Queensland, Div Speech Pathol, St Lucia, Qld 4072, Australia.	m.kuruvilla@uq.edu.au	Murdoch, Bruce E/C-1397-2012	Kuruvilla-Dugdale, Mili/0000-0001-7900-2364			BYRD D, 1995, J SPEECH HEAR RES, V38, P821, DOI 10.1044/jshr.3804.821; Cheng HY, 2005, J MED SPEECH-LANG PA, V13, P15; DAGENAIS PA, 1994, J PHONETICS, V22, P225, DOI 10.1016/S0095-4470(19)30202-5; DAGENAIS PA, 1995, J COMMUN DISORD, V28, P303, DOI 10.1016/0021-9924(95)00059-1; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P462, DOI 10.1044/jshr.1203.462; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; Gibbon F, 2004, CLIN LINGUIST PHONET, V18, P285, DOI 10.1080/02699200410001663362; GIBBON F, 1990, BRIT J DISORD COMMUN, V25, P329; Gibbon F, 2000, J MED SPEECH-LANG PA, V8, P239; Gibbon FE, 2003, CLIN LINGUIST PHONET, V17, P365, DOI 10.1080/0269920031000079976; Gibbon Fiona., 1999, COARTICULATION DATA, P229; GOLDSTEIN P, 1994, CLIN LINGUIST PHONET, V8, P201, DOI 10.3109/02699209408985307; Goozee J V, 2001, Logoped Phoniatr Vocol, V26, P51; Goozee JV, 1999, J MED SPEECH-LANG PA, V7, P209; Goozee JV, 2003, J MED SPEECH-LANG PA, V11, P115; Goozee JV, 2000, THESIS U QUEENSLAND; HARDCASTLE W, 1989, CLIN LINGUIST PHONET, V3, P1, DOI 10.3109/02699208908985268; HARDCASTLE WJ, 1991, J PHONETICS, V19, P251, DOI 10.1016/S0095-4470(19)30343-2; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HARDCASTLE WJ, 1987, J SPEECH HEAR RES, V30, P171, DOI 10.1044/jshr.3002.171; HARDCASTLE WJ, 1985, BRIT J DISORD COMMUN, V20, P249; HARDCASTLE WJ, 2004, 26 WORLD C INT ASS L; JONES W, 1995, EUR J DISORDER COMM, V30, P183; Kent R. D., 1997, NEW PHONOLOGIES DEV, P247; KENT RD, 1975, J SPEECH HEAR DISORD, V40, P467, DOI 10.1044/jshd.4004.467; Math Works Inc, 2004, MATL HIGH PERF NUM C; SCOTT D, 2004, EPGLAB MANUAL UNPUB; Statistical Package for the Social Sciences, 2001, SPSS ADV STAT 11 0; THEODOROS DG, 1995, BRAIN INJURY, V9, P671, DOI 10.3109/02699059509008225; ZIEGLER W, 1986, BRIT J DISORD COMMUN, V21, P173; [No title captured]	31	6	7	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9206	1464-5076		CLIN LINGUIST PHONET	Clin. Linguist. Phon.		2008	22	9					703	725		10.1080/02699200802176378			23	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	349YG	WOS:000259318600003	18608248				2022-02-06	
J	Rodset, M				Rodset, Marianne			Adolescents with Traumatic Brain Injury and their School Situation: A Qualitative Study	SCANDINAVIAN JOURNAL OF DISABILITY RESEARCH			English	Article								Traumatic brain injury (TBI) is the most common cause of acquired disability among adolescents, but few studies have addressed how the adolescents themselves experience the after-effects of TBI. The aim of this study was to gain insight into the adolescents' own perspective and coping in their school situation. Data from six adolescents with TBI in a traditional school setting were collected through semi-structured interviews. The results indicated experiences of academic shortcoming, but the social aspects presented a greater source of concern. Some reported increased stress in the teacher-student relationship. Optimism and recovery over time were important attributes for coping, as well as access to environmental resources.	[Rodset, Marianne] Univ Oslo, Dept Special Needs Educ, Oslo, Norway; Univ Oslo, Dept Special Needs Educ, POB 1140,Blindern, N-0318 Oslo, Norway		Rodset, M (corresponding author), Univ Oslo, Dept Special Needs Educ, POB 1140,Blindern, N-0318 Oslo, Norway.	marianne.rodset@uv.uio.no					Bruke W. H., 1990, BRAIN INJURY, V4, P371; Bryhn G., 2002, HJERNE OG ATFERD; Chan RCK, 2000, BRAIN INJURY, V14, P227, DOI 10.1080/026990500120709; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Falk AC, 2006, ACTA PAEDIATR, V95, P1533, DOI 10.1080/08035250600731957; Finset A., 2002, HODESKADE; Folkman S., 1984, STRESS; Frostad P., 2007, EUR J SPEC NEEDS EDU, V22, P15, DOI DOI 10.1080/08856250601082224; Gjaerum B., 1998, MESTRING SOM MULIGHE; Grue L., 2001, 101 NOVA; Hansen H., 1994, THESIS; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hutzler Y., 2005, EUR J SPEC NEEDS EDU, V20, P309, DOI [10.1080/08856250500156038, DOI 10.1080/08856250500156038]; Jemta L, 2007, ACTA PAEDIATR, V96, P1184, DOI 10.1111/j.1651-2227.2007.00387.x; Keefe E. B., 2006, LISTENING EXPERTS ST; Kvale S., 2001, KVALITATIVE FORSKNIN; Lazarus R.S., 1999, STRESS EMOTION NEW S; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lightfoot J, 1999, CHILD CARE HLTH DEV, V25, P267, DOI 10.1046/j.1365-2214.1999.00112.x; McDonald S, 2000, APHASIOLOGY, V14, P339, DOI 10.1080/026870300401397; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Myklebust J.O., 2007, INT J INCLUSIVE EDUC, V11, P215, DOI [10.1080/13603110500375432, DOI 10.1080/13603110500375432]; Ogden T., 2001, SOSIAL KOMPETANSE PR; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Skaalvik E. M., 1996, SELVOPPFATNING MOTIV; SKARBREVIK KJ, 2005, EUROPEAN J SPECIAL N, V20, P387, DOI DOI 10.1080/08856250500268601; Sommerschild H., 1998, MESTRING SOM MULIGHE; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; TEASDALE G, 1974, LANCET, V2, P81; Thuen E., 2004, SCAND J EDUC RES, V48, P493, DOI DOI 10.1080/003138042000272140; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Tyler J. S., 1999, TRAUMATIC BRAIN INJU; Tysnes A. M., 1997, SKOLESITUASJONEN BAR; Westling Allodi M., 2000, EUROPEAN J SPECIAL N, V15, P69, DOI DOI 10.1080/088562500361718; Wood RL, 2001, NEUROBEHAVIOURAL DIS, P1; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	40	6	6	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1501-7419	1745-3011		SCAND J DISABIL RES	Scand. J. Disabil. Res.		2008	10	2					90	103		10.1080/15017410801927807			14	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V84MI	WOS:000212456700002		gold			2022-02-06	
B	Sadavoy, J; Lanctot, KL; Deb, S	Tyrer, P; Silk, KR			Sadavoy, Joel; Lanctot, Krista L.; Deb, Shoumitro	Tyrer, P; Silk, KR		Management of behavioural and psychological symptoms of dementia and acquired brain injury	CAMBRIDGE TEXTBOOK OF EFFECTIVE TREATMENTS IN PSYCHIATRY			English	Article; Book Chapter							NURSING-HOME RESIDENTS; BRIGHT LIGHT TREATMENT; SEROTONIN REUPTAKE INHIBITORS; ALZHEIMERS-DISEASE PATIENTS; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; CLOSED-HEAD-INJURY; DOUBLE-BLIND TRIAL; SEXUAL ACTING-OUT; AGGRESSIVE-BEHAVIOR		[Sadavoy, Joel] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Deb, Shoumitro] Univ Birmingham, Dept Psychiat, Queen Elizabeth Psychiat Hosp, Birmingham, W Midlands, England; [Lanctot, Krista L.] Sunnybrook Hlth Sci Ctr, Dept Psychiat, Toronto, ON M4N 3M5, Canada		Sadavoy, J (corresponding author), Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada.		Sadavoy, Joel/Q-4237-2019; Lanctot, Krista L./AAY-4820-2020; Sadavoy, Joel/O-1035-2016	Lanctot, Krista L./0000-0001-7024-6637; 			AFFLECK JW, 1988, LANCET, V1, P230; Aitken L, 1999, Int Psychogeriatr, V11, P263, DOI 10.1017/S1041610299005827; Allen NHP, 1996, BRIT J PSYCHIAT, V169, P293, DOI 10.1192/bjp.169.3.293; Allen-Burge R, 1999, INT J GERIATR PSYCH, V14, P213, DOI 10.1002/(SICI)1099-1166(199903)14:3<213::AID-GPS974>3.0.CO;2-0; ALLMAN P, 1992, J ROY SOC MED, V85, P423; Amella EJ, 2004, NURS CLIN N AM, V39, P607, DOI 10.1016/j.cnur.2004.02.014; American Psychiatric Association, 1997, AM J PSYCHIAT S, V154; ANCILL RJ, 1991, INT CLIN PSYCHOPHARM, V6, P141, DOI 10.1097/00004850-199100630-00002; Ancoli-Israel S, 2003, AM J GERIAT PSYCHIAT, V11, P194, DOI 10.1176/appi.ajgp.11.2.194; [Anonymous], 2004, NURSING HLTH SCI, V6, P11; AREOSA SA, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003154.pub4; ARNOLD SE, 1993, AM J PSYCHIAT, V150, P1564; ARONSON MK, 1993, J AM GERIATR SOC, V41, P507, DOI 10.1111/j.1532-5415.1993.tb01886.x; Ashton D, 1993, BRIT J NURSING, V2, P894; Auchus AP, 1997, J NEUROPSYCH CLIN N, V9, P591; Azouvi P, 1999, BRAIN INJURY, V13, P797, DOI 10.1080/026990599121188; BAINES S, 1987, BRIT J PSYCHIAT, V151, P222, DOI 10.1192/bjp.151.2.222; Ballard C, 2005, BMJ-BRIT MED J, V330, P874, DOI 10.1136/bmj.38369.459988.8F; Ballard C, 2002, INT J GERIATR PSYCH, V17, P140, DOI 10.1002/gps.543; BAUMGARTEN M, 1990, J AM GERIATR SOC, V38, P221, DOI 10.1111/j.1532-5415.1990.tb03495.x; BEBER CR, 1965, DIS NERV SYST, V26, P591; Beck A.T., 1983, DEV SOCIOTROPY AUTON; Beck CK, 2002, NURS RES, V51, P219, DOI 10.1097/00006199-200207000-00002; Bellus SB, 1996, BRAIN INJURY, V10, P849, DOI 10.1080/026990596123954; Berger G, 2004, INT J GERIATR PSYCH, V19, P223, DOI 10.1002/gps.1055; BIRD M, 1995, INT J GERIATR PSYCH, V10, P305, DOI 10.1002/gps.930100407; Bird M. J, 2000, COGNITIVE REHABILITA, P843; Birks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001190.pub3; Bourgeois MS, 1997, GERONTOLOGIST, V37, P30, DOI 10.1093/geront/37.1.30; Bourgeois S., 1998, REV FRANCOPHONE CLIN, V2, P1; Brandt J, 1998, INT J GERIATR PSYCH, V13, P509, DOI 10.1002/(SICI)1099-1166(199808)13:8<509::AID-GPS809>3.0.CO;2-R; Brink C, 1980, Geriatr Nurs, V1, P241, DOI 10.1016/S0197-4572(80)80037-1; Britton KR, 1998, BRAIN INJURY, V12, P703, DOI 10.1080/026990598122269; Brodaty H, 2001, INT J GERIATR PSYCH, V16, P504, DOI 10.1002/gps.382; Brodaty H, 2003, J CLIN PSYCHIAT, V64, P134, DOI 10.4088/JCP.v64n0205; BROOK P, 1975, BRIT J PSYCHIAT, V127, P42, DOI 10.1192/bjp.127.1.42; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Burgener SC, 1998, GERIATR NURS, V19, P121, DOI 10.1016/S0197-4572(98)90055-6; Burgio L, 1996, Int Psychogeriatr, V8 Suppl 1, P45, DOI 10.1017/S1041610296003079; BURGIO LD, 1994, J GERONTOL, V49, pP230, DOI 10.1093/geronj/49.5.P230; Burke WJ, 1997, INT J GERIATR PSYCH, V12, P519, DOI 10.1002/(SICI)1099-1166(199705)12:5<519::AID-GPS534>3.0.CO;2-Q; BURKE WJ, 1994, AM J GERIAT PSYCHIAT, V2, P352, DOI 10.1097/00019442-199402040-00011; BURNS A, 1990, J NERV MENT DIS, V178, P20, DOI 10.1097/00005053-199001000-00004; Calvanio R, 2000, BRAIN INJURY, V14, P933; Camberg L, 1999, J AM GERIATR SOC, V47, P446, DOI 10.1111/j.1532-5415.1999.tb07237.x; Cantillon M, 1996, AM J GERIAT PSYCHIAT, V4, P263, DOI 10.1097/00019442-199622430-00011; CARLSON DL, 1995, MAYO CLIN PROC, V70, P1108, DOI 10.4065/70.11.1108; CARSTENSEN LL, 1981, GERONTOLOGIST, V21, P329, DOI 10.1093/geront/21.3.329; Chan WC, 2001, INT J GERIATR PSYCH, V16, P1156, DOI 10.1002/gps.504; ChathamShowalter PE, 1996, J NEUROPSYCH CLIN N, V8, P96; CHATTERJEE A, 1992, ARCH NEUROL-CHICAGO, V49, P486, DOI 10.1001/archneur.1992.00530290070014; CHESROW EJ, 1965, CLIN MED, V71, P1001; Cheston R, 1998, BRIT J MED PSYCHOL, V71, P211, DOI 10.1111/j.2044-8341.1998.tb00987.x; Christensen DB, 1998, J AM GERIATR SOC, V46, P620, DOI 10.1111/j.1532-5415.1998.tb01081.x; Clare L, 2003, COCHRANE DATABASE SY; Clark M E, 1998, J Gerontol Nurs, V24, P10; COCCARO EF, 1990, AM J PSYCHIAT, V147, P1640; Cohen G. D, 1988, TREATMENTS ALZHEIMER, P96; Cohen-Mansfield J, 1998, J GERONTOL A-BIOL, V53, pM65, DOI 10.1093/gerona/53A.1.M65; Cohen-Mansfield J, 1992, Int Psychogeriatr, V4 Suppl 2, P221; Cohen-Mansfield J, 1998, GERONTOLOGIST, V38, P199, DOI 10.1093/geront/38.2.199; COHENMANSFIELD J, 1989, J GERONTOL, V44, pM77, DOI 10.1093/geronj/44.3.M77; COHENMANSFIELD J, 1990, J AM GERIATR SOC, V38, P785, DOI 10.1111/j.1532-5415.1990.tb01470.x; COHENMANSFIELD J, 1986, J AM GERIATR SOC, V34, P722, DOI 10.1111/j.1532-5415.1986.tb04303.x; CohenMansfield J, 1997, INT J GERIATR PSYCH, V12, P1079, DOI 10.1002/(SICI)1099-1166(199711)12:11<1079::AID-GPS689>3.0.CO;2-P; COHENMANSFIELD J, 1986, J AM GERIATR SOC, V34, P711, DOI 10.1111/j.1532-5415.1986.tb04302.x; COLENDA CC, 1991, HOSP COMMUNITY PSYCH, V42, P287; Colenda CC, 1997, ALZ DIS ASSOC DIS, V11, P175, DOI 10.1097/00002093-199709000-00011; COOPER AJ, 1987, J CLIN PSYCHIAT, V48, P368; COVINGTON JS, 1975, SOUTHERN MED J, V68, P719, DOI 10.1097/00007611-197506000-00015; CRAIG TJ, 1982, AM J PSYCHIAT, V139, P1262; Cummings JL, 2002, DEMENT GERIATR COGN, V13, P67, DOI 10.1159/000048636; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; CUTLER NR, 1985, ARCH NEUROL-CHICAGO, V42, P744, DOI 10.1001/archneur.1985.04210090008003; Cuvo A. J, 1976, MENT RETARD, V24, P22; De Deyn PP, 1999, NEUROLOGY, V53, P946, DOI 10.1212/WNL.53.5.946; De Deyn PP, 2005, CLIN NEUROL NEUROSUR, V107, P497, DOI 10.1016/j.clineuro.2005.03.013; De Deyn PP, 2004, INT J GERIATR PSYCH, V19, P115, DOI 10.1002/gps.1032; De Klerk-Rubin V, 1995, J DEMENTIA CARE  MAY, P22; Deb S, 1999, AM J PSYCHIAT, V156, P374; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; DEHLIN O, 1985, ACTA PSYCHIAT SCAND, V71, P190, DOI 10.1111/j.1600-0447.1985.tb01270.x; Den Boer JA, 2000, HUM PSYCHOPHARM CLIN, V15, P315, DOI 10.1002/1099-1077(200007)15:5<315::AID-HUP204>3.0.CO;2-Y; Denny A., 1997, J GERONTOLOGY NURS A, V52A, pM369; Devanand DP, 1997, ARCH GEN PSYCHIAT, V54, P257; Devereaux M, 1997, THESIS COLL ST CATHE; DeYoung Sandra, 2002, J Gerontol Nurs, V28, P22; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; DRACHMAN DA, 1992, J AM GERIATR SOC, V40, P463, DOI 10.1111/j.1532-5415.1992.tb02012.x; Dwyer M, 2000, INT PSYCHOGERIATR, V12, P463, DOI 10.1017/S104161020000658X; Eames P, 1999, BRAIN INJURY, V13, P255, DOI 10.1080/026990599121629; EMORY LE, 1995, J HEAD TRAUMA REHAB, V10, P47; Erkinjuntti T, 2004, J NEUROL SCI, V226, P63, DOI 10.1016/j.jns.2004.09.018; Erkinjuntti T, 2002, LANCET, V359, P1283, DOI 10.1016/S0140-6736(02)08267-3; EVANS LK, 1989, J AM GERIATR SOC, V37, P65, DOI 10.1111/j.1532-5415.1989.tb01571.x; EVANS RW, 1987, J NERV MENT DIS, V175, P106, DOI 10.1097/00005053-198702000-00007; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Feldman H, 2001, NEUROLOGY, V57, P613, DOI 10.1212/WNL.57.4.613; Fetveit A, 2003, INT J GERIATR PSYCH, V18, P520, DOI 10.1002/gps.852; Finkel S I, 1996, Int Psychogeriatr, V8 Suppl 3, P497; Finkel SI, 2004, INT J GERIATR PSYCH, V19, P9, DOI 10.1002/gps.998; FINKEL SI, 1993, J AM GERIATR SOC, V41, P50, DOI 10.1111/j.1532-5415.1993.tb05948.x; Flynn BL, 1999, ANN PHARMACOTHER, V33, P178, DOI 10.1345/aph.16378; Galynker I, 1997, J NEUROPSYCH CLIN N, V9, P231; Gasio PF, 2003, EXP GERONTOL, V38, P207, DOI 10.1016/S0531-5565(02)00164-X; GERACIOTI TD, 1994, J CLIN PSYCHIAT, V55, P416; GERBER GJ, 1991, HOSP COMMUNITY PSYCH, V42, P843; Gibbons P, 1997, INT J GERIATR PSYCH, V12, P384, DOI 10.1002/(SICI)1099-1166(199703)12:3<384::AID-GPS525>3.0.CO;2-9; GLENN MB, 1989, AM J PHYS MED REHAB, V68, P221, DOI 10.1097/00002060-198910000-00004; GOLDWASSER AN, 1987, INT J AGING HUM DEV, V25, P209, DOI 10.2190/8UX8-68VC-RDYF-VK4F; Gormley N, 2001, AGE AGEING, V30, P141, DOI 10.1093/ageing/30.2.141; Graf A, 2001, BIOL PSYCHIAT, V50, P725, DOI 10.1016/S0006-3223(01)01178-7; Graneheim UH, 2001, J ADV NURS, V36, P256, DOI 10.1046/j.1365-2648.2001.01966.x; GREENDYKE RM, 1986, J NERV MENT DIS, V174, P290, DOI 10.1097/00005053-198605000-00005; GREENDYKE RM, 1986, J CLIN PSYCHIAT, V47, P423; GREENDYKE RM, 1984, J CLIN PSYCHOPHARM, V4, P282; Grohmann R, 2004, PHARMACOPSYCHIATRY, V37, pS27, DOI 10.1055/s-2004-815508; Gryle D., 1986, ABSTR CLIN INV MED, V9, P75; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; GUALTIERI CT, 1991, J CLIN PSYCHOPHARM, V11, P280, DOI 10.1097/00004714-199108000-00027; Gualtieri CT, 1991, J HEAD TRAUMA REHAB, V6, P90; HAAS JF, 1985, ARCH PHYS MED REHAB, V66, P472; Hagen B F, 1995, J Gerontol Nurs, V21, P7; Haight BK, 2003, CLIN PSYCHOL PSYCHOT, V10, P165, DOI 10.1002/cpp.367; HALE MS, 1982, J NERV MENT DIS, V170, P362, DOI 10.1097/00005053-198206000-00006; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HANLEY IG, 1981, BRIT J PSYCHIAT, V138, P10, DOI 10.1192/bjp.138.1.10; Haupt M, 2000, INT J GERIATR PSYCH, V15, P1125, DOI 10.1002/1099-1166(200012)15:12<1125::AID-GPS257>3.0.CO;2-F; Hausman C. P, 1991, CAREGIVING DEMENTIA; Haussermann P, 2003, INT PSYCHOGERIATR, V15, P181, DOI 10.1017/S104161020300886X; Herrmann N, 2004, AM J PSYCHIAT, V161, P1113, DOI 10.1176/appi.ajp.161.6.1113; Herrmann N, 2004, NEUROLOGY, V63, P200, DOI 10.1212/01.WNL.0000134774.19232.09; Herrmann N, 2004, J PSYCHOPHARMACOL, V18, P215, DOI 10.1177/0269881104042625; Herrmann N, 2001, CAN J NEUROL SCI, V28, pS96, DOI 10.1017/S0317167100001268; HERZ LR, 1992, HOSP COMMUNITY PSYCH, V43, P720; Hilton C, 2004, BEHAV COGN PSYCHOTH, V32, P457, DOI 10.1017/S1352465804001638; Holmberg SK, 1997, ARCH PSYCHIAT NURS, V11, P21, DOI 10.1016/S0883-9417(97)80046-5; Holmes C, 2004, NEUROLOGY, V63, P214, DOI 10.1212/01.WNL.0000129990.32253.7B; Hope T, 1999, BRIT J PSYCHIAT, V174, P39, DOI 10.1192/bjp.174.1.39; HORNE M, 1995, J CLIN PSYCHIAT, V56, P430; Hornstein A, 1996, BRAIN INJURY, V10, P145, DOI 10.1080/026990596124647; Howard R, 2001, INT J GERIATR PSYCH, V16, P714, DOI 10.1002/gps.418; HUSSIAN R A, 1988, Clinical Gerontologist, V8, P37; Hussian R. A, 1982, INT J BEHAV GERIATRI, V2, P33; HUSSIAN RA, 1987, J GERONTOL, V42, P558, DOI 10.1093/geronj/42.5.558; *INT COUNC HUM RIG, 2002, BEY VOL, P1; International Psychogeriatric Association, 1998, BEH PSYCH SYMPT DEM; JACKSON C, 1995, AM J PSYCHIAT, V152, P809; Jackson CW, 1996, J CLIN PSYCHIAT, V57, P372; Jansen IHM, 2001, J AM GERIATR SOC, V49, P474, DOI 10.1046/j.1532-5415.2001.49092.x; JENNETT B, 1975, LANCET, V1, P480; Jeste DV, 2000, AM J GERIAT PSYCHIAT, V8, P29, DOI 10.1097/00019442-200002000-00004; JONES SN, 1995, PROF PSYCHOL-RES PR, V26, P602, DOI 10.1037/0735-7028.26.6.602; Karli DC, 1999, BRAIN INJURY, V13, P63, DOI 10.1080/026990599121908; Katona CLE, 1998, INT J GERIATR PSYCH, V13, P100; Katz IR, 1999, J CLIN PSYCHIAT, V60, P107, DOI 10.4088/JCP.v60n0207; Kayser-Jones J, 1999, J AM GERIATR SOC, V47, P1187, DOI 10.1111/j.1532-5415.1999.tb05198.x; Kayser-Jones J, 1998, J AM GERIATR SOC, V46, P1378, DOI 10.1111/j.1532-5415.1998.tb06004.x; Kayser-Jones J, 1999, GERIATR NURS, V20, P77, DOI 10.1053/gn.1999.v20.97011; Kayser-Jones J, 1997, J Gerontol Nurs, V23, P14; Kazdin A. E., 1989, BEHAV MODIFICATION A; Keene J, 1999, INT J GERIATR PSYCH, V14, P541, DOI 10.1002/(SICI)1099-1166(199907)14:7<541::AID-GPS961>3.0.CO;2-P; Kessler R. C, 2007, METAANALYSIS EFFECTS; Kim E, 2002, J NEUROPSYCH CLIN N, V14, P202, DOI 10.1176/appi.neuropsych.14.2.202; Kim S, 2003, GERIATR NURS, V24, P239, DOI 10.1016/S0197-4572(03)00210-6; Kirkevold Oyvind, 2004, Br J Nurs, V13, P902; Krakowski M, 1997, COMPR PSYCHIAT, V38, P230, DOI 10.1016/S0010-440X(97)90031-6; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; Kruglov LS, 2003, INT J GERIATR PSYCH, V18, P402, DOI 10.1002/gps.844; Kyomen HH, 1999, AM J GERIAT PSYCHIAT, V7, P339; Lai CKY, 2004, INT PSYCHOGERIATR, V16, P33, DOI 10.1017/S1041610204000055; Lai CKY, 2003, J ADV NURS, V44, P173, DOI 10.1046/j.1365-2648.2003.02781.x; Lanctot K. L., 1998, J CLIN PSYCHIAT, V59, P562; Lanctot KL, 2002, INT J GERIATR PSYCH, V17, P531, DOI 10.1002/gps.636; Lanctot KL, 1998, J CLIN PSYCHIAT, V59, P550, DOI 10.4088/JCP.v59n1010; Landreville P, 1998, INT PSYCHOGERIATR, V10, P397; Lawlor BA, 2004, J CLIN PSYCHIAT, V65, P5; LAWLOR BA, 1994, INT J GERIATR PSYCH, V9, P55, DOI 10.1002/gps.930090112; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Libin Alexander, 2004, Am J Alzheimers Dis Other Demen, V19, P111, DOI 10.1177/153331750401900209; Lonergan E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003945.pub3; LOVELL BB, 1995, PSYCHIAT RES, V57, P7, DOI 10.1016/0165-1781(95)02550-G; Low LF, 2002, INT J GERIATR PSYCH, V17, P779, DOI 10.1002/gps.697; Loy C, 2004, COCHRANE DB SYST REV; Lyketsos CG, 2003, ARCH GEN PSYCHIAT, V60, P737, DOI 10.1001/archpsyc.60.7.737; Lyketsos CG, 1999, INT J GERIATR PSYCH, V14, P520, DOI 10.1002/(SICI)1099-1166(199907)14:7<520::AID-GPS983>3.0.CO;2-M; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P1686, DOI 10.1176/appi.ajp.157.10.1686; Maryniak O, 2001, BRAIN INJURY, V15, P167, DOI 10.1080/026990501458399; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; MATTES JA, 1985, AM J PSYCHIAT, V142, P1108; Matthews EA, 1996, J ADV NURS, V24, P439, DOI 10.1046/j.1365-2648.1996.02102.x; McCallion P, 1999, GERONTOLOGIST, V39, P546, DOI 10.1093/geront/39.5.546; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; Meehan KM, 2002, NEUROPSYCHOPHARMACOL, V26, P494, DOI 10.1016/S0893-133X(01)00365-7; Mega MS, 1999, ARCH NEUROL-CHICAGO, V56, P1388, DOI 10.1001/archneur.56.11.1388; Meythaler JM, 2001, BRAIN INJURY, V15, P321, DOI 10.1080/026990501750111274; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; Miller M D, 1989, J Geriatr Psychiatry Neurol, V2, P11, DOI 10.1177/089198878900200103; Miller S, 2001, GERIATR NURS, V22, P66, DOI 10.1067/mgn.2001.115200; Mintzer J, 2001, INT J GERIATR PSYCH, V16, pS71, DOI 10.1002/1099-1166(200112)16:1+<::AID-GPS568>3.0.CO;2-M; MISHARA BL, 1973, INT J AGING HUM DEV, V4, P133, DOI 10.2190/R2M1-9HF1-GVA2-BQQH; MOLLOY DW, 1991, ACTA PSYCHIAT SCAND, V84, P103, DOI 10.1111/j.1600-0447.1991.tb01429.x; Moniz-Cook E, 2003, CLIN PSYCHOL PSYCHOT, V10, P197, DOI 10.1002/cpp.370; Montgomery P, 2004, SLEEP MED REV, V8, P47, DOI 10.1016/S1087-0792(03)00026-1; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; Moretti R, 2003, DRUG AGING, V20, P1035, DOI 10.2165/00002512-200320140-00003; MORTON I, 1991, INT J GERIATR PSYCH, V6, P327, DOI 10.1002/gps.930060511; Mosher-Ashley P. M., 1999, J CLIN GEROPSYCHOLOG, V5, P265; Muller U, 1999, BRAIN INJURY, V13, P805, DOI 10.1080/026990599121197; Mulsant BH, 2004, J CLIN PSYCHIAT, V65, P1708, DOI 10.4088/JCP.v65n1217; NADAL M, 1993, INT J GERIATR PSYCH, V8, P265, DOI 10.1002/gps.930080311; Nagaratnam N, 2003, ARCH GERONTOL GERIAT, V36, P247, DOI 10.1016/S0167-4943(02)00169-3; Nagaratnam N, 1998, ALZ DIS ASSOC DIS, V12, P330, DOI 10.1097/00002093-199812000-00013; Negley E N, 1990, J Gerontol Nurs, V16, P29; Newburn G, 1999, BRAIN INJURY, V13, P637; Nyenhuis DL, 1998, J AM GERIATR SOC, V46, P1437, DOI 10.1111/j.1532-5415.1998.tb06015.x; NYTH AL, 1990, BRIT J PSYCHIAT, V157, P894, DOI 10.1192/bjp.157.6.894; OLAFSSON K, 1992, ACTA PSYCHIAT SCAND, V85, P453, DOI 10.1111/j.1600-0447.1992.tb03211.x; Olin JT, 2001, AM J GERIAT PSYCHIAT, V9, P400, DOI 10.1176/appi.ajgp.9.4.400; Onder G, 2005, BRIT J PSYCHIAT, V187, P450, DOI 10.1192/bjp.187.5.450; Opie J, 2002, INT J GERIATR PSYCH, V17, P6, DOI 10.1002/gps.493; Oslin DW, 2003, J CLIN PSYCHIAT, V64, P875, DOI 10.4088/JCP.v64n0804; Ouslander JG, 2003, J AM GERIATR SOC, V51, P1287; Parmalee D. X., 1998, BRAIN INJURY, V2, P305; PATEL V, 1992, PSYCHOL MED, V22, P211, DOI 10.1017/S0033291700032876; Perino C, 2001, BRAIN INJURY, V15, P139, DOI 10.1080/026990501458371; Peskind ER, 2005, ALZ DIS ASSOC DIS, V19, P23, DOI 10.1097/01.wad.0000155067.16313.5e; Petracca G, 1996, J NEUROPSYCH CLIN N, V8, P270; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Pollock BG, 2002, AM J PSYCHIAT, V159, P460, DOI 10.1176/appi.ajp.159.3.460; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; Porsteinsson AP, 2001, AM J GERIAT PSYCHIAT, V9, P58, DOI 10.1176/appi.ajgp.9.1.58; Proctor R, 1999, LANCET, V354, P26, DOI 10.1016/S0140-6736(98)08237-3; PUSEY H, 2000, MENTAL HLTH CARE, V3, P204; Rabheru Kiran, 2004, Can J Psychiatry, V49, p41S; Rabinowitz J, 2004, J CLIN PSYCHIAT, V65, P1329, DOI 10.4088/JCP.v65n1006; Ragneskog H, 2001, Int J Nurs Pract, V7, P146, DOI 10.1046/j.1440-172X.2001.00254.x; Ragneskog H, 1996, SCAND J CARING SCI, V10, P11, DOI 10.1111/j.1471-6712.1996.tb00304.x; Ranen NG, 1996, J NEUROPSYCH CLIN N, V8, P338; RASKIN A, 1988, PSYCHOPHARMACOL BULL, V24, P721; RATEY JJ, 1992, J CLIN PSYCHOPHARM, V12, P362; REEVE W, 1985, AGE AGEING, V14, P119, DOI 10.1093/ageing/14.2.119; REIFLER BV, 1989, AM J PSYCHIAT, V146, P45; Reinhard DL, 1996, ARCH PHYS MED REHAB, V77, P80, DOI 10.1016/S0003-9993(96)90225-7; Reisberg B, 1996, Int Psychogeriatr, V8 Suppl 3, P301; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; REISBERG B, 1987, J CLIN PSYCHIAT, V48, P9; Remington R, 1999, THESIS U MASSACHUSET; ROBICHAUD L, 1994, AM J OCCUP THER, V48, P355, DOI 10.5014/ajot.48.4.355; Rockwood K, 2001, J NEUROL NEUROSUR PS, V71, P589, DOI 10.1136/jnnp.71.5.589; ROSBERGER Z, 1983, INT J BEHAV GERIATRI, V1, P33; ROSEN J, 1994, AM J GERIAT PSYCHIAT, V2, P52, DOI 10.1097/00019442-199400210-00008; ROSIN AJ, 1977, GERONTOLOGY, V23, P37, DOI 10.1159/000212172; Rosler M, 1998, BEHAV NEUROL, V11, P211; Rovner BW, 1996, J AM GERIATR SOC, V44, P7, DOI 10.1111/j.1532-5415.1996.tb05631.x; Rowland Todd R., 1992, Archives of Physical Medicine and Rehabilitation, V73, P963; Rubin E H, 1988, J Geriatr Psychiatry Neurol, V1, P16, DOI 10.1177/089198878800100104; Sadavoy J, 2004, PSYCHOTROPIC DRUGS E, P240; Sadavoy J., 1989, PSYCHIAT CONSEQUENCE; Sadavoy J., 1991, AM J ALZHEIMERS DIS, V6, P12, DOI DOI 10.1177/153331759100600304; SANDERS JF, 1965, GERIATRICS, V20, P739; SATLIN A, 1992, AM J PSYCHIAT, V149, P1028; Schatzberg AF, 2002, AM J GERIAT PSYCHIAT, V10, P541, DOI 10.1176/appi.ajgp.10.5.541; SCHIFF HB, 1982, AM J PSYCHIAT, V139, P1346; SCHNEIDER LS, 1990, J AM GERIATR SOC, V38, P553, DOI 10.1111/j.1532-5415.1990.tb02407.x; Schneider WN, 1999, BRAIN INJURY, V13, P863; Scott J, 2003, CLIN PSYCHOL PSYCHOT, V10, P186, DOI 10.1002/cpp.369; SHAW SH, 1992, J INT MED RES, V20, P150, DOI 10.1177/030006059202000207; Shelton PS, 1997, ANN PHARMACOTHER, V31, P319, DOI 10.1177/106002809703100309; Showalter PEC, 2000, BRAIN INJURY, V14, P997; Showalter PEC, 2000, J NEUROPSYCH CLIN N, V12, P395; SIEGLER IC, 1994, PSYCHOL AGING, V9, P464, DOI 10.1037/0882-7974.9.3.464; SINHA D, 1992, PSYCHIAT RES, V41, P73, DOI 10.1016/0165-1781(92)90020-4; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596; Sival RC, 2002, INT J GERIATR PSYCH, V17, P579, DOI 10.1002/gps.653; Skovdahl K, 2004, J CLIN NURS, V13, P515, DOI 10.1046/j.1365-2702.2003.00881.x; Skovdahl K, 2003, J CLIN NURS, V12, P888, DOI 10.1046/j.1365-2702.2003.00809.x; Skovdahl K, 2003, AGING MENT HEALTH, V7, P277, DOI 10.1080/1360786031000120679; Slaughter J, 1999, BRAIN INJURY, V13, P59, DOI 10.1080/026990599121890; Sloane PD, 2004, J AM GERIATR SOC, V52, P1795, DOI 10.1111/j.1532-5415.2004.52501.x; Smallwood J, 2001, INT J GERIATR PSYCH, V16, P1010, DOI 10.1002/gps.473; SMITH KR, 1994, ARCH NEUROL-CHICAGO, V51, P653, DOI 10.1001/archneur.1994.00540190029012; Snowden M, 2003, J AM GERIATR SOC, V51, P1305, DOI 10.1046/j.1532-5415.2003.51417.x; SNYDER M, 1995, GERIATR NURS, V16, P60, DOI 10.1016/S0197-4572(05)80005-9; So CC, 2002, AM J CLIN PATHOL, V118, P225, DOI 10.1309/4TEF-LVGX-WEQ9-R8W8; SOLMS M, 2002, BRAIN INNERWORLD INT; Spayd C. S., 1988, MENTAL HLTH CONSULTA, P123; Spector A., 2003, COCHRANE DATABASE SY, V3; Spector A., 1999, COCHRANE DATABASE SY, V4; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; STANISLAV SW, 1994, J CLIN PSYCHOPHARM, V14, P126; Stanislav SW, 1997, BRAIN INJURY, V11, P335, DOI 10.1080/026990597123494; Stanislav SW, 2000, BRAIN INJURY, V14, P261; STEWART JT, 1988, J CLIN PSYCHIAT, V49, P74; STOTSKY B, 1984, CLIN THER, V6, P546; Strauss ME, 1997, ARCH NEUROL-CHICAGO, V54, P257, DOI 10.1001/archneur.1997.00550150021010; Streams ME, 2003, INT J GERIATR PSYCH, V18, P915, DOI 10.1002/gps.946; Street JS, 2000, ARCH GEN PSYCHIAT, V57, P968, DOI 10.1001/archpsyc.57.10.968; Street JS, 2001, INT J GERIATR PSYCH, V16, pS62, DOI 10.1002/1099-1166(200112)16:1+<::AID-GPS569>3.0.CO;2-J; Sultzer DL, 1997, AM J GERIAT PSYCHIAT, V5, P60; SUNDERLAND T, 1989, PSYCHOPHARMACOLOGY, V99, P129, DOI 10.1007/BF00634466; Suzuki Mizue, 2004, Nurs Health Sci, V6, P11, DOI 10.1111/j.1442-2018.2003.00168.x; SWEARER JM, 1988, J AM GERIATR SOC, V36, P784, DOI 10.1111/j.1532-5415.1988.tb04260.x; Tabloski PA, 1995, AM J ALZHEIMERS CARE, V10, P10, DOI DOI 10.1177/153331759501000105; Takahashi H, 2003, PROG NEURO-PSYCHOPH, V27, P549, DOI 10.1016/S0278-5846(03)00040-X; Taragano FE, 1997, PSYCHOSOMATICS, V38, P246, DOI 10.1016/S0033-3182(97)71461-0; Tariot P N, 1996, Int Psychogeriatr, V8 Suppl 3, P317; Tariot P. N, 1996, INT PSYCHOGERIATR S, V8, P351; Tariot PN, 1999, J CLIN PSYCHIAT, V60, P684, DOI 10.4088/JCP.v60n1007; TARIOT PN, 1994, J AM GERIATR SOC, V42, P1160, DOI 10.1111/j.1532-5415.1994.tb06982.x; Tariot PN, 1998, AM J PSYCHIAT, V155, P54, DOI 10.1176/ajp.155.1.54; Tariot PN, 2000, NEUROLOGY, V54, P2269, DOI 10.1212/WNL.54.12.2269; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; Tariot PN, 2001, J AM GERIATR SOC, V49, P1590, DOI 10.1111/j.1532-5415.2001.49266.x; Tariot PN, 2001, CURR THER RES CLIN E, V62, P51, DOI 10.1016/S0011-393X(01)80042-4; Taverni JP, 1998, BRAIN INJURY, V12, P77; TERI L, 1992, PSYCHOL AGING, V7, P622, DOI 10.1037/0882-7974.7.4.622; Thomas DW, 1997, J MUSIC THER, V34, P246, DOI 10.1093/jmt/34.4.246; THORGRIMSEN L, 2003, COCHRANE DATABASE SY; Tierney MC, 2004, J AM GERIATR SOC, V52, P1435, DOI 10.1111/j.0002-8614.2004.52404.x; Trannel TJ, 2001, AM J PSYCHIAT, V158, P128, DOI 10.1176/appi.ajp.158.1.128; Trinh NH, 2003, JAMA-J AM MED ASSOC, V289, P210, DOI 10.1001/jama.289.2.210; VACCARO FJ, 1988, INT J AGING HUM DEV, V26, P71, DOI 10.2190/XW6E-VYJE-6HYM-NAXG; VACCARO FJ, 1990, PSYCHOL AGING, V5, P369, DOI 10.1037/0882-7974.5.3.369; VACCARO FJ, 1988, PSYCHOL AGING, V3, P22, DOI 10.1037/0882-7974.3.1.22; Whall AL., 1997, AM J ALZHEIMERS DIS, V12, P216, DOI [10.1177/153331759701200506, DOI 10.1177/153331759701200506]; Whelihan W. M, PSYCHOTHERAPY ELDERL; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Woods, 1995, POSITIVE APPROACHES; WOODS P, 1995, GERIATR NURS, V16, P9, DOI 10.1016/S0197-4572(05)80072-2; WOODS RT, 1996, HDB CLIN PSYCHOL AGE, P575; Wooltorton E, 2002, CAN MED ASSOC J, V167, P1269; Wooltorton E, 2004, CAN MED ASSOC J, V170, P1395, DOI 10.1503/cmaj.1040539; WROBLEWSKI BA, 1992, J CLIN PSYCHIAT, V53, P86; WROBLEWSKI BA, 1990, J CLIN PSYCHOPHARM, V10, P124, DOI 10.1097/00004714-199004000-00009; Wroblewski BA, 1997, BRAIN INJURY, V11, P37, DOI 10.1080/026990597123791; Wystanski M, 2000, INT J GERIATR PSYCH, V15, P582, DOI 10.1002/1099-1166(200007)15:7<582::AID-GPS152>3.0.CO;2-5; Zafonte RD, 1998, BRAIN INJURY, V12, P617; ZIMMER JG, 1984, AM J PUBLIC HEALTH, V74, P1118, DOI 10.2105/AJPH.74.10.1118; Zisselman MH, 1996, AM J OCCUP THER, V50, P47, DOI 10.5014/ajot.50.1.47	342	6	6	0	6	CAMBRIDGE UNIV PRESS	CAMBRIDGE	THE PITT BUILDING, TRUMPINGTON ST, CAMBRIDGE CB2 1RP, CAMBS, ENGLAND			978-0-52184-228-0				2008							187	216		10.1017/CBO9780511544392.012	10.1017/CBO9780511544392		30	Psychiatry	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychiatry	BYF84	WOS:000298475100012					2022-02-06	
J	Weiner, MF; Vega, GL; Diaz-Arrastia, R; Moore, C; Madden, C; Hudak, A; Lutjohann, D				Weiner, Myron F.; Vega, Gloria L.; Diaz-Arrastia, Ramon; Moore, Carol; Madden, Christopher; Hudak, Anne; Luetjohann, Dieter			Plasma 24S-hydroxycholesterol and other oxysterols in acute closed head injury	BRAIN INJURY			English	Article						closed head injury; 24-S-hydroxycholesterol; oxysterols	TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; CHOLESTEROL HOMEOSTASIS; CEREBROSPINAL-FLUID; DAMAGE; PROTEIN; TAU; S100B; CIRCULATION; METABOLISM	Primary objective: To determine if plasma levels of 24S-hydroxycholesterol, the primary catabolite of brain cholesterol, provide a measure of axonal damage in acute brain trauma. Research design: Determination of plasma 24S-hydroxycholesterol in a series of persons admitted to an intensive care unit for treatment of closed head injury. Methods and procedures: Levels of 24-S-hydroxycholesterol, 27-hydroxycholesterol, lathosterol and total cholesterol were measured in peripheral blood from 38 persons from 14-55 years of age treated by craniotomy and ventriculostomy for intractable intracerebral hypertension. Severity of brain injury was estimated by the Glasgow Coma Scale (range = 3-13, median = 6 points) and overall injury by the Injury Severity Scale (range = 10-48, median = 29). All subjects were intubated and anaesthetized with intravenous propofol. Plasma sterol levels were compared with those of age-matched control subjects. Outcomes and results: There was no significant increase in plasma 24-S-hydroxycholesterol in subjects with head injury, but measures of peripheral cholesterol synthesis were markedly reduced as compared with values for age-matched normal control subjects. Conclusion: Plasma 24S-hydroxycholesterol levels do not change with severe closed head injury.	[Weiner, Myron F.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Weiner, Myron F.; Diaz-Arrastia, Ramon; Moore, Carol] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Vega, Gloria L.] Univ Texas SW Med Ctr Dallas, Dept Clin Nutr, Dallas, TX 75390 USA; [Vega, Gloria L.] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA; [Madden, Christopher] Univ Texas SW Med Ctr Dallas, Dept Neurosurg, Dallas, TX 75390 USA; [Hudak, Anne] Univ Texas SW Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Luetjohann, Dieter] Univ Bonn, Dept Clin Pharmacol, D-5300 Bonn, Germany		Weiner, MF (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	myron.weiner@utsouthwestern.edu		Weiner, Myron/0000-0001-5682-4410; Diaz-Arrastia, Ramon/0000-0001-6051-3594	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [K12 RR023251] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG012300, P-30-AG12300] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [K12RR023251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG012300] Funding Source: NIH RePORTER		BAKALAR B, 2003, WIENER KLINISCHE WOC, V115, P9; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Bretillon L, 2000, J LIPID RES, V41, P840; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; DUNHAM CM, 2003, CRITICAL CARE, V7, P413; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; Holdenrieder S, 2004, NEUROSCI LETT, V368, P201, DOI 10.1016/j.neulet.2004.07.012; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; LUTJOHANN D, 1995, J LIPID RES, V36, P1763; Lutjohann D, 2000, J LIPID RES, V41, P195; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; TEASDALE G, 1974, LANCET, V2, P81; Vega GL, 2003, ARCH NEUROL-CHICAGO, V60, P510, DOI 10.1001/archneur.60.4.510; Vega GL, 2004, CURR ALZHEIMER RES, V1, P71, DOI 10.2174/1567205043480546; Weiss N, 2006, ANESTHESIOLOGY, V104, P658, DOI 10.1097/00000542-200604000-00008; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7	24	6	6	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2008	22	7-8					611	615		10.1080/02699050802196037			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	318MG	WOS:000257095300013	18568715	Green Accepted			2022-02-06	
J	Jaul, E; Calderon-Margalit, R				Jaul, Efraim; Calderon-Margalit, Ronit			Persistent vegetative state and dementia in the elderly	INTERNATIONAL PSYCHOGERIATRICS			English	Article						vegetative state; elderly; terminal dementia	DISABILITY RATING-SCALE; TRAUMATIC BRAIN INJURY; MEDICAL ASPECTS; COMA; CONSCIOUSNESS; MANAGEMENT; DISORDERS; DIAGNOSIS; DISEASE	Background: Very few studies have approached the issue of persistent vegetative state (PVS) within the elderly population. This study aims to assess the prevalence, determinants and prognosis of elderly patients with PVS admitted to a long-term geriatric facility. Methods: We conducted a cohort study in the setting of a Skilled Geriatric Nursing Department. All patients admitted during a 17-month period (N = 88) were included and tested for a diagnosis of PVS according to the Disability Rating Scale (DRS). Results: A clinical diagnosis of PVS was given to 15% of patients upon admission, whereas the DRS diagnosed 30.5% of patients as having PVS. During the study period, 12 out of 31 patients with PVS died, with a median survival of 127 days (range: 1-517 days). Conclusion: Our study suggests that PVS is an advanced stage in the natural history of dementia in the elderly. The low proportion of patients with PVS recognized as having this disorder upon admission suggests a low awareness among hospital personnel. Further studies of the prevalence and determinants of PVS in the severely disabled elderly population are warranted.	[Jaul, Efraim] Herzog Hosp, Skilled Geriatr Nursing Dept, Jerusalem, Israel; [Jaul, Efraim] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel; [Calderon-Margalit, Ronit] Hadassah Hebrew Univ, Braun Sch Publ Hlth & Community Med, Jerusalem, Israel		Jaul, E (corresponding author), Herzog Hosp, Dept Skilled Nursing, POB 35300, IL-91351 Jerusalem, Israel.	jaul@zahav.net.il					Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bates D, 2003, CLIN MED, V3, P249; Dyer C, 2003, BRIT MED J, V327, P67, DOI 10.1136/bmj.327.7406.67; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; KAUFMAN DM, 1992, NEW YORK STATE J MED, V92, P381; Lavrijsen JCM, 2005, J NEUROL NEUROSUR PS, V76, P1420, DOI 10.1136/jnnp.2004.058198; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Mann Jodi L, 2005, Consult Pharm, V20, P306, DOI 10.4140/TCP.n.2005.306; Mitrani VB, 2006, GERONTOLOGIST, V46, P97, DOI 10.1093/geront/46.1.97; Norton D, 1989, Decubitus, V2, P24; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; TALBOT LR, 1994, BRAIN INJURY, V8, P689, DOI 10.3109/02699059409151023; TEASDALE G, 1974, LANCET, V2, P81; TRESCH DD, 1991, ARCH INTERN MED, V151, P930, DOI 10.1001/archinte.151.5.930; Volicer L, 2001, CLIN GERIATR MED, V17, P377, DOI 10.1016/S0749-0690(05)70074-4; Volicer L, 1997, ARCH NEUROL-CHICAGO, V54, P1382, DOI 10.1001/archneur.1997.00550230051016; WALSHE TM, 1985, ARCH NEUROL-CHICAGO, V42, P1045, DOI 10.1001/archneur.1985.04060100027014; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; [No title captured]	23	6	6	0	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1041-6102			INT PSYCHOGERIATR	Int. Psychogeriatr.	DEC	2007	19	6					1064	1071		10.1017/S104161020600473X			8	Psychology, Clinical; Geriatrics & Gerontology; Gerontology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Geriatrics & Gerontology; Psychiatry	243DI	WOS:000251774700006	17234039				2022-02-06	
J	Merchant, RC; Zabbo, CP; Mayer, KH; Becker, BM				Merchant, Roland C.; Zabbo, Christopher P.; Mayer, Kenneth H.; Becker, Bruce M.			Factors associated with delay to emergency department presentation, antibiotic usage and admission for human bite injuries	CANADIAN JOURNAL OF EMERGENCY MEDICINE			English	Article						human bites; prophylaxis; antibiotics; emergency medicine; wound infection		Objectives: Evidence and consensus on best practices on the management of human bite injuries is lacking. Our objective was to identify factors that are associated with delay to emergency department (ED) presentation, antibiotic usage and patient admission. Methods: We present a retrospective chart review of adults treated for human bites. Multivariable logistic regression models used demographic characteristics and bite circumstances and characteristics as factors associated with ED presentation more than 24 hours after the bite, antibiotic usage and hospital admission. Results: Of the 388 patients evaluated for a human bite, 66.5% were bitten during an altercation; 23.8% presented more than 24 hours after the bite; 50.3% were bitten on the hands or fingers, 23.5% on an extremity and 17.8% on the head or neck. Only 7.7% of all patients sustained closed-fist injuries; the majority had occlusional or other kinds of bites. The majority of patients (77.3%) received antibiotics and 11.1% were admitted to hospital. Patients who had greater odds of presenting more than 24 hours after the bite were black (odds ratio [OR] 1.79, 95% confidence interval [CI] 1.02-3.13), Hispanic (OR 2.68, 95% CI 1.22-5.89) and those who had a non-occupational bite (OR 3.87, 95% CI, 1.68-8.90). Patients had a greater chance of receiving antibiotics if they were bitten during an altercation (OR 1.87, 95% CI, 1.09-3.20) and were bitten on the hands or fingers (OR 2.23, 95% CI 1.31-3.80). Patients had a greater chance of being admitted to the hospital if they were bitten during an altercation (OR 4.91, 95% CI 1.65-14.64), bitten on the hands or fingers (OR 5.26, 95% CI, 1.74-15.87) and if they presented >= 24 hours after the bite. Conclusion: Most patients presented to the ED within 24 hours of their injury and received antibiotics. The circumstances surrounding the bite appeared to be associated with delay to ED presentation, receipt of antibiotics and admission to the hospital. There are ethnic background differences in delay to ED presentation. ED clinicians in our study favour antibiotic usage and admission based on the body location of the bite, despite little evidence to support these practices.	[Merchant, Roland C.; Zabbo, Christopher P.; Becker, Bruce M.] Brown Univ, Dept Emergency Med, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA; [Merchant, Roland C.; Mayer, Kenneth H.; Becker, Bruce M.] Brown Univ, Dept Community Hlth, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA; [Mayer, Kenneth H.] Brown Univ, Dept Med, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA		Merchant, RC (corresponding author), Rhode Isl Hosp, Dept Emergency Med, 593 Eddy St,Claverick Bldg, Providence, RI 02903 USA.	rmerchant@lifespan.org			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 AI42853]; Warren Alpert Medical School of Brown University; The Miriam Hospital; National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [5 T32 DA13911]; Rhode Island Foundation; Elizabeth Glaser Pediatric AIDS Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA013911] Funding Source: NIH RePORTER	Dr. Merchant was supported by a National Institutes of Health training grant through the Division of Infectious Diseases, Warren Alpert Medical School of Brown University, The Miriam Hospital, from the National Institute on Drug Abuse, 5 T32 DA13911. This study was supported in part by grants from the National Institutes of Health to the Brown/Lifespan/Tufts Centers for AIDS Research (P30 AI42853), the Rhode Island Foundation, and the Elizabeth Glaser Pediatric AIDS Foundation.	BADDOUR LM, 2006, SOFT TISSUE INFECT D; Broder J, 2004, AM J EMERG MED, V22, P10, DOI 10.1016/j.ajem.2003.09.004; Bunzli WF, 1998, PHARMACOTHERAPY, V18, P227; CALLAHAM M, 1988, ANN EMERG MED, V17, P1321, DOI 10.1016/S0196-0644(88)80359-7; DEMETRIADES D, 1989, S AFR J SURG, V27, P185; DOUGLAS LG, 1975, AM FAM PHYSICIAN, V11, P93; GILBERT DN, 2006, SANFORD GUIDE ANTIMI; GOLDSTEIN EJC, 1992, CLIN INFECT DIS, V14, P633, DOI 10.1093/clinids/14.3.633; GRIEGO RD, 1995, J AM ACAD DERMATOL, V33, P1019, DOI 10.1016/0190-9622(95)90296-1; Kelleher AT, 1997, CLEV CLIN J MED, V64, P137, DOI 10.3949/ccjm.64.3.137; MARTIN LT, 1987, POSTGRAD MED, V81, P221, DOI 10.1080/00325481.1987.11699828; Medeiros I., 2001, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001738; Morgan M, 2005, J HOSP INFECT, V61, P1, DOI 10.1016/j.jhin.2005.02.007; SCHWAB RA, 2004, TINTINALLIS EMERGENC, P324; Talan DA, 2003, CLIN INFECT DIS, V37, P1481, DOI 10.1086/379331; Weber EJ, 2006, ROSENS EMERGENCY MED, P882; WOLFSON AB, 2005, HARWOOD NUSS CLIN PR, P1644	17	6	6	0	0	DECKER PUBL INC	HAMILTON	69 JOHN ST S, STE 310, HAMILTON, ONTARIO L8N 2B9, CANADA	1481-8035			CAN J EMERG MED	Can. J. Emerg. Med.	NOV	2007	9	6					441	448					8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	V12JY	WOS:000207596700006	18072990				2022-02-06	
J	O'Malley, AJ; Marcantortio, ER; Murkofsky, RL; Caudry, DJ; Buchanan, JL				O'Malley, A. James; Marcantortio, Edward R.; Murkofsky, Rachel L.; Caudry, Daryl J.; Buchanan, Joan L.			Deriving a model of the necessity to hospitalize nursing home residents	RESEARCH ON AGING			English	Article						hierarchical model; model-validity test; nursing home residents; Modified Delphi methods; predicting hospitalization	POTENTIALLY PREVENTABLE HOSPITALIZATIONS; LONG-TERM; OWNERSHIP TYPE; RATES; RISK	Although often important to recover from acute medical problems and exacerbations of chronic illness, hospitalizations can be traumatic for nursing home residents and costly for payers. It is important that unnecessary hospitalizations are avoided wherever possible. The authors derived and validated a diagnosisbased model to estimate the clinical necessity of hospitalizing nursing home residents with common conditions using data from an expert panel survey. Model validation involved a linked minimum data set-hospitalization claims data set. The expert panel of 12 experienced geriatricians rated the necessity of hospitalization for 1,948 clinical scenarios containing diagnoses, cognitive and functional status, age, gender, and advance directives. Primary diagnoses with the highest average necessity scores were respiratory failure, acute myocardial infarction, hip fracture, and brain injury. The secondary diagnosis-primary diagnosis interaction with the greatest impact was gastrointestinal bleed on gastroenteritis. Poor cognitive function and presence of an advance directive lowered the risk of hospitalization.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Cambridge, MA 02138 USA; Univ Hawaii, John A Burns Sch Med, Dept Geriatr Med, Honolulu, HI 96822 USA		O'Malley, AJ (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Cambridge, MA 02138 USA.		Marcantonio, Edward/U-3929-2017	Marcantonio, Edward/0000-0002-2911-4250			Ackermann RJ, 1998, ANN EMERG MED, V31, P749, DOI 10.1016/S0196-0644(98)70235-5; Agresti A., 2013, CATEGORICAL DATA ANA, V3; ANDERSON GFD, 1989, PAYMENT AMOUNT CAPIT; Buchanan JL, 2006, J AM GERIATR SOC, V54, P458, DOI 10.1111/j.1532-5415.2005.00620.x; Carter MW, 2003, GERONTOLOGIST, V43, P175, DOI 10.1093/geront/43.2.175; CLARK JD, 1990, SOC SCI MED, V30, P67, DOI 10.1016/0277-9536(90)90330-U; *CTR MED MED SERV, 2003, FED REGISTER, V68, P45351; Culler SD, 1998, MED CARE, V36, P804, DOI 10.1097/00005650-199806000-00004; DALKEY NC, 1972, STUDIES QUALITY LIFE, P1; ELLI RP, 1988, REFINING DIAGNOSTIC; FOLLAND S, 1989, J HEALTH ECON, V8, P85, DOI 10.1016/0167-6296(89)90010-6; Fried TR, 1997, J AM GERIATR SOC, V45, P265, DOI 10.1111/j.1532-5415.1997.tb00938.x; GILLICK M, 1983, J AM GERIATR SOC, V31, P74, DOI 10.1111/j.1532-5415.1983.tb05418.x; GILLICK MR, 1982, SOC SCI MED, V16, P1033, DOI 10.1016/0277-9536(82)90175-7; Intrator O, 2004, J AM GERIATR SOC, V52, P1730, DOI 10.1111/j.1532-5415.2004.52469.x; Intrator O, 2004, J AM GERIATR SOC, V52, P393, DOI 10.1111/j.1532-5415.2004.52111.x; KNICKMAN JR, 1985, INQUIRY-J HEALTH CAR, V22, P45; Konetzka RT, 2004, MED CARE, V42, P1001, DOI 10.1097/00005650-200410000-00009; LEFEVRE F, 1992, ARCH INTERN MED, V152, P2074, DOI 10.1001/archinte.152.10.2074; LEFF B, 1986, J AM GERIATR SOC, V47, P697; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; MORRIS JN, 1999, J GERONTOLOGY MED SC, V54; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; Saliba D, 2000, J AM GERIATR SOC, V48, P154, DOI 10.1111/j.1532-5415.2000.tb03906.x; Scott H D, 1988, R I Med J, V71, P69; Spector WD, 1998, HEALTH ECON, V7, P639, DOI 10.1002/(SICI)1099-1050(1998110)7:7<639::AID-HEC373>3.0.CO;2-0; TERESI JA, 1991, GERONTOLOGIST, V31, P795, DOI 10.1093/geront/31.6.795; Thompson RS, 1999, J FAM PRACTICE, V48, P291; Zimmerman S, 2002, J AM GERIATR SOC, V50, P1987, DOI 10.1046/j.1532-5415.2002.50610.x	29	6	6	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0164-0275	1552-7573		RES AGING	Res. Aging	NOV	2007	29	6					606	625		10.1177/0164027507305731			20	Gerontology	Social Science Citation Index (SSCI)	Geriatrics & Gerontology	222MS	WOS:000250302200006					2022-02-06	
J	Inaba, K; Teixeira, PGR; David, JS; Brown, C; Salim, A; Rhee, P; Browder, T; Dubose, J; Demetriades, D				Inaba, Kenji; Teixeira, Pedro G. R.; David, Jean-Stephane; Brown, Carlos; Salim, Ali; Rhee, Peter; Browder, Timothy; Dubose, Joseph; Demetriades, Demetrios			Computed tomographic brain density measurement as a predictor of elevated intracranial pressure in blunt head trauma	AMERICAN SURGEON			English	Article; Proceedings Paper	18th Annual Meeting of the Southern California Chapter of the American-College-of-Surgeons	JAN 19-21, 2007	Santa Barbara, CA	Amer Coll Surg, So Calif Chapter			SCAN; MONITOR; GRAVITY	There are no independent computed tomography (CT) findings predictive of elevated intracranial pressure (ICP). The purpose of this study was to evaluate brain density measurement on CT as a predictor of elevated ICP or decreased cerebral perfusion pressure (CPP). A prospectively collected database of patients with acute traumatic brain injury was used to identify patients who had a brain CT followed within 2 hours by ICP measurement. Blinded reviewers measured mean density in Hounsfield Units (HU) within a 100-mm(2) elliptical region at four standardized positions. Brain density measurement was compared for patients with an ICP of 20 or greater versus less than 20 mm Hg and CPP of 70 or greater versus less than 70 mm Hg. During a 2-year period, 47 patients had ICP monitoring after brain CT. Average age was 40 18 years old; 93.6 per cent were male; mean Injury Severity Score was 25 10; and Glasgow Coma Scale was 6 +/- 4. There was no difference in brain density measurement for observer 1, ICP less than 20 (26.3 HU) versus ICP 20 or greater (27.4 HU, P = 0.545) or for CPP less than 70 (27.1 HU) versus CPP 70 or greater (26.2, P = 0.624). Similarly, there was no difference for observer 2, ICP less than 20 (26.8 HU) versus ICP 20 or greater (27.4, P = 0.753) and CPP less than 70 (27.6 HU) versus CPP 70 or greater (26.2, P = 0.436). CT-measured brain density does not correlate with elevated ICP or depressed CPP and cannot predict patients with traumatic brain injury who would benefit from invasive ICP monitoring.	Univ So Calif, USC LAC Med Ctr, Los Angeles, CA 90033 USA; Univ So Calif, Div Trauma Surg & Surg Crit Care, Los Angeles, CA 90033 USA; Univ Lyon 1, Dept Anesthesiol & Crit Care, F-69365 Lyon, France		Inaba, K (corresponding author), Univ So Calif, USC LAC Med Ctr, 1200 N State St,Room 10-750, Los Angeles, CA 90033 USA.	Klnaba@surgery.usc.edu	David, Jean Stephane/H-9399-2019; INABA, KENJI/AAC-8532-2020; Teixeira, Pedro/H-2239-2011	David, Jean Stephane/0000-0001-6274-7044; Teixeira, Pedro/0000-0002-7258-7977			Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; Degos V, 2006, ANESTH ANALG, V103, P1229, DOI 10.1213/01.ane.0000237401.22688.22; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Hirsch W, 2000, PEDIATR RADIOL, V30, P439, DOI 10.1007/s002470000255; Khan SH, 1998, ACT NEUR S, V71, P50; Ko K, 2003, J TRAUMA, V55, P480, DOI 10.1097/01.TA.0000074111.04885.28; Lescot T, 2005, INTENS CARE MED, V31, P1042, DOI 10.1007/s00134-005-2709-y; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; MIZUTANI T, 1990, SURG NEUROL, V33, P178, DOI 10.1016/0090-3019(90)90181-N; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P479, DOI DOI 10.1089/NEU.2000.17.479	11	6	7	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	OCT	2007	73	10					1023	1026					4	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	221OH	WOS:000250236700022	17983073				2022-02-06	
J	Santhanam, R; Pillai, SV; Kolluri, SVR; Rao, UM				Santhanam, R.; Pillai, Shibu V.; Kolluri, Sastry V. R.; Rao, U. M.			Intensive care management of head injury patients without routine intracranial pressure monitoring	NEUROLOGY INDIA			English	Article						guidelines; intensive care; mortality; predictors; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; BRAIN-INJURIES; MORTALITY; PREDICTION; PROGNOSIS; THERAPY; RISK; DETERMINANTS; DYSFUNCTION	Background: Head injury contributes significantly to mortality and morbidity in India. Evaluation of the available trauma care facilities may help improve outcome. Aim: To evaluate the factors influencing the mortality of patients with head injury who had intensive care management and evolve strategies to improve outcome. Setting and Design: Retrospective study in a tertiary hospital where intracranial pressure monitoring (ICPM) is not routinely practiced. Materials and Methods: All patients with head injury managed in the intensive care unit in a two-year period were included. The factors evaluated were age, vital signs, Glasgow Coma scale score (GCS) at admission, pupillary light reflex (PR), oculocephalic reflex (OCR), hemodynamic stability, computerized tomography (CT) findings, diabetes mellitus, anemia, infections and abnormalities of serum sodium. Results: We analyzed 208 patients (202 without ICPM). In-hospital mortality was 64 (31%). Only 24 (11.5%) patients were admitted within one hour of injury, while one-third arrived after six hours. The clinical factors (at admission) that influenced mortality included age, GCS, PR, OCR and diastolic blood pressure (DBP). Effacement of the basal cisterns in the initial and repeat CT scans, hyperglycemia, hemodynamic instability and serum sodium imbalances were associated with higher mortality. The independent predictors of mortality by logistic regression were initial GCS, DBP, hemodynamic instability and effacement of cisterns on repeat CT. Conclusions: Mortality following head injury is high. Pre-hospital emergency medical services are disorganized. The key to reducing mortality within the limitations of our current trauma system is maintenance of DBP>70 mmHg and SBP >90 mmHg from the time of first contact.	[Santhanam, R.; Pillai, Shibu V.; Kolluri, Sastry V. R.] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India; [Rao, U. M.] Natl Inst Mental Hlth & Neurosci, Dept Neuroanaethesia, Bangalore 560029, Karnataka, India		Pillai, SV (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India.	drshibupillai@hotmail.com					Agarwal SR, 2006, NEUROL INDIA, V54, P13, DOI 10.4103/0028-3886.24695; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Ahmad FU, 2006, NEUROL INDIA, V54, P73; Boto GR, 2006, J NEUROL NEUROSUR PS, V77, P1054, DOI 10.1136/jnnp.2005.087056; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Ewig S, 1999, AM J RESP CRIT CARE, V159, P188, DOI 10.1164/ajrccm.159.1.9803097; GHAJAR JB, 1996, NEUROTRAUMA; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; HANS P, 1985, INTENS CARE MED, V11, P186, DOI 10.1007/BF00272401; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Joseph M, 2003, NEUROL INDIA, V51, P333; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; Lerner EB, 2003, ACAD EMERG MED, V10, P949, DOI 10.1197/S1069-6563(03)00313-0; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MOCK CN, 1993, J TRAUMA, V35, P518, DOI 10.1097/00005373-199310000-00004; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; NARAYAN RK, 1989, TXB HEAD INJURY, P420; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Parsons MW, 2002, ANN NEUROL, V52, P20, DOI 10.1002/ana.10241; Pillai S, 2004, NEUROL INDIA, V52, P67; Pillai SV, 2003, NEUROL INDIA, V51, P345; Ratanalert S, 2002, BRIT J NEUROSURG, V16, P487, DOI 10.1080/0268869021000030311; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Sirvent JM, 1997, AM J RESP CRIT CARE, V155, P1729, DOI 10.1164/ajrccm.155.5.9154884; TEASDALE G, 1974, LANCET, V2, P81; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Van KD, 2003, ESIS PUBL, V31, P3, DOI 10.1016/S1566-1369(03)80002-X; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; Wilkins IA, 2001, ANAESTHESIA, V56, P350, DOI 10.1046/j.1365-2044.2001.01708.x	44	6	6	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	OCT-DEC	2007	55	4					349	354					6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	242UB	WOS:000251750600007	18040107				2022-02-06	
J	Xi, ZQ; Wang, LY; Sun, JJ; Liu, XZ; Zhu, X; Xiao, F; Guan, LF; Li, JM; Wang, L; Wang, XF				Xi, Zhi-Qin; Wang, Lin-Yuan; Sun, Ji-Jun; Liu, Xian-Zeng; Zhu, Xi; Xiao, Fei; Guan, Li-Feng; Li, Jin-Mei; Wang, Liang; Wang, Xue-Feng			TDAG51 in the anterior temporal neocortex of patients with intractable epilepsy	NEUROSCIENCE LETTERS			English	Article						T cell death-associated gene 51; epilepsy; apoptosis; patients	KAINATE-INDUCED SEIZURES; PROTEIN-KINASE-C; TRAUMATIC BRAIN-INJURY; ADULT-RAT BRAIN; LOBE EPILEPSY; STATUS EPILEPTICUS; CELL-DEATH; HIPPOCAMPAL SCLEROSIS; INCREASED EXPRESSION; ANTIEPILEPTIC DRUGS	TDAG51 (T cell death-associated gene 5 1) is an apoptosis-associated protein. Our aim was to investigate TDAG51 expression in the anterior temporal neocortex of patients with intractable epilepsy (IE), and then to discuss the possible role of TDAG51 in IE. Tissue samples from the anterior temporal neocortex of 33 patients who had surgery for IE were used to detect TDAG51 expression by immumohistochernistry, immunofluorescence, and Western blotting. We compared these tissues with nine histologically normal anterior temporal lobes from intracranial hypertension patients who had decompression procedures. TDAG51 was mainly expressed in the cytoplasm of neurons and glial cells. TDAG51 in IE was significantly higher than that in the controls. These findings were consistently observed using Western blotting, immunofluorescence, and inummohistochemistry techniques. TDAG51 in patients with IE was significantly higher when compared with levels in the controls. This finding suggests TDAG51 is consistent with a possible role of this gene in the evolution of the pathology in IE. (c) 2007 Elsevier Ireland Ltd. All rights reserved.	Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing 400016, Peoples R China; Peking Univ, Sch Publ Hlth, Beijing 100083, Peoples R China; Peking Univ, Peoples Hosp, Dept Neurol, Beijing 100044, Peoples R China		Wang, XF (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, 1 You Yi Rd, Chongqing 400016, Peoples R China.	xfyp@163.com			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [98-1-3457] Funding Source: Medline		Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Chengyun D, 2006, NEUROL SCI, V27, P245, DOI 10.1007/s10072-006-0678-8; CREWS FT, 1992, J NEUROCHEM, V58, P1205, DOI 10.1111/j.1471-4159.1992.tb11330.x; Dawodu S, 2005, EPILEPSIA, V46, P23, DOI 10.1111/j.0013-9580.2005.21804.x; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1422, DOI 10.1001/archneur.57.10.1422; Ekdahl CT, 2003, NEUROBIOL DIS, V14, P513, DOI 10.1016/j.nbd.2003.08.022; Epsztein J, 2006, J NEUROSCI, V26, P7082, DOI 10.1523/JNEUROSCI.1666-06.2006; FUJIKAWA DG, 2005, EPILEPSY BEHAV S, V3, P3; Henshall DC, 2000, NEUROLOGY, V55, P250, DOI 10.1212/WNL.55.2.250; Henshall DC, 2001, CELL DEATH DIFFER, V8, P1169, DOI 10.1038/sj.cdd.4400921; Hinz T, 2001, CELL SIGNAL, V13, P345, DOI 10.1016/S0898-6568(01)00141-3; Hossain GS, 2003, J BIOL CHEM, V278, P30317, DOI 10.1074/jbc.M212897200; Huemer M, 2005, EPILEPSIA, V46, P1677, DOI 10.1111/j.1528-1167.2005.00264.x; Jeon SH, 2000, EXP MOL MED, V32, P227, DOI 10.1038/emm.2000.37; Jiang W, 2005, J NEUROSCI RES, V81, P581, DOI 10.1002/jnr.20566; Kwan P, 2005, EPILEPSIA, V46, P224, DOI 10.1111/j.0013-9580.2005.31904.x; Larner SF, 2005, J NEUROCHEM, V94, P97, DOI 10.1111/j.1471-4159.2005.03172.x; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; Li JM, 2006, BIOCHEM BIOPH RES CO, V348, P1389, DOI 10.1016/j.bbrc.2006.08.010; LI Y, 1997, DYNAMICS SMALL CONFI, V3, P301; McNamara RK, 2000, J NEUROSCI RES, V62, P416, DOI 10.1002/1097-4547(20001101)62:3<416::AID-JNR12>3.0.CO;2-V; Mielke K, 1999, NEUROSCIENCE, V91, P471, DOI 10.1016/S0306-4522(98)00667-8; MIZRAHI EM, 1990, EPILEPSIA, V31, P302, DOI 10.1111/j.1528-1157.1990.tb05380.x; Narkilahti S, 2003, NEUROPHARMACOLOGY, V44, P1068, DOI 10.1016/S0028-3908(03)00115-1; Neef R, 2002, CANCER RES, V62, P5920; Oberg HH, 2004, CELL DEATH DIFFER, V11, P674, DOI 10.1038/sj.cdd.4401407; Ozbas-Gerceker F, 2004, NEUROPATH APPL NEURO, V30, P651, DOI 10.1111/j.1365-2990.2004.00582.x; Park CG, 1996, IMMUNITY, V4, P583, DOI 10.1016/S1074-7613(00)80484-7; Rambeck B, 2006, EPILEPSIA, V47, P681, DOI 10.1111/j.1528-1167.2006.00504.x; Rho J, 2001, MOL CELL BIOL, V21, P8365, DOI 10.1128/MCB.21.24.8365-8370.2001; Riikonen R, 1999, EPILEPSIA, V40, P1642, DOI 10.1111/j.1528-1157.1999.tb02051.x; Sen A, 2006, J NEUROPATH EXP NEUR, V65, P55, DOI 10.1097/01.jnen.0000195940.48033.a2; Sisodiya SM, 2003, EPILEPSIA, V44, P1388, DOI 10.1046/j.1528-1157.2003.21803.x; Tan ZQ, 2001, NEUROREPORT, V12, P1979, DOI 10.1097/00001756-200107030-00040; Tang FR, 2004, HIPPOCAMPUS, V14, P87, DOI 10.1002/hipo.10156; Toyoshima Y, 2004, J BIOL CHEM, V279, P25898, DOI 10.1074/jbc.M400661200; Wang RX, 1998, J IMMUNOL, V161, P2201; Wu GS, 2005, J NEUROSCI, V25, P11014, DOI 10.1523/JNEUROSCI.3635-05.2005; Yamamoto A, 2006, J NEUROPATH EXP NEUR, V65, P217, DOI 10.1097/01.jnen.0000202886.22082.2a; Zucchini S, 2005, EPILEPSIA, V46, P52, DOI 10.1111/j.1528-1167.2005.01009.x	40	6	6	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	SEP 20	2007	425	1					53	58		10.1016/j.neulet.2007.08.016			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	222IQ	WOS:000250290100011	17870236				2022-02-06	
J	De Souza, M; Moncure, M; Lansford, T; Albaugh, G; Tarnoff, M; Goodman, M; Endress, R; Ross, SE				De Souza, Michelle; Moncure, Michael; Lansford, Todd; Albaugh, Gregory; Tarnoff, Michael; Goodman, Martin; Endress, Ryan; Ross, Steven E.			Nonoperative management of epidural Hematomas and subdural hematomas: Is it safe in lesions measuring one centimeter or less?	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							EXTRADURAL HEMATOMAS; HEAD-INJURIES	Background: Management of a patient with a closed head injury is based on neurologic status and computerized tomography scan results. We hypothesized that those patients with an epidural hematoma (EDH) or subdural hematoma (SDH) < 1 cm in thickness could safely be treated nonoperatively. Methods: We retrospectively reviewed charts of 204 consecutive patients with either an EDH or SDH. Results: There were 122 lesions :51 cm and 82 lesions > 1 cm. In the first group, 115 were managed nonoperatively, with 111 good outcomes (minimal deficit with a Rancho Los Amigos score [RLAS] >= 3), two poor outcomes (severely disabled with RLAS < 3), and two deaths. Twenty-eight patients with lesions greater than 1 cm had concomitant cerebral edema (CE) with an 89% mortality rate. The mortality rate in this group without CE was 20%, demonstrating the presence of CE in this group may have adversely affected the mortality rate, regardless of intervention. Conclusions: This data suggests that EDH or SDH < 1 cm thick can be safely managed nonoperatively unless there is concomitant CE.	Cooper Univ Hosp, UMDNH Robert Wood Johnson Med Sch, Dept Surg, Camden, NJ 08103 USA; Univ Kansas, Med Ctr, Dept Surg, Div Trauma Surg, Kansas City, KS 66103 USA; Univ Kansas, Med Ctr, Sch Med, Kansas City, KS 66103 USA		Moncure, M (corresponding author), 5027 Delp Pavil,Mail Stop 1011,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	mmoncure@kumc.edu					Bezircioglu H, 1996, J TRAUMA, V41, P696, DOI 10.1097/00005373-199610000-00016; CHEN TY, 1993, NEUROSURGERY, V32, P176, DOI 10.1227/00006123-199302000-00004; CROCE MA, 1994, J TRAUMA, V36, P820, DOI 10.1097/00005373-199406000-00012; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; HAMILTON M, 1992, AM J NEURORADIOL, V13, P853; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MATTHEW P, 1993, ACTA NEUROCHIR, V121, P100; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Quigley MR, 1997, J TRAUMA, V42, P7, DOI 10.1097/00005373-199701000-00003; Tuncer R, 1997, ACTA NEUROCHIR, V139, P203, DOI 10.1007/BF01844752; WONG CW, 1995, ACTA NEUROCHIR, V135, P38, DOI 10.1007/BF02307412	14	6	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2007	63	2					370	372		10.1097/TA.0b013e318124a95b			3	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	200AC	WOS:000248735300023	17693838				2022-02-06	
J	Papanicolaou, AC; Hasan, KM; Boake, C; Eluvathingal, TJ; Kramer, L				Papanicolaou, Andrew C.; Hasan, K. M.; Boake, C.; Eluvathingal, Thomas J.; Kramer, L.			Disruption of limbic pathways in a case of profound amnesia	NEUROCASE			English	Article						diffusion tensor imaging (DTI); amnesia; fornix; neuroimaging; conventional magnetic resonance imaging (CMRI)	TRAUMATIC BRAIN-INJURY; FRACTIONAL ANISOTROPY; DIFFUSION; COMPUTATION	We report a case of episodic amnesia in which the anatomical basis of injury was investigated by diffusion tensor imaging (DTI). Two months after an adult male suffered severe closed head injury, conventional magnetic resonance imaging (CMRI) revealed only a right superior frontal lesion. However, 14 years later, DTI revealed structural anomalies not visible on CMRI involving limbic white matter tracts, notably the fornix, which could explain the amnesia.	Univ Texas, Houston Med Sch, Dept Pediat Neurol & Neurosurg, Houston, TX USA; Univ Texas, Houston Med Sch, Dept Diagnost & Intervent Imaging, Houston, TX USA; Univ Texas, Houston Med Sch, Dept Phys Med & Rehabil, Houston, TX USA		Papanicolaou, AC (corresponding author), Univ Texas, Houston Med Sch, Ctr Clin Neurosci, Dept Pediat Neurosurg & Neurol, 1333 Moursund St,Suite H 114, Houston, TX 77030 USA.	Andrew.C.Papanicolaou@uth.tmc.edu	Hasan, Khader M./ABB-5767-2020		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS046588A] Funding Source: Medline		Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Hasan KM, 2005, J MAGN RESON IMAGING, V21, P735, DOI 10.1002/jmri.20296; Hasan KM, 2003, MAGNET RESON MED, V50, P589, DOI 10.1002/mrm.10552; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; Papanicolaou AC, 2006, AMNESIAS CLIN TXB ME; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; TEASDALE G, 1974, LANCET, V2, P81; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Xu DR, 2002, NEUROIMAGE, V17, P1131, DOI 10.1006/nimg.2002.1285	11	6	6	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1355-4794			NEUROCASE	Neurocase	AUG	2007	13	4					226	228		10.1080/13554790701594854			3	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	239IZ	WOS:000251513300002	17999344				2022-02-06	
J	Razak, KA; Pallas, SL				Razak, Khaleel A.; Pallas, Sarah L.			Inhibitory plasticity facilitates recovery of stimulus velocity tuning in the superior colliculus after chronic NMDA receptor blockade	JOURNAL OF NEUROSCIENCE			English	Article						traumatic brain injury; rodent; retinotectal; homeostatic plasticity; inhibitory plasticity; visual development	AUDITORY SPACE MAP; CAT VISUAL-CORTEX; RETINOTECTAL PROJECTION; ANTAGONISTS DISRUPT; FIELD PROPERTIES; GOLDEN-HAMSTER; DEVELOPMENTAL PLASTICITY; ORIENTATION SELECTIVITY; HOMEOSTATIC PLASTICITY; CORTICAL INHIBITION	The developing nervous system is shaped in important ways by spontaneous and stimulus-driven neural activity. Perturbation of normal activity patterns can profoundly affect the development of some neural response properties, whereas others are preserved through mechanisms that either compensate for or are unaffected by the perturbation. Most studies have examined the role of excitation in activity-dependent plasticity of response properties. Here, we examine the role of inhibition within the context of response selectivity for moving stimuli. The spatial extent of retinal input to the developing hamster superior colliculus (SC) can be experimentally increased by chronic NMDA receptor (NMDAR) blockade. Remarkably, stimulus velocity tuning is intact despite the increase in excitatory inputs. The goal of this study was to investigate whether plasticity in surround inhibition might provide the mechanism underlying this preservation of velocity tuning. Surround inhibition shapes velocity tuning in the majority of superficial layer SC neurons in normal hamsters. We show that despite the NMDAR blockade-induced increase in feedforward excitatory convergence from the retina, stimulus velocity tuning in the SC is maintained via compensatory plasticity in surround inhibition. The inhibitory surround increased in strength and spatial extent, and surround inhibition made a larger contribution to velocity tuning in the SC after chronic NMDAR blockade. These results show that inhibitory plasticity can preserve the balance between excitation and inhibition that is necessary to preserve response properties after developmental manipulations of neural activity. Understanding these compensatory mechanisms may permit their use to facilitate recovery from trauma or sensory deprivation.	Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA		Pallas, SL (corresponding author), Univ Calif Riverside, Dept Psychol, 900 Univ Ave, Riverside, CA 92521 USA.	bioslp@langate.gsu.edu	Pallas, Sarah L/W-1860-2019	Pallas, Sarah L/0000-0002-1760-7437	NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY-12696, R01 EY012696-01A1, R01 EY012696] Funding Source: Medline; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY012696] Funding Source: NIH RePORTER		Aamodt SM, 2000, J NEUROPHYSIOL, V83, P1580, DOI 10.1152/jn.2000.83.3.1580; Binns KE, 1997, DEV BRAIN RES, V99, P263, DOI 10.1016/S0165-3806(97)00004-7; Carrasco MM, 2005, J NEUROPHYSIOL, V94, P1962, DOI 10.1152/jn.00166.2005; CHALUPA LM, 1977, J PHYSIOL-LONDON, V270, P595, DOI 10.1113/jphysiol.1977.sp011971; CLINE HT, 1989, NEURON, V3, P413, DOI 10.1016/0896-6273(89)90201-8; Debski EA, 2002, CURR OPIN NEUROBIOL, V12, P93, DOI 10.1016/S0959-4388(02)00295-7; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FINLAY BL, 1979, NATURE, V280, P153, DOI 10.1038/280153a0; Fortin S, 1999, DEV BRAIN RES, V112, P55, DOI 10.1016/S0165-3806(98)00157-6; Gonzalez-Islas C, 2006, NEURON, V49, P563, DOI 10.1016/j.neuron.2006.01.017; GOODWIN AW, 1978, J PHYSIOL-LONDON, V277, P467, DOI 10.1113/jphysiol.1978.sp012285; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Henneberger C, 2005, EUR J NEUROSCI, V21, P431, DOI 10.1111/j.1460-9568.2005.03869.x; Hickmott PW, 1997, J NEUROPHYSIOL, V78, P1096, DOI 10.1152/jn.1997.78.2.1096; Huang L, 2001, J NEUROPHYSIOL, V86, P1179, DOI 10.1152/jn.2001.86.3.1179; Humphrey AL, 1998, J NEUROPHYSIOL, V80, P2991, DOI 10.1152/jn.1998.80.6.2991; Kotak VC, 2005, J NEUROSCI, V25, P3908, DOI 10.1523/JNEUROSCI.5169-04.2005; Lien CC, 2006, NAT NEUROSCI, V9, P372, DOI 10.1038/nn1649; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; MAGGI CA, 1986, EXPERIENTIA, V42, P531; MEYER RL, 1983, DEV BRAIN RES, V6, P293, DOI 10.1016/0165-3806(83)90068-8; MIZE RR, 1992, PROG BRAIN RES, V90, P219; OLSON MD, 1991, J COMP NEUROL, V303, P412, DOI 10.1002/cne.903030307; Pallas SL, 2006, J NEUROSCI, V26, P10358, DOI 10.1523/JNEUROSCI.3516-06.2006; PALLAS SL, 1989, VISUAL NEUROSCI, V2, P121, DOI 10.1017/S0952523800011986; PALLAS SL, 2006, EVOLUTION NERVOUS SY, P153; PATEL HH, 1978, J PHYSIOL-LONDON, V284, pP113; Razak KA, 2005, J NEUROPHYSIOL, V94, P3573, DOI 10.1152/jn.00816.2004; Razak KA, 2003, J NEUROPHYSIOL, V90, P110, DOI 10.1152/jn.01029.2002; Razak KA, 2006, VISUAL NEUROSCI, V23, P741, DOI 10.1017/S0952523806230062; RHOADES RW, 1978, J COMP NEUROL, V177, P17, DOI 10.1002/cne.901770104; RHOADES RW, 1978, J NEUROPHYSIOL, V41, P1466, DOI 10.1152/jn.1978.41.6.1466; Sceniak MP, 2006, J NEUROPHYSIOL, V95, P3865, DOI 10.1152/jn.01196.2005; SCHMIDT JT, 1990, J NEUROSCI, V10, P233; Schmidt JT, 2000, J NEUROBIOL, V42, P303, DOI 10.1002/(SICI)1097-4695(20000215)42:3<303::AID-NEU2>3.3.CO;2-1; SCHNUPP JWH, 1995, J NEUROSCI, V15, P1516; Sengpiel F, 1998, NEUROPHARMACOLOGY, V37, P607, DOI 10.1016/S0028-3908(98)00034-3; Shapley R, 2003, NEURON, V38, P689, DOI 10.1016/S0896-6273(03)00332-5; Shi J, 1997, J NEUROSCI, V17, P6264; SILBERSTEIN GB, 1982, DEV BIOL, V93, P272, DOI 10.1016/0012-1606(82)90259-7; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; SMITH AL, 1995, J NEUROSCI METH, V60, P211, DOI 10.1016/0165-0270(95)00014-L; STEIN BE, 1979, J COMP NEUROL, V183, P269, DOI 10.1002/cne.901830205; TIAO YC, 1976, J COMP NEUROL, V168, P483; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Varela JA, 1999, J NEUROSCI, V19, P4293; WICKELGREN BG, 1969, J NEUROPHYSIOL, V32, P16, DOI 10.1152/jn.1969.32.1.16; Zheng WM, 1999, SCIENCE, V284, P962, DOI 10.1126/science.284.5416.962	53	6	6	0	3	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	JUL 4	2007	27	27					7275	7283		10.1523/JNEUROSCI.1143-07.2007			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	186BP	WOS:000247754400021	17611280	Bronze, Green Published, Green Accepted			2022-02-06	
J	Llompart-Pou, JA; Raurich, JM; Ibanez, J; Burguera, B; Barcelo, A; Ayestaran, JI; Perez-Barcena, J				Llompart-Pou, Juan A.; Raurich, Joan M.; Ibanez, Jordi; Burguera, Bartolome; Barcelo, Antonia; Ayestaran, Jose I.; Perez-Barcena, Jon			Relationship between plasma adrenocorticotropin hormone and intensive care unit survival in early traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	18th Annual Meeting of the European-Society-of-Intensive-Care-Medicine	SEP 25-28, 2005	Amsterdam, NETHERLANDS	European Soc Intens Care Med		traumatic brain injury; plasma adrenocorticotropin; cortisol; outcome	CRITICALLY-ILL PATIENTS; CORTICOTROPIN STIMULATION; PITUITARY DYSFUNCTION; CORTISOL; SEVERITY; HYPOPITUITARISM; CLASSIFICATION; ACTH	Background: Hypothalamic pituitary adrenal response has been recently evaluated in patients with traumatic brain injury (TBI) with different results. Our objective was to study this response and its relationship with outcome in the early,stage after TBI. Methods: We conducted a prospective observational clinical study in the intensive care unit of a tertiary level university hospital. The study included 50 consecutive patients who suffered isolated TBI. Intracranial pressure (ICP) was measured by an intraparenchymal probe. All patients were sedated and mechanically ventilated. Second-level measures were provided as per protocol, when needed. We measured plasma adrenocorticotropin hormone (ACTH) levels, as well as baseline and stimulated serum cortisol after a high-dose corticotrophin stimulation test, within 2 days after TBI for all patients. Results: Mean age was 36 +/- 18 (range 16-77) years. Forty-four (88%) were male. Median Glasgow Coma Scale score was 7. Mean ACTH was 15.4 +/- 19.8 pg/mL. Mean baseline cortisol was 14.8 +/- 9.0 mu g/dL and mean stimulated cortisol was 27.1 +/- 7.3 mu g/dL and 30.5 +/- 7.2 mu g/dL at 30 and 60 minutes, respectively. Baseline and stimulated cortisol were not correlated with mortality. Logistic regression analysis revealed that, either plasma ACTH levels < 9 pg/mL or lack of indication to provide second-level measures to control ICP were significant independent predictors of survival. Conclusions: The presence of a low plasma ACTH concentration at an early stage of TBI and lack of indication to provide second-level measures to control ICP were associated with a higher intensive care unit survival.	Hosp Univ Son Dureta, Serv Med Intens, Palma de Mallorca 07014, Illes Balears, Spain; Hosp Univ Son Dureta, Serv Endocrinol, Palma de Mallorca, Illes Balears, Spain; Hosp Univ Son Dureta, Serv Anal Clin, Palma de Mallorca, Illes Balears, Spain		Llompart-Pou, JA (corresponding author), Hosp Univ Son Dureta, Serv Med Intens, C Andrea Doria 55, Palma de Mallorca 07014, Illes Balears, Spain.	jallompart@hsd.es		Barcelo Bennasar, Antonia/0000-0002-3170-5439			Abadal-Centellas JM, 2007, J TRAUMA, V62, P282, DOI 10.1097/01.ta.0000199422.01949.78; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; [Anonymous], 2000, J Neurotrauma, V17, P563; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BARTON RN, 1987, J TRAUMA, V27, P384, DOI 10.1097/00005373-198704000-00007; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P597; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P573; Cairns CJS, 2002, INTENS CARE MED, V28, P1357, DOI 10.1007/s00134-002-1399-y; CHIOLERO R, 1988, J TRAUMA, V28, P1368, DOI 10.1097/00005373-198809000-00011; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; DeLong WG, 2004, CLIN ORTHOP RELAT R, P57, DOI 10.1097/01.blo.0000130840.64528.1e; Dimopoulou I, 2005, INTENS CARE MED, V31, P1020, DOI 10.1007/s00134-005-2689-y; Dimopoulou I, 2004, INTENS CARE MED, V30, P1216, DOI 10.1007/s00134-004-2297-2; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hoen S, 2002, ANESTHESIOLOGY, V97, P807, DOI 10.1097/00000542-200210000-00010; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; OELKERS W, 1988, J CLIN ENDOCR METAB, V66, P181, DOI 10.1210/jcem-66-1-181; Pentelenyi T, 1992, Acta Neurochir Suppl (Wien), V55, P21; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Savaridas T, 2004, INTENS CARE MED, V30, P1479, DOI 10.1007/s00134-004-2306-5; Schwarz S, 2003, J NEUROL NEUROSUR PS, V74, P725, DOI 10.1136/jnnp.74.6.725; Suliman AM, 2002, CLIN ENDOCRINOL, V56, P533, DOI 10.1046/j.1365-2265.2002.01509.x; TEASDALE G, 1974, LANCET, V2, P81; The Brain TraumaFoundation, 2000, J NEUROTRAUM, V17, P583, DOI [10.1089/neu.2000.17.583, DOI 10.1089/NEU.2000.17.583]; Van den Berghe G, 2000, EUR J ENDOCRINOL, V143, P1, DOI 10.1530/eje.0.1430001; Venkatesh B, 2005, ANAESTH INTENS CARE, V33, P201, DOI 10.1177/0310057X0503300208; VERMES I, 1995, J CLIN ENDOCR METAB, V80, P1238, DOI 10.1210/jc.80.4.1238; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P917, DOI 10.1111/j.1530-0277.1990.tb01838.x	36	6	6	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2007	62	6					1457	1461		10.1097/01.ta.0000219143.69483.71			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	179YM	WOS:000247326600032	17563666				2022-02-06	
J	Desouza, M; Sycamore, M; Little, S; Kirker, SGB				Desouza, M.; Sycamore, M.; Little, S.; Kirker, S. G. B.			The Papworth Early Rehabilitation Programme: Vocational outcomes	DISABILITY AND REHABILITATION			English	Article						incapacity benefits; vocational rehabilitation; Papworth Trust	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; WORK; EMPLOYMENT; SATISFACTION; INDIVIDUALS; INDICATORS; RETURN; BACK	Background. There are 2.7 million people in the UK receiving incapacity benefits, costing approximately 18 pound billion pa. Government has adopted a policy of helping claimants back into work, through structured vocational rehabilitation schemes. There are no published results of vocational rehabilitation services in the UK. We present the results of the Papworth Trust vocational rehabilitation programme. Depending on the severity of their disability, the 'Early Rehab Programme' aims to get people on incapacity benefits: (a) into employment, (b) fit for and seeking work, (c) involved in voluntary work, (d) education, or (e) able to live independently. Methods. Retrospective chart survey and telephone follow up. Setting. Cambridgeshire. Results. Since 1995, 274 people attended for a preliminary interview, of which 107 subsequently started a full rehab programme. Eighty-seven were male and 20 female. Half had been unemployed for more than two years. Ninety-four completed the programme, of whom 53 had gained employment, 33 were 'work ready' and four were doing voluntary work. At long-term follow-up, 52 were employed, 12 were in voluntary work, and 7 had retired on medical grounds. Conclusions. This programme demonstrates that long-term Incapacity Benefit recipients can return to sustained employment, as shown in those who participated in the Papworth Trust's vocational rehabilitation programme.	Colman Hosp, Caroline House, Norwich NR2 2PJ, Norfolk, England; Addenbrookes NHS Trust, Lewin Stroke & Rehabil Unit, Cambridge CB2 2QQ, England; Papworth Trust, Papworth Everard, England		Desouza, M (corresponding author), Colman Hosp, Caroline House, Unthank Rd, Norwich NR2 2PJ, Norfolk, England.	mayadesouza@gmail.com					ARTHUR S, 1999, 106 DEP SOC SEC; Baker Patrick, 2005, Work, V24, P21; BALLS E, 1993, WORK WELFARE; *BRIT SOC REH MED, 2003, VOC REH WAY FORW REP; *BSRM JOBCENTRE PL, 2004, VOC ASS REH ACQ BRAI; CACKETT B, 2005, WORK BENEFIT DEPENDE; CARTER J, 2000, OCCUPATIONAL HLTH GU, P1; Chamberlain MA, 2004, CLIN MED, V4, P102, DOI 10.7861/clinmedicine.4-2-102; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Disler PB, 2001, BRIT MED J, V323, P121, DOI 10.1136/bmj.323.7305.121; DoH, 2005, NAT SERV FRAM LONG T; *DRC, 2000, DIS BRIEF MAY 2000; Floyd M, 2004, INT J REHABIL RES, V27, P99, DOI 10.1097/01.mrr.0000127638.09376.cd; Honey S., 1993, EMPLOYERS ATTITUDES; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Johnson R, 1998, NEUROPSYCHOL REHABIL, V8, P61, DOI 10.1080/713755552; Man DWK, 2004, BRAIN INJURY, V18, P577, DOI 10.1080/02699050310001646143; MEAGER M, 1999, 69 DFEE; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; PRESCOTTCLARKE P, 1990, EMPLOYMENT HANDICAP; ROSEN M, 1994, BACK PAIN, P1; Rowlingson K., 1996, DISABILITY BENEFITS; *TUC, 2004, DEF INC BEN; Vestling M, 2003, J REHABIL MED, V35, P127, DOI 10.1080/16501970310010475; WATSON PJ, 2001, BACK PAIN WORK NATL; Wehman P, 2000, AM J PHYS MED REHAB, V79, P161, DOI 10.1097/00002060-200003000-00009; WEHMAN P, 1989, J APPL BEHAV ANAL, V22, P395, DOI 10.1901/jaba.1989.22-395; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519	30	6	6	0	4	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.	APR 30	2007	29	8					671	677		10.1080/09638280600926538			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	161KB	WOS:000246012700008	17453989				2022-02-06	
J	Gonzalez-Garcia, E; Vilela-Soler, C; Roma-Ambrosio, J; Fenollosa-Entrena, B				Gonzalez-Garcia, E.; Vilela-Soler, C.; Roma-Ambrosio, J.; Fenollosa-Entrena, B.			The use of evoked potentials in the follow-up and prognosis of patients in coma following severe traumatic brain injury	REVISTA DE NEUROLOGIA			Spanish	Article						coma; consciousness disturbance; evoked potential; Glasgow outcome scale; mismatch negativity; traumatic brain injury		Introduction. When dealing with patients in coma, it can be very useful to have early access to objective tests that provide information about their clinical status and can help to establish a prognosis for survival and functional recovery. The value of evoked potentials (EP) in such cases is already well known, although only techniques that assess the neurological status have been used. Aim. To determine the usefulness of different types of evoked potentials as a means of reaching a short and medium term prognosis for survival and functional recovery in patients in coma as a result of traumatic brain injury (TBI). Patients and methods. Our study involved patients with an admission Glasgow coma score of 8 or below due to severe TBI. During the first 24 hours the following tests were carried out on patients: somatosensory EP (SSEP), brainstem auditory EP visual EP (VEP) obtained using stimulation goggles and mismatch negativity, as well as an imaging test (computerised axial tomography). The tests were repeated at one week and one month, and each patient was evaluated by means of the Glasgow scale and the Karnofsky scale. Results. We studied 22 patients (mean age: 39.95 years; interval: 15-84 years), 20 of them were males. The highest number of deaths occurred during the first week. There was a strong correlation between survival and the results from the SSEP and VEP. Conclusions. SSEP and VEP performed on admission were a valuable aid for reaching a short and medium term prognosis for survival Of patients in coma due to TBI, although they were not effective in evaluating a prognosis for functional recovery.	Hosp La Fe, Serv Neurofisiol Clin, E-46009 Valencia, Spain; Hosp La Fe, Serv Bioestadist, E-46009 Valencia, Spain; Univ Valencia, Dept Fisiol, E-46003 Valencia, Spain		Gonzalez-Garcia, E (corresponding author), Hosp La Fe, Serv Neurofisiol Clin, Avda Campanar 21, E-46009 Valencia, Spain.	gonzalelz_emi@gva.es		Gonzalez Garcia, Emilio/0000-0002-6065-1871			Amantini A, 2005, CLIN NEUROPHYSIOL, V116, P229, DOI 10.1016/j.clinph.2004.07.008; [Anonymous], 1972, JAMA, V220, P717; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BRADLEY GC, 2001, CRIT CARE MED, V29, P178; Chiappa KH, 1998, ELECTROEN CLIN NEURO, V106, P149, DOI 10.1016/S0013-4694(97)00118-1; CIGES M, 1992, POTENCIALES EVOCADOS; Fischer C., 2002, Annales de Readaptation et de Medecine Physique, V45, P448, DOI 10.1016/S0168-6054(02)00295-7; Fischer C, 2000, AUDIOL NEURO-OTOL, V5, P192, DOI 10.1159/000013880; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Guerit JM, 2000, ACTA NEUROL BELG, V100, P229; Iwasaki M, 2001, CLIN NEUROPHYSIOL, V112, P205, DOI 10.1016/S1388-2457(00)00506-X; JENNETT B, 1975, LANCET, V1, P480; KARNOFSKY DA, 1948, CANCER-AM CANCER SOC, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI [10.1097/00002060-200301000-00009, 10.1097/01.PHM.0000043771.90606.81]; Logi F, 2003, CLIN NEUROPHYSIOL, V114, P1615, DOI 10.1016/S1388-2457(03)00086-5; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Rothstein TL, 2000, J CLIN NEUROPHYSIOL, V17, P486, DOI 10.1097/00004691-200009000-00007; Young GB, 2003, CRIT CARE MED, V31, P994, DOI 10.1097/01.CCM.0000053668.75972.00	19	6	8	0	1	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	APR 1	2007	44	7					404	410		10.33588/rn.4407.2006225			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159PT	WOS:000245879200004	17420966				2022-02-06	
J	Christ, SE; Moinuddin, A; McKinstry, RC; DeBaun, M; White, DA				Christ, Shawn E.; Moinuddin, Asif; McKinstry, Robert C.; DeBaun, Michael; White, Desiree A.			Inhibitory control in children with frontal infarcts related to sickle cell disease	CHILD NEUROPSYCHOLOGY			English	Article						inhibitory control; executive ability; neuropsychology; cognition; frontal cortex; children; sickle cell disease	LIFE-SPAN; WORKING-MEMORY; FUNCTIONAL MRI; BRAIN-INJURY; PERFORMANCE; DISORDER; ABNORMALITIES; INTERFERENCE; IMPAIRMENT; COGNITION	Evidence from past studies indicates that children with traumatic brain injury experience difficulties with inhibitory control. Less is known about inhibitory control in children with frontal brain injury related to cerebral infarction. We compared the inhibitory performance of children with frontal infarcts related to sickle cell disease with that of a control group of children with sickle cell disease but no history of cerebral infarction. On a stimulus-response reversal task, children with frontal infarcts made significantly more accuracy errors in the inhibitory condition than controls. Findings from this study and from previous research suggest that impairments in inhibitory control are common following frontal injury in a range of pediatric populations.	Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA; Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA; Washington Univ, Med Ctr, Dept Pediat, Div Hematol Oncol,St Louis Childrens Hosp, St Louis, MO 63130 USA		Christ, SE (corresponding author), Univ Missouri, Dept Psychol Sci, 210 McAlester Hall, Columbia, MO 65211 USA.	research@shawnchrist.com		White, Desiree/0000-0001-9439-9574; Christ, Shawn/0000-0002-7206-528X			Armstrong FD, 1996, PEDIATRICS, V97, P864; ASARNOW RF, 1995, EUR ARCH PSY CLIN N, V245, P70, DOI 10.1007/BF02190733; Bedard AC, 2002, DEV NEUROPSYCHOL, V21, P93, DOI 10.1207/S15326942DN2101_5; Brandling-Bennett EM, 2003, DEV NEUROPSYCHOL, V24, P423, DOI 10.1207/S15326942DN2401_01; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; Casey BJ, 2002, DEV PSYCHOBIOL, V40, P237, DOI 10.1002/dev.10030; Casey BJ, 1997, J AM ACAD CHILD PSY, V36, P374, DOI 10.1097/00004583-199703000-00016; CHRIST S, IN PRESS DEV NEUROPS; CHRIST S, IN PRESS J AUTISM DE; Christ SE, 2003, NEUROPSYCHOLOGY, V17, P171, DOI 10.1037/0894-4105.17.1.171; Christ SE, 2001, DEV NEUROPSYCHOL, V20, P653, DOI 10.1207/875656401753549852; COMALLI PE, 1962, J GENET PSYCHOL, V100, P47, DOI 10.1080/00221325.1962.10533572; DIAMOND A, 1994, J NEUROSCI, V14, P3072; Diamond A., 1998, PREFRONTAL CORTEX EX, P144; FOWLER MG, 1988, J DEV BEHAV PEDIATR, V9, P213; FUKUSHIMA J, 1994, BIOL PSYCHIAT, V36, P21, DOI 10.1016/0006-3223(94)90058-2; GERSTADT CL, 1994, COGNITION, V53, P129, DOI 10.1016/0010-0277(94)90068-X; GUITTON D, 1985, EXP BRAIN RES, V58, P455; Kawashima R, 1996, BRAIN RES, V728, P79, DOI 10.1016/0006-8993(96)00389-7; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; KNIGHT S, 1995, ARCH DIS CHILD, V73, P316, DOI 10.1136/adc.73.4.316; Krasnegor N. A., 1997, DEV PREFRONTAL CORTE; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; MALLOY P, 1993, ARCH CLIN NEUROPSYCH, V8, P185, DOI 10.1016/0887-6177(93)90035-Y; MCCAULEY T, 2004, UNPUB; MILLER LB, 1999, HUMAN FRONTAL LOBES; Moser FG, 1996, AM J NEURORADIOL, V17, P965; Okoshi Y, 2001, PEDIATR NEUROL, V25, P221, DOI 10.1016/S0887-8994(01)00309-5; Psychological Corporation, 1999, WECHSL ABBR SCAL INT; Ridderinkhof KR, 1997, J EXP CHILD PSYCHOL, V65, P315, DOI 10.1006/jecp.1997.2367; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; Sano M, 1996, NEUROPSY NEUROPSY BE, V9, P242; SCHEIBEL RS, 1997, DEV PREFRONTAL CORTE; Steen RG, 1999, ANN NEUROL, V45, P279, DOI 10.1002/1531-8249(199903)45:3<279::AID-ANA2>3.0.CO;2-7; STUSS DT, 1992, BRAIN COGNITION, V20, P8, DOI 10.1016/0278-2626(92)90059-U; SWIFT AV, 1989, PEDIATRICS, V84, P1077; WASSERMAN AL, 1991, AM J PEDIAT HEMATOL, V13, P14; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; [No title captured]	48	6	6	1	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	MAR	2007	13	2					132	141		10.1080/09297040500346563			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	147UU	WOS:000245029000004	17364570				2022-02-06	
J	Yamamoto-Mitani, N; Matsuoka, K; Fujii, M				Yamamoto-Mitani, Noriko; Matsuoka, Keiko; Fujii, Masako			Home-based rehabilitation program for older adults with cognitive impairment: preliminary results	PSYCHOGERIATRICS			English	Article						aged; attention; cognition; family; rehabilitation; treatment effects	ATTENTION	Background: While there is a growing interest in cognitive rehabilitation for older adults, not enough data is available regarding its feasibility and effectiveness in an older population. The present study implemented a home-based cognitive rehabilitation program for older adults in order to explore the program's feasibility and effectiveness. Methods: The 8-month rehabilitation program consisted of multiple workbooks targeted at improving attention, memory and executive function. Study participants worked on the workbooks at home with family members, while professional cognitive rehabilitation staff periodically evaluated their progress. Attention, memory and executive function were evaluated at outset, at month 4 and at the end of month 8. Results: The nine initial participants had histories of subarachnoid hemorrhage or traumatic brain injury, or were outpatients of a memory clinic who had memory impairment. Six participants (66.7%) completed the 8-month program; one subject intentionally withdrew from the program while two others withdrew due to hospitalization. Among the six remaining participants, attention improved significantly between the month 4 and month 8 evaluations, and between the initial and month 8 evaluations. Within subsets of the attention test, significant improvement was seen in the visual selective attention domain. There was no change in memory or executive function, as well as the subjective difficulties in daily lives. Conclusions: This study suggests that a home-based cognitive rehabilitation program for older adults is feasible and may improve attention, especially visual selective attention. An 8-month rehabilitation program may have been of insufficient duration to generate significant improvements in memory or executive function.	[Yamamoto-Mitani, Noriko] Chiba Univ, Sch Nursing, Chuo Ku, Chiba 2608672, Japan; [Matsuoka, Keiko] Cognit Rehabil Terakoya, Tokyo, Japan; [Fujii, Masako] TBI Rehabil Res Ctr, Tokyo, Japan		Yamamoto-Mitani, N (corresponding author), Chiba Univ, Sch Nursing, Chuo Ku, Inohana 1-8-1, Chiba 2608672, Japan.	nyamamoto@faculty.chiba-u.jp					Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Doornhein K, 1998, NEUROPSYCHOL REHABIL, V8, P393, DOI 10.1080/713755579; FUJII M, 2004, REHABILITATION METHO, V2; FUJITA K, 2003, BRAIN INJ S1, V17, P120; GASPARRINI B, 1979, CLIN NEUROPSYCHOL, V1, P137; GIANUTSOS R, 1979, Journal of Clinical Neuropsychology, V1, P117, DOI 10.1080/01688637908414446; Kato M, 2003, BEHAV ASSESSMENT DYS; KUBOTA K, 2003, NINCHI RIHABIL, P20; LEFTOFF S, 1981, CLIN NEUROPSYCHOL, V3, P301; MALIA KB, 1997, BRAINWAVE R COGNITIV; MATSUDA O, 2003, GERONTOLOGY NEW HORI, V15, P322; MATSUDA O, 2003, GERONTOLOGY NEW HORI, V15, P133; McDowd JM, 2003, J GERONTOL B-PSYCHOL, V58, pP45, DOI 10.1093/geronb/58.1.P45; ONODERA A, 2001, ROUNEN SEISHIN IGAKU, V12, P1047; Ozdemir F, 2001, ARCH PHYS MED REHAB, V82, P1375, DOI 10.1053/apmr.2001.25973; Prigatano GP, 1999, J HEAD TRAUMA REHAB, V14, P308, DOI 10.1097/00001199-199906000-00009; Robertson I., 1994, TEST EVERYDAY ATTENT; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Towle D, 2016, CLIN REHABIL, V2, P303, DOI [10.1177/026921558800200406, DOI 10.1177/026921558800200406], DOI 10.1177/026921558800200406]; Warden DL, 2000, J HEAD TRAUMA REHAB, V15, P1092, DOI 10.1097/00001199-200010000-00003; WATAMORI Y, 2002, JAPANESE VERSION RIV; WILSON B, 1982, CORTEX, V18, P581, DOI 10.1016/S0010-9452(82)80055-5; Yamadori A., 1985, SHINKEISHINRIGAKU, V1, P82	24	6	7	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1346-3500	1479-8301		PSYCHOGERIATRICS	Psychogeriatrics	MAR	2007	7	1					14	20		10.1111/j.1479-8301.2007.00193.x			7	Geriatrics & Gerontology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Psychiatry	276GS	WOS:000254129900004		Bronze			2022-02-06	
J	El Khatib, K; Kadlub, N; Trost, O; Danino, AM; Malka, G				El Khatib, K.; Kadlub, N.; Trost, O.; Danino, A. -M.; Malka, G.			Dynamic external traction system for management of distal displaced fractures of the head of the proximal phalanx	CHIRURGIE DE LA MAIN			English	Article						proximal interphalangeal joint; dynamic external distractor; phalanx articular fracture	INTERPHALANGEAL JOINT; PILON FRACTURES; S-QUATTRO; FIXATION; DISLOCATION	Introduction. - Phalangeal fractures are generally underestimated injuries, but result in pain, stiffness, instability, degenerative arthritis and loss of finger function. Treatment varies from open reduction with internal fixation giving perfect anatomical reduction but a risk of side effects, to orthopaedic treatment with variable results. Unstable fractures must be fixed rigidly to minimize joint immobilization. It is this concept of solid fixation and early mobilization, which directed us in the choice of dynamic external distraction in the management of these fractures. Material and method. - The authors present a prospective study of twelve patients treated for unstable fractures of the proximal interphalangeal joint by closed reduction and dynamic external distractor, we describe this simple device created with pins and rubber bands and examine the functional clinical results.Results. - The average follow-up period was 7,5 months. We only noted one pin-track infection. Three patients complained of pain at postoperative follow up. In this series, the total active motion varied from 70 degrees to 120 degrees (average 94,16 degrees), the mean lack of extension was 5,6 degrees (from 0 to 15 degrees). Ten patients had good mobility and were satisfied. Discussion. - Different traction devices for the management of displaced intraarticular phalangeal fractures have been reported. Most of them are complex to construct and expensive. The traction system is simple to assemble, economical and it allows early active motion of the affected digits. We consider that it is an effective mode of treatment for the management of complex intraarticular phalangeal fractures. (c) 2007 Elsevier Masson SAS. Tons droits reserves.	[El Khatib, K.; Kadlub, N.; Trost, O.; Danino, A. -M.; Malka, G.] CHU Dijon, Hop Gen, Serv Chirurag Maxillofacial & Chirurg Plast, F-21033 Dijon, France		El Khatib, K (corresponding author), Hop Mil Instruct Mohammed 5, Serv Chirurag Plast Maxillofacial & Stomatol, Rabat, Morocco.	kelkhatib@gmail.com	danino, alain m/E-4103-2012	EL KHATIB, KARIM/0000-0003-4404-8092			Bain GI, 1998, J BONE JOINT SURG BR, V80B, P1014, DOI 10.1302/0301-620X.80B6.8030; BOSTOCK S, 1993, BRIT J SPORT MED, V27, P268, DOI 10.1136/bjsm.27.4.268; Chin KR, 1999, J HAND SURG-AM, V24A, P1263; De Smet L, 2002, J ORTHOP TRAUMA, V16, P668, DOI 10.1097/00005131-200210000-00009; DESORAS X, 1996, J HAND SURG BR S1, V21, P25; Dubert T, 2005, Chir Main, V24, P1, DOI 10.1016/j.main.2004.08.010; FAHMY NRM, 1990, J HAND SURG-BRIT EUR, V15B, P303, DOI 10.1016/0266-7681(90)90009-S; FAHMY NRM, 1994, J HAND SURG-BRIT EUR, V19B, P783, DOI 10.1016/0266-7681(94)90258-5; GAUL J, 1998, AM J ORTHOPSYCHIAT, P682; HASTINGS H, 1993, HAND CLIN, V9, P659; Hynes MC, 2001, J HAND SURG-BRIT EUR, V26, P122, DOI 10.1054/jhsb.2000.0521; INANAMI H, 1993, J HAND SURG-AM, V18A, P160, DOI 10.1016/0363-5023(93)90265-5; Jablecki J, 1997, Chir Narzadow Ruchu Ortop Pol, V62, P109; Johnson D, 2004, J HAND SURG-BRIT EUR, V29B, P76, DOI 10.1016/j.jhsb.2003.08.009; LONDON PS, 2001, HAND, V3, P155; Mullett JH, 1999, J HAND SURG-BRIT EUR, V24B, P350, DOI 10.1054/jhsb.1999.0071; NANAMI H, 1993, J HAND SURG-AM, V18, P160; SALTER RB, 1980, J BONE JOINT SURG AM, V62, P1232, DOI 10.2106/00004623-198062080-00002; Stark R H, 1993, Orthop Rev, V22, P609; SUZUKI Y, 1994, J HAND SURG-BRIT EUR, V19B, P98, DOI 10.1016/0266-7681(94)90059-0; Syed AA, 2003, J HAND SURG-BRIT EUR, V28B, P137, DOI 10.1016/S0266-7681(02)00300-5; TUBIANA R, 1981, ANN CHIR, V35, P757; WEISS APC, 1993, J HAND SURG-AM, V18A, P594, DOI 10.1016/0363-5023(93)90297-G	23	6	6	0	0	ELSEVIER	BRIDGEWATER	685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA	1297-3203	1769-6666		CHIR MAIN	Chir. Main.	FEB	2007	26	1					21	25		10.1016/j.main.2007.01.003			5	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	273OP	WOS:000253941300003	17418765				2022-02-06	
J	Ma, XQ; Zhang, HJ; Zhang, YH; Chen, YH; Wu, F; Du, JQ; Yu, HP; Zhou, ZL; Li, JY; Nan, FJ; Li, J				Ma, Xue-Qin; Zhang, Hua-Jie; Zhang, Ya-Hui; Chen, Yi-Hua; Wu, Fang; Du, Jun-Qing; Yu, Hai-Ping; Zhou, Zhong-Liang; Li, Jing-Ya; Nan, Fa-Jun; Li, Jia			Novel irreversible caspase-1 inhibitor attenuates the maturation of intracellular interleukin-1 beta	BIOCHEMISTRY AND CELL BIOLOGY			English	Article						caspase-1; inhibitor; slow binding; irreversible; IL-1 beta processing	TRAUMATIC BRAIN-INJURY; TRANSGENIC MOUSE MODEL; CONVERTING-ENZYME; INFLAMMATORY CASPASES; NEURONAL DEATH; APOPTOSIS; ACTIVATION; PROLIFERATION; FUNCTIONALITY; PANCREATITIS	Caspase-1, the most efficient enzyme in processing the proinflammatory cytokines interleukin 1 beta and interleukin 18 in humans, is associated with inflammatory diseases such as rheumatoid arthritis, osteoarthritis, and some neuronal diseases. We previously reported that isoquinoline-1,3,4-trione and its derivatives are novel caspase-3 inhibitors that could attenuate apoptosis in vitro and in vivo. Here we report a novel derivative of isoquinoline-1,3,4-trione that is highly potent in inhibiting caspase-1 activity in an irreversible and slow-binding manner, thus inhibiting cellular caspase-1 activity and the maturation of interleukin 1 beta in U-937 cells.	Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China; E China Normal Univ, Acad Life Sci, Shanghai 200062, Peoples R China		Nan, FJ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China.	fjnan@mail.shcnc.ac.cn; jli@mail.shcnc.ac.cn	Chen, Yihua/A-4323-2013; Chen, Yihua/O-2743-2019; Du, Junqing/B-7803-2016; Li, Jia/F-9116-2011	Chen, Yihua/0000-0003-1733-7980; Chen, Yihua/0000-0003-1733-7980; Du, Junqing/0000-0001-7449-1170; 			ALNEMRI ES, 1995, J BIOL CHEM, V270, P4312, DOI 10.1074/jbc.270.9.4312; Chen YH, 2006, J MED CHEM, V49, P1613, DOI 10.1021/jm050896o; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Copeland Robert A, 2005, Methods Biochem Anal, V46, P1; Dang LC, 1996, BIOCHEMISTRY-US, V35, P14910, DOI 10.1021/bi9617771; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; EAMSHAW WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI DOI 10.1146/ANNUREV.BI0CHEM.68.1383; Elliott PJ, 2003, J MOL MED, V81, P235, DOI 10.1007/s00109-003-0422-2; Guegan C, 2002, MOL CELL NEUROSCI, V20, P553, DOI 10.1006/mcne.2002.1136; Hayashi Y, 2001, BRAIN RES, V893, P113, DOI 10.1016/S0006-8993(00)03307-2; Huang CK, 2004, BIOCHEMISTRY-US, V43, P4568, DOI 10.1021/bi036022q; Kim KM, 2000, CLIN IMMUNOL, V97, P221, DOI 10.1006/clim.2000.4939; Kim R, 2001, INT J ONCOL, V18, P1227; Krakauer T, 2004, CLIN DIAGN LAB IMMUN, V11, P621, DOI 10.1128/CDLI.11.3.621-624.2004; Le GT, 2005, CURR MED CHEM, V12, P2963, DOI 10.2174/092986705774462851; Lee D, 2000, J BIOL CHEM, V275, P16007, DOI 10.1074/jbc.275.21.16007; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Moynagh PN, 2005, J ANAT, V207, P265, DOI 10.1111/j.1469-7580.2005.00445.x; Norman J, 1997, J INTERF CYTOK RES, V17, P113, DOI 10.1089/jir.1997.17.113; Nuttall ME, 2000, J ORTHOPAED RES, V18, P356, DOI 10.1002/jor.1100180306; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Pabbruwe MB, 2005, BIOTECHNOL LETT, V27, P1451, DOI 10.1007/s10529-005-1308-x; Rau B, 2001, CRIT CARE MED, V29, P1556, DOI 10.1097/00003246-200108000-00010; Rothwell N, 1997, J CLIN INVEST, V100, P2648, DOI 10.1172/JCI119808; Rudolphi K, 2003, OSTEOARTHR CARTILAGE, V11, P738, DOI 10.1016/S1063-4584(03)00153-5; Saha N, 1999, ARTHRITIS RHEUM, V42, P1577, DOI 10.1002/1529-0131(199908)42:8<1577::AID-ANR3>3.0.CO;2-Z; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Sharif M, 2004, ARTHRITIS RHEUM-US, V50, P507, DOI 10.1002/art.20020; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Wu JC, 1999, METHODS, V17, P320, DOI 10.1006/meth.1999.0746; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273	36	6	6	0	5	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0829-8211	1208-6002		BIOCHEM CELL BIOL	Biochem. Cell Biol.	FEB	2007	85	1					56	65		10.1139/O06-149			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	153BR	WOS:000245407200006	17464345				2022-02-06	
B	Butler, RW		Hunter, SJ; Donders, J		Butler, Robert W.			Cognitive rehabilitation	PEDIATRIC NEUROPSYCHOLOGICAL INTERVENTION: A CRITICAL REVIEW OF SCIENCE AND PRACTICE			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; CHILDREN; CANCER; INTERVENTIONS; PROGRAM; TRIAL		Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR USA		Butler, RW (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR USA.						[Anonymous], 1998, REH PERS TRAUM BRAIN; BARON IS, 1993, NEUROPSYCHOL REHABIL, V3, P389, DOI 10.1080/09602019308401448; Ben-Yishay Y., 1983, COGNITIVE REHABILITA, V1, P4; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Brett A W, 1998, Pediatr Rehabil, V2, P27; Butler R., MULTICENTER IN PRESS; Butler RW, 1999, PSYCHOTHERAPEUTIC INTERVENTIONS FOR ADULTS WITH BRAIN INJURY OR STROKE: A CLINICIAN'S TREATMENT RESOURCE, P97; Butler RW, 2005, J PEDIATR PSYCHOL, V30, P65, DOI 10.1093/jpepsy/jsi017; Butler RW, 2002, J INT NEUROPSYCH SOC, V8, P115, DOI 10.1017/S1355617701020112; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Gillett J, 2004, NEUROREHABILITATION, V19, P207; Glang A., 1997, STUDENTS ACQUIRED BR; High W. J., 2005, REHABILITATION TRAUM, P15; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Kazak AE, 2005, J PEDIATR PSYCHOL, V30, P29, DOI 10.1093/jpepsy/jsi013; Kendall PC, 1991, CHILD ADOLESCENT THE; Kennard MA, 1942, ARCH NEURO PSYCHIATR, V48, P227, DOI 10.1001/archneurpsyc.1942.02290080073002; Laatsch LK, 2004, BRAIN INJURY, V18, P957, DOI 10.1080/02699050410001672369; Levin H. S., 2000, CEREBRAL REORGANIZAT; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; Luria AR, 1963, RESTORATION FUNCTION; LYNCH W, 1982, COGNITIVE REHABILITA; Meichenbaum, 1977, COGNITIVE BEHAV MODI; [National Institute of Neurological Disorders and Stroke Department of Health and Human Services National Institutes of Health], 2004, COGN REH INT MOV BEN; O'flaherty Stephen, 2004, Pediatr Rehabil, V7, P267, DOI 10.1080/13638490410001727437; Ogg R., 2002, J INT NEUROPSYCH SOC, V8, P494; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Rasmussen T., 1996, ARE THEY THINKING; Sahler OJZ, 2005, J CONSULT CLIN PSYCH, V73, P272, DOI 10.1037/0022-006X.73.2.272; SIEGEL LM, 2004, COMPLETE IEP GUIDE A; Sohlberg M., 2001, COGNITIVE REHABILITA; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; STALLARD P, 2002, THINK GOOD FEEL GOOD; Thomson J, 2001, PAY ATTENTION CHILDR; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Wade SL, 2005, REHABIL PSYCHOL, V50, P337, DOI 10.1037/0090-5550.50.4.337; Wilson BA, 1997, J INT NEUROPSYCH SOC, V3, P487, DOI 10.1017/S1355617797004876; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU; [No title captured]	45	6	6	0	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	THE PITT BUILDING, TRUMPINGTON ST, CAMBRIDGE CB2 1RP, CAMBS, ENGLAND			978-0-521-87550-9				2007							444	464					21	Clinical Neurology; Psychology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychology	BXM34	WOS:000296371600020					2022-02-06	
J	Osada, D; Kameda, M; Tamai, K				Osada, Denju; Kameda, Masahiro; Tamai, Kazuya			PERSISTENT POSTEROLATERAL ROTATORY SUBLUXATION OF THE ELBOW IN CUBITUS VARUS: A CASE REPORT	JOURNAL OF HAND SURGERY-ASIAN-PACIFIC VOLUME			English	Article						Persistent Subluxation; Elbow; Cubitus Varus; Posterolateral Rotatory Instability		A 23-year-old woman who had an episode of elbow injury which was treated cast immobilisation in childhood with residual cubitus varus sustained a posterior fracture dislocation of the same elbow. She was treated with closed reduction. Six months later, however, her elbow became stiff, and a persistent posterolateral rotatory subluxation was noted. Operations were performed in two steps; first, the radial head, which was subluxed posteriorly, was reduced and the lateral collateral ligament complex was reconstructed, and second, the stiff elbow was mobilised. Two years after the first surgery, the function of the elbow was satisfactorily recovered.	[Osada, Denju; Kameda, Masahiro; Tamai, Kazuya] Dokkyo Med Univ, Sch Med, Dept Orthopaed, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan		Osada, D (corresponding author), Dokkyo Med Univ, Sch Med, Dept Orthopaed, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	osada@dokkyomed.ac.jp					ABE M, 1995, J BONE JOINT SURG BR, V77B, P582, DOI 10.1302/0301-620X.77B4.7615602; Abe M, 1997, J SHOULDER ELB SURG, V6, P405, DOI 10.1016/S1058-2746(97)90011-2; Ito Y, 2000, J JOINT SURG, V19, P37; NESTOR BJ, 1992, J BONE JOINT SURG AM, V74A, P1235, DOI 10.2106/00004623-199274080-00014; O'Driscoll SW, 2001, J BONE JOINT SURG AM, V83A, P1358, DOI 10.2106/00004623-200109000-00011; ODRISCOLL SW, 1991, J BONE JOINT SURG AM, V73A, P440, DOI 10.2106/00004623-199173030-00015; ODRISCOLL SW, 1992, CLIN ORTHOP RELAT R, P186; Olsen BS, 1998, J SHOULDER ELB SURG, V7, P19, DOI 10.1016/S1058-2746(98)90179-3; Olsen BS, 2003, J BONE JOINT SURG BR, V85B, P342, DOI 10.1302/0301-620X.85B3.13669; Osborne G, 1966, J Bone Joint Surg Br, V48, P340	10	6	6	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	2424-8355	2424-8363		J HAND SURG-ASIAN-PA	J. Hand Surg.-Asian Pac.-Vol.		2007	12	2					101	105		10.1142/S021881040700350X			5	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	V1C8K	WOS:000216787300010	18098362				2022-02-06	
J	Sawauchi, S; Murakami, S; Ogawa, T; Abe, T				Sawauchi, Satoshi; Murakami, Shigeyuki; Ogawa, Takeki; Abe, Toshiaki			Acute subdural hematoma associated with diffuse brain injury: Analysis of 526 cases in Japan neurotrauma data bank	NEUROLOGICAL SURGERY			Japanese	Article						Japan Neurotrauma Data Bank; acute subdural hernatoma; diffuse brain injury; traumatic brain injury; outcome	CT-SCAN; MORTALITY	OBJECTIVE Traumatic acute subdural hematomas (ASDH) in Japan Neurotrauma Data Bank were categorized into focal brain injury (FBI) group and diffuse brain injury (DBI) group, and were analyzed to clarify the pathophysiological and therapeutic aspects of these injuries. METHODS Data in Japan Neurotrauma Data Bank were reviewed for 1,002 severely head-injured patients treated at hospitals between 1998 and 2001; 526 of these patients had ASDH. ASDH in this data bank were categorized into FBI group and DBI group on the findings of CT scan. The clinical variables in these injuries were evaluated. RESULTS Of 526 patients with ASDH, 246 (46.8%) were categorized into FBI group, 280 (53.2%) were DBI group. The patients with DBI group were younger, injured in traffic accident, lower Glasgow Coma Scale (GCS), higher Injury Severity Score, poorer outcome, compared to those with FBI group. The patients in DBI group, who underwent decompressive craniectomy and craniotomy, had a significantly better outcome than those who underwent hematoma evacuation via burr hole. There were no relationship between the time from injury to operation and outcome in the patients with DBI group, whereas patients with early surgery in FBI group showed significantly poorer outcome. Hypothermia and the placement of intracranial pressure monitor improved outcome only in patients of DBI group. CONCLUSION It seems that the pathophysiological and therapeutic aspects of ASDH associated with DBI might differ from that with FBI alone.	Jikei Univ, Sch Med, Kashiwa Hosp, Dept Neurosurg, Kashiwa, Chiba 2778567, Japan; Jikei Univ, Sch Med, Dept Emergency Med, Kashiwa, Chiba 2778567, Japan; Jikei Univ, Sch Med, Dept Neuroanat, Kashiwa, Chiba 2778567, Japan		Sawauchi, S (corresponding author), Jikei Univ, Sch Med, Kashiwa Hosp, Dept Neurosurg, 163-1 Kashiwashita, Kashiwa, Chiba 2778567, Japan.	sawauchi@jikei.ac.jp					Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Gennarelli T A, 1984, Emerg Med Clin North Am, V2, P749; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	7	6	6	0	2	IGAKU-SHOIN LTD	TOKYO	5-24-3 HONGO BUNKYO-KU, TOKYO, 113 91, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	JAN	2007	35	1					43	51					9	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	135KQ	WOS:000244152900006	17228767				2022-02-06	
J	Suchy, Y; Eastvold, A; Whittaker, WJ; Strassberg, D				Suchy, Yana; Eastvold, Angela; Whittaker, Wilson J.; Strassberg, Donald			Validation of the Behavioral Dyscontrol Scale-Electronic Version: Sensitivity to subtle sequelae of mild traumatic brain	BRAIN INJURY			English	Article						executive; Behavioral Dyscontrol Scale; electronic tests; neuropsychological assessment	HEAD-INJURY; FUNCTIONAL STATUS; VERBAL FLUENCY; DEFICITS; PERFORMANCE; ATTENTION; VALIDITY; LESION; CORTEX; DAMAGE	Primary objective: To determine whether a new computer-administered battery (Behavioral Dyscontrol Scale-Electronic Version; BDS-EV) can detect subtle executive weaknesses among individuals with a self-reported history of mild head trauma (MHT), and to compare the utility of this battery to the original, non-electronic BDS and other traditional executive measures. Both BDS-EV and BDS are comprised of three factors (motor programming, environmental independence, and fluid intelligence). Method: Participants with (n = 19) and without (n = 24) MHT were compared on their performance on the BDS-EV, the non-electronic BDS, and three traditional measures of executive abilities. Results: Participants with MHT differed from those without MHT on the BDS-EV motor programming and environmental independence, but not on any other measures. Conclusion: The results show that electronic administration improved the sensitivity of the battery, and support prior findings that traditional executive measures are generally insensitive to subtle executive deficits associated with chronic MHT.	Univ Utah, Dept Psychol, Utah Brain Inst, Salt Lake City, UT 84112 USA		Suchy, Y (corresponding author), Univ Utah, Dept Psychol, Utah Brain Inst, 380 S 1530 E,Rm 502, Salt Lake City, UT 84112 USA.	yana.suchy@psych.utah.edu		Suchy, Yana/0000-0001-6513-565X			Ahola K, 1996, BRAIN COGNITION, V31, P1, DOI 10.1006/brcg.1996.0021; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Angrilli A, 1999, NEUROREPORT, V10, P1741, DOI 10.1097/00001756-199906030-00021; ARCIA E, 1994, BRAIN INJURY, V8, P395, DOI 10.3109/02699059409150991; Benton A, 2000, MULTILINGUAL APHASIA; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; BUTLER M, 1991, PROF PSYCHOL-RES PR, V22, P510, DOI 10.1037/0735-7028.22.6.510; Cato MA, 2004, J INT NEUROPSYCH SOC, V10, P453, DOI 10.1017/S1355617704103123; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; CHAPMAN LJ, 1987, BRAIN COGNITION, V6, P175, DOI 10.1016/0278-2626(87)90118-7; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cicerone KD, 1997, CLIN NEUROPSYCHOL, V11, P266, DOI 10.1080/13854049708400455; Cohen MJ, 2000, ARCH CLIN NEUROPSYCH, V15, P267, DOI 10.1016/S0887-6177(99)00017-7; COLLETTE F, 2002, NEUROSCI BIOBEHAV R, P105; Demakis GJ, 2003, NEUROPSYCHOLOGY, V17, P255, DOI 10.1037/0894-4105.17.2.255; Demakis GJ, 1997, PSYCHOL REP, V81, P443; Ecklund-Johnson E, 2004, CLIN NEUROPSYCHOL, V18, P395, DOI 10.1080/1385404049052415; Eslinger PJ, 1999, NEUROCASE, V5, P225, DOI 10.1080/13554799908402727; Golden C. J., 1998, STROOP COLOR WORD TE; Grigsby J, 1998, J AM GERIATR SOC, V46, P590, DOI 10.1111/j.1532-5415.1998.tb01075.x; Grigsby J, 2002, REHABIL PSYCHOL, V47, P291, DOI 10.1037//0090-5550.47.3.291; GRIGSBY J, 1992, PERCEPT MOTOR SKILL, V74, P883, DOI 10.2466/PMS.74.3.883-892; Grigsby J., 2002, J CLIN GEROPSYCHOLOG, V8, P25, DOI DOI 10.1023/A:1013094023856; GRIGSBY J, 2000, J CLIN GEROPSYCHOLOG, V6, P259, DOI DOI 10.1023/A:1009582728548; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Hart T, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P133; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; KAYE K, 1990, J AM GERIATR SOC, V38, P1304, DOI 10.1111/j.1532-5415.1990.tb03452.x; Leahy B, 2003, CLIN NEUROPSYCHOL, V17, P474, DOI 10.1076/clin.17.4.474.27941; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lezak M, 1994, NEUROPSYCHOLOGICAL A; LEZAK MD, 2004, NEUROPSYCHOLOGICAL A, P631; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; Manoach DS, 1997, NEUROREPORT, V8, P545, DOI 10.1097/00001756-199701200-00033; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; Mathiesen B. B., 2004, NEUROPSYCHOANALYSIS, V6, P47; MEYERS CA, 1992, J PSYCHIATR NEUROSCI, V17, P121; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Miller E, 1999, J FORENSIC PSYCHIATR, V10, P157, DOI 10.1080/09585189908402146; MILLER E, 1984, BRIT J CLIN PSYCHOL, V23, P53, DOI 10.1111/j.2044-8260.1984.tb00626.x; Mitchell DGV, 2002, NEUROPSYCHOLOGIA, V40, P2013, DOI 10.1016/S0028-3932(02)00056-8; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; PENDLETON MG, 1982, J CLIN NEUROPSYCHOL, V4, P307, DOI 10.1080/01688638208401139; Polo MD, 2002, NEUROPSYCHOLOGIA, V40, P2350, DOI 10.1016/S0028-3932(02)00127-6; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Ravnkilde B, 2002, J CLIN EXP NEUROPSYC, V24, P534, DOI 10.1076/jcen.24.4.534.1033; Reitan R. M., 1958, TRAIL MAKING TEST MA; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; REITAN RM, 1994, NEUROPSYCHOL REV, V4, P161, DOI 10.1007/BF01874891; REZAI K, 1993, ARCH NEUROL-CHICAGO, P636; ROSENBAUM A, 1994, J CONSULT CLIN PSYCH, V62, P1187, DOI 10.1037/0022-006X.62.6.1187; RUFF RM, 1998, RFFT RUFF FIGURAL FL; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Suchy Y, 2005, CLIN NEUROPSYCHOL, V19, P4, DOI 10.1080/13854040490888585; Suchy Y, 2003, CLIN NEUROPSYCHOL, V17, P492, DOI 10.1076/clin.17.4.492.27949; Suchy Y, 1997, CLIN NEUROPSYCHOL, V11, P258, DOI 10.1080/13854049708400454; Suchy Y, 1999, CLIN NEUROPSYCHOL, V13, P487, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT487; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Varney NR, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P115; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; WILSON J T L, 1992, Brain Injury, V6, P391, DOI 10.3109/02699059209008135; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328; Yucel M, 2002, AM J PSYCHIAT, V159, P251, DOI 10.1176/appi.ajp.159.2.251; Zachary R. A., 1986, SHIPLEY I LIVING SCA; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE	79	6	6	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2007	21	1					69	80		10.1080/02699050601149088			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	141FQ	WOS:000244564600009	17364522				2022-02-06	
J	Wen, L; Yang, XF; Liu, WG; Pan, DS; Shen, G; Zheng, XS; Xu, XY; Jiang, DY				Wen Liang; Yang Xiaofeng; Liu Weiguo; Pan Desheng; Shen Gang; Zheng Xuesheng; Xu Xiaoyan; Jiang Dingyao			Bilateral traumatic carotid cavernous fistula: The manifestations, transvascular embolization and prevention of the vascular complications after therapeutic embolization	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						bilateral traumatic carotid cavernous fistula; transvascular embolization; vascular complication	CAROTICOCAVERNOUS FISTULAS; DETACHABLE BALLOON; SINUS FISTULA; OCCLUSION; RESOLUTION	Bilateral traumatic carotid cavernous fistula is very rare after traumatic brain and facial injury. We present a 68-year-old woman with bilateral traumatic carotid cavernous fistula, who was treated with transarterial embolization by detachable balloon on both fistulas and recovered completely. We also reviewed the presentations, treatment and the complications after the transarterial embolization of this disorder.	Zhejiang Univ, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310009, Zhejiang, Peoples R China; Zhejiang Univ, Affiliated Hosp 2, Dept Radiol, Hangzhou 310009, Zhejiang, Peoples R China		Yang, XF (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Dept Neurosurg, 13th Floor,88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	jediwen@163.com					Alkhani A, 1999, SURG NEUROL, V52, P627, DOI 10.1016/S0090-3019(99)00132-9; Fabian TS, 1999, J TRAUMA, V47, P275, DOI 10.1097/00005373-199908000-00009; Fattahi TT, 2003, J CRANIOFAC SURG, V14, P240, DOI 10.1097/00001665-200303000-00020; Hantson P, 2006, CLIN NEUROL NEUROSUR, V108, P576, DOI 10.1016/j.clineuro.2005.03.010; HIGASHIDA RT, 1989, AM J ROENTGENOL, V153, P577, DOI 10.2214/ajr.153.3.577; Kamel HAM, 2000, NEURORADIOLOGY, V42, P462, DOI 10.1007/s002340000309; Kim JK, 1996, ACTA RADIOL, V37, P46; LOUIS B, 1980, HEAD INJURY, P313; Ng SH, 1999, J TRAUMA, V47, P1156, DOI 10.1097/00005373-199912000-00033; Oran I, 2004, NEURORADIOLOGY, V46, P234, DOI 10.1007/s00234-003-1142-6; Sanden U, 2003, J CLIN ULTRASOUND, V31, P319, DOI 10.1002/jcu.10175; SERBINENKO FA, 1974, J NEUROSURG, V41, P125, DOI 10.3171/jns.1974.41.2.0125; Shintani S, 2000, NEUROLOGY, V55, P1929, DOI 10.1212/WNL.55.12.1929; TAKENOSHITA Y, 1990, J CRANIO MAXILL SURG, V18, P41, DOI 10.1016/S1010-5182(05)80602-X; ZACHARIADES N, 1988, J CRANIO MAXILL SURG, V16, P385, DOI 10.1016/S1010-5182(88)80086-6	15	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JAN	2007	18	1					74	77		10.1097/01.scs.0000231629.18135.cd			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	131FM	WOS:000243853800014	17251840				2022-02-06	
J	Zabek, M; Zaczynski, A				Zabek, Miroslaw; Zaczynski, Artur			Golden hour and the dull reality. Analysis of traumatic brain injury management in pre-hospital and emergency care	NEUROLOGIA I NEUROCHIRURGIA POLSKA			English	Article						golden hour; pre-hospital treatment; emergency care; traumatic brain injury		Background and purpose: Continuous progress in medical sciences with simultaneous technological development has created an unavoidable need for a reorganisation of Emergency Health Care in Poland. Introduction of modern means of transport in pre-hospital care, formation of air rescue teams, or standardization of emergency information centres (CPR) play an important role in this reorganisation; however, so far, there is still a lack of coherence between the pre-hospital care and the management within the emergency room. Material and methods: The conducted study was based on an analysis of ambulance service records of 144 patients with severe traumatic brain injury that occurred in 2002-2004, who were in grave clinical status. The study also evaluated duration and distance covered by these patients during the period from the injury to complete surgical management. Relationships between patient's clinical status at admission and discharge, and the duration of pre-hospital and hospital work-up were also analysed. Results: Despite the existing organisational gaps, outcomes of the therapy of traumatic brain injury patients brought to the hospital by the ambulance directly from the accident scene were by far better than those observed in patients transported from remote lower reference centres, where tie-ups associated with the management process led to significantly longer delays thus resulting in poorer prognosis in these patients. Conclusions: According to the analysis the authors conclude that there is a need to reorganise the national system of emergency care in Poland. The most important issues are: to standardize the emergency medical records and initial emergency procedures, to organise multitrauma teams, and to decrease the time of the referral process and definitive care.	[Zabek, Miroslaw; Zaczynski, Artur] CMKP, Klin Neurochirurg & Urazow Ukladu Nerwowego, PL-03242 Warsaw, Poland		Zabek, M (corresponding author), CMKP, Klin Neurochirurg & Urazow Ukladu Nerwowego, Ul Kondratowica 8, PL-03242 Warsaw, Poland.	zabek@mds.pl		Zabek, Miroslaw/0000-0001-6847-2424			Blow O, 1999, J TRAUMA, V47, P964, DOI 10.1097/00005373-199911000-00028; BRONGEL L, 2000, KRAKOWSKIE WYDAWICTW, P3; BULLOCK R, 2000, BRAIN TRAUMA FDN, P15; Campbell J., 2000, BRIT GERMAN HIST 175, P99; CHECINSKI I, 2000, MED INTENS RATUNK, P18; COOPER PR, 2000, HEAD INJURY; CZERNICKI Z, 2000, NEUROTRAUMATOLOGIA, V1, P47; CZERNICKI Z, 2000, NEUROTRAUMATOLOGIA, V1, P25; FEBER J, 2003, URBAN PARTNER, P74; GABRIEL E, 2000, BRAIN TRAUMA FDN, P7; Glowacki Mariusz, 2002, Neurol Neurochir Pol, V36, P363; Jakubaszko J, 1999, MED INTENS RATUNK, V3, P261; JAKUBASZKO J, 1998, SYSTEM MEDYCYNY RATU, P79; Jarus-Dziedzic K, 1999, Neurol Neurochir Pol, V33, P151; Luchette F, 1997, J TRAUMA, V42, P490, DOI 10.1097/00005373-199703000-00017; MARSZALEK P, 1998, MEDYCYNA PRAKTYCZNA, P1; Rogers FB, 2003, J TRAUMA, V54, P9, DOI 10.1097/00005373-200301000-00002; WRONSKI J, 1997, POL PRZEGL CHIR, V8, P83; ZABEK M, 1997, URAZY CZASZKOWO MOZG, P9; Zawadzki A., 2006, MEDYCYNA RATUNKOWA K	20	6	6	0	4	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	WENEDOW ST 9-1, POZNAN, 61-614, POLAND	0028-3843			NEUROL NEUROCHIR POL	Neurol. Neurochir. Pol.		2007	41	1					22	27					6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	275ZF	WOS:000254110200003	17330177				2022-02-06	
J	Zhang, ZR; Fauser, U; Schluesener, HJ				Zhang, Zhiren; Fauser, Uwe; Schluesener, Hermann J.			Expression of RhoA by inflammatory macrophages and T cells in rat experimental autoimmune neuritis	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						experimental autoimmune neuritis; RhoA; macrophages; T cells	EXPERIMENTAL ALLERGIC NEURITIS; SPINAL-CORD-INJURY; PERIPHERAL NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; CLOSTRIDIUM-BOTULINUM; LESIONAL EXPRESSION; ACTIN CYTOSKELETON; ADP-RIBOSYLATION; MICROGLIAL CELLS; ANIMAL-MODELS	RhoA is one of the best-studied members of Rho GTPases. Experimental autoimmune neuritis (EAN), which is characterized by infiltration of T cells and macrophages into the peripheral nervous system, is an autoantigen-specific T-cell-mediated animal model of human Guillain-Barre Syndrome. In this study, RhoA expression has been investigated in the dorsal/ventral roots of EAN rats,by immunohistochemistry. A significant accumulation of RhoA+ cells was observed on Day 12, with a maximum around Day 15, correlating to the clinical severity of EAN. In dorsal/ventral roots of EAN, RhoA+ cells were seen in peri-vascular areas but also in the parenchyma. Furthermore, double-labelling experiments showed that the major cellular sources of RhoA were reactive macrophages and T cells. In conclusion, this is the first demonstration of the presence of RhoA in the dorsal/ventral roots of EAN. The time courses and cellular sources of RhoA together with the functions of RhoA indicate that RhoA may function to facilitate macrophage and T-cell infiltration in EAN and therefore could be a potential therapeutic target.	Univ Tubingen, Brain Res Inst, D-72076 Tubingen, Germany		Zhang, ZR (corresponding author), Univ Tubingen, Brain Res Inst, Calwer Str 3, D-72076 Tubingen, Germany.	zhangzhiren@yahoo.com	Zhang, Zhiren/O-1012-2019; zhang, zhiren/I-1046-2014	Zhang, Zhiren/0000-0002-5238-2835; zhang, zhiren/0000-0002-5238-2835			Aihara M, 2004, INT IMMUNOPHARMACOL, V4, P557, DOI 10.1016/j.intimp.2003.12.014; Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Angkachatchai V, 1999, J IMMUNOL, V163, P3819; Brabeck C, 2004, J NEUROTRAUM, V21, P697, DOI 10.1089/0897715041269597; Brabeck C, 2003, ARCH NEUROL-CHICAGO, V60, P1245, DOI 10.1001/archneur.60.9.1245; Bustelo XR, 2002, BIOESSAYS, V24, P602, DOI 10.1002/bies.10107; CHARDIN P, 1989, EMBO J, V8, P1087, DOI 10.1002/j.1460-2075.1989.tb03477.x; Conrad S, 2005, J COMP NEUROL, V487, P166, DOI 10.1002/cne.20561; Constantinescu CS, 2000, NEUROSCI LETT, V287, P171, DOI 10.1016/S0304-3940(00)01184-8; Constantinescu CS, 1998, IMMUNOL RES, V17, P217, DOI 10.1007/BF02786446; CRAGGS RI, 1984, ACTA NEUROPATHOL, V62, P316, DOI 10.1007/BF00687614; Donovan FM, 1997, J NEUROSCI, V17, P5316; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Eto M, 2002, CIRCULATION, V105, P1756, DOI 10.1161/01.CIR.0000015465.73933.3B; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Gold R, 1999, BRAIN PATHOL, V9, P343; Greenwood J, 2003, FASEB J, V17, P905, DOI 10.1096/fj.02-1014fje; Guo LH, 2005, J NEUROIMMUNOL, V163, P120, DOI 10.1016/j.jneuroim.2005.03.007; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hartung H P, 1988, Ann N Y Acad Sci, V540, P122, DOI 10.1111/j.1749-6632.1988.tb27058.x; Hartung HP, 1996, SPRINGER SEMIN IMMUN, V18, P97, DOI 10.1007/BF00792612; HARTUNG HP, 1988, BRAIN, V111, P1039, DOI 10.1093/brain/111.5.1039; HARVEY GK, 1995, BRAIN, V118, P1263, DOI 10.1093/brain/118.5.1263; HEININGER K, 1988, ANN NEUROL, V23, P326, DOI 10.1002/ana.410230403; Hendricks JJA, 2004, J EXP MED, V200, P1667, DOI 10.1084/jem.20040819; IZUMO S, 1985, LAB INVEST, V53, P209; Kafri M, 2005, J NEUROIMMUNOL, V168, P46, DOI 10.1016/j.jneuroim.2005.07.008; Kim JS, 2005, EXP MOL MED, V37, P575, DOI 10.1038/emm.2005.71; Kim JS, 2006, BLOOD, V108, P1821, DOI 10.1182/blood-2005-10-009191; Knaus UG, 2000, IMMUNOL RES, V21, P103, DOI 10.1385/IR:21:2-3:103; Kohno Y, 2004, PATHOL INT, V54, P693, DOI 10.1111/j.1440-1827.2004.01682.x; LANG P, 1992, J BIOL CHEM, V267, P11677; LININGTON C, 1984, J IMMUNOL, V133, P1946; Maderna P, 2002, AM J PATHOL, V160, P2275, DOI 10.1016/S0002-9440(10)61175-3; Maurer M, 2002, REV NEUROL-FRANCE, V158, pS7; Maurer M, 2002, CURR OPIN NEUROL, V15, P617, DOI 10.1097/00019052-200210000-00013; Negishi M, 2002, J BIOCHEM, V132, P157, DOI 10.1093/oxfordjournals.jbchem.a003205; Nguyen QD, 2002, FASEB J, V16, P565, DOI 10.1096/fj.01-0525com; Pixley FJ, 2005, J CELL SCI, V118, P1873, DOI 10.1242/jcs.02314; POLLARD JD, 1995, ANN NEUROL, V37, P467, DOI 10.1002/ana.410370409; POWELL HC, 1983, LAB INVEST, V48, P332; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2001, FEBS LETT, V498, P168, DOI 10.1016/S0014-5793(01)02481-4; ROSTAMI A, 1984, ANN NEUROL, V16, P680, DOI 10.1002/ana.410160610; RUBIN EJ, 1988, MOL CELL BIOL, V8, P418, DOI 10.1128/MCB.8.1.418; SCHABET M, 1991, J NEUROIMMUNOL, V31, P265, DOI 10.1016/0165-5728(91)90048-C; Schluesener HJ, 1997, GLIA, V20, P365, DOI 10.1002/(SICI)1098-1136(199708)20:4<365::AID-GLIA8>3.0.CO;2-4; Schluesener HJ, 1998, GLIA, V24, P244, DOI 10.1002/(SICI)1098-1136(199810)24:2<244::AID-GLIA9>3.0.CO;2-3; Schwab JM, 2005, J NEUROIMMUNOL, V163, P185, DOI 10.1016/j.jneuroim.2005.02.016; SHIN HC, 1989, NEUROSCI LETT, V102, P309, DOI 10.1016/0304-3940(89)90097-9; SPIES JM, 1995, J NEUROIMMUNOL, V57, P77, DOI 10.1016/0165-5728(94)00164-J; Stoll G, 2002, REV NEUROL-FRANCE, V158, P887; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Taylor JM, 2003, MUSCLE NERVE, V28, P344, DOI 10.1002/mus.10432; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Walters CE, 2002, J IMMUNOL, V168, P4087, DOI 10.4049/jimmunol.168.8.4087; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Woodside DG, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-2	60	6	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	JAN-FEB	2007	11	1					111	119		10.1111/j.1582-4934.2007.00004.x			9	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	153TN	WOS:000245458200010	17367505	Green Published, Bronze			2022-02-06	
J	Dutton, RP; Stein, DM				Dutton, Richard P.; Stein, Deborah M.			The use of factor VIIa in haemorrhagic shock and intracerebral bleeding	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						acute haemorrhagic shock; trauma; coagulopathy; resuscitation; traumatic brain injury; intracerebral bleeding; factor VIIa	RECOMBINANT-FACTOR-VIIA; ACTIVATED FACTOR-VII; COAGULATION-FACTOR VIIA; DOSE FACTOR VIIA; DOUBLE-BLIND; COAGULOPATHY; TRAUMA; TRIAL; EFFICACY; SURGERY	Factor VIIa is a revolutionary new pharmaceutical that promises to change the anaesthesia and critical care approach to major trauma. It is an extremely potent pro-coagulant agent, and white it enables haemostasis at the site of tissue injury, it also has the possibility of producing life-threatening thromboembolic complications. New data regarding FVIIa use is published almost every month, leading to a rapidly evolving clinical understanding of the potential indications, and potential pitfalls, of off-Label use. Determination of appropriate practice, including the ability to judge the risks and benefits of FVIIa therapy for individual cases, is still some years in the future, and will depend in arge part on clinical trials which are just getting underway. (C) 2006 Elsevier Ltd. All rights reserved.	Univ Maryland, Med Syst, R Adams Cowley Shock Trauma Ctr, College Pk, MD 20742 USA; Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA		Dutton, RP (corresponding author), 22 S Greene St, Baltimore, MD 21201 USA.	rdutton@umaryland.edu		Stein, Deborah/0000-0003-3683-3963			Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Clark AD, 2004, VOX SANG, V86, P120, DOI 10.1111/j.0042-9007.2004.00393.x; Deveras RAE, 2002, ANN INTERN MED, V137, P884, DOI 10.7326/0003-4819-137-11-200212030-00009; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; DUTTON RP, 2006, PERIOPERATIVE TRANSF, P289; FERRARA A, 1990, AM J SURG, V160, P515, DOI 10.1016/S0002-9610(05)81018-9; Friederich PW, 2003, LANCET, V361, P201, DOI 10.1016/S0140-6736(03)12268-4; Geeraedts LMG, 2005, INJURY, V36, P495, DOI 10.1016/j.injury.2004.08.001; Hedner Ulla, 2003, Clin Adv Hematol Oncol, V1, P112; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Khan AZ, 2005, AM J SURG, V189, P331, DOI 10.1016/j.amjsurg.2004.11.021; Lodge JPA, 2005, LIVER TRANSPLANT, V11, P973, DOI 10.1002/lt.20470; Lodge JPA, 2005, ANESTHESIOLOGY, V102, P269, DOI 10.1097/00000542-200502000-00006; Martinowitz U, 2001, J TRAUMA, V51, P431, DOI 10.1097/00005373-200109000-00002; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Meng ZH, 2003, J TRAUMA, V55, P886, DOI 10.1097/01.TA.0000066184.20808.A5; Monroe DM, 2003, ARTERIOSCL THROM VAS, V23, P8, DOI 10.1161/01.ATV.0000047645.37970.AB; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; O'Connell NM, 2003, TRANSFUSION, V43, P1711, DOI 10.1046/j.0041-1132.2003.00577.x; O'Neill PA, 2002, J TRAUMA, V52, P400, DOI 10.1097/00005373-200202000-00034; Park P, 2003, NEUROSURGERY, V53, P34, DOI 10.1227/01.NEU.0000068830.54968.A8; Raobaikady R, 2005, BRIT J ANAESTH, V94, P586, DOI 10.1093/bja/aei102; Stein DM, 2005, J TRAUMA, V59, P609, DOI 10.1097/01.ta.0000177655.67763.df; Tanaka KA, 2003, ANESTHESIOLOGY, V98, P1513, DOI 10.1097/00000542-200306000-00034	24	6	8	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	DEC	2006	37	12					1172	1177		10.1016/j.injury.2006.09.001			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	123TQ	WOS:000243319200011	17087958				2022-02-06	
J	Foley, J; Garcia, J; Harris, K; Golden, C; Todd, M				Foley, Jessica; Garcia, Jessica; Harris, Kristen; Golden, Charles; Todd, Mark			Can the MMPI-2 discriminate between mild-moderate TBI and other neurologic and psychiatric populations?	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						Alzheimer's dementia; depression; MMPI-2; personality changes; somatic; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; POSTCONCUSSION SYNDROME; ALZHEIMERS-DISEASE; SYMPTOMS; PSYCHOSIS; DEMENTIA; VALIDITY; ADULTS	MMPI-2 maintains an extensive empirical base with psychiatric populations, although more recently, neurologically compromised patients have documented unique elevation patterns. This study examined mild-moderate TBI patients, Alzheimer's Dementia patients, and Psychiatric controls on MMPI-2 scales. Participants included 160 outpatients (TBI n = 26, AD n = 74, Psychiatric n = 60). Controlling for family-wise-error, five ANCOVAs were conducted on five MMPI-2 scales, correcting for age and education. TBI and Psychiatric group means were significantly higher than AD group means for scales Hypochondriasis, Depression, and Hysteria at an alpha of .01. Results support previous research with mild TBI patients, and further document a unique pattern of elevations in this population.	Nova SE Univ, Ft Lauderdale, FL 33314 USA; N Broward Med Ctr, Deerfield Beach, FL USA		Foley, J (corresponding author), 1040 Seminole Dr 1052, Ft Lauderdale, FL 33304 USA.	jfoley@post.harvard.edu					ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P111; Askin-Edgar S., 2004, ESSENTIALS NEUROPSYC, P421; Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; Brodaty H, 1996, Int Psychogeriatr, V8, P609, DOI 10.1017/S104161029600292X; Burke J M, 1989, Brain Inj, V3, P35, DOI 10.3109/02699058909008071; BUTCHER JN, 2001, MMPI 2 MANUAL ADM SO; Cattelani R, 1996, BRAIN INJURY, V10, P187, DOI 10.1080/026990596124502; Craig R. J., 1999, INTERPRETING PERSONA; DAHLSTROM WG, 1972, OBJECTIVE PERSONALIT, P85; Emilien G, 1996, ACTA NEUROL BELG, V96, P89; FERGUSON RJ, 1995, COGNITIVE BEHAV TREA, P615; Fridman EA, 2000, CNS DRUGS, V14, P191, DOI 10.2165/00023210-200014030-00002; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; GOLDEN Z, 2003, J HEAD TRAUMA REHAB, V18, P733; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; GRAHAM JR, 2000, MMPI 2 ASSESSING PER; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; LENINGER BE, 1991, BRAIN INJURY, V5, P199; McAllister TW, 2002, NEUROREHABILITATION, V17, P357; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Mirakhur A, 2004, INT J GERIATR PSYCH, V19, P1035, DOI 10.1002/gps.1203; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Palav A, 2001, J HEAD TRAUMA REHAB, V16, P275, DOI 10.1097/00001199-200106000-00006; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Schneider LS, 2004, J PSYCHIATR RES, V38, P105, DOI 10.1016/S0022-3956(03)00092-X; Schreinzer D, 2005, INT J GERIATR PSYCH, V20, P137, DOI 10.1002/gps.1263; Silver J. M., 1991, NEUROPSY NEUROPSY BE, V4, P12; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	34	6	7	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	DEC	2006	116	12					1377	1389		10.1080/00207450500514334			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	112TR	WOS:000242550600001	17145674				2022-02-06	
J	Gagnon, J; Bouchard, MA; Rainville, C				Gagnon, J; Bouchard, MA; Rainville, C			Differential diagnosis between borderline personality disorder and organic personality disorder following traumatic brain injury	BULLETIN OF THE MENNINGER CLINIC			English	Article							CLOSED HEAD-INJURY; PSYCHIATRIC-DISORDERS; BEHAVIORAL SEQUELAE; SOCIAL-ADJUSTMENT; OBJECT RELATIONS; RELATIVES VIEW; SELF-CONCEPT; AXIS-I; PSYCHOPATHOLOGY; DAMAGE	Organic personality disorder (OPD) is the traditional diagnostic category used to account for personality disturbances after traumatic brain injury (TBI). The recent use of Axis-II personality disorders, notably borderline personality disorder (BPD), has appeared in the TBI literature as an alternative to OPD. This would presumably offer a better description and understanding of the multiple clinical manifestations of these personality changes and disorders. This article offers a view that it is possible and fruitful to use both diagnoses in a complementary manner. An accurate recognition of the respective phenomenologies of both BPD and OPD is a key factor in achieving a differential diagnosis, including, if required, a dual diagnosis. The phenomenology of both conditions in reference to DSM-IV criteria is compared and illustrated through two clinical vignettes.	Univ Sherbrooke, Fac Lettres & Sci Humaines, Dept Psychol, Sherbrooke, PQ J1K 2R1, Canada; Univ Montreal, Montreal, PQ H3C 3J7, Canada; Inst Univ Geriatr Montreal, Montreal, PQ, Canada		Gagnon, J (corresponding author), Univ Sherbrooke, Fac Lettres & Sci Humaines, Dept Psychol, 2500 Blvd Univ, Sherbrooke, PQ J1K 2R1, Canada.	jean.gagnon@usherbrooke.ca					American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; ANDRULONIS PA, 1981, PSYCHIAT CLIN N AM, V4, P47; Bateman A., 2004, PSYCHOTHERAPY BORDER; Benson D.F., 1986, FRONTAL LOBES; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; BOND MR, 1984, CLOSED HEAD INJURY P, P148; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROOKS N, 1984, CLOSED HEAD INJURY P, P123; Duffy J. D., 2001, FRONTAL LOBES NEUROP, P113; Eames P, 1985, Int Rehabil Med, V7, P130; Eisenberg, 1987, NEUROBEHAVIORAL RECO, P215; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; FORD B, 1976, MED J AUSTRALIA, V1, P603, DOI 10.5694/j.1326-5377.1976.tb140904.x; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; Gagnon J, 2006, BRAIN INJURY, V20, P67, DOI 10.1080/02699050500309668; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; GRANT I, 1987, NEUROBEHAVIORAL RECO, P232; GRIFFITHS DM, 1998, BEHAV SUPPORTS INDIV; Groswasser Z, 1998, J HEAD TRAUMA REHAB, V13, P69, DOI 10.1097/00001199-199802000-00009; Gunderson J. G., 2001, BORDERLINE PERSONALI; GUNDERSON JG, 1978, AM J PSYCHIAT, V135, P792; GUNDERSON JG, 1981, AM J PSYCHIAT, V138, P896; GUNDERSON JG, 1984, BORDERLINE PERSONALI; Hart T, 1993, J HEAD TRAUMA REHAB, V8, P1; Hecaean H, 1975, PSYCHIATRIC ASPECTS, P137; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; HOWARD ME, 1988, J HEAD TRAUMA REHAB, V3, P14; Hyman SE, 2002, BIOL PSYCHIAT, V51, P933, DOI 10.1016/S0006-3223(02)01408-7; JARVIE HF, 1954, J NEUROL NEUROSUR PS, V17, P14, DOI 10.1136/jnnp.17.1.14; Judd T., 1996, ECOLOGICAL VALIDITY, P315; KERNBERG O, 1967, J AM PSYCHOANAL ASS, V15, P641, DOI 10.1177/000306516701500309; KERNBERG OF, 1984, OBJECT RELATIONS THE; KERNBERG OF, 1975, CURRENT HST PERSPECT, P123; Kerr N., 1977, SOCIAL PSYCHOL ASPEC, V1st, P317; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kraus M. F., 2001, FRONTAL LOBES NEUROP, P199; KRAVETZ S, 1995, BRAIN INJURY, V9, P131, DOI 10.3109/02699059509008186; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Lecours S, 1997, INT J PSYCHOANAL, V78, P855; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEWIS L, 1990, J NERV MENT DIS, V178, P69, DOI 10.1097/00005053-199002000-00001; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Lipowski Z., 1975, PSYCHIATRIC ASPECTS, P11; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; LISHMAN WA, 1978, J IRISH MED ASSOC, V71, P306; Luria A.R., 1973, WORKING BRAIN INTRO; Mahler M., 1968, HUMAN SYMBIOSIS VICI; Manchester D, 1997, BRAIN INJURY, V11, P605, DOI 10.1080/026990597123296; Masterson JF, 1976, PSYCHOTHERAPY BORDER; MASTERSON JF, 1985, REAL SELF DEV SELF O; MILLON T, 1995, DSM, V4, P3; NOVACK TA, 1983, INT J CLIN NEUROPSYC, V6, P139; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; OSHANICK GJ, 1994, NEUROPSYCHIATRY TRAU, P163; PARIS J, 1988, J PERS DISORD, V2, P189; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; Prigatano G. P., 1987, COMMUNITY REENTRY HE, P1; PRIGATANO GP, 1986, NEUROPSYCHOLOGICAL R, P29; SALLOWAY SP, 1994, J NEUROPSYCH CLIN N, V6, P388; SEGAL BM, 1990, FAMILY ENV BORDERLIN, P27; Simpson G, 2001, J HEAD TRAUMA REHAB, V16, P556, DOI 10.1097/00001199-200112000-00004; Skodol AE, 2002, BIOL PSYCHIAT, V51, P936, DOI 10.1016/S0006-3223(02)01324-0; SLAGLE DA, 1990, INT J PSYCHIAT MED, V20, P1, DOI 10.2190/BE6W-DCY1-V71N-N7J7; Spatt J, 1997, ACTA NEUROL SCAND, V95, P173, DOI 10.1111/j.1600-0404.1997.tb00091.x; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Starkstein SE, 1997, J NERV MENT DIS, V185, P108, DOI 10.1097/00005053-199702000-00007; STERN JM, 1985, ISRAEL J PSYCHIAT, V22, P83; Strain J.J., 1975, PSYCHOL CARE MED ILL; STRATTON MC, 1995, REHABILITATION NURSI, V20, P3223; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Teichner G, 1999, Rehabil Nurs, V24, P207; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; TYERMAN A, 1984, NURSING, V26, P679; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WESTEN D, 1991, J PERS ASSESS, V56, P56, DOI 10.1207/s15327752jpa5601_6; WESTEN D, 1993, SELF EMOTIONAL DISTR, P334; Wood R. L., 1987, BRAIN INJURY REHABIL; Zeilig G, 1996, BRAIN INJURY, V10, P591, DOI 10.1080/026990596124160; [No title captured]	91	6	6	0	7	GUILFORD PUBLICATIONS INC	NEW YORK	72 SPRING STREET, NEW YORK, NY 10012 USA	0025-9284			B MENNINGER CLIN	Bull. Menninger Clin.	WIN	2006	70	1					1	28		10.1521/bumc.2006.70.1.1			28	Psychiatry; Psychology, Psychoanalysis	Social Science Citation Index (SSCI)	Psychiatry; Psychology	024IX	WOS:000236189800001	16545030				2022-02-06	
J	Dell'Acqua, R; Sessa, P; Pashler, H				Dell'Acqua, Roberto; Sessa, Paola; Pashler, Harold			A neuropsychological assessment of dual-task costs in closed-head injury patients using Cohen's effect size estimation method	PSYCHOLOGICAL RESEARCH-PSYCHOLOGISCHE FORSCHUNG			English	Article							TRAUMATIC BRAIN-INJURY; OVERLAPPING TASKS; PRACTICAL SCALE; INTERFERENCE; PERFORMANCE; BOTTLENECK; ATTENTION; DECISION; DAMAGE	A test of whether patients suffering from a severe closed-head injury (CHI) were affected by disproportionate dual-task costs compared to those of healthy control participants was carried out through a direct comparison of CHI effects on dual-task (psychological refractory period, or PRP) performance and on single-task performance. In the dual-task condition of the present experiment, independent choice-responses were required to two sequential stimuli presented at a variable stimulus onset asynchrony (SOA). A significant delay of the reaction time (RT) to the second stimulus was reported by both CHI patients and controls at short (SOA) compared to long SOA, i.e., a PRP effect. The PRP effect was more pronounced for CHI patients than controls. In the single-task condition, a single choice-response was required to a stimulus presented in isolation. The RT produced by CHI patients in the single-task paradigm was longer than the RT produced by controls. CHI effects on dual-task performance and on single-task performance were compared following (1) their transformation into Cohen's ds, and (2) the application of a correction algorithm taking into account the different reliability of single-task and dual-task measures. The analysis of Cohen's ds revealed that CHI effects on performance were, if anything, smaller in the dual-task condition than in the single-task condition. The results imply that CHI patient's slower responding in single- and dual-task performance reflects a single common cause-slowing of the central processing.	Univ Padua, Dept Dev Psychol, I-35131 Padua, Italy; Univ Calif San Diego, Dept Psychol 0109, La Jolla, CA 92093 USA		Dell'Acqua, R (corresponding author), Univ Padua, Dept Dev Psychol, Via Venezia 8, I-35131 Padua, Italy.	dar@unipd.it	Dell'Acqua, Roberto/B-1682-2008; Sessa, Paola/B-9523-2008	Dell'Acqua, Roberto/0000-0002-3393-1907; Sessa, Paola/0000-0002-8748-2633			BROOKS DN, 1984, CLOSED HEAD INJURY P; Cohen J., 2013, STAT POWER ANAL BEHA; Dell'Acqua R, 2003, EXP BRAIN RES, V152, P29, DOI 10.1007/s00221-003-1512-7; Dell'Acqua R, 2001, EXP BRAIN RES, V136, P364, DOI 10.1007/s002210000586; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; GRONWALL D, 1975, LANCET, V2, P995; Hein G, 2005, EXP BRAIN RES, V160, P223, DOI 10.1007/s00221-004-2006-y; Hunter J. E., 1990, METHODS METAANALYSIS; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MCCANN RS, 1992, J EXP PSYCHOL HUMAN, V18, P471, DOI 10.1037/0096-1523.18.2.471; Miller E, 1970, Cortex, V6, P121; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; PASHLER H, 1989, Q J EXP PSYCHOL-A, V41, P19, DOI 10.1080/14640748908402351; Pashler HE, 1998, ATTENTION, P155, DOI DOI 10.1016/J.TICS.2005.01.008; Richer F, 1998, BRAIN COGNITION, V37, P173; RUTHRUFF E, 2005, IN PRESS PSYCHOL RES; Schubert T, 1999, J EXP PSYCHOL HUMAN, V25, P408, DOI 10.1037/0096-1523.25.2.408; SPINNLER H, 1987, J NEUROLOGICAL SCI S, V8; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; VANSELST M, 1994, Q J EXP PSYCHOL-A, V47, P631, DOI 10.1080/14640749408401131; VanSelst M, 1997, COGNITIVE PSYCHOL, V33, P266, DOI 10.1006/cogp.1997.0662; WELFORD AT, 1959, Q J EXP PSYCHOL, V11, P193, DOI 10.1080/17470215908416312	26	6	7	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-0727	1430-2772		PSYCHOL RES-PSYCH FO	Psychol. Res.-Psychol. Forsch.	NOV	2006	70	6					553	561		10.1007/s00426-005-0016-4			9	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	109DY	WOS:000242289300015	16142490				2022-02-06	
J	Falconer, EK; Geffen, GM; Olsen, SL; McFarland, K				Falconer, Emmaline Kate; Geffen, Gina Malke; Olsen, Sara Louise; McFarland, Ken			The rapid screen of concussion: An evaluation of the non-word repetition test for use in mTBI research	BRAIN INJURY			English	Article						sub-vocal rehearsal; working memory; mTBI; nonword repetition	TRAUMATIC BRAIN-INJURY; ADULT AGE-DIFFERENCES; WORKING-MEMORY; HEAD-INJURY; PROCESSING-SPEED; MILD; DEFICITS; LANGUAGE	Primary objectives: (1) To investigate the Nonword Repetition test (NWR) as an index of sub-vocal rehearsal deficits after mild traumatic brain injury (mTBI); (2) to assess the reliability, validity and sensitivity of the NWR; and (3) to compare the NWR to more sensitive tests of verbal memory. Research design: An independent groups design. Methods and procedures: Study 1 administered the NWR to 46 mTBI and 61 uninjured controls with the Rapid Screen of Concussion (RSC). Study 2 compared mTBI, orthopaedic and uninjured participants on the NWR and the Hopkins Verbal Learning Test (HVLT-R). Main outcomes and results: The NWR did not improve the diagnostic accuracy of the RSC. However, it is reliable and indexes sub-vocal rehearsal speed. These findings provide evidence that although the current form of the NWR lacks sensitivity to the impact of mTBI, the development of a more sensitive test of sub-vocal rehearsal deficits following mTBI is warranted.	Univ Queensland, Sch Med, Cognit Psychophysiol Lab, Brisbane, Qld 4006, Australia; Univ Queensland, Sch Psychol, Brisbane, Qld 4006, Australia		Geffen, GM (corresponding author), Univ Queensland, Sch Med, Cognit Psychophysiol Lab, Edith Cavell Bldg,Herston Rd, Brisbane, Qld 4006, Australia.	geffen@psy.uq.edu.au					Alexander M. P., 2002, PRINCIPLES FRONTAL L, P159; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A., 1992, SPEED CAPACITY LANGU; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benedict, 2001, HOPKINS VERBAL LEARN; Bennett T L, 1997, Appl Neuropsychol, V4, P1, DOI 10.1207/s15324826an0401_1; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Cheung H, 2000, PSYCHOL REC, V50, P373, DOI 10.1007/BF03395361; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Comerford VE, 2002, J CLIN EXP NEUROPSYC, V24, P409, DOI 10.1076/jcen.24.4.409.1044; De Monte VE, 2005, J CLIN EXP NEUROPSYC, V27, P224, DOI 10.1080/13803390490515766; De Monte VE, 2004, J CLIN EXP NEUROPSYC, V26, P628, DOI 10.1080/13803390490504443; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; FRIEZ J, 2001, J CLIN EXPT NEUROPSY, V23, P19; Gathercole S., 1994, NEUROPSYCHOLOGY, V8, P494, DOI DOI 10.1037/0894-4105.8.4.494; GATHERCOLE SE, 1991, BRIT J PSYCHOL, V82, P387, DOI 10.1111/j.2044-8295.1991.tb02407.x; Gathercole SE., 1996, CHILDRENS TEST NONWO; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KEPPEL G, 1980, INTRO DESIGN ANAL ST; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; KWAPIL KJ, 2003, BRAIN IMPAIR, V4, P155; KWAPIL KJ, 2004, BRAIN IMPAIRMENT S, V5, P34; LEVIN HS, 1998, ACQUIRED APHASIA, P481; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Martin N, 1996, BRAIN LANG, V52, P83, DOI 10.1006/brln.1996.0005; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrea M, 2001, J ATHL TRAINING, V36, P274; NERALIC M, 2001, THESIS U QUEENSLAND; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; RASKIN SA, 2000, NEUROPSYCHOLOGICAL M; Robb MP, 2004, CLIN LINGUIST PHONET, V18, P1, DOI 10.1080/0269920031000105336; Sahlen B, 1999, INT J LANG COMM DIS, V34, P337, DOI 10.1080/136828299247441; Salthouse T. A., 1994, NEUROPSYCHOLOGY, V8, P535, DOI [10.1037/0894-4105.8.4.535, DOI 10.1037/0894-4105.8.4.535]; SALTHOUSE TA, 1992, ACTA PSYCHOL, V79, P155, DOI 10.1016/0001-6918(92)90030-H; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Umile EM, 1998, BRAIN INJURY, V12, P577; Venkatagiri HS, 1999, J FLUENCY DISORD, V24, P209, DOI 10.1016/S0094-730X(99)00010-8; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; WALKER J, 1992, J SPEECH HEAR RES, P35; Wechsler, 1997, WECHSLER ADULT INTEL	56	6	6	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2006	20	12					1251	1263		10.1080/02699050601049601			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	110DF	WOS:000242357800004	17132548				2022-02-06	
J	Ozisik, K; Ozisik, P; Yildirim, E; Misirlioglu, M; Tuncer, S				Ozisik, K.; Ozisik, P.; Yildirim, E.; Misirlioglu, M.; Tuncer, S.			Expression of antiapoptotic survivin and aven genes in rat heart tissue after traumatic brain injury	TRANSPLANTATION PROCEEDINGS			English	Article							CARDIAC MYOCYTES; APOPTOSIS; INHIBITOR; MODEL	We have recently shown that experimental traumatic brain injury (TBI) results in ultrastructural damage in heart tissue. The aim of this study was to determine the two antiapoptotic signals "survivin" and "aven" in rat heart tissue following TBI, and comparing the effects of erythropoietin (EPO) and methylprednisolone (MPS). Thirty-six Wistar-Albino female rats weighing 190 to 230 g were randomly allocated into six groups: group I underwent head trauma with no treatment; group 2 and group 3, head trauma and intraperitoneally delivered EPO (1000 IU/kg) and MPS (30 mg/kg), respectively; group 4 (vehicle), head trauma and intraperitoneal albumin (0.4 mL/rat); groups 5 and 6, control and sham-operated groups, respectively. Three-hundred g-cm impact trauma was produced by the method of weight-drop. Real-time quantitative polymerase chain reactions were used to estimate survivin and aven gene expression at the total RNA level. Both survivin and aven were higher among the treatment than the trauma group (P =.0006,.0001 and P =.0038,.0033, respectively). Comparing survivin and aven between EPO and NIPS treatment groups showed no significance (P =.3027,.2171, respectively). Also, both survivin and aven were significantly higher among the treatment than the vehicle, the control, or the sham-operated groups. These findings suggested that both EPO and MPS may play important roles in the expression of antiapoptotic survivin and aven genes in heart tissue after TBI.	Ankara Numune Educ & Res Hosp, Dept Thorac & Cardiovasc Surg, Ankara, Turkey		Ozisik, K (corresponding author), Ankara Numune Educ & Res Hosp, Dept Thorac & Cardiovasc Surg, 4 Cad 71 Sokak 8-3 Yildiz, Ankara, Turkey.	sozisik2002@yahoo.com	TUNCER, Serdar/AAG-4780-2021	TUNCER, Serdar/0000-0002-5776-2212; OZISIK, PINAR/0000-0001-5183-8100			Abbate A, 2006, INT J CARDIOL, V111, P371, DOI 10.1016/j.ijcard.2005.07.061; Altieri DC, 2001, TRENDS MOL MED, V7, P542, DOI 10.1016/S1471-4914(01)02243-2; BLAINE EM, 1984, TRANSPLANTATION, V38, P459, DOI 10.1097/00007890-198411000-00003; Blanc-Brude OP, 2002, NAT MED, V8, P987, DOI 10.1038/nm750; Bruinsma GJBB, 1997, J SURG RES, V68, P7, DOI 10.1006/jsre.1997.5002; Carter BZ, 2001, BLOOD, V97, P2784, DOI 10.1182/blood.V97.9.2784; Chau BN, 2000, MOL CELL, V6, P31, DOI 10.1016/S1097-2765(00)00005-8; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Emir M, 2005, TOHOKU J EXP MED, V207, P119, DOI 10.1620/tjem.207.119; Emir M, 2004, TRANSPLANT P, V36, P2935, DOI 10.1016/j.transproceed.2004.11.101; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Mouw G, 2002, METAB BRAIN DIS, V17, P143, DOI 10.1023/A:1019921904378; Ozisik K, 2004, AM J TRANSPLANT, V4, P900, DOI 10.1111/j.1600-6143.2004.00448.x; Santini D, 2004, J CLIN PATHOL, V57, P1321, DOI 10.1136/jcp.2004.018986; Tamm I, 1998, CANCER RES, V58, P5315	15	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2006	38	9					2784	2787		10.1016/j.transproceed.2006.08.100			4	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Surgery; Transplantation	109FY	WOS:000242294500010	17112829				2022-02-06	
J	Reza, F; Ikoma, K; Chuma, T; Mano, Y				Reza, Faruque; Ikoma, Katsunori; Chuma, Takayo; Mano, Yukio			Correlations between neuropsychological test results and P300 latency during silent-count and button-press tasks in post-traumatic brain injury patients	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						P300 latency; silent-count; button-press; memory score; intelligence score; post-traumatic brain injury patients	EVENT-RELATED POTENTIALS; CLOSED HEAD-INJURY; EVOKED-POTENTIALS; AUDITORY-STIMULI; TRAUMATIC COMA; DEPRESSION; AMPLITUDE; PERFORMANCE; COMPONENT; AGE	To evaluate the correlations between memory function and intelligence and event-related potential, the P300 component for different tasks was studied for 30 post-traumatic brain injury patients (mean age 31.6 +/- 13.7 years; 23 male and 7 female). Memory function, intelligence, and depression were measured by using the Mini-Mental State Examination, the revised Wechsler Adult Intelligence Scale and the Self-Rating Depression Scale, respectively. P300 latency was measured during silent-count and button-press tests at three midline scalp (Fz, Cz, and Pz) sites for all subjects by using an auditory 'odd-ball' paradigm. Neuropsychological memory score was predicted by intelligence score, but neurophysiological P300 latency was predicted by memory score for the silent-count test and by intelligence score for the button-press test. These results show that the P300 event-related potential component is sensitive to the diverse nature of cognitive deficits in post-traumatic brain injury patients during different types of discrimination tasks. However, future research is necessary to replicate and extend these findings. (C) 2006 Elsevier Ltd. All rights reserved.	Hokkaido Univ, Grad Sch Med, Dept Rehabil Med, Sapporo, Hokkaido 0608638, Japan		Ikoma, K (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Rehabil Med, N15 W7, Sapporo, Hokkaido 0608638, Japan.	ikoma@med.hokudai.ac.jp	Ikoma, Katsunori/D-8158-2012; , Faruque Reza/L-9994-2016	, Faruque Reza/0000-0002-0302-6623			ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; Baguley IJ, 1997, ARCH PHYS MED REHAB, V78, P1248, DOI 10.1016/S0003-9993(97)90339-7; BARRETT G, 1987, ELECTROEN CLIN NEURO, V66, P409, DOI 10.1016/0013-4694(87)90210-0; BARRETT PT, 1992, HDB INDIVIDUAL DIFFE, P25; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; CYNTHIA MS, 2001, BRAIN INJURY, V15, P561; DOEBRICH HM, 1986, SURG NEUROL, V26, P112; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOODIN DS, 1978, ELECTROEN CLIN NEURO, V44, P447, DOI 10.1016/0013-4694(78)90029-9; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kane NM, 1996, INTENS CARE MED, V22, P39, DOI 10.1007/BF01728329; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Maeshima S, 2003, J CLIN NEUROSCI, V10, P60, DOI 10.1016/S0967-5868(02)00117-0; Maeshima S, 2002, BRAIN INJURY, V16, P1, DOI 10.1080/02699050110088245; Mochizuki Y, 2001, J CLIN NEUROSCI, V8, P407, DOI 10.1054/jocn.2000.0850; Munoz-Ruata J, 2000, J INTELL DISABIL RES, V44, P567, DOI 10.1046/j.1365-2788.2000.00276.x; PFEFFERBAUM A, 1984, ELECTROEN CLIN NEURO, V59, P85, DOI 10.1016/0168-5597(84)90026-1; Polich J, 1996, PSYCHOPHYSIOLOGY, V33, P334, DOI 10.1111/j.1469-8986.1996.tb01058.x; POLICH J, 1987, BIOL PSYCHOL, V25, P61, DOI 10.1016/0301-0511(87)90067-6; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; RUMPL E, 1988, J CLIN NEUROPHYSIOL, V5, P237, DOI 10.1097/00004691-198807000-00002; SALISBURY DF, 1994, PSYCHOPHYSIOLOGY, V31, P29, DOI 10.1111/j.1469-8986.1994.tb01022.x; Salisbury DF, 2001, CLIN NEUROPHYSIOL, V112, P1676, DOI 10.1016/S1388-2457(01)00607-1; SARA G, 1994, J AFFECT DISORDERS, V31, P29, DOI 10.1016/0165-0327(94)90124-4; SHAGASS C, 1981, BIOL PSYCHIAT, V11, P1007; Vandoolaeghe E, 1998, J AFFECT DISORDERS, V48, P105, DOI 10.1016/S0165-0327(97)00165-1; VOGEL F, 1987, HUM NEUROBIOL, V6, P173; YINGLING CD, 1990, LANCET, V336, P873, DOI 10.1016/0140-6736(90)92372-O; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008; Zurron M, 1998, PERS INDIV DIFFER, V24, P279, DOI 10.1016/S0191-8869(97)00150-5	30	6	7	0	2	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2006	13	9					917	922		10.1016/j.jocn.2004.11.026			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	116ZK	WOS:000242842100006	17049245	Green Submitted			2022-02-06	
J	Ringel, F; Bieringer, F; Baethmann, A; Plesnila, N				Ringel, Florian; Bieringer, Frank; Baethmann, Alexander; Plesnila, Nikolaus			Effect of oxidative stress on glial cell volume	JOURNAL OF NEUROTRAUMA			English	Article						C6 glioma cells; cell volume; cytotoxic brain edema; free radicals; oxidative stress; reactive oxygen species (ROS)	FUNCTIONAL INTERACTIONS; FREE-RADICALS; RAT; MECHANISMS; ASTROCYTES; GLUTAMATE; ACIDOSIS; MICRODIALYSIS; LACTACIDOSIS; HYPERTROPHY	Cytotoxic brain edema is a major contributor of tissue damage following cerebral ischemia and traumatic brain injury. The pathophysiology of cytotoxic edema formation is still not well understood. Although it is widely believed that oxidative stress causes cytotoxic brain edema, experimental proof is lacking. The aim of the present study was therefore to examine the effect of oxidative stress on cell volume of glial cells. C6 glial cells were exposed to hydrogen peroxide and the superoxide forming complex hypoxanthine/xanthine oxidase (HX/XO). Exposure to hydrogen peroxide (0.5-5 mM) resulted in initial cell shrinkage by 5.7 +/- 1.5 % (mean +/- SEM; p < 0.05) and was followed by a dose-dependent recovery to baseline. Exposure to superoxide anions generated by HX/XO provoked a delayed, but sustained decrease of cell volume by 11.8 +/- 0.9% (P < 0.05). Cell volume showed no tendency to recover upon sustained exposure to superoxide. Neither hydrogen peroxide nor HX/XO exposure was associated with a decrease of cell viability. Thereby, the present study demonstrates that oxidative stress by hydrogen peroxide and superoxide anions does not induce cytotoxic cell swelling and suggests that free radicals are not directly involved in the formation of cytotoxic brain edema.	Univ Munich, Ctr Med, Dept Neurosurg, Lab Expt Neurosurg,Inst Surg Res, D-81366 Munich, Germany; Univ Bonn, Dept Neurosurg, D-5300 Bonn, Germany		Plesnila, N (corresponding author), Univ Munich, Ctr Med, Dept Neurosurg, Lab Expt Neurosurg,Inst Surg Res, March Str 15, D-81366 Munich, Germany.	plesnila@med.uni-muenchen.de	Ringel, Florian/E-4933-2014; Plesnila, Nikolaus/T-7522-2019				BAETHMAN A, 1978, NEUROSURG REV, V1, P85; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; Bindokas VP, 1996, J NEUROSCI, V16, P1324; CHAN PH, 1982, J NEUROCHEM, V38, P525, DOI 10.1111/j.1471-4159.1982.tb08659.x; Chen YM, 2000, J NEUROCHEM, V75, P939, DOI 10.1046/j.1471-4159.2000.0750939.x; HALLBRUCKER C, 1993, EUR J BIOCHEM, V211, P449, DOI 10.1111/j.1432-1033.1993.tb17570.x; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; HALLIWELL B, 1986, ARCH BIOCHEM BIOPHYS, V246, P501, DOI 10.1016/0003-9861(86)90305-X; Haskew RE, 2002, J NEUROCHEM, V82, P903, DOI 10.1046/j.1471-4159.2002.01037.x; Hensel M, 1997, INT J MICROCIRC, V17, P67, DOI 10.1159/000179209; HINSHAW DB, 1993, BRAIN RES, V615, P13, DOI 10.1016/0006-8993(93)91110-E; HYSLOP PA, 1988, J BIOL CHEM, V263, P1665; HYSLOP PA, 1995, BRAIN RES, V671, P181, DOI 10.1016/0006-8993(94)01291-O; JAKUBOVICZ DE, 1987, BRAIN RES, V435, P138, DOI 10.1016/0006-8993(87)91594-0; KACHEL V, 1976, J HISTOCHEM CYTOCHEM, V24, P211, DOI 10.1177/24.1.1254918; KEMPSKI O, 1983, BRAIN RES, V279, P217, DOI 10.1016/0006-8993(83)90180-4; KEMPSKI O, 1988, NEUROCHEM PATHOL, V9, P109; KEMPSKI O, 1992, PROG BRAIN RES, V94, P69; KIMELBERG HK, 1995, J CEREBR BLOOD F MET, V15, P409, DOI 10.1038/jcbfm.1995.51; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; Kourie JI, 1998, AM J PHYSIOL-CELL PH, V275, pC1, DOI 10.1152/ajpcell.1998.275.1.C1; KUPPUSAMY P, 1989, J BIOL CHEM, V264, P9880; Lopez-Ongil S, 1999, FREE RADICAL BIO MED, V26, P501, DOI 10.1016/S0891-5849(98)00223-8; PARKER KK, 1980, SCIENCE, V208, P179, DOI 10.1126/science.6102413; Pepperl S, 2001, AM J PHYSIOL-LUNG C, V280, pL905, DOI 10.1152/ajplung.2001.280.5.L905; Plesnila N, 1999, J NEUROTRAUM, V16, P831, DOI 10.1089/neu.1999.16.831; Ringel F, 2000, J NEUROCHEM, V75, P125, DOI 10.1046/j.1471-4159.2000.0750125.x; Robb SJ, 1999, J NEUROSCI RES, V55, P674, DOI 10.1002/(SICI)1097-4547(19990315)55:6<674::AID-JNR3>3.0.CO;2-J; SAHA N, 1993, BIOCHEM J, V296, P701, DOI 10.1042/bj2960701; Schlenker T, 2000, GASTROENTEROLOGY, V118, P395, DOI 10.1016/S0016-5085(00)70222-8; SCHNEIDER GH, 1992, CAN J PHYSIOL PHARM, V70, pS334, DOI 10.1139/y92-280; Servitja JM, 2000, J NEUROCHEM, V75, P788, DOI 10.1046/j.1471-4159.2000.0750788.x; Shenberger JS, 2002, AM J RESP CELL MOL, V27, P250, DOI 10.1165/ajrcmb.27.2.4785; Simon F, 2002, BIOL RES, V35, P215, DOI 10.4067/S0716-97602002000200013; STAUB F, 1994, J CEREBR BLOOD F MET, V14, P1030, DOI 10.1038/jcbfm.1994.135; STAUB F, 1990, J CEREBR BLOOD F MET, V10, P866, DOI 10.1038/jcbfm.1990.143; Tournier C, 1997, EUR J BIOCHEM, V244, P587, DOI 10.1111/j.1432-1033.1997.00587.x; Tsai KL, 1997, J PHYSIOL-LONDON, V502, P161, DOI 10.1111/j.1469-7793.1997.161bl.x; Tu VC, 2002, J PHARMACOL EXP THER, V300, P1101, DOI 10.1124/jpet.300.3.1101; WALZ W, 1983, PROG NEUROBIOL, V20, P133, DOI 10.1016/0301-0082(83)90013-8; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139	43	6	7	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2006	23	11					1693	1704		10.1089/neu.2006.23.1693			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	106RK	WOS:000242118200010	17115914				2022-02-06	
J	Francisco, GE				Francisco, G. E.			Successful treatment of posttraumatic hemiballismus with intrathecal baclofen therapy	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						brain injuries; spasticity; hemiballismus; intrathecal therapy	CEREBRAL ORIGIN; SPASTICITY; PALSY	Intrathecal baclofen (ITB) therapy is widely used in the management of spastic hypertonia and dystonia resulting from a multitude of conditions that present with upper motor neuron syndrome signs, such as cerebral palsy, stroke, brain and spinal injuries, and multiple sclerosis. We report successful management of posttraumatic hemiballismus and dystonia with ITB in a 43-yr-old man who sustained a traumatic brain injury secondary to an assault in 1978. He subsequently developed hemiballismus in the right lower limb and dystonia of the distal right upper limb spreading proximally to involve the shoulder. The ballistic movement of the lower limb was severe enough to cause the patient to fall out of his chair and limit his ability to perform activities of daily living safely. He had been on various oral medications and received botulinum toxin and phenol injections, but none alleviated the symptoms. The patient elected to receive the ITB pump. Before ITB, he had an average of 10-12 ballism episodes of the right lower limb per hour. During observed episodes, the right hip would flex up to about 90 degrees, with a fully extended knee. After ITB pump implantation and upward dose titration, the frequency of ballistic right leg movements decreased to about three per day, and the right hip flexed to only 30 degrees. In addition, there was increased ability to isolate individual distal joint movements in the right lower limb. The patient currently receives 202.4 mu g/day ITB and continues to benefit almost 6 yrs after ITB pump implantation. This report highlights the emerging role of ITB in managing movement disorders other than dystonia spastic hypertonia and dystonia.	Baylor Coll Med, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Houston, TX USA; Inst Rehabil & Res, Houston, TX USA		Francisco, GE (corresponding author), 1333 Moursund St, Houston, TX 77030 USA.						Albright AL, 2003, J NEUROSURG, V98, P291, DOI 10.3171/jns.2003.98.2.0291; Armstrong RW, 1997, J NEUROSURG, V87, P409, DOI 10.3171/jns.1997.87.3.0409; Comella, 1999, Curr Treat Options Neurol, V1, P1, DOI 10.1007/s11940-999-0026-4; Gilmartin R, 2000, J CHILD NEUROL, V15, P71, DOI 10.1177/088307380001500201; HILL DR, 1981, NATURE, V290, P149, DOI 10.1038/290149a0; Kant R, 1996, BRAIN INJURY, V10, P155, DOI 10.1080/026990596124665; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P155, DOI 10.1053/apmr.2001.19246; WHITTIER JR, 1947, ARCH NEURO PSYCHIATR, V58, P672, DOI 10.1001/archneurpsyc.1947.02300350022002	8	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	SEP	2006	85	9					779	782		10.1097/01.phm.0000233173.32432.6f			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	077PV	WOS:000240043000009	16924190				2022-02-06	
J	Schoenberg, MR; Lange, RT; Iverson, GL; Chelune, GJ; Scott, JG; Adams, RL				Schoenberg, Mike R.; Lange, Rael T.; Iverson, Grant L.; Chelune, Gordon J.; Scott, James G.; Adams, Russell L.			Clinical validation of the General Ability Index - Estimate (GAI-E): Estimating premorbid GAI	CLINICAL NEUROPSYCHOLOGIST			English	Article; Proceedings Paper	32nd Annual Meeting of the International-Neuropsychological-Society	FEB 04-07, 2004	Baltimore, MD	Int Neuropsychol Soc			ADULT INTELLIGENCE SCALE; REGRESSION-BASED METHODS; DEMOGRAPHIC-VARIABLES; COMBINED PERFORMANCE; IQ; ACCURACY	The clinical utility of the General Ability Index-Estimate (GAI-E; Lange, Schoenberg, Chelune, Scott, & Adams, 2005) for estimating premorbid GAI scores was investigated using the WAIS-III standardization clinical trials sample (The Psychological Corporation, 1997). The GAI-E algorithms combine Vocabulary, Information, Matrix Reasoning, and Picture Completion subtest raw scores with demographic variables to predict GAI. Ten GAI-E algorithms were developed combining demographic variables with single subtest scaled scores and with two subtests. Estimated GAI are presented for participants diagnosed with dementia (n = 50), traumatic brain injury (n = 20), Huntington's disease (n = 15), Korsakoff's disease (n = 12), chronic alcohol abuse (n = 32), temporal lobectomy (n = 17), and schizophrenia (n = 44). In addition, a small sample of participants without dementia and diagnosed with depression (n = 32) was used as a clinical comparison group. The GAI-E algorithms provided estimates of GAI that closely approximated scores expected for a healthy adult population. The greatest differences between estimated GAI and obtained GAI were observed for the single subtest GAI-E algorithms using the Vocabulary, Information, and Matrix Reasoning subtests. Based on these data, recommendations for the use of the GAI-E algorithms are presented.	Case Western Reserve Univ, Sch Med, Univ Hosp Cleveland, Dept Neurol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; Riverview Hosp, Coquitlam, BC, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA		Schoenberg, MR (corresponding author), Case Western Reserve Univ, Sch Med, Univ Hosp Cleveland, Dept Neurol, HH 5,11100 E Euclid Ave, Cleveland, OH 44106 USA.	Michael.Schoenberg@uhhs.com	Schoenberg, Mike R/J-9018-2012	Iverson, Grant/0000-0001-7348-9570; Schoenberg, Mike/0000-0003-1355-3651			Axelrod BN, 1999, J CLIN EXP NEUROPSYC, V21, P368, DOI 10.1076/jcen.21.3.368.916; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; CRAWFORD JR, 1989, PERS INDIV DIFFER, V10, P793, DOI 10.1016/0191-8869(89)90126-8; CRAWFORD JR, 1990, PERS INDIV DIFFER, V11, P209, DOI 10.1016/0191-8869(90)90018-M; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Franzen MD, 1997, ARCH CLIN NEUROPSYCH, V12, P711, DOI 10.1016/S0887-6177(97)00046-2; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P77, DOI 10.1016/j.acn.2005.07.007; Ivnik RJ, 1992, CLIN NEUROPSYCHOL, V6, P1, DOI DOI 10.1080/13854049208401877; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Lange RT, 2005, CLIN NEUROPSYCHOL, V19, P73, DOI 10.1080/13854040490888549; LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P497, DOI 10.1080/01688638508401281; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; NELSON HE, 1975, BRIT J SOC CLIN PSYC, V14, P259, DOI 10.1111/j.2044-8260.1975.tb00178.x; Powell BD, 2003, ARCH CLIN NEUROPSYCH, V18, P277, DOI 10.1016/S0887-6177(02)00135-X; *PSYCH CORP, 2001, MAN WECHS TEST AD RE; *PSYCH CORP, 1997, WECHS AD INT SCAL 3; REYNOLDS CR, 1979, CLIN NEUROPSYCHOLOGY, V1, P36; Schoenberg MR, 2004, ARCH CLIN NEUROPSYCH, V19, P1103, DOI 10.1016/j.acn.2003.12.008; Schoenberg MR, 2003, CLIN NEUROPSYCHOL, V17, P308, DOI 10.1076/clin.17.3.308.18088; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; Schopp LH, 2001, REHABIL PSYCHOL, V46, P279, DOI 10.1037/0090-5550.46.3.279; Scott JG, 1997, CLIN NEUROPSYCHOL, V11, P146, DOI 10.1080/13854049708407043; SmithSeemiller L, 1997, ARCH CLIN NEUROPSYCH, V12, P739, DOI 10.1016/S0887-6177(97)00047-4; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Stebbins GT, 1998, CLIN NEUROPSYCHOLOGY, P76; Tulsky DS, 2001, PSYCHOL ASSESSMENT, V13, P566, DOI 10.1037/1040-3590.13.4.566; VANDERPLOEG RD, 1995, ARCH CLIN NEUROPSYCH, V10, P225, DOI 10.1016/0887-6177(94)00042-O; Vanderploeg RD, 1996, PSYCHOL ASSESSMENT, V8, P404, DOI 10.1037/1040-3590.8.4.404; Veiel HOF, 2001, PSYCHOL ASSESSMENT, V13, P356, DOI 10.1037/1040-3590.13.3.356; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weiss L. G., 1999, CANADIAN J SCH PSYCH, V14, P1, DOI [10.1177/082957359901400202, DOI 10.1177/082957359901400202]; WILSON RS, 1978, J CONSULT CLIN PSYCH, V46, P1554, DOI 10.1037/0022-006X.46.6.1554; YATES AJ, 1956, J MENT SCI, V102, P409, DOI 10.1192/bjp.102.428.409	38	6	6	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	SEP	2006	20	3					365	381		10.1080/138540491005866			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Psychology; Neurosciences & Neurology	071MT	WOS:000239607000002	16895853				2022-02-06	
J	Mhatre, M; Hensley, K; Nguyen, A; Grammas, P				Mhatre, Molina; Hensley, Kenneth; Nguyen, Albert; Grammas, Paula			Chronic thrombin exposure results in an increase in apolipoprotein-E levels	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						Alzheimer's disease; brain injury; apolipoprotein-E4; spatial memory; beta-amyloid; cognitive deficits	SPORADIC ALZHEIMERS-DISEASE; TRAUMATIC BRAIN-INJURY; AMYLOID BETA-PEPTIDE; RAT SCIATIC-NERVE; HEAD-INJURY; CHOLESTEROL TRANSPORT; FIBRIL FORMATION; E POLYMORPHISM; TYPE-4 ALLELE; IN-VITRO	Studies have shown that individuals with both a history of traumatic brain injury and inheritance of apolipoprotein E-4 (ApoE4) allele are associated with a poor neurologic outcome and an increased risk for Alzheimer's disease. We assessed the hypothesis that thrombin released during brain injury causes an increase in apolipoprotein-E levels and such increase in the levels of apolipoprotein-E4 isoform may have amyloiclogenic effects. Rats received either thrombin (100 nm, 0.25 mu l/hr, 28 days) or vehicle via intracerebroventricular (i.c.v.) infusion. Thrombin treatment increased apolipoprotein-E levels in hippocampus as compared to vehicle treatment (P < 0.001). Infusion of human apolipoprotein-E4 (0.6 ng/hr, i.c.v., 56 days) into rats resulted in beta-amyloid deposition and increased the number of GFAP-positive astrocytes. ApoE4 infusion also resulted in significant spatial memory deficits. These findings suggest that thrombin released during brain injury may contribute to an increase in apolipoprotein-E levels. Such increase in Apolipoprotein-E4 isoform facilitates P-amyloid deposition and cognitive deficits. (c) 2006 wiley-Liss, Inc.	Oklahoma Med Res Fdn, Free Rad Biol & Aging Res Program, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Psychiat & Behav Sci, Oklahoma City, OK 73190 USA; Texas Tech Univ, Hlth Sci Ctr, Inst Hlth Aging, Lubbock, TX 79409 USA		Mhatre, M (corresponding author), Oklahoma Med Res Fdn, Free Rad Biol & Aging Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	molina-mhatre@omrf.ouhsc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG015964] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG015964, AG 15964] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS044154] Funding Source: Medline		Ali SM, 1996, MOL BRAIN RES, V38, P37, DOI 10.1016/0169-328X(95)00301-8; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; CASTANO EM, 1995, J BIOL CHEM, V270, P17610, DOI 10.1074/jbc.270.29.17610; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crutcher KA, 2004, J MOL NEUROSCI, V23, P181, DOI 10.1385/JMN:23:3:181; Emmerling MR, 2000, ANN NY ACAD SCI, V903, P118, DOI 10.1111/j.1749-6632.2000.tb06357.x; Fagan AM, 2000, MICROSC RES TECHNIQ, V50, P297, DOI 10.1002/1097-0029(20000815)50:4<297::AID-JEMT9>3.0.CO;2-C; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Golabek AA, 1996, J BIOL CHEM, V271, P10602, DOI 10.1074/jbc.271.18.10602; Graham DI, 1999, CELL MOL NEUROBIOL, V19, P19, DOI 10.1023/A:1006937205905; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Harry GJ, 2000, BRAIN BEHAV IMMUN, V14, P288, DOI 10.1006/brbi.2000.0606; Horsburgh K, 1997, BRAIN RES, V763, P103, DOI 10.1016/S0006-8993(97)00411-3; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; LEBLANC AC, 1990, J NEUROSCI RES, V25, P162, DOI 10.1002/jnr.490250203; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Mhatre M, 2004, NEUROBIOL AGING, V25, P783, DOI 10.1016/j.neurobiolaging.2003.07.007; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, P28; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; REBECK GW, 1993, NEURON, V11, P575; Sadowski M, 2004, AM J PATHOL, V165, P937, DOI 10.1016/S0002-9440(10)63355-X; SANAN DA, 1994, J CLIN INVEST, V94, P860, DOI 10.1172/JCI117407; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schauwecker PE, 1998, EXP NEUROL, V149, P87, DOI 10.1006/exnr.1997.6679; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; White F, 2001, EXP NEUROL, V169, P307, DOI 10.1006/exnr.2001.7655; WISNIEWSKI T, 1994, AM J PATHOL, V145, P1030	34	6	7	0	1	WILEY-LISS	HOBOKEN	DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	AUG 1	2006	84	2					444	449		10.1002/jnr.20887			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	069NY	WOS:000239456700022	16683250	Green Accepted			2022-02-06	
J	Rodriguez, N; Febrer, A; Melendez, M				Rodriguez, N.; Febrer, A.; Melendez, M.			Autonomic dysfunction in children with traumatic brain injury	REVISTA DE NEUROLOGIA			English	Article						autonomic dysfunction; baclofen; children; hypertension; hyperthermia; midazolam; severe traumatic brain injury; spasticity; tachycardia; withdrawal syndrome	HEAD-INJURY; SCALE; DYSAUTONOMIA; HYPERTHERMIA; HYPERTENSION; INSTABILITY; SEIZURES; FEVER; COMA	Introduction. Autonomic dysfunction syndrome following traumatic brain injury is a situation involving adrenergic hyperactivity produced by the lack of control over the autonomous nervous system at a central level. The difficulties involved in its therapeutic management make it even more important. Case reports. We report the cases of a boy and a girl aged 6 and 12 years, respectively, who had suffered a severe traumatic brain injury with important brain damage that included diencephalic and mesencephalic compromise and areas of diffuse axonal injury. From the acute phase onwards, they presented episodes of hypertension, tachycardia, excessive sweating and spasticity in the form of attacks that initially led to a differential diagnosis between sepsis, opiate and/or benzodiazepine withdrawal syndrome and epilepsy. The length of time spent in coma was very long and the attacks went on throughout the awakening phase almost until the moment they were discharged from hospital, despite trying different treatments. In our cases, orally administered baclofen and midazolam seemed to be the most effective. Conclusions. Autonomic dysfunction is difficult to manage. There are no standardised treatments and speculation continues with regard to its true promoter We might think that the central injury is the cause of the process and that the autonomic dysfunction increases the secondary lesion and contributes to the functional worsening. If we take into account that the survival rate of the children is high despite the severity of the injuries and although the dysautonomia can be self-limiting with time, we believe that its treatment is essential if the ultimate aim is to minimise the sequelae.	Hosp Univ Sant Joan De Deu, Serv Rehabil & Med Fis, E-08950 Esplugas de Llobregat, Barcelona, Spain		Rodriguez, N (corresponding author), Hosp Univ Sant Joan De Deu, Serv Rehabil & Med Fis, Pg Sant Joan de Deu,2, E-08950 Esplugas de Llobregat, Barcelona, Spain.	nrodri-guez@hsjdbcn.org	Melendez Plumed, Mar/D-4742-2017	Melendez Plumed, Mar/0000-0001-8100-6460			Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Bicudo J N, 1999, Rev Assoc Med Bras (1992), V45, P15, DOI 10.1590/S0104-42301999000100004; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; CARMEL PW, 1985, ACTA NEUROCHIR, V75, P113, DOI 10.1007/BF01406331; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; De Tanti A, 2005, BRAIN INJURY, V19, P1277, DOI 10.1080/02699050500309270; Fernandez-Ortega JF, 2004, REV NEUROLOGIA, V39, P715, DOI 10.33588/rn.3908.2004034; Fonsmark L, 1999, CRIT CARE MED, V27, P196, DOI 10.1097/00003246-199901000-00052; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Ginsberg MD, 1998, STROKE, V29, P529, DOI 10.1161/01.STR.29.2.529; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Krach LE, 1997, J NEUROL REHABIL, V11, P41; LABI M L C, 1990, Brain Injury, V4, P365, DOI 10.3109/02699059009026189; MEYTHALER JM, 1994, ARCH PHYS MED REHAB, V75, P816; PRANZATELLI MR, 1991, J CHILD NEUROL, V6, P115, DOI 10.1177/088307389100600204; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rossitch E Jr, 1988, Br J Neurosurg, V2, P471, DOI 10.3109/02688698809029601; Russo RN, 2000, J PAEDIATR CHILD H, V36, P283, DOI 10.1046/j.1440-1754.2000.00485.x; SIMARD JM, 1989, AM J CARDIOL, V63, pC32, DOI 10.1016/0002-9149(89)90403-7; SNEED RC, 1995, ARCH PHYS MED REHAB, V76, P101, DOI 10.1016/S0003-9993(95)80051-4; TEASDALE G, 1974, LANCET, V2, P81	24	6	6	0	3	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	AUG 1	2006	43	3					143	146		10.33588/rn.4303.2004453			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	081SQ	WOS:000240337700004	16871479				2022-02-06	
J	Vigue, B; Geeraerts, T; Le Guen, M; Engrand, N; Ract, C				Vigue, B.; Geeraerts, T.; Le Guen, M.; Engrand, N.; Ract, C.			Therapeutic hypothermia	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article; Proceedings Paper	27th Conference of the Association-de-Neuroanesthesie-Reanimation-de-Langue-Francaise	NOV 17-18, 2005	Toulouse, FRANCE	Assoc Neuroanesthesie Reanimat Langue Francaise		hypothermia; fever; head injury; cerebral ischemia; intracranial pressure.	TRAUMATIC BRAIN-INJURY; MILD HYPOTHERMIA; MODERATE HYPOTHERMIA; INTRACRANIAL-PRESSURE; FOREBRAIN ISCHEMIA; CARDIAC-ARREST; TEMPERATURE; HYPERTENSION; HYPERTHERMIA; OXYGENATION	The benefit of,therapeutic hypothermia after severe head injury is highly controversial. However, hypothermia is still used and studied in this context for multiple reasons. Efficacy of hypothermia is demonstrated after cerebral ischemia in numerous animal studies and after cardiac arrest in human studies. Hyperthermia is a major independent factor of outcome after cerebral ischemic or traumatic brain injury. Moreover, ICP is related to core temperature, and hypothermia may be used to decrease intracranial hypertension. However, many questions are still unresolved and can explain discrepancies between clinical studies: direct measurement of cerebral temperature, relationship between ICP, temperature and PaCO2, level and duration of hypothermia and precise methods for cooling and particularly for rewarming. (c) 2006 Elsevier SAS. Tous droits reserves.	CHU Bicetre, Dept Anesthesie Reanimat, F-94275 Le Kremlin Bicetre, France		Vigue, B (corresponding author), CHU Bicetre, Dept Anesthesie Reanimat, F-94275 Le Kremlin Bicetre, France.	bernard.vigue@bct.ap-hop-paris.fr					Bernard SA, 1997, ANN EMERG MED, V30, P146, DOI 10.1016/S0196-0644(97)70133-1; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Chatzipanteli K, 1999, J NEUROCHEM, V72, P2047, DOI 10.1046/j.1471-4159.1999.0722047.x; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; COLBOURNE F, 1994, BRAIN RES, V654, P265, DOI 10.1016/0006-8993(94)90488-X; DEXTER F, 1995, ANESTHESIOLOGY, V83, P405, DOI 10.1097/00000542-199508000-00021; DIETRICH WD, 1990, STROKE, V21, P1318, DOI 10.1161/01.STR.21.9.1318; GADKARY CS, 2003, THERAPEUTIC HYPOTHER; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; Hachimi-Idrissi S, 2002, Eur J Emerg Med, V9, P193, DOI 10.1097/00063110-200206000-00020; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Holzer M, 2002, NEW ENGL J MED, V346, P549; Horiguchi T, 2003, J NEUROTRAUM, V20, P511, DOI 10.1089/089771503765355577; Inamasu J, 2002, ANN EMERG MED, V40, P220, DOI 10.1067/mem.2002.123697; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kawai N, 2000, J NEUROTRAUM, V17, P193, DOI 10.1089/neu.2000.17.193; LEONOV Y, 1990, STROKE, V21, P1600, DOI 10.1161/01.STR.21.11.1600; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Mayer SA, 2004, CRIT CARE MED, V32, P2508, DOI 10.1097/01.CCM.0000147441.39670.37; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mori K, 1998, NEUROL RES, V20, P719; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Reglodi D, 2000, EXP NEUROL, V163, P399, DOI 10.1006/exnr.2000.7367; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Schmutzhard E, 2002, CRIT CARE MED, V30, P2481, DOI 10.1097/00003246-200211000-00013; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; STEEN PA, 1983, ANESTHESIOLOGY, V58, P527, DOI 10.1097/00000542-198306000-00009; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Tremey B, 2004, ANN FR ANESTH, V23, P474, DOI 10.1016/j.annfar.2004.01.017; Vigue B, 2000, INTENS CARE MED, V26, P722, DOI 10.1007/s001340051238; Wang Y, 2000, STROKE, V31, P1386, DOI 10.1161/01.STR.31.6.1386; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	44	6	6	0	3	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	AUG	2006	25	8					838	844		10.1016/j.annfar.2006.03.017			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology	087OH	WOS:000240751200009	16675188				2022-02-06	
J	Crichlow, R; Williamson, S; Geurin, M; Heggem, H				Crichlow, Renee; Williamson, Steve; Geurin, Mike; Heggem, Heather			Self-reported injury history in native American professional rodeo competitors	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						rodeo; athletic injury; concussion; helmet; protective equipment; native American; injury; head injury	EPIDEMIOLOGIC ANALYSIS	Objective: Evaluation of rodeo injury and the use of protective equipment. Design: Cross-sectional survey. Setting: Indian National Finals Rodeo 2004 in San Jacinto, CA. Participants: One hundred sixty-nine native American, professional rodeo competitors. Assessment: On-site survey completed before competition. A total of 180 native American competitors received the survey. Respondents reported the event of participation, prior injury histories (including number, type and disability), use of protective equipment, and access to health care. Main Outcome Measurements: Main outcomes were determined before survey distribution and included self-reported injury rate, time away from rodeo secondary to injury, and protective equipment usage during competition. Results: Total 94% response rate. There was a range of injury history-from 100% of bull riders to only 24% of tie-down ropers-reporting a history of injuries. Forty percent of competitors reported using protective equipment; of these, 32% reported wearing vests. Twenty-six percent of the competitors had a history of injury that prevented them from working an average of 3.2 months. Conclusions: As hypothesized, a greater injury rate resulted from rough stock events; older competitors are more likely to have had work time loss from injury; and vests are the most frequently used protective equipment in rodeo.	Rocky Mt Coll, Billings, MT USA; Univ Washington WWAMI Network, Montana Family Med Residency Program, Billings, MT USA		Crichlow, R (corresponding author), 123 S 27th St,Suite B, Billings, MT 59101 USA.	Reneec4@u.washington.edu					Butterwick DJ, 2005, CLIN J SPORT MED, V15, P192, DOI 10.1097/01.jsm.0000160553.87755.2a; Butterwick DJ, 1996, CLIN J SPORT MED, V6, P171, DOI 10.1097/00042752-199607000-00006; Butterwick DJ, 2002, CLIN J SPORT MED, V12, P30, DOI 10.1097/00042752-200201000-00009; Butterwick DJ, 2002, AM J SPORT MED, V30, P193, DOI 10.1177/03635465020300020801; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P224; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P796; Ketai LH, 2000, INJURY, V31, P757, DOI 10.1016/S0020-1383(00)00108-X; LANDEN DD, 1995, PUBLIC HEALTH REP, V110, P350; Petridou E, 2004, EPIDEMIOLOGY, V15, P428, DOI 10.1097/01.ede.0000129519.76945.0d; WOODEN WS, 1996, RODEO AM	10	6	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X			CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2006	16	4					352	354		10.1097/00042752-200607000-00012			3	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	077FD	WOS:000240012500012	16858221				2022-02-06	
J	Lewis, DH; Bluestone, JP; Savina, M; Zoller, WH; Meshberg, EB; Minoshima, S				Lewis, David H.; Bluestone, Judith P.; Savina, Maryann; Zoller, William H.; Meshberg, Emily B.; Minoshima, Satoshi			Imaging cerebral activity in recovery from chronic traumatic brain injury: A preliminary report	JOURNAL OF NEUROIMAGING			English	Article						cerebral perfusion SPECT; traumatic brain injury	PREFRONTAL ACTIVATION PROBE; ANATOMIC STANDARDIZATION; SPECT; IMAGES; FMRI	People in chronic phase of traumatic brain injury (TBI) are often told that there will be no further recovery in brain function that they are in a "static phase." Holistic Approach to NeuroDevelopment and Learning Efficiency (HANDLE(R)), an alternative therapy, aims to improve function by teaching a series of physical and mental activities that clients perform and encouraging changes in lifestyle. Five subjects (3 males) with chronic TBI (at least 3 years since ictus) completed the HANDLE Institute's program and were prospectively evaluated. Each had six regional cerebral blood flow (rCBF) single-photon emission computed tomography (SPECT) scans over 7 months (scans n = 30). Paired scans were performed with injection of Tc-99m ECD to image rCBF at rest and during the HANDLE "Crossed Arm Bounce" (CAB) exercise before the program, at 3-4 months into the program, and at 6-7 months, after the program had ended. SPECT images were analyzed statistically using Neurostat in which image sets were coregistered and warped into Talaraich atlas for pairwise subtraction between conditions. Group analysis of SPECT showed that CAB activated (increased rCBF) vermis and cerebellar hemispheres in first two paired scans and anterior cingulate and vermis on the final pair. Increased rCBF at rest occurred in cerebellar hemispheres, vermis, and right dorsomedial frontal cortex. These preliminary observations suggest that there may be a role of the hindbrain (vermis and cerebellum) with HANDLE treatment of chronic TBI.	Univ Washington, Harborview Med Ctr, Sch Med, Dept Radiol,Div Nucl Med, Seattle, WA 98104 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA; HANDLE Inst, Seattle, WA USA		Lewis, DH (corresponding author), Univ Washington, Harborview Med Ctr, Sch Med, Dept Radiol,Div Nucl Med, 325 9th Ave,359772, Seattle, WA 98104 USA.	lewis@u.washington.edu	Lewis, David H/AAM-7997-2021	Lewis, David H/0000-0003-1927-1073; Minoshima, Satoshi/0000-0002-0043-3047			Allen G, 2003, AM J PSYCHIAT, V160, P262, DOI 10.1176/appi.ajp.160.2.262; Audenaert K, 2001, NUCL MED COMMUN, V22, P135, DOI 10.1097/00006231-200102000-00004; Audenaert K, 2000, EUR J NUCL MED, V27, P1800, DOI 10.1007/s002590000351; Aumann T D, 2002, Cerebellum, V1, P69, DOI 10.1080/147342202753203104; BLUESTONE JP, 2002, CHURKENDOOSE ANTHOLO; Boyden ES, 2003, NEURON, V39, P1031, DOI 10.1016/S0896-6273(03)00562-2; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Ekerot CF, 2003, CEREBELLUM, V2, P101, DOI 10.1080/14734220309411; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Gundel H, 2003, AM J PSYCHIAT, V160, P1946, DOI 10.1176/appi.ajp.160.11.1946; ICHISE M, 1994, J NUCL MED, V35, P217; Kistler WM, 2003, CEREBELLUM, V2, P44, DOI 10.1080/14734220309426; Laatsch L, 1999, BRAIN INJURY, V13, P555, DOI 10.1080/026990599121304; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; MASDEU JC, 1995, J NEUROIMAGING, V5, pS53; MINOSHIMA S, 1993, INT CONGR SER, V1030, P409; MINOSHIMA S, 1994, J NUCL MED, V35, P1528; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tsuchida T, 1996, J NUCL MED, V37, P1237; Van Laere KJ, 2002, J NUCL MED, V43, P458; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	22	6	6	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	JUL	2006	16	3					272	277		10.1111/j.1552-6569.2006.00034.x			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	057UC	WOS:000238619700012	16808830				2022-02-06	
J	Zhang, YL; Qiu, SD; Zhang, PB; Shi, W				Zhang, YL; Qiu, SD; Zhang, PB; Shi, W			BrdU-labelled neurons regeneration after cerebral cortex injury in rats	CHINESE MEDICAL JOURNAL			English	Article						neural stem cells; neural progenitor cells; neurogenesis; brain injury	TRAUMATIC BRAIN-INJURY; SUBVENTRICULAR ZONE; CELL-PROLIFERATION; MOUSE; DIFFERENTIATION; NEUROGENESIS; MIGRATION		Xian Jiaotong Univ, Sch Med, Xian 710061, Peoples R China; Shaanxi Prov Peoples Hosp, Dept Neurosurg, Xian 710068, Peoples R China		Qiu, SD (corresponding author), Xian Jiaotong Univ, Sch Med, Xian 710061, Peoples R China.						Brazel CY, 2003, PROG NEUROBIOL, V69, P49, DOI 10.1016/S0301-0082(03)00002-9; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Gritti A, 2002, J PHYSIOL-PARIS, V96, P81, DOI 10.1016/S0928-4257(01)00083-3; Jankovski A, 1998, EUR J NEUROSCI, V10, P3853, DOI 10.1046/j.1460-9568.1998.00397.x; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Li Y, 2002, J NEUROL SCI, V193, P137, DOI 10.1016/S0022-510X(01)00657-8; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Taupin P, 2006, RESTOR NEUROL NEUROS, V24, P9; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Yoshiya K, 2003, J NEUROTRAUM, V20, P1147, DOI 10.1089/089771503770802844	15	6	7	0	0	CHINESE MEDICAL ASSOCIATION	BEIJING	42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	JUN 20	2006	119	12					1026	1029		10.1097/00029330-200606020-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057ZX	WOS:000238634900010	16805987	gold			2022-02-06	
J	Chan, RCK; Lai, MK				Chan, Raymond C. K.; Lai, M. K.			Latent structure of the Test of Everyday Attention: Convergent evidence from patients with traumatic brain injury	BRAIN INJURY			English	Article						attention; confirmatory factor analysis; traumatic brain injury	CANTONESE VERSION; VALIDITY; RELIABILITY; SYSTEM	Aim: The present study aimed to examine the nature of attention distinctions among sub-tests of the Test of Everyday Attention ( TEA) underlying the performance of patients with traumatic brain injury ( TBI). Method: Confirmatory factor analysis was performed among a group of 92 patients with TBI experiencing chronic post-concussive symptoms. Comparisons were made of the fit of the previously identified models based on exploratory factor analysis, comprising three-to-four factors. Main outcome: The results indicated that the 3-factor model with a visual selection component, a sustained attention component and a switching component provided an appropriate account of attentional performance than the other two 4-factor models. Conclusion: These findings are consistent with those of healthy sample. This study, therefore, provides convergent evidence on the latent structure of the TEA. It is consistent and stable across healthy and clinical populations.	Sun Yat Sen Univ, Dept Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Guangzhou 510275, Peoples R China; Chinese Acad Sci, Inst Psychol, Beijing, Peoples R China; Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China		Chan, RCK (corresponding author), Sun Yat Sen Univ, Dept Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Guangzhou 510275, Peoples R China.	edschchq@zsu.edu.cn	Chan, Raymond CK/B-6717-2009; Lai, Man Kin/F-8754-2015	Chan, Raymond CK/0000-0002-3414-450X; Lai, Man Kin/0000-0001-7292-1480			Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; Benson D.F., 1986, FRONTAL LOBES; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Chan RCK, 2003, PSYCHOL REP, V93, P1275; Chan RCK, 2002, CLIN REHABIL, V16, P900, DOI 10.1191/0269215502cr574oa; Chan RCK, 2000, BRAIN INJURY, V14, P227, DOI 10.1080/026990500120709; CHAN RCK, UNPUB ARCH CLIN NEUR; Cohen R. M., 1998, NEUROPSY NEUROPSY BE, V1, P3; Crawford JR, 1997, BRIT J CLIN PSYCHOL, V36, P609, DOI 10.1111/j.2044-8260.1997.tb01265.x; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Joreskog K., 1999, LISREL 8 STRUCTURAL; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Manly T., 1998, TEST EVERYDAY ATTENT; Mesulam M., 1985, PRINCIPLES BEHAV NEU; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; PRIBRAM KH, 1975, PSYCHOL REV, V82, P116, DOI 10.1037/h0076780; Robertson I., 1994, TEST EVERYDAY ATTENT; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; Tatham, 1998, MULTIVARIATE DATA AN; TOIT S, 1999, INTERATIVE LISREL US; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; YAMAGUCHI S, 1994, BRAIN, V117, P553, DOI 10.1093/brain/117.3.553	24	6	6	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2006	20	6					653	659		10.1080/02699050600676974			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	062LU	WOS:000238947100010	16754290				2022-02-06	
J	Hashimoto, K; Nakamura, T; Wada, I; Yoshida, K; Satoh, S; Abo, M; Seta, H; Ohashi, M				Hashimoto, K; Nakamura, T; Wada, I; Yoshida, K; Satoh, S; Abo, M; Seta, H; Ohashi, M			How great is willingness to pay for recovery from sequelae after severe traumatic brain injury in Japan?	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; family; contingent valuation method; willingness-to-pay; rehabilitation	CONTINGENT VALUATION	Objective: To evaluate the burden on families with a family member suffering traumatic brain injury sequelae in Japan. Design: Cross-sectional study. Methods: Family members' burden from the sequelae of traumatic brain injury was estimated by use of willingness-to-pay models and the contingent valuation method. A national survey among 1707 members of the Japan Traumatic Brain Injury Association was conducted by postal questionnaire with open-ended questions. A total of 509 (29.8%) of the family members responded (405 men and 104 women). Mean age of patients with traumatic brain injury was 33.4 (SD 14.3) years and of responding family members 53.3 (SD 14.5) years. Results: Willingness-to-pay for the family member's recovery from sequelae of traumatic brain injury (8,694,502 Japanese yen; 79,134 US dollars/year) was similar to that reported for a family member's survival from incurable terminal disease (8,342,953 Japanese yen; 75,934 US dollars/year). Conclusion: The data indicate that family members perceive the burden of a family member with traumatic brain injury sequelae as similar to what would have been caused by an incurable terminal disease.	Jikei Univ, Sch Med, Dept Rehabil Med, Minato Ku, Tokyo 105, Japan; Tokyo Med & Dent Univ, Inst Med Res, Dept Neurotraumatol, Tokyo, Japan; Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan; Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 305, Japan; Kanagawa REhabil Hosp, Dept Rehabil Med, Atsugi, Kanagawa, Japan		Hashimoto, K (corresponding author), Jikei Univ, Sch Med, Dept Rehabil Med, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 105, Japan.	keiman@theia.ocn.ne.jp		Abo, Masahiro/0000-0001-6701-4974; Hashimoto, Keiji/0000-0003-2412-860X; Yoshida, Kentaro/0000-0001-7768-2837			BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Droste TM, 1998, LANCET, V352, P1533, DOI 10.1016/S0140-6736(05)60348-0; Ho JJ, 2005, ACCIDENT ANAL PREV, V37, P537, DOI 10.1016/j.aap.2005.01.005; *JAP NAT TAX AG, OUTL RES STAT SURV F; Liu JT, 2000, HEALTH ECON, V9, P319, DOI 10.1002/1099-1050(200006)9:4<319::AID-HEC521>3.0.CO;2-3; Mitchell R.C., 2013, USING SURVEYS VALUE; Ohashi M, 2000, JPN J REHABIL MED, V37, P121; Zarkin GA, 2000, J SUBST ABUSE TREAT, V18, P149, DOI 10.1016/S0740-5472(99)00030-6	8	6	7	0	0	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAR	2006	38	2					141	143		10.1080/16501970500441690			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	022IT	WOS:000236049600012	16546774	gold			2022-02-06	
J	Hagood, SK; McGinn, MJ; Sun, D; Colello, RJ				Hagood, SK; McGinn, MJ; Sun, D; Colello, RJ			Characterizing the mitogenic effect of basic fibroblast growth factor in the adult rat striatum	JOURNAL OF NEUROTRAUMA			English	Article						CNS; gliogenesis; growth factors; neurogenesis; proliferation; stem cells	CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; CELL-PROLIFERATION; HEPARAN-SULFATE; SPINAL-CORD; NEURAL PROGENITORS; DENTATE GYRUS; RODENT BRAIN; MOUSE BRAIN; STEM-CELLS	The limited regenerative capacity of the adult central nervous system (CNS) renders it unable to fully recover from injury or disease. Although stem and progenitor cells have been shown to reside throughout the brain, in most regions they exist as quiescent cell populations and do not divide sufficiently to replace damaged or destroyed cells. In an effort to stimulate the proliferative capacity of these multipotent cells, we sought to determine the in vivo response of the adult CNS to an exogenous application of basic fibroblast growth factor (bFGF), a known mitogen to stem and progenitor cells. Specifically, we administered bFGF to the striatum of adult rats at varying concentrations (1, 10, 100, 1,000, or 10,000 ng/mL in saline) so as to establish a dose response curve for bFGF-induced cell proliferation. Forty-eight hours following bFGF administration, animals were injected with 5-bromodeoxyuridine to label dividing cells. Of the doses assessed, we found that 1,000 ng/mL bFGF generated the greatest proliferative response over that observed in animals given a control saline injection. Further, the proliferative response of the striatum to bFGF administration could be enhanced twofold by supplementing this growth factor with heparin sulfate, a factor that facilitates the binding of bFGF to its receptors. By determining the maturational fate of the proliferating cell population, we found that a significant proportion of newly generated cells resulting from bFGF administration differentiated into astrocytes. Collectively, these studies demonstrate the potential of bFGF to promote proliferation in the adult brain, which can be exploited to facilitate cell replacement therapies.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Anat & Neurobiol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Richmond, VA 23298 USA		Colello, RJ (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	rcolello@hsc.vcu.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01NS039851-03] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039851] Funding Source: NIH RePORTER		ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amat JA, 1996, GLIA, V16, P368, DOI 10.1002/(SICI)1098-1136(199604)16:4<368::AID-GLIA9>3.0.CO;2-W; Belluardo N, 1997, J COMP NEUROL, V379, P226; Bjarkam CR, 2004, BIOL PSYCHIAT, V56, P213, DOI 10.1016/j.biopsych.2003.12.025; Blesch A, 2004, YONSEI MED J, V45, P28; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; COPPERKUHN CM, 2002, BRAIN RES DEV BRAIN, V134, P13; DAHL D, 1976, BRAIN RES, V116, P150, DOI 10.1016/0006-8993(76)90257-2; Dono R, 2003, AM J PHYSIOL-REG I, V284, pR867, DOI 10.1152/ajpregu.00533.2002; Eclancher F, 1996, BRAIN RES, V737, P201, DOI 10.1016/0006-8993(96)00732-9; ERNFORS P, 1990, J NEUROSCI RES, V27, P10, DOI 10.1002/jnr.490270103; FREIDMAN B, 1989, GLIA, V2, P380; GOMEZPINILLA F, 1992, NEUROSCIENCE, V49, P771, DOI 10.1016/0306-4522(92)90355-6; GOMEZPINILLA F, 1995, J NEUROSCI, V15, P2021, DOI 10.1523/JNEUROSCI.15-03-02021.1995; GOSPODAROWICZ D, 1986, J CELL PHYSIOL, V128, P475, DOI 10.1002/jcp.1041280317; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Hopkins A., 1993, CLIN NEUROLOGY MODER; Jin KL, 2003, ANN NEUROL, V53, P405, DOI 10.1002/ana.10506; KILPATRICK TJ, 1995, J NEUROSCI, V15, P3653; King LA, 2000, GENE THER, V7, P1103, DOI 10.1038/sj.gt.3301198; KORNBLUM HI, 1990, BRAIN RES, V535, P255, DOI 10.1016/0006-8993(90)91608-J; Kuan CY, 2004, J NEUROSCI, V24, P10763, DOI 10.1523/JNEUROSCI.3883-04.2004; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kukekov VG, 1997, GLIA, V21, P399, DOI 10.1002/(SICI)1098-1136(199712)21:4<399::AID-GLIA7>3.0.CO;2-Z; Lin XH, 1999, DEVELOPMENT, V126, P3715; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Messam CA, 2000, EXP NEUROL, V161, P585, DOI 10.1006/exnr.1999.7319; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; MOSCATELLI D, 1989, J CELL BIOL, V109, P2519, DOI 10.1083/jcb.109.5.2519; Nakao N, 1996, EXP NEUROL, V138, P144, DOI 10.1006/exnr.1996.0053; Palmer TD, 1999, J NEUROSCI, V19, P8487; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Racekova E, 2000, Bratisl Lek Listy, V101, P450; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROGHANI M, 1994, J BIOL CHEM, V269, P3976; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; SANTAOLALLA J, 1995, J NEUROSCI RES, V42, P172, DOI 10.1002/jnr.490420204; Sarnat HB, 1998, BRAIN DEV-JPN, V20, P88, DOI 10.1016/S0387-7604(97)00111-3; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; SUN D, 2001, SOC NEUR ABSTR, V27, P115; Thom SR, 2004, P NATL ACAD SCI USA, V101, P13660, DOI 10.1073/pnas.0405642101; Tropepe V, 1997, J NEUROSCI, V17, P7850; Venkataraman G, 1996, P NATL ACAD SCI USA, V93, P845, DOI 10.1073/pnas.93.2.845; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Weiss S, 1996, J NEUROSCI, V16, P7599; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Yoshimura Shinichi, 2004, Nihon Ronen Igakkai Zasshi, V41, P58	51	6	9	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2006	23	2					205	215		10.1089/neu.2006.23.205			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	020HX	WOS:000235900600009	16503804				2022-02-06	
J	Andersson, EE; Emanuelson, I; Olsson, M; Stalhammar, D; Starmark, JE				Andersson, EE; Emanuelson, I; Olsson, M; Stalhammar, D; Starmark, JE			The new Swedish Post-Concussion Symptoms Questionnaire: A measure of symptoms after mild traumatic brain injury and its concurrent validity and inter-rater reliability	JOURNAL OF REHABILITATION MEDICINE			English	Article						post-concussion; mild traumatic brain injury; rehabilitation; assessment methods	MINOR HEAD-INJURY; FOLLOW-UP; ANEURYSMAL SAH; WESTERN SWEDEN; EPIDEMIOLOGY; INTERVIEW; ADULTS; TRIAL	Objective: To study the concurrent validity and the inter-rater reliability of the Post-Concussion Symptoms Questionnaire. Design: The approach was to study the concurrent validity of the Post-Concussion Symptoms Questionnaire when used as an interview questionnaire compared with a self-report questionnaire administered by the patients. The inter-rater reliability was also studied when 2 different raters administered the Post-Concussion Symptoms Questionnaire interview. Patients: Thirty-five patients with mild traumatic brain injury were consecutively contacted by telephone and asked whether they would be willing to participate in a follow-up intervention. Methods: The Post-Concussion Symptoms Questionnaire was completed by the patients, who answered "Yes'' or "No'' to the standardized questions. The patients were then interviewed to check the certain "Yes'' or "No'' answers, 0-10 days after having completed the first Post-Concussion Symptoms Questionnaire. The raters filled in their ratings independently. Results: The concurrent validity of answers in the questionnaire compared with those in the interview ranged from 82% to 100% agreement. The inter-rater reliability results ranged from 93% to 100% agreement between the raters. Conclusion: The Post-Concussion Symptoms Questionnaire with answers of "Yes'' or "No'' is a valid instrument. High reliability was found between the raters.	Univ Gothenburg, Inst Clin Neurosci, Unit Neuropsychol & Neuropsychiat, Gothenburg, Sweden; Univ Gothenburg, Inst Hlth Women & Children, Paediat Sect, Gothenburg, Sweden; Sodra Alvsborg Hosp, Rehabil Ctr, Boras, Sweden		Andersson, EE (corresponding author), Sch Hlth Sci, Dept Rehabil, Box 1026, SE-55111 Jonkoping, Sweden.	elisabeth.elgmark@hhj.hj.se		Elgmark Andersson, Elisabeth/0000-0002-2049-4170			Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; ASBERG M, 1978, CPRS DEV APPL PSYCHI; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Caveness W F, 1977, Trans Am Neurol Assoc, V102, P136; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; ELGMARK EA, 2005, IN PRESS ACTA NEUROC; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LJUNGGREN B, 1985, J NEUROSURG, V62, P673, DOI 10.3171/jns.1985.62.5.0673; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; MCNEMAR Q, 1969, PSYCHOL STAT; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Paniak C, 2000, BRAIN INJURY, V14, P219; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Rodholm M, 2001, ACTA NEUROL SCAND, V103, P379, DOI 10.1034/j.1600-0404.2001.103006379.x; RODHOLM M, 2003, THESIS GOTEBORG U GO; Ruff RM, 1999, BRAIN INJURY, V13, P943; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Svensson E, 2002, J REHABIL MED, V34, P251, DOI 10.1080/165019702760390338; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177	33	6	6	0	3	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	JAN	2006	38	1					26	31		10.1080/16501970500310564			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	005SV	WOS:000234845000005	16548083	gold			2022-02-06	
J	Ben Smail, D; Samuel, C; Rouy-Thenaisy, K; Regnault, J; Azouvi, P				Ben Smail, D; Samuel, C; Rouy-Thenaisy, K; Regnault, J; Azouvi, P			Bromocriptine in traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; bromocriptine; Parkinson's syndrome; dopaminergic agonists; LDOPA	WORKING-MEMORY; ADULT NORMS; HEAD-INJURY; PARKINSONISM; AGONIST; DYSFUNCTION; MODULATION; MECHANISMS; DEXTERITY; DEFICITS	The authors report the case of a 63-year-old patient with severe traumatic brain injury (TBI) associated with Parkinson's syndrome, whose performances were dramatically improved by bromocriptine therapy, with an improvement of the scores, not only on tests evaluating motor functions but also on tests evaluating the patient's cognitive functions. However, no improvement was observed with levodopa.	Univ Versailles, Fac Med, Serv Med Phys & Readaptat, F-78000 Versailles, France		Ben Smail, D (corresponding author), Univ Versailles, Fac Med, Serv Med Phys & Readaptat, F-78000 Versailles, France.	djamel.bensmail@rpc.aphp.fr	Bensmail, Djamel/R-6035-2018	Bensmail, Djamel/0000-0001-9360-9330			Arnsten AFT, 1998, TRENDS COGN SCI, V2, P436, DOI 10.1016/S1364-6613(98)01240-6; BROWN RM, 1979, BRAIN RES, V168, P133, DOI 10.1016/0006-8993(79)90132-X; CARDOSO F, 1995, ARCH NEUROL-CHICAGO, V52, P263, DOI 10.1001/archneur.1995.00540270055019; Collin C, 1988, Int Disabil Stud, V10, P61; CRISMON ML, 1988, CLIN NEUROPHARMACOL, V11, P462, DOI 10.1097/00002826-198810000-00007; CROUZON O, 1929, PRESSE MED, V37, P1325; DOBKIN BH, 1993, ANN NEUROL, V33, P313, DOI 10.1002/ana.410330315; Doder M, 1999, J NEUROL NEUROSUR PS, V66, P380, DOI 10.1136/jnnp.66.3.380; FACTOR SA, 1988, MOVEMENT DISORD, V3, P30, DOI 10.1002/mds.870030105; HOLDEN MK, 1984, PHYS THER, V64, P35, DOI 10.1093/ptj/64.1.35; JANKOVIC J, 1994, NEUROLOGY, V44, P2006, DOI 10.1212/WNL.44.11.2006; Karli DC, 1999, BRAIN INJURY, V13, P63, DOI 10.1080/026990599121908; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LINDENBERG R, 1964, Dtsch Z Nervenheilkd, V185, P637; LUCIANA M, 1992, J COGNITIVE NEUROSCI, V4, P58, DOI 10.1162/jocn.1992.4.1.58; Luciana M, 1997, J COGNITIVE NEUROSCI, V9, P330, DOI 10.1162/jocn.1997.9.3.330; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; MATHIOWETZ V, 1985, OCCUP THER J RES, V5, P24, DOI 10.1177/153944928500500102; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; NAYERNOURI T, 1985, SURG NEUROL, V24, P263, DOI 10.1016/0090-3019(85)90035-7; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; TAYLOR AE, 1986, BRAIN, V109, P279, DOI 10.1093/brain/109.2.279	25	6	6	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2006	20	1					111	115		10.1080/02699050500309700			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	001AQ	WOS:000234505000012	16403706				2022-02-06	
J	Browne, GJ				Browne, GJ			Cervical spinal injury in children's community rugby football	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							CORD INJURIES; AUSTRALIAN FOOTBALLERS; LEAGUE; UNION	Objective: To examine the characteristics of cervical spinal injury (CSI) in school aged children injured in community based rugby football who presented to the emergency department for assessment. Methods: This is a retrospective descriptive case series study reviewing the medical records of all children younger than 15 years of age who presented to the emergency department at the Children's Hospital at Westmead, Sydney, Australia for assessment of injury to the cervical spine between 2000 and 2003. Results: There were 125 children with CSI; most (97%) were boys of mean age 12.7 years. Injuries occurred throughout the season, with an unexpected peak in June. Neck pain was the main presenting complaint (98%). Neurological symptoms were reported in 43%, half having concussion. Hyperextension of the neck accounted for a third of all cases and was usually the result of a spear tackle. Appropriate treatment of the cervical spine on the field of play before transport to hospital was inconsistently performed. Half of the players with CSI suffered secondary injuries, consisting of concussive head injury, faciomaxillary injury, eye injury, or limb fracture. Admission to hospital was common, with all children admitted undergoing further radiological assessment. Two minor fractures were reported and no permanent neurological disability. Overall, no adverse events were reported and the clinical outcome was good. Conclusion: CSI in children playing rugby football is rarely catastrophic although often associated with other injuries. Continued efforts are needed to educate players and referees to prevent injury.	Childrens Hosp Inst Sports Med, Sydney, NSW, Australia		Browne, GJ (corresponding author), Childrens Hosp Inst Sports Med, Sydney, NSW, Australia.	garyb@chw.edu.au					Armour KS, 1997, NEW ZEAL MED J, V110, P462; Brigham CD, 2003, J BONE JOINT SURG AM, V85A, P381, DOI 10.2106/00004623-200302000-00032; BURRY HC, 1988, BRIT MED J, V296, P149, DOI 10.1136/bmj.296.6616.149; Cantu RC, 2000, NEUROSURGERY, V47, P673, DOI 10.1097/00006123-200009000-00029; Davis PM, 1998, CLIN SPORT MED, V17, P147, DOI 10.1016/S0278-5919(05)70069-7; Donaldson A., 2004, HEALTH PROMOT J AUST, V15, P155; Noakes TD, 1999, S AFR MED J, V89, P540; Quarrie KL, 2002, SPORTS MED, V32, P633, DOI 10.2165/00007256-200232100-00003; Rotem TR, 1998, MED J AUSTRALIA, V168, P379, DOI 10.5694/j.1326-5377.1998.tb138989.x; Scher AT, 1998, CLIN SPORT MED, V17, P195, DOI 10.1016/S0278-5919(05)70073-9; TAYLOR TKF, 1987, MED J AUSTRALIA, V147, P112, DOI 10.5694/j.1326-5377.1987.tb133298.x; Taylor TKF, 2003, ANZ J SURG, V73, P493; TAYLOR TKF, 2004, J BONE JOINT SURG S4, V86, P489	13	6	6	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2006	40	1					68	71		10.1136/bjsm.2005.020636			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	995YG	WOS:000234140600016	16371495	Green Published, Bronze			2022-02-06	
J	de Andrade, AF; de Almeida, AN; Bor-Seng-Shu, E; Lourenco, L; Mandel, M; Marino, R				de Andrade, AF; de Almeida, AN; Bor-Seng-Shu, E; Lourenco, L; Mandel, M; Marino, R			The value of cranial computed tomography in high-risk, mildly head-injured patients	SURGICAL NEUROLOGY			English	Article						traumatic brain injury; CT scan; mild head injury; Glasgow Coma Scale; Glasgow Outcome Scale	MANAGEMENT; TRAUMA; PREDICTORS; DIAGNOSIS; EMERGENCY; ADULTS; SCANS	Background: The purpose of this article was to assess if high-risk, mildly head-injured patients with normal CT scan present an outcome similar to the group with "low-risk MHI." Methods: A total of 379 hospital charts of inpatients with Glasgow Coma Scale scores of 13, 14, and 15 were reviewed. Information regarding age, fGCS, trauma mechanism, cranial CT scan findings, hospital course, and follow-up using the GOS were obtained from all patients. Results: Patients were separated in 3 groups: fGCS 13 (46 patients), fGCS 14 (138 patients), and fGCS 15 (195 patients). The groups with different scores on fGCS did not differ regarding CT scan abnormalities, surgical treatment. or outcome. Patients were also separated in 2 groups based on CT scan findings: 266 patients had CT interpreted as abnormal and 113 had CT interpreted as normal. The 2 groups differed statistically regarding surgical treatment and scores on GOS (P < .05). There was no statistically significant difference between the 2 groups regarding sex, trauma mechanism, fGCS, or age. Conclusions: Our findings support the idea that a normal cranial CT scan in patients with fGCS scores of 13 or higher ascertain a low-risk MHI outcome and, therefore, such patients must be included in this category of traumatic brain injury. On the other hand, patients with cranial CT scan abnormalities should be included in the group with moderate head injury. (c) 2006 Elsevier Inc. All rights reserved.	Univ Sao Paulo, Hosp Clin, Fac Med,Sch Med, Dept Neurol,Disciplina Neurocirurgia Sao Paulo, Sao Paulo, Brazil		de Andrade, AF (corresponding author), Univ Sao Paulo, Hosp Clin, Fac Med,Sch Med, Dept Neurol,Disciplina Neurocirurgia Sao Paulo, Rua Eneas Carvalho Aguiar 225,Caixa Postal 8091, Sao Paulo, Brazil.	alandrade@hcnet.usp.br	BOR-SENG-SHU, EDSON/H-7784-2013; de Almeida, Antonio Nogueira/A-2957-2016; BOR-SENG-SHU, EDSON/AAC-9762-2019; Almeida, Antonio/O-5506-2019; Mandel, Mauricio/AAD-7775-2022; Mandel, Mauricio/K-5619-2013	BOR-SENG-SHU, EDSON/0000-0002-6713-8974; de Almeida, Antonio Nogueira/0000-0002-0796-7025; BOR-SENG-SHU, EDSON/0000-0002-6713-8974; Almeida, Antonio/0000-0002-0796-7025; Mandel, Mauricio/0000-0001-6811-6059; Mandel, Mauricio/0000-0001-6811-6059			Arienta C, 1997, SURG NEUROL, V48, P213, DOI 10.1016/S0090-3019(97)00019-0; Bor-Seng-Shu E, 1997, CHILD NERV SYST, V13, P605, DOI 10.1007/s003810050151; Bor-Seng-Shu Edson, 2004, Neurosurg Focus, V16, pECP1; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; de Andrade AF, 2001, WORLD J SURG, V25, P1186; FISCHER RP, 1981, J TRAUMA, V21, P920, DOI 10.1097/00005373-198111000-00002; Geijerstam JL, 2005, EMERG MED J, V22, P103; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; LIVINGSTON DH, 1991, AM SURGEON, V57, P14; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; MORAN SG, 1994, AM SURGEON, V60, P533; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROS S P, 1989, Pediatric Emergency Care, V5, P216, DOI 10.1097/00006565-198912000-00003; SERVADEI F, 1995, J TRAUMA, V39, P696, DOI 10.1097/00005373-199510000-00015; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; STEIN SC, 1992, J NEUROSURG, V77, P562, DOI 10.3171/jns.1992.77.4.0562; STEIN SC, 1991, ANN EMERG MED, V20, P1286, DOI 10.1016/S0196-0644(05)81066-2; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TAHERI PA, 1993, ARCH SURG-CHICAGO, V128, P289	29	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.		2006	65			1			S10	S13		10.1016/j.surneu.2005.11.034			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	015CK	WOS:000235529300003					2022-02-06	
J	Desapriya, E; Pike, I; Babul, S				Desapriya, E.; Pike, I.; Babul, S.			PUBLIC ATTITUDES, EPIDEMIOLOGY AND CONSEQUENCES OF DRINKING AND DRIVING IN BRITISH COLUMBIA	IATSS RESEARCH			English	Article						Public attitudes; Causes of fatal and serious injury; Risk taking behavior; Driving under influence (DUI); Restraint use		Injury is the ninth most common cause of premature death worldwide and the third most common cause of years lived with disability. Many early deaths are related to motor vehicle crashes (MVC's): each year, MVC's kill 1.2 million people (3,242 deaths/day) and injure or disable 20-50 million more. The Global Burden of Disease Study, conducted in the early 1990s, predicted that traffic-related injuries will become the third largest contributor to global death and disability by the year 2020. The identification of effective strategies for the prevention of traffic related injuries is of global health importance. The substantial effect of alcohol on road safety has long been recognized, and a variety of important initiatives to combat this problem have been introduced with some measurable success. Canadians have rated drinking and driving as one of the most important social issues facing them today, placing it ahead of other prominent issues, including health care, pollution, and the state of the economy. Two factors that have contributed strongly to motor vehicle injuries and fatalities in British Columbia (BC) and Canada are alcohol-impaired driving and failure to use seat belts. Drivers who operated motor vehicles after drinking were less likely to wear seat belts, and so they continue to be a major traffic safety concern. When compared to restrained occupants, unrestrained occupants were almost 5 times more likely to die (Odds Ratios (OR) 4.70), or be injured (OR 4.66). Fractures (OR 10.70, 95% confidence intervals [CI] 7.35-15.5), lacerations (OR 7.50, CI 5.55-10.15) bleeding (OR 7.14, CI 4.97-10.26) and concussions (OR 5.49, CI 2.71-11.12), were the more common types of injuries experienced by unrestrained occupants compared to the restrained occupants. Laws mandate the use of safety belts by motor vehicle occupants, and driving under the influence of alcohol is a generic term for a series of offences under the Canadian Criminal Code. Violation of Road Traffic Laws continues to be a serious 'social problem' and can often have fatal consequences as demonstrated in this study.	[Desapriya, E.; Pike, I.; Babul, S.] Ctr Community Child Hlth Res, BC Injury Res & Prevent Unit, Vancouver, BC, Canada; [Desapriya, E.; Pike, I.; Babul, S.] Univ British Columbia, Fac Med, Dept Pediat, Vancouver, BC, Canada		Desapriya, E (corresponding author), Ctr Community Child Hlth Res, BC Injury Res & Prevent Unit, Vancouver, BC, Canada.			Babul, Shelina/0000-0002-0227-2574; Pike, Ian/0000-0002-6860-7760			AAA Foundation for Traffic Safety, 2002, DRUNK DRIV SEEK ADD; [Anonymous], 2010, NAT OCC RESTR PROGR; [Anonymous], 2003, TRAFF COLL STAT; [Anonymous], 2001, AM J PREVENTIVE MED, V21, P16; Beirness D. J., 2005, ROAD SAFETY MONITOR; BEIRNESS DJ, 1997, DWI REPEAT OFFENDERS; BLINCOE L, 2002, EC IMPACT MOTOR VEHI; Boase P, 2004, J SAFETY RES, V35, P223, DOI 10.1016/j.jsr.2004.03.005; Brewer R D, 1995, Arch Fam Med, V4, P499, DOI 10.1001/archfami.4.6.499; Council on Scientific Affairs, 1986, JAMA-J AM MED ASSOC, P255; Cummings P, 2003, ACCIDENT ANAL PREV, V35, P143, DOI 10.1016/S0001-4575(01)00087-2; DeJong W, 1998, ANNU REV PUBL HEALTH, V19, P359, DOI 10.1146/annurev.publhealth.19.1.359; Desapriya E. B., 2004, BMJ-BRIT MED J, V328, P855; Dinh-Zarr TB, 2001, AM J PREV MED, V21, P48, DOI 10.1016/S0749-3797(01)00378-6; Elder RW, 2004, AM J PREV MED, V27, P57, DOI 10.1016/j.amepre.2004.03.002; EVANS L, 1990, ACCIDENT ANAL PREV, V22, P167, DOI 10.1016/0001-4575(90)90067-U; Fleming MF, 1997, JAMA-J AM MED ASSOC, V277, P1039, DOI 10.1001/jama.277.13.1039; FOSS RD, 1994, AM J PUBLIC HEALTH, V84, P1732, DOI 10.2105/AJPH.84.11.1732; Halman SI, 2002, BRIT MED J, V324, P1123, DOI 10.1136/bmj.324.7346.1123; Jonah B, 1999, ACCIDENT ANAL PREV, V31, P421, DOI 10.1016/S0001-4575(98)00081-5; Jonah B. A., 1990, HLTH ED RES, V5, P139, DOI DOI 10.1093/HER/5.2.139; KENDALL P, 2002, PUBLIC HLTH APPROACH; KOELEGA HS, 1995, PSYCHOPHARMACOLOGY, V118, P233, DOI 10.1007/BF02245951; Krug, 2002, INJURY LEADING CAUSE; MARINE WM, 1994, J TRAUMA, V36, P96, DOI 10.1097/00005373-199401000-00015; McCaig L. F, 2003, 335 NAT CTR HLTH STA, V335; MCCARROLL JR, 1962, J CHRON DIS, V15, P811, DOI 10.1016/0021-9681(62)90051-6; National Cancer Institute of Canada, 2001, CANADIAN CANC STAT; National Center for Statistics and Analysis, 2001, TRAFF SAF FACTS 2001; National Institute on Alcohol Abuse and Alcoholism, 1994, NIH PUBL, P233; ORSAY EM, 1990, ANN EMERG MED, V19, P258; Peek-Asa C, 1999, AM J PREV MED, V16, P57, DOI 10.1016/S0749-3797(98)00116-0; PeekAsa C, 1996, J TRAUMA, V41, P989, DOI 10.1097/00005373-199612000-00008; Rivara FP, 2000, JAMA-J AM MED ASSOC, V283, P2826, DOI 10.1001/jama.283.21.2826; Salzberg PM, 2004, J SAFETY RES, V35, P215, DOI 10.1016/j.jsr.2004.03.008; Shinar D., 2001, ACCIDENT ANAL PREV, V33, P243; Shults RA, 2004, J SAFETY RES, V35, P189, DOI 10.1016/j.jsr.2004.03.002; Shults RA, 2001, AM J PREV MED, V21, P66, DOI 10.1016/S0749-3797(01)00381-6; Sleet D. A., 2002, TRAFFIC INJ PREV, V3, P266, DOI DOI 10.1080/15389580214623; The Canadian Council of Motor Transport Administrators (CCMTA), 2002, TRANSP CAN ROAD SAF; Vinson DC, 2003, J STUD ALCOHOL, V64, P358, DOI 10.15288/jsa.2003.64.358; WELLSPARKER E, 1995, ADDICTION, V90, P907, DOI 10.1111/j.1360-0443.1995.tb03500.x; World Health Organization, 2003, WHO FACTS INJ ROAD T; ZADOR PL, 1991, J STUD ALCOHOL, V52, P302, DOI 10.15288/jsa.1991.52.302	44	6	6	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0386-1112	2210-4240		IATSS RES	IATSS Res.		2006	30	1					101	110		10.1016/S0386-1112(14)60160-6			10	Transportation	Emerging Sources Citation Index (ESCI)	Transportation	V47YN	WOS:000209987200010		gold			2022-02-06	
J	Deutsch, PM; Kendall, SL; Daninhirsch, C; Cimino-Ferguson, S; McCollom, P				Deutsch, Paul M.; Kendall, Sherie L.; Daninhirsch, Carrie; Cimino-Ferguson, Sara; McCollom, Patricia			Vocational outcomes after brain injury in a patient population evaluated for Life Care Plan reliability	NEUROREHABILITATION			English	Article; Proceedings Paper	1st International Conference on Vocational Outcomes in Traumatic Brain Injury	APR 14-16, 2005	Vancouver, CANADA			return to work; traumatic brain injury; vocation; life care plan; disability; rehabilitation	HEAD-INJURY; MEMORY TEST; WORK; RETURN; PREDICTORS; VARIABLES; RECOVERY; MODEL	This retrospective cohort study examined the vocational outcomes in forty-four traumatically brain injured patients. Patient files selected were limited to those who were seen for the development of an original Life Care Plan and were subsequently seen at least once for a complete update of that plan. Patients who were retired at the time of the brain injury were excluded. Each participant was actively involved in litigation at the time of the initial evaluation as well as at the time of his or her update evaluation. Traumatic brain injury resulted from various etiologies. Vocational outcomes were analyzed in relation to severity of injury, age at onset, gender and education. Vocational outcome was reported as a return to work, supported employment, return to school or training or permanent total disability. Twenty-one patients were classified as permanent-total disabilities. Twenty-three returned to work, supported employment, or were successfully in school and expected to return to work. This 52% rate of vocational or school participation is particularly noteworthy since all cases were actively in litigation. A significant trend was found for severity of injury, and level of education, but not for age at onset or gender. These factors are discussed in relation to the subjects' participation in third party civil litigation and implications for Life Care Planning.	Paul M Deutsch & Associates PA, Oviedo, FL 32765 USA; Univ Kentucky, Coll Med, Dept Behav Sci, Lexington, KY 40536 USA; Midway Coll, Div Nursing, Midway, KY USA; Management Consulting & Rehabil Serv Inc, Alkeny, IA USA; LifeCare Econ Ltd, Alkeny, IA USA		Deutsch, PM (corresponding author), Paul M Deutsch & Associates PA, 10 Windsormere Way,Suite 400, Oviedo, FL 32765 USA.	pdeut18893@mac.com					Binder LM, 1996, AM J PSYCHIAT, V153, P7; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Hayden ME, 2000, J HEAD TRAUMA REHAB, V15, P1000, DOI 10.1097/00001199-200008000-00004; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Kowalske K, 2000, J HEAD TRAUMA REHAB, V15, P989, DOI 10.1097/00001199-200008000-00003; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Warrington E, 1984, RECOGNITION MEMORY T, V1	18	6	6	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2006	21	4					305	314					10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Rehabilitation	145VU	WOS:000244894700005	17361047				2022-02-06	
J	Summers, MJ				Summers, MJ			Increased inattentional blindness in severe traumatic brain injury: Evidence for reduced distractibility?	BRAIN INJURY			English	Article						inattentional blindness; divided attention; focused attention; traumatic brain injury	CLOSED-HEAD INJURY; SELECTIVE ATTENTION; CONSTRUCT-VALIDITY; DIVIDED ATTENTION; TASK-PERFORMANCE; INFORMATION; TRAIL; DEFICITS; MILD; DISSOCIATION	Primary objective: To examine the role of selective attention and visual perception in medicating inattentional blindness in a severe traumatic brain injured sample. Research design: Cross-sectional design with age and education matched control sample. Methods and procedures: Twenty participants with severe traumatic brain injury (n = 10) and matched controls (n = 10) completed a series of tests of focused attention (Stroop test), divided attention (Trail Making Test), visual perception (Visual Object and Space Perception Battery) and two tasks of inattentional blindness. Main outcomes and results: The group with severe TBI were significantly slower on the Stroop test and TMT and displayed significantly elevated Stroop interference and TMT ratio scores. On the inattentional blindness tasks, fewer TBI participants identified a distracting stimulus. Conclusion: The results indicate severe TBI is associated with deficits to focused and divided attention with the finding of a potentially more debilitating impairment arising from reduced distractibility following severe TBI.	Univ Tasmania, Sch Psychol, Launceston, Tas 7250, Australia		Summers, MJ (corresponding author), Univ Tasmania, Sch Psychol, Launceston, Tas 7250, Australia.	mathew.summers@utas.edu.au	Summers, Mathew J/G-3168-2011	Summers, Mathew J/0000-0002-3869-4920			Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; BATCHELOR J, 1995, CLIN NEUROPSYCHOL, V9, P180, DOI 10.1080/13854049508401600; BOND MR, 1990, REHABILITATION ADULT, P59; Brown GG, 1999, J INT NEUROPSYCH SOC, V5, P308, DOI 10.1017/S1355617799544020; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; Dimitrov M, 2003, BRAIN COGNITION, V52, P258, DOI 10.1016/S0278-2626(03)00080-0; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Gibson B.S., 2001, ATTRACTION DISTRACTI, V133, P51, DOI DOI 10.1016/S0166-4115(01)80005-4; Kinsella GJ, 1998, NEUROPSYCHOL REHABIL, V8, P351, DOI 10.1080/713755576; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mack A, 2003, CURR DIR PSYCHOL SCI, V12, P180, DOI 10.1111/1467-8721.01256; MACK A, 1988, BRADFORD BOOKS SERIE, P273; Mack A., 1998, VISUAL ATTENTION, V8, P55; MILLER E, 1981, BRIT J CLIN PSYCHOL, V20, P69, DOI 10.1111/j.2044-8260.1981.tb00498.x; Moore CM, 2003, VIS COGN, V10, P299, DOI 10.1080/13506280143000041; Most SB, 2001, PSYCHOL SCI, V12, P9, DOI 10.1111/1467-9280.00303; NEILL WT, 1977, J EXP PSYCHOL HUMAN, V3, P444, DOI 10.1037/0096-1523.3.3.444; NEISSER U, 1975, COGNITIVE PSYCHOL, V7, P480, DOI 10.1016/0010-0285(75)90019-5; Neisser U., 1979, PERCEPTION ITS DEV T, P201; Newby EA, 1998, PERCEPTION, V27, P1025, DOI 10.1068/p271025; ODONNELL JP, 1994, J CLIN PSYCHOL, V50, P596, DOI 10.1002/1097-4679(199407)50:4<596::AID-JCLP2270500416>3.0.CO;2-S; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Posner Michael I., 1992, CURRENT DIRECTIONS P, V1, P11, DOI [DOI 10.1111/1467-8721.EP10767759, 10.1111/1467-8721.ep10767759]; Potter DD, 2002, J INT NEUROPSYCH SOC, V8, P828, DOI 10.1017/S1355617702860118; Rees G, 1999, SCIENCE, V286, P2504, DOI 10.1126/science.286.5449.2504; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Schmitter-Edgecombe M, 1998, J INT NEUROPSYCH SOC, V4, P144, DOI 10.1017/S1355617798001441; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; Simons DJ, 2000, VIS COGN, V7, P1, DOI 10.1080/135062800394658; Simons DJ, 2000, TRENDS COGN SCI, V4, P147, DOI 10.1016/S1364-6613(00)01455-8; Simpson A, 2000, NEUROPSYCHOLOGY, V14, P310, DOI 10.1037//0894-4105.14.2.310; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1999, NEUROPSYCHOLOGIA, V37, P1005, DOI 10.1016/S0028-3932(98)00158-4; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Vakil E, 1996, DEV NEUROPSYCHOL, V12, P313, DOI 10.1080/87565649609540655; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANZOMEREN AH, 1981, REACTION TIME ATTENT, V163; Warrington E. K., 1991, VISUAL OBJECT SPACE; Whyte J, 1998, J INT NEUROPSYCH SOC, V4, P127, DOI 10.1017/S1355617798001271; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Whyte J, 2000, J INT NEUROPSYCH SOC, V6, P1, DOI 10.1017/S1355617700611013; Wolfe JM, 1999, MIT BRAD COGN PSYCH, P71; Zoccolotti P, 2000, CORTEX, V36, P93, DOI 10.1016/S0010-9452(08)70839-6	60	6	6	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2006	20	1					51	60		10.1080/02699050500309742			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	001AQ	WOS:000234505000006	16403700				2022-02-06	
J	Vartiainen, MV; Rinne, MB; Lehto, TM; Pasanen, ME; Sarajuuri, JM; Alaranta, HT				Vartiainen, Matti V.; Rinne, Marjo B.; Lehto, Tommi M.; Pasanen, Matti E.; Sarajuuri, Jaana M.; Alaranta, Hannu T.			The test - retest reliability of motor performance measures after traumatic brain injury	EUROPEAN JOURNAL OF PHYSIOTHERAPY			English	Article						Agility; balance; co-ordination; motor skills; physiotherapy; rehabilitation; repeatability; sense of rhythm		Physically well recovered traumatically brain injured (TBI) patients complain of impaired motor performance, which may not be apparent in conventional neurological examination. A reliable test battery measuring mild physical impairment in TBI populations would be a welcome tool for clinical practice. The aim of this study was to evaluate the test - retest reliability of static and dynamic balance, running in a figure-of-eight (agility) and rhythm co-ordination tests. Thirty-four well-recovered TBI inpatients and 36 healthy male volunteers were tested on two occasions. The change in the mean, the typical error and the intra-class correlation coefficient (ICC) were used as statistics of reliability for continuous measurements and Cohen's kappa coefficient for categorical variables. The best result of consecutive trials within each test showed the best reliability. In the tandem walking tests and running figure-of-eight tests, the reliability was lower in the TBI group than in the controls but still good. The repeatability of static balance and the rhythm co-ordination was moderate in both groups. A slight training effect from test to retest session was observed in most of the performance tests. Balance, rhythm co-ordination and agility tests proved to be reliable for testing TBI men, and can therefore be used in clinical setting.	[Vartiainen, Matti V.; Lehto, Tommi M.; Sarajuuri, Jaana M.; Alaranta, Hannu T.] Kapyla Rehabil Ctr, Helsinki, Finland; [Rinne, Marjo B.; Pasanen, Matti E.] UKK Inst Hlth Promot Res, Tampere, Finland		Vartiainen, MV (corresponding author), Nordenskioldinkatu 18 B, Helsinki 00251, Finland.	matti.vartiainen@invalidiliitto.fi	Sarajuuri, Jaana/AAD-8665-2019	Sarajuuri, Jaana/0000-0002-6432-0295	Finnish Ministry of Education [196/722/2000]	This study was supported by the Finnish Ministry of Education grant no 196/722/2000. The researchers would like to express their gratitude to all participants.	Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Baumgartner T. A., 2003, MEASUREMENT EVALUATI; BERG KO, 1992, ARCH PHYS MED REHAB, V73, P1073; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Choy NL, 2002, AUST J PHYSIOTHER, V48, P35, DOI 10.1016/S0004-9514(14)60280-4; Di Russo F, 2005, J NEUROTRAUM, V22, P297; Dombovy ML, 1997, BRAIN INJURY, V11, P305, DOI 10.1080/026990597123467; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Geiger RA, 2001, PHYS THER, V81, P995, DOI 10.1093/ptj/81.4.995; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laukkanen R, 1993, THESIS U KUOPIO, P23; Lezak M.D., 2000, INT HDB NEUROPSYCHOL, P67, DOI [10.1007/978-1-4757-5569-5_4, DOI 10.1007/978-1-4757-5569-5_4]; Masanic CA, 1998, ARCH PHYS MED REHAB, V79, P811, DOI 10.1016/S0003-9993(98)90361-6; Moseley AM, 2003, J HEAD TRAUMA REHAB, V18, P526, DOI 10.1097/00001199-200311000-00006; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Quinn B, 2000, BRAIN INJURY, V14, P1063; Rinne MB, 2001, INT J SPORTS MED, V22, P192, DOI 10.1055/s-2001-16384; Rossi C, 1996, ARCH PHYS MED REHAB, V77, P1062, DOI 10.1016/S0003-9993(96)90069-6; Suni JH, 1996, ARCH PHYS MED REHAB, V77, P399, DOI 10.1016/S0003-9993(96)90092-1; Suni JH, 1998, PHYS THER, V78, P134, DOI 10.1093/ptj/78.2.134; SWAINE BR, 1993, PHYS THER, V73, P71, DOI 10.1093/ptj/73.2.71; TEGNER Y, 1986, AM J SPORT MED, V14, P156, DOI 10.1177/036354658601400212; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa; Vitale AE, 1997, BRAIN INJURY, V11, P67, DOI 10.1080/026990597123827; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P289, DOI 10.1016/S1388-2457(03)00348-1; Zomeren AH, 1989, CLOSED HEAD INJURY P, P75	34	6	7	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2167-9169	2167-9177		EUR J PHYSIOTHER	Eur. J. Physiother.		2006	8	2					50	59		10.1080/14038190600700195			10	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V1Y6E	WOS:000217353500002					2022-02-06	
S	Yeo, RA; Brooks, WM; Jung, RE		Moffett, JR; Tieman, SB; Weinberger, DR; Coyle, JT; Namboodiri, AMA		Yeo, RA; Brooks, WM; Jung, RE			NAA and higher cognitive function in humans	N-ACETYLASPARTATE: A UNIQUE NEURONAL MOLECULE IN THE CENTRAL NERVOUS SYSTEM	Advances in Experimental Medicine and Biology		English	Article; Proceedings Paper	1st International Symposium on N-Acetylaspartate	SEP 13-14, 2004	Bethesda, MD	Natl Inst Mental Hlth, Natl Inst Neurol Disorder & Stroke, Natl Inst Child Hlth & Human Dev, Natl Inst Hlth, Off Rare Dis			MAGNETIC-RESONANCE-SPECTROSCOPY; TRAUMATIC BRAIN INJURY; PROTON MR SPECTROSCOPY; N-ACETYL ASPARTATE; IN-VIVO; GENERAL INTELLIGENCE; BIOCHEMICAL MARKERS; ACETYLASPARTATE; RECOVERY; REPRODUCIBILITY		Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA; Univ Kansas, Med Ctr, Hogland Brain Imaging Ctr, Lawrence, KS 66045 USA; Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA		Yeo, RA (corresponding author), Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA.	ryeo@unm.edu; wbrooks@kumc.edu; rjung@salud.unm.edu		brooks, william/0000-0001-6227-7636; Jung, Rex/0000-0003-3718-0597			ANDERSON B, 2003, BRAIN IMAGING SCI ST, P29; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barker PB, 2001, ANN NEUROL, V49, P423, DOI 10.1002/ana.90; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Boltshauser E, 2004, NEUROPEDIATRICS, V35, P255, DOI 10.1055/s-2004-821036; BOTTOMLEY PA, 1992, JMRI-J MAGN RESON IM, V2, P1, DOI 10.1002/jmri.1880020102; BOTTOMLEY PA, 1987, ANN NY ACAD SCI, V508, P333, DOI 10.1111/j.1749-6632.1987.tb32915.x; Brooks WM, 1999, MAGNET RESON MED, V41, P193, DOI 10.1002/(SICI)1522-2594(199901)41:1<193::AID-MRM27>3.3.CO;2-G; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; DADAMO AF, 1966, J NEUROCHEM, V13, P961, DOI 10.1111/j.1471-4159.1966.tb10292.x; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; Driscoll I, 2003, CEREB CORTEX, V13, P1344, DOI 10.1093/cercor/bhg081; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Gasparovic C, 2001, J NEUROTRAUM, V18, P241, DOI 10.1089/08977150151070856; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; Hamilton DA, 1999, PSYCHOBIOLOGY, V27, P453; JENSEN AR, 1983, INTELLIGENCE, V7, P217, DOI 10.1016/0160-2896(83)90030-2; Jung RE, 1999, NEUROREPORT, V10, P3327, DOI 10.1097/00001756-199911080-00014; Jung RE, 1999, P ROY SOC B-BIOL SCI, V266, P1375, DOI 10.1098/rspb.1999.0790; Jung RE, 2000, CLIN NEUROPSYCHOL, V14, P535, DOI 10.1076/clin.14.4.535.7198; JUNG RE, 2003, P INT SOC MAGN RESON, V11, P2006; JUNG RE, 2004, P 1 INT S N AC BETH; JUNG RE, IN PRESS IH MRS STUD; JUNG RE, 2004, P INT SOC MAGN RESON, V11, P2431; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; LEWINE JD, 1995, FUNCTIONAL BRAIN IMA; Lim KO, 2002, NMR BIOMED, V15, P587, DOI 10.1002/nbm.789; Macmillan CSA, 2002, ACTA NEUROCHIR, V144, P853, DOI 10.1007/s00701-002-0966-x; Martin E, 2001, ANN NEUROL, V49, P518, DOI 10.1002/ana.102; Martinez-Bisbal MC, 2004, EUR J NEUROL, V11, P187, DOI 10.1046/j.1468-1331.2003.00746.x; Mullins PG, 2003, MAGNET RESON MED, V50, P704, DOI 10.1002/mrm.10598; Narayanan S, 2001, J NEUROL, V248, P979, DOI 10.1007/s004150170052; ONEILL J, MAGN RES MED, V43, P244; Pfleiderer B, 2004, NEUROSCIENCE, V123, P1053, DOI 10.1016/j.neuroscience.2003.11.008; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rael LT, 2004, BIOCHEM BIOPH RES CO, V319, P847, DOI 10.1016/j.bbrc.2004.04.200; RAZ N, 1999, HDB AGING COGNITION, P1; Ross AJ, 2004, BRAIN RES REV, V44, P83, DOI 10.1016/j.brainresrev.2003.11.001; TALLAN HH, 1957, J BIOL CHEM, V224, P41; VANDENBOOGAART A, 1994, MAGNET RESON MED, V31, P347, DOI 10.1002/mrm.1910310402; WEERS DC, NEUROMETABOLIC ABNOR	46	6	7	0	6	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES	0065-2598	2214-8019	0-387-30171-2	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2006	576						215	226					12	Biochemistry & Molecular Biology; Medicine, Research & Experimental; Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine; Neurosciences & Neurology	BED79	WOS:000236895900015	16802715				2022-02-06	
J	Collins, ME; Misukanis, TM				Collins, Matthew E.; Misukanis, Tom M.			CHIROPRACTIC MANAGEMENT OF A PATIENT WITH POST TRAUMATIC VERTIGO OF COMPLEX ORIGIN	JOURNAL OF CHIROPRACTIC MEDICINE			English	Article						Brain Injuries; Manipulation; Chiropractic; Exercise Therapy; Neuropsychology; Post-concussion Syndrome; Vertigo		Objective: To illustrate a case of vertigo in a patient with cervical spine injury and mild traumatic brain injury following a motor vehicle accident and present chiropractic and rehabilitative procedures used for management. Clinical Features: A 30-year-old female had neck pain, head pain, a variety of cognitive problems, vertigo, and restricted cervical range of motion following a serious motor vehicle collision. Following several weeks of chiropractic management with positive progress the patient suddenly had worsening of the vertigo and the cognitive problems. Positional vertigo was ruled out by the emergency room doctors and a neurologist. A neuropsychological assessment indicated that mild traumatic brain injury was present. Intervention: The patient began chiropractic treatment with both passive and active care, prior to the vertigo incident. Following the vertigo incident, treatment was modified to include 6 weeks of cervical exercises in clinic and at home. The patient reported resolution of the vertigo following the chiropractic treatment plan. Conclusion: This case reports presents an example of vertigo that improved under chiropractic management. This case illustrates the benefits of adding mild traumatic brain injury to differential diagnoses, co-managing care with other providers, and modifying treatment when necessary. Further research is suggested to study the contribution that chiropractic management could offer to those with neurological injury.			Collins, ME (corresponding author), DACRB, 671 North Snelling Ave, St Paul, MN 55104 USA.	Matc506@aol.com					Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Bracher ESB, 2000, J MANIP PHYSIOL THER, V23, P96, DOI 10.1016/S0161-4754(00)90074-5; Chandler J., 1998, FUNCTIONAL REHABILIT, P98; Cocchiarella L, 2002, GUIDES EVALUATION MA, P373; Cole A, 1998, FUNCTIONAL REHABILIT, P127; CORDO PJ, 1982, J NEUROPHYSIOL, V47, P287, DOI 10.1152/jn.1982.47.2.287; DALBY BJ, 1993, J MANIP PHYSIOL THER, V16, P392; Definition of a mild traumatic brain injury, 1993, J HEAD TRAUMA REHAB, P86; Friz-Ritson D., 2000, CONSERVATIVE MANAGEM, P221; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Janda V., 1996, REHABILITATION SPINE, P97; Kaneoka K, 1999, SPINE, V24, P763, DOI 10.1097/00007632-199904150-00006; Lewit K., 1999, MANIPULATIVE THERAPY, P83; Linder HP, 1999, T ROY SOC S AFR, V54, P1, DOI 10.1080/00359199909520399; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Souza T, 2001, DIFFERENTIAL DIAGNOS, P441; Terret A., 2000, CONSERVATIVE MANAGEM, P553; Uzzell BP, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P1; Vanderploeg RD, 2000, CLIN GUIDE NEUROPSYC, P3; Wenberg S, 2001, J BODYWORK MOV THER, V5, P2; [No title captured]; [No title captured]	22	6	6	0	2	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0899-3467	1556-3715		J CHIROPR MED	J. Chiropr. Med.	WIN	2005	4	1					32	38		10.1016/S0899-3467(07)60110-4			7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V02KF	WOS:000213668000005	19674644	Green Published			2022-02-06	
J	Kemp, S; Goulding, P; Spencer, J; Mitchell, AJ				Kemp, S; Goulding, P; Spencer, J; Mitchell, AJ			Unusually rapid and severe cognitive deterioration after mild traumatic brain injury	BRAIN INJURY			English	Article						mild traumatic brain injury; Alzheimer's disease; neuropsychology	ALZHEIMERS-DISEASE; HEAD-INJURY; RISK-FACTOR; AUTONOETIC CONSCIOUSNESS; APOLIPOPROTEIN-E; APOE GENOTYPE; DIAGNOSIS; MEMORY; SPECT	A 56-year-old man (AB) presented with dramatic cognitive deterioration following a mild traumatic brain injury. There was no indication of severe brain injury or significant anoxic encephalopathy. Detailed history indicated no significant pre-morbid cognitive deficits. His pre-injury psychosocial and occupational functioning was intact. Cognition functioning was impaired immediately post-injury and remained impaired. Neuropsychological examination at 8 months post-injury showed severe cognitive deficits. The cognitive profile was consistent with Alzheimer's disease. MRI at 1-year post-injury showed minor ischaemic changes not consistent with hypoxic injury and insufficient to explain his cognitive problems. Early SPECT was consistent with a diagnosis of Alzheimer's disease and a repeat SPECT showed a significant deterioration in an Alzheimer pattern. AB was seen for detailed serial neuropsychological examination over a 3-year period, which revealed clear evidence of cognitive deterioration consistent with Alzheimer's disease. AB is presented as an unusual case of rapid progressive AD following a mild head injury.	St Jamess Univ Hosp, Leeds, W Yorkshire, England; Leicester Gen Hosp, Leicester LE5 4PW, Leics, England		Kemp, S (corresponding author), St Jamess Univ Hosp, Leeds, W Yorkshire, England.	steven.kemp@leedsth.nhs.uk	Mitchell, Alex J/A-3090-2009; Mitchell, Alex/Z-1920-2019; Mitchell, Alex J/P-5671-2015	Mitchell, Alex J/0000-0001-6014-598X; Mitchell, Alex/0000-0001-6014-598X; Mitchell, Alex J/0000-0001-6014-598X			Brooks N, 2003, J NEUROL NEUROSUR PS, V74, P1014, DOI 10.1136/jnnp.74.8.1014; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Graham DI, 1999, ACT NEUR S, V73, P89; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hartman RE, 2002, J NEUROSCI, V22, P10083; Hinkebein JH, 2003, BRAIN INJURY, V17, P1035, DOI 10.1080/0269905031000110490; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Jagust W, 2001, NEUROLOGY, V56, P950, DOI 10.1212/WNL.56.7.950; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Krupa Mariusz, 2003, Neurol Neurochir Pol, V37, P1223; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; McGrath J, 2000, BEHAV NEUROL, V12, P201, DOI 10.1155/2000/612185; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nandoe RDS, 2002, J ALZHEIMERS DIS, V4, P303, DOI 10.3233/JAD-2002-4405; Piolino P, 2003, BRAIN, V126, P2203, DOI 10.1093/brain/awg222; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Silverman DHS, 2004, J NUCL MED, V45, P594; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; Wilson JTL, 2003, J NEUROL NEUROSUR PS, V74, P841, DOI 10.1136/jnnp.74.7.841	25	6	6	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2005	19	14					1269	1276		10.1080/02699050500309353			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	983ZF	WOS:000233270200011	16286343				2022-02-06	
J	Melo, JRT; Oliveira, J; da Silva, RA; Moreira, ED				Melo, JRT; Oliveira, J; da Silva, RA; Moreira, ED			Prognostic factors about morbidity and lethality in head injury	ARQUIVOS DE NEURO-PSIQUIATRIA			Portuguese	Article						head injury; morbidity; lethality	BRAIN; POPULATION; TRAUMA	Objective: To define the prognostic factors in head injury victims. Method: Assessment and notification of 555 medical files from victims with head injury assisted at the General Hospital of Bahia during 2001. Results: We verified morbidity rates of 19.6% and lethality rates of 22.9%, with most deaths occurring in men after the third decade of life; the injuries involved traffic accidents that were responsible for 64 (50.4%) deaths. Older age, traffic accidents and fever were predictors of death in the multivariable analysis. Fever was the only significant predictor of morbidity. Conclusion: Fever is an independent and modifiable predictor of death and morbidity in patients with traumatic brain injury.	Hosp Geral Estado Bahia, Salvador, BA, Brazil; Univ Fed Bahia, Fac Med Bahia, BR-41170290 Salvador, BA, Brazil; Univ Sao Paulo, Fac Med, BR-05508 Sao Paulo, Brazil		Melo, JRT (corresponding author), Hosp Sao Rafael, Pesquisador Associado FIOCRUZ, Ave Sao Rafael 2152 3 Andar Setor A, BR-41256900 Salvador, BA, Brazil.	robertotude@hotmail.com	Moreira, Edson D/J-1758-2012; Oliveira-Filho, Jamary/B-6441-2016; Moreira, Edson/W-7437-2019	Moreira, Edson D/0000-0002-7081-8348; Oliveira-Filho, Jamary/0000-0003-1915-0423; Moreira, Edson/0000-0002-7081-8348			ANDRADE AF, 1996, TEMAS ATUAIS NEUROCI, V2, P1; ANDRADE AF, 2003, ORIENTACAO FAMILIARE; Bordignon KC, 2002, ARQ NEURO-PSIQUIAT, V60, P204, DOI 10.1590/S0004-282X2002000200004; CHESNUT RM, 1997, J TRAUMA S, V42, P19; Croce MA, 2002, J TRAUMA, V53, P889, DOI 10.1097/00005373-200211000-00013; FARAGE I, 2002, REV ASSOC MED BRAS, V48, P133; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; *I BRAS GEOGR EST, 2002, RES U CENS 2000; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; KRAUS JF, 1996, NEUROLOGY TRAUMA, P3; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; MASINI M, 1994, THESIS SAO PAULO; MATAMOROS MR, 1996, BASES TERAPIA INTENS, P133; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Melo JRT, 2004, ARQ NEURO-PSIQUIAT, V62, P711, DOI 10.1590/S0004-282X2004000400027; Melo JRT, 2003, CIENCIA SAUDE, V3, P31; MELO JRT, 2004, THESIS SALVADOR; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; Pickett W, 2001, CAN MED ASSOC J, V165, P288; Quigley MR, 1997, J TRAUMA, V42, P7, DOI 10.1097/00005373-199701000-00003; REGEL G, 1995, J TRAUMA, V38, P70, DOI 10.1097/00005373-199501000-00020; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Vajkoczy P, 1999, CLIN NEUROL NEUROSUR, V101, P175, DOI 10.1016/S0303-8467(99)00033-5; *WHO, 2003, VIOL INJ PREV; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; Zafonte RD, 2001, ARCH PHYS MED REHAB, V82, P306, DOI 10.1053/apmr.2001.18226	27	6	7	0	2	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	DEC	2005	63	4					1054	1057		10.1590/S0004-282X2005000600026			4	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	993WP	WOS:000233987900026	16400428	Green Published, gold			2022-02-06	
J	Banos, JH; Elliott, TR; Schmitt, M				Banos, JH; Elliott, TR; Schmitt, M			Factor structure of the Rey Auditory Verbal Learning Test in adults with spinal cord injury	REHABILITATION PSYCHOLOGY			English	Article						Rey Auditory Verbal Learning Test; spinal cord injury; memory	TRAUMATIC BRAIN-INJURY; SUBSTANCE-ABUSE; PERFORMANCE; POPULATION; STROKE; NORMS; AVLT; AGE	Objective: To develop a conceptual framework to guide interpretation of the Rey Auditory Verbal Learning Test (A. Rey, 1958) and similar list-learning tasks across the adult life span for individuals with spinal cord injury (SCI). Study Design: Factor analysis with comparisons of sample-based and norm-based factor scores across age groups. Participants: 221 individuals with SCI undergoing inpatient rehabilitation. Results: The retained model consisted of 3 correlated factors: General Verbal Learning, Auditory Attention, and Inaccurate Recall. Cross-sectional age trends suggest decreased auditory attention and verbal learning with increasing age. The inverse pattern was observed for inaccurate recall. Conclusions: These factors are consistent with other models using similar methodology. The results offer a means of identifying barriers to meeting the educational and therapeutic goals of post-SCI rehabilitation.	Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL USA; Univ Alabama, Dept Psychol, Birmingham, AL 35294 USA		Banos, JH (corresponding author), SRC 530,1717 6th Ave S, Birmingham, AL 35249 USA.	banos@uab.edu	Elliott, Timothy R./I-5301-2012	Elliott, Timothy R./0000-0002-6608-7714			Banos JH, 2004, NEUROPSYCHOLOGY, V18, P60, DOI 10.1037/0894-4105.18.1.60; Bondi MW, 1998, J INT NEUROPSYCH SOC, V4, P319, DOI 10.1017/S1355617798003191; CAHAN C, 1993, PARAPLEGIA, V31, P172, DOI 10.1038/sc.1993.33; DELIS D, 1987, CALIFORNIA VERBAL LE; ELLIOTT TR, 1996, TOPICS SPINAL CORD I, V2, P34; Elwood RW, 1995, NEUROPSYCHOL REV, V5, P173, DOI 10.1007/BF02214761; Frisbie J H, 1984, J Am Paraplegia Soc, V7, P71; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; Gorsuch R.L., 1983, FACTOR ANAL; Hadjiev DI, 2003, EUR J NEUROL, V10, P577, DOI 10.1046/j.1468-1331.2003.00651.x; HEINEMANN AW, 1995, REHABIL PSYCHOL, V40, P125; Hess DW, 2003, REHABIL PSYCHOL, V48, P151, DOI 10.1037/0090-5550.48.3.151; Kirshner HS, 2003, SOUTH MED J, V96, P354, DOI 10.1097/01.SMJ.0000063469.77850.08; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kozora E, 1999, NEUROPSY NEUROPSY BE, V12, P178; Kurylo M, 2001, REHABIL PSYCHOL, V46, P247, DOI 10.1037/0090-5550.46.3.247; MOSES JA, 1989, INT J CLIN NEUROPSYC, V11, P30; PARSONS O, 1995, ALCOHOLISM CLIN EXPT, V22, P954; QUERY WT, 1983, J CLIN PSYCHOL, V39, P136, DOI 10.1002/1097-4679(198301)39:1<136::AID-JCLP2270390125>3.0.CO;2-Q; Rey A, 1958, LEXAMEN CLINIQUE PSY; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; RYAN JJ, 1984, INT J CLIN NEUROPSYC, V6, P239; SAVAGE RM, 1992, ARCH CLIN NEUROPSYCH, V7, P407, DOI 10.1016/0887-6177(92)90153-E; Schmidt M., 1996, REY AUDITORY VERBAL; Schmitt MM, 2004, REHABIL PSYCHOL, V49, P288, DOI 10.1037/0090-5550.49.4.288; SCHUENEMAN AL, 1982, SCI DIG, V64, P35; Smith G. E., 1992, PSYCHOL ASSESSMENT, V4, P382, DOI DOI 10.1037/1040-3590.4.3.382; Tun CG, 1997, REHABIL PSYCHOL, V42, P163, DOI 10.1037/0090-5550.42.3.163; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Winslow C, 2003, AM J PHYS MED REHAB, V82, P803, DOI 10.1097/01.PHM.0000078184.08835.01; [No title captured]	32	6	6	0	5	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2005	50	4					375	380		10.1037/0090-5550.50.4.375			6	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	990KL	WOS:000233741700007					2022-02-06	
J	Waydhas, C; Flohe, S				Waydhas, C; Flohe, S			Criteria for secondary operations in patients with multiple injuries	UNFALLCHIRURG			German	Article						damage control orthopaedics; multiple injuries; fractures; multiple organ failure; multiple trauma; wounds; nonpenetrating	INFLAMMATORY RESPONSE SYNDROME; LENGTH-OF-STAY; ORGAN FAILURE; TRAUMA PATIENTS; VASCULAR-SURGERY; BLUNT TRAUMA; MAJOR TRAUMA; MORTALITY; SEVERITY; SEPSIS	Background. Operability is mainly determined by the interaction between the magnitude of an operation and the patient's tolerance for the procedure. A further factor is the benefit gained by performing the procedure versus the squealae caused by its omission. Results. Major operations within the first 3 days after trauma appear to have an increased risk, particularly if they are performed during impaired respiratory function (PO2/FiO(2) ratio < 280 mmHg) or increased inflammatory status. Such interventions are recommended to be postponed until a later time. Surgical interventions after day 3 require an individual decision with respect to the timing of the operation. Criteria that are of value in this decision comprise a PO2/FiO(2) ratio above 280 mmHg, a stable circulation, a platelet count above 100.000 to 150.000/mu l, normal global coagulation tests, only moderate systemic inflammation as indicated by C-reactive protein or interleukin-6 levels, a normal fluid balance and in case of traumatic brain injury there should be no signs of increased intracranial pressure. Whether liver function, level of PEEP catecholamin Conclusion. The pathophysiological consequences of accidental trauma show a phasic course with respect to the immunomodulatory response. An operative trauma inflicted by a secondary surgical intervention contributes an additional burden. Depending on the inflammatory phase during which this secondary hit is inflicted there may be a disturbance of homoeostasis that may even lead to multiple organ failure. Whether this happens can depend on type and magnitude of the surgical intervention. Minor operations result in smaller systemic effects and will be less critical with respect to operability.	Univ Klinikum Essen, Klin Unfallchirurg, D-45147 Essen, Germany		Waydhas, C (corresponding author), Univ Klinikum Essen, Klin Unfallchirurg, Hufelandstr 55, D-45147 Essen, Germany.	christian.waydhas@uni-essen.de		Flohe, Sascha/0000-0002-8033-1242			Aller MA, 2004, EXP BIOL MED, V229, P170, DOI 10.1177/153537020422900206; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Cuthbertson DP, 1942, LANCET, V1, P433; CUTHBERTSON DP, 1932, QUART J MEDICINE, V25, P233; ERTEL W, 1995, J TRAUMA, V39, P879, DOI 10.1097/00005373-199511000-00011; Ertel W, 1998, UNFALLCHIRURG, V101, P520, DOI 10.1007/s001130050304; FAIST E, 1983, J TRAUMA, V23, P775, DOI 10.1097/00005373-198309000-00002; Flohe S, 2004, INTENS CARE MED, V30, P96, DOI 10.1007/s00134-003-2041-3; Galle C, 2000, J VASC SURG, V32, P234, DOI 10.1067/mva.2000.107562; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; Goris R, 2000, MULTIPLE ORGAN FAILU, P71; Lendemans S, 2004, UNFALLCHIRURG, V107, P203, DOI 10.1007/s00113-004-0729-7; Moore FA, 1996, J TRAUMA, V40, P501, DOI 10.1097/00005373-199604000-00001; Mutlu Leman K, 2004, Best Pract Res Clin Anaesthesiol, V18, P407, DOI 10.1016/S1521-6896(03)00117-4; Napolitano LM, 2000, J TRAUMA, V49, P647, DOI 10.1097/00005373-200010000-00011; NastKolb D, 1997, J TRAUMA, V42, P446, DOI 10.1097/00005373-199703000-00012; NastKolb D, 1996, ORTHOPADE, V25, P266; NASTKOLB D, 2005, IN PRESS UNFALLCHIRU; Offner P, 2000, MULTIPLE ORGAN FAILU, P30; Pape HC, 2000, CRIT CARE MED, V28, P3441, DOI 10.1097/00003246-200010000-00012; Pape HC, 2001, J TRAUMA, V50, P989, DOI 10.1097/00005373-200106000-00004; Regel G, 1997, UNFALLCHIRURG, V100, P234; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; SAUAIA A, 1993, AM J SURG, V166, P606, DOI 10.1016/S0002-9610(05)80664-6; SAVINO JA, 1985, SURG CLIN N AM, V65, P763; Scalea TM, 2000, J TRAUMA, V48, P613, DOI 10.1097/00005373-200004000-00006; SHOEMAKER WC, 1982, CRIT CARE MED, V10, P390, DOI 10.1097/00003246-198206000-00013; Sido Bernd, 2004, Best Pract Res Clin Anaesthesiol, V18, P439, DOI 10.1016/j.bpa.2003.12.006; TAEGER G, 2005, IN PRESS J TRAUMA; Talmor M, 1999, ARCH SURG-CHICAGO, V134, P81, DOI 10.1001/archsurg.134.1.81; Uehara M, 1999, CRIT CARE MED, V27, P1295, DOI 10.1097/00003246-199907000-00015; VACANTI CJ, 1970, ANESTH ANAL CURR RES, V49, P564; VODINH J, 1989, SURGERY, V105, P360; Waydhas C, 1996, J TRAUMA, V40, P624, DOI 10.1097/00005373-199604000-00018; WAYDHAS C, 1992, ARCH SURG-CHICAGO, V127, P460; WAYDHAS C, 1994, UNFALLCHIRURG, V97, P244; WAYDHAS C, 1995, UNFALLCHIRURG, V98, P455	38	6	7	0	0	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	OCT	2005	108	10					866	871		10.1007/s00113-005-0991-3			6	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	979FC	WOS:000232926800011	16133287				2022-02-06	
J	Choi, CB; Kim, HY; Han, DY; Kang, YW; Han, YM; Jeun, SS; Choe, BY				Choi, CB; Kim, HY; Han, DY; Kang, YW; Han, YM; Jeun, SS; Choe, BY			In vivo H-1 MR spectroscopic findings in traumatic contusion of ICR mouse brain induced by fluid percussion injury	EUROPEAN JOURNAL OF RADIOLOGY			English	Article; Proceedings Paper	12th Annual Meeting of the International-Society-for-Magnetic-Resonance-in-Medicine	MAY 15-21, 2004	Kyoto, JAPAN	Int Soc Magnet Resonance Med		trauma; contusion; fluid percussion injury (FPI); magnetic resonance spectroscopy (MRS)	MAGNETIC-RESONANCE-SPECTROSCOPY; INTRACEREBRAL INFLAMMATORY RESPONSE; CEREBRAL METABOLITES; PROTON MRS; RAT; SPECTRA; INVIVO; MODEL	Purpose: The purpose of this study was to investigate the proton metabolic differences of the right parietal cortex with experimental brain contusions of ICR mouse induced by fluid percussion injury (FPI) compared to normal controls and to test the possibility that H-1 magnetic resonance spectroscopy (MRS) findings could provide neuropathologic criteria in the diagnosis and monitoring of traumatic brain contusions. Materials and methods: A homogeneous group of 20 ICR male mice was used for MRI and in vivo H-1 MRS. Using image-guided, water-suppressed in vivo H-1 MRS with a 4.7 T MRI/MRS system, we evaluated the MRS measurement of the relative proton metabolite ratio between experimental brain contusion of ICR mouse and healthy control subjects. Results: After trauma, NAA/Cr ratio, as a neuronal marker decreased significantly versus controls, indicating neuronal loss. The ratio of NAA/Cr in traumatic brain contusions was 0.90 +/- 0.11, while that in normal control subjects was 1.13 +/- 0.12 (P = 0.001). The Cho/Cr ratio had a tendency to rise in experimental brain contusions (P = 0.02). The Cho/Cr ratio was 0.91 +/- 0.17, while that of the normal control subjects was 0.76 +/- 0.15. However, no significant difference of Glx/Cr was established between the experimental traumatic brain injury models and the normal controls. Discussion and conclusions: The present H-1 MRS study shows significant proton metabolic changes of parietal cortex with experimental brain contusions of ICR mouse induced by FPI compared to normal controls. In vivo H-1 MRS may be a useful modality for the clinical evaluation of traumatic contusions and could aid in better understanding the neuropathologic process of traumatic contusions induced by FPI. (C) 2004 Elsevier Ireland Ltd. All rights reserved.	Catholic Univ Korea, Coll Med, Kangnam St Marys Hosp, Dept Biomed Engn, Seoul 137040, South Korea; Catholic Univ Korea, Coll Med, Kangnam St Marys Hosp, Dept Neurosurg, Seoul 137040, South Korea		Choe, BY (corresponding author), Catholic Univ Korea, Coll Med, Kangnam St Marys Hosp, Dept Biomed Engn, 505 Banpo Dong, Seoul 137040, South Korea.	bychoe@catholic.ac.kr					Auer DP, 2000, BIOL PSYCHIAT, V47, P305, DOI 10.1016/S0006-3223(99)00159-6; Brambilla P, 2002, NEUROPSYCHOPHARMACOL, V26, P546, DOI 10.1016/S0893-133X(01)00388-8; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; CASTILLO M, 1995, AM J NEURORADIOL, V16, P233; CHOE BY, 1995, INVEST RADIOL, V30, P502, DOI 10.1097/00004424-199508000-00008; CHOE BY, 2000, KOR J MAGN RESON MED, V4, P94; CROSS JH, 1993, J INHERIT METAB DIS, V16, P800, DOI 10.1007/BF00711912; FRAHM J, 1989, MAGNET RESON MED, V9, P79, DOI 10.1002/mrm.1910090110; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; GIDEON P, 1992, MAGN RESON IMAGING, V10, P983, DOI 10.1016/0730-725X(92)90453-7; GRAHAM GD, 1993, STROKE, V24, P1891, DOI 10.1161/01.STR.24.12.1891; GUIMARAES AR, 1995, NEUROSCIENCE, V69, P1095, DOI 10.1016/0306-4522(95)00300-8; HANSTOCK CC, 1988, P NATL ACAD SCI USA, V85, P1821, DOI 10.1073/pnas.85.6.1821; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; MacKay S, 1996, RADIOLOGY, V198, P537, DOI 10.1148/radiology.198.2.8596863; MATHEWS VP, 1995, AM J ROENTGENOL, V165, P633, DOI 10.2214/ajr.165.3.7645484; McIntosh TK, 1996, LAB INVEST, V74, P315; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; NEGENDANK W, 1992, NMR BIOMED, V5, P303, DOI 10.1002/nbm.1940050518; ROSS B, 1994, MAGN RESON QUART, V10, P191; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Stanley JA, 2000, BIOL PSYCHIAT, V48, P357, DOI 10.1016/S0006-3223(00)00949-5; STANLEY JA, 1995, MAGNET RESON MED, V34, P17, DOI 10.1002/mrm.1910340105; VANDERKNAAP MS, 1990, RADIOLOGY, V176, P509, DOI 10.1148/radiology.176.2.2164237	25	6	6	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	JUL	2005	55	1					96	101		10.1016/j.ejrad.2004.10.009			6	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Radiology, Nuclear Medicine & Medical Imaging	944QP	WOS:000230444200010	15950105				2022-02-06	
J	Gelabert-Gonzalez, M; Iglesias-Pais, M; Serramito-Garcia, R; Fernandez-Villa, J; Garcia-Allut, A; Martinez-Rumbo, R				Gelabert-Gonzalez, M; Iglesias-Pais, M; Serramito-Garcia, R; Fernandez-Villa, J; Garcia-Allut, A; Martinez-Rumbo, R			Simultaneous bilateral extradural haematoma	NEUROCIRUGIA			Spanish	Article						bilateral epidural haematoma; head injury; computed tomography; skull fracture	SUPRATENTORIAL EPIDURAL HEMATOMAS; FOSSA; ADULT	Introduction. Epidural haematomas are one of the most common complications of closed head injuries. Bilateral extradural haematomas are rare, usually acute, and generally associated with severe trauma and a high mortality. Objective. The purpose of this paper is to present six cases of bilateral extradural haematomas seen at our service during the last 24 years and found a incidence of 2.5% of all cases of extradural haematomas surgically treated. Results. There were 5 males and 1 female with a mean age of 32.6 years (range 16-55). In 3 cases haematoma was across the midline and in the other 3 cases haematomas was found at different locations on either side. Skull fracture was present in all cases. Surgical approach was the primary treatment in all cases. Mortality in our series was 50%. Conclusions. Bilateral extradural haematomas is a rare condition and the prognosis is mainly dependent of the pre-operative neurological state.	Hosp Clin, Serv Neurocirugia, Santiago De Compostela 15706, Spain; Univ Santiago, Dept Cirugia, E-15705 Santiago De Compostela, Spain		Gelabert-Gonzalez, M (corresponding author), Hosp Clin, Serv Neurocirugia, La Choupana, Santiago De Compostela 15706, Spain.			Gelabert-Gonzalez, Miguel/0000-0002-9462-0045			Arienta C, 1986, J Neurosurg Sci, V30, P139; BARLOW P, 1985, SURG NEUROL, V23, P411, DOI 10.1016/0090-3019(85)90219-8; Bozbuga M, 1999, NEUROSURG REV, V22, P34, DOI 10.1007/s101430050006; BURBRIDGE B, 1993, CAN ASSOC RADIOL J, V44, P390; DAVELLA D, 1985, NEUROCHIRURGIA, V28, P178; DHARKER SR, 1991, ACTA NEUROCHIR, V110, P29, DOI 10.1007/BF01402044; FRANK E, 1982, SURG NEUROL, V17, P218, DOI 10.1016/0090-3019(82)90285-3; GELABERT M, 1993, BRIT J NEUROSURG, V7, P95, DOI 10.3109/02688699308995063; Gelabert M, 1997, BRIT J NEUROSURG, V11, P573; GELABERT M, 1987, REV NEUROL, V76, P189; Gelabert-Gonzalez M, 2005, NEUROCIRUGIA, V16, P256; Gorgulu A, 2000, NEUROSURG REV, V23, P30, DOI 10.1007/s101430050028; GRABEL JC, 1989, NEUROSURGERY, V25, P828, DOI 10.1227/00006123-198911000-00024; GUPTA SK, 1992, CLIN NEUROL NEUROSUR, V94, P127, DOI 10.1016/0303-8467(92)90069-F; Herrera EJ, 2000, CHILD NERV SYST, V16, P585, DOI 10.1007/s003810000340; Ramzan A, 2002, NEUROL INDIA, V50, P217; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; Rochat P, 2002, CLIN NEUROL NEUROSUR, V105, P39, DOI 10.1016/S0303-8467(02)00099-9; Roy GC, 1884, LANCET, V2, P319; Servadei F, 1997, ACTA NEUROCHIR, V139, P273, DOI 10.1007/BF01808821; SERVADEI F, 1995, ACTA NEUROCHIR, V133, P50, DOI 10.1007/BF01404947; SUBRAHMANIAN MV, 1975, BRIT J SURG, V62, P397, DOI 10.1002/bjs.1800620517; SUZUKI S, 1982, ACTA NEUROCHIR, V65, P61, DOI 10.1007/BF01405442; Wolfsberger S, 2004, NEUROSURG REV, V27, P128, DOI 10.1007/s10143-003-0315-4	24	6	6	0	0	SOCIEDAD LUSO-ESPANOLA NEUROCIRUGIA	SANTANDER	C/O J M IZQUIERDO HOSPITAL VALDECILLA, 39908 SANTANDER, SPAIN	1130-1473			NEUROCIRUGIA	Neurocirugia	JUN	2005	16	3					256	260					5	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	943JG	WOS:000230349100003	16007324				2022-02-06	
J	Minambres, E; Lopez-Escribano, H; Ballesteros, MA; Pena, M; Lopez-Hoyos, M				Minambres, E; Lopez-Escribano, H; Ballesteros, MA; Pena, M; Lopez-Hoyos, M			Apoptosis of Jurkat cells induced by serum of patients with acute severe brain injury	INTENSIVE CARE MEDICINE			English	Article						acute brain injury; apoptosis; in vitro; Jurkat cells; outcome	FATAL HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; OXYGEN-SATURATION; JUGULAR BULB; DEATH; BCL-2; CONTUSIONS	Objective: To investigate the capacity of serum samples draining from the neuronal lesions to induce apoptosis of the lymphoid Jurkat cells in vitro and to analyze whether this effect is related to patient outcome. Design and setting: Prospective clinical investigation in a 21-bed intensive care unit (ICU) in a university hospital. Patients: Forty-two patients who had suffered from acute brain injury ( traumatic brain injury or spontaneous intracranial hemorrhage) requiring intensive care. Interventions: Blood samples were obtained simultaneously from jugular bulb vein ( regional) and from central venous catheter ( systemic) on admission to the ICU and after 24, 48, and 72 h. Jurkat cells were incubated in the presence of 10% of heat-inactivated patients sera. The percentages of apoptotic cultured cells was measured by staining with annexin V and propidium iodide. Measurements and results: Regional serum draining from the lesions induced higher percentages of early and late apoptotic cells than systemic serum. The apoptotic effect was clearer with the sera from the patients who developed brain death. The apoptotic effect maintained a relationship with the mortality and the functional outcome at 6 months after the injury. Conclusions: Despite being performed on lymphoid cells because of the easier technical handling, our data help to elucidate the role of apoptosis for brain damage in acute brain injury. This and other undergoing studies on neuronal cells will enhance the understanding and management of apoptotic cell death in patients with acute brain injury admitted to the ICU.	Hosp Univ Marques de Valdecilla, Div Immunol, Santander 39008, Spain; Hosp Univ Marques de Valdecilla, Dept Intens Care, Santander 39008, Spain		Lopez-Hoyos, M (corresponding author), Hosp Univ Marques de Valdecilla, Div Immunol, Santander 39008, Spain.	inmlhm@humv.es	Minambres, Eduardo/H-7761-2019; Lopez-Hoyos, Marcos/ABC-1024-2020	Lopez-Hoyos, Marcos/0000-0003-0562-427X; Ballesteros, Maria A/0000-0002-4032-9973			ANDREWS PJD, 1991, BRIT J ANAESTH, V67, P553, DOI 10.1093/bja/67.5.553; Bilbault P, 2004, INTENS CARE MED, V30, P408, DOI 10.1007/s00134-003-2118-z; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Diaz-Reganon G, 2002, INTENS CARE MED, V28, P1724, DOI 10.1007/s00134-002-1543-8; Gong C, 2001, NEUROSURGERY, V48, P875, DOI 10.1097/00006123-200104000-00037; Guo RF, 2000, J CLIN INVEST, V106, P1271, DOI 10.1172/JCI10793; Hausmann R, 2004, INT J LEGAL MED, V118, P32, DOI 10.1007/s00414-003-0413-4; JENNETT B, 1975, LANCET, V1, P480; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Le Berre R, 2004, INTENS CARE MED, V30, P1204, DOI 10.1007/s00134-004-2165-0; Lopez-Escribano H, 2002, ARTHRITIS RHEUM, V46, P3290, DOI 10.1002/art.10684; Macmillan CSA, 2000, INTENS CARE MED, V26, P1028, DOI 10.1007/s001340051315; Matsushita K, 2000, J CEREBR BLOOD F MET, V20, P396, DOI 10.1097/00004647-200002000-00022; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; MINAMBRES E, 2004, MED INTENSIVA, V28, P319; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Pravdenkova SV, 1996, BRAIN RES, V729, P151, DOI 10.1016/S0006-8993(96)00222-3; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; RINK A, 1995, AM J PATHOL, V147, P1575; Rodrigues CMP, 2003, P NATL ACAD SCI USA, V100, P6087, DOI 10.1073/pnas.1031632100; Shaw K, 2001, CLIN NEUROPATHOL, V20, P106; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; TEASDALE G, 1974, LANCET, V2, P81; WATKINS MW, 2000, EXCEL PROGRAM CALCUL; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y	32	6	6	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	JUN	2005	31	6					791	798		10.1007/s00134-005-2635-z			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932UC	WOS:000229578000007	15843918				2022-02-06	
J	Morgan, A; Ward, E; Murdoch, B; Bilbie, K				Morgan, A; Ward, E; Murdoch, B; Bilbie, K			Six-month outcome for dysphagia following traumatic brain injury: Radiological assessment	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							VIDEOFLUOROSCOPIC EVALUATION; SWALLOWING DISORDERS; CEREBRAL-PALSY; NORMAL ADULTS; CHILDREN; PHYSIOLOGY; PNEUMONIA; SEVERITY	The coexistence of a swallowing impairment, or dysphagia, can severely impact upon the medical condition and recovery of a child with traumatic brain injury (TBI; Logemann, Pepe, & Mackay, 1994). Despite this fact, there is limited data that provide evidence of the progression or outcome of dysphagia in the pediatric population post-TBI (Rowe, 1999). The present study aimed to (1) provide a prospective radiologically based profile of swallowing outcome and (2) determine the clinical significance of any persistent physiological swallowing deficits by investigating the presence/absence of any coexistent respiratory complications. Seven children with moderate/severe TBI were evaluated via an initial videofluoroscopic swallowing assessment (VFSS) at an average of 24.1 days postinjury, during the acute phase of management. A follow-up VFSS was conducted at an average of 7 months, 3 weeks postinjury. The physiological impairment, swallowing safety, swallowing efficiency, and functional swallowing outcomes of the acute phase post-TBI were compared with reassessment results at 6 months post-TBI. The presence/absence of lower respiratory tract infection/respiratory complications in the past 6 months postinjury were recorded.VFSS revealed a number of residual physiological oropharyngeal swallowing impairments and reduced swallowing efficiency. However, all participants presented with clinically safe and functional swallowing outcomes at 6 months post-TBI, with no recent history of respiratory complication. This study indicates good functional swallowing and respiratory outcomes for patients at 6-months post-TBI despite the presence of persistent physiological swallowing impairment.	Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; Univ Queensland, Mater Childrens Hosp, Brisbane, Qld 4101, Australia		Morgan, A (corresponding author), Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia.	a.morgan1@uq.edu.au	Bolton, Kate/AAH-2756-2020; Ward, Elizabeth/F-9652-2010; Murdoch, Bruce E/C-1397-2012; Morgan, Angela/J-5235-2017	Ward, Elizabeth/0000-0002-2680-8978; Morgan, Angela/0000-0003-1147-7405			BECK T J, 1990, Dysphagia, V5, P118, DOI 10.1007/BF02412634; CASAS MJ, 1995, DYSPHAGIA, V10, P155, DOI 10.1007/BF00260969; Cook I J, 1989, Dysphagia, V4, P8, DOI 10.1007/BF02407397; Derkay CS, 1998, OTOLARYNG CLIN N AM, V31, P397, DOI 10.1016/S0030-6665(05)70060-8; Dodds W J, 1989, Dysphagia, V3, P171, DOI 10.1007/BF02407219; DODDS WJ, 1990, AM J ROENTGENOL, V154, P953, DOI 10.2214/ajr.154.5.2108569; Freson M., 1994, Acta Oto-Rhino-Laryngologica Belgica, V48, P127; Friedman B, 2000, DYSPHAGIA, V15, P153, DOI 10.1007/s004550010018; Kahrilas PJ, 1997, GASTROENTEROLOGY, V113, P1457, DOI 10.1053/gast.1997.v113.pm9352847; Langmore SE, 1998, DYSPHAGIA, V13, P69, DOI 10.1007/PL00009559; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; Lefton-Greif MA, 1998, PEDIAT VIDEOFLUOROSC; LOGEMANN JA, 1989, ARCH PHYS MED REHAB, V70, P767; LOGEMANN JA, 1990, NEUROLOGY, V40, P1136, DOI 10.1212/WNL.40.7.1136; Logemann JA, 1998, EVALUATION TREATMENT; Logemann JA, 1994, J HEAD TRAUMA REHAB, V9, P43; LOGEMANN JA, 1989, J HEAD TRAUMA REHAB, V4, P24; LOGEMANN JA, 1982, AM SPEECH LANG HEAR; Logemann JA., 1993, MANUAL VIDEOFLUOROGR, V2nd ed.; MANDELSTAM P, 1970, GASTROENTEROLOGY, V58, P32; Martin Bonnie J. W., 1994, Dysphagia, V9, P1; Morgan A, 2004, J CLIN NEUROSCI, V11, P182, DOI 10.1016/S0967-5868(03)00195-4; Morgan A, 2003, J HEAD TRAUMA REHAB, V18, P239, DOI 10.1097/00001199-200305000-00002; Morgan A, 2002, J HEAD TRAUMA REHAB, V17, P220, DOI 10.1097/00001199-200206000-00004; NEWMAN LA, 1991, INVEST RADIOL, V26, P870, DOI 10.1097/00004424-199110000-00005; Newman LA, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e106; O'Donoghue S, 1999, FOLIA PHONIATR LOGO, V51, P158, DOI 10.1159/000021494; O'Neil KH, 1999, DYSPHAGIA, V14, P139, DOI 10.1007/PL00009595; OTT DJ, 1993, AM J ROENTGENOL, V161, P507, DOI 10.2214/ajr.161.3.8352094; Ott DJ, 1998, DYSPHAGIA, V13, P148; Palmer Jeffrey B., 1993, Dysphagia, V8, P209, DOI 10.1007/BF01354540; Reilly S, 1996, J PEDIATR-US, V129, P877, DOI 10.1016/S0022-3476(96)70032-X; ROBBINS J, 1992, GASTROENTEROLOGY, V103, P823, DOI 10.1016/0016-5085(92)90013-O; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Rowe LA, 1999, J HEAD TRAUMA REHAB, V14, P497, DOI 10.1097/00001199-199910000-00010; TANIGUCHI MH, 1994, DEV MED CHILD NEUROL, V36, P495; Tracy J F, 1989, Dysphagia, V4, P90, DOI 10.1007/BF02407151	37	6	6	0	13	DELMAR CENGAGE LEARNING	FLORENCE	PO BOX 6904, FLORENCE, KY 41022-6904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	JUN	2005	13	2					109	125					17	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	934LC	WOS:000229709300006					2022-02-06	
J	Santos, A; Borges, N; Cerejo, A; Sarmento, A; Azevedo, I				Santos, A; Borges, N; Cerejo, A; Sarmento, A; Azevedo, I			Catalase activity and thiobarbituric acid reactive substances (TBARS) production in a rat model of diffuse axonal injury. Effect of gadolinium and amiloride	NEUROCHEMICAL RESEARCH			English	Article						head trauma; rat; catalase; TBARS; mechanogated membrane ion channel blockers	CONCUSSIVE BRAIN-INJURY; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; KUPFFER CELLS; AMINO-ACIDS; EXPRESSION; EXCITOTOXICITY; EPIDEMIOLOGY; INHIBITION	This study evaluated the effect of mechanogated membrane ion channel blockers on brain catalase (CAT) activity and thiobarbituric acid reactive substances (TBARS) production after traumatic brain injury (TBI). A weight drop trauma model was used. Controls were sham-operated and received no weight drop. Gadolinium (GAD) or amiloride (AMI) were administered to control and experimental rats (30 min after TBI). Brain CAT activity and TBARS production were measured. When blood vessels were washed out with saline perfusion brain CAT activity significantly increased up to 6 h after trauma, decreasing significantly by 24 h; GAD or AMI administration preserved CAT activity 24 h after TBI. TBARS production increased after trauma, this effect being significantly reversed by GAD or AMI administration. GAD significantly decreased TBARS production in control animals. Mechanogated membrane ion channels may be involved in the genesis of the ionic disruption leading to oxidative stress and other secondary injury processes in head trauma.	Univ Porto, Fac Med, Serv Bioquim U38 FCT, P-4200319 Oporto, Portugal; Univ Porto, Fac Ciencias Nutr & Alimentacao, P-4200465 Oporto, Portugal; Hosp Sao Joao, Serv Neurocirurgia, P-4200 Oporto, Portugal		Santos, A (corresponding author), Univ Porto, Fac Med, Serv Bioquim U38 FCT, P-4200319 Oporto, Portugal.	alejandr@med.up.pt	Cerejo, Antonio/AAT-7863-2020; Borges, Nuno/K-7051-2013; Sarmento, Antonio/M-5235-2013	Cerejo, Antonio/0000-0001-9136-873X; Borges, Nuno/0000-0001-6357-0615; Sarmento, Antonio/0000-0001-5269-7231; Santos, Alejandro/0000-0003-0706-5301			AEBI H, 1984, METHOD ENZYMOL, V105, P121; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; Borges N, 2004, INT J NEUROSCI, V114, P217, DOI 10.1080/00207450490249419; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buege J A, 1978, Methods Enzymol, V52, P302; Dringen R, 2005, J NEUROSCI RES, V79, P157, DOI 10.1002/jnr.20280; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FLOYD RA, 1991, ARCH GERONTOL GERIAT, V12, P155, DOI 10.1016/0167-4943(91)90025-L; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fouquet F, 1997, NEUROBIOL DIS, V3, P271, DOI 10.1006/nbdi.1997.0127; Gotoh H, 1999, NEUROSCIENCE, V92, P1323, DOI 10.1016/S0306-4522(99)00032-9; HALLIWELL B, 2000, FREE RADICAL BIO MED, P105; Hamill OP, 1996, PHARMACOL REV, V48, P231; Hirrlinger J, 2002, J NEUROCHEM, V82, P635, DOI 10.1046/j.1471-4159.2002.00999.x; Ho YS, 1997, J BIOL CHEM, V272, P16644, DOI 10.1074/jbc.272.26.16644; Hoffman SW, 2000, J NEUROTRAUM, V17, P415, DOI 10.1089/neu.2000.17.415; Horakova L, 2000, GEN PHYSIOL BIOPHYS, V19, P195; Inoue M, 2003, CURR MED CHEM, V10, P2495, DOI 10.2174/0929867033456477; Islekel S, 1999, RES EXP MED, V199, P167, DOI 10.1007/s004330050121; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; Kraus J, 1996, NEUROTRAUMA, P13; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MUIR JK, 1995, J NEUROTRAUM, V12, P179, DOI 10.1089/neu.1995.12.179; Muriel P, 2001, COMP BIOCHEM PHYS C, V130, P219, DOI 10.1016/S1532-0456(01)00237-X; Nicholson A, 2003, ATHEROSCLEROSIS SUPP, V4, P287, DOI 10.1016/S1567-5688(03)91226-8; Niess C, 2002, ACTA NEUROPATHOL, V104, P79, DOI 10.1007/s00401-002-0525-9; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; Regner A, 2001, J NEUROTRAUM, V18, P783, DOI 10.1089/089771501316919148; Reinert MM, 1999, NEUROL RES, V21, P330, DOI 10.1080/01616412.1999.11740940; Schad A, 2003, J HISTOCHEM CYTOCHEM, V51, P751, DOI 10.1177/002215540305100606; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; SMITH ME, 1993, J NEUROSCI RES, V35, P480, DOI 10.1002/jnr.490350504; Sokolova T, 2001, NEUROSCI LETT, V297, P129, DOI 10.1016/S0304-3940(00)01689-X; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; VALADKA AB, 1996, TRAUMA, P267; Vaz R, 1998, ACTA NEUROCHIR, V140, P371, DOI 10.1007/s007010050111; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Zhong Z, 1995, J PHARMACOL EXP THER, V275, P1512	46	6	6	0	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAY	2005	30	5					625	631		10.1007/s11064-005-2750-9			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	951EH	WOS:000230911400006	16176066				2022-02-06	
J	Cyffka, R; Jackisch, T; Lein, T; Bonnaire, F				Cyffka, R; Jackisch, T; Lein, T; Bonnaire, F			Simultaneous bilateral ventral and dorsal shoulder dislocation following an epileptic convulsion - a rare combination of injuries	UNFALLCHIRURG			German	Article						dorsal shoulder dislocation; ventral shoulder dislocation fracture; reduction manoeuvre	POSTERIOR FRACTURE-DISLOCATION; SEIZURE; MANAGEMENT; PATIENT; JOINT	We report about a 29 year old male patient who had a simultaneous bilateral ventral and dorsal shoulder dislocation. The dislocation happened during a first incident of an epileptic convulsion, previously not diagnosed. On the right shoulder following a closed reduction manoeuvre a dislocation fracture was seen. It needed operative open reduction and fixation with angular stable plate osteosynthesis. The locked dorsal shoulder dislocation on the left was operated dorsally secondary via a dorsal approach. In a first step the reduction was carried out and in the same intervention the humeral head defect was lifted and supported in a closed technique under radiographic control. 6 months postoperatively the patient was free of pain in both shoulder joints. The range of motion was unimpeded on the left and only with slight deficits in abduction and anteversion on the right. The diagnostics and the treatment strategy for this rare injury combination are described critically in this paper.	Klinikum Dresden, Klin Unfall Hand & Wiederherstellungschirurg, D-01069 Dresden, Germany		Cyffka, R (corresponding author), Klinikum Dresden, Klin Unfall Hand & Wiederherstellungschirurg, Friedrichstr 41, D-01069 Dresden, Germany.	cyffka-ro@khdf.de					BAUER R, 1997, ORTHOPADISCHE OPERAT, P116; Bosscha K, 1998, UNFALLCHIRURG, V101, P405, DOI 10.1007/s001130050288; Buhler M, 2002, J SHOULDER ELB SURG, V11, P339, DOI 10.1067/mse.2002.124524; Clough T M, 2001, Eur J Emerg Med, V8, P161; Dinopoulos HT, 1999, INT ORTHOP, V23, P128, DOI 10.1007/s002640050327; Dunlop C C R, 2002, Acta Orthop Belg, V68, P168; Engel T, 1999, UNFALLCHIRURG, V102, P897, DOI 10.1007/s001130050499; Gehr J, 1999, UNFALLCHIRURG, V102, P393, DOI 10.1007/s001130050424; Gerber Christian, 1997, P9; Gosens T, 2000, SEIZURE-EUR J EPILEP, V9, P446, DOI 10.1053/seiz.2000.0418; Hashmi FR, 2002, AM J EMERG MED, V20, P127, DOI 10.1053/ajem.2002.31132; HAWKINS RJ, 1987, J BONE JOINT SURG AM, V69A, P9, DOI 10.2106/00004623-198769010-00003; KRISTENSEN W, 1990, UGESKRIFT LAEGER, V152, P25; Kumar UD, 2001, IETE TECH REV, V18, P5, DOI 10.1080/02564602.2001.11416935; Lill H, 1996, UNFALLCHIRURG, V99, P801, DOI 10.1007/s001130050058; Mancini GB, 2002, ORTHOPEDICS, V25, P433; MATSEN FA, 1998, SHOULDER, V2, P611; MILLS KLG, 1974, INJURY, V6, P39, DOI 10.1016/0020-1383(74)90169-7; Mynter H, 1902, ANN SURG, V36, P117, DOI 10.1097/00000658-190207000-00014; Ng ABY, 2000, ULSTER MED J, V69, P171; NICOLA FG, 1981, J BONE JOINT SURG AM, V63, P1175, DOI 10.2106/00004623-198163070-00018; PAGE AE, 1995, J ORTHOP TRAUMA, V9, P526, DOI 10.1097/00005131-199509060-00012; POIGENFURST J, 1976, HEFTE UNFALLHEILKD, V126, P83; RibacobaMontero R, 1997, SEIZURE, V6, P403, DOI 10.1016/S1059-1311(97)80040-4; ROCKWOOD CA, 1998, SHOULDER, V2, P611; ROWE CR, 1982, J BONE JOINT SURG AM, V64, P494, DOI 10.2106/00004623-198264040-00004; Ryan J, 1997, BRIT J SPORT MED, V31, P74, DOI 10.1136/bjsm.31.1.74; Stimson LA, 1900, MED REC, V57, P356; Sturzenegger M, 1985, Aktuelle Traumatol, V15, P180; WIEDEMANN E, 2002, SCHULTERCHIRURGIE, P375; Yuen MC, 2001, AM J EMERG MED, V19, P64, DOI 10.1053/ajem.2001.20014	31	6	6	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	APR	2005	108	4					327	331		10.1007/s00113-004-0878-8			5	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	925XD	WOS:000229085900011	15856129				2022-02-06	
J	Mihalik, JP; Myers, JB; Sell, TC; Anish, EJ				Mihalik, JP; Myers, JB; Sell, TC; Anish, EJ			Maxillofacial fractures and dental trauma in a high school soccer goalkeeper: A case report	JOURNAL OF ATHLETIC TRAINING			English	Article						bleeding; seizure; airway management; emergency care	OCULAR INJURIES; SPORTS INJURIES; MOUTHGUARD USE; EYE INJURIES; YOUTH; LEVEL	Objective: To present the case of a 17-year-old male soccer goalkeeper who sustained maxillofacial fractures and dental trauma after being struck in the face by an opponent's knee. Background: Because of the nature of the sport and a lack of protective headgear, soccer players are at risk for sustaining maxillofacial trauma. Facial injuries can complicate the routine management of on-field medical emergencies often encountered by certified athletic trainers. The appropriate management of maxillofacial trauma on the playing field may help to reduce both the immediate and long-term morbidity and mortality associated with these injuries. Differential Diagnosis: Lacerated superior labial artery, lacerated upper lip, dental fractures, maxillofacial fractures, orbital blowout fracture, closed head injury, cervical spine injury, cerebrovascular accident. Treatment: The athlete received immediate on-field medical care and was subsequently transported to the hospital, where diagnostic testing was performed and further treatment was provided. Hospital inpatient management included dental and plastic surgery. After discharge from the hospital, the athlete underwent several additional dental procedures, including gingival surgery and nonsurgical endodontic treatments. The fractures were followed closely to assure that adequate healing had occurred. The athlete did not return to soccer. Uniqueness: Certified athletic trainers need to be prepared for on-field medical emergencies. Bleeding associated with maxillofacial trauma can complicate basic medical interventions such as airway maintenance. Inappropriate on-field management may result in unnecessary morbidity and mortality for the injured athlete. Therefore, immediate recognition of the severity of the injury is needed in order to institute appropriate airway-management strategies. Conclusions: It is sometimes necessary to consider nonstandard methods of airway management in order to first address heavy bleeding that may be associated with facial trauma. Achieving hemostasis is essential in order to prevent potentially life-threatening complications related to hemorrhage, such as airway obstruction and hypovolemic shock.	Univ N Carolina, Sports Med Res Lab, Chapel Hill, NC 27599 USA; Univ Pittsburgh, Pittsburgh, PA USA		Mihalik, JP (corresponding author), Univ N Carolina, Sports Med Res Lab, CB 8700,Fetzer Gymnasium S Rd, Chapel Hill, NC 27599 USA.	jasonm@unc.edu	Mihalik, Jason P/E-7059-2010	Mihalik, Jason/0000-0001-6085-8322			Barr A, 2000, BRIT J SPORT MED, V34, P456, DOI 10.1136/bjsm.34.6.456; BENKIBLER W, 1993, MED SCI SPORT EXER, V25, P1330; Blinkhorn FA, 2000, ENDOD DENT TRAUMATOL, V16, P162; BURKE MJ, 1983, JAMA-J AM MED ASSOC, V249, P2682, DOI 10.1001/jama.249.19.2682; Cerulli G, 2002, J CRANIOFAC SURG, V13, P627, DOI 10.1097/00001665-200209000-00006; Cheng TL, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.3.e32; Delilbasi C, 2004, ORAL SURG ORAL MED O, V97, P23, DOI 10.1016/j.tripleo.2003.10.008; Ferrari CH, 2002, DENT TRAUMATOL, V18, P144, DOI 10.1034/j.1600-9657.2002.00017.x; Filipe JAC, 2003, ARCH OPHTHALMOL-CHIC, V121, P687; Filipe JAC, 1997, OPHTHALMOLOGY, V104, P313; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Hildebrandt J R, 1982, Clin Sports Med, V1, P449; JONES NP, 1994, BRIT J SPORT MED, V28, P272, DOI 10.1136/bjsm.28.4.272; Kvittem B, 1998, J PUBLIC HEALTH DENT, V58, P288, DOI 10.1111/j.1752-7325.1998.tb03011.x; Levin L, 2003, DENT TRAUMATOL, V19, P237, DOI 10.1034/j.1600-9657.2003.00196.x; Luthje P, 1996, SCAND J MED SCI SPOR, V6, P180; MACEWEN CJ, 1989, BRIT J OPHTHALMOL, V73, P888, DOI 10.1136/bjo.73.11.888; MACEWEN CJ, 1987, BRIT J OPHTHALMOL, V71, P701, DOI 10.1136/bjo.71.9.701; Peterson L, 2000, AM J SPORT MED, V28, pS51; PINKHAM J R, 1991, Dental Clinics of North America, V35, P609; Poulsen T D, 1991, Br J Sports Med, V25, P151; SULLIVAN JA, 1980, AM J SPORT MED, V8, P325, DOI 10.1177/036354658000800505; Tucker AM, 1997, SPORTS MED, V23, P21, DOI 10.2165/00007256-199723010-00003; VINGER PF, 1980, SURV OPHTHALMOL, V25, P47, DOI 10.1016/0039-6257(80)90075-2	24	6	6	0	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	APR-JUN	2005	40	2					116	119					4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	934OJ	WOS:000229717800008	15970958				2022-02-06	
J	Heriseanu, R; Baguley, IJ; Siewa-Younan, S				Heriseanu, R; Baguley, IJ; Siewa-Younan, S			Two-point discrimination following traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						traumatic brain injury; two point discrimination; injury severity; FIM	FRONTAL-SUBCORTICAL CIRCUITS; DIFFUSE AXONAL INJURY; HEAD-INJURY; CEREBRAL-PALSY; LESIONS; SCALE; HAND; REHABILITATION; RELIABILITY; DISORDERS	This study investigated two point discrimination (TPD) perception in survivors of traumatic brain injury (TBI). Inpatient and outpatient survivors of severe TBI and age-matched healthy controls aged between 16 and 65 years were included in the study with a mean TPD of 3.61, 3.41 and 2.61 min respectively. Significant group effects were seen in TPD between subjects with TBI and controls. TPD deficits did not appear to be influenced by GCS or PTA duration, nor did they show evidence of improvement over time. Similarly, CT scan data did not explain the observed TPD differences in TBI survivors. Admission functional independence measure (FIM), a global measure of functional independence, had a strong negative correlation with TPD. The lack of change in TPD over time mirrors other basic markers of neurological recovery but is at odds with TBI outcome literature reporting continuing improvements in function for at least 5 years post injury. (c) 2004 Elsevier Ltd. All rights reserved.	Westmead Hosp, Brain Injury Rehabil Serv, Westmead, NSW 2145, Australia		Baguley, IJ (corresponding author), Westmead Hosp, Brain Injury Rehabil Serv, POB 533, Wentworthville, NSW 2145, Australia.	ianb@biru.wsahs.nsw.gov.au	Baguley, Ian J/K-6878-2013; Baguley, Ian/AAM-5828-2021	Baguley, Ian J/0000-0001-5650-3705; 			Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Bates B, 1995, PHYS EXAMINATION HIS, P491; Bigley G.K., 1990, CLIN METHODS HIST PH, P343; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; DELLON AL, 1983, J HAND SURG-AM, V8, P865; DELLON AL, 1987, J HAND SURG-AM, V12A, P693, DOI 10.1016/S0363-5023(87)80049-7; Feld JA, 2001, NEUROREHAB NEURAL RE, V15, P239, DOI 10.1177/154596830101500312; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; GANONG WF, 1999, REV MED PHYSL, P130; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Katz D, 1992, J HEAD TRAUMA REHAB, V72, P1, DOI [10.1097/00001199-200501000-00008, DOI 10.1097/00001199-200501000-00008]; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KNECHT S, 2000, NEUROPSYCHOLOGIA US, V34, P669; KREUTZER JS, 1993, J HEAD TRAUMA REHAB, V8, P47; LESNY I, 1971, DEV MED CHILD NEUROL, V13, P330; LESNY I, 1993, DEV MED CHILD NEUROL, V35, P402; Masanic CA, 1998, ARCH PHYS MED REHAB, V79, P811, DOI 10.1016/S0003-9993(98)90361-6; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; MOBERG E, 1990, SCAND J REHABIL MED, V22, P127; MOBERG E, 1962, NEUROLOGY, V12, P8, DOI 10.1212/WNL.12.1.8; OLBRICH HM, 1986, SURG NEUROL, V26, P112, DOI 10.1016/0090-3019(86)90362-9; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PAUSE M, 1989, BRAIN, V112, P1599, DOI 10.1093/brain/112.6.1599; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; ROLAND E, 1976, ARCH NEUROL-CHICAGO, V33, P543; ROLAND PE, 1987, EXP BRAIN RES, V66, P303; SALANOVA V, 1995, BRAIN, V118, P1289, DOI 10.1093/brain/118.5.1289; *SANT CLAR VALL ME, 1990, FUNCT IND MEAS FIM F; SEIDEL HM, 1987, MOSBYS GUIDE PHYS EX, P575; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Swartz MH, 1994, TXB PHYS DIAGNOSIS H, P437; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	38	6	6	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	FEB	2005	12	2					156	160		10.1016/j.jocn.2004.03.029			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	910JI	WOS:000227926900010	15749417				2022-02-06	
J	Faden, AI; Movsesyan, VA; Fang, XL; Wang, SM				Faden, AI; Movsesyan, VA; Fang, XL; Wang, SM			Identification of novel neuroprotective agents using pharmacophore modeling	CHEMISTRY & BIODIVERSITY			English	Article; Proceedings Paper	Symposium on Looking to the Future - Computational Methods in Drug Design	APR 03-06, 2005	Casa Maderni, Virginia Tech Ctr European Studies & Architecture, San Vitale, SWITZERLAND	Virginia Tech	Casa Maderni, Virginia Tech Ctr European Studies & Architecture		THYROTROPIN-RELEASING-HORMONE; SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; IN-VITRO; TRH; RECOVERY; ANTAGONIST; IMPACT	In addition to its endocrine function, for which it was named, thyrotropin-releasing hormone (TRH) has substantial neuroprotective actions as well as other physiological effects. We have developed a number of modified TRH analogues as well as cyclic dipeptides structurally related to a major metabolic product of TRH, which have enhanced neuroprotective activity but none of the other major physiological effects of TRH. The extensive structure-activity data developed with these compounds were used to develop a pharmacophore model. Subsequently, a web-based pharmacophore searching program was used to query several large three-dimensional databases. Of the 219 compounds identified whose structures met the pharmacophore model, 15 were chosen for study in a classical model of neuronal cell death in vitro; five of these, 2-6, showed neuroprotective activity. Thus, pharmacophore modeling developed from neuroprotective small peptides can be used to identify novel lead compounds as neuroprotective agents.	Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA		Faden, AI (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, 3970 Reservoir Rd NW,Res Bldg,Rm EP12, Washington, DC 20057 USA.	fadena@georgetown.edu		Wang, Shaomeng/0000-0002-8782-6950	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS41119] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS041119] Funding Source: NIH RePORTER		AKDEMIR H, 1993, RES EXP MED, V193, P297, DOI 10.1007/BF02576237; ARIAS MJ, 1987, SURG NEUROL, V28, P335, DOI 10.1016/0090-3019(87)90054-1; BASSIRI RM, 1973, J CLIN INVEST, V52, P1616, DOI 10.1172/JCI107339; BEHRMANN DL, 1993, EXP NEUROL, V119, P258, DOI 10.1006/exnr.1993.1028; BEHRMANN DL, 1994, EXP NEUROL, V126, P61, DOI 10.1006/exnr.1994.1042; Bredesen DE, 1996, NEUROSCIENTIST, V2, P181, DOI 10.1177/107385849600200313; CEYLAN S, 1992, RES EXP MED, V192, P23, DOI 10.1007/BF02576254; CEYLAN S, 1990, RES EXP MED, V190, P111, DOI 10.1007/PL00020013; Faden AI, 1999, AM J PHYSIOL-REG I, V277, pR1196, DOI 10.1152/ajpregu.1999.277.4.R1196; FADEN AI, 1981, NEW ENGL J MED, V305, P1063, DOI 10.1056/NEJM198110293051806; Faden AI, 1996, PHARMACOL TOXICOL, V78, P12, DOI 10.1111/j.1600-0773.1996.tb00173.x; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P355, DOI 10.1097/01.WCB.0000046144.31247.33; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P342, DOI 10.1097/01.WCB.0000046143.31247.FD; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; FADEN AI, 1984, NEUROLOGY, V34, P1280, DOI 10.1212/WNL.34.10.1280; Fang XL, 2002, J CHEM INF COMP SCI, V42, P192, DOI 10.1021/ci010083i; FUKUDA N, 1979, FOLIA PHARMACOL JPN, V75, P321, DOI 10.1254/fpj.75.321; Maas AIR, 2001, EXPERT OPIN INV DRUG, V10, P753, DOI 10.1517/13543784.10.4.753; MANAKA S, 1978, NEUROSCI LETT, V8, P255, DOI 10.1016/0304-3940(78)90131-3; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; Panter S. S., 1992, PRINCIPLES PRACTICE, P32; PITTS LH, 1995, J NEUROTRAUM, V12, P235, DOI 10.1089/neu.1995.12.235; Prakash KRC, 2002, BIOORGAN MED CHEM, V10, P3043, DOI 10.1016/S0968-0896(02)00132-3; Puniak MA, 1991, J NEUROTRAUM, V8, P193, DOI 10.1089/neu.1991.8.193; TAKAMI K, 1991, JPN J PHARMACOL, V57, P405, DOI 10.1254/jjp.57.405; WANG GL, 1991, CHINESE MED J-PEKING, V104, P939; Wang SM, 2000, J MED CHEM, V43, P351, DOI 10.1021/jm990516x; Yakovlev Alexander G, 2004, NeuroRx, V1, P5, DOI 10.1602/neurorx.1.1.5	29	6	6	0	2	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1612-1872	1612-1880		CHEM BIODIVERS	Chem. Biodivers.		2005	2	11					1564	1570		10.1002/cbdv.200590127			7	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Chemistry	989RW	WOS:000233692500014	17191955				2022-02-06	
J	Garcia, AV; Torrecillas, FL; de Arcos, FA; Garcia, MP				Garcia, AV; Torrecillas, FL; de Arcos, FA; Garcia, MP			Effects of executive impairments on maladaptive explanatory styles in substance abusers: clinical implications	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						executive functions; explanatory style; learned helplessness; neuropsychological impairment; substance abuse; rehabilitation	TRAUMATIC BRAIN INJURY; LEARNED HELPLESSNESS; ATTRIBUTIONAL STYLE; DRUG-ABUSE; CONSTRUCT-VALIDITY; SELF-MEDICATION; COCAINE; ADDICTION; BEHAVIOR; PERSONALITY	Our study examined the relation between neuropsychological impairment of executive functions and explanatory styles, according to the Abramson model of learned helplessness in humans, in a sample of substance abusers. Thirty-eight polysubstance abusers were assessed during an abstinence period using a selective neuropsychological battery for the evaluation of the executive functions, as well as the Attributional Style Questionnaire (ASQ) for the assessment of the three dimensions of explanatory style: Internality-Externality, Stability-Instability and Globality-Specificity. Multiple regression analyses showed significant relationships among performance on different neuropsychological tasks sensitive to executive functions and characteristic cognitive styles. The results showed the performance on cognitive flexibility and response inhibition tasks is directly related to making more internal attributions for positive situations, and inversely related to the appearance of more stable attributions for negative events. Likewise, adequate performance on working memory tasks was related to development of more global attributions for failures. These results are partially congruent with the learned helplessness model and particularly relevant for the clinical management of substance abusers and the success on the treatment and rehabilitation of these subjects. (C) 2004 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Univ Granada, Fac Psicol, Dept Personalidad Evaluac & Tratamiento Psicol, E-18071 Granada, Spain		Garcia, AV (corresponding author), Univ Granada, Fac Psicol, Dept Personalidad Evaluac & Tratamiento Psicol, Campus Cartuja S-N, E-18071 Granada, Spain.	averdejo@ugr.es	Lopez-Torrecillas, Francisca/C-8267-2018; Verdejo-Garcia, Antonio/AAV-1147-2021; Perez-Garcia, Miguel/F-9630-2010	Verdejo-Garcia, Antonio/0000-0001-8874-9339; Perez-Garcia, Miguel/0000-0003-4775-7556			ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Ardila A., 1994, NEUROPSYCHOLOGICAL E; Barkley RA, 2001, NEUROPSYCHOL REV, V11, P1, DOI 10.1023/A:1009085417776; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1690, DOI 10.1016/S0028-3932(02)00016-7; Besson A, 1996, PSYCHOPHARMACOLOGY, V123, P71, DOI 10.1007/BF02246283; Besson A, 1999, PHARMACOL BIOCHEM BE, V64, P541, DOI 10.1016/S0091-3057(99)00102-1; BESSON A, 1997, PHARM BIOCH BEHAV, V60, P519; Di Chiara G, 1999, EUR J PHARMACOL, V375, P13, DOI 10.1016/S0014-2999(99)00372-6; DOWD ET, 1986, INT J ADDICT, V21, P589, DOI 10.3109/10826088609083543; ECHEBURUA E, 1988, REV VACA PSICOLOGIA, V1, P71; FALSSTEWART W, 1994, REHABIL PSYCHOL, V39, P75, DOI 10.1037/0090-5550.39.2.75; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; GAWIN FH, 1986, ARCH GEN PSYCHIAT, V43, P107; Golden CJ, 1978, STROOP COLOR WORD TE; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; GUTIERRES SE, 1994, INT J ADDICT, V29, P1761, DOI 10.3109/10826089409128256; Heaton RK, 1991, COMPREHENSIVE NORMS; Higgins NC, 1999, EDUC PSYCHOL MEAS, V59, P804, DOI 10.1177/00131649921970152; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Joiner TE, 1996, COGNITIVE THER RES, V20, P51, DOI 10.1007/BF02229243; Joiner TE, 1999, COGNITIVE THER RES, V23, P105, DOI 10.1023/A:1018766825706; KHANTZIAN EJ, 1985, AM J PSYCHIAT, V142, P1259; Klein J. L., 1998, DISS ABSTR INT B, V58, P4454; KUHL J, 1981, J PERS SOC PSYCHOL, V40, P155, DOI 10.1037/0022-3514.40.1.155; KUHL J, 1994, J PERS SOC PSYCHOL, V66, P1103, DOI 10.1037/0022-3514.66.6.1103; LABBE JE, 1999, DISS ABSTR INT B, V60, P834; Lopez-Torrecilla F., 2000, PSICOTHEMA, V12, P331; LUBUSKO AA, 1994, BRAIN INJURY, V8, P65, DOI 10.3109/02699059409150959; LUNDEN A, 1995, VET PARASITOL, V56, P23, DOI 10.1016/0304-4017(94)00670-8; MILLER L, 1990, J SUBST ABUSE TREAT, V7, P31, DOI 10.1016/0740-5472(90)90034-N; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; OVERMIER JB, 1967, J COMP PHYSIOL PSYCH, V60, P213; PETERSON C, 1982, COGNITIVE THER RES, V6, P287, DOI 10.1007/BF01173577; PIATT AL, 1996, 15 ANN M NAT AC NEUR; Pineda DA, 2000, REV NEUROLOGIA, V30, P764, DOI 10.33588/rn.3008.99646; QUINLESS FW, 1988, NURS RES, V37, P11; REICH JW, 1987, AM J DRUG ALCOHOL AB, V13, P73, DOI 10.3109/00952998709001501; Reitan RM, 1992, TRAIL MAKING TEST MA; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rogers RD, 2001, CURR OPIN NEUROBIOL, V11, P250, DOI 10.1016/S0959-4388(00)00204-X; SEGURA M, 1983, CUESTIONARIO ESTILO; SEISDEDOS N, 1994, CAMBIOS TEST FLEXIBI; SELIGMAN ME, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024514; Sterling RC, 1996, J ADDICT DIS, V15, P13, DOI 10.1300/J069v15n02_02; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Valencia NJ, 2000, PSICOL CONDUCT, V2, P283; VERDEJO A, 2002, ADICCIONES, V14, P345; Verdejo-Garcia AJ, 2005, ADDICT BEHAV, V30, P89, DOI 10.1016/j.addbeh.2004.04.015; Verheul R, 2001, EUR PSYCHIAT, V16, P274, DOI 10.1016/S0924-9338(01)00578-8; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WEINER B, 1985, PSYCHOL REV, V92, P548, DOI 10.1037/0033-295X.92.4.548; WEINER B, 1980, J PERS SOC PSYCHOL, V39, P186, DOI 10.1037/0022-3514.39.2.186; WEISS RD, 1992, AM J DRUG ALCOHOL AB, V18, P121, DOI 10.3109/00952999208992825; WILL MJ, 1997, PHARM BIOCH BEHAV, V60, P655	54	6	6	1	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2005	20	1					67	80		10.1016/j.acn.2004.03.002			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	886WI	WOS:000226263200004	15620814	Bronze			2022-02-06	
J	Mayfield, J; Homack, S				Mayfield, Joan; Homack, Susan			Behavioral Considerations Associated With Traumatic Brain Injury	PREVENTING SCHOOL FAILURE			English	Article						behavior problems; cognitive deficits; traumatic brain injury (TBI)		Children who sustain traumatic brain injury (TBI) can experience significant cognitive deficits. These deficits may significantly impair their functioning in the classroom, resulting in the need for academic and behavioral modifications. Behavior and social problems can be the direct or indirect result of brain injury. Difficulties in paying attention, staying on task, and predicting the consequences of actions may be associated with behavior problems (M. Ylvisaker, T. Feeney, & F. Szekeres, 1998). A neuropsychological evaluation provides information to parents and teachers about the extent of the child's cognitive deficits and explains cognitive strengths and weaknesses. When teachers are provided with this information, they are able to develop appropriate strategies to optimize the child's ability to learn and function in the classroom.	[Mayfield, Joan] Baylor Hosp, Our Childrens House, Dallas, TX 75246 USA; [Homack, Susan] Texas A&M Univ, Neurosci, College Stn, TX 77843 USA		Mayfield, J (corresponding author), Baylor Hosp, Our Childrens House, Dallas, TX 75246 USA.						Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BANICH MT, 1990, NEUROPSYCHOLOGIA, V28, P35, DOI 10.1016/0028-3932(90)90084-2; BRAZZELLI M, 1994, CORTEX, V30, P27, DOI 10.1016/S0010-9452(13)80323-1; Bruce D. A., 1995, TRAUMATIC HEAD INJUR, P40; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; DEATON AV, 1994, ED DIMENSIONS ACQUIR, P239; Deb S, 2004, BRAIN INJURY, V18, P1, DOI 10.1080/0269905031000110463; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Guthrie E, 1999, CHILD ADOL PSYCH CL, V8, P807; HALEY S M, 1991, Physical and Occupational Therapy in Pediatrics, V11, P1; Hemphill L., 1994, J COMMUNICATIVE DISO, V27, P91; KEEFE KA, 1989, J SPEECH HEAR DISORD, V54, P395, DOI 10.1044/jshd.5403.395; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; Lord-Maes J., 1997, CHILDHOOD TRAUMATIC, P101; Lowenthal B., 1998, TRANSDISCIPLINARY J, V8, P377; Max JE, 1998, BRAIN INJURY, V12, P31; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; McGuire LM, 1998, BRAIN INJURY, V12, P207, DOI 10.1080/026990598122683; REID DB, 1993, J CLIN PSYCHOL, V49, P245, DOI 10.1002/1097-4679(199303)49:2<245::AID-JCLP2270490219>3.0.CO;2-1; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; RUTTER M, 1982, AM J PSYCHIAT, V139, P21; Stuss D. T., 1987, FRONTAL LOBES REVISI, P141; Swift EE, 2003, J DEV BEHAV PEDIATR, V24, P24, DOI 10.1097/00004703-200302000-00007; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; Wilkening B., 1997, CHILDHOOD TRAUMATIC, P79; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375; YLVISAKER M, 1998, TRAUMATIC BRAIN INJU, P271; [No title captured]	39	6	6	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1045-988X	1940-4387		PREV SCH FAIL	Prev. Sch. Fail.		2005	49	4					17	22		10.3200/PSFL.49.4.17-22			6	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	V2Y9C	WOS:000218037100004					2022-02-06	
J	Mazzeo, AT; Bullock, R				Mazzeo, AT; Bullock, R			Effect of bacterial meningitis complicating severe head trauma upon brain microdialysis and cerebral perfusion	NEUROCRITICAL CARE			English	Article						meningitis; traumatic brain injury; microdialysis; cerebral blood flow; pyruvate; glutamate	BLOOD-FLOW; POSTTRAUMATIC MENINGITIS; CEREBROSPINAL-FLUID; INTERSTITIAL FLUID; AMINO-ACIDS; LACTATE; AUTOREGULATION; INFECTIONS; CHEMOKINES; MICROGLIA	Introduction: This article describes changes in regional cerebral perfusion and brain metabolism in a case of bacterial meningitis complicating severe traumatic brain injury. Case report: As part of clinical monitoring of patients with severe head injury, cerebral microdialysis was performed and extracellular concentration of glucose, lactate, glutamate, and pyruvate was determined. A thermal diffusion probe was used for bedside monitoring of cerebral blood flow. Acinetobacter meningitis complicated the clinical course on the seventh post-admission day and dramatically altered the neurochemistry. Microdialysate analysis showed glucose under the detection limit, lactate at moderately high levels, and a marked increase in glutamate and pyruvate levels. A reduction of cerebral perfusion was detected in the early phase of meningitis, probably secondary to vascular complications related to the inflammatory process. Discussion: This case describes an emerging area of study and practice in patients with brain injury. It demonstrates how cerebral perfusion monitoring and study of brain metabolism can provide an early detection of secondary events that complicate severe head injury and can contribute to a better understanding of the complex pathogenetic mechanisms responsible for neuronal damage.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Richmond, VA 23298 USA; Univ Messina, Dept Neurosci Psychiat & Anesthesiol Sci, Div Anesthesia & Intens Care, Messina, Italy		Mazzeo, AT (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, W Hosp 8th Floor,South Wing,1200 E Broad St, Richmond, VA 23298 USA.	annateresamazzeo@unime.it		Mazzeo, Anna Teresa/0000-0002-8454-7243			Alves OL, 2003, ANN NY ACAD SCI, V993, P25, DOI 10.1111/j.1749-6632.2003.tb07508.x; BALTAS I, 1994, NEUROSURGERY, V35, P422, DOI 10.1227/00006123-199409000-00009; Gliemroth J, 2002, CLIN NEUROL NEUROSUR, V105, P27, DOI 10.1016/S0303-8467(02)00088-4; GUERRAROMERO L, 1993, PEDIATR RES, V33, P510, DOI 10.1203/00006450-199305000-00018; GUERRAROMERO L, 1992, J INFECT DIS, V166, P546, DOI 10.1093/infdis/166.3.546; Hausler KG, 2002, EUR J NEUROSCI, V16, P2113, DOI 10.1046/j.1460-9568.2002.02287.x; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; JENNETT B, 1981, MANAGEMENT HEAD INJU, P193; Kielian T, 2004, FRONT BIOSCI-LANDMRK, V9, P732, DOI 10.2741/1266; Koedel U, 1998, J CEREBR BLOOD F MET, V18, P67, DOI 10.1097/00004647-199801000-00007; Leib SL, 1999, CLIN INFECT DIS, V29, P69, DOI 10.1086/520184; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Matschke J, 2001, FORENSIC SCI INT, V115, P199, DOI 10.1016/S0379-0738(00)00328-5; Merkelbach S, 1998, AM J NEURORADIOL, V19, P433; Moller K, 2000, CRIT CARE MED, V28, P1027, DOI 10.1097/00003246-200004000-00019; Moller K, 2002, ACTA ANAESTH SCAND, V46, P567, DOI 10.1034/j.1399-6576.2002.460515.x; Moller K, 2000, STROKE, V31, P1116, DOI 10.1161/01.STR.31.5.1116; Nau R, 2002, TRENDS NEUROSCI, V25, P38, DOI 10.1016/S0166-2236(00)02024-5; PERRY VL, 1993, PEDIATR RES, V34, P187, DOI 10.1203/00006450-199308000-00017; Ries S, 1997, J NEUROL, V244, P51; Schmitt B, 1998, EUR J PEDIATR, V157, P863, DOI 10.1007/s004310050954; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; TUNKEL AR, 1993, CLIN MICROBIOL REV, V6, P118, DOI 10.1128/CMR.6.2.118-136.1993; TUNKEL AR, 1990, HDB CLIN NEUROLOGY H, V13, P317; TUREEN JH, 1990, J CLIN INVEST, V85, P577, DOI 10.1172/JCI114475; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF	27	6	6	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2005	2	3					282	287		10.1385/NCC:2:3:282			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	955DD	WOS:000231204500007	16159076				2022-02-06	
J	Mukhida, K; Kobayashi, NR; Mendez, I				Mukhida, K; Kobayashi, NR; Mendez, I			A novel role for parkin in trauma-induced central nervous system secondary injury	MEDICAL HYPOTHESES			English	Article							SPINAL-CORD-INJURY; JUVENILE PARKINSONISM; OXIDATIVE DAMAGE; POINT MUTATIONS; ALPHA-SYNUCLEIN; S-NITROSYLATION; CYTOCHROME-C; BRAIN; GENE; FAMILIES	Recently, Loss-of-function mutations of parkin have been identified as being causally related to autosomal recessive juvenile parkinsonism, the most common form of familial Parkinson's disease. In addition to functioning as an E3 ubiquitin ligase that facilitates the proteasomal degradation of proteins with abnormal conformations, parkin protects dopaminergic neurons from oxidative stress-mediated death by regulating mitochondrial function. Parkin is expressed throughout the brain in a variety of functional and neurochemical systems. We propose that parkin's role in protecting neurons from oxidative stress may extend beyond the nigrostriatal system to include neurons in other regions of the central nervous system. This is relevant for therapeutic strategies for brain and spinal cord injury because oxidative stress leading to lipid peroxidation and protein and nucleic acid oxidation is a significant cause of secondary injury and thus neuronal death following traumatic injuries to the central nervous system. A novel model system to verify the process of oxidative stress as a causative factor in trauma-induced secondary injury mechanisms would be to induce traumatic brain and spinal cord injury in parkin-null mice. This is expected to provide the proof-of-principle that a cascade of oxidative stress is a causal event leading to secondary neuronal injury, that parkin functions outside of the dopaminergic system to protect other neurons from oxidative stress, and that antioxidant pharmacotherapy is a rational therapeutic approach to decrease trauma-induced neuronal injury. (c) 2005 Elsevier Ltd. All rights reserved.	Dalhousie Univ, Cell Restorat Lab, Dept Anat & Neurobiol, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Cell Restorat Lab, Dept Surg, Halifax, NS B3H 4H7, Canada		Mukhida, K (corresponding author), Dalhousie Univ, Cell Restorat Lab, Dept Anat & Neurobiol, 12th Floor,Sir Charles Tupper Med Bldg,5850 Coll, Halifax, NS B3H 4H7, Canada.	kmukhida@dal.ca					Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; CHRISTIE SD, 2004, UNPUB; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Fehlings M, 2000, CONT MANAGEMENT SPIN, P33; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Hattori N, 1998, BIOCHEM BIOPH RES CO, V249, P754, DOI 10.1006/bbrc.1998.9134; Huang Y, 2004, BRAIN RES REV, V46, P44, DOI 10.1016/j.brainresrev.2004.04.007; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Ishikawa A, 1996, NEUROLOGY, V47, P160, DOI 10.1212/WNL.47.1.160; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Li SX, 2000, NEUROL RES, V22, P171, DOI 10.1080/01616412.2000.11758605; Lohmann E, 2003, ANN NEUROL, V54, P176, DOI 10.1002/ana.10613; Lucking CB, 1998, LANCET, V352, P1355, DOI 10.1016/S0140-6736(05)60746-5; Luo J, 2004, NEUROSCI LETT, V359, P167, DOI 10.1016/j.neulet.2004.02.027; Maier CM, 2002, NEUROSCIENTIST, V8, P323, DOI 10.1177/107385840200800408; Malik AS, 2003, J NEUROTRAUM, V20, P463, DOI 10.1089/089771503765355531; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Mori H, 1998, NEUROLOGY, V51, P890, DOI 10.1212/WNL.51.3.890; Namiki J, 2000, J NEUROTRAUM, V17, P1219, DOI 10.1089/neu.2000.17.1219; Nisipeanu P, 1999, NEUROLOGY, V53, P1602, DOI 10.1212/WNL.53.7.1602; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Periquet M, 2001, AM J HUM GENET, V68, P617, DOI 10.1086/318791; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Rawal N, 2003, NEUROLOGY, V60, P1378, DOI 10.1212/01.WNL.0000056167.89221.BE; Schwartz G, 2002, PROG BRAIN RES, V137, P177; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Stichel CC, 2000, EUR J NEUROSCI, V12, P4181, DOI 10.1046/j.1460-9568.2000.01314.x; Tassin J, 1998, AM J HUM GENET, V63, P88, DOI 10.1086/301934; Wells JEA, 2003, BRAIN, V126, P1628, DOI 10.1093/brain/awg178; XU W, 2004, SPINAL CORD, V42, P1; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Zarate-Lagunes M, 2001, J COMP NEUROL, V432, P184, DOI 10.1002/cne.1096; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	39	6	7	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses		2005	64	6					1120	1123		10.1016/j.mehy.2004.12.020			4	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	921VG	WOS:000228792800012	15823698				2022-02-06	
J	Nakanishi, K; Hirasawa, H; Oda, S; Shiga, H; Matsuda, K; Nakamura, M; Hirano, T; Hirayama, Y; Moriguchi, T; Watanabe, E; Nitta, M				Nakanishi, K; Hirasawa, H; Oda, S; Shiga, H; Matsuda, K; Nakamura, M; Hirano, T; Hirayama, Y; Moriguchi, T; Watanabe, E; Nitta, M			Intracranial pressure monitoring in patients with fulminant hepatic failure treated with plasma exchange and continuous hemodiafiltration	BLOOD PURIFICATION			English	Article						intracranial pressure; hepatic encephalopathy; artificial liver support; plasma exchange; continuous hemodiafiltration	ACUTE LIVER-FAILURE; TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; MODERATE HYPOTHERMIA; PERFUSION-PRESSURE; TRANSPLANTATION; AUTOREGULATION; MANAGEMENT; METABOLISM; ICP	Background/Aims: To study the influence of our artificial liver support (ALS) on intracranial pressure (ICP) and to evaluate the significance of ICP monitoring in fulminant hepatic failure (FHF) patients treated with ALS. Methods: ICP was measured in 13 consecutive FHF patients treated with ALS. Maximum value in ICP every day was employed as ICPmax of the day. We analyzed the correlation: (a) between ICPmax and consciousness level; (b) between ICP and colloid osmotic pressure ( COP), and ( c) between ICP and PaCO2. Results: ICP in 11 patients of 13 was controlled <20 mm Hg through our ALS. A significant positive correlation between ICPmax and consciousness level was found (p < 0.01). Although there was a significantly negative correlation between ICP and COP (p < 0.001), there was no correlation between ICP and PaCO2. Conclusions: We conclude that our ALS does not have any adverse effects on ICP and that ICP monitoring is one of the inevitable monitorings in the management of FHF. Copyright (C) 2005 S. Karger AG, Basel.	Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chuo Ku, Chiba 2608677, Japan		Nakanishi, K (corresponding author), Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608677, Japan.	kaznaka@air.linkclub.or.jp	Watanabe, Eizo/AAO-4780-2021	Watanabe, Eizo/0000-0001-6731-909X			Alperin NJ, 2000, RADIOLOGY, V217, P877, DOI 10.1148/radiology.217.3.r00dc42877; ASCHER NL, 1993, ARCH SURG-CHICAGO, V128, P677; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; EDDY VA, 1995, AM SURGEON, V61, P24; Firsching R, 2000, J NEUROSURG, V93, P33, DOI 10.3171/jns.2000.93.1.0033; Gill RQ, 2001, J CLIN GASTROENTEROL, V33, P191, DOI 10.1097/00004836-200109000-00005; HANID MA, 1980, GUT, V21, P866, DOI 10.1136/gut.21.10.866; Hattori H, 1998, TRANSPLANTATION, V65, P686, DOI 10.1097/00007890-199803150-00015; Helmke K, 2000, TRANSPLANTATION, V70, P392, DOI 10.1097/00007890-200007270-00029; Herrera JL, 1998, DIGEST DIS, V16, P274, DOI 10.1159/000016877; HIRASAWA H, 1988, ARTIF ORGANS, V12, P382, DOI 10.1111/j.1525-1594.1988.tb02792.x; Hirasawa H, 1997, Ther Apher, V1, P228, DOI 10.1111/j.1744-9987.1997.tb00143.x; HOOFNAGLE JH, 1995, HEPATOLOGY, V21, P240, DOI 10.1002/hep.1840210137; Jalan R, 1999, LANCET, V354, P1164, DOI 10.1016/S0140-6736(98)12440-6; Jalan R, 2001, Curr Opin Crit Care, V7, P257, DOI 10.1097/00075198-200108000-00008; Jalan R, 2001, HEPATOLOGY, V34, P50, DOI 10.1053/jhep.2001.25386; Lane PL, 2000, CAN J SURG, V43, P442; Maitinez-Manas RM, 2000, J NEUROL NEUROSUR PS, V69, P82, DOI 10.1136/jnnp.69.1.82; Mascia L, 2000, INTENS CARE MED, V26, P202, DOI 10.1007/s001340050046; Moraine JJ, 2000, J NEUROSURG, V92, P606, DOI 10.3171/jns.2000.92.4.0606; Sadahiro T, 2001, CRIT CARE MED, V29, P1386, DOI 10.1097/00003246-200107000-00014; Schmidt B, 2000, J NEUROSURG, V92, P793, DOI 10.3171/jns.2000.92.5.0793; Vigue B, 2000, INTENS CARE MED, V26, P722, DOI 10.1007/s001340051238; Wagner N, 2000, ACTA OTO-LARYNGOL, P44	24	6	7	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0253-5068	1421-9735		BLOOD PURIFICAT	Blood Purif.		2005	23	2					113	118		10.1159/000083205			6	Hematology; Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Urology & Nephrology	903IZ	WOS:000227420700003	15640603				2022-02-06	
J	Rose, JM				Rose, JM			Continuum of care model for managing mild traumatic brain injury in a workers' compensation context: A description of the model and its development	BRAIN INJURY			English	Article							POST-CONCUSSION SYNDROME; MINOR HEAD-INJURY; WORD MEMORY TEST; NEUROPSYCHOLOGICAL REHABILITATION; POSTCONCUSSION SYNDROME; MANAGEMENT; CLAIMANTS; SEQUELAE	Mild traumatic brain injuries are a significant health problem that can result in distress and disability for people who go on to develop post-concussion syndrome or symptoms. In order to improve healthcare outcomes following a mild traumatic brain injury, the Workers' Compensation Board of Alberta developed a continuum of care model to assist its staff ( e. g. claim adjudication and case management) to manage these claims. A continuum of care model acts as a road map that illustrates typical recovery patterns and treatment best practices, and builds in checkpoints where decisions for assessment and treatment can be made. The model was developed from a review of the research literature selected to determine the best evidence-based practices for treating mild traumatic brain injury, and the most appropriate timing for assessments and treatments. Local and international experts in the field of brain injury assessment and rehabilitation also contributed to the development of the final model.	Millard Hlth, Edmonton, AB T5G 0W6, Canada		Rose, JM (corresponding author), Millard Hlth, 131 Airport Rd, Edmonton, AB T5G 0W6, Canada.	jerry.rose@wcb.ab.ca					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Allen L., 1997, CARB 97 MANUAL COMPU; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; CYTOWIC RE, 1987, NEUROPSYCHOLOGICAL S, P226; Deahl MP, 2001, J TRAUMA STRESS, V14, P527, DOI 10.1023/A:1011160606866; Delis DC, 1987, CALIFORNIA VERBAL LE; DIKMEN SS, 1998, RECOVERY, V9, P10; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Everly G S Jr, 2000, Int J Emerg Ment Health, V2, P211; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Ferguson R. J., 1995, SOURCEBOOK PSYCHOL T SOURCEBOOK PSYCHOL T, P615; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 1996, WORD MEMORY TEST USE; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Ho MR, 1997, ARCH CLIN NEUROPSYCH, V12, P1; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; LARRABEE GJ, IN PRESS DIFFERENTIA; Lees-Haley PR, 2001, NEUROREHABILITATION, V16, P267; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; MARGULIES S, 1998, RECOVERY, V9, P24; MATEER K, 1992, PHYS MED REHABILITAT, P143; MATTSON J, 1992, PHYS MED REHABILITAT, P183; MCBEATH JG, 1994, HEADACHE, V34, P148, DOI 10.1111/j.1526-4610.1994.hed3403148.x; Miller MA, 1997, J PSYCHOSOM RES, V43, P279, DOI 10.1016/S0022-3999(97)00118-9; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Mitchell J T, 1983, JEMS, V8, P36; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; MOSER C, 2000, BACK WORK, V4, P5; NAGY J, 2000, COMMUNICATION    SEP; NAGY J, 2002, COMMUNICATION    MAY; Nikolaj S, 1998, OCCUP MED, V13, P357; OSHANICK G, 2000, COMMUNICATION    SEP; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Richards D., 2001, J MENTAL HLTH, V10, P351, DOI [DOI 10.1080/09638230124190, 10.1080/09638230124190]; ROSE S, 2003, COCHRANE LIB, V2; *SAAQ, 2000, UNPUB GUID DET MILD; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; van Emmerik AAP, 2002, LANCET, V360, P766, DOI 10.1016/S0140-6736(02)09897-5; Wright JC, 1996, BRIT J CLIN PSYCHOL, V35, P399, DOI 10.1111/j.2044-8260.1996.tb01194.x; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; ZASLER ND, 1996, MED REHABILITATION T, P131	56	6	6	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2005	19	1					29	39		10.1080/02699050310001617361			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	875AS	WOS:000225392600004	15762099				2022-02-06	
J	Savage, RC				Savage, Ronald C.			The Great Leap Forward: Transitioning Into the Adult World	PREVENTING SCHOOL FAILURE			English	Article						adolescents; transition; traumatic brain injury (TBI)		Transitioning from high school to the adult world is a complicated process for adolescents with traumatic brain injuries (TBIs). The Individuals With Disabilities Education Act (IDEA) requires transition services for students with disabilities. This article describes those services and how to customize these services to support the needs of students with TBI before and after they leave public school.	[Savage, Ronald C.] Lash & Associates Publishing Training Haddonfield, Camden, NJ 08033 USA		Savage, RC (corresponding author), Lash & Associates Publishing Training Haddonfield, Camden, NJ 08033 USA.						*AAMR, 2004, SUPP INT SCAL; Adamovich B., 1997, SCALES COGNITIVE ABI; Bancroft NeuroHealth, 2000, FAM TRANS HD; Blosser J., 2003, PEDIAT TRAUMATIC BRA, P97; Brain Injury Association of New York State (BIANYS), 2004, TRANS AD WORLD; Clark G. M., 1998, ASS TRANSITION PLANN; Coastline Community College, 2005, ACQ BRAIN INJUR PROG; Elksnin N., 1988, TEACHING OCCUPATIONA; FIELD S, 1998, SELF DETERMINATION S; Goodwin J., 1999, GOING COLL STUDENT B; Hamilton M., 1997, LEARING WELL SCH CHO; Kreutzer J. S., 2000, THINKING ABOUT WORK; Lash M., 1997, YOUR TEENAGER INJURE; National Information Center for Children and Youth With Disabilities (NICHCY), 1999, TRANS PLANN TEAM EF; POLLACK I, 1994, ED DIMENSIONS ACQUIR, P303; Rusch F. R., 1998, HIGH SCH TRANSITION; Ryan T. V., 1996, PEDIAT NEUROPSYCHOLO, P42; Savage R, 2001, BRAIN INJURY SOURCE, V5, P24; Sherwin E., 2003, BRAIN INJURY SOURCE, V6, P42; Sohlberg M. M., 2001, PROSPECTIVE MEMORY S; Thomas DF, 1997, J HEAD TRAUMA REHAB, V12, P48, DOI 10.1097/00001199-199704000-00006; Wehman P., 1998, DEV TRANSITION PLANS	22	6	6	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1045-988X	1940-4387		PREV SCH FAIL	Prev. Sch. Fail.		2005	49	4					43	52		10.3200/PSFL.49.4.43-52			10	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	V2Y9C	WOS:000218037100007					2022-02-06	
J	Thomas, MS; Zhang, WR; Jordan, PM; Saragovi, HU; Taglialatela, G				Thomas, Michael S.; Zhang, WenRu; Jordan, Paivi M.; Saragovi, H. Uri; Taglialatela, Giulio			Signaling pathways mediating a selective induction of nitric oxide synthase II by tumor necrosis factor alpha in nerve growth factor-responsive cells	JOURNAL OF NEUROINFLAMMATION			English	Article							NF-KAPPA-B; SEPTAL CHOLINERGIC NEURONS; INJURED SPINAL-CORD; ALZHEIMERS-DISEASE; NUCLEUS BASALIS; NEURODEGENERATIVE DISEASES; ANTIINFLAMMATORY DRUGS; ABERRANT EXPRESSION; OXIDATIVE DAMAGE; REACTIVE OXYGEN	Background: Inflammation and oxidative stress play a critical role in neurodegeneration associated with acute and chronic insults of the nervous system. Notably, affected neurons are often responsive to and dependent on trophic factors such as nerve growth factor (NGF). We previously showed in NGF-responsive PC12 cells that tumor necrosis factor alpha (TNF alpha) and NGF synergistically induce the expression of the free-radical producing enzyme inducible nitric oxide synthase (iNOS). We proposed that NGF-responsive neurons might be selectively exposed to iNOS-mediated oxidative damage as a consequence of elevated TNF alpha levels. With the aim of identifying possible therapeutic targets, in the present study we investigated the signaling pathways involved in NGF/TNF alpha-promoted iNOS induction. Methods: Western blotting, RT-PCR, transcription factor-specific reporter gene systems, mutant cells lacking the low affinity p75NTR NGF receptor and transfections of TNF alpha/NGF chimeric receptors were used to investigate signalling events associated with NGF/TNF alpha-promoted iNOS induction in PC12 cells. Results: Our results show that iNOS expression resulting from NGF/TNF alpha combined treatment can be elicited in PC12 cells. Mutant PC12 cells lacking p75NTR did not respond, suggesting that p75NTR is required to mediate iNOS expression. Furthermore, cells transfected with chimeric TNF alpha/NGF receptors demonstrated that the simultaneous presence of both p75NTR and TrkA signaling is necessary to synergize with TNF alpha to mediate iNOS expression. Lastly, our data show that NGF/TNF alpha-promoted iNOS induction requires activation of the transcription factor nuclear factor kappa B (NF-kappa B). Conclusion: Collectively, our in vitro model suggests that cells bearing both the high and low affinity NGF receptors may display increased sensitivity to TNF alpha in terms of iNOS expression and therefore be selectively at risk during acute (e.g. neurotrauma) or chronic (e.g. neurodegenerative diseases) conditions where high levels of pro-inflammatory cytokines in the nervous system occur pathologically. Our results also suggest that modulation of NF kappa B-promoted transcription of selective genes could serve as a potential therapeutic target to prevent neuroinflammation-induced neuronal damage.	[Thomas, Michael S.; Zhang, WenRu; Jordan, Paivi M.; Taglialatela, Giulio] Univ Texas Med Branch Galveston, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Saragovi, H. Uri] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada		Taglialatela, G (corresponding author), Univ Texas Med Branch Galveston, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	msthomas@utmb.edu; wezhang@utmb.edu; pmroozen@utmb.edu; uri.saragovi@mcgill.ca; gtaglial@utmb.edu			UTMB Sealy Endowed Fund for Biomedical Research; NIEHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [T32 ES007254]; UTMB Sealy Center for Aging	This work was supported in part by a research development grant by the UTMB Sealy Endowed Fund for Biomedical Research. Michael Thomas is supported by an NIEHS training grant pre-doctoral fellowship from T32 ES007254 and the UTMB Sealy Center for Aging pre-doctoral fellowship.	Aloe L, 1999, CYTOKINE, V11, P45, DOI 10.1006/cyto.1998.0397; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; Barone FC, 2000, EXPERT OPIN INV DRUG, V9, P2281, DOI 10.1517/13543784.9.10.2281; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Butterfield DA, 2003, J NEUROCHEM, V86, P1313, DOI 10.1046/j.1471-4159.2003.01948.x; Cacquevel M, 2004, CURR DRUG TARGETS, V5, P529, DOI 10.2174/1389450043345308; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Chandross KJ, 1998, GLIA, V24, P21, DOI 10.1002/(SICI)1098-1136(199809)24:1<21::AID-GLIA3>3.0.CO;2-3; Consilvio C, 2004, EXP NEUROL, V187, P1, DOI 10.1016/j.expneurol.2003.12.009; Creange A, 1998, REV NEUROL, V154, P208; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Darville MI, 1998, DIABETOLOGIA, V41, P1101, DOI 10.1007/s001250051036; de la Monte SM, 2000, NEUROBIOL AGING, V21, P309, DOI 10.1016/S0197-4580(99)00108-6; Diaz-Ruiz A, 2002, NEUROSCI LETT, V319, P129, DOI 10.1016/S0304-3940(01)02540-X; Dirnagl U, 2004, E SCHERING RES FDN W, V47, P87; Emerit J, 2004, BIOMED PHARMACOTHER, V58, P39, DOI 10.1016/j.biopha.2003.11.004; Floden AM, 2005, J NEUROSCI, V25, P2566, DOI 10.1523/JNEUROSCI.4998-04.2005; Floyd RA, 1999, FREE RADICAL BIO MED, V26, P1346, DOI 10.1016/S0891-5849(98)00293-7; Foehr ED, 2000, J NEUROSCI, V20, P7556; Giasson BI, 2002, FREE RADICAL BIO MED, V32, P1264, DOI 10.1016/S0891-5849(02)00804-3; Gold BG, 2004, NEUROL RES, V26, P371, DOI 10.1179/016164104225013734; Gupta A, 2003, INT J CLIN PRACT, V57, P36; HARTIKKA J, 1988, J NEUROSCI, V8, P2967; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; HEFTI F, 1986, J NEUROSCI, V6, P2155; Hoozemans JJM, 2003, CURR DRUG TARGETS, V4, P461, DOI 10.2174/1389450033490902; Isaksson J, 2004, SPINAL CORD; Jiang H, 2005, NEUROSCI LETT, V375, P59, DOI 10.1016/j.neulet.2004.10.067; Kim HK, 2004, PAIN, V111, P116, DOI 10.1016/j.pain.2004.06.008; KISS JZ, 1994, EMBO J, V13, P5284, DOI 10.1002/j.1460-2075.1994.tb06862.x; Kong GY, 2000, BRAIN RES, V878, P105, DOI 10.1016/S0006-8993(00)02716-5; La Rosa G, 2004, J NEUROSURG-SPINE, V1, P311, DOI 10.3171/spi.2004.1.3.0311; Lad SP, 2003, J BIOL CHEM, V278, P24808, DOI 10.1074/jbc.M212270200; Law A, 2001, BRAIN RES REV, V35, P73, DOI 10.1016/S0165-0173(00)00051-5; Lee SC, 1999, J NEUROPATH EXP NEUR, V58, P1163, DOI 10.1097/00005072-199911000-00006; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Luth HJ, 2001, BRAIN RES, V913, P57, DOI 10.1016/S0006-8993(01)02758-5; Luth HJ, 2002, BRAIN RES, V953, P135, DOI 10.1016/S0006-8993(02)03280-8; Macdonald NJ, 2000, NEUROREPORT, V11, P3453, DOI 10.1097/00001756-200011090-00011; McGeer EG, 2003, PROG NEURO-PSYCHOPH, V27, P741, DOI 10.1016/S0278-5846(03)00124-6; McGeer Patrick L, 2002, Sci Aging Knowledge Environ, V2002, pre3, DOI 10.1126/sageke.2002.29.re3; McGeer PL, 2002, J NEUROVIROL, V8, P529, DOI 10.1080/13550280290100969; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; MCGEER PL, 1984, NEUROLOGY, V34, P741, DOI 10.1212/WNL.34.6.741; Mielke K, 2002, MOL CELL NEUROSCI, V20, P211, DOI 10.1006/mcne.2002.1132; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; OHMICHI M, 1992, BIOCHEMISTRY-US, V31, P4034, DOI 10.1021/bi00131a019; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Pappas TC, 2003, AGING CELL, V2, P83, DOI 10.1046/j.1474-9728.2003.00039.x; Parmentier-Batteur S, 2001, J CEREBR BLOOD F MET, V21, P15, DOI 10.1097/00004647-200101000-00003; PEREZPOLO JR, 1990, MOL NEUROBIOL, V4, P57, DOI 10.1007/BF02935585; Perry G, 2000, INT J DEV NEUROSCI, V18, P417, DOI 10.1016/S0736-5748(00)00006-X; Perry G, 2003, ACTA NEUROPATHOL, V106, P552, DOI 10.1007/s00401-003-0761-7; Pompl PN, 2003, FASEB J, V17, P725, DOI 10.1096/fj.02-0876fje; Popovich PG, 2003, TRENDS PHARMACOL SCI, V24, P13, DOI 10.1016/S0165-6147(02)00006-8; RINNE JO, 1987, J NEUROL SCI, V79, P67, DOI 10.1016/0022-510X(87)90260-7; Rogerio F, 2005, DEV BRAIN RES, V154, P217, DOI 10.1016/j.devbrainres.2004.10.017; ROVELLI G, 1993, P NATL ACAD SCI USA, V90, P8717, DOI 10.1073/pnas.90.18.8717; Sarchielli P, 2003, AMINO ACIDS, V25, P427, DOI 10.1007/s00726-003-0028-6; Stoll G, 2002, J PERIPHER NERV SYST, V7, P13, DOI 10.1046/j.1529-8027.2002.02002.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sundararajan S, 2004, DRUG NEWS PERSPECT, V17, P229, DOI 10.1358/dnp.2004.17.4.829049; Sung YJ, 2004, NEUROL RES, V26, P195, DOI 10.1179/016164104225013761; Szutowicz A, 2004, J NEUROCHEM, V90, P952, DOI 10.1111/j.1471-4159.2004.02556.x; Taglialatela G, 1998, NEUROREPORT, V9, P489, DOI 10.1097/00001756-199802160-00024; Taglialatela G, 1997, J NEUROSCI RES, V47, P155; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Tarkowski E, 2003, BRAIN RES BULL, V61, P255, DOI 10.1016/S0361-9230(03)00088-1; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Urushitani M, 1998, ANN NEUROL, V44, P796, DOI 10.1002/ana.410440514; Van Beek J, 2003, ANN NY ACAD SCI, V992, P56; VOGELS OJM, 1990, NEUROBIOL AGING, V11, P3, DOI 10.1016/0197-4580(90)90056-6; Wenk GL, 2003, NEUROSCIENCE, V121, P719, DOI 10.1016/S0306-4522(03)00545-1; Weydt Patrick, 2002, Curr Opin Investig Drugs, V3, P1720; Woo SB, 2004, FASEB J, V18, pC273	80	6	7	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.		2005	2								19	10.1186/1742-2094-2-19			13	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	V29PC	WOS:000208759300019	16144552	gold, Green Published			2022-02-06	
J	Ishii, T; Sawauchi, S; Taya, E; Ohtsuka, TO; Takao, H; Murakami, S; Morooka, S; Yuhki, E; Abe, T				Ishii, T; Sawauchi, S; Taya, E; Ohtsuka, TO; Takao, H; Murakami, S; Morooka, S; Yuhki, E; Abe, T			Acute spontaneous subdural hematoma of arterial origin	NEUROLOGICAL SURGERY			Japanese	Article						acute spontaneous subdural hematoma; CT scan; cortical artery; head injury; non-traumatic	RUPTURE; POINTS; FORM	Background : Acute subdural hematoma is usually associated with cerebral contusion or laceration of the bridging veins following a head injury. However, several cases of acute subdural hematoma Without head injury (acute spontaneous subdural hematoma) have been reported. Methods : Among 162 cases Of acute subdural hematoma admitted to Our departments between 1996 and 2003, we repoort eight cases of acute spontaneous subdural hematoma. These cases fulfilled the following criteria. 1) Head injury was either trivial or absent. 2) Neither aneurysin nor arteriovenous malformation was apparent. 3) CT scan revealed neither brain contusion nor traumatic subarachnoid hemorrhage. 4) At operation, laceration of the cortical,Artery was observed. In this article, we describe the clinical feature (age, sex, Glasgow Coma Scale [GCS] Score oil admission, past history, CT appearance, and Outcome) associated with this condition. Results : Patients ranged in age from 68 to 85 years (average 74.8 vears), and were comprised of 3 males and 5 females. Previous medical history included cerebral infarction in 6 of the 8 patients and myocardial infarction in 1 patient. These seven patients were taking antiplatelet manifestation. GCS on admission ranged from 4 to 13. Five of the 7 patients on antiplatelet medication had secondary insults, such as hypoxia. On CT, hematoma thickness ranged from 13.2mm to 42.5mm (average 22.6mm), and midline shift ranged from 10.0mm to 24.0mm (average 16.5mm). Neurological outcome evaluated using the Glasgow Outcome Scale was as follows, good recovery n=2, moderate disability n=2, severe disability n=3, persistent vegetative state rill. Conclusion : The mechanism of acute spontaneous subdural hematoma is influenced by the presence of pre-existing cerebrovascular disease and by the use of antiplatelet agents. In such cases, the possibility of cortical arterial bleeding Should be taken into account, and craniotomy should be performed.	Jikei Univ, Sch Med, Dept Neurosurg, Minato Ku, Tokyo 1058461, Japan; Jikei Univ, Sch Med, Dept Neurosurg, Kashiwa Hosp, Tokyo 1058461, Japan; Fuji City Gen Hosp, Dept Neurosurg, Fuji, Shizuoka, Japan		Ishii, T (corresponding author), Jikei Univ, Sch Med, Dept Neurosurg, Minato Ku, 3-25-8 Nishishinbashi, Tokyo 1058461, Japan.						Arienta C, 1986, J Neurosurg Sci, V30, P197; DRAKE CG, 1961, J NEUROSURG, V18, P587; JAMIESON KG, 1972, J NEUROSURG, V37, P137, DOI 10.3171/jns.1972.37.2.0137; Koc RK, 1997, SURG NEUROL, V47, P9, DOI 10.1016/S0090-3019(96)00150-4; Lefranc F, 2001, ACTA NEUROCHIR, V143, P977, DOI 10.1007/s007010170002; Matsuyama T, 1997, SURG NEUROL, V47, P423, DOI 10.1016/S0090-3019(96)00398-9; Maxeiner H, 2002, NEUROSURGERY, V50, P503, DOI 10.1097/00006123-200203000-00013; MCDERMOTT M, 1984, NEUROSURGERY, V14, P13, DOI 10.1227/00006123-198401000-00004; Missori P, 2000, ACTA NEUROCHIR, V142, P697, DOI 10.1007/s007010070115; Munro D, 1934, NEW ENGL J MED, V210, P1145; OBRIEN PK, 1974, J NEUROSURG, V41, P435, DOI 10.3171/jns.1974.41.4.0435; OIKAWA A, 1993, NEUROL RES, V15, P353; RENGACHARY SS, 1981, NEUROSURGERY, V8, P166, DOI 10.1227/00006123-198102000-00005; SCOTT M, 1949, JAMA-J AM MED ASSOC, V141, P596, DOI 10.1001/jama.1949.02910090022005; SHENKIN HA, 1982, J NEUROSURG, V57, P254, DOI 10.3171/jns.1982.57.2.0254; TAKEUCHI S, 1992, Neurologia Medico-Chirurgica, V32, P80, DOI 10.2176/nmc.32.80; TALALLA A, 1971, NEUROLOGY, V21, P19, DOI 10.1212/WNL.21.1.19; VANCE BM, 1950, AMA ARCH SURG, V61, P992, DOI 10.1001/archsurg.1950.01250021002002; YASUI T, 1995, SURG NEUROL, V43, P61, DOI 10.1016/0090-3019(95)80041-E; 1996, NO SHINKEI GEKA, V24, P665; 1987, NEURO MED CHIR TOKYO, V27, P117; 1982, NO SHINKEI GEKA, V10, P839; 1997, NO SHINKEI GEKA, V25, P841; 1997, NO SHINKEI GEKA, V25, P899	24	6	6	0	0	IGAKU-SHOIN LTD	TOKYO	5-24-3 HONGO BUNKYO-KU, TOKYO, 113 91, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	DEC	2004	32	12					1239	1244					6	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	886HG	WOS:000226216900005	15605693				2022-02-06	
J	Jin, Y; McEwen, ML; Ghandour, MS; Springer, JE				Jin, Y; McEwen, ML; Ghandour, MS; Springer, JE			Overexpression of XIAP inhibits apoptotic cell death in an oligodendroglial cell line	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						apoptosis; demyelination; IAPs; spinal cord injury; multiple sclerosis	SPINAL-CORD-INJURY; CHROMOSOME-LINKED INHIBITOR; TRANSIENT CEREBRAL-ISCHEMIA; DOPAMINE-INDUCED APOPTOSIS; TRAUMATIC BRAIN-INJURY; CYTOCHROME-C; DNA FRAGMENTATION; NEURONAL DEATH; RAT HIPPOCAMPUS; GENE-TRANSFER	1. This study describes the use of an oligodendroglial cell line (158N) to study the protective effects of X-chromosome-linked inhibitor of apoptosis (XIAP) overexpression. 2. 158N cells were transiently transfected with either pCMV-Myc-XIAP or control pCMV-Myc vector. At 48 h post-transfection, immunoblotting and immunocytochemical staining showed robust myc-XIAP overexpression in pCMV-Myc-XIAP transfected cells relative to pCMV-Myc-transfected cells and normal 158N cells. 158N cells were treated with either 100 nm staurosporine (STS) or 300 muM dopamine (DA) and cell survival/function determined using two cell viability assays. 3. Both STS and DA treatments resulted in increased apoptotic death of pCMV-Myc transfected cells. In contrast, there was significant decrease in apoptotic cell death in cells transfected with pCMV-Myc-XIAP. Finally, XIAP overexpression was found to significantly reduce caspase-3 enzyme activity levels in response to apoptotic stimuli. 4. These results provide evidence that XIAP overexpression promotes cell survival in a non-neuronal cell type derived from the central nervous system. In addition, these data suggest that the 158N oligodendroglial cell line is a suitable tool for transient transfection studies, which is a problem frequently encountered when attempting to introduce genes of interest in cultures of primary oligodendroglia.	Univ Kentucky, Ctr Med, Spinal Cord & Brain Injury Res Ctr, Dept Anat, Lexington, KY 40536 USA; Univ Kentucky, Ctr Med, Spinal Cord & Brain Injury Res Ctr, Dept Neurobiol, Lexington, KY 40536 USA; CNRS, Inst Phys Biol, F-67085 Strasbourg, France; Univ Kentucky, Coll Med, Lexington, KY 40506 USA		Springer, JE (corresponding author), Univ Kentucky, Ctr Med, Dept Anat & Neurobiol, 800 Rose St,MN 225, Lexington, KY 40536 USA.	jspring@uky.edu					BARZILAI A, 2000, J NEURAL TRANSM S, V59; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Cao GD, 2001, J NEUROSCI, V21, P4678, DOI 10.1523/JNEUROSCI.21-13-04678.2001; Chen J, 1998, J NEUROSCI, V18, P4914; Citron BA, 2000, EXP NEUROL, V166, P213, DOI 10.1006/exnr.2000.7523; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Conti AC, 1998, J NEUROSCI, V18, P5663; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duckett CS, 1998, MOL CELL BIOL, V18, P608, DOI 10.1128/MCB.18.1.608; Eberhardt O, 2000, J NEUROSCI, V20, P9126; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Feutz AC, 2001, GLIA, V34, P241, DOI 10.1002/glia.1058; Fujimura M, 1999, J NEUROSCI, V19, P3414; Hay BA, 2000, CELL DEATH DIFFER, V7, P1045, DOI 10.1038/sj.cdd.4400765; Holcik M, 2001, APOPTOSIS, V6, P253, DOI 10.1023/A:1011379307472; Jones DC, 2000, J NEUROCHEM, V74, P2296, DOI 10.1046/j.1471-4159.2000.0742296.x; Keane RW, 2001, J NEUROPATH EXP NEUR, V60, P422, DOI 10.1093/jnen/60.5.422; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Korhonen L, 2001, MOL CELL NEUROSCI, V17, P364, DOI 10.1006/mcne.2000.0935; Kugler S, 2000, CELL DEATH DIFFER, V7, P815, DOI 10.1038/sj.cdd.4400712; Lee HJ, 2001, J NEUROCHEM, V76, P602, DOI 10.1046/j.1471-4159.2001.00076.x; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Liu XZ, 1997, J NEUROSCI, V17, P5395; Namura S, 1998, J NEUROSCI, V18, P3659; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Pike BR, 1998, J NEUROSCI RES, V52, P505, DOI 10.1002/(SICI)1097-4547(19980601)52:5<505::AID-JNR3>3.3.CO;2-Y; RINK A, 1995, AM J PATHOL, V147, P1575; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Simons M, 1999, J NEUROCHEM, V72, P292, DOI 10.1046/j.1471-4159.1999.0720292.x; Springer JE, 2001, CLIN CHEM LAB MED, V39, P299, DOI 10.1515/CCLM.2001.046; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Springer JE, 2000, J NEUROSCI, V20, P7246; Stokes AH, 2000, BRAIN RES, V858, P1, DOI 10.1016/S0006-8993(99)02329-X; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Xu DG, 1999, J NEUROSCI, V19, P5026	39	6	7	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	DEC	2004	24	6					853	863		10.1007/s10571-004-6924-9			11	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	884NG	WOS:000226091700012	15672685				2022-02-06	
J	Hung, KS; Liang, CL; Wang, CH; Chang, HW; Park, N; Juo, SHH				Hung, KS; Liang, CL; Wang, CH; Chang, HW; Park, N; Juo, SHH			Outcome after traumatic frontal intracerebral haemorrhage: a comparison of unilateral and bilateral haematomas	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						intracerebral haemorrhage; frontal lobe; head injury; Glasgow coma score; outcome	HEAD TRAUMA; INJURY	Frontal intracerebral haemorrhage (ICH) is a common result of cranial trauma. Outcome differences between bilateral and unilateral frontal ICH are not well studied but would be valuable to predict prognosis in clinical practice. Two aims are proposed in this study: first to compare the risk of developing delayed ICH after bilateral or unilateral frontal ICH, and second to determine the variables helpful to predict outcome according to the Glasgow Outcome Scale (GOS). Between January 1993 and December 1997, 694 consecutive patients with traumatic ICH were admitted to the Chang Gung Medical Center within 24 h of the trauma. Patients with ICH in sites other than the frontal lobes were excluded. A total of 161 cases (mean age 46.3 +/- 20.3 years), including 57 bilateral (mean age 52.5 +/- 18.7 years) and 104 unilateral (mean age 42.9 +/- 20.5 years) traumatic frontal ICH were studied. Twenty-eight of 57 patients (49%) with bifrontal ICH versus 17 of 104 patients (16%) with unilateral frontal ICH had a further, delayed ICH. In 42 of 45 patients (93%) with delayed ICH, this occurred within 5 days of the initial trauma. Multivariate logistic regression was used to select significant predictors of outcome. We found that delayed ICH (p < 0.001), age (p = 0.004) and mechanism of injury (p = 0.001) explained the worse outcome in patients with bifrontal ICH. The best-fitting logistic regression model included three variables: delayed ICH (p = 0.011), initial GCS (p = 0.023), and a sum score of clinical and radiological variables (p = 0.003). Bifrontal ICH tended to occur in older patients after a fall and was associated with a higher risk of developing delayed ICH or brain stem compression compared to unilateral ICH damage. Using these three variables - delayed ICH, initial GCS, and the sum score - in a logistical regression model is useful to predict outcome in patients with traumatic frontal ICH and may aid patient management. (C) 2004 Elsevier Ltd. All rights reserved.	Columbia Univ, Coll Phys & Surg, Columbia Genome Ctr, New York, NY 10032 USA; Chang Gung Mem Hosp, Kaohsiung Med Ctr, Dept Trauma & Neurosurg, Kaohsiung, Taiwan; Kaohsiung Municipal Tatung Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; Chang Gung Mem Hosp, Kaohsiung Med Ctr, Dept Anaesthesiol, Kaohsiung, Taiwan; Natl Sun Yat Sen Univ, Dept Sci Biol, Kaohsiung 80424, Taiwan; Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan		Juo, SHH (corresponding author), Columbia Univ, Coll Phys & Surg, Columbia Genome Ctr, 1150 St Nicholas Ave,Room 531, New York, NY 10032 USA.	shj34@columbia.edu	Juo, Suh-Hang/C-9545-2009; Juo, Suh-Hang/A-1765-2010				Arboix A, 2000, CEREBROVASC DIS, V10, P229, DOI 10.1159/000016061; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; BROWN FD, 1978, J NEUROSURG, V48, P1019, DOI 10.3171/jns.1978.48.6.1019; COOPER PR, 1987, HEAD INJURY, P238; DIAZ FG, 1979, J NEUROSURG, V50, P217, DOI 10.3171/jns.1979.50.2.0217; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; MCBRIDE DQ, 1993, J NEUROTRAUMA S1, V10, pS227; McCarron MO, 1999, STROKE, V30, P1643, DOI 10.1161/01.STR.30.8.1643; McCormick WF, 1996, NEUROSURGERY, P2639; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; ROSES AD, 1995, NAT MED, V1, P603, DOI 10.1038/nm0795-603; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; STATHAM PF, 1989, J NEUROL NEUROSUR PS, V52, P351, DOI 10.1136/jnnp.52.3.351; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; TSEMENTZIS SA, 1985, NEUROSURGERY, V16, P562; YOUNG HA, 1984, NEUROSURGERY, V14, P22, DOI 10.1227/00006123-198401000-00006	18	6	6	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2004	11	8					849	853		10.1016/j.jocn.2003.06.009			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874BW	WOS:000225326900008	15519861				2022-02-06	
J	Kerr, LE; Birse-Archbold, JLA; Simon, A; Logan, N; Scott, F; Carlson, G; Nicholson, DW; Kelly, JS; Sharkey, J				Kerr, LE; Birse-Archbold, JLA; Simon, A; Logan, N; Scott, F; Carlson, G; Nicholson, DW; Kelly, JS; Sharkey, J			Differential regulation of caspase-3 by pharmacological and developmental stimuli as demonstrated using humanised caspase-3 mice	APOPTOSIS			English	Article						apoptosis; caspase-3; development; Fas; humanised mice	PROGRAMMED CELL-DEATH; INTERLEUKIN-1-BETA CONVERTING-ENZYME; TRAUMATIC BRAIN-INJURY; DEVELOPING NERVOUS-SYSTEM; CASPASE-3-DEFICIENT MICE; ACTIVATED CASPASE-3; DECREASED APOPTOSIS; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; MOUSE FOREBRAIN	Caspase-3 is a potential therapeutic target for a number of degenerative diseases. However the development of specific caspase-3 inhibitors has been hampered by inter-species differences and the high degree of homology shared by different caspases. To circumvent these issues, we have produced and characterised a humanised caspase-3 mouse line (possessing one copy of the human gene with both copies of the murine gene disrupted) by crossing human caspase-3 transgenic mice with nullizygous caspase-3 knock-out mice. Humanised mice appeared normal and survived to adulthood. Analysis of the human gene revealed that human pro-caspase-3 was expressed in the same tissues as its murine counterpart. However humanised mice retained the hypercellularity of frontal cortex seen in their knock-out parental line and there was no biochemical evidence of human protein processing during naturally occurring neuronal death taking place during brain development. In contrast, the human protein was cleaved by the mouse machinery following anti-Fas treatment of adult mice. These data suggest that there is a fundamental difference between the activation pathways leading to caspase-3 cleavage during naturally occurring cell death in development/embryogenesis and following an apoptotic stimulus in the adult.	Univ Edinburgh, Fujisawa Inst Neurosci Edinburgh, Edinburgh EH8 9JZ, Midlothian, Scotland; Merck & Co Inc, Merck Res Labs, San Diego, CA 92121 USA		Kerr, LE (corresponding author), Univ Edinburgh, Fujisawa Inst Neurosci Edinburgh, 1 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.	Lorraine.Kerr@ed.ac.uk		Sharkey, John/0000-0001-8288-1857			Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Boyce M, 2004, CELL DEATH DIFFER, V11, P29, DOI 10.1038/sj.cdd.4401339; Burek MJ, 1996, BRAIN PATHOL, V6, P427, DOI 10.1111/j.1750-3639.1996.tb00874.x; Cregan SP, 1999, J NEUROSCI, V19, P7860; De Bilbao F, 1999, J COMP NEUROL, V409, P339, DOI 10.1002/(SICI)1096-9861(19990705)409:3<339::AID-CNE1>3.0.CO;2-Q; Denault JB, 2003, J BIOL CHEM, V278, P34042, DOI 10.1074/jbc.M305110200; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; Fujita E, 1999, BIOCHEM BIOPH RES CO, V264, P550, DOI 10.1006/bbrc.1999.1387; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Juan TSC, 1996, ONCOGENE, V13, P749; Juan TSC, 1997, GENOMICS, V40, P86, DOI 10.1006/geno.1996.4548; Keramaris E, 2000, MOL CELL NEUROSCI, V15, P368, DOI 10.1006/mcne.2000.0838; Kerr LE, 2004, CELL DEATH DIFFER, V11, P1102, DOI 10.1038/sj.cdd.4401449; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Le DA, 2002, P NATL ACAD SCI USA, V99, P15188, DOI 10.1073/pnas.232473399; Lee D, 2001, J MED CHEM, V44, P2015, DOI 10.1021/jm0100537; Leonard JR, 2002, J NEUROPATH EXP NEUR, V61, P673, DOI 10.1093/jnen/61.8.673; Lippke JA, 1996, J BIOL CHEM, V271, P1825, DOI 10.1074/jbc.271.4.1825; Masumura M, 2000, MOL BRAIN RES, V80, P219, DOI 10.1016/S0169-328X(00)00163-7; Mejia ROS, 2001, NEUROSCIENTIST, V7, P480, DOI 10.1177/107385840100700604; Miyashita T, 1999, BIOCHEM BIOPH RES CO, V257, P724, DOI 10.1006/bbrc.1999.0447; Momoi T, 2003, NEUROREPORT, V14, P111, DOI 10.1097/00001756-200301200-00021; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Nuttall ME, 2001, DRUG DISCOV TODAY, V6, P85, DOI 10.1016/S1359-6446(00)01601-9; Pompeiano M, 2000, J COMP NEUROL, V423, P1; Robertson GS, 2000, BRAIN PATHOL, V10, P283, DOI 10.1111/j.1750-3639.2000.tb00262.x; Roth KA, 2000, P NATL ACAD SCI USA, V97, P466, DOI 10.1073/pnas.97.1.466; Russell D.W., 2001, MOL CLONING LAB MANU; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; Schulz JB, 1999, ANN NEUROL, V45, P421, DOI 10.1002/1531-8249(199904)45:4<421::AID-ANA2>3.0.CO;2-Q; Shimohama S, 1999, BIOCHEM BIOPH RES CO, V256, P381, DOI 10.1006/bbrc.1999.0344; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Srinivasan A, 1998, CELL DEATH DIFFER, V5, P1004, DOI 10.1038/sj.cdd.4400449; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; Urase K, 2003, DEV BRAIN RES, V145, P241, DOI 10.1016/j.devbrainres.2003.07.002; Ussat S, 2002, BIOCHEM BIOPH RES CO, V297, P1186, DOI 10.1016/S0006-291X(02)02358-6; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343	47	6	6	0	8	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1360-8185	1573-675X		APOPTOSIS	Apoptosis	NOV	2004	9	6					739	747		10.1023/B:APPT.0000045787.50848.e1			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	865KL	WOS:000224701500007	15505416				2022-02-06	
J	Capelle, HH; Wohrle, JC; Weigel, R; Bazner, H; Grips, E; Krauss, JK				Capelle, HH; Wohrle, JC; Weigel, R; Bazner, H; Grips, E; Krauss, JK			Movement disorders after intervertebral disc surgery: Coincidence or causal relationship?	MOVEMENT DISORDERS			English	Article						dystonia; intervertebral disc surgery; movement disorders; trauma; tremor	REFLEX SYMPATHETIC DYSTROPHY; TRAUMA INDUCE DYSTONIA; PERIPHERAL TRAUMA; PAINFUL LEGS; MOVING TOES; PAROXYSMAL DYSKINESIAS; CLINICAL-FEATURES; HEAD-INJURY; TREMOR; HEMIDYSTONIA	It is well known that brain injury or central traumatic lesions may result in the subsequent appearance of movement disorders such as dystonia or tremor. The concept that peripheral lesions to neural structures may be involved in the pathogenesis of movement disorders has been discussed controversely but has gained more widespread acceptance only recently. Here, we report on 6 patients who developed movement disorders after spinal disc surgery. The movement disorders became manifest with a delay of I day to 12 months after surgery. Of the six patients, 4 underwent cervical disc surgery, and 2 patients were operated on for lumbar disc herniation; 2 patients presented with paroxysmal kinesigenic segmental dystonia, 1 patient with focal dystonia, 2 with unilateral tremor, and 1 with bilateral tremor. The appearance of the movement disorder was associated with persistent dermatornal or segmental pain. In all patients, the anatomic distribution of the movement disorder was related to the nerve root or spinal segment of the corresponding disc level and the manifestation was in close temporal relation to the surgery. We conclude that spinal disc surgery may be another, thus far neglected, cause for movement disorders. The postoperative pain syndrome in all patients should be considered as an important factor of pathogenesis. Overall, movement disorders associated with disc surgery appear to be rare, yet they may cause significant discomfort to the affected individual. (C) 2004 Movement Disorder Society.	Univ Hosp, Klinikum Mannheim, Dept Neurosurg, D-68259 Mannheim, Germany; Univ Hosp, Klinikum Mannheim, Dept Neurol, D-68259 Mannheim, Germany		Krauss, JK (corresponding author), Univ Hosp, Klinikum Mannheim, Dept Neurosurg, Theodor Kutzer Ufer 1-3, D-68259 Mannheim, Germany.	joachim.krauss@nch.ma.uni-heidelberg.de					Abbruzzese G, 2003, MOVEMENT DISORD, V18, P231, DOI 10.1002/mds.10327; ALKAWI MZ, 1987, ARCH NEUROL-CHICAGO, V44, P692, DOI 10.1001/archneur.1987.00520190008006; Assal F, 1998, J NEUROL NEUROSUR PS, V64, P673, DOI 10.1136/jnnp.64.5.673; Bara-Jimenez W, 1998, ANN NEUROL, V44, P828, DOI 10.1002/ana.410440520; Becker G, 2002, MOVEMENT DISORD, V17, P710, DOI 10.1002/mds.10132; BHATIA KP, 1993, BRAIN, V116, P843, DOI 10.1093/brain/116.4.843; Blakeley J, 2002, MOVEMENT DISORD, V17, P726, DOI 10.1002/mds.10178; Blunt SB, 1996, MOVEMENT DISORD, V11, P723, DOI 10.1002/mds.870110620; BRIN MF, 1986, NEUROLOGY, V36, P119; Byrnes ML, 1998, BRAIN, V121, P977, DOI 10.1093/brain/121.5.977; CARDOSO F, 1995, ARCH NEUROL-CHICAGO, V52, P263, DOI 10.1001/archneur.1995.00540270055019; Chuang C, 2002, J NEUROL NEUROSUR PS, V72, P59, DOI 10.1136/jnnp.72.1.59; DEMIRKIRAN M, 1995, ANN NEUROL, V38, P571, DOI 10.1002/ana.410380405; DEUSCHL G, 1991, ARCH NEUROL-CHICAGO, V48, P1247, DOI 10.1001/archneur.1991.00530240051018; DEWEY RB, 1989, ARCH NEUROL-CHICAGO, V46, P862, DOI 10.1001/archneur.1989.00520440044020; DRESSLER D, 1994, MOVEMENT DISORD, V9, P13, DOI 10.1002/mds.870090104; Ellis SJ, 1997, J NEUROL NEUROSUR PS, V63, P110, DOI 10.1136/jnnp.63.1.110; Fahn S, 1988, Adv Neurol, V50, P431; FLOR H, 1998, NEUROSCIENCE NEW, V1, P4; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Frucht S, 2000, MOVEMENT DISORD, V15, P348, DOI 10.1002/1531-8257(200003)15:2<348::AID-MDS1028>3.0.CO;2-7; Ghika J, 1997, J NEUROL SCI, V152, P193, DOI 10.1016/S0022-510X(97)00186-X; GhikaSchmid F, 1997, J NEUROL SCI, V146, P109, DOI 10.1016/S0022-510X(96)00290-0; Hashimoto T, 2002, J NEUROL NEUROSUR PS, V73, P585, DOI 10.1136/jnnp.73.5.585; HERBAUT AG, 1989, J NEUROL NEUROSUR PS, V52, P1213, DOI 10.1136/jnnp.52.10.1213-a; JANKOVIC J, 1994, NEUROLOGY, V44, P2006, DOI 10.1212/WNL.44.11.2006; JANKOVIC J, 1988, J NEUROL NEUROSUR PS, V51, P1512, DOI 10.1136/jnnp.51.12.1512; Jankovic J, 2001, MOVEMENT DISORD, V16, P7, DOI 10.1002/1531-8257(200101)16:1<7::AID-MDS1005>3.0.CO;2-0; Jones EG, 1998, SCIENCE, V282, P1121, DOI 10.1126/science.282.5391.1121; Krauss JK, 1996, NEUROLOGY, V47, P1488, DOI 10.1212/WNL.47.6.1488; Krauss JK, 1999, J NEUROSURG, V90, P883, DOI 10.3171/jns.1999.90.5.0883; KRAUSS JK, 1992, J NEUROL NEUROSUR PS, V55, P1162, DOI 10.1136/jnnp.55.12.1162; Krauss JK, 2002, NEUROSURGERY, V50, P927, DOI 10.1097/00006123-200205000-00003; LANG A, 1990, NEUROLOGY, V40, P1476; Lenz FA, 1998, J COMP NEUROL, V399, P125; Loher TJ, 2001, NEUROLOGY, V56, P268, DOI 10.1212/WNL.56.2.268; MONDAY K, 1993, NEUROLOGY, V43, P349, DOI 10.1212/WNL.43.2.349; NATHAN PW, 1978, J NEUROL NEUROSUR PS, V41, P934, DOI 10.1136/jnnp.41.10.934; PETTIGREW LC, 1985, J NEUROL NEUROSUR PS, V48, P650, DOI 10.1136/jnnp.48.7.650; Sankhla C, 1998, J NEUROL NEUROSUR PS, V65, P722, DOI 10.1136/jnnp.65.5.722; SCHOTT GD, 1986, LANCET, V2, P712; SCHOTT GD, 1985, J NEUROL NEUROSUR PS, V48, P698, DOI 10.1136/jnnp.48.7.698; SCHWARTZMAN RJ, 1990, NEUROLOGY, V40, P57, DOI 10.1212/WNL.40.1.57; Supiot F, 2002, MOVEMENT DISORD, V17, P616, DOI 10.1002/mds.10116; TABURIN S, 2003, J NEUROL NEUROSUR PS, V74, P134; Tan EK, 2002, NEUROLOGY, V58, P661, DOI 10.1212/WNL.58.4.661; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; Weiner WJ, 2001, MOVEMENT DISORD, V16, P13, DOI 10.1002/1531-8257(200101)16:1<13::AID-MDS1016>3.0.CO;2-W; Wright RA, 2000, MOVEMENT DISORD, V15, P709, DOI 10.1002/1531-8257(200007)15:4<709::AID-MDS1017>3.0.CO;2-4; WULFF CH, 1982, ACTA NEUROL SCAND, V66, P283, DOI 10.1111/j.1600-0404.1982.tb04526.x	50	6	6	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-3185	1531-8257		MOVEMENT DISORD	Mov. Disord.	OCT	2004	19	10					1202	1208		10.1002/mds.20152			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	861MY	WOS:000224422000011	15368615				2022-02-06	
J	Gaggl, A; Rainer, H; Scharfegger, H; Attelscheck, D; Chiari, FM				Gaggl, A; Rainer, H; Scharfegger, H; Attelscheck, D; Chiari, FM			Sigmoid and transverse sinus thrombosis caused by mastoid implant - case report	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						sigmoid sinus thrombosis; maxillofacial implants; mastoid	CEREBRAL VENOUS THROMBOSIS; CLOSED-HEAD INJURY; DURAL SINUS; RHEOLYTIC THROMBECTOMY; PERCUTANEOUS IMPLANTS; SAGITTAL SINUS; TEMPORAL BONE; REHABILITATION; COMPLICATIONS; DIAGNOSIS	Introduction: Extraoral craniofacial implants are often used for retention of auricular prostheses. In this case report, the rare complication of sigmoid and transverse sinus thrombosis after implant placement in the mastoid is described. Case report: A 36-year-old man with congenital hypoplasia of the right ear was treated with an implant-based auricular prosthesis. One of the three implants in the mastoid area had to be removed because of an infection, whereas the other two implants were removed at the patient's request. Twenty-four days after implant removal, he was seen with sigmoid and transverse sinus thrombosis and successfully treated with fibrinolytic and consecutive anticoagulation therapy. Conclusions: Implants in the mastoid area are a very important aid for retention of auricular prostheses, but may have life-threatening intracranial consequences. (C) 2004 European Association for Cranio-Maxillofacial Surgery.	Cent Hosp, Dept Oral & Maxillofacial Surg, Klagenfurt, Austria; Cent Hosp, Dept Radiol, Klagenfurt, Austria		Gaggl, A (corresponding author), Landeskrankenhaus Klagenfurt, Abt Mund Kiefer & Gesichtschirurg, St Veiterstr 47, A-9020 Klagenfurt, Austria.	Alexander.Gaggl@lkh-klu.at					AMIRMAJDI NM, 1988, LARYNGOSCOPE, V98, P310; BEUMER J, 1995, SEMIN SURG ONCOL, V11, P200, DOI 10.1002/ssu.2980110305; Bonding P, 2000, ACTA OTO-LARYNGOL, P105; Bradley DT, 2002, LARYNGOSCOPE, V112, P1726, DOI 10.1097/00005537-200210000-00003; Brors M, 2001, NEURORADIOLOGY, V43, P144, DOI 10.1007/PL00006045; Chow K, 2000, STROKE, V31, P1420, DOI 10.1161/01.STR.31.6.1420; Davison S P, 1997, Ear Nose Throat J, V76, P436; DICKINS JRE, 1993, AM J OTOL, V14, P544; Dzialo AF, 2001, ARCH PHYS MED REHAB, V82, P683, DOI 10.1053/apmr.2001.19244; Gamillscheg A, 1989, Padiatr Padol, V24, P245; GHORAYEB BY, 1998, ARCH OTOLARYNGOL, V113, P749; GOLD S, 1993, AM J OTOLARYNG, V14, P327, DOI 10.1016/0196-0709(93)90090-T; Grees H, 2002, HNO, V50, P906, DOI 10.1007/s00106-002-0729-2; Han KW, 2002, PLAST RECONSTR SURG, V109, P496, DOI 10.1097/00006534-200202000-00013; Holgers K M, 1987, Int J Oral Maxillofac Implants, V2, P35; HOLGERS KM, 1988, AM J OTOL, V9, P56; Holzmann D, 1999, LARYNGOSCOPE, V109, P645, DOI 10.1097/00005537-199904000-00024; KELLY KE, 1991, OTOLARYNG HEAD NECK, V105, P617, DOI 10.1177/019459989110500414; Kolenda J, 1997, J OTOLARYNGOL, V26, P203; Kuczkowski J, 2001, INT J PEDIATR OTORHI, V60, P227, DOI 10.1016/S0165-5876(01)00524-9; Lang M, 2002, OPHTHALMOLOGE, V99, P49, DOI 10.1007/PL00007116; Low WK, 2002, ORL J OTO-RHINO-LARY, V64, P38, DOI 10.1159/000049267; LUNDGREN S, 1993, INT J ORAL MAX SURG, V22, P272, DOI 10.1016/S0901-5027(05)80514-4; Magliulo G, 1996, ANN OTO RHINOL LARYN, V105, P991, DOI 10.1177/000348949610501210; Mekayarajjananonth Trakol, 2002, J Oral Implantol, V28, P117, DOI 10.1563/1548-1336(2002)028<0117:ARFAIA>2.3.CO;2; MYLANUS EAM, 1994, ARCH OTOLARYNGOL, V120, P81; NIPARKO JK, 1993, AM J OTOL, V14, P343; PARAL SM, 1991, INT J ORAL MAXILLFAC, V6, P75; Perez-Duenas B, 2002, REV NEUROLOGIA, V35, P913, DOI 10.33588/rn.3510.2002315; Portmann D, 1997, Ear Nose Throat J, V76, P231; Reyes RA, 2000, OTOLARYNG HEAD NECK, V122, P272, DOI 10.1016/S0194-5998(00)70255-5; Satake R, 1997, Rinsho Shinkeigaku, V37, P309; Satoh H, 2000, NEUROL MED-CHIR, V40, P361, DOI 10.2176/nmc.40.361; Scarrow AM, 1999, AM J NEURORADIOL, V20, P1467; Srivastava AK, 2002, NEUROL INDIA, V50, P215; Staecker H, 1999, AM J OTOL, V20, P726; Sugar A, 1994, ORAL MAXILLOFAC SURG, V6, P755; Sztajzel R, 2001, HEADACHE, V41, P889, DOI 10.1046/j.1526-4610.2001.041009889.x; TSAI FY, 1992, AM J NEURORADIOL, V13, P1137; Vaidya B, 1998, THYROID, V8, P787, DOI 10.1089/thy.1998.8.787; Vazquez E, 2003, RADIOGRAPHICS, V23, P359, DOI 10.1148/rg.232025076; Yamakami I, 1998, NEUROL MED-CHIR, V38, P43, DOI 10.2176/nmc.38.43	42	6	6	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	OCT	2004	32	5					324	329		10.1016/j.jcms.2004.05.009			6	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	865NG	WOS:000224709200008	15458676				2022-02-06	
J	Schmid, DM; Hauri, D; Schurch, B				Schmid, DM; Hauri, D; Schurch, B			Nocturnal penile tumescence and rigidity (NPTR) findings in spinal cord injured men with erectile dysfunction	INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH			English	Article						erectile dysfunction; spinal cord injury; nocturnal penile tumescence; electrophysiology; neuronal erectile control	SLEEP; DIAGNOSIS; IMPOTENCE; PRESSURE; NERVES	This prospective study aimed at determining whether nocturnal penile tumescence and rigidity (NPTR) findings correlate to the neurologic disorders in spinal cord injured (SCI) patients suffering from erectile dysfunction (ED). A total of 25 acute SCI male patients with post-traumatic ED underwent neurological, electrophysiological and urodynamic examinations, respectively, as well as NPTR recordings. The mean value for rigidity (R), tumescence (T) and duration (D) during NTPR tests were 83.3%, 3.3 cm, 6.4 min in patients with a complete lesion above the sacral (S2-S4) spinal cord (n=10), 46.1%, 1.6 cm, 5.5 min in patients with a complete lesion involving the sacral metameres (n=5) and 89.8%, 3.8 cm, 29 min in patients with an incomplete suprasacral lesion (n=7). The differences among these groups were statistically significant (P<0.05). Patients with lesions involving both sacral and thoracolumbar spinal cord showed no erections (n=3). We found four NTPR patterns: (1) normal R and T, short D; (2) weak R and T, short D; (3) normal R, T and D; and (4) no erections, which can be assigned to different levels and completeness of spinal cord lesions. Nocturnal erections of normal quality need preservation of thoracolumbar and sacral neuronal control as well as partially intact connections of the spinal erection centres with brain areas responsible for sexual arousal.	Univ Zurich Hosp, Dept Urol, CH-8091 Zurich, Switzerland; Balgrist Univ Hosp, Spinal Cord Injury Ctr, Dept Neuroradiol, Zurich, Switzerland		Schmid, DM (corresponding author), Univ Zurich Hosp, Dept Urol, Frauenklin Str, CH-8091 Zurich, Switzerland.	daniel.max.schmid@usz.ch					Andersson KE, 1997, WORLD J UROL, V15, P14, DOI 10.1007/BF01275151; BEMELMANS BLH, 1991, J UROLOGY, V146, P777, DOI 10.1016/S0022-5347(17)37919-3; Bernabe J, 1999, AM J PHYSIOL-REG I, V276, pR441, DOI 10.1152/ajpregu.1999.276.2.R441; Bors E, 1960, UROL SURV, V10, P191; CHAPELLE PA, 1980, BRIT J UROL, V52, P216, DOI 10.1111/j.1464-410X.1980.tb02962.x; Colombo F, 1994, Arch Ital Urol Androl, V66, P159; COMARR AE, 1970, UROL INT, V25, P134, DOI 10.1159/000279669; COURTOIS FJ, 1995, PARAPLEGIA, V33, P628, DOI 10.1038/sc.1995.133; Courtois FJ, 1999, ARCH PHYS MED REHAB, V80, P1268, DOI 10.1016/S0003-9993(99)90028-X; Courtois FJ, 1998, SPINAL CORD, V36, P125, DOI 10.1038/sj.sc.3100584; COURTOIS FJ, 1993, PHYSIOL BEHAV, V53, P721, DOI 10.1016/0031-9384(93)90179-J; Cruz MR, 1999, J AUTONOM NERV SYST, V76, P15, DOI 10.1016/S0165-1838(98)00191-X; DAIL WG, 1989, J AUTONOM NERV SYST, V28, P251, DOI 10.1016/0165-1838(89)90153-7; DEGROAT WC, 1993, AUTONOMIC NERVOUS SY, V3, P467; FOWLER CJ, 1988, BRIT J UROL, V61, P63, DOI 10.1111/j.1464-410X.1988.tb09164.x; HERBERT J, 1973, PHYSIOL BEHAV, V10, P293, DOI 10.1016/0031-9384(73)90313-2; MARSHALL P, 1981, ARCH SEX BEHAV, V10, P1, DOI 10.1007/BF01542669; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; MORALES A, 1990, J UROLOGY, V143, P441, DOI 10.1016/S0022-5347(17)39986-X; PADMANATHAN H, 1988, UROL CLIN N AM, V15, P77; ROOT WS, 1947, AM J PHYSIOL, V151, P80, DOI 10.1152/ajplegacy.1947.151.1.80; SACHS BD, 1995, NEUROSCI BIOBEHAV R, V19, P211, DOI 10.1016/0149-7634(94)00063-7; Schmidt MH, 1999, SLEEP, V22, P409, DOI 10.1093/sleep/22.4.409; SCHMIDT MH, 1994, NEUROREPORT, V5, P561, DOI 10.1097/00001756-199401000-00007; Schmidt MH, 2000, J NEUROSCI, V20, P6640, DOI 10.1523/JNEUROSCI.20-17-06640.2000; Semans JH, 1938, J UROLOGY, V40, P836, DOI 10.1016/S0022-5347(17)71825-3; Stohrer M, 1999, NEUROUROL URODYNAM, V18, P139; THASE ME, 1987, AM J PSYCHIAT, V144, P89; Traish A, 2000, INT J IMPOT RES, V12, pS48, DOI 10.1038/sj.ijir.3900506; VANNUETEN J, 1992, EUR UROL, V22, P119; WAGNER G, 1989, J UROLOGY, V142, P723, DOI 10.1016/S0022-5347(17)38867-5; Wyndaele JJ, 1997, SPINAL CORD, V35, P213, DOI 10.1038/sj.sc.3100391	32	6	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0955-9930	1476-5489		INT J IMPOT RES	Int. J. Impot. Res.	OCT	2004	16	5					433	440		10.1038/sj.ijir.3901188			8	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	855LO	WOS:000223975000009	15014551	Bronze			2022-02-06	
J	Terrell, TR				Terrell, TR			Concussion in athletes	SOUTHERN MEDICAL JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; RETURN; PATHOPHYSIOLOGY; PERFORMANCE; GUIDELINES	Treatment of the "ding" or "bellring" complaint continues to involve tough decision-making. Combined multispecialty research-based guidelines have now evolved to permit better handling of return to contact during practice and formal competition. Dr. Terrell brings first-hand experience and current evidence-based criteria and discussion to the reader.	Univ S Carolina, Sch Med, Columbia, SC USA; Univ S Carolina, Athlet Dept, Columbia, SC USA		Terrell, TR (corresponding author), 3209 Colonial Dr, Columbia, SC 29203 USA.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; CARTLIDGE NEF, 1981, HEAD INJURY, P28; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; CNATU RC, 1999, NEUROLOGIC ATHLETIC, P117; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; DELANEY SJ, 2000, CLIN J SPORT MED, V54, P1488; Erlanger D, 2001, J ATHL TRAINING, V36, P280; GRAHAM DI, 1996, NEUROTRAUMA, P46; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Hofman PAM, 1999, MAGN RESON MED, V42, P803, DOI 10.1002/(SICI)1522-2594(199910)42:4<803::AID-MRM24>3.3.CO;2-6; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; JOHNSTON K, 2002, PHYS SPORSTMEDICINE, P30; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LOVELL M, 2002, 11 ANN M AM MED SOC; MARION DW, 1999, TRAUMATIC BRAIN INJU, P32; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Sallis RE, 2000, MED SCI SPORT EXER, V32, P1820, DOI 10.1097/00005768-200011000-00002; Terrell TR, 1999, AM FAM PHYSICIAN, V60, P738; TYSAVAER AT, 1981, BRIT J SPORT MED, V15, P163; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109	39	6	6	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0038-4348	1541-8243		SOUTH MED J	South.Med.J.	SEP	2004	97	9					837	842		10.1097/01.SMJ.0000140091.58338.1E			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855PL	WOS:000223986100012	15455966				2022-02-06	
J	Czigner, A; Mihaly, A; Farkas, O; Buki, A; Krisztin-Peva, B; Dobo, E; Barzo, P				Czigner, A; Mihaly, A; Farkas, O; Buki, A; Krisztin-Peva, B; Dobo, E; Barzo, P			Dynamics and regional distribution of c-fos protein expression in rat brain after a closed head injury	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						closed head injury; c-fos expression; immunochemistry; whole brain; rat	GENE-EXPRESSION; TRANSCRIPTION FACTORS; NERVOUS-SYSTEM; MESSENGER-RNA; INDUCTION; JUN; NEURONS; MODEL; DAMAGE; EDEMA	The objective of this study was to define the time- and brain-area-related distribution of c-fos expression in the brain during the first 24 h following a closed head injury in rats. In the control groups (n=32), only a few c-fos positive nuclei were observed in the brain and the c-fos staining did not change during the next 24 h. In the closed head injury group c-fos-positive cells were rare in the brain regions during the first 30 min. During the next 2 h, the number of c-fos-positive cells increased rapidly in the basal ganglions, the ventricular ependyma cells the corticospinal tract, the area postrema, the cerebral neocortex, and the corpus callosum. The increase was highest in the corpus callosum (317 +/- 44.5 mm(-2)), in the thalamic reticular nucleus (474.8 +/- 49.2 mm(-2)), in the dentate hilus (1090 +/- 187 mm(-2)) and in the cerebral neocortex (992 +/- 93 mm(-2)). Thereafter, the elevated c-fos expression gradually decreased and at 6 h post-closed head injury no significant differences were observed between the controls and the trauma group. We conclude that a closed head injury induces a large, transient increase of c-fos expression in the brain. Since the observed time course and regional differences in c-fos expression are in good agreement with the cognitive and memory deficits observed after human TBI it can be utilized in further investigations, especially to test the effects of various forms of pharmacological or cellular therapy.	Univ Szeged, Fac Med, Dept Neurosurg, H-6725 Szeged, Hungary; Univ Szeged, Fac Med, Dept Anat, H-6725 Szeged, Hungary; Univ Pecs, Fac Med, Dept Neurosurg, Pecs, Hungary		Barzo, P (corresponding author), Univ Szeged, Fac Med, Dept Neurosurg, Semmelweis 6, H-6725 Szeged, Hungary.	pbarzo@yahoo.com	Buki, Andras/B-1960-2010; Mihaly, Andras/K-5096-2012	Mihaly, Andras/0000-0002-6802-0169			Abrous DN, 1999, BRAIN RES, V826, P181, DOI 10.1016/S0006-8993(99)01259-7; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; Awasthi D, 2003, NEUROSCI LETT, V345, P29, DOI 10.1016/S0304-3940(03)00497-X; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Dave JR, 1997, NEUROREPORT, V8, P395, DOI 10.1097/00001756-199701200-00002; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DRAGUNOW M, 1987, NEUROSCI LETT, V82, P157, DOI 10.1016/0304-3940(87)90121-2; DRAGUNOW M, 1988, BRAIN RES, V455, P295, DOI 10.1016/0006-8993(88)90088-1; DRAGUNOW M, 1990, BRAIN RES, V527, P41, DOI 10.1016/0006-8993(90)91058-O; DRAGUNOW M, 1990, EXP NEUROL, V107, P236, DOI 10.1016/0014-4886(90)90141-E; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Giza CC, 2002, J NEUROTRAUM, V19, P387, DOI 10.1089/08977150252932352; Haas CA, 1999, NEUROSCIENCE, V90, P41, DOI 10.1016/S0306-4522(98)00462-X; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Inada K, 1998, J IMMUNOL, V161, P3853; Kaina B, 1997, CANCER RES, V57, P2721; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Lindsberg PJ, 1996, J CEREBR BLOOD F MET, V16, P82, DOI 10.1097/00004647-199601000-00010; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MARMAROU A, 1994, ACTA NEUROCHIR, P421; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; McKitrick DJ, 2000, BRAIN RES BULL, V53, P307, DOI 10.1016/S0361-9230(00)00346-4; Mihaly A, 1997, BRAIN RES, V761, P135, DOI 10.1016/S0006-8993(97)00317-X; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; PHILLIPS LL, 1992, J NEUROTRAUM, V9, P323, DOI 10.1089/neu.1992.9.323; POVLISHOCK JT, 1986, ACTA NEUROPATHOL, V70, P53, DOI 10.1007/BF00689514; RAGHUPATHI R, 1995, J CEREBR BLOOD F MET, V15, P467, DOI 10.1038/jcbfm.1995.58; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; SHARP JW, 1990, EXP NEUROL, V109, P323, DOI 10.1016/S0014-4886(05)80023-8; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; Whitfield PC, 2000, NEUROL RES, V22, P138, DOI 10.1080/01616412.2000.11741050; WOODSIDE B, 1995, BRAIN RES, V690, P48, DOI 10.1016/0006-8993(95)00586-F	45	6	6	0	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	AUG	2004	14	2					247	252					6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	838PW	WOS:000222726400019	15254773				2022-02-06	
J	Powell, MR; Gfeller, JD; Oliveri, MV; Stanton, S; Hendricks, B				Powell, MR; Gfeller, JD; Oliveri, MV; Stanton, S; Hendricks, B			The Rey AVLT serial position effect: A useful indicator of symptom exaggeration?	CLINICAL NEUROPSYCHOLOGIST			English	Article							FEIGNED COGNITIVE IMPAIRMENT; BASE RATES; PERFORMANCE; INCENTIVES; SIMULATION; SCALE; TESTS	This investigation explored the usefulness of serial position patterns during word recall on the Rey Auditory Verbal Learning Test (RAVLT; Rey, 1964) as an indicator of poor effort. Significantly better recall for early (primacy) and recent (recency) material defines the serial position effect (SPE; Rundus, 1971). The SPE on the RAVLT was examined in four groups: normal controls (NC), symptom-coached simulators (SC), test-coached simulators (TC), and a group of moderate to severe subacute traumatic brain injury (TBI) patients. Normal control participants and TBI patients demonstrated the expected SPE. Only the SC simulators clearly suppressed the primacy effect. The SPE appears neither sensitive nor specific enough to be used independently of more sensitive symptom validity tests in the detection of suboptimal effort. It may be especially problematic when used with clients presenting with sophisticated styles of exaggeration and in settings with lower base rates of compromised effort.	Mayo Clin, Rochester, MN 55905 USA; St Louis Univ, St Louis, MO 63103 USA; St Johns Mercy Med Ctr, St Louis, MO 63141 USA; Univ Missouri, St Louis, MO 63121 USA; Univ Wisconsin, Wausau, WI USA		Powell, MR (corresponding author), Mayo Clin, 200 1st St SW,Mayo Bldg, Rochester, MN 55905 USA.	powell.matthew@mayo.edu					Bernard L C, 1991, Arch Clin Neuropsychol, V6, P81, DOI 10.1016/0887-6177(91)90024-4; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; BIGLER ED, 1989, J CLIN PSYCHOL, V45, P277, DOI 10.1002/1097-4679(198903)45:2<277::AID-JCLP2270450216>3.0.CO;2-M; BINDER LM, 1993, ARCH CLIN NEUROPSYCH, V8, P137, DOI 10.1016/0887-6177(93)90031-U; Binder LM, 1996, AM J PSYCHIAT, V153, P7; DiCarlo MA, 2000, ARCH CLIN NEUROPSYCH, V15, P399, DOI 10.1016/S0887-6177(99)00031-1; Fletcher R.H., 1996, CLIN EPIDEMIOLOGY ES; Flowers KA, 1996, J NEUROLINGUIST, V9, P147, DOI 10.1016/0911-6044(95)00007-0; Frederick R. I., 1991, PSYCHOL ASSESSMENT J, V3, P596, DOI DOI 10.1037/1040-3590.3.4.596; Gervais RO, 2001, J RHEUMATOL, V28, P1892; GERVAIS RO, 2001, J FORENSIC NEUROPSYC, V2, DOI DOI 10.1300/J151V02N02_01; Gfeller JD, 2001, ARCH CLIN NEUROPSYCH, V16, P848; Gfeller JD, 1998, J CLIN PSYCHOL, V54, P431, DOI 10.1002/(SICI)1097-4679(199806)54:4<431::AID-JCLP5>3.0.CO;2-Q; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 1996, WORD MEMORY TEST USE; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; King JH, 1998, J CLIN EXP NEUROPSYC, V20, P603, DOI 10.1076/jcen.20.5.603.1124; Langeluddecke PM, 2003, ARCH CLIN NEUROPSYCH, V18, P181, DOI 10.1016/S0887-6177(01)00195-0; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Rey A., 1964, EXAMEN CLIN PSYCHOL; Reynolds CR, 1998, CRIT ISS NE, P261; RUNDUS D, 1971, J EXP PSYCHOL, V89, P63, DOI 10.1037/h0031185; SMITH GE, 2003, CLIN INTERPRETATION; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; SPRREN O, 1998, COMPENDIUM NEUROPSYC; Suhr JA, 2002, ARCH CLIN NEUROPSYCH, V17, P69, DOI 10.1016/S0887-6177(00)00102-5; Sullivan K, 2002, ARCH CLIN NEUROPSYCH, V17, P223, DOI 10.1016/S0887-6177(01)00110-X; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; [No title captured]	34	6	6	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	AUG	2004	18	3					465	476		10.1080/1385404049052409			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	875QP	WOS:000225437100011	15739816				2022-02-06	
J	Harnett, MA; Godfrey, HPD; Knight, RG				Harnett, MA; Godfrey, HPD; Knight, RG			Regression equations for predicting premorbid performance on executive test measures by persons with traumatic brain injuries	NEW ZEALAND JOURNAL OF PSYCHOLOGY			English	Article							ADULT READING TEST; DEMOGRAPHIC-VARIABLES; VERBAL FLUENCY; HEAD-INJURY; WAIS-R; CATEGORY TEST; INTELLIGENCE; VALIDITY; DEFICITS; IQ	Regression equations, using as predictors demographic variables and scores on tests resistant to the effects of brain injury, are often used to calculate predicted test scores on tests used in neuropsychological assessment. The discrepancy between a predicted and an obtained score can be used in the diagnosis of cognitive deficits resulting from brain damage. The aim of the present study was to develop regression equations that would allow the prediction of scores on tests sensitive to executive deficits and to apply these to data from persons with brain injuries. A total of 100 persons from the community were tested and the resultant equations were used to predict the scores of 40 persons with traumatic brain injuries. For those equations with multiple correlations in the order of .50, the numbers of persons classified using either the equations or the published normative tables were comparable. Procedures for determining the abnormality of an individual's test score discrepancy described by Crawford and Howell (1998), based on the output from multiple regression procedures, are discussed. Where normative data from a local sample are available, use of regression equations to determine the abnormality of a discrepancy can provide a useful means of validating conclusions based on the application of US or UK norms.	Univ Otago, Dept Psychol, Dunedin, New Zealand		Knight, RG (corresponding author), Univ Otago, Dept Psychol, POB 56, Dunedin, New Zealand.	rknight@psy.otago.ac.nz		Fountain, Mairead/0000-0003-0575-5368			BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Beck A., 1996, BECK DEPRESSION INVE; Benson D.F., 1986, FRONTAL LOBES; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; CARADOCDAVIES TH, 1995, NEUROEPIDEMIOLOGY, V14, P199, DOI 10.1159/000109797; Cockburn J, 1995, J Int Neuropsychol Soc, V1, P537; Crawford J. R., 1992, HDB NEUROPSYCHOLOGIC; Crawford JR, 1998, NEUROPSYCHOL REHABIL, V8, P255, DOI 10.1080/713755575; Crawford JR, 1998, J CLIN EXP NEUROPSYC, V20, P755, DOI 10.1076/jcen.20.5.755.1132; Crawford JR, 1997, CLIN NEUROPSYCHOL, V11, P192, DOI 10.1080/13854049708407050; CRAWFORD JR, 1989, PERS INDIV DIFFER, V10, P793, DOI 10.1016/0191-8869(89)90126-8; CRAWFORD JR, 1988, BRIT J PSYCHIAT, V153, P178, DOI 10.1192/bjp.153.2.178; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; CRAWFORD JR, 1989, BRIT J CLIN PSYCHOL, V28, P267, DOI 10.1111/j.2044-8260.1989.tb01376.x; CRAWFORD JR, 1990, BRIT J CLIN PSYCHOL, V29, P435, DOI 10.1111/j.2044-8260.1990.tb00908.x; CRAWFORD JR, 1992, BRIT J CLIN PSYCHOL, V31, P327, DOI 10.1111/j.2044-8260.1992.tb00999.x; Duncan J, 1997, COGNITIVE NEUROPSYCH, V14, P713, DOI 10.1080/026432997381420; Fortuny LA, 1996, CLIN NEUROPSYCHOL, V10, P419, DOI 10.1080/13854049608406702; Franzen MD, 1997, ARCH CLIN NEUROPSYCH, V12, P711, DOI 10.1016/S0887-6177(97)00046-2; Freeman J, 2000, BRIT J CLIN PSYCHOL, V39, P95, DOI 10.1348/014466500163130; GLOSSER G, 1990, J CLIN EXP NEUROPSYC, V12, P485, DOI 10.1080/01688639008400995; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Goodglass H, 1983, ASSESSMENT APHASIA R; Heaton R.K., 1981, WISCONSIN CARD SORTI; HEATON RK, 1993, WISCONSIN CARD SCORI; Heaton RK, 1999, WISCONSIN CARD SORTI; Hellman S. G., 1992, INT J METH PSYCH RES, V2, P151; Johnstone B, 1995, Appl Neuropsychol, V2, P24, DOI 10.1207/s15324826an0201_4; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; KARZMARK P, 1985, J CLIN EXP NEUROPSYC, V7, P412, DOI 10.1080/01688638508401273; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; MARTIN DJ, 1991, J CLIN PSYCHOL, V47, P684, DOI 10.1002/1097-4679(199109)47:5<684::AID-JCLP2270470509>3.0.CO;2-G; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Mercer WN, 1997, CLIN NEUROPSYCHOL, V11, P174, DOI 10.1080/13854049708407047; Milner B., 1964, FRONTAL GRANULAR COR, P313; MOSS AR, 1991, BRIT J CLIN PSYCHOL, V30, P179, DOI 10.1111/j.2044-8260.1991.tb00934.x; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; O'Brien LF, 1999, NEW ZEAL MED J, V112, P295; OCARROLL RE, 1987, BRIT J CLIN PSYCHOL, V26, P315, DOI 10.1111/j.2044-8260.1987.tb01367.x; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; RUSSELL EW, 1987, J CONSULT CLIN PSYCH, V55, P898, DOI 10.1037/0022-006X.55.6.898; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Spreen O., 1969, NEUROSENSORY CTR COM; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; TRANEL D, 1994, HDB NEUROPSYCHOLOGY, P125; VANDENBROEK MD, 1994, BRIT J CLIN PSYCHOL, V33, P509; [No title captured]	51	6	6	0	6	NEW ZEALAND PSYCHOL SOC	WELLINGTON	BUSINESS MANAGER PO BOX 4092, WELLINGTON, NEW ZEALAND	0112-109X	1179-7924		NEW ZEAL J PSYCHOL	N. Z. J. Psychol.	JUL	2004	33	2					78	87					10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	850HH	WOS:000223601300005					2022-02-06	
J	Ohashi, H; Kasuga, Y; Hata, N; Manabe, S; Takashima, Y; Lee, S; Yamakawa, R				Ohashi, H; Kasuga, Y; Hata, N; Manabe, S; Takashima, Y; Lee, S; Yamakawa, R			Morphological changes in the optic disc after vitrectomy and fluid-air exchange	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article							PARS-PLANA VITRECTOMY; MACULAR HOLE SURGERY; TOPOGRAPHIC MEASUREMENTS; NERVE HEAD; INTRAOCULAR-PRESSURE; CLOSED VITRECTOMY; RETINAL INJURY; ISCHEMIA; DAMAGE; MODEL	Background: Although many investigators have previously reported various ocular complications induced by vitrectomy, little is known about post-operative morphological changes in the optic disc. The purpose of this study is to evaluate the effect of vitrectomy and fluid-air (F-A) exchange on the post-operative morphology of the optic disc. Methods: We examined 31 eyes that had undergone vitrectomy for macular holes (22 eyes) or epiretinal membranes (9 eyes). Only the patients with macular holes were treated by fluid-air exchange. Morphological changes in the optic disc were evaluated using the Heidelberg Retina Tomograph. Results: C/D area ratios significantly decreased for 6 months post-operatively. The rim volumes significantly increased for I month following surgery. Cup volumes significantly decreased at 3 months after surgery. No significant change of mean cup depth was observed post-operatively. The eyes that had not been subjected to F-A exchange showed no significant morphological change following surgery. In contrast, the eyes that had undergone F-A exchange showed significant decrease in C/D area ratio and cup volume and an increase in rim volume and mean cup depth for considerable periods following surgery. Any of the patients showed no post-operative visual field loss. Conclusion: Whereas no visual field loss is observed, vitrectomy with F-A exchange induces morphological changes in the optic disc for significant periods following surgery.	Tenri Yorozu Hosp, Dept Ophthalmol, Tenri, Nara 6328552, Japan; Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan		Ohashi, H (corresponding author), Tenri Yorozu Hosp, Dept Ophthalmol, 200 Mishimacho, Tenri, Nara 6328552, Japan.	oha@kuhp.kyoto-u.ac.jp					Adachi M, 1996, GRAEF ARCH CLIN EXP, V234, P445, DOI 10.1007/BF02539411; BLAIR NP, 1991, ARCH OPHTHALMOL-CHIC, V109, P113, DOI 10.1001/archopht.1991.01080010115042; CHAUHAN BC, 1994, AM J OPHTHALMOL, V118, P9, DOI 10.1016/S0002-9394(14)72836-3; Ezra E, 1996, BRIT J OPHTHALMOL, V80, P519, DOI 10.1136/bjo.80.6.519; HORIGUCHI M, 1991, ARCH OPHTHALMOL-CHIC, V109, P1127, DOI 10.1001/archopht.1991.01080080087035; Hutton WL, 1996, OPHTHALMOLOGY, V103, P2152, DOI 10.1016/S0161-6420(96)30376-X; JANKNECHT P, 1994, BRIT J OPHTHALMOL, V78, P760, DOI 10.1136/bjo.78.10.760; Kerrison JB, 1996, ARCH OPHTHALMOL-CHIC, V114, P564, DOI 10.1001/archopht.1996.01100130556010; KUHN F, 1991, AM J OPHTHALMOL, V111, P42, DOI 10.1016/S0002-9394(14)76894-1; MATSUDA M, 1986, JPN J OPHTHALMOL, V30, P324; MCDONALD HR, 1988, ARCH OPHTHALMOL-CHIC, V106, P521; Mitamura Yoshinori, 1998, Nippon Ganka Gakkai Zasshi, V102, P59; MOORHEAD LC, 1979, AM J OPHTHALMOL, V88, P239, DOI 10.1016/0002-9394(79)90472-0; Ohji M, 1999, AM J OPHTHALMOL, V127, P62, DOI 10.1016/S0002-9394(98)00287-6; PARRISH R, 1982, OPHTHALMOLOGY, V89, P1472; Russell SR, 2001, ARCH OPHTHALMOL-CHIC, V119, P1653; Tamai K, 1997, EXP EYE RES, V65, P733, DOI 10.1006/exer.1997.0386; WEINREB RN, 1993, ARCH OPHTHALMOL-CHIC, V111, P636, DOI 10.1001/archopht.1993.01090050070031; Zangwill LM, 1996, AM J OPHTHALMOL, V122, P520, DOI 10.1016/S0002-9394(14)72112-9	19	6	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	JUN	2004	242	6					484	488		10.1007/s00417-004-0877-z			5	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	838VY	WOS:000222742600006	14968365				2022-02-06	
J	McGinn, MJ; Sun, D; Schneider, SL; Alexander, JK; Colello, RJ				McGinn, MJ; Sun, D; Schneider, SL; Alexander, JK; Colello, RJ			Epidermal growth factor-induced cell proliferation in the adult rat striatum	BRAIN RESEARCH			English	Article						stem cells; growth factors; mitogens; neurogenesis; gliogenesis; CNS	TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; SUBVENTRICULAR ZONE; NEUROTROPHIC FACTORS; FACTOR RECEPTOR; PRECURSOR CELL; GENE-TRANSFER; FACTOR-ALPHA	Current strategies for repairing the adult CNS following injury include cell transplantation and/or the use of viral vectors to deliver therapeutic agents. Although promising, both techniques are limited in their usefulness due to the immunological response triggered in the brain as a result of the introduction of foreign antigens. An alternative method to repair the damaged CNS is to stimulate endogenous cells within the brain to divide thereby replacing cells lost to injury. Since it has been shown that growth factors such as epidermal growth factor (EGF) are potent mitogens to CNS cells in vitro, we sought to assess the mitogenic effect of an in vivo application of EGF to the adult mammalian brain. Accordingly, varying doses of human recombinant EGF were administered to the striatum of adult rats, followed 48 h later by intraperitoneal injections of 5-bromodeoxyuridine (BrdU), a marker for cell proliferation. Of four doses assessed, 0.05 ng of EGF induced the highest levels of cell proliferation. To determine the cellular identity of these proliferating cells, animals were injected with H-3-thymidine 48 h following EGF administration to label dividing cells. Sections were subsequently immunostained for markers to astrocytes, microglia, oligodendrocytes, neural precursors, and mature neurons. Compared to controls, a significant proportion of the newly generated cells resulting from EGF administration were identified as immature and mature astrocytes. Collectively, these results provide valuable information for utilizing a growth factor administration approach to mobilize the proliferative response of endogenous cells to replace those lost to injury or disease. (C) 2004 Elsevier B.V. All rights reserved.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Anat & Neurobiol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Richmond, VA 23298 USA		Colello, RJ (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	rcolello@hse.vcu.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01NS039851-03] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039851] Funding Source: NIH RePORTER		Aberg MAI, 2000, J NEUROSCI, V20, P2896; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amat JA, 1996, GLIA, V16, P368, DOI 10.1002/(SICI)1098-1136(199604)16:4<368::AID-GLIA9>3.0.CO;2-W; ANCHAN RM, 1991, NEURON, V6, P923, DOI 10.1016/0896-6273(91)90233-P; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; CADAY CG, 1990, DEV BRAIN RES, V52, P241, DOI 10.1016/0165-3806(90)90240-Y; CALVO JL, 1991, BRAIN RES, V566, P333, DOI 10.1016/0006-8993(91)91720-L; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Craig CG, 1996, J NEUROSCI, V16, P2649; DAHL D, 1976, BRAIN RES, V116, P150, DOI 10.1016/0006-8993(76)90257-2; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; DYER CA, 1991, J NEUROSCI RES, V28, P607, DOI 10.1002/jnr.490280418; ELDRIDGE SR, 1990, CARCINOGENESIS, V11, P2245, DOI 10.1093/carcin/11.12.2245; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Fricker-Gates RA, 2000, EXP NEUROL, V165, P237, DOI 10.1006/exnr.2000.7482; GENSBURGER C, 1987, FEBS LETT, V217, P1, DOI 10.1016/0014-5793(87)81230-9; Glorioso JC, 2003, J NEUROVIROL, V9, P165, DOI 10.1080/13550280390193984; GOMEZPINILLA F, 1995, J NEUROSCI, V15, P2021, DOI 10.1523/JNEUROSCI.15-03-02021.1995; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Grisolia JS, 2002, BRAIN RES BULL, V57, P823, DOI 10.1016/S0361-9230(01)00766-3; Gritti A, 1999, J NEUROSCI, V19, P3287; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Hopkins A., 1993, CLIN NEUROLOGY MODER; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2003, ANN NEUROL, V53, P405, DOI 10.1002/ana.10506; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Jooss K, 2003, GENE THER, V10, P955, DOI 10.1038/sj.gt.3302037; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; King LA, 2000, GENE THER, V7, P1103, DOI 10.1038/sj.gt.3301198; KITCHENS DL, 1994, J NEUROBIOL, V25, P797, DOI 10.1002/neu.480250705; Kornblum HI, 2000, DEV NEUROSCI-BASEL, V22, P16, DOI 10.1159/000017423; Kornblum HI, 1997, J COMP NEUROL, V380, P243, DOI 10.1002/(SICI)1096-9861(19970407)380:2<243::AID-CNE7>3.0.CO;2-3; Krum JM, 1999, EXP NEUROL, V160, P348, DOI 10.1006/exnr.1999.7222; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kukekov VG, 1997, GLIA, V21, P399, DOI 10.1002/(SICI)1098-1136(199712)21:4<399::AID-GLIA7>3.0.CO;2-Z; LAZAR LM, 1992, J NEUROSCI, V12, P1688; LEUTZ A, 1981, CELL TISSUE RES, V220, P393; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lowenstein PR, 2003, GENE THER, V10, P946, DOI 10.1038/sj.gt.3302048; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; MEHLER MF, 1909, ARCH NEUROL-CHICAGO, V56, P780; Messam CA, 2000, EXP NEUROL, V161, P585, DOI 10.1006/exnr.1999.7319; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853; MORI K, 1970, J NEUROCHEM, V17, P835, DOI 10.1111/j.1471-4159.1970.tb02237.x; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Palmer TD, 1999, J NEUROSCI, V19, P8487; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Parent JM, 2002, EPILEPSY RES, V50, P179, DOI 10.1016/S0920-1211(02)00078-5; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; PLATASALAMAN CR, 1991, PEPTIDES, V12, P653, DOI 10.1016/0196-9781(91)90115-6; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROGERS AW, 1979, TECHNIQUES AUTORADIO; Sarnat HB, 1998, BRAIN DEV-JPN, V20, P88, DOI 10.1016/S0387-7604(97)00111-3; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; SEROOGY KB, 1995, BRAIN RES, V670, P157, DOI 10.1016/0006-8993(94)01300-7; SINDEN JD, 1992, CURR OPIN NEUROL NEU, V5, P902; Subramanian T, 2001, SEMIN NEUROL, V21, P103, DOI 10.1055/s-2001-13125; SUN D, 2001, ABSTR SOC NEUROSCI, V27, P115; Svendsen CN, 1999, BRAIN PATHOL, V9, P499, DOI 10.1111/j.1750-3639.1999.tb00538.x; Teramoto T, 2003, J CLIN INVEST, V111, P1125, DOI 10.1172/JCI200317170; THOMAS WE, 1992, BRAIN RES REV, V17, P61; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; WATABE K, 1994, J NEUROSCI RES, V39, P525, DOI 10.1002/jnr.490390504; Wei LC, 2002, DEV BRAIN RES, V139, P9, DOI 10.1016/S0165-3806(02)00509-6; Weiss S, 1996, J NEUROSCI, V16, P7599	72	6	9	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 8	2004	1007	1-2					29	38		10.1016/j.brainres.2003.12.054			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	815AV	WOS:000221016100004	15064133				2022-02-06	
J	Makino, Y				Makino, Y			Morphological changes of cerebral ventricular wall in traumatic brain injury evaluated via large histological specimens	JOURNAL OF NEUROTRAUMA			English	Article						cerebral ventricular wall; head injury; large specimen; morphological changes; survival time	DIFFUSE AXONAL INJURY; MINOR HEAD-INJURY; EXPERIMENTAL HYDROCEPHALUS; WHITE MATTER; EPENDYMA; DAMAGE	Large brain specimens were prepared from 50 head-injured and 50 non-head-injured cases that underwent medicolegal autopsy to critically examine the morphological changes in the periventricular tissue caused by injury to the head. Hemorrhagic damage to the ventricular wall was observed in 30 (60%) of the head-injury cases but was not observed in any of the non-head injured cases. Of 14 cases with only wounds to the scalp, five cases (35.7%) had ventricular wall damage. Of 40 cases in which death occurred within 24 h after injury, 25 (62.5%) showed ventricular wall damage. Of five cases of dying more than 24 h post-injury, only one revealed ventricular wall damage. This ventricular wall damage was frequently detected in the posterior (46%) and anterior horns (19%) of the lateral ventricle, near the attachment of the choroid plexus (19%). These morphological changes are considered primary damage, formed at the moment of impact in that concomitant hemorrhagic damage to the ventricular wall was also observed in all immediate death cases. Accordingly, detection of ventricular wall damage is considered a reliable means for deducing the occurrence of traumatic injury even in the cases where death occurs soon after injury.	Hirosaki Univ, Sch Med, Dept Forens Med, Hirosaki, Aomori 0368562, Japan		Makino, Y (corresponding author), Hirosaki Univ, Sch Med, Dept Forens Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	makino@med.u-ryukyu.ac.jp					ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BERRY K, 1994, AM J FOREN MED PATH, V15, P132, DOI 10.1097/00000433-199406000-00008; CROOKS DA, 1991, J PATHOL, V165, P5, DOI 10.1002/path.1711650103; FREYTAG E, 1963, ARCH PATHOL, V75, P402; Gennarelli T, 1996, NEUROSURGERY, V2, P2611; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GRAHAM DI, 1992, J CLIN PATHOL, V45, P840, DOI 10.1136/jcp.45.9.840; Graham DI, 1997, GREENFIELDS NEUROPAT, P197; Grcevic N, 1983, Acta Neurochir Suppl (Wien), V32, P79; GULTEKIN SH, 1994, ARCH PATHOL LAB MED, V118, P168; HARDMAN JM, 1997, TXB NEUROPATHOLOGY, P1179; Holbourn AHS, 1943, LANCET, V2, P438; INOUE A, 1982, NEUROL MED TOKYO, V16, P614; INOUE A, 1983, NEUROL MED TOKYO, V18, P9; LANKSCH W, 1976, CRANIAL COMPUTERIZED, P318; LEESTMA JE, 1997, NEUROPATHOLOGY DIAGN, P475; LINDENBERG R, 1955, AM J PATHOL, V31, P297; MALONEY AFJ, 1969, BRIT J SURG, V56, P23, DOI 10.1002/bjs.1800560106; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; MILHORAT TH, 1970, ARCH NEUROL-CHICAGO, V22, P397, DOI 10.1001/archneur.1970.00480230015002; NAG S, 1997, TXB NEUROPATHOLOGY, P111; NAKAMURA N, 1986, HEAD TRAUMA, P48; OGATA J, 1972, ACTA NEUROPATHOL, V21, P213, DOI 10.1007/BF00688500; PAGE RB, 1979, ANAT REC, V194, P83, DOI 10.1002/ar.1091940106; PAGE RB, 1979, ANAT REC, V194, P67, DOI 10.1002/ar.1091940105; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROY S, 1974, ANAT RECORD, V180, P547, DOI 10.1002/ar.1091800313; SARNAT HB, 1995, J NEUROPATH EXP NEUR, V54, P1, DOI 10.1097/00005072-199501000-00001; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SIMPSON RHW, 1985, FORENSIC SCI INT, V27, P229, DOI 10.1016/0379-0738(85)90142-2; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; ZUCCARELLO M, 1981, ACTA NEUROCHIR, V55, P283, DOI 10.1007/BF01808444	38	6	8	1	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAY	2004	21	5					585	594		10.1089/089771504774129919			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	821LK	WOS:000221461900009	15165366				2022-02-06	
J	Garcia-Pena, M; Sanchez-Cabeza, A				Garcia-Pena, M; Sanchez-Cabeza, A			Perceptive and praxic impairments in traumatic brain injury patients: Significance in activities of daily living	REVISTA DE NEUROLOGIA			Spanish	Article						activities of daily living; agnosia; apraxia; occupational therapy; perceptual impairment; traumatic brain injury	OCCUPATIONAL-THERAPY; HIERARCHICAL MODEL; UNILATERAL NEGLECT; IDEATIONAL APRAXIA; REHABILITATION; ADULTS; DYSFUNCTION; STROKE; POSTSTROKE; DEFICITS	Objective. The main goal of the present study is to describe the implication of different perceptive and praxic deficits in activities of daily living (ADL). We also review some assessing scales and intervention techniques used in the training of these mentioned alterations after a traumatic brain injury (TBI). Development. There are three kinds of processes important for a correct ideation, motor planification and execution of a learned purposeful movement (praxis). Some of these processes are related to the visual basic perception of the objects (colour form, size, etc). Others are related to the most complex perception functions (depth, location, recognition, etc). The third group of functions are those integrating the sensory information (discrimination right-left side, corporal scheme disorders, etc). If ADL performance needs a suitable functioning of different structures of the nervous central system, then assessment and treatment will be necessary to obtain the best independence level of TBI patients. This is the main objective in occupational therapy. ADL may be separated in two different groups: basic abilities (feeding, grooming, dressing, etc) and instrumental abilities (meal preparation, managing money, shopping, using public transportation, etc). Conclusion. Impairments in both praxic and perceptive processes constitute one of the most prevalent deficits in TBI patients. From a clinical point of view, these deficits may lack the capacity to carry an independent life.	Hosp Beata Maria Ana, Unidad Dano Cerebral, E-28007 Madrid, Spain		Garcia-Pena, M (corresponding author), Hosp Beata Maria Ana, Unidad Dano Cerebral, Vaquerias,7, E-28007 Madrid, Spain.	mgciap@yahoo.es					ABREU B, 1994, OCCUPATIONAL PERFORM; ALEXANDER MP, 1992, BRAIN, V115, P87, DOI 10.1093/brain/115.1.87; ARNADOTTIR G, 1990, BRAIN BEHAV ASSESSIN; Ayres A. J., 1985, DEV DYSPRAXIA ADULT; Bea-Munoz M, 2000, REHABILITACION MADRI, V34, P468; Benton A., 1994, CONTRIBUTIONS NEUROP; Benton A, 1993, CLIN NEUROPSYCHOLOGY, P165; BENTON A L, 1978, Archives of Neurology, V35, P364; Bouska MJ, 1983, MANUAL APPL MOTOR FR; Bruce M. A. G., 1994, AOTA SELF STUDY SERI; Butler J. A., 2000, BRIT J OCCUPATIONAL, V63, P319; CERMAK SA, 1994, TOP GERIATR REHABIL, V10, P42; CHAIKIN EL, 2001, NEUROLOGICAL REHABIL; Cohen A H, 1992, J Am Optom Assoc, V63, P530; DELROSARIODOMIN.M, 2002, MINUSVAL, V2, P62; DERENZI E, 1988, BRAIN, V111, P1173, DOI 10.1093/brain/111.5.1173; DERENZI E, 1982, BRAIN, V105, P301, DOI 10.1093/brain/105.2.301; Edmans J A, 1989, Int Disabil Stud, V11, P25; EFFERSON L, 1995, NEUROLOGICAL REHABIL, P769; Foundas A L, 1995, J Int Neuropsychol Soc, V1, P62; GARCIAPENA M, 2000, POLIBEA, V57, P34; Gardner M. F, 1982, TEST VISUAL PERCEPTU; GEORGEKERKHOFF J, 2000, J NEUROL NEUROSUR PS, V68, P691; GIL R, 1999, NEUROPSICOLOGIA, P75; GILES GM, 1988, AM J OCCUP THER, V42, P658, DOI 10.5014/ajot.42.10.658; GILES GM, 1993, BRAIN INJURY REHABIL; GILLEN G, 1998, STROKE REHABILITATIO; Goldenberg G, 1998, NEUROPSYCHOL REHABIL, V8, P123; Goldenberg G, 2001, NEUROPSYCHOL REHABIL, V11, P147, DOI 10.1080/09602010042000204; GOUVIER W D, 1991, Neuropsychology Review, V2, P3, DOI 10.1007/BF01108845; GRIEVE J, 1993, NEUROPSYCHOLOGY OCCU; Grieve J., 2000, NEUROPSICOLOGIA TERA; Hammill D.D., 1972, MVPT MOTOR FREE VISU; Hanna-Pladdy B, 2001, NEUROPSYCHOL REHABIL, V11, P539, DOI 10.1080/09602010143000022; HENDERSON A, 1992, SENSORY INTEGRATION, V21, P7; Hendrickx M.E., 1992, P SAN DIEGO SOC NATU, P1; HIER DB, 1983, NEUROLOGY, V33, P337, DOI 10.1212/WNL.33.3.337; Hooper HE., 1983, HOOPER VISUAL ORG TE; Ishihara S, 1962, TEST COLOUR BLINDNES; Jackson T., 1999, BRIT J OCCUPATIONAL, V62, P321; KATZMANN S, 1994, AM J OCCUP THER, V48, P259, DOI 10.5014/ajot.48.3.259; LAVER AJ, 1995, STRUCTURED OBSERVATI; LEONCARRION J, 1998, BRAIN INJURY SOURCES, V4, P31; LEVINE DN, 1985, NEUROLOGY, V35, P1010, DOI 10.1212/WNL.35.7.1010; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lin KC, 1996, AM J OCCUP THER, V50, P504, DOI 10.5014/ajot.50.7.504; Luria A.R., 1966, HIGHER CORTICAL FUNC; MACDONALD J, 1981, AM J OCCUP THER, V14, P72; Manly T, 2002, NEUROPSYCHOL REHABIL, V12, P289, DOI 10.1080/0960201044000101; MCCARTHY RA, 1990, COGNITIVE NEUROPSYCH; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; NEISTADT M, 1995, AM J OCCUP THER, V49, P551; NEISTADT ME, 1992, AM J OCCUP THER, V46, P141, DOI 10.5014/ajot.46.2.141; NEISTADT ME, 1988, AM J OCCUP THER, V42, P434, DOI 10.5014/ajot.42.7.434; NEISTADT ME, 1994, AM J OCCUP THER, V48, P421, DOI 10.5014/ajot.48.5.421; NEISTADT ME, 1994, AM J OCCUP THER, V48, P62, DOI 10.5014/ajot.48.1.62; NEISTADT ME, 1994, AM J OCCUP THER, V48, P225, DOI 10.5014/ajot.48.3.225; OCHIPA C, 1992, BRAIN, V115, P1061, DOI 10.1093/brain/115.4.1061; Okkema K., 1993, COGNITION PERCEPTION; POECK K, 1986, NEUROPSYCHOLOGIA, V24, P129, DOI 10.1016/0028-3932(86)90046-1; POST RB, 1986, AM J OPTOM PHYS OPT, V63, P94; ROSENBLOOOM A, 1990, PRINCIPLES PRACTICE; ROTHI LJG, 1991, COGN NEUROPSYCHOL, V8, P443, DOI 10.1080/02643299108253382; ROTHI LJG, 1984, BRAIN COGNITION, V3, P426, DOI 10.1016/0278-2626(84)90032-0; Roy E. A., 1985, NEUROPSYCHOLOGICAL S, V23, P111, DOI [10.1016/S0166-4115(08)61139-5, DOI 10.1016/S0166-4115(08)61139-5]; RUBIO KB, 1995, AM J OCCUP THER, V49, P551, DOI 10.5014/ajot.49.6.551; SANCHEZCABEZA A, 2002, REV INFORMATIVA ASOC, V28, P2; Shepherd RB, 2000, NEUROLOGICAL REHABIL; SUNDET K, 1988, J CLIN EXP NEUROPSYC, V10, P363, DOI 10.1080/01688638808408245; TATE RL, 1995, NEUROPSYCHOL REHABIL, V5, P273, DOI 10.1080/09602019508401473; Toglia J. P., 1989, OCCUPATIONAL THERAPY, V1, P36; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505; Toglia JP, 1992, COGNITIVE REHABILITA; TOGLIA JP, 1991, OCCUPATIONAL THERAPY, V3, P18; TROMBLY C, 1995, AM J OCCUP THER, V49, P711, DOI 10.5014/ajot.49.7.711; Unsworth C., 1999, COGNITIVE PERCEPTUAL, P1; WARREN M, 1993, AM J OCCUP THER, V47, P42, DOI 10.5014/ajot.47.1.42; WARREN M, 1993, AM J OCCUP THER, V47, P55, DOI 10.5014/ajot.47.1.55; WARREN M, 1994, VISUAL SPATIAL SKILL; Warrington E. K., 1991, VISUAL OBJECT SPACE; ZEMKE R, 1994, AOTA SELF STUDY SERI; ZOLTAN B, 1996, THEORICAL BASIS EVAL, P1; ZOLTAN B, 1986, ADULT STROKE PATIENT	83	6	7	0	9	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	APR 16	2004	38	8					775	784		10.33588/rn.3808.2003567			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	821LM	WOS:000221462100012	15122548				2022-02-06	
J	Duerstock, BS				Duerstock, BS			Double labeling serial sections to enhance three-dimensional imaging of injured spinal cord	JOURNAL OF NEUROSCIENCE METHODS			English	Article						three-dimensional reconstruction; 3D imaging; 3D visualization; spinal cord injury; neurotrauma; histopathology	RECONSTRUCTION; MORPHOMETRY; RAT; PATHOLOGY; TRAUMA	A method of double labeling a set of serial histological sections was performed to produce multiple three-dimensional (3D) reconstructions from the same segment of injured spinal cord. Alternate groups of consecutive histological sections were stained with Luxol fast blue with cresyl violet and Mallory's trichrome in order to reconstruct two different 3D images that reveal different pathological features of the same 1-month-old compression spinal cord injury. Three-dimensional visualization of the two reconstructions was accomplished using an isocontouring algorithm that automatically extracts surfaces of features of interest based on pixel intensity. The two 3D reconstructions demonstrated the sparing of myelinated nerve fibers and the composition of neuroglia through the chronic lesion of an adult guinea pig. The 3D images provided a comprehensive and explicit view of a chronically injured spinal cord that is not possible by the inspection of two-dimensional (2D) histological sections or from magnetic resonance imaging. Using every histological section, we believe this double labeling 3D reconstruction technique provides a more enhanced and accurate visualization of the entire spinal cord lesion than has been possible before. Furthermore, we contend that this double labeling technique can further elucidate the histopathological events of secondary injury at different time points post-injury by using different combinations of complementary histological makers. (C) 2003 Elsevier B.V. All rights reserved.	Purdue Univ, Sch Vet Med, Ctr Paralysis Res, Dept Basic Med Sci, W Lafayette, IN 47907 USA		Duerstock, BS (corresponding author), Purdue Univ, Sch Vet Med, Ctr Paralysis Res, Dept Basic Med Sci, 408 S Univ St, W Lafayette, IN 47907 USA.	bsd@purdue.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039288] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS/HD39288-01A1] Funding Source: Medline		BAJAJ CL, 1997, P IEEE VIS 97 C; BALENTINE JD, 1978, LAB INVEST, V39, P236; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; BLIGHT AR, 1991, J NEUROL SCI, V103, P156, DOI 10.1016/0022-510X(91)90159-5; Bresnahan JC, 1991, J NEUROTRAUM, V8, P91, DOI 10.1089/neu.1991.8.91; CHAWLA SD, 1981, CANCER BIOCHEM BIOPH, V5, P153; CHIMENTO TC, 1994, J NEUROPHYSIOL, V71, P1883, DOI 10.1152/jn.1994.71.5.1883; Duerstock BS, 2000, COMPUT MED IMAG GRAP, V24, P389, DOI 10.1016/S0895-6111(00)00034-3; Duerstock BS, 2003, J MICROSC-OXFORD, V210, P138, DOI 10.1046/j.1365-2818.2003.01130.x; Duerstock BS, 2002, J EXP BIOL, V205, P13; HALLIDAY GM, 1993, SYNAPSE, V15, P1, DOI 10.1002/syn.890150102; HASHIMOTO S, 1988, ACTA OTO-LARYNGOL, V105, P64, DOI 10.3109/00016488809119447; Hounnou GM, 2003, SURG RADIOL ANAT, V25, P21, DOI 10.1007/s00276-002-0091-9; LISS AG, 1995, J MICROSC-OXFORD, V178, P160, DOI 10.1111/j.1365-2818.1995.tb03592.x; Moriarty LJ, 1998, J NEUROL SCI, V155, P121, DOI 10.1016/S0022-510X(97)00203-7; Roesch S, 1996, J NEUROSCI METH, V69, P197, DOI 10.1016/S0165-0270(96)00062-3; SALISBURY JR, 1994, HISTOL HISTOPATHOL, V9, P773; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; YOUNG W, 1995, CONT MANAGEMENT SPIN, V27	19	6	8	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	MAR 15	2004	134	1					101	107		10.1016/j.jneumeth.2003.11.012			7	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	779YQ	WOS:000189330500011	15102508				2022-02-06	
J	Salci, K; Enblad, P; Piper, I; Contant, C; Nilsson, P				Salci, K; Enblad, P; Piper, I; Contant, C; Nilsson, P			A model for studies of intracranial volume pressure dynamics in traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						intracranial compliance; pressure-volume index; rat; TBI	SEVERE HEAD-INJURY; PRECURSOR PROTEIN IMMUNOREACTIVITY; AGGRESSIVE TREATMENT; CONTUSION TRAUMA; RAT-BRAIN; INDEX; COMPRESSION; MANAGEMENT; DEATH; TALK	The present study was undertaken to establish an experimental trauma model where it was possible to alter intracranial pressure (ICP) dynamics without raising intracranial pressure to abnormal levels and monitor metabolic disturbances with microdialysis. Thirty rats were intubated and mechanically ventilated before and after trauma. ICP was measured in the left ventricle. A weight-drop technique (21 g from 35 cm) with a brain compression of 1.5 mm was used to produce the injury. Intracranial compensatory volume was decreased 20 or 60 muL by placement of rubber film between the dura mater and bone. A bolus injection technique was used for the pressure volume response. ICP remained within normal limits for 2 h after trauma irrespective of the reduction in compensatory intracranial volume. Pressure-volume index decreased from 0.0825 +/- 0.009 to 0.0779 +/- 0.011 mL in the sham trauma and from 0.0871 +/- 0.018 to 0.0748 +/- 0.017 mL in the trauma groups (P < 0.015) when the intracranial volume was reduced by 60 muL. Intracranial compliance was not affected significantly. The present study shows that it is possible to vary ICP dynamics in a traumatic brain injury model without causing pathological increases in baseline ICP. This model may be used to study the effects of secondary insults (i.e., hypotension, hypoxia, hypercarbia, and hyperthermia) on the injured brain when ICP is normal but intracranial compensatory volume is impaired.	Univ Uppsala Hosp, Dept Neurosurg, S-75185 Uppsala, Sweden; So Gen Hosp, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Nilsson, P (corresponding author), Univ Uppsala Hosp, Dept Neurosurg, S-75185 Uppsala, Sweden.	Pelle.Nilsson@neurokir.uu.se					BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOTEL C, 1993, J EXP ANIM SCI, V36, P78; BOWERS SA, 1980, NEUROSURGERY, V6, P237; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; KINGMAN TA, 1988, J NEUROPATH EXP NEUR, V47, P128, DOI 10.1097/00005072-198803000-00005; KOSTELJANETZ M, 1986, NEUROSURGERY, V18, P17, DOI 10.1227/00006123-198601000-00004; Langfitt T W, 1969, Clin Neurosurg, V16, P436; LEWEN A, 1995, NEUROREPORT, V6, P357, DOI 10.1097/00001756-199501000-00032; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; MARMAROU A, 1991, J NEUROSURG S, V75, P59; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MELTON JE, 1984, AM J PHYSIOL, V246, pR533, DOI 10.1152/ajpregu.1984.246.4.R533; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Miller J D, 1975, Clin Neurosurg, V22, P76; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MILLER JD, 1975, J NEUROSURG, V42, P274, DOI 10.3171/jns.1975.42.3.0274; MILLER JD, 1974, INJURY, V5, P274; Morimoto Y, 1996, STROKE, V27, P1405, DOI 10.1161/01.STR.27.8.1405; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; NORDSTROM CH, 1988, BRAIN INJURY, V3, P267; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; REILLY PL, 1975, LANCET, V2, P375; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; SPIEGELBERG A, 1996, WORK C INT GROPU INT; SULLIVAN HG, 1977, J NEUROSURG, V47, P532, DOI 10.3171/jns.1977.47.4.0532; TANS JTJ, 1983, J NEUROSURG, V59, P810, DOI 10.3171/jns.1983.59.5.0810; WARME PE, 1991, ACTA NEUROCHIR, V110, P57, DOI 10.1007/BF01402049; Zwienenberg M, 1999, J NEUROTRAUM, V16, P1095, DOI 10.1089/neu.1999.16.1095	39	6	6	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2004	21	3					317	327		10.1089/089771504322972103			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	806CI	WOS:000220411600009	15115606				2022-02-06	
J	Christophis, P				Christophis, P			The prognostic value of somatosensory evoked potentials in traumatic primary and secondary brain stem lesions	ZENTRALBLATT FUR NEUROCHIRURGIE			English	Article						prognosis; head injury; brainstem lesion; vegetative state; SSEP	SEVERE HEAD-INJURY; OUTCOME PREDICTION; COMATOSE PATIENTS; CONDUCTION TIME; DEATH	To estimate the prognostic value of somatosensory evoked potentials elicited via stimulation of the median nerve (M-SSEP) in cases of primary and secondary brainstem lesions 126 patients with traumatic brainstem lesions (GCSless than or equal to6) were investigated on admission to our hospital. Various parameters of the patients' M-SSEP were compared with the corresponding data of 40 healthy persons. Latency and amplitude of the cervical (N14) and cortical (N20) derived potentials and the central conduction time (CCT) were taken into account. Changes or a loss of the N20 signal and of the CCT were related to clinical outcome for up to two years. All patients had a normal N14 bilaterally. Most patients with a primary brainstem lesion (n = 25) showed symmetrical N20 changes bilaterally. However, the majority of patients with a secondary brainstem lesion (n = 62) showed asymmetric N20 changes in M-SSEP which became more symmetrical in cases with marked progressive brainstem compression. Irrespective of a primary or secondary traumatic brainstem lesion, marked changes of N20 represented an unfavourable clinical prognosis. A loss of N20 was closely correlated with a very poor outcome (GOS1-2) if the N20 potential had not recovered within 48 hours. The recovery of this potential, however, was not necessarily correlated to a recovery of the brain function.	Neurochirurg Universitatsklin Giessen, D-35385 Giessen, Germany		Christophis, P (corresponding author), Neurochirurg Universitatsklin Giessen, Klinikstr 29, D-35385 Giessen, Germany.	Petros.Christophis@neuro.med.uni-giessen.de					ANZISKA BJ, 1980, ARCH NEUROL-CHICAGO, V37, P222, DOI 10.1001/archneur.1980.00500530060009; BRUNO RL, 1991, ORTHOPEDICS, V14, P1269; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; CHRISTOPHIS P, 1998, HELLENIC NEUROSURG, V5, P80; CHRISTOPHIS P, 1989, ADV NEUROSURG, V17, P102; DENOYER M, 1991, BRAIN RES, V539, P287, DOI 10.1016/0006-8993(91)91633-C; GOLDIE WD, 1981, NEUROLOGY, V31, P248, DOI 10.1212/WNL.31.3.248; GOODWIN SR, 1991, CRIT CARE MED, V19, P518, DOI 10.1097/00003246-199104000-00011; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; GREENBERG RP, 1982, ANN NY ACAD SCI, V388, P683, DOI 10.1111/j.1749-6632.1982.tb50835.x; HAUPT WF, 1987, NERVENARZT, V58, P653; HOFFMANN O, 1990, PC STAT VERSION 2 03; HOULDEN DA, 1990, NEUROSURGERY, V27, P701, DOI 10.1227/00006123-199011000-00006; HUME AL, 1979, ANN NEUROL, V5, P379, DOI 10.1002/ana.410050412; HUTCHINSON DO, 1991, ELECTROEN CLIN NEURO, V78, P228, DOI 10.1016/0013-4694(91)90037-5; JUDSON JA, 1990, CRIT CARE MED, V18, P363, DOI 10.1097/00003246-199004000-00003; KONASIEWICZ SJ, 1994, J TRAUMA, V37, P370, DOI 10.1097/00005373-199409000-00006; KRIEGER D, 1995, CRIT CARE MED, V23, P1123, DOI 10.1097/00003246-199506000-00020; Li Shunwei, 1993, Chinese Medical Sciences Journal, V8, P101; LINDSAY K, 1990, NEUROSURGERY, V26, P278, DOI 10.1227/00006123-199002000-00015; NOEL P, 1975, BRAIN, V98, P113, DOI 10.1093/brain/98.1.113; REDGRAVE P, 1985, NEUROSCIENCE, V16, P659, DOI 10.1016/0306-4522(85)90199-X; RIESECKER F, 1987, Z EEG EMG, V18, P36; RIFFEL B, 1987, EEG-EMG-Z ELEK ELEKT, V18, P192; RIFFEL B, 1994, PSYCHIATRIE NEUROLOG; RUMPL E, 1983, ELECTROEN CLIN NEURO, V56, P583, DOI 10.1016/0013-4694(83)90026-3; Stein H, 1996, ZBL CHIR, V121, P985; TATEMICHI TK, 1992, ANN NEUROL, V32, P162, DOI 10.1002/ana.410320207; TSUBOKAWA T, 1990, Brain Injury, V4, P315, DOI 10.3109/02699059009026185; WALSER H, 1983, Z EEG EMG, V13, P79	30	6	10	0	2	JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH	STUTTGART	RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY	0044-4251			ZBL NEUROCHIR	Zent.bl. Neurochir.	FEB	2004	65	1					25	31		10.1055/s-2004-44885			7	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	800ER	WOS:000220012200005	14981573				2022-02-06	
J	Grundy, PL; Patel, N; Harbuz, MS; Lightman, SL; Sharples, PM				Grundy, PL; Patel, N; Harbuz, MS; Lightman, SL; Sharples, PM			Adrenalectomy further suppresses the NT-3 mRNA response to traumatic brain injury but this effect is not reversed with corticosterone	MOLECULAR BRAIN RESEARCH			English	Article						traumatic brain injury; fluid percussion injury; NT-3; neurotrophic factor; glucocorticoid; hippocampus	NEUROTROPHIC FACTOR EXPRESSION; FLUID-PERCUSSION MODEL; NERVE GROWTH-FACTOR; RAT HIPPOCAMPUS; GLUCOCORTICOIDS MODULATE; NEURONS; BDNF; STRESS	Fluid percussion injury (FPI) and in situ hybridisation were used to evaluate the expression of NT-3 mRNA in the hippocampus after traumatic brain injury (TBI) in adrenal-intact and adrenalectomised rats (with or without corticosterone replacement). FPI and adrenalectomy independently significantly reduced the expression of NT-3 mRNA in the dentate gyros (DG) and CA2 region. The effects of adrenalectomy in the CA2 region were partially reversed with corticosterone. In adrenalectomised animals undergoing FPI, a further significant decrease in NT-3 mRNA was observed in the DG, but this was not reversed by corticosterone. Glucocorticoids may, therefore, play a role in the basal regulation of NT-3 in the hippocampus, but the role of glucocorticoids in the modulation of the NT-3 response to TBI is unclear. (C) 2003 Elsevier B.V. All rights reserved.	Frenchay Hosp, Dept Neurosurg, Bristol BS16 1LE, Avon, England; Univ Bristol, Bristol Royal Infirm, Res Ctr Neuroendocrinol, Bristol BS2 8HW, Avon, England; UBHT Educ Ctr, Dept Paediat Neurol, Bristol BS2 8AE, Avon, England		Grundy, PL (corresponding author), Frenchay Hosp, Dept Neurosurg, Bristol BS16 1LE, Avon, England.	p.l.grundy@doctors.org.uk		Lightman, Stafford/0000-0002-8546-9646			Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; Barde Y A, 1994, Prog Clin Biol Res, V390, P45; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Chao HM, 1998, ENDOCRINOLOGY, V139, P3112, DOI 10.1210/en.139.7.3112; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; Grundy PL, 2000, NEUROREPORT, V11, P3381, DOI 10.1097/00001756-200010200-00023; Grundy PL, 2001, BRAIN RES, V892, P386, DOI 10.1016/S0006-8993(00)03258-3; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; HARBUZ MS, 1989, J ENDOCRINOL, V122, P705, DOI 10.1677/joe.0.1220705; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; LAUTERBORN J, 1995, NEUROSCIENCE, V68, P363, DOI 10.1016/0306-4522(95)00150-H; LINDHOLM D, 1994, J NEUROBIOL, V25, P1362, DOI 10.1002/neu.480251105; LINDHOLM D, 1994, ANN NY ACAD SCI, V746, P195; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mocchetti I, 1996, J NEUROSCI, V16, P2141; NAKAO N, 1995, EXP NEUROL, V131, P1, DOI 10.1016/0014-4886(95)90002-0; Schaaf MJM, 1997, J NEUROSCI RES, V48, P334, DOI 10.1002/(SICI)1097-4547(19970515)48:4<334::AID-JNR5>3.3.CO;2-F; SCULLY JL, 1995, MOL BRAIN RES, V31, P158; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; Smith MA, 1995, ANN NY ACAD SCI, V771, P234, DOI 10.1111/j.1749-6632.1995.tb44684.x; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; YAMAKI T, 1994, J NEUROTRAUM, V11, P613, DOI 10.1089/neu.1994.11.613; Yang JT, 1998, NEUROREPORT, V9, P3477, DOI 10.1097/00001756-199810260-00026; Zhang WR, 1999, BRAIN RES, V842, P211, DOI 10.1016/S0006-8993(99)01818-1	28	6	6	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-328X			MOL BRAIN RES	Mol. Brain Res.	JAN 5	2004	120	2					188	192		10.1016/j.molbrainres.2003.09.018			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	775ZM	WOS:000189090600012	14741409				2022-02-06	
J	Hofoss, D				Hofoss, D			Healthy living does not reduce life satisfaction among physically handicapped persons	PATIENT EDUCATION AND COUNSELING			English	Article						physical handicap; life-style; life satisfaction	QUALITY-OF-LIFE; TRAUMATIC BRAIN INJURY; SPINAL-CORD-INJURY; EMPLOYMENT; IMPACT; DISABILITIES; STYLE; POPULATION; DEPRESSION; PROMOTION	Smoking, drinking, over-eating and sedentary living may be regarded as ways of compensating for losses inflicted by physical handicaps. Therefore, promoting healthy life-styles among physically handicapped persons may amount to reducing their life satisfaction. This article examines the life-style and life satisfaction of all self-reported somatically handicapped respondents 25-50 years of age in a mid-Norwegian county. Persons with physical handicaps had more unhealthy habits than the general population. But life-style was not related to degree of physical handicap. And quality of life among the physically handicapped was not associated with life-style. Efforts to promote healthy living may not threaten the quality of life of physically handicapped persons. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.	Fdn Hlth Serv Res, N-1474 Nordbyhagen, Norway		Hofoss, D (corresponding author), Fdn Hlth Serv Res, POB 55, N-1474 Nordbyhagen, Norway.	dhofoss@heltef.no					Anderson Caroline J, 2002, J Spinal Cord Med, V25, P184; Anderson CJ, 2002, ARCH PHYS MED REHAB, V83, P791, DOI 10.1053/apmr.2002.32742; BECKER HA, 1989, INT J REHABIL RES, V12, P235, DOI 10.1097/00004356-198909000-00001; BLOOM RW, 2001, J ADOLESCENT HEALTH, V28, P481; Bradley CJ, 2002, PSYCHO-ONCOLOGY, V11, P188, DOI 10.1002/pon.544; Burger H, 1997, PROSTHET ORTHOT INT, V21, P35; Burke V, 1999, HEALTH EDUC RES, V14, P269, DOI 10.1093/her/14.2.269; Carran MA, 1999, EPILEPSIA, V40, P1755, DOI 10.1111/j.1528-1157.1999.tb01594.x; CARTWRIGHT K, 2000, HIST FAMILY, V5, P1, DOI DOI 10.1016/S1081-602X(00)00029-4; Dijkers M, 1997, SPINAL CORD, V35, P829, DOI 10.1038/sj.sc.3100571; ERIKSEN J, 1986, FUNKSJONSHEMMEDE NOR; Escobedo LG, 1998, ADDICTION, V93, P433, DOI 10.1046/j.1360-0443.1998.93343311.x; Fingleton B, 1984, MODELS CATEGORY COUN; Fisher RS, 2000, EPILEPSY RES, V41, P39, DOI 10.1016/S0920-1211(00)00126-1; Franks MM, 2002, J AGING HEALTH, V14, P336, DOI 10.1177/08964302014003002; FRANKSTROMBORG M, 1990, SOC SCI MED, V31, P1159, DOI 10.1016/0277-9536(90)90237-M; GILBERT GN, 1981, MODELLING SOC; Gilson SF, 1998, AM J PUBLIC HEALTH, V88, P134, DOI 10.2105/AJPH.88.1.134-a; Gordon MM, 2002, ANN RHEUM DIS, V61, P66, DOI 10.1136/ard.61.1.66; Gottlieb A, 2001, AGING-CLIN EXP RES, V13, P11, DOI 10.1007/BF03351488; Hakim EA, 2000, DISABIL REHABIL, V22, P288; Hallert C, 2002, SCAND J GASTROENTERO, V37, P39, DOI 10.1080/003655202753387338; Hicken BL, 2002, J REHABIL RES DEV, V39, P359; Hogan A, 2000, DISABIL REHABIL, V22, P352; Holicky R, 1999, DISABIL REHABIL, V21, P250; HOLMEN J, 1989, 5 NAT I PUBL HLTH; HOLMEN J, 1990, 4 NAT I PUBL HLTH; KASHANI JH, 1983, J CLIN PSYCHIAT, V44, P256; Kemp BJ, 1997, ARCH PHYS MED REHAB, V78, P187, DOI 10.1016/S0003-9993(97)90262-8; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kreuter M, 2000, SPINAL CORD, V38, P2, DOI 10.1038/sj.sc.3100933; Lacaille D, 2001, J RHEUMATOL, V28, P2315; Lannero E, 2002, PEDIAT ALLERG IMM-UK, V13, P182, DOI 10.1034/j.1399-3038.2002.01055.x; Maere Ase, 1994, Tidsskrift for den Norske Laegeforening, V114, P1187; MASTEKAASA A, 1984, SOC INDIC RES, V14, P385, DOI 10.1007/BF00300450; Reinhold-Keller E, 2002, ARTHRIT RHEUM-ARTHR, V47, P320, DOI 10.1002/art.10458; RICHMAN L, 1978, J ABNORM CHILD PSYCH, V6, P11, DOI 10.1007/BF00915777; Rimmer JH, 1999, PHYS THER, V79, P495, DOI 10.1093/ptj/79.5.495; SARIS W, 1984, CAUSAL MODELLING NON; Stabler B, 2001, HORM RES, V56, P55, DOI 10.1159/000048136; UPTON GJG, 1991, STATISTICIAN, V40, P169, DOI 10.2307/2348489; van Manen JG, 2001, PERITON DIALYSIS INT, V21, P595; WAALER HT, 1984, 4 NAT I PUBL HLTH; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Weil E, 2002, JAMA-J AM MED ASSOC, V288, P1265, DOI 10.1001/jama.288.10.1265; Zwerling C, 2002, J OCCUP ENVIRON MED, V44, P358, DOI 10.1097/00043764-200204000-00017	46	6	6	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0738-3991	1873-5134		PATIENT EDUC COUNS	Patient Educ. Couns.	JAN	2004	52	1					17	22		10.1016/S0738-3991(02)00244-6			6	Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Social Sciences - Other Topics	768WG	WOS:000188592700003	14729286				2022-02-06	
J	Wyss-Coray, T				Wyss-Coray, T			Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						cytokine; neurodegeneration; amyloid; TGF-beta; signaling	TGF-BETA; CELL-DEATH; TGF-BETA-1	Neurodegenerative diseases are becoming an increasing social and economical burden as our population ages; but current knowledge of the processes leading to these diseases is still limited, and no effective treatments are available. Neurodegeneration in Alzheimer's disease (AD) is the most common cause of dementia and afflicts an estimated 4 million people in this country alone. Because accumulation of beta-amyloid (Abeta) peptide appears central to AD pathogenesis, large efforts have been directed at understanding and interfering with AD production or aggregation. These efforts have largely identified the processes resulting in Abeta production from the larger amyloid precursor protein (APP) and have revealed that Abeta peptide is also produced at low levels in the healthy brain. Interestingly, Abeta production is rapidly increased after neuronal injury, and traumatic brain injury is a known risk factor for AD and Parkinson's disease. In contrast, brain injury in young individuals does not seem to result in AD, and brain injury in animal models can promote Abeta clearance. This suggests that certain factors associated with injury might be able to reduce the accumulation of AD. Accumulation of Abeta peptide might be reduced either directly by stimulating phagocytes or other Abeta-degrading processes, or indirectly, by reducing neuronal injury and thus lowering the production of Abeta peptide. Directing the brain's natural mechanisms for clearing Abeta or increasing neuroprotection might therefore be reasonable approaches in interfering with AD pathogenesis.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; VA Palo Alto Hlth Care Syst, GRECC, Palo Alto, CA 94304 USA		Wyss-Coray, T (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	twc@stanford.edu	Wyss-Coray, Tony/AAF-3380-2019	Wyss-Coray, Tony/0000-0001-5893-0831			Bonyadi M, 1997, NAT GENET, V15, P207, DOI 10.1038/ng0297-207; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Chin J, 2002, J NEUROSCI, V22; Dennler S, 2002, J LEUKOCYTE BIOL, V71, P731; Dunker N, 2001, DEVELOPMENT, V128, P1933; FINCH CE, 1993, J CELL BIOCHEM, V53, P314, DOI 10.1002/jcb.240530408; Flanders KC, 1998, PROG NEUROBIOL, V54, P71, DOI 10.1016/S0301-0082(97)00066-X; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; JOHNSON EM, 1993, ANNU REV NEUROSCI, V16, P31, DOI 10.1146/annurev.ne.16.030193.000335; Krieglstein K, 2000, NAT NEUROSCI, V3, P1085, DOI 10.1038/80598; Letterio JJ, 2000, CYTOKINE GROWTH F R, V11, P81, DOI 10.1016/S1359-6101(99)00031-3; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Roberts A.B., 1996, MOL CELLULAR BIOL WO, P275; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Unsicker K, 2002, ADV EXP MED BIOL, V513, P353; Weinstein M, 2000, CYTOKINE GROWTH F R, V11, P49, DOI 10.1016/S1359-6101(99)00028-3; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Zhang F, 1997, SCIENCE, V275, P1318, DOI 10.1126/science.275.5304.1318; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	19	6	6	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.		2004	24	1					149	153		10.1385/JMN:24:1:149			5	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	849EO	WOS:000223521700022	15314264				2022-02-06	
J	Lado, WE; Persinger, MA				Lado, WE; Persinger, MA			Mechanical impacts to the skulls of rats produce specific deficits in maze performance and weight loss: Evidence for apoptosis of cortical neurons and implications for clinical neuropsychology	PERCEPTUAL AND MOTOR SKILLS			English	Article							TRAUMATIC BRAIN INJURY; HEAD-INJURY; ALZHEIMERS-DISEASE; CASPASE-6; SEIZURES; MODELS	The purpose of this experiment was to induce closed head injuries that might be applicable to clinical neuropsychology. Six adult female albino rats were struck over the right dorsal skull by a 200-gm weight that fell through a 0.9-m tube while another six rats served as controls. The rats that received the impact to the skulls displayed significantly more weight loss and fewer completions of the maze during the subsequent two to four days (effect size about 40%) while their open field behaviors, response latencies to thermal stimulation of the feet, and immobility within a conditioned fear setting did not differ significantly from those of controls. Histological analyses of the brains about 35 days after the impact indicated striking alterations in the morphology of cerebral cortical neurons, strongly suggestive of an apoptotic-like process, within the dorsal cerebral cortices below the likely impact site. Distributions of clusters of these aberrant-looking cells were also evident opposite to the impact site within the ventral cerebrum. Because apoptosis is involved with minimal inflammation and edema, detection of diffuse apoptosis by MRI and CT would be unlikely even though the influence on adaptability would be significant.	Laurentian Univ, Dept Biol, Behav Neurosci Lab, Sudbury, ON P3E 2C6, Canada		Persinger, MA (corresponding author), Laurentian Univ, Dept Biol, Behav Neurosci Lab, Sudbury, ON P3E 2C6, Canada.						Alberts B., 2002, MOL BIOL CELL, V4th; BakerPrice LA, 1996, PERCEPT MOTOR SKILL, V83, P491, DOI 10.2466/pms.1996.83.2.491; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; Cook LL, 1999, TOXICOL LETT, V109, P77, DOI 10.1016/S0378-4274(99)00123-X; ELSON LM, 1994, SEMIN NEUROL, V14, P8, DOI 10.1055/s-2008-1041053; GEDYE A, 1989, J AM GERIATR SOC, V37, P970, DOI 10.1111/j.1532-5415.1989.tb07283.x; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; HAYES RL, 1989, MILD HEAD INJURY, P54; Henshall DC, 2002, NEUROBIOL DIS, V10, P71, DOI 10.1006/nbdi.2002.0505; Kerr JFR, 2002, TOXICOLOGY, V181, P471, DOI 10.1016/S0300-483X(02)00457-2; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; Pellegrini L, 1999, J BIOL CHEM, V274, P21011, DOI 10.1074/jbc.274.30.21011; PERSINGER M A, 1969, Developmental Psychobiology, V2, P168, DOI 10.1002/dev.420020307; PERSINGER MA, 1995, PSYCHOL REP, V77, P707, DOI 10.2466/pr0.1995.77.3.707; Persinger MA, 2001, INT J NEUROSCI, V106, P169, DOI 10.3109/00207450109149747; PERSINGER MA, 1994, PHYSIOL BEHAV, V56, P225, DOI 10.1016/0031-9384(94)90188-0; Persinger MA, 1995, PERCEPT MOTOR SKILL, V81, P1283, DOI 10.2466/pms.1995.81.3f.1283; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; [No title captured]	20	6	6	0	0	PERCEPTUAL MOTOR SKILLS	MISSOULA	PO BOX 9229, MISSOULA, MT 59807 USA	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	DEC	2003	97	3	2				1115	1127		10.2466/PMS.97.7.1115-1127			13	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	774JK	WOS:000188976200015	15002855				2022-02-06	
J	Vigue, B				Vigue, B			Update on medical management of severe head trauma	NEUROCHIRURGIE			French	Article						brain injury; multimodal monitoring; emergency treatments	CEREBRAL PERFUSION-PRESSURE; BRAIN-INJURY; INTRACRANIAL-PRESSURE; HYPOTHERMIA; MORTALITY; HYPOTENSION; NOREPINEPHRINE; TEMPERATURE; DOPAMINE; MANNITOL	Significant progress in prognosis after brain injury has been achieved over the last 20 years. Knowledge of post-traumatic brain hypersensitivity to ischemic events is critical for management. Therefore, all recommended emergency treatments (intubation, oxygenation, prevention of hypotension) focus on situations where oxygen delivery to the brain is compromised (peripheral hypoxia or hypotension but also compressible cerebral hematoma). Analysis of European prehospital medical care showed success in peripheral oxygenation but no real benefit regarding blood pressure. Guidelines for osmotherapy in patients with pupil anormalies are not followed despite recent studies emphasizing better prognosis after acute perfusion of high-dose mannitol followed by rapid surgical treatment. It is well known that a short delay between trauma and surgery improves prognosis. After controlling peripheral hemodynamics and hemostasis, multimodal monitoring (intracranial pressure, transcranial Doppler, SvjO(2)) is necessary to achieve cerebral hemodynamic equilibrium. Management during the first hours after trauma is important for outcome in patients with traumatic brain injury. A well-organized medical referral system with close collaboration between specialists will be able to control this socially accepted silent epidemic.	CHU Bicetre, Dept Anesthesie Reanimat, F-94275 Le Kremlin Bicetre, France		Vigue, B (corresponding author), CHU Bicetre, Dept Anesthesie Reanimat, F-94275 Le Kremlin Bicetre, France.	bernard.vigue@bct.ap-hop-paris.fr					Agenor PR, 1999, J INT MONEY FINANC, V18, P1, DOI 10.1016/S0261-5606(98)00043-6; BERNABEI AF, 1992, J TRAUMA, V33, P835, DOI 10.1097/00005373-199212000-00007; BONE LB, 1994, J TRAUMA, V37, P262, DOI 10.1097/00005373-199408000-00019; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CHAN KH, 1993, NEUROSURGERY, V32, P547, DOI 10.1227/00006123-199304000-00009; Cherian L, 1997, CRIT CARE MED, V25, P1378, DOI 10.1097/00003246-199708000-00027; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cruz J, 2001, NEUROSURGERY, V49, P864; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GREGORY JS, 1991, J TRAUMA, V31, P795, DOI 10.1097/00005373-199106000-00009; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; LEMOIGNO S, 2001, INTERET DOPPLER TRAN, pS266; Maas Andrew I.R., 2000, Curr Opin Crit Care, V6, P281, DOI 10.1097/00075198-200008000-00008; Malone DL, 2001, J TRAUMA, V51, P458, DOI 10.1097/00005373-200109000-00006; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Ract C, 2001, INTENS CARE MED, V27, P101, DOI 10.1007/s001340000754; Ract C, 2001, J NEUROTRAUM, V18, P1247, DOI 10.1089/089771501317095287; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROUXEL JMP, 2000, ANN FR ANESTH, pS313; Schmidt EA, 2002, ACT NEUR S, V81, P133; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; *SRLF, 1997, REANIM URG, V6, P335; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; TAZAROURTE K, 2000, ANN FR ANESTH, pS312; TEASDALE G, 1974, LANCET, V26, P971; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; UTERBERG A, 1999, INTENS CARE MED, V25, P348; VASSAR MJ, 1998, ARCH SURG-CHICAGO, V123, P1149; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vigue B, 2000, INTENS CARE MED, V26, P722, DOI 10.1007/s001340051238; Vigue B, 1999, INTENS CARE MED, V25, P445, DOI 10.1007/s001340050878; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	49	6	8	0	1	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	DEC	2003	49	6					583	594					12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	770QQ	WOS:000188742200004	14735003				2022-02-06	
J	Nirula, R; Kaufman, R; Tencer, A				Nirula, R; Kaufman, R; Tencer, A			Traumatic brain injury and automotive design: Making motor vehicles safer	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	33rd Annual Meeting of the Western-Trauma-Association	FEB 23-28, 2003	SNOWBIRD, UTAH	Western Trauma Assoc		traumatic brain injury; vehicle design; contact points; roof rail	HEAD-INJURY; OUTCOMES; COSTS	Background: Traumatic brain injury (TBI) remains a major public health problem in the United States. Identifying and modifying vehicle designs associated with TBI will have a significant impact on the frequency and severity of TBI in motor vehicle crashes (MVCs). Our objective, therefore, was to identify interior vehicle contact points associated with severe TBI (head Abbreviated Injury Scale score > 3) among drivers and determine the extent to which modifications of these contact points impact the likelihood of severe TBI. Methods: We analyzed drivers in MVCs from the 1993 to 2001 National Automotive Sampling System database. The odds of severe TBI with respect to various vehicle contact points were estimated using multivariate logistic regression. Using computer simulation software, the magnitude of driver head deceleration was modeled while manipulating vehicle design features. The potential impact of this design modification on the frequency and hospital charges of TBI cases was estimated. Results: There were 18,313 drivers involved who were victims of TBI, equating to a national sample size of 3,275,472 cases. The most frequent contact point associated with severe TBI was the roof rail (odds ratio, 2.0; 95% confidence interval, 1.2-3.3). Increasing roof rail padding thickness to 5.0 cm reduced the peak acceleration from 700 g to 218 g, which would potentially reduce the attributable number of severe TBI cases per year from 2,730 to 210, thereby reducing annual acute care charges from $136.5 million to $10.5 million. Conclusion:. Contact with the roof rail significantly increases the likelihood of TBI in MVCs. Minor increases in padding at these points may reduce the frequency of severe TBI, which would have a substantial effect on health care costs.	Crash Injury Res & Engn Network Ctr, Seattle, WA USA; Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA		Nirula, R (corresponding author), 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.						AGRAN PF, 1992, ACCIDENT ANAL PREV, V24, P349, DOI 10.1016/0001-4575(92)90047-M; *ASS ADV AUT MED, ABBR INJ SCALE 1990; Got C., 1978, P 22 STAPP CAR CRASH; HAPPEE R, 1998, SAE983150 STAPP; Hillary FG, 2002, BRAIN INJURY, V16, P729, DOI 10.1080/02699050110119844; HODGSON VR, 1977, DOTHS1462230 WAYN ST; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; JAGGER J, 1987, NEUROSURGERY, V20, P815, DOI 10.1227/00006123-198705000-00028; JAGGER J, 1992, J NEUROTRAUM, V9, pS313; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; MATSUMOTO H, 1991, P 13 INT TECHN C EXP; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; NAHUM AM, 1976, P 21 STAPP CAR CRASH; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NILSON G, 1994, P 14 C ENH SAF VEH M; Nirula R, 2003, ACCIDENT ANAL PREV, V35, P201, DOI 10.1016/S0001-4575(01)00104-X; REDELMEIER DA, 1993, J GEN INTERN MED, V8, P199, DOI 10.1007/BF02599267; Siegel JH, 2001, J TRAUMA, V51, P975, DOI 10.1097/00005373-200111000-00024; Tencer AF, 2002, SPINE, V27, P34; TSUKAWA I, 1996, OPTIMIZATION CRUSH C; VIANO D, 1990, 902328 SOC AUT ENG; YANG J, 1994, P 14 C ENH SAF VEH M	22	6	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2003	55	5					844	848		10.1097/01.TA.0000087645.62474.91			5	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	744EG	WOS:000186614500008	14608154				2022-02-06	
J	Haley, SM; Dumas, HM; Rabin, JP; Ni, PS				Haley, SM; Dumas, HM; Rabin, JP; Ni, PS			Early recovery of walking in children and youths after traumatic brain injury	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							CLOSED HEAD-INJURY; CEREBRAL-PALSY	A consecutive series of 106 children and adolescents (mean age 10 years, 6 months; SD 4 years, 8 months) with recent traumatic brain injury admitted to a regional hospital-based rehabilitation program was assessed to determine the rate of walking recovery, and characteristics that distinguish between independent walkers, non-walkers, and device-assisted walkers at hospital discharge. Data were collected through a retrospective medical record review of patients admitted between 1994 and 2001. Mean hospital stays were 66.7 days (SD 88.5, range 7 to 140 days). All children (72 male, 34 female) had recent injuries (from 1 to 8 weeks after onset of traumatic brain injury) and were independent walkers before injury. Sixty-four children (60.4%) were discharged as independent walkers, 13 (12.3%) walked with the assistance of a device, and 29 (27.3%) were non-walkers. Non-walkers had a higher proportion of prolonged loss of consciousness, lower-extremity injury, impaired responsiveness, and lower-extremity spasticity than independent walkers. In addition, non-walkers had poorer discharge mobility and social function scores, longer average hospital stays, and a greater proportion of non-community discharges. Device-only walkers were older, more likely to be male, and had a higher proportion of lower-extremity injuries than independent walkers. Results highlight several demographic, clinical, and outcome variables that distinguish independent walkers from device-assisted walkers and non-walkers. These variables might help to determine the prognosis for ambulation, resource needs, and discharge plans for children and adolescents with traumatic brain injury after episodes of inpatient rehabilitation.	Boston Univ, Sargent Coll Hlth & Rehabil Sci, Ctr Rehabil Effectiveness, Boston, MA 02115 USA; Res Ctr Children Special Hlth Care Needs, Boston, MA USA; Franciscan Childrens Hosp, Phys Rehabil Program, Boston, MA USA		Haley, SM (corresponding author), Boston Univ, Sargent Coll Hlth & Rehabil Sci, Ctr Rehabil Effectiveness, 635 Commonwealth Ave, Boston, MA 02115 USA.	smhaley@bu.edu		Ni, Pengsheng/0000-0003-1774-2185			Bartonek A, 2001, DEV MED CHILD NEUROL, V43, P253, DOI 10.1017/S0012162201000482; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; DAPAZ A, 1994, DEV MED CHILD NEUROL, V36, P130; Dumas HM, 2003, CHILD NERV SYST, V19, P114, DOI 10.1007/s00381-002-0696-7; Emanuelson I, 1996, CHILD NERV SYST, V12, P460, DOI 10.1007/BF00261625; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; KRIEL RL, 1988, ARCH PHYS MED REHAB, V69, P678; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TRAHAN J, 1994, DEV MED CHILD NEUROL, V36, P787; VanderSchaaf PJ, 1997, PEDIATR NEUROL, V16, P306, DOI 10.1016/S0887-8994(97)00025-8; Williams EN, 1999, DEV MED CHILD NEUROL, V41, P446, DOI 10.1017/S0012162299000985; [No title captured]; [No title captured]	16	6	6	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	OCT	2003	45	10					671	675		10.1017/S0012162203001257			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	728VE	WOS:000185736400004	14515938				2022-02-06	
J	Schmitter-Edgecombe, M; Chaytor, NS				Schmitter-Edgecombe, M; Chaytor, NS			Self-ordered pointing performance following severe closed-head injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; DUAL-TASK PERFORMANCE; VERBAL WORKING-MEMORY; DIVIDED ATTENTION; PREFRONTAL CORTEX; FRONTAL-CORTEX; DEFICITS; DISEASE; DISSOCIATIONS; DYSFUNCTION	This study investigated executive aspects of working memory in a severe closed-head injured (CHI) population. Thirty-four severe CHI participants (>1 year postinjury) and 34 controls completed an abstract design version of Petrides and Milner's (1982) self-ordered pointing task. CHI participants made more errors than controls on the 16-item trial, but not the 9-item trial. Both CHI and control participants were able to make use of strategic processing to improve SOPT performance. As anticipated, errors on the SOPT were associated with another measure of working memory (i.e., Reading Span Test) for the control group. In contrast, for the CHI participants, errors on the SOPT were associated with a measure of delayed visual memory (i.e., Wechsler Memory Scale - Revised Visual Reproduction II subtest). Our findings suggest that, as a group, the primary factor resulting in poorer SOPT performance by the CHI group was a memory deficit and not the ability to utilize executive aspects of working memory.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, POB 4820, Pullman, WA 99164 USA.			Chaytor, Naomi/0000-0001-8821-289X	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03 HD35838] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD035838] Funding Source: NIH RePORTER		ADAMS JH, 1980, NEUROPATH APPL NEURO, V6, P319, DOI 10.1111/j.1365-2990.1980.tb00217.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baddeley A.D., 1994, NEUROPSYCHOLOGY, V8, P485, DOI [10.1037/0894-4105.8.4.485, DOI 10.1037/0894-4105.8.4.485]; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Brouwer W, 2001, BRAIN COGNITION, V46, P54, DOI 10.1016/S0278-2626(01)80033-6; BROUWER WH, 1989, CORTEX, V25, P219, DOI 10.1016/S0010-9452(89)80038-3; Bublak P, 2000, J CLIN EXP NEUROPSYC, V22, P176, DOI 10.1076/1380-3395(200004)22:2;1-1;FT176; Cohen J., 2013, STAT POWER ANAL BEHA; CORWIN J, 1993, CLIN NEUROPSYCHOL, V7, P3, DOI 10.1080/13854049308401883; Curtis CE, 2000, NEUROPSYCHOLOGIA, V38, P1503, DOI 10.1016/S0028-3932(00)00062-2; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; DAIGNEAULT S, 1992, DEV NEUROPSYCHOL, V8, P99, DOI 10.1080/87565649209540518; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DELIS D, 1987, CALIFORNIA VERBAL LE; DULANEY CL, 1994, J EXP PSYCHOL LEARN, V20, P470, DOI 10.1037/0278-7393.20.2.470; ENGLE RW, 1999, MODELS WORKING MEMOR; Farinpour R, 2000, J INT NEUROPSYCH SOC, V6, P548, DOI 10.1017/S1355617700655042; Gansler DA, 1996, BRAIN COGNITION, V30, P194, DOI 10.1006/brcg.1996.0012; Golden J. C., 1978, STROOP COLOR WORD TE; Heaton RK, 1981, MANUAL WISCONSIN CAR; KAPLAN E, 1991, WECHSLER ADULT INTEL; LAFLECHE G, 1995, NEUROPSYCHOLOGY, V9, P313, DOI 10.1037/0894-4105.9.3.313; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyake A., 1999, MODELS WORKING MEMOR; Nissley HM, 2002, NEUROPSYCHOLOGY, V16, P111, DOI 10.1037//0894-4105.16.1.111; Osterrieth PA, 1994, ARCH PSYCHOL, V30, P286; Owen AM, 1996, BRAIN, V119, P1597, DOI 10.1093/brain/119.5.1597; PANIAK CE, 1989, J CLIN EXP NEUROPSYC, V11, P631, DOI 10.1080/01688638908400921; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P873, DOI 10.1073/pnas.90.3.873; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P162; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rich JB, 1996, NEUROPSY NEUROPSY BE, V9, P99; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Sattler J. M., 1988, ASSESSMENT CHILDREN; Schmitter-Edgecombe M, 2001, J INT NEUROPSYCH SOC, V7, P615, DOI 10.1017/S1355617701755099; SchmitterEdgecombe M, 1996, NEUROPSYCHOLOGY, V10, P155; Shimamura A.P., 1994, NEUROPSYCHOLOGY, V8, P408, DOI DOI 10.1037/0894-4105.8.3.408; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; TEASDALE G, 1974, LANCET, V2, P81; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1981, WECHSLER ADULT INTEL; West R, 1998, NEUROPSYCHOLOGY, V12, P546, DOI 10.1037/0894-4105.12.4.546	58	6	6	0	0	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	OCT	2003	25	7					918	932		10.1076/jcen.25.7.918.16484			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	739WM	WOS:000186369800003	13680440				2022-02-06	
J	Edwards, DW; Dahmen, BA; Wanlass, RL; Holmquist, LA; Wicks, JJ; Davis, C; Morrison, TL				Edwards, DW; Dahmen, BA; Wanlass, RL; Holmquist, LA; Wicks, JJ; Davis, C; Morrison, TL			Personality assessment in neuropsychology - The nonspecificity of MMPI-2 neurocorrection methods	ASSESSMENT			English	Article						neurocorrection; MMPI-2; personality assessment; brain injury	CLOSED-HEAD TRAUMA; VALIDITY; INJURY	Three established methods of neurocorrection claim to improve Minnesota Multiphasic Per sonality Inventory (MMPI)/MMPI-2 validity with closed-head injury (CHI) patients. These methods (which suggest removing "neurological" items from scoring) were employed here comparing 35 CHI patients with 35 psychiatric patients with elevated profiles. The 14-item correction changed 2-point codes for 41% of CHI and 31% of psychiatric profiles, the 30 item system changed 77% of CHI and 71% of psychiatric profiles, whereas the 37-item system changed 80% of CHI and 71% of psychiatric profiles. There were no significant differences between the two groups in number of profiles changed or number of neurocorrective items endorsed. Using each of the three correction systems, the following percentage of profiles remained elevated: 99%, 87%, and 89%, respectively.	Univ Calif Davis, Volunteer Fac, Dept Psychiat & Behav Sci, Davis, CA 95616 USA; NYU, New York, NY USA; Univ Calif Davis, Dept Phys Med & Rehabil, Davis, CA 95616 USA; Univ Oklahoma, Ctr Hlth Sci, Dept Pediat, Norman, OK 73019 USA		Edwards, DW (corresponding author), Univ Calif Davis, Volunteer Fac, Dept Psychiat & Behav Sci, Davis, CA 95616 USA.						Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P111; Brulot MM, 1997, CLIN NEUROPSYCHOL, V11, P391, DOI 10.1080/13854049708400468; Butcher J.N., 1989, MMPI 2 MINNESOTA MUL; Dunn JT, 1995, ASSESSMENT, V2, P47; EDWARDS DW, 1993, J PERS ASSESS, V61, P1, DOI 10.1207/s15327752jpa6101_1; FARR SP, 1988, MMPI USE SPECIFIC PO, P214; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; Gass CS, 1997, ARCH CLIN NEUROPSYCH, V12, P199, DOI 10.1016/S0887-6177(96)00032-7; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; Hathaway SR, 1940, J PSYCHOL, V10, P249, DOI 10.1080/00223980.1940.9917000; LeesHaley PR, 1996, ARCH CLIN NEUROPSYCH, V11, P45, DOI 10.1016/0887-6177(95)00011-9; MEYERINK LH, 1988, J CLIN PSYCHOL, V44, P764, DOI 10.1002/1097-4679(198809)44:5<764::AID-JCLP2270440517>3.0.CO;2-Y; REITAN RM, 1974, CLIN NEUROPSYCHOLOGY, P19; ZILLMER EA, 1996, ASSESSMENT, V3, P209, DOI DOI 10.1177/1073191196003003003; [No title captured]	16	6	6	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911			ASSESSMENT	Assessment	SEP	2003	10	3					222	227		10.1177/1073191103254491			6	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	716CT	WOS:000185011800002	14503645				2022-02-06	
J	Skeel, RL; Bounds, T; Johnstone, B; Lloyd, J; Harms, N				Skeel, RL; Bounds, T; Johnstone, B; Lloyd, J; Harms, N			Age differences in a sample of state vocational rehabilitation clients with traumatic brain injury	REHABILITATION PSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; UNITED-STATES; OLDER-ADULTS; RECOVERY	To examine the relations among age, neuropsychological functioning, and vocational rehabilitation following traumatic brain injury (TBI). Study Design and Participants: Prospective study of 78 adults (18-57 years) who qualified for services with the Missouri Division of Vocational Rehabilitation (DVR), based on a history of TBI followed from enrollment to case closure. Group differences based on age were examined for neuropsychological and vocational outcome with multivariate analysis of variance and nonparametric methods. Main Outcome Measures: Neuropsychological test data and DVR data regarding vocational placement. Results: Age-related differences were present for a measure of mental flexibility, isolated demographic characteristics, and I DVR service category. Contrary to hypotheses, there were no age-related differences in vocational outcome. Conclusions: In contrast to hospital-based samples, age does not appear to be a negative indicator for individuals admitted to a state DVR program.	Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA; Univ Missouri, Dept Hlth Psychol, Sch Hlth Profess, Columbia, MO 65211 USA		Skeel, RL (corresponding author), Cent Michigan Univ, Dept Psychol, 136 Sloan Hall, Mt Pleasant, MI 48859 USA.	reid.skeel@cmich.edu		Johnstone, Brick/0000-0001-8845-9649			Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; DEFILIPPIS NA, 1991, MANUAL BOOKLET CATEG; DIKMEN S, 1995, J HEAD TRAUMA REHAB, V10, P74, DOI 10.1097/00001199-199502000-00008; Fleming J, 1999, BRAIN INJURY, V13, P417; FORTEZA JA, 1994, HDB IND ORG PSYCHOL, V4, P447; FROMMAUCH D, 1983, J CLIN NEUROPSYCHOL, V5, P221, DOI 10.1080/01688638308401171; GOLDSTEIN FC, 1995, J HEAD TRAUMA REHAB, V10, P57, DOI 10.1097/00001199-199502000-00007; Goldstein FC, 1999, J NEUROPSYCH CLIN N, V11, P38, DOI 10.1176/jnp.11.1.38; Hawkins ML, 1996, J TRAUMA, V41, P257, DOI 10.1097/00005373-199608000-00010; Johnstone B, 1998, BRAIN INJURY, V12, P569, DOI 10.1080/026990598122331; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KEMP B, 1990, GERIATRIC REHABILITA, P295; KLOVE H, 1963, MED CLIN N AM, V47, P1647, DOI 10.1016/S0025-7125(16)33515-5; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; Rasch J. D., 1979, J CONSULT CLIN PSYCH, V10, P28; Reeder KP, 1996, J HEAD TRAUMA REHAB, V11, P22, DOI 10.1097/00001199-199606000-00006; Reitan RM, 1992, TRAIL MAKING TEST MA; Reitan RM, 1985, HALSTEADREITAN NEURO; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; SAHGAL V, 1989, SCAND J REHABIL MED, V21, P71; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Warr P, 1994, HDB IND ORG PSYCHOL, V4, P485; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WEHMAN P, 2000, TRAUMATIC BRAIN INJU, P201; WEST M, 1995, J VOCATIONAL REHABIL, V5, P281; WOODCOCK RW, 1989, WOODCOCKJOHNSON PSYC; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	38	6	6	0	2	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2003	48	3					145	150		10.1037/0090-5550.48.3.145			6	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	717FY	WOS:000185077900003					2022-02-06	
J	Cock, J; Fordham, C; Cockburn, J; Haggard, P				Cock, J; Fordham, C; Cockburn, J; Haggard, P			Who knows best? Awareness of divided attention difficulty in a neurological rehabilitation setting	BRAIN INJURY			English	Article							TRAUMATIC BRAIN-INJURY; DUAL-TASK PERFORMANCE; IMPAIRED AWARENESS; SELF-AWARENESS; MEMORY; INTERFERENCE; MOTOR	Objective: To explore whether patients relearning to walk after acquired brain injury and showing cognitive-motor interference were aware of divided attention difficulty; whether their perceptions concurred with those of treating staff. Design: Patients and neurophysiotherapists (from rehabilitation and disabled wards) completed questionnaires. Factor analyses were applied to responses. Correlations between responses, clinical measures and experimental decrements were examined. Results: Patient/staff responses showed some agreement; staff reported higher levels of perceived difficulty; responses conformed to two factors. One factor (staff/patients alike) reflected expectations about functional/motor status and did not correlate with decrements. The other factor (patients) correlated significantly with dual-task motor decrement, suggesting some genuine awareness of difficulty (cognitive performance prioritized over motor control). The other factor (staff) correlated significantly with cognitive decrement (gait prioritized over sustained attention). Conclusions: Despite some inaccurate estimation of susceptibility; patients and staff do exhibit awareness of divided attention difficulty, but with a limited degree of concurrence. In fact, our results suggest that patients and staff may be sensitive to different aspects of the deficit. Rather than 'Who knows best?', it is a question of 'Who knows what?.	Univ Reading, Dept Psychol, Reading RG6 2AH, Berks, England; UCL, Inst Congit Neurosci, London WC1E 6BT, England		Cock, J (corresponding author), Univ Bern, Inst Psychol, Muesmattstr 45, CH-3000 Bern 9, Switzerland.	josephine.cock@psy.unibe.ch	Haggard, Patrick/A-5081-2010	Haggard, Patrick/0000-0001-7798-793X			Bourke PA, 1996, Q J EXP PSYCHOL-A, V49, P525, DOI 10.1080/027249896392487; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Brouwer WH, 1997, NEUROPSYCHOL REHABIL, V7, P177, DOI 10.1080/713755536; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Camicioli R, 1997, NEUROLOGY, V48, P955, DOI 10.1212/WNL.48.4.955; Cicerone KD, 1997, CLIN NEUROPSYCHOL, V11, P266, DOI 10.1080/13854049708400455; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Cockburn J, 2003, CLIN REHABIL, V17, P167, DOI 10.1191/0269215503cr597oa; Collin C, 1988, Int Disabil Stud, V10, P61; CRUTCHER RJ, 1994, PSYCHOL SCI, V5, P241, DOI 10.1111/j.1467-9280.1994.tb00619.x; Dixon RA, 2001, J CLIN EXP NEUROPSYC, V23, P650, DOI 10.1076/jcen.23.5.650.1242; Fleming JM, 1996, BRAIN INJURY, V10, P1; Fong KNK, 2001, BRAIN INJURY, V15, P443, DOI 10.1080/02699050010005940; Haggard P, 2000, J NEUROL NEUROSUR PS, V69, P479, DOI 10.1136/jnnp.69.4.479; HARRIS JE, 1983, EVERYDAY MEMORY ACTI; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; HART T, 1986, CLIN NEUROPSYCHOLOGY, P21; Kinsella GJ, 1998, NEUROPSYCHOL REHABIL, V8, P351, DOI 10.1080/713755576; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; Marshall SC, 1997, ARCH PHYS MED REHAB, V78, P7, DOI 10.1016/S0003-9993(97)90002-2; McManus IC, 1997, BRIT J HEALTH PSYCH, V2, P301, DOI 10.1111/j.2044-8287.1997.tb00544.x; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Ozer Mark N, 1999, Top Stroke Rehabil, V6, P43, DOI 10.1080/10749357.1999.11869235; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Pashler H., 1998, ATTENTION, P115; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Trosset M W, 1996, J Int Neuropsychol Soc, V2, P315; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Vilkki J, 1996, NEUROPSYCHOLOGIA, V34, P1051, DOI 10.1016/0028-3932(96)00028-0; Wade D, 1992, MEASUREMENT NEUROLOG; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	39	6	6	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2003	17	7					561	574		10.1080/0269905031000088306			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	690HG	WOS:000183541900003	12775269				2022-02-06	
J	Goic, A; Armas, R				Goic, A; Armas, R			Decentralization of health care and medical teaching. The Chilean experience	REVISTA MEDICA DE CHILE			Spanish	Article						education, medical, graduate; education, medical, undergraduate; health care facilities, manpower, and services; health systems agencies	SCHOOL-OF-MEDICINE; EDUCATION	In Chile there has been a close interaction between medical teaching and health care. In 1943, the University of Chile School of Medicine (founded in 1833) created Chairs in several public hospitals. The University of Chile School of Public Health (founded in 1943) played a key role in the creation in 1952 of a centralized National Health Service (NHS). The NHS had outpatient clinics and hospitals all over the country and was responsible for health care and for the promotion of health and disease prevention programs. In 1954, the NHS and the School of Medicine set up Residencies and General Practitioners programs aimed at improving the distribution of specialists and general practitioners throughout the country. In 1979, the NHS was replaced with 27 autonomous Health Services headed by the ministry of Health, while the administration of primary care outpatient clinics was transferred to the municipal government. However, sanitary programs were still managed at the central level. Higher education also expanded and was decentralized. There are currently 60 universities and 17 medical schools, compared to eight and six, respectively, in 1981. The number of students in higher education has increased by 370% in 20 years. At the present time, the Chilean health case system is a predominantly public system with a strong and sizeable private system. Sixty two percent of the population is covered by public health insurance, while 27% is covered by private insurance. New and well equipped private clinics have multiplied. Private non profit institutions manage the prevention and treatment of work related injuries and diseases. Chile's outstanding health indicators (fertility rate: 17.2 x 1, 000; mortality: 5.4 x 1,000; maternal mortality: 2.3 x 10,000; neonatal mortality: 4.5 x 1,000; life expectancy: 76 years) are a direct consequence of the improved social, cultural and economic condition of the general populations as well as of the sanitary programs sustained over the past half century.									*ALF IMPR, 1980, CIN FAC MED PONT U C; *AS GREM ISAPRES S, 2000, SINT SIST SAL CHIL S; BARAHONA R, 1972, REV MED CHILE, V100, P821; BIELC F, 1972, REV MED CHILE, V100, P816; COKE RC, 1980, REV MED CHILE, V108, P1073; COSTACASARETTO C, 1979, REV MED CHILE, V107, P865; CRUZ RA, 1979, REV MED CHILE, V107, P84; FIGUEROA L, 1974, REV MED CHILE, V102, P462; Goic A, 1999, REV MED CHILE, V127, P1183; GOIC A, 1975, REV MED CHILE, V103, P38; GOIC A, 1983, REV MED CHILE, V111, P343; Goic A, 2002, REV MED CHILE, V130, P917; GOIC A, 1999, SERIE DOCUMENTOS ACA, V1; GOIC A, 1975, JAMA-J AM MED ASSOC, V233, P466; GOIC A, 1992, ENSAYO ED MED CHILE; GRASSET A, 1995, SALUD SIGLO 21 CAMBI, P131; HERNAN R, 1945, REV MED CHILE, V73, P275; HUNNEUS C, 1988, REFORMA U VEINTE DES; *I SAL PREV CHIL, 1995, AT SAL CHIL; Infante A D, 1968, Rev Med Chil, V96, P348; JIMENEZ J, 1988, 1688 CORP PROM U; JIMENEZ J, 1988, 1788 CORP PROM U; LARRAIN C, 2002, SOC MED SANTIAGO DES; MARDONESR J, 1977, REV MED CHILE, V105, P654; MEDINA E, 1988, REV MED CHILE, V116, P1327; MEDINA E, 1971, REV MED CHILE, V99, P455; MERINO RA, 1991, REV MED CHILE, V119, P472; *MIN SAL, 2002, OBJ SANT DEC 2000 20; *MIN SAL ORG PAN S, 1995, AT SAL CHIL; *MIN SAL ORG PAN S, 2002, IND BAS SAL 2002; MIRANDA E, 1990, REV CENTRO ESTUDIOS; *NUM CENT, 1972, REV MED CHILE, V100, P763; PARGA GL, 1974, MERCURIO        0712; ROA A, 1983, B FACULTAD MED, V3, P11; SANCHEZ H, 1988, 1888 CORP PROM U; SILVA AG, 1946, DIA MED, V16, P407; VIEL B, 1961, MED SOCIALIZADA SU A; 1990, LEY 18 962 ORG CONST; 2002, B ACAD CHILENA MED, V39, P167; 1962, TER C FAC LAT MED AN, P74; 1977, REV MEC CHILE, V105, P649	41	6	9	0	5	SOC MEDICA SANTIAGO	SANTIAGO 9	BERNARDA MORIN 488 PROVIDENCIA, CASILLA 168 CORREO 55, SANTIAGO 9, CHILE	0034-9887			REV MED CHILE	Rev. Medica Chile	JUL	2003	131	7					788	798					11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718JZ	WOS:000185142900012	14513701				2022-02-06	
J	Isono, M; Goda, M; Kobayashi, H; Wu, JL				Isono, M; Goda, M; Kobayashi, H; Wu, JL			TGF-alpha overexpression induces astrocytic hypertrophy after cortical stab wound injury	NEUROLOGICAL RESEARCH			English	Article						TGF-alpha; astrogliosis; traumatic brain injury	GROWTH-FACTOR ALPHA; TRANSGENIC MICE; INTERLEUKIN-6; ASTROGLIOSIS; EXPRESSION; NEOPLASIA	To determine the exact role of TGF-alpha in glial activation after traumatic brain injury, we investigated the astroglial and microglial responses after cortical stab wound injury in TGF-alpha overexpressing mice. Adult male B602-TgN (MMTVTGFA) 29RjC transgenic mice were used for the subjects. This transgenic line carries a TGF-alpha cDNA under the control of the dexamethasone-inducible MMTV promoter. Thus, exogenous administration of dexamethasone induces TGF-alpha overexpression. Male B6D2F1/J mice at the same age served as wild-type animals. After the cortical stab wound injury, expression of glial fibrilary acidic protein, CD-11b and interleukine-6 were investigated immunohistochemically. The results indicate that TGF-alpha might affect astrocytic hypertrophy without affecting microgliosis not only in the normal condition, but also in the pathological condition. Moreover, overexpression of TGF-alpha induced obvious expression of IL-6 around the lesion. This fact might indicate possible role of TGF-alpha in affecting neuronal function.	Oita Med Univ, Dept Neurosurg, Oita 8795593, Japan		Isono, M (corresponding author), Oita Med Univ, Dept Neurosurg, 1-1 Idaigaoka, Oita 8795593, Japan.		Goda, Makoto/R-3164-2019				JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; JUNIER MP, 1994, J NEUROSCI, V14, P4206; Junier MP, 2000, PROG NEUROBIOL, V62, P443, DOI 10.1016/S0301-0082(00)00017-4; Lisovoski F, 1997, J NEUROPATH EXP NEUR, V56, P459, DOI 10.1097/00005072-199705000-00001; MATSUI Y, 1990, CELL, V61, P1147, DOI 10.1016/0092-8674(90)90077-R; Rabchevsky AG, 1998, J NEUROSCI, V18, P10541, DOI 10.1523/jneurosci.18-24-10541.1998; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; SCHACHNER M, 1983, IMMUNOHISTOCHEMISTRY, P399; Streit WJ, 2000, J NEUROSCI RES, V61, P10, DOI 10.1002/1097-4547(20000701)61:1<10::AID-JNR2>3.0.CO;2-E; Suzuki S, 1999, J CEREBR BLOOD F MET, V19, P1256, DOI 10.1097/00004647-199911000-00010	10	6	6	0	0	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	JUL	2003	25	5					546	550		10.1179/016164103101201814			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	704PP	WOS:000184348900019	12866207				2022-02-06	
J	McCunn, M; Mauritz, W; Dutton, RP; Alexander, C; Handley, C; Scalea, TM				McCunn, M; Mauritz, W; Dutton, RP; Alexander, C; Handley, C; Scalea, TM			Impact of culture and policy on organ donation: A comparison between two urban trauma centers in developed nations	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						organ donation; trauma; developed nations; cultural differences; policy differences	EPIDEMIOLOGY; FRONTIER; BLACKS	Background: The similarities and differences in organ donation policies, consent rates, and number of organs transplanted from patients declared "brain dead" after traumatic injury in different countries has not been previously reported. Methods: An international trauma survey questionnaire was developed. Analysis of two responding centers with regard to organ donation practices between urban, free-standing adult trauma hospitals is presented: the R Adams Cowley Shock Trauma Center (STC) in Baltimore, Maryland, and the Lorenz Bohler Hospital (LBH) in Vienna, Austria. Results: Hospital admissions resulting from traumatic brain injury (TBI) account for a significantly greater number of admissions at the STC than at the LBH (761 vs. 276), and the STC has a higher number of patients admitted with severe TBI (Glasgow Coma Scale score < 8). Of 39 medically suitable brain-dead patients at the STC, 18 went to organ donation. At the LBH, 16 patients were declared brain-dead, 7 were considered to be medically suitable, and all 7 went to donation. A "presumed consent" organ donation policy in Austria resulted in 100% of medically suitable patients going to donation at the LBH. With a volunteer donation policy at the STC, 46% of patients went to donation. Of those families who refused donation at the STC, 9 of 16 eligible African Americans (56%), 10 of 21 eligible Caucasians (48%), 1 Hispanic, and I Native American Indian family declined donation. Conclusion: "Presumed" organ donation in Austria led to 4 organs transplanted per trauma brain-death at the LBH, as compared with 3.8 organs per brain-death at the STC. The greater number of patients with severe TBI at the STC accounts for a similar organ donation rate compared with the LBH, despite the fact that the consent at the STC is voluntary and at the LBH is "presumed." A higher organ donation rate in the United States would result in a greater number of organ transplants from patients who die after traumatic injury and a resultant increase in potential lives saved. There does not appear to be a significant difference in ethnicity between families who accept and those who refuse organ donation after traumatic brain death declaration at the STC.	Univ Maryland, Dept Crit Care Med, R Adams Cowley Shock Trauma Ctr, Div Anesthesiol, Baltimore, MD 21202 USA; Univ Maryland, Dept Surg, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21202 USA; Transplant Res Ctr Maryland, Program Dev & Donat Serv Ctr, Baltimore, MD USA; Johns Hopkins Univ, Int Sch Adv Studies, Washington, DC USA; Trauma Hosp Lorenz Bohler, Dept Anesthesia & Crit Care Med, Vienna, Austria		McCunn, M (corresponding author), Univ Maryland, Dept Crit Care Med, R Adams Cowley Shock Trauma Ctr, Div Anesthesiol, 22 S Greene St, Baltimore, MD 21202 USA.			Mauritz, Walter/0000-0001-9043-3712			Bowman KW, 2000, J PALLIATIVE CARE, V16, pS17, DOI 10.1177/082585970001601S05; CALLENDER CO, 1991, NEW ENGL J MED, V325, P442, DOI 10.1056/NEJM199108083250631; CALLENDER CO, 1995, TRANSPL P, V27, P1441; Gallagher C, 1996, J Transpl Coord, V6, P186; HALL LE, 1991, TRANSPLANT P, V23, P2500; Henderson SO, 1998, ANN EMERG MED, V31, P466, DOI 10.1016/S0196-0644(98)70255-0; Johnson CM, 2001, J TRAUMA, V51, P110, DOI 10.1097/00005373-200107000-00018; Martinelli A M, 1993, AORN J, V58, P236, DOI 10.1016/S0001-2092(07)65228-4; Ndlovu S R, 1998, J Transpl Coord, V8, P241; Nunez Olarte JM, 2001, CANC CONTROL, V8, P46; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; Siminoff L A, 1999, J Transpl Coord, V9, P250; Siminoff LA, 2001, JAMA-J AM MED ASSOC, V286, P71, DOI 10.1001/jama.286.1.71; The Gallup Organization Inc, 1993, AM PUBL ATT ORG DON; *TRANSPL RES CTR, 2000, DAT TRANSPL RES CTR; Vincent JL, 2001, CRIT CARE MED, V29, pN52, DOI 10.1097/00003246-200102001-00010	17	6	6	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2003	54	5					995	999		10.1097/01.TA.0000022461.76930.4E			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	687BN	WOS:000183356100033	12777916				2022-02-06	
J	Salguero-Alcaniz, MP; Lorca-Marin, JA; Alameda-Bailen, JR				Salguero-Alcaniz, MP; Lorca-Marin, JA; Alameda-Bailen, JR			Numerical and calculation processing: Evidence for a case from cognitive neuropsychology	REVISTA DE NEUROLOGIA			Spanish	Article						acalculia; aphasia; brain damage; lexical access; magnitude; numerical processing.	ARABIC NUMERALS	Introduction. This paper, which deals with cognitive Neuropsychology, attempts to contribute to the understanding of normal cognitive processing by examining and analysing the deficits acquired by individuals who have suffered brain damage. Aims. Our aim was to analyse the different cognitive processes involved in numerical processing (NP) and in calculation, together with the relations between them. Patients and methods. A quadriplegic patient with sequelae that include motor aphasia and deep dysgraphia as the residual pathologies of a traumatic brain injury, with a history of over four years; language comprehension is preserved (both oral and written) and there is no verbal expression whatsoever. Expression is achieved functionally by means of a specially adapted laser pointer. Assessment of NP and calculation was performed Results. A Iterations were observed in the calculation system, one in the recognition of arithmetical signs and the other in the execution of arithmetical operations. Conclusions. 1. Calculation skills are independent of those required to perform numerical recoding and of lexical or encyclopaedic numerical knowledge. 2. Recognition of arithmetical signs is independent of and therefore dissociated from, data retrieval and the execution of calculation procedures. 3. Data retrieval processes and those required for the execution of calculations are independent. Therefore, the calculation system consists of different elements that are independent from one another.	Univ Huelva, Dept Psicol, E-21007 Huelva, Spain				MARIN, JOSE ANDRES LORCA/AAC-2292-2019; LORCA MARIN, JOSE ANDRES/F-2751-2011; Alameda-Bailen, Jose-Ramon/P-2807-2014	MARIN, JOSE ANDRES LORCA/0000-0003-0331-020X; LORCA MARIN, JOSE ANDRES/0000-0003-0331-020X; Alameda-Bailen, Jose-Ramon/0000-0002-6095-838X			COHEN L, 1994, BRAIN, V117, P267, DOI 10.1093/brain/117.2.267; Cuetos F., 1998, SPAN J PSYCHOL, V1, P18; Cuetos F., 1997, COGNITIVA, V9, P207, DOI 10.1174/021435597760392458; Delazer M, 1997, CORTEX, V33, P697, DOI 10.1016/S0010-9452(08)70727-5; FERRO JM, 1980, CORTEX, V16, P175, DOI 10.1016/S0010-9452(80)80032-3; GREWEL F, 1952, BRAIN, V75, P397, DOI 10.1093/brain/75.3.397; Luria A. R, 1978, CEREBRO Y LENGUAJE; Luria A. R., 1985, LENGUAJE PENSAMIENTO; MCCLOSKEY M, 1985, BRAIN COGNITION, V4, P171, DOI 10.1016/0278-2626(85)90069-7; NOEL MP, 1995, BRAIN COGNITION, V29, P151, DOI 10.1006/brcg.1995.1274; SOKOL SM, 1991, J EXP PSYCHOL LEARN, V17, P355, DOI 10.1037/0278-7393.17.3.355; WARRINGTON EK, 1982, Q J EXP PSYCHOL-A, V34, P31, DOI 10.1080/14640748208400856; [No title captured]; [No title captured]	14	6	6	1	5	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	MAY 1	2003	36	9					817	820		10.33588/rn.3609.2002344			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680RP	WOS:000182991400004	12717667				2022-02-06	
J	Brooks, BM; Rose, FD; Johnson, DA; Andrews, TK; Gulamali, R				Brooks, BM; Rose, FD; Johnson, DA; Andrews, TK; Gulamali, R			Support for children following traumatic brain injury: the views of Educational Psychologists	DISABILITY AND REHABILITATION			English	Article							CLOSED-HEAD-INJURY; ADOLESCENTS; AGE; RECOVERY; MEMORY	Purpose: For many years, neuroscientific research appeared to support the view that the young brain was more resilient and better able to withstand damage than the mature brain. More recent neuroscience research has questioned this view. Nevertheless, the view that 'younger is better' continues to be accepted by many medical practitioners. The present study sought to establish whether the training and experience of educational psychologists has made them aware that young children are particularly vulnerable to long-term effects of brain injury. Method. Educational psychologists were asked to estimate the need for additional social/family and educational support, and how long such additional support would be needed, in four fictitious but clinically-based case studies which differed only in the reported age of the child/adolescent at the time of the injury. Results: Educational psychologists consistently rated young children with brain injuries as needing more additional social/family support for longer than adolescents. Conclusions: These results suggest that there is an appreciation of the additional needs of young children who have sustained brain injuries within our educational system.	Univ E London, Sch Psychol, London E15 4LZ, England; Lothian Primary Care NHS, Child & Family Mental Hlth Serv, Edinburgh, Midlothian, Scotland; W London Mental Hlth Trust, London, England		Brooks, BM (corresponding author), Univ E London, Sch Psychol, Romford Rd, London E15 4LZ, England.						Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; FAHY TJ, 1967, LANCET, V2, P475; Finger S., 1988, BRAIN INJURY RECOVER, P117; FINGER S, 1982, BRAIN DAMAGE RECOVER, P135; Goldman PS, 1974, PLASTICITY RECOVERY; HART K, 1988, J CLIN PSYCHOL, V44, P780, DOI 10.1002/1097-4679(198809)44:5<780::AID-JCLP2270440519>3.0.CO;2-1; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; KOLB B, 1990, FUNDAMENTALS HUMAN N, P695; LENNEBERG EH, 1968, NEUROPSYCHOLOGY DEV, P147; Levin HS, 1996, CORTEX, V32, P461, DOI 10.1016/S0010-9452(96)80004-9; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; Milner B, 1974, Neurosci Res Program Bull, V12, P213; Milner B., 1973, NEUROSCIENCES 3RD ST, P75; Rutter M, 1970, NEUROPSYCHIATRIC STU; Siddiqui UN, 1996, MED SCI RES, V24, P237; SOLTMANN O, 1876, JB KINDERHEILK, V9, P106; Teuber H L, 1975, Ciba Found Symp, P159; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Verger K, 2000, BRAIN INJURY, V14, P495; VULPIAN A, 1866, LECONS DUE PHYSL GEN; Webb C, 1996, BRAIN INJURY, V10, P303, DOI 10.1080/026990596124476	26	6	6	0	4	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.	JAN 7	2003	25	1					51	56		10.1080/09638280210151987			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	633YL	WOS:000180312500006	12554392				2022-02-06	
J	Sousa, J; Sharma, RR; Pawar, SJ; Mahapatra, A; Lad, SD				Sousa, J; Sharma, RR; Pawar, SJ; Mahapatra, A; Lad, SD			Long term outcome in patients with severe head injury and bilateral fixed dilated pupils	NEUROLOGY INDIA			English	Article						pupil; unreactive; dilated; severe head injury; outcome	CEREBRAL BLOOD-FLOW; TRAUMATIC BRAIN INJURY; COMA DATA-BANK; CONSCIOUSNESS; MANAGEMENT; EXPERIENCE; CHILDREN; HEMATOMA; SCALE	Patients with severe head injury with bilateral dilated unreactive pupils are considered to have a grave prognosis. Hence proper planning and aggressive management becomes mandatory for achieving good results. We present the outcome of consecutive 166 patients with severe head injury, admitted between January 1996 and December 2000 and analysed retrospectively. All the patients had an initial GCS of 8 or less and post resuscitation bilateral dilated unreactive pupils. Our aim was to analyze the long term outcome in these patients and identify the other significant prognostic factors. Of the 166 patients, 42 (25.30%) had a functional outcome (good recovery in 10.24%, moderate disability in 15.06%), and 124 (74.69%) had a poor outcome (death in 58.43% and severe disability in 16.26% of cases). There were 45 patients with polytrauma and 24 of these patients (53.33%) succumbed to the injuries. Obliteration of the basal cisterns and contusion were the common CT scan findings. Factors adversely affecting the survival included age of the patient, polytrauma with shock, initial GCS of 3 or 4, and compression of the basal cisterns on the initial CT scans. At follow up, most of the patients with a functional outcome showed a significant improvement in their motor function but continued to have neuro-behavioral and cognitive deficits.	Khoula Hosp, Dept Neurosurg, Muscat 116, Oman								ALEXANDRE A, 1983, J NEUROSURG, V59, P751, DOI 10.3171/jns.1983.59.5.0751; ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRAAKMAN R, 1980, NEUROSURGERY, V6, P62; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; BRICOLO A, 1977, J NEUROSURG, V47, P680, DOI 10.3171/jns.1977.47.5.0680; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; CHAN KH, 1992, J NEUROL NEUROSUR PS, V55, P787, DOI 10.1136/jnnp.55.9.787; CHESNUT RM, 1993, HEAD INJURY, P225; CRONE KR, 1987, NEUROSURGERY, V21, P532, DOI 10.1227/00006123-198710000-00015; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; GUTERMAN P, 1970, J NEUROSURG, V32, P330; HEIDEN JS, 1983, PHYS THER, V63, P1946, DOI 10.1093/ptj/63.12.1946; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JONNETT B, 1979, NEUROSURGERY, V4, P283; KENNEDY C, 1957, J CLIN INVEST, V36, P1130, DOI 10.1172/JCI103509; KISHORE PRS, 1981, AM J NEURORADIOL, V2, P307; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARMAROU A, 1991, J NEUROSURG S, V75, P59; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; NEWFIELD P, 1980, NEUROSURGERY, V6, P596; NIEDEGGEN A, 1989, ACTA NEUROCHIR, V101, P117, DOI 10.1007/BF01410525; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; ROSS DA, 1989, J NEUROSURG, V71, P498, DOI 10.3171/jns.1989.71.4.0498; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P140; TEASDALE G, 1974, LANCET, V2, P81; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875	39	6	6	0	0	NEUROL SOC INDIA	CHANDIGARH	C/O J S CHOPRA, PGIMER, DEPT NEUROLOGY, CHANDIGARH 160 012, INDIA	0028-3886			NEUROL INDIA	Neurol. India	DEC	2002	50	4					430	435					6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	649KG	WOS:000181206900007	12577090				2022-02-06	
J	Wilson, WJ; Penn, C; Saffer, D; Aghdasi, F				Wilson, WJ; Penn, C; Saffer, D; Aghdasi, F			Improving the prediction of outcome in severe acute closed head injury by using discriminant function analysis of normal auditory brainstem response latencies and amplitudes	JOURNAL OF NEUROSURGERY			English	Article						auditory brainstem response; discriminant function analysis; head injury	MULTIMODALITY-EVOKED-POTENTIALS; INTRA-CRANICAL PRESSURE; PROGNOSTIC IMPLICATIONS; COMATOSE PATIENTS; EXPERIENCE; FEATURES	Object. The auditory brainstem response (ABR) is a useful addition to standard medical measures for predicting outcome in patients with severe acute closed head injury (ACHI). Limiting this success, however, is the poor predictive value of a so-called "normal" ABR. In this study the authors used discriminant function analysis (DFA) of ABR Wave I, III, and V latencies and amplitudes to improve the predictive accuracy of the normal ABR, both as a single measure and in combination with other standard medical measures. Methods. The DFAs were conducted using the ABR and medical results in 68 patients with severe ACHI (30 who died [ACHI-died], and 38 who survived [ACHI-lived]) who presented with normal ABR responses in the neurosurgical intensive care unit of the authors' hospital in Johannesburg. All patients had undergone surgery to remove an intracranial hematoma. Correct predictions of outcome by ABR DFA measures were 83% for the ACHI-died group (48% at greater than or equal to 90% confidence level) and 87% for the ACHI-lived group (71% at greater than or equal to 90% confidence level); by medical DFA measures the correct predictions were 83% for the ACHI-died group (96% at greater than or equal to 90% confidence level) and 95% for the ACHI-lived group (94% at greater than or equal to 90% confidence level); and by combined ABR and medical DFA measures correct predictions were 100% for the ACHI-died group (100% at greater than or equal to 90% confidence level) and 97% for the ACHI-lived group (100% at greater than or equal to 90% confidence level). Conclusions. The DFA of ABR Wave I, III, and V latencies and amplitudes improved the predictive ability of normal ABR results to rates similar to those obtained using DFA for the medical measures, although at lower confidence levels. The DFA of the combined ABR and medical measures improved correct predictions to rates significantly higher than for either of the measures on its own.	Univ Witwatersrand, Dept Speech Pathol & Audiol, Johannesburg, South Africa; Univ Witwatersrand, Dept Elect Engn, Johannesburg, South Africa; Chris Hani Baragwanath Hosp, Dept Neurol, Suweto, South Africa		Wilson, WJ (corresponding author), Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia.		, Wayne/M-8937-2019; Wilson, Wayne J/F-8735-2010	, Wayne/0000-0002-8141-5173; Wilson, Wayne J/0000-0002-8141-5173			BARELLI A, 1991, CRIT CARE MED, V19, P1374, DOI 10.1097/00003246-199111000-00013; BECKER DP, 1982, NEUROLOGICAL SURGERY, V4, P1938; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Chatrian GE, 1996, ELECTROEN CLIN NEURO, V99, P103, DOI 10.1016/0013-4694(96)96059-9; Chiappa KH, 1998, ELECTROEN CLIN NEURO, V106, P149, DOI 10.1016/S0013-4694(97)00118-1; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; FACCO E, 1985, ELECTROEN CLIN NEURO, V62, P332, DOI 10.1016/0168-5597(85)90041-3; GANES T, 1988, ELECTROEN CLIN NEURO, V69, P6, DOI 10.1016/0013-4694(88)90030-2; GARCIALARREA L, 1987, ELECTROEN CLIN NEURO, V68, P446, DOI 10.1016/0168-5597(87)90056-6; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; Hall, 1992, HDB AUDITORY EVOKED; HALL JW, 1988, AM J OTOL, V9, P36; HALL JW, 1986, EAR HEARING, V7, P383, DOI 10.1097/00003446-198612000-00007; Hood L.J., 1998, CLIN APPL AUDITORY B; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1981, MANAGEMENT HEAD INJU; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LINDSAY K, 1990, NEUROSURGERY, V26, P278, DOI 10.1227/00006123-199002000-00015; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; LYLE DM, 1986, J NEUROSURG, V65, P15, DOI 10.3171/jns.1986.65.1.0015; Musiek F E, 1994, NEUROAUDIOLOGY CASE; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; PAPANICOLAOU AC, 1986, NEUROSURGERY, V18, P173, DOI 10.1227/00006123-198602000-00009; SOUSTIEL JF, 1993, ELECTROEN CLIN NEURO, V87, P277, DOI 10.1016/0013-4694(93)90180-4; STENING WA, 1986, AUST NZ J SURG, V56, P549, DOI 10.1111/j.1445-2197.1986.tb07098.x; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; WILSON WJ, 2001, THESIS U WITWATERSRA; [No title captured]	30	6	12	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	NOV	2002	97	5					1062	1069		10.3171/jns.2002.97.5.1062			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	613BC	WOS:000179109800014	12450027				2022-02-06	
J	Wong, ASH; Simpson, DA; Jones, NR; Gilligan, JE				Wong, ASH; Simpson, DA; Jones, NR; Gilligan, JE			Camel racing: a new cause of extradural haemorrhage in Australia	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						extradural haematoma; head injury; retrieval; camel; helmet; rural surgery	HEMATOMA	Camel racing is a relatively new sport in Australia. A 52 year old woman fell from her camel during a country race. Although she was wearing an approved equestrian helmet, she suffered a skull fracture and a life-threatening extradural haematoma. Her treatment highlights the key issues of management of head injuries in remote places. A paramount requirement is close collaboration between the country medical practitioner, neurosurgeon and retrieval specialist. (C) 2002 Published by Elsevier Science Ltd.	Royal Adelaide Hosp, Dept Neurosurg, Adelaide, SA 5000, Australia; Univ Adelaide, Rd Accident Res Unit, Adelaide, SA, Australia		Jones, NR (corresponding author), Royal Adelaide Hosp, Dept Neurosurg, Adelaide, SA 5000, Australia.						BULLIET RW, 1975, CAMEL WHEEL, P36; DAN NG, 1986, AUST NZ J SURG, V56, P353; GIBBS RM, 1969, HIST S AUSTR, P58; Gilligan JE, 1999, MED J AUSTRALIA, V171, P617, DOI 10.5694/j.1326-5377.1999.tb123822.x; JONES NR, 1993, BRIT J NEUROSURG, V7, P469; MCKISSOCK W, 1960, LANCET, V2, P167; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; *NEUR SOC AUSTR, 2000, MAN AC NEUR RUR REM; NORDSTROM CH, 1989, BRAIN INJURY, V3, P253; SIMPSON DA, 1988, INJURY, V19, P309; STEPHANOV S, 1993, BRIT J NEUROSURG, V7, P461, DOI 10.3109/02688699308995067	11	6	6	0	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2002	9	6					719	721		10.1054/jocn.2001.1051			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	620CY	WOS:000179516900029	12604296				2022-02-06	
J	Leclercq, PD; Stephenson, MS; Murray, LS; McIntosh, TK; Graham, DI; Gentleman, SM				Leclercq, PD; Stephenson, MS; Murray, LS; McIntosh, TK; Graham, DI; Gentleman, SM			Simple morphometry of axonal swellings cannot be used in isolation for dating lesions after traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						APP; axonal swellings; image analysis; survival time; traumatic axonal injury	AMYLOID PRECURSOR PROTEIN; HUMAN CORPUS-CALLOSUM; MYELINATED NERVE-FIBERS; HEAD-INJURY; STRETCH-INJURY; OPTIC-NERVE; CYTOCHEMICAL EVIDENCE; BETA-APP; NEUROPATHOLOGY; MARKER	Disruption of fast axonal transport as a result of traumatic brain injury is characterized by the accumulation of beta-amyloid precursor protein (APP) in axonal swellings. A recent report has suggested a correlation between the size of axonal swellings and survival time up to about 85 h after blunt head injury. The authors of the report concluded that this correlation, in conjunction with other evidence, might be useful in forensic science for timing injuries. To test this hypothesis we have used image analysis software to measure a number of different morphological parameters of axonal swellings. Paraffin sections from 63 cases of fatal head injury were stained with an antibody raised against the N-terminus of APP and counterstained with haematoxylin. Three different measurements were made of the APP-immunoreactive axonal swellings from the corpus callosum: (i) minimum and (ii) maximum Feret diameters, and (iii) area. Linear regression revealed a significant correlation between survival time and the minimum Feret diameter (P <0.0001) and the area (P <0.001) of axonal swellings. Our findings are in agreement with the previous study in that there is a significant correlation between axonal swelling size and survival time. However, we would suggest that the large variability in swelling size within individual cases and the heterogeneity of the original trauma seriously compromise the utility of such information in the timing of lesions.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Neuroinflammat, Div Neurosci & Psychol Med, London W6 8RP, England; So Gen Hosp, Inst Neurol Sci, Univ Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland; Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; Vet Adm Med Ctr, Philadelphia, PA USA		Gentleman, SM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Neuroinflammat, Div Neurosci & Psychol Med, Charing Cross Campus,St Dunstans Rd, London W6 8RP, England.						Aboitiz F, 1996, NEUROREPORT, V7, P1761, DOI 10.1097/00001756-199607290-00013; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; ABOITIZ F, 1992, BRAIN RES, V598, P154, DOI 10.1016/0006-8993(92)90179-D; ADAMS JH, 1976, NEUROPATH APPL NEURO, V2, P323, DOI 10.1111/j.1365-2990.1976.tb00506.x; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Adams JH, 1992, GREENFIELDS NEUROPAT, P106; BAETHMANN A, 2000, RESTOR NEUROL NEUROS, V16, P173; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BOUILLON B, 2000, RESTOR NEUROSCI, V16, P174; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Dolinak D, 2000, NEUROPATH APPL NEURO, V26, P448, DOI 10.1046/j.1365-2990.2000.00273.x; Dolinak D, 2000, ACTA NEUROPATHOL, V100, P553, DOI 10.1007/s004010000218; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Gentleman SM, 1999, NEUROPATH APPL NEURO, V25, P41; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Kannus P, 1999, AM J EPIDEMIOL, V149, P143; Kaur B, 1999, J CLIN PATHOL, V52, P203, DOI 10.1136/jcp.52.3.203; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Leclercq PD, 2001, J NEUROTRAUM, V18, P1, DOI 10.1089/089771501750055721; LEWEN A, 1995, NEUROREPORT, V6, P357, DOI 10.1097/00001756-199501000-00032; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; Maxwell WL, 1999, J NEUROTRAUM, V16, P273, DOI 10.1089/neu.1999.16.273; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; OCHS S, 1994, NEUROSCIENCE, V61, P361, DOI 10.1016/0306-4522(94)90237-2; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Pierce JES, 1996, J NEUROSCI, V16, P1083; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; STONE JR, 2000, RESTOR NEUROL NEUROS, V16, P304; Wilkinson AE, 1999, ACTA NEUROPATHOL, V98, P197, DOI 10.1007/s004010051069	42	6	9	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	2002	19	10					1183	1192		10.1089/08977150260337985			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	605MJ	WOS:000178681400007	12427327				2022-02-06	
J	Perea-Bartolome, MV; Ladera-Fernandez, V; Morales-Ramos, F				Perea-Bartolome, MV; Ladera-Fernandez, V; Morales-Ramos, F			Mnemonic performance in mild traumatic brain injury	REVISTA DE NEUROLOGIA			Spanish	Article						immediate/delayed memory; logical verbal memory; mild traumatic brain injury; verbal learning; visuo-constructive memory; visuospatial memory	MINOR HEAD-INJURY; SYMPTOMS; MEMORY	Introduction. Over the past few years there has been a lot of discussion over whether the mnemonic disorders that can appear after a mild traumatic brain injury (TBI)present as transitory deficits or can remain as permanent sequelae. Aims. To study whether there are mnemonic disorders in mild TBI or not, and to examine their evolution over the first year. Patients and methods. 60 adult subjects of both sexes with mild TBI, all of whom satisfied the critetia of the Mild Traumatic Brain Injury Interdisciplinary Special Interest Group of the American Congress ofRehabilitation Medicine, were studied at four different moments of their evolution (during the first seven days, atone month, at six months and at one year after the traumatism). The sample was completed with 60 normal adult subjects who shared similar demographic characteristics. Material: clinical scales for measuring TBI, cognitive screening tests and neuropsychological mnemonic tests that measure verbal learning, immediate and delayed logical verbal memory, visuospatial and visuo-constructive memory. Statistical analysis: data were analysed using ANOVA of repeated measures and a posteriori testing using Scheffe F-test. Conclusions. Memory was affected in these patients for at least the first week after the traumatic injury took place. At one month, immediate and delayed logical verbal memory and visuo-constructive memory showed cognitive performances that were similar to the control group. Learning and the verbal auditory capacity to retain a list of words were still altered one year after the traumatic injury occurred.	Univ Salamanca, Dept Psicol Basica Psicobiol & Metodol, Fac Psicol, E-37008 Salamanca, Spain; Hosp Virgen Vega, Serv Neurocirug, Salamanca, Spain				Ladera, Valentina/Q-6132-2017; Perea, M.Victoria/B-2904-2018	Ladera, Valentina/0000-0003-4075-4483; Perea, M.Victoria/0000-0002-0258-8480			Babcock H, 1940, MEASUREMENT EFFICIEN; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BENTON AL, 1988, TEST RETENCION VISUA; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GENTILINI N, 1989, MILD HEAD INJURY, P163; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KOKMEN E, 1987, MAYO CLIN PROC, V62, P281, DOI 10.1016/S0025-6196(12)61905-3; KRAUS J, 1988, MILD HEAD INJURY, P8; LADERA V, 1992, THESIS U SALAMANCA; LEESHALEY PR, 1994, J CLIN PSYCHOL, V50, P252, DOI 10.1002/1097-4679(199403)50:2<252::AID-JCLP2270500217>3.0.CO;2-T; LENINGER B, 1990, J NEUROL NEUROSUR PS, V53, P293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; McAllister Thomas W., 1994, P357; MILLIS SR, 1995, BRAIN INJURY, V9, P509, DOI 10.3109/02699059509008210; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Perea MV, 1999, REV NEUROLOGIA, V28, P999, DOI 10.33588/rn.2810.98321; Perea MV, 1999, REV NEUROLOGIA, V29, P1099, DOI 10.33588/rn.2912.99373; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rey A, 1987, TEST COPIA FIGURA CO; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ruff R., 1989, MILD HEAD INJURY, P152; TEASDALE G, 1974, LANCET, V2, P117; UZZELL BP, 1987, SURG NEUROL, V27, P419, DOI 10.1016/0090-3019(87)90247-3; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	29	6	8	1	6	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	OCT 1	2002	35	7					607	612		10.33588/rn.3507.2001011			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	606KP	WOS:000178733400003	12389144				2022-02-06	
J	Rodrigues, RND; Silva, AAAAE				Rodrigues, RND; Silva, AAAAE			Excessive daytime sleepiness after traumatic brain injury: association with periodic limb movements and REM behavior disorder. Case report	ARQUIVOS DE NEURO-PSIQUIATRIA			Portuguese	Article						cranial trauma; dopaminergic pathways; hypocretin; REM behaviour disorder; periodic leg movements		A 52 year-old male patient, had complaint of "restless sleep". His wife informed that for the past ten years the patient had presented intense and aggressive body movements, and sometimes, violent dreams. The patient also complained of excessive daytime sleepiness. His relevant previous medical history included a traumatic brain injury at the age of 28 which left him in coma for two months. A video-polysomnography showed periodic leg movements and, during REM sleep, aggressive and agitated behaviour. The multiple sleep latency test revealed extremely short latencies. Initially, he was treated with levodopa-benzerazide, 100/25 mg, 2 hours before bedtime. After 10 weeks his overnight behaviour pattern improved and leg movements diminished. This case supports the hypothesis of an association between cranial trauma and alterations in the dopaminergic pathways represented by periodic leg movements during sleep and a sleep behaviour disorder and proposes the possibility of hypothalamic hypocretin involvement in its pathophysiology.	Univ Brasilia, Univ Hosp, Lab Sono, Brasilia, DF, Brazil								AESCH B, 1999, ENCY MED CHIR NEUROL, P17585; ALDRICH MS, 1999, SLEEP MED, P325; ALDRICH MS, 1999, SLEEP MED, P175; Amitai N, 2001, SLEEP, V24, pA99; AMULF I, 2001, SLEEP, V24, pA372; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Chiu HFK, 2000, SLEEP, V23, P513; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; GUILLEMINAULT C, 1983, NEUROLOGY, V33, P1584, DOI 10.1212/WNL.33.12.1584; Guilleminault C, 2000, NEUROLOGY, V54, P653, DOI 10.1212/WNL.54.3.653; GUILLEMINAULT C, 2000, PRINCIPLES PRACTICE, P687; HAUSER R, 2001, DOENCA PARKINSON PER, P35; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; LAI JM, 1999, SLEEP, V22, pS314; Mahowald MW, 2000, PRINCIPLES PRACTICE, P724; Mignot E, 2000, PRINCIPLES PRACTICE, P663; Nielsen TA, 2000, PRINCIPLES PRACTICE, V3rd, P753; Ripley B, 2001, SLEEP, V24, pA322	18	6	6	0	0	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	SEP	2002	60	3A					656	660		10.1590/S0004-282X2002000400028			5	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	589NW	WOS:000177767200028	12244410	Green Published, gold			2022-02-06	
J	Toliver-Kinsky, T; Rassin, D; Perez-Polo, JR				Toliver-Kinsky, T; Rassin, D; Perez-Polo, JR			NF-kappa B activity decreases in basal forebrain of young and aged rats after hyperoxia	NEUROBIOLOGY OF AGING			English	Article; Proceedings Paper	Meeting on Brain Aging - Identifying Accelerators and Brakes	NOV, 2001	SAN DIEGO, CALIFORNIA			aged; NF-kappa B; hyperoxia; oxidative stress; basal forebrain	TRAUMATIC BRAIN INJURY; OXYGEN-FREE-RADICALS; OXIDATIVE STRESS; DNA-BINDING; TRANSCRIPTION FACTORS; LIPID-PEROXIDATION; LIMBIC STRUCTURES; SEIZURE ACTIVITY; REL ONCOGENE; PC12 CELLS	Hyperoxia is an oxidative stressor that triggers signaling cascades via changes in promoter activation by transcription factors. The transcription factor NF-kappaB has been shown to regulate transcription of many genes that play a role in inflammation and recovery from acute or chronic trauma. Here we describe the effects of hyperoxia on basal levels of NF-kappaB activity in young and aged rat forebrain. The results would suggest that chronic stress may have different effects on NF-kappaB basal activity levels as compared to the effects of an acute stress such as hyperoxia and that there is a diminished response to hyperoxia in the aged basal forebrain. (C) 2002 Elsevier Science Inc. All rights reserved.	Univ Texas, Med Branch, Dept Pediat, Galveston, TX 77550 USA; Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77550 USA		Perez-Polo, JR (corresponding author), Univ Texas, Med Branch, Dept Human Biol Chem & Genet, 301 Univ Bldg, Galveston, TX 77555 USA.		Perez-Polo, Jose R./B-6250-2009; Toliver-Kinsky, Tracy/ABE-2048-2020				ARONSON BD, 1993, BRAIN RES REV, V18, P315, DOI 10.1016/0165-0173(93)90015-R; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bethea JR, 1998, J NEUROSCI, V18, P3251; Boschert U, 1997, NEUROREPORT, V8, P3077, DOI 10.1097/00001756-199709290-00014; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; BOURS V, 1992, MOL CELL BIOL, V12, P685, DOI 10.1128/MCB.12.2.685; BOURS V, 1990, NATURE, V348, P76, DOI 10.1038/348076a0; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; BROWNELL E, 1989, ONCOGENE, V4, P935; BRUCE AJ, 1995, FREE RADICAL BIO MED, V18, P993, DOI 10.1016/0891-5849(94)00218-9; Cardozo-Pelaez F, 1999, MOVEMENT DISORD, V14, P972, DOI 10.1002/1531-8257(199911)14:6<972::AID-MDS1010>3.0.CO;2-0; Clemens JA, 1997, STROKE, V28, P1073, DOI 10.1161/01.STR.28.5.1073; COTMAN CW, 1994, ANN NY ACAD SCI, V747, P36; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Driver AS, 2000, NEUROTOXICOL TERATOL, V22, P175, DOI 10.1016/S0892-0362(99)00069-0; Edwards M, 1998, J NEUROSCI RES, V54, P635, DOI 10.1002/(SICI)1097-4547(19981201)54:5<635::AID-JNR8>3.3.CO;2-8; FAROOQUI MYH, 1987, COMP BIOCHEM PHYS B, V88, P177, DOI 10.1016/0305-0491(87)90097-6; FOSTER MJ, 1996, P NATL ACAD SCI USA, V93, P4765; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; GHOSH S, 1990, CELL, P62; Glasgow JN, 2000, J NEUROCHEM, V75, P1377, DOI 10.1046/j.1471-4159.2000.0751377.x; GOMI F, 1995, J NUTR SCI VITAMINOL, V41, P139, DOI 10.3177/jnsv.41.139; HENSLEY K, 1995, BBA-MOL BASIS DIS, V1270, P203, DOI 10.1016/0925-4439(95)00043-4; HOTHERSALL JS, 1981, ENZYME, V26, P271, DOI 10.1159/000459190; Howard BJ, 1996, J NEUROCHEM, V67, P2045; Kent TA, 1999, J NEUROSCI RES, V55, P357, DOI 10.1002/(SICI)1097-4547(19990201)55:3<357::AID-JNR11>3.0.CO;2-W; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KOONG AC, 1994, CANCER RES, V54, P1425; KOUDELOVA J, 1994, PHYSIOL RES, V43, P169; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416; MERCURIO F, 1992, DNA CELL BIOL, V11, P523, DOI 10.1089/dna.1992.11.523; MEYER M, 1993, EMBO J, V12, P20005; MIZUNO Y, 1986, J NEUROCHEM, V46, P1344, DOI 10.1111/j.1471-4159.1986.tb01745.x; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; PAXINOS G, 1985, RAT NERVOUS SYSTEM F, V1; Qiu JX, 2001, J NEUROSCI RES, V64, P223, DOI 10.1002/jnr.1070.abs; Rong YQ, 1996, J NEUROCHEM, V67, P662; RUBEN SM, 1991, SCIENCE, V251, P1490, DOI 10.1126/science.2006423; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; SALMINEN A, 1995, BIOCHEM BIOPH RES CO, V212, P939, DOI 10.1006/bbrc.1995.2060; SCHENK H, 1994, P NATL ACAD SCI USA, V91, P1672, DOI 10.1073/pnas.91.5.1672; SCHMID RM, 1991, NATURE, V352, P733, DOI 10.1038/352733a0; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Sonenshein GE, 1997, SEMIN CANCER BIOL, V8, P113, DOI 10.1006/scbi.1997.0062; Taglialatela G, 1996, NEUROREPORT, V7, P977, DOI 10.1097/00001756-199604100-00004; Taglialatela G, 1998, FREE RADICAL BIO MED, V25, P936, DOI 10.1016/S0891-5849(98)00131-2; Taglialatela G, 1997, J NEUROSCI RES, V47, P155; Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2; Toliver-Kinsky T, 2000, J NEUROCHEM, V75, P2241, DOI 10.1046/j.1471-4159.2000.0752241.x; ToliverKinsky T, 1997, J NEUROSCI RES, V48, P580, DOI 10.1002/(SICI)1097-4547(19970615)48:6<580::AID-JNR11>3.0.CO;2-Z; VIANI P, 1991, J NEUROCHEM, V56, P253, DOI 10.1111/j.1471-4159.1991.tb02589.x; YANG KY, 1995, NEUROSCI LETT, V197, P101, DOI 10.1016/0304-3940(95)11919-N; ZHANG JR, 1993, J NEUROCHEM, V61, P1640, DOI 10.1111/j.1471-4159.1993.tb09798.x	59	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580			NEUROBIOL AGING	Neurobiol. Aging	SEP-OCT	2002	23	5					899	905	PII S0197-4580(02)00023-4	10.1016/S0197-4580(02)00023-4			7	Geriatrics & Gerontology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	615EA	WOS:000179231800031	12392794				2022-02-06	
J	Fowler, J; MacKinnon, MA; Raghupathi, R; Saatman, KE; McIntosh, TK; Graham, DI				Fowler, J; MacKinnon, MA; Raghupathi, R; Saatman, KE; McIntosh, TK; Graham, DI			Age does not influence DNA fragmentation in the hippocampus after fatal traumatic brain injury in young and aged humans compared with controls	CLINICAL NEUROPATHOLOGY			English	Article						traumatic brain injury; children and adults; hippocampus; TUNEL staining	MISSILE HEAD-INJURY; ALZHEIMERS-DISEASE; INTRACRANIAL-PRESSURE; CELL-DEATH; CHILDREN; DAMAGE; RAT; NEUROPATHOLOGY; ADOLESCENTS; DEPOSITION	Paraffin sections from the hippocampus of 12 head-injured patients (Group A, aged between 4 and 12 years n = 6 and Group B, aged between 64 and 89 years n = 6) and associated age-matched controls were stained by the terminal deoxynucleotidyl transferase-mediated biotinylated deoxyuridine triphosphate nick end labeling (TUNEL) technique for evidence of in-situ DNA fragmentation. TUNEL+ cells were of 2 Types: I (non-apoptotic) and 11 (apoptotic). In addition sections stained H&E, combined Luxol Fast Blue/Cresyl Violet and by immunohistochemistry for astrocytes (GFAP) and macrophages (CD68) were used to characterize the lesions. Small numbers of Type I TUNEL+ cells were seen in all sectors of the hippocampus except CA2 of both Groups A and B. Type 11 TUNEL+ cells were mainly found in the white matter. They constituted less than 1% of all TUNEL+ cells. There were similar or fewer TUNEL+ cells in the corresponding areas in the controls compared with the head-injured patients. However, in the dentate fascia and the CA4 sector of the Group B cases, larger numbers of TUNEL+ cells were seen in controls than after trauma. In the grey matter most TUNEL+ cells had the morphology of necrosis that corresponded with foci of selective neuronal damage. Only a few TUNEL+ cells were seen in white matter. The occasional Type I TUNEL+ cells were seen in grey matter. It is concluded that the amount arid distribution of DNA fragmentation in children and adults is Similar and therefore at least in the hippocampus does not provide an explanation for age as an independent variable of outcome after traumatic brain injury in childhood.	Univ Glasgow, So Gen Hosp, Dept Neuropathol, Inst Neurol Sci,S Glasgow Univ Hosp NHS Trust, Glasgow G51 4TF, Lanark, Scotland; Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA		Graham, DI (corresponding author), Univ Glasgow, So Gen Hosp, Dept Neuropathol, Inst Neurol Sci,S Glasgow Univ Hosp NHS Trust, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.			Fowler, Jill/0000-0003-3204-1221	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50-NS08803] Funding Source: Medline		ADAMS JH, 1989, SCOT MED J, V34, P399, DOI 10.1177/003693308903400106; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; Clark D, 1999, IEEE INTERNET COMPUT, V3, P13; Conti AC, 1998, J NEUROSCI, V18, P5663; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; GRAHAM DI, 1987, NEUROPATH APPL NEURO, V13, P209, DOI 10.1111/j.1365-2990.1987.tb00184.x; GRAHAM DI, 2002, IN PRESS GREENFIELDS; Griffin WST, 1998, BRAIN PATHOL, V8, P65; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; KOTAPKA MJ, 1993, NEUROPATH APPL NEURO, V19, P128, DOI 10.1111/j.1365-2990.1993.tb00417.x; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; LEURSSEN TG, 1988, J NEUROSURG, V68, P409; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; NG HK, 1989, ACTA NEUROPATHOL, V78, P438; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; RINK A, 1995, AM J PATHOL, V147, P1575; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Runnerstam M, 2001, J NEUROTRAUM, V18, P259, DOI 10.1089/08977150151070892; Shaw K, 2001, CLIN NEUROPATHOL, V20, P106; Shiozaki T, 2001, J NEUROTRAUM, V18, P665, DOI 10.1089/089771501750357618; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; Vollmer DG, 1991, J NEUROSURG S, V75, P37; Williams S, 2001, ACTA NEUROPATHOL, V102, P581, DOI 10.1007/s004010100410; WILSON S, 1999, J NEUROTRAUM, V16, P1001; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78	42	6	6	0	1	DUSTRI-VERLAG DR KARL FEISTLE	OBERHACHING	BAJUWARENRING 4, D-82041 OBERHACHING, GERMANY	0722-5091			CLIN NEUROPATHOL	Clin. Neuropathol.	JUL-AUG	2002	21	4					156	162					7	Clinical Neurology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	576BD	WOS:000176982200004	12143927				2022-02-06	
J	Grouios, G				Grouios, G			Phantom smelling	PERCEPTUAL AND MOTOR SKILLS			English	Article							RECENT TRAUMATIC AMPUTATIONS; UPPER-EXTREMITY AMPUTEES; CORTICAL REORGANIZATION; LIMB PAIN; TEMPORAL LOBECTOMY; SOMATOSENSORY CORTEX; IDENTIFICATION TEST; AMERICAN VETERANS; AUDITORY-CORTEX; EARLY-CHILDHOOD	A case of phantom smelling (phantosmia) is described in a 28-yr-old man who developed permanent bilateral anosmia after a serious injury to olfaction-related brain structures at the age of 25 years, The findings indicate that, Eden years after loss of input from olfactory receptors, the neural representation of olfactory perception can still recreate olfactory sensations without an conscious recall of them, This indicates that the neural representation of olfactory sensations remains functional and implies that neuronal activity in the olfactory organ or in other brain structures gives rise to olfactory experiences perceived as originating from the perception of original odor substances, The report suggests the intriguing possibility that the olfactory perception is not a passive process that merely reflects its normal input from the olfactory system but is continuously generated by a neural representation in the olfactory organ or in other olfaction-related brain structures, based on both genetic and sensory determinants, To the author's knowledge this is the first reported case of its kind.	Aristotle Univ Thessaloniki, Thessaloniki, Greece		Grouios, G (corresponding author), 43 Dimitsanas St, Thessaloniki 54454, Greece.	ggrouios@phed.auth.gr					Berlucchi G, 1997, TRENDS NEUROSCI, V20, P560, DOI 10.1016/S0166-2236(97)01136-3; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1, DOI 10.1152/physrev.1990.70.1.1; Birbaumer N, 1997, J NEUROSCI, V17, P5503; Brasic JR, 1998, PERCEPT MOTOR SKILL, V86, P851, DOI 10.2466/pms.1998.86.3.851; Buchel C, 1998, BRAIN, V121, P1193, DOI 10.1093/brain/121.7.1193; CARLEN PL, 1978, NEUROLOGY, V28, P211, DOI 10.1212/WNL.28.3.211; CODERRE TJ, 1993, PAIN, V52, P259, DOI 10.1016/0304-3959(93)90161-H; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; COHN R, 1971, ARCH NEUROL-CHICAGO, V25, P468, DOI 10.1001/archneur.1971.00490050102009; CONOMY JP, 1973, ARCH NEUROLOGY PSYCH, V66, P610; DAVIS RL, 1993, COMPUT FLUID DYN, V1, P79; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; DOTY RL, 1989, PERCEPT PSYCHOPHYS, V45, P381, DOI 10.3758/BF03210709; Doty RL, 1995, SMELL IDENTIFICATION, Vthird; Draycott S, 1998, BRIT J CLIN PSYCHOL, V37, P341, DOI 10.1111/j.2044-8260.1998.tb01390.x; Elbert T, 1997, EXP BRAIN RES, V117, P161, DOI 10.1007/s002210050210; ELBERT T, 1994, NEUROREPORT, V5, P2593, DOI 10.1097/00001756-199412000-00047; ESKENAZI B, 1983, NEUROPSYCHOLOGIA, V21, P365, DOI 10.1016/0028-3932(83)90023-4; ESKENAZI B, 1986, NEUROPSYCHOLOGIA, V24, P553, DOI 10.1016/0028-3932(86)90099-0; ETTLIN TM, 1980, EUR NEUROL, V19, P12, DOI 10.1159/000115122; FARLEY D, 1968, BRIT J SURG, V55, P40, DOI 10.1002/bjs.1800550112; Fisher CM, 1999, CAN J NEUROL SCI, V26, P53; Flor H, 1998, EXP BRAIN RES, V119, P205, DOI 10.1007/s002210050334; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Florence SL, 1995, J NEUROSCI, V15, P8083; FRIED I, 1995, J NEUROSURG, V83, P60, DOI 10.3171/jns.1995.83.1.0060; Gallinek A, 1939, AM J PSYCHIAT, V96, P413, DOI 10.1176/ajp.96.2.413; GILLIATT RW, 1952, J NEUROL NEUROSUR PS, V15, P264, DOI 10.1136/jnnp.15.4.264; Grouios G, 2001, J VISUAL IMPAIR BLIN, V95, P30, DOI 10.1177/0145482X0109500104; Grouios G, 1996, MED SCI RES, V24, P507; Grouios G, 1996, MED SCI RES, V24, P503; Grouios G, 1998, MED SCI RES, V26, P219; Grouios G, 1998, MED SCI RES, V26, P213; Grouios G, 1999, PERCEPT MOTOR SKILL, V89, P791, DOI 10.2466/PMS.89.7.791-798; GROUIOS G, 1999, PHYS THER REV, V4, P29; Henkin R I, 1977, Trans Am Neurol Assoc, V102, P146; Henkin RI, 2000, J COMPUT ASSIST TOMO, V24, P106, DOI 10.1097/00004728-200001000-00022; Herman J, 1998, ANN INTERN MED, V128, P76, DOI 10.7326/0003-4819-128-1-199801010-00029; Jain N, 1997, NATURE, V386, P495, DOI 10.1038/386495a0; Jasper K, 1963, GEN PSYCHOPATHOLOGY; JENSEN TS, 1983, PAIN, V17, P243, DOI 10.1016/0304-3959(83)90097-0; JONESGOTMAN M, 1988, NEUROPSYCHOLOGIA, V26, P387, DOI 10.1016/0028-3932(88)90093-0; JONESGOTMAN M, 1993, BRAIN COGNITION, V22, P182, DOI 10.1006/brcg.1993.1033; Kaas JH, 1998, NATURE, V391, P331, DOI 10.1038/34782; KATZ J, 1992, J NEUROL NEUROSUR PS, V55, P811, DOI 10.1136/jnnp.55.9.811; KELLNER CH, 1992, AM J PSYCHIAT, V149, P422; Knecht S, 1998, BRAIN, V121, P717, DOI 10.1093/brain/121.4.717; Knecht S, 1998, PAIN, V77, P209, DOI 10.1016/S0304-3959(98)00102-X; KOBAL G, 1991, SMELL TASTE HLTH DIS, P255; Kolb LC, 1959, AM HDB PSYCHIATRY, P749; KOSSLYN SM, 1992, WET MIND; KUJALA T, 1995, EXP BRAIN RES, V104, P519; Kwapil TR, 1996, SCHIZOPHRENIA BULL, V22, P371, DOI 10.1093/schbul/22.2.371; LIVINGSTON KE, 1945, J NEUROSURG, V2, P251, DOI 10.3171/jns.1945.2.3.0251; Melzack R, 1997, BRAIN, V120, P1603, DOI 10.1093/brain/120.9.1603; MELZACK R, 1992, SCI AM, V266, P120, DOI 10.1038/scientificamerican0492-120; MELZACK R, 1990, TRENDS NEUROSCI, V13, P88, DOI 10.1016/0166-2236(90)90179-E; Mills CK, 1908, J AMER MED ASSOC, V51, P879; MITCHELL SW, 1872, INJURIES NERVES THIE; Montoya P, 1997, PAIN, V72, P87, DOI 10.1016/S0304-3959(97)00004-3; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; NAUTA WJH, 1960, ANAT REC, V136, P251; Pankow L, 1997, OPTOMETRY VISION SCI, V74, P138, DOI 10.1097/00006324-199703000-00023; Pantev C, 1999, BRAIN RES, V842, P192, DOI 10.1016/S0006-8993(99)01835-1; POTTER H, 1980, NEUROPSYCHOLOGIA, V18, P621, DOI 10.1016/0028-3932(80)90101-3; PRICE JL, 1983, J COMP NEUROL, V215, P63, DOI 10.1002/cne.902150106; Ramachandran V. S., 1995, P227; RAMACHANDRAN VS, 1993, P NATL ACAD SCI USA, V90, P10413, DOI 10.1073/pnas.90.22.10413; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Rauschecker JP, 1999, TRENDS NEUROSCI, V22, P74, DOI 10.1016/S0166-2236(98)01303-4; Riddoch G, 1941, BRAIN, V64, P197, DOI 10.1093/brain/64.4.197; Royet JP, 1999, J COGNITIVE NEUROSCI, V11, P94, DOI 10.1162/089892999563166; SANDYK R, 1981, S AFR MED J, V60, P950; SCHECHTER PJ, 1974, J NEUROL NEUROSUR PS, V37, P802, DOI 10.1136/jnnp.37.7.802; SCHULTZ G, 1991, PERCEPTION, V20, P809, DOI 10.1068/p200809; SHERMAN RA, 1983, AM J PHYS MED REHAB, V62, P227; SHERMAN RA, 1984, PAIN, V18, P83, DOI 10.1016/0304-3959(84)90128-3; Shipley M., 1991, HUMAN SENSE SMELL, P29; SIEGEL RK, 1978, AM J PSYCHIAT, V150, P1897; SUMNER D, 1962, LANCET, V2, P895; TANABE T, 1975, J NEUROPHYSIOL, V38, P1269, DOI 10.1152/jn.1975.38.5.1269; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; VANHOESEN GW, 1975, BRAIN RES, V95, P1, DOI 10.1016/0006-8993(75)90204-8; VONBONIN G, 1949, J COMP NEUROL, V90, P243, DOI 10.1002/cne.900900206; WALL PD, 1974, EXP NEUROL, V43, P580, DOI 10.1016/0014-4886(74)90197-6; Wang G, 1998, IEEE T MED IMAGING, V17, P251, DOI 10.1109/42.700737; WARD LC, 1990, J CLIN PSYCHOL, V46, P436, DOI 10.1002/1097-4679(199007)46:4<436::AID-JCLP2270460411>3.0.CO;2-M; WHITEHEAD MC, 1995, EXP NEUROL, V132, P239, DOI 10.1016/0014-4886(95)90029-2; ZATORRE RJ, 1991, BRAIN, V114, P71; [No title captured]	91	6	6	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0031-5125	1558-688X		PERCEPT MOTOR SKILL	Percept. Mot. Skills	JUN	2002	94	3	1				841	850		10.2466/PMS.94.2.841-850			10	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	561UL	WOS:000176161100020	12081289				2022-02-06	
J	Amos, A				Amos, A			Remediating deficits of switching attention in patients with acquired brain injury	BRAIN INJURY			English	Article							CLOSED-HEAD INJURY; CARD SORTING TEST; SCHIZOPHRENIA; PERFORMANCE	Objective: This study was designed to evaluate the remediating effects of two types of aid on a test of switching attention administered to patients with acquired brain injury (ABI). Based on the separation of cognitive functions suggested by a neural network model, it was hypothesized that external inhibition of obsolete rules, and increased salience Of stimuli, would differentially improve the WCST performance of participants with ABI. Design and method: The Wisconsin Card Sorting Test (WCST) performance of 24 patients with ABI assigned to three treatment groups (no treatment, external inhibition, increased stimulus salience) was compared to normal controls. Main outcomes: External inhibition of learned rules reduced perseverative errors, while increased stimuli salience reduced random errors, committed by patients with ABI. Conclusions: The pattern of results supports the separation of functions in switching attention suggested by a neural network model, and establishes minimal aids necessary for remediating deficits associated with ABI.	Univ Western Australia, State Head Injury Unit, Nedlands, WA 6907, Australia		Amos, A (corresponding author), Univ Western Australia, State Head Injury Unit, Hosp Ave, Nedlands, WA 6907, Australia.		Amos, Andrew J/J-1418-2012	Amos, Andrew J/0000-0002-9145-0212			Amos A, 2000, J COGNITIVE NEUROSCI, V12, P505, DOI 10.1162/089892900562174; BECERRA R, THESIS MURDOCH U W A; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; BUCHSBAUM MS, 1990, SCHIZOPHRENIA BULL, V16, P379, DOI 10.1093/schbul/16.3.379; Chan RCK, 2000, BRAIN INJURY, V14, P227, DOI 10.1080/026990500120709; Chen SHA, 1997, BRAIN INJURY, V11, P197; COLE M, 1990, CONT NEUROPSYCHOLOGY, P27; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; Galletly CA, 2000, J PSYCHIATR NEUROSCI, V25, P117; Heaton R.K., 1981, WISCONSIN CARD SORTI; Hellman SG, 1998, SCHIZOPHR RES, V34, P67, DOI 10.1016/S0920-9964(98)00088-7; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Stratta P, 1997, PSYCHOPATHOLOGY, V30, P59, DOI 10.1159/000285030; [No title captured], DOI DOI 10.1177/107319119600300108	16	6	6	0	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	2002	16	5					407	413		10.1080/02699050110104435			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	553TX	WOS:000175692500004	12097224				2022-02-06	
J	Greiffenstein, MF; Baker, WJ; Gola, T				Greiffenstein, MF; Baker, WJ; Gola, T			Anosmia and remote outcome in closed head injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article								The value of posttraumatic anosmia as a predictor of late social outcomes was examined in a sample of closed head injury (CHI) patients. Unemployment rates were equally high in both the anosmic and nonanosmic closed head injury patients. The groups also did not differ in psychiatric or neuropsychological status. Anosmic patients had longer initial hospital stays and deeper initial comatose/confusional states. Anosmia does not appear to add incrementally to disability status and it does not automatically imply the presence of basal-frontal damage.	Psychol Syst Inc, Royal Oak, MI USA		Greiffenstein, MF (corresponding author), 26862 Woodward Ave,Suite 103, Royal Oak, MI 48067 USA.	mfg@neuro-psychology.com					Adams R. D., 1993, PRINCIPLES NEUROLOGY; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Costanzo R. M., 1992, J HEAD TRAUMA REHAB, V7, P15, DOI DOI 10.1097/00001199-199203000-00005; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Golden J. C., 1978, STROOP COLOR WORD TE; GREEN PG, 2002, NEUROREHABILITATION; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; Heaton R.K., 1981, WISCONSIN CARD SORTI; Kreutzer J S, 1988, Brain Inj, V2, P205, DOI 10.3109/02699058809150945; Lewin W, 1964, Clin Neurosurg, V12, P237; Ogawa T, 1999, ACTA OTO-LARYNGOL, P50; RAUSCH R, 1975, NATURE, V255, P557, DOI 10.1038/255557a0; Reitan RM, 1985, HALSTEADREITAN NEURO; Seiden AM, 2001, LARYNGOSCOPE, V111, P9, DOI 10.1097/00005537-200101000-00002; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; Wechsler D, 1987, MEMORY SCALE REVISED; Yousem DM, 1999, ACAD RADIOL, V6, P264, DOI 10.1016/S1076-6332(99)80449-8	21	6	6	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2002	24	5					705	709		10.1076/jcen.24.5.705.1011			5	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	573RJ	WOS:000176844400013					2022-02-06	
J	Montanez, S; Kline, AE; Selwyn, AP; Suozzi, JC; Butler, SE; Hernandez, TD				Montanez, S; Kline, AE; Selwyn, AP; Suozzi, JC; Butler, SE; Hernandez, TD			Vigabatrin directed against kindled seizures following cortical insult: Impact on epileptogenesis and somatosensory recovery	JOURNAL OF NEUROTRAUMA			English	Article						anteromedial cortex lesion; GABA; kindling; seizures; somatosensory deficits	GAMMA-VINYL-GABA; BILATERAL CUTANEOUS STIMULATION; TRAUMATIC BRAIN-INJURY; DORSAL RAPHE NEURONS; FUNCTIONAL RECOVERY; AMINOBUTYRIC-ACID; 4-AMINO-HEX-5-ENOIC ACID; POSTTRAUMATIC EPILEPSY; ANTEROMEDIAL CORTEX; GLUCOSE-UTILIZATION	The anticonvulsant drug vigabatrin has not been found to be detrimental to the recovery process when administered following focal cortical insult. This finding is in contrast to the negative postinjury consequences of other anticonvulsant drugs (e.g., phenobarbital and diazepam) with more direct activation of the GABA/benzodiazepine receptor complex. Moreover, phenobarbital directed against kindled seizures affects functional recovery more adversely than either the drug or subconvulsive seizures alone. The purpose of the present study was to determine whether vigabatrin (150, 200, and 250 mg/kg) directed against kindled seizures would impact recovery from lesion-induced somatosensory deficits. Vigabatrin was coupled with daily electrical kindling of the amygdala during the first week after a unilateral anteromedial cortex (AMC) lesion. Somatosensory recovery was assessed using bilateral tactile stimulation tests. Animals receiving the highest dose of vigabatrin prior to electrical kindling (250 mg/kg vigabatrin/kindled) remained significantly impaired even after two months of testing relative to vehicle/kindled, kindled/250 mg/kg vigabatrin, which received vigabatrin after electrical kindling, and the 150, 200, and 250 mg/kg vigabatrin/nonkindled groups (p < 0.0001). In contrast, neither vigabatrin (at any of the doses tested) nor subconvulsive kindled seizures impacted the recovery process (p > 0.05) when administered alone (i.e., without the drug + seizure interaction). These data add to the accumulating experimental and clinical evidence suggesting that the neurobehavioral consequences of the interaction between anticonvulsant drugs and subclinical seizures after brain insult are detrimental to functional recovery.	Univ Colorado, Dept Psychol, Behav Neurosci Program, Boulder, CO 80309 USA		Hernandez, TD (corresponding author), Univ Colorado, Dept Psychol, Behav Neurosci Program, Campus Box 345, Boulder, CO 80309 USA.	terid@psych.colorado.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R29NS030595] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-30595] Funding Source: Medline		ABDULGHANI AS, 1981, BIOCHEM PHARMACOL, V30, P363, DOI 10.1016/0006-2952(81)90067-8; ALLAN AM, 1992, BRAIN RES, V588, P255, DOI 10.1016/0006-8993(92)91583-Z; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; ANNETT LE, 1992, BRAIN, V115, P825, DOI 10.1093/brain/115.3.825; ARNOLD PS, 1973, EXP NEUROL, V40, P457, DOI 10.1016/0014-4886(73)90087-3; BARTH TM, 1990, STROKE, V21, P153; BARTH TM, 1990, J NEUROSCI, V10, P3449; BARTH TM, 1994, BEHAV NEUROSCI, V108, P818, DOI 10.1037/0735-7044.108.4.818; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; BENMENACHEM E, 1995, EPILEPSIA, V36, pS95, DOI 10.1111/j.1528-1157.1995.tb06003.x; BRAILOWSKY S, 1986, BRAIN RES, V362, P322, DOI 10.1016/0006-8993(86)90457-9; Buytaert KA, 2001, BRAIN RES, V894, P121, DOI 10.1016/S0006-8993(01)01987-4; Chadwick D, 2000, LANCET, V355, P334, DOI 10.1016/S0140-6736(99)00452-3; COOPER RM, 1984, EXP NEUROL, V86, P261, DOI 10.1016/0014-4886(84)90185-7; CRISOSTOMO EA, 1988, ANN NEUROL, V23, P94, DOI 10.1002/ana.410230117; DAUTH GW, 1985, ANN NEUROL, V17, P431, DOI 10.1002/ana.410170503; Dietz M A, 1991, J Stroke Cerebrovasc Dis, V1, P37, DOI 10.1016/S1052-3057(11)80018-2; DURING MJ, 1992, BRAIN RES, V584, P36, DOI 10.1016/0006-8993(92)90875-A; ERDO SL, 1991, BRAIN RES, V542, P254, DOI 10.1016/0006-8993(91)91575-L; Feeney D M, 1987, Brain Inj, V1, P27, DOI 10.3109/02699058709034441; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; FEENEY DM, 1985, PHYSIOL PSYCHOL, V13, P197; FEENEY DM, 1991, J NEUROL REHABIL, V5, P113; GALLAGER DW, 1984, NATURE, V308, P74, DOI 10.1038/308074a0; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; GOLDSTEIN LB, 1995, J NEUROL NEUROSUR PS, V58, P753, DOI 10.1136/jnnp.58.6.753; GOLDSTEIN LB, 1991, J NEUROL REHABIL, V5, P129; GRANT SM, 1991, DRUGS, V41, P889, DOI 10.2165/00003495-199141060-00007; HALONEN T, 1991, EPILEPSIA, V32, P242, DOI 10.1111/j.1528-1157.1991.tb05251.x; HAMM RJ, 1995, EXP NEUROL, V136, P143, DOI 10.1006/exnr.1995.1091; HAMMOND EJ, 1985, GEN PHARMACOL, V16, P441, DOI 10.1016/0306-3623(85)90002-3; HANNILA T, 1990, BRAIN RES, V537, P363, DOI 10.1016/0006-8993(90)90387-Q; Hernandez T D, 1990, Restor Neurol Neurosci, V1, P323, DOI 10.3233/RNN-1990-1503; HERNANDEZ TD, 1995, BRAIN RES, V673, P208, DOI 10.1016/0006-8993(94)01415-E; HERNANDEZ TD, 1989, BRAIN RES, V487, P89, DOI 10.1016/0006-8993(89)90943-8; Hernandez TD, 1997, NEUROLOGY, V48, P803, DOI 10.1212/WNL.48.4.803; HERNANDEZ TD, 1992, BRAIN RES, V582, P221, DOI 10.1016/0006-8993(92)90136-W; HERNANDEZ TD, 1990, BRAIN RES, V517, P294, DOI 10.1016/0006-8993(90)91040-N; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Hernandez TD, 1998, ADV BEHAV BIOL, V48, P361; HERNANDEZ TD, 1994, BRAIN RES, V635, P300, DOI 10.1016/0006-8993(94)91451-6; Hernandez TD, 1997, TRENDS PHARMACOL SCI, V18, P59, DOI 10.1016/S0165-6147(96)01027-9; HERNANDEZ TD, 1989, CEREBROVASC DIS, P327; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; HOVDA DA, 1987, EXP NEUROL, V97, P391, DOI 10.1016/0014-4886(87)90099-9; Ito T, 1996, LIFE SCI, V59, P169, DOI 10.1016/0024-3205(96)00199-3; Jolkkonen J, 1996, NEUROREPORT, V7, P2031, DOI 10.1097/00001756-199608120-00036; JONES TA, 1992, BEHAV BRAIN RES, V51, P1, DOI 10.1016/S0166-4328(05)80306-7; JUNG MJ, 1977, J NEUROCHEM, V29, P797, DOI 10.1111/j.1471-4159.1977.tb10721.x; KAMPHUIS W, 1990, BRAIN RES, V511, P63, DOI 10.1016/0006-8993(90)90225-Z; KAMPHUIS W, 1991, BRAIN RES, V545, P33, DOI 10.1016/0006-8993(91)91266-4; KAMPHUIS W, 1991, NEUROSCIENCE, V41, P425, DOI 10.1016/0306-4522(91)90338-O; Kline A. E., 1998, Society for Neuroscience Abstracts, V24, P738; Kline AE, 2000, BRAIN RES, V880, P38, DOI 10.1016/S0006-8993(00)02762-1; Leach JP, 1996, SEIZURE-EUR J EPILEP, V5, P229, DOI 10.1016/S1059-1311(96)80041-0; LIPPERT B, 1977, EUR J BIOCHEM, V74, P441, DOI 10.1111/j.1432-1033.1977.tb11410.x; LOSCHER W, 1980, J NEUROCHEM, V34, P1603, DOI 10.1111/j.1471-4159.1980.tb11250.x; LOSCHER W, 1989, EUR J PHARMACOL, V163, P1, DOI 10.1016/0014-2999(89)90389-0; Loup F, 2000, J NEUROSCI, V20, P5401, DOI 10.1523/JNEUROSCI.20-14-05401.2000; Lucas JH, 1997, NEUROSCIENTIST, V3, P89; MALCANGIO M, 1995, CLIN NEUROPHARMACOL, V18, P285, DOI 10.1097/00002826-199508000-00001; MEYER JS, 1970, ARCH NEUROL-CHICAGO, V23, P241, DOI 10.1001/archneur.1970.00480270051007; Montanez S, 2000, BRAIN RES, V860, P29, DOI 10.1016/S0006-8993(00)01951-X; MORIMOTO K, 1989, JPN J PSYCHIAT NEUR, V43, P459; NARITOKU DK, 1995, TRAUMATIC BRAIN INJU, P43; NEAL MJ, 1990, BRIT J PHARMACOL, V100, P324, DOI 10.1111/j.1476-5381.1990.tb15803.x; PAPPIUS HM, 1981, ANN NEUROL, V9, P484, DOI 10.1002/ana.410090511; Pitkanen A, 1996, NEUROLOGY, V47, pS12, DOI 10.1212/WNL.47.1_Suppl_1.12S; Pitkanen A, 1996, EPILEPSY RES, V24, P29, DOI 10.1016/0920-1211(95)00093-3; Qume M, 1997, BRIT J PHARMACOL, V122, P539, DOI 10.1038/sj.bjp.0701383; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; ROSE FD, 1987, BEHAV BRAIN RES, V24, P195, DOI 10.1016/0166-4328(87)90057-X; ROSE L, 1994, STROKE, V25, P1973, DOI 10.1161/01.STR.25.10.1973; RUNDFELDT C, 1992, EUR J PHARMACOL, V213, P351, DOI 10.1016/0014-2999(92)90624-D; Schallert T, 1998, RESTORATIVE NEUROLOGY, P91; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; SCHALLERT T, 1985, DEV PSYCHOBIOL, V18, P501, DOI 10.1002/dev.420180607; SHIN C, 1986, BRAIN RES, V398, P370, DOI 10.1016/0006-8993(86)91498-8; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; vandenPol AN, 1996, J NEUROSCI, V16, P4283; VandenPol AN, 1997, NEUROSCIENTIST, V3, P281, DOI 10.1177/107385849700300509; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Von Monakow C., 1969, BRAIN BEHAV, VI, P27; Wallace AE, 1999, RESTOR NEUROL NEUROS, V14, P35; WATSON CW, 1945, J NEUROPHYSIOL, V8, P221; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037	88	6	6	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2001	18	11					1255	1266		10.1089/089771501317095296			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	491KC	WOS:000172106700007	11721744				2022-02-06	
J	McCrory, P				McCrory, P			New treatments for concussion: The next millennium beckons	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; traumatic brain injury; drug therapy; pharmacology	TRAUMATIC BRAIN INJURY; THYROTROPIN-RELEASING-HORMONE; SEVERE HEAD-INJURY; NEUROTROPHIC FACTORS; NALOXONE; TRIAL; CNS; RAT; METHYLPREDNISOLONE; EXPRESSION	As increased understanding of the pathophysiology of mild traumatic brain injury and concussion develops, so the scientific rationale for interventional pharmacological therapy becomes paramount. A number of agents have been postulated or have been the subject of anecdotal noncontrolled trials. This paper reviews the published evidence in this regard. To date no effective pharmacological therapy exists that satisfies Class I evidence-based medicine criteria.	Univ Melbourne, Ctr Sports Med Res & Educ, Melbourne, Vic, Australia; Univ Melbourne, Brain Res Inst, Melbourne, Vic, Australia		McCrory, P (corresponding author), 31 Grosvenor Parade, Balwyn, Vic 3103, Australia.		McCrory, Paul/Q-8688-2019				ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BRACKEN MB, 1993, J NEUROSURG, V79, P500, DOI 10.3171/jns.1993.79.4.0500; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRAUGHLER JM, 1988, J NEUROSURG, V64, P985; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; CLIFTON G L, 1989, Journal of Neurotrauma, V6, P71, DOI 10.1089/neu.1989.6.71; COMPTON J S, 1990, British Journal of Neurosurgery, V4, P9, DOI 10.3109/02688699009000676; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; FADEN AI, 1993, J NEUROTRAUM, V10, P91, DOI 10.1089/neu.1993.10.91; FADEN AI, 1984, NEUROLOGY, V34, P1280, DOI 10.1212/WNL.34.10.1280; GILBERT H, 1968, HEADACHE, V8, P57; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HALLENBECK JM, 1983, J NEUROSURG, V58, P749, DOI 10.3171/jns.1983.58.5.0749; Hatton J, 1997, J NEUROSURG, V86, P779, DOI 10.3171/jns.1997.86.5.0779; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Kimelberg H K, 1987, Cent Nerv Syst Trauma, V4, P3; LANGFITT TW, 1966, J NEUROSURG, V24, P47, DOI 10.3171/jns.1966.24.1.0047; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P373, DOI 10.1089/neu.1993.10.373; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; Narayan RK, 1996, NEUROTRAUMA; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OKIYAMA K, 1994, J NEUROTRAUM, V11, P83, DOI 10.1089/neu.1994.11.83; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; POVISHLOK J, 1996, ACTA NEUROCHIR SUPP, V66, P81; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; TAKAYAMA Y, 1995, BRAIN PATHOL, V5, P427; TAYLOR AR, 1966, HEAD INJURY, P235; TEASDALE G, 1992, J NEUROTRAUM, V9, pS545; TUSZYNSKI MH, 1995, MOL NEUROBIOL, V10, P151, DOI 10.1007/BF02740673; Yang SY, 1998, J NEUROSURG, V89, P297, DOI 10.3171/jns.1998.89.2.0297; YOSHIDA S, 1983, NEUROLOGY, V33, P166, DOI 10.1212/WNL.33.2.166; Zhao BY, 1998, J NEUROSCI RES, V52, P7, DOI 10.1002/(SICI)1097-4547(19980401)52:1<7::AID-JNR2>3.0.CO;2-I	36	6	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X			CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2001	11	3					190	193		10.1097/00042752-200107000-00010			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	454YG	WOS:000169998900009	11495324				2022-02-06	
J	DePompei, R; Frye, D; DuFore, M; Hunt, P				DePompei, R; Frye, D; DuFore, M; Hunt, P			Traumatic brain injury collaborative planning group: A protocol for community intervention	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						case management; community reintegration; TBI collaboration		Objective: The Traumatic Brain Injury Collaborative Planning Group was formed in December 1992 to address service gaps and better use agencies and their programs to meet the specialized needs of individuals with traumatic brain injury (TBI). Setting: The group meetings served as the interagency link between service providers for comprehensive planning and problem solving. Outcome Measures: This article focuses on the three main tasks of this group: (1) interagency case planning among participating agencies: (2) provision of training and networking opportunities for sec-ice providers working with this population: (3) development of creative funding mechanisms for community education and support ser vices to assist individuals to live and work in the community Methods: Thr methods used to organize the collaborative, direct it toward the three main tasks, and maintain it without any agency funding are outlined. Results: Data collected about the 21 persons served in the past 3 years is provided. and protocol forms are shared. Conclusion: This model of collaboration throughout a countywide area has been used as a basis for similar development in several other states. reintegration, TBI collaboration.	Univ Akron, Sch Speech Language Pathol & Audiol, Akron, OH 44325 USA; Edwin Shaw Hosp, Akron, OH USA; Case Management Cty Summit Board Mental Retardat, Tallmadge, OH USA; Ohio Brain Injury Assoc, Akron, OH USA		DePompei, R (corresponding author), Univ Akron, Sch Speech Language Pathol & Audiol, Polsky Bldg 188H, Akron, OH 44325 USA.						ADAMS R, 1996, J INS MED, V23, P223; Ashley M J, 1994, J Insur Med, V26, P348; CONDELUCCI A, 1995, DIFFERENCE; DeJong G., 1989, J HEAD TRAUMA REHAB, V4, P1; DEJONG G, 1991, PSYCHOL SOCIAL IMPAC; Goka R S, 1991, J Insur Med, V23, P252; Hosack K, 1999, Nurs Case Manag, V4, P14; JOHNSON J, 1999, REPORT REHABILITATIO; JOHNSON J, 1999, GUIDE MED SERVICES P; MILLER N, 1992, HLTH AFFAIRS, V1, P162; OPPER R, 1996, CONTINUUM INTERDISCI, V16, P3; Patterson P K, 1999, Care Manag J, V1, P87; Rolland JS, 1994, FAMILIES ILLNESS DIS; Spearman RC, 2001, J HEAD TRAUMA REHAB, V16, P47, DOI 10.1097/00001199-200102000-00007; Ylvisaker M., 1998, COLLABORATIVE BRAIN	15	6	6	0	1	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	2001	16	3					217	237		10.1097/00001199-200106000-00002			21	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	442YY	WOS:000169313600002	11346445				2022-02-06	
J	Schutt, S; Horn, P; Roth, H; Quintel, M; Schilling, L; Schmiedek, P; Schurer, L				Schutt, S; Horn, P; Roth, H; Quintel, M; Schilling, L; Schmiedek, P; Schurer, L			Bedside monitoring of cerebral blood flow by transcranial thermo-dye-dilution technique in patients suffering from severe traumatic brain injury or subarachnoid hemorrhage	JOURNAL OF NEUROTRAUMA			English	Article						bedside technique; cerebral blood flow; stable xenon CT; subarachnoid hemorrhage; thermo-dye-dilution; traumatic brain injury	ARTERIOVENOUS OXYGEN DIFFERENCE; SEVERE HEAD-INJURY; COMATOSE PATIENTS; JUGULAR BULB; XENON; THERMODILUTION; METABOLISM; SATURATION; HYPEREMIA; VELOCITY	Bedside measurement of cerebral blood flow (CBF) represents an important feature in monitoring of neurointensive care patients which is hard to establish. Therefore, we adopted a recently described thermo-dye-dilution-based approach for monitoring CBF in patients suffering from severe cerebral insults, that is, traumatic brain injury (TBI) or subarachnoid hemorrhage (SAH). Combined fiberoptic-thermistor catheters were placed in one jugular venous bulb and in the abdominal aorta of 16 patients. Following central venous injection of a 50-mL bolus of precooled indocyanine green (ICG) solution, CBF was determined as a function of the mean transit times of coldness and dye. In addition, measurements of CBF using stable xenon-enhanced computerized tomography (sXe-CT) were simultaneously performed in 10 patients. A total of 272 thermo-dye-dilution measurements yielded 196 valid results, with CBF ranging from 26.2 to 144.8 mL 100 g(-1) min(-1). Reproducibility was fairly good, with the standard deviation within sets of repeated measurements being 6.3 mL 100 g(-1) min(-1) and 9.4 as the mean coefficient of variation. Simultaneously obtained values with sXe-CT displayed a good correlation (r = 0.843, p < 0.01); however, the thermo-dye-dilution method consistently overestimated CBF. Data analysis using the Bland and Altman methodology revealed a large bias of 45.7 mL 100 g(-1) min(-1) with a +/-2 SD range of 37 mL 100 g(-1) min(-1), indicating a rather poor agreement. The thermo-dye-dilution method proved a reasonably reproducible technique, enabling repeated long-term bedside measurements of CBF in neurointensive care patients with a minimum of time effort. However, a high failure rate was also noted, and consistent overestimation of perfusion was observed in comparison to sXe-CT measurements. Although the thermo-dye-dilution technique has been successfully validated in patients with normal neurovascular function, its applicability for bedside monitoring of CBF appears uncertain in patients suffering from severe TBI or SAH.	Univ Hosp Mannheim, Fac Clin Med Mannheim, Dept Anesthesiol & Intens Care Med, Heidelberg, Germany; Univ Hosp Mannheim, Fac Clin Med Mannheim, Dept Neurosurg, Heidelberg, Germany		Schilling, L (corresponding author), Heidelberg Univ, Fac Clin Med Mannheim, Div Neurosurg Res, Dept Neurosurg, Theodor Kutzer Ufer 1-3, D-68135 Mannheim, Germany.	lothar.schilling@nch.ma.uni-heidelberg.de					AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; ANDREWS PJD, 1991, BRIT J ANAESTH, V67, P553, DOI 10.1093/bja/67.5.553; BASSINGTHWAIGHTE JB, 1967, MAYO CLIN PROC, V42, P137; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clyde BL, 1996, NEUROSURGERY, V38, P896, DOI 10.1097/00006123-199605000-00008; FATOUROS PP, 1987, INVEST RADIOL, V22, P705, DOI 10.1097/00004424-198709000-00003; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; JUNCK L, 1985, J CEREBR BLOOD F MET, V5, P126, DOI 10.1038/jcbfm.1985.16; Keller E, 2000, CRIT CARE MED, V28, P511, DOI 10.1097/00003246-200002000-00037; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; KIRKPATRICK PJ, 1995, J NEUROSURG, V83, P963, DOI 10.3171/jns.1995.83.6.0963; LANGFITT TW, 1966, J NEUROSURG, V24, P47, DOI 10.3171/jns.1966.24.1.0047; Lassen N. A., 1979, TRACER KINETIC METHO; LASSEN NA, 1966, LANCET, V2, P1113, DOI 10.1016/S0140-6736(66)92199-4; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Matz P G, 1997, Clin Neurosurg, V44, P267; MEILCK F, 1996, BR J ANESTH, V76, pA12; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P28; Melot C, 1996, J CEREBR BLOOD F MET, V16, P1263, DOI 10.1097/00004647-199611000-00022; Metz C, 1998, J CEREBR BLOOD F MET, V18, P332, DOI 10.1097/00004647-199803000-00012; MEYERSON BA, 1991, NEUROSURGERY, V29, P750, DOI 10.1227/00006123-199111000-00018; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; ROBERTSON CS, 1988, J TRAUMA, V28, P1523, DOI 10.1097/00005373-198811000-00002; SCHUTT S, 1998, ZBL NEUROCHIR S101, V59; SHENKIN HA, 1948, ARCH NEURO PSYCHIATR, V60, P240, DOI 10.1001/archneurpsyc.1948.02310030021002; STOCCHETTI N, 1994, NEUROSURGERY, V34, P38; TEASDALE G, 1974, LANCET, V2, P81; VANDERLINDEN J, 1991, J THORAC CARDIOV SUR, V102, P95; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Wietasch GJK, 2000, ANESTHESIOLOGY, V92, P367, DOI 10.1097/00000542-200002000-00017; YONAS H, 1981, J COMPUT ASSIST TOMO, V5, P591, DOI 10.1097/00004728-198108000-00029; Yonas H, 1996, NEUROSURG CLIN N AM, V7, P605	39	6	6	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2001	18	6					595	605		10.1089/089771501750291837			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	445ZQ	WOS:000169488800003	11437082				2022-02-06	
J	Munoz-Cespedes, JM; Paul-Lapedriza, N				Munoz-Cespedes, JM; Paul-Lapedriza, N			The detection of possible cases of simulation after a traumatic brain injury	REVISTA DE NEUROLOGIA			Spanish	Article; Proceedings Paper	38th Meeting of the LECE	NOV 02-04, 2000	MALAGA, SPAIN			forensic assessment; head injury; neuropsychology; simulation	MILD HEAD-INJURY; DIGIT RECOGNITION TEST; MEMORY TEST; DEFICITS; SYMPTOMS; BATTERY; FAKING; SCALE	Objective. To show the degree of detection of simulation, defined as the conscious, intentional production of false or exaggerated physical and psychological symptoms, motivated by external rewards such as payments by influence companies and compensations. Development. In forensic circles, a major problem is under consideration, namely recognition of the existence and nature of cognitive alterations after mild head injury (HI), since it is estimated that in 5-10% of the cases of mild HI there may be simulation of cognitive and emotional deficit, with further difficulty of differential diagnosis between simulation and the post-concussion syndrome. Conclusions. The forensic assessment of cognitive alterations following HI should include a clinical interview and neuropsychological evaluation. The former helps to determine the causal relationship between the traumatic accident and the resulting damage, continuance of symptoms and the existence or not of a premorbid pathological slate. Although there is still nor completely reliable, valid marker which permits one to be completely certain that the person is a simulator, neuropsychological evaluation permits suspicion of it in three aspects: 1. General indicators showing lack of internal consistence in the results of the person evaluated 2. Specific tests to detect possible cases of simulation. 3. Profiles of responses which characterize possible simulators and neuropsychological evaluation tests.	Univ Complutense Madrid, Fac Psicol, Dept Psicol Bacica Proc Cognitivos, E-28223 Madrid, Spain; Hosp Beata Maria Ana Hermanas Hospitalarias, Unidad Darno Cerebral, Madrid, Spain								Adams R. L., 1996, NEUROPSYCHOLOGY CLIN, P455; Altrocchi PH, 1996, NEUROLOGY, V46, P278; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; American Psychiatric Association, 1995, DIAGN STAT MAN MENT; Barraquer Bordas L L, 1992, Arch Neurobiol (Madr), V55, P193; BERNARD LC, 1993, ARCH CLIN NEUROPSYCH, V8, P539, DOI 10.1016/0887-6177(93)90054-5; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1993, CLIN NEUROPSYCHOL, V7, P104, DOI DOI 10.1080/13854049308401892; BINDER LM, 1996, AM J PSYCHIAT, V153, P5; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Binks PG, 1997, ARCH CLIN NEUROPSYCH, V12, P41, DOI 10.1016/S0887-6177(96)00019-4; BRUYN GW, 1990, HDB CLIN NEUROLOGY, V13, P421; CESPEDES JMM, 1997, NEUROPSIQUIATRIA DAN, P347; Cullum C, 1991, FORENSIC NEUROPSYCHO, P141; FAUST D, 1995, NEUROL CLIN, V13, P255, DOI 10.1016/S0733-8619(18)30044-6; FAUST D, 1996, NEUROPSYCHIATRY, P973; FERRERO J, EVALUACION DETERIORO; FRANZEN M D, 1990, Neuropsychology Review, V1, P247, DOI 10.1007/BF01112573; GOEBEL RA, 1983, J CLIN PSYCHOL, V39, P731, DOI 10.1002/1097-4679(198309)39:5<731::AID-JCLP2270390515>3.0.CO;2-T; GOLDEN CJ, 1986, FORENSIC NEUROPSYCHO; Griffin GAE, 1997, J CLIN PSYCHOL, V53, P757, DOI 10.1002/(SICI)1097-4679(199711)53:7<757::AID-JCLP14>3.0.CO;2-K; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; IVERSON GL, 1995, BRAIN INJURY, V9, P35, DOI 10.3109/02699059509004569; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; McKinzey RK, 1997, ARCH CLIN NEUROPSYCH, V12, P585, DOI 10.1016/S0887-6177(97)00005-X; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 1996, NEUROREHABILITATION, V7, P55, DOI 10.3233/NRE-1996-7106; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; MITTENBERG W, 1993, PSYCHOL ASSESSMENT, V5, P33; Munoz-Cespedes JM, 1998, REV NEUROLOGIA, V27, P844, DOI 10.33588/rn.27159.98118; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; PANKRATZ L, 1975, J CONSULT CLIN PSYCH, V43, P25; PUENTE AE, 1995, NEUROPSICOLOGIA PROB, P211; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rutherford W. H., 1989, MILD HEAD INJURY, P217; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Trueblood W, 1993, J CLIN EXP NEUROPSYC, V5, P197; Warrington E, 1984, RECOGNITION MEMORY T, V1; WILLIAMS AD, 1997, PRACTICE FORENSIC NE, P71; Wilson J, 1996, J NUCL MED, V37, P1256; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	50	6	8	1	2	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	APR 16	2001	32	8					773	778		10.33588/rn.3208.2000186			6	Clinical Neurology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	438XA	WOS:000169078500016	11391516				2022-02-06	
J	Folzer, SM				Folzer, SM			Psychotherapy with "mild" bain-injured patients	AMERICAN JOURNAL OF ORTHOPSYCHIATRY			English	Article							TRAUMATIC BRAIN INJURY	A review of neuropsychological studies reveals that patients with mild brain injuries suffer front a wide range of cognitive, physical, and emotional problems. Yet, their symptoms may he overlooked because of inadequate assessment. Family involvement and group work are described as beneficial for these patients. Individual psychotherapy is indicated for those who have a more realistic perception of their skill level, can adjust to a new self, and are able to manage emotional reactions.	Community Coll Philadelphia, Behav Hlth Human Serv Curriculum, Philadelphia, PA USA		Folzer, SM (corresponding author), Whitemarsh Behav Hlth Care, 600 Germantown Pike, Lafayette Hill, PA 19444 USA.						Bennett TL., 1987, COGNITIVE REHABILITA, V5, P10; Bennett TL, 1989, COGNITIVE REHABILITA, V7, P20; BERK S, 1996, PENNS PSYCH ASS M PH; CICERONE K, 1991, J HEAD TRAUMA REHAB, V5, P30; CICERONE K, 1998, BRAIN INJURY SOURCE, V2, P12; CICERONE KD, 1989, REHABIL PSYCHOL, V34, P105, DOI 10.1037//0090-5550.34.2.105; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; COPE DN, 1994, J HEAD TRAUMA REHAB, V9, P1, DOI 10.1097/00001199-199409000-00003; Gauggel S, 2000, NEUROPSYCHOLOGY, V14, P125; HEILBRONNER R, 1998, BRAIN INJURY SOURCE, V2, P52; HEILBRONNER R, 1998, BRAIN INJURY SOURCE, V2, P22; Howard M., 1983, MANUAL BEHAV MANAGEM; KAY T, 1986, MINOR HEAD INJURY IN; Levin H.S., 1989, MILD HEAD INJURY; MARGOLIS E, 1998, BRAIN INJURY SOURCE, V2, P24; MARGOLIS E, 1998, BRAIN INJURY SOURCE, V2, P50; Mateer CA, 1996, J HEAD TRAUMA REHAB, V11, P1; MCALLISTER T, 1992, PSYCHIAT CLIN N AM, V2, P395; MCCLELLAND RJ, 1988, BRIT J PSYCHIAT, V153, P141, DOI 10.1192/bjp.153.2.141; MILLER L, 1993, J COGNITIVE REHABILI, V11, P18; Miller L, 1996, J COGNITIVE REHABILI, V14, P8; Miller L, 1991, COGNITIVE REHABILITA, V9, P24; Miller L., 1996, J COGNITIVE REHABILI, V14, P6; NOVACK TA, 1988, REHABIL COUNS BULL, V31, P313; Osborn C. L., 1998, MY HEAD DOCTORS OWN; PEPPING M, 1998, BRAIN INJURY SOURCE, V2, P14; PEPPING M, 1998, BRAIN INJURY SOURCE, V2, P40; PEPPING M, 1998, BRAIN INJURY SOURCE, V2, P48; PriceLackey P, 1996, AM J OCCUP THER, V50, P306, DOI 10.5014/ajot.50.4.306; Prigatano G.P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199112000-00004, DOI 10.1097/00001199-199112000-00004]; Prigatano GP., 1988, J HEAD TRAUMA REHAB, V3, P45; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; RABASCA L, 1998, APA MONITOR, V29, P27; ROCCHIO C, 1997, BRAIN INJURY SOURCE, V1, P44; ROCCHIO C, 1997, BRAIN INJURY SOURCE, V1, P34; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; SACKS P, 1991, TREATING FAMILIES BR; Vanderploeg R., 2000, BRAIN INJURY SOURCE, V4, P14; Vanderploeg R., 2000, BRAIN INJURY SOURCE, V4, P43; Vilkki J, 1999, NEUROPSYCHOLOGY, V13, P298, DOI 10.1037/0894-4105.13.2.298; WEST M, 2001, BRAIN INJURY SOURCE, V5, P24; WEST M, 2001, BRAIN INJURY SOURCE, V5, P48; WILLIAMS A, 2000, BRAIN INJURY SOURCE, V4, P47; WILLIAMS A, 2000, BRAIN INJURY SOURCE, V4, P40	44	6	6	0	1	AMER ORTHOPSYCHIATRIC ASSOC	NEW YORK	330 SEVENTH AVE, 18TH FL, NEW YORK, NY 10001 USA	0002-9432			AM J ORTHOPSYCHIAT	Am. J. Orthopsychiatr.	APR	2001	71	2					245	251		10.1037/0002-9432.71.2.245			7	Psychiatry; Social Work	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Social Work	427NH	WOS:000168411900010	11347365				2022-02-06	
J	Malina, A; Regan, T; Bowers, D; Millis, S				Malina, A; Regan, T; Bowers, D; Millis, S			Psychometric analysis of the visual form discrimination test	PERCEPTUAL AND MOTOR SKILLS			English	Article								The Visual Form Discrimination Test is a matching-to-sample test involving visual discrimination. Although normative information has been presented, limited psychometric data have been available. The current study estimated the internal consistency and additional psychometric properties of the test in a sample of 66 persons with acute traumatic brain injury. internal consistency as measured by alpha was 66. A homogeneous sample and a restricted range of scores likely attenuated this estimate. Using the standard cutoff score, only 32% of the sample showed impaired performance. Visual form discrimination as measured by this test may be affected less by traumatic brain injury than other cognitive processes such as attention and memory.	Wayne State Univ, Sch Med, Detroit, MI 48202 USA		Malina, A (corresponding author), Evanston NW Healthcare, Dept Psychiat, 500 Davis St,Suite 800, Evanston, IL 60201 USA.						Benton A.L., 1983, CONTRIBUTIONS NEUROP; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Huck SW, 1996, READING STAT RES; IVERSON GL, 1997, J COGNITIVE REHABILI, V15, P20; KASKIE B, 1995, ARCH NEUROL-CHICAGO, V52, P422, DOI 10.1001/archneur.1995.00540280120025; KREUTZER JS, 1993, J HEAD TRAUMA REHAB, V8, P47; LICHTENBERG PA, 1994, CLIN NEUROPSYCHOL, V8, P462, DOI 10.1080/13854049408402048; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; Wilcox R., 1997, INTRO ROBUST ESTIMAT; [No title captured]	11	6	6	0	1	PERCEPTUAL MOTOR SKILLS	MISSOULA	PO BOX 9229, MISSOULA, MT 59807 USA	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	APR	2001	92	2					449	455		10.2466/PMS.92.2.449-455			7	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	430DR	WOS:000168558800016	11361306				2022-02-06	
J	Brown, SA; McCauley, SR; Levin, HS; Boake, C; Goldfader, PR; McCormick, SD; Rockers, D; Butters, M; Kareken, DA; Gostnell, D; Clifton, GL				Brown, SA; McCauley, SR; Levin, HS; Boake, C; Goldfader, PR; McCormick, SD; Rockers, D; Butters, M; Kareken, DA; Gostnell, D; Clifton, GL			Factor analysis of an outcome interview for use in clinical trials of traumatically brain-injured patients - A preliminary study	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Glasgow Outcome Scale; outcome; brain injury; factor analysis	SEVERE HEAD-INJURY; DISABILITY RATING-SCALE; REHABILITATION; RELIABILITY; DEPRESSION; PROGNOSIS; RECOVERY; TRAUMA	Objective: To study the factor structure, internal consistency, concurrent validity, and sensitivity to detect change in patient report of problems of a structured interview in relationship with accepted outcome measures. Design: Outcome status of patients with severe traumatic brain injury participating in a randomized, phase ill, multicenter clinical trial was assessed at 6 mo postinjury using the Glasgow Outcome Scale, the Disability Rating Scale, and the Severe Traumatic Brain Injury Outcome Interview. Results: Exploratory factor analysis of the Severe Traumatic Brain Injury Outcome Interview produced a meaningful five-factor model: (1) activities of daily living; (2) cognitive; (3) affective; (4) behavioral; and (5) instrumental activities of daily living. The internal consistency of the factors ranged from moderate (0.61 instrumental activities of daily living) to high (0.94 activities of daily living); the interfactor correlations were moderate. The summed factor scores were significantly correlated with measures of global outcome: the Glasgow Outcome Scale (r = 0.66; P < 0.0001) and the Disability Rating Scale (r = 0.61; P < 0.0001). Patient report of cognitive problems correlated moderately with the neuropsychological tests. The summed factor scores were sensitive to change over time. Conclusions: Overall, the interview assessed the major important features of outcome pertinent to traumatic brain injury and demonstrated greater sensitivity to subtle changes over time than the unidimensional approaches, such as the Glasgow Outcome Scale and Disability Rating Scale.	Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Univ Houston, Dept Psychol, Houston, TX 77004 USA; Univ Texas, Hlth Sci Ctr, Dept Phys Med & Rehabil, Houston, TX USA; Univ Texas, Hlth Sci Ctr, Dept Neurosurg, Houston, TX USA; St Louis Univ, Dept Neurol, St Louis, MO 63103 USA; Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Pittsburgh, PA USA; Indiana Univ, Sch Med, Dept Neurol, Neuropsychol Sect, Indianapolis, IN 46202 USA; Oregon Hlth Sci Univ, Div Neurosurg, Portland, OR 97201 USA		Levin, HS (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, 133 Moursund Ave,Room A205, Houston, TX 77030 USA.		Kareken, David/Z-1960-2019; Butters, Meryl/AAR-2863-2021	Kareken, David/0000-0003-0855-8300	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-32786] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS032786] Funding Source: NIH RePORTER		Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; Boake C, 1996, AM J PHYS MED REHAB, V75, P105, DOI 10.1097/00002060-199603000-00005; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; BOND MR, 1984, CLOSED HEAD INJURY P, P148; BRAND N, 1987, PSYCHOL MED, V17, P145, DOI 10.1017/S0033291700013040; CADOUXHUDSON TAD, 1994, OUTCOME MEASURES TRA, P25; CAVALLI M, 1981, CORTEX, V17, P545, DOI 10.1016/S0010-9452(81)80061-5; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; GRAFMAN J, 1995, TRAUMATIC HEAD INJUR, P235; HALL K, 1993, J HEAD TRAUMA REHAB, V9, P60; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; Hamsher K., 1989, MULTILINGUAL APHASIA; HART RP, 1987, J CONSULT CLIN PSYCH, V55, P101, DOI 10.1037/0022-006X.55.1.101; HUTTER BO, 1993, NEUROSURGERY, V33, P999; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Larrabee GJ, 1988, NEUROPSYCHOLOGY, V2, P173, DOI 10.1037//0894-4105.2.3-4.173; LEVIN HS, 1995, J NEUROTRAUM, V12, P601, DOI 10.1089/neu.1995.12.601; LINDSAY JT, 1998, J NEUROTRAUM, V15, P573; Livingston M G, 1985, Int Rehabil Med, V7, P145; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; MAZAUX JM, 1997, ARCH PHYS MED REHAB, V78, P156; MICELI G, 1981, Journal of Clinical Neuropsychology, V3, P53, DOI 10.1080/01688638108403113; Osterrieth PA, 1994, ARCH PSYCHOL, V30, P286; PARKS RW, 1988, J CLIN EXP NEUROPSYC, V10, P565, DOI 10.1080/01688638808402795; Prigatano G. P., 1991, AWARENESS DEFICIT BR; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; ROYBYRNE PP, 1986, ARCH GEN PSYCHIAT, V43, P265; Smith A., 1982, SYMBOL DIGIT MODALIT; SMITH RM, 1979, CLIN NEUROPSYCHOLOGY, P48; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; Trites R. L., 1977, NEUROPSYCHOLOGICAL T; VANIER M, IN PRESS ARCH PHYS M; [No title captured]	41	6	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAR	2001	80	3					196	205		10.1097/00002060-200103000-00009			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	407KQ	WOS:000167271100007	11237274				2022-02-06	
J	Eakman, AM; Nelson, DL				Eakman, AM; Nelson, DL			The effect of hands-on occupation on recall memory in men with traumatic brain injuries	OCCUPATIONAL THERAPY JOURNAL OF RESEARCH			English	Article									Helen Jorgenson Rehabil Ctr, Billings, MT USA; Med Coll Ohio, Dept Occupat Therapy, Sch Allied Hlth, Toledo, OH 43699 USA		Eakman, AM (corresponding author), Helen Jorgenson Rehabil Ctr, Billings, MT USA.						Abreu BC, 1998, COGNITION AND OCCUPATION IN REHABILITATION, P51; Averbuch S, 1998, COGNITION AND OCCUPATION IN REHABILITATION, P99; Breines E, 1986, ORIGINS ADAPTATIONS; Dewey J., 1966, DEMOCRACY ED; DUNTON WR, 1925, OCCUPATIONAL THERAPY, V4, P277; LARSSON C, 1987, SCAND J REHABIL MED, V19, P99; MALKMUS M, 1974, RANCHO LOS AMIGOS HO; NELSON DL, 1994, AOTA SELF STUDY SERI, V2, P9; Scott A.D., 1995, OCCUPATIONAL THERAPY, P705; Sweet J., 1982, CLIN NEUROPSYCHOLOGY, V4, P159; Toglia JP, 1998, COGNITION AND OCCUPATION IN REHABILITATION, P5; Tracy S., 1910, STUDIES INVALID OCCU; Vakil E, 1998, NEUROPSYCHOL REHABIL, V8, P31, DOI 10.1080/713755550; WARNER DA, 1989, THESIS W MICHIGAN U; Wechsler D., 1945, WECHSLER MEMORY SCAL	15	6	6	0	0	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0276-1599			OCCUP THER J RES	Occup. Ther. J. Res.	SPR	2001	21	2					109	114		10.1177/153944920102100205			6	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	424FB	WOS:000168220600005					2022-02-06	
J	Hux, K; Burke, R; Elliot, J; Ross, M; Hrnicek, T				Hux, K; Burke, R; Elliot, J; Ross, M; Hrnicek, T			Communication interaction differences between natural speakers and AAC users with traumatic brain injury	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							VERBAL IMPAIRMENT; HEAD	This study explored differences in communication mode and function between survivors of traumatic brain injury (TBI) who rely on natural speech and survivors of TBI who rely on terete-speech augmentative and alternative communication (AAC) devices as a primary means of communication. Four adults, ranging in age from 26 to 33 years, were each observed for 2 hours of conversational interaction with peers and/or staff members of a transitional living facility. Results showed that, although AAC users and natural speakers spent equivalent amounts of time in the Listening mode, AAC users initiated less conversation, produced fewer questions and comments, and spent substantially more time in message generation than natural speakers. Although the introduction of text-to-speech devices to nonspeaking survivors of TBI can solve many communication problems, professionals must weigh the relative benefits and drawbacks of relying on such systems and encourage the use of multiple communication modes to express a variety of intents.	Univ Nebraska, Barkley Mem Ctr 318E, Barkley Ctr Special Educ & Commun Disorders, Lincoln, NE 68588 USA; Qual Living Inc, Dept Speech Language Pathol, Omaha, NE USA		Hux, K (corresponding author), Univ Nebraska, Barkley Mem Ctr 318E, Barkley Ctr Special Educ & Commun Disorders, Lincoln, NE 68588 USA.		Hux, Karen/AAQ-2078-2020				*APPL COMP INC, 1993, HYP COMP SOFTW; Beukelman D. R., 1991, AUGMENT ALTERN COMM, V7, P171, DOI [10.1080/07434619112331275883, DOI 10.1080/07434619112331275883]; Beukelman D R, 1998, AUGMENTATIVE ALTERNA; BROOKS D, 1996, UNL OBSERVER SOFTWAR; BUZOLICH MJ, 1988, J SPEECH HEAR RES, V31, P3, DOI 10.1044/jshr.3101.03; Coelho C. A., 1992, CLIN APHASIOLOGY, V21, P183; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; Farrier L. D., 1985, AUGMENTATIVE ALTERNA, V1, P65, DOI DOI 10.1080/07434618512331273551; Honsinger M., 1989, AUGMENT ALTERN COMM, V5, P101, DOI [10.1080/07434618912331275076, DOI 10.1080/07434618912331275076]; Kertesz A., 1982, W APHASIA BATTERY; Kraat A. W., 1984, P 2 INT C REH ENG OT, P43; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; Milton S. B., 1984, CLIN APHASIOLOGY, V14, P114; Rustad RA, 1993, COGNITIVE ASSESSMENT; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Stuart S, 2000, AUG ALTER COMMUN SER, P25; Yorkston K. M., 1996, SENTENCE INTELLIGIBI; Yorkston KM, 1989, J HEAD TRAUMA REHAB, V4, P1	21	6	6	0	8	SINGULAR PUBLISHING GROUP INC	SAN DIEGO	401 WEST A ST, STE 325, SAN DIEGO, CA 92101-7904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	MAR	2001	9	1					71	86					16	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	412PB	WOS:000167562600008					2022-02-06	
J	Hsu, HC; Chen, HJ; Lu, K; Liang, CL				Hsu, HC; Chen, HJ; Lu, K; Liang, CL			Reversible bilateral internuclear ophthalmoplegia following head injury	ACTA OPHTHALMOLOGICA SCANDINAVICA			English	Article						head injury; internuclear ophthalmoplegia; medial longitudinal fasciculus; magnetic resonance imaging		Purpose: Internuclear ophthalmoplegia is a syndrome produced by a lesion in the medial longitudinal fasciculus, Head trauma is a rare cause. We describe an unusual case of bilateral internuclear ophthalmoplegia as an isolated sequela following a minor head injury that resolved completely 3 months later. Methods: Case report. Magnetic resonance images. Results: A 34-year-old male developed typical bilateral internuclear ophthalmoplegia after closed head injury. Attempted convergence was normal, Magnetic resonance imaging clearly delineated the focal hemorrhage in the medial longitudinal fasciculus region by showing a small bright lesion in the pontomesencephalic junction in the midline on both T2-weighted and T1-weighted images. The diplopia resolved 4 weeks later. Three months after the accident, his versions were completely normal. Conclusion: Isolated internuclear ophthalmoplegia should be considered in the differential diagnosis when one encounters an adduction deficit in a recently traumatized patient. Magnetic resonance images enhance the ability to correlate the clinical findings with the anatomic lesion.	Chang Gung Univ, Chang Gung Mem Hosp, Dept Ophthalmol, Kaohsiung 83305, Taiwan; Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung 83305, Taiwan		Hsu, HC (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Ophthalmol, Kaohsiung 123,Ta Pei Rd, Kaohsiung 83305, Taiwan.						ATLAS SW, 1987, AM J NEURORADIOL, V8, P243; BAKER RS, 1979, J NEUROSURG, V51, P552, DOI 10.3171/jns.1979.51.4.0552; BECK RW, 1981, ANN OPHTHALMOL, V13, P671; CATALANO RA, 1986, AM J OPHTHALMOL, V101, P491, DOI 10.1016/0002-9394(86)90657-4; COGAN DG, 1970, ARCH OPHTHALMOL-CHIC, V84, P583; Constantoyannis C, 1998, BRIT J NEUROSURG, V12, P377, DOI 10.1080/02688699844943; DEVEREAUX MW, 1979, NEUROLOGY, V29, P251, DOI 10.1212/WNL.29.2.251; Fay PM, 1999, J NEURO-OPHTHALMOL, V19, P131; HALLER KA, 1990, OPHTHALMOLOGY, V97, P1162; Hunnewell J, 1998, J NEURO-OPHTHALMOL, V18, P277; KEANE JR, 1987, J CLIN NEURO-OPHTHAL, V7, P165; MUELLER C, 1993, DEV MED CHILD NEUROL, V35, P163; RICH JR, 1974, ARCH OPHTHALMOL-CHIC, V92, P66; ROSATI G, 1981, EUR NEUROL, V20, P80, DOI 10.1159/000115211	14	6	6	0	0	SCRIPTOR PUBLISHER	HVIDOVRE	SOVANGSVEJ 1-5, DK-2650 HVIDOVRE, DENMARK	1395-3907			ACTA OPHTHALMOL SCAN	Acta Ophthalmol. Scand.	FEB	2001	79	1					57	59		10.1034/j.1600-0420.2001.079001057.x			3	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	394TK	WOS:000166539200015	11167289				2022-02-06	
J	Mukherjee, D; Heller, W; Alper, JS				Mukherjee, D; Heller, W; Alper, JS			Social and institutional factors in adjustment to traumatic brain injury	REHABILITATION PSYCHOLOGY			English	Article							DEPRESSION; EMOTION	A longitudinal case study of a working-class heterosexual White man who sustained a traumatic brain injury in a motor vehicle accident is used to delineate social and institutional factors that play a role in adjustment to brain injury. Data gathered from multiple sources (e.g., medical records, neuropsychological assessment, participant observation, and interviews) and sustained contact with the participant and his family over a 10-month time span reveal a complex and multidetermined view of the adjustment process. The case illustrates the critical need for an advocate, a requirement that becomes particularly acute when cognitive disabilities interfere with a person's ability to function effectively on his or her own. The factors that people with brain injuries and advocates must face include shifting of responsibilities, time, paperwork, negotiation of finances, and issues related to class and disability status. Moving beyond the individual focus on deficits and impairments to looking at the institutional, social, and cultural factors that influence the adjustment process will give clinicians and researchers a broader context for understanding brain injury and helping patients adjust.	Univ Illinois, Dept Psychol, Urbana, IL 61801 USA; Carle Clin Assoc, Urbana, IL USA		Mukherjee, D (corresponding author), Univ Chicago, Maclean Ctr Clin Med Eth, W732-MC 6098,5841 S Maryland Ave, Chicago, IL 60637 USA.			Mukherjee, Debjani/0000-0002-8233-8608; Heller, Wendy/0000-0002-6854-558X			Banich M.T., 1997, NEUROPSYCHOLOGY NEUR; Beck AT, 1990, BECK ANXIETY INVENTO; Beck AT, 1987, BECK DEPRESSION INVE; Benton A., 1978, MULTILINGUAL APHASIA; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Benton AL, 1991, FRONTAL LOBE FUNCTIO; BODY R, 1995, TRAUMATIC BRAIN INJU, P245; Borod JC, 1993, NEUROPSYCHOLOGY, V7, P445, DOI DOI 10.1037/0894-4105.7.4.445; Cohen SR, 1997, PALLIATIVE MED, V11, P3; COLE M, 1990, CROSS CULTURAL PERSP, P279; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CUMMINGS CM, 1995, PSYCHOL INTERVENTION, P234; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; Feld S., 1996, SENSES PLACE; FINE M, 1988, J SOC ISSUES, V44, P3, DOI 10.1111/j.1540-4560.1988.tb02045.x; Fries Kenny, 1997, STARING BACK DISABIL; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; Gill C. J., 1994, REFRAMING WOMENS HLT, P357; Goodglass H., 1972, ASSESSMENT APHASIA R; Heaton R.K., 1981, WISCONSIN CARD SORTI; Heller W, 1997, COGNITION EMOTION, V11, P637, DOI 10.1080/026999397379845a; HELLER W, 1995, J ABNORM PSYCHOL, V104, P327, DOI 10.1037/0021-843X.104.2.327; HELLER W, 1997, EMOTIONAL SOCIAL INF; HELLER W, 1997, NEUROPSYCHOLOGY NEUR, P398; Ingstad B., 1995, DISABILITY CULTURE; JENNETT B, 1975, LANCET, V1, P480; KOSS MP, 1991, HDB CLIN PSYCHOL MED, P201; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Moos RH, 1994, LIFE STRESSORS SOCIA; MUKHERJEE D, 1998, THESIS U ILLINOIS UR; OLSON D, 1996, HLTH CARE ISSUES CON; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Reitan R, 1985, HALSTEAD REITAN NEUR; Shweder R.A., 1990, CULTURAL PSYCHOL ESS, P1, DOI [DOI 10.1017/CBO9781139173728.002, 10.1017/cbo9781139173728.002]; SHWEDER RA, 1993, ANNU REV PSYCHOL, V44, P497, DOI 10.1146/annurev.ps.44.020193.002433; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; [No title captured]; 1999, TESTIMONY CHILDRENS; 1998, GAOHEHS9855	45	6	6	0	4	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2001	46	1					82	99		10.1037/0090-5550.46.1.82			18	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	398XP	WOS:000166782000007					2022-02-06	
J	Sawauchi, S; Yuhki, K; Abe, T				Sawauchi, S; Yuhki, K; Abe, T			The relationship between delayed traumatic intracerebral hematoma and coagulopathy in patients diagnosed with a traumatic subarachnoid hemorrhage	NEUROLOGICAL SURGERY			Japanese	Article						head injury; delayed traumatic intracerebral hematoma; traumatic subarachnoid hemorrhage; coagulation; computed tomography	HEAD-INJURY; COAGULATION DISORDERS	It has long been recognized that a traumatic insult to brain tissue may result in substantive coagulation abnormalities. The present study was carried our in an attempt to find out the association of coagulopathy and the development of delayed traumatic intracerebral hematoma (DTICH) in patients diagnosed with a traumatic subarachnoid hemorrhage (TSAH). Sixty-three patients were diagnosed as having TSAH from the initial CT scans obtained within 2 hours after trauma. On admission, peripheral blood samples for coagulation studies were taken within 6 hours after injury. All patients had subsequent CT scans performed within 24 hours of admission. Thirty (47.6%) of 63 patients exhibited radiological evidence of DTICH on their subsequent CT scans. There was a significant correlation between the increased value of serum fibrinogen degradation product (FDP > 40 mug/ml) and the development of DTICH. We observed that the origin of the hematoma might be caused by those radiographically unidentifiable parenchymal lesions often found with TSAH on the initial CT scan. We conclude that a clotting study at the time of admission is of value in predicting the occurrence of DTICH associated with TSAH.	Jikei Univ, Sch Med, Dept Neurosurg, Minato Ku, Tokyo 1058461, Japan; Fuji City Gen Hosp, Dept Neurosurg, Fuji, Shizuoka, Japan								BROWN FD, 1978, J NEUROSURG, V48, P1019, DOI 10.3171/jns.1978.48.6.1019; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; EVANS JP, 1945, J NEUROSURG, V2, P306, DOI 10.3171/jns.1945.2.4.0306; EVANS JP, 1946, J NEUROSURG, V3, P101, DOI 10.3171/jns.1946.3.2.0101; GREENE JP, 1995, J NEUROSURG, V83, P445; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; SHIGEMORI M, 1990, Neurologia Medico-Chirurgica, V30, P396, DOI 10.2176/nmc.30.396; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; TANAKA T, 1988, J NEUROSURG, V69, P203, DOI 10.3171/jns.1988.69.2.0203; VANDERSANDE JJ, 1981, J NEUROSURG, V55, P718, DOI 10.3171/jns.1981.55.5.0718; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357	16	6	10	0	0	IGAKU-SHOIN LTD	TOKYO	5-24-3 HONGO BUNKYO-KU, TOKYO, 113 91, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	FEB	2001	29	2					131	137					7	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	421KT	WOS:000168064100004	11260889				2022-02-06	
J	Boulu, RG; Mesenge, C; Charriaut-Marlangue, C; Verrecchia, C; Plotkine, M				Boulu, RG; Mesenge, C; Charriaut-Marlangue, C; Verrecchia, C; Plotkine, M			Poly(ADP-ribose) polymerase, its potential role in neuronal death	BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE			French	Article						NAD(+)ADP-robosyltransferase; nitric oxyde, physiopathology; cerebral ischemia; brain injuries; apoptosis; necrosis	INTERCELLULAR-ADHESION MOLECULE-1; FOCAL CEREBRAL-ISCHEMIA; NITRIC-OXIDE; BRAIN-INJURY; BINDING DOMAIN; DNA-BINDING; SYNTHETASE; ACTIVATION; PEROXYNITRITE; INHIBITOR	Poly(ADP-ribose) polymerase (PARP, EC 2.4.2.30) is known,l as a nuclear enzyme that is activated by DNA str and breaks to participate in DNA repair: It is also called poly (ADP-ribose) synthase (PARS) ol poly(ADP-ribose) transferase (PADRT). In physiological conditions PARP plays an important, role in maintaining genomic stability However; in sever al pathological situations, which include massive DNA injury (brain ischemia for example), excessive activation of PARP call deplete stores of nicotinamide adenine dinucleotide (NAD(+)), the PARP substrate, which, with the subsequent ATP depletion, leans to cell death. PARP activation appears to play a major role in neuronal death included by cerebral ischemia, traumatic blain injury Parkinson disease and other pathologies. PARP inhibitors (3-aminobenzamide and other compounds) and PARP gene deletion induced dramatic neuroprotection in experimental animals (rats, mice). Accordingly these data suggest that PARP inhibitors could provide a novel therapeutic approach in a wide range of neurodegenerative disorders including cerebral ischemia and traumatic brain injury.	Univ Paris 05, Fac Sci Pharmaceut & Biol, F-75270 Paris 06, France		Boulu, RG (corresponding author), Univ Paris 05, Fac Sci Pharmaceut & Biol, 4 Ave Observ, F-75270 Paris 06, France.		MARCHAND-LEROUX, Catherine/L-7453-2017; , CHARRIAUT-MARLANGUE/H-3249-2019	MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; 			BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; BOULIKAS T, 1992, ANAL BIOCHEM, V203, P252, DOI 10.1016/0003-2697(92)90310-4; CharriautMarlangue C, 1996, J CEREBR BLOOD F MET, V16, P186, DOI 10.1097/00004647-199603000-00002; Cosi C, 1999, ANN NY ACAD SCI, V890, P227, DOI 10.1111/j.1749-6632.1999.tb07998.x; COST C, 1999, ANN NY ACAD SCI, V890, P366; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Ducrocq S, 2000, J NEUROCHEM, V74, P2504, DOI 10.1046/j.1471-4159.2000.0742504.x; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Endres M, 1998, EUR J PHARMACOL, V351, P377, DOI 10.1016/S0014-2999(98)00381-1; Endres M, 1998, NEUROSCI LETT, V248, P41, DOI 10.1016/S0304-3940(98)00224-9; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Ferrante RJ, 1999, BRAIN RES, V823, P177, DOI 10.1016/S0006-8993(99)01166-X; Forman LJ, 1998, NEUROCHEM RES, V23, P141, DOI 10.1023/A:1022468522564; Fukuyama N, 1998, J CEREBR BLOOD F MET, V18, P123, DOI 10.1097/00004647-199802000-00001; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; HIROMATSU Y, 1993, IMMUNOLOGY, V80, P330; Jeggo PA, 1998, CURR BIOL, V8, pR49, DOI 10.1016/S0960-9822(98)70032-6; KAMESHITA I, 1984, J BIOL CHEM, V259, P4770; KAUFMANN SH, 1993, CANCER RES, V53, P3976; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; LAUTIER D, 1993, MOL CELL BIOCHEM, V122, P171, DOI 10.1007/BF01076101; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lo EH, 1998, STROKE, V29, P830, DOI 10.1161/01.STR.29.4.830; Love S, 1999, NEUROPATH APPL NEURO, V25, P98; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Meier HL, 1999, ANN NY ACAD SCI, V890, P330, DOI 10.1111/j.1749-6632.1999.tb08010.x; MENISSIERDEMURCIA J, 1989, J MOL BIOL, V210, P229, DOI 10.1016/0022-2836(89)90302-1; Mesenge C, 1998, EUR J PHARMACOL, V353, P53, DOI 10.1016/S0014-2999(98)00432-4; Mesenge C, 1999, J CEREB BLOOD FLOW M, V19, pS390; OLIVERPOZO FJ, 1998, MED SCI, V14, P1196; Pieper AA, 1999, TRENDS PHARMACOL SCI, V20, P171, DOI 10.1016/S0165-6147(99)01292-4; Plaschke K, 2000, NEUROSCI LETT, V284, P109, DOI 10.1016/S0304-3940(00)00988-5; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; SCHREIBER V, 1992, EMBO J, V11, P3263, DOI 10.1002/j.1460-2075.1992.tb05404.x; Schulz JB, 1997, MOL CELL BIOCHEM, V174, P193, DOI 10.1023/A:1006852306789; Scovassi AI, 1999, MOL CELL BIOCHEM, V199, P125; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Szabo C, 1996, P NATL ACAD SCI USA, V93, P1753, DOI 10.1073/pnas.93.5.1753; Takahashi K, 1999, NEUROREPORT, V10, P2017, DOI 10.1097/00001756-199907130-00005; Takahashi K, 1997, J CEREBR BLOOD F MET, V17, P1137, DOI 10.1097/00004647-199711000-00001; Takahashi K, 1999, BRAIN RES, V829, P46, DOI 10.1016/S0006-8993(99)01335-9; Tokime T, 1998, J CEREBR BLOOD F MET, V18, P991, DOI 10.1097/00004647-199809000-00008; Wallis RA, 1996, BRAIN RES, V710, P169, DOI 10.1016/0006-8993(95)01278-8; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; ZHANG J, 1995, J NEUROCHEM, V65, P1411; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500; Zingarelli B, 1998, CIRC RES, V83, P85, DOI 10.1161/01.RES.83.1.85	53	6	6	0	1	ELSEVIER MASSON SAS EDITEUR	ISSY LES  MOULINEAUX CEDEX	62, RUE CAMILLE DESMOULINS, ISSY LES  MOULINEAUX CEDEX, 92442, FRANCE	0001-4079			B ACAD NAT MED PARIS	Bull. Acad. Natl. Med.		2001	185	3					555	565		10.1016/S0001-4079(19)34539-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446JT	WOS:000169510700006	11501263				2022-02-06	
J	Gates, MA; Dunnett, SB				Gates, MA; Dunnett, SB			The influence of astrocytes on the development, regeneration and reconstruction of the nigrostriatal dopamine system	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						astrocyte; development; transplantation; circuitry; reconstruction; repair; neurodegenerative disease; brain injury; nigrostriatal circuit	CENTRAL-NERVOUS-SYSTEM; CHONDROITIN SULFATE PROTEOGLYCAN; EMBRYONIC VENTRAL MESENCEPHALON; NEURO-ASTROGLIAL INTERACTIONS; LATERAL GANGLIONIC EMINENCE; ADULT-MOUSE NEOCORTEX; EXTRACELLULAR-MATRIX; IN-VITRO; SUBVENTRICULAR ZONE; CELL-LINE	Over the past few decades astrocytes have emerged from being considered simple packing tissue in the brain to become major players in the development, survival and functioning of central nervous system (CNS) neurons. As the influence that astrocytes (and the various molecules they produce) have on the development of CNS neurons becomes more evident, it will be important to consider how this information can be exploited to bring about better protection, recovery and/or regeneration of circuits which are destroyed in the adult CNS due to trauma or common neurodegenerative episodes. Although the characterisation of astrocytic responses to brain injuries, neurodegenerative disease, and cell transplantation are becoming more common, we still known little about how astrocytes influence the (re)growth or reconstruction of neural circuitry after the development period is ended, or indeed what is the overall impact of an astrocytic presence on the growth of neurons in the adult CNS. With the major hurdle of recognition of the importance astrocytes in the function and recovery of the adult CNS now cleared, a new chapter in the development of powerful new treatments for CNS disorders and injuries is now open. The following is a brief review of what we know about how astrocytes influence the growth and connectivity of the nigrostriatal circuit during development, and how these cells may affect efforts to reform this circuit after it's destruction/degeneration in the adult CNS (as commonly happens in Parkinson's disease). As we obtain more information on the specific influence of these cells in various developmental, traumatic and disease events we can expect to find better ways toward combating major disorders of the human CNS.	Cardiff Univ, Brain Repair Grp, Sch Biosci, Cardiff CF10 3US, S Glam, Wales		Gates, MA (corresponding author), Cardiff Univ, Brain Repair Grp, Sch Biosci, Museum Ave,POB 911, Cardiff CF10 3US, S Glam, Wales.		Dunnett, Stephen B/A-5869-2010	Dunnett, Stephen B/0000-0003-1826-1578			Anton ES, 1996, J NEUROSCI, V16, P2283; AUTILLOTOUATI A, 1988, J NEUROSCI RES, V19, P326, DOI 10.1002/jnr.490190308; Barker RA, 1996, EXP NEUROL, V141, P79, DOI 10.1006/exnr.1996.0141; BICKNESE AR, 1994, J NEUROSCI, V14, P3500; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; Borlongan CV, 1998, NEUROREPORT, V9, P3703, DOI 10.1097/00001756-199811160-00025; Bovolenta P, 2000, PROG NEUROBIOL, V61, P113, DOI 10.1016/S0301-0082(99)00044-1; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Brecknell JE, 1996, NEUROSCIENCE, V74, P775, DOI 10.1016/0306-4522(96)00167-4; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; BRODKEY JA, 1993, EXP NEUROL, V123, P251, DOI 10.1006/exnr.1993.1158; Canning DR, 1996, INT J DEV NEUROSCI, V14, P153, DOI 10.1016/0736-5748(96)00004-4; CHAMAK B, 1987, J NEUROSCI, V7, P3163; CHUN JJM, 1988, J CELL BIOL, V106, P857, DOI 10.1083/jcb.106.3.857; CROSSIN KL, 1989, DEV BIOL, V136, P381, DOI 10.1016/0012-1606(89)90264-9; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; DENISDONINI S, 1984, NATURE, V307, P641, DOI 10.1038/307641a0; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Dunnett S B, 1993, Curr Opin Neurobiol, V3, P790, DOI 10.1016/0959-4388(93)90155-R; Dunnett S.B., 1992, NEURAL TRANSPLANTATI; Dunnett SB, 2000, NEUROMETH, V36, P133, DOI 10.1007/978-1-59259-690-4_8; Dunnett SB, 2000, NEUROMETH, V36, P3, DOI 10.1007/978-1-59259-690-4_1; Dunnett SB, 1997, BRAIN RES PROTOC, V1, P91, DOI 10.1016/S1385-299X(96)00015-3; DUNNETT SB, 1981, BRAIN RES, V229, P209, DOI 10.1016/0006-8993(81)90759-9; DUNNETT SB, 1998, ADV RES NEURODEGENER, P115; DUNNETT SB, 1990, CEREBRAL CORTEX RAT, P589; DUNNETT SB, 1997, NEUROBIOLOGY, P253; DUNNETT SB, 1993, NEUROLOGICAL REHABIL, P93; Eng LF, 1987, PROG BRAIN RES <D>, V71, P439; Eriksson C, 2000, EXP NEUROL, V164, P184, DOI 10.1006/exnr.2000.7424; FAISSNER A, 1995, GLIA, V13, P233, DOI 10.1002/glia.440130402; Fawcett JW, 1997, CELL TISSUE RES, V290, P371, DOI 10.1007/s004410050943; FAWCETT JW, 1989, DEV BIOL, V135, P449, DOI 10.1016/0012-1606(89)90193-0; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; FAWCETT JW, 1994, J NEUROL, V241, P25; FAWCETT JW, 1992, NEURODEGENERATION, P81; Fidler PS, 1999, J NEUROSCI, V19, P8778, DOI 10.1523/JNEUROSCI.19-20-08778.1999; FOKSEANG J, 1995, BRAIN RES, V689, P207, DOI 10.1016/0006-8993(95)00575-B; Garwood J, 1999, J NEUROSCI, V19, P3888; Gates MA, 1998, NEUROSCIENCE, V84, P1013, DOI 10.1016/S0306-4522(97)00512-5; Gates MA, 1996, J NEUROSCI, V16, P8005; GATES MA, 1995, J COMP NEUROL, V361, P249, DOI 10.1002/cne.903610205; GATES MA, 1993, J CHEM NEUROANAT, V6, P179, DOI 10.1016/0891-0618(93)90040-B; Gates MA, 1996, NEUROSCIENCE, V74, P579, DOI 10.1016/0306-4522(96)00146-7; HOFFMAN S, 1988, J CELL BIOL, V106, P519, DOI 10.1083/jcb.106.2.519; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Hynds DL, 1999, EXP NEUROL, V160, P244, DOI 10.1006/exnr.1999.7212; Jessell TM, 2000, CURR OPIN NEUROBIOL, V10, P599, DOI 10.1016/S0959-4388(00)00136-7; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Law AKT, 1999, DEV BIOL, V216, P622, DOI 10.1006/dbio.1999.9498; LAYWELL ED, 1992, P NATL ACAD SCI USA, V89, P2634, DOI 10.1073/pnas.89.7.2634; Leavitt BR, 1999, EXP NEUROL, V157, P43, DOI 10.1006/exnr.1999.6982; LETOURNEAU PC, 1994, J NEUROSCI, V14, P915, DOI 10.1523/JNEUROSCI.14-03-00915.1994; LOCHTER A, 1991, J CELL BIOL, V113, P1159, DOI 10.1083/jcb.113.5.1159; Lundberg C, 1996, NEUROBIOL DIS, V3, P33, DOI 10.1006/nbdi.1996.0004; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Meiners S, 1995, J NEUROSCI, V15, P8096; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Moon LDF, 2000, EXP NEUROL, V161, P49, DOI 10.1006/exnr.1999.7230; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; OBRIEN TF, 1992, DEV BRAIN RES, V65, P259, DOI 10.1016/0165-3806(92)90187-2; ONIFER SM, 1993, EXP NEUROL, V122, P130, DOI 10.1006/exnr.1993.1114; PFRIEGER FW, 1995, CELL, V83, P671, DOI 10.1016/0092-8674(95)90178-7; Philips MF, 1999, J NEUROSURG, V90, P116, DOI 10.3171/jns.1999.90.1.0116; Powell EM, 1999, GLIA, V26, P73, DOI 10.1002/(SICI)1098-1136(199903)26:1<73::AID-GLIA8>3.0.CO;2-S; Powell EM, 1997, MOL CELL NEUROSCI, V10, P27, DOI 10.1006/mcne.1997.0629; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; Reier P J, 1988, Adv Neurol, V47, P87; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROUSSELET A, 1988, DEV BIOL, V129, P495, DOI 10.1016/0012-1606(88)90395-8; RUDGE JS, 1989, EXP NEUROL, V103, P1, DOI 10.1016/0014-4886(89)90180-5; RUDGE JS, 1990, J NEUROSCI, V10, P3594; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; SHEPPARD AM, 1991, J NEUROSCI, V11, P3928; SHULTS CW, 1990, NEUROSCIENCE, V38, P427, DOI 10.1016/0306-4522(90)90039-7; SMITH GM, 1990, DEV BIOL, V138, P377, DOI 10.1016/0012-1606(90)90204-V; SMITH GM, 1986, J COMP NEUROL, V251, P23, DOI 10.1002/cne.902510103; SMITHTHOMAS LC, 1995, J CELL SCI, V108, P1307; SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; STEINDLER DA, 1989, DEV BIOL, V131, P243, DOI 10.1016/S0012-1606(89)80056-9; STEINDLER DA, 1993, ANNU REV NEUROSCI, V16, P445, DOI 10.1146/annurev.ne.16.030193.002305; STEINDLER DA, 1995, J NEUROSCI, V15, P1971, DOI 10.1523/JNEUROSCI.15-03-01971.1995; TAYLOR J, 1993, J NEUROSCI RES, V35, P347, DOI 10.1002/jnr.490350402; Thomas LB, 1996, GLIA, V17, P1; Toresson H, 1999, DEVELOPMENT, V126, P1317; Wilby MJ, 1999, J NEUROSCI, V19, P2301; XU ZC, 1992, NEUROSCIENCE, V48, P95, DOI 10.1016/0306-4522(92)90341-X; ZHOU FC, 1989, NEUROSCIENCE, V30, P19, DOI 10.1016/0306-4522(89)90350-3	94	6	7	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2001	19	1-2					67	83					17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582YH	WOS:000177378400007	12082230				2022-02-06	
J	Schatz, P; Hughes, LJ; Chute, DL				Schatz, P; Hughes, LJ; Chute, DL			Underutilization of neuropsychology in traumatic brain injury rehabilitation: Is managed care to blame?	NEUROREHABILITATION			English	Article						neuropsychology; assessment; rehabilitation; brain injury; managed care		We evaluated factors determining which individuals received neuropsychological evaluations (NPEs) following traumatic brain injury (TBI). Comprehensive records from a Statewide/sponsored Head Injury Program were followed from 1985-1995 to monitor effects of managed care on provision (or absence) of formal NPEs and ultimately on rehabilitation outcome. Only 26% of 273 individuals received NPEs (within their first three years post-injury). In the years prior to and after large changes in managed care, there were no differences in the provision of formal NPEs. Discriminant analysis identified functional status at discharge from primary rehabilitation and total number of rehabilitation facilities as the two variables that most distinguished those who had received NPEs with 69% classification accuracy. Between group analyses revealed that individuals were more likely to receive NPEs if they were young, involved in liability claims, attended multiple rehabilitation facilities, or had higher functional status at discharge from primary rehabilitation, regardless of the nature or severity of their TBI. Individuals receiving formal NPEs ultimately achieved higher levels of functional independence, suggesting a potential selection bias. Individuals were no more likely to receive NPEs according to insurance status (,private versus government assisted) or as a function of the decade of their injury (1980's versus 1990's). It appears that health-care reform has had no deleterious effect on neuropsychologists' ability to provide consultative services for this population, and following TBI, only a discrete sample of individuals receive and benefit from NPEs.	St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA; Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA		Schatz, P (corresponding author), St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA.	pschatz@sju.edu		Schatz, Philip/0000-0002-6222-6545			*AM HOSP ASS, 1992, AM HOSP ASS HOSP STA; BOND MR, 1976, SCAND J REHABIL MED, V8, P127; Cripe LI, 1987, COGNITIVE REHABILITA, V5, P18; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Do H K, 1988, Rehabil Nurs, V13, P71; Gardner W, 1999, ARCH CLIN NEUROPSYCH, V14, P779; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; GOLDEN CJ, 1983, CLIN NEUROPSYCHOL, P35; Guilmette T J, 1990, Arch Clin Neuropsychol, V5, P373, DOI 10.1016/0887-6177(90)90016-I; HARRIS DP, 1997, J OUTCOMES MEASUREME, V1, P23; Horowitz T, 1997, ARCH CLIN NEUROPSYCH, V12, P338, DOI 10.1093/arclin/12.4.338a; JENNETT B, 1983, REHAB HEAD INJURED A, P291; KATZ DL, 1994, ARCH NEUROL-CHICAGO, V15, P661; Kraus JF, 1993, HEAD INJURY, P1; LeesHaley PR, 1996, ARCH CLIN NEUROPSYCH, V11, P45, DOI 10.1016/0887-6177(95)00011-9; LEZAK MD, 1995, NEUROPSYCHOL ASSESSM; Light DW, 1997, AM J PSYCHIAT, V154, P443; Luckey J W, 1982, Eval Program Plann, V5, P319, DOI 10.1016/0149-7189(82)90004-0; LYNCH WJ, 1983, REHABILITATION HEAD, P291; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; MOLITOR AJ, 1990, HLTH REPORTER, V11, P1; *PENN STAT I STAT, 1989, 1992 PENN ABSTR; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sbordone R., 2000, BRAIN INJURY SOURCE, V4, P10; Sbordone RJ, 1999, STUD NEUROPSYCHOL DE, P227; Schatz P, 1996, ARCH CLIN NEUROPSYCH, V11, P444; Schatz P, 1998, ARCH CLIN NEUROPSYCH, V13, P147; SCHATZ P, 1995, THESIS DREXEL U; Seretny M L, 1986, Arch Clin Neuropsychol, V1, P5, DOI 10.1016/0887-6177(86)90021-1; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; Sosin DM, 1996, BRAIN INJURY, V10, P47; TEASDALE G, 1974, LANCET, V2, P81; WADE TC, 1977, AM PSYCHOL, V32, P874, DOI 10.1037/0003-066X.32.10.874; WOLFE GR, 1987, COGNITIVE REHAB, V5, P20	35	6	6	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2001	16	4					281	287					7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	521VC	WOS:000173861200013	11790915				2022-02-06	
J	Harris, OA; Lane, B; Lewen, A; Matz, PG				Harris, OA; Lane, B; Lewen, A; Matz, PG			Infratentorial traumatic brain hemorrhage: May outcome be predicted by initial GCS?	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	49th Annual Meeting of the Congress-of-Neurosurgeons	OCT 30-NOV 03, 1999	BOSTON, MASSACHUSETTS	Congress Neurosurg		brain injury; brain stein; Glasgow Coma Scale; outcome; trauma	SEVERE HEAD-INJURY; STEM LESIONS; CONSCIOUSNESS; SCALE; COMA	Background: Overall prognosis of nonpenetrating traumatic brain hemorrhage may be predicted by neurologic function days after insult. The relationship between immediate function and outcome has not been examined for infratentorial traumatic brain hemmorhage (iTBH) identified on computed tomographic (CT) scan. Given the severity of brain stem injury, it is conceivable that immediate function may be predictive. Methods: A retrospective review of 1,500 brain injuries occurring at our institution identified 18 patients (1.2%) with iTBH on CT scan (eight brain stem, five cerebellum five both). Demographics, supratentorial injuries, and outcome at 6 months (Glasgow Outcome Scale) were recorded. Results: Initial Glasgow Coma Scale (GCS) in 11 patients was less than 5 (group I). Seven patients had GCS scores greater than or equal to 6 (group 11). Nine patients in group I either died or were vegetative. In group II, one died; none were vegetative (p < 0.02). Regression analysis demonstrated a strong correlation between initial GCS and Glasgow Outcome Scale scores at 6 months for all patients (p < 0.001) Conclusion: We conclude that initial GCS score may he predictive of long-term outcome in patients with CT scan evidence of iTBH-a relationship to be explored further for prognostic information.	Palo Alto VA Hlth Care Syst, Surg Serv 112N, Palo Alto, CA 94304 USA; Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; Stanford Univ, Dept Neuroradiol, Stanford, CA 94305 USA; Santa Clara Valley Med Ctr, Dept Surg, San Jose, CA 95128 USA		Matz, PG (corresponding author), Palo Alto VA Hlth Care Syst, Surg Serv 112N, 3801 Miranda Ave, Palo Alto, CA 94304 USA.		Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348			COOPER PR, 1979, NEUROSURGERY, V4, P115, DOI 10.1227/00006123-197902000-00002; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Gean AD, 1994, IMAGING HEAD TRAUMA; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Glantz SA, 1992, PRIMER BIOSTATISTICS; HASHIMOTO T, 1993, NEUROSURG REV, V16, P291, DOI 10.1007/BF00383839; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V2, P81; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; LEVY ML, 1994, NEUROSURGERY, V35, P77, DOI 10.1227/00006123-199407000-00012; MEYER CA, 1991, RADIOLOGY, V179, P813, DOI 10.1148/radiology.179.3.2027997; Ogawa T, 1992, Acta Neurochir Suppl (Wien), V55, P8; POZZATI E, 1982, J NEUROSURG, V56, P691, DOI 10.3171/jns.1982.56.5.0691; SOKOL JH, 1978, SURG NEUROL, V10, P340; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	19	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2000	49	6					1076	1082		10.1097/00005373-200012000-00017			7	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	383XG	WOS:000165909500018	11130492				2022-02-06	
J	Banister, K; Chambers, IR; Siddique, MS; Fernandes, HM; Mendelow, AD				Banister, K; Chambers, IR; Siddique, MS; Fernandes, HM; Mendelow, AD			Intracranial pressure and clinical status: assessment of two intracranial pressure transducers	PHYSIOLOGICAL MEASUREMENT			English	Article						intracranial pressure; MicroSensor transducer; traumatic brain injury; monitoring	STRAIN-GAUGE TRANSDUCERS; SEVERE HEAD-INJURY; MICROSENSOR	The aim of this study was to determine the in vivo accuracy and reliability of intracranial pressure (ICP) measurement using the Codman MicroSensor by comparison with the Camino TCP transducer and associated clinical and radiological information. Paired ICP readings were recorded every minute in 17 patients. A total of 56 790 validated paired measurements were obtained over a wide range of ICP values (-16 nun Hg to 114 mm Hg). Recording periods ranged from 3 hours to 6 days (median 31 hours). In 11 patients the MicroSensor and Camino readings were in good agreement. Paired readings were within 10 mm Hg fur 99% of the recording time and both readings were compatible with clinical intracranial events at all times (in one case it was not possible to verify the clinical information). In six patients large differences occurred between transducer readings (>10 mm Hg apart for 42% of the recording period). In one case, either reading could have been compatible with intracranial clinical events. In two cases, although both readings were comparable, Camino readings were more consistent with clinical and radiological Endings. In three cases, the MicroSensor readings were inconsistent with the clinical condition of the patients whereas the Camino readings were compatible. These results suggest that, during routine clinical use in our department, the MicroSensor provided misleading information in 18% of our patients and thus is not sufficiently reliable for routine use in the detection of adverse clinical events.	Newcastle Gen Hosp, Dept Reg Med Phys, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Newcastle Gen Hosp, Dept Neurosurg, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England		Banister, K (corresponding author), Newcastle Gen Hosp, Dept Reg Med Phys, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.		Mendelow, Alexander/AAW-2878-2021				ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Chambers IR, 1998, ACT NEUR S, V71, P42; CHAMBERS IR, 1990, NEUROSURGERY, V26, P421, DOI 10.1227/00006123-199003000-00007; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Czosnyka M, 1996, NEUROSURGERY, V38, P219, DOI 10.1097/00006123-199601000-00053; GAMBARDELLA G, 1993, CHILD NERV SYST, V9, P470, DOI 10.1007/BF00393552; GOPINATH SP, 1995, NEUROSURGERY, V36, P1137, DOI 10.1227/00006123-199506000-00011; GOPINATH SP, 1993, J NEUROSCI METH, V49, P11, DOI 10.1016/0165-0270(93)90104-Y; Gray WP, 1996, NEUROSURGERY, V39, P927, DOI 10.1097/00006123-199611000-00008; Lundberg N, 1960, ACTA PSYCHIAT NEUR S, V36, P149; MILLER JD, 1989, INTRACRANIAL PRESSUR, V7, P5; PIPER IR, 1995, NEUROSURGERY, V36, P1142, DOI 10.1227/00006123-199506000-00012; SCHICKNER DJ, 1992, SURG NEUROL, V37, P251, DOI 10.1016/0090-3019(92)90147-F; Signorini DF, 1997, NEUROSURGERY, V41, P1213, DOI 10.1097/00006123-199711000-00050; Signorini DF, 1998, BRIT J NEUROSURG, V12, P223	16	6	8	0	2	IOP PUBLISHING LTD	BRISTOL	DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND	0967-3334			PHYSIOL MEAS	Physiol. Meas.	NOV	2000	21	4					473	479		10.1088/0967-3334/21/4/304			7	Biophysics; Engineering, Biomedical; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering; Physiology	378WJ	WOS:000165608100005	11110245				2022-02-06	
J	Holtzer, R; Burright, RG; Lynn, SJ; Donovick, PJ				Holtzer, R; Burright, RG; Lynn, SJ; Donovick, PJ			Behavioural differences between psychiatric patients with confirmed versus non-confirmed traumatic brain injuries	BRAIN INJURY			English	Article							GORDON DIAGNOSTIC SYSTEM; CLOSED HEAD-INJURY; DEPRESSION; PREVALENCE; ATTENTION; PERFORMANCE; DISORDERS; ABUSE	The relationship between history of Traumatic Brain Injury (TBI) and BDI-2 depression scores at admission and discharge from the hospital was assessed in acutely hospitalized psychiatric patients. The participants were assigned to three groups: (1) no reported history of TBI (n = 18), (2) reported but not confirmed TBI history (n = 13), and (3) reported and confirmed TBI history (n = 15). It was found that confirmed history of TBI was associated with elevated BDI-2 depression scores. In contrast, the non-confirmed TBI group was characterized by over-reporting of psychological distress, as measured by MMPI-2 validity indices, 100% prevalence of alcohol use history, and depression scores that were intermediate between the control and confirmed TBI groups.	SUNY Binghamton, Dept Psychol, Environm Neuropsychol Lab, Binghamton, NY 13902 USA; United Hlth Serv Hosp, Neuropsychol Unit, Johnson City, NY USA		Donovick, PJ (corresponding author), SUNY Binghamton, Dept Psychol, Environm Neuropsychol Lab, Binghamton, NY 13902 USA.			Holtzer, Roee/0000-0001-6639-0724			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ATTEBERRYBENNETT J, 1986, INT J CLIN NEUROPSYC, V8, P114; Azar B., 1997, APA MONITOR, V28, P1; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BREWIN CR, 1993, PSYCHOL BULL, V113, P82, DOI 10.1037/0033-2909.113.1.82; BURG JS, 1995, BRAIN INJURY, V9, P395, DOI 10.3109/02699059509005779; Burg JS, 1996, J CLIN PSYCHOL MED S, V3, P243, DOI 10.1007/BF01993910; BURG JS, IN PRESS BRAIN INJUR; BURTON LA, 1994, J NEUROLOGICAL REHAB, V8, P63, DOI DOI 10.1177/136140969400800202; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; DMELLO DA, 1995, AM J DRUG ALCOHOL AB, V21, P257, DOI 10.3109/00952999509002693; Donovick PJ, 1996, J CLIN PSYCHOL MED S, V3, P131, DOI 10.1007/BF01996133; FEDEROFF PJ, 1992, AM J PSYCHIAT, V147, P918; Gordon M, 1988, INSTRUCTION MANUAL G; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HOLTZER R, 1998, ADHD HYPERRACTIVITY, V25, P2; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kaemmer, 1989, MINNESOTA MULTIPHASI; Kaufman A.S., 1990, KAUFMAN BRIEF INTELL; KAY T, 1986, UNSEEN INJURY MINOR; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; KWENTUS JA, 1985, PSYCHOSOMATICS, V26, P8, DOI 10.1016/S0033-3182(85)72900-3; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LINDSAY DS, 1994, APPL COGNITIVE PSYCH, V8, P281, DOI 10.1002/acp.2350080403; McGuire LM, 1998, BRAIN INJURY, V12, P207, DOI 10.1080/026990598122683; POSNER MI, 1984, J NEUROSCI, V4, P1863; RASILE DA, 1995, INT J PSYCHOL, V30, P35, DOI 10.1080/00207599508246972; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; Rogers R., 1997, CLIN ASSESSMENT MALI; Rogers R., 1994, ASSESSMENT, V1, P227, DOI DOI 10.1177/107319119400100302; Shum DHK, 1990, CLIN NEUROPSYCHOL, V4, P151, DOI DOI 10.1080/13854049008401508; SIVEC HJ, 1995, J PERS ASSESS, V64, P295, DOI 10.1207/s15327752jpa6402_9; SLAGLE DA, 1990, INT J PSYCHIAT MED, V20, P1, DOI 10.2190/BE6W-DCY1-V71N-N7J7; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; Taylor Craig A., 1994, P81; Wechsler D, 1981, WAISR MANUAL; [No title captured], DOI DOI 10.1037/0894-4105.7.3.296	43	6	6	0	2	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2000	14	11					959	973		10.1080/02699050050191904			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	373UC	WOS:000165306800002	11104136				2022-02-06	
J	Takahashi, I; Kitahara, T; Endo, M; Ohwada, T				Takahashi, I; Kitahara, T; Endo, M; Ohwada, T			Clinical analysis of hypothermia in children with severe head injury	NEUROLOGICAL SURGERY			Japanese	Article						children; hypothermia; severe head injury	TRAUMATIC BRAIN INJURY; MODERATE HYPOTHERMIA; HYPERTENSION; PROTECTION; RAT	Therapeutic hypothermia may improve outcome after severe head injury, but its efficacy has not been established in children with a severe head injury. The authors evaluated the effects of hypothemia (33-34 degreesC) in 9 severely closed head-injured children (under 16 years old). The cooling period was 3 to 21 days (mean 9.3). Hypothermia significantly reduced ICP when it reached 33 - 34 degreesC. From 3 to 6 months after injury, 6 (67%) of the 9 patients had good outcome (good recovery in 2 and moderate disability in 4), but 3 (33%) had poor outcome (severe disability in 2 and vegetative state in one). Complications, including infectious disorders (pneumonia, meningitis, sepsis), cardio-vascular system dysfunction (cardiac arrhythmia, hypotension), decreased platelet counts, hypokalemia, diabetes insipidus, acute pancreatitis occurred during hypothermia in 7 patients (78%). The results of this study suggest that treatment with hypothermia in children with severe head injury is often accompanied complications, but it is an effective method to control intracranial hypertension and may have improved the outcome.	Teine Keijinkai Hosp, Dept Emergency, Teine Ku, Sapporo, Hokkaido 0068555, Japan								BAKER CJ, 1991, SURG NEUROL, V36, P175, DOI 10.1016/0090-3019(91)90109-M; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BIGGART MJ, 1990, J PEDIATR-US, V117, P179, DOI 10.1016/S0022-3476(05)80526-8; BOUTROS A, 1977, CRIT CARE MED, V5, P234, DOI 10.1097/00003246-197709000-00005; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHOPP M, 1991, STROKE, V22, P37, DOI 10.1161/01.STR.22.1.37; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; CONN AW, 1979, PEDIATR CLIN N AM, V26, P691; DEAN JM, 1981, NEUROSURGERY, V9, P627; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; FAY T, 1943, ASS RES NERV MENT DI, V24, P611; FREWEN TC, 1982, J PEDIATR-US, V100, P663, DOI 10.1016/S0022-3476(82)80782-8; LEONOV Y, 1990, J CEREBR BLOOD F MET, V10, P57, DOI 10.1038/jcbfm.1990.8; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MICHENFELDER JD, 1977, STROKE, V8, P87, DOI 10.1161/01.STR.8.1.87; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; ROSOMOFF HL, 1956, J NEUROSURG, V13, P332; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; STEEN PA, 1979, STROKE, V10, P522, DOI 10.1161/01.STR.10.5.522	21	6	6	0	2	IGAKU-SHOIN LTD	TOKYO	5-24-3 HONGO BUNKYO-KU, TOKYO, 113 91, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	NOV	2000	28	11					983	989					7	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	386YC	WOS:000166092300006	11127594				2022-02-06	
J	Cudmore, LJ; Segalowitz, SJ; Dywan, J				Cudmore, LJ; Segalowitz, SJ; Dywan, J			EEG coherence shows altered frontal-parietal communication in mild TBI during a dual-task	BRAIN AND COGNITION			English	Article							HEAD-INJURY	Increased attentional resources required by dual-task demands are thought to necessitate involvement of prefrontal cortex (PFC) and its communication with regions of posterior cortex. We used EEG coherence to examine the effect of mild traumatic brain injury (MTBI) on frontal-parietal communication during single- and dual-task conditions in an additive factors model (easy and difficult tone discrimination; with and without verbal working memory task). Similar increases in response time and errors were found with discrimination difficulty and dual-task for all groups. Frontal-parietal beta coherence showed an interaction: Coherence increased during the dual-task for the MTBI groups only. Results suggest a cortical activation "cost" in MTBI when faced with tasks that require division of attentional resources. (C) 2000 Academic Press.	Univ Waterloo, Waterloo, ON N2L 3G1, Canada; Brock Univ, St Catharines, ON L2S 3A1, Canada		Cudmore, LJ (corresponding author), Univ Waterloo, Waterloo, ON N2L 3G1, Canada.						Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; THATCHER RW, 1987, SCIENCE, V236, P1110, DOI 10.1126/science.3576224	4	6	6	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	OCT	2000	44	1					86	90					5	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	358FJ	WOS:000089547300022					2022-02-06	
J	Drobetz, H; Freudenschuss, B; Kutscha-Lissberg, E; Buchinger, W; Mauritz, W				Drobetz, H; Freudenschuss, B; Kutscha-Lissberg, E; Buchinger, W; Mauritz, W			Treatment of severe brain trauma in Austria	ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE			German	Article						severe head injury; guidelines; intracranial pressure monitoring; hyperventilation; glucocorticoides; trauma databank	SEVERE HEAD-INJURY; RANDOMIZED CLINICAL-TRIAL; INTRACRANIAL HYPERTENSION; MANAGEMENT; MANNITOL	We performed this study in order to assess epidemiology and current practice of treatment of severe traumatic brain injury in Austria. Our survey followed the methods of a study published by I. Ghajar et at in the USA in 1995 and we compared the results to the Brain Trauma Foundation's "Guidelines For The Management Of Severe Head Injury". Methods: The collected data represent answers to telephone interviews of 60 surgical intensive care units. We were able to evaluate data from all departments which treat severe brain traumas (Glasgow Coma Scale less than or equal to 8) in Austria. Results: At the time the treatment modalities of severe head injuries are not homogeneous and there are also big interdisciplinary management differences (trauma surgeons Versus neurosurgeons). Conclusions: Results showed that there is a need for a brain trauma databank in Austria, We also recommend formation of an interdisciplinary brain trauma working group in order to control whether guidelines and standardized therapeutic modalities are being followed.	AO Krankenhaus Neunkirchen, Abt Unfallchirurg, A-2620 Neunkirchen, Austria; AO Krankenhaus Amstettenn, Abt Unfallchirurg, Amstetten, Austria; AO Krankenhaus Horn, Abt Unfallchirurg, Horn, Austria; Lorenz Bohler Unfallkrankenhaus, Inst Anasthesiol & Intens Med, Vienna, Austria		Drobetz, H (corresponding author), AO Krankenhaus Neunkirchen, Abt Unfallchirurg, Peischingerstr 19, A-2620 Neunkirchen, Austria.						BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; BERGER S, 1995, NEUROSURGERY, V37, P107; BRAAKMAN R, 1983, J NEUROSURG, V58, P326, DOI 10.3171/jns.1983.58.3.0326; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; BULLOCK R, 1996, GUIDELINES MANAGEMEN; Bullock Ross, 1996, Journal of Neurotrauma, V13, P639; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1997, J TRAUMA S, V42, P4; CHESNUT RM, 1997, J TRAUMA S, V42, P19; Dinkel M, 1998, ANASTH INTENSIVMED, V39, P399; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Erhard J, 1996, UNFALLCHIRURG, V99, P534; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Hart LE, 1997, CLIN J SPORT MED, V7, P1, DOI 10.1097/00042752-199701000-00001; Hartl R, 1997, ZBL CHIR, V122, P181; Jantzen JP, 1997, ANASTH INTENSIVMED, V38, P89; MAURITZ W, 1996, ACTA ANAESTHEISOL S, V109, P53; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; SHACKFORD SR, 1997, J TRAUMA S, V42, P48; 1997, ZBL NEUROCHIR, V58, P13	24	6	6	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0939-2661			ANASTH INTENSIV NOTF	Anasthesiol. Intensivmed. NotfMed. Schmerzther.	OCT	2000	35	10					630	634		10.1055/s-2000-7365			11	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	369FE	WOS:000165054600004	11116494				2022-02-06	
J	Snyder, C; Hux, K				Snyder, C; Hux, K			Traumatic brain injury survivors' ability to reduce idiosyncrasy in semantic organization	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article								Seven adult survivors of traumatic brain injury (TBT) and 10 adults without neurological impairment performed two experimental tasks related to semantic organization. The study served as a replication and expansion of the research performed by Hux, Beukelman, Dombrovskis, and Snyder (1993). Both experimental tasks involved placing exemplar cards representing basic-level items within four categories on a visual display board to demonstrate strength of association with superordinate labels. One task provided participants with a means of demonstrating personal organizational strategies, and the second encouraged them to demonstrate strategies they thought others would use. Results confirmed that TBI survivors use idiosyncratic strategies to organize semantic information. The findings have implications for the treatment of people with acquired semantic disorders, especially regarding the design of augmentative and alternative communication devices.	Univ Nebraska, Barkley Mem Ctr Special Educ & Commun Disorders, Lincoln, NE 68583 USA		Hux, K (corresponding author), Univ Nebraska, Barkley Mem Ctr 318E, Lincoln, NE 68583 USA.		Hux, Karen/AAQ-2078-2020				Fried-Oken M., 1992, J HEAD TRAUMA REHAB, V9, DOI [DOI 10.1097/00001199-199209000-00008, 10.1097/00001199-199209000-00008]; GRUEN AK, 1990, J COMMUN DISORD, V23, P163, DOI 10.1016/0021-9924(90)90020-Y; Hough MS, 1997, BRAIN INJURY, V11, P801; Hux K., 1993, AUGMENTATIVE ALTERNA, V9, P119, DOI 10.1080/07434619312331276501; HUX K, 1993, J MED SPEECH-LANG PA, V1, P121; HUX K, 1997, J MED SPEECH-LANG PA, V5, P181; Kaplan E, 1983, BOSTON NAMING TEST; Kertesz A., 1982, W APHASIA BATTERY; Ladtkow Margaret, 1993, Seminars in Speech and Language, V14, P61, DOI 10.1055/s-2008-1064159; LEVINE SP, 1992, J HEAD TRAUMA REHAB, V7, P46, DOI DOI 10.1097/00001199-199209000-00007	10	6	6	0	6	SINGULAR PUBLISHING GROUP INC	SAN DIEGO	401 WEST A ST, STE 325, SAN DIEGO, CA 92101-7904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	SEP	2000	8	3					187	197					11	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	351VT	WOS:000089179400007					2022-02-06	
J	Boutin, H; Dauphin, F; Jauzac, P; MacKenzie, ET				Boutin, H; Dauphin, F; Jauzac, P; MacKenzie, ET			Exofocal alterations in opioidergic receptor densities following focal cerebral ischemia in the mouse	EXPERIMENTAL NEUROLOGY			English	Article						[H-3]diprenorphine; [H-3]DAMGO; [H-3]DADLE; [H-3]U69,593; autoradiography; thalamus; striatum	TRAUMATIC BRAIN INJURY; RAT NUCLEUS-ACCUMBENS; IN-SITU HYBRIDIZATION; DENTATE GYRUS; MESSENGER-RNA; ULTRASTRUCTURAL-LOCALIZATION; ALZHEIMERS-DISEASE; GLUTAMATE RELEASE; ARTERY OCCLUSION; AGONIST	In previous studies of our group, we have reported differential alterations in opioidergic receptor subtypes densities in infarcted and periinfarcted brain tissue following middle cerebral artery occlusion (MCAO) in mice. Other studies have also described subcortical alterations consecutive to focal cortical ischemia. For a better understanding of ischemic processes in exofocal areas, we have investigated the evolution of opioidergic receptors following focal cortical ischemia through the quantification of relative binding densities, B-max and K-d values for the mu, delta, and kappa subtypes. Our results demonstrate that opioid receptor subtypes exhibit adaptations at distance from the ischemic core, mainly in the striatum, the thalamus, and the substantia nigra. Indeed, mu and delta B-max values were increased in ventral thalamic nuclei, while kappa relative binding densities were transiently increased in nucleus medialis dorsalis and nucleus lateralis, pars posterior. Moreover, the B-max of mu and delta receptors were transiently decreased at 6 h post-MCAO in ipsi- and contralateral patches and matrices of the striatum. Conversely, the mu B-max values were increased in ipsi- and contralateral substantia nigra, pars compacta, and pars reticulata, 24 h following MCAO. In contralateral substantia nigra, pars compacta, kappa B-max was found to be decreased at 24 h post-MCAO. These alterations could reflect neuronal dysfunction in exofocal brain structures, consecutively to the degeneration of defined neuroanatomical pathways. Our study indicates that opioidergic receptors could be used as markers of the neuronal reorganization that take place in subcortical areas following an ischemic insult Of the brain cortex. (C) 2000 Academic Press.	Univ Caen, CNRS UMR 6551, Ctr CYCERON, F-14074 Caen, France		Boutin, H (corresponding author), Univ Manchester, Sch Biol Sci, 1-124 Stopford Bldg,Oxford Rd, Manchester M13 9P5, Lancs, England.		Boutin, Herve/C-4532-2011; Mackenzie, Eric Thomson/L-1938-2015; Dauphin, Francois/B-1642-2012	MacKenzie, Eric T/0000-0003-1057-7033; Boutin, Herve/0000-0002-0029-5246			ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; ARVIDSSON U, 1995, J NEUROSCI, V15, P3328; Bemana I, 1998, J NEUROTRAUM, V15, P117, DOI 10.1089/neu.1998.15.117; BENFENATI F, 1991, BRAIN RES, V546, P171, DOI 10.1016/0006-8993(91)91175-Z; BIRCH PJ, 1991, BRIT J PHARMACOL, V103, P1919; Boutin H, 1999, STROKE, V30, P1271, DOI 10.1161/01.STR.30.6.1271; Boutin H, 1998, BRAIN RES, V787, P237, DOI 10.1016/S0006-8993(97)01485-6; BuchkremerRatzmann I, 1996, STROKE, V27, P1105, DOI 10.1161/01.STR.27.6.1105; Cohen RM, 1999, SYNAPSE, V33, P282, DOI 10.1002/(SICI)1098-2396(19990915)33:4<282::AID-SYN5>3.0.CO;2-5; Commons KG, 1996, BRAIN RES, V738, P181, DOI 10.1016/S0006-8993(96)00774-3; Commons KG, 1997, J COMP NEUROL, V381, P373; DAWSON VL, 1994, EXP NEUROL, V128, P88, DOI 10.1006/exnr.1994.1115; Drake CT, 1996, J COMP NEUROL, V370, P377; DYER RG, 1991, EXP BRAIN RES, V85, P230; FERNANDEZ A, 1994, NEUROSCIENCE, V61, P73, DOI 10.1016/0306-4522(94)90061-2; FUJIE W, 1990, STROKE, V21, P1485, DOI 10.1161/01.STR.21.10.1485; Gerfen CR, 1996, HAND CHEM N, V12, P371; Gracy KN, 1997, J NEUROSCI, V17, P4839; Gueniau C, 1997, J PHARMACOL EXP THER, V282, P1; HILLER JM, 1987, BRAIN RES, V406, P17, DOI 10.1016/0006-8993(87)90764-5; IKEDA M, 1993, BRAIN RES, V616, P211, DOI 10.1016/0006-8993(93)90211-5; ITOH J, 1993, BRAIN RES, V619, P223, DOI 10.1016/0006-8993(93)91615-Y; ITOH J, 1993, EUR J PHARMACOL, V234, P9, DOI 10.1016/0014-2999(93)90699-I; Jones E.G., 1985, THALAMUS; LEMOINE C, 1994, NEUROSCIENCE, V62, P635, DOI 10.1016/0306-4522(94)90464-2; MacKay KB, 1996, BRAIN RES, V712, P329, DOI 10.1016/0006-8993(95)01559-0; MACKAY KB, 1993, BRAIN RES, V618, P213, DOI 10.1016/0006-8993(93)91268-W; MACKAY KB, 1992, PHARMACOLOGY OF CEREBRAL ISCHEMIA 1992, P207; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MCLEAN S, 1986, BRAIN RES, V378, P49, DOI 10.1016/0006-8993(86)90285-4; NAGASAWA H, 1992, J NEUROSCI RES, V31, P507, DOI 10.1002/jnr.490310314; NAGASAWA H, 1994, BRAIN RES BULL, V35, P347, DOI 10.1016/0361-9230(94)90112-0; Nordborg C, 1996, ACTA NEUROPATHOL, V91, P61; OFRI D, 1992, BRAIN RES, V581, P252, DOI 10.1016/0006-8993(92)90715-L; PERRY DC, 1992, MOL CHEM NEUROPATHOL, V16, P95, DOI 10.1007/BF03159963; RINNE JO, 1993, NEUROSCI LETT, V161, P77, DOI 10.1016/0304-3940(93)90144-A; RUPALLA K, 1997, J CEREB BLOOD FLOW M, V17, pS255; Schlegelmilch BB, 1995, AMA WINTER EDUC CONF, V6, P1; SILVIA RC, 1987, BRAIN RES, V403, P52, DOI 10.1016/0006-8993(87)90121-1; SIMMONS ML, 1994, J NEUROPHYSIOL, V72, P1697, DOI 10.1152/jn.1994.72.4.1697; SMITH JAM, 1993, NEUROSCIENCE, V55, P935, DOI 10.1016/0306-4522(93)90309-4; Soriano MA, 1996, NEUROREPORT, V7, P425, DOI 10.1097/00001756-199601310-00012; Svingos AL, 1996, J NEUROSCI, V16, P4162; TING P, 1994, ACTA NEUROCHIR, P253; WAGNER JJ, 1992, J NEUROSCI, V12, P132; WAKSMAN G, 1987, BRAIN RES, V436, P205, DOI 10.1016/0006-8993(87)91663-5; Weeks RA, 1997, J CEREBR BLOOD F MET, V17, P943, DOI 10.1097/00004647-199709000-00003; WELSH FA, 1987, J NEUROCHEM, V49, P846, DOI 10.1111/j.1471-4159.1987.tb00971.x; WEVERS A, 1995, NEUROSCI LETT, V195, P125, DOI 10.1016/0304-3940(95)11797-Z; Yamashita K, 1996, BRAIN RES, V735, P285, DOI 10.1016/0006-8993(96)00578-1	51	6	6	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	AUG	2000	164	2					314	321		10.1006/exnr.2000.7400			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	348VF	WOS:000089006600007	10915570				2022-02-06	
J	Hotz, GA; Stewart, KJ; Petrin, D; Villanueva, PA; Cohn, SM; Nedd, KJ; Puentes, G; Duncan, R				Hotz, GA; Stewart, KJ; Petrin, D; Villanueva, PA; Cohn, SM; Nedd, KJ; Puentes, G; Duncan, R			Neurobehavioural outcomes of penetrating and tangential gunshot wounds to the head	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; ADULT CIVILIANS; SCALE; COMA; DISABILITY; VIOLENCE; SCORE; CARE	Objective: The objective of this study was to compare penetrating and tangential gunshot wounds to the head with regards to demographic, neurobehavioural and clinical outcome measures. Methods: Twenty-nine patients with penetrating gunshot wounds (P-GSW) and 11 patients with tangenital gunshot wound (T-GSW) to the head admitted to an acute neurotrauma service were compared using standardized neurobehavioural and clinical outcome measures. Results: The mean GCS was 10.5 +/- 0.79 for the P-GSW group and 13.4 +/- 0.72 for the T-GSW group. The mean AIS-CNS for the P-GSW group was 5.00 +/- 0 and for the T-GSW group was 3.7 +/- 0.27. Significance was found on Digit Span (p < 0.05) and Block Design (p < 0.009) subtests. Outcomes between the two groups were similar, except for significant differences were found for acute length of stay (LOS) (P-GSW was 47.72 +/- 13.2 and T-GSW group was 13.0 +/- 1.3, p = 0.005) and for acute care charges (P-GSW group was $150533+/-23834 and T-GSW group was $70712+/-16587, p = 0.05). Conclusions: Initially, a penetrating gunshot wound is a more severe and costly injury than a tangential gunshort wound to the head, however T-GSW possess significant deficits and, if the patient survives past the acute phase of recovery, the two groups have similar functional outcomes. Future prospective trials should be conducted utilizing standard classification, neuropsychological, and clinical outcome measures.	Univ Miami, Sch Med, Ryder Trauma Ctr T405, Div Neurorehabil, Miami, FL 33136 USA		Hotz, GA (corresponding author), Univ Miami, Sch Med, Ryder Trauma Ctr T405, Div Neurorehabil, 1800 NW 10th Ave, Miami, FL 33136 USA.						Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Cooper PR, 1993, HEAD INJURY, P355; Hamster K., 1983, MULTILINGUAL APHASIA; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; HEATON RK, 1996, NEUROPSYCHOLOGICAL A, P100; *HRS OFF HLTH PROM, 1996, INJ FLOR MORT FACTS; Ikeda RM, 1997, J ORTHOP TRAUMA, V11, P147, DOI 10.1097/00005131-199704000-00001; JACOBS DG, 1995, AM SURGEON, V61, P647; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KAUFMAN HH, 1985, NEUROSURGERY, V16, P754, DOI 10.1227/00006123-198506000-00002; KAUFMAN HH, 1995, NEUROSURG CLIN N AM, V6, P701, DOI 10.1016/s1042-3680(18)30426-1; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MALKMUS D, 1974, RANCHO LEVELS COGNIT; Mehta Z, 1996, NEUROPSYCHOLOGIA, V34, P441, DOI 10.1016/0028-3932(95)00120-4; MILLIS SR, 1995, BRAIN INJURY, V9, P509, DOI 10.3109/02699059509008210; ORDOG GJ, 1995, J TRAUMA, V38, P291, DOI 10.1097/00005373-199502000-00029; Osterrieth PA, 1994, ARCH PSYCHOL, V30, P286; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A., 1964, EXAMEN CLIN PSYCHOL; SCHWAB CW, 1995, J TRAUMA, V38, P163; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stone JL, 1996, J TRAUMA, V40, P57, DOI 10.1097/00005373-199601000-00011; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; *UN DAT SYST MED R, 1993, GUID UN DAT SET MED; VALENA N, 1997, AM J PHYS MED REHABI, V76, P163; WECHSLER D, 1974, MANUAL WAIS R; Zafonte RD, 1997, BRAIN INJURY, V11, P403	30	6	8	0	0	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	2000	14	7					649	657					9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	335AV	WOS:000088220600005	10914646				2022-02-06	
J	Tecoult, E; Mesenge, C; Stutzmann, JM; Plotkine, M; Wahl, F				Tecoult, E; Mesenge, C; Stutzmann, JM; Plotkine, M; Wahl, F			Influence of anesthesia protocol in experimental traumatic brain injury	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						anesthesia; chloral hydrate; halothane; mouse; propofol; traumatic brain injury; experimental design	EXPERIMENTAL HEAD-INJURY; CHLORAL HYDRATE; PROPOFOL; MICE; NEURONS; RECEPTORS; MIDAZOLAM; HALOTHANE; BLOCKADE; RECOVERY	Most pharmacologic studies on brain trauma in animals are performed while the animals are under general anesthesia, which can interfere with brain metabolism and modify the experimental results. This study investigates the effects of three anesthetic drugs (halothane 2% and 4%, propofol at 10 mg/kg, and chloral hydrate at 400 mg/kg) on the traumatic brain injury-induced neurologic deficit in mice. Trauma was induced with a weight-drop device. For each drug, animals were divided into four groups; the first did not receive either anesthesia or trauma, the second received anesthesia but no trauma, the third received a trauma without anesthesia, and the fourth received anesthesia before the trauma. A neurologic examination using two different scorings (string and grip test) was performed 1 hour and 24 hours after the trauma. Mortality after trauma was increased for halothane 4% (48% versus 20% in unanesthetized mice), propofol (80% versus 30%), and chloral hydrate (70% versus 44%). Halothane 2% did not increase the mortality in traumatized mice. Halothane 2% or 4% anesthesia did not modify the string score after the trauma, Grip score after the trauma was better in mice anesthetized with halothane at either 2% or 4%. Mice injured under anesthesia with chloral hydrate had worse grip and string scores (P < .05) than unanesthetized mice. These results lead us to question the influence of anesthesia on the results obtained in experimental neurophamacologic studies, particularly when there are discrepancies between two studies on the same pharmacologic treatment, which differ in their anesthesia protocols.	Aventis Pharma SA, Dept CNS, Ctr Rech Vitry Alfortville, F-94400 Vitry Sur Seine, France; Ctr Hosp Univ Limoges, Dept Anesthesie Reanimat, Limoges, France; Univ Paris 05, Fac Sci Pharmaceut & Biol, Pharmacol Lab, Paris, France		Wahl, F (corresponding author), Aventis Pharma SA, Dept CNS, Ctr Rech Vitry Alfortville, 13 Quai Jules Guesde, F-94400 Vitry Sur Seine, France.						ADODRA S, 1995, BRIT J PHARMACOL, V115, P953, DOI 10.1111/j.1476-5381.1995.tb15903.x; ARNFRED I, 1962, ARCH INT PHARMACOD T, V139, P67; Cervantes M, 1995, Arch Med Res, V26, P385; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Dringenberg HC, 1996, J NEURAL TRANSM, V103, P693, DOI 10.1007/BF01271229; FRAGEN RJ, 1994, ANESTHESIA, P229; GREEN TR, 1994, TOXICOL APPL PHARM, V129, P163, DOI 10.1006/taap.1994.1240; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HANS P, 1994, J NEUROSURG ANESTH, V6, P249; HAYASHI Y, 1994, ARCH INT PHARMACOD T, V328, P251; HEXEBERG E, 1995, LAB ANIM, V29, P400, DOI 10.1258/002367795780740069; Hollrigel GS, 1996, J NEUROPHYSIOL, V76, P2412, DOI 10.1152/jn.1996.76.4.2412; Koblin DD., 1994, ANESTHESIA, P67; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LOWSON S, 1991, BRIT J PHARMACOL, V102, P879, DOI 10.1111/j.1476-5381.1991.tb12270.x; Mack P. O. P., 1994, Annals Academy of Medicine Singapore, V23, P470; MARANA E, 1982, RESUSCITATION, V10, P89, DOI 10.1016/0300-9572(82)90016-8; MARTIN LC, 1992, MOL NEUROPHARMACOL, V2, P225; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; MIRSKI MA, 1995, CRIT CARE MED, V23, P2038, DOI 10.1097/00003246-199512000-00013; NUGENT M, 1982, ANESTHESIOLOGY, V56, P172, DOI 10.1097/00000542-198203000-00003; PANTER SS, 1992, J NEUROTRAUM, V9, P47, DOI 10.1089/neu.1992.9.47; PAVLIN EG, 1994, ANESTHESIA, P125; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Ratnakumari L, 1997, ANESTHESIOLOGY, V86, P428, DOI 10.1097/00000542-199702000-00018; REVES JG, 1994, ANESTHESIA, P247; Rojavin MA, 1997, INT J RADIAT BIOL, V72, P475; Saito R, 1997, J CEREBR BLOOD F MET, V17, P857, DOI 10.1097/00004647-199708000-00004; SALZMAN SK, 1993, RES COMMUN CHEM PATH, V80, P59; SCHWARTZ RD, 1995, J NEUROSCI, V15, P529; SHAPIRA Y, 1993, EUR J ANAESTH, V10, P155; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPIRA Y, 1994, STROKE, V25, P1637, DOI 10.1161/01.STR.25.8.1637; SILVERMAN J, 1993, LAB ANIM SCI, V43, P210; SMITH W, 1993, LAB ANIM, V27, P30, DOI 10.1258/002367793781082377; SPILLERT C R, 1990, Brain Injury, V4, P199, DOI 10.3109/02699059009026166; TANELIAN DL, 1993, ANESTHESIOLOGY, V78, P757, DOI 10.1097/00000542-199304000-00020; VANAKEN H, 1995, NEUROANAESTHETIC PRA, P91; YAMAKURA T, 1995, NEUROSCI LETT, V188, P187, DOI 10.1016/0304-3940(95)11431-U	41	6	7	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2000	12	3					255	261		10.1097/00008506-200007000-00010			7	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	330PB	WOS:000087969500010	10905576				2022-02-06	
J	Pepin, M; Dumont, C; Hopps, S				Pepin, M; Dumont, C; Hopps, S			Relationship between cognitive capabilities and social participation among people with traumatic brain injury	BRAIN INJURY			English	Article							HEAD-INJURY; RECOVERY; SKILLS	This study attempts to determine the relationship between cognitive capabilities and social participation, over a 1-year period, among people who have experienced traumatic brain-injury (TBI). Using the Disability Creation Process as a basis for making hypotheses, three research questions were examined: (1) Do cognitive capabilities improve over time?; (2) Does social participation improve over time?; and (3) Are these two concepts related over time? The results and their clinical implications on rehabilitation are discussed, along with the limitations of this study.	Inst Readaptat Deficience Phys Quebec, Quebec City, PQ G1M 2S8, Canada		Dumont, C (corresponding author), Inst Readaptat Deficience Phys Quebec, 525 Blvd Wilfrid Hamel, Quebec City, PQ G1M 2S8, Canada.						Begin C, 1999, SYSTEME SANTE QUEBEC; Bush JW., 1982, HEALTH PSYCHOL, V1, P61, DOI [10.1037/0278-6133.1.1.61, DOI 10.1037/0278-6133.1.1.61]; CHATTERJEE K, 1987, Cardiovascular Drugs and Therapy, V1, P1, DOI 10.1007/BF02125827; Chisholm D, 1997, SOC PSYCH PSYCH EPID, V32, P68, DOI 10.1007/BF00788923; Colarusso RP, 1972, MOTOR FREE VISUAL PE; DUMONT C, 1997, REV CANADIENNE EVALU, V12, P35; EBRAHIM S, 1995, SOC SCI MED, V41, P1383, DOI 10.1016/0277-9536(95)00116-O; Fisher WP, 1997, PHYS MED REHABILITAT, V11, P357; FOUGEYROLLAS P, 1999, REVISION PROPOSITION; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Kail R, 1995, MEMORY PERFORMANCE AND COMPETENCIES, P71; LUNDGREN CC, 1986, AM J OCCUP THER, V40, P397, DOI 10.5014/ajot.40.6.397; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; Millis S R, 1994, Int J Neurosci, V79, P165; NEISTADT ME, 1984, AM J OCCUP THER, V38, P671, DOI 10.5014/ajot.38.10.671; OSTBY S, 1991, Brain Injury, V5, P9, DOI 10.3109/02699059108998506; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; PANIKOFF LB, 1983, AM J OCCUP THER, V37, P735, DOI 10.5014/ajot.37.11.735; RILEY E, 1993, REGIONALISATION SERV; SEAMAN B, 1993, J COGNITIVE REHABILI, V2, P6; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Wilson BA, 1998, CURR OPIN NEUROBIOL, V8, P281, DOI 10.1016/S0959-4388(98)80152-9	22	6	6	0	5	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2000	14	6					563	572					10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	325WN	WOS:000087699600006	10887889				2022-02-06	
J	Van Reempts, J; Borgers, M				Van Reempts, J; Borgers, M			Animal models of stroke: Compromise between consistency and clinical relevance?	NEUROSCIENCE RESEARCH COMMUNICATIONS			English	Article						stroke; ischemia; animal model; neuroprotection	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN INJURY; PROGRAMMED CELL-DEATH; ARTERY OCCLUSION; NEURONAL DEATH; NEUROPATHOLOGICAL CONSEQUENCES; INTRACEREBRAL HEMORRHAGE; NEOCORTICAL INFARCTION; CORTICAL INFARCTION; RODENT MODELS	Experimental stroke can be induced by permanent or temporal reduction of oxygen supply in focal brain regions of a variety of animal species in order to produce a reliable functional deficit with or without the formation of reproducible infarcts. The resulting lesion depends on the size of the occluded vessels and the territory that they supply. This can include a complete hemisphere, a major perfusion territory, specific functional regions or unpredictable lacunar fields. The outcome depends on the residual flow to the affected area and the timely restoration of blood supply. Areas of low flow, either in the occluded region or in the apposing penumbra, deserve attention for therapeutic rescue. This is also true for areas remote from the compromised structure. Since the progression of injury and the response of the different brain constituents are multifactorial and behave in a rather unpredictable and variable way, treatment is a complex matter. The evolution of acute or delayed neuronal injury and secondary phenomena such as edema formation, inflammatory reaction and retrograde degeneration may require well-timed approaches based on various mechanisms of action. In this paper current experimental models are reviewed and pharmacotherapeutic measures will be discussed in relation to the pathogenesis of stroke.	Janssen Res Fdn, Dept Life Sci Neuropathol, B-2340 Beerse, Belgium		Van Reempts, J (corresponding author), Janssen Res Fdn, Dept Life Sci Neuropathol, Turnhoutseweg 30, B-2340 Beerse, Belgium.						ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Becker KJ, 1998, CURR OPIN NEUROL, V11, P45, DOI 10.1097/00019052-199802000-00008; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; BETZ A L, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P133; BRINT S, 1988, J CEREBR BLOOD F MET, V8, P474, DOI 10.1038/jcbfm.1988.88; Caplan LR, 1997, ARCH NEUROL-CHICAGO, V54, P1222, DOI 10.1001/archneur.1997.00550220032010; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; CharriautMarlangue C, 1995, NEUROREPORT, V7, P61, DOI 10.1097/00001756-199512000-00014; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Chopp M, 1996, ACT NEUR S, V66, P21; COYLE P, 1984, STROKE, V15, P711, DOI 10.1161/01.STR.15.4.711; DeGraba TJ, 1998, NEUROLOGY, V51, pS62, DOI 10.1212/WNL.51.3_Suppl_3.S62; DELZOPPO GJ, 1995, J INTERN MED, V237, P79; DEMULDER G, 1999, IN PRESS ACTA NEUROC; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; DESHPANDE J, 1992, EXP BRAIN RES, V88, P91, DOI 10.1007/BF02259131; DIETRICH WD, 1986, J CEREBR BLOOD F MET, V6, P184, DOI 10.1038/jcbfm.1986.31; Dietrich WD, 1998, INT REV NEUROBIOL, V42, P55, DOI 10.1016/S0074-7742(08)60608-X; DIETRICH WD, 1987, ACTA NEUROPATHOL, V72, P326, DOI 10.1007/BF00687263; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; FUTRELL N, 1988, ANN NEUROL, V23, P251, DOI 10.1002/ana.410230307; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GINSBERG MD, 1989, STROKE, V20, P1627, DOI 10.1161/01.STR.20.12.1627; GROME JJ, 1988, J CEREBR BLOOD F MET, V8, P89, DOI 10.1038/jcbfm.1988.11; HAKIM AM, 1987, CAN J NEUROL SCI, V14, P557; HALLENBECK JM, 1990, ARCH NEUROL-CHICAGO, V47, P1245, DOI 10.1001/archneur.1990.00530110107027; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hartl R, 1996, J CEREBR BLOOD F MET, V16, P1108; HASELDONCKX M, 1999, IN PRESS ACTA NEUROC; HEISS WD, 1994, J CEREBR BLOOD F MET, V14, P892, DOI 10.1038/jcbfm.1994.120; Herz RCG, 1998, BRAIN RES, V791, P223, DOI 10.1016/S0006-8993(98)00106-1; HIRAMATSU K, 1993, ACTA NEUROCHIR, V120, P66, DOI 10.1007/BF02001472; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; HUNTER AJ, 1995, TRENDS PHARMACOL SCI, V16, P123, DOI 10.1016/S0165-6147(00)88999-3; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; ITO U, 1975, ACTA NEUROPATHOL, V32, P209, DOI 10.1007/BF00696570; KANEKO D, 1985, STROKE, V16, P76, DOI 10.1161/01.STR.16.1.76; KAPLAN B, 1991, STROKE, V22, P1032, DOI 10.1161/01.STR.22.8.1032; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; KLATZO I, 1985, BRIT J ANAESTH, V57, P18, DOI 10.1093/bja/57.1.18; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; Koizumi J, 1986, JPN J STROKE, V8, P1, DOI DOI 10.3995/JSTROKE.8.1; Koroshetz WJ, 1996, TRENDS PHARMACOL SCI, V17, P227, DOI 10.1016/0165-6147(96)10020-1; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; KUDO M, 1982, STROKE, V13, P505, DOI 10.1161/01.STR.13.4.505; Lin BW, 1999, ACTA NEUROPATHOL, V97, P359, DOI 10.1007/s004010050999; LINNIK MD, 1993, STROKE, V24, P2002, DOI 10.1161/01.STR.24.12.2002; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MACRAE IM, 1993, J CEREBR BLOOD F MET, V13, P276, DOI 10.1038/jcbfm.1993.34; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MATHEW P, 1994, ACTA NEUROCHIR, P428; MCAULEY MA, 1995, CEREBROVAS BRAIN MET, V7, P153; McIntosh TK, 1996, LAB INVEST, V74, P315; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; NAKAYAMA H, 1988, J CEREBR BLOOD F MET, V8, P357, DOI 10.1038/jcbfm.1988.71; OBRENOVITCH TP, 1995, CEREBROVAS BRAIN MET, V7, P1; PENAR PL, 1987, EXP NEUROL, V96, P393, DOI 10.1016/0014-4886(87)90057-4; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; ROBINSON RG, 1975, NATURE, V255, P332, DOI 10.1038/255332a0; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Rosenblum WI, 1997, J NEUROTRAUM, V14, P313, DOI 10.1089/neu.1997.14.313; Savitz SI, 1998, NEUROSURGERY, V42, P555, DOI 10.1097/00006123-199803000-00026; Schmid-Elsaesser R, 1998, STROKE, V29, P2162, DOI 10.1161/01.STR.29.10.2162; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; SIESJO BK, 1993, PROG BRAIN RES, V96, P1; SINAR EJ, 1987, J NEUROSURG, V66, P568, DOI 10.3171/jns.1987.66.4.0568; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; TYSON GW, 1984, ANN NEUROL, V15, P559, DOI 10.1002/ana.410150608; VANREEMPTS J, 1987, STROKE, V18, P1113, DOI 10.1161/01.STR.18.6.1113; VANREEMPTS J, 1989, J CEREB BLOOD FLO S1, V9, pS169; VANREEMPTS J, 1990, CEREBRAL ISCHEMIA RE, P235; Wagner KR, 1996, STROKE, V27, P490, DOI 10.1161/01.STR.27.3.490; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Witte OW, 1997, ADV NEUROL, V73, P207; Zhang AG, 1997, J CEREBR BLOOD F MET, V17, P123, DOI 10.1097/00004647-199702000-00001; ZIVIN JA, 1987, BRAIN RES, V435, P305, DOI 10.1016/0006-8993(87)91613-1; [No title captured]	86	6	6	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	0893-6609			NEUROSCI RES COMMUN	Neurosci. Res. Commun.	MAY-JUN	2000	26	3					161	172		10.1002/1520-6769(200005/06)26:3<161::AID-NRC4>3.0.CO;2-N			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	327QA	WOS:000087803200004					2022-02-06	
J	Imberti, R; Ciceri, M; Bellinzona, G; Pugliese, R				Imberti, R; Ciceri, M; Bellinzona, G; Pugliese, R			The use of hyperventilation in the treatment of plateau waves in two patients with severe traumatic brain injury - Contrasting effects on cerebral oxygenation	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						brain injury; plateau waves; hyperventilation; cerebral tissue oxygenation; SjO(2)	INTRACRANIAL-PRESSURE; MODEL	We present the case reports of two patients with severe traumatic brain injury who, in the absence of external stimuli, developed episodes of acute elevation of intracranial pressure (plateau waves) associated with jugular bulb oxyhemoglobin (SjO(2)) desaturation, severe reduction of cerebral tissue PO2 (PbrO(2)), and deterioration of neurological status. In all of these episodes hyperventilation was successful in extinguishing plateau waves, but in one patient it was associated with an improvement of both the global (increased SjO(2)) and local (increased PbrO(2)) cerebral perfusion, while in the other patient it was associated with a reduction of both SjO(2) and PbrO(2). In both patients the effects of hyperventilation (and other pharmacological treatments) were short-lived; plateau waves reappeared and the patients had to be submitted to decompressive craniotomy (first patient) and cerebrospinal fluid (CSF) drainage (second patient). We conclude that hyperventilation can he useful as a temporary measure to treat plateau waves, but cerebral oxygenation should always be monitored to avoid iatrogenic cerebral ischemia.	Policlin San Matteo, IRCCS, Serv Anestesia & Rianimaz 2, I-27100 Pavia, Italy; Policlin San Matteo, IRCCS, Clin Neurochirurg, I-27100 Pavia, Italy; Univ Pavia, I-27100 Pavia, Italy		Imberti, R (corresponding author), Policlin San Matteo, IRCCS, Serv Anestesia & Rianimaz 2, I-27100 Pavia, Italy.						CRUZ J, 1992, J TRAUMA, V32, P401, DOI 10.1097/00005373-199203000-00020; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; GANDO S, 1989, CRIT CARE MED, V17, P1083, DOI 10.1097/00003246-198910000-00030; HAYASHI M, 1987, J NEUROSURG, V67, P97, DOI 10.3171/jns.1987.67.1.0097; HAYASHI M, 1991, BRAIN, V114, P2681, DOI 10.1093/brain/114.6.2681; Imberti R, 1997, ACTA ANAESTH SCAND, V41, P536, DOI 10.1111/j.1399-6576.1997.tb04738.x; KATAYAMA Y, 1984, J NEUROSURG, V61, P713, DOI 10.3171/jns.1984.61.4.0713; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; MARION DW, 1991, NEUROSURGERY, V29, P869, DOI 10.1227/00006123-199112000-00011; RISBERG J, 1969, J NEUROSURG, V31, P303, DOI 10.3171/jns.1969.31.3.0303; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Ursino M, 1997, J APPL PHYSIOL, V82, P1256, DOI 10.1152/jappl.1997.82.4.1256; YASUNAMI T, 1987, ACTA NEUROL SCAND, V76, P94, DOI 10.1111/j.1600-0404.1987.tb03552.x	13	6	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	APR	2000	12	2					124	127		10.1097/00008506-200004000-00011			4	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	300YL	WOS:000086281300011	10774609				2022-02-06	
J	Teasdale, TW; Engberg, AW				Teasdale, TW; Engberg, AW			Disability pensions in relation to traumatic brain injury: a population study	BRAIN INJURY			English	Article							YOUNG MEN; FINLAND; NORWAY; LIFE	From a Danish national register of hospitalizations, all patients were identified who had a discharge diagnosis of traumatic brain injury between the years 1979-1993 inclusive, at ages 18-66 years inclusive. These were classified as having suffered either a concussion (n = 74398), a cranial fracture (n = 4452) or a cerebral contusion (n = 8141). Patients in each of these groups were then checked in annual registers of disability pension awards between 1979-1995. Disability pensions had been awarded to 16% of the concussion group, 18% of the fracture group, and 33% of the contusion soup. Date of application, grounds for the application, and the pension level awarded were noted. Analysis of the date of application for the disability pension revealed that in all groups a high proportion of the pension applications had been made prior to the injury. Among the concussion group, the pension award appeared to be independent of the injury itself Rather, being awarded a disability pension appeared to be related to conditions which themselves are risk factors for a traumatic brain injury, e.g. chronic skeletomuscular disease and psychiatric disorders including alcoholism. Comparison with population statistics revealed that the relative risk of being assigned a low or intermediate disability pension is markedly elevated among the concussion group, especially at younger ages and among males. For the fracture and contusion groups, a clear post-injury elevation in rate was detectable, especially for highest level pensions.	Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; Hvidovre Univ Hosp, Div Stroke, Med Ctr, Hvidovre, Denmark; MRC, Cognit & Brain Sci Unit, Cambridge, England		Teasdale, TW (corresponding author), Univ Copenhagen, Dept Psychol, Copenhagen, Denmark.						Claussen B, 1998, SCAND J SOC MED, V26, P1; Eden L, 1998, SCAND J SOC WELFARE, V7, P300, DOI 10.1111/j.1468-2397.1998.tb00250.x; Engberg A, 1998, EUR J EPIDEMIOL, V14, P165, DOI 10.1023/A:1007492025190; ENGBERG A, 1995, ACTA NEUROLOGIC S164, V92; Guberan E, 1998, INT J EPIDEMIOL, V27, P1026, DOI 10.1093/ije/27.6.1026; JENNETT B, 1998, EPIDEMIOLOGY NEUROLO, P75; Kaprio J, 1996, J EPIDEMIOL COMMUN H, V50, P653, DOI 10.1136/jech.50.6.653; LEVIN HS, 1999, MILD HEAD INJURY; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Manninen P, 1997, INT J EPIDEMIOL, V26, P1063, DOI 10.1093/ije/26.5.1063; Mansson NO, 1998, INT J EPIDEMIOL, V27, P1019, DOI 10.1093/ije/27.6.1019; Rognerud MA, 1998, EUR J EPIDEMIOL, V14, P457, DOI 10.1023/A:1007448120325; Salminen JK, 1997, ACTA PSYCHIAT SCAND, V95, P242, DOI 10.1111/j.1600-0447.1997.tb09626.x; SCHALEN W, 1994, BRAIN INJURY, V8, P33; Teasdale TW, 1997, BRIT MED J, V315, P569; Upmark M, 1999, ADDICTION, V94, P507, DOI 10.1046/j.1360-0443.1999.9445076.x; Upmark M, 1999, J EPIDEMIOL COMMUN H, V53, P223, DOI 10.1136/jech.53.4.223; Upmark M, 1997, EUR J PUBLIC HEALTH, V7, P20, DOI 10.1093/eurpub/7.1.20	18	6	6	0	3	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	2000	14	4					363	372					10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	302UE	WOS:000086383400006	10815844				2022-02-06	
J	Persinger, MA				Persinger, MA			Subjective improvement following treatment with carbamazepine (Tegretol) for a subpopulation of patients with traumatic brain injuries	PERCEPTUAL AND MOTOR SKILLS			English	Article							SEIZURES	Over a 3-yr period, 19 patients who had sustained brain traumas during motor vehicle incidents and who exhibited abnormal scores for a dichotic word-listening task and Roberts' Epileptic Spectrum Disorder Inventory more than one year after the injury were recommended for treatment with carbamazepine (Tegretol). The psychiatric profile of these patients, as defined by the Minnesota Multiphasic Personality Inventory, was similar to the profile of patients from other studies who had displayed more objective improvement following this treatment. Of the 14 patients 12 who followed the recommendation retrospectively reported that within a few weeks after treatment they experienced marked reductions in the incidence of sudden confusion and depression, increased attention and focus, and either elimination or attenuation of an aversive sensed presence. Such results suggest that many of the debilitating symptoms that persist for months to years after a traumatic brain injury may be electrical in nature rather than due to "psychological responses" and might be treatable by appropriate dosages of carbamazepine or other, e.g., Gabapentin (Neurontin) antiepileptic compounds.	Laurentian Univ, Dept Psychol, Clin Neurosci Lab, Sudbury, ON P3E 2C6, Canada		Persinger, MA (corresponding author), Laurentian Univ, Dept Psychol, Clin Neurosci Lab, Sudbury, ON P3E 2C6, Canada.						BABB TL, 1987, ELECTROEN CLIN NEURO, V66, P467, DOI 10.1016/0013-4694(87)90093-9; BakerPrice LA, 1996, PERCEPT MOTOR SKILL, V83, P491, DOI 10.2466/pms.1996.83.2.491; BUREAU Y R J, 1991, Psychological Reports, V69, P171, DOI 10.2466/PR0.69.5.171-176; BUREAU YRJ, 1995, ELECTRO MAGNETOBIOL, V14, P1, DOI 10.3109/15368379509028464; LEPPIK IE, 1990, COMPREHENSIVE EPILEP, P525; Persinger MA, 1995, PERCEPT MOTOR SKILL, V81, P1283, DOI 10.2466/pms.1995.81.3f.1283; PERSINGER MA, 1995, PERCEPT MOTOR SKILL, V80, P1101; Roberts RJ, 1988, NEUROPSYCHOLOGY, V2, P183, DOI 10.1037//0894-4105.2.3-4.183; ROBERTS RJ, 1992, EPILEPSY RES, V13, P167, DOI 10.1016/0920-1211(92)90073-3; VINCENT KR, 1984, MMPI 168 CODEBOOK	10	6	7	0	4	PERCEPTUAL MOTOR SKILLS	MISSOULA	PO BOX 9229, MISSOULA, MT 59807 USA	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	FEB	2000	90	1					37	40		10.2466/PMS.90.1.37-40			4	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	297GV	WOS:000086075100005	10769880				2022-02-06	
J	Godber, T; Anderson, V; Bell, R				Godber, T; Anderson, V; Bell, R			The measurement anl diagnostic utility of intrasubtest scatter in pediatric neuropsychology	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							ITEM FIT STATISTICS; CLOSED-HEAD INJURY; CRANIAL IRRADIATION; PERSON-FIT; WISC-III; ATTENTION; CHILDREN; PERFORMANCE; SEQUELAE; LEUKEMIA	Intrasubtest scatter (ISS) is a measure of person's tendency toward inconsistency when responding to test items. It has been claimed that ISS may be suggestive of intellectual inefficiency, difficulty with recall of specific information, or fluctuating levels of arousal/attention. The research investigating these claims has been inconclusive. possibly because traditional indices of ISS may not adequately measure inconsistent responding. Item Response Theory (IRT) approaches to the detection of unusual response sequences appear to have a much firmer psychometric foundation but have been largely ignored in the neurodiagnostic literature. This study compares the utility of traditional and IRT-based indices of ISS in identifying children known to be experiencing information-processing difficulties. The WISC-R item responses of 100 children who have received cranial irradiation treatment for leukemia are compared with those of 100 healthy children. Results confirm the diagnostic utility of an IRT-based measure of unusual test behavior in this clinical group. (C) 2000 John Wiley & Sons, Inc.	La Trobe Univ, Bendigo, Victoria 3550, Australia; Univ Melbourne, Parkville, Vic 3052, Australia		Godber, T (corresponding author), La Trobe Univ, Bendigo, Victoria 3550, Australia.	t.godber@bendigo.latrobe.edu.au		Bell, Richard/0000-0001-7486-3720			Anastasi A., 1988, PSYCHOL TESTING; ANDERSON V, 1994, ARCH DIS CHILD, V70, P476, DOI 10.1136/adc.70.6.476; Anderson V, 1997, Pediatr Rehabil, V1, P63; Barkley R.A., 1994, FRAMES REFERENCE ASS, P69; BAUMEISTER RF, 1988, J PERS, V56, P571, DOI 10.1111/j.1467-6494.1988.tb00903.x; BELL RC, 1981, THESIS U W AUSTR; Berger M., 1982, MODEL INTELLIGENCE, P13; BOONE DE, 1992, PSYCHOL REP, V71, P483, DOI 10.2466/PR0.71.6.483-487; BROUWERS P, 1990, AM J PEDIAT HEMATOL, V12, P174; CORRELL RE, 1993, PERCEPT MOTOR SKILL, V76, P99, DOI 10.2466/pms.1993.76.1.99; COUSENS P, 1988, J CHILD PSYCHOL PSYC, V29, P839, DOI 10.1111/j.1469-7610.1988.tb00757.x; Daniel A., 1983, POWER PRIVILEGE PRES; DUMONT R, 1995, J PSYCHOEDUC ASSESS, V13, P271, DOI 10.1177/073428299501300306; Eysenck H. J., 1957, DYNAMICS ANXIETY HYS; FEINBERG JR, 1991, J CLIN PSYCHOL, V47, P327, DOI 10.1002/1097-4679(199105)47:3<327::AID-JCLP2270470302>3.0.CO;2-M; Francis DJ, 1994, FRAMES REFERENCE ASS, P29; Glaser R, 1949, EDUC PSYCHOL MEAS, V9, P727, DOI 10.1177/001316444900900408; Groth-Marnat G, 1997, HDB PSYCHOL ASSESSME; Guttman L., 1950, MEASUREMENT PREDICTI, P60; HALLENBECK CE, 1965, PSYCHOL REP, V17, P339, DOI 10.2466/pr0.1965.17.2.339; HOLDSWORTH L, 1974, DEV MED CHILD NEUROL, V16, P746; Hulin CL, 1983, ITEM RESPONSE THEORY; KAPLAN E, 1991, WAIS NEUROPSYCHOLOGI; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; KAVALE KA, 1984, LEARN DISABILITY Q, V7, P136, DOI 10.2307/1510314; KELLERMAN H, 1991, HDB PSYCHODIAGNOSTIC; Khoo, 1993, QUEST INTERACTIVE TE; Kramer J.J., 1987, J PSYCHOEDUC ASSESS, V5, P37, DOI [https://doi.org/10.1177/073428298700500105, DOI 10.1177/073428298700500105]; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lord F, 1983, NEW HORIZONS TESTING, P51; LORR M, 1941, EDUC PSYCHOL MEAS, V1, P303; Maller SJ, 1997, J SCHOOL PSYCHOL, V35, P299, DOI 10.1016/S0022-4405(97)00010-1; MCDERMOTT PA, 1992, J SPEC EDUC, V25, P504, DOI 10.1177/002246699202500407; Mirsky A.F., 1996, ATTENTION MEMORY EXE, P71; MITTENBERG W, 1991, J CLIN PSYCHOL, V19, P420; Mittenberg W., 1989, PSYCHOL ASSESSMENT J, V1, P273; MULHERN RK, 1985, MED PEDIATR ONCOL, V13, P318, DOI 10.1002/mpo.2950130604; NICKOLS J, 1963, J CLIN PSYCHOL, V17, P56; ODOUGHERTY M, 1984, J ABNORM PSYCHOL, V93, P178, DOI 10.1037/0021-843X.93.2.178; Palmer JO., 1983, PSYCHOL ASSESSMENT C; RAPAPORT D, 1968, DIAGNOSTIC PSYCHOL T; Rasch Georg, 1980, PROBABILISTIC MODELS; Rudner LM, 1996, APPL MEAS EDUC, V9, P91, DOI 10.1207/s15324818ame0901_8; Sattler JM, 1992, ASSESSMENT CHILDREN, Vthird; SCHMITT AP, 1984, ANN M AM ED RES ASS; SMITH RM, 1994, EDUC PSYCHOL MEAS, V54, P42, DOI 10.1177/0013164494054001005; SMITH RM, 1986, EDUC PSYCHOL MEAS, V46, P359, DOI 10.1177/001316448604600210; SMITH RM, 1991, EDUC PSYCHOL MEAS, V51, P541, DOI 10.1177/0013164491513003; STREISSGUTH AP, 1995, DEV PSYCHOPATHOL, V7, P419, DOI 10.1017/S0954579400006611; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; THOMPSON RJ, 1980, J CONSULT CLIN PSYCH, V48, P440, DOI 10.1037/0022-006X.48.4.440; van der Linden W.J., 1997, HDB MODERN ITEM RESP; VANDERPLOEG RD, 1994, CLIN GUIDE NEUROPSYC; WATSON CG, 1965, J CONSULT PSYCHOL, V29, P596, DOI 10.1037/h0022785; Wechsler D., 1958, MEASUREMENT APPRAISA; Wechsler D., 1974, WECHSLER INTELLIGENC; Wilkinson G. S., 1993, WIDE RANGE ACHIEVEME; Willmes K, 1992, NEUROPSYCHOL REHABIL, P103; WRIGHT B, 1969, EDUC PSYCHOL MEAS, V29, P23, DOI 10.1177/001316446902900102; WRIGHT BD, 1979, BICAL CALIBRATING IT	61	6	6	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9762	1097-4679		J CLIN PSYCHOL	J. Clin. Psychol.	JAN	2000	56	1					101	112		10.1002/(SICI)1097-4679(200001)56:1<101::AID-JCLP9>3.0.CO;2-J			12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	270CL	WOS:000084517800009	10661372				2022-02-06	
J	O'Dell, DM; Muir, JK; Zhang, C; Bareyre, FM; Saatman, KE; Raghupathi, R; Welsh, F; McIntosh, TK				O'Dell, DM; Muir, JK; Zhang, C; Bareyre, FM; Saatman, KE; Raghupathi, R; Welsh, F; McIntosh, TK			Lubeluzole treatment does not attenuate neurobehavioral dysfunction or CA3 hippocampal neuronal loss following traumatic brain injury in rats	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Hippocampus; lubeluzole; Morris water maze; nitric oxide; traumatic brain injury	EXCITATORY AMINO-ACIDS; NITRIC-OXIDE SYNTHASE; SODIUM-CHANNEL BLOCKER; ACUTE ISCHEMIC STROKE; POSTTRAUMATIC HYPOTHERMIA; GLUTAMATE NEUROTOXICITY; COGNITIVE IMPAIRMENT; NMDA ANTAGONISTS; CEREBRAL EDEMA; HEAD-INJURY	Purpose: One of the downstream consequences of glutamate-induced NMDA (N-methyl-D-aspartate) receptor activation following traumatic brain injury (TBI) is production of nitric oxide (NO). Ln this study, we evaluated the ability of lubeluzole, a novel neuroprotective compound which downregulates the glutamate-activated nitric oxide pathway and blocks sodium and voltage-sensitive calcium channels, to improve behavioral and histological outcome in rats following TBI. Methods: Rats were anesthetized and subjected to moderate lateral fluid percussion brain injury (2.4-2.6 atm) or were surgically prepared but not injured (sham). Fifteen minutes after injury, animals received a bolus of either vehicle (n = 12 injured, n = 14 uninjured) or lubeluzole (0.31 mg/kg, n = 12 injured, n = 8 uninjured) through the jugular vein followed by a one hour infusion of vehicle or lubeluzole (0.31 mg/kg). Animals were tested at 48 hours post-injury for cognitive performance in the Morris water maze, neuromotor function, and limb placing function, and then sacrificed. Results: While brain injury resulted in significant cognitive and motor deficits, injured animals treated with lubeluzole did not differ in spatial memory performance, neuromotor score, or limb placing function from injured, vehicle-treated animals. Furthermore, there was no difference in the mean number of ipsilateral hippocampal CA3 neurons between injured rats treated with vehicle and those treated with lubeluzole. Conclusions: This single-dose study failed to demonstrate a beneficial effect of lubeluzole on the acute behavioral or histological sequelae following TBI.	Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		McIntosh, TK (corresponding author), Univ Penn, Dept Neurosurg, 3320 Smith Walk,Room 105-C Hayden Hall, Philadelphia, PA 19104 USA.		Raghupathi, Ramesh/AAX-5538-2021				Aronowski J, 1996, NEUROPHARMACOLOGY, V35, P689, DOI 10.1016/S0028-3908(96)00046-9; Ashton D, 1997, BRAIN RES, V745, P210, DOI 10.1016/S0006-8993(96)01094-3; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; BECKMAN JS, 1991, J DEV PHYSIOL, V15, P53; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; BRAUGHLER J, 1987, J BIOL CHEM, V262, P10434; BRAUGHLER JM, 1992, J NEUROTRAUM, V9, pS1; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BULLOCK R, 1992, BRIT J CLIN PHARMACO, V34, P396, DOI 10.1111/j.1365-2125.1992.tb05648.x; BULLOCK R, 1988, ANN NY ACAD SCI, V11, P290; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1987, J NEUROSCI, V7, P357; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Cobbs CS, 1997, BRAIN RES, V751, P336, DOI 10.1016/S0006-8993(96)01429-1; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Culmsee C, 1998, EUR J PHARMACOL, V342, P193, DOI 10.1016/S0014-2999(97)01499-4; DAWSON TM, 1994, PROG BRAIN RES, V103, P365; DEMERLEPALLARDY C, 1991, BIOCHEM BIOPH RES CO, V181, P456, DOI 10.1016/S0006-291X(05)81441-X; DERYCK M, 1992, BRAIN RES, V573, P44; DeRyck M, 1996, J PHARMACOL EXP THER, V279, P748; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Diener HC, 1996, STROKE, V27, P76, DOI 10.1161/01.STR.27.1.76; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Grotta J, 1997, STROKE, V28, P2338, DOI 10.1161/01.STR.28.12.2338; HALEY JE, 1992, NEURON, V8, P211, DOI 10.1016/0896-6273(92)90288-O; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; Hamm RJ, 1996, J NEUROTRAUM, V13, P325, DOI 10.1089/neu.1996.13.325; Haseldonckx M, 1997, STROKE, V28, P428, DOI 10.1161/01.STR.28.2.428; HAYES RL, 1988, J NEUROTRAUM, V5, P287; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; INGLIS F, 1992, J NEUROTRAUM, V9, P75, DOI 10.1089/neu.1992.9.75; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Lesage AS, 1996, J PHARMACOL EXP THER, V279, P759; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; MAIESE K, 1993, J NEUROSCI RES, V36, P77, DOI 10.1002/jnr.490360109; MAIESE K, 1993, J NEUROSCI, V13, P3034; Maiese K, 1997, J NEUROCHEM, V68, P710; Marrannes R, 1998, J PHARMACOL EXP THER, V286, P201; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; MUIR JK, 1997, J NEUROTRAUM, V14, P804; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NORONHADUTRA AA, 1993, FEBS LETT, V321, P59, DOI 10.1016/0014-5793(93)80621-Z; ODELL DM, 1995, J NEUROSURG, V83, P878, DOI 10.3171/jns.1995.83.5.0878; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; OKIYAMA K, 1997, J NEUROTRAUM, V14, P61; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Osikowska-Evers BA, 1995, J CEREB BLOOD FLO S1, V15, p380S; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Sakamoto KI, 1997, J NEUROTRAUM, V14, P349, DOI 10.1089/neu.1997.14.349; Scheller DKA, 1997, EUR J PHARMACOL, V338, P243, DOI 10.1016/S0014-2999(97)81927-9; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Smith DH, 1997, NEUROSCI LETT, V231, P135, DOI 10.1016/S0304-3940(97)00551-X; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Stein DG, 1991, J NEUROTRAUM, V8, P281, DOI 10.1089/neu.1991.8.281; SUN FY, 1995, BRAIN RES, V673, P133, DOI 10.1016/0006-8993(94)01413-C; Urenjak J, 1996, PHARMACOL REV, V48, P21; Wahl F, 1997, BRAIN RES, V756, P247, DOI 10.1016/S0006-8993(97)00144-3; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8	74	6	6	0	0	IOS PRESS	AMSTERDAM	VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2000	16	2					127	134					8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	299CB	WOS:000086177300006	12671215				2022-02-06	
J	Perea, MV; Ladera, V; Morales, F				Perea, MV; Ladera, V; Morales, F			Predictive value of rapid tests of cognitive condition in head injury	REVISTA DE NEUROLOGIA			Spanish	Article						cognitive prediction; Glasgow Coma Scale; Galveston Orientation and Amnesia Test; head injury; Mini-Mental State Examination; Short Test of Mental Status; neuropsicology	MINI-MENTAL-STATE; BRAIN INJURY; SCALE	Introduction. Neuropsychological assessment after head injury (HI) is sometimes not possible because of the physical and/or cognitive condition of the patient, or the lack of neuropsychological specialists at the hospital. Therefore clinical scales and rapid tests are used to obtain information about the severity of the lesion and the general cognitive condition. Objective. To determine whether the rapid clinical scales used to assess the severity of HI (Glasgow Coma Scale, GCS), presence or absence of post-traumatic amnesia (Galveston Orientation and Amnesia Test, GOAT) and general cognitive condition (Mini-Mental State Examination, MMSE, and Short Test of Mental Status, STMS) predict the cognitive condition one year after the head injury. Patients and methods. We made a prospective, longitudinal, observational study of 100 persons of both sexes with HI, assessed on admission by the Neurosurgical Department, and one year after the trauma in the Outpatient Clinic. Clinical scales were used to assess the severity of HI, cognitive screening tests, neuropsychological attention, linguistic, memory and practical constructive tests were also done. Statistical analysis was by simple regression. Results. The GCS only explained a small percentage of the results obtained for immediate memory. The GOAT predicted the linguistic and verbal memory test performance. The MMSE and STMS explained a high proportion of the execution of neurophychological tasks (attention, linguistic, memory and practical construction) one year after the trauma. Conclusions. With the MMSE and STMS valid results may be obtained when it is not possible to carry out general neuropsychological assessment [REV NEUROL 1999; 29: 1099-103].	Univ Salamanca, Dept Psicol Basica Psicobiol & Metadol, Fac Psicol, E-37008 Salamanca, Spain; Hosp Virgen Vega, Serv Neurocirurgia, Salamanca, Spain				Perea, M. Victoria/B-2904-2018; Ladera, Valentina/Q-6132-2017	Perea, M. Victoria/0000-0002-0258-8480; Ladera, Valentina/0000-0003-4075-4483			Ashley M. J., 1993, J HEAD TRAUMA REHAB, V8, P30; Babcock H, 1940, MEASUREMENT EFFICIEN; BENTON AL, 1988, TEST RETENCION VISUA; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; FAUSTMAN WO, 1990, ACTA PSYCHIAT SCAND, V81, P126, DOI 10.1111/j.1600-0447.1990.tb06464.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goodglass H, 1986, EVALUACION AFASIA TR; HORN L, 1989, J AM GERIATR SOC, V37, P848, DOI 10.1111/j.1532-5415.1989.tb02265.x; KAPLAN E, 1986, TEST VOCABULARIO BOS; KARZMARK P, 1992, Brain Injury, V6, P213, DOI 10.3109/02699059209029662; KOKMEN E, 1987, MAYO CLIN PROC, V62, P281, DOI 10.1016/S0025-6196(12)61905-3; KOKMEN E, 1991, ARCH NEUROL-CHICAGO, V48, P725, DOI 10.1001/archneur.1991.00530190071018; KURTH SM, 1994, BRAIN INJURY, V8, P489, DOI 10.3109/02699059409151001; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MILLS V M, 1992, Brain Injury, V6, P219, DOI 10.3109/02699059209029663; Perea MV, 1999, REV NEUROLOGIA, V28, P999, DOI 10.33588/rn.2810.98321; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rey A, 1987, TEST COPIA FIGURA CO; RYAN T V, 1992, Brain Injury, V6, P175, DOI 10.3109/02699059209029656; TEASDALE G, 1974, LANCET, V2, P117; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; War Department Adjutant General's Office, 1944, ARM IND TEST BATT MA; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	27	6	7	0	3	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	DEC 16	1999	29	12					1099	1103		10.33588/rn.2912.99373			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	275HE	WOS:000084814100002	10652729				2022-02-06	
J	Muszynski, CA; Hayman, LA; Weingarten, K; Prow, HW; Cole, JW; Contant, CF				Muszynski, CA; Hayman, LA; Weingarten, K; Prow, HW; Cole, JW; Contant, CF			Conservative management of extra-axial hematomas diagnosed by CT	NEURORADIOLOGY			English	Article						head injury; epidural hematoma; subdural hematoma; computed tomography	ACUTE SUBDURAL-HEMATOMA; ACUTE EPIDURAL HEMATOMA; RAPID SPONTANEOUS RESOLUTION; SEVERE HEAD-INJURY; NONOPERATIVE MANAGEMENT; NEURORADIOLOGISTS ROLE	Our purpose was to assess the role of serial CT in recently traumatized patients with clinically stable extra-axial intracranial hematomas (EACH) and a midline shift of less than 0.5 cm. A retrospective review of 91 imaging studies in 41 patients (with 45 EACH) was done to assess the time between trauma and CT; the presence and type of skull fracture; the volume, type, and location of the EACH; the presence of associated edema and/or contusion. Over a 19-day followup, 11% of the dense EACH increased in volume and 27% decreased. An adjacent skull fracture was seen most frequently in patients with a decrease in EACH volume. Clinical data remain the key to determining the need for neurosurgical intervention in patients with EACH. Follow-up CT afforded no data which altered the medical management of these patients. However, it may be said to have alerted the clinician to an increase in the size of the EACH in 11% of cases, which could mandate close observation of this group.	Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Herbert J Frensley Ctr Imaging Res, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Holy Name Hosp, Dept Radiol, Teaneck, NJ 07666 USA		Hayman, LA (corresponding author), Baylor Coll Med, Dept Radiol, 1 Baylor Plaza, Houston, TX 77030 USA.						AOKI N, 1988, J NEUROSURG, V68, P149, DOI 10.3171/jns.1988.68.1.0149; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; HAMILTON M, 1992, AM J NEURORADIOL, V13, P853; KAUFMAN HH, 1995, NEUROSURGERY, V16, P606; KUROIWA T, 1993, J NEUROSURG, V78, P126, DOI 10.3171/jns.1993.78.1.0126; MAKIYAMA Y, 1985, Nihon University Journal of Medicine, V27, P123; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NAGAO T, 1986, NEUROSURGERY, V19, P465, DOI 10.1227/00006123-198609000-00024; Narayan RK, 1991, PRINCIPLES NEUROSURG, P235; Niikawa S, 1989, Neurol Med Chir (Tokyo), V29, P820, DOI 10.2176/nmc.29.820; PASZTOR A, 1987, Acta Chirurgica Hungarica, V28, P57; POLMAN CH, 1986, NEUROSURGERY, V19, P446, DOI 10.1227/00006123-198609000-00019; PROW HW, 1996, NEUROLOGY TRAUMA, P28; SAGHER O, 1992, AM J NEURORADIOL, V13, P860; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SERVADEI F, 1989, J TRAUMA, V29, P880, DOI 10.1097/00005373-198906000-00030	18	6	6	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0028-3940			NEURORADIOLOGY	Neuroradiology	DEC	1999	41	12					875	881		10.1007/s002340050859			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	266RT	WOS:000084314400002	10639660				2022-02-06	
J	Martinez-Tica, JF; Berbarie, R; Davenport, P; Zornow, MH				Martinez-Tica, JF; Berbarie, R; Davenport, P; Zornow, MH			Monitoring brain PO2, PCO2, and pH during graded levels of hypoxemia in rabbits	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						brain oxygen; brain carbon dioxide; brain pH; inhalational hypoxia; continuous cerebral monitoring; rabbit	TISSUE OXYGEN; CARBON-DIOXIDE; ISCHEMIA; INJURY; TEMPERATURE	Brain ischemia and hypoxia are of concern when they occur following traumatic brain injury because they frequently result in potentially preventable secondary brain damage. In this study, we examined the ability of an implantable catheter (Paratrend 7; Diametrics Medical, St. Paul, MN) to continuously measure brain tissue pH, PCO2, and PO2 during graded levers of hypoxia. Values obtained from this catheter were compared with simultaneous measurements of arterial and sagittal sinus blood. As expected, there was a good correlation between the changes in pH, PCO2, and PO2 in brain tissue and sagittal sinus blood. Brain tissue PO2 was numerically lower than sagittal sinus blood at all inspired levels of oxygen. These data suggest that the Paratrend 7 may be useful in monitoring brain tissue oxygen tension in patients at risk for regional cerebral ischemia and hypoxia.	Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA		Zornow, MH (corresponding author), Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029403] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS 29403] Funding Source: Medline		ARTRU AA, 1980, ANESTHESIOLOGY, V52, P466, DOI 10.1097/00000542-198006000-00002; Bacher A, 1998, ANESTHESIOLOGY, V88, P403, DOI 10.1097/00000542-199802000-00019; BELL BA, 1984, NEUROSURGERY, V14, P238, DOI 10.1227/00006123-198402000-00023; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; GLUCKMAN PD, 1997, NEUROPROTECTION CNS, P409; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Hoffman WE, 1997, NEUROSURGERY, V40, P294, DOI 10.1097/00006123-199702000-00012; Hoffman WE, 1996, ANESTH ANALG, V82, P582, DOI 10.1097/00000539-199603000-00027; Hoffman WE, 1997, SURG NEUROL, V47, P455, DOI 10.1016/S0090-3019(97)82798-X; KEYKHAH MM, 1988, ANESTHESIOLOGY, V69, P566, DOI 10.1097/00000542-198810000-00017; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; MAAS AIR, 1993, ACTA NEUROCHIR, P50; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P58; Pearigen P, 1996, BRAIN RES, V725, P184; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; ZAUNER A, 1995, NEUROSURGERY, V37, P1168, DOI 10.1227/00006123-199512000-00017	17	6	6	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	1999	11	4					260	263		10.1097/00008506-199910000-00006			4	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	241LL	WOS:000082884700006	10527145				2022-02-06	
J	Yorkston, KM; Jaffe, KM; Liao, SQ; Polissar, NL				Yorkston, KM; Jaffe, KM; Liao, SQ; Polissar, NL			Recovery of written language production in children with traumatic brain injury: outcomes at one year	APHASIOLOGY			English	Article							COHORT; DISCOURSE	The purpose of this study is to determine if the pattern of deficits in written language production persists at one year after resolution post traumatic amnesia. Seventy-one children, aged 8 to 15 years, with mild, moderate and severe closed head injury were compared with controls who were individually matched on the premorbid characteristics of age, gender, school grade, behaviour and academic performance. For children with severe injury, deficits in written language persist at 1 year. Although the extent of the deficits lessens somewhat, the pattern of deficit at 1 month and 1 year are similar.	Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA		Yorkston, KM (corresponding author), Univ Washington, Dept Rehabil Med, Box 356490, Seattle, WA 98195 USA.						CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CHAPMAN SB, 1996, DIAGNOSIS THERAPY PA, P41; CHAPMAN SB, 1997, AM J SPEECH-LANG PAT, V6, P50, DOI DOI 10.1044/1058-0360.0602.50; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; HAMMILL DD, 1978, TEST WRITTEN LANGUAG; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; JENNETT B, 1975, LANCET, V1, P480; Kufera J. A., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI 10.1044/1058-0360.0602.66; Snedecor G, 1967, STAT METHODS, V6th; Yorkston KM, 1997, ARCH PHYS MED REHAB, V78, P1096, DOI 10.1016/S0003-9993(97)90134-9	14	6	6	0	4	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0268-7038			APHASIOLOGY	Aphasiology	SEP-NOV	1999	13	9-11					691	700		10.1080/026870399401803			10	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	248MM	WOS:000083279200007					2022-02-06	
J	Vargo, JM; Grachek, RA; Rockswold, GL				Vargo, JM; Grachek, RA; Rockswold, GL			Light deprivation soon after frontal brain trauma accelerates recovery from attentional deficits and promotes functional normalization of basal ganglia	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	11th Annual Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 14-17, 1998	SANIBEL, FL	E Assoc Surg Trauma		traumatic brain injury; contusion; rat; neglect; attention; frontal cortex; basal ganglia; striatum; caudate; immediate early gene expression; light deprivation; darkness	PREFRONTAL CORTEX LESIONS; STRIATAL FOS EXPRESSION; C-FOS; UNILATERAL NEGLECT; SENSORY NEGLECT; RATS; DOPAMINE; INJURY; SENSORIMOTOR; AMPHETAMINE	Background: Light deprivation significantly accelerates recovery from attention deficits (neglect) after cortical ablation in rats. We hypothesized that light deprivation mould improve recovery after traumatic contusive brain injury (TBI) and do so by enhancing dopaminergic function in the ipsilateral basal ganglia, Methods: Adult rats received left frontal contusion injury and were placed into darkness or standard light/dark cycling for 48 hours. Neurologic evaluation included attentional and sensorimotor tasks. Amphetamine-induced production of the immediate early gene protein product Fos was quantified to determine neuronal dopaminergic response in caudate-putamen (striatum). Results: Unilateral frontal TBI produced severe contralateral deficits in all tasks. Postoperative light deprivation resulted in improved recovery from attentional but not sensorimotor deficits. Five days after injury, ipsilateral striatal Fos expression was reduced by 51% in TBI rats experiencing normal light cycling (p < 0.006), In contrast, postoperative light deprivation normalized striatal Fos expression, ES 6 weeks, all TBI rats demonstrated nearly full recovery and striatal Fos expression was symmetrical between the two striata, Conclusion: Postoperative light deprivation may improve recovery from TBI-induced attention deficits by normalizing basal ganglia function.	MMRF, HCMC, Dept Surg, Minneapolis, MN 55404 USA; Univ Minnesota, Dept Neurosurg, Inst Brain & Immune Disorders, Minneapolis, MN 55455 USA		Vargo, JM (corresponding author), MMRF, HCMC, Dept Surg, 600 HFA Bldg 860-D3,914 S 8th St, Minneapolis, MN 55404 USA.						BERRETTA S, 1992, J NEUROPHYSIOL, V68, P767, DOI 10.1152/jn.1992.68.3.767; CENCI MA, 1993, EUR J NEUROSCI, V5, P1062, DOI 10.1111/j.1460-9568.1993.tb00959.x; CORWIN JV, 1986, EXP NEUROL, V94, P683, DOI 10.1016/0014-4886(86)90247-5; CORWIN JV, 1993, BEHAV BRAIN RES, V56, P187, DOI 10.1016/0166-4328(93)90038-R; CORWIN JV, 1991, SOC NEUR ABSTR, V21, P175; CROWNE DP, 1983, SCIENCE, V220, P527, DOI 10.1126/science.6836298; DENES G, 1982, BRAIN, V105, P543, DOI 10.1093/brain/105.3.543; DEUEL RK, 1983, EXP NEUROL, V81, P733, DOI 10.1016/0014-4886(83)90340-0; DEUEL RK, 1984, ANN NEUROL, V15, P521, DOI 10.1002/ana.410150603; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; DRAGUNOW M, 1990, NEUROSCIENCE, V37, P287, DOI 10.1016/0306-4522(90)90399-O; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; GROENEWEGEN HJ, 1990, PROG BRAIN RES, V85, P95; HARRELL LE, 1974, LIFE SCI, V15, P2079, DOI 10.1016/0024-3205(74)90024-1; HEILMAN KM, 1985, INT J CLIN NEUROPSYC, P243, DOI DOI 10.1002/ANA.410100433; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; KINSELLA G, 1980, MED J AUSTRALIA, V2, P663; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MULLER U, 1994, PROG NEURO-PSYCHOPH, V18, P1103, DOI 10.1016/0278-5846(94)90114-7; PAUL ML, 1992, J NEUROSCI, V12, P3729, DOI 10.1523/jneurosci.12-10-03729.1992; PELLIGRINO LJ, 1976, STEREOTAXIC ATLAS RA; Robertson IH, 1997, NEUROPSYCHOLOGY, V11, P290, DOI 10.1037/0894-4105.11.2.290; Rosomoff HL, 1996, CRIT CARE MED, V24, pS48; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Schuller JJ, 1998, BRAIN RES, V788, P315, DOI 10.1016/S0006-8993(97)01492-3; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SNYDERKELLER AM, 1991, EXP NEUROL, V113, P155, DOI 10.1016/0014-4886(91)90171-8; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; Vargo JM, 1996, SYNAPSE, V22, P291; Vargo JM, 1998, BEHAV NEUROSCI, V112, P387, DOI 10.1037/0735-7044.112.2.387; Vargo JM, 1996, BEHAV BRAIN RES, V72, P39; VARGO JM, 1989, BEHAV NEUROSCI, V103, P1017, DOI 10.1037/0735-7044.103.5.1017; VARGO JM, 1995, SYNAPSE, V20, P305, DOI 10.1002/syn.890200404; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Whyte J, 1993, REHABILITATION MED P, P825	39	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	1999	47	2					265	272		10.1097/00005373-199908000-00008			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	226LK	WOS:000082021300009	10452460				2022-02-06	
J	Li, YB; Carlson, E; Murakami, K; Copin, JC; Luche, R; Chen, SF; Epstein, CJ; Chan, PH				Li, YB; Carlson, E; Murakami, K; Copin, JC; Luche, R; Chen, SF; Epstein, CJ; Chan, PH			Targeted expression of human CuZn superoxide dismutase gene in mouse central nervous system	JOURNAL OF NEUROSCIENCE METHODS			English	Article						central nervous system; copper-zinc superoxide dismutase; neuron-specific enolase promoter; Purkinje cells; reactive oxygen species; transgenic mouse	AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN INJURY; TRANSGENIC MICE; ANIMAL-MODEL; NEURONS; DAMAGE; OVEREXPRESSION; ATTENUATION; SOD1; DEGENERATION	Copper-zinc superoxide dismutase (CuZnSOD) is an important enzyme for the detoxification of reactive oxygen species. Particularly in the central nervous system (CNS), reactive oxygen species are often associated with acute brain injuries and chronic neurodegeneration. It has been demonstrated in vivo that there is an inverse correlation between CuZnSOD activity and neuronal death after acute brain injury. To further understand the protective role of CuZnSQD upon neurons, we have generated transgenic mouse lines with targeted expression of the human CuZnSOD gene (SOD1) that is driven by a rat neuron-specific enolase gene promoter in neurons of the CNS. The transgenic SOD1 expression was restricted to the CNS identified by reverse transcriptase-polymerase chain reaction and SOD gel electrophoresis assays. The CuZnSOD activity was significantly increased in the brain stem of the transgenic mice. Immunostaining of human CuZnSOD activity showed that Purkinje cells in the cerebellar cortex were the most intensely stained neurons in the CNS of the transgenic mice. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Calif San Francisco, Sch Med, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; Stanford Univ, Sch Med, Dept Neurosurg, Palo Alto, CA 94304 USA		Chan, PH (corresponding author), Univ Calif San Francisco, Sch Med, Dept Neurol Surg, San Francisco, CA 94143 USA.		Copin, Jean-Christophe/K-6890-2012		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS014543, R01NS025372, P50NS014543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG008938] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG08938] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS14543, NS25372] Funding Source: Medline		BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; CEBALLOSPICOT I, 1991, BRAIN RES, V552, P198, DOI 10.1016/0006-8993(91)90084-9; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; Copin JC, 1996, J NEUROTRAUM, V13, P233, DOI 10.1089/neu.1996.13.233; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; ELROYSTEIN O, 1986, EMBO J, V5, P615, DOI 10.1002/j.1460-2075.1986.tb04255.x; EPSTEIN CJ, 1987, P NATL ACAD SCI USA, V84, P8044, DOI 10.1073/pnas.84.22.8044; Fattori E, 1995, EUR J NEUROSCI, V7, P2441, DOI 10.1111/j.1460-9568.1995.tb01042.x; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; GURNEY ME, 1995, SCIENCE, V269, P149, DOI 10.1126/science.269.5221.149-a; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; KINOUCHI H, 1991, P NATL ACAD SCI USA, V88, P11158, DOI 10.1073/pnas.88.24.11158; KUBISCH HM, 1994, P NATL ACAD SCI USA, V91, P9956, DOI 10.1073/pnas.91.21.9956; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SAKIMURA K, 1995, MOL BRAIN RES, V28, P19, DOI 10.1016/0169-328X(94)00177-G; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7	26	6	6	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	JUL 1	1999	89	1					49	55		10.1016/S0165-0270(99)00037-0			7	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	226EH	WOS:000082007000007	10476683				2022-02-06	
J	Powell, J				Powell, J			Assessment of rehabilitation outcomes in community/outreach settings	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN INJURY; INTEGRATION QUESTIONNAIRE; DEPRESSION; STROKE	Whilst the importance of community-based rehabilitation treatment programmes for people with acquired brain injury is increasingly recognised, there are as yet few well-validated outcome measures which take account both of the specific (participation-related) foci of treatment in this setting and of methodological constraints that make inpatient techniques difficult to use. There is rarely the opportunity for extended observation of clients' day-to-day functioning, nor is it usually possible to seek consensual judgements from a multidisciplinary team as with some of the well-established disability measures that are generally the instruments of choice in hospital settings. Attempts to import such instruments into community assessment rely on administration techniques (e.g. interview) which have not been adequately validated in most cases, and whose reliability and accuracy is unknown. An additional limitation is that many patients living in the community score at ceiling on these measures despite having significant difficulties in living independently or in resuming premorbid social activities and roles. The composition, client group, and clinical framework of the multidisciplinary RNRU Outreach Team is described to illustrate the requirements of assessment techniques in community rehabilitation. The team has been subjected to a randomised controlled treatment trial, necessitating the use of sensitive and reliable quantitative assessment measures which were applicable across a functionally heterogeneous group. In the absence of suitable existing measures, the BICRO-39 scales were developed and validated on a sample of 235 patients with acquired brain injury. Clients and/or their carers rate the client's functioning in various domains; the scales show good test-retest reliability, high agreement between clients and carers, and reasonable construct validity. Most of the subscales are sensitive to change over a period of community-based rehabilitation.	Univ London Goldsmiths Coll, Dept Psychol, London SE14 6NW, England; Homerton Hosp, RNRU Outreach Team, London, England								BROOKS CA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199508000-00002; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hamilton BB, 1987, REHABILITATION OUTCO, P137; HOLBROOK M, 1983, AGE AGEING, V12, P166, DOI 10.1093/ageing/12.2.166; HUGHES D, 1995, TRAUMATIC BRAIN INJU; Johnston M, 1996, PSYCHOLOGIST, V9, P205; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; MAHONEY F I, 1965, Md State Med J, V14, P61; McGregor K, 1997, SOC SCI MED, V45, P295, DOI 10.1016/S0277-9536(96)00345-0; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Novak S., 1996, CLIN REHABILITATION, V10, P128; ODDY M, 1996, BRAIN INJURY IMPROVE; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; SEGAL ME, 1995, AM J PHYS MED REHABI, V74, P277; Spencer KA, 1997, PSYCHOL BULL, V122, P132; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	21	6	6	0	7	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL-OCT	1999	9	3-4					457	471		10.1080/096020199389518			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	242GV	WOS:000082932900019					2022-02-06	
J	Fan, L; Yakovlev, AG; Faden, AI				Fan, L; Yakovlev, AG; Faden, AI			Site-specific cleavage of 28S rRNA as a marker of traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; brain injury; fragmentation; rRNA	TRANSIENT FOREBRAIN ISCHEMIA; DELAYED NEURONAL DEATH; RIBOSOMAL-RNA; TRANSCRIPTION FACTORS; DNA FRAGMENTATION; PROTEIN-SYNTHESIS; XENOPUS OOCYTES; MESSENGER-RNAS; CELL-DEATH; RAT-BRAIN	A cleavage product of 28S rRNA was isolated from ipsilateral hippocampus of rat brain subjected to lateral fluid percussion induced traumatic brain injury (TBI), Northern blot analysis demonstrated that the corresponding cDNA fragment hybridized to 28S rRNA and three cleavage products. Two of the cleaved rRNA fragments (1.3 kb and 0.9 kb) were also observed in differentiated PC12 cells undergoing apoptosis induced by NGF withdrawal. The third fragment (0.6 kb) was detected only in rat brain tissue subjected to trauma, suggesting specific cleavage of 28S following TBI. The 0.6-kb fragment was found only in cortex and hippocampus ipsilateral to the trauma site, but not in brain stem, contralateral cortex or contralateral hippocampus, 28S rRNA cleavage was detected beginning 2 h after trauma and reflected injury severity. Although cleavage of 28S rRNA has been reported in association with apoptosis in white blood cells and apoptosis occurs in the experimental head injury model used, the pattern of 28S rRNA cleavage observed with TBI differs from those observed in apoptotic PC12 cells or those reported for white blood cells. Thus, whereas 28S rRNA fragmentation appears to be a marker of posttraumatic brain injury, its precise role in the secondary injury process remains to be established.	Georgetown Univ, Med Ctr, Georgetown Inst Cognit & Computat Sci, Washington, DC 20007 USA; Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA		Faden, AI (corresponding author), Georgetown Univ, Med Ctr, Georgetown Inst Cognit & Computat Sci, 3970 Reservoir Rd NW,Rm EP-04, Washington, DC 20007 USA.	fadena@giccs.georgetown.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS27849] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [CCR306634] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027849] Funding Source: NIH RePORTER		BABA H, 1994, NEUROCHEM RES, V19, P1091, DOI 10.1007/BF00968721; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CROWE MJ, 1995, SOC NEUR ABS, V21; DELIC J, 1993, INT J RADIAT BIOL, V64, P39, DOI 10.1080/09553009314551091; DRAGUNOW M, 1995, BRAIN RES REV, V21, P1, DOI 10.1016/0165-0173(95)00003-L; Eldadah BA, 1996, NUCLEIC ACIDS RES, V24, P4092, DOI 10.1093/nar/24.20.4092; Faden AI, 1996, PHARMACOL TOXICOL, V78, P12, DOI 10.1111/j.1600-0773.1996.tb00173.x; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAN L, 1995, MOL BRAIN RES, V30, P125; FODSTAD O, 1977, EUR J BIOCHEM, V74, P209, DOI 10.1111/j.1432-1033.1977.tb11383.x; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; GJERTSEN BT, 1994, J CELL SCI, V107, P3363; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; GREENHALGH DA, 1990, BRIT J CANCER, V61, P415, DOI 10.1038/bjc.1990.91; HADJIOLOV AA, 1984, NUCLEIC ACIDS RES, V12, P3677, DOI 10.1093/nar/12.8.3677; HOUGE G, 1995, MOL CELL BIOL, V15, P2051; HOUGE G, 1993, FEBS LETT, V315, P16, DOI 10.1016/0014-5793(93)81123-H; Houge G, 1996, EXPERIENTIA, V52, P963, DOI 10.1007/BF01920105; HSU D, 1994, J BACTERIOL, V176, P4761, DOI 10.1128/JB.176.15.4761-4765.1994; LARSON DE, 1993, P NATL ACAD SCI USA, V90, P7933, DOI 10.1073/pnas.90.17.7933; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MESNER PW, 1995, J NEUROSCI, V15, P7357; MIKUCKI SA, 1991, J NEUROSCI RES, V30, P213, DOI 10.1002/jnr.490300122; Pravdenkova SV, 1996, BRAIN RES, V729, P151, DOI 10.1016/S0006-8993(96)00222-3; QUACH TT, 1993, ANN NY ACAD SCI, V679, P423, DOI 10.1111/j.1749-6632.1993.tb18333.x; RADZIOCH D, 1987, J IMMUNOL, V139, P805; RINK A, 1995, AM J PATHOL, V147, P1575; RINK AD, 1994, SOC NEUR ABS, V20, P114; SANDVIG K, 1992, EXP CELL RES, V200, P253, DOI 10.1016/0014-4827(92)90171-4; SAXENA SK, 1991, J BIOL CHEM, V266, P21208; SAXENA SK, 1990, J BIOL CHEM, V265, P3263; SHIGENO T, 1990, NEUROSCI LETT, V120, P117, DOI 10.1016/0304-3940(90)90182-9; TORTOSA A, 1994, ACTA NEUROPATHOL, V88, P67, DOI 10.1007/BF00294361; VOLPE BT, 1995, NEUROSCI LETT, V186, P157, DOI 10.1016/0304-3940(95)11310-S; WATSON JB, 1994, J NEUROSCI RES, V39, P108, DOI 10.1002/jnr.490390113; WU G, 1993, BIOCHEM CELL BIOL, V71, P372, DOI 10.1139/o93-055; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; YAKOVLEV AG, 1995, J NEUROTRAUM, V12, P767, DOI 10.1089/neu.1995.12.767; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; ZAITZEV IZ, 1983, B EXP BIOL MED, V9, P96; ZHANG JS, 1992, NUCLEIC ACIDS RES, V20, P1271, DOI 10.1093/nar/20.6.1271	41	6	6	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	1999	16	5					357	364		10.1089/neu.1999.16.357			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	200WC	WOS:000080562200002	10369556				2022-02-06	
J	Finnie, JW; Blumbergs, PC; Manavis, J				Finnie, JW; Blumbergs, PC; Manavis, J			Multifocal cerebellar granular layer necrosis in traumatically head-injured lambs	VETERINARY PATHOLOGY			English	Article						focal cerebellar granular layer necrosis; lambs; pediatric head injury model		In a blunt, nonmissile, head impact model of traumatic brain injury in 4-5-week-old Merino lambs, multiple foci of internal granular layer necrosis were found in all 10 impacted animals. This lesion has not previously been reported after human or animal head injury. Temporal lobe impact contusions, predominantly microscopic (8/10) and contralateral contusions (2/10), parenchymal (10/10) and subarachnoid (10/10) hemorrhage, and widely distributed axonal injury were also observed. Although the precise pathogenesis of this focal granule cell necrosis and often attendant red cell change in Purkinje cells was unclear, an ischemic etiology due to trauma-related vascular damage is postulated.	Inst Med & Vet Sci, Neuropathol Lab, Adelaide, SA 5000, Australia		Blumbergs, PC (corresponding author), Inst Med & Vet Sci, Neuropathol Lab, POB 14,Rundle Mall, Adelaide, SA 5000, Australia.						Blumbergs PC, 1997, HEAD INJURY PATHOPHY, P39; Finnie J, 1999, J CLIN NEUROSCI, V6, P38, DOI 10.1016/S0967-5868(99)90601-X; Finnie JW, 1997, AUST VET J, V75, P204, DOI 10.1111/j.1751-0813.1997.tb10067.x; FINNIE JW, 1993, PATHOLOGY, V25, P99, DOI 10.3109/00313029309068912; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; LINDENBERG R, 1982, HISTOL HISTOPATHOL, P1018; Simpson MG, 1996, NEUROTOXICOLOGY, V17, P471; Summers BA, 1995, VET NEUROPATHOLOGY, P34; Ward JD, 1996, NEUROTRAUMA, P859	10	6	6	0	2	AMER COLL VET PATHOLOGIST	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	0300-9858			VET PATHOL	Vet. Pathol.	MAY	1999	36	3					256	258		10.1354/vp.36-3-256			3	Pathology; Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Pathology; Veterinary Sciences	283ND	WOS:000085280900010	10332835				2022-02-06	
J	Pradat-Diehl, P; Masure, MC; Lauriot-Prevost, MC; Vallat, C; Bergego, C				Pradat-Diehl, P; Masure, MC; Lauriot-Prevost, MC; Vallat, C; Bergego, C			Impairment of visual recognition after a traumatic brain injury	REVUE NEUROLOGIQUE			French	Article							RECOVERY; AGNOSIA	Impaired vision and cerebral blindness were observed in a patient who had suffered brain trauma. One year after the trauma, the impairment was characterized by low visual acuity, visual field restricted to central tunnel vision and impaired recognition of objects line drawings, colors and faces. Vision improved six years after the,brain trauma with more rapid recognition of objects and line drawings, increased visual acuity and broadening of the visual field Reading was possible at this time. However, prosopagnosia remained very severe and was still the primary complaint of the patient. improvement of visual function continuing for several years after a brain injury is discussed on the basis of cognitive and neurophysiological knowledge. The place of rehabilitation is discussed. Functional improvement is explained by extrastriate cortical afferences and the cortical network of visual pathways.	Hop La Pitie Salpetriere, Serv Reeduc Neurol, F-75013 Paris, France; CEA, Serv Hosp Frederic Joliot, URA CNRS 2210, F-91406 Orsay, France		Pradat-Diehl, P (corresponding author), Hop La Pitie Salpetriere, Serv Reeduc Neurol, 47 Blvd Hop, F-75013 Paris, France.						BARON JC, 1987, AGRESSOLOGIE, V28, P201; Belin P, 1996, NEUROLOGY, V47, P1504, DOI 10.1212/WNL.47.6.1504; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BERGEGO C, 1989, Annales de Readaptation et de Medecine Physique, V32, P563; BERGEGO C, 1995, NEUROPSYCHOLOGIE TRA, P205; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Damasio H., 1989, LESION ANAL NEUROPSY; DUCARNE B, 1981, REV NEUROL, V137, P741; FYTCHE DH, 1995, BRAIN 6, V118, P1375; GIRARD P, 1994, REV NEUROL, V151, P457; GOLDENBERG G, 1991, BRAIN COGNITION, V15, P160, DOI 10.1016/0278-2626(91)90024-3; Humphreys G. W., 1987, VISUAL OBJECT PROCES, P281; HUMPHREYS GW, 1987, SEE NOT SEE CASE STU, P34; HUMPHREYS GW, 1994, COGNITIVE NEUROPSYCH, P39; KASTEN E, 1995, RESTOR NEUROL NEUROS, V8, P113, DOI 10.3233/RNN-1995-8302; KERKHOFF G, 1994, ARCH NEUROL-CHICAGO, V51, P474, DOI 10.1001/archneur.1994.00540170050016; Metz-Lutz M, 1991, REV NEUROPSYCHOL, V1, P73; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; OTTO I, 1992, J COGNITIVE NEUROSCI, V4, P35, DOI 10.1162/jocn.1992.4.1.35; PRADATDIEHL P, 1991, ANN READAPTATION MED, V24, P449; Riddoch M. J., 1993, BIRMINGHAM OBJECT RE; SCHNEIDER GE, 1969, SCIENCE, V163, P895, DOI 10.1126/science.163.3870.895; SEKI K, 1995, NEUROPSYCHOLOGIA, V33, P595, DOI 10.1016/0028-3932(94)00138-F; SNODGRASS JG, 1980, EXPT PSYCHOL HUMAN L, V8, P174; SPARR SA, 1991, BRAIN, V114, P789, DOI 10.1093/brain/114.2.789; THURSTONE LL, 1959, TEST FORMES IDENTIQU; WILSON BA, 1993, CORTEX, V29, P529, DOI 10.1016/S0010-9452(13)80258-4; ZIHL J, 1985, BRAIN, V108, P335, DOI 10.1093/brain/108.2.335	28	6	6	0	6	MASSON EDITEUR	PARIS 06	120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE	0035-3787			REV NEUROL	Rev. Neurol.	MAY	1999	155	5					375	382					8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	214PT	WOS:000081336900006	10427601				2022-02-06	
J	Cheung, DS; Kharasch, M				Cheung, DS; Kharasch, M			Evaluation of the patient with closed head trauma: An evidence based approach	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article							COMPUTED-TOMOGRAPHY; BRAIN INJURY; INTRACRANIAL HEMATOMA; SKULL FRACTURE; CT FINDINGS; MILD; ALCOHOL; PREDICTORS; CHILDREN; SEVERITY	This article approaches the subject of dosed head trauma from the time-sensitive vantage point of the emergency physician. As the clinical scenario unfolds, he or she constantly evaluates the need for diagnostic tests as information is received from paramedics, nurses, and the history and physical examination. This article provides a synopsis and a critique of original clinical trials to aid the emergency physician in making an evidence based decision.	Northwestern Mem Hosp, Div Emergency Med, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Internal Med, Div Emergency Med, Chicago, IL 60611 USA; Emergency Med Residency McGaw Med Ctr, Chicago, IL USA		Cheung, DS (corresponding author), Northwestern Mem Hosp, Div Emergency Med, 216 E Super 2nd Floor, Chicago, IL 60611 USA.						BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; BRUCE DA, 1989, PEDIATR ANN, V18, P483; CHAN KH, 1990, J NEUROSURG, V72, P189, DOI 10.3171/jns.1990.72.2.0189; CHESNUT RM, 1994, NEUROSURGERY, V34, P840, DOI 10.1227/00006123-199405000-00008; COOPER PR, 1983, NEUROSURGERY, V13, P136, DOI 10.1227/00006123-198308000-00005; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; DOEZEMA D, 1991, ANN EMERG MED, V20, P1281, DOI 10.1016/S0196-0644(05)81065-0; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; FEDERLE MP, 1982, DIAGN IMAGING, P34; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; FULTON RL, 1993, SURG GYNECOL OBSTET, V176, P327; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; GALLAGHER SS, 1984, AM J PUBLIC HEALTH, V74, P1340, DOI 10.2105/AJPH.74.12.1340; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; HANS JS, 1984, RADIOLOGY, V150, P71; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; HERBERT M, 1997, AUDIO DIGEST EMERGEN, V14; Ingebrigtsen T, 1996, ACTA NEUROL SCAND, V93, P207; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; JENNETT B, 1980, CLIN RADIOL, V31, P463, DOI 10.1016/S0009-9260(80)80195-4; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; JONES JJ, 1981, LANCET, V2, P850; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; KRAUS JF, 1990, AM J DIS CHILD, V144, P683; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; MASTERS SJ, 1980, AM J ROENTGENOL, V135, P539, DOI 10.2214/ajr.135.3.539; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; McGregor K, 1997, SOC SCI MED, V45, P295, DOI 10.1016/S0277-9536(96)00345-0; McMordie W R, 1988, Brain Inj, V2, P357, DOI 10.3109/02699058809150908; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; Miller EC, 1996, ANN EMERG MED, V27, P290, DOI 10.1016/S0196-0644(96)70261-5; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; MONHANTY SK, 1991, J TRAUMA, V31, P801; Ogawa T, 1992, Acta Neurochir Suppl (Wien), V55, P8; OLDENDORF WH, 1985, WESTERN J MED, V142, P82; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; RIVARA F, 1987, PEDIATRICS, V80, P579; ROBERTS CJ, 1981, LANCET, V2, P791; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; SAYWELL RM, 1989, J AM GERIATR SOC, V37, P625, DOI 10.1111/j.1532-5415.1989.tb01253.x; SCHUTZMAN SA, 1993, ANN EMERG MED, V22, P535, DOI 10.1016/S0196-0644(05)81938-9; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SERVADEI F, 1988, J NEUROL NEUROSUR PS, V51, P526, DOI 10.1136/jnnp.51.4.526; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; SNOW RB, 1986, NEUROSURGERY, V18, P45, DOI 10.1227/00006123-198601000-00008; STACHNIAK J, 1994, J CLIN ANESTH, V6, P437, DOI 10.1016/S0952-8180(05)80020-0; STEIN SC, 1993, BRAIN INJURY, V7, P425, DOI 10.3109/02699059309029685; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Sullivan T E, 1994, J Neurosci Nurs, V26, P24; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; WEHMAN P, 1994, AM J PHYS MED REHAB, V73, P280, DOI 10.1097/00002060-199407000-00010; Zimmerman R A, 1994, Neuroimaging Clin N Am, V4, P349	59	6	6	0	4	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0733-8627			EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	FEB	1999	17	1					9	+		10.1016/S0733-8627(05)70044-4			16	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	182EW	WOS:000079486700003	10101338				2022-02-06	
S	Andrews, RJ		Trembly, B; Slikker, W		Andrews, RJ			Neuroprotective "agents" in surgery - Secret "agent" man, or common "agent" machine?	NEUROPROTECTIVE AGENTS: FOURTH INTERNATIONAL CONFERENCE	ANNALS OF THE NEW YORK ACADEMY OF SCIENCES		English	Article; Proceedings Paper	4th International Conference on Neuroprotective Agents - Clinical and Experimental Aspects	NOV 15-19, 1998	ANNAPOLIS, MARYLAND	US FDA, Natl Ctr Toxicol Res, Dept Vet Affairs Med Ctr			CORONARY-ARTERY BYPASS; COMPLICATIONS; STROKE; IDENTIFICATION; ANGIOPLASTY; PROGRESS; OUTCOMES; TRIALS; BIOPSY	The search for clinically-effective neuroprotective agents has received enormous support in recent years-an estimated $200 million by pharmaceutical companies on clinical trials for traumatic brain injury alone, At the same time, the pathophysiology of brain injury has proved increasingly complex, rendering the likelihood of a single agent "magic bullet" even more remote. On the other hand, great progress continues with technology that makes surgery less invasive and less risky. One example is the application of endovascular techniques to treat coronary artery stenosis, where both the invasiveness of sternotomy and the significant neurological complication rate (due to microemboli showering the cerebral vasculature) can be eliminated. In this paper we review aspects of intraoperative neuroprotection both present and future. Explanations for the slow progress on pharmacologic neuroprotection during surgery are presented, Examples of technical advances that have had great impact on neuroprotection during surgery are given both from coronary artery stenosis surgery and from surgery for Parkinson's disease. To date, the progress in neuroprotection resulting from such technical advances is an order of magnitude greater than that resulting from pharmacologic agents used during surgery. The progress over the last 20 years in guidance during surgery (CT and MRT image-guidance) and in surgical access (endoscopic and endovascular techniques) will soon be complemented by advances in our ability to evaluate biological tissue intraoperatively in real-time. As an example of such technology, the NASA Smart Probe project is considered. In the long run (i.e., in 10 years or more), pharmacologic "agents" aimed at the complex pathophysiology of nervous system injury in man-will be-the key to true intraoperative neuroprotection. In the near term, however, it is more likely that mundane "agents" based on computers, microsensors, and microeffectors will be the major impetus to improved intraoperative neuroprotection.	Texas Tech Univ, Div Neurosurg, Hlth Sci Ctr, El Paso, TX 79905 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA		Andrews, RJ (corresponding author), Texas Tech Univ, Div Neurosurg, Hlth Sci Ctr, 4800 Alberta Ave, El Paso, TX 79905 USA.		Andrews, Russell/AAI-6319-2020				ADAMS RJ, 1995, STROKE, V26, P2216, DOI 10.1161/01.STR.26.12.2216; Andrews R, 1997, STEREOT FUNCT NEUROS, V68, P72, DOI 10.1159/000099906; Andrews RJ, 1997, ANN NY ACAD SCI, V825, P288, DOI 10.1111/j.1749-6632.1997.tb48440.x; ANDREWS RJ, 1996, INTRAOPERATIVE NEURO; Barbut D, 1997, ANN THORAC SURG, V63, P998, DOI 10.1016/S0003-4975(96)01254-4; BARBUT D, 1997, ANN THORAC SURG, V64, P545; BENABID AL, 1998, TXB STEREOTACTIC FUN, P1199; Bittl JA, 1996, NEW ENGL J MED, V335, P1290, DOI 10.1056/NEJM199610243351707; Chauhan A, 1998, CATHETER CARDIO DIAG, V43, P11; Diederich NJ, 1998, NEUROL CLIN, V16, P125, DOI 10.1016/S0733-8619(05)70370-4; DOPPENBERG EMR, 1997, ANN NY ACAD SCI, V825, P305; FELER CA, 1998, TXB STEREOTACTIC FUN, P1213; Friedman Allan, 1996, P3225; GILDENBERG PL, 1987, NEUROSURGERY, V20, P983, DOI 10.1227/00006123-198706000-00029; GILSBACH J, 1987, ACTA NEUROCHIR, V89, P77, DOI 10.1007/BF01406671; GOETZ CG, 1998, NEUROBASE; GOLD JP, 1995, J THORAC CARDIOV SUR, V110, P1302, DOI 10.1016/S0022-5223(95)70053-6; GROTTA J, 1994, CEREBROVASC DIS, V4, P115, DOI 10.1159/000108466; Hammon JW, 1997, ANN THORAC SURG, V63, P1613, DOI 10.1016/S0003-4975(97)00261-0; Kasner SE, 1997, ANN EMERG MED, V30, P642, DOI 10.1016/S0196-0644(97)70084-2; Kondziolka D, 1998, NEUROL CLIN, V16, P35, DOI 10.1016/S0733-8619(05)70366-2; Kulkarni AV, 1998, J NEUROSURG, V89, P31, DOI 10.3171/jns.1998.89.1.0031; Lindsay J, 1998, CATHETER CARDIO DIAG, V43, P1, DOI 10.1002/(SICI)1097-0304(199801)43:1<1::AID-CCD1>3.0.CO;2-F; MURKIN JM, 1996, ANESTH ANALG, V82, pS328; PULLAN LM, NEUROTHERAPEUTICS EM, P275; Rieke F., 1997, SPIKES EXPLORING NEU; SHAW PJ, 1985, BRIT MED J, V291, P1384, DOI 10.1136/bmj.291.6506.1384; SLUSHER BS, 1996, NEUROTHERAPEUTICS EM, P343; SOO TM, 1996, STEREOT FUNCT NEUROS, V64, P183; Young RF, 1998, J NEUROSURG, V89, P183, DOI 10.3171/jns.1998.89.2.0183	30	6	6	0	1	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-222-3	ANN NY ACAD SCI	Ann.NY Acad.Sci.		1999	890						59	72		10.1111/j.1749-6632.1999.tb07981.x			14	Biochemistry & Molecular Biology; Multidisciplinary Sciences; Clinical Neurology; Pharmacology & Pharmacy	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Science & Technology - Other Topics; Neurosciences & Neurology; Pharmacology & Pharmacy	BP50F	WOS:000085330700006	10668414				2022-02-06	
J	Souter, MJ; Andrews, PJD; Pereirinha, MR; Signorini, DF; Jones, PA; Miller, JD				Souter, MJ; Andrews, PJD; Pereirinha, MR; Signorini, DF; Jones, PA; Miller, JD			Delayed intracranial hypertension: Relationship to leukocyte count	CRITICAL CARE MEDICINE			English	Article						brain injury; coma; critical care; cytokines; hypotension; hypoxemia; intracranial hypertension; leukocytosis; monitoring; outcome	HEAD-INJURY; RAT-BRAIN; INTERLEUKIN-6 LEVELS; TRAUMATIC INJURY; INTENSIVE-CARE; CYTOKINES; TISSUE; IL-6; PRESSURE; PLASMA	Objective: Secondary intracranial hypertension has been linked to leukocytosis. We examined our data bank containing physiologic recordings and outcome data of severely head injured patients to investigate the relationship between delayed increases in intracranial pressure (ICP), defined as occurring after a 12-hr period of normal ICP values, and leukocytosis. Design: A retrospective study of observational data. Setting: Regional neurosurgical unit and intensive care unit. Patients: Sixty-four patients suffered increased ICP >20 mm Hg. Thirty-five patients fulfilled selection criteria for delayed increases in ICP (group 1). Twenty-nine patients with increased ICP with no preceding or intervening periods of normal ICP were selected as a comparison group (group 2). Measurements and Main Results: Comparison of 12-month outcome revealed that 11% of group 1 patients died, with 49% remaining severely disabled, in contrast to group 2, where 35% of patients died and 14% were left severely disabled (p =.021). The pattern of outcome was independent of monitoring time, or injury severity. Regression modeling was performed for prediction of delayed increase in ICP. Of 46 patients with an initial increase then decrease in leukocyte count in the first 48 hrs, 65% experienced delayed increases in ICP, as compared with 18% of the 11 patients without this pattern (p =.011). Conclusions: Patients with delayed increases have a significantly different pattern of outcome. Change in leukocyte count from admission to day 2 is a significant predictor of such a delayed increase.	Univ Edinburgh, Western Gen Hosp, Dept Anaesthesia, Edinburgh, Midlothian, Scotland; Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland; Hosp Santa Maria, Lisbon, Portugal		Souter, MJ (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Anaesthesia, Edinburgh, Midlothian, Scotland.		Souter, Michael/ABE-1890-2020				Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; BRAQUET P, 1989, INT ARCH ALLER A IMM, V88, P88, DOI 10.1159/000234755; CORTBUS F, 1994, ACTA NEUROCHIR, V130, P117, DOI 10.1007/BF01405511; Dalakas Marinos C., 1995, Annals of Neurology, V37, pS2; Damas P, 1997, CRIT CARE MED, V25, P405, DOI 10.1097/00003246-199703000-00006; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; GIULIAN D, 1989, J NEUROSCI, V9, P4416; HARIRI RJ, 1994, BRAIN RES, V636, P139, DOI 10.1016/0006-8993(94)90188-0; HIRANO T, 1990, IMMUNOL TODAY, V11, P443, DOI 10.1016/0167-5699(90)90173-7; HORI K, 1989, CANCER RES, V49, P2606; JENNETT B, 1975, LANCET, V1, P480; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; KALMOVARIN N, 1991, INFLAMMATION, V15, P369, DOI 10.1007/BF00917353; LUMPKIN MD, 1987, SCIENCE, V238, P452, DOI 10.1126/science.2821618; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; MATHIESEN T, 1993, J NEUROSURG, V78, P562, DOI 10.3171/jns.1993.78.4.0562; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; MILLER LG, 1991, MOL PHARMACOL, V39, P105; POBER JS, 1990, PHYSIOL REV, V70, P427, DOI 10.1152/physrev.1990.70.2.427; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; STAHL WM, 1987, CRIT CARE MED, V15, P545, DOI 10.1097/00003246-198706000-00001; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; YAMASAKI Y, 1992, NEUROSCI LETT, V142, P45, DOI 10.1016/0304-3940(92)90616-F; YATES DW, 1990, BRIT MED J, V301, P1090, DOI 10.1136/bmj.301.6760.1090; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375	32	6	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	JAN	1999	27	1					177	181		10.1097/00003246-199901000-00048			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	159ET	WOS:000078159400045	9934913				2022-02-06	
J	Golding, EM; Golding, RM				Golding, EM; Golding, RM			A mathematical assessment of the precision of parameters in measuring resonance spectra	JOURNAL OF MAGNETIC RESONANCE			English	Article						correlation length; correlated noise; errors; magnetic resonance spectroscopy; signal; standard deviations; traumatic head injury		The accurate interpretation of in vivo magnetic resonance spectroscopy (MRS) spectra requires a complete understanding of the associated noise-induced errors, In this paper, we address the effect of complex correlated noise patterns on the measurement of a set of peak parameters. This is examined initially at the level of a single spectral analysis followed by addressing the noise-induced errors associated with determining the signal parameters from the peak parameters. We describe a relatively simple method for calculating these errors for any correlated noise pattern in terms of the noise standard deviation and correlation length. The results are presented in such a way that an estimate of the errors may be made from a single MRS spectrum. We also explore how, under certain circumstances, the lineshape of the signal may be determined. We then apply these results to reexamine a set of in vivo P-31 MRS spectra obtained from rat brain prior to and following moderate fluid percussion injury. The approach outlined in this paper will demonstrate how meaningful results may be obtained from spectra where the signal-to-noise ratio (SNR) is quite small and where knowledge of the precise shape of the signal and the detail of the noise pattern is unknown, In essence, we show how to determine the expected errors in the spectral parameters from an estimate of the SNR from a single spectrum, thereby allowing a more discriminative interpretation of the data. (C) 1998 Academic Press.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Townsville Gen Hosp, Natl Unit Miltidisciplinary Studies Spinal Pain, Townsville, Qld 4810, Australia		Golding, EM (corresponding author), Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA.						CHEN L, 1986, CHEMOMETRICS INTELL, V0001, P00051; Ernst R.R., 1966, ADV MAGNETIC OPTICAL, V2, P1, DOI DOI 10.1016/B978-1-4832-3115-0.50008-9; GADIAN DG, 1982, NUCL MAGNETIZ REASON; Golding EM, 1996, MAGNET RESON MED, V35, P174, DOI 10.1002/mrm.1910350208; HAMILTON WC, 1964, STAT PHYSICAL SCI; INGWALL JS, 1982, AM J PHYSIOL, V242, pH729, DOI 10.1152/ajpheart.1982.242.5.H729; MAUDSLEY AA, 1995, J MAGN RESON SER B, V106, P47, DOI 10.1006/jmrb.1995.1007; POSENER DW, 1974, J MAGN RESON, V14, P121, DOI 10.1016/0022-2364(74)90266-2; Press WH., 1992, NUMERICAL RECIPES FO, V2; Priestley MB., 1981, SPECTRAL ANAL TIME S; SHAW D, 1976, FOURIER TRANSFORM NM; VINK R, 1988, J BIOL CHEM, V263, P757	12	6	6	0	0	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1090-7807			J MAGN RESON	J. Magn. Reson.	DEC	1998	135	2					380	405		10.1006/jmre.1998.1591			26	Biochemical Research Methods; Physics, Atomic, Molecular & Chemical; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Physics; Spectroscopy	151MZ	WOS:000077725400011	9878467				2022-02-06	
J	Gorlach, C; Benyo, Z; Wahl, M				Gorlach, C; Benyo, Z; Wahl, M			Reduced reactivity of the middle cerebral artery and its large branches after cold lesion	JOURNAL OF NEUROTRAUMA			English	Article						cortical lesion; endothelin; ETA receptor; ETB receptor; vascular reactivity	TRAUMATIC BRAIN INJURY; RAT BASILAR ARTERY; ENDOTHELIN RECEPTOR; NITRIC-OXIDE; BLOOD-FLOW; ISCHEMIA; MODEL; RELAXATION; RESPONSES; PLASMA	The aim of this study was to measure vascular reactivity in the isolated middle cerebral artery (MCA) after brain injury. Segments of MCA were prepared from control, sham-operated, and cold-lesioned rats. Cold lesion was induced by application of a precooled (-78 degrees C) copper cylinder (diameter 5 mm) for 60 sec to the intact dura over the parietal cortex. Endothelin-l (ET-1) (10(-12) to 3 x 10(-7) M) induced a dose-dependent contraction with a pot (-log(10) EC50) of 8.36 +/- 0.12 (mean +/- SEM) and an E-max (maximal response) of 2.41 +/- 0.15 mN (millinewton) at 10(-7) M in sham-operated animals under resting conditions. This maximum contraction induced by 10(-7) M ET-1 was significantly (p < 0.05) reduced 24 and 48 h after cold lesion by 41% and 30%, respectively. After precontraction with 10(-5) M prostaglandin (PG) F-2 alpha, ET-3 (10(-12) to 10(-8) M) relaxed the MCA with an E-max of 0.42 +/- 0.07 mN at 10(-8) M and a pD(2) of 9.20 +/- 0.19 in sham-operated animals. This relaxation was reduced 24 and 48 h after cold lesion by 19% and 62% at 10(-8) M, respectively. Concentration-effect curves for bradykinin (BK, 10(-8) to 10(-5) M) in uridine triphosphate (UTP, 10(-4) M)-precontracted MCA segments revealed relaxation with a pD(2) of 7.08 +/- 0.10 and an E-max of 0.65 +/- 0.06 mN at 10(-6) M in sham-treated animals. This effect of BK was reduced by 35% and 20% at 10(-6) M 24 and 48 h after cold lesion, respectively. In addition, the contractile responses to 124 mM K+, 10(-5) M PGF(2 alpha) and the dilation induced by 10(-3) sodium nitroprusside (SNP) were reduced in MCA segments taken 24 and 48 h after lesion compared with shams. We conclude that attenuation of ET effects can be explained, at least in part, by tachyphylaxis to ETs. The unspecific reduction of vascular reactivity may result from spreading depression.	Univ Munich, Inst Physiol, D-80336 Munich, Germany; Semmelweis Univ, Inst Physiol 2, Dept Expt Res, H-1085 Budapest, Hungary		Gorlach, C (corresponding author), Univ Munich, Inst Physiol, Pettenkoferstr 12, D-80336 Munich, Germany.		Benyo, Zoltan/C-9184-2009	Benyo, Zoltan/0000-0001-6015-0359			ADNER M, 1993, NEUROREPORT, V4, P441, DOI 10.1097/00001756-199304000-00026; Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; BARONE FC, 1994, J CEREBR BLOOD F MET, V14, P337, DOI 10.1038/jcbfm.1994.41; DIXON CE, 1991, J NEUROSCI METH, V39, P253; EHRENREICH H, 1995, CLEV CLIN J MED, V62, P105, DOI 10.3949/ccjm.62.2.105; EHRENREICH H, 1992, RES EXP MED, V192, P257, DOI 10.1007/BF02576282; ERISKAT J, 1994, ACTA NEUROCHIR, P425; FEGER GI, 1994, J CEREBR BLOOD F MET, V14, P845, DOI 10.1038/jcbfm.1994.106; Feger GI, 1997, RES EXP MED, V196, P327, DOI 10.1007/s004330050042; FEGER GI, 1998, THESIS U MUNICH GERM; FERRER M, 1992, BRAIN RES, V599, P186, DOI 10.1016/0006-8993(92)90390-U; FUKURODA T, 1994, BRIT J PHARMACOL, V113, P336, DOI 10.1111/j.1476-5381.1994.tb16901.x; Gorlach C, 1998, N-S ARCH PHARMACOL, V358, pR213; Gorlach C, 1996, PEPTIDES, V17, P1373, DOI 10.1016/S0196-9781(96)00223-9; Gorlach C, 1998, KIDNEY INT, V54, pS224; GORLACH C, 1998, IN PRESS J CEREB BLO, V18; KAUSER K, 1990, J PHARMACOL EXP THER, V252, P93; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LOFFLER BM, 1993, FEBS LETT, V333, P108, DOI 10.1016/0014-5793(93)80384-7; MACRAE IM, 1993, J CEREBR BLOOD F MET, V13, P276, DOI 10.1038/jcbfm.1993.34; Mathew P, 1996, J NEUROSURG, V85, P860, DOI 10.3171/jns.1996.85.5.0860; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MCKENZIE AL, 1955, J NEUROTRAUM, V12, P257; MITCHELL DE, 1973, LANCET, V2, P215; MURRAY MA, 1992, AM J PHYSIOL, V263, pH1643; Nag S, 1996, J NEUROPATH EXP NEUR, V55, P880, DOI 10.1097/00005072-199608000-00003; OBRENOVITCH TP, 1995, CEREBROVAS BRAIN MET, V7, P1; Patel TR, 1996, J CEREBR BLOOD F MET, V16, P679, DOI 10.1097/00004647-199607000-00019; ROBINSON MJ, 1990, J CEREBR BLOOD F MET, V10, P285, DOI 10.1038/jcbfm.1990.46; SALOM JB, 1993, BRIT J PHARMACOL, V109, P826, DOI 10.1111/j.1476-5381.1993.tb13649.x; Salzman SK, 1996, J NEUROTRAUM, V13, P93, DOI 10.1089/neu.1996.13.93; SCHILLING L, 1995, J CEREBR BLOOD F MET, V15, P699, DOI 10.1038/jcbfm.1995.86; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHARKEY J, 1993, J CEREBR BLOOD F MET, V13, P865, DOI 10.1038/jcbfm.1993.108; Stoffel M, 1997, J NEUROTRAUM, V14, P339, DOI 10.1089/neu.1997.14.339; SUDJARWO A, 1993, LIFE SCI, V53, P431, DOI 10.1016/0024-3205(93)90647-L; TEASDALE E, 1990, HDB CLIN NEUROLOGY, V13, P143; Touzani O, 1997, J CEREBR BLOOD F MET, V17, P1157, DOI 10.1097/00004647-199711000-00004; WAHL M, 1988, J CEREBR BLOOD F MET, V8, P621, DOI 10.1038/jcbfm.1988.109; WAHL M, 1987, BRAIN RES, V411, P72, DOI 10.1016/0006-8993(87)90682-2; YAMADA G, 1995, J CARDIOVASC PHARM, V26, pS486; ZIV I, 1992, STROKE, V23, P1014, DOI 10.1161/01.STR.23.7.1014	45	6	6	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	1998	15	12					1067	1075		10.1089/neu.1998.15.1067			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	148FW	WOS:000077495200007	9872463				2022-02-06	
J	Ito, J; Murata, M; Kawaguchi, S				Ito, J; Murata, M; Kawaguchi, S			Spontaneous regeneration and recovery of hearing function of the central auditory pathway in young rats	NEUROSCIENCE LETTERS			English	Article						regeneration; central auditory tract; rat; wheat germ agglutinin-conjugated horseradish peroxidase; fluorescent dye; auditory brain stem response	AXONAL REGENERATION; REPLACEMENT	Spontaneous regeneration of the auditory pathway after transecton of the ventral cochlear tract of the brain stem to pens was examined in young rats by the anterograde tracing method with wheat germ agglutinin-conjugated horseradish peroxidase. Care was taken to cut the tract as sharply as possible to minimize traumatic injuries. About 59% of the young rats examined showed successful regeneration. Functional recovery of hearing by the regenerated fibers was confirmed by the auditory brain stem response. Thus, the present findings contradict the widely held view that the mammalian central auditory system cannot be restored following damage. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.	Otsu Red Cross Hosp, Dept Otolaryngol, Otsu, Shiga 5200046, Japan; Kyoto Univ, Fac Med, Dept Integrat Brain Sci, Kyoto 6068501, Japan		Ito, J (corresponding author), Otsu Red Cross Hosp, Dept Otolaryngol, 1-1-35 Nagara, Otsu, Shiga 5200046, Japan.						ADLER HJ, 1995, J NEUROCYTOL, V24, P111, DOI 10.1007/BF01181554; AGUAYO AJ, 1983, BIRTH DEFECTS-ORIG, V19, P327; CAJAL S, 1928, DEGENERATION REGENER, P482; CLEMENTE CD, 1964, INT REV NEUROBIOL, V6, P257, DOI 10.1016/S0074-7742(08)60771-0; DEOLMOS J, 1977, NEUROSCI LETT, V6, P107, DOI 10.1016/0304-3940(77)90004-0; Inoue T, 1998, NEUROSCI LETT, V247, P151, DOI 10.1016/S0304-3940(98)00297-3; IWASHITA Y, 1994, NATURE, V367, P167, DOI 10.1038/367167a0; KAO CC, 1977, EXP NEUROL, V54, P591, DOI 10.1016/0014-4886(77)90259-X; KAWAGUCHI S, 1986, J COMP NEUROL, V245, P258, DOI 10.1002/cne.902450208; KIKUKAWA S, 1998, IN PRESS NEUROSCI LE; KROMER LF, 1980, BRAIN RES, V210, P173; LIPPE WR, 1991, HEARING RES, V56, P203, DOI 10.1016/0378-5955(91)90171-5	12	6	6	0	2	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	OCT 2	1998	254	3					173	176		10.1016/S0304-3940(98)00694-6			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128GH	WOS:000076397000013	10214985				2022-02-06	
J	Fabiano, RJ; Daugherty, J				Fabiano, RJ; Daugherty, J			Rehabilitation considerations following mild traumatic brain injury	JOURNAL OF REHABILITATION			English	Article							HEAD-INJURY; POPULATION; IMPAIRMENT; SYMPTOMS	Traumatic brain injuries occur at epidemic rates with annual incidence in the United States reported at several million (Berker, 1996). The majority of these injuries are classified as mild in severity (Gamboa, 1994). Many who suffer mild traumatic brain injury experience impairments in cognitive and psychological functioning that can impede employment, resulting in decreased performance and frequent job changes. Efficient and effective rehabilitation is imperative for reducing the personal and economic losses associated with mild traumatic brain injury. An overview of rehabilitation following mild traumatic brain injury is provided, with emphasis on the contribution of neuropsychological assessment to the rehabilitation process, types of rehabilitation services that can be usefully employed, and the critical role of vocational rehabilitation.	Michigan State Univ, E Lansing, MI 48824 USA		Fabiano, RJ (corresponding author), PAR Rehab Serv, 780 W Lake Lansing Rd,Suite 300, E Lansing, MI 48823 USA.						Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; ARONOW HU, 1987, J HEAD INJURY REHABI, V2, P24; Bergquist TF, 1994, J HEAD TRAUMA REHAB, V9, P50, DOI 10.1097/00001199-199412000-00007; Berker E, 1996, INT J NEUROSCI, V85, P195, DOI 10.3109/00207459608986683; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BROOKS CA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199508000-00002; CLEMENTS AD, 1997, J REHABILITATION JAN, P3; CONBOY TJ, 1986, REHABIL PSYCHOL, V31, P203, DOI 10.1037//0090-5550.31.4.203; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Denny-Brown D., 1942, NEW ENGL J MED, V227, P771; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dixon CE, 1993, J HEAD TRAUMA REHAB, V8, P1; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; GAMBOA AM, 1994, ANAL UNDERSTANDING P; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; HALL K, 1995, COST EFFECTIVENESS E; JENNETT B, 1976, NEW ZEAL MED J, V84, P144; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; KAY T, 1991, MINOR HEAD INJURY IN; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Kreutzer JS, 1990, COMMUNITY INTEGRATIO; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McGrath J, 1997, NEUROPSYCHOL REHABIL, V7, P231, DOI 10.1080/713755532; MCMAHON B, 1987, BUSINESS HLTH; MILLER L, 1996, J COGNITIVE REHABILI, V1, P8; POSTHUMA A, 1988, COGNITIVE REHABILITA, V6, P22; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; RUFF RM, 1990, COMMUNITY FOLLOWING, P85; SACHS PR, 1993, REHABIL PSYCHOL, V38, P87, DOI 10.1037/h0080294; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; SOHBERG MM, 1989, INTRO COGNITIVE REHA; Strauss I, 1934, ARCH NEURO PSYCHIATR, V31, P893, DOI 10.1001/archneurpsyc.1934.02250050011001; SWEENEY JE, 1992, CLIN NEUROPSYCHOL, V6, P443, DOI 10.1080/13854049208401870; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VOGENTHALER DR, 1987, JI REHABILITATION, V4, P21; Wood R. L., 1987, BRAIN INJURY REHABIL; [No title captured]	41	6	9	0	1	NATL REHABILITATION ASSN-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	OCT-DEC	1998	64	4					9	14					6	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	141BT	WOS:000077123300003					2022-02-06	
J	Kitagawa, H; Setoguchi, Y; Fukuchi, Y; Mitsumoto, Y; Koga, N; Mori, T; Abe, K				Kitagawa, H; Setoguchi, Y; Fukuchi, Y; Mitsumoto, Y; Koga, N; Mori, T; Abe, K			DNA fragmentation and HSP72 gene expression by adenovirus-mediated gene transfer in postischemic gerbil hippocampus and ventricle	METABOLIC BRAIN DISEASE			English	Article						gene transfer; lacZ gene; ischemia; apoptosis	DELAYED NEURONAL DEATH; INTERLEUKIN-1 RECEPTOR ANTAGONIST; TRANSIENT FOREBRAIN ISCHEMIA; GLOBAL-ISCHEMIA; RAT-BRAIN; TEMPORAL PROFILE; MESSENGER-RNA; VECTOR; CELL; APOPTOSIS	A replication defective adenoviral vector containing the E. coli lacZ gene (AdCMVnLacZ) was directly injected into right hippocampus and lateral ventricle immediately after 5 min of transient global ischemia in gerbils. The relations between the lacZ gene expression and DNA fragmentation or heat shock protein 72 (HSP72) immunoreactivity were examined up to 21 days post ischemia. The lacZ gene was transiently expressed at 1 day in the hippocampus except around the CA1 region, while a large number of the periventricular cells strongly expressed the lacZ gene from 8 h to 7 days. In CA1 layer, terminal deoxynucleotidyl dUTP nick end labeling (TUNEL) positive cells, which were present only adjacent to the needle track at 8 h to 1 day, became more extensive in the whole CAI layer at 3 to 7 days. TUNEL-positive cells were also detected around the DG at 1 day, around the needle track at 8 h to 3 days, and in the choroid plexus cells at 7 days. HSP72 staining was detected in the subiculum at 1 to 3 days, the dentate granule cells at 8 h to 1 day, and in the CA3 or CA4 pyramidal cells at 1 to 3 days. Some lacZ expressing cells were double-positive with HSP72 in DG, while the majority of those were distinguished from the TUNEL-positive cells. Pyramidal neurons were almost completely lost in the CAI sector at 7 days after the ischemia. The present study demonstrates the successful LacZ gene transfer into the hippocampus and ventricle of postischemic gerbil brain except in the vulnerable CA1 layer by adenoviral vector injection. However, adenovirus-mediated gene transfer may induce indirect apoptotic cell death in the DG and ventricle, in addition to direct traumatic injury around the needle track.	Okayama Univ, Sch Med, Dept Neurol, Okayama 7008558, Japan; Otsuka Pharmaceut Co Ltd, Tokushima New Drug Res Inst, Tokushima 77101, Japan; Juntendo Univ, Sch Med, Dept Resp Med, Tokyo 113, Japan		Abe, K (corresponding author), Okayama Univ, Sch Med, Dept Neurol, 2-5-1 Shikatacho, Okayama 7008558, Japan.		Setoguchi, Yasuhiro/AAE-1448-2021	Setoguchi, Yasuhiro/0000-0002-0892-6364; Koga, Nobuyuki/0000-0001-8034-7984			ABE K, 1991, NEUROSCI LETT, V125, P166, DOI 10.1016/0304-3940(91)90018-O; Abe K, 1997, NEUROSCI LETT, V226, P53, DOI 10.1016/S0304-3940(97)00243-7; Abe K, 1997, BRAIN RES, V763, P191, DOI 10.1016/S0006-8993(97)00389-2; ABE K, 1995, STROKE, V26, P1478, DOI 10.1161/01.STR.26.8.1478; AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; BAJOCCHI G, 1993, NAT GENET, V3, P229, DOI 10.1038/ng0393-229; BETZ AL, 1995, J CEREBR BLOOD F MET, V15, P547, DOI 10.1038/jcbfm.1995.68; BilangBleuel A, 1997, P NATL ACAD SCI USA, V94, P8818, DOI 10.1073/pnas.94.16.8818; BREAKEFIELD XO, 1993, NAT GENET, V3, P187, DOI 10.1038/ng0393-187; BYRNES AP, 1995, NEUROSCIENCE, V66, P1015, DOI 10.1016/0306-4522(95)00068-T; CharriautMarlangue C, 1996, J CEREBR BLOOD F MET, V16, P186, DOI 10.1097/00004647-199603000-00002; Chen J, 1997, J CEREBR BLOOD F MET, V17, P2, DOI 10.1097/00004647-199701000-00002; DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219; DESHPANDE J, 1992, EXP BRAIN RES, V88, P91, DOI 10.1007/BF02259131; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Heistad DD, 1996, STROKE, V27, P1688, DOI 10.1161/01.STR.27.9.1688; Honkaniemi J, 1996, MOL BRAIN RES, V42, P79, DOI 10.1016/S0169-328X(96)00121-0; IWAI T, 1995, BRAIN RES, V671, P305, DOI 10.1016/0006-8993(94)01363-M; KAWAGOE J, 1992, J CEREBR BLOOD F MET, V12, P794, DOI 10.1038/jcbfm.1992.110; KIHARA S, 1994, NEUROSCI LETT, V175, P133, DOI 10.1016/0304-3940(94)91097-9; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; LASALLE GL, 1993, SCIENCE, V259, P988, DOI 10.1126/science.8382374; LEE TH, 1994, STROKE, V25, P1425, DOI 10.1161/01.STR.25.7.1425; LI Y, 1995, J CEREBR BLOOD F MET, V15, P389, DOI 10.1038/jcbfm.1995.49; MACMANUS JP, 1995, J CEREBR BLOOD F MET, V15, P728, DOI 10.1038/jcbfm.1995.93; MACMANUS JP, 1993, NEUROSCI LETT, V164, P89, DOI 10.1016/0304-3940(93)90864-H; Newman KD, 1995, J CLIN INVEST, V96, P2955, DOI 10.1172/JCI118367; NITATORI T, 1995, J NEUROSCI, V15, P1001; NOWAK TS, 1991, J CEREBR BLOOD F MET, V11, P432, DOI 10.1038/jcbfm.1991.84; Petito CK, 1997, J CEREBR BLOOD F MET, V17, P967, DOI 10.1097/00004647-199709000-00006; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; SEI Y, 1994, NEUROSCI LETT, V171, P179, DOI 10.1016/0304-3940(94)90634-3; SETOGUCHI Y, 1994, BLOOD, V84, P2946; States BA, 1996, J CEREBR BLOOD F MET, V16, P1165, DOI 10.1097/00004647-199611000-00011; THILMANN R, 1986, ACTA NEUROPATHOL, V71, P88, DOI 10.1007/BF00687967; VASS K, 1988, ACTA NEUROPATHOL, V77, P128; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; Yang GY, 1997, BRAIN RES, V751, P181, DOI 10.1016/S0006-8993(96)01277-2; YOSHIDOMI M, 1989, J NEUROCHEM, V53, P137	41	6	6	0	1	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490			METAB BRAIN DIS	Metab. Brain Dis.	SEP	1998	13	3					211	223		10.1023/A:1023224025407			13	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	130AH	WOS:000076496400004	9804366				2022-02-06	
J	Jamali, S; Bodjarian, N; Vigue, B; Mazoit, JX; Samii, K; Tadie, M				Jamali, S; Bodjarian, N; Vigue, B; Mazoit, JX; Samii, K; Tadie, M			Increase in the chronically monitored cerebrospinal fluid pressure after experimental brain injury in rats	BRAIN INJURY			English	Article							ACUTE SUBDURAL-HEMATOMA; DIFFUSE AXONAL INJURY; CEREBRAL BLOOD-FLOW; INTRACRANIAL-PRESSURE; HEAD-INJURY; SUBARACHNOID HEMORRHAGE; ANIMAL-MODEL; SECONDARY; DYNAMICS; HYPOXIA	The early effects of experimental brain injury with diffuse axonal lesions on intracranial pressure (ICP), mean arterial pressure (MAP) and cerebral perfusion pressure (CPP) in rats have been already studied. The aim of this experiment was to examine the effects of brain injury on ICP, MAP and CPP during the first few days post-injury. In order to do that, an accurate technique of ICP measurement had to be developed. In a series of eight rats, a translumbar intrathecal catheter (TIC) was surgically introduced allowing repeated measurements of cerebrospinal fluid pressure (CSFP). Under anaesthesia, a second series of nine rats were equipped simultaneously with TIC and an intracranial fiberoptic device to measure ICP. Simultaneous measurements of CSFP and ICP were recorded for baseline values, than during and after jugular compression which was intended to induce an acute and significant increase in ICP. A third series of 53 rats having TIC received an experimental severe brain injury. MAP was measured non-invasively and CPP was calculated as CPP - MAP. CSFP, MAP and CPP were intermittently measured during 5-6 post-traumatic days and compared to the values obtained during ten control rats (SHAM). A clinical score was used to compare clinical condition. The results showed that the translumbar CSFP accurately measured ICP in rats having normal or acutely increased ICP. The experimental brain injury induced increased CSFP lasting up to 5-6 days, with increased MAP during the first 6 hours. CPP Values were compromised at 24-48 hours. The clinical performance was reduced in the brain-injured rats. The translumbar technique of CSFP measurement reflected exact ICP in normal and acutely increased ICP in rats. Experimental brain injury with diffuse axonal lesions can increase lumbar CSFP in rats for many days.	Univ Paris 11, Fac Med Paris Sud, Lab Expt Neurosurg, Le Kremlin Bicetre, France; Univ Paris 11, Fac Med Paris Sud, Lab Anesthesiol, Le Kremlin Bicetre, France		Jamali, S (corresponding author), Hop Bicetre, Dept Anesthesiol Reanimat Chirurg, 78 Av Gl Leclerc, F-94275 Le Kremlin Bicetre, France.						ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ANDREWS B T, 1988, Neurological Research, V10, P123; BARTH KNM, 1992, NEUROSURGERY, V30, P138, DOI 10.1227/00006123-199201000-00028; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOTEL C, 1994, J EXP ANIM SCI, V36, P78; BROCK M, 1972, LANCET, V1, P595; DOCZI T, 1986, NEUROSURGERY, V18, P733, DOI 10.1227/00006123-198606000-00010; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; FRERICHS KU, 1985, J CEREBRAL BLOOD FLO, V5, P420; Giulioni M, 1986, J Neurosurg Sci, V30, P177; HAYES KC, 1970, J APPL PHYSIOL, V28, P872, DOI 10.1152/jappl.1970.28.6.872; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; KITA H, 1994, ACTA NEUROCHIR, P452; KOEDEL U, 1994, BRAIN RES, V644, P25, DOI 10.1016/0006-8993(94)90342-5; KURODA Y, 1994, NEUROSURGERY, V35, P106, DOI 10.1227/00006123-199407000-00016; LEROUX PD, 1991, CHILD NERV SYST, V7, P34, DOI 10.1007/BF00263831; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; MORIMOTO Y, 1993, CRIT CARE MED, V21, P104, DOI 10.1097/00003246-199301000-00020; NAKAMURA K, 1987, HYPERTENSION, V10, P635, DOI 10.1161/01.HYP.10.6.635; NATH FP, 1986, J NEUROSURG, V65, P697, DOI 10.3171/jns.1986.65.5.0697; PLANGGER C, 1992, ACTA NEUROL SCAND, V86, P252, DOI 10.1111/j.1600-0404.1992.tb05080.x; RAHIMIFAR M, 1989, J NEUROSURG, V70, P932, DOI 10.3171/jns.1989.70.6.0932; SEVERS WB, 1991, AVIAT SPACE ENVIR MD, V62, P944; SHAH V, 1993, HEPATOLOGY, V17, P1117, DOI 10.1016/0270-9139(93)90131-6; SHORT BL, 1994, CRIT CARE MED, V22, P1262, DOI 10.1097/00003246-199408000-00010; SOLOMON RA, 1985, STROKE, V16, P58, DOI 10.1161/01.STR.16.1.58; VERLOOY J, 1990, J NEUROSCI METH, V31, P1, DOI 10.1016/0165-0270(90)90002-W; YANG YB, 1993, J APPL PHYSIOL, V74, P2067, DOI 10.1152/jappl.1993.74.5.2067	32	6	6	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	1998	12	6					525	536		10.1080/026990598122485			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	ZU400	WOS:000074193300008	9638329				2022-02-06	
J	Malina, AC; Bowers, DA; Millis, SR; Uekert, S				Malina, AC; Bowers, DA; Millis, SR; Uekert, S			Internal consistency of the Warrington Recognition Memory Test	PERCEPTUAL AND MOTOR SKILLS			English	Article							WORDS; FACES	The Recognition Memory Test is frequently used to assess memory; however, one of the commonly cited limitations is a lack of data on reliability. The current study was undertaken to estimate the internal consistency reliability of the test with a sample of 72 persons with traumatic brain injury. Acceptable estimates of internal consistency for both subtests were obtained.	Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Detroit, MI 48202 USA		Malina, AC (corresponding author), Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, 261 Mack Blvd, Detroit, MI 48201 USA.						ADAMS RL, 1989, 10 MENTAL MEASUREMEN, P313; Aggleton JP, 1996, NEUROPSYCHOLOGIA, V34, P51, DOI 10.1016/0028-3932(95)00150-6; Baxendale SA, 1997, NEUROPSYCHOLOGIA, V35, P591, DOI 10.1016/S0028-3932(96)00123-6; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; DIESFELDT H, 1989, BRIT J CLIN PSYCHOL, V28, P247, DOI 10.1111/j.2044-8260.1989.tb01374.x; HERMANN BP, 1995, J EPILEPSY, V8, P139, DOI 10.1016/0896-6974(95)00022-6; KAPUR N, 1987, BRIT J CLIN PSYCHOL, V26, P144, DOI 10.1111/j.2044-8260.1987.tb00741.x; LENG NR, 1990, CLIN REHABIL, V4, P159; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MORRIS RG, 1995, BRIT J CLIN PSYCHOL, V34, P571, DOI 10.1111/j.2044-8260.1995.tb01490.x; Norusis Marija., 1993, SPSS WINDOWS PROFESS; RAPSCAK SZ, 1994, CORTEX, V30, P565; Warrington E, 1984, RECOGNITION MEMORY T, V1	14	6	6	1	4	PERCEPTUAL MOTOR SKILLS	MISSOULA	PO BOX 9229, MISSOULA, MT 59807 USA	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	JUN	1998	86	3	2				1320	1322		10.2466/pms.1998.86.3c.1320			3	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	105BD	WOS:000075051600034	9700808				2022-02-06	
J	Turkstra, LS				Turkstra, LS			The effect of stimulus presentation rate on syntax test performance in brain-injured adolescents	APHASIOLOGY			English	Article							CLOSED-HEAD-INJURY; WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; CHILDREN; COMPREHENSION; ADULTS; DISCOURSE; DEFICITS	The purpose of this study was to explore how testing procedure influences performance after traumatic brain injury, and how this influence varies as a function of the subject's information-processing abilities. Twelve brain-injured subjects completed three versions of the Listening/Grammar subtest of the Test of Adolescent Language. In the first condition, sentences were presented at 2-s intervals, in the second at 4-s intervals, and in the third at variable intervals controlled by the subject. Scores in each condition were correlated with measures of working memory storage and processing ability. Performance in the 2-s condition was significantly influenced by working memory processing ability, whereas performance in the 4-s condition was significantly influenced by working memory storage ability. Both aspects of working memory contributed to performance in the variable condition, although only processing was significant. As a group, subjects with better working memory processing ability preferred the variable interval condition, which allowed greater flexibility, while subjects with poor processing ability found it more difficult. The results are discussed in terms of clinical assessment and intervention.	Univ Arizona, Tucson, AZ USA		Turkstra, LS (corresponding author), Case Western Reserve Univ, Dept Commun Sci, 11206 Euclid Ave, Cleveland, OH 44106 USA.		Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921			ABEL SM, 1972, J ACOUST SOC AM, V51, P1219, DOI 10.1121/1.1912963; BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; Blosser J L, 1992, Clin Commun Disord, V2, P52; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CROSSON B, 1993, CLIN NEUROPSYCHOL, V7, P250, DOI 10.1080/13854049308401897; Daneman M, 1996, PSYCHON B REV, V3, P422, DOI 10.3758/BF03214546; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; GAULIN CA, 1994, PERCEPT MOTOR SKILL, V79, P55, DOI 10.2466/pms.1994.79.1.55; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; HAMMILL D, 1991, DETROIT TESTS LEARNI; Hammill D. D., 1994, TEST ADOLESCENT ADUL; HARTLEY LL, 1995, COGNITIVECOMMUNICATI; HAUT MW, 1991, BRAIN COGNITION, V17, P31, DOI 10.1016/0278-2626(91)90064-F; JENNETT B, 1975, LANCET, V1, P480; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; MIYAKE A, 1994, COGNITIVE NEUROPSYCH, V11, P671, DOI 10.1080/02643299408251989; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; ROST M, 1990, LISTENING LANGUAGE L; ROYER JM, 1981, CONTEMP EDUC PSYCHOL, V6, P187, DOI 10.1016/0361-476X(81)90001-1; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; SEMEL W, 1995, CLIN EVALUATION LANG; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; TOMPKINS CA, 1994, J SPEECH HEAR RES, V37, P896, DOI 10.1044/jshr.3704.896; TROMP E, 1991, J CLIN EXP NEUROPSYC, V13, P821, DOI 10.1080/01688639108405100; TURKSTRA LS, 1997, UNPUB SUPPLEMENTARY; TURKSTRA LS, 1998, IN PRESS J SPEECH HE; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; YLVISAKER M, 1989, TOP LANG DISORD, V9, P34, DOI 10.1097/00011363-198903000-00005	33	6	6	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0268-7038			APHASIOLOGY	Aphasiology	JUN	1998	12	6					421	433		10.1080/02687039808249541			13	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	ZM372	WOS:000073531900001					2022-02-06	
J	Donders, J				Donders, J			Performance discrepancies between the Children's Category Test (CCT) and the California Verbal Learning Test Children's (CVLT-C) version in the standardization sample	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						assessment; learning ability; test score discrepancies	TRAUMATIC BRAIN INJURY; INTERMEDIATE	Standardization data for the Children's Category Test (CCT) and California Verbal Learning Test-Children's Version (CVLT-C) were used to evaluate covariances and statistically significant discrepancies between the T scores of those instruments, as well as the base rate of specific discrepancies. The results indicate that the CCT and CVLT-C share only a limited amount of common variance and that statistically significant discrepancies between the respective T scores are actually quite common. It is suggested that evaluation of the potential clinical significance of a discrepancy between the obtained results of these two instruments in individual cases should include consideration of the presented base rates.	Mary Free Bed Hosp, Psychol Serv, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.						BOLL T, 1993, CHILDRENS CATEGORY T; BORNSTEIN RA, 1989, PSYCHOL ASSESSMENT J, V1, P203; DELIS D, 1994, CALIFORNIA VERBAL LE; DELIS D, 1987, CALIFORNIA VERBAL LE; Donders J, 1996, ARCH CLIN NEUROPSYCH, V11, P131, DOI 10.1016/0887-6177(95)00005-4; Donders J, 1995, CHILD NEUROPSYCHOL, V1, P19, DOI 10.1080/09297049508401339; Fletcher JM, 1995, HDB PEDIAT PSYCHOL, P362; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; MATARAZZO JD, 1984, HDB INTELLIGENCE THE, P899; Mittenberg W, 1991, PSYCHOL ASSESS, V3, P492; Reitan R. M., 1992, NEUROPSYCHOLOGICAL E; REYNOLDS CR, 1984, J SPEC EDUC, V18, P451, DOI 10.1177/002246698401800403; SILVERSTEIN AB, 1981, J CLIN PSYCHOL, V37, P392, DOI 10.1002/1097-4679(198104)37:2<392::AID-JCLP2270370230>3.0.CO;2-8; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Ylvisaker M., 1994, ED DIMENSIONS ACQUIR, P69; [No title captured]	17	6	6	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	1998	4	3					242	246		10.1017/S1355617798002422			5	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	103FA	WOS:000075146400002	9622999				2022-02-06	
J	McHenry, MA				McHenry, MA			Velopharyngeal airway resistance disorders after traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							HEAD-INJURY; DYSARTHRIA	Objective: Disorders affecting velopharyngeal port closure may result in the perception of hypernasality. This study was designed to determine (1) the incidence of velopharyngeal airway resistance deficits after traumatic brain injury, (2) the relation between velopharyngeal airway resistance and dysarthria severity, and (3) the relation between velopharyngeal airway resistance and perceived hypernasality. Design: Case series. Setting: Community re-entry residential rehabilitation program. Patients: Eighty-three consecutive referrals for speech production evaluations. Main Outcome Measures: Velopharyngeal airway resistance at the time of the evaluation. Results: About half the patients evidenced reduced velopharyngeal airway resistance. Subjects who evidenced mild or absent dysarthria typically had no velopharyngeal deficits, while subjects who evidenced severe dysarthria had very low velopharyngeal airway resistance. With few exceptions, the severity of the velopharyngeal airway resistance deficit was associated with perceived hypernasality. Conclusions: Velopharyngeal airway resistance disorders after traumatic brain injury are common. Discrepancies between velopharyngeal airway resistance and perceived hypernasality may be caused by intelligibility, speaking style, or nonrepresentative sampling. (C) 1998 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	Galveston Inst Human Commun, Transit Learning Community, Galveston, TX USA		McHenry, MA (corresponding author), 1528 Postoff St, Galveston, TX 77553 USA.						BARLOW S M, 1989, Journal of Voice, V3, P283, DOI 10.1016/S0892-1997(89)80050-5; BARLOW SM, 1991, J COMPUTER USERS SPE, V7, P211; ENDERBY P, 1990, BRIT J DISORD COMMUN, V25, P341; HORII Y, 1981, CLEFT PALATE J, V18, P279; KENT RD, 1989, J SPEECH HEAR DISORD, V54, P482, DOI 10.1044/jshd.5404.482; MCHENRY M, 1994, BRAIN INJURY, V8, P363, DOI 10.3109/02699059409150987; MCHENRY M, 1996, M AM SPEECH LANG HEA; MCHENRY MA, 1994, J MED SPEECH-LANG PA, V2, P59; THEODOROS D, 1993, BRAIN INJURY, V7, P59, DOI 10.3109/02699059309008157; WORKINGER M S, 1992, Brain Injury, V6, P183, DOI 10.3109/02699059209029657; Yorkston K., 1984, COMPUTERIZED ASSESSM	11	6	6	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	1998	79	5					545	549		10.1016/S0003-9993(98)90071-5			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	ZM198	WOS:000073514500013	9596397				2022-02-06	
J	Levi, L; Guilburd, JN; Bar-Yosef, G; Zaaroor, M; Soustiel, JF; Feinsod, M				Levi, L; Guilburd, JN; Bar-Yosef, G; Zaaroor, M; Soustiel, JF; Feinsod, M			Severe head injury in children - analyzing the better outcome over a decade and the role of major improvements in intensive care	CHILDS NERVOUS SYSTEM			English	Article						brain injury, severe; children prognosis; intensive care	COMA DATA-BANK; TRAUMATIC COMA; PROGNOSIS	We suggest a few possible explanations, including improvement of intensive care, as the main cause, for the improved outcome after severe head injury in children and present the predictors of outcome observed in a contemporary series. From January 1984 to June 1988 we saw 117 children (ages 0-14) with postresuscitation GCS (Glasgow Come Scale) scores of 3-8. The more recent cohort of children seen in 1994-1996 vias made up of 152 patients. Apart from standard statistics we used a segmentation method called CHAID (SSPS software). Previously known predictors of outcome are found still to apply in our series. Although in the recent period there was a lower proportion of patients with GCS 3-4(11% versus 32%), a higher percentage had suffered multiple trauma (56% versus 33%). The rates. of craniotomy and of ICP monitoring were similar (66% and 61%). Comparison of the two cohorts for outcome at discharge and through 1 year shows that mortality fell from 33% to 10% and the proportion achieving improvement of neurological status increased from 24% to 56%. CHAID analysis showed that the mortality rates of patients within specific groups declined significantly over the two periods: (1) a significant reduction in mortality was seen in patients with GCS 5-7, especially those with diffuse axonal injury (DAI) (17.3% to 0%); (2) no child admitted in shock survived in the earlier period, whereas 7 with GCS 4-6 survived during the recent period. Thr best model for mortality prediction includes GCS, and in the GCS 4-7 subgroup, the presence of subdural hematoma. It seems that the trend toward better immediate outcome is continuous, and this is the more striking when the severity of injury is taken into consideration. Our belief is that the modern medical and surgical techniques, although incurring higher costs and necessitating ongoing intensity, are well worth the effort.	Technion Israel Inst Technol, Fac Med, Rambam Med Ctr, Dept Neurosurg, Haifa, Israel		Levi, L (corresponding author), Technion Israel Inst Technol, Fac Med, Rambam Med Ctr, Dept Neurosurg, POB 7091, Haifa, Israel.						ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; BENSARD DD, 1994, J PEDIATR SURG, V29, P11, DOI 10.1016/0022-3468(94)90514-2; BORN JD, 1985, NEUROSURGERY, V16, P595, DOI 10.1227/00006123-198505000-00002; FROWEIN RA, 1992, J NEUROSURG, V76, pA397; Hall JR, 1996, J PEDIATR SURG, V31, P72, DOI 10.1016/S0022-3468(96)90322-X; Hill DA, 1997, J TRAUMA, V42, P62, DOI 10.1097/00005373-199701000-00011; KUMAR R, 1991, CHILD NERV SYST, V7, P299, DOI 10.1007/BF00304824; LAICHOO O, 1996, PEDIATR NEUROSURG, V24, P285; LEVI L, 1989, NEUROEPIDEMIOLOGY, V8, P316, DOI 10.1159/000110200; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LUERSSEN TG, 1995, PEDIATR NEUROSURG, V23, P34, DOI 10.1159/000120933; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; QUIGLEY J, 1997, J TRAUMA, V42, P7; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WALD SL, 1992, J NEUROSURG, V76, pA397; WARME PE, 1991, ACTA NEUROCHIR, V110, P57, DOI 10.1007/BF01402049; ZUCCARELLO M, 1985, CHILD NERV SYST, V1, P158, DOI 10.1007/BF00735731	21	6	8	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	APR-MAY	1998	14	4-5					195	202		10.1007/s003810050210			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	ZT407	WOS:000074082600012	9660122				2022-02-06	
J	Quigley, PA; Smith, SW; Strugar, J				Quigley, PA; Smith, SW; Strugar, J			Successful experiences with clinical pathways in rehabilitation	JOURNAL OF REHABILITATION			English	Article								Rehabilitation professionals from the Veterans Affairs Hospital (VAH) in Tampa, Florida, have four years of experience developing, utilizing and revising clinical pathways specific to most frequent rehabilitation admission diagnoses (such as strokes, traumatic brain injury, and pain diagnoses) of clients requiring comprehensive inpatient rehabilitation. The preparation, framework, and experiences of rehabilitation professionals using clinical pathways as the core method of operation are presented in this article. In addition, this article describes the interdisciplinary process utilized to develop and implement the clinical pathways for stroke and traumatic brain injury patients, and discusses the outcomes experienced by rehabilitation professionals. These clinical pathways focus on outcomes rather than process, Outcome measures are specific to program evaluation outcomes and include access to programs, functional status gains, length of stay, and length of stay efficiency. This article challenges readers to question clinical pathways that specify processes rather than outcomes, and argues the benefit of outcome-specific clinical pathways for use in rehabilitation settings.	James A Haley Vet Hosp, Tampa, FL 33612 USA		Quigley, PA (corresponding author), James A Haley Vet Hosp, 118-673,13000 N 30th St, Tampa, FL 33612 USA.						FALCONER J, 1993, ORB              JAN, P8; Heacock D, 1994, J Nurs Care Qual, V8, P38; IRRANG J, 1995, ORTHOP CLIN N AM, V26, P561; *NAT CTR COST CONT, 1997, OUTC STROK AMP ALG I; PARKER A, 1972, MONOGRAPH U EXTENSIO, V3; ROMITO D, 1990, REHABILITATION NURSI, V15, P154; Ross Gary, 1997, Journal of the American Osteopathic Association, V97, P269; *UB FDN ACT INC, 1992, UN DAT SYST MED REH; WENDLAND C, 1976, TEAM DELIVERY PRIMAR	9	6	6	0	1	NATL REHABILITATION ASSN-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	APR-JUN	1998	64	2					29	32					4	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	114TN	WOS:000075625400006					2022-02-06	
J	Goldberg, G; Karazim, E				Goldberg, G; Karazim, E			Application of evoked potentials to the prediction of discharge status in minimally responsive patients: A pilot study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						evoked potentials; prognosis; traumatic brain injury	PERSISTENT VEGETATIVE STATE; SEVERE HEAD-INJURY; COMATOSE PATIENTS; OUTCOME PREDICTION; ANOXIC COMA; CLINICAL EXAMINATION; PROGNOSTIC VALUE; BRAIN INJURY; TRAUMA; SCALE	Evoked potentials (EPs) have been shown to have useful prognostic value during the acute phase of traumatic and anoxic coma. We have hypothesized that EPs obtained in the subacute phase can be used to assess prognosis for functional recovery in minimally responsive patients with diffuse brain damage due to either brain trauma or anoxia. This pilot study correlated graded brainstem auditory evoked potentials (BAEPs) and upper extremity somatosensory evoked potentials (UESSEPs) with outcome grade based on the discharge Disability Rating Scale (DRS) score of 33 patients admitted to a responsiveness assessment program of a brain injury rehabilitation unit with an initial DRS score of 22 or greater. Results indicated a significant correlation with outcome grade for both the BAEP grade (P < .02) and the UESSEP grade (P < .02). The BAEP had a higher sensitivity and lower specificity, as false-positive exceeded false-negative predictions. The UESSEP tended to predict outcome more accurately and with a balanced number of false-positive and false-negative predictions. EPs were also found to be useful for detecting occult impairment of sensory function. This pilot study demonstrates that EPs performed near the time of admission to the rehabilitation unit can be useful in guiding the rehabilitation management of the minimally responsive patient by helping to predict functional recovery and to detect occult impairment of sensory systems.	Temple Univ, Sch Med, Moss Rehab Hosp,Dept Phys Med & Rehabil, Drucker Brain Injury Ctr,Electrodiagnost Ctr, Philadelphia, PA 19141 USA; Allied Serv Hosp, Dept Phys Med & Rehabil, Scranton, PA USA		Goldberg, G (corresponding author), Temple Univ, Sch Med, Moss Rehab Hosp,Dept Phys Med & Rehabil, Drucker Brain Injury Ctr,Electrodiagnost Ctr, 1200 W Tabor Rd, Philadelphia, PA 19141 USA.	goldberg@vm.temple.edu					ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; ANDREWS K, 1993, BRIT MED J, V306, P1600, DOI 10.1136/bmj.306.6892.1600; ANDREWS K, 1995, BRIT MED J, V310, P1137, DOI 10.1136/bmj.310.6987.1137a; ANDREWS K, 1993, BRIT MED J, V306, P1597, DOI 10.1136/bmj.306.6892.1597; ANGELL M, 1994, NEW ENGL J MED, V330, P1524, DOI 10.1056/NEJM199405263302110; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bassetti C, 1996, J NEUROL NEUROSUR PS, V61, P610, DOI 10.1136/jnnp.61.6.610; BECA J, 1995, J PEDIATR-US, V126, P44, DOI 10.1016/S0022-3476(95)70498-1; BUTTINAR D, 1996, PFLUGERS ARCH EUR S2, V431, pR289; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; Cassell EJ, 1996, ANN INTERN MED, V125, P146, DOI 10.7326/0003-4819-125-2-199607150-00014; CELESIA, 1993, ANN NEUROL, V33, P386; Chen R, 1996, CRIT CARE MED, V24, P672, DOI 10.1097/00003246-199604000-00020; Childs NL, 1996, BRIT MED J, V313, P944; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Cranford R, 1996, BRIT MED J, V313, P5, DOI 10.1136/bmj.313.7048.5; DAVIS A, 1993, BRIT MED J, V307, P202, DOI 10.1136/bmj.307.6897.202; Facco E., 1993, Neurophysiologie Clinique, V23, P237, DOI 10.1016/S0987-7053(05)80233-3; GANES T, 1988, ELECTROEN CLIN NEURO, V69, P6, DOI 10.1016/0013-4694(88)90030-2; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; GREENBERG RP, 1982, ANN NY ACAD SCI, V388, P683, DOI 10.1111/j.1749-6632.1982.tb50835.x; Guerit J. M., 1993, Neurophysiologie Clinique, V23, P209, DOI 10.1016/S0987-7053(05)80231-X; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; HUME AL, 1979, ANN NEUROL, V5, P379, DOI 10.1002/ana.410050412; HUTCHINSON DO, 1991, ELECTROEN CLIN NEURO, V78, P228, DOI 10.1016/0013-4694(91)90037-5; Jennett B, 1972, Clin Neurosurg, V19, P200; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JUDSON JA, 1990, CRIT CARE MED, V18, P363, DOI 10.1097/00003246-199004000-00003; Kane NM, 1996, INTENS CARE MED, V22, P39, DOI 10.1007/BF01728329; KEREN O, 1994, BRAIN INJURY, V8, P239, DOI 10.3109/02699059409150976; Madl C, 1996, ARCH NEUROL-CHICAGO, V53, P512, DOI 10.1001/archneur.1996.00550060054017; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; OVERGAARD J, 1973, LANCET, V2, P631; Payne K, 1996, ANN INTERN MED, V125, P104, DOI 10.7326/0003-4819-125-2-199607150-00004; PHILIP PA, 1994, PHYS MED REH CLIN N, V5, P643; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RAPPAPORT M, 1996, MED REHABILITATION T; RAPPAPORT M, 1994, J HEAD TRAUMA REHAB, V9, P94; RAPPAPORT M, 1986, J HEAD TRAUMA REHABI, P00015, DOI DOI 10.1097/00001199-198603000-00005; Rohlf F. L., 1981, BIOMETRY; SHIN DY, 1989, ARCH PHYS MED REHAB, V70, P189; Sonnet M. L., 1993, Neurophysiologie Clinique, V23, P227, DOI 10.1016/S0987-7053(05)80232-1; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; TEASDALE G, 1974, LANCET, V2, P81; Wade DT, 1996, BRIT MED J, V313, P943; WALSER H, 1985, ARCH NEUROL-CHICAGO, V42, P32, DOI 10.1001/archneur.1985.04060010038013; WERNER RA, 1992, CRIT REV PHYS MED RE, V4, P105; WHYTE J, 1995, ARCH PHYS MED REHAB, V76, P804, DOI 10.1016/S0003-9993(95)80543-5; WHYTE J, 1997, IN PRESS REHABILITAT; ZENTNER J, 1994, NEUROL RES, V16, P89	52	6	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	1998	13	1					51	68		10.1097/00001199-199802000-00008			18	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YW212	WOS:000071909700008	9565704				2022-02-06	
J	Wall, JR; Niemczura, JG; Rosenthal, M				Wall, JR; Niemczura, JG; Rosenthal, M			Community-based training and employment: an effective program for persons with traumatic brain injury	NEUROREHABILITATION			English	Article						traumatic brain injury; vocational rehabilitation; work adjustment training; supported employment; community-based training	SUPPORTED EMPLOYMENT; WORK; RETURN; REHABILITATION	Occupational entry is an important issue for persons with disabilities, as many become or remain unemployed after their injury. After traumatic brain injury (TBI), individuals exhibit high unemployment rates, especially those persons with injuries of greater severity, a limited premorbid work history and/or persons from economically disadvantaged backgrounds. Vocational rehabilitation programs have been developed to improve employability. Traditional vocational rehabilitation approaches, based on integrating work skills with cognitive rehabilitation models have proven only minimally effective with TBI. The supported employment model has been demonstrated to be much more effective with this group, as has an approach that combines vocational and psychosocial skills training along with job support. Even with these generally successful approaches, the literature on vocational rehabilitation in clients from economically disadvantaged environments who are diagnosed with TBI is limited. An approach for the economically disadvantaged, which combines work skills training in a real work community along with supported employment is presented. (C) 1998 Elsevier Science Ireland Ltd.	Inst Rehabil, Detroit, MI USA; Wayne State Univ, Sch Med, Detroit, MI USA		Wall, JR (corresponding author), Univ Indianapolis, Dept Psychol, 1400 E Hanna Ave, Indianapolis, IN 46227 USA.						Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; FEISTPRICE S, 1995, REHAB COUNS B, V38, P121; FRASER RT, 1995, NEUROREHABILITATION, V5, P39, DOI 10.3233/NRE-1995-5104; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; KIERNAN W, 1989, EC IND DISABILITY LO; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; SKORD KG, 1994, BRAIN INJURY, V8, P383, DOI 10.3109/02699059409150989; Walls RT, 1996, REHABIL COUNS BULL, V40, P153; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; WEST MD, 1995, BRAIN INJURY, V9, P301, DOI 10.3109/02699059509008200; WHEATON JE, 1995, REHABIL COUNS BULL, V38, P224; White S., 1991, DISABILITY PREVALENC; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; 1994, J DISABIL POL STUD, V5, P81	19	6	6	0	7	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	JAN	1998	10	1					39	49		10.1016/S1053-8135(97)00043-7			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YV946	WOS:000071880300005	24525815				2022-02-06	
J	Hough, MS; Pierce, RS; Difilippo, M; Pabst, MJ				Hough, MS; Pierce, RS; Difilippo, M; Pabst, MJ			Access and organization of goal-derived categories after traumatic brain injury	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; SEMANTIC CATEGORIES; COMMON CATEGORIES; FRONTAL-LOBE; APHASIA; MEMORY; PERFORMANCE; FLUENCY; CONFUSIONS; ATTENTION	This study examined the access and organization of goal-derived categories in semantic memory with a group of chronic traumatic brain injured TBI adults and a group of age and gender-matched neurologically-intact controls. Goal-derived categories are developed by individuals for use in specialized contexts to achieve a goal, such as 'things to take on a camping trip.' Categories were presented to subjects in two task contexts: category verification and exemplar generation. Overall, the TBI subjects were able to accurately identify and organize category exemplars within particular categories. Interestingly, the TBI subjects produced significantly more total responses than the neurologically-intact subjects on exemplar generation; however, a high percentage of their responses (one-third) were inaccurate, consisting of out-of-set responses and repetitions. These findings suggest that difficulties in retrieval may exist in the presence of relatively intact access and organization of goal-derived category structure. The results are discussed relative to deficits in the executive control of verifying goal-directed behaviour and incomplete category representation.	KENT STATE UNIV,SCH SPEECH PATHOL & AUDIOL,KENT,OH 44242; AVON CITY SCH,AVON,OH; CRF ASSOCIATES INC,GREENVILLE,NC		Hough, MS (corresponding author), E CAROLINA UNIV,DEPT COMMUN SCI & DISORDERS,GREENVILLE,NC 27858, USA.						ADAMOVICH A, 1985, COGNITIVE REHABILITA; ADAMOVICH B, 1984, CLIN APHASIOLOGY C P, P124; ADAMOVICH BB, 1990, FOLIA PHONIATR, V42, P11, DOI 10.1159/000266015; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; BARSALOU L, 1983, MEM COGNITION, V8, P211; Barsalou L.W., 1987, CONCEPTS CONCEPTUAL, P101; BARSALOU LW, 1991, PSYCHOL LEARN MOTIV, V27, P1, DOI 10.1016/S0079-7421(08)60120-6; BARSALOU LW, 1985, J EXP PSYCHOL LEARN, V11, P629, DOI 10.1037/0278-7393.11.1-4.629; BARSALOU LW, 1992, FRAMES, FIELDS, AND CONTRASTS, P21; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BAYLES KA, 1991, J COGNITIVE NEUROSCI, V3, P1568; Brooks D. N, 1990, REHABILITATION ADULT, P163; CARAMAZZA A, 1990, COGNITIVE NEUROPSYCH, V7, P161, DOI 10.1080/02643299008253441; CROWE SF, 1992, J CLIN EXP NEUROPSYC, V14, P327, DOI 10.1080/01688639208402832; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; Deelman B.G., 1990, TRAUMATIC BRAIN INJU, P49; Dunn LM., 1981, PEABODY PICTURE VOCA; FISHER JM, 1985, SEMIN NEUROL, V5, P197, DOI 10.1055/s-2008-1041516; FREEDMAN PE, 1987, J NEUROL NEUROSUR PS, V50, P398, DOI 10.1136/jnnp.50.4.398; GAINOTTI G, 1986, BRAIN LANG, V28, P181, DOI 10.1016/0093-934X(86)90101-X; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; GROHER ME, 1990, REHABILITATION ADULT, P294; GRUEN AK, 1990, J COMMUN DISORD, V23, P163, DOI 10.1016/0021-9924(90)90020-Y; HAGEN C, 1979, ANN CONV AM SPEECH L; HALVORSON K, 1986, ANN CONV AM SPEECH L; Hartley L. L, 1995, COGNITIVE COMMUNICAT; HASHER L, 1979, J EXPT PSYCHOL GEN, V108, P365; HAUT MW, 1991, BRAIN COGNITION, V17, P31, DOI 10.1016/0278-2626(91)90064-F; HILLERT D, 1992, J NEUROLINGUIST, V7, P23, DOI 10.1016/0911-6044(92)90010-T; HOUGH MS, 1993, APHASIOLOGY, V7, P335, DOI 10.1080/02687039308249515; HOUGH MS, 1988, THESIS KENT STATE U; HUX K, 1993, J MED SPEECH-LANG PA, V1, P121; Johnson, 1977, WOODCOCK JOHNSON PSY; JURGENS V, 1993, ANN M INT NEUR SOC G; KENNEDY MRT, 1991, COMMUNICATION DISORD, P123; KOEMEDALUTZ M, 1987, BRAIN LANG, V30, P321, DOI 10.1016/0093-934X(87)90106-4; KUDO T, 1987, BRAIN LANG, V30, P33, DOI 10.1016/0093-934X(87)90026-5; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1988, BRAIN COGNITION, V7, P283, DOI 10.1016/0278-2626(88)90003-6; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LOHMAN T, 1989, APHASIOLOGY, V3, P685, DOI 10.1080/02687038908249036; LURIA A, 1974, WORKING BRAIN; MCCLEARY C, 1988, BRAIN LANG, V34, P183, DOI 10.1016/0093-934X(88)90132-0; MCCLEARY C, 1988, APHASIOLOGY, V2, P343, DOI 10.1080/02687038808248935; MITCHELL DB, 1989, MEM COGNITION, V17, P337, DOI 10.3758/BF03198472; OBRZUT JE, 1990, TRAUMATIC BRAIN INJU, P165; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; RAPP BC, 1989, COGNITIVE NEUROPSYCH, V6, P251, DOI 10.1080/02643298908253420; RICHARDSON JTE, 1984, CORTEX, V20, P413, DOI 10.1016/S0010-9452(84)80009-X; ROSCH E, 1975, J EXP PSYCHOL GEN, V104, P192, DOI 10.1037/0096-3445.104.3.192; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; Rosch Eleanor, 1978, COGNITION CATEGORIZA, P27; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Stuss D. T, 1987, NEUROBEHAVIORAL RECO, V166; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; VANZOMEREN AH, 1990, TRAUMATIC BRAIN INJU, P33; WICKENS CD, 1984, VARITIES ATTENTION; Ylvisaker M., 1994, LANGUAGE INTERVENTIO, P546	63	6	6	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	NOV	1997	11	11					801	814					14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YA149	WOS:A1997YA14900004	9354257				2022-02-06	
J	Vaughan, N; Agner, D; Clinchot, DM				Vaughan, N; Agner, D; Clinchot, DM			Perseveration and wandering as a predictor variable after brain injury	BRAIN INJURY			English	Article							ALZHEIMERS-DISEASE	Perseveration and wandering are well recognized sequelae of traumatic brain injury. They are believed to arise as a constellation of behaviours from lesions involving the frontal, temporal, or parietal lobes or subcortical motor regions. Attention and memory deficits are believed to contribute to the presence of perseveration and wandering. Patients who perseverate and/or wander after brain injury tend to have poorer outcomes and slower rates of progress. This prospective study is based on 32 consecutive admissions to a brain injury rehabilitation unit over a 4-month period. For each patient data was collected on perseverative behaviours, wandering, Functional Independence Measure, total number of rehabilitative days, supervision requirement at discharge and discharge disposition. Perseveration and wandering were assessed using the Agitated Behaviour Scale and clinical observations of the primary physician, physical and occupational therapist and speech-language pathologist. Correlations between perseverative and wandering behaviours were made with the variables identified.	OHIO STATE UNIV,DODD HALL DAVIS CTR,DEPT PHYS MED & REHABIL,COLUMBUS,OH 43210					Clinchot, Daniel/0000-0002-2810-7227			CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P33, DOI 10.1097/00002060-199302000-00008; GRANGER CV, 1992, AM J PHYS MED REHAB, V71, P108, DOI 10.1097/00002060-199204000-00009; HORN LJ, 1996, MED REHABILITATION T, P573; HOTZ G, 1995, BRAIN INJURY, V9, P161, DOI 10.3109/02699059509008189; HOTZ G, 1995, BRAIN INJURY, V9, P151, DOI 10.3109/02699059509008188; MILLER TP, 1993, J GERIATR PSYCH NEUR, V6, P235, DOI 10.1177/089198879300600410; RYAN JP, 1995, J GERIATR PSYCH NEUR, V8, P209, DOI 10.1177/089198879500800402; TERI L, 1990, J GERONTOL, V45, P58	9	6	6	0	5	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	NOV	1997	11	11					815	819		10.1080/026990597123025			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	YA149	WOS:A1997YA14900005	9354258				2022-02-06	
J	Wright, M; Geffen, G; Geffen, L				Wright, M; Geffen, G; Geffen, L			Comparative effects of ageing and dementia of the Alzheimer type on orientation of visual attention	DEMENTIA AND GERIATRIC COGNITIVE DISORDERS			English	Article						ageing; dementia of the Alzheimer type; covert visual attention	CLOSED-HEAD-INJURY; SELECTIVE ATTENTION; VISUOSPATIAL ATTENTION; COVERT ORIENTATION; SPATIAL ATTENTION; DIVIDED ATTENTION; WORKING MEMORY; DISEASE; INFORMATION; INHIBITION	Age-related changes and the effects of dementia of the Alzheimer type (DAT) were investigated during a visual orienting attention task in which attention was pre-cued to one or other hemifields. Central cues were either valid, neutral, invalid or NoGo (inhibitory). The response time cost-benefit analysis showed a decreased benefit after valid cueing in the old compared with the young group with no change in the cost of invalid cueing. The older group were also slower over all cue types. These results suggest there is an age-related reduced ability to covertly orient attention in a visual hemifield before target onset. In contrast, the DAT group showed an increased response time benefit and showed a trend for a decreased cost in response time compared with controls. This was due to slowest response times after neutral cues. They also made significantly more response errors particularly following neutral cueing, and were less able to inhibit responses on NoGo trials than controls. The increased benefit and reduced cost found in the DAT group was interpreted as an impairment in dividing attention between left and right target locations.	QUEENSLAND HLTH, BRISBANE, QLD, AUSTRALIA; UNIV QUEENSLAND, DEPT PSYCHOL, COGNIT PSYCHOPHYSIOL LAB, BRISBANE, QLD, AUSTRALIA; UNIV QUEENSLAND, DEPT PSYCHIAT, COGNIT PSYCHOPHYSIOL LAB, BRISBANE, QLD, AUSTRALIA				Wright, Margaret J/H-3308-2014; Wright, Margaret Jane/A-4560-2016	Wright, Margaret Jane/0000-0001-7133-4970			ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Baddeley, 1990, HUMAN MEMORY THEORY; BADDELEY A, 1986, Q J EXP PSYCHOL-A, V38, P603, DOI 10.1080/14640748608401616; CRAIK FIM, 1982, ADV STUDY COMMUNICAT, V8, P95; CREMONAMETEYARD SL, 1992, NEUROPSYCHOLOGIA, V30, P123, DOI 10.1016/0028-3932(92)90022-E; FOLK CL, 1992, PSYCHOL AGING, V7, P453, DOI 10.1037/0882-7974.7.3.453; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FREED DM, 1989, NEUROPSYCHOLOGIA, V27, P325, DOI 10.1016/0028-3932(89)90022-5; FREED DM, 1988, NEUROPSYCHOLOGIA, V26, P895, DOI 10.1016/0028-3932(88)90057-7; Greenwood P.M., 1994, AGING NEUROPSYCHOL C, V1, P188, DOI [DOI 10.1080/13825589408256576, 10.1080/13825589408256576]; GREENWOOD PM, 1993, NEUROPSYCHOLOGIA, V31, P471, DOI 10.1016/0028-3932(93)90061-4; HARTLEY AA, 1990, J EXP PSYCHOL HUMAN, V16, P523, DOI 10.1037/0096-1523.16.3.523; HASHER L, 1991, J EXP PSYCHOL LEARN, V17, P163, DOI 10.1037/0278-7393.17.1.163; HOYER WJ, 1987, COGNITIVE DEV, V2, P59, DOI 10.1016/S0885-2014(87)90035-9; HUPPERT FA, 1994, DEMENTIA NORMAL AGIN; MADDEN DJ, 1986, COGNITIVE DEV, V1, P335, DOI 10.1016/S0885-2014(86)80008-9; MCDOWD JM, 1992, PSYCHOL AGING, V7, P65, DOI 10.1037/0882-7974.7.1.65; MOUNTCASTLE VB, 1978, J ROY SOC MED, V71, P14; NEBES RD, 1989, CORTEX, V25, P305, DOI 10.1016/S0010-9452(89)80045-0; Nelson H. E, 1982, NATIONAL ADULT READI; NESTOR PG, 1991, NEUROPSYCHOLOGIA, V29, P379, DOI 10.1016/0028-3932(91)90026-5; NISSEN MJ, 1985, J GERONTOL, V40, P185, DOI 10.1093/geronj/40.2.185; OKEN BS, 1994, NEUROLOGY, V44, P657, DOI 10.1212/WNL.44.4.657; PARASURAMAN R, 1992, BRAIN, V115, P711, DOI 10.1093/brain/115.3.711; Parasuraman R., 1993, NEUROPSYCHOLOGY, V7, P242, DOI [10.1037/0894-4105.7.3.242, DOI 10.1037/0894-4105.7.3.242]; PETERSEN SE, 1985, J NEUROPHYSIOL, V54, P867, DOI 10.1152/jn.1985.54.4.867; PETERSEN SE, 1987, NEUROPSYCHOLOGIA, V25, P97, DOI 10.1016/0028-3932(87)90046-7; PLUDE DJ, 1989, PSYCHOL AGING, V4, P98, DOI 10.1037/0882-7974.4.1.98; POSNER MI, 1987, TRENDS NEUROSCI, V10, P13, DOI 10.1016/0166-2236(87)90116-0; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, J NEUROSCI, V4, P1863; POSNER MI, 1982, PHILOS T ROY SOC B, V298, P187, DOI 10.1098/rstb.1982.0081; SALTHOUSE TA, 1990, DEV REV, V10, P101, DOI 10.1016/0273-2297(90)90006-P; STRAYER DL, 1987, PSYCHOL AGING, V2, P99, DOI 10.1037/0882-7974.2.2.99; TIPPER SP, 1991, B PSYCHONOMIC SOC, V29, P45; WILLSHIRE D, 1991, J CLIN EXP NEUROPSYC, V13, P204, DOI 10.1080/01688639108401038; WRIGHT MJ, 1994, AUST J PSYCHOL, V46, P63, DOI 10.1080/00049539408259475; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; [No title captured]; [No title captured]	40	6	6	1	10	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1420-8008	1421-9824		DEMENT GERIATR COGN	Dement. Geriatr. Cogn. Disord.	NOV-DEC	1997	8	6					366	375		10.1159/000106657			10	Geriatrics & Gerontology; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Neurosciences & Neurology; Psychiatry	YD427	WOS:A1997YD42700007	9370090				2022-02-06	
J	SmithSeemiller, L; Lovell, MR; Franzen, MD; Smith, SS; Townsend, RN				SmithSeemiller, L; Lovell, MR; Franzen, MD; Smith, SS; Townsend, RN			Neuropsychological function in restrained versus unrestrained motor vehicle occupants who suffer Closed Head Injury	BRAIN INJURY			English	Article							SEAT-BELT USE; TRAUMA; ACCIDENTS; BEHAVIORS; STUDENTS; CRASHES; VICTIMS	It is known that using seatbelts reduces the incidence and severity of closed head injury (CHI) from motor vehicle crashes. One would expect unrestrained occupants in motor vehicle crashes to suffer more severe CHIs than restrained occupants, as reflected by Glasgow Coma Scale (GCS) scores. One might also expect an increased risk of focal injury due to contact forces in unrestrained occupants. The purpose of this study was to test the hypothesis that failure to use seatbelts results in increased severity of neuropsychological sequelae, even with GCS controlled. We also examined the impact of demographic variables on seatbelt use. Subjects included patients admitted to a hospital trauma service who were suspected of having suffered CHI. All patients completed neuropsychological testing, which was entered into a data base along with demographic and clinical information. People who had documented use of seatbelt restraints were compared with those who were unrestrained. Results confirmed that certain demographic variables are associated with the use of seatbelts. Results also suggested that failure to use seatbelt restraints is associated with more severe impairment on tests that are sensitive to frontal lobe dysfunction.	HENRY FORD MED CTR,DETROIT,MI		SmithSeemiller, L (corresponding author), ALLEGHENY GEN HOSP,DEPT PSYCHIAT,ALLEGHENY CTR 4,8TH FLOOR,PITTSBURGH,PA 15212, USA.						ALEKOUMBIDES A, 1987, INT J CLIN NEUROPSYC, V9, P11; ARAJARVI E, 1986, BRIT J ORAL MAX SURG, V24, P251, DOI 10.1016/0266-4356(86)90089-6; Benton A., 1978, MULTILINGUAL APHASIA; BRADBURY A, 1993, ARCH EMERG MED, V10, P15; CHAMPION HR, 1981, CRIT CARE MED, V9, P672, DOI 10.1097/00003246-198109000-00015; GENNARELLI TA, 1987, HEAD INJ MECH S REP, P9; GOLDBAUM GM, 1986, JAMA-J AM MED ASSOC, V255, P2459, DOI 10.1001/jama.255.18.2459; HART RP, 1988, BRAIN COGNITION, V7, P31, DOI 10.1016/0278-2626(88)90019-X; Katz D, 1992, J HEAD TRAUMA REHAB, V72, P1, DOI [10.1097/00001199-200501000-00008, DOI 10.1097/00001199-200501000-00008]; KNIGHT KK, 1991, J OCCUP ENVIRON MED, V33, P705, DOI 10.1097/00043764-199106000-00011; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LICHTENSTEIN MJ, 1989, J FAM PRACTICE, V28, P289; MACKAY GM, 1995, J TRAUMA, V38, P533, DOI 10.1097/00005373-199504000-00012; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; OLECKNO WA, 1990, PUBLIC HEALTH, V104, P155, DOI 10.1016/S0033-3506(05)80371-3; PREUSSER DF, 1991, ACCIDENT ANAL PREV, V23, P475, DOI 10.1016/0001-4575(91)90013-U; Reitan R, 1986, TRAIL MAKING TEST MA; Robinson L J, 1991, Arch Clin Neuropsychol, V6, P27, DOI 10.1016/0887-6177(91)90019-6; Ryan G.A., 1989, P INT IRCOBI C BIOM, P27; RYAN GA, 1992, WORLD J SURG, V16, P398, DOI 10.1007/BF02104438; RYAN GA, 1992, AUST J PUBLIC HEALTH, V16, P269; SIEGEL JH, 1993, J TRAUMA, V34, P736, DOI 10.1097/00005373-199305000-00017; STODUTO G, 1993, ACCIDENT ANAL PREV, V25, P411, DOI 10.1016/0001-4575(93)90070-D; TEASDALE G, 1974, LANCET, V2, P81; TIPTON RM, 1990, ACCIDENT ANAL PREV, V22, P543, DOI 10.1016/0001-4575(90)90026-H; Wechsler D, 1987, MEMORY SCALE REVISED	26	6	6	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	OCT	1997	11	10					735	742					8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XY415	WOS:A1997XY41500004	9354249				2022-02-06	
J	Thomas, DF; Menz, FE				Thomas, DF; Menz, FE			Validation of the Vocational Assessment Protocol	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							TRAUMATIC BRAIN INJURY; REHABILITATION; RETURN; WORK; PREDICTION; ADULTS	Objective: To report the psychometric properties of the Vocational Assessment Protocol (VAP), including estimates of its internal consistency reliability and construct and criterion-related validity. Design: VAPs were completed on consecutive referrals of persons with a brain injury as they entered vocational evaluation programs at 20 nationally distributed sites funded by state vocational rehabilitation agencies. Follow-up data on employment status and earnings were obtained 6 months after the completion of a VAP using a follow-up instrument designed for this purpose. Subjects: VAPs were completed for 149 subjects, with complete follow-up data obtained on 116. Subjects were typically male, single, white, injured in their late teens to early 20s, and had experienced closed head injuries with extended coma and/or amnesia durations reported. At the time of referral, subjects were on average 6 years postinjury. Instrumentation: The VAP was used to obtain ratings of functional skills and vocational related behaviors using eight of the nine profiles that constitute the entire instrument. These profiles included a structured interview (personal demographics interview), three clinical profiles (physical, social-emotional, and neuropsychological), and four vocational profiles (lob-search skills, Interviewing skills, critical work behavior, and social adaptive behavior). A one-page, 13-item questionnaire was used to collect employment data in a follow-up conducted 6 months after VAPs were completed. Results: All VAP profiles had high internal consistency reliability, and each profile was composed of a small number of factors that accounted for the majority of the response variability, indicating factors that imply both high reliability and construct validity. Criterion validity was found to be high for several of the profiles in terms of ability to predict employment status at an acceptable level of significance. A number of the skills and behaviors included on the four vocational profiles (job-search skills, interviewing skills, critical work behavior, and social adaptive behavior) and one clinical profile (social-emotional) were significantly correlated with employment at the 6-month follow-up. Conclusions: The VAP exhibited psychometric properties that suggest it to be both reliable and valid as a means of examining many of the basic vocational-related skills and functional behaviors related to employment for persons with a brain injury.	MAYO HLTH SYST,EAU CLAIRE,WI		Thomas, DF (corresponding author), UNIV WISCONSIN,STOUT VOCAT REHABIL INST,REHABIL RES & TRAINING CTR,214 10TH AVE,MENOMONIE,WI 54751, USA.						Abrams D., 1993, J HEAD TRAUMA REHAB, V8, P59; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; FABIANO RJ, 1995, REHABIL PSYCHOL, V40, P223, DOI 10.1037/0090-5550.40.3.223; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; HUBER I, 1993, J COGNITIVE REHABILI, V11, P22; JACOBS H, 1993, JOB SEEKING SKILLS T; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Millis S R, 1994, Int J Neurosci, V79, P165; PARENTE R, 1991, J HEAD TRAUMA REHAB, V6, P35; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Ragnarsson KT, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI DOI 10.1097/00001199-199308020-00003; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; Thomas DF, 1997, J HEAD TRAUMA REHAB, V12, P48, DOI 10.1097/00001199-199704000-00006; THOMAS DF, 1996, VOCATIONAL ASSESSMEN; THOMAS DF, 1993, COMMUNITY BASED EMPL; THOMAS DF, 1994, VOCATIONAL ASSESSMEN; Thomas DF, 1996, J VOCATIONAL REHABIL, V7, P243; THOMAS DF, 1990, AM REHABILITATIO SUM, P33; THOMAS DF, 1988, ADAPT TRANSIVION CUR, P3; THOMAS DF, 1990, AM REHABIL       SUM, P20; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27	27	6	6	1	1	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1997	12	5					72	87		10.1097/00001199-199710000-00007			16	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YA515	WOS:A1997YA51500007					2022-02-06	
J	Godbout, A				Godbout, A			Structured habituation training for movement provoked vertigo after severe traumatic brain injury: A single-case experiment	BRAIN INJURY			English	Article							REHABILITATION	The purpose of this study was to evaluate the effect of structured habituation training (HT) for movement provoked vertigo (PV) secondary to unilateral peripheral hypofunction in a 16 year old patient who had sustained a severe TBI. Treatment of PV with severe TBI patients can be quite different from other patients with vestibular deficits because of the physiological, behavioural and cognitive sequelae of brain trauma. A single-subject experimental paradigm using an ABA protocol was used to assess efficacy of HT. The data were submitted to C statistic analysis. The transformed data were submitted to combined visual and statistical analysis by the celeration line with a directional one-tailed test and the two-standard deviation band method. Significant change in duration from sitting to supine without triggering vertigo was found between baseline phase (A) and structured HT phase (B) and was maintained for 1 month after the end of treatment. This single-case experiment demonstrates successful structured HT for PV for a 16 year old severe TBI patient. Important clinical decisions (time of introduction of treatment, type of activity, pacing, frequency, intensity, repetition, support and education) necessary to achieve optimal resolution of PV with HT in severe TBI patients are discussed.			Godbout, A (corresponding author), INST READAPTAT MONTREAL, SERV PHYSIOTHERAPIE, 6300 RUE DARLINGTON, MONTREAL, PQ H3S 2J4, CANADA.						BERMAN J, 1976, J OTOLARYNGOL, V7, P237; BROOKES GB, 1994, ACTA OTO-LARYNGOL, P40; COHEN H, 1995, OTOLARYNG HEAD NECK, V112, P526, DOI 10.1016/S0194-5998(95)70206-7; COHEN H, 1994, AM J OCCUPATIONAL TH, V10, P919; COHEN H, 1992, OTOLARYNGOLOGY HEAD, V5, P638; GIZZI M, 1995, J HEAD TRAUMA REHAB, V10, P60, DOI 10.1097/00001199-199512000-00009; Herdman S. J., 1993, PHYSICAL MED REHABIL, V7, P559; Herdman SJ, 1994, VESTIBULAR REHABILIT, P287; HORAK FB, 1992, OTOLARYNG HEAD NECK, V106, P175, DOI 10.1177/019459989210600220; HUNTER M, PHYSICA THERAPY, V6, P363; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; MRUZEK M, 1995, LARYNGOSCOPE, V105, P686, DOI 10.1288/00005537-199507000-00004; NORRE M E, 1981, Agressologie, V22, P37; Norre M E, 1978, Acta Otorhinolaryngol Belg, V32, P421; NORRE ME, 1980, J LARYNGOL OTOL, V94, P971, DOI 10.1017/S0022215100089726; NORRE ME, 1988, ARCH OTOLARYNGOL, V114, P883; NORRE ME, 1980, J LARYNGOL OTOL, V94, P689, DOI 10.1017/S0022215100089453; NORRE ME, 1988, INT J REHABILITATION, V2, P117; NORRE ME, 1984, OTONEUROLOGY, P23; NOURBAKHSH MR, 1994, PHYS THER, V74, P768, DOI 10.1093/ptj/74.8.768; OTTENBACHER JK, 1986, EVALUATING CLIN CHAN; ROLAND SP, 1995, TRAUMATIC BRAIN INJU, P132; SHEPARD NT, 1993, ANN OTO RHINOL LARYN, V102, P198, DOI 10.1177/000348949310200306; SHEPARD NT, 1995, OTOLARYNG HEAD NECK, V112, P173, DOI 10.1016/S0194-5998(95)70317-9; SHUMWAY-COOK A, 1989, Seminars in Hearing, V10, P196; Shumway-Cook A, 1994, VESTIBULAR REHABILIT, P347; SHUTTY MS, 1991, ARCH PHYS MED REHAB, V72, P473; SMITH DB, 1990, NEUROL CLIN, V8, P199, DOI 10.1016/S0733-8619(18)30350-5; SMITHWEELCOCK M, 1991, SEMINARS HEARING, V3, P297; STZURM T, 1994, J VESTIBUL RES-EQUIL, V6, P461; TRYON WW, 1982, J APPL BEHAV ANAL, V15, P578; TUOHIMAA P, 1978, ACTA OTO-LARYNGOL, V359, P5; UMPHRED DA, 1995, NEUROLOGICAL REHABIL, P92; ZEE DS, 1994, VESTIBULAR REHABILIT, P67	34	6	6	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	1997	11	9					629	641		10.1080/026990597123188			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	XT726	WOS:A1997XT72600002	9376831				2022-02-06	
J	Graham, DI; Maxwell, WL; Nicoll, JAR				Graham, DI; Maxwell, WL; Nicoll, JAR			Neurotrauma: Axonal damage in short surviving head injury and the influence of Apolipoprotein E on outcome	BRAIN PATHOLOGY			English	Article; Proceedings Paper	XIIIth International Congress of Neuropathology	SEP 07-12, 1997	PERTH, AUSTRALIA	Int Soc Neuropathol, Austr & New Zealand Soc Neuropathol, AMGEN Austr, Austr Tourist Commiss, Perth Convent Ctr, Quantas Airlines, Univ W Austr, Royal Perth Hosp, Austr Neuromuscular Res Inst			ALZHEIMERS-DISEASE; BETA; PATHOGENESIS	There is increasing evidence that most forms of traumatic brain damage are not immediate, i.e. rather it is a process and not an event that is set into motion by mechanical loading of neurones and their axons, and the vascular system. One of the principal determinants of outcome after injury map well be an ability of nerve cells and their processes to modulate ionic fluxes including Ca2+ through membrane defects generated by mechanical injury, the activation of voltage dependent channels and through receptor mediator channels, such as those associated with the NMDA receptor and possibly non-NMDA receptors. If the cell is capable of binding sequestering, exchanging or pumping Ca2+ then restoration of pre-traumatic levels of intracellular free Ca2+ will occurr. If these functions are compromised then a series of enzyme and gene activation may begin. These and other processes singly or in combination will produce acute cell death (necrosis) or delayed cell death (apoptosis). The outcome following head injury is therefore a product of many factors including the genome of the patient. Prospects for improved outcome after closed head injury will require a better understanding of the mechanisms of injury and the types and time course of the ensuing pathology (4). Not only should it then be possible to reduce mortality by prevention or avoidance of head injury, given that it has now been established that the principal mechanisms of brain damage are either contact or acceleration/deceleration, but also reduce the amount of disability in survivors by various neuroprotective therapies. From a clinical point of view treatment is directed at the type of damage diagnosed and, in particular, as to whether the neurological condition of the patient is due to a focal mass lesion or diffuse injury to the brain. The detection and management of mass lesions is of paramount importance given the urgent need for surgical evacuation in order to prevent raised intracranial pressure, internal herniation and compression of the brain stem. Such focal brain injuries result from localised damage and account for approximately 50 per cent of patients with severe head injuries and some two-thirds of deaths associated with head injury. In contrast diffuse brain injuries are associated with widespread dysfunction, which may be functional as in the case of concussion or may involve structural damage as occurs in prolonged traumatic coma without mass lesions. It is now recognised that the principal pathology in these patients is widespread damage to axons, a condition that is described as diffuse axonal injury. The diffuse brain injuries which account for about 40 per cent of cases with severe injuries and for about one-third of deaths due to head injury are the most frequent cause of persisting neurological disability in survivors (3). Although the nature and distribution of damage after head injury is diverse there is increasing evidence that apolipoprotein E (apoE) polymorphism is a putative susceptibility risk factor for the effects of head injury. The mechanisms by which apoE influences outcome following brain injury is not clear but there is increasing evidence that apoE allelic variation modulates the development and outcome of several diseases of the central nervous system.	UNIV GLASGOW,LAB HUMAN ANAT,GLASGOW,LANARK,SCOTLAND		Graham, DI (corresponding author), UNIV GLASGOW,DEPT NEUROPATHOL,GLASGOW,LANARK,SCOTLAND.						BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Gennarelli TA, 1997, NEUROSCIENTIST, V3, P73, DOI 10.1177/107385849700300117; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, V1, P197; MAXWELL WL, 1997, IN PRESS J NEUROTRAU; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; PETTUS EH, 1996, BRAIN RES, V772, P1; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROSES AD, 1995, NAT MED, V1, P603, DOI 10.1038/nm0795-603; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; TEASDEALE GM, 1997, IN PRESS LANCET; THIBAULT LE, 1992, BRAIN INJURY MACRO M, V14, P3; WINSTON FK, 1993, J BIOMECH ENG-T ASME, V115, P160, DOI 10.1115/1.2894116	20	6	6	0	2	INT SOC NEUROPATHOLOGY	PITTSBURGH	200 LOTHROP ST A506, PITTSBURGH, PA 15213	1015-6305			BRAIN PATHOL	Brain Pathol.	SEP	1997	7	4					1285	1288					4	Clinical Neurology; Neurosciences; Pathology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	XQ527	WOS:A1997XQ52700414					2022-02-06	
J	Jordan, F; Ward, K; CremonaMeteyard, S				Jordan, F; Ward, K; CremonaMeteyard, S			Word-finding in the conversational discourse of children with closed head injury	APHASIOLOGY			English	Article							INTELLECTUAL ABILITY; LANGUAGE PERFORMANCE; BRAIN INJURY; ADOLESCENTS; IMPAIRMENT; SKILLS	Despite the fact that dysnomia or word-finding difficulty is consistently documented as a characteristic feature of the language sequelae of childhood closed head injury (CHI), few studies have examined the effects of such word-finding problems on language performance outside the constraints of a standard confrontation naming test. The present study examined evidence for word-finding difficulties in both confrontation naming and conversation in a group of 11 children (aged 9-17) who had experienced a severe CHI. Performance of the children with CHI was compared to that of a control group individually matched for age, gender and handedness. The children with CHI demonstrated inferior performance on the test of confrontation naming. In addition, the children with CHI were found to have a conversational error profile that was different from the control group. These findings are discussed with respect to the relationship between standard test performance and communicative competence in the conversational discourse setting.	UNIV QUEENSLAND, ST LUCIA, QLD 4067, AUSTRALIA								BASSETT SS, 1990, J PEDIATR PSYCHOL, V15, P225, DOI 10.1093/jpepsy/15.2.225; Benson DF, 1979, APHASIA ALEXIA AGRAP; BOCK JK, 1982, PSYCHOL REV, V89, P1, DOI 10.1037/0033-295X.89.1.1; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; CORMACK RA, 1994, AUSTR J HUMAN COMMUN, V22, P74; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; Damico J. S., 1985, COMMUNICATION SKILLS, P165; DENNIS M, 1992, TOP LANG DISORD, V13, P66, DOI 10.1097/00011363-199211000-00008; DOLLAGHAN CA, 1992, TOP LANG DISORD, V12, P56, DOI 10.1097/00011363-199202000-00007; Ewing-Cobbs L., 1985, SPEECH LANGUAGE EVAL, P97; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1985, HEAD INJURY REHABILI, P71; Fisher J. P., 1992, 100 PICTURES NAMING; Frey, 1994, Adolesc Med, V5, P311; FULD PA, 1977, DEV MED CHILD NEUROL, V19, P495; GERMAN DJ, 1991, J SPEECH HEAR RES, V34, P309, DOI 10.1044/jshr.3402.309; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HECAEN H, 1983, NEUROPSYCHOLOGIA, V21, P581, DOI 10.1016/0028-3932(83)90055-6; IMES C, 1983, COGNITIVE REHABILITA, V1, P11; JORDAN F M, 1990, Brain Injury, V4, P27; JORDAN FM, 1995, APHASIOLOGY, V9, P23, DOI 10.1080/02687039508248686; JORDAN FM, 1994, BRAIN INJURY, V8, P501, DOI 10.3109/02699059409151002; Jordan FM, 1996, BRAIN INJURY, V10, P91, DOI 10.1080/026990596124575; Jordan FM, 1996, APHASIOLOGY, V10, P755, DOI 10.1080/02687039608248448; JORDAN FM, 1993, APHASIOLOGY, V7, P503, DOI 10.1080/02687039308248626; JORDAN FM, 1990, AUSTR J HUMAN COMMUN, V18, P1; Kaplan E, 1983, BOSTON NAMING TEST; KENNEDY M, 1991, COMMUNICATION DISORD; Kolb B., 1990, FUNDAMENTALS HUMAN N; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; MACLACHLAN BG, 1988, J SPEECH HEAR DISORD, V53, P2, DOI 10.1044/jshd.5301.02; PARSONS CL, 1989, AUSTR J HUMAN COMMUN, V17, P37; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; TEASDALE G, 1974, LANCET, V2, P81; Wiig E., 1984, LANGUAGE ASSESSMENT; WIIG EH, 1975, J LEARN DISABIL, V8, P578, DOI 10.1177/002221947500800909; WILLIAMS J, 1995, DEV NEUROPSYCHOL, V11, P201, DOI 10.1080/87565649509540613; [No title captured]	41	6	6	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	SEP	1997	11	9					877	888		10.1080/02687039708250462			12	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	XW027	WOS:A1997XW02700004					2022-02-06	
J	Larson, WL; Beydoun, A; Albers, JW; Wald, JJ				Larson, WL; Beydoun, A; Albers, JW; Wald, JJ			Collet-Sicard syndrome mimicking neuralgic amyotrophy	MUSCLE & NERVE			English	Article						neuralgic amyotrophy; Collet-Sicard syndrome; spinal accessory neuropathy; adenocarcinoma; electromyography	CLOSED-HEAD-INJURY	A man with shoulder pain, wasting, and weakness had ipsilateral cranial nerve abnormalities. Electrodiagnostic studies supported a diagnosis of neuralgic amyotrophy, but we later demonstrated a spinal accessory mononeuropathy with ipsilateral hypoglossal weakness (Collet-Sicard syndrome). Magnetic resonance imaging demonstrated an inaccessible occipital condyle mass, and disseminated adenocarcinoma was subsequently diagnosed. Although cranial mononeuropathies can occur in neuralgic amyotrophy, this case illustrates the importance of identifying a focal lesion, and highlights the localizing value of electrodiagnosis. (C) 1997 John Wiley & Sons, Inc.	UNIV MICHIGAN,MED CTR,DEPT NEUROL,ANN ARBOR,MI 48109				Beydoun, Ahmad/ABE-8111-2021	Beydoun, Ahmad/0000-0002-9047-1185			Arpa J, 1991, Neurologia, V6, P65; ENGLAND JD, 1987, MUSCLE NERVE, V10, P60, DOI 10.1002/mus.880100112; GAUTHIER JC, 1970, HDB CLIN NEUROLOGY, V8, P95; GREENBERG HS, 1981, NEUROLOGY, V31, P530, DOI 10.1212/WNL.31.5.530; JUNIOS JL, 1987, BRAIN, V110, P197; LECHEVALIER T, 1988, ARCH INTERN MED, V148, P2035, DOI 10.1001/archinte.148.9.2035; MOHANTY SK, 1973, J NEUROSURG, V38, P86, DOI 10.3171/jns.1973.38.1.0086; PACHNER AR, 1985, NEUROLOGY, V35, P47, DOI 10.1212/WNL.35.1.47; PIERRE PA, 1990, MUSCLE NERVE, V13, P704, DOI 10.1002/mus.880130807; Ruiz J, 1995, Neurologia, V10, P391; SANDERS EACM, 1988, J NEUROL, V235, P323, DOI 10.1007/BF00314184; SERRATRICE G, 1992, REV NEUROL, V148, P47; SHARMA BS, 1994, CLIN NEUROL NEUROSUR, V96, P197, DOI 10.1016/0303-8467(94)90063-9; Silvestrini M, 1991, Riv Neurol, V61, P135; SWEENEY PJ, 1995, NEUROLOGY CLIN PRACT, P1731; Tappin JA, 1996, J NEUROL NEUROSUR PS, V60, P14, DOI 10.1136/jnnp.60.1.14; WANI MA, 1991, J TRAUMA, V31, P1437, DOI 10.1097/00005373-199110000-00025; Wilbourn AJ, 1993, PERIPHERAL NEUROPATH, V2, P911	18	6	6	0	0	JOHN WILEY & SONS INC	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158-0012	0148-639X			MUSCLE NERVE	Muscle Nerve	SEP	1997	20	9					1173	1177		10.1002/(SICI)1097-4598(199709)20:9<1173::AID-MUS13>3.0.CO;2-U			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XR371	WOS:A1997XR37100013	9270675	Green Published			2022-02-06	
J	Silvestri, S; Aronson, S				Silvestri, S; Aronson, S			Severe head injury: Prehospital and emergency department management	MOUNT SINAI JOURNAL OF MEDICINE			English	Article						head trauma; hyperventilation; mannitol; intracranial pressure; cerebral perfusion pressure; emergency medical services	CEREBRAL BLOOD-FLOW; PROPHYLACTICALLY ADMINISTERED PHENYTOIN; INTRA-CRANICAL PRESSURE; POST-TRAUMATIC SEIZURES; BRAIN INJURY; INTRACRANIAL HYPERTENSION; SUPEROXIDE-DISMUTASE; PERFUSION-PRESSURE; MULTICENTER TRIAL; ORAL INTUBATION	Head trauma causes approximately 75,000 deaths each year in the United States. Both hypoxia and hypovolemia are individual predictors of poor outcome in the patient with severe head trauma. Management begins in the field and is focused on ensuring oxygenation and maintaining a blood pressure that supports cerebral perfusion. In the trauma center, intracranial pressure monitoring may be helpful in guiding the management of increased intracranial pressure. Mannitol, given in intermittent bolus infusions, is the therapy of choice for increased intracranial pressure. Hyperventilation has been shown to decrease cerebral perfusion and should be avoided; it is a temporizing procedure that is reserved for those cases that demonstrate signs of increased intracranial pressure pending initiation of other therapies.			Silvestri, S (corresponding author), CUNY MT SINAI SCH MED, DEPT EMERGENCY MED, BOX 1149, 1 E 100TH ST, NEW YORK, NY 10029 USA.						BARRY KG, 1961, NEW ENGL J MED, V264, P1085, DOI 10.1056/NEJM196105252642105; BOREL C, 1990, CHEST, V98, P180, DOI 10.1378/chest.98.1.180; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; BROWN FD, 1979, J NEUROSURG, V50, P423, DOI 10.3171/jns.1979.50.4.0423; BULLOCK R, 1996, GUIDELINES MANAGEMEN; CAMPBELL JE, 1995, BASIC TRAUMA LIFE SU, P23; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton G L, 1995, New Horiz, V3, P474; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Gaab M R, 1994, Zentralbl Neurochir, V55, P135; GABRIEL GM, 1996, J CRIT ILLNESS, V11, P75; GENTLEMAN D, 1992, INT SURG, V77, P297; GRAHAM DI, 1971, LANCET, V1, P265; HAYASHI N, 1994, ACTA NEUROCHIR, P541; HOLLEY J, 1989, ANN EMERG MED, V18, P1237, DOI 10.1016/S0196-0644(89)80067-8; ISRAEL RS, 1988, ANN EMERG MED, V17, P560; JAMES HE, 1980, ACTA NEUROCHIR, V51, P161, DOI 10.1007/BF01406742; KASSELL NF, 1982, STROKE, V13, P59, DOI 10.1161/01.STR.13.1.59; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; KERR ME, 1993, HEART LUNG, V22, P516; KLOTI J, 1987, CHILD NERV SYST, V3, P103, DOI 10.1007/BF00271134; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; MAJERNICK TG, 1986, ANN EMERG MED, V15, P417, DOI 10.1016/S0196-0644(86)80178-0; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; MCGRAW CP, 1983, NEUROSURGERY, V13, P269, DOI 10.1227/00006123-198309000-00009; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; Miller J D, 1993, Acta Neurochir Suppl (Wien), V57, P152; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MUIZELAAR JP, 1993, ANN EMERG MED, V22, P1014, DOI 10.1016/S0196-0644(05)82744-1; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OLSHAKER J, 1996, CLIN PRACTICE EMERGE, P404; Raichle ME, 1972, STROKE, V3, P566, DOI 10.1161/01.STR.3.5.566; RHEE KJ, 1990, ANN EMERG MED, V19, P511, DOI 10.1016/S0196-0644(05)82179-1; RHEE KJ, 1994, ANN EMERG MED, V23, P37, DOI 10.1016/S0196-0644(94)70005-2; ROBERTSON CS, 1991, J NEUROSURG, V74, P43, DOI 10.3171/jns.1991.74.1.0043; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; ROSNER MJ, 1987, NEUROSURGERY, V21, P147, DOI 10.1227/00006123-198708000-00003; Sayre MR, 1996, ACAD EMERG MED, V3, P840, DOI 10.1111/j.1553-2712.1996.tb03528.x; SMITH JS, 1990, J TRAUMA, V30, P1533, DOI 10.1097/00005373-199012000-00017; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Temkin N R, 1991, Neurosurg Clin N Am, V2, P425; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; WALLS RM, 1993, ANN EMERG MED, V22, P1008, DOI 10.1016/S0196-0644(05)82743-X; WHITE RJ, 1992, NEW ENGL J MED, V327, P1507; WOLF AL, 1993, J NEUROSURG, V78, P54, DOI 10.3171/jns.1993.78.1.0054; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007	58	6	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0027-2507	1931-7581		MT SINAI J MED	Mt. Sinai J. Med.	SEP-OCT	1997	64	4-5					329	338					10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XU938	WOS:A1997XU93800012	9293735				2022-02-06	
J	Ashwal, S; Holshouser, BA				Ashwal, S; Holshouser, BA			New neuroimaging techniques and their potential role in patients with acute brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain; central nervous system; diffusion-weighted imaging; functional imaging; injury; magnetic resonance spectroscopy; outcome; perfusion imaging; prognosis; trauma	MAGNETIC-RESONANCE SPECTROSCOPY; CLOSED-HEAD-INJURY; DIFFUSION-WEIGHTED MR; FOCAL CEREBRAL-ISCHEMIA; CLINICAL-APPLICATIONS; FUNCTIONAL MRI; BLOOD-VOLUME; PERFUSION; SUBACUTE; CONTRAST	Advances in structural and functional neuroimaging techniques are likely to improve our understanding of the pathophysiology of disorders of consciousness due to traumatic and nontraumatic brain injury. As this evolves over the next decade, such data, combined with clinical and other neurodiagnostic modalities, will allow the development of predictive models that will have a variety of bedside applications. In this review several of the newer neuroimaging techniques that use magnetic resonance imaging are described, as are the basic principles required for their acquisition and their potential clinical and research applications.	LOMA LINDA UNIV, SCH MED, DEPT RADIOL, LOMA LINDA, CA USA								Adams HP, 1996, NEUROLOGY, V47, P835; ARONEN HJ, 1994, RADIOLOGY, V191, P41, DOI 10.1148/radiology.191.1.8134596; ASHWAL S, 1995, ANN NEUROL, V38, P552; AULD KL, 1995, PEDIATR NEUROL, V12, P323, DOI 10.1016/0887-8994(95)00062-K; BEREK K, 1995, STROKE, V26, P543, DOI 10.1161/01.STR.26.4.543; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; BOLINGER L, 1996, CLIN MAGNETIC RESONA, V1; BUXTON RB, 1996, CLIN MAGNETIC RESONA, V1; CHOE BY, 1995, INVEST RADIOL, V30, P502, DOI 10.1097/00004424-199508000-00008; CHRISTIANSEN P, 1993, ACTA NEUROL SCAND, V87, P195; COHEN MS, 1994, TRENDS NEUROSCI, V17, P268, DOI 10.1016/0166-2236(94)90055-8; CONNELLY A, 1995, MAGN RESON IMAGING, V13, P1233, DOI 10.1016/0730-725X(95)02037-T; Desmond JE, 1995, BRAIN, V118, P1411, DOI 10.1093/brain/118.6.1411; DETRE JA, 1994, NMR BIOMED, V7, P75, DOI 10.1002/nbm.1940070112; DETRE JA, 1995, ANN NEUROL, V38, P618, DOI 10.1002/ana.410380410; FISER DH, 1994, PEDIATR CLIN N AM, V41, P1423; FISHER M, 1995, JAMA-J AM MED ASSOC, V274, P908; FISHER M, 1992, ANN NEUROL, V32, P115, DOI 10.1002/ana.410320202; GENTRY LR, 1994, RADIOLOGY, V191, P1; GOPLERUD JM, 1993, CLIN PERINATOL, V20, P345, DOI 10.1016/S0095-5108(18)30397-X; GRAHAM GD, 1995, STROKE, V26, P225, DOI 10.1161/01.STR.26.2.225; GROENENDAAL F, 1994, PEDIATR RES, V35, P148, DOI 10.1203/00006450-199402000-00004; HANNAY JH, 1996, NEUROTRAUMA; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Holshouser BA, 1997, RADIOLOGY, V202, P487, DOI 10.1148/radiology.202.2.9015079; HOPE PL, 1991, CLIN PERINATOL, V18, P535, DOI 10.1016/S0095-5108(18)30511-6; ICHISE M, 1994, J NUCL MED, V35, P217; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JACKSON GD, 1994, NEUROLOGY, V44, P850, DOI 10.1212/WNL.44.5.850; JIANG Q, 1994, J CEREBR BLOOD F MET, V14, P732, DOI 10.1038/jcbfm.1994.94; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KAUFMANN MA, 1992, RESUSCITATION, V23, P199, DOI 10.1016/0300-9572(92)90003-U; Kreis R, 1996, J CLIN INVEST, V97, P1142, DOI 10.1172/JCI118528; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; Kuzniecky RI, 1996, EPILEPSIA, V37, pS10, DOI 10.1111/j.1528-1157.1996.tb06017.x; KWONG KK, 1995, MAGN RESON QUART, V11, P1; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; LANFERMANN H, 1995, RADIOLOGY, V196, P203, DOI 10.1148/radiology.196.1.7784568; LATCHAW RE, 1995, NEUROSURGERY, V37, P619, DOI 10.1227/00006123-199510000-00003; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LeBihan D, 1996, J NEURORADIOLOGY, V23, P1; Leeds Norman E., 1994, Current Opinion in Oncology, V6, P254, DOI 10.1097/00001622-199405000-00006; Levin HS, 1996, ARCH NEUROL-CHICAGO, V53, P88, DOI 10.1001/archneur.1996.00550010108024; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEVIN JM, 1995, J NEUROPSYCH CLIN N, V7, P511; LIPPER MH, 1985, AM J ROENTGENOL, V144, P483, DOI 10.2214/ajr.144.3.483; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Martin E, 1996, PEDIATR RES, V40, P749, DOI 10.1203/00006450-199611000-00015; MATHEWS VP, 1995, AM J ROENTGENOL, V165, P633, DOI 10.2214/ajr.165.3.7645484; MINTOROVITCH J, 1994, J CEREBR BLOOD F MET, V14, P332, DOI 10.1038/jcbfm.1994.40; MOATS RA, 1995, J COMPUT ASSIST TOMO, V19, P480, DOI 10.1097/00004728-199505000-00025; MOONEN CTW, 1995, BIOL PSYCHIAT, V37, P141, DOI 10.1016/0006-3223(94)00260-A; Moseley ME, 1996, SURG NEUROL, V45, P385, DOI 10.1016/0090-3019(95)00421-1; MURATA T, 1995, J NEUROL NEUROSUR PS, V58, P100, DOI 10.1136/jnnp.58.1.100; NOMURA Y, 1994, AM J NEURORADIOL, V15, P231; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; PARDO FS, 1994, INT J RADIAT ONCOL, V30, P663, DOI 10.1016/0360-3016(92)90953-F; Patel M R, 1995, Magn Reson Imaging Clin N Am, V3, P425; PEDEN CJ, 1993, DEV MED CHILD NEUROL, V35, P502; Penrice J, 1996, PEDIATR RES, V40, P6, DOI 10.1203/00006450-199607000-00002; PRAYER L, 1993, ACTA RADIOL, V34, P593; PRICHARD JW, 1993, DIS NERVOUS SYSTEM C, V2; RAJAGOPALAN P, 1995, PROG NEURO-PSYCHOPH, V19, P351, DOI 10.1016/0278-5846(95)00017-P; ROBERTS TPL, 1993, J CEREBR BLOOD F MET, V13, P940, DOI 10.1038/jcbfm.1993.117; ROSEN BR, 1991, MAGNET RESON MED, V22, P293, DOI 10.1002/mrm.1910220227; ROSS B, 1994, MAGN RESON QUART, V10, P191; SEVICK RJ, 1992, RADIOLOGY, V185, P687, DOI 10.1148/radiology.185.3.1438745; SHU S, IN PRESS PEDIAT NEUR; SMITH DH, 1995, J NEUROTRAUM, V12, P573, DOI 10.1089/neu.1995.12.573; Stein SC, 1996, NEUROTRAUMA; SUTTON LN, 1995, PEDIATR NEUROSURG, V22, P81, DOI 10.1159/000120881; TIEN RD, 1994, AM J ROENTGENOL, V162, P671, DOI 10.2214/ajr.162.3.8109520; TODD DAY, 1996, AM J PSYCHIAT, V153, P200; TSURUDA JS, 1990, AM J NEURORADIOL, V11, P925; VANDERKNAAP MS, 1992, ANN NEUROL, V31, P202, DOI 10.1002/ana.410310211; Wang ZY, 1996, AM J ROENTGENOL, V167, P191, DOI 10.2214/ajr.167.1.8659371; WARACH S, 1992, RADIOLOGY, V182, P41, DOI 10.1148/radiology.182.1.1727307; Warach S, 1996, NEUROLOGY, V47, P89, DOI 10.1212/WNL.47.1.89; WARACH S, 1995, ANN NEUROL, V37, P231, DOI 10.1002/ana.410370214; WARACH S, 1996, CLIN MAGNETIC RESONA, V1; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; WOOD DMG, 1995, BRAIN RES BULL, V38, P545, DOI 10.1016/0361-9230(95)02026-0	83	6	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1997	12	4					13	35		10.1097/00001199-199708000-00004			23	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XP104	WOS:A1997XP10400004					2022-02-06	
J	Ferrera, PC				Ferrera, PC			Traumatic carotid-cavernous sinus fistula with spontaneous resolution	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						carotid-cavernous sinus fistula; traumatic	OPHTHALMIC VEIN APPROACH; EMBOLIZATION; CLASSIFICATION; COMPLICATIONS; MANAGEMENT; ARTERY; SYSTEM	A 77-year-old woman presented with unilateral ocular pain, exophthalmos, vascular tinnitus, and chemosis several weeks after a minor closed head injury. Cerebral angiography showed a carotid-cavernous sinus fistula. One week later the patient's symptoms abruptly ceased. A brief discussion of the presentation and management of these fistulas is presented. Copyright (C) 1997 by W.B. Saunders Company.			Ferrera, PC (corresponding author), ALBANY MED CTR,DEPT EMERGENCY MED,ALBANY,NY 12208, USA.						ABRAHAMSON IA, 1955, AM J OPHTHALMOL, V39, P521, DOI 10.1016/0002-9394(55)92249-2; AHUJA A, 1992, NEUROSURGERY, V31, P774; BARKER WF, 1968, ANN SURG, V167, P568, DOI 10.1097/00000658-196804000-00014; BARROW DL, 1985, J NEUROSURG, V62, P248, DOI 10.3171/jns.1985.62.2.0248; BENNETT DR, 1973, JAMA-J AM MED ASSOC, V224, P1637, DOI 10.1001/jama.224.12.1637; BICKERSTAFF ER, 1970, BRIT J OPHTHALMOL, V54, P186, DOI 10.1136/bjo.54.3.186; BROSNAHAN D, 1992, J NEUROL NEUROSUR PS, V55, P553, DOI 10.1136/jnnp.55.7.553; CALON B, 1995, J NEUROSURG, V83, P910, DOI 10.3171/jns.1995.83.5.0910; CONLEY FK, 1975, J NEUROSURG, V43, P357, DOI 10.3171/jns.1975.43.3.0357; Dandy W. E., 1941, AM J OPHTHALMOL, V24, P365; Dardenne G J, 1975, Surg Neurol, V3, P105; DEBRUN G, 1981, J NEUROSURG, V55, P678, DOI 10.3171/jns.1981.55.5.0678; DEBRUN GM, 1988, NEUROSURGERY, V22, P285, DOI 10.1227/00006123-198802000-00001; DEBRUN GM, 1983, AM J NEURORADIOL, V4, P355; DONNELL MS, 1978, SURG NEUROL, V10, P115; EGGERS F, 1979, J NEUROSURG, V51, P543, DOI 10.3171/jns.1979.51.4.0543; Goto K, 1986, Acta Radiol Suppl, V369, P576; GRONSKI HW, 1975, SOUTHERN MED J, V68, P1096, DOI 10.1097/00007611-197509000-00011; HALBACH VV, 1988, AM J NEURORADIOL, V9, P741; HALBACH VV, 1987, AM J NEURORADIOL, V8, P627; KELTNER JL, 1987, OPHTHALMOLOGY, V94, P1585; KUPERSMITH MJ, 1986, OPHTHALMOLOGY, V93, P906; LEWIS AI, 1995, NEUROSURGERY, V36, P239, DOI 10.1227/00006123-199502000-00001; Locke CE, 1924, ANN SURG, V80, P1; MASON TH, 1954, J NEUROSURG, V11, P323; MILLER NR, 1995, J NEUROSURG, V83, P838, DOI 10.3171/jns.1995.83.5.0838; MIYACHI S, 1993, SURG NEUROL, V39, P105, DOI 10.1016/0090-3019(93)90086-G; MOTARJEME A, 1973, RADIOLOGY, V108, P83, DOI 10.1148/108.1.83; PALESTINE AG, 1981, ARCH OPHTHALMOL-CHIC, V99, P1600; PARKINSON D, 1973, J NEUROSURG, V38, P99, DOI 10.3171/jns.1973.38.1.0099; POTTER JM, 1954, BRIT MED J, V2, P786, DOI 10.1136/bmj.2.4891.786; RAMOS M, 1953, J NEUROSURG, V10, P178, DOI 10.3171/jns.1953.10.2.0178; REIDERGROSSWASSER I, 1993, BRAIN INJURY, V7, P547, DOI 10.3109/02699059309008183; SERBINENKO FA, 1974, J NEUROSURG, V41, P125, DOI 10.3171/jns.1974.41.2.0125; SHIMIZU T, 1988, NEUROSURGERY, V22, P550, DOI 10.1227/00006123-198803000-00017; SPINELLI HM, 1994, ANN PLAS SURG, V33, P377, DOI 10.1097/00000637-199410000-00004; TENG MMH, 1995, RADIOLOGY, V194, P705, DOI 10.1148/radiology.194.3.7862966; TSAI FY, 1983, AM J NEURORADIOL, V4, P357; UFLACKER R, 1986, RADIOLOGY, V159, P175, DOI 10.1148/radiology.159.1.3952304; WESSBECHER F, 1992, AM J NEURORADIOL, V13, P331	40	6	6	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0735-6757			AM J EMERG MED	Am. J. Emerg. Med.	JUL	1997	15	4					386	388		10.1016/S0735-6757(97)90134-0			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XJ133	WOS:A1997XJ13300016	9217534				2022-02-06	
J	Neistadt, ME; Smith, RE				Neistadt, ME; Smith, RE			Teaching diagnostic reasoning: Using a classroom-as-clinic methodology with videotapes	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						curriculum; education	OCCUPATIONAL-THERAPY EDUCATION; FIELDWORK; SCIENCE; SKILLS	Objectives. The purpose of this study was to examine the effects of a ''classroom-as-clinic'' format, using videotaped occupational therapy evaluations, on students' diagnostic reasoning skills. In the classroom-as-clinic format, students write a problem list on the basis of preliminary client information before viewing the videotape. Method. A post-hoc experimental design was used to compare the accuracy of treatment plan problem lists for two groups of senior occupational therapy students-one group viewed two videotapes of client-therapist interactions without a classroom-as-clinic format (n = 82), and one group viewed the same videotapes within the context of a classroom-as clinic format (n = 45). Both groups viewed the same two videotapes. Videotape 1 was of a client with a brain stem infarct, and Videotape 2 was of a client with traumatic brain injury. Results. Subjects experiencing a classroom-as-clinic format identified significantly more occupational therapy problems for Videotape 1 than those who did not have preevaluation information. There was no significant difference between the two subject groups in the accuracy of their problem lists for Videotape 2. Only subjects in the non-classroom-as-clinic group showed a significant improvement from Videotape 1 to Videotape 2 in occupational therapy problem identification. Conclusion. This study suggests that to be truly effective when used with videotapes, the classroom-as-clinic methodology needs to be combined with explicit coaching in problem sensing and problem definition.			Neistadt, ME (corresponding author), UNIV NEW HAMPSHIRE, DEPT OCCUPAT THERAPY, 4 LIB WAY, DURHAM, NH 03824 USA.						[Anonymous], 1994, Am J Occup Ther, V48, P1047; BAZYK S, 1989, AM J OCCUP THER, V43, P465, DOI 10.5014/ajot.43.7.465; CLARK F, 1993, AM J OCCUP THER, V47, P1067, DOI 10.5014/ajot.47.12.1067; COHN ES, 1989, AM J OCCUP THER, V43, P240, DOI 10.5014/ajot.43.4.240; CREPEAU EB, 1991, AM J OCCUP THER, V45, P1016, DOI 10.5014/ajot.45.11.1016; DUTTON R, 1995, CLIN REASONING PHYSI; FIELD E, 1992, J PHYSICAL THERAPY E, V6, P3; FLEMING MH, 1991, AM J OCCUP THER, V45, P1007, DOI 10.5014/ajot.45.11.1007; FLEMING MH, 1991, AM J OCCUP THER, V45, P988, DOI 10.5014/ajot.45.11.988; HAMILTON LC, 1993, STAT STATA, V3; Higgs J, 1990, NZ J PHYSIOTHERAPY, V18, P13; MATTINGLY C, 1991, AM J OCCUP THER, V45, P979, DOI 10.5014/ajot.45.11.979; MATTINGLY C, 1991, AM J OCCUP THER, V45, P998, DOI 10.5014/ajot.45.11.998; Mattingly C, 1994, CLIN REASONING FORMS; NEISTADT ME, 1992, AM J OCCUP THER, V46, P814, DOI 10.5014/ajot.46.9.814; Neistadt ME, 1996, AM J OCCUP THER, V50, P676, DOI 10.5014/ajot.50.8.676; NEISTADT ME, 1987, AM J OCCUP THER, V41, P631, DOI 10.5014/ajot.41.10.631; NEISTADT ME, 1986, P OCCUPATIONAL THERA, P67; NEUHAUS BE, 1988, AM J OCCUP THER, V42, P288, DOI 10.5014/ajot.42.5.288; ROGERS JC, 1982, OCCUP THER J RES, V2, P195, DOI 10.1177/153944928200200401; ROGERS JC, 1983, AM J OCCUP THER, V37, P601, DOI 10.5014/ajot.37.9.601; ROGERS JC, 1991, AM J OCCUP THER, V45, P1045, DOI 10.5014/ajot.45.11.1045; ROYEEN CB, 1995, AM J OCCUP THER, V49, P338, DOI 10.5014/ajot.49.4.338; SCHELL BA, 1993, AM J OCCUP THER, V47, P605, DOI 10.5014/ajot.47.7.605; SCHWARTZ KB, 1991, AM J OCCUP THER, V45, P1033, DOI 10.5014/ajot.45.11.1033; VANLEIT B, 1995, AM J OCCUP THER, V49, P349, DOI 10.5014/ajot.49.4.349; ZIMMERMAN SS, 1995, AM J OCCUP THER, V49, P153, DOI 10.5014/ajot.49.2.153	27	6	6	0	5	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	MAY	1997	51	5					360	368		10.5014/ajot.51.5.360			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	WU605	WOS:A1997WU60500006	9127062				2022-02-06	
J	Stachura, Z; Kowalski, J; Obuchowicz, E; Huzarska, M; Herman, ZS				Stachura, Z; Kowalski, J; Obuchowicz, E; Huzarska, M; Herman, ZS			Concentration of enkephalins in cerebrospinal fluid of patients after severe head injury	NEUROPEPTIDES			English	Article							TRAUMATIC BRAIN INJURY; BETA-ENDORPHIN; SPINAL-CORD; RAT-BRAIN; PEPTIDES; OPIATE; CSF	We studied head-injured patients treated at the Department of Neurosurgery, Silesian University School of Medicine, Katowice. The patients underwent lumbar puncture on days 1, 4 and 7 for diagnostic reasons. The levels of leu-enkephalin (LENK) and met-enkephalin (MENK) were examined in 4.5 ml of cerebrospinal fluid (CSF). The control group included patients with lumbar discopathy from whom CSF fluid was collected during myelography. Enkephalins were extracted by column chromatography and their levels were assayed radioimmunologically. The results indicate that enkephalins may play a certain role in the pathophysiological response of nervous tissue to traumatic injury. Constantly elevated MENK levels together with decreasing LENK levels in patients with a Glasgow coma scale score less than or equal to 8 may be useful as a poor prognostic factor. It is also suggested that LENK and MENK play different pathophysiological roles.			Stachura, Z (corresponding author), SILESIAN UNIV,SCH MED,DEPT CLIN PHARMACOL,MEDYKOW 18 ST,PL-40752 KATOWICE,POLAND.			Kowalski, Jan/0000-0001-6455-4502			AKIL H, 1978, LIFE SCI, V23, P121, DOI 10.1016/0024-3205(78)90259-X; ATWEH SF, 1983, BRIT MED BULL, V39, P47, DOI 10.1093/oxfordjournals.bmb.a071789; BASKIN DS, 1981, LANCET, V2, P272; BRADLEY PB, 1984, BRIT J PHARMACOL, V83, P763, DOI 10.1111/j.1476-5381.1984.tb16231.x; CUPO A, 1985, J NEUROIMMUNOL, V8, P57, DOI 10.1016/S0165-5728(85)80047-3; FADEN AI, 1983, EUR J PHARMACOL, V91, P321, DOI 10.1016/0014-2999(83)90487-9; FADEN AI, 1984, BRIT J PHARMACOL, V81, P271, DOI 10.1111/j.1476-5381.1984.tb10074.x; FADEN AI, 1985, REGUL PEPTIDES, V11, P35, DOI 10.1016/0167-0115(85)90029-1; FLAMM ES, 1985, J NEUROSURG, V63, P390, DOI 10.3171/jns.1985.63.3.0390; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; LYETH BG, 1995, NEUROPEPTIDES, V29, P11, DOI 10.1016/0143-4179(95)90051-9; MARSCHALL K, 1989, GEN PHARMACOL, V20, P399, DOI 10.1016/0306-3623(89)90185-7; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; NAPPI G, 1986, J NEUROL NEUROSUR PS, V49, P17, DOI 10.1136/jnnp.49.1.17; SANDOR P, 1986, BRAIN RES, V386, P122, DOI 10.1016/0006-8993(86)90148-4; SJOSTROM S, 1988, ANESTH ANALG, V67, P976; TERENIUS L, 1987, LIFE SCI, V41, P805, DOI 10.1016/0024-3205(87)90167-6; VECSEI L, 1992, NEUROPEPTIDES, V22, P111, DOI 10.1016/0143-4179(92)90065-5; WESCHE D, 1977, N-S ARCH PHARMACOL, V301, P79, DOI 10.1007/BF00501267	19	6	6	0	2	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4179			NEUROPEPTIDES	Neuropeptides	FEB	1997	31	1					78	81		10.1016/S0143-4179(97)90024-X			4	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	WN450	WOS:A1997WN45000015	9574842				2022-02-06	
J	Goran, DA; Fabiano, RJ; Crewe, N				Goran, DA; Fabiano, RJ; Crewe, N			Employment following severe traumatic brain injury: The utility of the individual ability profile system (IAP)	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							CLOSED HEAD-INJURY; MILD; REHABILITATION	The results of a survey of employment outcome and their relationship to psychometric indices indicated that competitive employment following severe traumatic brain injury is an ambitious endeavor While 98% of the subjects sampled were either employed or in school premorbidly, 43% of the subjects were unemployed postinjury. Specifically, the Individual Ability Profile (IAP) (Dean, 1982, 1983) variables developed to assist in the clinical interpretation of the results of the WAIS-R were most highly related to employment outcome. A discriminant function analysis utilizing these variables yielded hit rates of 82% for the unemployed category and 92% for the full-time employment grouping. These results further highlighted the useful role of neuropsychological testing in assisting in vocational rehabilitation planning. Future research is required to further elucidate those neuropsychological abilities that subsequently affect employability following severe traumatic brain injury. (C) 1997 National Academy of Neuropsychology. Published by Elsevier Science Ltd.			Goran, DA (corresponding author), MICHIGAN STATE UNIV,DEPT PSYCHOL,310 GILTNER HALL,E LANSING,MI 48823, USA.						BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BENYISHAY Y, 1983, REHABILITATION HEAD; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CONBOY TJ, 1986, REHABIL PSYCHOL, V31, P203, DOI 10.1037//0090-5550.31.4.203; DEAN RS, 1982, ADV SCH PSYCHOL, V2; DEAN RS, 1983, MANUAL REPORT INDIVI; Denny-Brown D., 1942, NEW ENGL J MED, V227, P771; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; FABIANO RJ, 1995, REHABIL PSYCHOL, V40, P223, DOI 10.1037/0090-5550.40.3.223; FAHY TJ, 1967, LANCET, V2, P475; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; GAMBOA AM, 1994, ANAL UNDERSTANDING P; GUILMETTER T, 1991, RHODE ISLAND BAR J, V39, P7; HAFFEY WJ, 1989, REHABIL PSYCHOL, V34, P147, DOI 10.1037//0090-5550.34.2.147; HEATON RK, 1978, J NERV MENT DIS, V116, P408; JENNETT B, 1976, NEW ZEAL MED J, V84, P144; KALSBEEK WD, 1980, J NEUROSURG, V53, P519; Kaplan S. P., 1988, J APPLIED REHABILITA, V19, P3; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; KAY T, 1988, ANNOTATED BIBLIOGRAP; KLONOFF P, 1994, ANAL UNDERSTANDING P, P107; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEVIN HS, 1985, CENTRAL NERVOUS SYST, P281; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LEZAK MD, 1978, J CLIN PSYCHIAT, V29, P592; MCKINLAY W, 1983, J NEUROL NEUROSUR PS, V43, P798; MCMAHON B, 1987, BUSINESS HLTH; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; PRIBRAM KH, 1975, PSYCHOL REV, V82, P116, DOI 10.1037/h0076780; Prigatano G. P., 1987, COMMUNITY REENTRY HE, P1; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSS ED, 1979, ARCH NEUROL-CHICAGO, V36, P144, DOI 10.1001/archneur.1979.00500390062006; ROSS RA, 1971, ANN M AM PSYCH ASS 1; ROWBOTHAM GF, 1954, BRIT MED J, V1, P726, DOI 10.1136/bmj.1.4864.726; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; U.S. Department of Health and Human Services, 1989, INT HEAD INJ TASK FO; *US DEP LAB EMPL T, 1981, SEL CHAR OCC DEF DIC; VOGENTHALER DR, 1987, J REHABIL, V53, P15; Wechsler, 1984, WECHSLER MEMORY SCAL; WEHMAN P, 1990, VOCATIONAL REHABILIT; [No title captured]; [No title captured]	46	6	7	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.		1997	12	7					691	698		10.1016/S0887-6177(97)00004-8			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	YB885	WOS:A1997YB88500009	14590663	Bronze			2022-02-06	
J	Ichai, C; Ciais, JF; Grimaud, D				Ichai, C; Ciais, JF; Grimaud, D			Internal environment and intracranial hypertension.	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article; Proceedings Paper	18th French Language Conference on Neuroanesthesia and Reanimation	NOV 21-22, 1996	CLERMONT FERRA, FRANCE			intracranial hypertension; cerebral oedemia; oncotic pressure; osmolarity; carbon dioxide; temperature; glucose	CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; CEREBROSPINAL-FLUID VOLUME; COLLOID ONCOTIC PRESSURE; TRAUMATIC BRAIN INJURY; WATER-CONTENT; PROLONGED HYPERVENTILATION; MODERATE HYPOTHERMIA; PLASMA OSMOLALITY; HEMORRHAGIC-SHOCK	Intracranial pressure depends on cerebral tissue volume, cerebrospinal fluid volume (CSFV) and cerebral blood volume (CBV). Physiologically, their sum is constant (Monro-Kelly equation) and ICP remains stable. When the blood brain barrier (BBB) is intact, the volume of cerebral tissue depends on the osmotic pressure gradient. When it is injured, water movements accross the BBB depend on the hydrostatic pressure gradient. CBV depends essentially on cerebral blood flow (CBF), which is strongly regulated by cerebral vascular resistances. In experimental studies, a decrease in oncotic pressure does not increase cerebral oedema and intracranial hypertension (ICHT). On the other hand, plasma hypoosmolarity increases cerebral water content and therefore ICP, if the BBB is intact. If it is injured, neither hypoosmolarity nor hypooncotic pressure modify cerebral oedema. Therefore, all hypotonic solutes may aggravate cerebral oedema and are contra-indicated in case of ICHT. On the other hand, hypooncotic solutes do not modify ICP. The osmotic therapy is one of the most important therapeutic tools for acute ICHT. Mannitol remains the treatment of choice. It acts very quickly. An IV perfusion of 0.25 g.kg(-1) is administered over 20 minutes when ICP increases. Hypertonic saline solutes act in the same way, however they are not more efficient than mannitol. CO2 is the strongest modulating factor of CBF. Hypocapnia, by inducing cerebral vasoconstriction, decreases CBF and CBV. Hyperventilation is an efficient and rapid means for decreasing ICP. However, it cannot be used systematically without an adapted monitoring, as hypocapnia may aggravate cerebral ischaemia. Hyperthermia is an aggravating factor for ICHT, whereas moderate hypothermia seems to be beneficial both for ICP and cerebral metabolism. Hyperglycaemia has no direct effect on cerebral volume, but it may aggravate ICHT by inducing cerebral lactic acidosis and cytotoxic oedema. Therefore, infusion of glucose solutes is contra-indicated in the first 24 hours following head trauma and blood glucose concentration must be closely monitored and controlled during ICHT episodes.			Ichai, C (corresponding author), HOP ST ROCHE,DEPT ANESTHESIE REANIMAT,5 RUE PIERRE DEVOLUY,F-06006 NICE,FRANCE.						ALBRIGHT AL, 1984, J NEUROSURG, V60, P481, DOI 10.3171/jns.1984.60.3.0481; ANDREWS RJ, 1993, SURG NEUROL, V39, P218, DOI 10.1016/0090-3019(93)90186-5; ARCHER DP, 1994, ANN FR ANESTH, V13, P57, DOI 10.1016/S0750-7658(94)80187-8; ARCHER DP, 1994, NEUROANESTHESIS NEUR, P1; ARTRU AA, 1987, J CEREBR BLOOD F MET, V7, P471, DOI 10.1038/jcbfm.1987.90; Artru F, 1983, Agressologie, V24, P407; BARIE PS, 1993, J TRAUMA, V35, P88, DOI 10.1097/00005373-199307000-00015; BELL BA, 1987, LANCET, V1, P66; BERNARD C, 1885, LECONS PHENOMENES VI; Boulard G, 1983, Agressologie, V24, P383; BOULARD G, 1994, NEUROANESTHESIE NEUR, P161; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; CHRISTENSEN MS, 1974, BRIT J ANAESTH, V46, P348, DOI 10.1093/bja/46.5.348; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Cold GE, 1992, INTENSIVE CARE WORLD, V9, P172; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; FORTUNE JB, 1995, J TRAUMA, V39, P463; GAJDOS P, 1991, REANIM SOINS INTENS, V7, P162; GUIDET B, 1995, REAN URG, V4, P305; GUNNAR W, 1988, SURGERY, V103, P398; HANSEN NB, 1986, PEDIATR RES, V20, P147, DOI 10.1203/00006450-198602000-00010; HARDER DR, 1985, PFLUG ARCH EUR J PHY, V403, P402, DOI 10.1007/BF00589253; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; HARTWELL RC, 1993, NEUROSURGERY, V32, P444, DOI 10.1227/00006123-199303000-00017; HOCHWALD GM, 1976, ARCH NEUROL-CHICAGO, V33, P339, DOI 10.1001/archneur.1976.00500050025005; ICHAI C, 1994, ANN FR ANESTH, V13, P68, DOI 10.1016/S0750-7658(94)80189-4; KAIEDA R, 1989, ANESTHESIOLOGY, V71, P554, DOI 10.1097/00000542-198910000-00013; KAIEDA R, 1989, NEUROSURGERY, V24, P671, DOI 10.1227/00006123-198905000-00003; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; KLINGELHOFER J, 1992, STROKE, V23, P962, DOI 10.1161/01.STR.23.7.962; KRIVOSICHORBER R, 1995, PROTECTION CEREBRALE, P133; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LASSEN NA, 1976, BRIT J ANAESTH, V48, P419; LEFAUCONNIER JM, 1984, REV NEUROL, V2, P89; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; MARTINS AN, 1976, AM J PHYSIOL, V231, P127, DOI 10.1152/ajplegacy.1976.231.1.127; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; MICHENFELDER JD, 1991, ANESTHESIOLOGY, V75, P130, DOI 10.1097/00000542-199107000-00021; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MUIZELAAR JP, 1988, J NEUROSURG, V69, P923, DOI 10.3171/jns.1988.69.6.0923; NATH F, 1986, J NEUROSURG, V65, P41, DOI 10.3171/jns.1986.65.1.0041; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; PATEL PM, 1993, J NEUROSURG ANESTH, V5, P62; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; POMERANZ S, 1993, J NEUROSURG, V79, P241, DOI 10.3171/jns.1993.79.2.0241; RABARY O, 1994, ANN FR ANESTH, V13, P111, DOI 10.1016/S0750-7658(94)80194-0; RAICHLE ME, 1970, ARCH NEUROL-CHICAGO, V23, P394, DOI 10.1001/archneur.1970.00480290014002; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; RAVUSSIN P, 1986, J NEUROSURG, V64, P104, DOI 10.3171/jns.1986.64.1.0104; RAVUSSIN P, 1995, PROTECTION CEREBRALE, P98; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; Silver P, 1996, INTENS CARE MED, V22, P434, DOI 10.1007/BF01712160; TAKIZAWA H, 1986, NEUROSURGERY, V19, P1; TOMMASINO C, 1988, CRIT CARE MED, V16, P862, DOI 10.1097/00003246-198809000-00009; TOMMASINO C, 1994, ANN FR ANESTH, V13, P62, DOI 10.1016/S0750-7658(94)80188-6; TRACHTMAN H, 1992, PEDIATR NEPHROL, V6, P104, DOI 10.1007/BF00856852; WARNER DS, 1988, ANESTHESIOLOGY, V68, P86, DOI 10.1097/00000542-198801000-00014; WISNER DH, 1990, J TRAUMA, V30, P75, DOI 10.1097/00005373-199001000-00011; WITHLEY JM, 1991, SURGERY, V110, P514; WOLF AL, 1993, J NEUROSURG, V78, P54, DOI 10.3171/jns.1993.78.1.0054; YOSHIDA K, 1991, J NEUROSURG, V74, P87, DOI 10.3171/jns.1991.74.1.0087; YOSHIHARA M, 1995, J NEUROSURG, V82, P386, DOI 10.3171/jns.1995.82.3.0386; YOUNG NL, 1995, PROTECTION CEREBRALE, P79; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011; ZORNOW MH, 1988, ANESTHESIOLOGY, V69, P180, DOI 10.1097/00000542-198808000-00005; ZORNOW MH, 1987, ANESTHESIOLOGY, V67, P936, DOI 10.1097/00000542-198712000-00010	73	6	6	0	2	EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	141 RUE JAVEL, 75747 PARIS, FRANCE	0750-7658			ANN FR ANESTH	Ann. Fr. Anest. Reanim.		1997	16	4					435	444		10.1016/S0750-7658(97)81476-1			10	Anesthesiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	XF746	WOS:A1997XF74600018	9750595				2022-02-06	
J	Max, JE; Smith, WL; Sato, Y; Mattheis, PJ; Robin, DA; Stierwalt, JAG; Lindgren, SD; Castillo, C				Max, JE; Smith, WL; Sato, Y; Mattheis, PJ; Robin, DA; Stierwalt, JAG; Lindgren, SD; Castillo, C			Mania and hypomania following traumatic brain injury in children and adolescents	NEUROCASE			English	Article						secondary mania; traumatic brain injury; children and adolescents	HEAD TRAUMA; LITHIUM	The first series of secondary mania reported in children and adolescents is described. Four of 50 subjects (8%) from a prospective study of consecutive children hospitalized following traumatic brain injury developed mania or hypomania. The phenomenology is discussed regarding the overlapping diagnoses of mania, attention-deficit hyperactivity disorder, organic personality syndrome and the 'frontal lobe syndrome'. Severity of injury, lesion location and family history of major mood disorder may be implicated in the etiology of secondary mania. Lengthy episodes and similar frequency of irritability and elation may be characteristic.	UNIV IOWA,DEPT PSYCHIAT,IOWA CITY,IA 52242; UNIV IOWA,DEPT RADIOL,IOWA CITY,IA 52242; UNIV IOWA,DEPT SPEECH PATHOL & AUDIOL,IOWA CITY,IA 52242; UNIV IOWA,DEPT PEDIAT,IOWA CITY,IA 52242; UNIV MONTANA,RURAL INST DISABILITIES,MISSOULA,MT 59812; CEDAR CTR,CEDAR RAPIDS,IA				Robin, Donald/F-2109-2010	Sato, Yutaka/0000-0002-5245-232X			American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; Andreasen N.C., 1994, PSYCHAT EPIDEMIOLOGY, P349; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CHAMBERS WJ, 1985, ARCH GEN PSYCHIAT, V42, P696; COHN CK, 1977, DIS NERV SYST, V38, P630; Damasio H., 1989, LESION ANAL NEUROPSY; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; GOODWIN FK, 1990, MANIC DEPRESSIVE ILL, P127; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; JOSHI P, 1985, J DEV BEHAV PEDIATR, V6, P352; KHANNA S, 1985, CAN J PSYCHIAT, V30, P236, DOI 10.1177/070674378503000325; LISHMAN WA, 1987, ORGANIC PSYCHIATRY, P137; Max J. E., 1992, NEUROPSYCHIATRIC RAT; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; ORVASCHEL H, 1982, J AM ACAD CHILD PSY, V21, P392, DOI 10.1016/S0002-7138(09)60944-4; SHAFFER D, 1995, TRAUMATIC HEAD INJUR, P117; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; STARKSTEIN SE, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P288; TEASDALE G, 1974, LANCET, V2, P81; WOZNIAK J, 1995, J AM ACAD CHILD PSY, V34, P867, DOI 10.1097/00004583-199507000-00010	20	6	6	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD, ENGLAND OX2 6DP	1355-4794			NEUROCASE	Neurocase		1997	3	2					119	126					8	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	XL491	WOS:A1997XL49100005					2022-02-06	
J	Ramsbacher, J; Brock, M; Kombos, T				Ramsbacher, J; Brock, M; Kombos, T			Permanent postoperative anosmia: A hitherto undescribed complication following surgery of the posterior cranial fossa in the sitting position	ACTA NEUROCHIRURGICA			English	Article						anosmia; sitting position; postoperative complication	TENSION PNEUMOCEPHALUS; AIR-EMBOLISM; OPERATION; ANEURYSMS	Although the sitting position offers advantages for posterior fossa surgery, it is accompanied by complications such as air embolism and pneumatocephalus. Subdural and epidural haematomas are less common postoperative complications of posterior fossa surgery. To the best of our knowledge, however, anosmia is not a known sequela of surgery in the sitting position. It has been described following aneurysm surgery in the rostral part of the circle of Willis and is, of course, well known in traumatic brain injury.			Ramsbacher, J (corresponding author), FREE UNIV BERLIN,MED CTR BENJAMIN FRANKLIN,DEPT NEUROSURG,HINDENBURGDAMM 30,D-12200 BERLIN,GERMANY.						DALRYMPLE DG, 1980, BRIT J ANAESTH, V51, P1079; Delank KW, 1996, LARYNGO RHINO OTOL, V75, P154, DOI 10.1055/s-2007-997554; ELTON RJ, 1994, BRIT J ANAESTH, V73, P247, DOI 10.1093/bja/73.2.247; ERIKSEN KD, 1990, J NEUROSURG, V72, P864, DOI 10.3171/jns.1990.72.6.0864; HERBERHOLD C, 1976, Rhinology (Utrecht), V14, P109; JAFEK BW, 1989, ARCH NEUROL-CHICAGO, V46, P300, DOI 10.1001/archneur.1989.00520390066018; KISHAN A, 1990, CLIN NEUROL NEUROSUR, V92, P245, DOI 10.1016/0303-8467(90)90027-3; PAPADOPOULOS G, 1994, ACTA NEUROCHIR, V126, P140, DOI 10.1007/BF01476424; PAPADOPOULOS G, 1993, ANAESTHESIST, V42, P648; POOL JL, 1961, J NEUROSURG, V18, P98, DOI 10.3171/jns.1961.18.1.0098; SEILER RW, 1984, NEUROSURGERY, V18, P472; SINGH VP, 1990, CLIN NEUROL NEUROSUR, V92, P258, DOI 10.1016/0303-8467(90)90030-9; SMELT W L H, 1988, Acta Anaesthesiologica Belgica, V39, P223; STANDEFER M, 1984, NEUROSURGERY, V14, P649, DOI 10.1227/00006123-198406000-00001; WATANABE E, 1989, ELECTROEN CLIN NEURO, V74, P194, DOI 10.1016/0013-4694(89)90005-9; WILDER BL, 1982, NEUROSURGERY, V11, P530; YASUI N, 1992, ACTA NEUROCHIR, V118, P91, DOI 10.1007/BF01401292; YOUNG ML, 1986, NEUROSURGERY, V18, P157, DOI 10.1227/00006123-198602000-00007	18	6	6	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1997	139	5					482	483		10.1007/BF01808889			2	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	XC750	WOS:A1997XC75000040	9204122				2022-02-06	
J	Sahjpaul, RL; Lee, D; Munoz, DG				Sahjpaul, RL; Lee, D; Munoz, DG			Fatal reaction from inadvertent intrathecal entry of ionic contrast medium during a nephrogram	ACTA NEUROPATHOLOGICA			English	Article						inadvertent intrathecal entry; ionic contrast medium; neurotoxicity; neuropathology	MYELOGRAPHY	A fatal case of inadvertent intrathecal entry of an ionic contrast medium during a nephrogram is reported. The patient developed seizures and failed to regain consciousness following the event, Computerized tomography revealed extensive intraventricular and subarachnoid hyperdensity and cerebrospinal fluid analysis revealed markedly elevated protein content. At autopsy a traumatic communication between the kidney and thecal sac was identified, Histopathological examination revealed cytoplasmic shrinkage and eosinophilia, nuclear pyknosis and karyorrhexis in neocortical neurons. Central chromatolysis was seen in brain stem motor nuclei and anterior horn cell neurons. The neuropathological findings appear to be on the basis of direct neurotoxicity from the contrast medium and excitotoxic injury secondary to seizure activity. Inadvertent intrathecal administration of ionic contrast media is a rare occurrence with often fatal consequences despite aggressive medical management.	UNIV WESTERN ONTARIO, DEPT CLIN NEUROL SCI, DIV NEURORADIOL, LONDON, ON, CANADA; UNIV WESTERN ONTARIO, DEPT CLIN NEUROL SCI, DIV NEUROPATHOL, LONDON, ON, CANADA		Sahjpaul, RL (corresponding author), UNIV WESTERN ONTARIO, DEPT CLIN NEUROL SCI, DIV NEUROSURG, LONDON, ON, CANADA.		Munoz, David G./AAQ-8003-2020	Munoz, David G./0000-0003-0957-6244			BOHN HP, 1992, AM J NEURORADIOL, V13, P1515; CHALOUPKA JC, 1993, AM J NEURORADIOL, V14, P784; HALABURT H, 1973, NEURORADIOLOGY, V5, P70, DOI 10.1007/BF00337486; HILAL SK, 1978, RADIOLOGY, V126, P417, DOI 10.1148/126.2.417; LEE BCP, 1980, NEURORADIOLOGY, V20, P229, DOI 10.1007/BF00342089; NAKAZAWA K, 1988, INTENS CARE MED, V15, P55; RAPOPORT SI, 1974, AM J ROENTGENOL, V122, P186, DOI 10.2214/ajr.122.1.186; RIVERA E, 1995, NEUROSURGERY, V36, P413, DOI 10.1227/00006123-199502000-00027; ROSATI G, 1992, EUR J RADIOL, V15, P95, DOI 10.1016/0720-048X(92)90131-R; TURNER OA, 1966, NEUROLOGY, V16, P230, DOI 10.1212/WNL.16.3.230; WOLLIN DG, 1967, J CAN ASSOC RADIOL, V19, P296	11	6	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	JAN	1997	93	1					101	103		10.1007/s004010050589			3	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	WA520	WOS:A1997WA52000015	9006664				2022-02-06	
J	Semlyen, JK; Summers, SJ; Barnes, MP				Semlyen, JK; Summers, SJ; Barnes, MP			The predictive validity of the Newcastle Independence Assessment Form Research (NIAF-R): Further development of an alternative measure	JOURNAL OF NEUROLOGIC REHABILITATION			English	Article						Newcastle Independence Assessment Form Research (NIAF-R); neurologic rehabilitation; functional assessment; outcome measurement; predictive validity	TRAUMATIC BRAIN INJURY; DISABILITY RATING-SCALE; SEVERE HEAD-INJURY; OUTCOME MEASURES; REHABILITATION; RETURN; WORK; RECOVERY	Earlier payers have detailed the conceptualization, development, and testing of the Newcastle Independence Assessment Form (NIAF-R), an alternative global outcome measure. This article establishes the predictive validity of the measure. Predictive validity was examined by applying two different prediction models, using functional status and return to work (RTW) as the two outcome variables. Multiple linear and logistic reagression analyses indicated that the NIAF-R, when incorporated in equations with age and injury severity, the latter determined by length of coma, was consistently predicting functional status from as early as 8 weeks and return to work from as early as 12 weeks post-injury. Prediction of functional status was especially significant, with the NIAF-R accounting for up to 90 percent of the variance. Prediction of return to work, although consistent, was less powerful. Implications for the validity of the NIAF-R, with particular reference to prognosis and rehabilitation planning, are presented.	Univ Newcastle Upon Tyne, Acad Unit Neurol Rehabil, Hunters Moor Reg Rehabil Ctr, Newcastle Upon Tyne NE2 4NR, Tyne & Wear, England					SEMLYEN, JOANNA/0000-0001-5372-1344			CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; DISLER PB, 1993, ARCH PHYS MED REHAB, V74, P139; ELIASON MR, 1984, PHYS THER, V64, P1357, DOI 10.1093/ptj/64.9.1357; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Hamilton BB, 1987, REHABILITATION OUTCO, P137; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; HUMPHREY M, 1980, INJURY, V12, P107, DOI 10.1016/0020-1383(80)90133-3; JENNETT B, 1975, LANCET, V1, P480; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Keith R A, 1987, Adv Clin Rehabil, V1, P6; KEITH RA, 1995, AM J PHYS MED REHAB, V74, P73, DOI 10.1097/00002060-199501000-00013; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MAHONEY F I, 1965, Md State Med J, V14, P61; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; SANDEL ME, 1995, J NEUROL REHABIL, V9, P111; Semlyen JK, 1996, J NEUROL REHABIL, V10, P251; SEMLYEN JK, IN PRESS BRAIN INJ; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Wade D, 1992, MEASUREMENT NEUROLOG; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27	29	6	6	0	0	DEMOS PUBLICATIONS	NEW YORK	386 PARK AVE S STE 201, NEW YORK, NY 10016-8804 USA	0888-4390			J NEUROL REHABIL	J. Neurol. Rehabil.		1997	11	4					213	218					6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	YN769	WOS:000071204700003					2022-02-06	
J	Shapira, Y; Gurevich, B; Artru, AA; Lam, AM; Israel, E; Zachari, S; Gurman, G; Feldman, Z				Shapira, Y; Gurevich, B; Artru, AA; Lam, AM; Israel, E; Zachari, S; Gurman, G; Feldman, Z			Influence of closed head injury on isoflurane MAC in the rat	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						inhalational anesthetic; isoflurane; minimal anesthetic concentration; brain; neurologic outcome; edema	CRYOGENIC BRAIN INJURY; ANESTHETIC REQUIREMENT; 5-PERCENT DEXTROSE; NEUROLOGIC STATUS; RAPID INFUSION; TRAUMA; EDEMA; KETAMINE	We designed the present study to determine whether the minimum alveolar concentration (MAC) for isoflurane is decreased after closed head trauma (CHT) in rats and, if so, whether the decrease of MAC is related to the severity of neurological impairment following CHT. Isoflurane MAC was determined in 36 Sprague-Dawley rats. Then, at time = 0 h, animals were grouped. Group 1 (n = 8) received no CHT, group 2 (n = 14) received moderate CHT, and group 3 (n = 14) received severe CHT. Neurological severity score (NSS, 0 = no deficit and 25 = maximal impairment) and MAC were determined at 1, 4, 24, and 48 h. In groups 1 and 2, isoflurane MAC at 1, 2, 24, and 48 h (1.0-1.1 +/- 0.8-1.2%, median +/- range) was not significantly different from baseline (1.0-1.1 +/- 1.0-1.1%). In group 3, isoflurane MAC at 1, 2, 24, and 48 h (0.4 +/- 0.2-0.5%) was decreased as compared to baseline (1.1 +/- 1.0-1.1%). In group 2, NSS at 1 h was 18 +/- 11-21 and improved by 48 h to 9 +/- 4-15. In group 3, NSS at 1 h was 24 +/- 22-25 and was not significantly different from NSS at 48 h (24 +/- 24-25). Thus, moderate CHT does not significantly alter isoflurane MAC, whereas severe CHT equivalent to a Glasgow Coma Scale score of 3 to 6 significantly decreases isoflurane MAC.	SOROKA MED CTR,DIV NEUROSURG,IL-84101 BEER SHEVA,ISRAEL; BEN GURION UNIV NEGEV,FAC HLTH SCI,BEER SHEVA,ISRAEL; UNIV WASHINGTON,SCH MED,DEPT ANESTHESIOL,SEATTLE,WA 98195		Shapira, Y (corresponding author), SOROKA MED CTR,DIV ANESTHESIOL,POB 151,IL-84101 BEER SHEVA,ISRAEL.			Feldman, Zeev/0000-0002-9719-3894			ARCHER DP, 1993, ANESTHESIOLOGY, V78, P937, DOI 10.1097/00000542-199305000-00019; ARCHER DP, 1991, ANESTHESIOLOGY, V75, P634, DOI 10.1097/00000542-199110000-00013; BAILEY PL, 1990, ANESTHESIA, P281; BLAISE GA, 1991, CAN J PHYSIOL PHARM, V69, P752, DOI 10.1139/y91-112; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CULLEN DJ, 1970, ANESTHESIOLOGY, V32, P28, DOI 10.1097/00000542-197001000-00009; EGER EI, 1965, ANESTHESIOLOGY, V26, P756, DOI 10.1097/00000542-196511000-00010; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; FISCHER LD, 1993, BIOSTATISTICS METHOD, P304; FISHER LD, 1993, BIOSTATISTICS METHOD, P418; FRAGEN RJ, 1990, ANESTHESIA, P225; KOBLIN DD, 1990, ANESTHESIA, P51; LAM AM, 1995, ANESTHETIC MANAGEMEN, P181; MUNSON ES, 1970, ANESTHESIOLOGY, V32, P507, DOI 10.1097/00000542-197006000-00007; PARENTERMINI A, 1990, LUNG, V168, P259, DOI 10.1007/BF02719702; QUASHA AL, 1980, ANESTHESIOLOGY, V53, P315, DOI 10.1097/00000542-198010000-00008; RAMPIL IJ, 1993, ANESTHESIOLOGY, V78, P707, DOI 10.1097/00000542-199304000-00014; SAIDMAN LJ, 1967, ANESTHESIOLOGY, V28, P994, DOI 10.1097/00000542-196711000-00009; SHAPIRA Y, 1992, J NEUROSURG ANESTH, V4, P231, DOI 10.1097/00008506-199210000-00001; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPIRA Y, 1992, ANESTH ANALG, V75, P238; SHAPIRA Y, 1994, STROKE, V25, P1637, DOI 10.1161/01.STR.25.8.1637; SHAPIRA Y, 1993, J CEREB BLOOD FLOW M, V13, P932; SHAPIRA Y, 1992, ANESTH ANALG, V74, P282; TANIFUJI Y, 1976, BRIT J ANAESTH, V48, P947, DOI 10.1093/bja/48.10.947; WHITE PF, 1974, ANESTHESIOLOGY, V40, P52, DOI 10.1097/00000542-197401000-00012	29	6	6	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	1997	9	1					51	57		10.1097/00008506-199701000-00012			7	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	WA715	WOS:A1997WA71500011	9016441				2022-02-06	
J	Nicoll, JAR				Nicoll, JAR			Genetics and head injury	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						traumatic brain injury; genetics; apolipoprotein E; amyloid beta-protein; Alzheimer's disease	ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; GENOTYPE; BRAIN; APOE		UNIV GLASGOW,DEPT NEUROPATHOL,GLASGOW,LANARK,SCOTLAND				Nicoll, James/I-9253-2017	Nicoll, James/0000-0002-9444-7246			ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; HORSBURGH K, 1995, ALZHEIMERS RES, V1, P123; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; NATHAN BP, 1995, J BIOL CHEM, V270, P19791, DOI 10.1074/jbc.270.34.19791; NEWMAN MF, 1995, ANN THORAC SURG, V59, P1326, DOI 10.1016/0003-4975(95)00076-W; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROSES AD, 1995, NAT MED, V1, P603, DOI 10.1038/nm0795-603; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; STRITTMATTER WJ, 1994, EXP NEUROL, V125, P163, DOI 10.1006/exnr.1994.1019	13	6	6	0	0	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0NE	0305-1846			NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	DEC	1996	22	6					515	517		10.1111/j.1365-2990.1996.tb01128.x			3	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	WC179	WOS:A1996WC17900011	9004240				2022-02-06	
J	Bullock, MR; Povlishock, JT				Bullock, MR; Povlishock, JT			The use of hyperventilation in the acute management of severe traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article							CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; INTRACRANIAL HYPERTENSION; CO2 REACTIVITY; METABOLISM; PRESSURE; OXYGEN		UNIV CALIF SAN FRANCISCO, SAN FRANCISCO, CA 94143 USA; UNIV TEXAS, SCH MED, HOUSTON, TX USA; CORNELL UNIV, COLL MED, ITHACA, NY 14853 USA; UNIV PITTSBURGH, COLL MED, PITTSBURGH, PA 15260 USA; TEMPLE UNIV, SCH MED, PHILADELPHIA, PA 19122 USA; UNIV WASHINGTON, SCH MED, SEATTLE, WA 98195 USA; UNIV ALABAMA, BIRMINGHAM, AL USA; ALLEGHENY GEN HOSP, DEPT NEUROL SURG, PITTSBURGH, PA 15212 USA		Bullock, MR (corresponding author), VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, RICHMOND, VA 23284 USA.						BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; COLD GE, 1981, ACTA ANAESTH SCAND, V25, P397, DOI 10.1111/j.1399-6576.1981.tb01673.x; COLD GE, 1989, ACTA NEUROCHIR, V98, P153, DOI 10.1007/BF01407342; COLD GE, 1986, ACTA ANAESTH SCAND, V30, P453, DOI 10.1111/j.1399-6576.1986.tb02452.x; CROCKARD HA, 1973, BMJ-BRIT MED J, V4, P634, DOI 10.1136/bmj.4.5893.634; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; CRUZ J, 1994, J NEUROSURG, V80, P143, DOI 10.3171/jns.1994.80.1.0143; CRUZ J, 1991, NEUROSURGERY, V29, P743, DOI 10.1227/00006123-199111000-00017; FIESCHI C, 1974, J NEUROL NEUROSUR PS, V37, P1378, DOI 10.1136/jnnp.37.12.1378; GOTOH F, 1965, ARCH NEUROL-CHICAGO, V12, P410, DOI 10.1001/archneur.1965.00460280080008; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; GRAHAM DI, 1971, LANCET, V1, P265; HEISS WD, 1992, J CEREBR BLOOD F MET, V12, P193, DOI 10.1038/jcbfm.1992.29; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARION DW, 1991, NEUROSURGERY, V29, P869, DOI 10.1227/00006123-199112000-00011; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; Raichle ME, 1972, STROKE, V3, P566, DOI 10.1161/01.STR.3.5.566; RAICHLE ME, 1970, ARCH NEUROL-CHICAGO, V23, P394, DOI 10.1001/archneur.1970.00480290014002; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; ROBERTSON CS, 1988, J TRAUMA, V28, P1523, DOI 10.1097/00005373-198811000-00002; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; SALVANT JB, 1993, NEUROSURGERY, V33, P387; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; SHRODER ML, 1994, NEUROSURGERY, V80, P324; TENJIN H, 1990, ACTA NEUROCHIR, V104, P121, DOI 10.1007/BF01842829	35	6	6	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	1996	13	11					699	703					5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	VU812	WOS:A1996VU81200010					2022-02-06	
J	Crepeau, F; Belleville, S; Duchesne, G				Crepeau, F; Belleville, S; Duchesne, G			Disorganisation of behavior in a multiple subgoals scheduling task following traumatic brain injury	BRAIN AND COGNITION			English	Article; Proceedings Paper	TENNET VII - Theoretical and Experimental Neuropsychology	AUG 14-16, 1996	UNIV QUEBEC MONTREAL, MONTREAL, CANADA		UNIV QUEBEC MONTREAL		FRONTAL-LOBE DAMAGE; LESIONS; DEFICITS; MEMORY	Inability to do more than one thing simultaneously is a typical sequel of traumatic brain injury. Seven TBI adults were compared to normal controls when performing a multiple subgoals task within a time limit. The experimental task was a revised version of the Six Element Task (Shallice & Burgess, 1991, Brain, 114, 727-741). In this task, participants have to achieve six subgoals concurrently within a 15-min time limit. Results show that TBI individuals are not strategic in their allocation of time. They invest in a smaller number of subtasks, shift less between subtasks and do not respect time limits. The four TBI participants who performed the worst on the task had neurological and neuropsychological indications of frontal lobe damage.			Crepeau, F (corresponding author), CTR HOSP COTE DES NEIGES, CTR RECH, 4565 CHEMIN REINE MARIE, MONTREAL, PQ H3W 1W5, CANADA.						DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Fuster JM, 1989, PREFRONTAL CORTEX, V2nd; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; VERIN M, 1993, NEUROPSYCHOLOGIA, V31, P1379, DOI 10.1016/0028-3932(93)90105-9; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; WIEGERSMA S, 1990, NEUROPSYCHOLOGIA, V28, P95, DOI 10.1016/0028-3932(90)90089-7	8	6	6	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626	1090-2147		BRAIN COGNITION	Brain Cogn.	NOV	1996	32	2					266	268					3	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Psychology	VZ841	WOS:A1996VZ84100072					2022-02-06	
J	Friedl, W; Karches, C				Friedl, W; Karches, C			Management of acute neurosurgical trauma in a hospital without a neurosurgical department	CHIRURG			German	Article						neurotrauma of the head; acute management	CHRONIC SUBDURAL-HEMATOMA	Head traumas frequently occur in polytrauma patients but are also found as isolated injuries. In our hospital trauma center without a neurosurgical department, in a 21-month period, 489 patients with head/brain trauma were treated. This represents 6.5 % of all patients treated in the trauma and reconstructive surgery clinic. In commotio cerebri (CC = 89.5 % of the patients) constant conservative management and an uneventful course were observed; in 69 patients with contusio cerebri, 18 craniotomy operations had to be performed. In contrast, in only two cases was reoperation because of recurrent hematoma necessary. In four cases with complex and/or additional injuries, transfer to a neurosurgical center took place, and in two cases photo-phone consultation with that center was used. The mortality was 14.5 %. The diagnostic and therapeutic regimens for the different types of injury and the requirements for the management of head/brain trauma in trauma centers without neurosurgical departments are presented: emergency service and medical staff, emergency room management, intensive care management, qualified neurological examination, X-ray imaging, including CT scan, OF-room equipment and trained surgeons. If these requirements are not available in a given hospital, early transfer of all patients for whom surgical manage ment could be necessary to a neurosurgical department should be attempted. Only in patients with severe bleeding must immediate craniotomy be performed even in hospitals which do not have all the above mentioned facilities. In patients with intracerebral bleeding, bleeding in the dorsal fossa, injury of brain nerves, carotid artery or sinus cavernosus injuries, frontobasal injuries with liquor fistula or pneumonencephalon, transfer of the patients to specialized neurosurgical centers is indicated. With this selection, we obtained the same results in a trauma center without a neurosurgical department as reported in the literature. This avoids overloading neurosurgical centers with head/brain injury patients.			Friedl, W (corresponding author), KLINIKUM ASCHAFFENBURG, CHIRURG KLIN UNFALL & WIEDERHERSTELLUNGSCHIRURG 2, HASENKOPF 1, ASCHAFFENBURG, GERMANY.						Brock M, 1994, Zentralbl Neurochir, V55, P204; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; KRETSCHMER H, 1985, AKUTBEHANDLUNG SCHAD; KRUPP WF, 1995, BRIT J NEUROSURG, V9, P619, DOI 10.1080/02688699550040909; KUNZ U, 1993, UNFALLCHIRURG, V96, P595; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; Sonne N M, 1994, Ugeskr Laeger, V156, P295; YAMAMOTO T, 1993, RECENT ADVANCES IN NEUROTRAUMATOLOGY, P91	8	6	6	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0009-4722	1433-0385		CHIRURG	Chirurg	NOV	1996	67	11					1107	1113		10.1007/s001040050111			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	VU375	WOS:A1996VU37500007	9035945				2022-02-06	
J	Lindquist, C; Kihlstrom, L				Lindquist, C; Kihlstrom, L			Department of Neurosurgery, Karolinska Institute: 60 years	NEUROSURGERY			English	Article						functional neurosurgery; Karolinska Institute; Leksell, Lars; neurosurgical history; Olivecrona, Herbert; pain; radiosurgery; stereotactic surgery	SPINAL-CORD STIMULATION; RADIOSURGERY	THE SWEDISH NEUROSURGICAL school was created during the 1920s by Herbert Olivecrona, who became the first professor of neurosurgery at the Karolinska Institute. He pioneered procedures for the treatment of arteriovenous malformations and acoustic neuromas. He was among the first to make direct attacks on berry aneurysms. Many outstanding neurosurgeons in Europe were trained by him. Clinical research to refine and minimize surgical interventions has continued to be the most important feature of the neurosurgery department at the Karolinska Institute. Lars Leksell, Olivecrona's successor, was a leader in stereotactic surgery and the creator of radiosurgery. His tool, the gamma knife, is in worldwide use today. Leksell and his students have defined the indications for radiosurgery and introduced stereotactic techniques into microsurgery. Today, 3000 neurosurgical procedures are performed annually in the four operating rooms of the department of neurosurgery. More than 300 of the procedures are performed with the gamma knife, and at least one-third of the patients are foreign referrals. There is a strong emphasis on clinically oriented research and development. There are research programs for radiosurgery, management of pain, neurooncology, treatment of traumatic brain injury, and treatment of vasospasm after subarachnoid hemorrhage.	KAROLINSKA INST,DEPT NEUROSURG,STOCKHOLM,SWEDEN		Lindquist, C (corresponding author), KAROLINSKA HOSP,DEPT NEUROSURG,S-17176 STOCKHOLM,SWEDEN.		Lindquist, Christer E/E-4127-2018	Lindquist, Christer E/0000-0001-8708-5243			BACKLUND EO, 1985, J NEUROSURG, V62, P169, DOI 10.3171/jns.1985.62.2.0169; BERGSTRAND H, 1936, GEFASSMISSBILDUNGEN; Granit R, 1944, BRAIN, V67, P125, DOI 10.1093/brain/67.2.125; HAKANSON S, 1981, NEUROSURGERY, V9, P638, DOI 10.1227/00006123-198112000-00005; KIHLSTROM L, 1995, NEUROSURGERY, V36, P294, DOI 10.1227/00006123-199502000-00008; LEKSELL L, 1971, ACTA CHIR SCAND, V137, P763; LEKSELL L, 1951, ACTA CHIR SCAND, V102, P316; LEKSELL L, 1939, ACTA CHIR SCAND, V82, P262; Leksell L, 1949, ACTA CHIR SCAND, V99, P229; LEKSELL L, 1955, ACTA CHIR SCAND, V110, P301; Leksell L., 1945, ACTA PHYSIOL SCAND S, V10, P1; LINDEROTH B, 1994, NEUROSURGERY, V34, P484, DOI 10.1227/00006123-199403000-00014; LINDEROTH B, 1995, SEMIN NEUROSCI, V7, P263, DOI 10.1006/smns.1995.0030; LINDQUIST C, 1989, NEUROSURGERY, V25, P802, DOI 10.1227/00006123-198911000-00018; Lysholm E., 1935, ACTA RADIOL S, V24, P1; Lysholm E, 1938, BRIT J RADIOL, V11, P273; MEYERSON BA, 1995, PAIN, V61, P229, DOI 10.1016/0304-3959(94)00171-A; MEYERSON BA, 1986, NEUROSURGERY, V18, P59, DOI 10.1227/00006123-198601000-00010; MOGARD J, 1994, J COMPUT ASSIST TOMO, V18, P177, DOI 10.1097/00004728-199403000-00002; NORLEN G, 1953, J NEUROSURG, V10, P404, DOI 10.3171/jns.1953.10.4.0404; OLIVCRONA H, 1948, ARCH NEURO PSYCHIATR, V59, P567, DOI 10.1001/archneurpsyc.1948.02300400003001; Olivecrona H, 1940, J NEUROL PSYCHIATRY, V3, P141, DOI 10.1136/jnnp.3.2.141; Olivecrona H, 1927, CHIRURG BEHANDLUNG G; OLIVECRONA H, 1957, CONGENITAL ARTERIOVE; SJOQVIST O., 1938, ACTA PSYCHIAT KBH, V17, P1; STEINER L, 1972, ACTA CHIR SCAND, V138, P459	26	6	6	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0148-396X			NEUROSURGERY	Neurosurgery	NOV	1996	39	5					1016	1021					6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	VP349	WOS:A1996VP34900069	8905759				2022-02-06	
J	Roberts, MA; Verduyn, WH; Manshadi, FF; Hines, ME				Roberts, MA; Verduyn, WH; Manshadi, FF; Hines, ME			Episodic symptoms in dysfunctioning children and adolescents following mild and severe traumatic brain injury	BRAIN INJURY			English	Article							NEUROPSYCHIATRIC SEQUELAE; HEAD-INJURIES; TOMOGRAPHY; EPILEPSY	The present investigation examines the phenomenology of episodic symptoms in dysfunctioning children and adolescents following mild (n = 25) or severe (n = 25) traumatic brain injury (TBI). TBI patients in both groups commonly endorsed symptoms such as staring spells, memory gaps, and temper outbursts. Anticonvulsant response in the 27 patients treated, reflected moderate to substantial improvement in 92%. A dose-response relationship between injury severity and number of episodic symptoms was not observed; however, patients in the severe TBI sample did produce significantly more defective performances on a dichotic word-listening task (DWLT) and lower IQ values. Defective DWLT performance was also significantly associated with greater number of episodic symptoms endorsed, but only in the mild TBI sample. Parallels with epilepsy spectrum disorder and clinical implications for paediatric TBI are discussed.	PHYS MED & REHABIL ASSOCIATES,WATERLOO,IA; OTTUMWA REG MED CTR,OTTUMWA,IA		Roberts, MA (corresponding author), UNIV IOWA,UNIV HOSP SCH 351,IOWA CITY,IA 52242, USA.						American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ARDILA A, 1993, EPILEPSIA, V34, P133, DOI 10.1111/j.1528-1157.1993.tb02385.x; Barkley R. A., 1990, ATTENTION DEFICIT HY; BARNHILL LJ, 1989, NEUROPSY NEUROPSY BE, V2, P211; COPE DN, 1994, J HEAD TRAUMA REHAB, V9, P1, DOI 10.1097/00001199-199409000-00003; DONOHOE NV, 1994, EPILEPSIES CHILDHOOD; GROTE CL, 1995, J CLIN EXP NEUROPSYC, V17, P1, DOI 10.1080/13803399508406575; GUALTIERI CT, 1991, RITALIN THEORY PATIE, P171; Hines M E, 1995, Appl Neuropsychol, V2, P1, DOI 10.1207/s15324826an0201_1; Lantz J. A., 1990, PSYCHOL MANAGEMENT T, P133; LEE GP, 1994, EPILEPSY RES, V19, P153, DOI 10.1016/0920-1211(94)90025-6; LEVIN HS, 1989, J NEUROL NEUROSUR PS, V52, P1162, DOI 10.1136/jnnp.52.10.1162; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LIU YK, 1984, SPINE, V9, P329, DOI 10.1097/00007632-198405000-00001; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; NEPPE VM, 1988, HOSP COMMUNITY PSYCH, V39, P389; RICHARDSON ED, 1994, CLIN NEUROPSYCHOL, V8, P416, DOI 10.1080/13854049408402044; Roberts M A, 1994, Appl Neuropsychol, V1, P45, DOI 10.1207/s15324826an0101&2_9; ROBERTS MA, 1995, BRAIN INJURY, V9, P427, DOI 10.3109/02699059509008202; ROBERTS MA, PEDIAT INVENTORY NEU; Roberts RJ, 1990, NEUROPSYCHOLOGY, V4, P65; ROBERTS RJ, 1992, EPILEPSY RES, V13, P167, DOI 10.1016/0920-1211(92)90073-3; TIERNEY JG, 1995, MED PSYCH P, V3, P307; VERDUYN W H, 1992, Brain Injury, V6, P245, DOI 10.3109/02699059209029666; [No title captured]	25	6	6	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	OCT	1996	10	10					739	747		10.1080/026990596124007			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	VH730	WOS:A1996VH73000004	8879664				2022-02-06	
J	Kraiuhin, C; Shores, EA; Roberts, C				Kraiuhin, C; Shores, EA; Roberts, C			Sensitivity of the WAIS-R Verbal-Performance IQ difference and intersubtest scatter to traumatic brain injury	BRAIN INJURY			English	Article								The Wechsler Adult Intelligence Scale-Revised (WAIS-R) Verbal IQ-Performance IQ (VIQ-PIQ) discrepancy and a number oi indices of intersubtest scatter were examined in 25 subjects with a history of traumatic brain injury (TBI) and magnetic resonance imagining (MRI) evidence of structural brain abnormality. Abnormal VIQ-PIQ differences and scatter index values were identified by referring to published normal base rates. Only 16% of the subjects were identified as abnormal on any one of these WAIS-R measures, which suggests these measures are largely insensitive to the presence of structural brain abnormality in TBI.	MACQUARIE UNIV,SCH BEHAV SCI,SYDNEY,NSW 2109,AUSTRALIA		Kraiuhin, C (corresponding author), WESTMEAD HOSP,BRAIN INJURY UNIT,WESTMEAD,NSW 2145,AUSTRALIA.			Shores, Edwin A/0000-0003-1553-5131			BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; BELL D, 1992, MEDICO LEGAL ASSESSM; DELEMOS MM, 1981, WAISR AUSTRALIAN SU; ELWOOD RW, 1993, CLIN NEUROPSYCHOL, V7, P224, DOI 10.1080/13854049308401527; FAUST D, 1991, Neuropsychology Review, V2, P205, DOI 10.1007/BF01109045; FAUST D, 1991, BRAIN DAMAGE CLAIMS, V1; Jennett B, 1981, MANAGEMENT HEAD INJU; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; KAUFMAN AS, 1976, J LEARN DISABIL, V9, P160; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MATARAZZO JD, 1988, J CLIN PSYCHOL, V44, P940, DOI 10.1002/1097-4679(198811)44:6<940::AID-JCLP2270440615>3.0.CO;2-A; MATARAZZO JD, 1984, J CLIN NEUROPSYCHOL, V6, P381; McLean JE., 1990, PSYCHOL ASSESSMENT J, V2, P289, DOI [10.1037/1040-3590.2.3.289, DOI 10.1037/1040-3590.2.3.289]; MCLEAN JE, 1989, J CLIN PSYCHOL, V45, P912; PHILLIPS WC, 1983, AM J ROENTGENOL, V140, P1265, DOI 10.2214/ajr.140.6.1265; PLAKE BS, 1981, J CLIN PSYCHOL, V37, P142, DOI 10.1002/1097-4679(198101)37:1<142::AID-JCLP2270370127>3.0.CO;2-8; REED DG, 1988, J PSYCHIAT LAW, P405; Ryan J.J., 1992, PSYCHOL ASSESSMENT, V4, P63, DOI [https://doi.org/10.1037/1040-3590.4.1.63, DOI 10.1037/1040-3590.4.1.63]; SELZ M, 1979, J CONSULT CLIN PSYCH, V47, P258, DOI 10.1037/0022-006X.47.2.258; SHINKA JA, 1994, PSYCHOL ASSESSMENT, V6, P364; SILVERSTEIN AB, 1982, J CONSULT CLIN PSYCH, V50, P234; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1958, MEASUREMENT APPRAISA; Wechsler D., 1974, WECHSLER INTELLIGENC; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; WILLSON VL, 1985, J CLIN PSYCHOL, V41, P254, DOI 10.1002/1097-4679(198503)41:2<254::AID-JCLP2270410220>3.0.CO;2-4; Wolman BB., 1985, HDB INTELLIGENCE THE, P899; [No title captured]	28	6	7	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	SEP	1996	10	9					677	685		10.1080/026990596124098			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	VB635	WOS:A1996VB63500005	8853870				2022-02-06	
J	Boswell, WC; Boyd, CR; Lord, SA				Boswell, WC; Boyd, CR; Lord, SA			Percutaneous endoscopic gastrostomy with T-bar fixation in children	SURGICAL LAPAROSCOPY & ENDOSCOPY			English	Article						percutaneous endoscopic gastrostomy; gastrostomy; T-bar fixation; pediatrics		Percutaneous endoscopic gastrostomy (PEG) with the Ponsky ''pull'' technique has been the standard technique for pediatric gastrostomy tube placement since 1979. We evaluated safety and efficacy of PEG with the ''push'' technique and T-bar fixation. We reviewed PEGs performed in pediatric patients (less than or equal to 17 years) over a 31-month period, excluding patients with previous abdominal surgery. We evaluated age, indications, location, time, and complications. Endoscopy was performed, the stomach insufflated, and the anterior abdominal wall transilluminated. T-bar fasteners were inserted percutaneously under endoscopic control. Fasteners were ejected from the needle tip with a stylet and secured. A 14 or 18 French gastrostomy tube was placed through the center of previously placed T-bar fasteners by using a modified Seldinger technique. Fifteen children (mean age, 9 years) underwent the procedure for the need for long-term enteral alimentation (severe closed head injury) (n = 7), for progressive neurologic dysfunction with feeding disorder (n = 7), or for failure to thrive (cystic fibrosis) (n = 1). No significant major postoperative complications occurred. The technique proved safe and effective for gastrostomy in children.	MEM MED CTR, DEPT SURG EDUC, SAVANNAH, GA 31403 USA								BROWN AS, 1986, RADIOLOGY, V158, P543, DOI 10.1148/radiology.158.2.2934763; CAVE DR, 1986, GASTROINTEST ENDOSC, V32, P294, DOI 10.1016/S0016-5107(86)71852-X; DEITEL M, 1988, CAN J SURG, V31, P102; GAUDERER MWL, 1986, CURR PROB SURG, V23, P659; GAUDERER MWL, 1980, J PEDIATR SURG, V15, P872, DOI 10.1016/S0022-3468(80)80296-X; GREIF JM, 1986, GASTROINTEST ENDOSC, V32, P292, DOI 10.1016/S0016-5107(86)71851-8; JARNAGIN WR, 1992, ARCH SURG-CHICAGO, V127, P261; MEGUID MM, 1979, SURG GYNECOL OBSTET, V149, P27; PERSON JL, 1986, GASTROINTEST ENDOSC, V32, P309, DOI 10.1016/S0016-5107(86)71867-1; RUSSELL TR, 1984, AM J SURG, V148, P132, DOI 10.1016/0002-9610(84)90300-3; WASILJEW BK, 1982, AM J SURG, V143, P194; WILLS JS, 1985, RADIOLOGY, V154, P71, DOI 10.1148/radiology.154.1.3964955	12	6	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1051-7200			SURG LAPAROSC ENDOSC	Surg. Laparoscopy Endosc.	AUG	1996	6	4					262	265		10.1097/00019509-199608000-00003			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	VA483	WOS:A1996VA48300003	8840446				2022-02-06	
J	Ford, MR; Khalil, M				Ford, MR; Khalil, M			Evoked potential findings in mild traumatic brain injury .2. Scoring system and individual discrimination	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							HEAD-INJURY	Objective: To present an objective scoring system for evoked potential (EP) and electroencephalogram (EEG) findings from patients with suspected mild traumatic brain injury (TBI) as described in the preceding report and to rule out potentially confounding variables. Design: Matched two-group comparison design, with a second matched replication group. Setting: Private, ambulatory, nonemergency facility specializing in assessment, pain management, and rehabilitation of spine and related injuries. Patients and Other Participants: Patients were 54 consecutive referrals for computerized EP/EEG evaluation with histories of primarily motor vehicle accidents and symptoms consistent with mild TBI. Normal controls were 27 screened volunteers. Patients were arbitrarily divided into two groups and matched to the controls on the basis of age and gender. Main Outcome Measures: Outcome measures not included in this phase of investigation. A 0- to 10-point, objective scoring system based on EP and EEG differences was developed to quantify degree of electrophysiological abnormality (as defined by similarity to mild TBI ''profile'') in each subject's recordings. Results: Using a cut-off score of 5.0, 100% of normals were correctly classified, while 74% of the initial group of patients and 52% of a replication group were outside the normal range. The patient scores were not attributable to medication effects or poor performance on the P300 condition tasks. Scores were not related to loss of consciousness (LOG) at the time of the accident or to length of time postinjury. Conclusions: A reliable, objective scoring system was developed based on EP and EEG differences found in mild TBI. The scoring system was effective in discriminating individual patient and control recordings with clinically relevant accuracy. The results were not related to medication effects or poor performance on the attention tasks. Together, these two reports present evidence of electrophysiological dysfunction in mild TBI, with sufficient specificity for clinical application.	AUSTIN NEURO INST PA,FUNCT NEUROIMAGING LAB,AUSTIN,TX								FORD MR, UNPUB EVOKED POTENTI; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P154, DOI 10.1177/155005948101200402	4	6	6	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1996	11	3					16	21		10.1097/00001199-199606000-00005			6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UP774	WOS:A1996UP77400005					2022-02-06	
J	Pang, A; Lewis, SW				Pang, A; Lewis, SW			Bipolar affective disorder minus left prefrontal cortex equals schizophrenia	BRITISH JOURNAL OF PSYCHIATRY			English	Article							CLASSIFICATION; DIAGNOSIS; TWINS	Background. An investigation of the relationship between bipolar affective disorder and schizophrenia, following a severe head injury and removal of the left prefrontal cortex. Method. A single case report. Results. An individual with past history of bipolar affective disorder suffered traumatic damages to the left prefrontal cortex with a second lesion in the left temporal robe. The patient developed typical schizophrenia nine months later. The relevance of his brain lesions in determining the schizophrenic symptoms is discussed. Conclusion. We propose that the specific pattern of brain injury in this patient was sufficient to change the phenotype from bipolar affective disorder to schizophrenia.	CHINESE UNIV HONG KONG,SHA TIN,HONG KONG; UNIV S MANCHESTER,WITHINGTON HOSP,MANCHESTER M20 8LR,LANCS,ENGLAND					Lewis, Shon/0000-0003-1861-4652			CORYELL W, 1980, AM J PSYCHIAT, V137, P48; CROW TJ, 1990, BRIT J PSYCHIAT, V156, P788, DOI 10.1192/bjp.156.6.788; GUR RE, 1993, SCHIZOPHRENIA BULL, V19, P337, DOI 10.1093/schbul/19.2.337; HARLOW J, 1968, MASSACHUSETTS MED SO, V2, P338; KENDELL RE, 1987, BRIT MED BULL, V43, P499, DOI 10.1093/oxfordjournals.bmb.a072198; KENDLER KS, 1982, BRIT J PSYCHIAT, V141, P563, DOI 10.1192/bjp.141.6.563; LEWIS SW, 1989, PSYCHOL MED, V19, P5, DOI 10.1017/S0033291700010977; LEWIS SW, 1990, BRIT J PSYCHIAT, V157, P600, DOI 10.1192/bjp.157.4.600; LIDDLE PF, 1992, BRIT J PSYCHIAT, V160, P179, DOI 10.1192/bjp.160.2.179; MURRAY RM, 1992, SCHIZOPHRENIA BULL, V18, P319, DOI 10.1093/schbul/18.2.319; TAYLOR MA, 1992, AM J PSYCHIAT, V149, P22; TSUANG MT, 1981, ARCH GEN PSYCHIAT, V38, P535	12	6	6	0	2	ROYAL COLLEGE OF PSYCHIATRISTS	LONDON	BRITISH JOURNAL OF PSYCHIATRY 17 BELGRAVE SQUARE, LONDON, ENGLAND SW1X 8PG	0007-1250			BRIT J PSYCHIAT	Br. J. Psychiatry	MAY	1996	168	5					647	650		10.1192/bjp.168.5.647			4	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	UJ345	WOS:A1996UJ34500020	8733807				2022-02-06	
J	Schwarzkopf, SR; Dreinhofer, KE; Haas, NP; Tscherne, H				Schwarzkopf, SR; Dreinhofer, KE; Haas, NP; Tscherne, H			Traumatic dislocation of the hip	UNFALLCHIRURG			German	Article						dislocation of the hip; complications; follow-up studies; femur head necrosis	POSTERIOR DISLOCATION; FRACTURE-DISLOCATION; SEVERITY	The final outcome following isolated traumatic dislocation of the hip that is reduced within 6 h is generally believed to be excellent. Forty-nine patients with an isolated dislocation of the hip were treated between 1974 and 1989 at the Department of Traumatology of the Hannover Medical School. The majority of patients were involved in traffic accidents, and 42 had associated injuries. All dislocations primarily treated at our hospital were reduced by closed methods within 3 h, (average 85 min, range 10-180 min), followed by early mobilisation with partial weight-bearing for 2-3 weeks. 42 patients were evaluated after an average follow-up period of 7.7 years, Radiological signs of partial necrosis were seen in two patients. Mild arthrosis was found in seven patients, moderate degeneration in two and heterotopic ossifications in four patients (two Brooker II, one Brooker III, one hip ankylosed), Twenty-nine of 33 MRI examinations were normal, Despite early reduction only 9/12 anterior and 14/30 posterior dislocations revealed excellent and good results according to the Thompson and Epstein classification. According to the present study the important prognostic factors are the direction of the dislocation, the overall injury severity and the age at the time of injury.			Schwarzkopf, SR (corresponding author), UNIV ULM, ORTHOPAD KLIN, ORTOPAD ABT, REHABIL KRANKENHAUSES, OBERER ESELSBERG 45, D-89081 ULM, GERMANY.		Dreinhoefer, Karsten/AAO-9680-2021	Dreinhoefer, Karsten/0000-0001-6021-2804			ARMSTRONG JR, 1948, J BONE JOINT SURG BR, V30, P430, DOI 10.1302/0301-620X.30B3.430; BARNBECK F, 1987, ZBL CHIR, V112, P783; BECK E, 1979, HEFTE UNFALLHEILKD, V140, P221; BOHLER L, 1948, J BONE JOINT SURG BR, V30, P729; BRAV EA, 1962, J BONE JOINT SURG AM, V44, P1115, DOI 10.2106/00004623-196244060-00007; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; CHARNLEY J, 1972, Journal of Bone and Joint Surgery British Volume, V54, P61; DAUBIGNE RM, 1954, J BONE JOINT SURG AM, V36-A, P451, DOI 10.2106/00004623-195436030-00001; Epstein HC., 1980, TRAUMATIC DISLOCATIO; EPSTEIN HC, 1973, CLIN ORTHOP RELAT R, V92, P116; EPSTEIN HC, 1980, CLIN ORTHOP; Funsten RV, 1938, J BONE JOINT SURG, V20, P124; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; HOUGAARD K, 1986, ARCH ORTHOP TRAUM SU, V106, P32, DOI 10.1007/BF00435649; HOUGAARD K, 1987, J BONE JOINT SURG AM, V69A, P679, DOI 10.2106/00004623-198769050-00007; HUNTER G A, 1969, Journal of Bone and Joint Surgery British Volume, V51, P38; JACOB JR, 1987, CLIN ORTHOPAEDICS, V214, P249; JASKULKA RA, 1991, J BONE JOINT SURG BR, V73, P465, DOI 10.1302/0301-620X.73B3.1670451; JUNGBLUTH KH, 1978, BERUFSGENOSSENSCHAFT, V33, P69; LAMKE LO, 1970, ACTA ORTHOP SCAND, V41, P188, DOI 10.3109/17453677008991506; Levin P, 1992, SKELETAL TRAUMA, V1, P1329; MITCHELL DG, 1989, CLIN ORTHOP RELAT R, V244, P60; Morton KS, 1959, CAN J SURG, V3, P67; NICOLL EA, 1952, J BONE JOINT SURG BR, V34, P503; NIEDERWIESER B, 1991, HEFTE UNFALLHEIKUNDE, V220, P59; PANNICKE A, 1979, HEFTE UNFALLHEILKD, V140, P205; PROCTOR H, 1973, INJURY, V5, P1, DOI 10.1016/S0020-1383(73)80002-6; REIGSTAD A, 1980, J TRAUMA, V20, P603, DOI 10.1097/00005373-198007000-00010; ROSENTHAL RE, 1979, J TRAUMA, V19, P572, DOI 10.1097/00005373-197908000-00005; Sarkar M R, 1990, Unfallchirurgie, V16, P3, DOI 10.1007/BF02587988; SCHLICKEWEI W, 1993, INJURY, V24, P27, DOI 10.1016/0020-1383(93)90078-K; STEWART MJ, 1975, ACTA ORTHOP SCAND, V46, P507; STUCK W G, 1949, South Surg, V15, P659; STULBERG BN, 1989, CLIN ORTHOP RELAT R, V240, P181; SURACI AJ, 1986, J TRAUMA, V26, P458, DOI 10.1097/00005373-198605000-00008; THOMPSON VP, 1951, J BONE JOINT SURG AM, V33-A, P746, DOI 10.2106/00004623-195133030-00023; TSCHERNE H, 1987, CHIRURG, V58, P631; TSCHERNE H, 1988, HEFTE UNFALLHEILKD; UPADHYAY SS, 1983, J BONE JOINT SURG BR, V65, P150, DOI 10.1302/0301-620X.65B2.6826619; UPADHYAY SS, 1981, J BONE JOINT SURG BR, V63, P548, DOI 10.1302/0301-620X.63B4.7298682; WEIGAND H, 1978, UNFALLHEILKUNDE, V81, P20; WOLFEL R, 1991, HEFTE UNFALLHEILKD, V220, P60; YANG RS, 1991, CLIN ORTHOP RELAT R, P218	43	6	6	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0177-5537			UNFALLCHIRURG	Unfallchirurg	MAR	1996	99	3					168	174					9	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	UD761	WOS:A1996UD76100003	8685721				2022-02-06	
J	Kant, R; Zeiler, D				Kant, R; Zeiler, D			Hemiballismus following closed head injury	BRAIN INJURY			English	Article							HEMICHOREA-HEMIBALLISM; MOVEMENT-DISORDERS; BASAL GANGLIA; THALAMOTOMY; INFARCTION; LESIONS	Movement disorders are relatively rare after closed head injury (CHI), but when present they can go unrecognized if clinicians are not aware of their occurrence. We are presenting a case of hemiballismus which was not recognized over 3 years and was labelled as malingering or as psychosomatic. The symptoms have responded significantly to pharmacological interventions. The SPECT scan of the brain showed the lesions in the subthalamic areas while MRI, CT scans of brain and EEGs were reported normal. It is concluded that one should be aware of the existence of movement disorders after mild to moderate CHI, and that SPECT scan of the brain should be considered if a patient is symptomatic and other neuroimaging studies prove 'normal'.	MED COLL PENN,DEPT PSYCHIAT,PITTSBURGH,PA; HAHNEMANN UNIV,PITTSBURGH,PA				Kant, Ravi/F-7025-2013	Kant, Ravi/0000-0003-3878-9775			ANDREW J, 1982, J NEUROL NEUROSUR PS, V45, P815, DOI 10.1136/jnnp.45.9.815; ANTIN SP, 1967, NEUROLOGY, V17, P1068, DOI 10.1212/WNL.17.11.1068; BEDWELL SF, 1960, NEUROLOGY, V10, P619, DOI 10.1212/WNL.10.6.619; BULLARD DE, 1984, J NEUROSURG, V61, P316, DOI 10.3171/jns.1984.61.2.0316; CHANDRA V, 1982, ANN NEUROL, V12, P407, DOI 10.1002/ana.410120422; DAVIS JM, 1976, JAMA-J AM MED ASSOC, V235, P2812; DEWEY RB, 1989, ARCH NEUROL-CHICAGO, V46, P862, DOI 10.1001/archneur.1989.00520440044020; DUBINSKY RM, 1989, MOVEMENT DISORD, V4, P310, DOI 10.1002/mds.870040404; GILBERT GJ, 1975, JAMA-J AM MED ASSOC, V233, P535, DOI 10.1001/jama.233.6.535; GLASS JP, 1984, NEUROLOGY, V34, P204, DOI 10.1212/WNL.34.2.204; GONCE M, 1983, J NEUROL, V229, P121, DOI 10.1007/BF00313451; ICHISE M, 1994, J NUCL MED, V35, P217; KASE CS, 1981, NEUROLOGY, V31, P452; KREMER M, 1947, J NEUROL NEUROSUR PS, V10, P49, DOI 10.1136/jnnp.10.2.49; LANG AE, 1985, CAN J NEUROL SCI, V12, P125, DOI 10.1017/S0317167100046825; LENTON RJ, 1981, BRIT MED J, V283, P17, DOI 10.1136/bmj.283.6283.17; LEVESQUE MF, 1992, STEREOT FUNCT NEUROS, V58, P26, DOI 10.1159/000098967; LODDER J, 1981, NEUROLOGY, V31, P484, DOI 10.1212/WNL.31.4_Part_2.484; MARTIN JP, 1968, HDB CLIN NEUROLOGY, P435; MELAMED E, 1978, ANN NEUROL, V4, P582, DOI 10.1002/ana.410040627; MODESTI LM, 1979, APPL NEUROPHYSIOLOGY, P267; NATH A, 1987, NEUROLOGY, V37, P37, DOI 10.1212/WNL.37.1.37; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; Pearce J, 1972, JAMA, V219, P1345, DOI 10.1001/jama.219.10.1345; ROSENBLUM WI, 1981, NEUROSURGERY, V9, P613, DOI 10.1227/00006123-198112000-00001; ROWLANDS IP, 1972, BRIT MED J, V2, P296, DOI 10.1136/bmj.2.5808.296-c; SALOMEZ J, 1982, LARC MED, V10, P869; SRINIVAS K, 1987, NEUROLOGY, V37, P1428, DOI 10.1212/WNL.37.8.1428; TAMAOKA A, 1987, J NEUROL, V234, P124, DOI 10.1007/BF00314118; Tognetti F, 1986, Acta Neurol (Napoli), V8, P150; Tomlinson B, 1970, J CLIN PATHOL S4, V23, P154; VIDAKOVIC A, 1994, J NEUROL NEUROSUR PS, V57, P945, DOI 10.1136/jnnp.57.8.945; WHITTIER JR, 1949, J COMP NEUROL, V90, P281, DOI 10.1002/cne.900900303; WHITTIER JR, 1949, J COMP NEUROL, V90, P319, DOI 10.1002/cne.900900304; WILSON JTL, 1992, J HEAD TRAUMA REHAB, V7, P29	35	6	6	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	FEB	1996	10	2					155	158		10.1080/026990596124665			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	UB726	WOS:A1996UB72600011	8696317				2022-02-06	
J	Sandel, ME				Sandel, ME			Medical management of the comatose, vegetative, or minimally responsive patient	NEUROREHABILITATION			English	Article						brain injury; medical complications; coma; vegetative state	SEVERE HEAD-INJURY; TRAUMATIC BRAIN INJURY; VENTRICULAR ENLARGEMENT; POSTTRAUMATIC SEIZURES; DIABETES-INSIPIDUS; HYDROCEPHALUS; REHABILITATION; DISORDERS; EPILEPSY	This review outlines the range of medical problems occurring in brain injured patients in coma or emerging from coma, including the population of vegetative and minimally responsive patients. This range of medical problems includes those associated with the original brain injury or associated injuries, those representing complications of bedrest, and those caused by the use of medications that may retard recovery or contribute to an obtunded or comatose state. The review is organized by organ systems, each section including a brief discussion with reference to more indepth discussions in other sources. A number of algorithms are included to define approaches to evaluation of common clinical presentations which may be helpful to clinicians treating this population in acute or subacute settings.			Sandel, ME (corresponding author), UNIV PENN,MED CTR,DEPT REHABIL MED,5 W GATES BLDG,3400 SPRUCE ST,PHILADELPHIA,PA 19104, USA.						BARRECA T, 1980, J CLIN ENDOCR METAB, V51, P1279, DOI 10.1210/jcem-51-6-1279; BELL RM, 1988, J TRAUMA, V28, P923, DOI 10.1097/00005373-198807000-00004; BERROL S, 1992, TRAUMATIC BRAIN INJU, V3; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; BROOKE MM, 1986, ARCH PHYS MED REHAB, V67, P634; BUSCH L, 1989, ARCH PHYS MED REHAB, V70, pA33; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; CORDOSA ER, 1985, SURG NEUROL, V23, P261; Costanzo RM, 1986, CLIN MEASUREMENTS TA, P565; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; CRYER PE, 1980, NEW ENGL J MED, V303, P436; DOUGHERTY D, 1992, PHYS MED REHABIL CLI, V3, P389; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; FEENEY DM, 1979, ARCH NEUROL-CHICAGO, V36, P8, DOI 10.1001/archneur.1979.00500370038005; FITZSIMMONS AS, 1993, ARCH PHYS MED REHAB, V74, P770, DOI 10.1016/0003-9993(93)90042-9; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1981, CLIN ORTHOP RELAT R, V155, P162; GERARD G, 1986, SEMIN NEUROL, V6, P17, DOI 10.1055/s-2008-1041443; GIZZI M, 1995, J HEAD TRAUMA REHABI, V10, P33; HACKENBERRY LE, 1982, CRIT CARE MED, V10, P641; HERZOG AG, 1982, ARCH NEUROL-CHICAGO, V39, P133, DOI 10.1001/archneur.1982.00510150003001; HORN LJ, 1989, PHYS MED REHABIL STA, V3; JACKSON MD, 1989, ARCH PHYS MED REHAB, V70, P553; JENNETT B, 1990, REHABILITATION ADULT; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; KAUFMAN HH, 1995, CENTRAL NERVOUS SYST, P187; KIEL MK, 1994, ARCH PHYS MED REHAB, V75, P116; KISHORE PRS, 1978, NEURORADIOLOGY, V16, P261, DOI 10.1007/BF00395266; KLINGBEIL GEG, 1985, ARCH PHYS MED REHAB, V66, P44; KLINGBEIL GEG, 1988, ARCH PHYS MED REHAB, V69, P493; LABI ME, 1989, BRAIN INJURY, V4, P365; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; LERMAN RM, 1989, CURR CONCEPTS REHABI, P50; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEW MF, 1993, PHYS MED REHABIL STA, V7, P519; MARKWALDER TM, 1989, J NEUROSURG, V25, P352; MEYERS CA, 1983, J NEUROL NEUROSUR PS, V46, P1092, DOI 10.1136/jnnp.46.12.1092; MEYTHALER JM, 1994, ARCH PHYS MED REHAB, V75, P816; NOTMAN DD, 1980, J TRAUMA, V20, P599, DOI 10.1097/00005373-198007000-00009; PIDCOCK FS, 1994, ARCH PHYS MED REHAB, V5, P695; REYNOLDS EH, 1985, DRUGS, V29, P570, DOI 10.2165/00003495-198529060-00004; SAKAI C S, 1984, Seminars in Hearing, V5, P157, DOI 10.1055/s-0028-1095229; SANDEL ME, 1986, ARCH PHYS MED REHAB, V67, P469; SANDEL ME, 1993, ARCH PHYS MED REHAB, V74, P411; SANDEL ME, MED REHABILITATION T; SANDEL ME, 1993, ARCH PHYS MED REHAB, V74, P1284; SANDEL ME, 1990, ARCH PHYS MED REHAB, V71, P764; SANDEL ME, 1990, COMA EMERGING PATIEN; SPIELMAN G, 1983, ARCH PHYS MED REHAB, V64, P539; STEIN S, 1990, COMA EMERGING PATIEN, P543; STONE L, 1988, CLIN ORTHOP RELAT R, V233, P136; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; VANDONGEN KJ, 1980, NEUROSURGERY, V7, P14, DOI 10.1227/00006123-198007000-00003; WHYTE J, 1986, J HEAD TRAUMA REHAB, V1, P39; WIKKELSO C, 1986, ACTA NEUROL SCAND, V73, P566, DOI 10.1111/j.1600-0404.1986.tb04601.x; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; YARKONY GM, 1987, CLIN ORTHOP RELAT R, P93; YOUNG B, 1992, J NEUROTRAUM, V9, pS375	59	6	7	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	FEB	1996	6	1					9	17		10.1016/1053-8135(95)00144-1			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TZ377	WOS:A1996TZ37700003	24525682				2022-02-06	
J	LeonCarrion, J; RodriguezDuarte, R; BarrosoMartin, JM; Machuca, F; DominguezMorales, MR				LeonCarrion, J; RodriguezDuarte, R; BarrosoMartin, JM; Machuca, F; DominguezMorales, MR			The attentional system in brain injury survivors	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						brain injury; attention neuropsychology; cognition; Posner's attentional system		The present study was designed to check the model of attention proposed by Posner and Petersen (1990), in patients with traumatic brain injury. We analyzed a series of neuropsychological tests administered to these patients after they were discharged from the hospital. Scores obtained from this group were subjected to factor analysis. The results of this analysis could be characterized by four factors which accounted for 85.4% of the variance. According to our data, factor 1 (perceptual and motor speed) and factor 2 (vigilance and alertness) represent Posner's posterior attention system. Factor 3 (encoding) and factor 4 (shifting) represent Posner's anterior attention system (AAS), but we have to consider that the AAS is not only attention but is shared by other cognitive processes. The results also suggest that the attention system could be stable and could be defined independently from the type of patient and type of illness.	UNIV SEVILLA,TRAUMATOL HOSP VIRGEN ROCIO,SEVILLE,SPAIN		LeonCarrion, J (corresponding author), UNIV SEVILLA,HUMAN COGNIT NEUROPSYCHOL LAB,AVDA SAN FRANCISCO JAVIER S-N,E-41018 SEVILLE,SPAIN.						DAIGNEAULT S, 1989, J CLIN EXPT NEUROPSY, V10, P58; GENTILINI M, 1989, MILD HEAD INJURY, P163; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; Kahneman D., 1973, ATTENTION EFFORT; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Mirsky A., 1989, INTEGRATING THEORY P; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Shum DHK, 1990, CLIN NEUROPSYCHOL, V4, P151, DOI DOI 10.1080/13854049008401508; WOOD RL, 1988, J LEARN DISABIL, V21, P327, DOI 10.1177/002221948802100603	11	6	6	0	3	GORDON BREACH SCI PUBL LTD	READING	C/O STBS LTD PO BOX 90, READING, BERKS, ENGLAND RG1 8JL	0020-7454			INT J NEUROSCI	Int. J. Neurosci.		1996	85	3-4					231	236		10.3109/00207459608986685			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	UL238	WOS:A1996UL23800006	8734561				2022-02-06	
J	Nemeth, AJ				Nemeth, AJ			Behavior-descriptive data on cognitive, personality, and somatic residua after relatively mild brain trauma: Studying the syndrome as a whole	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							MINOR HEAD-INJURY; SYMPTOMS; SEQUELAE; PSYCHOLOGY; TOMOGRAPHY; RECOVERY	Protracted symptomatology in some victims of mild traumatic brain injury (MTBI) continues to puzzle researchers. This study endeavors to demonstrate that all aspects of the syndrome - cognitive, physical, personal/psychosocial, and situational - must be considered along with their nonlinear interaction, for resolving the issue and advancing our understanding of the disorder's dual etiology. The sample consisted of 21 MTBI patients referred for clinical-neuropsychologic evaluation. The Grounded Theory model was followed for data generation and retrospective analysis of records. Raw-score profiles, consisting of self-reports and reports of reliable observers tabulated on 20 behavioral categories of cognitive, personality, and somatic dysfunction, were studied against the background of biographical and situational information. The individually specific meaning of profile variables in the context of their interaction with personality and life-situational factors (as uncovered through comparative analysis of pre- and post-injury functioning) was portrayed in excerpts from case studies. Copyright (C) 1996 National Academy of Neuropsychology									ADAMS KM, 1991, J CLIN EXP NEUROPSYC, V13, P388, DOI 10.1080/01688639108401053; BARTON S, 1994, AM PSYCHOL, V49, P5, DOI 10.1037/0003-066X.49.1.5; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; BOHNEN N, 1992, BRIT J PSYCHIAT, V159, P860; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; CARTLIDGE NEF, 1978, SCOT MED J, V23, P103, DOI 10.1177/003693307802300146; CHELUNE GJ, 1986, NEUROPSYCHOLOGY HDB; CHRITCHLEY M, 1969, LATE EFFECTS HEAD IN, P3; Cohen F, 1983, HDB HLTH HLTH CARE H, P608; Denzin Norman K, 1978, RES ACT THEORETICAL; ERICKSON C, 1986, HDB CLIN MEMORY ASSE; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Glaser B., 1967, DISCOVERY GROUNDED T; Glaser B.G., 1978, THEORETICAL SENSITIV; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1974, PSYCHOL EFFECTS CONC; HART T, 1986, CLIN NEUROPYSCHOLOGY; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; HEINRICHS RW, 1990, PROF PSYCHOL-RES PR, V21, P171, DOI 10.1037/0735-7028.21.3.171; HENWOOD KL, 1992, BRIT J PSYCHOL, V83, P97, DOI 10.1111/j.2044-8295.1992.tb02426.x; Jacobson SA, 1963, POSTTRAUMATIC SYNDRO; Kaplan E., 1983, HOLISTIC DEV PSYCHOL; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KELLY R, 1975, Forensic Science, V6, P17, DOI 10.1016/0300-9432(75)90219-8; KELLY R, 1981, J ROY SOC MED, V74, P242; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEVIN HS, 1989, MILD HEAD INJURY, pR8; LEVIN HS, 1988, 2 NEURO MED; LEVINE R, 1992, ANAL DYNAMIC PSYCHOL; LEWIS A, 1942, P ROY SOC MED, V35, P601; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; LEZAK MD, 1978, AM J PHYS MED REHAB, V57, P9; LEZAK MD, 1984, CLIN NEUROPSYCHOLOGY; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Luria A. R., 1979, MAKING MIND; LURIA AR, 1977, AM PSYCHOL, V32, P959, DOI 10.1037/0003-066X.32.11.959; Marshall LF, 1989, MILD HEAD INJURY, P276; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V0005, P00213, DOI DOI 10.1037/0894-4105.5.3.213; MECHANIC D, 1983, HDB HLTH HLTH CARE H, P591; MERSKEY H, 1972, BRAIN, V95, P521, DOI 10.1093/brain/95.3.521; NEMETH AJ, 1991, MED TRIAL TECHNIQUE, V37, P478; NEMETH AJ, 1995, IN PRESS WHY DO SOME; NEMETH AJ, 1989, AM J TRIAL ADVOC, V12, P239; NEMETH AJ, 1995, AM J FORENSIC PSYCH, V13, P47; NEWCOMBE F, 1979, HDB BEHAVIORAL NEURO, V2, P495; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Patton M.Q., 1990, QUALITATIVE EVALUATI; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 1986, CLIN NEUROPSYCHOLOGY, P135; RENNIE DL, 1988, CAN PSYCHOL, V29, P139, DOI 10.1037/h0079765; RENNIE DL, 1990, CLIENT CTR EXPT THER; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSE D, 1987, TRENDS NEUROSCI, V10, P196, DOI 10.1016/0166-2236(87)90146-9; ROTHKE S, 1989, INT J CLIN NEUROPSYC, V11, P134; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Rutherford W. H., 1989, MILD HEAD INJURY, P217; Sacks O., 1990, CONT NEUROPSYCHOLOGY, P181; SEKINO H, 1981, Neurologia Medico-Chirurgica, V21, P677; SHAPIRO MB, 1970, PSYCHOL ASSESSMENT M, P645; SOLOMON GF, 1993, BRAIN BEHAV IMMUN, V7, P352, DOI 10.1006/brbi.1993.1035; Strauss I, 1934, ARCH NEURO PSYCHIATR, V31, P893, DOI 10.1001/archneurpsyc.1934.02250050011001; SYMONDS C, 1962, LANCET, V1, P1; TAYLOR AR, 1967, BRIT MED J, V3, P67, DOI 10.1136/bmj.3.5557.67; Teuber H-L, 1969, LATE EFFECTS HEAD IN, P13; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; VARNEY NR, 1995, J HEAD TRAUMA REHAB, V10, P18; VARNEY NR, 1990, COGNITIVE REHABILITA, V8, P30; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Walsh K. W., 1985, UNDERSTANDING BRAIN; Walsh K. W., 1978, NEUROPSYCHOLOGY CLIN; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; WRIGHTSON P, 1989, MILD HEAD INJURY, P245	77	6	6	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.		1996	11	8					677	695		10.1016/S0887-6177(96)80004-7			19	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	VY435	WOS:A1996VY43500004		Bronze			2022-02-06	
J	COWELL, LC; COHEN, RF				COWELL, LC; COHEN, RF			AMANTADINE - A POTENTIAL ADJUVANT THERAPY FOLLOWING TRAUMATIC BRAIN INJURY	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article									SPAULDING REHABIL HOSP, OUTPATIENT TBI SERV, BOSTON, MA USA; NEW ENGLAND REHABIL HOSP, WOBURN, MA USA		COWELL, LC (corresponding author), HARVARD UNIV, SCH MED, DIV PHYS MED & REHABIL, BOSTON, MA 02115 USA.						ALLEN RM, 1983, CLIN NEUROPHARMACOL, V6, pS64; Andersson Stein, 1992, Tidsskrift for den Norske Laegeforening, V112, P2070; ATKINSON WL, 1986, ARCH INTERN MED, V146, P1751, DOI 10.1001/archinte.146.9.1751; Chandler M C, 1988, Brain Inj, V2, P309; DUFF KC, 1994, VIROLOGY, V202, P287, DOI 10.1006/viro.1994.1345; Gilman AG, 1990, GOODMAN GILMANS PHAR, V8th; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; KORNHUBER J, 1991, EUR J PHARM-MOLEC PH, V206, P297, DOI 10.1016/0922-4106(91)90113-V; MARIN RS, 1995, J NEUROPSYCH CLIN N, V7, P23; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; ROCA RP, 1990, J AM GERIATR SOC, V38, P675, DOI 10.1111/j.1532-5415.1990.tb01428.x; Roth J. R, 1986, BIOCH BASIS NEUROPHA; SCHWAB RS, 1969, J AMER MED ASSOC, V208, P1168, DOI 10.1001/jama.208.7.1168; SHIELDS WD, 1985, NEUROLOGY, V35, P579, DOI 10.1212/WNL.35.4.579; SIEVER LJ, 1981, J CLIN PSYCHOPHARM, V1, P2, DOI 10.1097/00004714-198101000-00002; STOOF JC, 1992, CLIN NEUROL NEUROSUR, V94, pS4; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; WILCOX JA, 1990, NEUROPSYCHOBIOLOGY, V23, P144	18	6	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	1995	10	6					91	94		10.1097/00001199-199512000-00018			4	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ661	WOS:A1995TJ66100014					2022-02-06	
J	GLASS, I; GROSWASSER, Z; GROSWASSERREIDER, I				GLASS, I; GROSWASSER, Z; GROSWASSERREIDER, I			IMPERSISTENT EXECUTION OF SACCADIC EYE-MOVEMENTS AFTER TRAUMATIC BRAIN INJURY	BRAIN INJURY			English	Article								A dynamic scoring system was developed to quantitatively resolve the ability of a subject to persistently execute a repeated motor act. Saccadic eye movements in response to pseudo-random and periodic stimuli were examined in patients with traumatic brain injury (TBI) and in normal subjects. Results indicated significantly lower dynamic persistence scores for the former group (50.5 +/- 32.2% vs 94.1 +/- 4.4%). Analysis of the patients' data revealed a stronger association of low scores with right hemisphere damage than with left hemisphere damage (39.4 +/- 28.9% vs 76.6 +/- 15.6%). Results are interpreted in terms of high-level attention impairments, not in terms of specific deficits in eye movement ability.	TEL AVIV UNIV, SACKLER FAC MED, IL-69978 TEL AVIV, ISRAEL		GLASS, I (corresponding author), LOEWENSTEIN HOSP & REHABIL CTR, POB 3, IL-43100 RAANANA, ISRAEL.						DALLOS PJ, 1963, IEEE T AUTOMAT CONTR, P218; FISHER M, 1956, J NERV MENT DIS, V123, P201, DOI 10.1097/00005053-195603000-00001; GUTTON D, 1985, EXPT BRAIN RES, V58, P455; JOYNT RJ, 1962, NEUROLOGY, V12, P876, DOI 10.1212/WNL.12.12.876; KERTESZ A, 1985, NEUROLOGY, V35, P662, DOI 10.1212/WNL.35.5.662; Luria AR, 1969, HDB CLINICAL NEUROLO, P725; RON S, 1989, BRAIN BEHAV EVOLUT, V33, P179, DOI 10.1159/000115925; RON S, 1986, SENSORIMOTOR PLASTIC, P201; RON S, 1980, PROGR OCULOMOTOR RES, P233; STARK L, 1962, IRE T HUM FACT ELECT, VHFE3, P52, DOI 10.1109/THFE2.1962.4503342; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; ZEE DS, 1984, NEUROOPHTHALMOLOGY, V3, P141	12	6	6	0	1	TAYLOR & FRANCIS LTD LONDON	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	NOV-DEC	1995	9	8					769	775		10.3109/02699059509008233			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	TH499	WOS:A1995TH49900002	8605510				2022-02-06	
J	ARAKAWA, S; NAKAMURA, S; KAWASHIMA, N; NISHIIKE, S; OKUYAMA, S				ARAKAWA, S; NAKAMURA, S; KAWASHIMA, N; NISHIIKE, S; OKUYAMA, S			ANTAGONIZING EFFECTS OF VA-045 ON REDUCED ACTIVITY OF RAT LOCUS-COERULEUS NEURONS FOLLOWING HEAD-INJURY OR INTRAVENOUS-INJECTION OF CLONIDINE	LIFE SCIENCES			English	Article						VA-045; LOCUS COERULEUS; HEAD INJURY; CLONIDINE; CONSCIOUSNESS	ELECTROENCEPHALOGRAPHIC ACTIVITY; POWER SPECTRUM; CERULEUS; MICROINFUSION; HIPPOCAMPUS; ACTIVATION; NEOCORTEX; RECEPTOR	Based on the finding that VA-045, a novel apovincaminic acid derivative, had improved disturbance in consciousness, we examined the effects of the drug an the electrical activity of locus coeruleus (LC) neurons in animal models of consciousness disturbance. The animal models of consciousness disturbance used in this experiment were closed head injury (CHI) and intravenous injection of clonidine. CHI as well as clonidine injection reduced the spontaneous activity of LC neurons. The reduction of the spontaneus activity of LC neurons following CHI or clonidine injection was restored by intravenous injection of VA-045. The change of LC neuronal activity induced by VA-045 preceded desynchronization of EEG. These results suggest that VA-045 exerts its ameliorating effect on consciousness disturbance, at least in part, by augmenting the spontaneous activity of noradrenergic LC neurons.	YAMAGUCHI UNIV, SCH MED, DEPT PHYSIOL, UBE, YAMAGUCHI 755, JAPAN; KANAZAWA UNIV, FAC MED, DEPT PHYSIOL, KANAZAWA, ISHIKAWA 920, JAPAN; TAISHO PHARMACEUT CO LTD, MED RES LABS, 1ST LAB, OMIYA, SAITAMA 330, JAPAN; OSAKA UNIV, SCH MED, DEPT OTOLARYNGOL, SUITA, OSAKA 565, JAPAN					Nakamura, Shoji/0000-0002-8004-8893			Arakawa Shiro, 1994, Japanese Journal of Pharmacology, V64, p198P; ASHTON H, 1987, BRAIN STEM DISORDERS, pP547; ASTONJONES G, 1991, PROG BRAIN RES, V88, P47; BAGETTA G, 1990, BRIT J PHARMACOL, V101, P655, DOI 10.1111/j.1476-5381.1990.tb14136.x; BERRIDGE CW, 1993, NEUROSCIENCE, V55, P381, DOI 10.1016/0306-4522(93)90507-C; BERRIDGE CW, 1991, J NEUROSCI, V11, P3135; BUTLER PD, 1990, J NEUROSCI, V10, P176; CEDARBAUM JM, 1976, BRAIN RES, V112, P413, DOI 10.1016/0006-8993(76)90297-3; DESARRO GB, 1987, BRIT J PHARMACOL, V90, P675; DESARRO GB, 1988, BRIT J PHARMACOL, V95, P1278; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; JACOBS BL, 1986, PROG NEUROBIOL, V27, P183, DOI 10.1016/0301-0082(86)90008-0; KAWASHIMA Y, 1993, J MED CHEM, V36, P815, DOI 10.1021/jm00059a004; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MIYATA N, 1993, LIFE SCI, V52, pPL181, DOI 10.1016/0024-3205(93)90115-J; NAKAMURA S, 1977, J PHYSIOL-LONDON, V267, P641, DOI 10.1113/jphysiol.1977.sp011830; NAKAMURA S, 1990, PROG NEUROBIOL, V34, P505, DOI 10.1016/0301-0082(90)90018-C; OKUYAMA S, 1994, GEN PHARMACOL, V25, P1311; OKUYAMA S, 1993, LIFE SCI, V53, pPL273, DOI 10.1016/0024-3205(93)90603-Z; OKUYAMA S, 1994, LIFE SCI, V55, P1577, DOI 10.1016/0024-3205(94)00319-X; OKUYAMA S, 1993, RES COMMUN CHEM PATH, V82, P91; SEGAL IS, 1988, ANESTHESIOLOGY, V69, P818, DOI 10.1097/00000542-198812000-00004; YAMADA S, 1994, RES COMMUN MOL PATH, V86, P83	24	6	6	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	SEP 29	1995	57	19					1803	1810		10.1016/0024-3205(95)02158-F			8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	RX236	WOS:A1995RX23600010	7475922				2022-02-06	
J	SAPONJIC, RM; HOANE, MR; BARBAY, S; BARTH, TM				SAPONJIC, RM; HOANE, MR; BARBAY, S; BARTH, TM			SCOPOLAMINE FACILITATES RECOVERY OF FUNCTION FOLLOWING UNILATERAL ELECTROLYTIC SENSORIMOTOR CORTEX LESIONS IN THE RAT	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						FORELIMB-PLACING; MUSCARINIC RECEPTOR; ACETYLCHOLINE; SECONDARY BRAIN DAMAGE	TRAUMATIC BRAIN INJURY; CEREBRAL-ARTERY OCCLUSION; PROTEIN-KINASE-C; SUBSTANTIA NIGRA; CAUDATE-PUTAMEN; GLOBUS PALLIDUS; FRONTAL-CORTEX; MOTOR CORTEX; AMPHETAMINE; BEHAVIOR	Following brain injury there is an excessive release of excitatory neurotransmitters that may lead to secondary cell death. Although much research has focused on glutamate-NMDA receptor interactions, acetylcholine-muscarinic receptor interactions may also prove to be important for an understanding of the pathophysiological events that lead to secondary degeneration after brain damage. Previous experiments have shown that the muscarinic receptor antagonist scopolamine facilitates recovery from very transient (1 h-10 days) behavioral deficits after fluid percussion injury. The present study extends these findings by investigating whether scopolamine can facilitate recovery from the more enduring behavioral deficits (14-60 days) that follow electrolytic lesions of the rat somatic sensorimotor cortex (SMC). Rats received unilateral lesions of the SMC and a regimen of scopolamine (1 mg/kg) or saline beginning 15 min after surgery. Following SMC lesions rats exhibited an impairment in placing the forelimb contralateral to the lesion as well as an ipsilateral somatosensory asymmetry on a bilateral tactile stimulation test. Rats treated with scopolamine showed a reduction in the initial magnitude of the contralateral placing deficit and an accelerated rate of recovery compared with saline-treated control rats. In contrast, scopolamine had no effect on recovery from the ipsilateral somatosensory asymmetry. These data are consistent with the idea that muscarinic receptor stimulation plays a role in the production of secondary brain damage, that blockade of this receptor leads to a facilitation of recovery on some behavioral tasks, and that electrolytic lesions may trigger some of the same posttraumatic events described in other models of neural trauma.	TEXAS CHRISTIAN UNIV,DEPT PSYCHOL,FT WORTH,TX 76129; TEXAS CHRISTIAN UNIV,CHEM BEHAV PROGRAM,FT WORTH,TX 76129					Hoane, Michael/0000-0001-7779-2657			ARNFRED T, 1968, ACTA PHARMACOL TOX, V26, P384; BARABAN JM, 1987, TRENDS NEUROSCI, V10, P57, DOI 10.1016/0166-2236(87)90022-1; Barbay S., 1992, Society for Neuroscience Abstracts, V18, P870; BARBAY S, 1994, THESIS; BARTH TM, 1990, STROKE, V21, P153; BARTH TM, 1994, BEHAV NEUROSCI, V108, P818, DOI 10.1037/0735-7044.108.4.818; BARTH TM, 1987, EXP NEUROL, V95, P661, DOI 10.1016/0014-4886(87)90307-4; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; BERRIDGE MJ, 1989, JAMA-J AM MED ASSOC, V262, P1834; BIELENBERG GW, 1991, BRAIN RES, V552, P338, DOI 10.1016/0006-8993(91)90101-Z; CARLTON PL, 1970, PSYCHOPHARMACOLOGY, V2, P377; CARLTON PL, 1961, J PHARMACOL EXP THER, V134, P91; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; CHERAMY A, 1973, EUR J PHARMACOL, V21, P246, DOI 10.1016/0014-2999(73)90234-3; CHOI DW, 1987, J NEUROSCI, V7, P357; CORWIN JV, 1986, EXP NEUROL, V94, P683, DOI 10.1016/0014-4886(86)90247-5; COSTALL B, 1972, NEUROPHARMACOLOGY, V11, P645, DOI 10.1016/0028-3908(72)90073-1; COSTALL B, 1972, NEUROPHARMACOLOGY, V11, P317, DOI 10.1016/0028-3908(72)90017-2; DAIL WG, 1981, BRAIN RES, V211, P79, DOI 10.1016/0006-8993(81)90068-8; DIETRICH WD, 1990, STROKE, V21, P147; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FADEN AI, 1993, TRENDS PHARMACOL SCI, V13, P29; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; FEENEY DM, 1988, PHARM APPROACHES TRE, P121; FIBIGER HC, 1970, J COMP PHYSIOL PSYCH, V72, P384, DOI 10.1037/h0029741; FOSTER AC, 1987, NEUROSCI LETT, V76, P307, DOI 10.1016/0304-3940(87)90420-4; GILL R, 1987, J NEUROSCI, V7, P3343; Goldstein L B, 1990, Restor Neurol Neurosci, V1, P311, DOI 10.3233/RNN-1990-1501; GOODALE DB, 1973, PHARMACOLOGIST, V15, P174; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; HARA H, 1993, BRAIN RES, V618, P251, DOI 10.1016/0006-8993(93)91273-U; Hayes R L, 1986, Cent Nerv Syst Trauma, V3, P163; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; HOVDA DA, 1984, BRAIN RES, V298, P358, DOI 10.1016/0006-8993(84)91437-9; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; JONES TA, 1992, BEHAV BRAIN RES, V51, P1, DOI 10.1016/S0166-4328(05)80306-7; KACZMAREK LK, 1987, TRENDS NEUROSCI, V10, P30, DOI 10.1016/0166-2236(87)90122-6; KLAWANS HL, 1972, J NEUROL SCI, V17, P303, DOI 10.1016/0022-510X(72)90035-4; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1992, J NEUROTRAUMA S2, V9, P463; METZ B, 1971, J NEUROSURG, V35, P523, DOI 10.3171/jns.1971.35.5.0523; MEYER PM, 1963, J COMP PHYSIOL PSYCH, V56, P402, DOI 10.1037/h0049297; NEAFSEY EJ, 1982, BRAIN RES, V232, P151, DOI 10.1016/0006-8993(82)90617-5; Paxinos G, 1986, RAT BRAIN STEREOTAXI; ROBINSON SE, 1990, BRAIN RES, V511, P141, DOI 10.1016/0006-8993(90)90233-2; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SACHS E, 1957, J NEUROSURG, V14, P22, DOI 10.3171/jns.1957.14.1.0022; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; SCHMANKE TD, 1993, SOC NEUR ABSTR, V19, P1130; STADLER H, 1973, BRAIN RES, V55, P476, DOI 10.1016/0006-8993(73)90317-X; SUTTON RL, 1989, BEHAV NEUROSCI, V103, P327; TOWER DB, 1949, CAN J RES E, V27, P120, DOI 10.1139/cjr49e-017; Von Monakow C, 1969, BRAIN BEHAVIOR, P27; WEST M, 1981, BRAIN RES, V225, P271, DOI 10.1016/0006-8993(81)90835-0	62	6	6	0	1	ELSEVIER SCI PUBL IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.	SEP	1995	8	4					205	212					8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RZ059	WOS:A1995RZ05900006	21551826				2022-02-06	
J	KOSMIDIS, MH; FANTIE, BD				KOSMIDIS, MH; FANTIE, BD			IMPAIRED AVOIDANCE-LEARNING AFTER CLOSED-HEAD INJURY - DISSOCIATION BETWEEN 2 TASKS DUE TO CLASSICAL-CONDITIONING	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							ANTICIPATORY BEHAVIOR DEFICITS; ATTENTION; SEQUELAE; DYSFUNCTION; CHILDREN; RECOVERY; BRAIN	Like controls, a Closed-Head Injury (CHI) group learned quickly to press a button during a 3-s warning stimulus in order to avoid a noxious buzzer. In a similar task, however, the CHI group had greater difficulty achieving the learning criterion compared to controls when required to prevent an innocuous visual display (i.e., a circle). The difficulty levels of these two avoidance tasks were identical. The major differences concerned the temporal contiguity of the warning cue with the stimulus to be avoided and the intrinsic aversiveness of the buzzer compared to the appearance of a circle on a computer screen. We hypothesize that, although both tasks were operant in essential character, the buzzer may have produced a degree of classical conditioning. These results suggest that CHI survivors may have some difficulty forming connections between arbitrary stimuli when performance depends almost entirely upon conscious, effortful processing. When a stimulus is sufficiently noxious to be capable of producing an affective or autonomic response. however, automatic processes may aid in the formation of associations.	AMERICAN UNIV,HUMAN NEUROPSYCHOL LAB,WASHINGTON,DC 20016		KOSMIDIS, MH (corresponding author), NIMH,PSYCHOL & PSYCHOPATHOL LAB,9000 ROCKVILLE PIKE,BLDG 10,ROOM 4C110,BETHESDA,MD 20892, USA.		Kosmidis, Mary H/AAN-2104-2021	Fantie, Bryan D./0000-0002-1901-378X; Kosmidis, Mary/0000-0001-8790-1220			Benson D.F., 1986, FRONTAL LOBES; BENSON DF, 1989, NEUROLOGY PSYCHIAT M, P266; BLEIBERG J, 1985, INT J CLIN NEUROPSYC, V7, P153; BLOUIN A, 1985, C DIS OPERATIONS MAN; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; FANTIE B D, 1989, Society for Neuroscience Abstracts, V15, P132; FANTIE BD, 1994, CLIN NEUROPSYCHOL, V8, P379, DOI 10.1080/13854049408402040; FANTIE BD, 1988, CANADIAN PSYCHOL, V29, P235; FANTIE BD, 1991, NEUROPSYCHOLOGY LAW, P186; FREEDMAN PE, 1987, J NEUROL NEUROSUR PS, V50, P398, DOI 10.1136/jnnp.50.4.398; FRITH CD, 1988, BRIT J PSYCHIAT, V15, P437; GOLDBERG E, 1989, CONT APPRAOCHES PSYC, P213; GOLDBERG G, 1987, FRONTAL LOBES REVISI, P273; GRUBB RL, 1974, NEUROLOGICAL PATHOPH, P292; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; Hecaean H, 1975, PSYCHIATRIC ASPECTS, P137; Heilman K.M., 1983, LOCALIZATION NEUROPS, P471; HIRST W, 1982, PSYCHOL BULL, V91, P435, DOI 10.1037/0033-2909.91.3.435; Holbourn AHS, 1943, LANCET, V2, P438; Kolb B., 1990, FUNDAMENTALS HUMAN N; LAMPERT PW, 1984, JAMA-J AM MED ASSOC, V251, P2676, DOI 10.1001/jama.251.20.2676; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; Lezak M., 1984, CLIN NEUROPSYCHOLOGY, P29; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; Luria A.R., 1966, HIGHER CORTICAL FUNC; Luria A.R., 1973, WORKING BRAIN; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MESULAM MM, 1987, PRINCIPLES BEHAV NEU, P125; MILNER B, 1984, TRENDS NEUROSCI, V7, P403, DOI 10.1016/S0166-2236(84)80143-5; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; MIRSKY AF, 1987, ENVIRON HEALTH PERSP, V74, P191, DOI 10.2307/3430449; MIRSKY AF, 1995, NEUROPSYCHOLOGICAL A, P17; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Paivio A., 1971, IMAGERY VERBAL PROCE; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1987, PSYCHOBIOLOGY, V15, P107; PRIBRAM KH, 1975, PSYCHOL REV, V82, P116, DOI 10.1037/h0076780; Reitan R. M., 1986, TRAUMATIC BRAIN INJU, VI; ROTHKE S, 1987, INT J CLIN NEUROPSYC, V9, P81; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; STUSS DT, 1993, DEMENTIA, V4, P220, DOI 10.1159/000107326; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; Teuber H.-L., 1964, FRONTAL GRANULAR COR; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wechsler D, 1987, MEMORY SCALE REVISED; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; [No title captured]; [No title captured]; [No title captured]; [No title captured]	53	6	6	0	1	SWETS ZEITLINGER BV	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG	1995	17	4					622	633		10.1080/01688639508405150			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	RQ803	WOS:A1995RQ80300011	7593480				2022-02-06	
J	RYAN, GA; VILENIUS, ATS				RYAN, GA; VILENIUS, ATS			FIELD AND ANALYTIC OBSERVATIONS OF IMPACT BRAIN INJURY IN FATALLY INJURED PEDESTRIANS	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	Head Injury 1994 - International Symposium on Head Injury Research	OCT 12-14, 1994	WASHINGTON, DC	Natl Highway Traff Safety Adm, Head Injury Res Program, George Washington Univ		BIOMECHANICS; BRAIN INJURY; IMPACT; INJURY THRESHOLD; MATHEMATICAL MODEL		To develop more effective head protection against impact injury, maximum levels of mechanical impact or injury tolerance criteria, or both, should be specified for particular levels of injury and for particular structures of the brain, By using a development of an existing very simplified model of the head-vehicle impact for pedestrians we were able to make estimates of the peak angular acceleration and change in angular velocity of head impacts for fatally injured pedestrians, This model also enabled us to examine the relationship between the parameters of the impact, and the critical strain curves for brain injury proposed by Margulies and Thibault (1992). It was found that the offset of the impact from the center of mass of the head was a major influence, and, in addition, in impacts with a combined head/vehicle stiffness above 130 kN/m, the head impact velocity and change in head angular velocity were important, whereas for impacts with lower stiffness, the stiffness of the impact structure and hence, peak angular acceleration, were the major influences, Transformed into the frequency domain, the 130 kN/m region corresponds roughly to a harmonic of the natural frequency of the brain and skull, and the change in behavior may be related to decoupling of the skull and brain at impact, In 12 cases of lateral head impact, all but one case with visible injury in the corpus callosum were found to lie close to or above the 10% critical strain curve, Despite the very wide error limits around each data point, there is sufficient consistency between the field observations of brain injury and the analytic findings to suggest that the 10% critical strain curve represents a threshold for brain injury, expressed in terms of peak angular acceleration and change in angular velocity.	UNIV MELBOURNE,DEPT MECH & MFG ENGN,MELBOURNE,VIC,AUSTRALIA		RYAN, GA (corresponding author), UNIV WESTERN AUSTRALIA,DEPT PUBL HLTH,RD ACCIDENT PREVENT RES UNIT,NEDLANDS,WA 6009,AUSTRALIA.						GADD CW, 1961, 10TH P STAPP CAR CRA, P809; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; RYAN GA, 1994, J TRAUMA, V36, P469; VERSACE J, 1971, 15TH P STAPP CAR CRA, P771; VILENIUS ATS, 1994, ACCIDENT ANAL PREV, V26, P563, DOI 10.1016/0001-4575(94)90018-3; WILLINGER RW, 1992, 1992 INT RES C BIOM, P179; WILLINGER RW, 1991, 35TH P ANN C DES PLA, P387	8	6	6	1	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	1995	12	4					627	634		10.1089/neu.1995.12.627			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RY920	WOS:A1995RY92000014	8683614				2022-02-06	
J	STEIN, SC; DOOLIN, EJ				STEIN, SC; DOOLIN, EJ			MANAGEMENT OF MINOR CLOSED-HEAD INJURY IN CHILDREN AND ADOLESCENTS	PEDIATRIC SURGERY INTERNATIONAL			English	Article						HEAD INJURY; CHILDREN; PEDIATRICS; MINOR HEAD INJURY		In order to develop a systematic, evidence-based approach to minor closed head injury (CHI) in the pediatric patient, case records were reviewed of all 2,533 children and adolescents admitted to Cooper Hospital/University Medical Center for minor CHI during the years 1986 to 1992. A survey was taken during a 6-month period of 734 consecutive pediatric patients discharged from the Emergency Department for minimal CHI (out of a total of 10,275 children during the entire 7 years of the study). Categories of minor CHI derived from studies in adults were used to group data. For each category of minor CHI, the frequency of various complications such as skull fracture, intracranial lesions, and need for neurosurgical intervention was determined. Also reviewed were survival and neurological outcome 6 months following injury. Children with moderate CHI had a 37% incidence of intracranial lesions on computed tomography (CT) scan and 9% of them required intracranial surgery. The incidences of intracranial lesions and surgical intervention in the mild CHI group were 12% and 2.6%, respectively. Children with Glasgow Coma Scale scores of 13 belonged in the moderate rather than the mild CHI group, as evidenced by their higher risk. Skull fracture was not highly correlated with intracranial pathology or the need for surgery. Age had no significant impact on the incidence of lesions, rate of surgery or outcome. Both intracranial lesions and surgery were extremely rare in the minimal CHI group. We propose three categories of minor CHI based upon relative severity (minimal, mild, and moderate) and offer a simple management scheme for each category. Based on our experience with this approach, we estimate that 80% of children with minor CHI can safely be discharged from the Emergency Department. Cranial CT scanning will be required in only 7% of cases, but when indicated, will be extremely valuable in guiding further care.	UNIV MED & DENT NEW JERSEY,COOPER HOSP,MED CTR,ROBERT WOOD JOHNSON MED SCH,DEPT SURG,CAMDEN,NJ 08103									0	6	6	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0179-0358			PEDIATR SURG INT	Pediatr. Surg. Int.	AUG	1995	10	7					465	471					7	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	RR506	WOS:A1995RR50600007					2022-02-06	
J	MOSELEY, A; ROTEM, W				MOSELEY, A; ROTEM, W			ESTABLISHING STANDARDS FOR THE PROVISION OF BRAIN INJURY SERVICES	BRAIN INJURY			English	Article								Standards and an assessment process were developed to evaluate the quality of traumatic brain injury services in New South Wales, Australia, by The Australian Council on Healthcare Standards. The set of standards developed addressed the provision of rehabilitation services, the management of human and physical resources, education, research and quality assurance. An educational peer review model was used to conduct on-site assessments of the 14 public sector Brain Injury Rehabilitation Program Services. Data collected on the level of compliance with the standards showed a high rate of conformity, particularly in the areas of patient management, the provision of outpatient and community services, and staff development. Feedback from the participating services indicated that the assessment process was regarded as a useful tool for identifying problems and improving services. The standards and assessment process were shown to be an effective tool for evaluating the quality of services provided, and repeat assessments will enable the ongoing development of services to be monitored.	AUSTRALIAN COUNCIL HEALTHCARE STAND,WATERLOO,NSW 2017,AUSTRALIA; LIDCOMBE HOSP,HEAD INJURY UNIT,LIDCOMBE,NSW,AUSTRALIA								CASTLES I, 1993, YB AUSTR 1994, P117; Donabedian A, 1989, Qual Assur Health Care, V1, P3; Donabedian A, 1986, QRB Qual Rev Bull, V12, P99; LOHR KN, 1988, INQUIRY-J HEALTH CAR, V25, P37; MEISENHEIMER CG, 1985, QUALITY ASSURANCE CO; ROSEN A, 1991, AREA INTEGRATED MENT; [No title captured]; 1992, HOME COMMUNITY NURSI; 1987, LIVING NURSING HOME; 1991, ACCREDITATION GUIDE; 1985, MANUAL STANDARDS COM; 1987, BRAIN INJURY PROGRAM, P1; 1992, COMMISSION ACCREDITA	13	6	6	0	0	TAYLOR & FRANCIS LTD LONDON	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAY-JUN	1995	9	4					355	364		10.3109/02699059509005775			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	QY080	WOS:A1995QY08000003	7640681				2022-02-06	
J	BELL, KR; TALLMAN, CA				BELL, KR; TALLMAN, CA			COMMUNITY REENTRY OF LONG-TERM INSTITUTIONALIZED BRAIN-INJURED PERSONS	BRAIN INJURY			English	Article								Although evidence exists for delayed recovery after traumatic brain injury, patients who do not receive rehabilitation early after their injuries often remain permanently in long-term care facilities. Case reports of five severely brain-injured persons who were discharged into long-term nursing care facilities for at least 1 year before initial rehabilitation admission are discussed. After prescreening for evidence of functional improvement, these patients were admitted to a rehabilitation unit with the goal of community discharge. Functional improvement was evaluated using the Functional Independence Measure (FIM) and additional categories of function. Community discharge was successfully achieved in all five patients, who demonstrated particular improvement in bathing, transfers, memory, bowel management, problem solving and independence during waking hours. Further efforts should be made to identify patients in long-term care facilities who might benefit from rehabilitation services, and to identify those factors which contribute to successful community discharge.			BELL, KR (corresponding author), UNIV WASHINGTON,DEPT REHABIL MED,RJ-30,SEATTLE,WA 98195, USA.			Bell, Kathleen/0000-0002-0928-2046			BOND MR, 1990, REHABILITATION ADULT, P70; GRANGER CV, 1994, AM J PHYS MED REHAB, V73, P51, DOI 10.1097/00002060-199473010-00012; GROSWASSER Z, 1990, J NEUROSURG, V72, P81, DOI 10.3171/jns.1990.72.1.0081; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; THOMSEN IV, 1992, SCANDINAVIAN J REH S, V25, P142; TUEL S M, 1992, Brain Injury, V6, P363, DOI 10.3109/02699059209034951	8	6	6	0	0	TAYLOR & FRANCIS LTD LONDON	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	APR	1995	9	3					315	320		10.3109/02699059509008201			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	QR499	WOS:A1995QR49900008	7606240				2022-02-06	
J	JOSEPH, AB; WROBLEWSKI, B				JOSEPH, AB; WROBLEWSKI, B			DEPRESSION, ANTIDEPRESSANTS, AND TRAUMATIC BRAIN INJURY	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article									HARVARD UNIV,SCH MED,BOSTON,MA 02115; MIDDLESEX HOSP,CTR NEUROBEHAV REHABIL,WALTHAM,MA; MASSACHUSETTS STATEWIDE HEAD INJURY PROGRAM,BOSTON,MA; MASSACHUSETTS COLL PHARM & ALLIED HLTH SCI,GREENERY REHABIL CTR,BOSTON,MA; TUFTS UNIV,SCH MED,DEPT REHABIL MED,BOSTON,MA 02111		JOSEPH, AB (corresponding author), MCLEAN HOSP,BOSTON,MA, USA.						CASSIDY JW, 1994, J HEAD TRAUMA REHAB, V9, P43, DOI 10.1097/00001199-199409000-00005; Joseph A B, 1993, Behav Neurol, V6, P221, DOI 10.3233/BEN-1993-6408; Joseph A. B., 1992, MOVEMENT DISORDERS N; JURG RE, 1993, J NERV MENT DIS, V181, P91; Mysiw W.J., 1987, J HEAD TRAUMA REHAB, V2, P34, DOI [10.1097/00001199-198712000-00007, DOI 10.1097/00001199-198712000-00007]; NAUTA WJH, 1989, NEUROLOGY PSYCHIATRY; PRESKORN SH, 1991, J CLIN PSYCHIAT, V52, P23; SILVER JM, 1990, J CLIN PSYCHIAT, V51, P33; WROBLEWSKI B, 1992, J HEAD TRAUMA REHAB, V7, P109; Wroblewski Bruno, 1993, Brain Injury, V7, P353, DOI 10.3109/02699059309034962	10	6	6	0	1	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1995	10	2					90	95		10.1097/00001199-199504000-00010			6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QR039	WOS:A1995QR03900010					2022-02-06	
J	Bigler, ED				Bigler, ED			Brain morphology and intelligence	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							DEGENERATIVE CHANGES; HEAD CIRCUMFERENCE; SIZE; INJURY; SCHIZOPHRENIA; LOCATION; HUMANS; INVIVO; LIFE; AGE	Although the correlations are modest (similar to r = 0.35), brain size as determined by magnetic resonance imaging has been positively related to measures of psychometric intelligence. Three studies dealing with brain size-IQ relationships are presented in patients who have suffered traumatic brain injury (TBI). Study 1 was an examination of whether the brain size-IQ relationship was proportionally maintained in response to TBI-induced atrophic changes in the brain. Study 2 was an examination of whether smaller brain size at the time of injury was a risk factor for more significant decline in IQ after injury. Study 3 was an examination of whether focal lesion volume plays a role in postinjury brain size-IQ relations. Results indicated that trauma-induced atrophic brain changes are related neither to postinjury IQ nor focal lesion volume. However, patients with TBI with smaller brain size at the time of injury did have significantly lower postinjury IQ scores when compared to a matched group that had larger premorbid brain size. These latter findings are discussed in terms of potentially greater neuronal redundancy in the larger brain. The fact that brain size-IQ relationships do not hold in the posttraumatic atrophic or focally damaged brain indicates the complexity of the relation between brain size and morphology.	LDS HOSP, SALT LAKE CITY, UT USA		Bigler, ED (corresponding author), BRIGHAM YOUNG UNIV, DEPT PSYCHOL, 1086 SPENCER W KIMBALL TOWER, PROVO, UT 84602 USA.						ALLMAN J, 1981, PRIMATE BRAIN EVOLUT, P13; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; AMRSTRONG E, 1981, PRIMATE BRAIN EVOLUT; ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; ANDERSON CV, 1994, BRAIN INJURY, V8, P565, DOI 10.3109/02699059409151008; ANDREASEN NC, 1993, AM J PSYCHIAT, V150, P130; APPLETON RE, 1991, DEV MED CHILD NEUROL, V33, P884; Bach-y-Rita P., 1980, RECOVERY FUNCTION TH; BACHYRITA P, 1990, NEUROPSYCHOLOGIA, V28, P547, DOI 10.1016/0028-3932(90)90033-K; BEALS KL, 1984, CURR ANTHROPOL, V25, P301, DOI 10.1086/203138; Benton AL, 1991, FRONTAL LOBE FUNCTIO; Bigler E D, 1988, Arch Clin Neuropsychol, V3, P81, DOI 10.1016/0887-6177(88)90029-7; Bigler E D, 1988, Arch Clin Neuropsychol, V3, P279, DOI 10.1016/0887-6177(88)90020-0; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; Bigler E. D., 1989, NEUROPSYCHOLOGICAL F; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; BIGLER ED, 1995, INTELLIGENCE, V21, P109, DOI 10.1016/0160-2896(95)90041-1; BIGLER ED, 1992, ARCH CLIN NEUROPSYCH, V7, P449, DOI 10.1016/0887-6177(92)90158-J; BIGLER ED, 1994, BRAIN INJURY, V8, P231, DOI 10.3109/02699059409150975; BIGLER ED, 1988, DIAGNOSTIC CLIN NEUR; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; BRACHA HS, 1995, NEUROPSY NEUROPSY BE, V8, P44; BULLOCK TH, 1993, BRAIN BEHAV EVOLUT, V41, P88, DOI 10.1159/000113826; CLARKE LP, 1995, MAGN RESON IMAGING, V13, P343, DOI 10.1016/0730-725X(94)00124-L; CULLUM CM, 1990, TRAUMATIC BRAIN INJU, P129; DAMASIO H, 1994, SCIENCE, V264, P1101; DeMyer W, 1986, Pediatr Neurol, V2, P321, DOI 10.1016/0887-8994(86)90072-X; DEMYER W, 1994, PEDIAT NEUROLOGY PRI, P205; DETTERMAN DK, 1994, NEUROPSYCHOLOGY INDI, P35; DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974; DORMAN C, 1991, DEV MED CHILD NEUROL, V33, P267; DUARA R, 1991, ARCH NEUROL-CHICAGO, V48, P410, DOI 10.1001/archneur.1991.00530160078018; EGAN V, 1994, PERS INDIV DIFFER, V17, P357, DOI 10.1016/0191-8869(94)90283-6; FILIPEK PA, 1995, J CHILD NEUROL, V10, pS62, DOI 10.1177/08830738950100S113; FILIPEK PA, 1989, ANN NEUROL, V25, P61, DOI 10.1002/ana.410250110; FINGER S., 1994, ORIGINS NEUROSCIENCE; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GALE SD, 1994, NEUROPSY NEUROPSY BE, V7, P160; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; GLASSMAN RB, 1987, NEUROSCI BIOBEHAV R, V11, P275, DOI 10.1016/S0149-7634(87)80014-3; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; GRAFMAN J, 1986, J NEUROSCI, V6, P301; Grafman J., 1989, PREOPERATIVE EVENTS, P277; HAIER RJ, IN PRESS INTELLIGENC; HENN FA, 1992, SCHIZOPHRENIA BRAIN; HO KC, 1980, ARCH PATHOL LAB MED, V104, P635; Jerison H.J., 1973, EVOLUTION BRAIN INTE, V45; JERISON HJ, 1988, COMP NEUROSCIENCE NE, P168; JERNIGAN TL, 1991, ARCH NEUROL-CHICAGO, V48, P539, DOI 10.1001/archneur.1991.00530170103028; JOHNSON FW, 1991, GENET SOC GEN PSYCH, V117, P313; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; JONES GH, 1991, BRIT J PSYCHIAT, V159, P435, DOI 10.1192/bjp.159.3.435; KAUFMAN AS, 1991, J CLIN PSYCHOL, V47, P801, DOI 10.1002/1097-4679(199111)47:6<801::AID-JCLP2270470611>3.0.CO;2-C; KELSOE JR, 1988, ARCH GEN PSYCHIAT, V45, P533; LARSEN JP, 1990, BRAIN LANG, V39, P289, DOI 10.1016/0093-934X(90)90015-9; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LOU HC, 1994, DEV MED CHILD NEUROL, V36, P826; LYNN R, 1990, PERS INDIV DIFFER, V11, P273, DOI 10.1016/0191-8869(90)90241-I; LYNN R, 1994, PERS INDIV DIFFER, V17, P257, DOI 10.1016/0191-8869(94)90030-2; OBoyle MW, 1995, DEV NEUROPSYCHOL, V11, P415, DOI 10.1080/87565649509540630; Osborn AG, 1994, DIAGNOSTIC NEURORADI; RADINSKY L, 1981, PRIMATE BRAIN EVOLUT, P29; Ratcliffe S.G., 1994, BASIC APPROACHES GEN, P99; RATCLIFFE SG, 1994, DEV MED CHILD NEUROL, V36, P533; RAZ N, 1992, ARCH NEUROL-CHICAGO, V49, P412, DOI 10.1001/archneur.1992.00530280106030; ROBB RA, 1994, 3 DIMENSIONAL BIOMED; SCHAIE KW, 1994, AM PSYCHOL, V49, P304, DOI 10.1037/0003-066X.49.4.304; SCHOFIELD PW, 1995, ARCH NEUROL-CHICAGO, V52, P95, DOI 10.1001/archneur.1995.00540250103019; SCHULTZ RT, 1994, ANN NEUROL, V35, P732, DOI 10.1002/ana.410350615; SCHWARTZ M, 1985, ANN NEUROL, V42, P1743; SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0; Stelmack RM, 1995, DEV NEUROPSYCHOL, V11, P445, DOI 10.1080/87565649509540631; STERN Y, 1995, NEUROLOGY, V45, P55, DOI 10.1212/WNL.45.1.55; Stott D. H, 1983, BRIT J DEV PSYCHOL, V1, P279, DOI [10.1111/j.2044-835X.1983.tb00900.x, DOI 10.1111/J.2044-835X.1983.TB00900.X]; TURKHEIMER E, 1990, J CLIN EXP NEUROPSYC, V12, P549, DOI 10.1080/01688639008401001; VANVALEN L, 1974, AM J PHYS ANTHROPOL, V40, P417, DOI 10.1002/ajpa.1330400314; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1974, WECHSLER INTELLIGENC; WEILLER C, 1995, ANN NEUROL, V37, P723, DOI 10.1002/ana.410370605; WICKETT JC, 1994, PERS INDIV DIFFER, V16, P831, DOI 10.1016/0191-8869(94)90227-5; WILLERMAN L, 1992, INTELLIGENCE, V16, P315, DOI 10.1016/0160-2896(92)90012-G; WILLERMAN L, 1991, INTELLIGENCE, V15, P223, DOI 10.1016/0160-2896(91)90031-8; WILLERMAN L, 1994, PERSP INDIV, P35; WILLERMAN L, 1992, SCIENCE, V254, P1584; WOOD CC, 1978, PSYCHOL REV, V85, P582, DOI 10.1037/0033-295X.85.6.582; WOOD CC, 1980, PSYCHOL REV, V87, P474, DOI 10.1037/0033-295X.87.5.474; YEO RA, 1987, BRAIN COGNITION, V6, P15, DOI 10.1016/0278-2626(87)90043-1; YEO RA, 1990, NEUROPSY NEUROPSY BE, V3, P290	90	6	6	1	8	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	8756-5641			DEV NEUROPSYCHOL	Dev. Neuropsychol.		1995	11	4					377	403		10.1080/87565649509540628			27	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	UJ359	WOS:A1995UJ35900002					2022-02-06	
J	DINAN, T				DINAN, T			TREATMENT APPROACHES TO THERAPY-RESISTANT DEPRESSION	JOURNAL OF PSYCHOPHARMACOLOGY			English	Article						DEPRESSION; LITHIUM; SSRIS; TCAS; THERAPY RESISTANCE; REVIEW	LITHIUM AUGMENTATION; REFRACTORY DEPRESSION; TRICYCLIC ANTIDEPRESSANTS; ENDOGENOUS-DEPRESSION; UNIPOLAR DEPRESSION; SEROTONIN RECEPTORS; MAJOR DEPRESSION; HEAD-INJURY; AMITRIPTYLINE; COMBINATION	Resistance to antidepressant treatment is a controversial field and therapy resistance has received a wide range of definitions. The field has suffered from a lack of consensus on how to classify treatment resistance and from the related failure to standardise clinical criteria in trials of new therapeutic approaches. A significant proportion of tricyclic antidepressant (TCA)-resistant depression results from the failure to sustain an adequate course of therapy. This can be due to either inadequate prescribing or the poor tolerability of TCAs. The majority of cases of treatment resistance, however, involve antidepressant therapy at a dose and duration that would normally be expected to be effective. In these cases, therapy may fail for many reasons. Refractory depression may occur in patients with medical conditions such as subclinical hypothyroidism, stroke and closed head injuries. Patients with alcoholism may prove refractory to treatment, as may those receiving certain medications, notably calcium channel blockers. Certain subtypes of depression, such as rapid-cycling disorder and delusional depression, also appear to be more refractory to treatment. A variety of therapeutic approaches have been applied to treatment-resistant depression but, for most of these, placebo-controlled clinical trials with substantial numbers of patients have not been conducted. Selective serotonin re-uptake inhibitors (SSRIs) may have a role to play in TCA-resistant patients as a result of their superior tolerability; monoamine oxidase inhibitors (MAOIs) also have a significant therapeutic role. ECT has an important role to play in patients who failed to respond to successive drug therapies. Of the various add-on therapies, thyroid augmentation (triiodothyronine) of antidepressant treatment has shown promise, and definite benefits have been established for lithium augmentation. Evidence has emerged to show that lithium is not only effective as an adjunct to TCA therapy, but also to the better tolerated SSRIs. However, further trials will be necessary to determine the optimal dosage and treatment duration for lithium augmentation.			DINAN, T (corresponding author), ST BARTHOLOMEWS HOSP,DEPT PSYCHOL MED,LONDON,ENGLAND.			Dinan, Timothy/0000-0002-2316-7220			ALARCON RD, 1985, COMPR PSYCHIAT, V26, P522, DOI 10.1016/0010-440X(85)90019-7; AUSTIN MPV, 1991, BRIT J PSYCHIAT, V159, P510, DOI 10.1192/bjp.159.4.510; BRIDGES PK, 1983, BRIT J PSYCHIAT, V142, P626, DOI 10.1192/bjp.142.6.626; BRODERICK P, 1982, NEUROPHARMACOLOGY, V21, P671, DOI 10.1016/0028-3908(82)90010-7; COWEN PJ, 1991, BRIT J PSYCHIAT, V159, P341, DOI 10.1192/bjp.159.3.341; DEMONTIGNY C, 1981, BRIT J PSYCHIAT, V138, P252, DOI 10.1192/bjp.138.3.252; DEMONTIGNY C, 1983, ARCH GEN PSYCHIAT, V40, P1327; DINAN TG, 1988, INT CLIN PSYCHOPHARM, V3, P151, DOI 10.1097/00004850-198804000-00005; DINAN TG, 1993, ACTA PSYCHIAT SCAND, V88, P300, DOI 10.1111/j.1600-0447.1993.tb03461.x; DINAN TG, 1989, ACTA PSYCHIAT SCAND, V80, P97, DOI 10.1111/j.1600-0447.1989.tb01306.x; DINAN TG, 1993, INT CLIN PSYCHOPHARM, V8, P221, DOI 10.1097/00004850-199300840-00003; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; DINAN TG, 1993, ALCOHOL ABUSE, P22; ECCLESTON D, 1990, BRIT J PSYCHIAT, V156, P889, DOI 10.1192/bjp.156.6.889; GITLIN MJ, 1987, J AFFECT DISORDERS, V13, P267, DOI 10.1016/0165-0327(87)90046-2; GLASSMAN AH, 1975, AM J PSYCHIAT, V132, P716; GRAHAMESMITH DG, 1974, BRIT J PHARMACOL, V52, P19, DOI 10.1111/j.1476-5381.1974.tb09682.x; HALE AS, 1987, BRIT J PSYCHIAT, V151, P213, DOI 10.1192/bjp.151.2.213; HEALY D, 1985, J AFFECT DISORDERS, V9, P285, DOI 10.1016/0165-0327(85)90059-X; HEALY D, 1983, J PSYCHIAT RES, V17, P251, DOI 10.1016/0022-3956(82)90003-6; HENINGER GR, 1983, ARCH GEN PSYCHIAT, V40, P1335; HOWLAND RH, 1993, J CLIN PSYCHIAT, V54, P47; JOFFE RT, 1993, ARCH GEN PSYCHIAT, V50, P387; KATO A, 1988, PROTEIN ENG, V2, P153, DOI 10.1093/protein/2.2.153; KELLER MB, 1988, PSYCHOPHARMACOL BULL, V24, P75; KELLER MB, 1992, ARCH GEN PSYCHIAT, V49, P809; KLEIN DE, 1980, DIAGNOSIS DRUG TREAT, P277; KNAPP S, 1975, J PHARMACOL EXP THER, V193, P812; LEONARD BE, 1991, INT CLIN PSYCHOPHARM, V6, P13, DOI 10.1097/00004850-199107001-00004; LINGJAERDE O, 1974, ACTA PSYCHIAT SCAND, V50, P233, DOI 10.1111/j.1600-0447.1974.tb08212.x; LINNOILA M, 1990, ANTIDEPRESSANTS 30 Y, P71; MOBAYED M, 1990, J AFFECT DISORDERS, V19, P237, DOI 10.1016/0165-0327(90)90100-M; MONTGOMERY SA, 1993, J PSYCHOPHARMACOL, V7, P19, DOI 10.1177/0269881193007001041; MURPHY BEP, 1991, J CLIN PSYCHOPHARM, V11, P121; NELSEN MR, 1993, PSYCHIAT CLIN N AM, V16, P541; OBRIEN S, 1993, BRIT J PSYCHIAT, V162, P363, DOI 10.1192/bjp.162.3.363; OWENS MJ, 1994, CLIN CHEM, V40, P288; PAYKEL ES, 1982, ARCH GEN PSYCHIAT, V39, P1041; PRANGE AJ, 1969, AM J PSYCHIAT, V126, P457, DOI 10.1176/ajp.126.4.457; PRICE LH, 1986, AM J PSYCHIAT, V143, P1387; PRICE LH, 1983, AM J PSYCHIAT, V140, P318; SCHATZBERG AF, 1983, AFFECTIVE DISORD, P77; SCHOPF J, 1989, PHARMACOPSYCHIATRY, V22, P174, DOI 10.1055/s-2007-1014602; SCHOU M, 1990, LITHIUM, V1, P3; STEIN G, 1993, BRIT J PSYCHIAT, V162, P634, DOI 10.1192/bjp.162.5.634; THASE ME, 1989, J CLIN PSYCHIAT, V50, P385; THOMPSON C, 1994, 19TH CINP WASH; TREISER SL, 1981, SCIENCE, V213, P1529, DOI 10.1126/science.6269180; TYRER P, 1976, BRIT J PSYCHIAT, V128, P354, DOI 10.1192/bjp.128.4.354; 1989, J AFFECT DISORDERS, V17, P197	50	6	6	0	2	OXFORD UNIV PRESS UNITED KINGDOM	OXFORD	WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP	0269-8811			J PSYCHOPHARMACOL	J. Psychopharmacol.		1995	9	2		S			199	204		10.1177/0269881195009002051			6	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	RU720	WOS:A1995RU72000005	22297239				2022-02-06	
J	DRUMMOND, JC				DRUMMOND, JC			FLUID MANAGEMENT OF HEAD-INJURED PATIENTS	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article; Proceedings Paper	23rd Congress of the Scandinavian-Society-of-Anaesthesiologists	JUN 12-16, 1995	REYKJAVIK, ICELAND	Scandinavian Soc Anaesthesiologists			CEREBRAL BLOOD-FLOW; COLLOID ONCOTIC PRESSURE; TRAUMATIC BRAIN INJURY; INTRACRANIAL-PRESSURE; HYDROXYETHYL STARCH; PERFUSION-PRESSURE; HYPERTONIC SALINE; HEMORRHAGIC-SHOCK; CRYOGENIC INJURY; MANNITOL		VET ADM MED CTR,SAN DIEGO,CA		DRUMMOND, JC (corresponding author), UNIV CALIF SAN DIEGO,SAN DIEGO,CA 92103, USA.						BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUZARTH WF, 1982, LANCET          0508, P1061; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CHAN KH, 1993, NEUROSURGERY, V32, P547, DOI 10.1227/00006123-199304000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLAES Y, 1992, ANESTH ANALG, V75, P24; COTTRELL JE, 1977, ANESTHESIOLOGY, V47, P28, DOI 10.1097/00000542-197707000-00006; DEWITT DS, 1992, AM J PHYSIOL, V163, pH1276; GUNNAR W, 1988, SURGERY, V103, P398; HANSEN TD, 1994, NEUROSURGERY, V34, P505, DOI 10.1227/00006123-199403000-00017; HYODO A, 1989, STROKE, V20, P534, DOI 10.1161/01.STR.20.4.534; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; KAIEDA R, 1989, ANESTHESIOLOGY, V71, P554, DOI 10.1097/00000542-198910000-00013; KAIEDA R, 1989, NEUROSURGERY, V24, P671, DOI 10.1227/00006123-198905000-00003; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; KOROSUE K, 1990, J NEUROSURG, V73, P576, DOI 10.3171/jns.1990.73.4.0576; LONDON MJ, 1989, J THORAC CARDIOV SUR, V97, P785; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MCMANUS ML, 1993, ANESTHESIOLOGY, V79, pA769; MCMANUS ML, 1992, J NEUROSURG ANESTH, V4, P300; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; PROUGH DS, 1985, CRIT CARE MED, V13, P407, DOI 10.1097/00003246-198505000-00008; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; RUDEHILL A, 1993, J NEUROSURG ANESTH, V5, P4; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SMERLING A, 1992, J NEUROSURG ANESTH, V4, P1, DOI 10.1097/00008506-199201000-00001; STRAUSS RG, 1988, TRANSFUSION, V28, P257, DOI 10.1046/j.1537-2995.1988.28388219155.x; TODD M, 1990, NEUROSURGERY, V26, P546; TRANMER BI, 1989, NEUROSURGERY, V25, P173, DOI 10.1227/00006123-198908000-00004; WARNER DS, 1988, ANESTHESIOLOGY, V68, P86, DOI 10.1097/00000542-198801000-00014	34	6	6	0	0	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.		1995	39			105			107	111		10.1111/j.1399-6576.1995.tb04286.x			5	Anesthesiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	RN486	WOS:A1995RN48600029					2022-02-06	
J	BANJA, J; JOHNSTON, MV				BANJA, J; JOHNSTON, MV			OUTCOMES EVALUATION IN TBI REHABILITATION .3. ETHICAL PERSPECTIVES AND SOCIAL-POLICY	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							DISABILITY RATING-SCALE; SEVERE HEAD-INJURY; TRAUMATIC BRAIN INJURY; PATIENT SATISFACTION; EARLY INTERVENTION; HEALTH-INSURANCE; PRACTICAL SCALE; NEW-HAVEN; CARE; QUALITY	The choice and interpretation of rehabilitation outcomes are suffused with personal and social values. In this article we examine the ethical implications of outcomes evaluation. The viewpoints of key parties to the rehabilitation process are considered. Self-determination of persons served is of central significance. Valuative conflicts in practice frequently obscure the meaning of a ''good'' outcome. Outcome studies can contribute to the development of a just policy but bear serious ethical responsibilities. Although these issues are general to rehabilitation, persons with TBI are at special risk of being disenfranchised. A new paradigm or clinical philosophy is needed to respond to the new and divergent pressures facing clinical rehabilitation.	KESSLER INST REHABIL,E ORANGE,NJ; KESSLER INST REHABIL,W ORANGE,NJ		BANJA, J (corresponding author), EMORY UNIV,CTR REHABIL MED,ATLANTA,GA 30322, USA.						ADAMOVICH BLB, 1992, NEUROREHABILITATION, V2, P42; Allen M., 1979, INTRO MEASUREMENT TH; [Anonymous], 1980, INT CLASSIFICATION I; [Anonymous], 1990, CLIN PRACTICE GUIDEL; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; Antonak R. F., 1993, J HEAD TRAUMA REHAB, V8, P87, DOI DOI 10.1097/00001199-199312000-00009; Ashley M. J., 1993, J HEAD TRAUMA REHAB, V8, P30; Auerbach VS, 1993, MED PSYCHIAT PRACTIC, V2, P515; BANJA JD, 1994, J HEAD TRAUMA REHAB, V9, P111; BANJA JD, 1993, STAFF DEV CLIN INTER, P23; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; Bowers D., 1989, ARCH PHYS MED REHAB, V70, pA58; Brooks D N, 1979, Int Rehabil Med, V1, P160; BUNCH WH, 1994, AM J PHYS MED REHAB, V73, P40, DOI 10.1097/00002060-199473010-00010; BURTON LA, 1993, J REHABIL, V4, P34; CALLAHAN D, 1993, AM J PHYS MED REHAB, V72, P101, DOI 10.1097/00002060-199304000-00009; CAREY RG, 1988, ARCH PHYS MED REHAB, V69, P337; CHUBON RA, 1987, EVAL HEALTH PROF, V10, P186, DOI 10.1177/016327878701000203; CLEARY PD, 1988, INQUIRY-J HEALTH CAR, V25, P25; CLEARY PD, 1990, EFFECTIVENESS AND OUTCOMES IN HEALTH CARE, P152; CLIFFORD HA, 1987, HARVARD LAW REV, V99, P727; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; COLLINS LM, IN PRESS AM J PHYS M; Cope D., 1993, J HEAD TRAUMA REHAB, V8, P1; COPE D N, 1991, Brain Injury, V5, P127, DOI 10.3109/02699059109008084; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; COPE DN, IN PRESS BRAIN INJ; Corrigan J D, 1994, NeuroRehabilitation, V4, P109, DOI 10.3233/NRE-1994-4207; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; DEJONG G, 1982, ARCH PHYS MED REHAB, V63, P68; DEJONG G, 1993, ARCH PHYS MED REHAB, V74, P1017, DOI 10.1016/0003-9993(93)90055-F; DIKMEN S, IN PRESS J HEAD TRAU; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; DODWELL D, 1988, J NEUROL NEUROSUR PS, V51, P833, DOI 10.1136/jnnp.51.6.833; DURGIN CJ, 1993, STAFF DEV CLIN INTER, P3; EAMES P, 1985, J NEUROL NEUROSUR PS, V48, P613, DOI 10.1136/jnnp.48.7.613; ELIASON MR, 1984, PHYS THER, V64, P1357, DOI 10.1093/ptj/64.9.1357; ELLWOOD PM, 1988, NEW ENGL J MED, V318, P1549, DOI 10.1056/NEJM198806093182329; EMHOFF TA, 1991, J TRAUMA, V9, P1227; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Evans R W, 1991, J Insur Med, V23, P192; Evans RW, 1992, J HEAD TRAUMA REHAB, V7, P24; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; FISHER WP, IN PRESS ARCH PHYS M; FLANAGAN JC, 1982, ARCH PHYS MED REHAB, V63, P56; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; FORER SK, 1992, NEUROREHABIL, V2, P52; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; Fraser R. T., 1991, J HEAD TRAUMA REHAB, V6, P46; FRYER LJ, 1987, J HEAD TRAUMA REHAB, V2, P51, DOI DOI 10.1097/00001199-198709000-00007; FUHRER MJ, 1994, AM J PHYS MED REHAB, V73, P358, DOI 10.1097/00002060-199409000-00010; GENSEMER IB, 1989, ANN EMERG MED, V18, P9, DOI 10.1016/S0196-0644(89)80303-8; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Granger CV, 1984, FUNCTIONAL ASSESSMEN; GRANGER CV, 1986, TOP GERIATR REHABIL, P59; HAFFEY WJ, 1989, MODELS BRAIN INJURY; HAFFEY WJ, 1989, J HEAD TRAUMA REHAB, V4, P43, DOI DOI 10.1097/00001199-198903000-00007; HAFFEY WJ, 1979, REHABIL PSYCHOL, V34, P147; HAFFEY WJ, 1990, NEUROPSYCHOLOGY EVER; Hagan C., 1982, COGNITIVE REHABILITA, P131; Hagen C, 1994, NeuroRehabilitation, V4, P58, DOI 10.3233/NRE-1994-4109; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall K, 1992, NEUROREHABILITATION, V2, P98, DOI DOI 10.3233/NRE-1992-2410; Hall K M, 1994, NeuroRehabilitation, V4, P76, DOI 10.3233/NRE-1994-4204; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HALL KM, IN PRESS J HEAD TRAU; HAMILTON B B, 1991, Archives of Physical Medicine and Rehabilitation, V72, P790; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hartley L. L., 1990, NEUROPSYCHOLOGY EVER, P125; HARVEY RF, 1981, ARCH PHYS MED REHAB, V62, P456; Harvey Richard F., 1992, Archives of Physical Medicine and Rehabilitation, V73, P956; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; JACKSON H F, 1992, Brain Injury, V6, P109, DOI 10.3109/02699059209029650; JELLINEK MS, 1993, JAMA-J AM MED ASSOC, V270, P1737, DOI 10.1001/jama.270.14.1737; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1992, PROGNOSIS NEUROLOGIC, P85; JOHNSTON M V, 1991, Brain Injury, V5, P155, DOI 10.3109/02699059109008086; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; JOHNSTON MV, 1991, AM J PHYS MED REHAB, V70, P40, DOI 10.1097/00002060-199102000-00008; JOHNSTON MV, 1994, AM J PHYS MED REHAB, V73, P296, DOI 10.1097/00002060-199407000-00014; JOHNSTON MV, 1989, NEUROTRAUMA; JOHNSTON MV, 1993, REHABILITATION MED P, P240; JOHNSTON MV, 1987, REHABILITATION OUTCO; JOHNSTON MV, 1992, J HEAD TRAUMA REHAB, V7, P68; JOHNSTON MV, 1992, ARCH PHYS MED REHAB, V73, pS6; JOHNSTON MV, IN PRESS MED REHABIL; JONSEN AR, 1992, CLIN ETHICS, P146; KASSIRER JP, 1993, NEW ENGL J MED, V329, P1263, DOI 10.1056/NEJM199310213291710; KEITH RA, 1991, ARCH PHYS MED REHAB, V72, P269; KREUTZER JS, 1993, J HEAD TRAUMA REHAB, V8, P47; KRITCHEVSKY SB, 1991, JAMA-J AM MED ASSOC, V266, P1817, DOI 10.1001/jama.266.13.1817; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; LEHMKUHL LD, 1993, BRAIN INJURY GLOSSAR; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LIGHT DW, 1992, JAMA-J AM MED ASSOC, V267, P2503, DOI 10.1001/jama.267.18.2503; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; LINDER JC, 1992, HOSP HEALTH SERV ADM, V37, P143; LOHR KN, 1992, MED CARE, V30, pMS1, DOI 10.1097/00005650-199205001-00001; LONG WB, 1994, ARCH PHYS MED REHAB, V75, P144; LUBECK RC, 1991, J REHABILITATION ADM, V15, P216; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; MALKMUS D, 1979, REHABILITATION HEAD; MAROSSZEKY J, 1992, JUN C PROGR MED REH; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; MCDOWELL I, 1987, MEASURING HLTH GUIDE; MILLS V M, 1992, Brain Injury, V6, P219, DOI 10.3109/02699059209029663; MURRAY TH, 1992, HASTINGS CENT REP, V22, P12, DOI 10.2307/3562941; Novack T A, 1993, NeuroRehabilitation, V3, P79, DOI 10.3233/NRE-1993-3309; NOVACK TA, 1988, 65TH ANN C AM C REH; NOVACK TA, 1992, J HEAD TRAUMA REHAB, V6, P69; PAPASTRAT LA, 1992, J HEAD TRAUMA REHAB, V7, P11; Posavac Emil, 1989, PROGRAM EVALUATION M; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Prigatano GP., 1988, J HEAD TRAUMA REHAB, V3, P45; PUTNAM SH, 1992, CLIN NEUROPSYCHOL, V6, P383; Rader M A, 1989, Brain Inj, V3, P141, DOI 10.3109/02699058909004545; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROCCA B, 1989, J TRAUMA, V29, P299, DOI 10.1097/00005373-198903000-00004; ROSENTHAL M, 1992, NEUROREHABILITATION, V2, P1; Sakata R, 1991, Brain Inj, V5, P411, DOI 10.3109/02699059109008114; SCHERZER BP, 1986, ARCH PHYS MED REHAB, V67, P366; SCRANTON J, 1970, Archives of Physical Medicine and Rehabilitation, V51, P1; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; Spilker B, 1990, QUALITY LIFE ASSESSM; Spittler J F, 1993, Anasthesiol Intensivmed Notfallmed Schmerzther, V28, P213, DOI 10.1055/s-2007-998910; SPIVACK G, 1992, Brain Injury, V6, P419, DOI 10.3109/02699059209008138; SUNDANCE PL, 1992, NOV ANN AAPM RACRM C; TEASDALE G, 1974, LANCET, V2, P81; Timmons M, 1987, J HEAD TRAUMA REHAB, V2, P64; TUEL S M, 1992, Brain Injury, V6, P363, DOI 10.3109/02699059209034951; UDINARONOW H, 1987, J HEAD TRAUMA REHABI, V2, P224; VOGELSBERG RT, 1990, VOCATIONAL REHABILIT; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; Wade D, 1992, MEASUREMENT NEUROLOG; WARE JE, 1988, MED CARE, V26, P393, DOI 10.1097/00005650-198804000-00008; WEBER DO, 1992, HEALTHCARE FORUM JUL, P16; WEHMAN P, 1993, AM J PHYS MED REHAB, V72, P355; WENNBERG JE, 1987, LANCET, V1, P1185, DOI 10.1016/s0140-6736(87)92152-0; WENNBERG JE, 1989, NEW ENGL J MED, V321, P1168, DOI 10.1056/NEJM198910263211706; WENNBERG JE, 1990, AHCPR C P RES METHOD; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WHYTE J, IN PRESS AM J PHYS M; WILKERSON FDL, 1992, ARCH PHYS MED REHAB, V72, P111; WILLER B, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P18; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wood RLL, 1990, NEUROBEHAVIORAL SEQU; WRIGHT BD, 1989, ARCH PHYS MED REHAB, V70, P856; 1993, CARF STANDARDS MANUA; 1988, PROGRAM EVALUATION I; 1993, 1993 DIRECTORY ACCRE; 1989, QUAL REV B, V15, P330; 1991, NATIONAL DIRECTORY H; 1992, 1021059 US HOUS REPR; 1994, ACCREDITATION MANUAL; 1990, PROGRAM EVALUATION V; 1990, PRIMER CLIN INDICATO; 1980, PROGRAM EVALUATION O; 1993, NIH933509 PUBL; 1993, PUTTING OUTCOMES RES; 1993, HLTH OUTCOMES RES PR; 1989, PROGRAM EVALUATION G	172	6	6	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	1994	75	12			SI		SC19	SC26					8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	PY709	WOS:A1994PY70900004	7993178				2022-02-06	
J	TYLER, JS; COLSON, S				TYLER, JS; COLSON, S			COMMON PEDIATRIC DISABILITIES - MEDICAL ASPECTS AND EDUCATIONAL-IMPLICATIONS	FOCUS ON EXCEPTIONAL CHILDREN			English	Article							TRAUMATIC BRAIN INJURY; FRAGILE-X-SYNDROME; NORTHERN CALIFORNIA COUNTIES; ATTENTION DEFICIT DISORDER; CEREBRAL-PALSY; NEUROPSYCHOLOGICAL ASPECTS; COGNITIVE DEFICITS; SPECIAL EDUCATORS; CHILDHOOD-CANCER; CHRONIC ILLNESS	The recent movement to include students with disabilities in general education classrooms poses a variety of challenges to school personnel. Many classrooms are now accommodating a wider variety of diversity, including a significant group of students with complex medical disorders (Smith & Luckasson, 1992; Stainback & Stainback, 1989). Successful inclusion of these students will depend on educators having a more comprehensive understanding of these disabilities and learning to collaborate with medical personnel. Advances in medical technology have changed the course for students in several ways. For example, it has dramatically increased the survival rate of at-risk neonates, as well as reduced the risk of life-threatening complications commonly associated with many disabilities (Brown, 1993; Goldson, 1993; Warshaw, 1992). In addition, major progress has been made in the ability to determine the etiology of many disorders, and associated research has provided insights into multidisciplinary treatments and interventions. As these medical advances continue, more and more children with disabilities will be entering the general education classroom. It is imperative, therefore, that educators possess current information and the skills necessary to collaborate effectively with medical and ancillary personnel. This article provides a brief overview of common pediatric disabilities and their implications for educators. An increased understanding of these disabilities will enable educators to explain the child's disability to parents and general education teachers, to make appropriate referrals for students who have not been identified, and to facilitate the assessment process and thereby achieve more appropriate programming. In this article each disability is defined, and current information about incidence and causes is summarized. Diagnosis is also discussed, including common characteristics. The complications section covers information about associated deficits in the cognitive, language, motor, behavioral, and academic areas. Finally, multidisciplinary intervention approaches are described and a list of resources for obtaining additional information is provided.			TYLER, JS (corresponding author), UNIV KANSAS,MED CTR,DEPT SPECIAL EDUC,TRAUMAT BRAIN INJURY PROJECT,KANSAS CITY,KS 66103, USA.						ACCARDO PJ, 1991, ATTENTION DEFICIT DI; ALDENKAMP AP, 1990, EPILEPSIA, V31, pS9, DOI 10.1111/j.1528-1157.1990.tb05874.x; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Barkley R. A., 1990, ATTENTION DEFICIT HY; BATSHAW ML, 1992, CHILDREN DISABILITIE, P489; Bender B., 1986, GENETICS LEARNING DI, P175; BINNIE CD, 1990, EPILEPSIA, V31, pS2, DOI 10.1111/j.1528-1157.1990.tb05864.x; BROWN RT, 1993, J LEARN DISABIL, V26, P74, DOI 10.1177/002221949302600201; BROWN RT, 1993, J LEARN DISABIL, V26, P4, DOI 10.1177/002221949302600101; BUTLER RW, 1993, J PEDIATR PSYCHOL, V18, P319, DOI 10.1093/jpepsy/18.3.319; CHAMOVITZ I, 1985, HEAD INJURY REHABILI, P383; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; CHAPMAN CA, 1993, NEUROFIBROMATOSIS NE, V15, P6; COPELAND DR, 1988, J CHILD NEUROL, V3, P53, DOI 10.1177/088307388800300113; CUMMINS SK, 1993, J PEDIATR-US, V123, P230, DOI 10.1016/S0022-3476(05)81693-2; DAM M, 1990, EPILEPSIA, V31, pS26, DOI 10.1111/j.1528-1157.1990.tb05866.x; Deaton A, 1994, ED DIMENSIONS ACQUIR, P257; DEATON AV, 1994, ED DIMENSIONS ACQUIR, P239; EICHER PS, 1993, PEDIATR CLIN N AM, V40, P537; *EP FDN AM, 1987, TEACH ROL CHILDR EP; FERNBACH DJ, 1994, PRINCIPLES PRACTICE, P678; FISHMAN MA, 1994, PRINCIPLES PRACTICE, P2058; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; FOWLER M, 1992, CHADD ED MANUAL; FREEMAN JM, 1992, PEDIATR ANN, V21, P355, DOI 10.3928/0090-4481-19920601-07; GLAZE DG, 1994, PRINCIPLES PRACTICE, P2048; GOLDEN GS, 1992, PEDIATR CLIN N AM, V39, P715; GOLDEN GS, 1987, TXB PEDIATRIC NEUROL, P75; GOLDSON E, 1993, MED FRAGILE INFANT, P1; GRETHER JK, 1993, PEDIATRICS, V92, P854; Hagberg G., 1984, EPIDEMIOLOGY CEREBRA, P116; Hagerman R J, 1987, Curr Probl Pediatr, V17, P621; HENRIKSEN O, 1990, EPILEPSIA, V31, pS21, DOI 10.1111/j.1528-1157.1990.tb05865.x; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; KANDA T, 1984, DEV MED CHILD NEUROL, V26, P438; KAUFMAN BA, 1994, PEDIATR ANN, V23, P18, DOI 10.3928/0090-4481-19940101-07; KAZAK AE, 1993, J PEDIATR PSYCHOL, V18, P313, DOI 10.1093/jpepsy/18.3.313; KENNEDY CR, 1986, J HEAD TRAUMA REHAB, V1, P66; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; Kurtz Lisa A., 1992, P441; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MAHONEY DH, 1994, PRINCIPLES PRACTICE, P679; MASSAGLI TL, 1994, PEDIATR ANN, V23, P29, DOI 10.3928/0090-4481-19940101-08; MCCAULEY E, 1987, CHILD DEV, V58, P464, DOI 10.1111/j.1467-8624.1987.tb01394.x; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; MEADOWS AT, 1985, CA-CANCER J CLIN, V35, P271, DOI 10.3322/canjclin.35.5.271; MICHAEL RJ, 1992, INTERVENTION SCH CLI, V27, P211; MICHAUD LJ, 1993, ARCH PHYS MED REHAB, V74, P368; Mira M. P., 1992, TRAUMATIC BRAIN INJU; MIRA MP, 1991, FOCUS EXCEPT CHILD, V23, P1; MITCHELL EA, 1987, CLIN PEDIATR, V26, P406, DOI 10.1177/000992288702600805; MUNIR K, 1987, J AM ACAD CHILD PSY, V26, P844, DOI 10.1097/00004583-198726060-00008; NAEYE RL, 1989, AM J DIS CHILD, V143, P1154, DOI 10.1001/archpedi.1989.02150220044018; *NAT NEUR FDN, 1994, QUEST ANSW; PERCY AK, 1994, PRINCIPLES PRACTICE, P2025; PROUTY LA, 1988, AM J MED GENET, V30, P123, DOI 10.1002/ajmg.1320300111; PURVIS P, 1992, PEDIATR CLIN N AM, V39, P451; REISS AL, 1990, BIOL PSYCHIAT, V27, P223, DOI 10.1016/0006-3223(90)90652-I; RICCARDI VM, 1994, PRINCIPLES PRACTICE, P2128; RICCIO C, 1993, EXCEPT CHILDREN, V60, P108; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; ROSMAN NP, 1994, PRINCIPLES PRACTICE, P2038; Ross D. M, 1982, HYPERACTIVITY CURREN; SANTOS KE, 1992, REM SPEC EDUC, V13, P32, DOI 10.1177/074193259201300206; Savage R. C., 1994, ED DIMENSIONS ACQUIR, P3; SCHWEICH PJ, 1994, PRINCIPLES PRACTICE, P827; SEXSON SB, 1993, J LEARN DISABIL, V26, P115, DOI 10.1177/002221949302600204; SHAPIRO BK, 1994, PRINCIPLES PRACTICE, P679; Shapiro Bruce K., 1992, P259; SHERMAN SL, 1991, FRAGILE X SYNDROME D, P634; SMITH DD, 1992, INTRO SPECIAL ED TEA; SMITH SM, 1989, REM SPEC EDUC, V10, P20, DOI 10.1177/074193258901000306; STAINBACK W, 1989, ED ALL STUDENTS MAIN; STILL GF, 2002, LANCET, P1008; SZATMARI P, 1989, J CHILD PSYCHOL PSYC, V30, P219, DOI 10.1111/j.1469-7610.1989.tb00236.x; TEASDALE G, 1974, LANCET, V2, P81; THEOBALD TM, 1987, AM J MED GENET, V28, P1, DOI 10.1002/ajmg.1320280102; TUNIK MG, 1992, PEDIATR CLIN N AM, V39, P1007; TUNNESTEN WW, 1994, PRINCIPLES PRACTICE, P2176; TURNBULL JD, 1993, AM J DIS CHILD, V147, P54; Tyler J. S., 1993, TEACH EXCEPT CHILD, V25, P24; TYLER JS, 1991, LD FORUM, V16, P69; *UN CER PALS ASS, 1993, CER PALS FACTS FIG; *US DEP ED, 1991, POL MEM ADD; WABER DP, 1979, DEV MED CHILD NEUROL, V21, P58; WARSHAW JB, 1992, GROWTH GENETICS HORM, V8, P123; Wolf-Schein E G, 1987, ASHA, V29, P35; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447; 1992, FED REGISTER, V57, P44802; 1990, AM J DIS CHILD, V144, P627	94	6	6	0	8	LOVE PUBL CO	DENVER	1777 SOUTH BELLAIRE ST, DENVER, CO 80222	0015-511X			FOCUS EXCEPT CHILD	Focus Except. Child	DEC	1994	27	4					1	16					16	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	PZ986	WOS:A1994PZ98600001					2022-02-06	
J	SZEKERES, SF; MESERVE, NF				SZEKERES, SF; MESERVE, NF			COLLABORATIVE INTERVENTION IN SCHOOLS AFTER TRAUMATIC BRAIN INJURY	TOPICS IN LANGUAGE DISORDERS			English	Article						CHILDREN; COGNITIVE COMMUNICATIVE DISABILITY; COLLABORATION; EDUCATION; TRAUMATIC BRAIN INJURY	CHILDREN	Recognition that traumatic brian injury (TBI) in children has enduring effects on school performance has led to the addition of TBI as an educational disability category. Because many of the communication problems of these children can be attributed to cognitive disruption, speech-language pathologists must broaden the scope of assessment and focus intervention on significant cognitive-communicative and metacognitive needs. Collaboration, including participation of the family and student, is seen as the most sensible and efficient service delivery model for children with TBI. In this article, principles and procedures of collaborative intervention are discussed, and intervention activities that embody these principles are outlined.	GENESEE FINGER LAKES REG TRAUMAT BRAIN INJURY, SPENCERPORT, NY USA		SZEKERES, SF (corresponding author), NAZARETH COLL, DEPT SPEECH LANGUAGE PATHOL, ROCHESTER, NY 14618 USA.						Benton AL, 1991, FRONTAL LOBE FUNCTIO; BLOSSER JL, 1989, TOP LANG DISORD, V9, P67, DOI 10.1097/00011363-198903000-00007; BROWN AL, 1979, LEVELS PROCESSING ME; BUTLER KG, 1993, TOP LANG DISORD, V14, pR4; Christensen S., 1990, LANG SPEECH HEAR SER, V21, P110; COHEN SB, 1991, J HEAD TRAUMA REHAB, V6, P56; COOLEY E, 1991, J HEAD TRAUMA REHAB, V6, P47; ELLIS ES, 1993, J LEARN DISABIL, V26, P448, DOI 10.1177/002221949302600706; EWINGCOBBS L, 1990, TRAUMATIC BRAIN INJU; FENNELL EB, 1992, ADV CHILD NEUROPSYCH, V1; Fletcher J, 1987, NEUROBEHAVIORAL RECO; FLETCHER J, 1988, HDB PEDIATRIC PSYCHO; Fujiki M., 1984, LANG SPEECH HEAR SER, V15, P98; GIANGRECO M, 1990, COACH CAYUGA ONONDAG; GIANGRECO MF, 1991, CRITICAL ISSUES LIVE; GILLET P, 1986, ACAD THER, V21, P389, DOI 10.1177/105345128602100401; HAGEN JW, 1975, ADV CHILD DEV BEHAVI, V10; HAMRENIETUPSKI S, 1992, TEACHING EXCEPTIONAL, V24, P6; ISTOMINA ZM, 1975, SOV PSYCHOL, V13, P5, DOI 10.2753/RPO1061-040513045; JOHNSON LJ, 1990, J SPEC EDUC, V24, P69, DOI 10.1177/002246699002400106; KAISER G, 1986, HEAD INJURIES NEWBOR; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; LAMBIE RA, 1980, FOCUS EXCEPT CHILD, V13, P1; Lehr E, 1990, PSYCHOL MANAGEMENT T; LYNCH W, 1993, 7TH ANN C COGN REH C; MILLER GA, 1989, LANGUAGE SPEECH, V20; Mira M. P., 1992, TRAUMATIC BRAIN INJU; *NAT ASS STAT BOAR, 1992, WINN ALL CALL INCL S; NEVIN A, 1987, HDB SPECIAL ED RES P; *NY STAT ED DEP, 1993, FIELD MEM TRAUM BRAI; PALINCSAR AS, 1994, LANGUAGE LEARNING DI; PRESSLEY M, 1990, COGNITIVE STRATEGY R; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; SCHAFFNER C, 1991, OPENING DOORS STRATE; SCHEID K, 1993, HELPING STUDENTS STR; SHAPIRO K, 1987, HEAD INJURY; SMIRNOV AA, 1973, PROBLEMS PSYCHOL MEM; SZEKERES S, 1985, HEAD INJURY REHABILI; Szekeres Shirley F., 1992, Seminars in Speech and Language, V13, P293, DOI 10.1055/s-2008-1064204; TELZROW C, 1990, TRAUMATIC BRAIN INJU; THOUSAND J, 1989, ED ALL STUDENTS MAIN; WILLAIMS JM, 1991, HEAD INJURY FAMILY M; YLVISAKER M, 1989, TOP LANG DISORD, V9, P34, DOI 10.1097/00011363-198903000-00005; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006; YLVISAKER M, 1994, ED DIMENSIONS ACQUIR; YORK J, 1992, FOCUS EXCEPT CHILD, V25, P1; [No title captured]	47	6	6	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-8294	1550-3259		TOP LANG DISORD	Top. Lang. Disord.	NOV	1994	15	1					21	36		10.1097/00011363-199411000-00004			16	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	PL838	WOS:A1994PL83800004					2022-02-06	
J	YLVISAKER, M; KOLPAN, KI; ROSENTHAL, M				YLVISAKER, M; KOLPAN, KI; ROSENTHAL, M			COLLABORATION IN PREPARING FOR PERSONAL-INJURY SUITS AFTER TBI	TOPICS IN LANGUAGE DISORDERS			English	Article						ASSESSMENT; EXPERT TESTIMONY; LITIGATION; TBI	CLOSED HEAD-INJURY; FRONTAL-LOBE DAMAGE; VERBAL IMPAIRMENT; CHILDREN; CHILDHOOD; LANGUAGE; SEQUELAE; CONSEQUENCES; ADOLESCENTS; DISCOURSE	In many cases, traumatic brain injury (TBI) is associated with personal injury litigation requiring rehabilitation professionals to serve as expert witnesses. Increasingly, speech-language pathologists have been called on to play this role. Because of the nature of communication impairment after TBI, the testimony of speech-language pathologists often overlaps with that of neuropsychologists. The purposes of this article are to describe critical aspects of personal injury litigation and expert testimony, describe communication deficits associated with cognitive and psychosocial impairment common after TBI, and promote a collaborative approach to assessment and preparation for legal testimony.	LAW OFF KENNETH I KOLPAN PC,BOSTON,MA; WAYNE STATE UNIV,DETROIT,MI 48202; REHABIL INST CHICAGO,CHICAGO,IL 60611		YLVISAKER, M (corresponding author), COLL ST ROSE,DEPT COMMUN DISORDERS,ALBANY,NY 12203, USA.						ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; ARSENI C, 1970, PSYCHIAT NEUROL NEUR, V73, P105; Baddeley A., 1992, SPEED CAPACITY LANGU; Benson D.F., 1986, FRONTAL LOBES; BENTON A, 1991, DEV NEUROPSYCHOL, V7, P275, DOI 10.1080/87565649109540495; Benton AL, 1991, FRONTAL LOBE FUNCTIO; Bigler E D, 1988, Arch Clin Neuropsychol, V3, P279, DOI 10.1016/0887-6177(88)90020-0; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CAMPBELL TF, 1990, J SPEECH HEAR DISORD, V55, P567, DOI 10.1044/jshd.5503.567; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; DELIS M, 1983, CALIFORNIA VERBAL LE; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; EIBEN CF, 1984, ARCH PHYS MED REHAB, V65, P168; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GERMAN D, 1989, NATIONAL COLLEGE ED; GERMAN D, 1990, NATIONAL COLLEGE ED; GOLDEN CJ, 1985, LURIANEBRASKA NEUROP; GOLDMAN PS, 1971, EXP NEUROL, V32, P366, DOI 10.1016/0014-4886(71)90005-7; Goodglass H, 1983, ASSESSMENT APHASIA R; GRATTAN LM, 1991, DEV NEUROPSYCHOL, V7, P283, DOI 10.1080/87565649109540496; GRATTAN LM, 1992, BRAIN COGNITION, V20, P185, DOI 10.1016/0278-2626(92)90068-W; GROSS CR, 1985, TRAUMA CENTRAL NERVO; Hagen C, 1981, TOP LANG DIS, V1, P73; HALPERN H, 1973, J SPEECH HEAR DISORD, V38, P162, DOI 10.1044/jshd.3802.162; HEDRICK DL, 1984, SEQUENCED INVENTORY; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; KALSBEEK WD, 1980, J NEUROSURGERY S, V53, P19; Kertesz A., 1982, W APHASIA BATTERY; Lahey M., 1988, LANGUAGE DISORDERS L; LEAHY LF, 1987, PERSISTENT DEFICITS; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; MATEER CA, 1991, DEV NEUROPSYCHOL, V7, P359, DOI 10.1080/87565649109540498; MCCAULEY RJ, 1984, J SPEECH HEAR DISORD, V49, P34, DOI 10.1044/jshd.4901.34; MILLER JD, 1990, REHABILITATION ADULT; Newcombe F., 1969, MISSILE WOUNDS BRAIN; PANG D, 1985, HEAD INJURY REHABILI; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; PETTERSON L, 1988, SENSITIVITY EMOTIONA; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; REITAN R, 1985, HALSTEAD REITAN TEST; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; SEMEL E, 1987, CLIN EVALUATION LANG; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Spreen O., 1977, NEUROSENSORY CTR COM, VRev; TURKINGTON C, 1986, APA MONITOR, P17; Wechsler, 1981, WECHSLER MEMORY SCAL; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; WIIG EH, 1988, TEST LANGUAGE COMPET; WILLIAMS D, 1992, BRAIN COGNITION, V20, P196, DOI 10.1016/0278-2626(92)90069-X; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447; YLVISAKER M, 1994, ED DIMENSIONS ACQUIR; YLVISAKER M, IN PRESS SEMINARS SP; 1988, ASHA, V30, P79	62	6	6	0	4	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0271-8294			TOP LANG DISORD	Top. Lang. Disord.	NOV	1994	15	1					1	20		10.1097/00011363-199411000-00003			20	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	PL838	WOS:A1994PL83800003					2022-02-06	
J	YOSHIDA, K; FURUSE, M; IZAWA, A; IIZIMA, N; HIRANO, T; KUCHIWAKI, H; INAO, S; SUGITA, K				YOSHIDA, K; FURUSE, M; IZAWA, A; IIZIMA, N; HIRANO, T; KUCHIWAKI, H; INAO, S; SUGITA, K			DYNAMICS OF CEREBRAL METABOLISM IN PATIENTS WITH CHRONIC SUBDURAL-HEMATOMA EVALUATED WITH PHOSPHORUS-31 MR SPECTROSCOPY BEFORE AND AFTER SURGERY	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article						HEMATOMA, SUBDURAL; BRAIN, METABOLISM; MAGNETIC RESONANCE, SPECTROSCOPY; SURGERY; BRAIN, MAGNETIC RESONANCE	NUCLEAR MAGNETIC-RESONANCE; TRAUMATIC BRAIN INJURY; BLOOD-FLOW; NMR-SPECTROSCOPY; HEAD-INJURY; INVIVO; CAT; ISCHEMIA; PH	PURPOSE: To determine whether the depression of cerebral bioenergetic metabolism caused by chronic subdural hematomas can account for neurologic dysfunction and whether the degree of metabolic depression may be useful for clinical assessment and therapy. METHODS: Sixteen patients who had chronic subdural hematomas with hemiparesis and/or mental disturbances underwent phosphorous 31 MR spectroscopy before and 10 to 14 days after surgery. Phosphorous 31 MR spectroscopy was also performed on 5 patients who had chronic subdural hematomas with only slight headaches who were treated by conservative therapy and on 10 healthy volunteers. RESULTS: The preoperative phosphocreatine-to-inorganic phosphate ratio (2.10 +/- 0.36) improved to normal values (2.69 +/- 0.44) after evacuation of hematomas. This improvement was accompanied by complete disappearance of hemiparesis and/or mental disturbance. Brain tissue pH also improved from 7.07 +/- 0.11 to 7.205 +/- 0.13 after surgery. On the other hand, patients who had chronic subdural hematomas with only slight headaches had the same phosphocreatine-to-inorganic phosphate ratio and brain intracellular pH as healthy volunteers. CONCLUSION: The phosphocreatine-to-inorganic phosphate ratio may be useful for determining when to operate on patients with chronic subdural hematomas and to assess the efficacy of treatment.	NAKATSUGAWA MUNICIPAL GEN HOSP,DEPT NEUROSURG,NAKATSUGAWA,JAPAN; NAKATSUGAWA MUNICIPAL GEN HOSP,DEPT RADIOL,NAKATSUGAWA,JAPAN; SHIMADZU CENT RES LAB,KYOTO,JAPAN		YOSHIDA, K (corresponding author), NAGOYA UNIV,SCH MED,DEPT NEUROSURG,SHOWA KU,65 TSURUMAI CHO,NAGOYA,AICHI 466,JAPAN.						BOTTOMLEY PA, 1986, RADIOLOGY, V160, P763, DOI 10.1148/radiology.160.3.3737915; BRODERSEN P, 1975, ACTA NEUROL SCAND, V51, P233, DOI 10.1111/j.1600-0404.1975.tb07604.x; BTECH DTD, 1982, PEDIATRICS, V70, P310; DUCKROW RB, 1981, J NEUROSURG, V54, P607, DOI 10.3171/jns.1981.54.5.0607; GERMANO IM, 1988, J CEREBR BLOOD F MET, V8, P24, DOI 10.1038/jcbfm.1988.4; GJERRIS F, 1975, ACTA NEUROCHIR, V31, P267; GONZALEZMENDEZ R, 1984, J MAGN RESON, V57, P526, DOI 10.1016/0022-2364(84)90270-1; HILBERMAN M, 1984, J CEREBR BLOOD F MET, V4, P334, DOI 10.1038/jcbfm.1984.50; HOULT DI, 1974, NATURE, V252, P285, DOI 10.1038/252285a0; IKEDA K, 1990, SURG NEUROL, V33, P87, DOI 10.1016/0090-3019(90)90017-J; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; NARUSE S, 1984, BRAIN RES, V296, P370, DOI 10.1016/0006-8993(84)90076-3; ORDIDGE RJ, 1988, MAGNET RESON MED, V8, P323, DOI 10.1002/mrm.1910080309; ORDIDGE RJ, 1986, J MAGN RESON, V66, P283, DOI 10.1016/0022-2364(86)90031-4; PETROFF OAC, 1984, ANN NEUROL, V16, P169, DOI 10.1002/ana.410160203; PETROFF OAC, 1985, NEUROLOGY, V35, P781, DOI 10.1212/WNL.35.6.781; PRICHARD JW, 1983, P NATL ACAD SCI-BIOL, V80, P2748, DOI 10.1073/pnas.80.9.2748; SCHNALL MD, 1988, MAGNET RESON MED, V6, P15, DOI 10.1002/mrm.1910060103; TANAKA A, 1992, NEUROSURGERY, V30, P370, DOI 10.1227/00006123-199203000-00010; TANAKA A, 1990, NEUROSURGERY, V27, P554, DOI 10.1227/00006123-199010000-00009; THULBORN KR, 1982, J CEREBR BLOOD F MET, V2, P299, DOI 10.1038/jcbfm.1982.31; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; WEINSTEI.JD, 1968, J NEUROSURG, V28, P513, DOI 10.3171/jns.1968.28.6.0513; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; YOSHIDA K, 1991, J NEUROSURG, V74, P87, DOI 10.3171/jns.1991.74.1.0087	25	6	6	0	0	AMER SOC NEURORADIOLOGY	OAK BROOK	2210 MIDWEST RD, OAK BROOK, IL 60521	0195-6108			AM J NEURORADIOL	Am. J. Neuroradiol.	OCT	1994	15	9					1681	1686					6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	PL564	WOS:A1994PL56400014	7847213				2022-02-06	
J	KAUFMAN, BA; DACEY, RG				KAUFMAN, BA; DACEY, RG			ACUTE-CARE MANAGEMENT OF CLOSED-HEAD INJURY IN CHILDHOOD	PEDIATRIC ANNALS			English	Article											KAUFMAN, BA (corresponding author), ST LOUIS CHILDRENS HOSP,DEPT NEUROSURG,1 CHILDRENS PLAZA,ST LOUIS,MO 63110, USA.							0	6	6	0	0	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086	0090-4481			PEDIATR ANN	Pediatr. Annu.	JAN	1994	23	1					18	&		10.3928/0090-4481-19940101-07			0	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	MU563	WOS:A1994MU56300004	8152861				2022-02-06	
J	OKUYAMA, S; KAWASHIMA, N; ARAKI, H; OTOMO, S; SHIMA, K				OKUYAMA, S; KAWASHIMA, N; ARAKI, H; OTOMO, S; SHIMA, K			EFFECTS OF AN APOVINCAMINIC ACID-DERIVATIVE VA-045 ON NEURONAL-ACTIVITY IN RAT-BRAIN STEM RETICULAR-FORMATION	LIFE SCIENCES			English	Article						VA-045; CLOSED HEAD INJURY; BRAIN STEM RETICULAR FORMATION; CLONIDINE; SCOPOLAMINE; CORTICAL EEG	CLONIDINE	Extracellular single unit and spontaneous cortical electroencephalographic (ECoG) recordings were made in the brain stem reticular formation (RF) and the frontal cortex, respectively, of urethane-anesthetized rats. VA-045, an apovincaminic acid derivative had no significant effects on the spontaneous firing rate of the RF neurons and ECoG. Closed head injury (CHI) was induced by dropping a 400 g weight through a tube from 70 cm on a steel helmet placed on the vertex. CHI led to a reduction in the firing rate of RF neurons and ECoG synchronization. VA-045 dose-dependently reversed the CHI-induced decrease in the firing rate of RF and led to ECoG desyncronization. Clonidine, an alpha2 adrenoceptor agonist, and scopolamine, a muscarinic receptor antagonist, also reduced the firing rate of RF and led to ECoG desyncronization. Clonidine, an alpha2 adrenoceptor agonist, and scopolamine, a muscarinic receptor antagonist, also reduced the firing rate of RF neurons and led to ECoG synchronization. VA-045 dose-dependently antagonized the effects of clonidine, but not the effects of scopolamine on RF neuronal activity and ECoG. Thus, VA-045 has an ameliorating effect on the CHI-induced depression of neuronal activity in the RF. A central alpha2 adrenoceptor antagonistic action may be involved.	NATL DEF MED COLL, DEPT NEUROSURG, TOKOROZAWA, SAITAMA 359, JAPAN		OKUYAMA, S (corresponding author), TAISHO PHARMACEUT CO LTD, RES CTR, DEPT PHARMACOL, 1-403 YOSHINO CHO, OMIYA, SAITAMA 330, JAPAN.						Arakawa Shiro, 1994, Japanese Journal of Pharmacology, V64, p198P; ASHTON H, 1987, BRAIN SYSTEMS DISORD; BLOOR BC, 1982, ANESTH ANALG, V61, P741; BUZSAKI G, 1988, NEUROSCIENCE, V26, P735, DOI 10.1016/0306-4522(88)90095-4; DESARRO GB, 1987, BRIT J PHARMACOL, V90, P675; DOZE VA, 1989, ANESTHESIOLOGY, V71, P75, DOI 10.1097/00000542-198907000-00014; HAYASHI Y, 1993, BRIT J ANAESTH, V71, P108, DOI 10.1093/bja/71.1.108; HELKE CJ, 1980, BRAIN RES, V188, P425, DOI 10.1016/0006-8993(80)90042-6; KAWASHIMA Y, 1993, J MED CHEM, V36, P815, DOI 10.1021/jm00059a004; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MIYATA N, 1993, LIFE SCI, V52, pPL181, DOI 10.1016/0024-3205(93)90115-J; OKUYAMA S, 1988, ARCH INT PHARMACOD T, V296, P246; OKUYAMA S, 1993, LIFE SCI, V53, pPL273, DOI 10.1016/0024-3205(93)90603-Z; OKUYAMA S, 1993, RES COMMUN CHEM PATH, V82, P91; OKUYAMA S, 1994, IN PRESS GEN PHARM; Pellegrino L. J., 1967, STEREOTAXIC ATLAS RA; SALMOIRAGHI GC, 1963, J NEUROPHYSIOL, V26, P581, DOI 10.1152/jn.1963.26.4.581; WEBSTER KE, 1978, BIOL BASIS SCHIZOPHR, P3	18	6	6	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.		1994	55	20					1577	1584		10.1016/0024-3205(94)00319-X			8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	PL073	WOS:A1994PL07300007	7968229				2022-02-06	
J	SCHMID, A; ROTZSCHER, V				SCHMID, A; ROTZSCHER, V			TYPE AND SEVERITY OF SKATEBOARD INJURIES	UNFALLCHIRURG			German	Article								In this study 101 patients who had sustained a total of 123 skateboard injuries and had been treated in the Department of Surgery at the Elisabeth-Krankenhaus in Essen between December 1989 and July 1991 were reviewed. The ages of the patients ranged between 6 and 22 years; most injuries were sustained between the ages of 12 and 17 years (67.3%). The upper extremity was injured in 50.4%. Lower extremity injuries occured in 23.5%, head and face injuries in 22.7%, and chest injuries in 3.4%. The most common type ofinjury was a fracture (37.3%), most frequently to the wrist and forearm (56.5% of the fractures), followed by contusions (18.7%), lacerations (13.8%) and abrasions (10.6%). Of the 101 patients, 20 had to be hospitalized altogether 25 times, for an average duration of 7.3 days per person. The reasons for hospitalization were fractures in 18 patients, which had to be treated by open reduction and internal fixation in 7 cases and closed reduction in 14 cases. Concussion of the brain made hospitalization necessary for 2 cases.			SCHMID, A (corresponding author), CHRISTIAN ALBRECHTS UNIV KIEL,ALLGEMEIN & THORAXCHIRURG ABT,ARNOLD HELLER STR 7,D-24105 KIEL,GERMANY.							0	6	6	3	5	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0177-5537			UNFALLCHIRURG	Unfallchirurg	DEC	1993	96	12					641	644					4	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	MM604	WOS:A1993MM60400007	8128259				2022-02-06	
J	LEVIN, HS; MENDELSOHN, D; BRUCE, D; HARWARD, H; CULHANE, KA; EISENBERG, HM				LEVIN, HS; MENDELSOHN, D; BRUCE, D; HARWARD, H; CULHANE, KA; EISENBERG, HM			REVERSIBILITY OF CEREBRAL ATROPHY AFTER HEAD-INJURY IN CHILDREN	NEUROSURGERY			English	Article						CENTRAL NERVOUS SYSTEM TRAUMA; HEAD INJURY; MAGNETIC RESONANCE IMAGING; PLASTICITY	CENTRAL NERVOUS-SYSTEM; BRAIN	REVERSIBLE CEREBRAL ATROPHY in humans has been documented by computed tomography in alcoholics and has been described as an incidental finding after head injury in children. Two children were studied who had sustained a severe closed head injury, 1 and 5 years previously, after which cerebral atrophy had developed, according to subacute computed tomography. Reversible cerebral atrophy was seen on magnetic resonance images of both patients. Despite normal appearance on magnetic resonance images more than 1 year after injury, both patients exhibited residual neuropsychological impairment on a broad range of cognitive and memory tests.	UNIV TEXAS, HLTH SCI CTR, SW MED SCH, DEPT RADIOL, DALLAS, TX 75235 USA; UNIV TEXAS, HLTH SCI CTR, SW MED SCH, DEPT NEUROSURG, DALLAS, TX 75235 USA		LEVIN, HS (corresponding author), UNIV TEXAS, MED BRANCH, DIV NEUROSURG, D-73, GALVESTON, TX 77550 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER		Benton A., 1976, MULTILINGUAL APHASIA; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CARLEN PL, 1987, ACTA MED SCAND, P19; CAROLAN PL, 1986, PEDIATR NEUROSCI, V12, P140; Delis DC, 1987, CALIFORNIA VERBAL LE; DREWE E A, 1975, Cortex, V11, P8; GHATAK NR, 1989, J NEUROPATH EXP NEUR, V48, P507, DOI 10.1097/00005072-198909000-00002; GRADY MS, 1989, J NEUROSURG, V71, P534, DOI 10.3171/jns.1989.71.4.0534; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; HARPER CG, 1988, J NEUROL NEUROSUR PS, V51, P124, DOI 10.1136/jnnp.51.1.124; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; KAYE JA, 1990, ARCH NEUROL-CHICAGO, V47, P1336, DOI 10.1001/archneur.1990.00530120082014; REKATE HL, 1988, PEDIATR NEUROSCI, V14, P77, DOI 10.1159/000120367; SCHROTH G, 1988, NEURORADIOLOGY, V30, P385, DOI 10.1007/BF00404102; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D., 1974, WECHSLER ADULT INTEL	17	6	6	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	DEC	1992	31	6					1117	1122		10.1227/00006123-199212000-00021			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KD087	WOS:A1992KD08700021	1470324				2022-02-06	
J	PEACH, RK				PEACH, RK			FACTORS UNDERLYING NEUROPSYCHOLOGICAL TEST-PERFORMANCE IN CHRONIC SEVERE TRAUMATIC BRAIN INJURY	JOURNAL OF SPEECH AND HEARING RESEARCH			English	Article						TRAUMATIC BRAIN INJURY; COGNITION; LANGUAGE PERFORMANCE; APHASIA; FACTOR ANALYSIS	HEAD-INJURY; CHILDREN; MEMORY	The neuropsychological test performance of subjects with traumatic brain injury (TBI) of the closed head type was investigated using a test battery consisting of traditional clinical instruments with expanded language measures. TBI subjects were specifically selected to include only those with a pattern of predominantly diffuse cerebral injury to allow conclusions regarding language performance in the absence of focal aphasia-producing lesions. Factor analysis of the test scores resulted in the extraction of three interpretable factors associated with performance on this battery: perceptual, general language, and mental efficiency. The results were compared to those obtained in previous factor-analytic studies of brain-damaged subjects, revealing patterns for the language/verbal subtests that diverged from those observed formerly. Two explanations are considered for these findings, the first interpretation centering on the notion of select impairments to specific cognitive processes and the second relating to impairments in the capacity to allocate resources effectively.	EMORY UNIV,SCH MED,DEPT BIOCHEM,ATLANTA,GA 30322; UNIV GEORGIA,DEPT COMMUN SCI & DISORDERS,ATHENS,GA 30602								ADAMOVICH BB, 1985, COGNITIVE REHABILITA; BARNES GW, 1974, J NERV MENT DIS, V158, P50, DOI 10.1097/00005053-197401000-00007; BAXTER R, 1985, HEAD INJURY REHABILI, P245; BORNSTEIN RA, 1983, J CLIN NEUROPSYCHOL, V5, P105, DOI 10.1080/01688638308401158; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; Cohen J., 1983, APPL MULTIPLE REGRES, V2nd ed.; CORRIGAN JD, 1988, INT J CLIN NEUROPSYC, V10, P25; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; GOLDSTEIN G, 1972, PERCEPT MOTOR SKILL, V34, P603, DOI 10.2466/pms.1972.34.2.603; HAGEN C, 1986, HDB SPEECH LANGUAGE, P1003; HEILBRONNER RL, 1988, INT J CLIN NEUROPSYC, V10, P20; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; HYND GW, 1990, ASSESSING ADOLESCENT, P638; JARVIS PE, 1984, HALSTEAD REITAN TEST; Jennett B, 1981, MANAGEMENT HEAD INJU; Kahneman D., 1973, ATTENTION EFFORT; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; Kertesz A., 1982, W APHASIA BATTERY; Kertesz A, 1979, APHASIA ASS DISORDER; LANSDELL H, 1977, J CONSULT CLIN PSYCH, V45, P412, DOI 10.1037/0022-006X.45.3.412; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; LYNCH WJ, 1983, REHABILITATION HEAD, P291; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; REITAN RM, 1976, MANUAL ADM NEUROPSYC; ROYCE JR, 1976, MULTIVARIATE BEHAVIO, V4, P381; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Stevens J., 1986, APPLIED MULTIVARIATE; SWIERCINSKY DP, 1979, PERCEPT MOTOR SKILL, V48, P231, DOI 10.2466/pms.1979.48.1.231; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; WERTZ RT, 1985, CLIN MANAGEMENT NEUR, P1; 1988, USERS GUIDE; [No title captured]	34	6	6	0	1	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	10801 ROCKVILLE PIKE RD, ROCKVILLE, MD 20852-3279	0022-4685			J SPEECH HEAR RES	J. Speech Hear. Res.	AUG	1992	35	4					810	818		10.1044/jshr.3504.810			9	Language & Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	JH467	WOS:A1992JH46700012	1405538				2022-02-06	
J	FABIANO, RJ; GORAN, DA				FABIANO, RJ; GORAN, DA			A PRINCIPAL COMPONENT ANALYSIS OF THE KATZ ADJUSTMENT SCALE IN A TRAUMATIC BRAIN INJURY REHABILITATION SAMPLE	REHABILITATION PSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; MILD	The KAS-R1 was completed by relatives of 88 clients who had enrolled in a post-acute rehabilitation program for the treatment of traumatic brain injury. The items were subjected to a principal component analysis. The analysis yielded 10 statistically significant component groups. Internal consistency as determined by Cronbach alpha ranged from .78 to .94. Moderate correlations were observed between a number of component groups suggesting some overlap in components derived. The results suggest that the 127 items of the KAS-R1 form component groups which may represent categorically differentiated behavioral symptoms. Future research is needed to discern the extent to which the component groups describe behavioral phenomena.	MICHIGAN STATE UNIV,REHABIL COUNSELOR TRAINING PROGRAM,E LANSING,MI 48824								BAER DM, 1983, NEUROLOGICAL REV, V40, P195; BLEIBERG J, 1984, 5TH ANN TRAUM HEAD I; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; CONBOY TJ, 1986, REHABIL PSYCHOL, V31, P203, DOI 10.1037//0090-5550.31.4.203; CORTHELL DW, 1985, 12TH I REH ISS REP; CRIPE L, 1991, MAR INT BRAIN INJ S; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; DEATON AV, 1986, REHABIL PSYCHOL, V31, P231, DOI 10.1037//0090-5550.31.4.231; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; GRAHAM JR, 1972, J CLIN PSYCHOL, V28, P380, DOI 10.1002/1097-4679(197207)28:3+<380::AID-JCLP2270280323>3.0.CO;2-B; GRANT I, 1987, NEUROBEHAVIORAL RECO; Guilford J. P., 1956, FUNDAMENTAL STATISTI; HAFFEY WJ, 1989, REHABIL PSYCHOL, V34, P147, DOI 10.1037//0090-5550.34.2.147; HIER DB, 1983, NEUROLOGY, V33, P337, DOI 10.1212/WNL.33.3.337; JACKSON JK, 1991, 1991 INT BRAIN INJ S; KARPMAN T, 1986, J APPLIED REHABILITA, V17, P28; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; LEZAK MD, 1978, J CLIN PSYCHIAT, V29, P592; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; PRIBRAM KH, 1975, PSYCHOL REV, V82, P116, DOI 10.1037/h0076780; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1987, COMMUNITY REENTRY HE; PRIGATANO GP, 1987, NEUROBEHAVIORAL RECO; RIMEL RW, 1983, REHABILITATION HEAD; SPIERS PA, 1985, PRINCIPLES BEHAVIORA; VALENSTEIN E, 1979, CLIN NEUROPSYCHOLOGY; [No title captured]	29	6	7	0	0	SPRINGER PUBL CO	NEW YORK	536 BROADWAY, NEW YORK, NY 10010-3955	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	SUM	1992	37	2					75	85		10.1037/h0079096			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	JD777	WOS:A1992JD77700001					2022-02-06	
J	CROOKS, DA; SCHOLTZ, CL; VOWLES, G; GREENWALD, S; EVANS, S				CROOKS, DA; SCHOLTZ, CL; VOWLES, G; GREENWALD, S; EVANS, S			AXONAL INJURY IN CLOSED HEAD-INJURY BY ASSAULT - A QUANTITATIVE STUDY	MEDICINE SCIENCE AND THE LAW			English	Article							BRAIN-DAMAGE; DIAGNOSIS	Due to the controversy in the literature regarding the time course of axonal balloon formation in human material, we wished to determine if it was possible to diagnose axonal injury before the development of axonal balloonings. The hypothesis was that the presence of axonal swellings or axonal enlargements associated with a glial reaction could be used as a diagnostic aid in human axonal injury before 12 hours. The brains of eight individuals that survived for less than 48 hours following head injury, and also had evidence of axonal injury using the criteria of Vanezis et al. (1987), were systematically studied by looking at axonal swellings, axonal balloonings, reactive astrocytes, maximum diameter of axonal enlargements and density of axonal enlargements. Controls were eight selected cases without neurological disease. The variables studied were assessed in 25 fields from ten different areas of the brain, using silver stains and immunoperoxidase for glial fibrillary acidic protein (GFAP). Logarithms of one plus the count of each variable were taken from the raw data and these were analysed using percentile distribution and the median, the t-test, Mann-Whitney U test and the Wilcoxon signed rank test. We conclude that quantitation of axonal damage allows the detection of mild degrees of axonal injury that could be overlooked on routine examination, and that the criteria of axonal enlargements, rather than axonal balloonings, are indications of axonal damage, cannot be endorsed with the evidence provided.	UNIV LONDON LONDON HOSP,COLL MED,DEPT EPIDEMIOL & MED STAT,LONDON E1 1BB,ENGLAND		CROOKS, DA (corresponding author), ROYAL LONDON HOSP,DEPT MORBID ANAT,LONDON E1 1BB,ENGLAND.		Greenwald, Stephen E/C-6928-2012	Greenwald, Stephen/0000-0002-8471-7070			ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1985, MED SCI LAW, V25, P265, DOI 10.1177/002580248502500407; ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Adams JH, 1982, RECENT ADV NEUROPATH, P165; ADAMS JH, 1984, RECENT ADV HISTOPATH, V12, P241; Adams JH, 1975, HDB CLIN NEUROLOGY, V23, P35; ALVES WM, 1985, CENTRAL NERVOUS SYST, P255; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GRAHAM DI, 1989, MILD MODERATE HEAD I, P63; IMAJO T, 1984, AM J FOREN MED PATH, V5, P217, DOI 10.1097/00000433-198409000-00005; IMAJO T, 1987, AM J FOREN MED PATH, V8, P217, DOI 10.1097/00000433-198708030-00004; JANE J, 1982, SEMINARS NEUROLOGICA, P229; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; JANE JA, 1985, SEMINARS NEUROLOGICA, P27; LINDENBERG R, 1955, AM J PATHOL, V31, P297; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; Rand CW, 1934, ARCH NEURO PSYCHIATR, V31, P527, DOI 10.1001/archneurpsyc.1934.02250030067004; SIMPSON RHW, 1987, S AFR MED J, V71, P10; SIMPSON RHW, 1985, FORENSIC SCI INT, V27, P229, DOI 10.1016/0379-0738(85)90142-2; VANEZIS P, 1987, FORENSIC SCI INT, V35, P1, DOI 10.1016/0379-0738(87)90018-1	28	6	6	0	0	CHILTERN PUBLISHING	BEACONSFIELD	34 AYLESBURY END, BEACONSFIELD, BUCKS, ENGLAND HP9 1LW	0025-8024			MED SCI LAW	Med. Sci. Law	APR	1992	32	2					109	117		10.1177/106002809203200204			9	Law; Medicine, Legal; Pathology	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Government & Law; Legal Medicine; Pathology	JV300	WOS:A1992JV30000004	1377323				2022-02-06	
J	TERMINASSIAN, A; BONNET, F; GUERRINI, P; RICOLFI, F; DELAUNAY, F; BEYDON, L; CATOIRE, P				TERMINASSIAN, A; BONNET, F; GUERRINI, P; RICOLFI, F; DELAUNAY, F; BEYDON, L; CATOIRE, P			CAROTID-ARTERY INJURY - VALUE OF DOPPLER SCREENING IN HEAD TRAUMA PATIENTS	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article								A case is reported of a patient with a traumatic aneurysm of the intracranial part of the carotid artery occurring after a traffic accident. The patient was admitted in coma (Glasgow score 5), and presented with a depressed fracture of the frontal and parietal bones, a fracture of the left petrous pyramid and of the left anterior clinoid process, as well as of the right tympanic bone and temporomandibular joint. The borders of the left carotid canal seemed unaltered. Despite the lack of localised neurological signs, cervical and transcranial Doppler ultrasonography was carried out. Intracranial carotid blood flow was found to be altered on both sides. Angiography showed a false carotid aneurysm on the left side (carotid siphon portion C3), and a moderate irregular stenosis of the C2 part on the right. There were no brain lesions on the CT scan. Prophylactic treatment with heparin was started. The patient recovered normal consciousness within a fortnight. The false aneurysm increased in volume and was treated by embolisation. Flow speeds in the carotid siphons also returned to normal. The usefulness of routine screening of patients with petrous bone fractures with Doppler ultrasound is discussed.			TERMINASSIAN, A (corresponding author), HOP HENRI MONDOR,DEPT ANESTHESIE & REANIMAT,51 AVE MARECHAL LATTRE TASSIGNY,F-94010 CRETEIL,FRANCE.							0	6	6	0	0	EDITIONS SCIENTIFIQUES ELSEVIER	PARIS CEDEX 15	141 RUE JAVEL, 75747 PARIS CEDEX 15, FRANCE	0750-7658			ANN FR ANESTH	Ann. Fr. Anest. Reanim.		1992	11	5					598	600		10.1016/S0750-7658(05)80767-1			3	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	JW855	WOS:A1992JW85500017	1476290				2022-02-06	
J	DUBOV, WE; BACH, JR				DUBOV, WE; BACH, JR			DELAYED PRESENTATION OF A CAROTID-CAVERNOUS SINUS FISTULA IN A PATIENT WITH TRAUMATIC BRAIN INJURY	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						CAROTID-CAVERNOUS FISTULA; EMBOLIZATION; HEAD INJURY; DETACHABLE BALLOON CATHETER		Carotid-cavernous sinus fistulas are rare complications of traumatic brain injury, facial trauma and postorthognathic surgery. A high level of clinical suspicion is necessary, particularly for patients who are unable to communicate, to establish the diagnosis. A case of delayed presentation of a carotid-cavernous sinus fistula after traumatic brain injury is presented. This case illustrates that early recognition of this disorder is crucial to prevent significant morbidity.	UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT PHYS MED & REHABIL,NEWARK,NJ 07103								AHMADI J, 1983, AM J NEURORADIOL, V4, P131; BARROW DL, 1982, J NEUROSURG, V56, P396, DOI 10.3171/jns.1982.56.3.0396; BARROW DL, 1985, J NEUROSURG, V62, P248, DOI 10.3171/jns.1985.62.2.0248; BUTLER EC, 1970, LARYNGOSCOPE, V80, P292, DOI 10.1288/00005537-197002000-00014; DEBRUN G, 1981, J NEUROSURG, V55, P678, DOI 10.3171/jns.1981.55.5.0678; GARLAND SD, 1977, J ORAL SURG, V35, P832; GEE W, 1985, SURV OPHTHALMOL, V29, P276, DOI 10.1016/0039-6257(85)90151-1; GRONSKI HW, 1975, SOUTHERN MED J, V68, P1096, DOI 10.1097/00007611-197509000-00011; HES J, 1988, INT J ORAL MAX SURG, V17, P295, DOI 10.1016/S0901-5027(88)80006-7; JONES GM, 1989, BRIT J ORAL MAX SURG, V27, P481, DOI 10.1016/S0266-4356(89)80006-3; MULLAN S, 1985, NEUROSURGERY, P1483; NIANTU J, 1982, J ORAL MAXILLOFAC SU, V40, P52; PARKINSON DWIGHT, 1964, CANADIAN J SURG, V7, P251; PHELPS CD, 1982, AM J OPHTHALMOL, V93, P423, DOI 10.1016/0002-9394(82)90132-5; ROBERTSON JM, 1977, BRIT J ORAL SURG, V14, P195, DOI 10.1016/0007-117X(77)90020-8; ROGER R, 1972, J ORAL SURG, V30, P4; SERBINENKO FA, 1974, J NEUROSURG, V41, P125, DOI 10.3171/jns.1974.41.2.0125; VINUELA F, 1984, J NEUROSURG, V60, P976, DOI 10.3171/jns.1984.60.5.0976; WILSON CB, 1966, J NEUROSURG, V34, P111; ZACHARIADES N, 1988, J CRANIO MAXILL SURG, V16, P385, DOI 10.1016/S1010-5182(88)80086-6	20	6	6	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	AUG	1991	70	4					178	180		10.1097/00002060-199108000-00003			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	GB568	WOS:A1991GB56800003	1878174				2022-02-06	
J	MERRITT, KL; EVANS, RL				MERRITT, KL; EVANS, RL			FAMILY SATISFACTION WITH MEDICAL-CARE AFTER TRAUMATIC BRAIN INJURY	PSYCHOLOGICAL REPORTS			English	Article									VET ADM MED CTR, ACSW, 1660 S COLUMBIAN WAY, SEATTLE, WA 98108 USA									0	6	6	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0033-2941	1558-691X		PSYCHOL REP	Psychol. Rep.	AUG	1990	67	1					129	130		10.2466/PR0.67.5.129-130			2	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	DX245	WOS:A1990DX24500022	2236389				2022-02-06	
J	LEHMAN, LB; RAVICH, SJ				LEHMAN, LB; RAVICH, SJ			CLOSED HEAD-INJURIES IN ATHLETES	CLINICS IN SPORTS MEDICINE			English	Article											LEHMAN, LB (corresponding author), CONEY ISL HOSP,DEPT SURG,2601 OCEAN PKWY,BROOKLYN,NY 11235, USA.							0	6	6	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0278-5919			CLIN SPORT MED	Clin. Sports Med.	APR	1990	9	2					247	261					15	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	CY452	WOS:A1990CY45200003	2183945				2022-02-06	
J	WAGNER, MT; WILLIAMS, JM; LONG, CJ				WAGNER, MT; WILLIAMS, JM; LONG, CJ			THE ROLE OF SOCIAL NETWORKS IN RECOVERY FROM HEAD TRAUMA	INTERNATIONAL JOURNAL OF CLINICAL NEUROPSYCHOLOGY			English	Article							INJURY	To determine the extent to which social factors may serve as one set of mediating variables which influence eventual outcome following closed head injury, 40 head-injured subjects and 26 non-injured comparison subjects were administered questionnaires assessing recovery of function and social network structure during a long-term follow-up evaluation. The findings indicate head-injured subjects complained of more physical, cognitive, emotional, and vocational problems. Further, significant structural differences were found in the head-injured subjects' social networks. These results suggest a strong relationship between social network support and the eventual level of recovery from head injury and offer a theoretical framework for understanding some of the social aspects of recovery from a neurological injury.	MEMPHIS STATE UNIV,DEPT PSYCHOL,MEMPHIS,TN 38152		WAGNER, MT (corresponding author), UNIV ROCHESTER,MONROE COMMUNITY HOSP,DEPT PREVENT FAMILY & REHABIL MED,ROCHESTER,NY 14603, USA.						ANDERON DW, 1980, J NEUROSURGERY S NOV; Brooks D N, 1979, Int Rehabil Med, V1, P166; BROOKS N, 1984, CLOSED HEAD INJURY P; CASSEL J, 1974, INT J HEALTH SERV, V4, P471, DOI 10.2190/WF7X-Y1L0-BFKH-9QU2; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIMATTEO MR, 1981, SOCIAL NETWORKS SOCI; ECKENRODE J, 1981, SOCIAL NETWORKS SOCI; FORD B, 1976, MED J AUSTRALIA, V1, P603, DOI 10.5694/j.1326-5377.1976.tb140904.x; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; STOKES JP, 1983, AM J COMMUN PSYCHOL, V11, P141, DOI 10.1007/BF00894363; Wellman B, 1981, SOCIAL NETWORKS SOCI; [No title captured]	16	6	6	0	1	MELNIC PRESS INC	MADISON	PO BOX 6216, MADISON, WI 53716	0197-3681			INT J CLIN NEUROPSYC			1990	12	3-4					131	137					7	Psychology, Clinical; Neurosciences	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology; Neurosciences & Neurology	GU317	WOS:A1990GU31700007					2022-02-06	
J	BARRY, P; OLEARY, J				BARRY, P; OLEARY, J			ROLES OF THE PSYCHOLOGIST ON A TRAUMATIC BRAIN INJURY REHABILITATION TEAM	REHABILITATION PSYCHOLOGY			English	Article									SINAI HOSP, DETROIT, MI 48235 USA		BARRY, P (corresponding author), NEUROL CTR CORTLAND, NEW MED HEAD INJURY SYST, POB 5510, 28 KELLOGG RD, CORTLAND, NY 13045 USA.						Alfano D. P., 1987, CLIN NEUROPSYCHOL, V1, P105; BARRY PB, 1986, COGNITIVE REHABILITA, V4, P18; CAPLAN B, 1982, ARCH PHYS MED REHAB, V63, P362; COHEN RF, 1988, J HEAD TRAUMA REHAB, V3, P12; Cook TD., 1979, QUASIEXPERIMENTATION; COSTA L, 1983, J CLIN NEUROPSYCHOL, V5, P1, DOI 10.1080/01688638308401147; DEMBO T, 1973, AM PSYCHOL, V28, P719, DOI 10.1037/h0035761; DILLER L, 1987, NEUROPSYCHOL REHABIL, P3; FORDYCE WE, 1982, REHABIL PSYCHOL, V27, P5; GOLD JR, 1982, PROF PSYCHOL, V13, P397, DOI 10.1037/0735-7028.13.3.397; Horton A. M., 1988, J HEAD TRAUMA REHAB, V3, P57; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MORRIS RJ, 1987, REHABIL PSYCHOL, V15, P1; POPHAM W, 1974, EVULATION ED; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP., 1988, J HEAD TRAUMA REHAB, V3, P45; ROSENTHAL M, 1986, REHABIL PSYCHOL, V31, P37; TANKLE R, 1988, J HEAD TRAUMA REHAB, V3, P24; VINEBERG S E, 1971, Archives of Physical Medicine and Rehabilitation, V52, P8; Wood R. L., 1987, BRAIN INJURY REHABIL; Wright G. N., 1980, TOTAL REHABILITATION	21	6	6	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	SUM	1989	34	2					83	90					8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	AE974	WOS:A1989AE97400005					2022-02-06	
J	DEUTSCHMAN, CS				DEUTSCHMAN, CS			PHYSIOLOGY AND METABOLISM IN CLOSED HEAD-INJURY	WORLD JOURNAL OF SURGERY			English	Article											DEUTSCHMAN, CS (corresponding author), JOHNS HOPKINS UNIV HOSP, SCH MED, DEPT ANESTHESIOL & CRIT CARE MED, BLALOCK 14, BALTIMORE, MD 21205 USA.		Deutschman, Clifford/AAN-2742-2021				ASKANAZI J, 1981, SURGERY, V89, P478; ASKANAZI J, 1980, ANN SURG, V191, P40, DOI 10.1097/00000658-198001000-00008; ASKANAZI J, 1980, JAMA-J AM MED ASSOC, V243, P1444, DOI 10.1001/jama.243.14.1444; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; CERRA FB, 1979, J TRAUMA, V19, P621, DOI 10.1097/00005373-197908000-00010; CERRA FB, 1982, CRITICAL CARE STATE, pL1; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; CLIFTON GL, 1981, NEUROSURGERY, V8, P309, DOI 10.1227/00006123-198103000-00002; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; COVELLI HD, 1981, ANN INTERN MED, V95, P579, DOI 10.7326/0003-4819-95-5-579; DEITRICK JE, 1948, AM J MED, V4, P3, DOI 10.1016/0002-9343(48)90370-2; DEUTSCHMAN CS, 1985, SURG FORUM, V36, P46; DEUTSCHMAN CS, IN PRESS J NEUROSURG; ELWYN DH, 1979, ANN SURG, V190, P117, DOI 10.1097/00000658-197907000-00023; ELWYN DH, 1979, AM J CLIN NUTR, V32, P1597; FATH JJ, 1985, PRACTICE SURGERY; FEIBEL J, 1983, J CLIN ENDOCR METAB, V57, P1245, DOI 10.1210/jcem-57-6-1245; FELIG P, 1969, J CLIN INVEST, V48, P584, DOI 10.1172/JCI106017; FELIG P, 1970, NEW ENGL J MED, V282, P166; FELL D, 1984, CRIT CARE MED, V12, P649, DOI 10.1097/00003246-198408000-00009; GLICKMAN N, 1948, J NUTR, V36, P41, DOI 10.1093/jn/36.1.41; GUNDERSEN HJG, 1977, DIABETES, V26, P551, DOI 10.2337/diab.26.6.551; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; JENNETT B, 1981, MANAGEMENT HEAD INJU, P145; LEVI J, 1976, ARCH INTERN MED, V136, P25, DOI 10.1001/archinte.136.1.25; LONG CL, 1981, METABOLISM, V30, P765, DOI 10.1016/0026-0495(81)90022-6; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MILLER SL, 1984, S AFR MED J, V65, P90; NORDENSTROM J, 1981, CLIN PHYSIOL, V1, P525, DOI 10.1111/j.1475-097X.1981.tb00919.x; OYAMA T, 1975, CAN ANAESTH SOC J, V22, P696, DOI 10.1007/BF03013318; PENTELENYI T, 1979, INJURY, V10, P201, DOI 10.1016/0020-1383(79)90009-3; POPP AJ, 1982, J SURG RES, V32, P416, DOI 10.1016/0022-4804(82)90121-4; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; Reichenbach DD, 1970, HUM PATHOL, V1, P125, DOI [10.1016/S0046-8177(70)80007-7, DOI 10.1016/S0046-8177(70)80007-7]; ROBERTSON CS, 1984, NEUROSURGERY, V15, P307, DOI 10.1227/00006123-198409000-00003; ROBERTSON CS, 1985, J NEUROSURG, V63, P714, DOI 10.3171/jns.1985.63.5.0714; ROWE JW, 1979, CLIN RES, V27, pA594; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SCHONHEYDER F, 1954, SCAND J CLIN LAB INV, V6, P178, DOI 10.3109/00365515409136355; SCHULTEAMESCH J, 1980, ACTA NEUROCHIR, V54, P243, DOI 10.1007/BF01407091; SHOEMAKER WC, 1982, CRIT CARE MED, V10, P398, DOI 10.1097/00003246-198206000-00015; TWYMAN D, 1985, JPEN-PARENTER ENTER, V9, P679, DOI 10.1177/0148607185009006679; VAUGHAN GM, 1982, J TRAUMA, V22, P263, DOI 10.1097/00005373-198204000-00001; WILMORE DW, 1983, SURGICAL NUTRITION, P65	45	6	9	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	APR	1987	11	2					182	193		10.1007/BF01656401			12	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	G6695	WOS:A1987G669500009	3590820				2022-02-06	
J	PAYNEJOHNSON, JC				PAYNEJOHNSON, JC			EVALUATION OF COMMUNICATION COMPETENCE IN PATIENTS WITH CLOSED HEAD-INJURY	JOURNAL OF COMMUNICATION DISORDERS			English	Article											PAYNEJOHNSON, JC (corresponding author), HOWARD UNIV,DEPT COMMUN ARTS & SCI,WASHINGTON,DC 20059, USA.						AMMONS RB, 1962, QUICK TEXT QT; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; FODOR IE, 1972, J NEUROL NEUROSUR PS, V35, P818, DOI 10.1136/jnnp.35.6.818; Goodglass H., 1972, ASSESSMENT APHASIA R; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; HALPERN H, 1973, J SPEECH HEAR DISORD, V38, P162, DOI 10.1044/jshd.3802.162; HANNAY HJ, 1977, EUROPEAN M INT NEURO; HEILMAN KM, 1977, J NEUROLOGY NEUROSUR, V34, P265; HOWE JR, 1975, NEUROLOGY, V25, P286, DOI 10.1212/WNL.25.3.286; KARNIK PP, 1975, INT SURG, V60, P466; LEVIN HS, 1976, CORTEX, V12, P175, DOI 10.1016/S0010-9452(76)80021-4; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; Luria A.R., 1970, TRAUMATIC APHASIA; MAKISHIMA K, 1975, ARCH OTOLARYNGOL, V101, P426; Miller E, 1970, Cortex, V6, P121; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; Schuell H., 1965, MINNESOTA TEST DIFFE; Spreen O., 1969, NEUROSENSORY CTR COM; WARRINGT.EK, 1970, NATURE, V228, P628, DOI 10.1038/228628a0; WIIG EH, 1976, LANGUAGE DISABILITIE	22	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0021-9924			J COMMUN DISORD	J. Commun. Disord.	AUG	1986	19	4					237	249		10.1016/0021-9924(86)90030-4			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	D6919	WOS:A1986D691900001	2427551				2022-02-06	
J	GYORI, E				GYORI, E			PROLONGED SURVIVAL WITHOUT NEUROLOGIC DEFICIT FOLLOWING TRAUMATIC DORSOLATERAL BRAIN-STEM INJURY	CLINICAL NEUROPATHOLOGY			English	Article									DADE CTY MED EXAMINER DEPT, MIAMI, FL 33136 USA								ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; CHASE TN, 1968, NEUROLOGY, V18, P357, DOI 10.1212/WNL.18.4.357; CROMPTON MR, 1966, LANCET, V2, P938; HADFIELD MG, 1968, ARCH NEUROL-CHICAGO, V19, P467, DOI 10.1001/archneur.1968.00480050037003; JELLINGER K, 1970, J NEUROL SCI, V10, P51, DOI 10.1016/0022-510X(70)90091-2; JELLINGER K, 1969, LATE EFFECTS HEAD IN, P168; MITCHELL DE, 1973, LANCET, V2, P215; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PLUM F, 1978, DIAGNOSIS STUPOR COM, P19; SPRAGUE J M, 1963, Arch Ital Biol, V101, P225; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; STRONG OS, 1959, HUMAN NEUROANATOMY, P224; SUNG JH, 1981, J NEUROPATH EXP NEUR, V40, P551, DOI 10.1097/00005072-198109000-00006; Tomlinson B E, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P154; [No title captured]; [No title captured]; [No title captured]	20	6	6	0	0	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0722-5091			CLIN NEUROPATHOL	Clin. Neuropathol.		1985	4	3					121	126					6	Clinical Neurology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	AMP47	WOS:A1985AMP4700006	4017326				2022-02-06	
J	LAUBICHLER, W; SORGO, G				LAUBICHLER, W; SORGO, G			MEDICAL EXAMINATION OF PATIENTS WITH CONCUSSION	WIENER KLINISCHE WOCHENSCHRIFT			German	Article									UNIV SALZBURG, INST GERICHT MED, A-5020 SALZBURG, AUSTRIA								BAUMER L, 1949, DEUT MED WOCHENSCHR, P1265; BAY E, 1968, Medizinische Welt, P2571; Bay E, 1951, NERVENARZT, V22, P52; Boeters U, 1968, Hefte Unfallheilkd, V94, P250; FROWEIN R, 1948, KLIN WOCHENSCHR, V26, P79, DOI 10.1007/BF01742696; GRUNER O, 1951, DTSCH Z GERICHTL MED, V49, P592; HARRER G, 1967, ARZTLICHE PRAXIS, V19, P27; HARRER G, 1950, DTSCH MED RUNDSCHAU, V4; ILLCHMANN-CHRIST A, 1951, Arch Orthop Unfallchir, V44, P586, DOI 10.1007/BF00415766; JANZEN R, 1966, DEUT MED WOCHENSCHR, V85, P2229; KESSEL K, 1969, NEUROTRAUMATOLOGIE E, V1; Laubichler W, 1973, Beitr Gerichtl Med, V30, P264; LAUBICHLER W, 1973, OSTERR RICHTERZ, V51, P2; LECHNER H, 1954, Confin Neurol, V14, P219; LOB A, 1959, Arztl Wochensch, V14, P372; MIFKA P, 1963, Comp Biochem Physiol, V9, P858; SCHERZER E, 1969, 3 VEN S GRAZ; SCHLEYER F, 1956, Monatsschr Unfallheilkd Versicherungsmed, V59, P97; SORGO G, IN PRESS; UNTERHARNSCHEIDT F, 1971, FORTSCHR NEUROL P I, V39, P109; VENZLAFF U, 1970, MED WELT, P550; Voss R, 1953, NERVENARZT, V24, P155; WANKE R, 1948, PATHOPHOLOGISCHE PHY; WANKE R, 1966, TGL PRAXIS, V1, P99; WIECK HH, 1956, DEUT MED WOCHENSCHR, V81, P1345, DOI 10.1055/s-0028-1115128	25	6	6	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0043-5325	1613-7671		WIEN KLIN WOCHENSCHR	Wien. Klin. Wochen.		1974	86	2					39	45					7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	R9729	WOS:A1974R972900002	4439926				2022-02-06	
J	FERNANDO, OU; MARIANO, GT; GURDJIAN, ES; HODGSON, VR				FERNANDO, OU; MARIANO, GT; GURDJIAN, ES; HODGSON, VR			ELECTROCARDIOGRAPHIC PATTERNS IN EXPERIMENTAL CEREBRAL CONCUSSION	JOURNAL OF NEUROSURGERY			English	Article																	BYER E, 1947, AM HEART J, V33, P796, DOI 10.1016/0002-8703(47)90025-2; CHASON JL, 1966, J TRAUM, V6, P767, DOI 10.1097/00005373-196611000-00008; CROPP GJ, 1960, CIRCULATION, V22, P25, DOI 10.1161/01.CIR.22.1.25; DELGADO JOSE M R., 1960, PHYSIOL REVS, V40, P146; FALSETTI HL, 1966, DIS CHEST, V49, P420, DOI 10.1378/chest.49.4.420; FENTZ EL, 1962, CIRCULATION, V25, P22; FOLTZ EL, 1953, J NEUROSURG, V10, P342, DOI 10.3171/jns.1953.10.4.0342; FRIEDBERG CK, 1966, DISEASES HEART, V1, P44; GLASSER RL, 1960, AM J PHYSIOL, V198, P421, DOI 10.1152/ajplegacy.1960.198.2.421; GURDJIAN ES, 1944, WAR MED, V6, P173; HADDAD B. F., 1955, NEUROLOGY, V5, P798; HERSCH C, 1961, CIRCULATION, V23, P853, DOI 10.1161/01.CIR.23.6.853; HUGENHOL.PG, 1967, AM HEART J, V74, P438, DOI 10.1016/0002-8703(67)90089-0; KORTEWEG GCJ, 1957, J NEUROPHYSIOL, V20, P100, DOI 10.1152/jn.1957.20.1.100; MANNING JW, 1962, AM J PHYSIOL, V203, P1120, DOI 10.1152/ajplegacy.1962.203.6.1120; MELVILLE KI, 1963, AM J CARDIOL, V12, P781, DOI 10.1016/0002-9149(63)90281-9; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; PORTER RW, 1962, AM HEART J, V64, P815, DOI 10.1016/0002-8703(62)90180-1; TARAN LM, 1952, B ST FRANCIS SAN, V9, P15; UEDA H, 1962, JPN HEART J, V3, P455; WASSERMAN F, 1956, AM J MED SCI, V231, P502, DOI 10.1097/00000441-195605000-00003; YANOWITZ F, 1966, CIRC RES, V18, P416, DOI 10.1161/01.RES.18.4.416	22	6	6	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.		1969	31	1					34	&		10.3171/jns.1969.31.1.0034			0	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	D6555	WOS:A1969D655500006	4978536				2022-02-06	
J	COE, JE; CALVIN, TH; RUDENBERG, FH; YEW, CH				COE, JE; CALVIN, TH; RUDENBERG, FH; YEW, CH			CONCUSSION-LIKE STATE FOLLOWING CERVICAL CORD INJURY IN MONKEY	JOURNAL OF TRAUMA			English	Article																	Flamm E S, 1966, Surg Forum, V17, P414; FRIEDE RL, 1960, J NEUROPATH EXP NEUR, V19, P266, DOI 10.1097/00005072-196004000-00007; MARTINEZ JD, 1963, 63WA281 AM SOC MED E	3	6	6	0	0							J TRAUM			1967	7	4					512	+		10.1097/00005373-196707000-00003			1	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	96123	WOS:A19679612300003	4961089				2022-02-06	
J	SPIEGEL, EA; SPIEGELADOLF, M; WYCIS, HT; MARKS, M; LEE, AJ				SPIEGEL, EA; SPIEGELADOLF, M; WYCIS, HT; MARKS, M; LEE, AJ			SUBCORTICAL CHANGES IN CEREBRAL CONCUSSION	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article																	ARNAUD M, 1933, B MEM SOC NAT CHIR, V59, P843; BERNER O, 1935, NORSKE VIDENSKAPS MN, P57; COX LB, 1946, SURGERY, V19, P669; Davidson EC, 1925, B JOHNS HOPKINS HOSP, V37, P217; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DOW RS, 1945, J NEUROPHYSIOL, V8, P161; DURET H, 1920, ALCAN PARIS, V2, P161; GEREB T, 1940, CONFIN NEUROL, V3, P115; GIERLICH J, 1936, DTSCH Z GES GERICHLI, V26, P100; GURDJIAN ES, 1943, SURG GYNECOL OBSTET, V76, P623; HOAGLAND HUDSON, 1940, SCIENCE, V92, P537, DOI 10.1126/science.92.2397.537; Hoff H, 1930, Z GESAMTE NEUROL PSY, V129, P583, DOI 10.1007/BF02865077; Holbourn AHS, 1943, LANCET, V2, P438; JASPER H, 1945, RES PUBL ASS NERV ME, V24, P388; KRAL A, 1925, MED KLINIK, V31, P910; KRAL A, 1925, MED KLINIK, V31, P876; PICKLES W, 1947, NEW ENGL J MED, V236, P858, DOI 10.1056/NEJM194706052362302; Rand CW, 1931, ARCH SURG-CHICAGO, V23, P357, DOI 10.1001/archsurg.1931.01160090002001; SELINSKY H, 1939, T AM NEUROL ASSOC, P190; SPIEGEL E, 1946, FED P, V5, P98; SPIEGEL EA, 1946, AM J PHYSIOL, V146, P12, DOI 10.1152/ajplegacy.1946.146.1.12; Spiegel EA, 1934, ARCH NEURO PSYCHIATR, V31, P469, DOI 10.1001/archneurpsyc.1934.02250030009001; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; WEINBERG I S, 1946, Am Rev Sov Med, V4, P25; Williams D, 1941, BRAIN, V64, P223, DOI 10.1093/brain/64.4.223	25	6	6	1	1	AMER ASSN NEUROPATHOLOGISTS INC	LAWRENCE	1041 NEW HAMPSHIRE ST, LAWRENCE, KS 66044	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.		1948	7	2					162	171		10.1097/00005072-194804000-00004			10	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	UZ240	WOS:A1948UZ24000004	18915132				2022-02-06	
J	STEWART, JV; BARROW, DW				STEWART, JV; BARROW, DW			CONCUSSION DEAFNESS	ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY			English	Article																		0	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0886-4470			ARCH OTOLARYNGOL	Arch. Otolaryngol. Head Neck Surg.		1946	44	3					274	279					6	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Surgery	UY144	WOS:A1946UY14400003	20999283				2022-02-06	
J	Krems, KD; Schoepele, GM; Erlanger, J				Krems, KD; Schoepele, GM; Erlanger, J			Nerve concussion	PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article									Washington Univ, Physiol Dept, Sch Med, St Louis, MO USA								Cattel M, 1930, SCIENCE, V71, P17, DOI 10.1126/science.71.1827.17; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93	2	6	6	0	0	BLACKWELL PUBLISHING INC	MALDEN	350 MAIN ST, MALDEN, MA 02148 USA	0037-9727			P SOC EXP BIOL MED	Proc. Soc. Exp. Biol. Med.	JAN	1942	49	1					73	75					3	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	V35PV	WOS:000202407100026					2022-02-06	
J	Engineer, RS; Podolsky, SR; Fertel, BS; Grover, P; Jimenez, H; Simon, EL; Smalley, CM				Engineer, Rakesh S.; Podolsky, Seth R.; Fertel, Baruch S.; Grover, Purva; Jimenez, Heather; Simon, Erin L.; Smalley, Courtney M.			A Pilot Study to Reduce Computed Tomography Utilization for Pediatric Mild Head Injury in the Emergency Department Using a Clinical Decision Support Tool and a Structured Parent Discussion Tool	PEDIATRIC EMERGENCY CARE			English	Article						pediatric mild head injury; clinical decision support tool; shared decision making; care path utilization; radiation exposure	CT; CHILDREN; SYSTEMS; PECARN; RULES; PREDICTION; FEATURES	Introduction The American College of Emergency Physicians embarked on the "Choosing Wisely" campaign to avoid computed tomographic (CT) scans in patients with minor head injury who are at low risk based on validated decision rules. We hypothesized that a Pediatric Mild Head Injury Care Path could be developed and implemented to reduce inappropriate CT utilization with support of a clinical decision support tool (CDST) and a structured parent discussion tool. Methods A quality improvement project was initiated for 9 weeks to reduce inappropriate CT utilization through 5 interventions: (1) engagement of leadership, (2) provider education, (3) incorporation of a parent discussion tool to guide discussion during the emergency department (ED) visit between the parent and the provider, (4) CDST embedded in the electronic medical record, and (5) importation of data into the note to drive compliance. Patients prospectively were enrolled when providers at a pediatric and a freestanding ED entered data into the CDST for decision making. Rate of care path utilization and head CT reduction was determined for all patients with minor head injury based on International Classification of Diseases, Ninth Revision codes. Targets for care path utilization and head CT reduction were established a priori. Results were compared with baseline data collected from 2013. Results The CDST was used in 176 (77.5%) of 227 eligible patients. Twelve patients were excluded based on a priori criteria. Adherence to recommendations occurred in 162 (99%) of 164 patients. Head CT utilization was reduced from 62.7% to 22% (odds ratio, 0.17; 95% confidence interval, 0.12-0.24) where CDST was used by the provider. There were no missed traumatic brain injuries in our study group. Conclusion A Pediatric Mild Head Injury Care Path can be implemented in a pediatric and freestanding ED, resulting in reduced head CT utilization and high levels of adherence to CDST recommendations.	[Engineer, Rakesh S.; Podolsky, Seth R.; Fertel, Baruch S.; Grover, Purva; Jimenez, Heather; Simon, Erin L.; Smalley, Courtney M.] Cleveland Clin Hlth Syst, Emergency Serv Inst, E19,9500 Euclid Ave, Cleveland, OH 44195 USA		Smalley, CM (corresponding author), Cleveland Clin Hlth Syst, Emergency Serv Inst, E19,9500 Euclid Ave, Cleveland, OH 44195 USA.	courtney.smalley@gmail.com					Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Gupta A, 2014, J AM MED INFORM ASSN, V21, pE347, DOI 10.1136/amiajnl-2013-002536; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Kharbanda AB, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1745; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Nishijima DK, 2015, ANN EMERG MED, V65, P72, DOI 10.1016/j.annemergmed.2014.08.019; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Raja AS, 2012, RADIOLOGY, V262, P468, DOI 10.1148/radiol.11110951; Roshanov PS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f657; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; The Joint Commission, 2016, PROP NAT PAT SAF GOA	20	5	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	DEC	2021	37	12					E1670	E1674		10.1097/PEC.0000000000001501			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	XK6NI	WOS:000727579500177	29768294				2022-02-06	
J	Yeung, C; Bhatia, R; Bhattarai, B; Sinha, M				Yeung, Claudia; Bhatia, Rahul; Bhattarai, Bikash; Sinha, Madhumita			Role of Salivary Biomarkers in Predicting Significant Traumatic Brain Injury An Exploratory Study	PEDIATRIC EMERGENCY CARE			English	Article						salivary biomarkers; traumatic brain injury; S100B; glial fibrillary acidic protein; neuron-specific enolase	FIBRILLARY ACIDIC PROTEIN; NEURON-SPECIFIC ENOLASE; CEREBROSPINAL-FLUID; SERUM; S100B	Objectives The highest rates of traumatic brain injury (TBI)-related morbidity and mortality occur in young children and adolescents. The objective of this study was to describe the levels of 3 biomarkers (S100B, glial fibrillary acidic protein, neuron-specific enolase) in saliva of children with TBI requiring inpatient admission at a pediatric trauma center and compare these levels in children without TBI. Methods A convenience sample of 24 children aged 0 to 18 years, presenting with acute isolated TBI, was enrolled prospectively. The non-TBI comparison groups consisted of patients with medical complaints and musculoskeletal injuries only. Salivary specimens were collected, and biomarkers were measured using quantitative enzyme-linked immunosorbent assay method. Demographic, clinical data, and brain imaging findings were obtained. Results Seventy-four children were enrolled. Twenty-four had TBI (mean age, 5.07 years; SD, 4.8 years); 14 subjects (58.3%) with TBI were found to have significant traumatic brain injury (SBI) on computed tomography scan. S100B levels were significantly higher in TBI group compared with those with musculoskeletal injury only (median, 113.2 pg/mL vs 18 pg/mL; P = 0.021). Area under the receiver operating characteristic curve for S100B in predicting SBI was 0.675; the optimum threshold for S100B to achieve the optimum sensitivity and specificity of SBI was at 86.9 pg/mL for SBI versus no injury group. Conclusions S100B levels in saliva were higher in children with TBI and may be predictive of SBI identified by presence of computed tomography abnormalities. Larger studies are needed to replicate our findings in using a noninvasive diagnostic measure for children with TBI and SBI.	[Yeung, Claudia] Phoenix Childrens Hosp, Dept Emergency Med, 1919 E Thomas Rd, Phoenix, AZ 85016 USA; [Bhatia, Rahul; Sinha, Madhumita] Arizona Childrens Ctr, Dept Pediat, Phoenix, AZ USA; [Bhattarai, Bikash] Maricopa Integrated Hlth Syst, Dept Res, Phoenix, AZ USA		Yeung, C (corresponding author), Phoenix Childrens Hosp, Dept Emergency Med, 1919 E Thomas Rd, Phoenix, AZ 85016 USA.	cyeung@phoenixchildrens.com			Maricopa Medical Foundation's House Staff Achievement Grant	This researchwas supported by the Maricopa Medical Foundation's House Staff Achievement Grant awarded to C.Y.	Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Calcagnile O, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-13; CDC, INJURY PREVENTION CO; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Faul M, 2010, TRAUMATIC BRAIN INJU; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee YH, 2009, AM J DENT, V22, P241; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Ramont L, 2005, CLIN CHEM LAB MED, V43, P1215, DOI 10.1515/CCLM.2005.210; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	21	5	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	DEC	2021	37	12					E1373	E1376		10.1097/PEC.0000000000002050			4	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	XK6NI	WOS:000727579500122	32149999				2022-02-06	
J	Zhai, KF; Duan, H; Wang, W; Zhao, SY; Khan, GJ; Wang, MT; Zhang, YH; Thakur, K; Fang, XM; Wu, C; Xiao, JB; Wei, ZJ				Zhai, Kefeng; Duan, Hong; Wang, Wei; Zhao, Siyu; Khan, Ghulam Jilany; Wang, Mengting; Zhang, Yuhan; Thakur, Kiran; Fang, Xuemei; Wu, Chao; Xiao, Jianbo; Wei, Zhaojun			Ginsenoside Rg1 ameliorates blood-brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release	ACTA PHARMACEUTICA SINICA B			English	Article						Traumatic brain injury; Exosome; MiRNA-21; Blood-brain barrier; Ginsenoside Rg1; Nonmuscle myosin IIA	MYOSIN IIA; EXPRESSION; MICRORNAS; ROLES	During the traumatic brain injury (TBI), improved expression of circulatory miR-21 serves as a diagnostic feature. Low levels of exosome-miR-21 in the brain can effectively improve neuroinflammation and blood-brain barrier (BBB) permeability, reduce nerve apoptosis, restore neural function and ameliorate TBI. We evaluated the role of macrophage derived exosomes-miR-21 (M-Exos-miR-21) in disrupting BBB, deteriorating TBI, and Rg1 interventions. IL-1 beta-induced macrophages (IIM)-Exos-miR-21 can activate NF-kappa B signaling pathway and induce the expressions of MMP-1,-3 and -9 and dwnregulate the levels of tight junction proteins (TJPs) deteriorating the BBB. Rg1 reduced miR-21-5p content in IIM-Exos (RIIM-Exos). The interaction of NMIIA-HSP90 controlled the release of Exos-miR-21, this interaction was restricted by Rg1. Rg1 could inhibit the Exos-miR-21 release in peripheral blood flow to brain, enhancing TIMP3 protein expression, MMPs proteolysis, and restricting TJPs degradation thus protected the BBB integrity. Conclusively, Rg1 can improve the cerebrovascular endothelial injury and hold the therapeutic potential against TBI disease. (C) 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.	[Zhai, Kefeng; Duan, Hong; Wang, Wei; Zhao, Siyu; Wang, Mengting; Zhang, Yuhan; Fang, Xuemei; Wu, Chao] Suzhou Univ, Suzhou Engn Res Ctr Nat Med & Funct Food, Sch Biol & Food Engn, Suzhou 234000, Peoples R China; [Thakur, Kiran; Wei, Zhaojun] Hefei Univ Technol, Sch Food & Biol Engn, Hefei 230009, Peoples R China; [Xiao, Jianbo] Univ Vigo, Fac Food Sci & Technol, Dept Analyt Chem & Food Sci, Ourense Campus, E-32004 Orense, Spain; [Wang, Wei] Anhui Polytech Univ, Sch Biol & Food Engn, Wuhu 241000, Peoples R China; [Duan, Hong] Guangxi Normal Univ, Key Lab Chem & Mol Engn Med Resources, Guilin 541004, Peoples R China; [Khan, Ghulam Jilany] Univ Cent Punjab, Fac Pharm, Dept Pharmacol & Therapeut, Lahore 54000, Pakistan		Duan, H (corresponding author), Suzhou Univ, Suzhou Engn Res Ctr Nat Med & Funct Food, Sch Biol & Food Engn, Suzhou 234000, Peoples R China.; Wei, ZJ (corresponding author), Hefei Univ Technol, Sch Food & Biol Engn, Hefei 230009, Peoples R China.; Xiao, JB (corresponding author), Univ Vigo, Fac Food Sci & Technol, Dept Analyt Chem & Food Sci, Ourense Campus, E-32004 Orense, Spain.; Duan, H (corresponding author), Guangxi Normal Univ, Key Lab Chem & Mol Engn Med Resources, Guilin 541004, Peoples R China.	szxydh@163.com; jianboxiao@uvigo.es; zjwei@hfut.edu.cn	Xiao, Jianbo/C-7323-2012; Wei, Zhaojun/H-5341-2017; Khan, Ghulam Jilany/C-2135-2017	Xiao, Jianbo/0000-0003-3311-770X; Wei, Zhaojun/0000-0003-1729-209X; Khan, Ghulam Jilany/0000-0002-2748-5314	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601034, 31850410476]; Anhui Provincial Science Fund for Distinguished Young Scholars (China) [2008085J39]; Focus on Research and Development Projects in Anhui Province (China) [1804a0802225]; State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University, China) [CMEMR2020-B13]; Natural Science Foundation of Anhui Educational Committee (China) [KJ2018ZD044, KJ2020A0728]; Key Disciplines of Pharmacy (China) [2019xjzdxk2]; Back-up Candidates for Academic and Technical Leaders of Suzhou University (China) [2018XJHB06]; Key Research Project of Suzhou University (China) [2019yzd06]	This work was supported by National Natural Science Foundation of China (81601034 and 31850410476) , Anhui Provincial Science Fund for Distinguished Young Scholars (2008085J39, China) , Focus on Research and Development Projects in Anhui Province (1804a0802225, China) , State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (CMEMR2020-B13, Guangxi Normal University, China) , the Natural Science Foundation of Anhui Educational Committee (KJ2018ZD044 and KJ2020A0728, China) , Key Disciplines of Pharmacy (2019xjzdxk2, China) , the Back-up Candidates for Academic and Technical Leaders of Suzhou University (2018XJHB06, China) , and Key Research Project of Suzhou University (2019yzd06, China) .	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Bhalala OG, 2013, NAT REV NEUROL, V9, P328, DOI 10.1038/nrneurol.2013.67; Cao GS, 2016, J ETHNOPHARMACOL, V183, P18, DOI 10.1016/j.jep.2016.02.028; Chen HR, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2273; Dhanda S, 2018, MOL NEUROBIOL, V55, P3642, DOI 10.1007/s12035-017-0521-7; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Du MJ, 2017, ONCOTARGET, V8, P63703, DOI 10.18632/oncotarget.19476; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao YY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0939-5; Ge XT, 2019, J NEUROTRAUM, V36, P1291, DOI 10.1089/neu.2018.5728; Ha D, 2016, ACTA PHARM SIN B, V6, P287, DOI 10.1016/j.apsb.2016.02.001; Han L, 2021, ACTA PHARM SIN B, V11, P2306, DOI 10.1016/j.apsb.2020.11.023; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Hartmann D, 2016, CIRCULATION, V134, P1973, DOI 10.1161/CIRCULATIONAHA.116.022478; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; He CY, 2016, ACTA PHARM SIN B, V6, P593, DOI 10.1016/j.apsb.2016.05.001; Hu Q, 2021, ACTA PHARM SIN B, V11, P1493, DOI 10.1016/j.apsb.2020.12.014; Iizuka Y, 2015, J IMMUNOL, V195, P4760, DOI 10.4049/jimmunol.1500979; Jiang B, 2017, TRANSL STROKE RES, V8, P183, DOI 10.1007/s12975-016-0506-2; Kalra H, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1690217; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Li P, 2018, BLOOD, V131, P686, DOI 10.1182/blood-2017-08-802140; Li X, 2019, ACTA PHARM SIN B, V9, P639, DOI 10.1016/j.apsb.2018.12.002; Li YH, 2019, ACTA PHARM SIN B, V9, P1113, DOI 10.1016/j.apsb.2019.10.001; Lin MB, 2015, ACTA PHARM SIN B, V5, P277, DOI 10.1016/j.apsb.2015.02.001; Liu YL, 2019, J ADV RES, V18, P137, DOI 10.1016/j.jare.2019.02.005; Liu YL, 2017, ACTA PHARMACOL SIN, V38, P1445, DOI 10.1038/aps.2017.103; Mann AP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11980; Meissner L, 2016, J NEUROTRAUM, V33, P713, DOI 10.1089/neu.2015.4077; Miller KE, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00447; Neerukonda SN, 2019, J VIROL METHODS, V263, P1, DOI 10.1016/j.jviromet.2018.10.004; Osier N, 2018, MOL NEUROBIOL, V55, P9280, DOI 10.1007/s12035-018-1054-4; Ping SN, 2019, NEUROBIOL DIS, V132, DOI 10.1016/j.nbd.2019.104561; Ren XS, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2019.1698795; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Shi YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10523; Sobue A, 2018, GLIA, V66, P1034, DOI 10.1002/glia.23299; Song L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09720-x; Tominaga N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7716; Vallon M, 2014, CELL MOL LIFE SCI, V71, P3489, DOI 10.1007/s00018-014-1625-0; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Wang R, 2013, CHIN J NAT MEDICINES, V11, P30, DOI 10.3724/SP.J.1009.2013.00030; Wang Rui, 2009, Chinese Journal of Natural Medicines, V7, P315, DOI [10.3724/SP.J.1009.2009.00315, 10.3724/SP.J.1009.2008.00315]; Wang WJ, 2020, J NEUROVIROL, V26, P84, DOI 10.1007/s13365-019-00800-8; Wang Y, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00075; Wang Y, 2016, INT J BIOL SCI, V12, P1341, DOI 10.7150/ijbs.15992; Xiao J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.181; Xie WJ, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120270; Yang XX, 2021, ACTA PHARM SIN B, V11, P1434, DOI 10.1016/j.apsb.2020.10.010; Zhai KF, 2019, J AGR FOOD CHEM, V67, P2856, DOI 10.1021/acs.jafc.9b00185; Zhai KF, 2017, BRIT J PHARMACOL, V174, P2818, DOI 10.1111/bph.13885; Zhai KF, 2015, THROMB HAEMOSTASIS, V114, P173, DOI 10.1160/TH14-10-0880; Zhang YW, 2020, ACTA PHARMACOL SIN B, V10, P557, DOI 10.1016/j.apsb.2019.10.008; Zhu BY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13170-w	56	5	5	6	6	INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES	BEIJING	C/O EDITORIAL BOARD OF ACTA PHARMACEUTICA SINICA, 1 XIANNONGTAN ST, BEIJING, 100050, PEOPLES R CHINA	2211-3835	2211-3843		ACTA PHARM SIN B	Acta Pharm. Sin. B	NOV	2021	11	11					3493	3507		10.1016/j.apsb.2021.03.032			15	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	XH2GY	WOS:000725260200011	34900532	Green Published, gold			2022-02-06	
J	Zhan, XH; Liu, YZ; Raymond, SJ; Alizadeh, HV; Domel, AG; Gevaert, O; Zeineh, MM; Grant, GA; Camarillo, DB				Zhan, Xianghao; Liu, Yuzhe; Raymond, Samuel J.; Vahid Alizadeh, Hossein; Domel, August G.; Gevaert, Olivier; Zeineh, Michael M.; Grant, Gerald A.; Camarillo, David B.			Rapid Estimation of Entire Brain Strain Using Deep Learning Models	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Brain modeling; Strain; Head; Kinematics; Iron; Magnetic heads; Feature extraction; Mild traumatic brain injury; whole-brain strain; finite element; deep learning	INSTRUMENTED MOUTHGUARD; RECURRENT CONCUSSION; IMPACT; INJURY; RISK; PLAYERS	Objective: Many recent studies suggest that brain deformation resulting from head impacts are linked to the corresponding clinical outcome, such as mild traumatic brain injury (mTBI). Even if several finite element (FE) head models have been developed and validated to calculate brain deformation based on impact kinematics, the clinical application of these FE head models is limited due to the time-consuming nature of FE simulations. This work aims to accelerate the brain deformation calculation and thus improve the potential for clinical applications. Methods: We propose a deep learning head model with a five-layer deep neural network and feature engineering, and trained and tested the model on 2511 head impacts from a combination of head model simulations and on-field college football and mixed martial arts impacts. Results: The proposed deep learning head model can calculate the maximum principal strain (Green Lagrange) for every element in the entire brain in less than 0.001 s with an average root mean squared error of 0.022 and a standard deviation of 0.001 over twenty repeats with random data partition and model initialization. Conclusion: Trained and tested using the dataset of 2511 head impacts, this model can be applied to various sports in the calculation of brain strain with accuracy, and its applicability can even further be extended by incorporating data from other types of head impacts. Significance: In addition to the potential clinical application in real-time brain deformation monitoring, this model will help researchers estimate the brain strain from a large number of head impacts more efficiently than using FE models.	[Zhan, Xianghao; Liu, Yuzhe; Raymond, Samuel J.; Vahid Alizadeh, Hossein; Domel, August G.; Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Gevaert, Olivier] Stanford Univ, Dept Biomed Informat, Stanford, CA 94305 USA; [Zeineh, Michael M.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Grant, Gerald A.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA		Liu, YZ (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	yuzheliu@stanford.edu		Zeineh, Michael/0000-0002-6940-9096; Zhan, Xianghao/0000-0002-7058-2603	Department of Bioengineering, Stanford University; Office of Naval Research Young Investigator ProgramOffice of Naval Research [N00014-16-12949]	This work was supported by the Department of Bioengineering, Stanford University and the Office of Naval Research Young Investigator Program under Grant N00014-16-12949. (Xianghao Zhan and Yuzhe Liu contributed equally to this work.)	Abadi M, 2016, ACM SIGPLAN NOTICES, V51, P1, DOI [10.1145/3022670.2976746, 10.1145/2951913.2976746]; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Birmingham G, 2014, PROCEEDINGS OF THE ASME SUMMER BIOENGINEERING CONFERENCE - 2013, PT B; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Domel AG, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87085-2; Faraway J. J., 2014, LINEAR MODELS R; Funk J, 2017, CHARLOTTESVILLE BIOM; Gabler LF, 2020, ANN BIOMED ENG, V48, P2599, DOI 10.1007/s10439-020-02654-2; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038357; Gabrieli D, 2020, J BIOMECH ENG-T ASME, V142, DOI 10.1115/1.4046866; Garimella HT, 2019, ANN BIOMED ENG, V47, P1889, DOI 10.1007/s10439-018-02166-0; Ghazi K, 2020, J NEUROTRAUM, V38; Giudice JS, 2019, ANN BIOMED ENG, V47, P464, DOI 10.1007/s10439-018-02155-3; Gomez AD, 2019, IEEE T BIO-MED ENG, V66, P1456, DOI 10.1109/TBME.2018.2874591; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guiza Fabian, 2017, Crit Care Med, V45, pe316, DOI 10.1097/CCM.0000000000002080; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hardy W. N., TECH PAPERS; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Holbourn AHS, 1943, LANCET, V2, P438; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Kang H.-S, 1997, P STAPP CAR CRASH J, V106, P3849; King DB, 2015, ACS SYM SER, V1214, P1; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kuo C, 2018, J BIOMECH, V76, P220, DOI 10.1016/j.jbiomech.2018.05.024; Laksari K, 2020, J NEUROTRAUM, V37, P982, DOI 10.1089/neu.2018.6340; Li X, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02493-4; Liu, ARXIV210205728, V2021; Liu L, ARXIV210203088, P2021; Liu Y., 2020, ARXIV PREPRINT ARXIV; Liu YZ, 2020, ANN BIOMED ENG, V48, P2580, DOI 10.1007/s10439-020-02629-3; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Miotto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26094; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Morris J., 2019, ARCH PHYS MED REHAB, V100, pE5; Motiwale S, 2016, 2016 3RD IEEE EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL AND HEALTH INFORMATICS, P204, DOI 10.1109/BHI.2016.7455870; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; O'Keeffe E, 2020, J NEUROTRAUM, V37, P347, DOI 10.1089/neu.2019.6483; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Saboori P, 2019, ANN BIOMED ENG, V47, P1982, DOI 10.1007/s10439-019-02199-z; Schneider DK, 2019, J NEUROTRAUM, V36, P2831, DOI 10.1089/neu.2019.6398; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Taigman Y, 2014, PROC CVPR IEEE, P1701, DOI 10.1109/CVPR.2014.220; Tiernan S, 2020, P I MECH ENG H, V234, P1472, DOI 10.1177/0954411920947850; da Silva IBV, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P2664, DOI 10.1109/IJCNN.2011.6033567; Wang Y, 2020, SENSOR ACTUAT A-PHYS, V307, DOI 10.1016/j.sna.2020.111874; Wu LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17864-3; Wu SCJ, 2020, BRAIN IMAGING BEHAV, V14, P1638, DOI 10.1007/s11682-019-00094-8; Wu S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46594-x; Zacharaki EI, 2008, IEEE T BIO-MED ENG, V55, P1233, DOI 10.1109/TBME.2007.905484; Zhan X, 2020, ARXIV201210006; Zhan X, ARXIV210205020, P2021; Zhan XH, 2020, MEASUREMENT, V158, DOI 10.1016/j.measurement.2020.107588; Zhan XH, 2019, PROCEEDINGS OF 2019 IEEE 7TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND COMPUTATIONAL BIOLOGY (ICBCB 2019), P56, DOI 10.1109/ICBCB.2019.8854643; Zhan XH, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18092936; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P449, DOI 10.1007/s10237-016-0829-7	68	5	5	8	8	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	NOV	2021	68	11					3424	3434		10.1109/TBME.2021.3073380			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WJ5JI	WOS:000709080500028	33852381				2022-02-06	
J	Macnow, T; Curran, T; Tolliday, C; Martin, K; McCarthy, M; Ayturk, D; Babu, KM; Mannix, R				Macnow, Theodore; Curran, Tess; Tolliday, Courtney; Martin, Kirsti; McCarthy, Madeline; Ayturk, Didem; Babu, Kavita M.; Mannix, Rebekah			Effect of Screen Time on Recovery From Concussion A Randomized Clinical Trial	JAMA PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; UNITED-STATES; SYMPTOMS; ACCURACY; CHILDREN; SUPPORT; SPORT; REST	IMPORTANCE There are limited data to guide screen time recommendations after concussion. OBJECTIVE To determine whether screen time in the first 48 hours after concussion has an effect on the duration of concussive symptoms. DESIGN, SETTING, AND PARTICIPANTS This randomized clinical trialwas conducted in the pediatric and adult emergency departments of a tertiary medical center between June 2018 and February 2020. Participants included a convenience sample of patients aged 12 to 25 years presenting to the emergency department within 24 hours of sustaining a concussion. A total of 162 patients were approached, 22 patients met exclusion criteria, and 15 patients declined participation; 125 participants were enrolled and randomized. INTERVENTIONS Patients were either permitted to engage in screen time (screen time permitted group) or asked to abstain from screen time (screen time abstinent group) for 48 hours after injury. MAIN OUTCOMES AND MEASURES The primary outcomewas days to resolution of symptoms, defined as a total Post-Concussive Symptom Scale (PCSS) score of 3 points or lower. Patients completed the PCSS, a 22-symptom scale that grades each symptom from 0 (not present) to 6 (severe), each day for 10 days. Kaplan-Meier curves and Cox regression modeling were used to compare the 2 groups. A Wilcoxon rank sum test was also performed among participants who completed the PCSS each day through recovery or conclusion of the study period. RESULTS Among 125 patients with concussion, the mean (SD) age was 17.0 (3.4) years; 64 participants (51.2%) were male. A total of 66 patients were randomized to the screen time permitted group, and 59 patients were randomized to the screen time abstinent group. The Cox regression model including the intervention group and the patient's self-identified sex demonstrated a significant effect of screen time (hazard ratio [HR], 0.51; 95% CI, 0.29-0.90), indicating that participants who engaged in screen time were less likely to recover during the study period. In total, 91 patients were included in the Wilcoxon rank sum test (47 patients from the screen time permitted group, and 44 patients from the screen time abstinent group). The screen time permitted group had a significantly longer median recovery time of 8.0 days (interquartile range [IQR], 3.0 to >10.0 days) compared with 3.5 days (IQR, 2.0 to >10.0 days; P =.03) in the screen time abstinent group. The screen time permitted group reported a median screen time of 630 minutes (IQR, 415-995 minutes) during the intervention period compared with 130 minutes (IQR, 61-275 minutes) in the screen time abstinent group. CONCLUSIONS AND RELEVANCE The findings of this study indicated that avoiding screen time during acute concussion recovery may shorten the duration of symptoms. A multicenter study would help to further assess the effect of screen time exposure.	[Macnow, Theodore; Curran, Tess; McCarthy, Madeline; Ayturk, Didem; Babu, Kavita M.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Macnow, Theodore; Tolliday, Courtney; Martin, Kirsti; McCarthy, Madeline] UMass Mem Childrens Med Ctr, Dept Pediat, 55 Lake Ave N, Worcester, MA 01655 USA; [Babu, Kavita M.] UMass Mem Med Ctr, Dept Emergency Med, Worcester, MA USA; [Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Mannix, Rebekah] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA		Macnow, T (corresponding author), UMass Mem Childrens Med Ctr, Dept Pediat, 55 Lake Ave N, Worcester, MA 01655 USA.	theodore.macnow@umassmemorial.org					Araujo T, 2017, COMMUN METHODS MEAS, V11, P173, DOI 10.1080/19312458.2017.1317337; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Centers for Disease Control and Prevention, 2019, REC CONC; Christensen MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165331; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Eckner JT, 2017, CLIN J SPORT MED, V27, P266, DOI 10.1097/JSM.0000000000000346; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Hale L, 2015, SLEEP MED REV, V21, P50, DOI 10.1016/j.smrv.2014.07.007; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jakobsen JC, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0442-1; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Montagni I, 2016, CEPHALALGIA, V36, P1020, DOI 10.1177/0333102415620286; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Nowacki R, 2017, EUR J PAEDIATR NEURO, V21, P382, DOI 10.1016/j.ejpn.2016.10.009; Orben A, 2019, PSYCHOL SCI, V30, P682, DOI 10.1177/0956797619830329; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Robb M., 2020, COMMON SENSE CENSUS; Scharkow M, 2016, COMMUN METHODS MEAS, V10, P13, DOI 10.1080/19312458.2015.1118446; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schutzman, 2018, PATIENT ED HEAD INJU; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	39	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	NOV	2021	175	11					1124	1131		10.1001/jamapediatrics.2021.2782		SEP 2021	8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	WR7QV	WOS:000694672200007	34491285				2022-02-06	
J	Maski, K; Trotti, LM; Kotagal, S; Auger, RR; Rowley, JA; Hashmi, SD; Watson, NF				Maski, Kiran; Trotti, Lynn Marie; Kotagal, Suresh; Auger, R. Robert; Rowley, James A.; Hashmi, Sarah D.; Watson, Nathaniel F.			Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline	JOURNAL OF CLINICAL SLEEP MEDICINE			English	Article						hypersomnia; narcolepsy; idiopathic hypersomnia; Kleine-Levin syndrome; dementia with lewy bodies; Parkinson's disease; traumatic brain injury; myotonic dystrophy; multiple sclerosis; treatment	QUALITY; GRADE	Introduction: This guideline establishes clinical practice recommendations for the treatment of central disorders of hypersomnolence in adults and children. Methods: The American Academy of Sleep Medicine commissioned a task force of experts in sleep medicine to develop recommendations and assign strengths to each recommendation, based on a systematic review of the literature and an assessment of the evidence using the GRADE process. The task force provided a summary of the relevant literature and the quality of evidence, the balance of benefits and harms, patient values and preferences, and resource use considerations that support the recommendations. The AASM Board of Directors approved the final recommendations. Recommendations: The following recommendations are intended to guide clinicians in choosing a specific treatment for central disorders of hypersomnolence in adults and children. Each recommendation statement is assigned a strength ("strong" or "conditional"). A "strong" recommendation (ie, "We recommend ... ") is one that clinicians should follow under most circumstances. A "conditional" recommendation (ie, "We suggest ...") is one that requires that the clinician use clinical knowledge and experience and strongly consider the individual patient's values and preferences to determine the best course of action. Under each disorder, strong recommendations are listed in alphabetical order followed by the conditional recommendations in alphabetical order. The section on adult patients with hypersomnia because of medical conditions is categorized based on the clinical and pathological subtypes identified in ICSD-3. The interventions in all the recommendation statements were compared to no treatment. Adult patients with narcolepsy 1. We recommend that clinicians use modafinil for the treatment of narcolepsy in adults. (STRONG) 2. We recommend that clinicians use pitolisant for the treatment of narcolepsy in adults. (STRONG) 3. We recommend that clinicians use sodium oxybate for the treatment of narcolepsy in adults. (STRONG) 4. We recommend that clinicians use solriamfetol for the treatment of narcolepsy in adults. (STRONG) 5. We suggest that clinicians use armodafinil for the treatment of narcolepsy in adults. (CONDITIONAL) 6. We suggest that clinicians use dextroamphetamine for the treatment of narcolepsy in adults. (CONDITIONAL) 7. We suggest that clinicians use methylphenidate for the treatment of narcolepsy in adults. (CONDITIONAL) Adult patients with idiopathic hypersomnia 8. We recommend that clinicians use modafinil for the treatment of idiopathic hypersomnia in adults. (STRONG) 9. We suggest that clinicians use clarithromycin for the treatment of idiopathic hypersomnia in adults. (CONDITIONAL) 10. We suggest that clinicians use methylphenidate for the treatment of idiopathic hypersomnia in adults. (CONDITIONAL) 11. We suggest that clinicians use pitolisant for the treatment of idiopathic hypersomnia in adults. (CONDITIONAL) 12. We suggest that clinicians use sodium oxybate for the treatment of idiopathic hypersomnia in adults. (CONDITIONAL) Adult patients with Kleine-Levin syndrome 13. We suggest that clinicians use lithium for the treatment of Kleine-Levin syndrome in adults. (CONDITIONAL) Adult patients with hypersomnia due to medical conditions Hypersomnia secondary to alpha-synucleinopathies 14. We suggest that clinicians use armodafinil for the treatment of hypersomnia secondary to dementia with Lewy bodies in adults. (CONDITIONAL) 15. We suggest that clinicians use modafinil for the treatment of hypersomnia secondary to Parkinson's disease in adults. (CONDITIONAL) 16. We suggest that clinicians use sodium oxybate for the treatment of hypersomnia secondary to Parkinson's disease in adults. (CONDITIONAL) Posttraumatic hypersomnia 17. We suggest that clinicians use armodafinil for the treatment of hypersomnia secondary to traumatic brain injury in adults. (CONDITIONAL) 18. We suggest that clinicians use modafinil for the treatment of hypersomnia secondary to traumatic brain injury in adults. (CONDITIONAL) Adult patients with genetic disorders associated with primary central nervous system somnolence 19. We suggest that clinicians use modafinil for the treatment of hypersomnia secondary to myotonic dystrophy in adults. (CONDITIONAL) Adult patients with hypersomnia secondary to brain tumors, infections, or other central nervous system lesions 20. We suggest that clinicians use modafinil for the treatment of hypersomnia secondary to multiple sclerosis in adults. (CONDITIONAL) Pediatric patients with narcolepsy 21. We suggest that clinicians use modafinil for the treatment of narcolepsy in pediatric patients. (CONDITIONAL) 22. We suggest that clinicians use sodium oxybate for the treatment of narcolepsy in pediatric patients. (CONDITIONAL)	[Maski, Kiran] Boston Childrens Hosp, Dept Neurol, 333 Longwood Ave, Boston, MA 02130 USA; [Trotti, Lynn Marie] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Kotagal, Suresh] Mayo Clin, Dept Neurol, Rochester, MN USA; [Auger, R. Robert] Mayo Clin, Dept Psychiat & Psychol, Coll Med, Rochester, MN USA; [Rowley, James A.] Wayne State Univ, Sch Med, Dept Med, Detroit, MI 48201 USA; [Hashmi, Sarah D.] Amer Acad Sleep Med, Darien, IL USA; [Watson, Nathaniel F.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA USA		Maski, K (corresponding author), Boston Childrens Hosp, Dept Neurol, 333 Longwood Ave, Boston, MA 02130 USA.	Kiran.Maski@childrens.harvard.edu					American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Maski K, 2021, J CLIN SLEEP MED, V17, P1895, DOI 10.5664/jcsm.9326; Morgenthaler TI, 2007, SLEEP, V30, P1705, DOI 10.1093/sleep/30.12.1705; Morgenthaler TI, 2016, J CLIN SLEEP MED, V12, P129, DOI 10.5664/jcsm.5412; U.S. National Library of Medicine, NUV PROV PREGN REG	7	5	5	1	1	AMER ACAD SLEEP MEDICINE	DARIEN	2510 N FRONTAGE RD, DARIEN, IL 60561 USA	1550-9389	1550-9397		J CLIN SLEEP MED	J. Clin. Sleep Med.	SEP 1	2021	17	9					1882	1894		10.5664/jcsm.9328			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XW5PP	WOS:000735671300017	34743789	Bronze			2022-02-06	
J	Fergusson, NA; Hoiland, RL; Thiara, S; Foster, D; Gooderham, P; Rikhraj, K; Grunau, B; Christenson, J; Ainslie, PN; Griesdale, DEG; Sekhon, MS				Fergusson, Nicholas A.; Hoiland, Ryan L.; Thiara, Sonny; Foster, Denise; Gooderham, Peter; Rikhraj, Kiran; Grunau, Brian; Christenson, Jim; Ainslie, Philip N.; Griesdale, Donald E. G.; Sekhon, Mypinder S.			Goal-Directed Care Using Invasive Neuromonitoring Versus Standard of Care After Cardiac Arrest: A Matched Cohort Study*	CRITICAL CARE MEDICINE			English	Article						brain oxygenation; cardiac arrest; cerebral oxygen delivery; hypoxic ischemic brain injury; neuromonitoring; secondary injury	MILD THERAPEUTIC HYPOTHERMIA; NEAR-INFRARED SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; NEUROCRITICAL CARE; PHASE-II; CARDIOPULMONARY; RESUSCITATION; INCREASES; STATEMENT; CONSENSUS	PURPOSE: Following return of spontaneous circulation after cardiac arrest, hypoxic ischemic brain injury is the primary cause of mortality and disability. Goal-directed care using invasive multimodal neuromonitoring has emerged as a possible resuscitation strategy. We evaluated whether goal-directed care was associated with improved neurologic outcome in hypoxic ischemic brain injury patients after cardiac arrest. DESIGN: Retrospective, single-center, matched observational cohort study. SETTING: Quaternary academic medical center. PATIENTS: Adult patients admitted to the ICU following return of spontaneous circulation postcardiac arrest with clinical evidence of hypoxic ischemic brain injury defined as greater than or equal to 10 minutes of cardiac arrest with an unconfounded postresuscitation Glasgow Coma Scale of less than or equal to 8. INTERVENTIONS: We compared patients who underwent goal-directed care using invasive neuromonitoring with those treated with standard of care (using both total and matched groups). MEASUREMENTS AND MAIN RESULTS: Goal-directed care patients were matched 1:1 to standard of care patients using propensity scores and exact matching. The primary outcome was a 6-month favorable neurologic outcome (Cerebral Performance Category of 1 or 2). We included 65 patients, of whom 21 received goal-directed care and 44 patients received standard of care. The median age was 50 (interquartile range, 35-61), 48 (74%) were male, and seven (11%) had shockable rhythms. Favorable neurologic outcome at 6 months was significantly greater in the goal-directed care group (n = 9/21 [43%]) compared with the matched (n = 2/21 [10%], p = 0.016) and total (n = 8/44 [18%], p = 0.034) standard of care groups. Goal-directed care group patients had higher mean arterial pressure (p < 0.001 vs total; p = 0.0060 vs matched) and lower temperature (p = 0.007 vs total; p = 0.041 vs matched). CONCLUSIONS: In this preliminary study of patients with hypoxic ischemic brain injury postcardiac arrest, goal-directed care guided by invasive neuromonitoring was associated with a 6-month favorable neurologic outcome (Cerebral Performance Category 1 or 2) versus standard of care. Significant work is required to confirm this finding in a prospectively designed study.	[Fergusson, Nicholas A.] Univ British Columbia, MD Undergrad Program, Vancouver, BC, Canada; [Hoiland, Ryan L.; Griesdale, Donald E. G.] Univ British Columbia, Div Crit Care Med, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada; [Thiara, Sonny; Foster, Denise; Griesdale, Donald E. G.; Sekhon, Mypinder S.] Univ British Columbia, Dept Med, Div Crit Care Med, Vancouver, BC, Canada; [Ainslie, Philip N.] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Ctr Heart Lung & Vasc Hlth, Kelowna, BC, Canada; [Gooderham, Peter] Univ British Columbia, Dept Surg, Div Neurosurg, Vancouver, BC, Canada; [Rikhraj, Kiran; Grunau, Brian; Christenson, Jim] Univ British Columbia, Dept Emergency Med, Vancouver, BC, Canada; [Griesdale, Donald E. G.] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada		Sekhon, MS (corresponding author), Univ British Columbia, Dept Med, Div Crit Care Med, Vancouver, BC, Canada.	mypindersekhon@gmail.com		Grunau, Brian/0000-0003-4103-1383	Vancouver General Hospital Foundation; Stryker Canada; Baxter Canada; Vancouver Coastal Health Research Institute Clinician Scientist Award; Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research	Supported, in part, by the Vancouver General Hospital Foundation.; Dr. Gooderham received funding from Stryker Canada and Baxter Canada. Dr. Grunau received funding from Stryker Canada. Dr. Sekhon is also supported by the Vancouver Coastal Health Research Institute Clinician Scientist Award. Dr. Griesdale is supported through a Health Professional-Investigator Award from the Michael Smith Foundation for Health Research. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Ameloot K, 2019, EUR HEART J, V40, P1804, DOI 10.1093/eurheartj/ehz120; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Braumann S, 2020, CLIN RES CARDIOL, V109, P1402, DOI 10.1007/s00392-020-01640-x; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cardim D, 2018, BRIT J ANAESTH, V121, P523, DOI 10.1016/j.bja.2018.05.058; Cardim D, 2019, RESUSCITATION, V137, P221, DOI 10.1016/j.resuscitation.2019.01.002; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Coppler PJ, 2015, RESUSCITATION, V89, P86, DOI 10.1016/j.resuscitation.2015.01.020; Eastwood GM, 2016, RESUSCITATION, V104, P83, DOI 10.1016/j.resuscitation.2016.03.023; Grasner JT, 2016, RESUSCITATION, V105, P188, DOI 10.1016/j.resuscitation.2016.06.004; Greer DM, 2006, SEMIN NEUROL, V26, P373, DOI 10.1055/s-2006-948317; Hoiland RL, 2020, RESUSCITATION, V156, P280, DOI 10.1016/j.resuscitation.2020.07.035; Hoiland RL, 2020, INTENS CARE MED, V46, P1969, DOI 10.1007/s00134-020-06200-5; Hoiland RL, 2020, RESUSCITATION, V152, P184, DOI 10.1016/j.resuscitation.2020.03.016; Hollenberg J, 2008, CIRCULATION, V118, P389, DOI 10.1161/CIRCULATIONAHA.107.734137; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jakkula P, 2018, INTENS CARE MED, V44, P2091, DOI 10.1007/s00134-018-5446-8; Javaudin F, 2018, RESUSCITATION, V127, P8, DOI 10.1016/j.resuscitation.2018.03.020; Kramer AH, 2011, NEUROCRIT CARE, V14, P329, DOI 10.1007/s12028-011-9530-y; Lascarrou JB, 2019, NEW ENGL J MED, V381, P2327, DOI 10.1056/NEJMoa1906661; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Lunt M, 2014, AM J EPIDEMIOL, V179, P226, DOI 10.1093/aje/kwt212; Naito H, 2016, THER HYPOTHERMIA TEM, V6, P189, DOI 10.1089/ther.2016.0009; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Sekhon MS, 2020, CRIT CARE MED, V48, P378, DOI 10.1097/CCM.0000000000004138; Sekhon MS, 2019, RESUSCITATION, V141, P96, DOI 10.1016/j.resuscitation.2019.05.036; Sekhon MS, 2019, CRIT CARE MED, V47, P960, DOI 10.1097/CCM.0000000000003745; Sekhon MS, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1832-9; Sekhon MS, 2017, CAN J NEUROL SCI, V44, P350, DOI 10.1017/cjn.2017.25; Sekhon MS, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1670-9; Shin SD., 2012, CIRCULATION, V126, pA230; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Stiell IG, 2009, ANN EMERG MED, V53, P241, DOI 10.1016/j.annemergmed.2008.03.018; Tanguay-Rioux X, 2018, RESUSCITATION, V128, P88, DOI 10.1016/j.resuscitation.2018.05.002; Wyllie J, 2015, RESUSCITATION, V95, pE169, DOI 10.1016/j.resuscitation.2015.07.045; Zive DM, 2018, RESUSCITATION, V131, P74, DOI 10.1016/j.resuscitation.2018.07.023	41	5	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	AUG	2021	49	8					1333	1346		10.1097/CCM.0000000000004945			14	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TK3ZG	WOS:000674100000030	33711002				2022-02-06	
J	Singh, G; Sharma, M; Kumar, GA; Rao, NG; Prasad, K; Mathur, P; Pandian, JD; Steinmetz, JD; Biswas, A; Pal, PK; Prakash, S; Sylaja, PN; Nichols, E; Dua, T; Kaur, H; Alladi, S; Agarwal, V; Aggarwal, S; Ambekar, A; Bagepally, BS; Banerjee, TK; Bender, RG; Bhagwat, S; Bhargava, S; Bhatia, R; Chakma, JK; Chowdhary, N; Dey, S; Dirac, MA; Feigin, VL; Ganguli, A; Golechha, MJ; Gourie-Devi, M; Goyal, V; Gupta, G; Gupta, PC; Gupta, R; Gururaj, G; Hemalatha, R; Jeemon, P; Johnson, CO; Joshi, P; Kant, R; Kataki, AC; Khurana, D; Krishnankutty, RP; Kyu, HH; Lim, SS; Lodha, R; Ma, R; Malhotra, R; Malhotra, R; Mathai, M; Mehrotra, R; Misra, UK; Mutreja, P; Naghavi, M; Naik, N; Nguyen, M; Pandey, A; Parmar, P; Perianayagam, A; Prabhakaran, D; Rath, GK; Reinig, N; Roth, GA; Sagar, R; Sankar, MJ; Shaji, KS; Sharma, RS; Sharma, S; Singh, R; Srivastava, MVP; Stark, BA; Tandon, N; Thakur, JS; ThekkePurakkal, AS; Thomas, SV; Tripathi, M; Vongpradith, A; Wunrow, HY; Xavier, D; Shukla, DK; Reddy, KS; Panda, S; Dandona, R; Murray, CJL; Vos, T; Dhaliwal, RS; Dandona, L				Singh, Gagandeep; Sharma, Meenakshi; Kumar, G. Anil; Rao, N. Girish; Prasad, Kameshwar; Mathur, Prashant; Pandian, Jeyaraj D.; Steinmetz, Jaimie D.; Biswas, Atanu; Pal, Pramod K.; Prakash, Sanjay; Sylaja, P. N.; Nichols, Emma; Dua, Tarun; Kaur, Harkiran; Alladi, Suvarna; Agarwal, Vivek; Aggarwal, Sumit; Ambekar, Atul; Bagepally, Bhavani S.; Banerjee, Tapas K.; Bender, Rose G.; Bhagwat, Sadhana; Bhargava, Stuti; Bhatia, Rohit; Chakma, Joy K.; Chowdhary, Neerja; Dey, Subhojit; Dirac, M. Ashworth; Feigin, Valery L.; Ganguli, Atreyi; Golechha, Mahaveer J.; Gourie-Devi, M.; Goyal, Vinay; Gupta, Gaurav; Gupta, Prakash C.; Gupta, Rajeev; Gururaj, Gopalkrishna; Hemalatha, Rajkumar; Jeemon, Panniyammakal; Johnson, Catherine O.; Joshi, Pradeep; Kant, Rajni; Kataki, Amal C.; Khurana, Dheeraj; Krishnankutty, Rinu P.; Kyu, Hmwe H.; Lim, Stephen S.; Lodha, Rakesh; Ma, Rui; Malhotra, Rajesh; Malhotra, Ridhima; Mathai, Matthews; Mehrotra, Ravi; Misra, Usha K.; Mutreja, Parul; Naghavi, Mohsen; Naik, Nitish; Nguyen, Minh; Pandey, Anamika; Parmar, Priya; Perianayagam, Arokiasamy; Prabhakaran, Dorairaj; Rath, Goura K.; Reinig, Nickolas; Roth, Gregory A.; Sagar, Rajesh; Sankar, Mari J.; Shaji, K. S.; Sharma, R. S.; Sharma, Shweta; Singh, Ravinder; Srivastava, M. V. Padma; Stark, Benjamin A.; Tandon, Nikhil; Thakur, J. S.; ThekkePurakkal, Akhil S.; Thomas, Sanjeev, V; Tripathi, Manjari; Vongpradith, Avina; Wunrow, Han Y.; Xavier, Denis; Shukla, D. K.; Reddy, K. Srinath; Panda, Samiran; Dandona, Rakhi; Murray, Christopher J. L.; Vos, Theo; Dhaliwal, R. S.; Dandona, Lalit			The burden of neurological disorders across the states of India: the Global Burden of Disease Study 1990-2019	LANCET GLOBAL HEALTH			English	Article							TREATMENT GAP; EPILEPSY; PREVALENCE; EPIDEMIOLOGY; ORGANIZATION; POPULATION; PATTERNS; SERVICES	Background A systematic understanding of the burden of neurological disorders at the subnational level is not readily available for India. We present a comprehensive analysis of the disease burden and trends of neurological disorders at the state level in India. Methods Using all accessible data from multiple sources, we estimated the prevalence or incidence and disability adjusted life-years (DALYs) for neurological disorders from 1990 to 2019 for all states of India as part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2019. We assessed the contribution of each neurological disorder to deaths and DALYs in India in 2019, their trends in prevalence or incidence and DALY rates over time, and heterogeneity between the states of India. We also assessed the Pearson correlation coefficient between Sociodemographic Index (SDI) of the states and the prevalence or incidence and DALY rates of each neurological disorder. Additionally, we estimated the contribution of known risk factors to DALYs from neurological disorders. We calculated 95% uncertainty intervals (UIs) for the mean estimates. Findings The contribution of non-communicable neurological disorders to total DALYs in India doubled from 4middot0% (95% UI 3middot2-5middot0) in 1990 to 8middot2% (6middot6-10middot2) in 2019, and the contribution of injury-related neurological disorders increased from 0middot2% (0middot2-0middot3) to 0middot6% (0middot5-0middot7). Conversely, the contribution of communicable neurological disorders decreased from 4middot1% (3middot5-4middot8) to 1middot1% (0middot9-1middot5) during the same period. In 2019, the largest contributors to the total neurological disorder DALYs in India were stroke (37middot9% [29middot9-46middot1]), headache disorders (17middot5% [3middot6-32middot5]), epilepsy (11middot3% [9middot0-14middot3]), cerebral palsy (5middot7% [4middot2-7middot7]), and encephalitis (5middot3% [3middot7-8middot9]). The crude DALY rate of several neurological disorders had considerable heterogeneity between the states in 2019, with the highest variation for tetanus (93middot2 times), meningitis (8middot3 times), and stroke (5middot5 times). SDI of the states had a moderate significant negative correlation with communicable neurological disorder DALY rate and a moderate significant positive correlation with injury-related neurological disorder DALY rate in 2019. For most of the non communicable neurological disorders, there was an increase in prevalence or incidence from 1990 to 2019. Substantial decreases were evident in the incidence and DALY rates of communicable neurological disorders during the same period. Migraine and multiple sclerosis were more prevalent among females than males and traumatic brain injuries were more common among males than females in 2019. Communicable diseases contributed to the majority of total neurological disorder DALYs in children younger than 5 years, and non-communicable neurological disorders were the highest contributor in all other age groups. In 2019, the leading risk factors contributing to DALYs due to non communicable neurological disorders in India included high systolic blood pressure, air pollution, dietary risks, high fasting plasma glucose, and high body-mass index. For communicable disorders, the identified risk factors with modest contributions to DALYs were low birthweight and short gestation and air pollution. Interpretation The increasing contribution of non-communicable and injury-related neurological disorders to the overall disease burden in India, and the substantial state-level variation in the burden of many neurological disorders highlight the need for state-specific health system responses to address the gaps in neurology services related to awareness, early identification, treatment, and rehabilitation.	[Singh, Gagandeep] Dayanand Med Coll, Dept Neurol, Ludhiana, Punjab, India; [Sharma, Meenakshi; Aggarwal, Sumit; Bhargava, Stuti; Chakma, Joy K.; Kant, Rajni; Mehrotra, Ravi; Sharma, R. S.; Sharma, Shweta; Singh, Ravinder; Shukla, D. K.; Panda, Samiran; Dhaliwal, R. S.; Dandona, Lalit] Indian Council Med Res, New Delhi 110029, India; [Kumar, G. Anil; Kaur, Harkiran; Krishnankutty, Rinu P.; Malhotra, Ridhima; Mutreja, Parul; Pandey, Anamika; Prabhakaran, Dorairaj; ThekkePurakkal, Akhil S.; Reddy, K. Srinath; Dandona, Rakhi; Dandona, Lalit] Publ Hlth Fdn India, Gurugram 122002, National Capita, India; [Rao, N. Girish] Natl Inst Mental Hlth & Neurosci, Ctr Publ Hlth, Dept Epidemiol, Bengaluru, India; [Pal, Pramod K.; Alladi, Suvarna] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bengaluru, India; [Prasad, Kameshwar] Rajendra Inst Med Sci, Ranchi, Bihar, India; [Mathur, Prashant] Indian Council Med Res, Natl Inst Dis Informat & Res, Bengaluru, India; [Pandian, Jeyaraj D.] Christian Med Coll & Hosp, Dept Neurol, Ludhiana, Punjab, India; [Steinmetz, Jaimie D.; Nichols, Emma; Bender, Rose G.; Dirac, M. Ashworth; Johnson, Catherine O.; Kyu, Hmwe H.; Lim, Stephen S.; Ma, Rui; Naghavi, Mohsen; Nguyen, Minh; Parmar, Priya; Reinig, Nickolas; Roth, Gregory A.; Stark, Benjamin A.; Vongpradith, Avina; Wunrow, Han Y.; Dandona, Rakhi; Murray, Christopher J. L.; Vos, Theo; Dandona, Lalit] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Biswas, Atanu] Bangur Inst Neurosci, Dept Neurol, Kolkata, India; [Biswas, Atanu] Inst Postgrad Med Educ & Res, Kolkata, India; [Prakash, Sanjay] Sumandeep Vidyapeeth, Smt BK Shah Med Inst & Res Ctr, Dept Neurol, Vadodara, India; [Sylaja, P. N.; Thomas, Sanjeev, V] Sree Chitra Tirunal Inst Med Sci & Technol, Dept Neurol, Trivandrum, Kerala, India; [Jeemon, Panniyammakal] Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Trivandrum, Kerala, India; [Dua, Tarun; Chowdhary, Neerja] WHO, Geneva, Switzerland; [Agarwal, Vivek] King Georges Med Univ, Dept Psychiat, Lucknow, Uttar Pradesh, India; [Ambekar, Atul] All India Inst Med Sci, Natl Drug Dependence Treatment Ctr, New Delhi, India; [Ambekar, Atul; Sagar, Rajesh] All India Inst Med Sci, Dept Psychiat, New Delhi, India; [Bhatia, Rohit; Srivastava, M. V. Padma; Tripathi, Manjari] All India Inst Med Sci, Dept Neurol, Neurosci Ctr, New Delhi, India; [Lodha, Rakesh; Sankar, Mari J.] All India Inst Med Sci, Dept Paediat, New Delhi, India; [Malhotra, Rajesh] All India Inst Med Sci, Dept Orthopaed, New Delhi, India; [Malhotra, Rajesh] All India Inst Med Sci, JPN Apex Trauma Ctr, New Delhi, India; [Naik, Nitish] All India Inst Med Sci, Dept Cardiol, New Delhi, India; [Rath, Goura K.] All India Inst Med Sci, Dept Radiat Oncol, New Delhi, India; [Tandon, Nikhil] All India Inst Med Sci, Dept Endocrinol, New Delhi, India; [Bagepally, Bhavani S.] Indian Council Med Res, Natl Inst Epidemiol, Chennai, Tamil Nadu, India; [Banerjee, Tapas K.] Natl Neurosci Ctr Calcutta, Kolkata, India; [Bhagwat, Sadhana] WHO, Kathmandu, Nepal; [Dey, Subhojit] Disha Fdn, Gurugram, India; [Feigin, Valery L.] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Ganguli, Atreyi; Gupta, Gaurav; Joshi, Pradeep] WHO, India Country Off, New Delhi, India; [Golechha, Mahaveer J.] Publ Hlth Fdn India, Indian Inst Publ Hlth Gandhinagar, Gandhinagar, India; [Gourie-Devi, M.] Inst Behav & Allied Sci, Dept Neurol, New Delhi, India; [Goyal, Vinay] Medanta, Inst Neurosci, Gurugram, India; [Gupta, Prakash C.] Healis Sekhsaria Inst Publ Hlth, Mumbai, Maharashtra, India; [Gupta, Rajeev] Eternal Heart Care Ctr & Res Inst, Jaipur, Rajasthan, India; [Gururaj, Gopalkrishna] Natl Inst Mental Hlth & Neurosci, Bengaluru, India; [Hemalatha, Rajkumar] Indian Council Med Res, Natl Inst Nutr, Hyderabad, India; [Kataki, Amal C.] Dr B Borooah Canc Inst, Gauhati, India; [Khurana, Dheeraj] Postgrad Inst Med Educ & Res, Dept Neurol, Chandigarh, India; [Thakur, J. S.] Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Mathai, Matthews] Univ Liverpool Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool, Merseyside, England; [Misra, Usha K.] Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India; [Perianayagam, Arokiasamy] Int Inst Populat Sci, Mumbai, Maharashtra, India; [Shaji, K. S.] Kerala Univ Hlth Sci, Trichur, India; [Xavier, Denis] St Johns Med Coll, Dept Pharmacol, Bengaluru, India		Dandona, L (corresponding author), Indian Council Med Res, New Delhi 110029, India.; Dandona, L (corresponding author), Publ Hlth Fdn India, Gurugram 122002, National Capita, India.	lalit.dandona@icmr.gov.in	Biswas, Atanu/AAE-2290-2020; Bagepally, Bhavani Shankara/A-4893-2009; Agarwal, Vivek/ABD-7717-2020; Mehrotra, Ravi/E-3285-2010; Aggarwal, Sumit/AAU-6844-2021; KS, SHAJI/J-4992-2016	Biswas, Atanu/0000-0001-5696-9839; Bagepally, Bhavani Shankara/0000-0003-0856-767X; Agarwal, Vivek/0000-0002-2534-1288; Mehrotra, Ravi/0000-0001-9453-1408; Aggarwal, Sumit/0000-0002-0652-1611; SAGAR, RAJESH/0000-0003-4563-7841; KS, SHAJI/0000-0002-6029-9679	Bill & Melinda Gates FoundationBill & Melinda Gates FoundationCGIAR; Indian Council of Medical Research, Department of Health Research, Ministry of Health and Family Welfare, Government of India	Bill & Melinda Gates Foundation; and Indian Council of Medical Research, Department of Health Research, Ministry of Health and Family Welfare, Government of India.	Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9; Banerjee TK, 2017, INT J GERIATR PSYCH, V32, P605, DOI 10.1002/gps.4499; Beghi E, 2019, LANCET NEUROL, V18, P357, DOI 10.1016/S1474-4422(18)30454-X; Bharucha NE, 2012, ANN INDIAN ACAD NEUR, V15, P352, DOI 10.4103/0972-2327.104360; Cieza A, 2020, LANCET, V396, P2006, DOI 10.1016/S0140-6736(20)32340-0; Cohen Adam B, 2013, Neurol Clin Pract, V3, P52, DOI 10.1212/CPJ.0b013e318283ff4f; Dandona L, 2017, LANCET, V390, P2437, DOI 10.1016/S0140-6736(17)32804-0; Dhillon PK, 2018, LANCET ONCOL, V19, P1289, DOI 10.1016/S1470-2045(18)30447-9; Dias A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002333; Directorate General of Health Services Government of India, 2020, NAT PROGR PREV CONTR NAT PROGR PREV CONTR; Dorsey ER, 2018, LANCET NEUROL, V17, P939, DOI 10.1016/S1474-4422(18)30295-3; Elliot VL, 2019, HEALTH SOC CARE COMM, V27, pE158, DOI 10.1111/hsc.12694; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Goel S, 2014, SEIZURE-EUR J EPILEP, V23, P41, DOI 10.1016/j.seizure.2013.09.010; Gourie-Devi M, 2014, NEUROL INDIA, V62, P588, DOI 10.4103/0028-3886.149365; Gourie-Devi M, 2008, NEUROL INDIA, V56, P4, DOI 10.4103/0028-3886.39304; Government of India, 2018, HLTH BEN PACK EMP CR HLTH BEN PACK EMP CR; Gupta BM., 2013, INT J NUTR PHARM NEU, V3, P254, DOI [DOI 10.4103/2231-0738.114849, 10.4103/2231-0738.114849]; Hara HS, 2015, NEUROEPIDEMIOLOGY, V45, P273, DOI 10.1159/000438509; Khadilkar SV, 2007, NEUROL INDIA, V55, P27, DOI 10.4103/0028-3886.30423; Knauss S, 2019, LANCET NEUROL, V18, P1078, DOI 10.1016/S1474-4422(19)30392-8; Kulkarni GB, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0549-x; Kumar H, 2012, J NEUROSCI RURAL PRA, V3, P12, DOI 10.4103/0976-3147.91923; Logroscino G, 2018, LANCET NEUROL, V17, P1083, DOI 10.1016/S1474-4422(18)30404-6; Ministry of Health and Family Welfare, 2020, NAT PROGR PREV MAN T NAT PROGR PREV MAN T; Ministry of Health and Family Welfare, REP TECHN GROUP POP REP TECHN GROUP POP; Ministry of Health and Family Welfare, NAT PROGR PREV MAN T NAT PROGR PREV MAN T; Ministry of Health and Family Welfare, 2016, 10 COMM REV MISS REP; Ministry of Health and Family Welfare, 2013, RASHTR BAL SWASTHY K RASHTR BAL SWASTHY K; Ministry of Health and Family Welfare Government of India, 2011, NAT PROGR HLTH CAR E; Murray CJL, 2020, LANCET, V396, P1223, DOI 10.1016/S0140-6736(20)30752-2; National Health Portal, 2019, MISS INDR MISS INDR; Nichols E, 2019, LANCET NEUROL, V18, P88, DOI 10.1016/S1474-4422(18)30403-4; Nizamie SH, 2009, EPILEPSY RES, V84, P146, DOI 10.1016/j.eplepsyres.2009.01.008; Pandey Sanjay, 2012, Indian J Public Health, V56, P227, DOI 10.4103/0019-557X.104253; Pandit L, 2014, MULT SCLER J, V20, P1651, DOI 10.1177/1352458514521503; Patel V, 2009, INT HEALTH, V1, P37, DOI 10.1016/j.inhe.2009.02.002; Patterson V, 2018, SEIZURE-EUR J EPILEP, V55, P4, DOI 10.1016/j.seizure.2017.12.006; Patterson V, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00120; Petersen I, 2016, INT J MENT HEALTH SY, V10, DOI 10.1186/s13033-016-0060-z; Prabhakaran D, 2018, LANCET GLOB HEALTH, V6, pE1339, DOI 10.1016/S2214-109X(18)30407-8; Press Information Bureau, COMPR MAT MIN HLTH F COMPR MAT MIN HLTH F; Rajbhandari H, 2019, SEIZURE-EUR J EPILEP, V64, P54, DOI 10.1016/j.seizure.2018.12.005; Rao GN, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0574-9; Ray BK, 2017, NEUROL INDIA, V65, P1280, DOI 10.4103/0028-3886.217979; Rodriguez MTS, 2018, NEUROLOGIA, V33, P313, DOI 10.1016/j.nrl.2015.10.005; Stovner LJ, 2018, LANCET NEUROL, V17, P954, DOI 10.1016/S1474-4422(18)30322-3; Wallin MT, 2019, LANCET NEUROL, V18, P269, DOI 10.1016/S1474-4422(18)30443-5; Wang HD, 2020, LANCET, V396, P1160, DOI 10.1016/S0140-6736(20)30977-6; WHO, 2020, GLOB ACT EP OTH NEUR GLOB ACT EP OTH NEUR; WHO, 2017, ATLAS COUNTR RES NEU; World Health Organization, 2017, GLOB ACT PLAN PUBL H	52	5	5	3	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2214-109X			LANCET GLOB HEALTH	Lancet Glob. Health	AUG	2021	9	8					E1129	E1144		10.1016/S2214-109X(21)00164-9			16	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	TP3PM	WOS:000677505700030	34273302	gold, Green Published			2022-02-06	
J	Asarnow, RF; Newman, N; Weiss, RE; Su, E				Asarnow, Robert F.; Newman, Nina; Weiss, Robert E.; Su, Erica			Association of Attention-Deficit/Hyperactivity Disorder Diagnoses With Pediatric Traumatic Brain Injury	JAMA PEDIATRICS			English	Article							DEFICIT HYPERACTIVITY DISORDER; PSYCHIATRIC-DISORDERS; HEAD-INJURIES; CHILDREN; MILD; ADOLESCENTS; SYMPTOMS; ADHD; TRAJECTORIES; PREVALENCE	IMPORTANCE There are conflicting accounts about the risk for attention-deficit/hyperactivity disorder (ADHD) following traumatic brain injury (TBI), possibly owing to variations between studies in acute TBI severity or when ADHD was assessed postinjury. Analysis of these variations may aid in identifying the risk. OBJECTIVE To conduct a meta-analysis of studies assessing ADHD diagnoses in children between ages 4 and 18 years following concussions and mild, moderate, or severe TBI. DATA SOURCES PubMed, Psyclnfo, and Cochrane Central Register of Controlled Trials (1981-December 19, 2019) were searched including the terms traumatic brain injury, brain injuries, closed head injury, blunt head trauma, concussion, attention deficit disorders, ADHD, and ADD in combination with childhood, adolescence, pediatric, infant, child, young adult, or teen. STUDY SELECTION Limited to English-language publications in peer-reviewed journals and patient age (4-18 years). Differences about inclusion were resolved through consensus of 3 authors. DATA EXTRACTION AND SYNTHESIS MOOSE guidelines for abstracting and assessing data quality and validity were used. Odds ratios with 95% credible intervals (Cris) are reported. MAIN OUTCOMES AND MEASURES The planned study outcome was rate of ADHD diagnoses. RESULTS A total of 12 374 unique patients with TBI of all severity levels and 43 491 unique controls were included in the 24 studies in this review (predominantly male: TBI, 61.8%; noninjury control, 60.9%; other injury control, 66.1%). The rate of pre-TBI ADHD diagnoses was 16.0% (95% Crl, 11.3%-21.7%), which was significantly greater than the 10.8% (95% Crl, 10.2%-11.4%) incidence of ADHD in the general pediatric population. Compared with children without injuries, the odds for ADHD were not significantly increased following concussion (<= 1year: OR, 0.32; 95% Crl, 0.05-1.13), mild TBI (<= 1 year: OR, 0.56; 0.16-1.43; >1 year: OR, 1.07; 95% Crl, 0.35-2.48), and moderate TBI (<= 1year: OR, 1.28; 95% Crl, 0.35-3.34; >1 year: OR, 3.67; 95% Crl, 0.83-10.56). The odds for ADHD also were not significantly increased compared with children with other injuries following mild TBI (<= 1 year: OR, 1.07; 95% Crl, 0.33-2.47; >1 year: OR, 1.18; 95% Crl, 0.32-3.12) and moderate TBI (<= 1year: OR, 2.34; 95% Crl, 0.78-5.47; >1 year: OR, 3.78; 95% Crl, 0.93-10.33). In contrast, the odds for ADHD following severe TBI were increased at both time points following TBI compared with children with other injuries (<= 1year: OR, 4.81; 95% Crl, 1.66-11.03; >1 year: OR, 6.70; 95% Crl, 2.02-16.82) and noninjured controls (<= 1 year: OR, 2.62; 95% Crl, 0.76-6.64; >1 year: OR, 6.25; 95% Crl, 2.06-15.06), as well as those with mild TBI (<= 1year OR, 5.69; 1.46-15.67: >1 year OR, 6.65; 2.14-16.44). Of 5920 children with severe TBI, 35.5% (95% Crl, 20.6%-53.2%) had ADHD more than 1 year postinjury. CONCLUSIONS AND RELEVANCE This study noted a significant association between TBI severity and ADHD diagnosis. In children with severe but not mild and moderate TBI, there was an association with an increase in risk for ADHD. The high rate of preinjury ADHD in children with TBI suggests that clinicians should carefully review functioning before a TBI before initiating treatment.	[Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychiat, 48-240 Semel Inst,760 Westwood Plaza, Los Angeles, CA 90024 USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Newman, Nina] Fielding Grad Univ, Sch Psychol, Playa Vista, CA USA; [Weiss, Robert E.; Su, Erica] Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA 90024 USA		Asarnow, RF (corresponding author), Univ Calif Los Angeles, Dept Psychiat, 48-240 Semel Inst,760 Westwood Plaza, Los Angeles, CA 90024 USA.	rasarnow@mednet.ucla.edu					Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barlow KM, 2013, HAND CLINIC, V112, P891, DOI 10.1016/B978-0-444-52910-7.00011-8; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Centers for Disease Control and Prevention, 2019, HLTH US 2018 DAT FIN; Chasle V, 2016, CHILD NERV SYST, V32, P2357, DOI 10.1007/s00381-016-3230-z; Dennis EL, 2017, NEUROIMAGE-CLIN, V15, P125, DOI 10.1016/j.nicl.2017.03.014; Dennis EL, 2017, NEUROLOGY, V88, P1392, DOI 10.1212/WNL.0000000000003808; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Konigs M, 2015, PEDIATRICS, V136, P534, DOI 10.1542/peds.2015-0437; Konrad K, 2003, COGNITIVE BRAIN RES, V16, P425, DOI 10.1016/S0926-6410(03)00057-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Liou YJ, 2018, J ADOLESCENT HEALTH, V63, P233, DOI 10.1016/j.jadohealth.2018.02.012; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1997, BRAIN INJURY, V11, P699; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P272, DOI 10.1176/appi.neuropsych.12040078; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P187, DOI 10.1176/appi.neuropsych.12010011; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Max JE, 2012, J AM ACAD CHILD PSY, V51, P1208, DOI 10.1016/j.jaac.2012.08.026; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Ornstein TJ, 2014, J INT NEUROPSYCH SOC, V20, P971, DOI 10.1017/S1355617714000903; PLUMMER M, 2003, P 3 INT WORKSH DISTR; R Development Core Team, 2012, R LANG ENV STAT COMP; Robert C.P. G., 2010, INTRO MONTE CARLO ME, V18, DOI [10.1007/978-1-4419-1576-4, DOI 10.1007/978-1-4419-1576-4, 10.1007/978-1- 4419-1576-4]; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Wade SL, 2020, J HEAD TRAUMA REHAB, V35, pE393, DOI 10.1097/HTR.0000000000000567; Wells G., 2000, NEWCASTLE OTTAWA SCA; Writer BW, 2009, J NEUROPSYCH CLIN N, V21, P362, DOI 10.1176/appi.neuropsych.21.4.362; Yang LY, 2016, PEDIATR RES, V80, P356, DOI 10.1038/pr.2016.85; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79	47	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	OCT	2021	175	10					1009	1016		10.1001/jamapediatrics.2021.2033		JUL 2021	8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	WD3RL	WOS:000673014500006	34251435				2022-02-06	
J	Rhoads, T; Neale, AC; Resch, ZJ; Cohen, CD; Keezer, RD; Cerny, BM; Jennette, KJ; Ovsiew, GP; Soble, JR				Rhoads, Tasha; Neale, Alec C.; Resch, Zachary J.; Cohen, Cari D.; Keezer, Richard D.; Cerny, Brian M.; Jennette, Kyle J.; Ovsiew, Gabriel P.; Soble, Jason R.			Psychometric implications of failure on one performance validity test: a cross-validation study to inform criterion group definition	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Performance validity; psychometrics; validation study; known-groups design; criterion group	TRAUMATIC BRAIN-INJURY; RELIABLE DIGIT SPAN; TOMM TRIAL 1; RATES; INDICATOR; ACCURACY; BELIEFS; ERRORS; BIAS	Introduction: Research to date has supported the use of multiple performance validity tests (PVTs) for determining validity status in clinical settings. However, the implications of including versus excluding patients failing one PVT remains a source of debate, and methodological guidelines for PVT research are lacking. This study evaluated three validity classification approaches (i.e. 0 vs. >= 2, 0-1 vs. >= 2, and 0 vs. >= 1 PVT failures) using three reference standards (i.e. criterion PVT groupings) to recommend approaches best suited to establishing validity groups in PVT research methodology. Method: A mixed clinical sample of 157 patients was administered freestanding (Medical Symptom Validity Test, Dot Counting Test, Test of Memory Malingering, Word Choice Test), and embedded PVTs (Reliable Digit Span, RAVLT Effort Score, Stroop Word Reading, BVMT-R Recognition Discrimination) during outpatient neuropsychological evaluation. Three reference standards (i.e. two freestanding and three embedded PVTs from the above list) were created. Rey 15-Item Test and RAVLT Forced Choice were used solely as outcome measures in addition to two freestanding PVTs not employed in the reference standard. Receiver operating characteristic curve analyses evaluated classification accuracy using the three validity classification approaches for each reference standard. Results: When patients failing only one PVT were excluded or classified as valid, classification accuracy ranged from acceptable to excellent. However, classification accuracy was poor to acceptable when patients failing one PVT were classified as invalid. Sensitivity/specificity across two of the validity classification approaches (0 vs. >= 2; 0-1 vs. >= 2) remained reasonably stable. Conclusions: These results reflect that both inclusion and exclusion of patients failing one PVT are acceptable approaches to PVT research methodology and the choice of method likely depends on the study rationale. However, including such patients in the invalid group yields unacceptably poor classification accuracy across a number of psychometrically robust outcome measures and therefore is not recommended.	[Rhoads, Tasha; Neale, Alec C.; Resch, Zachary J.; Cohen, Cari D.; Keezer, Richard D.; Cerny, Brian M.; Jennette, Kyle J.; Ovsiew, Gabriel P.; Soble, Jason R.] Univ Illinois, Coll Med, Dept Psychiat, 912 S Wood St MC 913, Chicago, IL 60612 USA; [Rhoads, Tasha; Neale, Alec C.; Resch, Zachary J.; Cohen, Cari D.] Rosalind Franklin Univ Med & Sci, Dept Psychol, Chicago, IL USA; [Keezer, Richard D.] Wheaton Coll, Dept Psychol, Wheaton, IL 60187 USA; [Cerny, Brian M.] IIT, Dept Psychol, Chicago, IL 60616 USA; [Soble, Jason R.] Univ Illinois, Coll Med, Dept Neurol, Chicago, IL USA		Rhoads, T (corresponding author), Univ Illinois, Coll Med, Dept Psychiat, 912 S Wood St MC 913, Chicago, IL 60612 USA.; Rhoads, T (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Psychol, Chicago, IL USA.	tasha.rhoads@gmail.com		Rhoads, Tasha/0000-0001-9708-0083; Resch, Zachary/0000-0002-3199-6168; Keezer, Richard/0000-0001-6599-8906; Soble, Jason/0000-0003-3348-8762			Abramson DA, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1774378; Alverson WA, 2019, CLIN NEUROPSYCHOL, V33, P1420, DOI 10.1080/13854046.2019.1599071; Bailey KC, 2018, ARCH CLIN NEUROPSYCH, V33, P895, DOI 10.1093/arclin/acx111; Bain KM, 2021, APPL NEUROPSYCH-ADUL, V28, P24, DOI 10.1080/23279095.2019.1585352; Bernstein MT, 2021, NEUROPSYCHOL REV, V31, P349, DOI 10.1007/s11065-020-09468-y; Boone K. B., 2002, DOT COUNTING TEST MA; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Buddin WH, 2014, CLIN NEUROPSYCHOL, V28, P525, DOI 10.1080/13854046.2014.906658; Bush S.S., 2013, MILD TRAUMATIC BRAIN, P57; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Critchfield E, 2019, CLIN NEUROPSYCHOL, V33, P1083, DOI 10.1080/13854046.2018.1508615; Dandachi-FitzGerald B, 2017, J CLIN EXP NEUROPSYC, V39, P257, DOI 10.1080/13803395.2016.1223278; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Fazio RL, 2017, CLIN NEUROPSYCHOL, V31, P251, DOI 10.1080/13854046.2016.1213316; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 2004, GREENS MED SYMPTOM V; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Jennette KJ, 2021, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2021.1900398; Kraemer LDR, 2020, PSYCHOL ASSESSMENT, V32, P442, DOI 10.1037/pas0000802; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Loring DW, 2016, ARCH CLIN NEUROPSYCH, V31, P313, DOI 10.1093/arclin/acw014; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Neale AC, 2020, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2020.1799076; Nelson N.W., 2013, MILD TRAUMATIC BRAIN, P119; Ovsiew GP, 2020, J CLIN EXP NEUROPSYC, V42, P473, DOI 10.1080/13803395.2020.1758635; Pliskin JI, 2021, ASSESSMENT, V28, P1871, DOI 10.1177/1073191120929093; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Resch ZJ, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1742718; Rogers R, 2008, CLIN ASSESSMENT MALI; Schroeder RW, 2019, CLIN NEUROPSYCHOL, V33, P466, DOI 10.1080/13854046.2018.1484517; Schroeder RW, 2016, CLIN NEUROPSYCHOL, V30, P515, DOI 10.1080/13854046.2016.1177118; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Sherman EMS, 2020, ARCH CLIN NEUROPSYCH, V35, P735, DOI 10.1093/arclin/acaa019; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Soble JR, 2021, PSYCHOL ASSESSMENT, V33, P568, DOI 10.1037/pas0001018; Soble JR, 2020, PSYCHOL ASSESSMENT, V32, P1087, DOI 10.1037/pas0000854; Soble JR, 2020, PSYCHOL INJ LAW, V13, P44, DOI 10.1007/s12207-019-09370-w; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Sweet JJ, 2021, CLIN NEUROPSYCHOL, V35, P1053, DOI 10.1080/13854046.2021.1896036; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Webber TA, 2020, ASSESSMENT, V27, P1399, DOI 10.1177/1073191118804874; White DJ, 2020, J CLIN EXP NEUROPSYC, V42, P459, DOI 10.1080/13803395.2020.1758634; Zuccato BG, 2018, PSYCHOL ASSESSMENT, V30, P1491, DOI 10.1037/pas0000596	57	5	5	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAY 28	2021	43	5					437	448		10.1080/13803395.2021.1945540		JUL 2021	12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	UC2DQ	WOS:000670808400001	34233580				2022-02-06	
J	Chesnutt, JC				Chesnutt, James C.			Evolving Science to Inform Emerging Concussion Practices	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							SYMPTOMS; EXERCISE; MODEL	Purpose: This article describes two concussion models built on the current state of science that help illustrate the complicated interactions among the multiple factors that drive concussion symptoms. Consideration of these models remind practitioners, including speech-language pathologists, to attend to factors that increase the risk of patients developing prolonged symptoms, as well as attend to symptoms that result from various interactions and may differentially respond to specific treatments. In particular, the models encourage personalized or precision medicine and the implementation of targeted, coordinated therapies.	[Chesnutt, James C.] Oregon Hlth & Sci Univ, Sch Med, Dept Family Med, Portland, OR 97201 USA; [Chesnutt, James C.] Oregon Hlth & Sci Univ, Sch Med, Dept Neurol, Portland, OR 97201 USA; [Chesnutt, James C.] Oregon Hlth & Sci Univ, Sch Med, Dept Orthoped & Rehabil, Portland, OR 97201 USA		Chesnutt, JC (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Family Med, Portland, OR 97201 USA.; Chesnutt, JC (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Neurol, Portland, OR 97201 USA.; Chesnutt, JC (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Orthoped & Rehabil, Portland, OR 97201 USA.	chesnutt@ohsu.edu		Chesnutt, James/0000-0001-5202-8425			Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Dachtyl SA, 2017, AM J SPEECH-LANG PAT, V26, P716, DOI 10.1044/2017_AJSLP-16-0138; Ferris LT, 2007, MED SCI SPORT EXER, V39, P728, DOI 10.1249/mss.0b013e31802f04c7; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kenzie ES, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00203; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Kim SK, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01103-8; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Mabry PL, 2008, AM J PREV MED, V35, pS211, DOI 10.1016/j.amepre.2008.05.018; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McNally KA, 2018, CHILD NEUROPSYCHOL, V24, P396, DOI 10.1080/09297049.2017.1280143; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; Wakeland W, 2015, AM J DRUG ALCOHOL AB, V41, P508, DOI 10.3109/00952990.2015.1043435; Wright J, 2021, AM J SPEECH-LANG PAT, V30, P1611, DOI 10.1044/2021_AJSLP-20-00306; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yue JK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00343	27	5	5	0	0	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	JUL	2021	30	4					1592	1597		10.1044/2021_AJSLP-20-00315			6	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	TY1ZS	WOS:000683585400002	33939490				2022-02-06	
J	Womble, MN; McAllister-Deitrick, J; Marchetti, GF; Reynolds, E; Collins, MW; Elbin, RJ; Kontos, AP				Womble, Melissa N.; McAllister-Deitrick, Jamie; Marchetti, Gregory F.; Reynolds, Erin; Collins, Michael W.; Elbin, R. J.; Kontos, Anthony P.			Risk Factors for Vestibular and Oculomotor Outcomes After Sport-Related Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; vestibular; ocularmotor; risk factors	HIGH-SCHOOL; SEX-DIFFERENCES; CONVERGENCE; RECOVERY; MIGRAINE; PREDICTORS; NEARPOINT	Objective: To investigate the association between risk factors and vestibular-oculomotor outcomes after sport-related concussion (SRC). Study Design: Cross-sectional study of patients seen 5.7 +/- 5.4 days (range 0-30 days) after injury. Setting: Specialty clinic. Participants: Eighty-five athletes (50 male athletes and 35 female athletes) aged 14.1 +/- 2.8 years (range 9-24 years) seeking clinical care for SRC. Interventions: Participants completed a clinical interview, history questionnaire, symptom inventory, and vestibular/ocularmotor screening (VOMS). Chi-square tests with odds ratios and diagnostic accuracy were used to examine the association between risk factors and VOMS outcomes. Main Outcome Measures: The VOMS. Results: Female sex (chi(2) = 4.9, P = 0.03), on-field dizziness (chi(2) = 7.1, P = 0.008), fogginess (chi(2) = 10.3, P = 0.001), and post-traumatic migraine (PTM) symptoms including headache (chi(2) = 16.7, P = 0.001), nausea (chi(2) = 10.9, P = 0.001), light sensitivity (chi(2) = 14.9, P = 0.001), and noise sensitivity (chi(2) = 8.7, P = 0.003) were associated with presence of one or more postconcussion VOMS score above clinical cutoff. On-field dizziness (chi(2) = 3.8, P = 0.05), fogginess (chi(2) = 7.9, P = 0.005), and PTM-like symptoms including nausea (chi(2) = 9.0, P = 0.003) and noise sensitivity (chi(2) = 7.2, P = 0.007) were associated with obtaining a postconcussion near-point convergence (NPC) distance cutoff >5 cm. The likelihood ratios were 5.93 and 5.14 for VOMS symptoms and NPC distance, respectively. Conclusions: Female sex, on-field dizziness, fogginess, and PTM symptoms were predictive of experiencing vestibular-oculomotor symptoms/impairment after SRC.	[Womble, Melissa N.] Inova Sports Med Concuss Program, Fairfax, VA USA; [McAllister-Deitrick, Jamie] Coastal Carolina Univ, Dept Kinesiol, Conway, SC USA; [Marchetti, Gregory F.] Duquesne Univ, Rangos Sch Hlth Sci, Dept Phys Therapy, Pittsburgh, PA 15219 USA; [Reynolds, Erin] Baylor Scott & White Sports Therapy & Res, Sports Concuss Ctr, Frisco, TX USA; [Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA USA; [Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA		Womble, MN (corresponding author), Inova Sports Med, Dept Sports Med, 8501 Arlington Blvd,Suite 200, Fairfax, VA 22031 USA.	Melissa.Womble@inova.org			National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1K01DC012332-01A1]	Supported in part by a grant to the University of Pittsburgh from the National Institute on Deafness and Other Communication Disorders (1K01DC012332-01A1). A poster containing this information was presented in November 2015 at the 35th annual conference of the National Academy of Neuropsychology (NAN). M. W. Collins is a cofounder and 10% shareholder of ImPACT Applications Inc. However, the ImPACT test was not used in the current study.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Covassin T, 2003, J ATHL TRAINING, V38, P238; Elbin RJ, 2013, TRANSL STROKE RES, V4, P425, DOI 10.1007/s12975-012-0237-y; Gordon KE, 2006, BRIT J SPORT MED, V40, P184, DOI 10.1136/bjsm.2005.022251; Gurvich C, 2013, BRAIN RES, V1537, P244, DOI 10.1016/j.brainres.2013.08.058; Hayes GJ, 1998, OPTOMETRY VISION SCI, V75, P506, DOI 10.1097/00006324-199807000-00019; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Maples WC, 2007, OPTOMETRY VISION SCI, V84, P224, DOI 10.1097/OPX.0b013e3180339f44; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Neinstein L, 2000, J ADOLESCENT HEALTH, V27, P119, DOI 10.1016/S1054-139X(99)00099-3; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Thompson TL, 2009, OCHSNER J, V9, P20	29	5	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2021	31	4					E193	E199		10.1097/JSM.0000000000000761			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WN3JX	WOS:000711669500003	31219931				2022-02-06	
J	Burd, RS; Jensen, AR; VanBuren, JM; Richards, R; Holubkov, R; Pollack, MM				Burd, Randall S.; Jensen, Aaron R.; VanBuren, John M.; Richards, Rachel; Holubkov, Richard; Pollack, Murray M.		Eunice Kennedy Shriver Natl Inst	Factors Associated With Functional Impairment After Pediatric Injury	JAMA SURGERY			English	Article							QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; STATUS SCALE; CHILDREN; MORTALITY; OUTCOMES; PREDICTION; MANAGEMENT; SYSTEMS	IMPORTANCE Short- and long-term functional impairment after pediatric injury may be more sensitive for measuring quality of care compared with mortality alone. The characteristics of injured children and adolescents who are at the highest risk for functional impairment are unknown. OBJECTIVE To evaluate categories of injuries associated with higher prevalence of impaired functional status at hospital discharge among children and adolescents and to estimate the number of those with injuries in these categories who received treatment at pediatric trauma centers. DESIGN, SETTING, AND PARTICIPANTS This prospective cohort study (Assessment of Functional Outcomes and Health-Related Quality of Life After Pediatric Trauma) included children and adolescents younger than 15 years who were hospitalized with at least 1 serious injury at 1 of 7 level 1 pediatric trauma centers from March 2018 to February 2020. EXPOSURE At least 1 serious injury (Abbreviated Injury Scale score, >= 3 [scores range from 1 to 6, with higher scores indicating more severe injury]) classified into 9 categories based on the body region injured and the presence of a severe traumatic brain injury (Glasgow Coma Scale score <9 or Glasgow Coma Scale motor score <5). MAIN OUTCOMES AND MEASURES New domain morbidity defined as a 2 points or more change in any of 6 domains (mental status, sensory, communication, motor function, feeding, and respiratory) measured using the Functional Status Scale (FSS) (scores range from 1 [normal] to 5 [very severe dysfunction] for each domain) in each injury category at hospital discharge. The estimated prevalence of impairment associated with each injury category was assessed in the population of seriously injured children and adolescents treated at participating sites. RESULTS This study included a sample of 427 injured children and adolescents (271 [63.5%] male; median age, 7.2 years [interquartile range, 2.5-11.7 years]), 74 (17.3%) of whom had new FSS domain morbidity at discharge. The proportion of new FSS domain morbidity was highest among those with multiple injured body regions and severe head injury (20 of 24 [83.3%]) and lowest among those with an isolated head injury of mild or moderate severity (1 of 84 [1.2%]). After adjusting for oversampling of specific injuries in the study sample, 749 of 5195 seriously injured children and adolescents (14.4%) were estimated to have functional impairment at hospital discharge. Children and adolescents with extremity injuries (302 of 749 [40.3%]) and those with severe traumatic brain injuries (258 of 749 [34.4%]) comprised the largest proportions of those estimated to have impairment at discharge. CONCLUSIONS AND RELEVANCE In this cohort study, most injured children and adolescents returned to baseline functional status by hospital discharge. These findings suggest that functional status assessments can be limited to cohorts of injured children and adolescents at the highest risk for impairment.	[Burd, Randall S.] Childrens Natl Med Ctr, Div Trauma & Burn Surg, 111 Michigan Ave NW, Washington, DC 20010 USA; [Jensen, Aaron R.] Univ Calif San Francisco, Benioff Childrens Hosp Oakland, Oakland, CA USA; [VanBuren, John M.; Richards, Rachel; Holubkov, Richard] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Pollack, Murray M.] Childrens Natl Hlth Syst, Dept Pediat, Washington, DC USA; [Pollack, Murray M.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA		Burd, RS (corresponding author), Childrens Natl Med Ctr, Div Trauma & Burn Surg, 111 Michigan Ave NW, Washington, DC 20010 USA.	rburd@childrensnational.org			Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network, NIH, Department of Health and Human Services [UG1HD050096, UG1HD049981, U10HD049983, UG1HD083170, UG1HD083166, UG1HD083171, U01HD049934]	This study was supported, in part, by cooperative agreements UG1HD050096 (Dr Meert), UG1HD049981 (Drs Burd and Pollack), U10HD049983 (Dr Carcillo), UG1HD083170 (Drs Hall and Yates), UG1HD083166 (Dr McQuillen), UG1HD083171 (Dr Mourani), and U01HD049934 (Drs VanBuren, Richards, Holubkov, and Dean) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network, NIH, Department of Health and Human Services.	Ahmed OZ, 2019, J TRAUMA ACUTE CARE, V86, P810, DOI 10.1097/TA.0000000000002120; Arguelles GR, 2021, J PEDIATR ORTHOPED, V41, pE74, DOI 10.1097/BPO.0000000000001659; Bennett TD, 2016, PEDIATR CRIT CARE ME, V17, P1147, DOI 10.1097/PCC.0000000000000934; Bonafide CP, 2013, PEDIATRICS, V131, pE1150, DOI 10.1542/peds.2012-2443; Cassidy LD, 2014, J PEDIATR SURG, V49, P189, DOI 10.1016/j.jpedsurg.2013.09.055; Chang MC., 2016, NATL TRAUMA DATA BAN; Cooper CG, 2013, PEDIATR CRIT CARE ME, V14, pE365, DOI 10.1097/PCC.0b013e3182917a4c; DESWIET M, 1980, PEDIATRICS, V65, P1028; Durand MB, 2019, J TRAUMA NURS, V26, P239, DOI 10.1097/JTN.0000000000000461; Flynn-O'Brien KT, 2017, J AM COLL SURGEONS, V224, P933, DOI 10.1016/j.jamcollsurg.2017.01.061; Gabbe BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113467; Gabbe BJ, 2011, J TRAUMA, V70, P1532, DOI 10.1097/TA.0b013e31820e8546; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; Marson Ben A, 2020, Bone Jt Open, V1, P167, DOI 10.1302/2633-1462.15.BJO-2020-0031; McCarthy A, 2016, INJURY, V47, P574, DOI 10.1016/j.injury.2015.12.028; Notrica DM, 2017, SURG CLIN N AM, V97, P1, DOI 10.1016/j.suc.2016.08.001; O'Reilly GM, 2012, INJURY, V43, P1917, DOI 10.1016/j.injury.2012.07.185; Pollack MM, 2015, CRIT CARE MED, V43, P1699, DOI 10.1097/CCM.0000000000001081; Pollack MM, 2014, JAMA PEDIATR, V168, P671, DOI 10.1001/jamapediatrics.2013.5316; Pollack MM, 2009, PEDIATRICS, V124, pE18, DOI 10.1542/peds.2008-1987; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Rabbia F, 2002, J HUM HYPERTENS, V16, P327, DOI 10.1038/sj.jhh.1001398; Raghunathan T.E., 2001, SURV METHODOL, V27, P85, DOI DOI 10.1002/SIM.1186; Rios-Diaz AJ, 2016, JAMA SURG, V151, P1101, DOI 10.1001/jamasurg.2016.2343; Rubin DB, 1987, MULTIPLE IMPUTATION, P258, DOI DOI 10.1002/9780470316696; Ryder C, 2020, CRIT PUBLIC HEALTH, V30, P352, DOI 10.1080/09581596.2019.1581918; Sakran JV, 2020, J AM COLL SURGEONS, V230, P819, DOI 10.1016/j.jamcollsurg.2020.01.032; van Baar ME, 2011, BURNS, V37, P930, DOI 10.1016/j.burns.2011.05.004; Williams KS, 2017, DEV NEUROREHABIL, V20, P443, DOI 10.1080/17518423.2017.1289419; Winthrop AL, 2005, J TRAUMA, V58, P468, DOI 10.1097/01.TA.0000153940.23471.B7	30	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6254	2168-6262		JAMA SURG	JAMA Surg.	AUG	2021	156	8								10.1001/jamasurg.2021.2058		JUN 2021	10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	TZ7HP	WOS:000658414600010	34076684				2022-02-06	
J	Michinaga, S; Inoue, A; Sonoda, K; Mizuguchi, H; Koyama, Y				Michinaga, Shotaro; Inoue, Ayana; Sonoda, Kyomi; Mizuguchi, Hiroyuki; Koyama, Yutaka			Down-regulation of astrocytic sonic hedgehog by activation of endothelin ETB receptors: Involvement in traumatic brain injury-induced disruption of blood brain barrier in a mouse model	NEUROCHEMISTRY INTERNATIONAL			English	Article						Sonic hedgehog; Endothelin-1; Blood-brain barrier; Traumatic brain injury	CEREBROSPINAL-FLUID; SOD1 EXPRESSION; PERMEABILITY; PATHWAY; PROTEIN; ANGIOGENESIS; INFLAMMATION; INHIBITION; EDEMA; CELLS	In the adult brain, sonic hedgehog acts on cerebral microvascular endothelial cells to stabilize the blood-brain barrier. The expression of sonic hedgehog by astrocytes is altered during brain injury, and this change has been shown to affect permeability of blood-brain barrier. However, much remains unknown about the regulation of astrocytic sonic hedgehog production. Our results showed that endothelin-1 reduced sonic hedgehog mRNA expression and extracellular protein release in mouse cerebral cultured astrocytes, but had no effect in bEnd.3, a mouse brain microvascular endothelial-derived cell line. The effect of endothelin-1 on astrocyte sonic hedgehog expression was suppressed by an ETB antagonist BQ788, but was unchanged by the ETA antagonist FR139317. In cultured astrocytes and bEnd.3, endothelin-1 did not affect the expression of the sonic hedgehog receptor-related molecules, patched-1 and smoothened. In an animal model of traumatic brain injury, fluid percussion injury on the mouse cerebrum increased the expression of sonic hedgehog, patched-1, and smoothened. Repeated administration of BQ788 enhanced sonic hedgehog expression at 5 days after fluid percussion injury. Histochemical examination revealed sonic hedgehog expression in glial fibrillary acidic protein-positive astrocytes in the cerebrum after fluid percussion injury. Administration of exogenous sonic hedgehog and BQ788 suppressed Evans blue extravasation, an indicator of blood vessel permeability, induced by fluid percussion injury. The effects of BQ788 on fluid percussion injury-induced Evans blue extravasation were reduced by the administration of jervine, a sonic hedgehog inhibitor. Altogether, these results suggest that endothelin-1 down-regulates astrocytic sonic hedgehog to promote disruption of the blood-brain barrier during traumatic brain injury.	[Michinaga, Shotaro; Inoue, Ayana; Sonoda, Kyomi; Mizuguchi, Hiroyuki] Osaka Ohtani Univ, Fac Pharm, Lab Pharmacol, 3-11-1 Nishikiori Kita, Tondabayashi, Osaka 5848540, Japan; [Koyama, Yutaka] Kobe Pharmaceut Univ, Lab Pharmacol, Higashinada Ku, 4-19-1 Motoyama Kita, Kobe, Hyogo 6688558, Japan; [Michinaga, Shotaro] Meiji Pharmaceut Univ, Dept Pharmacodynam, 2-522-1 Noshio, Kiyose, Tokyo 2048588, Japan		Koyama, Y (corresponding author), Kobe Pharmaceut Univ, Lab Pharmacol, Higashinada Ku, 4-19-1 Motoyama Kita, Kobe, Hyogo 6688558, Japan.	koyama-y@kobepharma-u.ac.jp		Koyama, Yutaka/0000-0002-6508-0094	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [18K06695, 16K18890, 20K16016]	This work was supported by the Japan Society for the Promotion of Science (grant numbers: 18K06695, 16K18890, 20K16016) .	Ahmed AI, 2012, J NEUROTRAUM, V29, P828, DOI 10.1089/neu.2011.1923; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Chatfield DA, 2011, NEUROCRIT CARE, V14, P55, DOI 10.1007/s12028-010-9413-7; Chechneva OV, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.446; Chen SC, 2017, NEUROSCIENCE, V352, P285, DOI 10.1016/j.neuroscience.2017.03.054; Cheslow L, 2016, CURR OPIN PHARMACOL, V26, P39, DOI 10.1016/j.coph.2015.09.010; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; He QW, 2013, MOL NEUROBIOL, V47, P976, DOI 10.1007/s12035-013-8396-8; Hostenbach S, 2016, PROG NEUROBIOL, V144, P88, DOI 10.1016/j.pneurobio.2016.04.009; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Ji H, 2012, NEUROSCI LETT, V506, P1, DOI 10.1016/j.neulet.2011.11.027; Ji H, 2012, BRAIN RES BULL, V87, P50, DOI 10.1016/j.brainresbull.2011.09.021; Jia F, 2014, J NEUROTRAUM, V31, P1225, DOI 10.1089/neu.2013.3230; Kim JY, 2015, NEUROSCIENCE, V304, P355, DOI 10.1016/j.neuroscience.2015.07.065; Koyama Y, 2011, NEUROSCIENCE, V192, P689, DOI 10.1016/j.neuroscience.2011.05.058; Koyama Y, 2012, GLIA, V60, P1954, DOI 10.1002/glia.22411; Koyama Y, 2010, J PHARMACOL SCI, V114, P433, DOI 10.1254/jphs.10195FP; LeComte MD, 2015, P NATL ACAD SCI USA, V112, P8726, DOI 10.1073/pnas.1501029112; Li YN, 2013, MOL NEUROBIOL, V47, P967, DOI 10.1007/s12035-013-8395-9; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Maier B, 2007, SHOCK, V27, P610, DOI 10.1097/shk.0b013e31802f9eaf; Michinaga S, 2020, NEUROPHARMACOLOGY, V175, DOI 10.1016/j.neuropharm.2020.108182; Michinaga S, 2020, J NEUROCHEM, V154, P330, DOI 10.1111/jnc.14957; Michinaga S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030571; Michinaga S, 2018, J NEUROTRAUM, V35, P1481, DOI 10.1089/neu.2017.5421; Mierzwa AJ, 2014, ASN NEURO, V6, DOI 10.1177/1759091414551782; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Petrov T, 2009, CAN J PHYSIOL PHARM, V87, P379, DOI [10.1139/Y09-022, 10.1139/y09-022]; Reynolds CA, 2011, NEUROL RES, V33, P197, DOI 10.1179/016164111X12881719352499; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Tenreiro MM, 2016, NEUROBIOL DIS, V91, P262, DOI 10.1016/j.nbd.2016.03.014; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wang YJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0110024, 10.1371/journal.pone.0096339, 10.1371/journal.pone.0085234, 10.1371/journal.pone.0108223]; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wu JC, 2020, TRANSL STROKE RES, V11, P720, DOI 10.1007/s12975-019-00771-2; Wu MY, 2020, BRAIN RES, V1727, DOI 10.1016/j.brainres.2019.146553; Xia YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068891; Zhen H, 2018, MOL IMMUNOL, V93, P31, DOI 10.1016/j.molimm.2017.09.020	44	5	5	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JUN	2021	146								105042	10.1016/j.neuint.2021.105042			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	RY1AN	WOS:000647649300004	33838160				2022-02-06	
J	Wu, L; Ji, NN; Wang, H; Hua, JY; Sun, GL; Chen, PP; Hua, R; Zhang, YM				Wu, Liang; Ji, Ning-ning; Wang, Hang; Hua, Jing-yu; Sun, Guo-lin; Chen, Pan-pan; Hua, Rong; Zhang, Yong-mei			Domino Effect of Interleukin-15 and CD8 T-Cell-Mediated Neuronal Apoptosis in Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						astrocytes; CD8 T cells; IL-15; neuronal apoptosis; traumatic brain injury	SYSTEM; NEUROINFLAMMATION; NEURODEGENERATION; NEUROPROTECTION; FLUOROCITRATE; INVOLVEMENT; INHIBITION; ACTIVATION; EXPRESSION; BLOCKADE	The effects of local factors on activation of immune cells infiltrating the central nervous system (CNS) in a rat model of traumatic brain injury (TBI) remain elusive. The cytokine, interleukin (IL)-15, is crucial for development and activation of CD8 T lymphocytes, a prominent lymphocytic population present in TBI lesions. We investigated whether IL-15 originates from astrocytes and whether IL-15 can evoke the CD8 T-lymphocyte response in TBI. We observed that astrocytes were activated in a rat model of TBI and that IL-15 was overexpressed on the surface of astrocytes. Further, CD8 T lymphocytes infiltrating TBI lesions colocalized with IL-15-expressing astrocytes. Activated CD8 T lymphocytes released granzyme B (Gra-b), which, in turn, activated caspase-3-induced poly(ADP-ribose) polymerase cleavage and, ultimately, neuronal apoptosis. Conversely, inhibition of astrocyte activation by pre-treatment with the specific inhibitor, fluorocitrate (FC), that reduces carbon flux through the Krebs cycle in astrocytes resulted in improved neurological function and memory. FC pre-treatment was also associated with downregulated IL-15 expression and CD8 T-cell activation as well as decreased levels of neuronal apoptosis, suggesting that IL-15 initiated a domino effect toward apoptosis. In contrast, rats pre-treated with recombinant rat IL-15 showed upregulated CD8 T-cell numbers and Gra-b levels, in addition to induction of neuronal apoptosis. Together, our results indicated that IL-15 could induce neuronal apoptosis by enhancing CD8 T-cell function in a rat model of TBI.	[Wu, Liang; Ji, Ning-ning; Wang, Hang; Hua, Jing-yu; Sun, Guo-lin; Chen, Pan-pan; Zhang, Yong-mei] Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, 209 Tongshan Rd, Xuzhou 221002, Jiangsu, Peoples R China; [Wu, Liang; Ji, Ning-ning] Xuzhou Med Univ, Dept Anesthesiol, Xuzhou Municipal Hosp, Xuzhou, Jiangsu, Peoples R China; [Hua, Rong] Xuzhou Med Univ, Fac Emergency Rescue Med, 209 Tongshan Rd, Xuzhou 221004, Jiangsu, Peoples R China; [Hua, Rong] Xuzhou Med Univ, Emergency Ctr, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China		Zhang, YM (corresponding author), Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, 209 Tongshan Rd, Xuzhou 221002, Jiangsu, Peoples R China.; Hua, R (corresponding author), Xuzhou Med Univ, Fac Emergency Rescue Med, 209 Tongshan Rd, Xuzhou 221004, Jiangsu, Peoples R China.	2539080987@gmail.com; zhangym700@xzhmu.edu.cn					Anthony DA, 2010, IMMUNOL REV, V235, P73, DOI 10.1111/j.0105-2896.2010.00907.x; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Bolitho P, 2007, CURR OPIN IMMUNOL, V19, P339, DOI 10.1016/j.coi.2007.04.007; Broberg M, 2008, EPILEPSY RES, V80, P132, DOI 10.1016/j.eplepsyres.2008.03.012; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Castillo EF, 2012, CYTOKINE, V59, P479, DOI 10.1016/j.cyto.2012.06.017; Chaitanya GV, 2010, NEUROSCIENCE, V165, P1203, DOI 10.1016/j.neuroscience.2009.10.067; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Collins-Praino LE, 2017, BRAIN BEHAV IMMUN, V60, P369, DOI 10.1016/j.bbi.2016.09.027; Cui CM, 2017, CELL PHYSIOL BIOCHEM, V42, P1888, DOI 10.1159/000479571; Diaz-Torne C, 2014, IMMUNOLOGY, V142, P354, DOI 10.1111/imm.12212; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gomez-Nicola D, 2008, GLIA, V56, P494, DOI 10.1002/glia.20628; HASSEL B, 1992, BRAIN RES, V576, P120, DOI 10.1016/0006-8993(92)90616-H; Hill LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04722-5; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Li MS, 2017, P NATL ACAD SCI USA, V114, pE396, DOI 10.1073/pnas.1612930114; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Mao XW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11155; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McInnes IB, 2003, ANN RHEUM DIS, V62, P51; Otani N, 2006, J CLIN NEUROSCI, V13, P934, DOI 10.1016/j.jocn.2005.10.018; Padmashri R, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/938023; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Ronald Zielke H, 2009, J NEUROCHEM, V109, P24, DOI 10.1111/j.1471-4159.2009.05941.x; Schneider-Hohendorf T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11153; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Stewart SE, 2012, BBA-PROTEINS PROTEOM, V1824, P59, DOI 10.1016/j.bbapap.2011.05.020; SWANSON RA, 1994, BRAIN RES, V664, P94, DOI 10.1016/0006-8993(94)91958-5; Tosiek MJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10888; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Wheaton P, 2011, J PSYCHOPHARMACOL, V25, P1581, DOI 10.1177/0269881110388331; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Xiong XX, 2013, NEUROCHEM INT, V62, P265, DOI 10.1016/j.neuint.2012.11.016; Yokoyama S, 2009, P NATL ACAD SCI USA, V106, P15849, DOI 10.1073/pnas.0908834106; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zielke HR, 2007, J NEUROCHEM, V101, P9, DOI 10.1111/j.1471-4159.2006.04335.x	47	5	5	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2021	38	10					1450	1463		10.1089/neu.2017.5607			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RZ6DB	WOS:000648685300011	30430911				2022-02-06	
J	Balestrini, CS; Moir, ME; Abbott, KC; Klassen, SA; Fischer, LK; Fraser, DD; Shoemaker, JK				Balestrini, Christopher S.; Moir, Marcy Erin; Abbott, Kolten C.; Klassen, Stephen A.; Fischer, Lisa K.; Fraser, Douglas D.; Shoemaker, Joel Kevin			Multimodal Assessment of Sport-Related Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sport-related concussion; symptoms; vestibular; oculomotor; multimodal; mTBI	KING-DEVICK TEST; POSTURAL STABILITY; HEAD-INJURY; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; SCREENING TOOL; BASE-LINE; SYMPTOMS; RECOVERY	Objective: The purpose of this study was to determine which assessments best identify athletes with sport-related concussion (SRC) from healthy controls in the acute/early subacute phase (within 10 days of SRC) of injury. Design: Prospective, cohort study. Setting: Specialty concussion clinic. Participants: Sixty-four athletes with SRC (52% male) and 59 matched (age and sex), healthy controls (56% male) aged 12 to 20 years (Mean [M] = 15.07, Standard Deviation [SD] = 2.23). Assessment: Participants completed symptom, cognitive, vestibular/oculomotor, near point of convergence (NPC), and balance assessments. Main Outcome Measures: Univariate analyses were conducted to compare athletes with SRC to healthy controls across all assessments. Assessments that significantly differed between the SRC group and healthy controls were used as predictors in an enter method logistic regression (LR) model and subsequent forward stepwise LR. Results: Results of LR analyses indicated that symptom inventory and symptom provocation on vestibular/oculomotor assessments significantly predicted athletes with SRC versus controls. The forward stepwise LR accurately classified 84.6% of the overall sample (78.3% of athletes with SRC and 91.2% of controls were accurately predicted) and accounted for 60.5% of the variance in predicting athletes with SRC versus controls. Total symptom inventory score (P = 0.003) and vestibular/oculomotor symptom provocation (P < 0.01) were the most sensitive and specific measures in a comprehensive, multimodal assessment for distinguishing athletes with SRC from healthy controls within 10 days of injury. Conclusions: Elements within a multimodal evaluation that are the most robust at discriminating athletes with SRC from healthy controls in the acute/early subacute phase of injury include symptom report and provocation of symptoms on vestibular/oculomotor assessment. These assessments should be considered in conjunction with other objective assessments (ie, NPC measurement and cognitive testing) as part of a comprehensive evaluation of SRC.	[Balestrini, Christopher S.] Schulich Sch Med & Dent, London, ON, Canada; [Moir, Marcy Erin; Abbott, Kolten C.; Klassen, Stephen A.; Fischer, Lisa K.; Fraser, Douglas D.; Shoemaker, Joel Kevin] Fac Hlth Sci, Sch Kinesiol, London, ON, Canada; [Abbott, Kolten C.; Fraser, Douglas D.] Childrens Hlth Res Inst, London, ON, Canada; [Shoemaker, Joel Kevin] Western Univ, Dept Physiol & Pharmacol, London, ON, Canada		Shoemaker, JK (corresponding author), Western Univ, Fac Hlth Sci, Sch Kinesiol, 1151 Richmond St, London, ON N6A 3K7, Canada.	kshoemak@uwo.ca	Fischer, Lisa K/H-3999-2015	Fischer, Lisa K/0000-0001-5992-0176	Children's Health Foundation, London, ON, Canada	This research was funded by the Children's Health Foundation, London, ON, Canada.	Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Baruch Martin, 2016, J Rehabil Res Dev, V53, P959, DOI 10.1682/JRRD.2015.06.0120; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gerrard PB, 2017, ARCH CLIN NEUROPSYCH, V32, P117, DOI 10.1093/arclin/acw097; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P744; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lovell MR, 2006, IMPACT NEUROPSYCHOLO; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; National Institute of Neurological Disorders and Stroke, 2017, SPORT REL CONC COMM; Pardini D., 2004, BR J SPORTS MED, V38, P661; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Sandel NK, 2018, BRAIN INJURY, V32, P493, DOI 10.1080/02699052.2018.1429020; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Tomczyk CP, 2018, J ATHL TRAINING, V53, P404, DOI 10.4085/1062-6050-84-17; Tsushima WT, 2018, APPL NEUROPSYCH-CHIL, V7, P14, DOI 10.1080/21622965.2016.1220860; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	51	5	5	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2021	31	3					257	265		10.1097/JSM.0000000000000734			9	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	SO2PJ	WOS:000658818900011	30908327	hybrid, Green Published			2022-02-06	
J	Cassetta, BD; Cairncross, M; Brasher, PMA; Panenka, WJ; Silverberg, ND				Cassetta, Briana D.; Cairncross, Molly; Brasher, Penelope M. A.; Panenka, William J.; Silverberg, Noah D.			Avoidance and Endurance Coping After Mild Traumatic Brain Injury Are Associated With Disability Outcomes	REHABILITATION PSYCHOLOGY			English	Article						avoidance learning; brain concussion; illness behavior; mild traumatic brain injury; prognosis	COGNITIVE-BEHAVIORAL THERAPY; POST-CONCUSSION SYNDROME; CHRONIC-FATIGUE-SYNDROME; FEAR-AVOIDANCE; ACTIVITY PATTERNS; RISK PATIENTS; HEAD-INJURY; PAIN; SYMPTOMS; BELIEFS	Objective: Fear-avoidance and endurance behavior are well-established maladaptive coping styles in several chronic health conditions. There is also emerging evidence that both fear-avoidance and endurance coping are associated with poor outcome from mild traumatic brain injury (mTBI). The current study sought to characterize the early trajectories of avoidance and endurance behavior and confirm their association with disability outcomes. Method: Adults with mTBI (N = 88) completed measures of avoidance, endurance, and postconcussive symptoms at clinic intake (M = 40.2 days since injury). Avoidance and endurance measures were readministered 1 month later (N = 79), and a measure of perceived functional disability (World Health Organization Disability Assessment Schedule 2.0) was completed 3 months after clinic intake (N = 69). Results: Avoidance and endurance coping were weakly positively correlated with each other at intake (r = .28) and at 1 month postintake (r = .28). Change scores on these two measures over time were not significantly correlated (r = .04). Avoidance coping tended to decrease over time (95% CI [0.6, 2.5]; p = .002), whereas changes in endurance coping were variable. In generalized linear modeling, higher avoidance and endurance at clinic intake and increasing (or less rapidly decreasing) levels of these coping styles over 1 month was associated with greater perceived disability ratings at 3 months, even after controlling for postconcussion symptom severity at intake. Conclusion: These findings suggest that avoidance and endurance behavior are distinct coping styles with unique trajectories during the subacute recovery period. The results also support the need for psychologically informed early interventions that target specific profiles of maladaptive coping to mitigate risk for poor outcomes post-mTBI.	[Cassetta, Briana D.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Cassetta, Briana D.; Cairncross, Molly; Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada; [Cairncross, Molly] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Brasher, Penelope M. A.] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Panenka, William J.] British Columbia Neuropsychiat Program, Vancouver, BC, Canada; [Panenka, William J.] BC Mental Hlth & Subst Use Serv Res Inst, Vancouver, BC, Canada; [Silverberg, Noah D.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada		Silverberg, ND (corresponding author), GF Strong Rehab Ctr, Vancouver Coastal Hlth Res Inst, Rehabil Res Program, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@ubc.ca		Panenka, William/0000-0001-7143-6512; Cassetta, Briana/0000-0002-4395-2197			Andrews NE, 2016, CLIN J PAIN, V32, P20, DOI 10.1097/AJP.0000000000000226; Band R, 2017, HEALTH PSYCHOL, V36, P264, DOI 10.1037/hea0000422; Bergbom S, 2015, J OCCUP REHABIL, V25, P518, DOI 10.1007/s10926-014-9558-x; Bergbom S, 2014, J OCCUP REHABIL, V24, P446, DOI 10.1007/s10926-013-9478-1; Brooks BL, 2016, ARCH CLIN NEUROPSYCH, V31, P1026, DOI 10.1093/arclin/acw079; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Chrisman SPD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00623; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Demmelmaier I, 2018, ARTHRIT CARE RES, V70, P695, DOI 10.1002/acr.23419; Evans JD, 1996, STRAIGHTFORWARD STAT; Hardin JW., 2007, GEN LINEAR MODELS EX; Hasenbring MI, 2012, PAIN, V153, P211, DOI 10.1016/j.pain.2011.10.019; Hasenbring MI, 2010, CLIN J PAIN, V26, P747, DOI 10.1097/AJP.0b013e3181e104f2; Herrold AA, 2021, DISABIL REHABIL, V43, P1313, DOI 10.1080/09638288.2019.1660914; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Huijnen IPJ, 2011, EUR J PAIN, V15, P748, DOI 10.1016/j.ejpain.2010.11.015; Iverson GL, 2018, J NEUROTRAUM, V35, P1156, DOI 10.1089/neu.2017.5402; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kindermans HPJ, 2011, J PAIN, V12, P1049, DOI 10.1016/j.jpain.2011.04.009; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Lohnberg JA, 2007, J CLIN PSYCHOL MED S, V14, P113, DOI 10.1007/s10880-007-9062-y; McCracken LM, 2007, PAIN, V130, P119, DOI 10.1016/j.pain.2006.11.016; Nielson WR, 2013, CLIN J PAIN, V29, P461, DOI 10.1097/AJP.0b013e3182608561; Nijs J, 2013, CLIN RHEUMATOL, V32, P1121, DOI 10.1007/s10067-013-2277-4; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Shrive Fiona M, 2006, BMC Med Res Methodol, V6, P57, DOI 10.1186/1471-2288-6-57; Silverberg ND, 2019, NEUROREHABILITATION, V44, P523, DOI 10.3233/NRE-192708; Silverberg ND, 2019, J NEUROTRAUM, V36, P1544, DOI 10.1089/neu.2018.6025; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Snell DL, 2020, BRAIN INJURY, V34, P610, DOI 10.1080/02699052.2020.1729417; Snell DL, 2020, J NEUROTRAUM, V37, P1566, DOI 10.1089/neu.2019.6729; Snell DL, 2017, J NEUROTRAUM, V34, P3256, DOI 10.1089/neu.2017.5234; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Spence M, 2005, PSYCHOL MED, V35, P583, DOI 10.1017/S0033291704003484; Suhr J, 2012, CLIN NEUROPSYCHOL, V26, P1128, DOI 10.1080/13854046.2012.713121; Tarvonen-Schroder S, 2018, J REHABIL MED, V50, P514, DOI 10.2340/16501977-2345; Ustun T, 2010, MEASURING HLTH DISAB; Van Damme S, 2015, CLIN J PAIN, V31, P115, DOI 10.1097/AJP.0000000000000096; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; van Koulil S, 2010, ARTHRIT CARE RES, V62, P1377, DOI 10.1002/acr.20268; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Weathers FW., 2013, PTSD CHECKLIST DSM 5; Westman AE, 2011, CLIN J PAIN, V27, P567, DOI 10.1097/AJP.0b013e318219ab6c; Whyte J, 2014, ARCH PHYS MED REHAB, V95, pS17, DOI 10.1016/j.apmr.2013.02.029; Wieser T, 2012, EUR J PAIN, V16, P268, DOI 10.1016/j.ejpain.2011.06.011; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	56	5	5	1	2	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2021	66	2					160	169		10.1037/rep0000372			10	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	TF3LK	WOS:000670616800006	33382332				2022-02-06	
J	Mez, J; Alosco, ML; Daneshvar, DH; Saltiel, N; Baucom, Z; Abdolmohammadi, B; Uretsky, M; Nicks, R; Martin, BM; Palmisano, JN; Nowinski, CJ; Montenigro, P; Solomon, TM; Mahar, I; Cherry, JD; Alvarez, VE; Dwyer, B; Goldstein, LE; Katz, DI; Cantu, RC; Kowall, NW; Tripodis, Y; Huber, BR; Stein, TD; Stern, RA; McKee, AC				Mez, Jesse; Alosco, Michael L.; Daneshvar, Daniel H.; Saltiel, Nicole; Baucom, Zachary; Abdolmohammadi, Bobak; Uretsky, Madeline; Nicks, Raymond; Martin, Brett M.; Palmisano, Joseph N.; Nowinski, Christopher J.; Montenigro, Philip; Solomon, Todd M.; Mahar, Ian; Cherry, Jonathan D.; Alvarez, Victor E.; Dwyer, Brigid; Goldstein, Lee E.; Katz, Douglas, I; Cantu, Robert C.; Kowall, Neil W.; Tripodis, Yorghos; Huber, Bertrand R.; Stein, Thor D.; Stern, Robert A.; McKee, Ann C.			Validity of the 2014 traumatic encephalopathy syndrome criteria for CTE pathology	ALZHEIMERS & DEMENTIA			English	Article						2014 traumatic encephalopathy syndrome research diagnostic criteria; Alzheimer&apos; s disease; attention; behavioral dysregulation; chronic traumatic encephalopathy; dementia; depression; diagnostic validity; executive function; explosivity; inter&#8208; rater reliability; memory; neuropathology; repetitive head impact exposure; traumatic brain injury		Introduction Validity of the 2014 traumatic encephalopathy syndrome (TES) criteria, proposed to diagnose chronic traumatic encephalopathy (CTE) in life, has not been assessed. Methods A total of 336 consecutive brain donors exposed to repetitive head impacts from contact sports, military service, and/or physical violence were included. Blinded to clinical information, neuropathologists applied National Institute on Neurological Disorders and Stroke/National Institute of Biomedical Imaging and Bioengineering CTE criteria. Blinded to neuropathological information, clinicians interviewed informants and reviewed medical records. An expert panel adjudicated TES diagnoses. Results A total of 309 donors were diagnosed with TES; 244 donors had CTE pathology. TES criteria demonstrated sensitivity and specificity of 0.97 and 0.21, respectively. Cognitive (odds ratio [OR] = 3.6; 95% confidence interval [CI]: 1.2-5.1), but not mood/behavior or motor symptoms, were significantly associated with CTE pathology. Having Alzheimer's disease (AD) pathology was significantly associated with reduced TES accuracy (OR = 0.27; 95% CI: 0.12-0.59). Discussion TES criteria provided good evidence to rule out, but limited evidence to rule in, CTE pathology. Requiring cognitive symptoms in revised criteria and using AD biomarkers may improve CTE pathology prediction.	[Mez, Jesse; Alosco, Michael L.; Daneshvar, Daniel H.; Saltiel, Nicole; Baucom, Zachary; Abdolmohammadi, Bobak; Uretsky, Madeline; Nicks, Raymond; Martin, Brett M.; Palmisano, Joseph N.; Nowinski, Christopher J.; Mahar, Ian; Cherry, Jonathan D.; Alvarez, Victor E.; Goldstein, Lee E.; Cantu, Robert C.; Kowall, Neil W.; Tripodis, Yorghos; Huber, Bertrand R.; Stein, Thor D.; Stern, Robert A.; McKee, Ann C.] Boston Univ, Alzheimers Dis Ctr, Sch Med, Boston, MA 02118 USA; [Mez, Jesse; Alosco, Michael L.; Daneshvar, Daniel H.; Saltiel, Nicole; Baucom, Zachary; Abdolmohammadi, Bobak; Uretsky, Madeline; Nicks, Raymond; Martin, Brett M.; Palmisano, Joseph N.; Nowinski, Christopher J.; Mahar, Ian; Cherry, Jonathan D.; Alvarez, Victor E.; Goldstein, Lee E.; Cantu, Robert C.; Kowall, Neil W.; Tripodis, Yorghos; Huber, Bertrand R.; Stein, Thor D.; Stern, Robert A.; McKee, Ann C.] Boston Univ, CTE Ctr, Sch Med, 72 East Concord St,B-7800, Boston, MA 02118 USA; [Mez, Jesse; Alosco, Michael L.; Saltiel, Nicole; Abdolmohammadi, Bobak; Uretsky, Madeline; Nicks, Raymond; Mahar, Ian; Dwyer, Brigid; Katz, Douglas, I; Kowall, Neil W.; Huber, Bertrand R.; Stern, Robert A.; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Daneshvar, Daniel H.] Harvard Med Sch, Dept Rehabil Med, Boston, MA 02115 USA; [Saltiel, Nicole; Nicks, Raymond; Cherry, Jonathan D.; Alvarez, Victor E.; Kowall, Neil W.; Huber, Bertrand R.; Stein, Thor D.; McKee, Ann C.] VA Boston Healthcare Syst, Boston, MA USA; [Saltiel, Nicole; Nicks, Raymond; Cherry, Jonathan D.; Alvarez, Victor E.; Huber, Bertrand R.; Stein, Thor D.; McKee, Ann C.] Dept Vet Affairs Med Ctr, Bedford, MA USA; [Baucom, Zachary; Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Martin, Brett M.; Palmisano, Joseph N.] Boston Univ, Sch Publ Hlth, Biostat & Epidemiol Data Analyt Ctr, Boston, MA 02118 USA; [Nowinski, Christopher J.; Cantu, Robert C.] Concuss Legacy Fdn, Boston, MA USA; [Montenigro, Philip] Univ New Hampshire, Dept Neuropsychol, Durham, NH 03824 USA; [Solomon, Todd M.] Avanir Pharmaceut Inc, Aliso Viejo, CA USA; [Cherry, Jonathan D.; Goldstein, Lee E.; Stein, Thor D.; McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Dwyer, Brigid; Katz, Douglas, I] Braintree Rehabil Hosp, Braintree, MA USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Coll Engn, Dept Biomed Engn, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Coll Engn, Dept Elect Engn, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Coll Engn, Dept Comp Engn, Boston, MA 02118 USA; [Cantu, Robert C.; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Cantu, Robert C.] Emerson Hosp, Dept Neurosurg, Concord, MA USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA		Mez, J (corresponding author), Boston Univ, CTE Ctr, Sch Med, 72 East Concord St,B-7800, Boston, MA 02118 USA.; Mez, J (corresponding author), Boston Univ, Sch Med, AD Ctr, 72 East Concord St,B-7800, Boston, MA 02118 USA.	jessemez@bu.edu		Uretsky, Madeline/0000-0002-7604-3619	World Wrestling Entertainment (WWE); Ivivi Health Sciences; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Department of Veteran AffairsUS Department of Veterans Affairs; Buoniconti Foundation; National Institutes of Health/National Institute on Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Boston University School of Medicine Department of Neurology; Department of DefenseUnited States Department of Defense; Alzheimer's AssociationAlzheimer's Association; Concussion Legacy Foundation; National Institute on Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659, U01NS093334, U54NS115266, R01NS078337, R56NS078337, K23NS102399]; National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG13846, 0572063345, R01AG057902, R01AG061028, K23AG046377, R01AG1649, R01AG062348, R21HD089088, F32NS096803]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [1UL1TR001430]; Department of DefenseUnited States Department of Defense [W81XWH-13-2-0095, W81XWH-13-20064, W81XWH1810580, PRARP-13267017]; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec -Sante (FRQS); Alzheimer's AssociationAlzheimer's Association [NIRG-15-362697, NIRG305779]; National Operating Committee on Standards for Athletic Equipment (NOCSAE); Nick and Lynn Buoniconti Foundation; Andlinger Foundation; WWE; NFL	Dr. Goldstein is a paid consultant to Johnson & Johnson, Janssen Research & Development LLC, and Rebiscan Inc and has received funding from the World Wrestling Entertainment (WWE) and Ivivi Health Sciences. Dr. Nowinski is the co-founder and chief executive officer of the Concussion Legacy Foundation, and serves as an advisor for Oxeia Biopharmaceuticals. Dr. Stern is a paid consultant to Biogen, is a member of theMackey-White Health and Safety Committee of the National Football League Players Association, receives royalties for published neuropsychological tests from Psychological Assessment Resources Inc, is a member of the Board of Directors of King-Devick Technologies, and reported grants from the National Institutes of Health during the conduct of the study. Dr. Cantu is a paid consultant to the National Football League Head Neck and Spine Committee, a vice president and chair of the scientific advisory committee of the National Operating Committee on Standards for Athletic Equipment, and a consultant to the Concussion Legacy Foundation; he also receives royalties from Houghton Mifflin Harcourt and compensation for expert legal opinion to the National Collegiate Athletic Association and National Hockey League and is a member of the Mackey-White Committee of the National Football League Players Association. Dr. McKee is a member of the Mackey-White Committee of the National Football League Players Association and reports receiving grants from the National Institutes of Health and Department of Veteran Affairs and other funding from Buoniconti Foundation during the conduct of the study. Dr. Alosco reported grants fromNational Institutes ofHealth/National Institute on Neurological Disorders and Stroke during the conduct of the study. Dr. Katz reported grants from Boston University School of Medicine Department of Neurology during the conduct of the study, receives royalties from Springer/Demos Publishing for a textbook on brain injury, serves as an expert witness in legal cases involving brain injury and concussion, receives a stipend from Encompass Health as program medical director for brain injury and chair of the annual Neurorehabilitation conference, and has received honoraria for a keynote address for the HealthSouth annual Medical Directors meeting. Dr. Mez reported grants from the National Institutes of Health, Department of Defense, Alzheimer's Association, and Concussion Legacy Foundation during the conduct of the study. No other disclosures were reported. This work was supported by the National Institute on Neurological Disorders and Stroke (U01NS086659, U01NS093334, U54NS115266, R01NS078337, R56NS078337, K23NS102399), National Institute of Aging (P30AG13846; supplement 0572063345, R01AG057902, R01AG061028, K23AG046377, R01AG1649, R01AG062348, R21HD089088, F32NS096803), National Center for Advancing Translational Sciences (1UL1TR001430), Department of Veterans Affairs (I01 CX001135, CSP 501, B6796-C, I01-CX001038), Department of Defense (W81XWH-13-2-0095, W81XWH-13-20064, W81XWH1810580, PRARP-13267017), Canadian Institutes of Health Research (CIHR), Fonds de Recherche du Quebec -Sante (FRQS), the Alzheimer's Association (NIRG-15-362697, NIRG305779), the NationalOperating Committee on Standards for Athletic Equipment (NOCSAE), the Nick and Lynn Buoniconti Foundation, the Concussion Legacy Foundation, the Andlinger Foundation, the WWE, and the NFL.; The authors gratefully acknowledge the use of the resources and facilities at VA Boston Healthcare System (Boston, Massachusetts, USA) and the Edith Nourse Rogers Memorial Veterans Hospital (Bedford, Massachusetts, USA). We also gratefully acknowledge the help of all members of the BostonUniversityCTE Centers, the VA-BU-CLF Brain Bank, and the Concussion Legacy Foundation (with special thanks to Lisa McHale), as well as the individuals and families whose participation and contributions made this work possible.	Alosco ML, 2020, ACTA NEUROPATHOL, V140, P495, DOI 10.1007/s00401-020-02197-9; Alosco ML, 2019, JAMA NEUROL, V76, P1298, DOI 10.1001/jamaneurol.2019.2244; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Alosco ML, 2017, J NEUROPSYCH CLIN N, V29, P6, DOI 10.1176/appi.neuropsych.16030043; Beach TG, 2012, J NEUROPATH EXP NEUR, V71, P266, DOI 10.1097/NEN.0b013e31824b211b; Bertens LCM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001531; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Braak H, 2008, NEUROLOGY, V70, P1916, DOI 10.1212/01.wnl.0000312279.49272.9f; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Daglas M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00981; de la Monte SM, 2014, ACTA NEUROPATHOL, V127, P71, DOI 10.1007/s00401-013-1233-3; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Ferman TJ, 2011, NEUROLOGY, V77, P875, DOI 10.1212/WNL.0b013e31822c9148; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Harris JM, 2015, ALZHEIMERS DEMENT, V11, P207, DOI 10.1016/j.jalz.2014.04.516; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; Mariani M, 2020, SEMIN NEUROL, V40, P370, DOI 10.1055/s-0040-1713624; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Vonsattel JPG, 2008, CELL TISSUE BANK, V9, P247, DOI 10.1007/s10561-008-9079-y; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9	46	5	5	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	OCT	2021	17	10					1709	1724		10.1002/alz.12338		APR 2021	16	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WP1PG	WOS:000637892200001	33826224	hybrid, Green Published			2022-02-06	
J	Zideman, DA; Singletary, EM; Borra, V; Cassan, P; Cimpoesu, CD; De Buck, E; Djarv, T; Handley, AJ; Klaassen, B; Meyran, D; Oliver, E; Poole, K				Zideman, David A.; Singletary, Eunice M.; Borra, Vere; Cassan, Pascal; Cimpoesu, Carmen D.; De Buck, Emmy; Djaerv, Therese; Handley, Anthony J.; Klaassen, Barry; Meyran, Daniel; Oliver, Emily; Poole, Kurtis			European Resuscitation Council Guidelines 2021: First aid	RESUSCITATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; CARBOHYDRATE-ELECTROLYTE BEVERAGE; REPEAT EPINEPHRINE TREATMENTS; 2015 INTERNATIONAL CONSENSUS; ACUTE MYOCARDIAL-INFARCTION; COUNTER-PRESSURE MANEUVERS; AMERICAN-HEART-ASSOCIATION; TRAUMATIC DENTAL INJURIES; NORMOBARIC OXYGEN-THERAPY; FOOD-INDUCED ANAPHYLAXIS	The European Resuscitation Council has produced these first aid guidelines, which are based on the 2020 International Consensus on Cardiopulmonary Resuscitation Science with Treatment Recommendations. The topics include the first aid management of emergency medicine and trauma. For medical emergencies the following content is covered: recovery position, optimal positioning for shock, bronchodilator administration for asthma, recognition of stroke, early aspirin for chest pain, second dose of adrenaline for anaphylaxis, management of hypoglycaemia, oral rehydration solutions for treating exertion-related dehydration, management of heat stroke by cooling, supplemental oxygen in acute stroke, and presyncope. For trauma related emergencies the following topics are covered: control of life-threatening bleeding, management of open chest wounds, cervical spine motion restriction and stabilisation, recognition of concussion, cooling of thermal burns, dental avulsion, compression wrap for closed extremity joint injuries, straightening an angulated fracture, and eye injury from chemical exposure.	[Zideman, David A.; Poole, Kurtis] Thames Valley Air Ambulance, Stokenchurch, England; [Singletary, Eunice M.] Univ Virginia, Dept Emergency Med, Charlottesville, VA 22903 USA; [Borra, Vere; De Buck, Emmy] Belgian Red Cross, Ctr Evidence Based Practice, Mechelen, Belgium; [Borra, Vere; De Buck, Emmy] Cochrane First Aid, Mechelen, Belgium; [Cassan, Pascal] Int Federat Red Cross & Red Crescent, Montrouge, France; [Cimpoesu, Carmen D.] Univ Med & Pharm Grigore T Popa, Emergency Dept, Iasi, Romania; [Cimpoesu, Carmen D.] Prehosp EMS SMURD Iasi Emergency Cty Hosp Sf Spir, Iasi, Romania; [De Buck, Emmy] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Fac Med, Leuven, Belgium; [Klaassen, Barry] Ninewells Hosp & Med Sch Dundee, Emergency Med, Dundee, Scotland; [Klaassen, Barry; Oliver, Emily] British Red Cross, London, England; [Meyran, Daniel] French Red Cross, Bataillon Marins Pompier, France; [Djaerv, Therese] Karolinska Univ Hosp, Karolinska Inst, Dept Med Solna, Solna, Sweden; [Djaerv, Therese] Karolinska Univ Hosp, Div Acute & Reparat Med, Solna, Sweden		Zideman, DA (corresponding author), Thames Valley Air Ambulance, Stokenchurch, England.	david.zideman@gmail.com					Abram S, 2010, SURG-J R COLL SURG E, V8, P218, DOI 10.1016/j.surge.2010.01.002; Adams WM, 2014, J STRENGTH COND RES, V28, P2380, DOI 10.1519/JSC.0000000000000501; Adnet F, 1999, CRIT CARE MED, V27, P745, DOI 10.1097/00003246-199904000-00028; Akkus S, 2016, AM J EMERG MED, V34, P1959, DOI 10.1016/j.ajem.2016.06.105; Ali K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059274, 10.1371/journal.pone.0068161]; Amirav I, 2007, J AEROSOL MED, V20, P1, DOI 10.1089/jam.2006.0561; Andersson L, 2012, DENT TRAUMATOL, V28, P88, DOI 10.1111/j.1600-9657.2012.01125.x; ANDREASEN JO, 1995, ENDOD DENT TRAUMATOL, V11, P59; [Anonymous], 2017, Br J Sports Med, V51, P872, DOI 10.1136/bjsports-2017-097508CRT5; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; [Anonymous], 1988, LANCET, V2, P349; ARAI YC, 2004, ANESTH ANALG, V1638, P41; Arai YCP, 2005, ANESTH ANALG, V100, P949, DOI 10.1213/01.ANE.0000148126.53015.F9; Arbel J, 2011, EUROINTERVENTION, V6, P1104, DOI 10.4244/EIJV6I9A192; Asimos AW, 2014, ANN EMERG MED, V64, P509, DOI 10.1016/j.annemergmed.2014.03.024; Ayling John, 2004, Emerg Med Serv, V33, P44; Balzer JO, 2007, EUR RADIOL, V17, P693, DOI 10.1007/s00330-006-0279-1; Banerji A, 2010, ALLERGY ASTHMA PROC, V31, P308, DOI 10.2500/aap.2010.31.3375; Baradaran-Rafii A, 2017, OCUL SURF, V15, P48, DOI 10.1016/j.jtos.2016.09.002; Barbash IM, 2002, CARDIOLOGY, V98, P141, DOI 10.1159/000066324; Bartlett N, 2008, J BURN CARE RES, V29, P828, DOI 10.1097/BCR.0b013e3181855c9a; Bartoletti A, 2008, EUR HEART J, V29, P618, DOI 10.1093/eurheartj/ehm563; Beaven A, 2017, MIL MED, V182, pE1929, DOI 10.7205/MILMED-D-16-00298; Behler RH, 2009, ULTRASONIC IMAGING, V31, P159, DOI 10.1177/016173460903100302; Bendahou M, 2014, AM J EMERG MED, V32, P1005, DOI 10.1016/j.ajem.2014.05.054; Bennett MT, 2015, HEART, V101, P1591, DOI 10.1136/heartjnl-2014-306627; BENTUR L, 1992, PEDIATRICS, V89, P133; Bequette BW, 2017, WILD ENVIRON MED, V28, P84, DOI 10.1016/j.wem.2017.01.030; Berger WE, 2006, CURR MED RES OPIN, V22, P1217, DOI 10.1185/030079906X112534; Bergs J, 2010, EUR J EMERG MED, V17, P2, DOI 10.1097/MEJ.0b013e32831040ec; Beynnon BD, 2006, AM J SPORT MED, V34, P1401, DOI 10.1177/0363546506288676; Bilgic S, 2015, PAK J MED SCI, V31, P1496, DOI 10.12669/pjms.316.8210; Bleakley CM, 2012, BRIT J SPORT MED, V46, P220, DOI 10.1136/bjsports-2011-090297; Borra V, 2020, J ATHL TRAINING, V55, P789, DOI 10.4085/1062-6050-0093.20; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Boulanger H, 2014, J VASC ACCESS, V15, P102, DOI 10.5301/jva.5000176; Bouvette CM, 1996, MAYO CLIN PROC, V71, P847, DOI 10.4065/71.9.847; Boyce SH, 2005, BRIT J SPORT MED, V39, P91, DOI 10.1136/bjsm.2003.009233; Bracard S, 2016, LANCET NEUROL, V15, P1138, DOI 10.1016/S1474-4422(16)30177-6; Bray JE, 2010, STROKE, V41, P1363, DOI 10.1161/STROKEAHA.109.571836; Bray JE, 2005, CEREBROVASC DIS, V20, P28, DOI 10.1159/000086201; Bridgman SA, 2003, EMERG MED J, V20, P508, DOI 10.1136/emj.20.6.508; Brignole M, 2002, J AM COLL CARDIOL, V40, P2053, DOI 10.1016/S0735-1097(02)02683-9; Brockow K, 2015, ALLERGY, V70, P227, DOI 10.1111/all.12548; Carlson JN, 2020, CUREUS, V12, DOI 10.7759/cureus.11401; Carlson JN, 2017, EMERG MED J, V34, P100, DOI 10.1136/emermed-2015-205637; Carter R, 2006, J APPL PHYSIOL, V101, P1744, DOI 10.1152/japplphysiol.00200.2006; Carter R, 2008, CURR SPORT MED REP, V7, pS20, DOI 10.1249/JSR.0b013e31817f38ff; Centers for Disease Control and Prevention, SYMPT TRAUM BRAIN IN; Chang CQ, 2010, CHINESE MED J-PEKING, V123, P3220, DOI 10.3760/cma.j.issn.0366-6999.2010.22.009; Charlton NP, 2021, PREHOSP EMERG CARE, V25, P235, DOI 10.1080/10903127.2020.1743801; Chen SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070742; Chenkin J, 2009, PREHOSP EMERG CARE, V13, P153, DOI 10.1080/10903120802706146; Chlan LL, 2005, NURS RES, V54, P391, DOI 10.1097/00006199-200511000-00005; Clarke DA, 2010, J PEDIATR-US, V156, P1019, DOI 10.1016/j.jpeds.2010.01.035; Cowley A, 2017, EUR J EMERG MED, V24, P158, DOI 10.1097/MEJ.0000000000000424; Crandall CG, 2010, ACTA PHYSIOL, V199, P407, DOI 10.1111/j.1748-1716.2010.02119.x; Croci F, 2004, EUROPACE, V6, P287, DOI 10.1016/j.eupc.2004.03.008; Cuttle L, 2008, WOUND REPAIR REGEN, V16, P626, DOI 10.1111/j.1524-475X.2008.00413.x; Davies G, 1996, INJURY, V27, P647, DOI 10.1016/S0020-1383(96)00115-5; De Brier N, 2020, DENT TRAUMATOL, V36, P453, DOI 10.1111/edt.12564; De Buck E, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013283.pub2; Djarv T, 2020, CUREUS, V12, DOI 10.7759/cureus.6862; Domergue S, 2015, J BURN CARE RES, V36, pE259, DOI 10.1097/BCR.0000000000000167; Douma MJ, 2020, RESUSCITATION, V148, P173, DOI 10.1016/j.resuscitation.2020.01.007; Dubois B, 2020, BRIT J SPORT MED, V54, P72, DOI 10.1136/bjsports-2019-101253; Dylla L, 2020, AM J EMERG MED, V38, P2324, DOI 10.1016/j.ajem.2019.11.002; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Elwood P C, 1979, J R Coll Gen Pract, V29, P413; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; EMERMAN CL, 1990, AM J EMERG MED, V8, P512, DOI 10.1016/0735-6757(90)90153-Q; Evans GH, 2017, J APPL PHYSIOL, V122, P945, DOI 10.1152/japplphysiol.00745.2016; Flores-Salamanca R, 2014, APPL PHYSIOL NUTR ME, V39, P1175, DOI 10.1139/apnm-2013-0576; Fong DTP, 2007, SPORTS MED, V37, P73, DOI 10.2165/00007256-200737010-00006; Freimark D, 2002, AM J CARDIOL, V89, P381, DOI 10.1016/S0002-9149(01)02256-1; Freire-Tellado M, 2017, RESUSCITATION, V115, P173, DOI 10.1016/j.resuscitation.2017.03.008; Freire-Tellado M, 2016, RESUSCITATION, V105, pE1, DOI 10.1016/j.resuscitation.2016.01.040; Frilling B, 2001, AM HEART J, V141, P200, DOI 10.1067/mhj.2001.112681; GAFFNEY FA, 1982, J TRAUMA, V22, P190, DOI 10.1097/00005373-198203000-00003; Gibson Rudy, 2016, J Spec Oper Med, V16, P21; Gibson Rudy, 2016, J Spec Oper Med, V16, P29; Glick Y, 2018, MIL MED, V183, P157, DOI 10.1093/milmed/usx169; GONZALEZALONSO J, 1992, INT J SPORTS MED, V13, P399, DOI 10.1055/s-2007-1021288; Groothuis JT, 2007, CLIN SCI, V112, P193, DOI 10.1042/CS20060241; Guo JY, 2011, CHIN J TRAUMATOL, V14, P151, DOI 10.3760/cma.j.issn.1008-1275.2011.03.005; Harbison J, 2003, STROKE, V34, P71, DOI 10.1161/01.STR.0000044170.46643.5E; Harcke HT, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-3447; Harris PR, 2019, J INT SOC SPORT NUTR, V16, DOI 10.1186/s12970-019-0282-y; Hasler RM, 2012, J TRAUMA ACUTE CARE, V72, P975, DOI 10.1097/TA.0b013e31823f5e8e; Hatamabadi HR, 2015, TRAUMA MON, V20, DOI 10.5812/traumamon.23862; Hauswald M, 1998, ACAD EMERG MED, V5, P214, DOI 10.1111/j.1553-2712.1998.tb02615.x; Heldenberg Eitan, 2015, Disaster Mil Med, V1, P1, DOI 10.1186/2054-314X-1-1; Hermansen MN, 2006, CHEST, V129, P1203, DOI 10.1378/chest.129.5.1203; Hertel J, 2002, J ATHL TRAINING, V37, P364; Hettiaratchy S, 2004, BRIT MED J, V328, P1555, DOI 10.1136/bmj.328.7455.1555; How CK, 2000, AM J EMERG MED, V18, P474, DOI 10.1053/ajem.2000.7349; Iguchi Y, 2011, CEREBROVASC DIS, V31, P51, DOI 10.1159/000320854; Inoue N, 2013, ASIA PAC ALLERGY, V3, P106, DOI 10.5415/apallergy.2013.3.2.106; Ismail I., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P769; Jabot J, 2009, INTENS CARE MED, V35, P85, DOI 10.1007/s00134-008-1293-3; Jacobs Lenworth, 2014, Am J Disaster Med, V9, P67, DOI 10.5055/ajdm.2014.0143; Jarvinen KM, 2008, J ALLERGY CLIN IMMUN, V122, P133, DOI 10.1016/j.jaci.2008.04.031; James LJ, 2015, EUR J APPL PHYSIOL, V115, P2621, DOI 10.1007/s00421-015-3254-1; James LJ, 2014, AMINO ACIDS, V46, P1217, DOI 10.1007/s00726-014-1680-8; Jandera V, 2000, BURNS, V26, P265, DOI 10.1016/S0305-4179(99)00133-3; Jensen JL, 2020, PREHOSP EMERG CARE, V24, P64, DOI 10.1080/10903127.2019.1605431; Jimenez-Pavon D, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0088-5; Julliand S, 2016, ARCH DIS CHILD, V101, P521, DOI 10.1136/archdischild-2015-308857; Kalman DS, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-1; Kang SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181099; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P305, DOI 10.2106/00004623-199173020-00021; Karpel JP, 1997, CHEST, V112, P348, DOI 10.1378/chest.112.2.348; KATCHERIAN DA, 1994, ORTHOP CLIN N AM, V25, P69; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Keen DA, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0129-8; Keikhavani A, 2016, CLIN CARDIA ELECTROP, V1, P5348; Kenefick RW, 2007, SPORTS MED, V37, P378, DOI 10.2165/00007256-200737040-00027; Kheirabadi BS, 2013, J TRAUMA ACUTE CARE, V75, P150, DOI 10.1097/TA.0b013e3182988afe; Kidwell CS, 2000, STROKE, V31, P71, DOI 10.1161/01.STR.31.1.71; Kim JG, 2020, HONG KONG J EMERG ME, V27, P24, DOI 10.1177/1024907918809499; Kim KH, 2005, CIRC J, V69, P1084, DOI 10.1253/circj.69.1084; Kolb JC, 1999, AM J EMERG MED, V17, P135, DOI 10.1016/S0735-6757(99)90044-X; Kordestani SS, 2012, CLIN APPL THROMB-HEM, V18, P501, DOI 10.1177/1076029611432745; Korenblat P, 1999, ALLERGY ASTHMA PROC, V20, P383, DOI 10.2500/108854199778251834; Kotwal RS, 2011, ARCH SURG-CHICAGO, V146, P1349, DOI 10.1001/archsurg.2011.213; Krediet CTP, 2008, CLIN AUTON RES, V18, P179, DOI 10.1007/s10286-008-0481-0; Krediet CTP, 2002, CIRCULATION, V106, P1684, DOI 10.1161/01.CIR.0000030939.12646.8F; Kulnik ST, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-033531; Kwan I., 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.Cd002803, DOI 10.1002/14651858.CD002803]; Lam R, 2016, AUST DENT J, V61, P4, DOI 10.1111/adj.12395; Lau WY, 2019, BMJ OPEN SPORT EXERC, V5, DOI 10.1136/bmjsem-2018-000478; Leanderson J, 1995, ACTA ORTHOP SCAND, V66, P529, DOI 10.3109/17453679509002308; Lehmann KG, 1999, AM HEART J, V138, P1118, DOI 10.1016/S0002-8703(99)70078-5; Lemyze M, 2011, EMERG MED J, V28, P532, DOI 10.1136/emj.2010.106625; Lewis CJ, 2017, J PLAST RECONSTR AES, V70, P563, DOI 10.1016/j.bjps.2017.02.013; Liao AY, 2014, BURNS, V40, P443, DOI 10.1016/j.burns.2013.08.006; Lin CB, 2012, CIRC-CARDIOVASC QUAL, V5, P514, DOI 10.1161/CIRCOUTCOMES.112.965210; LINDE F, 1984, SCAND J REHABIL MED, V16, P177; LIPSITZ LA, 1985, Q J MED, V55, P45; Litarowsky Jean A, 2004, J Sch Nurs, V20, P279; Litman RS, 2005, ANESTHESIOLOGY, V103, P484, DOI 10.1097/00000542-200509000-00009; LITTNER MR, 1983, ANN ALLERGY, V50, P309; Lyles William E 3rd, 2015, J Spec Oper Med, V15, P21; Marcano-Caldera M, 2018, DENT TRAUMATOL, V34, P164, DOI 10.1111/edt.12393; March Juan A, 2002, Prehosp Emerg Care, V6, P421, DOI 10.1080/10903120290938067; Markenson D, 2010, CIRCULATION, V122, pS934, DOI 10.1161/CIRCULATIONAHA.110.971150; Masento NA, 2014, BRIT J NUTR, V111, P1841, DOI 10.1017/S0007114513004455; Matias A, 2019, J INT SOC SPORT NUTR, V16, DOI 10.1186/s12970-019-0273-z; Mazdeh Mehrdokht, 2015, Acta Med Iran, V53, P676; McConnell MKT, 2012, J CARDIOVASC NURS, V27, pE1, DOI 10.1097/JCN.0b013e318223881b; McGrath T, 2009, WILD ENVIRON MED, V20, P166, DOI 10.1580/08-WEME-BR-220R1.1; McKenna ZJ, 2017, J STRENGTH COND RES, V31, P2965, DOI 10.1519/JSC.0000000000001871; Medoro I, 2017, PREHOSP EMERG CARE, V21, P476, DOI 10.1080/10903127.2017.1294222; Meyran D, 2020, CUREUS, V12, DOI 10.7759/cureus.11386; Mlekusch W, 2006, J ENDOVASC THER, V13, P23, DOI 10.1583/05-1679.1; Monsieurs KG, 2015, RESUSCITATION, V95, P1, DOI 10.1016/j.resuscitation.2015.07.038; Montgomery Harold R, 2019, J Spec Oper Med, V19, P27; Naimer SA, 2006, MIL MED, V171, P644, DOI 10.7205/MILMED.171.7.644; Narins CR, 2008, J INVASIVE CARDIOL, V20, P579; Navarro-Paton R, 2019, RESUSCITATION, V134, P104, DOI 10.1016/j.resuscitation.2018.10.030; Nguyen N, 2007, CATHETER CARDIO INTE, V69, P801, DOI 10.1002/ccd.21024; Nguyen NL, 2002, BURNS, V28, P173, DOI 10.1016/S0305-4179(01)00094-8; Niksefat M., 2019, Acta Medica Bulgarica, V46, P43, DOI 10.2478/amb-2019-0008; Noimark L, 2012, CLIN EXP ALLERGY, V42, P284, DOI 10.1111/j.1365-2222.2011.03912.x; O'Brien W, 2012, J CLIN NEUROSCI, V19, P241, DOI 10.1016/j.jocn.2011.06.009; O'Connor G, 2011, EUR J EMERG MED, V18, P225, DOI 10.1097/MEJ.0b013e3283440efd; O'Conor Daniel K, 2017, J Spec Oper Med, V17, P27; Oliver M, 2012, INJURY, V43, P1296, DOI 10.1016/j.injury.2012.04.021; Oren E, 2007, ANN ALLERG ASTHMA IM, V99, P429, DOI 10.1016/S1081-1206(10)60568-6; OSMOND MH, 1995, ACAD EMERG MED, V2, P651, DOI 10.1111/j.1553-2712.1995.tb03607.x; Ostenson CG, 2014, DIABETIC MED, V31, P92, DOI 10.1111/dme.12261; Osterberg KL, 2010, J APPL PHYSIOL, V108, P245, DOI 10.1152/japplphysiol.91275.2008; Ottosen CI, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0647-x; Ozer Sezin, 2012, Eur J Dent, V6, P370; Pabian PS, 2017, PHYS THER SPORT, V23, P123, DOI 10.1016/j.ptsp.2016.09.006; Padma MV, 2010, ANN INDIAN ACAD NEUR, V13, P284, DOI 10.4103/0972-2327.74203; Pargament JM, 2015, CLIN DERMATOL, V33, P234, DOI 10.1016/j.clindermatol.2014.10.015; Perez-Idarraga A, 2014, APPL PHYSIOL NUTR ME, V39, P1167, DOI 10.1139/apnm-2013-0434; Politiek MJ, 1999, EUR RESPIR J, V13, P988, DOI 10.1034/j.1399-3003.1999.13e10.x; Quan Dan, 2004, Prehosp Disaster Med, V19, P362; Rajan V, 2009, J BURN CARE RES, V30, P729, DOI 10.1097/BCR.0b013e3181ac059b; Ritwik P, 2015, DENT TRAUMATOL, V31, P97, DOI 10.1111/edt.12148; Roffe C, 2017, JAMA-J AM MED ASSOC, V318, P1125, DOI 10.1001/jama.2017.11463; Roffe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019113; Ronning OM, 1999, STROKE, V30, P2033, DOI 10.1161/01.STR.30.10.2033; Rostykus P, 2016, PREHOSP EMERG CARE, V20, P524, DOI 10.3109/10903127.2015.1128031; RUCINSKI T J, 1991, Journal of Orthopaedic and Sports Physical Therapy, V14, P65; Rudders SA, 2010, ANN ALLERG ASTHMA IM, V105, P85, DOI 10.1016/j.anai.2010.05.004; Rudders SA, 2010, PEDIATRICS, V125, pE711, DOI 10.1542/peds.2009-2832; Saat Mohamed, 2002, Journal of Physiological Anthropology and Applied Human Science, V21, P93, DOI 10.2114/jpa.21.93; Sahni GS, 2013, ANN TROP MED PUBLIC, V6, P89, DOI 10.4103/1755-6783.115203; Sairaku A, 2011, J INTERV CARD ELECTR, V31, P157, DOI 10.1007/s10840-011-9552-6; Sako A, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007271; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Savoie FA, 2015, SPORTS MED, V45, P1207, DOI 10.1007/s40279-015-0349-0; Scerbo MH, 2017, J TRAUMA ACUTE CARE, V83, P1165, DOI 10.1097/TA.0000000000001666; Schlemm E, 2017, STROKE, V48, P2184, DOI 10.1161/STROKEAHA.117.017281; Schneider AM, 2007, SPINE, V32, pE1, DOI 10.1097/01.brs.0000251019.24917.44; Schwarz T, 2009, VASA-J VASCULAR DIS, V38, P53, DOI 10.1024/0301-1526.38.1.53; Seery S, 2016, BRIT J NUTR, V116, P1013, DOI 10.1017/S0007114516002907; Seifert J, 2006, INT J SPORT NUTR EXE, V16, P420, DOI 10.1123/ijsnem.16.4.420; Serletis A, 2006, EUR HEART J, V27, P1965, DOI 10.1093/eurheartj/ehl147; Shirreffs SM, 2007, BRIT J NUTR, V98, P173, DOI 10.1017/S0007114507695543; Simonsson M, 2020, EUR HEART J, V41, P833, DOI 10.1093/eurheartj/ehz593; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Singletary EM, 2020, CIRCULATION, V142, pS284, DOI 10.1161/CIR.0000000000000897; Singletary EM, 2015, CIRCULATION, V132, pS574, DOI 10.1161/CIR.0000000000000269; Singletary EM, 2015, CIRCULATION, V132, pS269, DOI 10.1161/CIR.0000000000000278; Skinner AM, 2004, BURNS, V30, P82, DOI 10.1016/j.burns.2003.09.009; Sundstrom T, 2014, J NEUROTRAUM, V31, P531, DOI 10.1089/neu.2013.3094; Svatikova A, 2011, SLEEP MED, V12, P262, DOI 10.1016/j.sleep.2010.12.008; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Teixeira PGR, 2018, J AM COLL SURGEONS, V226, P769, DOI 10.1016/j.jamcollsurg.2018.01.047; TENHARKEL ADJ, 1994, CLIN SCI, V87, P553, DOI 10.1042/cs0870553; Thomas D Travis, 2016, Med Sci Sports Exerc, V48, P543, DOI 10.1249/MSS.0000000000000852; Tomaino M, 2014, EUROPACE, V16, P1515, DOI 10.1093/europace/euu125; Toppen W, 2020, J INTENSIVE CARE MED, V35, P1123, DOI 10.1177/0885066618820492; Trabattoni D, 2012, INT J CARDIOL, V156, P53, DOI 10.1016/j.ijcard.2010.10.030; Turkington PM, 2002, STROKE, V33, P2037, DOI 10.1161/01.STR.0000023576.94311.27; Utter AC, 2010, RES SPORTS MED, V18, P85, DOI 10.1080/15438620903321102; Valiente JS, 2009, J STRENGTH COND RES, V23, P2210, DOI 10.1519/JSC.0b013e3181bac56e; van der Woude HJ, 2004, RESP MED, V98, P816, DOI 10.1016/j.rmed.2004.03.001; van Dijk N, 2006, J AM COLL CARDIOL, V48, P1652, DOI 10.1016/j.jacc.2006.06.059; VERHEUGT FWA, 1990, AM J CARDIOL, V66, P267, DOI 10.1016/0002-9149(90)90833-M; Volterman KA, 2014, APPL PHYSIOL NUTR ME, V39, P1257, DOI 10.1139/apnm-2014-0047; Walker S B, 2001, Int J Nurs Pract, V7, P366, DOI 10.1046/j.1440-172X.2001.00291.x; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Waragai T, 2011, CATHETER CARDIO INTE, V78, P262, DOI 10.1002/ccd.23057; Weidman J, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0153-8; WEISS SJ, 1994, ANN EMERG MED, V24, P873, DOI 10.1016/S0196-0644(94)70205-5; Wieling W, 1996, J PHYSIOL-LONDON, V494, P601, DOI 10.1113/jphysiol.1996.sp021518; Wijnen AHC, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00045; Wojner-Alexandrov AW, 2005, STROKE, V36, P1512, DOI 10.1161/01.STR.0000170700.45340.39; WONG DH, 1989, CRIT CARE MED, V17, P979, DOI 10.1097/00003246-198910000-00002; Wong SH, 2000, INT J SPORT NUTR EXE, V10, P375, DOI 10.1123/ijsnem.10.4.375; Wong SHS, 2011, INT J SPORT NUTR EXE, V21, P300; Wright EH, 2019, BRIT J SURG, V106, P1472, DOI 10.1002/bjs.11263; Wu O, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-5; YAQUB BA, 1986, Q J MED, V59, P523; Yava A, 2012, EMERG MED J, V29, P544, DOI 10.1136/emj.2010.098053; Zhelev Z, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011427.pub2; Zhu ZhongSheng, 2010, Journal of Chinese Clinical Medicine, V5, P582; Zideman DA, 2015, RESUSCITATION, V95, pE225, DOI 10.1016/j.resuscitation.2015.07.047; Zideman DA, 2015, RESUSCITATION, V95, P278, DOI 10.1016/j.resuscitation.2015.07.031	246	5	5	2	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	APR	2021	161						270	290		10.1016/j.resuscitation.2021.02.013			21	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	RE4TN	WOS:000634148700001	33773828	Bronze, Green Published			2022-02-06	
J	Sabelli, AG; Messa, I; Giromini, L; Lichtenstein, JD; May, N; Erdodi, LA				Sabelli, Alana G.; Messa, Isabelle; Giromini, Luciano; Lichtenstein, Jonathan D.; May, Natalie; Erdodi, Laszlo A.			Symptom Versus Performance Validity in Patients with Mild TBI: Independent Sources of Non-credible Responding	PSYCHOLOGICAL INJURY & LAW			English	Article						Symptom validity; Performance validity; Mild TBI; Psychogenic interference; MMPI-2; Word memory test		This study was designed to examine the relative contribution of symptom (SVT) and performance validity tests (PVTs) to the evaluation of the credibility of neuropsychological profiles in mild traumatic brain injury (mTBI). An archival sample of 326 patients with mTBI was divided into four psychometrically defined criterion groups: pass both SVT and PVT; pass one, but fail the other; and fail both. Scores on performance-based tests of neurocognitive ability and self-reported symptom inventories were compared across the groups. As expected, PVT failure was associated with lower scores on ability tests (eta(2)(p) .042-.184; d 0.56-1.00; medium-large effects), and SVT failure was associated with higher levels of symptom report (eta(2)(p) .039-.312; d 0.32-1.58; small-very large effects). However, SVT failure also had a marginal deleterious effect on performance based measures (eta(2)(p) .017-.023; d 0.23-0.46; small-medium effects) and elevations on self-report inventories were observed in the context of PVT failure (eta(2)(p) .026; d 0.23-0.57; small-medium effects). SVT failure was associated with not only inflated symptom reports but also distorted configural patterns of psychopathology. Patients with clinically elevated somatic and depressive symptoms were twice as likely to fail PVTs. Consistent with previous research, SVTs and PVTs provide overlapping, but non-redundant information about the credibility of neuropsychological profiles associated with mTBI. Therefore, they should be used in combination to afford a comprehensive evaluation of cognitive and emotional functioning. The heuristic value of validity tests has both clinical and forensic relevance.	[Sabelli, Alana G.; Messa, Isabelle; Erdodi, Laszlo A.] Univ Windsor, Dept Psychol, Windsor, ON, Canada; [Giromini, Luciano] Univ Turin, Dept Psychol, Turin, Italy; [Lichtenstein, Jonathan D.] Dartmouth Hitchcock, Dept Psychiat, Lebanon, NH USA; [May, Natalie] Univ Windsor, Dept Integrat Biol, Windsor, ON, Canada		Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, Windsor, ON, Canada.	sabelli1@uwindsor.ca; messaha@uwindsor.ca; luciano.giromini@unito.it; Jonathan.D.Lichtenstein@hitchcock.org; mayb@uwindsor.ca; lerdodi@gmail.com					Abeare C, 2019, PSYCHOL INJ LAW, V12, P170, DOI 10.1007/s12207-019-09353-x; Abeare CA, 2021, CLIN NEUROPSYCHOL, V35, P1442, DOI 10.1080/13854046.2020.1779348; Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; Arbisi PA, 1995, PSYCHOL ASSESSMENT, V7, P424, DOI 10.1037/1040-3590.7.4.424; Armistead-Jehle P, 2015, APPL NEUROPSYCH-ADUL, V22, P147, DOI 10.1080/23279095.2014.880842; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bakvis P, 2010, EPILEPSY BEHAV, V19, P448, DOI 10.1016/j.yebeh.2010.08.026; Beck A.T., 1996, BECK DEPRESSION INVE, DOI DOI 10.1037/T00742-000; Bell BD, 1999, ARCH CLIN NEUROPSYCH, V14, P389, DOI 10.1016/S0887-6177(98)00020-1; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 1999, CLIN NEUROPSYCHOL, V13, P414; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P675, DOI 10.1016/j.acn.2007.07.005; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P1016, DOI 10.1080/13854040802441135; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Bush S.S., 2013, MILD TRAUMATIC BRAIN, P57; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butcher J.N., 2001, MINNESOTA MULTIPHASI; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Chafetz M, 2011, CLIN NEUROPSYCHOL, V25, P1239, DOI 10.1080/13854046.2011.586785; Copeland CT, 2016, ARCH CLIN NEUROPSYCH, V31, P18, DOI 10.1093/arclin/acv065; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; DeFlippis NA., 1997, MANUAL BOOKLET CATEG; Delis D.C., 1987, CVLT CALIFORNIA VERB; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dionysus KE, 2011, ARCH CLIN NEUROPSYCH, V26, P81, DOI 10.1093/arclin/acq096; Donders J, 2021, ARCH CLIN NEUROPSYCH, V36, P394, DOI 10.1093/arclin/acz057; Egeland J, 2015, APPL NEUROPSYCH-ADUL, V22, P215, DOI 10.1080/23279095.2014.910212; Eichstaedt KE, 2014, CLIN NEUROPSYCHOL, V28, P941, DOI 10.1080/13854046.2014.942374; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Erdodi L. A., 2020, ASSESSMENT FEIGNED C; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P113, DOI 10.1007/s12207-019-09352-y; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P155, DOI 10.1007/s12207-019-09356-8; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P307, DOI 10.1007/s12207-018-9337-7; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P1, DOI 10.1007/s12207-017-9309-3; Erdodi LA, 2018, ARCH CLIN NEUROPSYCH, V33, P845, DOI 10.1093/acn/acx110; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Fisher R.A, 1925, BIOL MONOGRAPHS MANU; Friedman A., 2015, PSYCHOL ASSESSMENT M; Friedman A.F., 2001, PSYCHOL ASSESSMENT M, V2nd ed.; Gaasedelen OJ, 2019, CLIN NEUROPSYCHOL, V33, P1467, DOI 10.1080/13854046.2019.1612947; Gass CS, 2017, APPL NEUROPSYCH-ADUL, V24, P108, DOI 10.1080/23279095.2015.1107563; Gass CS, 2012, J CLIN EXP NEUROPSYC, V34, P561, DOI 10.1080/13803395.2012.666228; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Giromini, 2020, INVENTORY PROBLEMS 2; Giromini L, 2020, PSYCHOL INJ LAW, V13, P261, DOI 10.1007/s12207-020-09385-8; Giromini L, 2020, APPL NEUROPSYCH-ADUL, V27, P504, DOI 10.1080/23279095.2019.1570929; Glassmire DM, 2019, PSYCHOL ASSESSMENT, V31, P120, DOI 10.1037/pas0000650; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; GRAHAM JR, 1991, J PERS ASSESS, V57, P264, DOI 10.1207/s15327752jpa5702_6; GRAHAM JR, 2000, MMPI 2 ASSESSING PER; Grant AF, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1769097; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2008, ADV INTERPRETATION P; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greene RL, 2000, MMPI 2 INTERPRETIVE; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Grossi LM, 2017, PSYCHOL ASSESSMENT, V29, P531, DOI 10.1037/pas0000364; Haggerty KA, 2007, CLIN NEUROPSYCHOL, V21, P917, DOI 10.1080/13854040600899724; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Harrison AG, 2007, ARCH CLIN NEUROPSYCH, V22, P577, DOI 10.1016/j.acn.2007.03.008; Hathaway SR, 1940, J PSYCHOL, V10, P249, DOI 10.1080/00223980.1940.9917000; Heaton R. K., 2004, REVISED COMPREHENSIV; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hosmer DW., 2000, APPL LOGISTIC REGRES, DOI [10.1002/0471722146, DOI 10.1002/0471722146, 10. 1002/0471722146]; Hurtubise J, 2020, APPL NEUROPSYCH-CHIL, V9, P337, DOI 10.1080/21622965.2020.1719409; Hurtubise JL, 2017, PSYCHOL INJ LAW, V10, P121, DOI 10.1007/s12207-017-9287-5; Iverson GL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218997; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; Jelicic, 2020, PSYCHOL CONSCIOUS, DOI [10.1037/cns0000224, DOI 10.1037/CNS0000224]; Johnson SC, 2012, CLIN NEUROPSYCHOL, V26, P1230, DOI 10.1080/13854046.2012.709886; Jurick SM, 2019, ARCH CLIN NEUROPSYCH, V34, P366, DOI 10.1093/arclin/acy048; Kanser RJ, 2019, CLIN NEUROPSYCHOL, V33, P90, DOI 10.1080/13854046.2018.1440006; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; King PR, 2014, J NERV MENT DIS, V202, P231, DOI 10.1097/NMD.0000000000000103; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Lace JW, 2020, PSYCHOL INJ LAW, V13, P303, DOI 10.1007/s12207-020-09382-x; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LARRABEE GJ, 1998, CLIN NEUROPSYCHOL, V4, P353; Larrabee GJ, 2017, CLIN NEUROPSYCHOL, V31, P1401, DOI 10.1080/13854046.2017.1363293; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lees-Haley, 1989, AM J FORENSIC PSYCH, V7, P81; LeesHaley P. R., 1991, AMER J FOREN PSYCHOL, V9, P5; Lichtenstein JD, 2019, PSYCHOL INJ LAW, V12, P146, DOI 10.1007/s12207-019-09350-0; Lichtenstein JD, 2019, PSYCHOL INJ LAW, V12, P127, DOI 10.1007/s12207-019-09354-w; Lichtenstein JD, 2019, DEV NEUROPSYCHOL, V44, P159, DOI 10.1080/87565641.2019.1565535; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Lupu T, 2018, APPL NEUROPSYCH-ADUL, V25, P532, DOI 10.1080/23279095.2017.1341410; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Martins M, 2010, APPL NEUROPSYCHOL, V17, P177, DOI 10.1080/09084281003715709; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Matthews CG., 1964, INSTRUCTION MANUAL A; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Merckelbach H, 2012, CLIN NEUROPSYCHOL, V26, P1217, DOI 10.1080/13854046.2012.710252; Merten T, 2016, PSYCHOL INJ LAW, V9, P102, DOI 10.1007/s12207-016-9257-3; Merten T, 2017, BEHAV SCI LAW, V35, P97, DOI 10.1002/bsl.2274; Merten T, 2013, PSYCHOL INJ LAW, V6, P122, DOI 10.1007/s12207-013-9155-x; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR., 2001, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n01_01, DOI 10.1300/J151V02N01_]; Miskey HM, 2020, J NEUROPSYCH CLIN N, V32, P161, DOI 10.1176/appi.neuropsych.17110340; Morris N.M., 2020, ARCH CLIN NEUROPSYCH; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; Nelson NW, 2010, CLIN NEUROPSYCHOL, V24, P701, DOI 10.1080/13854040903482863; Nelson NW, 2006, CLIN NEUROPSYCHOL, V20, P39, DOI 10.1080/13854040500459322; NICHOLS DS, 2011, ESSENTIALS MMPI 2 AS; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Persinger VC, 2018, CLIN NEUROPSYCHOL, V32, P1039, DOI 10.1080/13854046.2017.1419507; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Rai J., 2019, PSYCHOL NEUROSCIENCE, V12, P451, DOI [10.1037/pne0000175, DOI 10.1037/PNE0000175]; Rai JK, 2021, APPL NEUROPSYCH-ADUL, V28, P185, DOI 10.1080/23279095.2019.1613994; Reitan R, 1969, MANUAL ADM NEUROPSYC; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rienstra A, 2013, ARCH CLIN NEUROPSYCH, V28, P463, DOI 10.1093/arclin/act026; Robinson JS, 2018, ARCH CLIN NEUROPSYCH, V33, P238, DOI 10.1093/arclin/acx069; Rock PL, 2014, PSYCHOL MED, V44, P2029, DOI 10.1017/S0033291713002535; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; Rogers r, 1990, B AM ACAD PSYCH LAW; Rohling ML, 2010, CLIN NEUROPSYCHOL, V24, P119, DOI 10.1080/13854040903307243; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rowland JA, 2017, ARCH CLIN NEUROPSYCH, V32, P306, DOI 10.1093/arclin/acw107; Ruocco AC, 2008, CLIN NEUROPSYCHOL, V22, P547, DOI 10.1080/13854040701336444; SAVITZ DA, 1995, AM J EPIDEMIOL, V142, P904, DOI 10.1093/oxfordjournals.aje.a117737; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schroeder RW, 2019, CLIN NEUROPSYCHOL, V33, P466, DOI 10.1080/13854046.2018.1484517; Schutte C, 2015, PSYCHOL INJ LAW, V8, P100, DOI 10.1007/s12207-015-9225-3; SCHWARTZ MS, 1971, J CLIN PSYCHOL, V27, P89, DOI 10.1002/1097-4679(197101)27:1<89::AID-JCLP2270270121>3.0.CO;2-V; Shura RD, 2020, CLIN NEUROPSYCHOL, V34, P1025, DOI 10.1080/13854046.2019.1635209; Shura RD, 2017, PSYCHOL ASSESSMENT, V29, P1458, DOI 10.1037/pas0000436; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Shwartz SK, 2020, ARCH CLIN NEUROPSYCH, V35, P701, DOI 10.1093/arclin/acaa024; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Slick D. J., 2012, PEDIAT FORENSIC NEUR, P113; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Soble, 2019, CLIN NEUROPSYCHOL, V21, P209, DOI [10.1080/13825580601025932, DOI 10.1080/13825580601025932]; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Stenberg J, 2020, NEUROPSYCHOLOGY, V34, P560, DOI 10.1037/neu0000632; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Stevens A, 2018, J FORENSIC PSYCHI PS, V29, P794, DOI 10.1080/14789949.2018.1477974; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Suhr J, 2008, ARCH CLIN NEUROPSYCH, V23, P521, DOI 10.1016/j.acn.2008.05.003; Suhr J, 2012, CLIN NEUROPSYCHOL, V26, P1128, DOI 10.1080/13854046.2012.713121; Suhr JA, 2011, ARCH CLIN NEUROPSYCH, V26, P1, DOI 10.1093/arclin/acq094; Sumanti M, 2006, CLIN NEUROPSYCHOL, V20, P754, DOI 10.1080/13854040500428467; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tarachow S, 1947, PSYCHIAT QUART, V21, P233, DOI 10.1007/BF01641756; Thirthalli J, 2009, ASIAN J PSYCHIATR, V2, P74, DOI 10.1016/j.ajp.2009.04.004; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Tyson BT, 2018, EPILEPSY BEHAV, V87, P39, DOI 10.1016/j.yebeh.2018.08.010; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Viglione DJ, 2017, J PERS ASSESS, V99, P534, DOI 10.1080/00223891.2016.1233882; Vos L, 2020, J HEAD TRAUMA REHAB, V35, pE382, DOI 10.1097/HTR.0000000000000557; Walton SR, 2018, MED SCI SPORT EXER, V50, P1377, DOI 10.1249/MSS.0000000000001592; Webber TA, 2018, CLIN NEUROPSYCHOL, V32, P657, DOI 10.1080/13854046.2017.1415374; Whiteside DM, 2009, CLIN NEUROPSYCHOL, V23, P523, DOI 10.1080/13854040802389169; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496	199	5	5	1	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	MAR	2021	14	1					17	36		10.1007/s12207-021-09400-6		MAR 2021	20	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	RM7KH	WOS:000635032400001					2022-02-06	
J	Sarkar, B; Ma, XT; Agas, A; Siddiqui, Z; Iglesias-Montoro, P; Nguyen, PK; Kim, KK; Haorah, J; Kumar, VA				Sarkar, Biplab; Ma, Xiaotang; Agas, Agnieszka; Siddiqui, Zain; Iglesias-Montoro, Patricia; Nguyen, Peter K.; Kim, Ka Kyung; Haorah, James; Kumar, Vivek A.			In vivo neuroprotective effect of a self-assembled peptide hydrogel	CHEMICAL ENGINEERING JOURNAL			English	Article						Traumatic brain injury; Neuroprotection; Ependymin; Self-assembly	CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; BRAIN; INJURY; GLUTAMATE; GROWTH	Traumatic brain injury (TBI) is associated with poor intrinsic healing responses and long-term cognitive decline. A major pathological outcome of TBI is acute glutamate-mediated excitotoxicity (GME) experienced by neurons. Short peptides based on the neuroprotective extracellular glycoprotein ependymin have shown the ability to slow down the effect of GME - however, such short peptides tend to diffuse away from target sites after in vivo delivery. We have designed a self-assembling peptide containing an ependymin mimic that can form nanofibrous matrices. The peptide was evaluated in situ to assess neuroprotective utility after an acute fluid-percussion injury. This biomimetic matrix can conform to the intracranial damaged site after delivery, due its shear-responsive rheological properties. We demonstrated the potential efficacy of the peptide for supporting neuronal survival in vitro and in vivo. Our study demonstrates the potential of these implantable acellular hydrogels for managing the acute (up to 7 days) pathophysiological sequelae after traumatic brain injury. Further work is needed to evaluate less invasive administrative routes and long-term functional and behavioral improvements after injury.	[Sarkar, Biplab; Ma, Xiaotang; Agas, Agnieszka; Siddiqui, Zain; Iglesias-Montoro, Patricia; Nguyen, Peter K.; Kim, Ka Kyung; Haorah, James; Kumar, Vivek A.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Kumar, Vivek A.] New Jersey Inst Technol, Dept Chem & Mat Engn, Newark, NJ 07102 USA; [Kumar, Vivek A.] Rutgers Sch Dent Med, Dept Restorat Dent, Newark, NJ 07103 USA		Haorah, J (corresponding author), 111 Lock St,Room 120, University Hts, NE USA.; Kumar, VA (corresponding author), 138 Warren St,Room 316, Newark, NJ 07102 USA.	jhaorah@njit.edu; vak@njit.edu	Sarkar, Biplab/AAA-9297-2020	Sarkar, Biplab/0000-0002-9298-2392; Kumar, Vivek/0000-0001-7536-9281; Agas, Agnieszka/0000-0001-8564-3168	NJIT Undergraduate Research and Innovation (URI) Program; NJIT Startup funds;  [NIH 1R21AA028340-01];  [GRANT12882559];  [NIH R15 EY029504]	General: We would like to thank Dr. Roman Brukh (Rutgers) for characterization. We thank Dr. Volha Liaudanskaya and Dr. Jonathan Grasman for helpful discussions and feedback. Funding: This work was supported by grants NIH 1R21AA028340-01, GRANT12882559 (to J.H.) and NIH R15 EY029504, the NJIT Undergraduate Research and Innovation (URI) Program and NJIT Startup funds (to V.A.K.).	Adak A, 2020, ACS BIOMATER SCI ENG, V6, P2287, DOI 10.1021/acsbiomaterials.9b01829; Akhmanova M, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/167025; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Boeck CR, 2000, NEUROREPORT, V11, P709, DOI 10.1097/00001756-200003200-00011; Datusalia AK, 2018, EUR J PHARMACOL, V833, P524, DOI 10.1016/j.ejphar.2018.07.001; Di L, 2015, AAPS J, V17, P134, DOI 10.1208/s12248-014-9687-3; Edwards G, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6348; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Gorski JA, 2003, J NEUROSCI, V23, P6856; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210; Koser DE, 2016, NAT NEUROSCI, V19, P1592, DOI 10.1038/nn.4394; Kumar VA, 2016, BIOMATERIALS, V98, P113, DOI 10.1016/j.biomaterials.2016.04.032; Kumar VA, 2015, ACS NANO, V9, P860, DOI 10.1021/nn506544b; Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002; Lopez-Silva TL, 2020, BIOMATERIALS, V231, DOI 10.1016/j.biomaterials.2019.119667; Lutz AB, 2014, DEV CELL, V28, P7, DOI 10.1016/j.devcel.2013.12.002; Ma TC, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.582460; Ma X., 2019, MOL NEUROBIOL; Moore AN, 2018, BIOMATERIALS, V161, P154, DOI 10.1016/j.biomaterials.2018.01.033; Nguyen PK, 2018, ACS APPL BIO MATER, V1, P865, DOI 10.1021/acsabm.8b00283; Nguyen PK, 2018, ACS OMEGA, V3, P5980, DOI 10.1021/acsomega.8b00347; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Sanyal S, 2002, NATURE, V416, P870, DOI 10.1038/416870a; Sarkar B, 2019, ACS BIOMATER SCI ENG, V5, P4657, DOI 10.1021/acsbiomaterials.9b00967; Sarkar B, 2018, BIOMACROMOLECULES, V19, P3597, DOI 10.1021/acs.biomac.8b01137; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shashoua VE, 2003, BRAIN RES, V963, P214, DOI 10.1016/S0006-8993(02)04058-1; Song BB, 2012, BIOMATERIALS, V33, P9105, DOI 10.1016/j.biomaterials.2012.08.060; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027; Tuvikene J, 2016, J NEUROSCI, V36, P1290, DOI 10.1523/JNEUROSCI.3360-15.2016; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	35	5	5	7	33	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1385-8947	1873-3212		CHEM ENG J	Chem. Eng. J.	MAR 15	2021	408								127295	10.1016/j.cej.2020.127295			8	Engineering, Environmental; Engineering, Chemical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	QA2AI	WOS:000613250300002					2022-02-06	
J	Celorrio, M; Abellanas, MA; Rhodes, J; Goodwin, V; Moritz, J; Vadivelu, S; Wang, LR; Rodgers, R; Xiao, S; Anabayan, I; Payne, C; Perry, AM; Baldridge, MT; Aymerich, MS; Steed, A; Friess, SH				Celorrio, Marta; Abellanas, Miguel A.; Rhodes, James; Goodwin, Victoria; Moritz, Jennie; Vadivelu, Sangeetha; Wang, Leran; Rodgers, Rachel; Xiao, Sophia; Anabayan, Ilakkia; Payne, Camryn; Perry, Alexandra M.; Baldridge, Megan T.; Aymerich, Maria S.; Steed, Ashley; Friess, Stuart H.			Gut microbial dysbiosis after traumatic brain injury modulates the immune response and impairs neurogenesis	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Traumatic brain injury; Gut microbial dysbiosis; Antibiotics; Fear conditioning; Microglia; Monocytes; T cells; Neurogenesis		The influence of the gut microbiota on traumatic brain injury (TBI) is presently unknown. This knowledge gap is of paramount clinical significance as TBI patients are highly susceptible to alterations in the gut microbiota by antibiotic exposure. Antibiotic-induced gut microbial dysbiosis established prior to TBI significantly worsened neuronal loss and reduced microglia activation in the injured hippocampus with concomitant changes in fear memory response. Importantly, antibiotic exposure for 1 week after TBI reduced cortical infiltration of Ly6C(high) monocytes, increased microglial pro-inflammatory markers, and decreased T lymphocyte infiltration, which persisted through 1 month post-injury. Moreover, microbial dysbiosis was associated with reduced neurogenesis in the dentate gyrus 1 week after TBI. By 3 months after injury (11 weeks after discontinuation of the antibiotics), we observed increased microglial proliferation, increased hippocampal neuronal loss, and modulation of fear memory response. These data demonstrate that antibiotic-induced gut microbial dysbiosis after TBI impacts neuroinflammation, neurogenesis, and fear memory and implicate gut microbial modulation as a potential therapeutic intervention for TBI.	[Celorrio, Marta; Abellanas, Miguel A.; Rhodes, James; Goodwin, Victoria; Moritz, Jennie; Vadivelu, Sangeetha; Xiao, Sophia; Anabayan, Ilakkia; Payne, Camryn; Perry, Alexandra M.; Steed, Ashley; Friess, Stuart H.] Washington Univ, Dept Pediat, Div Crit Care Med, St Louis Sch Med, St Louis, MO 63130 USA; [Wang, Leran; Rodgers, Rachel; Baldridge, Megan T.] Washington Univ, Dept Med, Div Infect Dis, St Louis Sch Med, St Louis, MO USA; [Abellanas, Miguel A.; Aymerich, Maria S.] Univ Navarra, Fac Ciencias, Dept Bioquim & Genet, Pamplona, Spain; [Abellanas, Miguel A.; Aymerich, Maria S.] Univ Navarra, Programa Neurociencias, CIMA, Pamplona, Spain; [Aymerich, Maria S.] Inst Invest Sanitaria Navarra, IdiSNA, Pamplona, Spain		Friess, SH (corresponding author), Washington Univ, Dept Pediat, Div Crit Care Med, St Louis Sch Med, St Louis, MO 63130 USA.	friess@wustl.edu	Baldridge, Megan/T-7274-2019	Baldridge, Megan/0000-0002-7030-6131; Xiao, Sophia/0000-0002-0517-2229; Abellanas, Miguel/0000-0002-5680-1582	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS097721]; Boehringer-Ingelheim, GermanyBoehringer Ingelheim; Washington University School of Medicine; Children's Discovery Institute of Washington University; St. Louis Children's Hospital [CDI-CORE-2015-505, CDI-CORE-2019-813]; Foundation for Barnes-Jewish Hospital [3770, 4642]; Office of Research Infrastructure Programs (ORIP), a part of the NIH Office of the Director [OD021629]	This work was supported by the National Institutes of Health (R01NS097721). This study was also supported by an educational grant issued by Boehringer-Ingelheim, Germany. Fluorescent imaging was performed on a Zeiss Axio Imager Z2 Fluorescence Microscope with ApoTome 2 optical sectioning grid imager through the use of Washington University Center for Cellular Imaging (WUCCI) supported by Washington University School of Medicine, The Children's Discovery Institute of Washington University and St. Louis Children's Hospital (CDI-CORE-2015-505 and CDI-CORE-2019-813) and the Foundation for Barnes-Jewish Hospital (3770 and 4642). Confocal imaging was generated on a Zeiss LSM 880 Airyscan Confocal Microscope which was purchased with support from the Office of Research Infrastructure Programs (ORIP), a part of the NIH Office of the Director under grant OD021629.	Abellanas MA, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1628-8; Angelucci F, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1494-4; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chu C, 2019, NATURE, V574, P543, DOI 10.1038/s41586-019-1644-y; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Daglas M, 2019, CELL REP, V29, P1178, DOI 10.1016/j.celrep.2019.09.046; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Davies M, 2018, J NEUROTRAUM, V35, P790, DOI 10.1089/neu.2017.5354; Desbonnet L, 2015, BRAIN BEHAV IMMUN, V48, P165, DOI 10.1016/j.bbi.2015.04.004; Desmedt A, 2015, BIOL PSYCHIAT, V78, P290, DOI 10.1016/j.biopsych.2015.06.017; Erickson MA, 2011, BRAIN BEHAV IMMUN, V25, P1637, DOI 10.1016/j.bbi.2011.06.006; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Esen N, 2014, GLIA, V62, P1452, DOI 10.1002/glia.22692; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476; Garcia-Bonilla L, 2018, J NEUROSCI, V38, P6722, DOI 10.1523/JNEUROSCI.0324-18.2018; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Gebicke-Haerter PJ, 2001, MICROSC RES TECHNIQ, V54, P47, DOI 10.1002/jemt.1120; Gliem M, 2016, BBA-MOL BASIS DIS, V1862, P329, DOI 10.1016/j.bbadis.2015.11.004; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; Hickman S, 2018, NAT NEUROSCI, V21, P1359, DOI 10.1038/s41593-018-0242-x; Hoban AE, 2018, MOL PSYCHIATR, V23, P1134, DOI 10.1038/mp.2017.100; Hoffmann A, 2011, TRANSL STROKE RES, V2, P106, DOI 10.1007/s12975-010-0049-x; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huang CS, 2016, GLIA, V64, P507, DOI 10.1002/glia.22944; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Josefsdottir KS, 2017, BLOOD, V129, P729, DOI 10.1182/blood-2016-03-708594; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kaouane N, 2012, SCIENCE, V335, P1510, DOI 10.1126/science.1207615; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; Kipnis J, 2002, P NATL ACAD SCI USA, V99, P15620, DOI 10.1073/pnas.232565399; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Kountouras J, 2009, J NEUROL, V256, P758, DOI 10.1007/s00415-009-5011-z; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Levin H, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00925; Li G, 2018, J MOL CELL CARDIOL, V123, P92, DOI 10.1016/j.yjmcc.2018.09.002; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lu J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201829; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mezo C, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00988-5; Minter MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep30028; Mohle L, 2016, CELL REP, V15, P1945, DOI 10.1016/j.celrep.2016.04.074; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; Pasciuto E, 2020, CELL, V182, P625, DOI 10.1016/j.cell.2020.06.026; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Rogers GB, 2016, MOL PSYCHIATR, V21, P738, DOI 10.1038/mp.2016.50; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Schetters STT, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01905; Schmidt OI, 2007, ORTHOPADE, V36, P248, DOI 10.1007/s00132-007-1061-z; Schwartz M, 2001, TRENDS MOL MED, V7, P252, DOI 10.1016/S1471-4914(01)01993-1; Schwartz M, 2001, PROG NEUROBIOL, V65, P489, DOI 10.1016/S0301-0082(01)00009-0; Simon DW, 2020, BRAIN RES, V1747, DOI 10.1016/j.brainres.2020.147056; Singh V, 2018, J CEREBR BLOOD F MET, V38, P1293, DOI 10.1177/0271678X18780130; Stalnacke BM, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/9216931; Steed AL, 2017, SCIENCE, V357, P498, DOI 10.1126/science.aam5336; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Treangen TJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02757; Vuong HE, 2017, ANNU REV NEUROSCI, V40, P21, DOI 10.1146/annurev-neuro-072116-031347; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Willis EF, 2020, CELL, V180, P833, DOI 10.1016/j.cell.2020.02.013; Yang XD, 2018, BMC ANESTHESIOL, V18, DOI 10.1186/s12871-018-0642-1; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23; Younger D, 2019, MOL NEUROBIOL, V56, P5202, DOI 10.1007/s12035-018-1428-7; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	78	5	6	3	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	MAR 10	2021	9	1							40	10.1186/s40478-021-01137-2			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU6MA	WOS:000627392900001	33691793	Green Published, gold			2022-02-06	
J	Li, ZQ; Xiao, J; Xu, XY; Li, WY; Zhong, RY; Qi, LL; Chen, JH; Cui, GZ; Wang, S; Zheng, YX; Qiu, Y; Li, S; Zhou, X; Lu, Y; Lyu, JY; Zhou, B; Zhou, JW; Jing, NH; Wei, B; Hu, J; Wang, HY				Li, Zhiqi; Xiao, Jun; Xu, Xiaoyan; Li, Weiyun; Zhong, Ruiyue; Qi, Linlin; Chen, Jiehui; Cui, Guizhong; Wang, Shuang; Zheng, Yuxiao; Qiu, Ying; Li, Sheng; Zhou, Xin; Lu, Yao; Lyu, Jiaying; Zhou, Bin; Zhou, Jiawei; Jing, Naihe; Wei, Bin; Hu, Jin; Wang, Hongyan			M-CSF, IL-6, and TGF-beta promote generation of a new subset of tissue repair macrophage for traumatic brain injury recovery	SCIENCE ADVANCES			English	Article							CLOSED-HEAD INJURY; GROWTH-FACTOR-BETA; APOPTOTIC CELLS; ALTERNATIVE ACTIVATION; RISK-FACTORS; EXPRESSION; MONOCYTES; MICROGLIA; GENE; DIFFERENTIATION	Traumatic brain injury (TBI) leads to high mortality rate. We aimed to identify the key cytokines favoring TBI repair and found that patients with TBI with a better outcome robustly increased concentrations of macrophage colony-stimulating factor, interleukin-6, and transforming growth factor-beta (termed M6T) in cerebrospinal fluid or plasma. Using TBI mice, we identified that M2-like macrophage, microglia, and endothelial cell were major sources to produce M6T. Together with the in vivo tracking of mCherry+ macrophages in zebrafish models, we confirmed that M6T treatment accelerated blood-borne macrophage infiltration and polarization toward a subset of tissue repair macrophages that expressed similar genes as microglia for neuroprotection, angiogenesis and cell migration. M6T therapy in TBI mice and zebrafish improved neurological function while blocking M6T-exacerbated brain injury. Considering low concentrations of M6T in some patients with poor prognostic, M6T treatment might repair TBI via generating a previously unidentified subset of tissue repair macrophages.	[Li, Zhiqi; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China; [Li, Zhiqi; Wang, Hongyan] Fudan Univ, Neurosurg Inst, Shanghai 200040, Peoples R China; [Xiao, Jun; Xu, Xiaoyan; Li, Weiyun; Zhong, Ruiyue; Chen, Jiehui; Cui, Guizhong; Wang, Shuang; Zheng, Yuxiao; Qiu, Ying; Li, Sheng; Zhou, Xin; Lu, Yao; Zhou, Bin; Jing, Naihe] Univ Chinese Acad Sci, Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol,State Key Lab C, Shanghai 200031, Peoples R China; [Xu, Xiaoyan] NCI, Expt Immunol Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Li, Weiyun] Xiamen Univ, Sch Life Sci, Xiamen, Fujian, Peoples R China; [Qi, Linlin; Wei, Bin] Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China; [Qi, Linlin; Wei, Bin] Chinese Acad Sci, Wuhan Inst Virol, Wuhan, Peoples R China; [Zhou, Xin; Wei, Bin] Tongji Univ, Shanghai Peoples Hosp 10, Canc Ctr, Sch Med, Shanghai 200072, Peoples R China; [Lyu, Jiaying] Fudan Univ, Sch Publ Hlth, Dept Biostat, Shanghai, Peoples R China; [Zhou, Jiawei] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Hu, Jin] Shanghai Clin Med Ctr Neurosurg, Shanghai, Peoples R China; [Hu, Jin] Shanghai Key Lab Brain Funct & Restorat & Neural, Shanghai, Peoples R China; [Wang, Hongyan] Univ Chinese Acad Sci, Sch Life Sci, Hangzhou Inst Adv Study, Hangzhou 310024, Peoples R China		Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China.; Wang, HY (corresponding author), Fudan Univ, Neurosurg Inst, Shanghai 200040, Peoples R China.; Wei, B (corresponding author), Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China.; Wei, B (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Wuhan, Peoples R China.; Wei, B (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Canc Ctr, Sch Med, Shanghai 200072, Peoples R China.; Hu, J (corresponding author), Shanghai Clin Med Ctr Neurosurg, Shanghai, Peoples R China.; Hu, J (corresponding author), Shanghai Key Lab Brain Funct & Restorat & Neural, Shanghai, Peoples R China.; Wang, HY (corresponding author), Univ Chinese Acad Sci, Sch Life Sci, Hangzhou Inst Adv Study, Hangzhou 310024, Peoples R China.	weibinwhy@shu.edu.cn; hujin_dana@126.com; hongyanwang@sibcb.ac.cn	zhou, xin/AAY-4100-2021	zhou, xin/0000-0001-9281-3612; Cui, Guizhong/0000-0001-6394-2773	Chinese Academy of SciencesChinese Academy of Sciences [XDB19000000]; National Key R&D Program of China [2018YFA0107900]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81930038, 81825011, 81630043]; Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2018YFA0800702]; State Key Laboratory of Cell Biology, SIBCB, CAS [SKLCBKF2013003]; National Science Foundation for Distinguished Young ScholarsNational Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars	This work was supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB19000000), National Key R&D Program of China (2018YFA0107900), National Natural Science Foundation of China (81930038, 81825011, and 81630043), the Ministry of Science and Technology of China (2018YFA0800702), and the State Key Laboratory of Cell Biology, SIBCB, CAS (SKLCBKF2013003). H.W. is supported by National Science Foundation for Distinguished Young Scholars.	Anderson J, 2009, J NEUROTRAUM, V26, P1557, DOI 10.1089/neu.2008-0765; Boche D, 2003, J CEREBR BLOOD F MET, V23, P1174, DOI 10.1097/01.WCB.0000090080.64176.44; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Bune AJ, 2001, IMMUNOLOGY, V102, P103, DOI 10.1046/j.1365-2567.2001.01145.x; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cha SJ, 2015, J EXP MED, V212, P1391, DOI 10.1084/jem.20110575; Charo IF, 2007, CELL METAB, V6, P96, DOI 10.1016/j.cmet.2007.07.006; Chen J, 2017, NAT PROTOC, V12, P566, DOI 10.1038/nprot.2017.003; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Crouch EE, 2018, NAT PROTOC, V13, P738, DOI 10.1038/nprot.2017.158; Ewig S, 1999, AM J RESP CRIT CARE, V159, P188, DOI 10.1164/ajrccm.159.1.9803097; Fabregas N, 2002, Minerva Anestesiol, V68, P285; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Fricke ST, 2006, PROSTATE, V66, P708, DOI 10.1002/pros.20392; Fu CP, 2016, RESP PHYSIOL NEUROBI, V223, P16, DOI 10.1016/j.resp.2015.11.016; Glod J, 2006, BLOOD, V107, P940, DOI 10.1182/blood-2004-11-4403; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; HARDING CV, 1992, J CELL BIOL, V119, P531, DOI 10.1083/jcb.119.3.531; Hart SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033142; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI11638; Ishikawa K, 2000, J TRAUMA, V49, P912, DOI 10.1097/00005373-200011000-00020; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jiang XW, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1211219; Jimenez-Garcia L, 2015, EUR J IMMUNOL, V45, P273, DOI 10.1002/eji.201444806; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Korin B, 2017, NAT NEUROSCI, V20, P1300, DOI 10.1038/nn.4610; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Lasch M, 2016, LAB INVEST, V96, P830, DOI 10.1038/labinvest.2016.62; Li B, 2019, AGING-US, V11, P898, DOI 10.18632/aging.101786; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Lu J, 2010, J NEUROTRAUM, V27, P843, DOI 10.1089/neu.2010.1293; Luo J, 2007, J CLIN INVEST, V117, P3306, DOI 10.1172/JCI31763; Ma MM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-117; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13; McCormick SM, 2016, J BIOL CHEM, V291, P20574, DOI 10.1074/jbc.M116.746164; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Rodriguez O, 2016, J NEUROTRAUM, V33, P662, DOI 10.1089/neu.2015.4002; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Takeuchi A, 2001, J NEUROSCI RES, V65, P38, DOI 10.1002/jnr.1125; Tian Y, 2014, IEEE ACM T COMPUT BI, V11, P1009, DOI 10.1109/TCBB.2014.2338304; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vachon E, 2006, BLOOD, V107, P4149, DOI 10.1182/blood-2005-09-3808; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Willis EF, 2020, CELL, V180, P833, DOI 10.1016/j.cell.2020.02.013; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yao QY, 2018, J BIOL CHEM, V293, P16572, DOI 10.1074/jbc.RA118.003161; Zhang O, 2015, INT IMMUNOPHARMACOL, V26, P58, DOI 10.1016/j.intimp.2015.03.005	62	5	5	14	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	2375-2548			SCI ADV	Sci. Adv.	MAR	2021	7	11							eabb6260	10.1126/sciadv.abb6260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QW4IX	WOS:000628616300002	33712456	gold, Green Published			2022-02-06	
J	Alawieh, A; Chalhoub, RM; Mallah, K; Langley, EF; York, M; Broome, H; Couch, C; Adkins, D; Tomlinson, S				Alawieh, Ali; Chalhoub, Reda M.; Mallah, Khalil; Langley, E. Farris; York, Mikaela; Broome, Henry; Couch, Christine; Adkins, DeAnna; Tomlinson, Stephen			Complement Drives Synaptic Degeneration and Progressive Cognitive Decline in the Chronic Phase after Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE			English	Article						cognitive recovery; complement; neuroinflammation; therapy; traumatic brain injury	CONTROLLED CORTICAL IMPACT; REHABILITATION; INHIBITION; DEMENTIA; MOUSE; DYSFUNCTION; ACTIVATION; SYSTEM; C3	Cognitive deficits following traumatic brain injury (TBI) remain a major cause of disability and early-onset dementia, and there is increasing evidence that chronic neuroinflammation occurring after TBI plays an important role in this process. However, little is known about the molecular mechanisms responsible for triggering and maintaining chronic inflammation after TBI. Here, we identify complement, and specifically complement-mediated microglial phagocylosis of synapses, as a pathophysiological link between acute insult and a chronic neurodegenerative response that is associated with cognitive decline. Three months after an initial insult, there is ongoing complement activation in the injured brain of male C57B1/6 mice, which drives a robust chronic neuroinflammatory response extending to both hemispheres. This chronic neuroinflammatory response promotes synaptic degeneration and predicts progressive cognitive decline. Synaptic degeneration was driven by microglial phagocytosis of complement-opsonized synapses in both the ipsilateral and contralateral brain, and complement inhibition interrupted the degenerative neuroinflammatory response and reversed cognitive decline, even when therapy was delayed until 2 months after TBI. These findings provide new insight into our understanding of TBI pathology and its management; and whereas previous therapeutic investigations have focused almost exclusively on acute treatments, we show that all phases of TBI, including at chronic time points after TBI, may be amenable to therapeutic interventions, and specifically to complement inhibition.	[Alawieh, Ali; Chalhoub, Reda M.; Mallah, Khalil; Langley, E. Farris; York, Mikaela; Broome, Henry; Couch, Christine; Tomlinson, Stephen] Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Alawieh, Ali] Emory Univ, Dept Neurosurg, Sch Med, Atlanta, GA 30322 USA; [Chalhoub, Reda M.; Adkins, DeAnna] Med Univ South Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Adkins, DeAnna; Tomlinson, Stephen] Ralph Johnson Vet Adm Med Ctr, Charleston, SC 29401 USA		Tomlinson, S (corresponding author), Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA.; Tomlinson, S (corresponding author), Ralph Johnson Vet Adm Med Ctr, Charleston, SC 29401 USA.	tomlinss@musc.edu		Mallah, Khalil/0000-0001-7622-8106; Alawieh, Ali/0000-0003-2601-8850; Couch, Christine/0000-0002-2667-4746; Adkins, DeAnna L/0000-0002-3063-5731; tomlinson, stephen/0000-0002-6281-2122	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 CA138313, S10 OD018113, 1P20GM109040, U54GM10494, U54GM10491]; American Heart Association Pre-doctoral FellowshipAmerican Heart Association [15PRE25250009]; Department of Veterans Affairs Merit AwardsUS Department of Veterans Affairs [1BX004256, 1RX001141, 21RX002363, IK6BX005235]; National Institute of General Medical Sciences Award [P30GM103331]; National Institutes of Health-National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30 GM103342]	This work was supported by National Institutes of Health Grants 1P20GM109040, U54GM10494, and U54GM10491 to D.A. and S.T., Department of Veterans Affairs Merit Awards 1BX004256, 1RX001141, 21RX002363, and IK6BX005235 to S.T., and American Heart Association Pre-doctoral Fellowship 15PRE25250009 to A.A. Authors acknowledge the use of the MUSC Cell and Molecular Imaging Core (supported by awards from the National Institutes of Health P30 CA138313 and S10 OD018113), the Center for Oral Health Research (National Institute of General Medical Sciences Award P30GM103331), and the Josh Spruill Imaging Facility (National Institutes of Health-National Institute of General Medical Sciences P30 GM103342).	Alawieh A, 2018, J NEUROSCI, V38, P6527, DOI 10.1523/JNEUROSCI.0111-18.2018; Alawieh A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6459; Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Alawieh A, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00417; Atkinson C, 2005, J CLIN INVEST, V115, P2444, DOI 10.1172/JCI25208; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; De Luca R, 2018, NEUROPSYCHOL REHABIL, V28, P879, DOI 10.1080/09602011.2016.1211937; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Hallock H, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00537; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Lalancette-Hebert M, 2012, J NEUROSCI, V32, P10383, DOI 10.1523/JNEUROSCI.1498-12.2012; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Magdalon J, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00023; Metz Gerlinde A, 2009, J Vis Exp, DOI 10.3791/1204; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Neniskyte U, 2017, NAT REV NEUROSCI, V18, P658, DOI 10.1038/nrn.2017.110; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Rancan M, 2003, J CEREBR BLOOD F MET, V23, P1070, DOI 10.1097/01.WCB.0000084250.20114.2C; Rich MC, 2016, NEUROSCI LETT, V617, P188, DOI 10.1016/j.neulet.2016.02.025; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stahel PF, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-2; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; van Praag H, 1998, BEHAV BRAIN RES, V92, P21, DOI 10.1016/S0166-4328(97)00117-4; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	42	5	5	2	3	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	FEB 24	2021	41	8					1830	1843		10.1523/JNEUROSCI.1734-20.2020			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QM2PR	WOS:000621624200008	33446516	Bronze, Green Published			2022-02-06	
J	LaPlaca, MC; Huie, JR; Alam, HB; Bachstetter, AD; Bayir, H; Bellgowan, PF; Cummings, D; Dixon, CE; Ferguson, AR; Ferland-Beckham, C; Floyd, CL; Friess, SH; Galanopoulou, AS; Hall, ED; Harris, NG; Hawkins, BE; Hicks, RR; Hulbert, LE; Johnson, VE; Kabitzke, PA; Lafrenaye, AD; Lemmon, VP; Lifshitz, CW; Lifshitz, J; Loane, DJ; Misquitta, L; Nikolian, VC; Noble-Haeusslein, LJ; Smith, DH; Taylor-Burds, C; Umoh, N; Vovk, O; Williams, AM; Young, M; Zai, LLJ				LaPlaca, Michelle C.; Huie, J. Russell; Alam, Hasan B.; Bachstetter, Adam D.; Bayir, Hulya; Bellgowan, Patrick F.; Cummings, Diana; Dixon, C. Edward; Ferguson, Adam R.; Ferland-Beckham, Chantelle; Floyd, Candace L.; Friess, Stuart H.; Galanopoulou, Aristea S.; Hall, Edward D.; Harris, Neil G.; Hawkins, Bridget E.; Hicks, Ramona R.; Hulbert, Lindsey E.; Johnson, Victoria E.; Kabitzke, Patricia A.; Lafrenaye, Audrey D.; Lemmon, Vance P.; Lifshitz, Carrie W.; Lifshitz, Jonathan; Loane, David J.; Misquitta, Leonie; Nikolian, Vahagn C.; Noble-Haeusslein, Linda J.; Smith, Douglas H.; Taylor-Burds, Carol; Umoh, Nsini; Vovk, Olga; Williams, Aaron M.; Young, Margaret; Zai, Laila J.			Pre-Clinical Common Data Elements for Traumatic Brain Injury Research: Progress and Use Cases	JOURNAL OF NEUROTRAUMA			English	Article						big data; common data elements; missing value analysis; pre-clinical; reproducibility		Traumatic brain injury (TBI) is an extremely complex condition due to heterogeneity in injury mechanism, underlying conditions, and secondary injury. Pre-clinical and clinical researchers face challenges with reproducibility that negatively impact translation and therapeutic development for improved TBI patient outcomes. To address this challenge, TBI Pre-clinical Working Groups expanded upon previous efforts and developed common data elements (CDEs) to describe the most frequently used experimental parameters. The working groups created 913 CDEs to describe study metadata, animal characteristics, animal history, injury models, and behavioral tests. Use cases applied a set of commonly used CDEs to address and evaluate the degree of missing data resulting from combining legacy data from different laboratories for two different outcome measures (Morris water maze [MWM]; RotorRod/Rotarod). Data were cleaned and harmonized to Form Structures containing the relevant CDEs and subjected to missing value analysis. For the MWM dataset (358 animals from five studies, 44 CDEs), 50% of the CDEs contained at least one missing value, while for the Rotarod dataset (97 animals from three studies, 48 CDEs), over 60% of CDEs contained at least one missing value. Overall, 35% of values were missing across the MWM dataset, and 33% of values were missing for the Rotarod dataset, demonstrating both the feasibility and the challenge of combining legacy datasets using CDEs. The CDEs and the associated forms created here are available to the broader pre-clinical research community to promote consistent and comprehensive data acquisition, as well as to facilitate data sharing and formation of data repositories. In addition to addressing the challenge of standardization in TBI pre-clinical studies, this effort is intended to bring attention to the discrepancies in assessment and outcome metrics among pre-clinical laboratories and ultimately accelerate translation to clinical research.	[LaPlaca, Michelle C.] Emory Univ, Dept Biomed Engn, Georgia Inst Technol, Atlanta, GA 30322 USA; [Huie, J. Russell; Ferguson, Adam R.] Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, Weill Inst Neurosci, San Francisco, CA USA; [Alam, Hasan B.; Nikolian, Vahagn C.; Williams, Aaron M.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Bachstetter, Adam D.; Hall, Edward D.] Univ Kentucky, Dept Neurosci, Lexington, KY USA; [Bayir, Hulya; Dixon, C. Edward; Young, Margaret] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Bellgowan, Patrick F.; Cummings, Diana; Misquitta, Leonie; Taylor-Burds, Carol; Vovk, Olga] NIH, Bldg 10, Bethesda, MD 20892 USA; [Ferland-Beckham, Chantelle] Cohen Vet Biosci, Cambridge, MA USA; [Floyd, Candace L.] Univ Utah, Dept Phys Med & Rehabil, Salt Lake City, UT USA; [Friess, Stuart H.] Washington Univ, Div Crit Care Med, St Louis, MO 63110 USA; [Galanopoulou, Aristea S.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Harris, Neil G.] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA; [Hawkins, Bridget E.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Hicks, Ramona R.] One Mind, Rutherford, CA USA; [Hulbert, Lindsey E.] Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA; [Johnson, Victoria E.; Smith, Douglas H.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Kabitzke, Patricia A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Lafrenaye, Audrey D.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Lemmon, Vance P.] Univ Miami, Dept Neurol Surg, Miami, FL USA; [Lifshitz, Carrie W.; Lifshitz, Jonathan] Univ Arizona, Dept Child Hlth, Coll Med Phoenix, Phoenix, AZ USA; [Loane, David J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; [Noble-Haeusslein, Linda J.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Noble-Haeusslein, Linda J.] Univ Texas Austin, Dept Neurol, Austin, TX 78712 USA; [Umoh, Nsini] US Army Med Res & Mat Command, Dept Def, Frederick, MD USA; [Zai, Laila J.] Lucent Neurosci, Parker, CO USA; [LaPlaca, Michelle C.] San Francisco Vet Affairs Hlth Care Syst, San Francisco, CA USA		LaPlaca, MC (corresponding author), Georgia Inst Technol, Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.	michelle.laplaca@bme.gatech.edu	Loane, David/ABD-5177-2021; Hawkins, Bridget/H-4933-2015	Loane, David/0000-0003-0393-3503; Taylor-Burds, Carol/0000-0002-6784-2232; Hawkins, Bridget/0000-0002-1887-3657	NIH National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS096515-02S1, R01 NS091062-03S1]; NIH Center for Information Technology (CIT)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT); Biomedical Research Informatics Computing System (BRICS); Department of DefenseUnited States Department of Defense	Authors acknowledge NIH National Institute of Neurological Disorders and Stroke (NINDS, R21 NS096515-02S1 (JL), R01 NS091062-03S1 (CED)), NIH Center for Information Technology (CIT) and Biomedical Research Informatics Computing System (BRICS), and the Department of Defense for technical and financial contribution to the FITBIR program.	Baker D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001756; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; DeWitt DS, 2018, J NEUROTRAUM, V35, P2737, DOI 10.1089/neu.2018.5778; Dirnagl U, 2006, J CEREBR BLOOD F MET, V26, P1465, DOI 10.1038/sj.jcbfm.9600298; Duricki DA, 2016, NAT PROTOC, V11, P1112, DOI 10.1038/nprot.2016.048; Eisenberg, 2018, CONTROVERSIES SEVERE, P247; Fouad K, 2020, J NEUROTRAUM, V37, P831, DOI 10.1089/neu.2019.6674; Gulinello M, 2019, NEUROBIOL LEARN MEM, V165, DOI 10.1016/j.nlm.2018.01.001; Harte-Hargrove Lauren C, 2018, Epilepsia Open, V3, P13, DOI 10.1002/epi4.12234; Harte-Hargrove LC, 2017, EPILEPSIA, V58, P78, DOI 10.1111/epi.13906; Henderson VC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001489; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Howells DW, 2014, NAT REV NEUROL, V10, P37, DOI 10.1038/nrneurol.2013.232; Huie JR, 2018, CURR OPIN NEUROL, V31, P702, DOI 10.1097/WCO.0000000000000614; Ioannidis JPA, 2008, AM J EPIDEMIOL, V168, P374, DOI 10.1093/aje/kwn156; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kenall A, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0177-z; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Kent TA, 2016, TRANSL STROKE RES, V7, P274, DOI 10.1007/s12975-016-0463-9; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kochanek PM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00640; Kyzas PA, 2007, EUR J CANCER, V43, P2559, DOI 10.1016/j.ejca.2007.08.030; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lapinlampi N, 2017, EPILEPSY RES, V129, P87, DOI 10.1016/j.eplepsyres.2016.11.010; Little R. J., 2019, STAT ANAL MISSING DA, V793; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McNamee LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177371; Medaglia J.D., 2019, WHAT REPLICATION CRI; Rubin Leah H, 2007, J Undergrad Neurosci Educ, V5, pA71; Sheffield Cynthia L., 2017, Science & Technology Libraries, V36, P296, DOI 10.1080/0194262X.2017.1340223; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Tortella FC, 2016, METHODS MOL BIOL, V1462, P735, DOI 10.1007/978-1-4939-3816-2_40; Voelkl B, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003693; Voelkl B, 2016, TRENDS PHARMACOL SCI, V37, P509, DOI 10.1016/j.tips.2016.05.003; Wallach OD, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006930; Warner DS, 2014, JAMA NEUROL, V71, P1311, DOI 10.1001/jamaneurol.2014.1238; Watzlawick R, 2019, NEUROLOGY, V93, pE40, DOI 10.1212/WNL.0000000000007718; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	39	5	5	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2021	38	10					1399	1410		10.1089/neu.2020.7328		FEB 2021	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RZ6DB	WOS:000623737600001	33297844				2022-02-06	
J	Wu, TT; Hajiaghamemar, M; Giudice, JS; Alshareef, A; Margulies, SS; Panzer, MB				Wu, Taotao; Hajiaghamemar, Marzieh; Giudice, J. Sebastian; Alshareef, Ahmed; Margulies, Susan S.; Panzer, Matthew B.			Evaluation of Tissue-Level Brain Injury Metrics Using Species-Specific Simulations	JOURNAL OF NEUROTRAUMA			English	Article						axonal strain; concussion; diffuse axonal injury; finite element model; strain-rate		Traumatic brain injury (TBI) is a significant public health burden, and the development of advanced countermeasures to mitigate and prevent these injuries during automotive, sports, and military impact events requires an understanding of the intracranial mechanisms related to TBI. In this study, the efficacy of tissue-level injury metrics for predicting TBI was evaluated using finite element reconstructions from a comprehensive, multi-species TBI database. The database consisted of human volunteer tests, laboratory-reconstructed head impacts from sports, in vivo non-human primate (NHP) tests, and in vivo pig tests. Eight tissue-level metrics related to brain tissue strain, axonal strain, and strain-rate were evaluated using survival analysis for predicting mild and severe TBI risk. The correlation between TBI risk and most of the assessed metrics were statistically significant, but when injury data was analyzed by species, the best metric was often inconclusive and limited by the small datasets. When the human and animal datasets were combined, the injury analysis was able to delineate maximum axonal strain as the best predictor of injury for all species and TBI severities, with maximum principal strain as a suitable alternative metric. The current study is the first to provide evidence to support the assumption that brain strain response between human, pig, and NHP result in similar injury outcomes through a multi-species analysis. This assumption is the biomechanical foundation for translating animal brain injury findings to humans. The findings in the study provide fundamental guidelines for developing injury criteria that would contribute towards the innovation of more effective safety countermeasures.	[Wu, Taotao; Giudice, J. Sebastian; Alshareef, Ahmed; Panzer, Matthew B.] Univ Virginia, Ctr Appl Biomech, Charlottesville, VA USA; [Hajiaghamemar, Marzieh] Univ Texas San Antonio, Dept Biomed Engn, San Antonio, TX USA; [Margulies, Susan S.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Margulies, Susan S.] Emory Univ, Atlanta, GA 30322 USA		Panzer, MB (corresponding author), Univ Virginia, Ctr Appl Biomech, Brain Injury & Sports Concuss Ctr, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA.; Panzer, MB (corresponding author), Sports Concuss Ctr, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA.	panzer@virginia.edu			Football Research, Inc. (FRI); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS097549]	The research presented in this paper was made possible in part by a grant from Football Research, Inc. (FRI), and NIH R01NS097549.	Adams, 1987, SAE TECHNICAL PAPER; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alshareef A, 2020, J NEUROTRAUM, V37, P1546, DOI 10.1089/neu.2019.6847; Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Centers for Disease Control and Prevention, 2021, REPORT CONGRESS TRAU; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Chierto E, 2019, MOL NEUROBIOL, V56, P4231, DOI 10.1007/s12035-018-1372-6; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Elkin BS, 2019, CLIN BIOMECH, V64, P49, DOI 10.1016/j.clinbiomech.2018.03.021; ESTES MS, 1970, MECH ENG, V92, P58; Ewing C.L., 1972, NAMRL MONOGRAPH, V21; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Ghazi K, 2019, SCI REP-UK, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Hajiaghamemar M, 2021, J NEUROTRAUM, V38, P144, DOI 10.1089/neu.2019.6791; Hajiaghamemar M, 2020, J BIOMECH ENG-T ASME, V142, DOI 10.1115/1.4046393; Hajiaghamemar M, 2020, BIOMECH MODEL MECHAN, V19, P1109, DOI 10.1007/s10237-019-01273-8; Hardy W.N., 2001, STAPP CAR CRASH J, V45, P375; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Herculano-Houzel S., 2018, NEUROGLIA, V1, P193, DOI DOI 10.3390/NEUROGLIA1010014; Horstemeyer MF, 2019, ANN BIOMED ENG, V47, P1829, DOI 10.1007/s10439-019-02351-9; Hosmer Jr DW, 2013, APPL LOGISTIC REGRES, V3rd; Ibrahim NG, 2010, J NEUROTRAUM, V27, P1021, DOI 10.1089/neu.2009.1212; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kikuchi, 1982, SAE TECHNICAL PAPER; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lehman R.J., 1986, SAE TECHNICAL PAPER; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Margulies SS, 2015, BRAIN PATHOL, V25, P289, DOI 10.1111/bpa.12247; Mata-Mbemba D, 2018, J NEUROSURG, V129, P1317, DOI 10.3171/2017.6.JNS17466; Mata-Mbemba D, 2015, J NEUROTRAUM, V32, P359, DOI 10.1089/neu.2014.3453; McElhaney J.H., 1973, SAE TECHNICAL PAPER; McElhaney JH, 1973, PERSPECTIVES BIOMEDI, P215, DOI DOI 10.1007/978-1-349-01604-4_34; McMurry TL, 2015, TRAFFIC INJ PREV, V16, P618, DOI 10.1080/15389588.2014.991820; Mendis K, 1992, THESIS OHIO STATE U; Morrison III, 2007, STAPP CAR CRASH J, P51; Nakadate Hiromichi, 2017, Stapp Car Crash J, V61, P53; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pham, 2018, J BIOMECH ENG-T ASME, P140; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Sanchez EJ, 2017, J NEUROTRAUM, V34, P2410, DOI 10.1089/neu.2016.4681; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Wu TT, 2020, J NEUROTRAUM, V37, P410, DOI 10.1089/neu.2019.6576; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8	62	5	5	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2021	38	13					1879	1888		10.1089/neu.2020.7445		FEB 2021	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SU3SJ	WOS:000621898000001	33446011				2022-02-06	
J	McCrea, MA; Shah, A; Duma, S; Rowson, S; Harezlak, J; McAllister, TW; Broglio, SP; Giza, CC; Goldman, J; Cameron, KL; Houston, MN; McGinty, G; Jackson, JC; Guskiewicz, K; Mihalik, JP; Brooks, A; Pasquina, P; Stemper, BD				McCrea, Michael A.; Shah, Alok; Duma, Stefan; Rowson, Steven; Harezlak, Jaroslaw; McAllister, Thomas W.; Broglio, Steven P.; Giza, Christopher C.; Goldman, Joshua; Cameron, Kenneth L.; Houston, Megan N.; McGinty, Gerald; Jackson, Jonathan C.; Guskiewicz, Kevin; Mihalik, Jason P.; Brooks, Alison; Pasquina, Paul; Stemper, Brian D.			Opportunities for Prevention of Concussion and Repetitive Head Impact Exposure in College Football Players A Concussion Assessment, Research, and Education (CARE) Consortium Study	JAMA NEUROLOGY			English	Article								IMPORTANCE Concussion ranks among the most common injuries in football. Beyond the risks of concussion are growing concerns that repetitive head impact exposure (HIE) may increase risk for long-term neurologic health problems in football players. OBJECTIVE To investigate the pattern of concussion incidence and HIE across the football season in collegiate football players. DESIGN, SETTING, AND PARTICIPANTS In this observational cohort study conducted from 2015 to 2019 across 6 Division I National Collegiate Athletic Association (NCAA) football programs participating in the Concussion Assessment, Research, and Education (CARE) Consortium, a total of 658 collegiate football players were instrumented with the Head Impact Telemetry (HIT) System (46.5% of 1416 eligible football players enrolled in the CARE Advanced Research Core). Players were prioritized for instrumentation with the HIT System based on their level of participation (ie, starters prioritized over reserves). EXPOSURE Participation in collegiate football games and practices from 2015 to 2019. MAIN OUTCOMES AND MEASURES Incidence of diagnosed concussion and HIE from the HIT System. RESULTS Across 5 seasons, 528 684 head impacts recorded from 658 players (all male, mean age [SD], 19.02 [1.25] years) instrumented with the HIT System during football practices or gamesmet quality standards for analysis. Players sustained a median of 415 (interquartile range [IQR], 190-727) recorded head impacts (ie, impacts) per season. Sixty-eight players sustained a diagnosed concussion. In total, 48.5% of concussions (n = 33) occurred during preseason training, despite preseason representing only 20.8% of the football season (0.059 preseason vs 0.016 regular-season concussions per team per day; mean difference, 0.042; 95% CI, 0.020-0.060; P =.001). Total HIE in the preseason occurred at twice the proportion of the regular season (324.9 vs 162.4 impacts per team per day; mean difference, 162.6; 95% CI, 110.9-214.3; P <.001). Every season, HIE per athletewas highest in August (preseason) (median, 146.0impacts; IQR, 63.0-247.8) and lowest inNovember (median, 80.0impacts; IQR, 35.0-148.0). Over 5 seasons, 72% of concussions (n = 49) (game proportion, 0.28; 95% CI, 0.18-0.40; P <.001) and 66.9% of HIE (262.4 practices vs 137.2 games impacts per player; mean difference, 125.3; 95% CI, 110.0-140.6; P <.001) occurred in practice. Even within the regular season, total HIE in practices (median, 175.0impacts per player per season; IQR, 76.0-340.5) was 84.2% higher than in games (median, 95.0impacts per player per season; IQR, 32.0-206.0). CONCLUSIONS AND RELEVANCE Concussion incidence and HIE among college football players are disproportionately higher in the preseason than regular season, and most concussions and HIE occur during football practices, not games. These data point to a powerful opportunity for policy, education, and other prevention strategies to make the greatest overall reduction in concussion incidence and HIE in college football, particularly during preseason training and football practices throughout the season, without major modification to game play. Strategies to prevent concussion and HIE have important implications to protecting the safety and health of football players at all competitive levels.	[McCrea, Michael A.; Shah, Alok; Stemper, Brian D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Duma, Stefan; Rowson, Steven] Virginia Tech, Dept Biomed Engn, Blacksburg, VA USA; [Harezlak, Jaroslaw] Indiana Univ, Dept Epidemiol & Biostat, Sch Publ Hlth Bloomington, Bloomington, IN USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [Giza, Christopher C.] Univ Calif Los Angeles, Dept Neurosurg, UCLA Steve Tisch BrainSPORT Program, Los Angeles, CA 90024 USA; [Giza, Christopher C.] Univ Calif Los Angeles, Dept Pediat, UCLA Steve Tisch BrainSPORT Program, Los Angeles, CA 90024 USA; [Goldman, Joshua] Univ Calif Los Angeles, Dept Family Med & Orthoped Surg, Los Angeles, CA 90024 USA; [Cameron, Kenneth L.; Houston, Megan N.] Keller Army Hosp Mil Acad, John A Feagin Jr Sports Med Fellowship, New York, NY USA; [Cameron, Kenneth L.; Pasquina, Paul] Uniformed Serv Univ Hlth Sci, Dept Phys Med & Rehabil, Bethesda, MD USA; [McGinty, Gerald; Jackson, Jonathan C.] US Air Force Acad, Colorado Springs, CO 80840 USA; [Guskiewicz, Kevin; Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Brooks, Alison] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped & Rehabil, Madison, WI USA; [Stemper, Brian D.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA		McCrea, MA (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Ctr Neurotrauma Res, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA.	mmccrea@mcw.edu	Harezlak, Jaroslaw/P-8557-2014	Harezlak, Jaroslaw/0000-0002-3070-7686	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium; National Collegiate Athletic Association (NCAA); US Department of Defense (DOD)United States Department of Defense; US Army Medical Research Acquisition Activity, Fort Detrick, Maryland; Office of the Assistant Secretary of Defense for Health Affairs, through the Combat Casualty Care Research Program; Department of Defense, through the Joint Program Committee 6/Combat Casualty Care Research Program-Psychological Health and Traumatic Brain Injury ProgramUnited States Department of Defense [W81XWH1420151]	This publication was made possible in part with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded in part by the National Collegiate Athletic Association (NCAA) and the US Department of Defense (DOD). The US Army Medical Research Acquisition Activity, 820 Chandler St, Fort Detrick, Maryland, is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Combat Casualty Care Research Program, endorsed by the Department of Defense, through the Joint Program Committee 6/Combat Casualty Care Research Program-Psychological Health and Traumatic Brain Injury Program under award W81XWH1420151.	Asken BM, 2019, ANN BIOMED ENG, V47, P2094, DOI 10.1007/s10439-018-2088-5; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Campolettano ET, 2019, ANN BIOMED ENG, V47, P2086, DOI 10.1007/s10439-019-02309-x; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Rowson S, 2019, ANN BIOMED ENG, V47, P2048, DOI 10.1007/s10439-019-02329-7; Stemper BD, 2020, MED SCI SPORTS EXERC, DOI [10.1249/MSS.0000000000002283, DOI 10.1249/MSS.0000000000002283]; Stemper BD, 2019, ANN BIOMED ENG, V47, P2073, DOI 10.1007/s10439-019-02335-9; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165	16	5	5	2	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	MAR	2021	78	3					346	350		10.1001/jamaneurol.2020.5193		FEB 2021	5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QV3UL	WOS:000614935700001	33523101	Green Published			2022-02-06	
J	Woods, KS; Horvat, CM; Kantawala, S; Simon, DW; Rakkar, J; Kochanek, PM; Clark, RSB; Au, AK				Woods, Kendra S.; Horvat, Christopher M.; Kantawala, Sajel; Simon, Dennis W.; Rakkar, Jaskaran; Kochanek, Patrick M.; Clark, Robert S. B.; Au, Alicia K.			Intracranial and Cerebral Perfusion Pressure Thresholds Associated With Inhospital Mortality Across Pediatric Neurocritical Care*	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						cerebral perfusion pressure; intracranial hypertension; pediatric critical care		Objectives: Targets for treatment of raised intracranial pressure or decreased cerebral perfusion pressure in pediatric neurocritical care are not well defined. Current pediatric guidelines, based on traumatic brain injury, suggest an intracranial pressure target of less than 20 mm Hg and cerebral perfusion pressure minimum of 40-50 mm Hg, with possible age dependence of cerebral perfusion pressure. We sought to define intracranial pressure and cerebral perfusion pressure thresholds associated with inhospital mortality across a large single-center pediatric neurocritical care cohort. Design: Retrospective chart review. Setting: PICU, single quaternary-care center. Patients: Individuals receiving intracranial pressure monitoring from January 2012 to December 2016. Interventions: None. Measurements and Main Results: Intracranial pressure and cerebral perfusion pressure measurements from 262 neurocritical care patients (87 traumatic brain injury and 175 nontraumatic brain injury; 63% male; 8.3 +/- 5.8 yr; mortality 11.1%). Mean intracranial pressure and cerebral perfusion pressure had area under the receiver operating characteristic curves of 0.75 and 0.64, respectively, for association of inhospital mortality. Cerebral perfusion pressure cut points increased with age (< 2 yr = 47, 2 to < 8 yr = 58 mm Hg, >= 8 yr = 73 mm Hg). In the traumatic brain injury subset, mean intracranial pressure and cerebral perfusion pressure had area under the receiver operating characteristic curves of 0.70 and 0.78, respectively, for association of inhospital mortality. Traumatic brain injury cerebral perfusion pressure cut points increased with age (< 2 yr = 45, 2 to < 8 yr = 57, >= 8 yr = 68 mm Hg). Mean intracranial pressure greater than 15 mm Hg, male sex, and traumatic brain injury status were independently associated with inhospital mortality (odds ratio, 14.23 [5.55-36.46], 2.77 [1.04-7.39], and 2.57 [1.03-6.38], respectively; all p < 0.05). Mean cerebral perfusion pressure less than 67 mm Hg and traumatic brain injury status were independently associated with inhospital mortality (odds ratio, 5.16 [2.05-12.98] and 3.71 [1.55-8.91], respectively; both p < 0.01). In the nontraumatic brain injury subset, mean intracranial pressure had an area under the receiver operating characteristic curve 0.77 with an intracranial pressure cut point of 15 mm Hg, whereas mean cerebral perfusion pressure was not predictive of inhospital mortality. Conclusions: We identified mean intracranial pressure thresholds, utilizing receiver operating characteristic and regression analyses, associated with inhospital mortality that is below current guidelines-based treatment targets in both traumatic brain injury and nontraumatic brain injury patients, and age-dependent cerebral perfusion pressure thresholds associated with inhospital mortality that were above current guidelines-based targets in traumatic brain injury patients. Further study is warranted to identify data-driven intracranial pressure and cerebral perfusion pressure targets in children undergoing intracranial pressure monitoring, whether for traumatic brain injury or other indications.	[Woods, Kendra S.; Horvat, Christopher M.; Kantawala, Sajel; Simon, Dennis W.; Rakkar, Jaskaran; Kochanek, Patrick M.; Clark, Robert S. B.; Au, Alicia K.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15213 USA; [Woods, Kendra S.] Southern Illinois Univ, Dept Pediat, Div Crit Care, Sch Med, Springfield, IL USA; [Horvat, Christopher M.; Simon, Dennis W.; Rakkar, Jaskaran; Kochanek, Patrick M.; Clark, Robert S. B.; Au, Alicia K.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Horvat, Christopher M.; Kantawala, Sajel; Clark, Robert S. B.; Au, Alicia K.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Hlth Informat Clin Effectiveness, Pittsburgh, PA 15213 USA; [Horvat, Christopher M.; Simon, Dennis W.; Kochanek, Patrick M.; Clark, Robert S. B.; Au, Alicia K.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Brain Care Inst, Pittsburgh, PA 15213 USA; [Simon, Dennis W.; Kochanek, Patrick M.; Clark, Robert S. B.; Au, Alicia K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Sch Med, Pittsburgh, PA 15213 USA; [Woods, Kendra S.; Horvat, Christopher M.; Kantawala, Sajel; Simon, Dennis W.; Rakkar, Jaskaran; Kochanek, Patrick M.; Clark, Robert S. B.; Au, Alicia K.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA		Au, AK (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15213 USA.; Au, AK (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.; Au, AK (corresponding author), Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Hlth Informat Clin Effectiveness, Pittsburgh, PA 15213 USA.; Au, AK (corresponding author), Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Brain Care Inst, Pittsburgh, PA 15213 USA.; Au, AK (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Sch Med, Pittsburgh, PA 15213 USA.	auak@upmc.edu		Rakkar, Jaskaran/0000-0002-4786-1807	Children's Trust Fund; University of Pittsburgh Medical Center Children's Hospital of Pittsburgh Scientific Program; Society of Critical Care Medicine; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD);  [K23 NS104133];  [1K23 HD099331-01A1];  [T32 HD040686];  [R21 NS115174]	Supported, in part, by K23 NS104133 (to Dr. Au), 1K23 HD099331-01A1 (to Dr. Horvat), T32 HD040686 (to Dr. Rakkar), R21 NS115174 (to Dr. Clark), The Children's Trust Fund (to Drs. Horvat and Simon), and the University of Pittsburgh Medical Center Children's Hospital of Pittsburgh Scientific Program. Dr. Kochanek received funding from the Society of Critical Care Medicine (Editor-in-Chief of Pediatric Critical Care Medicine). Drs. Clark and Au are funded by the National Institute of Neurological Disorders and Stroke. Drs. Horvat and Rakkar are funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The remaining authors have disclosed that they do not have any potential conflicts of interest. For information regarding this article, E-mail: auak@upmc.edu	Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; BARZILAY Z, 1988, INTENS CARE MED, V14, P417, DOI 10.1007/BF00262899; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carter BG, 2008, CHILD NERV SYST, V24, P245, DOI 10.1007/s00381-007-0461-z; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; CHIRON C, 1992, J NUCL MED, V33, P696; Cruz J, 2002, NEUROSURGERY, V50, P774, DOI 10.1097/00006123-200204000-00017; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P280, DOI 10.1097/PCC.0000000000001736; Lescot T, 2011, INTENS CARE MED, V37, P875, DOI 10.1007/s00134-011-2182-8; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; PFENNINGER J, 1983, INTENS CARE MED, V9, P13, DOI 10.1007/BF01693699; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Suzuki K., 1990, NAGOYA MED J, V34, P159; Takahashi T, 1999, AM J NEURORADIOL, V20, P917; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vavilala MS, 2003, J NEUROSURG ANESTH, V15, P307, DOI 10.1097/00008506-200310000-00003; Wainwright Mark S, 2012, Acta Neurochir Suppl, V114, P67, DOI 10.1007/978-3-7091-0956-4_12; Walker CT, 2012, PEDIATR NEUROSURG, V48, P342, DOI 10.1159/000353608	25	5	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	FEB	2021	22	2					135	146		10.1097/PCC.0000000000002618			12	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	RL9RG	WOS:000639300000005	33229873	Green Accepted			2022-02-06	
J	Korley, F; Pauls, Q; Yeatts, SD; Jones, CMC; Corbett-Valade, E; Silbergleit, R; Frankel, M; Barsan, W; Cahill, ND; Bazarian, JJ; Wright, DW				Korley, Frederick; Pauls, Qi; Yeatts, Sharon D.; Jones, Courtney Marie Cora; Corbett-Valade, Emily; Silbergleit, Robert; Frankel, Michael; Barsan, William; Cahill, Nathan D.; Bazarian, Jeffrey J.; Wright, David W.		NETT Investigators	Progesterone Treatment Does Not Decrease Serum Levels of Biomarkers of Glial and Neuronal Cell Injury in Moderate and Severe Traumatic Brain Injury Subjects: A Secondary Analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III Trial	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; biomarkers; head trauma; traumatic brain injury		Early treatment of moderate/severe traumatic brain injury (TBI) with progesterone does not improve clinical outcomes. This is in contrast with findings from pre-clinical studies of progesterone in TBI. To understand the reasons for the negative clinical trial, we investigated whether progesterone treatment has the desired biological effect of decreasing brain cell death. We quantified brain cell death using serum levels of biomarkers of glial and neuronal cell death (glial fibrillary acidic protein [GFAP], ubiquitin carboxy-terminal hydrolase-L1 [UCH-L1], S100 calcium-binding protein B [S100B], and Alpha II Spectrin Breakdown Product 150 [SBDP]) in the Biomarkers of Injury and Outcome-Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (BIO-ProTECT) study. Serum levels of GFAP, UCHL1, S100B, and SBDP were measured at baseline (<= 4 h post-injury and before administration of study drug) and at 24 and 48 h post-injury. Serum progesterone levels were measured at 24 and 48 h post-injury. The primary outcome of ProTECT was based on the Glasgow Outcome Scale-Extended assessed at 6 months post-randomization. We found that at baseline, there were no differences in biomarker levels between subjects randomized to progesterone treatment and those randomized to placebo (p > 0.10). Similarly, at 24 and 48 h post-injury, there were no differences in biomarker levels in the progesterone versus placebo groups (p > 0.15). There was no statistically significant correlation between serum progesterone concentrations and biomarker values obtained at 24 and 48 h. When examined as a continuous variable, baseline biomarker levels did not modify the association between progesterone treatment and neurological outcome (p of interaction term >0.39 for all biomarkers). We conclude that progesterone treatment does not decrease levels of biomarkers of glial and neuronal cell death during the first 48 h post-injury.	[Korley, Frederick; Silbergleit, Robert; Barsan, William] Univ Michigan, Dept Emergency Med, Med Sch, 24 Frank Lloyd Wright Dr,Suite 3100, Ann Arbor, MI 48105 USA; [Pauls, Qi; Yeatts, Sharon D.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Jones, Courtney Marie Cora; Corbett-Valade, Emily; Bazarian, Jeffrey J.] Univ Rochester, Dept Emergency Med, Sch Med & Dent, Rochester, NY USA; [Jones, Courtney Marie Cora; Bazarian, Jeffrey J.] Univ Rochester, Dept Publ Hlth Sci, Sch Med & Dent, Rochester, NY USA; [Bazarian, Jeffrey J.] Univ Rochester, Dept Neurol, Sch Med & Dent, Rochester, NY USA; [Bazarian, Jeffrey J.] Univ Rochester, Dept Neurosurg, Sch Med & Dent, Rochester, NY USA; [Bazarian, Jeffrey J.] Univ Rochester, Dept Phys Med & Rehabil, Sch Med & Dent, Rochester, NY USA; [Frankel, Michael] Emory Univ, Sch Med, Dept Neurol, Grady Mem Hosp,Marcus Stroke & Neurosci Ctr, Atlanta, GA 30322 USA; [Wright, David W.] Emory Univ, Sch Med, Dept Emergency Med, Grady Mem Hosp,Marcus Stroke & Neurosci Ctr, Atlanta, GA USA; [Cahill, Nathan D.] Rochester Inst Technol, Sch Math Sci, Rochester, NY 14623 USA		Korley, F (corresponding author), Univ Michigan, Dept Emergency Med, Med Sch, 24 Frank Lloyd Wright Dr,Suite 3100, Ann Arbor, MI 48105 USA.	korley@med.umich.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS062778, 5U10NS059032, U01NS056975]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000454]; Emory Emergency Neurosciences Laboratory in the Department of Emergency Medicine, Emory School of Medicine; Grady Memorial Hospital	Supported by grants from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NS062778, 5U10NS059032, and U01NS056975) and the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1TR000454) and by the Emory Emergency Neurosciences Laboratory in the Department of Emergency Medicine, Emory School of Medicine, and Grady Memorial Hospital.	Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; Chen SY, 2016, EXP THER MED, V11, P2049, DOI 10.3892/etm.2016.3153; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Ercole A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0614-3; Frankel M, 2019, J NEUROTRAUM, V36, P2863, DOI 10.1089/neu.2018.5809; Hellewell SC, 2018, CRIT CARE MED, V46, P554, DOI 10.1097/CCM.0000000000002938; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Korley FK, 2019, J NEUROTRAUM, V36, P182, DOI 10.1089/neu.2017.5623; Korley FK, 2018, J NEUROTRAUM, V35, P1185, DOI 10.1089/neu.2017.5581; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; Office of the Government of the Czech Republic, 2006, DOM VIOL CHILD AB NE, P1; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2015, NEUROCRIT CARE, V22, P52, DOI 10.1007/s12028-014-0028-2; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	21	5	5	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2021	38	14					1953	1960		10.1089/neu.2020.7072		JAN 2021	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TD0YA	WOS:000613464600001	33319651				2022-02-06	
J	Hanscom, M; Loane, DJ; Aubretch, T; Leser, J; Molesworth, K; Hedgekar, N; Ritzel, RM; Abulwerdi, G; Shea-Donohue, T; Faden, AI				Hanscom, Marie; Loane, David J.; Aubretch, Taryn; Leser, Jenna; Molesworth, Kara; Hedgekar, Nivedita; Ritzel, Rodney M.; Abulwerdi, Gelareh; Shea-Donohue, Terez; Faden, Alan I.			Acute colitis during chronic experimental traumatic brain injury in mice induces dysautonomia and persistent extraintestinal, systemic, and CNS inflammation with exacerbated neurological deficits	JOURNAL OF NEUROINFLAMMATION			English	Article						TBI; DSS; Colitis; Neuroinflammation; Neurodegeneration; Neurobehavior; Systemic inflammation; Intestinal inflammation; Dysautonomia; Brain-gut		Background Disruptions of brain-gut axis have been implicated in the progression of a variety of gastrointestinal (GI) disorders and central nervous system (CNS) diseases and injuries, including traumatic brain injury (TBI). TBI is a chronic disease process characterized by persistent secondary injury processes which can be exacerbated by subsequent challenges. Enteric pathogen infection during chronic TBI worsened cortical lesion volume; however, the pathophysiological mechanisms underlying the damaging effects of enteric challenge during chronic TBI remain unknown. This preclinical study examined the effect of intestinal inflammation during chronic TBI on associated neurobehavioral and neuropathological outcomes, systemic inflammation, and dysautonomia. Methods Dextran sodium sulfate (DSS) was administered to adult male C57BL/6NCrl mice 28 days following craniotomy (Sham) or TBI for 7 days to induce intestinal inflammation, followed by a return to normal drinking water for an additional 7 to 28 days for recovery; uninjured animals (Naive) served as an additional control group. Behavioral testing was carried out prior to, during, and following DSS administration to assess changes in motor and cognitive function, social behavior, and mood. Electrocardiography was performed to examine autonomic balance. Brains were collected for histological and molecular analyses of injury lesion, neurodegeneration, and neuroinflammation. Blood, colons, spleens, mesenteric lymph nodes (mLNs), and thymus were collected for morphometric analyses and/or immune characterization by flow cytometry. Results Intestinal inflammation 28 days after craniotomy or TBI persistently induced, or exacerbated, respectively, deficits in fine motor coordination, cognition, social behavior, and anxiety-like behavior. Behavioral changes were associated with an induction, or exacerbation, of hippocampal neuronal cell loss and microglial activation in Sham and TBI mice administered DSS, respectively. Acute DSS administration resulted in a sustained systemic immune response with increases in myeloid cells in blood and spleen, as well as myeloid cells and lymphocytes in mesenteric lymph nodes. Dysautonomia was also induced in Sham and TBI mice administered DSS, with increased sympathetic tone beginning during DSS administration and persisting through the first recovery week. Conclusion Intestinal inflammation during chronic experimental TBI causes a sustained systemic immune response and altered autonomic balance that are associated with microglial activation, increased neurodegeneration, and persistent neurological deficits.	[Hanscom, Marie; Loane, David J.; Aubretch, Taryn; Leser, Jenna; Molesworth, Kara; Hedgekar, Nivedita; Ritzel, Rodney M.; Abulwerdi, Gelareh; Faden, Alan I.] Univ Maryland, Sch Med, Trauma & Anesthesiol Res STAR Ctr, Dept Anesthesiol & Shock, 685 West Baltimore St,MSTF 6-016, Baltimore, MD 21201 USA; [Loane, David J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland; [Shea-Donohue, Terez] Univ Maryland, Sch Med, Dept Radiat Oncol, Div Translat Radiat Sci DTRS, Baltimore, MD 21201 USA		Hanscom, M (corresponding author), Univ Maryland, Sch Med, Trauma & Anesthesiol Res STAR Ctr, Dept Anesthesiol & Shock, 685 West Baltimore St,MSTF 6-016, Baltimore, MD 21201 USA.	mariehanscom@gmail.com	Loane, David/ABD-5177-2021	Loane, David/0000-0003-0393-3503; Hanscom, Marie/0000-0001-8308-135X	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS110756, R01A1/DK-042316]; Science Foundation IrelandScience Foundation IrelandEuropean Commission [17/FRL/4860]; NIH (NIDDK) T32 award [DK067872]; Brain Injury Association of America Dissertation Award (Brain Injury Association of America's Brain Injury Research Fund)	This work was supported by National Institutes of Health (NIH) grants (R01NS110756, Dr. Alan I. Faden/Dr. David J. Loane; R01A1/DK-042316, Dr. Terez Shea-Donohue), and a Science Foundation Ireland grant (Dr. David J. Loane, 17/FRL/4860). Marie Hanscom was supported by an NIH (NIDDK) T32 award (DK067872; PI, Jean-Pierre Raufman) and a Brain Injury Association of America Dissertation Award (Brain Injury Association of America's Brain Injury Research Fund).	AGGARWAL A, 1994, GASTROENTEROLOGY, V106, P945, DOI 10.1016/0016-5085(94)90753-6; AKSELROD S, 1988, TRENDS PHARMACOL SCI, V9, P6, DOI 10.1016/0165-6147(88)90230-1; Al Omran Y, 2014, ADV EXP MED BIOL, V817, P135, DOI 10.1007/978-1-4939-0897-4_6; Ananthakrishnan AN, 2010, J CLIN GASTROENTEROL, V44, P272, DOI 10.1097/MCG.0b013e3181b2682a; Angoa-Perez M, 2013, JOVE-J VIS EXP, DOI 10.3791/50978; Babickova J, 2015, INFLAMMATION, V38, P1996, DOI 10.1007/s10753-015-0180-7; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Barrett JP, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0843-4; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Berberat PO, 2005, INFLAMM BOWEL DIS, V11, P350, DOI 10.1097/01.MIB.0000164017.06538.8a; Bernstein CN, 2019, INFLAMM BOWEL DIS, V25, P360, DOI 10.1093/ibd/izy235; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bramhall M, 2015, INFLAMM BOWEL DIS, V21, P1248, DOI 10.1097/MIB.0000000000000369; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Cailotto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087785; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Ciesielczyk K, 2017, ARCH MED SCI, V13, P246, DOI 10.5114/aoms.2015.55147; Clarke Gerard, 2020, Brain Behav Immun Health, V5, P100093, DOI 10.1016/j.bbih.2020.100093; Clipperton-Allen AE, 2014, HUM MOL GENET, V23, P3490, DOI 10.1093/hmg/ddu057; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Corrigan F, 2017, BRAIN BEHAV IMMUN, V64, P124, DOI 10.1016/j.bbi.2017.04.006; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; Cryan JF, 2019, PHYSIOL REV, V99, P1877, DOI 10.1152/physrev.00018.2018; Dantzer R, 2004, EUR J PHARMACOL, V500, P399, DOI 10.1016/j.ejphar.2004.07.040; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Deepika A, 2018, J NEUROTRAUM, V35, P1124, DOI 10.1089/neu.2017.5151; Doran SJ, 2020, CRIT CARE MED, V48, pE418, DOI 10.1097/CCM.0000000000004273; Elderman M, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0075-9; Emge JR, 2016, AM J PHYSIOL-GASTR L, V310, pG989, DOI 10.1152/ajpgi.00086.2016; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Fan WJ, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00107; Feng YK, 2019, BRAIN RES, V1707, P8, DOI 10.1016/j.brainres.2018.11.019; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Ferro JM, 2014, NEUROLOGIC ASPECTS 2, V120, P595; Filipovic BR, 2014, WORLD J GASTROENTERO, V20, P3552, DOI 10.3748/wjg.v20.i13.3552; Royes LFF, 2019, NEUROSCI BIOBEHAV R, V102, P345, DOI 10.1016/j.neubiorev.2019.05.012; Fu PF, 2020, ACS CHEM NEUROSCI, V11, P395, DOI 10.1021/acschemneuro.9b00607; Gampierakis I-A., 2020, MOL PSYCHIAT, V22, P1; Ghezzi A, 2001, NEUROL SCI, V22, pS117, DOI 10.1007/s100720100048; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Halfvarson J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.4; Han Y, 2018, NEUROSCI BULL, V34, P1058, DOI 10.1007/s12264-018-0288-5; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Heberling CA, 2013, MED HYPOTHESES, V80, P264, DOI 10.1016/j.mehy.2012.11.044; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Jackson JR, 2012, PSYCHIAT QUART, V83, P91, DOI 10.1007/s11126-011-9186-y; Jang SH, 2017, CHIN J NAT MEDICINES, V15, P192, DOI 10.1016/S1875-5364(17)30035-3; Jin HF, 2017, AM J PHYSIOL-GASTR L, V313, pG192, DOI 10.1152/ajpgi.00254.2016; Jin W, 2008, CYTOKINE, V44, P135, DOI 10.1016/j.cyto.2008.07.005; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kabadi SV, 2014, J CEREBR BLOOD F MET, V34, P502, DOI 10.1038/jcbfm.2013.228; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; Kao CH, 1998, AM J GASTROENTEROL, V93, P1108; Kealy J, 2020, J NEUROSCI, V40, P5681, DOI 10.1523/JNEUROSCI.2876-19.2020; Khan I, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8030126; Knox Natalie C, 2019, Curr Treat Options Gastroenterol, V17, P115, DOI 10.1007/s11938-019-00221-w; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Lagraoui M, 2012, FRONT NEUROL, V3; Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084; Lee HJ, 2018, MICROBIOL BIOTECHN L, V28, P175, DOI 10.4014/jmb.1709.09042; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Long TM, 2013, INFLAMM BOWEL DIS, V19, P1295, DOI 10.1097/MIB.0b013e318281f2fd; LOSSOS A, 1995, NEUROLOGY, V45, P416, DOI 10.1212/WNL.45.3.416; Ma EL, 2017, BRAIN BEHAV IMMUN, V66, P56, DOI 10.1016/j.bbi.2017.06.018; Matisz CE, 2020, PHYSIOL BEHAV, V216, DOI 10.1016/j.physbeh.2020.112802; Matteoli G, 2014, GUT, V63, P938, DOI 10.1136/gutjnl-2013-304676; McGlade E, 2015, BRAIN IMAGING BEHAV, V9, P535, DOI 10.1007/s11682-015-9379-3; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Munyaka P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109272; Neto JIS, 2004, ARQ NEURO-PSIQUIAT, V62, P969, DOI 10.1590/S0004-282X2004000600007; Neuendorf R, 2016, J PSYCHOSOM RES, V87, P70, DOI 10.1016/j.jpsychores.2016.06.001; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Nyuyki KD, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00058; Obenaus A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00161-4; OLESEN SP, 1987, ACTA PHYSIOL SCAND, V130, P63, DOI 10.1111/j.1748-1716.1987.tb08112.x; Olsen AB, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12121; Oria RB, 2016, NUTR REV, V74, P374, DOI 10.1093/nutrit/nuw008; Painsipp E, 2011, BRIT J PHARMACOL, V163, P1302, DOI 10.1111/j.1476-5381.2011.01326.x; Pathare N, 2020, BIOL RES NURS, V22, P495, DOI 10.1177/1099800420943961; Petruo VA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14345-5; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Ponsford J, 2018, J NEUROPSYCH CLIN N, V30, P262, DOI 10.1176/appi.neuropsych.18040093; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ritzel RM, 2020, NEUROBIOL DIS, V136, DOI 10.1016/j.nbd.2019.104713; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Rustgi SD, 2020, THER ADV GASTROENTER, V13, DOI 10.1177/1756284820915043; Sankaran-Walters S, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-10; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Schaffert J, 2018, NEUROPSYCHOLOGY, V32, P410, DOI 10.1037/neu0000423; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Shifrin H, 2017, J NEUROIMMUNE PHARM, V12, P484, DOI 10.1007/s11481-017-9735-8; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Stoyell-Conti FF, 2018, J CARDIOVASC ECHOGR, V28, P90, DOI 10.4103/jcecho.jcecho_51_17; Sun P, 2013, PLOS ONE, V8; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Tadin Hadjina, 2019, SCI REP-UK, V9; Tan M, 2011, BRIT J NEUROSURG, V25, P2, DOI 10.3109/02688697.2010.522745; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Urban RJ, 2020, J NEUROTRAUM, V37, P1037, DOI 10.1089/neu.2019.6688; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Valiyaveettil M, 2012, NEUROSCI LETT, V506, P141, DOI 10.1016/j.neulet.2011.10.067; van Langenberg DR, 2017, UNITED EUR GASTROENT, V5, P579, DOI 10.1177/2050640616663397; Villapol S, 2018, CELL MOL NEUROBIOL, V38, P121, DOI 10.1007/s10571-017-0554-5; Villaran RF, 2010, J NEUROCHEM, V114, P1687, DOI 10.1111/j.1471-4159.2010.06879.x; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Waddell J, 2016, EXP NEUROL, V275, P285, DOI 10.1016/j.expneurol.2015.09.003; Wagnerova A, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/8051870; Wang H, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw677; Wilson RS, 2007, NEUROLOGY, V69, P1911, DOI 10.1212/01.wnl.0000271087.67782.cb; Yu YRA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150606; Zhang B, 2020, GUT; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zhu CS, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060113; Zonis S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0281-0	128	5	5	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JAN 18	2021	18	1							24	10.1186/s12974-020-02067-x			31	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	PY2JM	WOS:000611875100002	33461596	gold, Green Published			2022-02-06	
J	Haider, MN; Patel, KS; Willer, BS; Videira, V; Wilber, CG; Mayer, AR; Master, CL; Mariotti, BL; Wertz, C; Storey, EP; Arbogast, KB; Park, G; Oglesbee, SJ; Bezherano, I; Aguirre, K; Fodero, JG; Johnson, BD; Mannix, R; Miecznikowski, JC; Leddy, JJ				Haider, M. Nadir; Patel, Kush S.; Willer, Barry S.; Videira, Victoria; Wilber, Charles G.; Mayer, Andrew R.; Master, Christina L.; Mariotti, Brandon L.; Wertz, Christopher; Storey, Eileen P.; Arbogast, Kristy B.; Park, Grace; Oglesbee, Scott J.; Bezherano, Itai; Aguirre, Kenneth; Fodero, Jesse G.; Johnson, Blair D.; Mannix, Rebekah; Miecznikowski, Jeffrey C.; Leddy, John J.			Symptoms upon postural change and orthostatic hypotension in adolescents with concussion	BRAIN INJURY			English	Article						concussion; adolescent; orthostatic intolerance; orthostatic hypotension; autonomic nervous system		Objective: Concussion is associated with dysautonomia, altered blood pressure (BP) control, and may cause Orthostatic Hypotension (OH). We measured prevalence of OH using the 1-minute supine-to-standing OH Test in adolescents with concussion and controls. Participants: Adolescents within 10 days of injury (Concussion Group, n = 297, 15.0 +/- 1.7 years, 59% male) were compared with controls (Control Group, n = 214, 15.0 +/- 1.5 years, 58% male). Methods: BP, heart rate (HR), and complaints of lightheadedness/dizziness were measured after 2-minute supine and 1-minute standing. Control Group was assessed once. Concussion Group was assessed twice; (1) initial visit (mean 6.0 +/- 3 days-since-injury) and (2) after clinical recovery (mean 46.3 +/- 42 days-since-injury). Results: Initial visit; Concussion Group reported feeling lightheaded/dizzy on postural change more often than the Control Group (37% vs 4%, p < .001) but did not differ in meeting standard OH criteria (3% vs 5%, p = .32). Experiencing symptoms did not correlate with meeting OH criteria, but correlated with abnormal vestibulo-ocular reflex. After clinical recovery; Concussion Group did not differ in experiencing lightheaded/dizziness on postural change than controls (4%, p = .65). Conclusion: Adolescents commonly experience orthostatic intolerance after concussion without meeting the standard criteria for OH.	[Haider, M. Nadir; Patel, Kush S.; Wilber, Charles G.; Bezherano, Itai; Aguirre, Kenneth; Leddy, John J.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, UBMD Dept Orthopaed & Sports Med, Buffalo, NY 14214 USA; [Haider, M. Nadir; Mariotti, Brandon L.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Willer, Barry S.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY 14214 USA; [Videira, Victoria] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Mayer, Andrew R.; Wertz, Christopher] Mind Res Network Lovelace Biomed & Environm Res I, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol & Psychiat, Albuquerque, NM USA; [Master, Christina L.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Div Orthoped Surg, Philadelphia, PA 19104 USA; [Master, Christina L.; Storey, Eileen P.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Park, Grace; Oglesbee, Scott J.] Univ New Mexico Hosp, Dept Emergency Med, Albuquerque, NM USA; [Fodero, Jesse G.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Emergency Med, Buffalo, NY 14214 USA; [Johnson, Blair D.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Exercise & Nutr Sci, Buffalo, NY 14214 USA; [Mannix, Rebekah] Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA; [Miecznikowski, Jeffrey C.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Biostat, Buffalo, NY 14214 USA		Haider, MN (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, UBMD Dept Orthopaed & Sports Med, Buffalo, NY 14214 USA.	haider@buffalo.edu		Johnson, Blair/0000-0002-1731-4415; Willer, Barry/0000-0002-9586-8448	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS094444]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [01 R01 NS098494-01A1, 1R01 NS097549-01A1]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01 NS094444 (JJL), NIH 01 R01 NS098494-01A1 (ARM), 1R01 NS097549-01A1 (CLM, KBA) and the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412 (JJL) to the University at Buffalo. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; [Anonymous], 1996, J NEUROL SCI, V144, P218; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Arciniegas, 2019, TXB TRAUMATIC BRAIN, P1880; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Bazarian JJ, 2010, J HEAD TRAUMA REHAB, V25, P225, DOI 10.1097/HTR.0b013e3181e7f784; Bighamian R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/459269; Bourgeois B, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009233; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Chapleau MW., 2012, BARORECEPTOR REFLEXE, P00161; Chorin E, 2015, AM J HYPERTENS, V28, P1157, DOI 10.1093/ajh/hpv007; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Cooke J, 2009, QJM-INT J MED, V102, P335, DOI 10.1093/qjmed/hcp020; Echemendia RJ., 2017, BR J SPORTS MED; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Giza CC, 2014, NEUROSURGERY, V75; Haider MN, 2020, CLIN J SPORT MED, V30, P513, DOI 10.1097/JSM.0000000000000687; Hasser EM, 2001, ANN NY ACAD SCI, V940, P454; Heyer GL, 2018, CLIN J SPORT MED, V28, P272, DOI 10.1097/JSM.0000000000000445; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Jaquet F, 1998, J HUM HYPERTENS, V12, P253, DOI 10.1038/sj.jhh.1000592; Juraschek SP, 2017, JAMA INTERN MED, V177, P1316, DOI 10.1001/jamainternmed.2017.2937; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kokorelis C, 2020, CLIN PEDIATR, V59, P75, DOI 10.1177/0009922819885656; Kolev OI, 2016, FUNCT NEUROL, V31, P75; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Low PA, 2008, CLIN AUTON RES, V18, P8, DOI 10.1007/s10286-007-1001-3; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKeag DB, 2009, CLIN J SPORT MED, V19, P343, DOI 10.1097/JSM.0b013e3181b2c114; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mujika I, 2000, SPORTS MED, V30, P79, DOI 10.2165/00007256-200030020-00002; Olufsen MS, 2005, J APPL PHYSIOL, V99, P1523, DOI 10.1152/japplphysiol.00177.2005; Pertab JL, 2018, NEUROREHABILITATION, V42, P397, DOI 10.3233/NRE-172298; Polak P, 2015, J HEAD TRAUMA REHAB, V30, pE32, DOI 10.1097/HTR.0000000000000037; Reneker JC, 2015, J SCI MED SPORT, V18, P366, DOI 10.1016/j.jsams.2014.05.002; Sala R, 2016, J SPORT MED PHYS FIT, V56, P794; SEDLMEIER P, 1989, PSYCHOL BULL, V105, P309, DOI 10.1037/0033-2909.105.2.309; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; Stewart JM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1673; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Wieling W, 2007, CLIN SCI, V112, P157, DOI 10.1042/CS20060091; Zhang J, 2007, J MANIP PHYSIOL THER, V30, P374, DOI 10.1016/j.jmpt.2007.04.001; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720	49	5	5	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 18	2021	35	2					226	232		10.1080/02699052.2021.1871951		JAN 2021	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QW7IZ	WOS:000608294500001	33459038	Green Accepted			2022-02-06	
J	Burma, JS; Copeland, PV; Macaulay, A; Smirl, JD				Burma, Joel S.; Copeland, Paige V.; Macaulay, Alannah; Smirl, Jonathan D.			The impact of high- and moderate-intensity exercise on near-point of convergence metrics	BRAIN INJURY			English	Article						Near point of convergence; divergence; diplopia; exercise; acute recovery; vision		Background: Near point of convergence (NPC) assesses the vergence ability of the visuo-oculomotor system; however, little is known regarding: the extent and duration exercise impacts NPC and the between- and within-day reliability of NPC metrics. Methods: An accommodative ruler with a miniature Snellen chart was placed upon the philtrum (upper lip). Participants (n=9) focused upon a 'V' sized 20/20, while the chart was moved at similar to 1-2 cm/s toward and away from the eyes (twice in each direction). Testing commenced at 8:00am with NPC measures being collected at baseline before three randomized conditions with serial follow-ups occurring at six post-condition timepoints (0-8 hours following). The conditions consisted of 25-minutes high-intensity intervals (10, one-minute intervals at similar to 85-90% heart-rate reserve), 45-minutes of moderate-intensity exercise (at similar to 50-60% heart-rate reserve), and a control condition (30-minutes quiet rest). Results: NPC was not impacted across any of the three conditions (all p > .59). Additionally, NPC measures between baseline conditions and across the control condition displayed very high levels of within-day and between-day reliability (coefficient of variation <3.8%). Conclusions: Future NPC measures using an accommodative ruler can be taken immediately following exercise and may be pertinent as a complementary tool in the future sideline screening of concussion.	[Burma, Joel S.; Copeland, Paige V.; Macaulay, Alannah; Smirl, Jonathan D.] Univ British Columbia, Fac Hlth & Exercise Sci, Concuss Res Lab, Kelowna, BC, Canada; [Burma, Joel S.; Smirl, Jonathan D.] Univ Calgary, Fac Kinesiol, Cerebrovasc Concuss Lab, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Burma, Joel S.; Smirl, Jonathan D.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Burma, Joel S.; Smirl, Jonathan D.] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada; [Burma, Joel S.; Smirl, Jonathan D.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Burma, Joel S.; Smirl, Jonathan D.] Univ Calgary, Integrated Concuss Res Program, Calgary, AB, Canada; [Burma, Joel S.; Smirl, Jonathan D.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Burma, Joel S.; Smirl, Jonathan D.] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada		Burma, JS (corresponding author), Univ Calgary, Fac Kinesiol, Cerebrovasc Concuss Lab, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	joel.burma@ucalgary.ca	Burma, Joel/AAL-1073-2021	Burma, Joel/0000-0001-9756-5793	Canada Foundation for InnovationCanada Foundation for InnovationCGIAR [30979]; Mitacs [IT03862]; Natural Science and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC) [1274829, 464009, 477210]; Innovations in Wellness Fund [65R25912]	The work was supported through the Canada Foundation for Innovation [30979], Mitacs [IT03862], the Natural Science and Engineering Research Council of Canada [1274829, 464009, 477210] and the Innovations in Wellness Fund [65R25912].	Abraham Neethu G, 2015, Oman J Ophthalmol, V8, P14, DOI 10.4103/0974-620X.149856; Ando S, 2013, EXERC SPORT SCI REV, V41, P87, DOI 10.1097/JES.0b013e318259ad37; Burma JS, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14458; Burma JS, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14467; Burma JS, 2020, APPL PHYSIOL NUTR ME, V45, P1156, DOI 10.1139/apnm-2019-0810; Burma JS, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14367; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Conroy Deirdre A, 2005, J Circadian Rhythms, V3, P3, DOI 10.1186/1740-3391-3-3; Coon S., 2019, ATHL TRAIN SPORT HEA, DOI [10.3928/19425864-20190613-01, DOI 10.3928/19425864-20190613-01]; DuPrey KM, 2017, AM J SPORT MED, V45, P2388, DOI 10.1177/0363546517705640; Eddy R, 2020, CLIN J SPORT MED, V30, P239, DOI 10.1097/JSM.0000000000000586; Fogt N, 2016, CLIN EXP OPTOM, V99, P30, DOI 10.1111/cxo.12301; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; HUNG G, 1986, DOC OPHTHALMOL, V62; Jung ME, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/191595; Kawano Y, 2011, HYPERTENS RES, V34, P281, DOI 10.1038/hr.2010.241; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; MAYS L, 1984, J NEUROPHYSIOL, V51; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; MILLER W, 1993, MED SCI SPORT EXER, V25; Moran Ryan N, 2020, Concussion, V5, pCNC73, DOI 10.2217/cnc-2020-0003; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Myers K J, 1976, J Am Optom Assoc, V47, P515; OMBONI S, 1993, HYPERTENSION, V22, P26, DOI 10.1161/01.HYP.22.1.26; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Phillips J, 2015, J EYE MOVEMENT RES, V8; Raghuram A, 2019, AM J OPHTHALMOL, V206, P235, DOI 10.1016/j.ajo.2019.04.008; Ratka J, 2020, BRAIN INJURY, V34, P110, DOI 10.1080/02699052.2019.1682194; Sammons EL, 2007, J APPL PHYSIOL, V103, P369, DOI 10.1152/japplphysiol.00271.2007; Santo AL, 2020, J SPORT REHABIL, V29, P1179, DOI 10.1123/jsr.2019-0428; Shechter A, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/259345; Thomson K, 2009, J SPORT SCI MED, V8, P259; van Donkelaar P, 2018, INT J SPORTS MED, V39, P682, DOI 10.1055/s-0044-101454; Vera J, 2017, OPTOMETRY VISION SCI, V94, P797, DOI 10.1097/OPX.0000000000001105; Wewege M, 2017, OBES REV, V18, P635, DOI 10.1111/obr.12532; WOODS R, 1995, OPHTHALMIC PHYSL OPT, V15; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	39	5	5	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 18	2021	35	2					248	254		10.1080/02699052.2021.1871953		JAN 2021	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QW7IZ	WOS:000608307000001	33455457				2022-02-06	
J	Ponomarenko, AI; Tyrtyshnaia, AA; Pislyagin, EA; Dyuizen, IV; Sultanov, RM; Manzhulo, IV				Ponomarenko, Arina, I; Tyrtyshnaia, Anna A.; Pislyagin, Evgeny A.; Dyuizen, Inessa, V; Sultanov, Ruslan M.; Manzhulo, Igor, V			N-docosahexaenoylethanolamine reduces neuroinflammation and cognitive impairment after mild traumatic brain injury in rats	SCIENTIFIC REPORTS			English	Article								At present, there is a growing interest in the study of the neurotropic activity of polyunsaturated fatty acids ethanolamides (N-acylethanolamines). N-docosahexaenoylethanolamine (DHEA, synaptamide) is an endogenous metabolite and structural analogue of anandamide, a widely studied endocannabinoid derived from arachidonic acid. The results of this study demonstrate that DHEA, when administered subcutaneously (10 mg/kg/day, 7 days), promotes cognitive recovery in rats subjected to mild traumatic brain injury (mTBI). In the cerebral cortex of experimental animals, we analyzed the dynamics of Iba-1-positive microglia activity changes and the expression of pro-inflammatory markers (IL1 beta, IL6, CD86). We used immortalized mouse microglial cells (SIM-A9) to assess the effects of DHEA on LPS-induced cytokines/ROS/NO/nitrite, as well as on CD206 (anti-inflammatory microglia) and the antioxidant enzyme superoxide dismutase (SOD) production. In vivo and in vitro experiments showed that DHEA: (1) improves indicators of anxiety and long-term memory; (2) inhibits the pro-inflammatory microglial cells activity; (3) decrease the level of pro-inflammatory cytokines/ROS/NO/nitrites; (4) increase CD206 and SOD production. In general, the results of this study indicate that DHEA has a complex effect on the neuroinflammation processes, which indicates its high therapeutic potential.	[Ponomarenko, Arina, I; Tyrtyshnaia, Anna A.; Dyuizen, Inessa, V; Sultanov, Ruslan M.; Manzhulo, Igor, V] Russian Acad Sci, AV Zhirmunsky Natl Sci Ctr Marine Biol, Far Eastern Branch, Vladivostok 690041, Russia; [Pislyagin, Evgeny A.] Russian Acad Sci, GB Elyakov Pacific Inst Bioorgan Chem, Far Eastern Branch, Vladivostok 690022, Russia		Manzhulo, IV (corresponding author), Russian Acad Sci, AV Zhirmunsky Natl Sci Ctr Marine Biol, Far Eastern Branch, Vladivostok 690041, Russia.	i-manzhulo@bk.ru	Manzhulo, Igor V./F-4480-2016		Russian Science FoundationRussian Science Foundation (RSF) [17-74-20006]; Russian Science FoundationRussian Science Foundation (RSF) [20-74-20000] Funding Source: Russian Science Foundation	This study is supported by the Russian Science Foundation (project 17-74-20006).	Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Cacci E, 2008, GLIA, V56, P412, DOI 10.1002/glia.20616; Calder PC, 2010, NUTRIENTS, V2, P355, DOI 10.3390/nu2030355; Calderon F, 2004, J NEUROCHEM, V90, P979, DOI 10.1111/j.1471-4159.2004.02520.x; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; DEVANE WA, 1994, P NATL ACAD SCI USA, V91, P6698, DOI 10.1073/pnas.91.14.6698; Ermolenko E, 2016, J FOOD SCI TECH MYS, V53, P1722, DOI 10.1007/s13197-015-2148-x; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao HM, 2003, J NEUROSCI, V23, P6181; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Haller J., 2013, PSYCHOPHARMACOLOGY B, V230; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Ishiyama T, 2007, EUR J PHARMACOL, V572, P160, DOI 10.1016/j.ejphar.2007.06.058; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kharebava G, 2015, BIOL OPEN, V4, P1660, DOI 10.1242/bio.013425; Kim HY, 2018, MOL ASPECTS MED, V64, P34, DOI 10.1016/j.mam.2018.03.004; Kim HY, 2013, PROSTAG LEUKOTR ESS, V88, P121, DOI 10.1016/j.plefa.2012.08.002; Kim HY, 2011, BIOCHEM J, V435, P327, DOI 10.1042/BJ20102118; Kim JY, 2015, CNS NEUROSCI THER, V21, P309, DOI 10.1111/cns.12360; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; Lehrmann E, 1997, J COMP NEUROL, V386, P461; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Maas E, 2008, AM J SPEECH-LANG PAT, V17, P277, DOI 10.1044/1058-0360(2008/025); Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Martini DN, 2018, INT J PSYCHOPHYSIOL, V132, P25, DOI 10.1016/j.ijpsycho.2017.09.019; McGuire JL, 2019, NEUROBIOL DIS, V132, DOI 10.1016/j.nbd.2019.104611; Miedel CJ, 2017, JOVE-J VIS EXP, DOI 10.3791/55523; Park T, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0751-z; Paton KF, 2020, EUR J PAIN, V24, P1990, DOI 10.1002/ejp.1641; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Rieger AM, 2011, JOVE-J VIS EXP, DOI 10.3791/2597; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sonti S, 2018, CHEM PHYS LIPIDS, V210, P90, DOI 10.1016/j.chemphyslip.2017.11.002; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Tyrtyshnaia A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249703; Tyrtyshnaia AA, 2020, MAR DRUGS, V18, DOI 10.3390/md18100516; Voormolen DC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111921; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Wang YJ, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0587-9	45	5	5	3	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JAN 12	2021	11	1							756	10.1038/s41598-020-80818-9			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM6XP	WOS:000621920400104	33436960	Green Published, gold			2022-02-06	
J	Baban, B; Braun, M; Khodadadi, H; Ward, A; Alverson, K; Malik, A; Nguyen, K; Nazarian, S; Hess, DC; Forseen, S; Post, AF; Vale, FL; Vender, JR; Hoda, MN; Akbari, O; Vaibhav, K; Dhandapani, KM				Baban, Babak; Braun, Molly; Khodadadi, Hesam; Ward, Ayobami; Alverson, Katelyn; Malik, Aneeq; Nguyen, Khoi; Nazarian, Skon; Hess, David C.; Forseen, Scott; Post, Alexander F.; Vale, Fernando L.; Vender, John R.; Hoda, Md Nasrul; Akbari, Omid; Vaibhav, Kumar; Dhandapani, Krishnan M.			AMPK induces regulatory innate lymphoid cells after traumatic brain injury	JCI INSIGHT			English	Article							CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; METFORMIN; INFLAMMATION; ACTIVATION; DIFFERENTIATION; MICRODIALYSIS; DEMENTIA; THERAPY; DISEASE	The CNS is regarded as an immunoprivileged organ, evading routine immune surveillance; however, the coordinated development of immune responses profoundly influences outcomes after brain injury. Innate lymphoid cells (ILCs) are cytokine-producing cells that are critical for the initiation, modulation, and resolution of inflammation, but the functional relevance and mechanistic regulation of ILCs are unexplored after acute brain injury. We demonstrate increased proliferation of all ILC subtypes within the meninges for up to 1 year after experimental traumatic brain injury (TBI) while ILCs were present within resected dura and elevated within cerebrospinal fluid (CSF) of moderate-to-severe TBI patients. In line with energetic derangements after TBI, inhibition of the metabolic regulator, AMPK, increased meningeal ILC expansion, whereas AMPK activation suppressed proinflammatory ILC1/ILC3 and increased the frequency of IL-10-expressing ILC2 after TBI. Moreover, intracisternal administration of IL-33 activated AMPK, expanded ILC2, and suppressed ILC1 and ILC3 within the meninges of WT and Rag1(-/-) mice, but not Rag1(-/-) IL2rg(-/-) mice. Taken together, we identify AMPK as a brake on the expansion of proinflammatory, CNS-resident ILCs after brain injury. These findings establish a mechanistic framework whereby immunometabolic modulation of ILCs may direct the specificity, timing, and magnitude of cerebral immunity.	[Baban, Babak; Khodadadi, Hesam; Malik, Aneeq; Vaibhav, Kumar] Augusta Univ, Dent Coll Georgia, Dept Oral Biol & Diagnost Sci, Augusta, GA USA; [Baban, Babak] Augusta Univ, Med Coll Georgia, Dept Surg, Augusta, GA USA; [Baban, Babak; Khodadadi, Hesam; Hess, David C.] Augusta Univ, Med Coll Georgia, Dept Neurol, Augusta, GA USA; [Braun, Molly; Ward, Ayobami; Alverson, Katelyn; Nguyen, Khoi; Post, Alexander F.; Vale, Fernando L.; Vender, John R.; Vaibhav, Kumar; Dhandapani, Krishnan M.] Augusta Univ, Med Coll Georgia, Dept Neurosurg, Augusta, GA 30912 USA; [Nazarian, Skon; Forseen, Scott] Augusta Univ, Med Coll Georgia, Dept Radiol & Imaging, Augusta, GA USA; [Hoda, Md Nasrul] Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA; [Akbari, Omid] Univ Southern Calif, Dept Mol Microbiol & Immunol, Keck Sch Med, Los Angeles, CA 90007 USA		Dhandapani, KM (corresponding author), Augusta Univ, Med Coll Georgia, Dept Neurosurg, Augusta, GA 30912 USA.	kdhandapani@augusta.edu	Vaibhav, Kumar/H-4120-2019	Dhandapani, Krishnan/0000-0001-7044-1117	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS110378, NS117565, NS114560]	We acknowledge the technical assistance of Jeanene Pihkala for flow cytometry. This work was supported by grants from the NIH (NS110378 to KMD/BB, NS117565 to KMD, and NS114560 to KV).	Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Bal SM, 2020, NAT REV IMMUNOL, V20, P552, DOI 10.1038/s41577-020-0282-9; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Braun M, 2018, BRAIN BEHAV IMMUN, V68, P224, DOI 10.1016/j.bbi.2017.10.021; Braun M, 2017, J IMMUNOL, V198, P3615, DOI 10.4049/jimmunol.1601948; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Chen XY, 2016, INNATE IMMUN-LONDON, V22, P696, DOI 10.1177/1753425916669862; Chevalier MF, 2017, J CLIN INVEST, V127, P2916, DOI 10.1172/JCI89717; Chiavolini D, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-36; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cortez VS, 2015, CURR OPIN IMMUNOL, V32, P71, DOI 10.1016/j.coi.2015.01.004; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; De Felice FG, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00094; Derecki N, PROTOCOL EXCHANGE, DOI [10.1038/protex.2014.030, DOI 10.1038/PROTEX.2014.030, 10.1038/protex.2014.030.]; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Hill JL, 2016, J NEUROCHEM, V139, P106, DOI 10.1111/jnc.13726; Hoshide Reid, 2016, Surg Neurol Int, V7, P84, DOI 10.4103/2152-7806.190439; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Killen MJ, 2019, EXPERT REV NEUROTHER, V19, P227, DOI 10.1080/14737175.2019.1582332; Kim HS, 2016, BMB REP, V49, P293, DOI 10.5483/BMBRep.2016.49.5.023; King MD, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09223; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kwong B, 2017, NAT IMMUNOL, V18, P1117, DOI 10.1038/ni.3816; Labuzek K, 2010, PHARMACOL REP, V62, P956; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Li T, 2017, NEUROMOL MED, V19, P541, DOI 10.1007/s12017-017-8468-4; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Ma TC, 2007, NEUROSCI LETT, V411, P98, DOI 10.1016/j.neulet.2006.10.039; Mangalam AK, 2016, J IMMUNOL, V197, P747, DOI 10.4049/jimmunol.1501549; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Seehus CR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02023-z; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Trabanelli S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00678-2; Vaibhav K, 2018, J EXP MED, V215, P2636, DOI 10.1084/jem.20171905; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wang S, 2017, CELL, V171, P201, DOI 10.1016/j.cell.2017.07.027	62	5	5	2	3	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA		2379-3708		JCI INSIGHT	JCI Insight	JAN 11	2021	6	1							e126766	10.1172/jci.insight.126766			13	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	PS0WX	WOS:000607653800001	33427206	Green Published, gold			2022-02-06	
J	DeJulius, CR; Bernardo-Colon, A; Naguib, S; Backstrom, JR; Kavanaugh, T; Gupta, MK; Duvall, CL; Rex, TS				DeJulius, C. R.; Bernardo-Colon, A.; Naguib, S.; Backstrom, J. R.; Kavanaugh, T.; Gupta, M. K.; Duvall, C. L.; Rex, T. S.			Microsphere antioxidant and sustained erythropoietin-R76E release functions cooperate to reduce traumatic optic neuropathy	JOURNAL OF CONTROLLED RELEASE			English	Article						Antioxidant; Microparticle; Intraocular; Neurotrauma; Neuroprotection; Sustained delivery; Erythropoietin		Wild-type erythropoietin (EPO) is promising for neuroprotection, but its therapeutic use is limited because it causes a systemic rise in hematocrit. We have developed an EPO-R76E derivative that maintains neuroprotective function without effects on hematocrit, but this protein has a short half-life in vivo. Here, we compare the efficacy and carrier-induced inflammatory response of two polymeric microparticle (MP) EPO-R76E sustained release formulations based on conventional hydrolytically degradable poly(lactic-co-glycolic acid) (PLGA) and reactive oxygen species (ROS)-degradable poly(propylene sulfide) (PPS). Both MP types effectively loaded EPO-R76E and achieved sustained release, providing detectable levels of EPO-R76E at the injection site in the eye in vivo for at least 28 days. Testing in an in vitro oxidative stress assay and a mouse model of blast-induced indirect traumatic optic neuropathy (bITON) showed that PPS and PLGA MP-mediated delivery of EPO-R76E provided therapeutic protection. While unloaded PLGA MPs inherently increase levels of pro-inflammatory cytokines in the bITON model, drug-free PPS MPs have innate antioxidant properties that provide therapeutic benefit both in vitro and in vivo. Both PLGA and PPS MPs enabled sustained release of EPO-R76E, providing therapeutic benefits including reduction in inflammation and axon degeneration, and preservation of visual function as measured by electroretinogram. The PPS-based MP platform is especially promising for further development, as the delivery system provides inherent antioxidant benefits that can be harnessed to work in complement with EPO-R76E or other drugs for neuroprotection in the setting of traumatic eye injury.	[DeJulius, C. R.; Backstrom, J. R.; Kavanaugh, T.; Gupta, M. K.; Duvall, C. L.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Bernardo-Colon, A.; Backstrom, J. R.; Rex, T. S.] Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, Nashville, TN 37235 USA; [Naguib, S.; Rex, T. S.] Vanderbilt Univ, Sch Med, Dept Ophthalmol & Visual Sci, Nashville, TN 37212 USA		Duvall, CL; Rex, TS (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.; Duvall, CL; Rex, TS (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, Nashville, TN 37235 USA.	craig.duvall@vanderbilt.edu; tonia.rex@vumc.org			DoDUnited States Department of Defense [W81XWH-15-1-0096, W81XWH-17-2-0055]; NEIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01 EY022349, U24 EY029893, P30EY008126, T32 EY021833]; NIBIBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [T32-EB021937]; Potocsnak Discovery Grant in Regenerative Medicine; Ayers Foundation Regenerative Visual Neuroscience Pilot Grant; Ret. Maj. General Stephen L. Jones, MD Fund; Vanderbilt University Medical Center Cell Imaging Shared Resource core facility (Clinical and Translational Science Award Grant from National Center for Research Resources) [UL1 RR024975]; Research Prevent Blindness, Inc. (VEI); NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 NS094595]	This work was supported by DoD W81XWH-15-1-0096 (TR), DoD W81XWH-17-2-0055 (TR), NEI R01 EY022349 (TR, CD), NEI U24 EY029893 (TR), NIBIB T32-EB021937 (CD), NIA R01 NS094595 (TR), Potocsnak Discovery Grant in Regenerative Medicine (TR), Ayers Foundation Regenerative Visual Neuroscience Pilot Grant (TR), Ret. Maj. General Stephen L. Jones, MD Fund (TR), Vanderbilt University Medical Center Cell Imaging Shared Resource core facility (Clinical and Translational Science Award Grant UL1 RR024975 from National Center for Research Resources), NEI P30EY008126 (VVRC), T32 EY021833 (VVRC) and Research Prevent Blindness, Inc. (VEI). The funding sources had no involvement in the study design, or collection, analysis, or interpretation of the data. The authors confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.	Bansal R, 2012, J OPHTHALMIC INFLAMM, V2, P1, DOI 10.1007/s12348-011-0042-x; Bernardo-Colon A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00719; Bernardo-Colon A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1061-4; Daniel E, 2014, OPHTHALMOLOGY, V121, P656, DOI 10.1016/j.ophtha.2013.10.019; Day S, 2011, AM J OPHTHALMOL, V152, P266, DOI 10.1016/j.ajo.2011.01.053; Doig RLO, 2014, EXP NEUROL, V261, P136, DOI 10.1016/j.expneurol.2014.06.007; Dollinger BR, 2017, TISSUE ENG PT A, V23, P1120, DOI 10.1089/ten.tea.2016.0495; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; Gregori NZ, 2015, OSLI RETINA, V46, P643, DOI 10.3928/23258160-20150610-08; Gupta MK, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201704107; Gupta MK, 2014, J AM CHEM SOC, V136, P14896, DOI 10.1021/ja507626y; Hines-Beard J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0499-5; Hines-Beard J, 2013, CURR GENE THER, V13, P275; Ji W, 2012, BIOMATERIALS, V33, P6604, DOI 10.1016/j.biomaterials.2012.06.018; Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1; Lisanti MP, 2011, CELL CYCLE, V10, P2440, DOI 10.4161/cc.10.15.16870; McDonnell P.J., 2019, Sustained Delivery of Therapeutic Agents to an Eye Compartment, Patent No. [US10369107B2, 10369107]; Miliaras G, 2013, J NEUROL SURG PART A, V74, P168, DOI 10.1055/s-0032-1330115; Naguib S, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104695; Napoli A, 2004, NAT MATER, V3, P183, DOI 10.1038/nmat1081; O'Grady KP, 2018, ACS BIOMATER SCI ENG, V4, P1251, DOI 10.1021/acsbiomaterials.6b00804; Pershing S, 2013, OPHTHAL SURG LAS IM, V44, P460, DOI 10.3928/23258160-20130909-07; Poole KM, 2015, BIOMATERIALS, V41, P166, DOI 10.1016/j.biomaterials.2014.11.016; Rajkovic O, 2019, ADV THER-GERMANY, V2, DOI 10.1002/adtp.201900038; Rex TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157411; Rex TS, 2009, EXP EYE RES, V89, P735, DOI 10.1016/j.exer.2009.06.017; Rex TS, 2004, MOL THER, V10, P855, DOI 10.1016/j.ymthe.2004.07.027; Rong XF, 2012, INVEST OPHTH VIS SCI, V53, P6025, DOI 10.1167/iovs.12-9898; Sahil K., 2011, INT J RES PHARM CHEM, V1, P1184; Sharma S, 2012, CAN J OPHTHALMOL, V47, P275, DOI 10.1016/j.jcjo.2012.03.026; Shelke NB, 2011, DRUG DELIV TRANSL RE, V1, P76, DOI 10.1007/s13346-010-0009-8; Shirley M, 2020, DRUG AGING, V37, P457, DOI 10.1007/s40266-020-00769-8; Singman EL, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0069-2; STEINSAPIR KD, 1994, SURV OPHTHALMOL, V38, P487, DOI 10.1016/0039-6257(94)90145-7; Steinsapir KD, 2011, AM J OPHTHALMOL, V151, P928, DOI 10.1016/j.ajo.2011.02.007; Sullivan T, 2011, NEUROCHEM RES, V36, P613, DOI 10.1007/s11064-010-0272-6; Sullivan TA, 2011, HUM GENE THER, V22, P1191, DOI 10.1089/hum.2011.052; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tripathy SK, 1996, P NATL ACAD SCI USA, V93, P10876, DOI 10.1073/pnas.93.20.10876; Tsujinaka H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14340-x; Vest V, 2019, J NEUROTRAUM, V36, P1646, DOI 10.1089/neu.2018.6046; Yang P, 2006, INVEST OPHTH VIS SCI, V47, P4598, DOI 10.1167/iovs.06-0140; Zhang JF, 2008, ACTA PHARMACOL SIN, V29, P1383, DOI 10.1111/j.1745-7254.2008.00885.x; Zhang W, 2017, COLLOID SURFACE B, V159, P327, DOI 10.1016/j.colsurfb.2017.07.088; Zolnik BS, 2007, J CONTROL RELEASE, V122, P338, DOI 10.1016/j.jconrel.2007.05.034	45	5	5	6	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0168-3659	1873-4995		J CONTROL RELEASE	J. Control. Release	JAN 10	2021	329						762	773		10.1016/j.jconrel.2020.10.010			12	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Pharmacology & Pharmacy	QT1EB	WOS:000626334700054	33049330	Green Accepted			2022-02-06	
J	Esopenko, C; Meyer, J; Wilde, EA; Marshall, AD; Tate, DF; Lin, AP; Koerte, IK; Werner, KB; Dennis, EL; Ware, AL; de Souza, NL; Menefee, DS; Dams-O'Connor, K; Stein, DJ; Bigler, ED; Shenton, ME; Chiou, KS; Postmus, JL; Monahan, K; Eagan-Johnson, B; van Donkelaar, P; Merkley, TL; Velez, C; Hodges, CB; Lindsey, HM; Johnson, P; Irimia, A; Spruiell, M; Bennett, ER; Bridwell, A; Zieman, G; Hillary, FG				Esopenko, Carrie; Meyer, Jessica; Wilde, Elisabeth A.; Marshall, Amy D.; Tate, David F.; Lin, Alexander P.; Koerte, Inga K.; Werner, Kimberly B.; Dennis, Emily L.; Ware, Ashley L.; de Souza, Nicola L.; Menefee, Deleene S.; Dams-O'Connor, Kristen; Stein, Dan J.; Bigler, Erin D.; Shenton, Martha E.; Chiou, Kathy S.; Postmus, Judy L.; Monahan, Kathleen; Eagan-Johnson, Brenda; van Donkelaar, Paul; Merkley, Tricia L.; Velez, Carmen; Hodges, Cooper B.; Lindsey, Hannah M.; Johnson, Paula; Irimia, Andrei; Spruiell, Matthew; Bennett, Esther R.; Bridwell, Ashley; Zieman, Glynnis; Hillary, Frank G.			A global collaboration to study intimate partner violence-related head trauma: The ENIGMA consortium IPV working group	BRAIN IMAGING AND BEHAVIOR			English	Article						Brain injury; Neuroimaging; Neuropsychological function; Psychosocial function; Intimate partner violence	POSTTRAUMATIC-STRESS-DISORDER; PROFESSIONAL FOOTBALL PLAYERS; ABUSIVE BEHAVIOR INVENTORY; MATTER TRACT ABNORMALITIES; POST-CONCUSSION SYNDROME; COMMON DATA ELEMENTS; BRAIN-INJURY; MENTAL-HEALTH; PROCESSING SPEED; APOLIPOPROTEIN-E	Intimate partner violence includes psychological aggression, physical violence, sexual violence, and stalking from a current or former intimate partner. Past research suggests that exposure to intimate partner violence can impact cognitive and psychological functioning, as well as neurological outcomes. These seem to be compounded in those who suffer a brain injury as a result of trauma to the head, neck or body due to physical and/or sexual violence. However, our understanding of the neurobehavioral and neurobiological effects of head trauma in this population is limited due to factors including difficulty in accessing/recruiting participants, heterogeneity of samples, and premorbid and comorbid factors that impact outcomes. Thus, the goal of the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium Intimate Partner Violence Working Group is to develop a global collaboration that includes researchers, clinicians, and other key community stakeholders. Participation in the working group can include collecting harmonized data, providing data for meta- and mega-analysis across sites, or stakeholder insight on key clinical research questions, promoting safety, participant recruitment and referral to support services. Further, to facilitate the mega-analysis of data across sites within the working group, we provide suggestions for behavioral surveys, cognitive tests, neuroimaging parameters, and genetics that could be used by investigators in the early stages of study design. We anticipate that the harmonization of measures across sites within the working group prior to data collection could increase the statistical power in characterizing how intimate partner violence-related head trauma impacts long-term physical, cognitive, and psychological health.	[Esopenko, Carrie] Rutgers Biomed & Hlth Sci, Sch Hlth Profess, Dept Rehabil & Movement Sci, Newark, NJ 07107 USA; [Esopenko, Carrie] Rutgers Biomed & Hlth Sci, Sch Hlth Profess, Dept Hlth Informat, Newark, NJ 07107 USA; [Meyer, Jessica] Summa Hlth Syst, Dept Psychiat, Akron, OH 44304 USA; [Wilde, Elisabeth A.; Tate, David F.; Dennis, Emily L.; Ware, Ashley L.; Bigler, Erin D.; Merkley, Tricia L.; Velez, Carmen; Hodges, Cooper B.; Lindsey, Hannah M.; Johnson, Paula] Univ Utah, Sch Med, Dept Neurol, Traumat Brain Injury & Concuss Ctr, Salt Lake City, UT 84132 USA; [Wilde, Elisabeth A.; Tate, David F.; Dennis, Emily L.; Hodges, Cooper B.; Lindsey, Hannah M.; Johnson, Paula] George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; [Marshall, Amy D.; Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Lin, Alexander P.] Harvard Med Sch, Brigham & Womens Hosp, Dept Clin Spect, Boston, MA 02115 USA; [Koerte, Inga K.] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-80336 Munich, Germany; [Koerte, Inga K.] Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Werner, Kimberly B.; Shenton, Martha E.] Univ Missouri, Coll Nursing, St Louis, MO 63121 USA; [Ware, Ashley L.] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada; [de Souza, Nicola L.] Rutgers State Univ, Sch Grad Studies, Biomed Sci, Newark, NJ 07103 USA; [Menefee, Deleene S.] Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Stein, Dan J.] Univ Cape Town, South African Med Res Council, Unit Risk & Resilience Mental Disorders, Dept Psychiat, ZA-7501 Cape Town, South Africa; [Stein, Dan J.] Univ Cape Town, South African Med Res Council, Unit Risk & Resilience Mental Disorders, Neurosci Inst, ZA-7501 Cape Town, South Africa; [Bigler, Erin D.; Merkley, Tricia L.; Hodges, Cooper B.; Lindsey, Hannah M.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Shenton, Martha E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA; [Shenton, Martha E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Shenton, Martha E.] Boston Healthcare Syst, Vet Affairs, Boston, MA 02130 USA; [Chiou, Kathy S.] Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA; [Postmus, Judy L.] Univ Maryland, Sch Social Work, 525 W Redwood St, Baltimore, MD 21201 USA; [Monahan, Kathleen] SUNY Stony Brook, Sch Social Welf, Stony Brook, NY 11794 USA; [Eagan-Johnson, Brenda] Traumat Brain Injury Educ Consulting, New Castle, PA 16101 USA; [van Donkelaar, Paul] Univ British Columbia, Sch Hlth & Exercise Sci, Kelowna, BC V1V 1V7, Canada; [Merkley, Tricia L.; Spruiell, Matthew] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Johnson, Paula] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Irimia, Andrei] Univ Southern Calif, Leonard Davis Sch Gerontol, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA; [Irimia, Andrei] Univ Southern Calif, Denney Res Ctr, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Bennett, Esther R.] Rutgers State Univ, Sch Social Work, New Brunswick, NJ 08901 USA; [Bridwell, Ashley; Zieman, Glynnis] Barrow Neurol Inst, Barrow Concuss & Brain Injury Ctr, Phoenix, AZ USA; [Hillary, Frank G.] Social Life & Engn Sci Imaging Ctr, University Pk, PA 16802 USA		Esopenko, C (corresponding author), Rutgers Biomed & Hlth Sci, Sch Hlth Profess, Dept Rehabil & Movement Sci, Newark, NJ 07107 USA.; Esopenko, C (corresponding author), Rutgers Biomed & Hlth Sci, Sch Hlth Profess, Dept Hlth Informat, Newark, NJ 07107 USA.	carrie.esopenko@rutgers.edu	Menefee, Deleene/AAZ-3382-2021; Hillary, Frank/AAN-8622-2021; Stein, Dan J/A-1752-2008; Merkley, Tricia L./AAN-2989-2020; Dennis, Emily/AAD-5223-2021; Irimia, Andrei/B-8275-2008; Koerte, Inga Katharina/AAW-3031-2021	Stein, Dan J/0000-0001-7218-7810; Dennis, Emily/0000-0001-7112-4009; Irimia, Andrei/0000-0002-9254-9388; Esopenko, Carrie/0000-0001-8607-5633	NIH/NINDS/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute of Neurological Disorders & Stroke (NINDS) [1U01NS086625-01]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS 100973, K99NS096116]; Department of Veterans Affairs, National Center for PTSDUS Department of Veterans Affairs [36C24118C0076]; Department of Veterans AffairsUS Department of Veterans Affairs [B6812C, 5 I01 RX00162]; PA Health Research Grant [4100077082]; South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC); BWH Program for Interdisciplinary NeuroscienceWomen's Brain Initiative; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01NS100952, U01NS093334]; European Research CommissionEuropean CommissionEuropean Commission Joint Research Centre [804326]; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [PJT-168863]; Canadian Department of Women and Gender Equality [GV-18385]; Max Bell Foundation [MB-18-A-15]; US Department of DefenseUnited States Department of Defense [W81XWH-18-1-0413]; Hanson-Thorell research scholarship; NIH, NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R01HD098172-01]	KDO has been supported by the NIH/NINDS/NICHD (1U01NS086625-01). ELD has received grants from NIH/NINDS (K99NS096116). KBW is supported by the Department of Veterans Affairs, National Center for PTSD (36C24118C0076). EAW received support from the Department of Veterans Affairs (B6812C; 5 I01 RX00162). FGH is supported by a PA Health Research Grant (SAP #4100077082). DJS is supported by the South African Medical Research Council. AL has been supported through the BWH Program for Interdisciplinary NeuroscienceWomen's Brain Initiative. IKK is supported by the NIH (5R01NS100952, U01NS093334) and the European Research Commission (ERC Starting Grant 804326). PvD is supported by grants from the Canadian Institutes of Health Research (PJT-168863), the Canadian Department of Women and Gender Equality (GV-18385), and the Max Bell Foundation (MB-18-A-15). AI is supported by the NIH/NINDS (R01 NS 100973), by the US Department of Defense (W81XWH-18-1-0413) and by a Hanson-Thorell research scholarship. ADM is supported by the NIH, NICHD (1R01HD098172-01).	Ackerman RJ, 2009, DISABILITIES INSIGHT, P107; Adams JW, 2018, J NEUROPATH EXP NEUR, V77, P757, DOI 10.1093/jnen/nly065; Afifi TO, 2009, J INTERPERS VIOLENCE, V24, P1398, DOI 10.1177/0886260508322192; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Anderson CA, 2010, NEUROREHABILITATION, V26, P47, DOI 10.3233/NRE-2010-0535; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Ard KL, 2011, J GEN INTERN MED, V26, P930, DOI 10.1007/s11606-011-1697-6; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Aupperle RL, 2016, J TRAUMA STRESS, V29, P33, DOI 10.1002/jts.22068; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bartnik-Olson B., 2019, CLIN UTILITY MAGNETI, DOI [10.31234/osf.io/gesvh, DOI 10.31234/OSF.IO/GESVH]; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; Bennett E.R., 2016, TRANSLATIONAL RES TR; Benton AL, 1994, MULTILINGUAL APHASIA; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bethell CD, 2017, ACAD PEDIATR, V17, pS51, DOI 10.1016/j.acap.2017.04.161; Bichard H., 2020, NEUROPSYCHOLOGICAL O, DOI [10.31234/osf.io/c6zbv, DOI 10.31234/0SF.I0/C6ZBV]; Bieniek KF, 2020, BRAIN PATHOL, V30, P63, DOI 10.1111/bpa.12757; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bigler ED, 2017, NEUROPSYCHOLOGY, V31, P934, DOI 10.1037/neu0000418; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Black M C., 2011, NATL INTIMATE PARTNE; Black MC., 2014, INTIMATE PARTNER VIO; Bogat GA, 2005, AM J COMMUN PSYCHOL, V36, P49, DOI 10.1007/s10464-005-6232-7; Bohn M., 1991, PROBLEMS DRUG DEPEND, V119, P233; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; BRIERE J, 1992, J CONSULT CLIN PSYCH, V60, P196, DOI 10.1037/0022-006X.60.2.196; Briere J., 1996, MEASUREMENT STRESS T; Brignone E, 2018, GEN HOSP PSYCHIAT, V55, P60, DOI 10.1016/j.genhosppsych.2018.10.006; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Brush LD, 1990, GENDER SOC, V4, P56, DOI 10.1177/089124390004001005; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Buysse D J, 1989, Psychiatry Res, V28, P193; Buysse DJ, 2010, SLEEP, V33, P781, DOI 10.1093/sleep/33.6.781; Caine D, 2000, J INT NEUROPSYCH SOC, V6, P86, DOI 10.1017/S1355617700611116; Calvillo M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01423; Campbell J., 2000, VIOLENCE WOMEN SYNTH; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Campbell JC, 2009, J INTERPERS VIOLENCE, V24, P653, DOI 10.1177/0886260508317180; CAMPBELL JC, 1986, ADV NURS SCI, V8, P36, DOI 10.1097/00012272-198607000-00006; Campbell TA, 2009, PSYCHIAT ANN, V39, P796, DOI 10.3928/00485713-20090728-01; Campbell-Sills L, 2009, J PSYCHIATR RES, V43, P1007, DOI 10.1016/j.jpsychires.2009.01.013; Capaldi DM, 2012, PARTN ABUSE, V3, P231, DOI 10.1891/1946-6560.3.2.231; Carbone-Lopez K, 2006, PUBLIC HEALTH REP, V121, P382, DOI 10.1177/003335490612100406; Chandra PS, 2009, ARCH WOMEN MENT HLTH, V12, P203, DOI 10.1007/s00737-009-0065-6; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Cho H, 2012, J INTERPERS VIOLENCE, V27, P344, DOI 10.1177/0886260511416469; Clements K, 2009, J FAM VIOLENCE, V24, P283, DOI 10.1007/s10896-009-9229-4; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Cunradi CB, 2002, J FAM VIOLENCE, V17, P377, DOI 10.1023/A:1020374617328; Dalla Libera AL, 2011, BRAIN INJURY, V25, P365, DOI 10.3109/02699052.2011.556107; Dams-O'Connor K, 2018, J NEUROTRAUM, V35, P1138, DOI 10.1089/neu.2017.5347; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Davies M, 2018, J NEUROTRAUM, V35, P790, DOI 10.1089/neu.2017.5354; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; De Boos J, 2019, EMERG MED AUSTRALAS, V31, P302, DOI 10.1111/1742-6723.13243; Deering C, 2001, PERCEPT MOTOR SKILL, V92, P682; Defense and Veterans Brain Injury Center, 2020, TBI MIL; DeFroda Steven F, 2016, Am J Orthop (Belle Mead NJ), V45, pE515; Delis D.C., 2017, CALIFORNIA VERBAL LE, V3rd; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dennis EL, 2022, HUM BRAIN MAPP, V43, P149, DOI 10.1002/hbm.25046; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; Dichter ME, 2019, WOMEN HEALTH ISS, V29, P440, DOI 10.1016/j.whi.2019.03.007; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dobash RP, 2004, BRIT J CRIMINOL, V44, P324, DOI 10.1093/bjc/azh026; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Dutton  M. A, 2003, RECRUITMENT RETENTIO; Dyar C, 2021, J INTERPERS VIOLENCE, V36, pNP8824, DOI 10.1177/0886260519846856; Edwards KM, 2015, TRAUMA VIOLENCE ABUS, V16, P359, DOI 10.1177/1524838014557289; Edwards KM, 2015, PSYCHOL VIOLENCE, V5, P112, DOI 10.1037/a0038656; Elliott DE, 2005, J COMMUNITY PSYCHOL, V33, P461, DOI 10.1002/jcop.20063; Esopenko C, 2017, J NEUROL NEUROSUR PS, V88, P512, DOI 10.1136/jnnp-2016-315260; Fedovskiy K, 2008, J IMMIGR MINOR HEALT, V10, P45, DOI 10.1007/s10903-007-9049-7; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; Fillinger S, 2019, ANAL BIOANAL CHEM, V411, P6791, DOI 10.1007/s00216-019-02074-9; Flegar SJ, 2011, AFR J PSYCHIATRY, V14, P310, DOI [10.4314/ajpsy.v14i4.9, http://dx.doi.org/10.4314/ajpsy.v14i4.9]; Fletcher J, 2010, SOC SCI MED, V70, P130, DOI 10.1016/j.socscimed.2009.09.030; Foa EB, 2018, J CLIN CHILD ADOLESC, V47, P38, DOI 10.1080/15374416.2017.1350962; Foerster RM, 2019, NEUROPSYCHOLOGY, V33, P309, DOI 10.1037/neu0000517; Ford JH, 2013, J NEUROTRAUM, V30, P1683, DOI 10.1089/neu.2012.2535; Ford-Gilboe M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012824; Fox CK, 2017, NEUROLOGY, V89, P2310, DOI 10.1212/WNL.0000000000004708; Fricker M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.94040; George E, 2019, RADIOLOGY, V291, P61, DOI 10.1148/radiol.2019180801; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Gilroy H, 2016, J SOC DISTRESS HOMEL, V25, P86, DOI 10.1080/10530789.2016.1245258; Goldin Y, 2016, PM&R, V8, P1104, DOI 10.1016/j.pmrj.2016.05.006; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Gondolf E W., 1997, OUT DARKNESS CONT PE, DOI 10.4135/9781483328058.n20; Green P, 2003, MED SYMPTOM VALIDITY; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Haag Halina Lin, 2019, Trauma Violence Abuse, p1524838019850623, DOI 10.1177/1524838019850623; Hacker K., 2013, COMMUNITY BASED PART, DOI [10.4135/9781452244181, DOI 10.4135/9781452244181]; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Hegarty K, 1999, J FAM VIOLENCE, V14, P399, DOI 10.1023/A:1022834215681; Hibar DP, 2018, MOL PSYCHIATR, V23, P932, DOI 10.1038/mp.2017.73; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoogman M, 2017, LANCET PSYCHIAT, V4, P310, DOI 10.1016/S2215-0366(17)30049-4; Hopkins RO, 2005, NEUROPSYCHOLOGY, V19, P233, DOI 10.1037/0894-4105.19.2.233; HUDSON WW, 1981, J MARRIAGE FAM, V43, P873, DOI 10.2307/351344; Hunnicutt G, 2017, J FAM VIOLENCE, V32, P471, DOI 10.1007/s10896-016-9854-7; Iovine-Wong PE, 2019, MIL MED, V184, pE201, DOI 10.1093/milmed/usy355; Irimia A, 2018, NEUROBIOL AGING, V66, P158, DOI 10.1016/j.neurobiolaging.2018.02.026; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Iverson KM, 2019, COMPR PSYCHIAT, V92, P13, DOI 10.1016/j.comppsych.2019.05.001; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Iverson KM, 2013, J TRAUMA STRESS, V26, P102, DOI 10.1002/jts.21781; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Jaffe AE, 2015, CLIN PSYCHOL REV, V40, P40, DOI 10.1016/j.cpr.2015.05.004; Jahanshad N, 2013, NEUROIMAGE, V81, P455, DOI 10.1016/j.neuroimage.2013.04.061; Johnson DC, 2011, MIL MED, V176, P161, DOI 10.7205/MILMED-D-10-00258; Jones L., 2001, TRAUMA VIOLENCE ABUS, V2, P99, DOI [10.1177/1524838001002002001, DOI 10.1177/1524838001002002001]; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Keene CD, 2018, ACTA NEUROPATHOL, V135, P303, DOI 10.1007/s00401-017-1801-z; Kessler RC, 2018, MOL PSYCHIATR, V23, DOI 10.1038/mp.2017.194; Kessler RC, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1353383; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Lagdon S, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.24794; Lanier C, 2009, VIOLENCE AGAINST WOM, V15, P1311, DOI 10.1177/1077801209346711; Lee E, 2019, BRAIN INJURY, V33, P985, DOI 10.1080/02699052.2019.1606448; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lendon CL, 2003, NEUROLOGY, V61, P683, DOI 10.1212/01.WNL.0000078033.81925.80; Leung FH, 2006, NEUROEPIDEMIOLOGY, V27, P13, DOI 10.1159/000093894; Li LZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002028; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Lipsky Robert H, 2015, Handb Clin Neurol, V127, P23, DOI 10.1016/B978-0-444-52892-6.00003-9; Lipsky S, 2006, ETHNIC HEALTH, V11, P81, DOI 10.1080/13557850500391410; Logan TK, 2008, VIOLENCE AGAINST WOM, V14, P1226, DOI 10.1177/1077801208323976; Long MK, 2019, J EMERG MED, V56, P554, DOI 10.1016/j.jemermed.2019.01.029; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Marshall AD, 2017, PSYCHOL ASSESSMENT, V29, P978, DOI 10.1037/pas0000393; Marx B P, 2013, DEV VALIDATION PTSDR; McAllister T. W, 2019, TXB TRAUMATIC BRAIN; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister Thomas W, 2015, Handb Clin Neurol, V128, P723, DOI 10.1016/B978-0-444-63521-1.00045-5; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Mcquown C, 2016, AM J EMERG MED, V34, P1281, DOI 10.1016/j.ajem.2016.04.029; Mengo C, 2020, J FAM VIOLENCE, V35, P181, DOI 10.1007/s10896-019-00053-3; Messing J. T., 2015, NATL I JUSTICE J, V275, P48; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Miles SR, 2016, J INTERPERS VIOLENCE, V31, P1795, DOI 10.1177/0886260515570746; Miller MW, 2018, HARVARD REV PSYCHIAT, V26, P57, DOI 10.1097/HRP.0000000000000167; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Monahan K, 2019, FUTUR NEUROL, V14, DOI 10.2217/fnl-2018-0031; Monahan K, 2019, J AGGRESS MALTREAT T, V28, P807, DOI 10.1080/10926771.2019.1628154; Monteiro, 2010, ALCOHOL SMOKING SUBS; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Murray CE, 2016, TRAUMA VIOLENCE ABUS, V17, P298, DOI 10.1177/1524838015584364; Myrga JM, 2016, NEUROREHAB NEURAL RE, V30, P920, DOI 10.1177/1545968316648409; National Coalition Against Domestic Violence, 2015, DOM VIOL NAT STAT; National Violence Against Women Prevention Research Center, 2001, FOST COLL PREV VIOL; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Neumeister P, 2017, SOC COGN AFFECT NEUR, V12, P555, DOI 10.1093/scan/nsw165; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; O'Campo P, 2006, BRIEF TREATMENT CRIS, V6, P99, DOI [DOI 10.1093/BRIEF-TREATMENT/MHJ010, 10.1093/brieftreatment/mhj010, DOI 10.1093/BRIEFTREATMENT/MHJ010]; Ochs HA, 1996, J AM DENT ASSOC, V127, P757, DOI 10.14219/jada.archive.1996.0311; Okuda M, 2011, PSYCHIAT SERV, V62, P959, DOI 10.1176/ps.62.8.pss6208_0959; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Parsons TD, 2018, CLIN NEUROPSYCHOL, V32, P16, DOI 10.1080/13854046.2017.1337932; Pathak N, 2019, MATURITAS, V121, P63, DOI 10.1016/j.maturitas.2018.12.011; Peek-Asa C, 2011, J WOMENS HEALTH, V20, P1743, DOI 10.1089/jwh.2011.2891; Peskine A, 2010, BRAIN INJURY, V24, P755, DOI 10.3109/02699051003709581; Petrosky E, 2017, MMWR-MORBID MORTAL W, V66, P741, DOI 10.15585/mmwr.mm6628a1; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Postmus JL, 2016, J INTERPERS VIOLENCE, V31, P2867, DOI 10.1177/0886260515581882; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raskin SA, 2009, BRAIN IMPAIR, V10, P23, DOI 10.1375/brim.10.1.23; Regehr C, 2008, J SOC SERV RES, V34, P5, DOI 10.1080/01488370802085890; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rennison Callie, 2003, Violence Vict, V18, P433, DOI 10.1891/vivi.2003.18.4.433; Ricks JL, 2016, PUBLIC HEALTH NUTR, V19, P914, DOI 10.1017/S1368980015001986; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Roos A, 2017, BRAIN IMAGING BEHAV, V11, P1629, DOI 10.1007/s11682-016-9644-0; Rosen V, 2020, NEUROSCI INSIGHTS, V15, DOI 10.1177/2633105520907895; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schmaal L, 2017, MOL PSYCHIATR, V22, P900, DOI 10.1038/mp.2016.60; Schmidt M., 1996, REY AUDITORY VERBAL; Schneider D, 2016, DEMOGRAPHY, V53, P471, DOI 10.1007/s13524-016-0462-1; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Schumacher JA, 2010, VIOLENCE VICTIMS, V25, P588, DOI 10.1891/0886-6708.25.5.588; Seedat S, 2005, PSYCHIAT RES-NEUROIM, V139, P249, DOI 10.1016/j.pscychresns.2005.06.001; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; SHEPARD MF, 1992, J INTERPERS VIOLENCE, V7, P291, DOI 10.1177/088626092007003001; Sheridan DJ, 2007, TRAUMA VIOLENCE ABUS, V8, P281, DOI 10.1177/1524838007303504; Sheridan LK, 2006, ARCH CLIN NEUROPSYCH, V21, P23, DOI 10.1016/j.acn.2005.07.003; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Simmons AN, 2008, BIOL PSYCHIAT, V64, P681, DOI 10.1016/j.biopsych.2008.05.027; Smirl JD, 2019, BRAIN INJURY, V33, P1529, DOI 10.1080/02699052.2019.1658129; Smith A., 1991, SYMBOL DIGIT MODALIT; Smith DJ, 2001, J EMERG MED, V21, P323, DOI 10.1016/S0736-4679(01)00402-4; Smith P H, 1995, Womens Health, V1, P273; Spitzer R.L., 2016, STRUCTURED CLIN INTE; St Ivany A, 2018, J FORENSIC NURS, V14, P198, DOI 10.1097/JFN.0000000000000220; St Ivany A, 2018, QUAL HEALTH RES, V28, P1708, DOI 10.1177/1049732318786705; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Stanford MS, 2003, ASSESSMENT, V10, P183, DOI 10.1177/1073191103010002009; Stanford MS, 2011, PROCEDURES CLASSIFIC; Stein D J, 2000, Dialogues Clin Neurosci, V2, P31; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stockman JK, 2015, J WOMENS HEALTH, V24, P256, DOI 10.1089/jwh.2014.4879.cxn; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Straus Murray A, 2004, Violence Vict, V19, P507; Straus SE, 2013, KNOWLEDGE TRANSLATION IN HEALTH CARE: MOVING FROM EVIDENCE TO PRACTICE, 2ND EDITION, P1, DOI 10.1002/9781118413555; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sugg N, 2015, MED CLIN N AM, V99, P629, DOI 10.1016/j.mcna.2015.01.012; Temple JR, 2007, VIOLENCE AGAINST WOM, V13, P285, DOI 10.1177/1077801206297437; Terry DP, 2018, BRAIN IMAGING BEHAV, V12, P631, DOI 10.1007/s11682-017-9719-6; Testa M, 2003, J INTERPERS VIOLENCE, V18, P735, DOI 10.1177/0886260503253232; Thompson PM, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0705-1; Thompson PM, 2014, BRAIN IMAGING BEHAV, V8, P153, DOI 10.1007/s11682-013-9269-5; TJADEN P, 2000, VIOLENCE WOMEN, V0006; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Treble-Barna A, 2017, J NEUROTRAUM, V34, P1919, DOI 10.1089/neu.2016.4840; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Tun PA, 2006, AGE AGEING, V35, P629, DOI 10.1093/ageing/afl095; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; U.S. Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; United States Government Accountability Office, 2020, DOM VIOL IMPR DAT NE; Uzan M, 2005, ACTA NEUROCHIR, V147, P715, DOI 10.1007/s00701-005-0529-z; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; Valera EM, 2018, J WOMENS HEALTH, V27, P735, DOI 10.1089/jwh.2017.6838; Weathers F., 2013, CLINICIAN ADMINISTER; Weathers FW., 2013, PTSD CHECKLIST DSM 5; Wechsler, 2008, WAIS 4 ADM SCORING M; Wechsler D., 2011, TEST PREMORBID FUNCT; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weitzman A, 2018, CRIMINOLOGY, V56, P574, DOI 10.1111/1745-9125.12181; Whitfield CL, 2003, J INTERPERS VIOLENCE, V18, P166, DOI 10.1177/0886260502238733; Widom CS, 2014, CHILD ABUSE NEGLECT, V38, P650, DOI 10.1016/j.chiabu.2013.11.004; Wilbur L, 2001, J EMERG MED, V21, P297, DOI 10.1016/S0736-4679(01)00398-5; Wilde EA., 2019, ENIGMA BRAIN INJURY, DOI [10.31234/osf.io/t96xb, DOI 10.31234/OSF.IO/T96XB]; Willer BS, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000423; Wilson JM, 2015, AM J ORTHOPSYCHIAT, V85, P586, DOI 10.1037/ort0000098; Wilson KS, 2007, J WOMENS HEALTH, V16, P1485, DOI 10.1089/jwh.2007.0385; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Wong JYH, 2014, TRAUMA VIOLENCE ABUS, V15, P22, DOI 10.1177/1524838013496333; Wood RLL, 2013, BRAIN INJURY, V27, P253, DOI 10.3109/02699052.2012.743181; World Health Organization, 2001, PUTT WOM 1 ETH SAF R; Wright KL, 2017, BRAIN INJURY, V31, P709, DOI 10.1080/02699052.2017.1285051; Wu V, 2010, TRAUMA VIOLENCE ABUS, V11, P71, DOI 10.1177/1524838010367503; Yoshihama M, 2011, VIOLENCE AGAINST WOM, V17, P295, DOI 10.1177/1077801211398229; Yu L, 2012, BEHAV SLEEP MED, V10, P6, DOI 10.1080/15402002.2012.636266; Yue JK, 2015, NEUROGENETICS, V16, P169, DOI 10.1007/s10048-015-0437-1; Zeng S, 2014, GENET TEST MOL BIOMA, V18, P202, DOI 10.1089/gtmb.2013.0421; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579; Zilkens RR, 2016, J FORENSIC LEG MED, V43, P1, DOI 10.1016/j.jflm.2016.06.005; Zivadinov R, 2018, J HEAD TRAUMA REHAB, V33, pE24, DOI 10.1097/HTR.0000000000000422; Zlotnick C, 2006, J INTERPERS VIOLENCE, V21, P262, DOI 10.1177/0886260505282564	298	5	5	2	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	APR	2021	15	2					475	503		10.1007/s11682-020-00417-0		JAN 2021	29	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	RK3RJ	WOS:000605507900001	33405096	Green Submitted, Green Accepted			2022-02-06	
J	Abeare, C; Erdodi, L; Messa, I; Terry, DP; Panenka, WJ; Iverson, GL; Silverberg, ND				Abeare, Christopher; Erdodi, Laszlo; Messa, Isabelle; Terry, Douglas P.; Panenka, William J.; Iverson, Grant L.; Silverberg, Noah D.			Development of Embedded Performance Validity Indicators in the NIH Toolbox Cognitive Battery	PSYCHOLOGICAL ASSESSMENT			English	Article						NIH Toolbox Cognitive Battery; performance validity; mild traumatic brain injury; computerized neurocognitive test	TRAUMATIC BRAIN-INJURY; CARD SORTING TEST; SYMPTOM VALIDITY; POOR EFFORT; MEMORY; TASK; UTILITY; IMPACT; SAMPLE; ADULTS	To assess noncredible performance on the NIH Toolbox Cognitive Battery (NIHTB-CB), we developed embedded validity indicators (EVIs). Data were collected from 98 adults (54.1% female) as part of a prospective multicenter cross-sectional study at 4 mild traumatic brain injury (mTBI) specialty clinics. Traditional EVIs and novel item-based EVIs were developed for the NIHTB-CB using the Medical Symptom Validity Test (MSVT) as criterion. The signal detection profile of individual EVIs varied greatly. Multivariate models had superior classification accuracy. Failing >= 4 traditional EVIs at the liberal cutoff or >= 3 at the conservative cutoff produced a good combination of sensitivity (.57 to .61) and specificity (.92 to .94) to MSVT. Combining the traditional and item-based EVIs improved sensitivity (.65 to .70) at comparable specificity (.91 to .95). In conclusion, newly developed EVIs within the NIHTB-CB effectively discriminated between patients who passed versus failed the MSVT. Aggregating EVIs within the same category into validity composites improved signal detection over univariate cutoffs. Item-based EVIs improved classification accuracy over that of traditional EVIs. However, the marginal gains hardly justify the burden of extra calculations. The newly introduced EVIs require cross-validation before wide-spread research or clinical application. Public Significance Statement In this study, we developed the first embedded validity indices within the NIH Toolbox Cognitive Battery in a sample of people with a recent history of mild traumatic brain injury. Embedded validity indices provide information about performance validity, or the degree to which test scores reflect test-taker ability on cognitive tests.	[Abeare, Christopher; Erdodi, Laszlo; Messa, Isabelle] Univ Windsor, Dept Psychol, Windsor, ON, Canada; [Terry, Douglas P.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Terry, Douglas P.; Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Terry, Douglas P.; Iverson, Grant L.] A Red Sox Fdn, Home Base, Charlestown, MA USA; [Terry, Douglas P.; Iverson, Grant L.] Massachusetts Gen Hosp Program, Charlestown, MA USA; [Panenka, William J.] Univ British Columbia, British Columbia Neuropsychiat Program, Dept Psychiat, Vancouver, BC, Canada; [Panenka, William J.] British Columbia Mental Hlth & Subst Use Res Inst, Vancouver, BC, Canada; [Silverberg, Noah D.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, GF Strong Rehab Ctr,4255 Laurel St, Vancouver, BC V5Z 269, Canada		Silverberg, ND (corresponding author), Vancouver Coastal Hlth Res Inst, Rehabil Res Program, GF Strong Rehab Ctr,4255 Laurel St, Vancouver, BC V5Z 269, Canada.	noah.silverberg@ubc.ca		Abeare, Christopher/0000-0002-7163-7434; Panenka, William/0000-0001-7143-6512	WorkSafeBC Specific Priorities Research Grant [RS2014-SP03]; University of Windsor; Vancouver Coastal Health Research Institute; Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research; Heinz Family Foundation; Spaulding Research Institute	This project received financial support from WorkSafeBC Specific Priorities Research Grant RS2014-SP03, awarded to Noah D. Silverberg and a Collaborative Research Grant from the University of Windsor to Christopher Abeare. Noah D. Silverberg received salary support from a Clinician-Scientist Career Development Award from the Vancouver Coastal Health Research Institute and a Health Professional Investigator Award from the Michael Smith Foundation for Health Research. The authors acknowledge unrestricted philanthropic support from the Heinz Family Foundation and the Spaulding Research Institute. Relevant ethical guidelines regulating research involving human participants were followed throughout the project. All data collection, storage, and processing were done in compliance with the Helsinki Declaration.	Abeare C, 2019, J HEAD TRAUMA REHAB, V34, pE20, DOI 10.1097/HTR.0000000000000451; Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; Arrington CM, 2004, PSYCHOL SCI, V15, P610, DOI 10.1111/j.0956-7976.2004.00728.x; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Axelrod BN, 2011, APPL NEUROPSYCHOL, V18, P27, DOI 10.1080/09084282.2010.523369; Baker, 2001, BASICS ITEM RESPONSE; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Boone K.B., 2013, CLIN PRACTICE FORENS; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Casaletto KB, 2016, J INT NEUROPSYCH SOC, V22, P364, DOI 10.1017/S135561771500137X; Dutilh G, 2012, ATTEN PERCEPT PSYCHO, V74, P454, DOI 10.3758/s13414-011-0243-2; Erdodi LA, 2020, ARCH CLIN NEUROPSYCH, V35, P188, DOI 10.1093/arclin/acz032; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Glassmire DM, 2019, PSYCHOL ASSESSMENT, V31, P120, DOI 10.1037/pas0000650; Green P, 2004, GREENS MED SYMPTOM V; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Higgins KL, 2017, ARCH CLIN NEUROPSYCH, V32, P259, DOI 10.1093/arclin/acw108; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Johnson SC, 2012, CLIN NEUROPSYCHOL, V26, P1230, DOI 10.1080/13854046.2012.709886; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Lace JW, 2020, PSYCHOL INJ LAW, V13, P303, DOI 10.1007/s12207-020-09382-x; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Lupu T, 2018, APPL NEUROPSYCH-ADUL, V25, P532, DOI 10.1080/23279095.2017.1341410; NINDS, 2017, NINDS COMM DAT EL; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; Pearson Assessment, 2009, ADV CLIN SOLUTIONS W; Roye S, 2019, CLIN NEUROPSYCHOL, V33, P1138, DOI 10.1080/13854046.2018.1520303; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Tulsky DS, 2017, REHABIL PSYCHOL, V62, P413, DOI 10.1037/rep0000174; Tyson BT, 2018, EPILEPSY BEHAV, V87, P39, DOI 10.1016/j.yebeh.2018.08.010; Weintraub S, 2014, J INT NEUROPSYCH SOC, V20, P567, DOI 10.1017/S1355617714000320; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020	48	5	5	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	JAN	2021	33	1					90	96		10.1037/pas0000958			7	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	PT7JD	WOS:000608786900008	33119374				2022-02-06	
J	Amirkhosravi, L; Khaksari, M; Soltani, Z; Esmaeili-Mahani, S; Karam, GA; Hoseini, M				Amirkhosravi, Ladan; Khaksari, Mohammad; Soltani, Zahra; Esmaeili-Mahani, Saeed; Karam, Gholamreza Asadi; Hoseini, Mojtaba			E2-BSA and G1 exert neuroprotective effects and improve behavioral abnormalities following traumatic brain injury: The role of classic and non-classic estrogen receptors	BRAIN RESEARCH			English	Article						E2-BSA; Neuroprotection; Neurobehavioral outcomes; Spatial memory; Traumatic brain injury; Classic estrogen receptors; Non-classic estrogen receptor	SEX STEROID-HORMONES; SPATIAL-LEARNING TASK; INTRACRANIAL-PRESSURE; NEUROLOGIC OUTCOMES; BARRIER DISRUPTION; ACTIVATION; EDEMA; 17-BETA-ESTRADIOL; GPR30; ALPHA	The role of classical and non-classical estrogen receptors (ERs) in mediating the neuroprotective effects of this hormone on brain edema and long-term behavioral disorders was evaluated after traumatic brain injury (TBI). Ovariectomized rats were divided as follows: E2 (17 beta-estradiol), E2-BSA (E2 conjugated to bovine serum albumin), G1 [G-protein-coupled estrogen receptor agonist (GPER)] or their vehicle was injected following TBI, whereas ICI (classical estrogen receptor antagonist), G15 (GPER antagonist), ICI + G15, and their vehicle were injected before the induction of TBI and the injection of E2 and E2-BSA. Brain water (BWC) and Evans blue (EB) contents were measured 24 h and 5 h after TBI, respectively. Intracranial pressure (ICP) and cerebral perfusion pressure (CPP) were measured before and at different times after TBI. Locomotor activity, anxiety-like behavior, and spatial memory were assessed on days 3, 7, 14, and 21 after injury. E2, E2-BSA, and G1 prevented the increase of BWC and EB content after TBI, and these effects were inhibited by ICI and G15. ICI and G15 also inhibited the beneficial effects of E2, E2-BSA on ICP, as well as CPP, after trauma. E2, E2-BSA, and G1 prevented the cognitive deficiency and behavioral abnormalities induced by TBI. Similar to the above parameters, ICI and G15 also reversed this E2 and E2-BSA effects on days 3, 7, 14, and 21. Our findings indicated that the beneficial effects of E2-BSA and E2 were inhibited by both ICI and G15, suggesting that GPER and classic ERs were involved in mediating the long-term effects of E2.	[Amirkhosravi, Ladan] Kerman Univ Med Sci, Fac Med, Dept Physiol, Kerman, Iran; [Khaksari, Mohammad] Kerman Univ Med Sci, Neurosci Res Ctr, Inst Neuropharmacol, Kerman, Iran; [Khaksari, Mohammad] Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Inst Neuropharmacol, Kerman, Iran; [Amirkhosravi, Ladan; Soltani, Zahra] Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Fac Med, Kerman, Iran; [Esmaeili-Mahani, Saeed; Hoseini, Mojtaba] Shahid Bahonar Univ Kerman, Fac Sci, Dept Biol, Kerman, Iran; [Karam, Gholamreza Asadi] Kerman Univ Med Sci, Sch Med, Dept Biochem, Kerman, Iran		Khaksari, M (corresponding author), Kerman Univ Med Sci, Neurosci Res Ctr, Inst Neuropharmacol, Kerman, Iran.; Khaksari, M (corresponding author), Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Inst Neuropharmacol, Kerman, Iran.	mkhaksari@kmu.ac.ir	Amirkhosravi, Ladan/AAW-9036-2021; Asadikaram, Gholamreza/AAG-4437-2021; Haddad, Mohammad Khaksari/AAB-9025-2019	Asadikaram, Gholamreza/0000-0002-9100-0756; Haddad, Mohammad Khaksari/0000-0003-0770-4281; Esmaeili Mahani, Saeed/0000-0001-5550-9806	Physiology Research Center of Kerman University of Medical Sciences (Kerman, Iran)	The present study was financially supported by the Physiology Research Center of Kerman University of Medical Sciences (Kerman, Iran).	Alexander A, 2017, NEUROPHARMACOLOGY, V113, P652, DOI 10.1016/j.neuropharm.2016.07.003; Amirkhosravi L., 2014, Iranian Journal of Veterinary Science and Technology, V6, P62; Baker AE, 2004, ENDOCRINOLOGY, V145, P5021, DOI 10.1210/en.2004-0619; Bao YJ, 2011, MOL CELL NEUROSCI, V48, P185, DOI 10.1016/j.mcn.2011.07.004; Bashiri H, 2016, NEUROPHARMACOLOGY, V105, P478, DOI 10.1016/j.neuropharm.2016.02.010; Baykara B, 2013, BIOTECH HISTOCHEM, V88, P250, DOI 10.3109/10520295.2013.769630; Bourque M, 2015, NEUROPHARMACOLOGY, V95, P343, DOI 10.1016/j.neuropharm.2015.04.006; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Broughton BRS, 2014, STROKE, V45, P835, DOI 10.1161/STROKEAHA.113.001499; Cheng Q, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160134; Chi OZ, 2004, HORM METAB RES, V36, P272, DOI 10.1055/s-2004-814478; Crandall C, 2006, J WOMENS HEALTH, V15, P14, DOI 10.1089/jwh.2006.15.14; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Dehghan Fatemeh, 2015, Iranian Biomedical Journal, V19, P165, DOI 10.7508/ibj.2015.03.006; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Dhandapani KM, 2005, ENDOCRINOLOGY, V146, P2749, DOI 10.1210/en.2005-0014; Duarte-Guterman P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129880; Fitzpatrick JL, 2002, J NEUROCHEM, V82, P674, DOI 10.1046/j.1471-4159.2002.01000.x; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Gabrielian L, 2011, J NEUROTRAUM, V28, P2103, DOI 10.1089/neu.2011.1785; Galea LAM, 2017, NEUROSCI BIOBEHAV R, V76, P363, DOI 10.1016/j.neubiorev.2016.03.024; Gilkes C., 2009, PATHO PHYSL CLIN PER, DOI [10.1016/j.mce.2005.11.015., DOI 10.1016/J.MCE.2005.11.015]; Gingerich S, 2010, NEUROSCIENCE, V170, P54, DOI 10.1016/j.neuroscience.2010.06.076; Gonzales RJ, 2007, J CEREBR BLOOD F MET, V27, P1841, DOI 10.1038/sj.jcbfm.9600483; Hadjimarkou MM, 2018, J STEROID BIOCHEM, V176, P57, DOI 10.1016/j.jsbmb.2017.04.012; Hajmohammadi M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01043; Hammond R, 2012, HORM BEHAV, V62, P367, DOI 10.1016/j.yhbeh.2012.07.004; Hammond R, 2011, BRAIN RES, V1379, P53, DOI 10.1016/j.brainres.2010.11.098; Hammond R, 2009, HORM BEHAV, V56, P309, DOI 10.1016/j.yhbeh.2009.06.008; Handa RJ, 2012, NEUROENDOCRINOLOGY, V96, P111, DOI 10.1159/000338397; Hart D, 2014, STEROIDS, V81, P49, DOI 10.1016/j.steroids.2013.11.004; Heyer A, 2005, J CEREBR BLOOD F MET, V25, P427, DOI 10.1038/sj.jcbfm.9600056; Hoffman GE, 2006, ENDOCRINE, V29, P217, DOI 10.1385/ENDO:29:2:217; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ishihara Y, 2016, STEROIDS, V113, P71, DOI 10.1016/j.steroids.2016.06.004; Jacob J, 2006, MOL CELL ENDOCRINOL, V246, P34, DOI 10.1016/j.mce.2005.11.015; Khaksari M, 2015, INT IMMUNOPHARMACOL, V28, P279, DOI 10.1016/j.intimp.2015.05.046; Khaksari M, 2015, BRAIN RES, V1618, P1, DOI 10.1016/j.brainres.2015.05.017; Khaksari M, 2013, IRAN J BASIC MED SCI, V16, P858; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Kim J., 2014, THESIS; Kim J, 2016, J NEUROSCI, V36, P3309, DOI 10.1523/JNEUROSCI.0257-15.2016; Lu D, 2016, BIOCHEM BIOPH RES CO, V477, P209, DOI 10.1016/j.bbrc.2016.06.044; Lu HH, 2018, J CELL PHYSIOL, V233, P1712, DOI 10.1002/jcp.26083; Lynch JF, 2016, NEUROBIOL LEARN MEM, V130, P83, DOI 10.1016/j.nlm.2016.01.010; Maggioli E, 2016, BRAIN BEHAV IMMUN, V51, P212, DOI 10.1016/j.bbi.2015.08.020; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marschner L, 2019, BEHAV BRAIN RES, V365, P222, DOI 10.1016/j.bbr.2018.02.040; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Mitchnick KA, 2019, PSYCHONEUROENDOCRINO, V107, P98, DOI 10.1016/j.psyneuen.2019.05.005; Mitterling KL, 2010, J COMP NEUROL, V518, P2729, DOI 10.1002/cne.22361; Naderi V, 2015, IRAN J BASIC MED SCI, V18, P138; Oconnor W.T., 2011, ANIMAL MODELS TRAUMA, DOI [10.1016/j.pharmthera.2011.01.001., DOI 10.1016/J.PHARMTHERA.2011.01.001]; Pan MX, 2018, CHIN J TRAUMATOL, V21, P224, DOI 10.1016/j.cjtee.2018.04.003; Raval AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060716; Roque C, 2019, FRONT NEUROENDOCRIN, V55, DOI 10.1016/j.yfrne.2019.100786; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Sawada M, 2000, J CEREBR BLOOD F MET, V20, P112, DOI 10.1097/00004647-200001000-00015; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Shin JA, 2016, FREE RADICAL BIO MED, V92, P78, DOI 10.1016/j.freeradbiomed.2016.01.010; Soltani Z, 2016, J PHYSIOL BIOCHEM, V72, P33, DOI 10.1007/s13105-015-0453-5; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Stevis PE, 1999, ENDOCRINOLOGY, V140, P5455, DOI 10.1210/en.140.11.5455; Suzuki S, 2007, P NATL ACAD SCI USA, V104, P6013, DOI 10.1073/pnas.0610394104; Suzuki T, 2008, J CELL PHYSIOL, V214, P662, DOI 10.1002/jcp.21255; Tang H, 2014, MOL CELL ENDOCRINOL, V389, P92, DOI 10.1016/j.mce.2014.05.005; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Walf AA, 2008, BEHAV NEUROSCI, V122, P974, DOI 10.1037/a0012749; Wang H, 2012, CARDIOVASC RES, V94, P96, DOI 10.1093/cvr/cvs090; Wu YX, 2018, MOL MED REP, V17, P5716, DOI 10.3892/mmr.2018.8618; Xu Y, 2003, J NEUROSCI RES, V74, P1, DOI 10.1002/jnr.10725; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; Yu HP, 2007, ANN SURG, V245, P971, DOI 10.1097/01.sla.0000254417.15591.88; Zhao TZ, 2016, NEUROSCIENCE, V328, P117, DOI 10.1016/j.neuroscience.2016.04.026; Zhao TZ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.449	79	5	5	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 1	2021	1750								147168	10.1016/j.brainres.2020.147168			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PC3VY	WOS:000596934400003	33096091				2022-02-06	
J	Pham, L; Wright, DK; O'Brien, WT; Bain, J; Huang, C; Sun, MJ; Casillas-Espinosa, PM; Shah, AD; Schittenhelm, RB; Sobey, CG; Brady, RD; O'Brien, TJ; Mychasiuk, R; Shultz, SR; McDonald, SJ				Pham, Louise; Wright, David K.; O'Brien, William T.; Bain, Jesse; Huang, Cheng; Sun, Mujun; Casillas-Espinosa, Pablo M.; Shah, Anup D.; Schittenhelm, Ralf B.; Sobey, Christopher G.; Brady, Rhys D.; O'Brien, Terence J.; Mychasiuk, Richelle; Shultz, Sandy R.; McDonald, Stuart J.			Behavioral, axonal, and proteomic alterations following repeated mild traumatic brain injury: Novel insights using a clinically relevant rat model	NEUROBIOLOGY OF DISEASE			English	Article						Concussion; Axonal injury; MRI; Biomarkers; Neurofilament light	WHITE-MATTER ABNORMALITIES; NEUROFILAMENT-LIGHT; NEUROCHEMICAL AFTERMATH; COGNITIVE IMPAIRMENT; SYNAPTIC PLASTICITY; DIFFUSION MRI; CONCUSSION; NEUROINFLAMMATION; MITOCHONDRIAL; DYSFUNCTION	A history of mild traumatic brain injury (mTBI) is linked to a number of chronic neurological conditions, however there is still much unknown about the underlying mechanisms. To provide new insights, this study used a clinically relevant model of repeated mTBI in rats to characterize the acute and chronic neuropathological and neurobehavioral consequences of these injuries. Rats were given four sham-injuries or four mTBIs and allocated to 7-day or 3.5-months post-injury recovery groups. Behavioral analysis assessed sensorimotor function, locomotion, anxiety, and spatial memory. Neuropathological analysis included serum quantification of neurofilament light (NfL), mass spectrometry of the hippocampal proteome, and ex vivo magnetic resonance imaging (MRI). Repeated mTBI rats had evidence of acute cognitive deficits and prolonged sensorimotor impairments. Serum NfL was elevated at 7 days post injury, with levels correlating with sensorimotor deficits; however, no NfL differences were observed at 3.5 months. Several hippocampal proteins were altered by repeated mTBI, including those associated with energy metabolism, neuroinflammation, and impaired neurogenic capacity. Diffusion MRI analysis at 3.5 months found widespread reductions in white matter integrity. Taken together, these findings provide novel insights into the nature and progression of repeated mTBI neuropathology that may underlie lingering or chronic neurobehavioral deficits.	[Pham, Louise; Sobey, Christopher G.; McDonald, Stuart J.] La Trobe Univ, Sch Life Sci, Dept Physiol Anat & Microbiol, Melbourne, Vic 3086, Australia; [Wright, David K.; O'Brien, William T.; Bain, Jesse; Sun, Mujun; Casillas-Espinosa, Pablo M.; Brady, Rhys D.; O'Brien, Terence J.; Mychasiuk, Richelle; Shultz, Sandy R.; McDonald, Stuart J.] Monash Univ, Dept Neurosci, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Huang, Cheng; Shah, Anup D.; Schittenhelm, Ralf B.] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Monash Prote & Metabol Facil, Melbourne, Vic 3800, Australia; [O'Brien, Terence J.; Shultz, Sandy R.] Alfred Hosp, Dept Neurol, Melbourne, Vic 3004, Australia; [Casillas-Espinosa, Pablo M.; Brady, Rhys D.; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Dept Med, Melbourne, Vic 3052, Australia; [Shah, Anup D.] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Monash Bioinformat Platform, Melbourne, Vic 3800, Australia		McDonald, SJ (corresponding author), Monash Univ, Dept Neurosci, Cent Clin Sch, Melbourne, Vic 3004, Australia.	stuart.mcdonald@monash.edu	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013	O'Brien, Terence/0000-0002-7198-8621; Sun, Mujun/0000-0002-9923-9913; Schittenhelm, Ralf/0000-0001-8738-1878; McDonald, Stuart/0000-0001-5190-3179	Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Australian Government Research Training Program ScholarshipAustralian GovernmentDepartment of Industry, Innovation and Science	PMC, TJO, RM and SRS would like to thank the Australian National Health and Medical Research Council for funding. This work was supported by an Australian Government Research Training Program Scholarship. The authors would also like to thank Mrs. Karen Griggs for her assistance throughout this project.	[Anonymous], 2019, FRONTIERS, DOI DOI 10.3389/FPHAR.2019.00920; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Archer DP, 2018, BRIT J ANAESTH, V121, P1272, DOI 10.1016/j.bja.2018.07.024; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Berto S, 2016, HUM MOL GENET, V25, P2451, DOI 10.1093/hmg/ddw110; Bodaleo FJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30069; Brady RD, 2016, J NEUROTRAUM, V33, P2154, DOI 10.1089/neu.2014.3836; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; Centers for Disease Control, 2019, TRAUM BRAIN INJ CONC; Chan CS, 2006, J NEUROSCI, V26, P223, DOI 10.1523/JNEUROSCI.4110-05.2006; Chater-Diehl EJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154836; Chatterjee M, 2019, NEURAL REGEN RES, V14, P206, DOI 10.4103/1673-5374.244776; Cheng WH, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-018-0461-0; Cheng WH, 2018, EXP NEUROL, V301, P26, DOI 10.1016/j.expneurol.2017.12.007; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Choi CSW, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0494-8; CColakoglu G, 2014, P NATL ACAD SCI USA, V111, pE394, DOI 10.1073/pnas.1313769110; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Escolas SM, 2020, MIL MED, V185, P154, DOI 10.1093/milmed/usz259; Eyolfson Eric, 2020, Cereb Cortex Commun, V1, ptgaa002, DOI 10.1093/texcom/tgaa002; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Gaetani L, 2019, J NEUROL NEUROSUR PS, V90, P870, DOI 10.1136/jnnp-2018-320106; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Gillardon F, 1998, NEUROSCIENCE, V84, P81, DOI 10.1016/S0306-4522(97)00479-X; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Godel M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140116; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Han SJ, 2017, J AM SOC NEPHROL, V28, P1200, DOI 10.1681/ASN.2016030349; Harper MM, 2010, J MOL NEUROSCI, V40, P269, DOI 10.1007/s12031-009-9211-x; Horie H, 2002, GLYCOCONJUGATE J, V19, P479, DOI 10.1023/B:GLYC.0000014077.84016.52; Huang Z, 2006, J NEUROSCI, V26, P11208, DOI 10.1523/JNEUROSCI.3526-06.2006; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Iverson GL, 2019, BRAIN, V142, P3672, DOI 10.1093/brain/awz286; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Johnstone MR, 2018, BRAIN INJURY, V32, P257, DOI 10.1080/02699052.2017.1394492; Kalinowska M, 2015, J BIOL CHEM, V290, P15909, DOI 10.1074/jbc.M115.640136; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Kim H, 2016, FREE RADICAL RES, V50, P853, DOI 10.1080/10715762.2016.1185519; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Lei WL, 2012, CELL RES, V22, P954, DOI 10.1038/cr.2012.40; Li WL, 2019, J CEREBR BLOOD F MET, V39, P2048, DOI 10.1177/0271678X18777916; Li YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122615; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Lynall RC, 2019, J SCI MED SPORT, V22, P503, DOI 10.1016/j.jsams.2018.10.012; Lyons DN, 2018, J NEUROTRAUM, V35, P2435, DOI 10.1089/neu.2018.5663; Mahajani S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05078-6; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Morita T, 2012, J BIOL CHEM, V287, P3349, DOI 10.1074/jbc.M111.295618; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Neo SH, 2017, NEURAL REGEN RES, V12, P1600, DOI 10.4103/1673-5374.217323; Panov A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/472459; Pham L, 2019, J NEUROTRAUM, V36, P2260, DOI 10.1089/neu.2018.6169; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Quinn DK, 2018, AM J PSYCHIAT, V175, P103, DOI 10.1176/appi.ajp.2017.17020235; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Rex CS, 2010, NEURON, V67, P603, DOI 10.1016/j.neuron.2010.07.016; Ribotta MG, 2004, ACTA NEUROCHIR SUPPL, V89, P87; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; San Martin Molina I., 2020, ENEURO, V7; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Schmidt H, 2013, CURR BIOL, V23, P244, DOI 10.1016/j.cub.2012.12.007; Schwaller B, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00003; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shalini SM, 2018, MOL NEUROBIOL, V55, P1537, DOI 10.1007/s12035-017-0413-x; Shi XW, 2019, J ALZHEIMERS DIS, V68, P1667, DOI 10.3233/JAD-181218; Shimazu T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19615-4; Shultz SR, 2020, J NEUROTRAUM, V37, P2381, DOI 10.1089/neu.2018.6149; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Smith DH, 2020, NAT REV NEUROL, V16, P457, DOI 10.1038/s41582-020-0382-y; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Sun MJ, 2019, BRAIN BEHAV IMMUN, V80, P536, DOI 10.1016/j.bbi.2019.04.038; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tan KN, 2018, J NEUROCHEM, V144, P431, DOI 10.1111/jnc.14275; Tentler D, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111427; Tournier JD, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116137; Uhlen M, 2019, SCIENCE, V366, P1471, DOI 10.1126/science.aax9198; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wang HC, 2010, J CEREBR BLOOD F MET, V30, P493, DOI 10.1038/jcbfm.2009.247; Wang J, 2018, EXP NEUROL, V302, P214, DOI 10.1016/j.expneurol.2018.01.007; Wang JY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09621; Weber T, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00148; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Weidinger A, 2017, FREE RADICAL BIO MED, V112, P74, DOI 10.1016/j.freeradbiomed.2017.10.107; Wen HX, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0656-0; White CJ, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00037-20; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wortman RC, 2018, ANN CLIN TRANSL NEUR, V5, P1588, DOI 10.1002/acn3.667; Wright DK, 2021, J NEUROTRAUM, V38, P983, DOI 10.1089/neu.2019.6886; Wright DK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51267-w; Wright DK, 2018, NEUROIMAGE-CLIN, V18, P315, DOI 10.1016/j.nicl.2018.01.033; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Wu CS, 2009, J NEUROSCI, V29, P7649, DOI 10.1523/JNEUROSCI.1027-09.2009; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zhao WQ, 2007, J NEUROCHEM, V100, P1211, DOI 10.1111/j.1471-4159.2006.04311.x; Zybura-Broda K, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00224	124	5	5	2	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	JAN	2021	148								105151	10.1016/j.nbd.2020.105151			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PR9UT	WOS:000607576400003	33127468	gold			2022-02-06	
J	Robba, C; Banzato, E; Rebora, P; Iaquaniello, C; Huang, CY; Wiegers, EJA; Meyfroidt, G; Citerio, G				Robba, Chiara; Banzato, Erika; Rebora, Paola; Iaquaniello, Carolina; Huang, Chao-Yuan; Wiegers, Eveline J. A.; Meyfroidt, Geert; Citerio, Giuseppe		Collaborative European NeuroTrauma	Acute Kidney Injury in Traumatic Brain Injury Patients: Results From the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Study	CRITICAL CARE MEDICINE			English	Article						acute kidney injury; kidney failure; osmotic diuretics; traumatic brain injury		OBJECTIVES: Acute kidney injury is frequent in polytrauma patients, and it is associated with increased mortality and extended hospital length of stay. However, the specific prevalence of acute kidney injury after traumatic brain injury is less recognized. The present study aims to describe the occurrence rate, risk factors, timing, and association with outcome of acute kidney injury in a large cohort of traumatic brain injury patients. DESIGN: The Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury is a multicenter, prospective observational, longitudinal, cohort study. SETTING: Sixty-five ICUs across Europe. PATIENTS: For the present study, we selected 4,509 traumatic brain injury patients with an ICU length of stay greater than 72 hours and with at least two serum creatinine values during the first 7 days of ICU stay. MEASUREMENTS AND MAIN RESULTS: We classified acute kidney injury in three stages according to the Kidney Disease Improving Global Outcome criteria: acute kidney injury stage 1 equals to serum creatinine x 1.5-1.9 times from baseline or an increase greater than or equal to 0.3 mg/dL in 48 hours; acute kidney injury stage 2 equals to serum creatinine x 2-2.9 times baseline; acute kidney injury stage 3 equals to serum creatinine x three times baseline or greater than or equal to 4 mg/dL or need for renal replacement therapy. Standard reporting techniques were used to report incidences. A multivariable Cox regression analysis was performed to model the cause-specific hazard of acute kidney injury and its association with the long-term outcome. We included a total of 1,262 patients. The occurrence rate of acute kidney injury during the first week was as follows: acute kidney injury stage 1 equals to 8% (n = 100), acute kidney injury stage 2 equals to 1% (n = 14), and acute kidney injury stage 3 equals to 3% (n = 36). Acute kidney injury occurred early after ICU admission, with a median of 2 days (interquartile range 1-4 d). Renal history (hazard ratio = 2.48; 95% CI, 1.39-4.43; p = 0.002), insulin-dependent diabetes (hazard ratio = 2.52; 95% CI, 1.22-5.197; p = 0.012), hypernatremia (hazard ratio = 1.88; 95% CI, 1.31-2.71; p = 0.001), and osmotic therapy administration (hazard ratio = 2.08; 95% CI, 1.45-2.99; p < 0.001) were significantly associated with the risk of developing acute kidney injury. Acute kidney injury was also associated with an increased ICU length of stay and with a higher probability of 6 months unfavorable Extended Glasgow Outcome Scale and mortality. CONCLUSIONS: Acute kidney injury after traumatic brain injury is an early phenomenon, affecting about one in 10 patients. Its occurrence negatively impacts mortality and neurologic outcome at 6 months. Osmotic therapy use during ICU stay could be a modifiable risk factor.	[Robba, Chiara] Policlin San Martino IRCCS Oncol & Neurosci, Dept Anaesthesia & Intens Care, Genoa, Italy; [Banzato, Erika; Rebora, Paola; Iaquaniello, Carolina; Citerio, Giuseppe] Univ Milano Bicocca, Dept Med & Surg, Monza, Italy; [Banzato, Erika] Univ Padua, Dept Stat Sci, Padua, Italy; [Huang, Chao-Yuan; Meyfroidt, Geert] Univ Hosp Leuven, Dept & Lab Intens Care Med, Leuven, Belgium; [Huang, Chao-Yuan; Meyfroidt, Geert] Katholieke Univ Leuven, Leuven, Belgium; [Wiegers, Eveline J. A.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Citerio, Giuseppe] ASST Monza, San Gerardo Hosp, Dept Emergency & Urgency, Neurointens Care Unit, Monza, Italy		Citerio, G (corresponding author), Univ Milano Bicocca, Dept Med & Surg, Monza, Italy.; Citerio, G (corresponding author), ASST Monza, San Gerardo Hosp, Dept Emergency & Urgency, Neurointens Care Unit, Monza, Italy.	giuseppe.citerio@unimib.it	Posti, Jussi P./Y-2908-2019; Sahuquillo, Juan/B-3577-2008; Raj, Rahul/K-7693-2012	Posti, Jussi P./0000-0002-5925-5193; Sahuquillo, Juan/0000-0003-0713-5875; Takala, Riikka/0000-0001-6342-0043; Raj, Rahul/0000-0003-4243-9591; Huang, Chao-Yuan/0000-0001-8823-4722; Kondziella, Daniel/0000-0001-5562-9808; Sanchez-Porras, Renan/0000-0002-9084-8114; Castano-Leon, Ana M/0000-0002-7918-5049; Newcombe, Virginia/0000-0001-6044-9035; Zeiler, Frederick/0000-0003-1737-0510	Framework 7 program of the European Union [602150]; Hannelore Kohl Stiftung (Germany); OneMind (United States); Integra LifeSciences Corporation (United States)	Data used in the preparation of this article were obtained in the context of The Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (registered at ClinicalTrials.gov NCT02210221), a large collaborative project, supported by the Framework 7 program of the European Union (602150). Supported, in part, by the Hannelore Kohl Stiftung (Germany), by OneMind (United States), and by Integra LifeSciences Corporation (United States).	Bagshaw SM, 2008, RENAL FAILURE, V30, P581, DOI 10.1080/08860220802134649; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Coritsidis G, 2015, J CLIN NEUROSCI, V22, P1332, DOI 10.1016/j.jocn.2015.02.025; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Corry Jesse J, 2014, World J Crit Care Med, V3, P61, DOI 10.5492/wjccm.v3.i2.61; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Ergin B, 2018, SHOCK, V50, P655, DOI 10.1097/SHK.0000000000001096; Gomes E, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-1; Goyal K, 2018, INDIAN J CRIT CARE M, V22, P632, DOI 10.4103/ijccm.IJCCM_156_18; Harrois A, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2265-9; Harrois A, 2017, CURR OPIN CRIT CARE, V23, P447, DOI 10.1097/MCC.0000000000000463; Karajala V, 2009, MINERVA ANESTESIOL, V75, P251; Kellum JA, 2008, CRIT CARE MED, V36, pS141, DOI 10.1097/CCM.0b013e318168c4a4; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; Kelly AM, 2008, ANN INTERN MED, V148, P284, DOI 10.7326/0003-4819-148-4-200802190-00007; Kumar AB, 2015, NEUROCRIT CARE, V22, P184, DOI 10.1007/s12028-014-0067-8; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Nongnuch A, 2014, CRIT CARE, V18, DOI 10.1186/cc13907; Seeliger E, 2012, INVEST RADIOL, V47, P240, DOI 10.1097/RLI.0b013e31823acbaa; Shi JW, 2018, RENAL FAILURE, V40, P85, DOI 10.1080/0886022X.2017.1419973; Skinner DL, 2014, INJURY, V45, P259, DOI 10.1016/j.injury.2013.07.013; Sovik S, 2019, INTENS CARE MED, V45, P407, DOI 10.1007/s00134-019-05535-y; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Wu XJ, 2014, RENAL FAILURE, V36, P1051, DOI 10.3109/0886022X.2014.917560; Yang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085029; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356	30	5	5	2	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	2021	49	1					112	126		10.1097/CCM.0000000000004673			15	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PE8RB	WOS:000598627500029	33060506	Green Published			2022-02-06	
J	Sakai, K; Takata, F; Yamanaka, G; Yasunaga, M; Hashiguchi, K; Tominaga, K; Itoh, K; Kataoka, Y; Yamauchi, A; Dohgu, S				Sakai, Kenta; Takata, Fuyuko; Yamanaka, Gaku; Yasunaga, Miho; Hashiguchi, Kana; Tominaga, Kazuki; Itoh, Kouichi; Kataoka, Yasufumi; Yamauchi, Atsushi; Dohgu, Shinya			Reactive pericytes in early phase are involved in glial activation and late-onset hypersusceptibility to pilocarpine-induced seizures in traumatic brain injury model mice	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Traumatic brain injury; Reactive pericytes; PDGFR beta; Imatinib; Microglia	STATUS EPILEPTICUS; AXONAL INJURY; EPILEPSY; DECREASES	In this study, among neurovascular unit (NVU) cells, we focused on pericyte reactivity in mice subjected to controlled cortical impact (CCI) to understand how traumatic brain injury (TBI) causes uncoordinated crosstalk in the NVU and alters neuronal activity. Histological analyses of brain pericytes, microglia and astrocytes were performed for up to 28 days after CCI in the injured ipsilateral hippocampus. To evaluate altered neuronal activity caused by CCI, we measured seizure susceptibility to a sub-threshold dose of pilocarpine on postoperative day 7, 14, 21 and 28. Platelet-derived growth factor receptor (PDGFR) beta immunoreactivity in pericytes significantly increased from 1 h to 4 days after CCI. The expression of Iba1 and GFAP, as markers of microglia and astrocytes, respectively, increased from 4 to 28 days after CCI. The severity of seizure induced by pilocarpine gradually increased, becoming significant at 28 days after CCI. Then, we treated CCI mice with an inhibitor of PDGFR signaling, imatinib, during the postoperative day 0-4 period. Imatinib lowered seizure susceptibility to pilocarpine and suppressed microglial activation in the injured hippocampus at postoperative day 28. These findings indicate that brain pericytes with rapidly increased PDGFR beta expression may drive TBI-induced dysregulation of NVU function and brain hyperexcitability. (C) 2020 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.	[Sakai, Kenta; Takata, Fuyuko; Yasunaga, Miho; Hashiguchi, Kana; Tominaga, Kazuki; Kataoka, Yasufumi; Yamauchi, Atsushi; Dohgu, Shinya] Fukuoka Univ, Fac Pharmaceut Sci, Dept Pharmaceut Care & Hlth Sci, Fukuoka 8140180, Japan; [Yamanaka, Gaku] Tokyo Med Univ, Dept Pediat & Adolescent Med, Tokyo 1600023, Japan; [Itoh, Kouichi] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Lab Pharmacotherapy & Expt Neurol, Tokushima, Kagawa 7692193, Japan		Takata, F (corresponding author), Fukuoka Univ, Fac Pharmaceut Sci, Dept Pharmaceut Care & Hlth Sci, Jonan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.	ftakata@fukuoka-u.ac.jp			Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [18K06712, 19K07338]; Central Research Institute of Fukuoka University [181044]	This work was supported by Grants-in-Aid for Scientific Research [(to FT) (C) 18K06712 and (to SD) (C) 19K07338] from the Japan Society for the Promotion of Science and by Funds [(to FT) no. 181044] from the Central Research Institute of Fukuoka University. The study sponsor had no role in the study design, in the collection, analysis, or interpretation of the data, in the writing of the report, or in the decision to submit the paper for publication.	Adams B, 1997, J NEUROSCI, V17, P5288; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Crouch EE, 2018, NAT PROTOC, V13, P738, DOI 10.1038/nprot.2017.158; Ferrini F, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/429815; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gaceb A, 2018, J CEREBR BLOOD F MET, V38, P45, DOI 10.1177/0271678X17719645; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Glushakov AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113689; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kharatishvili I, 2010, CURR OPIN NEUROL, V23, P183, DOI 10.1097/WCO.0b013e32833749e4; Lee SH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122510; Lier J, 2020, INT J LEGAL MED, V134, P2187, DOI 10.1007/s00414-020-02308-x; Machida T, 2015, NEUROSCI LETT, V599, P109, DOI 10.1016/j.neulet.2015.05.028; MASLANSKI JA, 1994, NEUROSCI LETT, V168, P225, DOI 10.1016/0304-3940(94)90456-1; Matsumoto J, 2018, BRAIN RES, V1692, P34, DOI 10.1016/j.brainres.2018.04.023; Matsumoto J, 2014, NEUROSCI LETT, V578, P133, DOI 10.1016/j.neulet.2014.06.052; Mazzuferi M, 2012, EXP NEUROL, V238, P156, DOI 10.1016/j.expneurol.2012.08.022; Muradashvili N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070077; Nikolakopoulou AM, 2016, ASN NEURO, V8, DOI 10.1177/1759091416630220; Nirwan N, 2018, EPILEPSY RES, V145, P93, DOI 10.1016/j.eplepsyres.2018.06.009; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Paxinos G., 2008, MOUSE BRAIN STEREOTA; da Cruz GMP, 2013, PHARMACOL BIOCHEM BE, V104, P144, DOI 10.1016/j.pbb.2013.01.002; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Reddy DS, 2013, INT J MOL SCI, V14, P18284, DOI 10.3390/ijms140918284; Reeves C, 2019, NEUROPATH APPL NEURO, V45, P609, DOI 10.1111/nan.12539; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smolders I, 1997, BRIT J PHARMACOL, V121, P1171, DOI 10.1038/sj.bjp.0701231; Su XJ, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00519; Takata F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-106; Tomkins Oren, 2011, Cardiovasc Psychiatry Neurol, V2011, P765923, DOI 10.1155/2011/765923; Uemura MT, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00080; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vlahovic G, 2006, BRIT J CANCER, V95, P1013, DOI 10.1038/sj.bjc.6603366; Wagner DC, 2013, ACTA NEUROBIOL EXP, V73, P79; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xu SB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01149; Zehendner CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13497	48	5	5	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	JAN	2021	145	1					155	165		10.1016/j.jphs.2020.11.008			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	PL0YE	WOS:000602857700019	33357774	gold			2022-02-06	
J	Singh, AK; Upadhyay, D; Pruseth, KL; Mezger, K; Nanda, JK; Maiti, S; Saha, D				Singh, Ajay K.; Upadhyay, Dewashish; Pruseth, Kamal Lochan; Mezger, Klaus; Nanda, Jayanta K.; Maiti, Sabyasachi; Saha, Dilip			Shock Metamorphic Features in the Archean Simlipal Complex, Singhbhum Craton, Eastern India: Possible Remnant of a Large Impact Structure	JOURNAL OF THE GEOLOGICAL SOCIETY OF INDIA			English	Article							TRACE-ELEMENT; ORISSA CRATON; SOUTH-AFRICA; ZIRCON; AGE; PB; QUARTZ; DEFORMATION; MAYURBHANJ; STISHOVITE	The Simlipal complex in eastern India is an elliptical structure with diameter of ca. 50 km coinciding with an elliptical region of high gravity. It overlies the Archaean basement of the Singhbhum craton and has a ring structure characterized by complex series of concentric ridges with inward dipping slopes. Quartz clasts in melt-breccias from the complex display diagnostic shock metamorphic features such as two to three sets of decorated and annealed planar deformation features (PDFs), spall and concussion micro-fractures, and the presence of coesite. They also preserve microstructures suggestive of crystallographically-controlled melting/amorphization along two or three planar directions, and within concussion micro-fractures. The inferred shock pressures in excess of 40-60 GPa are possible only during bolide impact. The Simlipal structure is possibly the remnant of a large complex impact crater having an original diameter of at least 50 km. Although zircons from an impact melt rock furnish a concordia age of 3107 +/- 14 Ma, in the absence of any unambiguous shock metamorphic effects in them, it is difficult to assign the age to the impact event. Therefore, the age of the impact is currently unconstrained.	[Singh, Ajay K.; Upadhyay, Dewashish; Pruseth, Kamal Lochan; Maiti, Sabyasachi] Indian Inst Technol IIT, Dept Geol & Geophys, Kharagpur 721302, W Bengal, India; [Mezger, Klaus] Univ Bern, Inst Geol Sci, Baltzerstr 1 3, CH-3012 Bern, Switzerland; [Mezger, Klaus] Univ Bern, Ctr Space & Habitabil, Baltzerstr 1 3, CH-3012 Bern, Switzerland; [Nanda, Jayanta K.] S-4-113 Niladrivihar, Bhubaneswar 751021, India; [Saha, Dilip] Indian Stat Inst, Geol Studies Unit, 203 BT Rd, Kolkata 700108, India		Upadhyay, D (corresponding author), Indian Inst Technol IIT, Dept Geol & Geophys, Kharagpur 721302, W Bengal, India.	dewashish@gg.iitkgp.ac.in	SINGH, AJAY KUMAR/AAD-7518-2022	SINGH, AJAY KUMAR/0000-0002-8743-6477	IIT Kharagpur; DSTDepartment of Science & Technology (India)	The U-Pb isotope and trace element data were generated at the Diamond Jubilee Radiogenic Isotope Facility of the Department of Geology and Geophysics, IIT Kharagpur. DU acknowledges financial support from IIT Kharagpur for setting up the laboratory. Biswajit Mishra is thanked for access to the DST funded EPMA National Facility of the Department.	Banerjee, 1964, GEOL SURV INDIA MISC, V8; BANERJEE PK, 1994, J GEOL SOC INDIA, V43, P353; Bose S, 2016, J METAMORPH GEOL, V34, P743, DOI 10.1111/jmg.12201; Byerly GR, 2002, SCIENCE, V297, P1325, DOI 10.1126/science.1073934; Chatterjee N, 2010, PRECAMBRIAN RES, V179, P99, DOI 10.1016/j.precamres.2010.02.013; Chattopadhyay S, 2015, PRECAMBRIAN RES, V266, P506, DOI 10.1016/j.precamres.2015.05.030; CHENNAKESAVULU N, 1980, J GEOL SOC INDIA, V21, P211; Crowley JL, 2005, GEOCHIM COSMOCHIM AC, V69, pA19; Davis DW, 2008, GEOLOGY, V36, P383, DOI 10.1130/G24502A.1; ENGELHARDT WV, 1965, NATURWISSENSCHAFTEN, V52, P489; Erickson TM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13985-7; Ernstson K, 2001, GEOLOGY, V29, P11, DOI 10.1130/0091-7613(2001)029<0011:CCITBC>2.0.CO;2; Fei Y., 1999, MANTLE PETROLOGY FIE, P189; Ferriere L, 2009, METEORIT PLANET SCI, V44, P925, DOI 10.1111/j.1945-5100.2009.tb00778.x; French BM, 2010, EARTH-SCI REV, V98, P123, DOI 10.1016/j.earscirev.2009.10.009; French BM, 1998, LUNAR PLANETARY I CO; Grieve R.A., 1996, J AUSTR GEOLOGY GEOP, V16, P399; Hamers MF, 2017, PHYS CHEM MINER, V44, P263, DOI 10.1007/s00269-016-0858-x; Iyengar S.V.P., 1981, INDIAN J EARTH SCI, V8, P61; Jackson JC, 2016, METEORIT PLANET SCI, V51, P946, DOI 10.1111/maps.12638; Jackson SE, 2004, CHEM GEOL, V211, P47, DOI 10.1016/j.chemgeo.2004.06.017; Johnson BC, 2012, NATURE, V485, P75, DOI 10.1038/nature10982; Kamo SL, 1996, EARTH PLANET SC LETT, V144, P369, DOI 10.1016/S0012-821X(96)00180-X; KIEFFER SW, 1971, J GEOPHYS RES, V76, P5449, DOI 10.1029/JB076i023p05449; Kumar A, 2017, PRECAMBRIAN RES, V292, P163, DOI 10.1016/j.precamres.2017.01.018; LANGENHORST F, 1994, EARTH PLANET SC LETT, V125, P407, DOI 10.1016/0012-821X(94)90229-1; Langenhorst F., 2002, B CZECH GEOL SURVEY, V77, P265; Li SS, 2018, GONDWANA RES, V54, P81, DOI 10.1016/j.gr.2017.10.006; LOWE DR, 1986, GEOLOGY, V14, P83, DOI 10.1130/0091-7613(1986)14<83:EASSOP>2.0.CO;2; Mandal N, 2006, J EARTH SYST SCI, V115, P643, DOI 10.1007/s12040-006-0002-2; Master S, 2019, METEORIT PLANET SCI, V54; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Melosh, 1989, IMPACT CRATERING GEO; Mishra S, 1999, PRECAMBRIAN RES, V93, P139, DOI 10.1016/S0301-9268(98)00085-0; Misra S, 2000, GONDWANA RES, V3, P205, DOI 10.1016/S1342-937X(05)70097-6; Mukhopadhyay J, 2008, J GEOL, V116, P449, DOI 10.1086/590133; Naqvi SM., 1987, PRECAMBRIAN GEOLOGY; Naumov M.V., 1996, 27 LUN PLAN SCI C; Pal SK, 2006, J INDIAN GEOPHYS UNI, V10, P313; Pandey OP, 2019, CHEM GEOL, V512, P85, DOI 10.1016/j.chemgeo.2019.02.040; Pati JK, 2008, METEORIT PLANET SCI, V43, P1383, DOI 10.1111/j.1945-5100.2008.tb00704.x; Pati JK, 2010, GEOL SOC AM SPEC PAP, V465, P571, DOI 10.1130/2010.2465(27); Ray, 2020, 51 LUN PLAN SCI C WO; Rudnick R.L., 2003, TREATISE GEOCHEM, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; Saha AK., 1994, MEM GEOL SOC INDIA, V27; SARKAR SS, 1982, J GEOL SOC INDIA, V23, P53; Short, 1968, SHOCK METAMORPHISM N, P31; Short, 1968, SHOCK METAMORPHISM N; Short, 1968, GERMANY SHOCK METAMO, P159; Simonson BM, 2009, PRECAMBRIAN RES, V169, P100, DOI 10.1016/j.precamres.2008.10.016; Singh A, 2020, SILICON-NETH, V12, P2301, DOI 10.1007/s12633-019-00325-z; Srivastava RK, 2019, PRECAMBRIAN RES, V329, P5, DOI 10.1016/j.precamres.2018.08.001; Stahle V, 2008, CONTRIB MINERAL PETR, V155, P457, DOI 10.1007/s00410-007-0252-2; STOFFLER D, 1994, METEORITICS, V29, P155, DOI 10.1111/j.1945-5100.1994.tb00670.x; STOFFLER D, 1971, J GEOPHYS RES, V76, P5474, DOI 10.1029/JB076i023p05474; Taylor S. R., 1985, CONTINENTAL CRUST IT; Upadhyay D, 2019, PRECAMBRIAN RES, V327, P255, DOI 10.1016/j.precamres.2019.04.009; Upadhyay D, 2014, PRECAMBRIAN RES, V252, P180, DOI 10.1016/j.precamres.2014.07.011; VANNOCKER S, 2003, SPECIAL PUBLICATION, V4; WIEDENBECK M, 1995, GEOSTANDARD NEWSLETT, V19, P1, DOI 10.1111/j.1751-908X.1995.tb00147.x	60	5	5	0	1	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0016-7622	0974-6889		J GEOL SOC INDIA	J. Geol. Soc. India	JAN	2021	97	1					35	47		10.1007/s12594-021-1623-4			13	Geosciences, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Geology	PQ3FZ	WOS:000606434500004					2022-02-06	
J	Valera, EM; Joseph, ALC; Snedaker, K; Breiding, MJ; Robertson, CL; Colantonio, A; Levin, H; Pugh, MJ; Yurgelun-Todd, D; Mannix, R; Bazarian, JJ; Turtzo, LC; Turkstra, LS; Begg, L; Cummings, DM; Bellgowan, PSF				Valera, Eve M.; Joseph, Annie-Lori C.; Snedaker, Katherine; Breiding, Matthew J.; Robertson, Courtney L.; Colantonio, Angela; Levin, Harvey; Pugh, Mary Jo; Yurgelun-Todd, Deborah; Mannix, Rebekah; Bazarian, Jeffrey J.; Turtzo, L. Christine; Turkstra, Lyn S.; Begg, Lisa; Cummings, Diana M.; Bellgowan, Patrick S. F.			Understanding Traumatic Brain Injury in Females: A State-of-the-Art Summary and Future Directions	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; intimate partner violence; sex differences; traumatic brain injury; women	INTIMATE-PARTNER-VIOLENCE; EMERGENCY-DEPARTMENT VISITS; SEX-BASED DIFFERENCES; OLDER-ADULTS; GENDER-DIFFERENCES; HEAD-INJURY; RECOVERY TRAJECTORIES; DIFFUSION TENSOR; HEALTH OUTCOMES; UNITED-STATES	In this report, we identify existing issues and challenges related to research on traumatic brain injury (TBI) in females and provide future directions for research. In 2017, the National Institutes of Health, in partnership with the Center for Neuroscience and Regenerative Medicine and the Defense and Veterans Brain Injury Center, hosted a workshop that focused on the unique challenges facing researchers, clinicians, patients, and other stakeholders regarding TBI in women. The goal of this "Understanding TBI in Women" workshop was to bring together researchers and clinicians to identify knowledge gaps, best practices, and target populations in research on females and/or sex differences within the field of TBI. The workshop, and the current literature, clearly highlighted that females have been underrepresented in TBI studies and clinical trials and have often been excluded (or ovariectomized) in preclinical studies. Such an absence in research on females has led to an incomplete, and perhaps inaccurate, understanding of TBI in females. The presentations and discussions centered on the existing knowledge regarding sex differences in TBI research and how these differences could be incorporated in preclinical and clinical efforts going forward. Now, a little over 2 years later, we summarize the issues and state of the science that emerged from the "Understanding TBI in Women" workshop while incorporating updates where they exist. Overall, despite some progress, there remains an abundance of research focused on males and relatively little explicitly on females.	[Valera, Eve M.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Mannix, Rebekah] Harvard Med Sch, Dept Pediat & Emergency Med, Boston, MA 02115 USA; [Valera, Eve M.; Joseph, Annie-Lori C.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Joseph, Annie-Lori C.] Suffolk Univ, Dept Psychol, Boston, MA 02114 USA; [Snedaker, Katherine] PINK Concuss, Norwalk, CT USA; [Breiding, Matthew J.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Injury Prevent, Atlanta, GA USA; [Breiding, Matthew J.] US PHS, Rockville, MD USA; [Robertson, Courtney L.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Robertson, Courtney L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, Dept Occupat Sci & Occupat Therapy, Rehabil Sci Inst, Toronto, ON, Canada; [Levin, Harvey] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Levin, Harvey] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Pugh, Mary Jo; Yurgelun-Todd, Deborah] VA Salt Lake City Healthcare Syst, Salt Lake City, UT USA; [Pugh, Mary Jo] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA; [Yurgelun-Todd, Deborah] Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84112 USA; [Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY USA; [Cummings, Diana M.; Bellgowan, Patrick S. F.] NIH, Neurosci Ctr, Bldg 10, Bethesda, MD 20892 USA; [Turtzo, L. Christine] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Begg, Lisa] NIH, Off Res Womens Hlth, Off Director DPCPSI, Bldg 10, Bethesda, MD 20892 USA; [Turkstra, Lyn S.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada		Valera, EM (corresponding author), 149 13th St,Rm 2660, Charlestown, MA 02129 USA.	eve_valera@hms.harvard.edu; ajoseph24@mgh.harvard.edu; Katherine@PINKconcussions.org; mbreiding@cdc.gov; crober48@jhmi.edu; angela.colantonio@utoronto.ca; hlevin@bcm.edu; Maryjo.pugh@hsc.utah.edu; deborah.yurgelun-todd@hsc.utah.edu; Rebekah.Mannix@childrens.harvard.edu; jeff_bazarian@urmc.rochester.edu; turtzolc@mail.nih.gov; turkstrl@mcmaster.ca; beggl@od.nih.gov; cummingsdi@mail.nih.gov; patrick.frostbellgowan@nih.gov	Joseph, Annie-Lori C/AAX-3221-2021; Turkstra, Lyn/ABC-5831-2021	Joseph, Annie-Lori/0000-0002-6773-7934; Turkstra, Lyn/0000-0002-6948-6921	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS112694-01]; Rappaport Fellowship; TBI Endpoints Award [PT13078]; NIH NICHD/NCMRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD071089]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; BrainScope	Eve Valera: NIH/NINDS award no. 1R01NS112694-01 (PI: E. Valera), Rappaport Fellowship; Harvey Levin: PT13078, TBI Endpoints Award (PI: G. Manley); Lyn Turkstra: NIH NICHD/NCMRR award no. R01 HD071089 (PI: L. Turkstra); L. Christine Turtzo: Intramural Research Program of the National Institutes of Neurological Disorders and Stroke.r Dr Eve Valera has been provided with honoraria and travel funds for research reported on in this review. She has also received grants from the National Institutes of Health. Dr Jeff Bazarian declares the following: Abbott Diagnostics (advisory board), BrainScope (research support), and Q30 Innovations (advisory board). All other authors declare that no competing financial conflicts exist.	Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006; American Psychological Association, 2015, APA DICT PSYCHOL, V2; [Anonymous], 2020, TABLE ACTIVE DUTY FE; Arambula SE, 2019, EXP NEUROL, V317, P168, DOI 10.1016/j.expneurol.2019.02.016; Arosarena OA, 2009, ARCH FACIAL PLAST S, V11, P48, DOI 10.1001/archfacial.2008.507; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Baumann RM, 2019, SEX RES SOC POLICY, V16, P278, DOI 10.1007/s13178-018-0334-0; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Black MC., 2014, INTIMATE PARTNER VIO; Blume HK, 2018, CURR OPIN PEDIATR, V30, P755, DOI 10.1097/MOP.0000000000000691; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Brickell TA, 2017, J NEUROTRAUM, V34, P300, DOI 10.1089/neu.2016.4403; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown SB, 2012, HEALTH CARE WOMEN IN, V33, P896, DOI 10.1080/07399332.2012.673654; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Chan Vincy, 2017, BMC Res Notes, V10, P371, DOI 10.1186/s13104-017-2682-x; Chan V, 2016, ARCH PHYS MED REHAB, V97, P772, DOI 10.1016/j.apmr.2016.01.011; Chan V, 2013, CAN J AGING, V32, P278, DOI 10.1017/S0714980813000317; Chandran A, 2020, RES SPORTS MED, V28, P42, DOI 10.1080/15438627.2019.1590834; Charlesworth H, 2004, SPORTING BODIES DAMA, P163; Cimino AN, 2019, J AGGRESS MALTREAT T, V28, P714, DOI 10.1080/10926771.2019.1587657; Clevenger AC, 2018, J MOL NEUROSCI, V64, P410, DOI 10.1007/s12031-018-1038-x; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Czosnyka M, 2008, ACTA NEUROCHIR SUPPL, V102, P25, DOI 10.1007/978-3-211-85578-2_5; D'Souza A, 2020, NEUROPSYCHOL REHABIL, DOI 10.1080/09602011.2020.1822882; Desai N, 2019, CLIN J SPORT MED, V29, P361, DOI 10.1097/JSM.0000000000000646; Despins EH, 2016, ARCH PHYS MED REHAB, V97, pS26, DOI 10.1016/j.apmr.2014.06.023; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Donders J, 2003, J HEAD TRAUMA REHAB, V18, P106, DOI 10.1097/00001199-200303000-00002; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Fabricius AM, 2020, QUAL HEALTH RES, V30, P1033, DOI 10.1177/1049732319900163; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fehr SD, 2019, CLIN J SPORT MED, V29, P11, DOI 10.1097/JSM.0000000000000494; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gray M, 2020, BRAIN INJURY, V34, P535, DOI 10.1080/02699052.2020.1725979; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; GUR RC, 1982, SCIENCE, V217, P659, DOI 10.1126/science.7089587; Haag HL, 2016, ARCH PHYS MED REHAB, V97, pS64, DOI 10.1016/j.apmr.2014.12.018; Haag Halina Lin, 2019, Trauma Violence Abuse, p1524838019850623, DOI 10.1177/1524838019850623; Haag HL, 2019, ED WEBSITE FRONTLINE; Hanafy S, 2020, DISABIL REHABIL, DOI 10.1080/09638288.2020.1774670; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Heidari S, 2019, GAC SANIT, V33, P203, DOI 10.1016/j.gaceta.2018.04.003; Henry LC, 2017, NEUROSCIENTIST, V23, P567, DOI 10.1177/1073858416651034; Herlitz A, 1999, NEUROPSYCHOLOGY, V13, P590, DOI 10.1037/0894-4105.13.4.590; Hsu HL, 2015, RADIOLOGY, V276, P828, DOI 10.1148/radiol.2015142549; Hunnicutt G, 2017, J FAM VIOLENCE, V32, P471, DOI 10.1007/s10896-016-9854-7; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Johnson PA, 2016, PRECISION MED SEX GE; Jones KM, 2019, BRAIN INJURY, V33, P884, DOI 10.1080/02699052.2019.1606445; Jones KM, 2018, J PRIM HEALTH CARE, V10, P81, DOI 10.1071/HC17038; Jullienne A, 2018, J NEUROTRAUM, V35, P1646, DOI 10.1089/neu.2017.5547; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Koerte IK, 2020, J NEUROIMAGING, V30, P387, DOI 10.1111/jon.12726; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Lifshitz J, 2019, J AGGRESS MALTREAT T, V28, P655, DOI 10.1080/10926771.2019.1644693; Lindsay S, 2016, ARCH PHYS MED REHAB, V97, pS33, DOI 10.1016/j.apmr.2014.04.032; Lippa SM, 2018, J HEAD TRAUMA REHAB, V33, P101, DOI 10.1097/HTR.0000000000000353; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McGlade E, 2015, BRAIN IMAGING BEHAV, V9, P535, DOI 10.1007/s11682-015-9379-3; McGuire C, 2017, CAN GERIATR J, V20, P2, DOI 10.5770/cgj.20.228; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; Mcquown C, 2016, AM J EMERG MED, V34, P1281, DOI 10.1016/j.ajem.2016.04.029; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Mollayeva T, 2021, DISABIL REHABIL, V43, P1872, DOI 10.1080/09638288.2019.1683235; Mollayeva T, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024674; Mollayeva T, 2019, ALZH DEMENT-DADM, V11, P355, DOI 10.1016/j.dadm.2019.03.003; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Mollayeva T, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005917; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Murtaj V, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00299; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; NINDS, UND TRAUM BRAIN INJ; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Ozinga SJ, 2018, J ATHL TRAINING, V53, P636, DOI 10.4085/1062-6050-129-17; Peters ME, 2016, INT PSYCHOGERIATR, V28, P1931, DOI 10.1017/S1041610216001666; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Rubin TG, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519844020; Ruigrok ANV, 2014, NEUROSCI BIOBEHAV R, V39, P34, DOI 10.1016/j.neubiorev.2013.12.004; Sabo D., 1994, ANN M NAT ATHL TRAIN; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Silva PPB, 2015, J NEUROTRAUM, V32, P1789, DOI 10.1089/neu.2015.3998; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smirl JD, 2019, BRAIN INJURY, V33, P1529, DOI 10.1080/02699052.2019.1658129; Smith S.G., 2017, NATL INTIMATE PARTNE; Snook ML, 2017, JAMA PEDIATR, V171, P879, DOI 10.1001/jamapediatrics.2017.1140; Song K, 2020, J PAIN, V21, P1005, DOI 10.1016/j.jpain.2019.12.009; Spychala MS, 2017, J NEUROSCI RES, V95, P462, DOI 10.1002/jnr.23962; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Stefaniak J, 2016, J NEUROL NEUROSUR PS, V87, P21, DOI 10.1136/jnnp-2015-311336; Stergiou-Kita M, 2016, ARCH PHYS MED REHAB, V97, pS40, DOI 10.1016/j.apmr.2015.04.008; Sutton M, 2019, J WOMENS HEALTH, V28, P473, DOI 10.1089/jwh.2018.7282; Taylor AN, 2018, J NEUROTRAUM, V35, P630, DOI 10.1089/neu.2017.5238; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Toor GK, 2016, ARCH PHYS MED REHAB, V97, pS54, DOI 10.1016/j.apmr.2015.02.010; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Turkstra LS, 2018, NEUROPSYCHOLOGIA, V111, P117, DOI 10.1016/j.neuropsychologia.2018.01.016; Turkstra LS, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00059; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; US Secretary of Defense, 2015, MEM IMPL GUID FULL I; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; Valera EM, 2019, J AGGRESS MALTREAT T, V28, P695, DOI 10.1080/10926771.2019.1581864; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu V, 2010, TRAUMA VIOLENCE ABUS, V11, P71, DOI 10.1177/1524838010367503; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Young K., 1995, Journal of Sport and Social Issues, V19, P45, DOI 10.1177/019372395019001004	144	5	5	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN	2021	36	1			SI		E1	E17		10.1097/HTR.0000000000000652			17	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PM7ZD	WOS:000604011200001	33369993	Bronze			2022-02-06	
J	Zhang, SF; Liu, Y; Sun, S; Wang, JY; Li, QF; Yan, RJ; Gao, YL; Liu, HL; Liu, SJ; Hao, WT; Dai, HT; Liu, CL; Sun, YM; Long, W; Mu, XY; Zhang, XD				Zhang, Shaofang; Liu, Ying; Sun, Si; Wang, Junying; Li, Qifeng; Yan, Ruijuan; Gao, Yalong; Liu, Haile; Liu, Shuangjie; Hao, Wenting; Dai, Haitao; Liu, Changlong; Sun, Yuanming; Long, Wei; Mu, Xiaoyu; Zhang, Xiao-Dong			Catalytic patch with redox Cr/CeO2 nanozyme of noninvasive intervention for brain trauma	THERANOSTICS			English	Article						nanozyme; multienzyme-like activity; RONS-scavenging; traumatic brain injury; noninvasive treatment	CERIUM OXIDE NANOPARTICLES; ENZYME-MIMETIC ACTIVITY; OXIDATIVE STRESS; ANTIOXIDANT; INJURY; INFLAMMATION; STATE; NEUROPROTECTION; EPIDEMIOLOGY; NANOCRYSTALS	Traumatic brain injury (TBI) is a sudden injury to the brain, accompanied by the production of large amounts of reactive oxygen and nitrogen species (RONS) and acute neuroinflammation responses. Although traditional pharmacotherapy can effectively decrease the immune response of neuron cells via scavenging free radicals, it always involves in short reaction time as well as rigorous clinical trial. Therefore, a noninvasive topical treatment method that effectively eliminates free radicals still needs further investigation. Methods: In this study, a type of catalytic patch based on nanozymes with the excellent multienzyme-like activity is designed for noninvasive treatment of TBI. The enzyme-like activity, free radical scavenging ability and therapeutic efficacy of the designed catalytic patch were assessed in vitro and in vivo. The structural composition was characterized by the X-ray diffraction, X-ray photoelectron spectroscopy and high-resolution transmission electron microscopy technology. Results: Herein, the prepared Cr-doped CeO2 (Cr/CeO2) nanozyme increases the reduced Ce3+ states, resulting in its enzyme-like activity 3-5 times higher than undoped CeO2. Furthermore, Cr/CeO2 nanozyme can improve the survival rate of LPS induced neuron cells via decreasing excessive RONS. The in vivo experiments show the Cr/CeO2 nanozyme can promote wound healing and reduce neuroinflammation of mice following brain trauma. The catalytic patch based on nanozyme provides a noninvasive topical treatment route for TBI as well as other traumas diseases. Conclusions: The catalytic patch based on nanozyme provides a noninvasive topical treatment route for TBI as well as other traumas diseases.	[Zhang, Shaofang; Liu, Ying; Sun, Si; Wang, Junying; Yan, Ruijuan; Liu, Haile; Dai, Haitao; Liu, Changlong; Zhang, Xiao-Dong] Tianjin Univ, Sch Sci, Inst Adv Mat Phys, Tianjin Key Lab Low Dimens Mat Phys & Preparing T, Tianjin 300350, Peoples R China; [Liu, Shuangjie; Hao, Wenting; Mu, Xiaoyu; Zhang, Xiao-Dong] Tianjin Univ, Acad Med Engn & Translat Med, Med Coll, Tianjin 300072, Peoples R China; [Sun, Yuanming; Long, Wei] Chinese Acad Med Sci & Peking Union Med Coll, Inst Radiat Med, Tianjin Key Lab Mol Nucl Med, Tianjin 300192, Peoples R China; [Li, Qifeng; Gao, Yalong] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Li, Qifeng; Gao, Yalong] Tianjin Med Univ, Key Lab Posttrauma Neuro Repair & Regenerat Cent, Gen Hosp, Tianjin 300052, Peoples R China		Zhang, XD (corresponding author), Tianjin Univ, Sch Sci, Inst Adv Mat Phys, Tianjin Key Lab Low Dimens Mat Phys & Preparing T, Tianjin 300350, Peoples R China.; Mu, XY; Zhang, XD (corresponding author), Tianjin Univ, Acad Med Engn & Translat Med, Med Coll, Tianjin 300072, Peoples R China.; Long, W (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Radiat Med, Tianjin Key Lab Mol Nucl Med, Tianjin 300192, Peoples R China.	longway@irm-cams.ac.cn; muxiaoyu@tju.edu.cn; xiaodongzhang@tju.edu.cn	Zhang, Xiaodong/F-4665-2015	Zhang, Xiaodong/0000-0002-7212-0138	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [91859101, 81971744, U1932107, 81471786, 82001952]; National Natural Science Foundation of Tianjin [19JCZDJC34000, 20JCYBJC00940]; Innovation Foundation of Tianjin University	This work was financially supported by the National Natural Science Foundation of China (Grant Nos. 91859101, 81971744, U1932107, 81471786 and 82001952) and National Natural Science Foundation of Tianjin (Nos. 19JCZDJC34000 and 20JCYBJC00940), the Innovation Foundation of Tianjin University.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Adams C, 2018, THERANOSTICS, V8, P4824, DOI 10.7150/thno.24747; Andre R, 2011, ADV FUNCT MATER, V21, P501, DOI 10.1002/adfm.201001302; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bao QQ, 2018, ACS NANO, V12, P6794, DOI 10.1021/acsnano.8b01994; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Caputo F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04098-6; Chen F, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201702748; Chen ZW, 2018, ACCOUNTS CHEM RES, V51, P789, DOI 10.1021/acs.accounts.8b00011; Chigurupati S, 2013, BIOMATERIALS, V34, P2194, DOI 10.1016/j.biomaterials.2012.11.061; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Di HX, 2020, THERANOSTICS, V10, P9303, DOI 10.7150/thno.46568; Fan KL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03903-8; Fan KL, 2017, CHEM COMMUN, V53, P424, DOI 10.1039/c6cc08542c; Fernandez-Garcia S, 2016, J PHYS CHEM C, V120, P1891, DOI 10.1021/acs.jpcc.5b09495; Gao LZ, 2017, THERANOSTICS, V7, P3207, DOI 10.7150/thno.19738; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Ghosh S, 2018, ANGEW CHEM INT EDIT, V57, P4510, DOI 10.1002/anie.201800681; Gubernatorova EO, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700176; Gupta A, 2016, J MATER CHEM B, V4, P3195, DOI 10.1039/c6tb00396f; Hagberg H, 2015, NAT REV NEUROL, V11, P192, DOI 10.1038/nrneurol.2015.13; Hao CL, 2019, J AM CHEM SOC, V141, P1091, DOI 10.1021/jacs.8b11856; Heckert EG, 2008, BIOMATERIALS, V29, P2705, DOI 10.1016/j.biomaterials.2008.03.014; Heckman KL, 2013, ACS NANO, V7, P10582, DOI 10.1021/nn403743b; Huang YY, 2019, CHEM REV, V119, P4357, DOI 10.1021/acs.chemrev.8b00672; Huang YY, 2016, ANGEW CHEM INT EDIT, V55, P6646, DOI 10.1002/anie.201600868; Jiang B, 2020, THERANOSTICS, V10, P687, DOI 10.7150/thno.39827; Kang DW, 2017, NANO RES, V10, P2743, DOI 10.1007/s12274-017-1478-6; Kelm M, 1997, J BIOL CHEM, V272, P9922; Kim CK, 2012, ANGEW CHEM INT EDIT, V51, P11039, DOI 10.1002/anie.201203780; Kwon HJ, 2016, ACS NANO, V10, P2860, DOI 10.1021/acsnano.5b08045; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee JY, 2019, THERANOSTICS, V9, P1029, DOI 10.7150/thno.29868; Lee SS, 2013, ACS NANO, V7, P9693, DOI 10.1021/nn4026806; Li YY, 2015, ANGEW CHEM INT EDIT, V54, P1832, DOI 10.1002/anie.201410398; Lin YH, 2014, ADV MATER, V26, P4200, DOI 10.1002/adma.201400238; Liu HL, 2019, ADV MATER, V31, DOI 10.1002/adma.201901015; Liu T, 2014, ADV MATER, V26, P3433, DOI 10.1002/adma.201305256; Liu XL, 2019, NANOSCALE, V11, P21046, DOI 10.1039/c9nr06596b; Liu ZW, 2019, BIOMATERIALS, V208, P21, DOI 10.1016/j.biomaterials.2019.04.007; Manickam DS, 2012, J CONTROL RELEASE, V162, P636, DOI 10.1016/j.jconrel.2012.07.044; Mitchell KJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01672-4; Montini T, 2016, CHEM REV, V116, P5987, DOI 10.1021/acs.chemrev.5b00603; Mu XY, 2019, NANO LETT, V19, P4527, DOI 10.1021/acs.nanolett.9b01333; Mu XY, 2019, ACS NANO, V13, P1870, DOI 10.1021/acsnano.8b08045; Naganuma T, 2017, NANO RES, V10, P199, DOI 10.1007/s12274-016-1278-4; Patel M, 2016, TRENDS PHARMACOL SCI, V37, P768, DOI 10.1016/j.tips.2016.06.007; Pirmohamed T, 2010, CHEM COMMUN, V46, P2736, DOI 10.1039/b922024k; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Singh N, 2017, ANGEW CHEM INT EDIT, V56, P14267, DOI 10.1002/anie.201708573; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Soh M, 2017, ANGEW CHEM INT EDIT, V56, P11399, DOI 10.1002/anie.201704904; Song YJ, 2010, ADV MATER, V22, P2206, DOI 10.1002/adma.200903783; Tao Y, 2015, ADV MATER, V27, P1097, DOI 10.1002/adma.201405105; Tsai YY, 2007, NANOMEDICINE-UK, V2, P325, DOI 10.2217/17435889.2.3.325; Vernekar AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6301; Wang H, 2019, ADV MATER, V31, DOI 10.1002/adma.201805368; Wang JY, 2018, SMALL, V14, DOI 10.1002/smll.201703736; Wang XY, 2017, THERANOSTICS, V7, P2277, DOI 10.7150/thno.19257; Wang YJ, 2015, NANOSCALE, V7, P13981, DOI 10.1039/c5nr02588e; Wei H, 2013, CHEM SOC REV, V42, P6060, DOI 10.1039/c3cs35486e; Wu HB, 2018, BIOMATERIALS, V151, P66, DOI 10.1016/j.biomaterials.2017.10.018; Xian PP, 2019, THERANOSTICS, V9, P5956, DOI 10.7150/thno.33872; Xu C, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2013.88; Xu JL, 2016, ADV FUNCT MATER, V26, P4124, DOI 10.1002/adfm.201504416; Yao J, 2018, CHEM SCI, V9, P2927, DOI 10.1039/c7sc05476a; Yoo D, 2017, ACS NANO, V11, P8600, DOI 10.1021/acsnano.7b03426; Zhang ZJ, 2017, J AM CHEM SOC, V139, P5412, DOI 10.1021/jacs.7b00601; Zhao SZ, 2020, THERANOSTICS, V10, P6278, DOI 10.7150/thno.42564; Zhou YB, 2017, BIOCONJUGATE CHEM, V28, P2903, DOI 10.1021/acs.bioconjchem.7b00673	74	5	5	26	40	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1838-7640			THERANOSTICS	Theranostics		2021	11	6					2806	2821		10.7150/thno.51912			16	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	PO2DZ	WOS:000604981700020	33456574	gold, Green Published			2022-02-06	
J	Hackett, EP; Pinho, MC; Harrison, CE; Reed, GD; Liticker, J; Raza, J; Hall, RG; Malloy, CR; Barshikar, S; Madden, CJ; Park, JM				Hackett, Edward P.; Pinho, Marco C.; Harrison, Crystal E.; Reed, Galen D.; Liticker, Jeff; Raza, Jaffar; Hall, Ronald G.; Malloy, Craig R.; Barshikar, Surendra; Madden, Christopher J.; Park, Jae Mo			Imaging Acute Metabolic Changes in Patients with Mild Traumatic Brain Injury Using Hyperpolarized [1-C-13]Pyruvate	ISCIENCE			English	Article							GLUCOSE-METABOLISM; PYRUVATE; LACTATE; KINETICS; PET	Traumatic brain injury (TBI) involves complex secondary injury processes following the primary injury. The secondary injury is often associated with rapid metabolic shifts and impaired brain function immediately after the initial tissue damage. Magnetic resonance spectroscopic imaging (MRSI) coupled with hyperpolarization of C-13-labeled substrates provides a unique opportunity to map the metabolic changes in the brain after traumatic injury in real-time without invasive procedures. In this report, we investigated two patients with acute mild TBI (Glasgow coma scale 15) but no anatomical brain injury or hemorrhage. Patients were imaged with hyperpolarized [1-C-13]pyruvate MRSI 1 or 6 days after head trauma. Both patients showed significantly reduced bicarbonate (HCO3-) production, and one showed hyperintense lactate production at the injured sites. This study reports the feasibility of imaging altered metabolism using hyperpolarized pyruvate in patients with TBI, demonstrating the translatability and sensitivity of the technology to cerebral metabolic changes after mild TBI.	[Hackett, Edward P.; Pinho, Marco C.; Harrison, Crystal E.; Reed, Galen D.; Liticker, Jeff; Malloy, Craig R.; Park, Jae Mo] Univ Texas Southwestern Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Pinho, Marco C.; Park, Jae Mo] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Reed, Galen D.] GE Healthcare, Dallas, TX 75390 USA; [Raza, Jaffar; Hall, Ronald G.] Texas Tech Univ, Dept Pharm Practice, Hlth Sci Ctr, Dallas, TX 75216 USA; [Malloy, Craig R.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Barshikar, Surendra] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Madden, Christopher J.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA; [Park, Jae Mo] Univ Texas Dallas, Dept Elect & Comp Engn, Richardson, TX 75080 USA		Park, JM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA.; Park, JM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA.; Park, JM (corresponding author), Univ Texas Dallas, Dept Elect & Comp Engn, Richardson, TX 75080 USA.	jaemo.park@utsouthwestern.edu	; Harrison, Crystal/F-2295-2011	Liticker, Jeffrey/0000-0002-8191-7384; Harrison, Crystal/0000-0002-8884-2805; Hall, Ronald/0000-0002-5616-8246	Texas Institute for Brain Injury and Repair of Peter O'Donnell Jr. Brain Institute; Mobility Foundation; National Institutes of Health of the United StatesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS107409-01A1, 5P41EB015908-32, 1S10OD018468-01]; Welch FoundationThe Welch Foundation [I-2009-20190330]	The Texas Institute for Brain Injury and Repair of Peter O'Donnell Jr. Brain Institute; The Mobility Foundation; National Institutes of Health of the United States (1R01NS107409-01A1, 5P41EB015908-32, 1S10OD018468-01); The Welch Foundation (I-2009-20190330). Personnel Support: We appreciate the research nurses and the MR technicians of the Advanced Imaging Research Center at UT Southwestern-Lucy Christie, Jeannie Baxter, Kelley Derner, Maida Tai, and Salvador Pena.	Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Bartnik-Olson Brenda L, 2013, Front Neuroenergetics, V5, P8, DOI 10.3389/fnene.2013.00008; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Brooks GA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00408; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; DeVience SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01736-x; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Gordon JW, 2019, MAGN RESON MED, V81, P2702, DOI 10.1002/mrm.27549; Greco T, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113289; Hurd RE, 2013, MAGN RESON MED, V70, P936, DOI 10.1002/mrm.24544; Hutchinson P, 2009, ACTA NEUROCHIR, V151, P51, DOI 10.1007/s00701-008-0169-1; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Kennedy BWC, 2012, J AM CHEM SOC, V134, P4969, DOI 10.1021/ja300222e; Kim Susan, 2017, Concussion, V2, pCNC48, DOI 10.2217/cnc-2017-0013; Lee E, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116113; Ma J., 2019, INT SOC MAGN RES MED; Magistretti PJ, 2018, NAT REV NEUROSCI, V19, P235, DOI 10.1038/nrn.2018.19; Moro N, 2016, BRAIN RES, V1642, P270, DOI 10.1016/j.brainres.2016.04.005; Park J.M., 2019, INT SOC MAGN RES MED; Park JM, 2012, MAGN RESON MED, V68, P1886, DOI 10.1002/mrm.24181; SHANK RP, 1985, BRAIN RES, V329, P364, DOI 10.1016/0006-8993(85)90552-9; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Varrone A, 2009, EUR J NUCL MED MOL I, V36, P2103, DOI 10.1007/s00259-009-1264-0; Viglianti BL, 2017, BIOMED PHARMACOTHER, V88, P1038, DOI 10.1016/j.biopha.2017.01.166; Wespi P, 2018, MAGN RESON MED, V80, P1882, DOI 10.1002/mrm.27197; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Xu T, 2011, NMR BIOMED, V24, P997, DOI 10.1002/nbm.1719	28	5	5	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA		2589-0042		ISCIENCE	iScience	DEC 18	2020	23	12							101885	10.1016/j.isci.2020.101885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH8QM	WOS:000600670000123	33344923	Green Published, gold			2022-02-06	
J	Gao, C; Yan, YN; Chen, G; Wang, T; Luo, CL; Zhang, MY; Chen, XP; Tao, LY				Gao, Cheng; Yan, Ya'nan; Chen, Guang; Wang, Tao; Luo, Chengliang; Zhang, Mingyang; Chen, Xiping; Tao, Luyang			Autophagy Activation Represses Pyroptosis through the IL-13 and JAK1/STAT1 Pathways in a Mouse Model of Moderate Traumatic Brain Injury	ACS CHEMICAL NEUROSCIENCE			English	Article						Moderate TBI; autophagy; pyroptosis; interleukin-13; JAK-1	CELL-DEATH; INFLAMMASOME; INHIBITOR; DAMAGE	The newly highlighted research into programmed cell death (PCD), autophagy dependent cell death and pyroptotic cell death, has shown that these processes are both strongly correlated with the pathological progression of traumatic brain injury (TBI). However, their cross-talk in TBI remains unclear. Here, a moderate TBI model was established to explore the relationship between autophagy and pyroptosis. Rapamycin was used to activate the process of autophagy, which was impaired in the moderate TBI model, and this treatment reversed the expression of pyroptosis associated proteins, interleukin-13 (IL-13) and the pJAK-1 pathway, which were upregulated significantly after TBI. The level of IL-13 was downregulated, and the JAK-1 pathway was blocked to reveal the molecular mechanisms by which autophagy inhibits pyroptosis; these two treatments reduced the expression levels of pyroptosis associated proteins. In addition, these three interventions reduced the formation of neuronal NLRP3, the extent of brain edema, and the degree of cortical neuron degeneration. Furthermore, the deficit in motor function post-TBI was also markedly alleviated. Collectively, our results demonstrated that autophagy activation exerts a neuroprotective effect by inhibiting pyroptotic cell death in the moderate TBI model, and the inhibitory effect was dependent on the downregulation of IL-13 and repression of the JAK-1-STAT-1 signaling pathway.	[Gao, Cheng; Yan, Ya'nan; Chen, Guang; Wang, Tao; Luo, Chengliang; Zhang, Mingyang; Chen, Xiping; Tao, Luyang] Soochow Univ, Dept Forens Med, Med Sch, Suzhou 215213, Peoples R China		Chen, XP; Tao, LY (corresponding author), Soochow Univ, Dept Forens Med, Med Sch, Suzhou 215213, Peoples R China.	xipingchen@suda.edu.cn; taoluyang@suda.edu.cn		Tao, Luyang/0000-0002-6598-1730	National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81530062, 81871536, 81971800]; Hui -Chun Chin and Tsung-Dao Lee Chinese Undergraduate Research Endowment (CURE)	This study was supported by the National Nature Science Foundation of China (Nos. 81530062, 81871536, and 81971800) and Hui -Chun Chin and Tsung-Dao Lee Chinese Undergraduate Research Endowment (CURE).	Abboud A, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00342; Ansari MA, 2015, J NEUROL SCI, V357, P41, DOI 10.1016/j.jns.2015.06.062; Bierbach B, 2008, STROKE, V39, P213, DOI 10.1161/STROKEAHA.107.496620; Bortolotti P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01900; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Chen YQ, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0722-z; Choi ME, 2020, ANNU REV PHYSIOL, V82, P297, DOI 10.1146/annurev-physiol-021119-034658; Clausen F, 2019, J NEUROTRAUM, V36, P201, DOI 10.1089/neu.2018.5636; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Galluzzi L, 2016, NAT REV NEUROSCI, V17, P467, DOI 10.1038/nrn.2016.51; Heneka MT, 2018, NAT REV NEUROSCI, V19, P610, DOI 10.1038/s41583-018-0055-7; Hensler T, 2000, INFLAMM RES, V49, P524, DOI 10.1007/s000110050626; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Kolosowska N, 2019, NEUROTHERAPEUTICS, V16, P1304, DOI 10.1007/s13311-019-00761-0; Kuwar R, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1471-y; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Lu YY, 2014, AUTOPHAGY, V10, P1895, DOI 10.4161/auto.32200; Luo YJ, 2019, CURR NEUROPHARMACOL, V17, P582, DOI 10.2174/1570159X17666181227170053; Ma SF, 2015, BRAIN BEHAV IMMUN, V45, P157, DOI 10.1016/j.bbi.2014.11.007; Mori S, 2016, BRAIN SCI, V13, p6(2); Nabavi SF, 2019, CRIT REV CL LAB SCI, V56, P182, DOI 10.1080/10408363.2019.1575333; O'Brien WT, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01778-5; Phadwal K, 2020, PHARMACOL THERAPEUT, V206, DOI 10.1016/j.pharmthera.2019.107430; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Shen X, 2016, NEUROCHEM INT, V96, P100, DOI 10.1016/j.neuint.2016.03.004; Song LM, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00063; van der Horn HJ, 2020, HUM BRAIN MAPP, V41, P617, DOI 10.1002/hbm.24827; Wu JF, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070693; Wu Q, 2018, INT J BIOCHEM CELL B, V94, P44, DOI 10.1016/j.biocel.2017.11.007; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Zeng XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0316-4; Zhang M., 2014, PLOS ONE, V9; Zhao XR, 2015, J NEUROSCI, V35, P11281, DOI 10.1523/JNEUROSCI.1685-15.2015	36	5	6	3	14	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	DEC 16	2020	11	24					4231	4239		10.1021/acschemneuro.0c00517			9	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	PH1TD	WOS:000600203100025	33170612				2022-02-06	
J	Dijkland, SA; Helmrich, IRAR; Nieboer, D; van der Jagt, M; Dippel, DWJ; Menon, DK; Stocchetti, N; Maas, AIR; Lingsma, HF; Steyerberg, EW				Dijkland, Simone A.; Helmrich, Isabel R. A. Retel; Nieboer, Daan; van der Jagt, Mathieu; Dippel, Diederik W. J.; Menon, David K.; Stocchetti, Nino; Maas, Andrew I. R.; Lingsma, Hester F.; Steyerberg, Ewout W.		CENTER-TBI Participants Investig	Outcome Prediction after Moderate and Severe Traumatic Brain Injury: External Validation of Two Established Prognostic Models in 1742 European Patients	JOURNAL OF NEUROTRAUMA			English	Article						clinical prediction model; external validation; outcome; prognosis; traumatic brain injury	RISK MODELS; IMPACT; CARE	The International Mission on Prognosis and Analysis of Clinical Trials in Traumatic Brain Injury (IMPACT) and Corticoid Randomisation After Significant Head injury (CRASH) prognostic models predict functional outcome after moderate and severe traumatic brain injury (TBI). We aimed to assess their performance in a contemporary cohort of patients across Europe. The Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) core study is a prospective, observational cohort study in patients presenting with TBI and an indication for brain computed tomography. The CENTER-TBI core cohort consists of 4509 TBI patients available for analyses from 59 centers in 18 countries across Europe and Israel. The IMPACT validation cohort included 1173 patients with GCS <= 12, age >= 14, and 6-month Glasgow Outcome Scale-Extended (GOSE) available. The CRASH validation cohort contained 1742 patients with GCS <= 14, age >= 16, and 14-day mortality or 6-month GOSE available. Performance of the three IMPACT and two CRASH model variants was assessed with discrimination (area under the receiver operating characteristic curve; AUC) and calibration (comparison of observed vs. predicted outcome rates). For IMPACT, model discrimination was good, with AUCs ranging between 0.77 and 0.85 in 1173 patients and between 0.80 and 0.88 in the broader CRASH selection (n = 1742). For CRASH, AUCs ranged between 0.82 and 0.88 in 1742 patients and between 0.66 and 0.80 in the stricter IMPACT selection (n = 1173). Calibration of the IMPACT and CRASH models was generally moderate, with calibration-in-the-large and calibration slopes ranging between -2.02 and 0.61 and between 0.48 and 1.39, respectively. The IMPACT and CRASH models adequately identify patients at high risk for mortality or unfavorable outcome, which supports their use in research settings and for benchmarking in the context of quality-of-care assessment.	[Dijkland, Simone A.; Helmrich, Isabel R. A. Retel; Nieboer, Daan; Lingsma, Hester F.; Steyerberg, Ewout W.] Erasmus MC, Univ Med Ctr, Ctr Med Decis Making, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [van der Jagt, Mathieu] Erasmus MC, Univ Med Ctr, Dept Intens Care, Rotterdam, Netherlands; [Dippel, Diederik W. J.] Erasmus MC, Univ Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anesthesia, Cambridge, England; [Stocchetti, Nino] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Anesthesia & Crit Care, Neurosci Intens Care Unit, Milan, Italy; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands		Dijkland, SA (corresponding author), Erasmus MC, Univ Med Ctr, Ctr Med Decis Making, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	s.dijkland@erasmusmc.nl	Vande Vyvere, Thijs/AAB-5180-2022; Sahuquillo, Juan/B-3577-2008; Posti, Jussi P./Y-2908-2019; Castano-Leon, Ana M/ABF-6322-2020; Raj, Rahul/K-7693-2012; Gomez, Pedro/E-2411-2014; van der Jagt, Mathieu/G-1905-2017	Vande Vyvere, Thijs/0000-0003-4032-5443; Sahuquillo, Juan/0000-0003-0713-5875; Posti, Jussi P./0000-0002-5925-5193; Castano-Leon, Ana M/0000-0002-7918-5049; Rossi, Sandra/0000-0002-9963-8121; Newcombe, Virginia/0000-0001-6044-9035; Raj, Rahul/0000-0003-4243-9591; Van Essen, Thomas/0000-0003-4657-5283; Coles, Jonathan/0000-0003-4013-679X; Zeiler, Frederick/0000-0003-1737-0510; Kondziella, Daniel/0000-0001-5562-9808; van der Naalt, Joukje/0000-0001-9873-2418; Gomez, Pedro/0000-0002-4185-5238; van der Jagt, Mathieu/0000-0003-2566-8325; Dippel, Diederik/0000-0002-9234-3515; Radoi, Andreea/0000-0002-0677-3544; Stewart, William/0000-0003-2199-2582; Sakowitz, Oliver/0000-0003-3248-6335; Sanchez-Porras, Renan/0000-0002-9084-8114	European UnionEuropean Commission [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	The research leading to these results was supported by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 602150 (CENTER-TBI). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA), and from Integra LifeSciences Corporation (USA).	[Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; Carter EL, 2016, BRIT J NEUROSURG, V30, P227, DOI 10.3109/02688697.2016.1139048; Damen JAAG, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026160; Dijkland SA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6401; Harvey D, 2018, BRIT J ANAESTH, V120, P138, DOI 10.1016/j.bja.2017.10.002; Huijben JA, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2377-x; Letsinger J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183552; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nieboer D, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0231-2; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Siregar S, 2019, INTERACT CARDIOV TH, V28, P333, DOI 10.1093/icvts/ivy338; Steyerberg E.W., 2009, CLIN PREDICTION MODE, P299; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Thompson DD, 2015, J CLIN EPIDEMIOL, V68, P1068, DOI 10.1016/j.jclinepi.2014.11.001; Turnbull AE, 2019, CRIT CARE MED, V47, P757, DOI 10.1097/CCM.0000000000003731; Van Calster B, 2016, J CLIN EPIDEMIOL, V74, P167, DOI 10.1016/j.jclinepi.2015.12.005; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Vergouwe Y, 2017, STAT MED, V36, P4529, DOI 10.1002/sim.7179; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223	28	5	5	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2021	38	10					1377	1388		10.1089/neu.2020.7300		DEC 2020	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RZ6DB	WOS:000599324600001	33161840	Green Submitted			2022-02-06	
J	Ren, DB; Chen, W; Cao, K; Wang, ZH; Zheng, P				Ren, Dabin; Chen, Wei; Cao, Ke; Wang, Zhihan; Zheng, Ping			Expression Profiles of Long Non-coding RNA and Messenger RNA in Human Traumatic Brain Injury	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article								Long non-coding RNAs (lncRNAs) and messenger RNAs (mRNAs) play an important role in central nervous diseases; however, the exact expression and co-expressed profiles in human traumatic brain injury (TBI) are still unknown. Therefore, we investigated whole blood in 12 patients with TBI and 4 healthy controls to observe expression characteristics with different severity. We identified 3,035 lncRNAs and 1,204 mRNAs differentially expressed in the severe TBI group, 2,362 lncRNAs and 656 mRNAs in the moderate group, and 433 lncRNAs and 100 mRNAs in the mild group. Enrichment analyses showed 30 signaling pathways such as inflammatory and immune response pathways. Subsequently, a lncRNA-gene co-expression network was generated for 717 lncRNA-mRNA pairs and most of them with a positive correlation. Based on GSEA analysis, we found that TBI caused severe immune abnormality reflected on Th1, Th2, and Th17 cell differentiation deficiency. Finally, the expression of one upregulated and one downregulated lncRNA was validated in all three TBI groups, which was consistent with the microarray results. In summary, our results show that expression profiles of lncRNAs and mRNAs are significantly different in bloods from different severity TBI especially in immune response, providing novel insight for lncRNAs in human TBI.	[Ren, Dabin; Cao, Ke; Zheng, Ping] Pudong New Area Peoples Hosp, Dept Neurosurg, Shanghai 200120, Peoples R China; [Chen, Wei] Shanghai East Hosp, Dept Neurosurg, Shanghai 200120, Peoples R China; [Wang, Zhihan] Fudan Univ, Pudong Hosp, Dept Neurosurg, Shanghai 200120, Peoples R China		Zheng, P (corresponding author), Pudong New Area Peoples Hosp, Dept Neurosurg, Shanghai 200120, Peoples R China.	jojo_ras@126.com		Zheng, Ping/0000-0002-3928-3875; Chen, Wei/0000-0001-7438-3241	Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701231]; Natural Science Foundation of ShanghaiNatural Science Foundation of Shanghai [16ZR1431500]; Featured Clinical Discipline Project of Shanghai Pudong [PWYst2018-01]; Key Discipline Group Construction Project of Shanghai Pudong [PWZxq2017-02]	This work was supported by Natural Science Foundation of China (grant number 81701231) and Natural Science Foundation of Shanghai (16ZR1431500), and was also funded by The Featured Clinical Discipline Project of Shanghai Pudong (PWYst2018-01) and Key Discipline Group Construction Project of Shanghai Pudong (PWZxq2017-02).	Alkan F, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1325; Ang CE, 2020, CURR OPIN GENET DEV, V65, P42, DOI 10.1016/j.gde.2020.05.006; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Chen GX, 2019, DOSE-RESPONSE, V17, DOI 10.1177/1559325819886766; Chen W, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00298; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators, 2019, GLOBAL REGIONAL NATL; Jiang J.-Y., Injury, V44, P1453; Kadakkuzha BM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00063; Kahaei M.S., 2020, METAB BRAIN DIS, V115, P305; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Li ZX, 2019, NEUROPSYCH DIS TREAT, V15, P1671, DOI 10.2147/NDT.S206624; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Tian Z, 2020, EUR J PHARMACOL, V873, DOI 10.1016/j.ejphar.2020.172935; Wang CF, 2017, J NEUROTRAUM, V34, P2100, DOI 10.1089/neu.2016.4642; Wu JC, 2020, NEUROSCIENCE, V440, P160, DOI 10.1016/j.neuroscience.2020.05.045; Wucher V, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1306; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang LX, 2019, NEURAL REGEN RES, V14, P632, DOI 10.4103/1673-5374.247467; Yevshin I, 2019, NUCLEIC ACIDS RES, V47, pD100, DOI 10.1093/nar/gky1128; Yu F, 2020, GENES-BASEL, V11, DOI 10.3390/genes11030267; Zhang J., 2020, CELL MOL NEUROBIOL, V26, P3027; Zhang WT, 2018, EXP THER MED, V16, P2080, DOI 10.3892/etm.2018.6359; Zhang YM, 2016, ACUPUNCT MED, V34, P48, DOI 10.1136/acupmed-2014-010742	27	5	5	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	DEC 4	2020	22						99	113		10.1016/j.omtn.2020.08.012			15	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	PC5SL	WOS:000597060500009	32919233	hybrid, Green Published			2022-02-06	
J	Bambini, V; Tonini, E; Ceccato, I; Lecce, S; Marocchini, E; Cavallini, E				Bambini, Valentina; Tonini, Elisabetta; Ceccato, Irene; Lecce, Serena; Marocchini, Eleonora; Cavallini, Elena			How to improve social communication in aging: Pragmatic and cognitive interventions	BRAIN AND LANGUAGE			English	Article						Pragmatics; Training; Aging; Metaphor; Off-topic verbosity; Social communication	TRAUMATIC BRAIN-INJURY; INTERPRETATION DEFICITS SUBSEQUENT; OLDER-ADULTS; AGE-DIFFERENCES; MEMORY; SCHIZOPHRENIA; VERBOSITY; PEOPLE; IMPACT; COMPREHENSION	Among all aspects of the linguistic and communicative competence, pragmatics seems especially vulnerable in aging, due also to cognitive decline. However, pragmatics has never been considered as an intervention target in healthy aging. Here we tested the effects of a novel training program to improve pragmatics (PragmaCom) in older adults, compared with an active cognitive control group in a randomized-controlled-trial design. Both the PragmaCom group and the control group improved in pragmatic skills such as understanding metaphors and avoiding off-topic speech, indicating that it is possible to improve pragmatics in aging both with a specific training and with a cognitive training. Individual cognitive factors predicted pragmatic improvement in the control group, while in the PragmaCom group benefits were less dependent on individual characteristics. We discuss the results in terms of pragmatic plasticity, highlighting the importance of these findings for promoting older adults' social communication and well-being.	[Bambini, Valentina; Tonini, Elisabetta] Univ Sch Adv Studies IUSS Pavia, Ctr Neurocognit Epistemol & Theoret Syntax NEtS, Piazza Vittoria 15, I-27100 Pavia, Italy; [Ceccato, Irene] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Via Luigi Polacchi 11, I-66100 Chieti, Italy; [Lecce, Serena; Cavallini, Elena] Univ Pavia, Dept Brain & Behav Sci, Piazza Botta 11, I-27100 Pavia, Italy; [Marocchini, Eleonora] Univ Genoa, Lab Language & Cognit, Via Balbi 30, I-16128 Genoa, Italy		Bambini, V (corresponding author), Univ Sch Adv Studies IUSS Pavia, Ctr Neurocognit Epistemol & Theoret Syntax NEtS, Piazza Vittoria 15, I-27100 Pavia, Italy.	valentina.bambini@iusspavia.it	Ceccato, Irene/AAC-1707-2019	Ceccato, Irene/0000-0003-4819-2120; Marocchini, Eleonora/0000-0003-4970-4511	MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca) PRIN (Progetti di Ricerca di Rilevante Interesse Nazionale) 2015 project "The Interpretative Brain: Understanding and Promoting Pragmatic Abilities across Lifespan and in Mental Illness" [201577HA9M]	This work was supported by the MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca) PRIN (Progetti di Ricerca di Rilevante Interesse Nazionale) 2015 project "The Interpretative Brain: Understanding and Promoting Pragmatic Abilities across Lifespan and in Mental Illness", project code 201577HA9M, awarded to VB and SL.	Agostoni G, 2020, SCHIZOPHRENIA BULL, V46, pS153; Anand R, 2011, INT J GERIATR PSYCH, V26, P961, DOI 10.1002/gps.2633; ARBUCKLE TY, 1993, J GERONTOL, V48, pP225, DOI 10.1093/geronj/48.5.P225; Arcara G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00070; Bambini V., 2020, UNPUB; Bambini V, 2020, NEUROPSYCHOLOGIA, V139, DOI 10.1016/j.neuropsychologia.2020.107332; Bambini V, 2016, COMPR PSYCHIAT, V71, P106, DOI 10.1016/j.comppsych.2016.08.012; Bambini V, 2016, BRAIN LANG, V153, P1, DOI 10.1016/j.bandl.2015.12.002; Bischetti L., 2019, CURR PSYCHOL, DOI [10.1007/s12144-019-00295-w, DOI 10.1007/S12144-019-00295-W]; Blake ML, 2013, AM J SPEECH-LANG PAT, V22, P146, DOI 10.1044/1058-0360(2012/12-0021); Borella E, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00099; Borella E, 2010, PSYCHOL AGING, V25, P767, DOI 10.1037/a0020683; Bottiroli S, 2017, ARCH GERONTOL GERIAT, V72, P91, DOI 10.1016/j.archger.2017.05.015; Bottiroli S, 2013, J EXP PSYCHOL-APPL, V19, P205, DOI 10.1037/a0034078; Bowles RP, 2005, J GERONTOL B-PSYCHOL, V60, pP234, DOI 10.1093/geronb/60.5.P234; Bowles RP, 2008, PSYCHOL AGING, V23, P366, DOI 10.1037/0882-7974.23.2.366; Brownell H, 2013, J HEAD TRAUMA REHAB, V28, P446, DOI 10.1097/HTR.0b013e31825b5e85; Burke DM, 2004, CURR DIR PSYCHOL SCI, V13, P21, DOI 10.1111/j.0963-7214.2004.01301006.x; Burke DM., 2008, HDB AGING COGNITION, P373; CARLOMAGNO S, 1991, APHASIOLOGY, V5, P419, DOI 10.1080/02687039108248544; Carlomagno S, 2000, NEUROPSYCHOL REHABIL, V10, P337, DOI 10.1080/096020100389183; Carotenuto A, 2018, BRAIN LANG, V185, P47, DOI 10.1016/j.bandl.2018.08.003; Carotenuto A, 2018, ARCH CLIN NEUROPSYCH, V33, P194, DOI 10.1093/arclin/acx061; Cavallini E, 2019, OPEN PSYCHOL, V1, P255, DOI DOI 10.1515/PSYCH-2018-0017; Cavallini E, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01123; Cavallini E, 2010, AGING CLIN EXP RES, V22, P314, DOI [10.1007/BF03337728, 10.3275/6704]; Cavelti M, 2018, SCHIZOPHR RES, V199, P2, DOI 10.1016/j.schres.2018.02.051; Champagne-Lavau M, 2012, REV FR LING APPL, V17, P89; Clark CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177707; Cummings L., 2014, PRAGMATIC DISORDERS; Daniluk B, 2020, INT J LANG COMM DIS, V55, P493, DOI 10.1111/1460-6984.12532; Davis GA, 2005, APHASIOLOGY, V19, P21, DOI 10.1080/02687030444000598; Del Sette P, 2020, COGNITIVE DEV, V56, DOI 10.1016/j.cogdev.2020.100958; Diaz MT, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00414; Diaz MT, 2016, LANG LINGUIST COMPAS, V10, P314, DOI 10.1111/lnc3.12199; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gabbatore I, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1612078; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Greenwood PM, 2007, NEUROPSYCHOLOGY, V21, P657, DOI 10.1037/0894-4105.21.6.657; Grice H. P., 1975, SYNTAX SEMANTICS, P41; Grindrod CM, 2019, AGING NEUROPSYCHOL C, V26, P842, DOI 10.1080/13825585.2018.1537437; Hagoort P., 2014, COGNITIVE NEUROSCIEN, P667; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; Hyter YD, 2017, PERSP PRAGMAT PHILO, V11, P493, DOI 10.1007/978-3-319-47489-2_19; Jagoe C, 2017, PERSP PRAGMAT PHILO, V11, P181, DOI 10.1007/978-3-319-47489-2_8; James LE, 1998, PSYCHOL AGING, V13, P355, DOI 10.1037/0882-7974.13.3.355; KLIEGL R, 1990, DEV PSYCHOL, V26, P894, DOI 10.1037/0012-1649.26.6.894; Lecce S, 2019, J CHILD LANG, V46, P393, DOI 10.1017/S030500091800048X; Lecce S, 2019, NEUROPSYCHOL REHABIL, V29, P440, DOI 10.1080/09602011.2017.1308871; Lovden M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00141; Lundgren K., 2016, PERSPECT ASHA SPEC I, V1, P66, DOI [10.1044/persp1.SIG2.66, DOI 10.1044/PERSP1.SIG2.66]; Lundgren K, 2011, APHASIOLOGY, V25, P456, DOI 10.1080/02687038.2010.500809; Mahncke HW, 2019, SCHIZOPHR RES, V208, P182, DOI 10.1016/j.schres.2019.03.006; Mak W, 2007, J INT NEUROPSYCH SOC, V13, P606, DOI 10.1017/S1355617707070750; Marini A, 2005, J PSYCHOLINGUIST RES, V34, P439, DOI 10.1007/s10936-005-6203-z; Mashal N, 2014, CREATIVITY RES J, V26, P158, DOI 10.1080/10400419.2014.901071; Mashal N, 2011, AGING NEUROPSYCHOL C, V18, P527, DOI 10.1080/13825585.2011.575202; Mejia-Constain B, 2010, ITAL J LINGUIST, V22, P41; Melogno S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070085; Messer Rachel H., 2015, HLTH AGING CLIN CARE, DOI [10.4137/hacce.s22981, DOI 10.4137/HACCE.S22981, 10.4137/HACCE.S22981]; Montemurro S, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01220; Morrone I, 2010, PSYCHOL AGING, V25, P697, DOI 10.1037/a0019578; Parola A, 2019, J NEUROLINGUIST, V51, P53, DOI 10.1016/j.jneuroling.2018.12.003; Pushkar D, 2000, PSYCHOL AGING, V15, P361, DOI 10.1037//0882-7974.15.2.361; Raven J. C., 1983, MANUAL RAVENS PROGR; Redick TS, 2015, EDUC PSYCHOL REV, V27, P617, DOI 10.1007/s10648-015-9314-6; Rosi A., 2019, OPEN PSYCHOL, V2019, P200, DOI [10.1515/psych-2018-0014, DOI 10.1515/PSYCH-2018-0014, 10.1515/PSYCH-2018-0014]; Ruffman T, 2010, PSYCHOL AGING, V25, P492, DOI 10.1037/a0018247; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; Savy R., 2007, SPECIFICHE TRASCRIZI; Seron X., 1993, APHASIA TREATMENT WO, P131; Shammi P, 2003, J INT NEUROPSYCH SOC, V9, P855, DOI 10.1017/S135561770396005X; Shnitzer-Meirovich S, 2018, RES DEV DISABIL, V74, P113, DOI 10.1016/j.ridd.2018.01.010; Sperber D., 1995, RELEVANCE COMMUNICAT; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Szucs M, 2017, MOUTON SER PRAGMAT, V17, P129, DOI 10.1515/9781501505089-008; Szymczynska P, 2017, J PSYCHIATR RES, V90, P67, DOI 10.1016/j.jpsychires.2017.02.009; Thurstone T. G., 1963, PRIMARY MENTAL ABILI; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2012, DISABIL REHABIL, V34, P1562, DOI 10.3109/09638288.2012.656788; Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; Tompkins CA, 2011, APHASIOLOGY, V25, P789, DOI 10.1080/02687038.2010.539784; Uekermann J, 2006, J INT NEUROPSYCH SOC, V12, P184, DOI 10.1017/S1355617706060280; Uekermann J, 2008, BRAIN COGNITION, V67, P51, DOI 10.1016/j.bandc.2007.11.003; Verhaeghen P, 1996, PSYCHOL AGING, V11, P164, DOI 10.1037/0882-7974.11.1.164; Zacks J. M., 2016, NEUROBIOLOGY LANGUAG, P661, DOI [10.1016/B978-0-12-407794-2.00053-5, DOI 10.1016/B978-0-12-407794-2.00053-5]; Zhang HY, 2019, NEUROPSYCHOLOGIA, V124, P254, DOI 10.1016/j.neuropsychologia.2018.11.017; Zinke K, 2014, DEV PSYCHOL, V50, P304, DOI 10.1037/a0032982	88	5	5	4	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	DEC	2020	211								104864	10.1016/j.bandl.2020.104864			13	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	OU4US	WOS:000591525900005	33137591				2022-02-06	
J	Goulding, DS; Vogel, RC; Gensel, JC; Morganti, JM; Stromberg, AJ; Miller, BA				Goulding, Danielle S.; Vogel, R. Caleb; Gensel, John C.; Morganti, Josh M.; Stromberg, Arnold J.; Miller, Brandon A.			Acute brain inflammation, white matter oxidative stress, and myelin deficiency in a model of neonatal intraventricular hemorrhage	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						intraventricular hemorrhage; hydrocephalus; CCR2; microglia	TUMOR-NECROSIS-FACTOR; TRAUMATIC BRAIN; PRETERM INFANTS; PREMATURE-INFANTS; INJURY; HYDROCEPHALUS; HEMOGLOBIN; MICROGLIA; OLIGODENDROCYTES; DEGENERATION	OBJECTIVE Neonatal intraventricular hemorrhage (IVH) leads to posthemorrhagic hydrocephalus (PHH), brain injury, and long-term disability. Current therapy for IVH is based on treating PHH but does not address the underlying brain injury. In order to develop pharmacological treatment for IVH, there must be a better understanding of the underlying pathology of this disease. This study was designed to determine the time course of the acute inflammation and oxidative stress that may underlie the progressive pathology of IVH. The authors sought to understand the temporal relationships among inflammation, oxidative stress, and white matter pathology in a rat model of IVH. METHODS A rat model of IVH consisting of hemoglobin injection into the lateral ventricle was used. Tissue was analyzed via biochemical and histological methods to map the spatiotemporal distribution of innate immune activation and oxidative stress. White matter was quantified using both immunohistochemistry and Western blot for myelin basic protein (MBP) in the corpus callosum. RESULTS IVH led to acute induction of inflammatory cytokines, followed by oxidative stress. Oxidative stress was concentrated in white matter, adjacent to the lateral ventricles. Animals with IVH initially gained weight at a lower rate than control animals and had larger ventricles and less MBP than control animals. CONCLUSIONS Experimental IVH induces global inflammation throughout the brain and oxidative stress concentrated in the white matter. Both of these phenomena occur early after IVH. This has implications for human neonates with immature white matter that is exquisitely sensitive to inflammation and oxidative stress. Antiinflammatory or antioxidant therapy for IVH may need to be initiated early in order to protect developing white matter.	[Goulding, Danielle S.; Vogel, R. Caleb; Miller, Brandon A.] Univ Kentucky, Dept Neurosurg, Lexington, KY USA; [Gensel, John C.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Morganti, Josh M.; Miller, Brandon A.] Univ Kentucky, Dept Neurosci, Lexington, KY USA; [Stromberg, Arnold J.] Univ Kentucky, Dept Stat, Lexington, KY USA; [Goulding, Danielle S.; Vogel, R. Caleb; Gensel, John C.; Morganti, Josh M.; Miller, Brandon A.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Morganti, Josh M.] Univ Kentucky, Coll Med, Sanders Brown Ctr Aging, Lexington, KY 40536 USA		Miller, BA (corresponding author), Univ Kentucky, Lexington, KY 40506 USA.	brandonmiller@uky.edu			University of Kentucky Center for Clinical and Translational Science (CCTS) KL2 program [UL1TR001998]; University of Kentucky CCTS Young Investigator Pilot Award [UL1TR001998]; Hydrocephalus Association; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21AG058006]	This publication is based upon work supported in part by University of Kentucky Center for Clinical and Translational Science (CCTS) KL2 program award no. UL1TR001998 (B.A. M.), University of Kentucky CCTS Young Investigator Pilot Award no. UL1TR001998 (B.A.M. and J.C.G.), a Hydrocephalus Association Innovator Award (B. A.M.), and NIH grant no. R21AG058006 (J.M.M.). We wish to thank Tom Dolan, Medical Illustrator, College of Medicine, University of Kentucky, for assistance with figures.	Back SA, 2006, MENT RETARD DEV D R, V12, P129, DOI 10.1002/mrdd.20107; Barkovich A. J., 2012, PEDIAT NEUROIMAGING; Cabrales P, 2013, ANTIOXID REDOX SIGN, V18, P2329, DOI 10.1089/ars.2012.4922; Christian EA, 2016, J NEUROSURG-PEDIATR, V17, P260, DOI 10.3171/2015.7.PEDS15140; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Dean JM, 2011, DEV NEUROSCI-BASEL, V33, P251, DOI 10.1159/000327242; El Waly B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00145; Elitt CM, 2014, NEUROSCIENCE, V276, P216, DOI 10.1016/j.neuroscience.2014.04.038; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Garton T, 2017, EXPERT OPIN THER TAR, V21, P1111, DOI 10.1080/14728222.2017.1397628; Garton TP, 2016, BRAIN RES, V1635, P86, DOI 10.1016/j.brainres.2015.12.060; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; Goulding DS, 2020, J NEUROSURG-PEDIATR, V25, P476, DOI 10.3171/2019.12.PEDS19625; Gram M, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-100; Guedes JR, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00549; Hart AR, 2008, DEV MED CHILD NEUROL, V50, P655, DOI 10.1111/j.1469-8749.2008.03050.x; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Ingram MCE, 2014, J NEUROSURG-PEDIATR, V14, P184, DOI 10.3171/2014.5.PEDS13602; Kahle KT, 2016, LANCET, V387, P788, DOI 10.1016/S0140-6736(15)60694-8; Karimy JK, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.8.FOCUS16278; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Martin JA, 2008, PEDIATRICS, V121, P788, DOI 10.1542/peds.2007-3753; Miller BA, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-28; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Mosser CA, 2017, PROG NEUROBIOL, V149-150, P1, DOI 10.1016/j.pneurobio.2017.01.002; Mukerji A, 2015, PEDIATRICS, V136, P1132, DOI 10.1542/peds.2015-0944; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; Pang Y, 2005, J NEUROSCI RES, V80, P226, DOI 10.1002/jnr.20450; Pang Y, 2003, DEV BRAIN RES, V140, P205, DOI 10.1016/S0165-3806(02)00606-5; Pavlova MA, 2013, BRAIN, V136, P998, DOI 10.1093/brain/aws334; Rhodes TJ, 2019, ACM SIGGRAPH 2019 EMERGING TECHNOLOGIES (SIGGRAPH '19), DOI 10.1145/3305367.3327984; Riva-Cambrin J, 2012, J NEUROSURG-PEDIATR, V9, P473, DOI 10.3171/2012.1.PEDS11292; Roze E, 2009, PEDIATRICS, V123, P1493, DOI 10.1542/peds.2008-1919; Silbereis JC, 2010, DIS MODEL MECH, V3, P678, DOI 10.1242/dmm.002915; Sriram S, 1997, NEUROLOGY, V48, P464, DOI 10.1212/WNL.48.2.464; Strahle J, 2012, TRANSL STROKE RES, V3, pS25, DOI 10.1007/s12975-012-0182-9; Strahle JM, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101787; Strahle JM, 2014, NEUROSURGERY, V75, P696, DOI 10.1227/NEU.0000000000000524; Sun F, 2010, GLIA, V58, P1304, DOI 10.1002/glia.21009; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Waller R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210888; Wan YF, 2019, CNS NEUROSCI THER, V25, P1134, DOI 10.1111/cns.13203; ZAJICEK JP, 1992, BRAIN, V115, P1611, DOI 10.1093/brain/115.6.1611	45	5	5	2	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2020	26	6					613	623		10.3171/2020.5.PEDS20124			11	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	PB5ZG	WOS:000596398300003	32858507				2022-02-06	
J	Neag, MA; Mitre, AO; Catinean, A; Mitre, CI				Neag, Maria-Adriana; Mitre, Andrei-Otto; Catinean, Adrian; Mitre, Calin-Iosif			An Overview on the Mechanisms of Neuroprotection and Neurotoxicity of Isoflurane and Sevoflurane in Experimental Studies	BRAIN RESEARCH BULLETIN			English	Article						Isoflurane; Mechanisms; Neuroprotection; Neurotoxicity; Sevoflurane	INDUCED COGNITIVE IMPAIRMENT; P75 NEUROTROPHIN RECEPTOR; BRAIN-BARRIER DISRUPTION; NEURONAL APOPTOSIS; ACTIVIN-A; PROVIDES NEUROPROTECTION; GLUCOSE DEPRIVATION; GENERAL-ANESTHESIA; SIGNALING PATHWAY; INJURY	Since their first use, anaesthetic agents have seen major advancements and are now an indispensable element of surgical procedures. Two of the most used volatile anaesthetics are isoflurane and sevoflurane. These have neuroprotective effects on adult brains in different brain disorders, ranging from traumatic to hypoxic or ischemia-reperfusion injuries. In new-borns and elderly patients these effects are reversed, and volatile anaesthetics might have a neurotoxic effect, affecting the recovery and neurological capabilities of these patients. Since we are still using volatile anaesthetics, it is important to know in which conditions these substances are neurotoxic and neuroprotective, as well as to better understand the mechanisms underlying these effects. In this review we aim to summarise the current knowledge on the mechanisms involved in neuroprotection and neurotoxicity of neonatal, adult and aged brains and how these vary based on the brains age and underlying pathologies. This review should guide future experimental research towards less studied mechanisms and should help the development of neuroprotective strategies. Also, we provide a short summary of the substances used in experimental studies to prevent the neurotoxic effect of isoflurane and sevoflurane.	[Neag, Maria-Adriana] Iuliu Hatieganu Univ Med & Pharm, Pharmacol Toxicol & Clin Pharmacol Dept, Cluj Napoca, Romania; [Mitre, Andrei-Otto] Iuliu Hatieganu Univ Med & Pharm, Fac Med, Cluj Napoca, Romania; [Catinean, Adrian] Iuliu Hatieganu Univ Med & Pharm, Dept Internal Med, Cluj Napoca, Romania; [Mitre, Calin-Iosif] Iuliu Hatieganu Univ Med & Pharm, Dept Anaesthesiol & Intens Care, Cluj Napoca, Romania		Mitre, AO (corresponding author), Iuliu Hatieganu Univ Med & Pharm, Fac Med, Cluj Napoca, Romania.	andrei.mitre97@gmail.com					Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Acharya NK, 2015, BRAIN RES, V1620, P29, DOI 10.1016/j.brainres.2015.04.054; Almutairi MMA, 2016, CELL MOL LIFE SCI, V73, P57, DOI 10.1007/s00018-015-2050-8; Andropoulos DB, 2018, FETAL DIAGN THER, V43, P1, DOI 10.1159/000475928; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Beck-Schimmer B, 2017, EUR J ANAESTH, V34, P764, DOI 10.1097/EJA.0000000000000668; Bedirli N, 2018, J INT MED RES, V46, P2828, DOI 10.1177/0300060518773265; Bedirli N, 2012, J NEUROSURG ANESTH, V24, P336, DOI 10.1097/ANA.0b013e318266791e; Biber K, 2014, GLIA, V62, P841, DOI 10.1002/glia.22654; Burchell SR, 2013, J INVEST MED, V61, P1078, DOI 10.2310/JIM.0b013e3182a07921; Callaway JK, 2016, BEHAV BRAIN RES, V303, P44, DOI 10.1016/j.bbr.2016.01.032; Cao WG, 2012, ANESTHESIOLOGY, V117, P791, DOI 10.1097/ALN.0b013e318266c62d; Cao YY, 2018, BEHAV BRAIN RES, V339, P39, DOI 10.1016/j.bbr.2017.09.004; CHAO MV, 1994, J NEUROBIOL, V25, P1373, DOI 10.1002/neu.480251106; Chen L, 2017, ARCH GERONTOL GERIAT, V73, P29, DOI 10.1016/j.archger.2017.07.004; Chen XT, 2016, INT J CLIN EXP MED, V9, P15780; Chen Y, 2015, BRIT J ANAESTH, V114, P327, DOI 10.1093/bja/aeu271; Cheng BQ, 2015, MOL NEUROBIOL, V52, P1580, DOI 10.1007/s12035-014-8959-3; Chi OZ, 2017, BRAIN RES BULL, V131, P1, DOI 10.1016/j.brainresbull.2017.02.007; Cui RS, 2018, EXP THER MED, V15, P4127, DOI 10.3892/etm.2018.5976; Deng J, 2014, PROG NEUROBIOL, V115, P210, DOI 10.1016/j.pneurobio.2014.01.001; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dong Y., 2020, MEDIATORS INFLAMM; Ebert S, 2007, NEUROSCI LETT, V413, P241, DOI 10.1016/j.neulet.2006.11.065; Fahnestock M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00129; Guo MY, 2019, NEUROL RES, V41, P923, DOI 10.1080/01616412.2019.1642564; He HF, 2018, DRUG DES DEV THER, V12, P629, DOI 10.2147/DDDT.S158313; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hua FZ, 2016, INT J MOL MED, V38, P1271, DOI 10.3892/ijmm.2016.2715; Huang LB, 2018, BIOMED PHARMACOTHER, V97, P412, DOI 10.1016/j.biopha.2017.10.142; Hwang JW, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112347; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Jiang M, 2017, MED GAS RES, V7, P48, DOI 10.4103/2045-9912.202910; Johnsen D, 2011, NEUROSCIENCE, V199, P368, DOI 10.1016/j.neuroscience.2011.09.053; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kawaguchi M, 2004, ANESTH ANALG, V98, P798; Kenny EM, 2019, CRIT CARE MED, V47, P410, DOI 10.1097/CCM.0000000000003555; Kim CC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0581-z; Kong F., 2013, PLOS ONE, V8; Lange M, 2009, ANESTHESIOLOGY, V110, P516, DOI 10.1097/ALN.0b013e318197ff62; Lawther BK, 2011, BJA EDUC, V11, P128, DOI 10.1093/bjaceaccp/mkr018; Lee BH, 2014, NEUROPHARMACOLOGY, V83, P9, DOI 10.1016/j.neuropharm.2014.03.011; Lee YM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/242709; Lei X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070645; Lemkuil BP, 2011, ANESTHESIOLOGY, V114, P49, DOI 10.1097/ALN.0b013e318201dcb3; Li H, 2013, NEUROBIOL DIS, V54, P216, DOI 10.1016/j.nbd.2012.12.014; Li SY, 2013, BRAIN RES, V1496, P84, DOI 10.1016/j.brainres.2012.12.025; Li W, 2017, EXP THER MED, V13, P2056, DOI 10.3892/etm.2017.4173; Li XM, 2014, J MOL NEUROSCI, V52, P286, DOI 10.1007/s12031-013-0141-2; Li YP, 2014, ADVNCS MTHMTCS EDUC, P1, DOI 10.1007/978-3-319-04993-9_1; Liang L, 2017, HUM EXP TOXICOL, V36, P1295, DOI 10.1177/0960327116688068; Liu JH, 2017, NEUROCHEM RES, V42, P595, DOI 10.1007/s11064-016-2114-7; Liu RZ, 2019, ACTA BIOCH BIOPH SIN, V51, P1134, DOI 10.1093/abbs/gmz104; Liu X, 2016, AGING CLIN EXP RES, V28, P633, DOI 10.1007/s40520-015-0466-5; Lu LX, 2006, APOPTOSIS, V11, P1603, DOI 10.1007/s10495-006-8762-3; Lu ZJ, 2018, EXP THER MED, V15, P4097, DOI 10.3892/etm.2018.5950; Ludwig PE, 2018, NEURAL REGEN RES, V13, P7, DOI 10.4103/1673-5374.224361; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; McMurtrey RJ, 2010, BRAIN RES, V1358, P184, DOI 10.1016/j.brainres.2010.08.015; Nasr VG, 2015, PEDIATR RES, V78, P2, DOI 10.1038/pr.2015.58; Pan B, 2017, AM J TRANSL RES, V9, P4521; Peng L, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00636; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Pi ZB, 2018, MOL MED REP, V17, P6497, DOI 10.3892/mmr.2018.8642; Preckel B, 2005, BEST PRACT RES-CLIN, V19, P331, DOI 10.1016/j.bpa.2005.01.003; Rang Z, 2016, CELL PHYSIOL BIOCHEM, V40, P796, DOI 10.1159/000453139; Restin T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184973; Robson NC, 2008, BLOOD, V111, P2733, DOI 10.1182/blood-2007-03-080994; Rothlin M., 2017, THER UMSCHAU, V50, P553; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Ryu YK, 2016, J NEUROSURG ANESTH, V28, P405, DOI 10.1097/ANA.0000000000000360; Schallner N, 2014, ANESTH ANALG, V119, P1429, DOI 10.1213/ANE.0000000000000488; Schilling JM, 2017, BRIT J ANAESTH, V119, P465, DOI 10.1093/bja/aew299; Scurrah A, 2018, ANAESTHESIA, V73, P769, DOI 10.1111/anae.14178; Sha HY, 2017, EUR REV MED PHARMACO, V21, P1959; Shan YY, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00964; Shan YY, 2018, DRUG DES DEV THER, V12, P3617, DOI 10.2147/DDDT.S180343; Shen QY, 2019, INFLAMMATION, V42, P1015, DOI 10.1007/s10753-019-00963-w; Shi CX, 2018, EUR REV MED PHARMACO, V22, P1770, DOI 10.26355/eurrev_201803_14595; Shi CX, 2020, MOL MED REP, V21, P123, DOI 10.3892/mmr.2019.10832; Shi J, 2009, FERTIL STERIL, V92, P1794, DOI 10.1016/j.fertnstert.2009.05.004; Skaper SD, 2018, METHODS MOL BIOL, V1727, P1, DOI 10.1007/978-1-4939-7571-6_1; Sohn HM, 2017, J ANESTH, V31, P36, DOI 10.1007/s00540-016-2277-z; Sorar M, 2018, TURK NEUROSURG; Stary CM, 2015, ANESTHESIOLOGY, V123, P810, DOI 10.1097/ALN.0000000000000824; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Sun MY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11445; Tian Y, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/3802324; Tian Y, 2015, CELL MOL NEUROBIOL, V35, P585, DOI 10.1007/s10571-014-0154-6; Wang HL, 2016, ACTA NEUROCHIR SUPPL, V121, P55, DOI 10.1007/978-3-319-18497-5_10; Wang N, 2018, CELL PHYSIOL BIOCHEM, V46, P618, DOI 10.1159/000488630; Wang Q, 2016, BIOMED PHARMACOTHER, V84, P535, DOI 10.1016/j.biopha.2016.09.075; Wang RW, 2019, DRUG DES DEV THER, V13, P501, DOI 10.2147/DDDT.S188636; Wang W, 2016, NEUROSCIENCE, V316, P328, DOI 10.1016/j.neuroscience.2015.11.001; Waterhouse N. J., 2016, COLD SPRING HARB PRO, V11, DOI 10.1101/pdb.prot087312; WELLS BA, 1963, SURGERY, V54, P216; Wen XR, 2016, MOL NEUROBIOL, V53, P1661, DOI 10.1007/s12035-015-9111-8; Wu J, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01777-6; Xia YM, 2019, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00486; Xie H, 2015, EUR REV MED PHARMACO, V19, P647; Xue H, 2019, DRUG DES DEV THER, V13, P1691, DOI 10.2147/DDDT.S197325; Yang SM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00902; Ye Z, 2015, J NEUROL SCI, V348, P216, DOI 10.1016/j.jns.2014.12.011; Yu H, 2014, OBESITY, V22, P2396, DOI 10.1002/oby.20879; Yuan H, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00314; Yuan M, 2018, BIOMED PHARMACOTHER, V97, P429, DOI 10.1016/j.biopha.2017.10.082; Zhan GF, 2019, AGING-US, V11, P1778, DOI 10.18632/aging.101871; Zhang H, 2018, J CANCER RES THER, V14, P1497, DOI 10.4103/jcrt.JCRT_164_18; Zhang HF, 2016, ANESTH ANALG, V122, P1377, DOI 10.1213/ANE.0000000000001172; Zhang S, 2018, EUR REV MED PHARMACO, V22, P3976, DOI 10.26355/eurrev_201806_15282; Zhang XM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153505; Zhang YN, 2019, CHEM-BIOL INTERACT, V308, P332, DOI 10.1016/j.cbi.2019.06.008; Zhang YA, 2016, NEUROCHEM RES, V41, P2517, DOI 10.1007/s11064-016-1963-4; Zhou H, 2019, J MOL NEUROSCI, V68, P275, DOI 10.1007/s12031-019-01303-1; Zhu W, 2010, NEUROSCIENCE, V169, P758, DOI 10.1016/j.neuroscience.2010.05.038; Zuo ZY, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-10	117	5	5	2	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	DEC	2020	165						281	289		10.1016/j.brainresbull.2020.10.011			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OT2JB	WOS:000590677100001	33080307				2022-02-06	
J	Wen, LB; Sun, JW; Chen, XG; Du, RL				Wen, Linbao; Sun, Jingwei; Chen, Xionggao; Du, Ruili			miR-135b-dependent downregulation of S100B promotes neural stem cell differentiation in a hypoxia/ischemia-induced cerebral palsy rat model	AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY			English	Article						cerebral palsy; microRNA-135b; S100B; signal transducer and acti-vator of transcription-3	TRAUMATIC BRAIN-INJURY; STAT3; INHIBITION; EXPRESSION; HYPOXIA; CHILDREN; PATHWAY; PROTEIN; GFAP	Cerebral palsy (CP) is frequently caused by brain injury during pregnancy, delivery, or the immediate postnatal period. The differentiation potential of neural stem cell (NSC) makes them effective in restoring injured tissues and organs with minimal risks of side effects. In this study, we identified a novel microRNA-135b (miR-135b) in CP and investigated its functional role in mediating NSC differentiation. CP models were established in Wistar rats and validated with the Y-maze test. Gainand loss-of-function experimentation was performed on CP rats. Then NSCs were isolated and the expression patterns of miR-135b and S100B were altered in NSCs. S100B exhibited high expression in the hippocampus tissues of CP models, which was targeted by miR-135b. miR-135b elevation or S100B silencing resulted in promoted NSC differentiation, alleviated brain injury, and inhibited NSC apoptosis in hippocampus tissues of CP rats. S100B downregulation targeted by miR-135b overexpression contributed to the inactivation of the signal transducer and activator of transcription-3 (STAT3) pathway, which promoted NSC differentiation and proliferation but inhibited NSC apoptosis. Our results highlight the suppressor role played by miR-135b in CP by inducing NSC differentiation via inactivation of S100B-dependent STAT3 pathway.	[Wen, Linbao; Sun, Jingwei; Chen, Xionggao] Guizhou Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Neurosurg, Guiyang, Peoples R China; [Du, Ruili] Guizhou Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Radiol, Guiyang, Peoples R China		Du, RL (corresponding author), Guizhou Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Radiol, Guiyang, Peoples R China.	drduruilin@163.com			Talent Cooperative Project from Guizhou Province Science and Technology Bureau	This study was supported by Talent Cooperative Project from Guizhou Province Science and Technology Bureau [(2017) No5735-04].	Aisen ML, 2011, LANCET NEUROL, V10, P844, DOI 10.1016/S1474-4422(11)70176-4; Aravamuthan BR, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104711; Barnett R, 2018, LANCET, V392, P545, DOI 10.1016/S0140-6736(18)31702-1; Bian M, 2019, CONTRIB DISCRET MATH, V14, P214; Cheng XA, 2011, NEUROSCI LETT, V493, P18, DOI 10.1016/j.neulet.2011.02.006; D'Angelo B, 2016, NEUROPHARMACOLOGY, V101, P13, DOI 10.1016/j.neuropharm.2015.09.017; Daadi MM, 2010, STROKE, V41, P516, DOI 10.1161/STROKEAHA.109.573691; Deng Rui, 2016, Zhongguo Dang Dai Er Ke Za Zhi, V18, P78; Duan Q, 2018, ARCH MED SCI, V14, P735, DOI 10.5114/aoms.2017.71076; Ellis IO, 2004, J CLIN PATHOL, V57, P233, DOI 10.1136/jcp.2003.007724; Gu F, 2005, J NEUROSCI RES, V81, P163, DOI 10.1002/jnr.20561; Guo Q, 2020, J CELL PHYSIOL, V235, P1274, DOI 10.1002/jcp.29043; He YQ, 2015, AM J CANCER RES, V5, P1382; Hristova M, 2016, J NEUROCHEM, V136, P981, DOI 10.1111/jnc.13490; Jensen A, 2013, Case Rep Transplant, V2013, P951827, DOI 10.1155/2013/951827; Ji F, 2013, J GENET GENOMICS, V40, P61, DOI 10.1016/j.jgg.2012.12.008; Ji HT, 2009, ANN NEUROL, V65, P209, DOI 10.1002/ana.21555; Kannan S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003162; Lange C, 2016, EMBO J, V35, P924, DOI 10.15252/embj.201592372; Lungu C, 2016, NEUROLOGY, V87, P1293, DOI 10.1212/WNL.0000000000003116; Min K, 2013, STEM CELLS, V31, P581, DOI 10.1002/stem.1304; Park ES, 2004, BRAIN DEV-JPN, V26, P190, DOI 10.1016/S0387-7604(03)00126-8; Peng QL, 2017, INT J NEUROSCI, V127, P1, DOI 10.3109/00207454.2015.1135334; Purandare Chaitanya, 2012, Case Rep Transplant, V2012, P825289, DOI 10.1155/2012/825289; Qin C, 2017, Zhonghua Shao Shang Za Zhi, V33, P682, DOI 10.3760/cma.j.issn.1009-2587.2017.11.005; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Riuzzi F, 2011, J CELL SCI, V124, P2389, DOI 10.1242/jcs.084491; Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010; Stefanovic B, 2017, J MED BIOCHEM, V36, P314, DOI 10.1515/jomb-2017-0018; Tan B, 2018, BIOCHEM BIOPH RES CO, V495, P78, DOI 10.1016/j.bbrc.2017.10.071; Trere D, 2007, ANN ONCOL, V18, P1004, DOI 10.1093/annonc/mdm074; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wang X, 2018, BIOL PSYCHIAT, V83, P395, DOI 10.1016/j.biopsych.2017.07.023; Xie XJ, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170186; Yang Y, 2006, NEUROREPORT, V17, P235, DOI 10.1097/01.wnr.0000199470.29357.8f; Yates D, 2011, NAT REV NEUROL, V7, P63, DOI 10.1038/nrneurol.2010.190; Yin YL, 2016, P NATL ACAD SCI USA, V113, pE3773, DOI 10.1073/pnas.1604519113; Yu L, 2011, DEV NEUROSCI-BASEL, V33, P312, DOI 10.1159/000327244; Zhang JL, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/5806146; Zhang LY, 2011, GLIA, V59, P486, DOI 10.1002/glia.21118; Zhang L, 2013, CANCER LETT, V331, P230, DOI 10.1016/j.canlet.2013.01.003; Zhang Y, 2016, EXP THER MED, V12, P809, DOI 10.3892/etm.2016.3366; Zhao YS, 2018, ANTIOXID REDOX SIGN, V28, P1323, DOI 10.1089/ars.2016.6883	44	5	5	0	2	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6143	1522-1563		AM J PHYSIOL-CELL PH	Am. J. Physiol.-Cell Physiol.	DEC	2020	319	6					C955	C966		10.1152/ajpcell.00481.2019			12	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	PB0LU	WOS:000596020400002	32491925				2022-02-06	
J	Young, G; Foote, WE; Kerig, PK; Mailis, A; Brovko, J; Kohutis, EA; McCall, S; Hapidou, EG; Fokas, KF; Goodman-Delahunty, J				Young, Gerald; Foote, William E.; Kerig, Patricia K.; Mailis, Angela; Brovko, Julie; Kohutis, Eileen A.; McCall, Shawn; Hapidou, Eleni G.; Fokas, Kathryn F.; Goodman-Delahunty, Jane			Introducing Psychological Injury and Law	PSYCHOLOGICAL INJURY & LAW			English	Article						Psychological injury; Law; Egg shell; Crumbling skull; Posttraumatic stress disorder; Chronic pain; Mild traumatic brain injury; Persistent postconcussion disorder; Somatic symptom disorder; Fictitious disorder; Assessment; MMPI-2-RF; PAI; Feigning; Malingering		Psychology injury and law is a specialized forensic psychology field that concerns reaching legal thresholds for actionable negligent or related injuries having a psychological component, such as for posttraumatic stress disorder, chronic pain, and mild traumatic brain injury. The presenting psychological injuries have to be related causally to the event at issue, and if pre-existing injuries, vulnerabilities, or psychopathologies are involved at baseline, they have to be exacerbated by the event at issue, or added to in unique ways such that the psychological effects of the event at issue go beyond the de minimis range. The articles in this special issue deal with the legal aspects of cases of psychological injury, including in legal steps and procedures to follow and the causal question of whether an index event is responsible for claimed injuries. They deal with the major psychological injuries, and others such as somatic symptom disorder and factitious disorder. They address best practices in assessment such that testimony and reports proffered to court are probative, i.e., helping the trier of fact to arrive at judicious decisions. The articles in the special issue review the reliable and valid tests in the field, including those that examine negative response bias, negative impression management, symptom exaggeration, feigning, and possible malingering. The latter should be ruled in only through the most compelling evidence in the whole file of an examinee, including test results and inconsistencies. The court will engage in admissibility challenges when testimony, reports, opinions, conclusions, and recommendations do not meet the expected standards of being scientific, comprehensive, impartial, and having considered all the reliable data at hand. The critical topics in the field that cut across the articles in the special issue relate to (a) conceptual and definitional issues, (b) confounds and confusions, (c) assessment and testing, (d) feigning/malingering, and (e) medicolegal/legal/court implications. The articles in the special issue are reviewed in terms of these five themes.	[Young, Gerald; Foote, William E.; Kerig, Patricia K.; Mailis, Angela; Brovko, Julie; Kohutis, Eileen A.; McCall, Shawn; Hapidou, Eleni G.; Fokas, Kathryn F.; Goodman-Delahunty, Jane] York Univ, Glendon Coll, Toronto, ON, Canada		Young, G (corresponding author), York Univ, Glendon Coll, Toronto, ON, Canada.	gyoung@glendon.yorku.ca		Goodman-Delahunty, Jane/0000-0003-4409-0063; Young, Gerald/0000-0002-3689-6924			Amer Psychological Assoc, 2013, AM PSYCHOL, V68, P7, DOI 10.1037/a0029889; American Psychiatric Association, 1994, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DSM 4 T DIAGNOSTIC S; APA [American Psychological Association], 2017, ETH PRINC PSYCH COD; Ben-Porath Y.S., 2020, MINNESOTA MULTIPHASI; Ben-Porath Y. S., 2011, MMPI 2 RF MINNESOTA; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Bianchini KJ., 2013, MILD TRAUMATIC BRAIN, P323; Butcher J., 2006, MINNESOTA MULTIPHASI; Butcher J.N., 1989, MMPI 2 MINNESOTA MUL; Drogin EY, 2020, INT J LAW PSYCHIAT, V71, DOI 10.1016/j.ijlp.2020.101595; Fokas KF, 2020, PSYCHOL INJ LAW, V13, P370, DOI 10.1007/s12207-020-09393-8; Foote WE, 2020, PSYCHOL INJ LAW, V13, P327, DOI 10.1007/s12207-020-09398-3; Kerig PK, 2020, PSYCHOL INJ LAW, V13, P383, DOI 10.1007/s12207-020-09397-4; Kohutis EA, 2020, PSYCHOL INJ LAW, V13, P354, DOI 10.1007/s12207-020-09392-9; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Mailis A, 2020, PSYCHOL INJ LAW, V13, P412, DOI 10.1007/s12207-020-09391-w; Morey L.C., 2007, PERSONALITY ASSESSME; Resick PA, 2012, J TRAUMA STRESS, V25, P241, DOI 10.1002/jts.21699; Sherman EMS, 2020, ARCH CLIN NEUROPSYCH, V35, P735, DOI 10.1093/arclin/acaa019; Silverberg ND, 2021, ARCH PHYS MED REHAB, V102, P76, DOI 10.1016/j.apmr.2020.08.022; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; van der Kolk B.A., 2009, NATL CHILD TRAUMATIC; Viglione DJ, 2017, J PERS ASSESS, V99, P534, DOI 10.1080/00223891.2016.1233882; World Health Organization, 2020, INT STAT CLASS DIS R, V11th; Young G, 2014, INT LIBR ETH LAW NEW, V56, P1, DOI 10.1007/978-94-007-7899-3; Young G., 2020, INTEGRATED SCI GLOBA, V9, pXX; Young G, 2020, PSYCHOL INJ LAW, V13, P427, DOI 10.1007/s12207-020-09395-6; Young G, 2019, PSYCHOL INJ LAW, V12, P225, DOI 10.1007/s12207-019-09360-y; Young G, 2015, PSYCHOL INJ LAW, V8, P188, DOI 10.1007/s12207-015-9232-4; Young G, 2014, PSYCHOL INJ LAW, V7, P61, DOI 10.1007/s12207-014-9186-y; Young G, 2008, PSYCHOL INJ LAW, V1, P224, DOI 10.1007/s12207-008-9021-4	35	5	5	2	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	DEC	2020	13	4			SI		452	463		10.1007/s12207-020-09396-5			12	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	PE4KT	WOS:000598334600007					2022-02-06	
J	Zhang, J; Safar, K; Emami, Z; Ibrahim, GM; Scratch, SE; da Costa, L; Dunkley, BT				Zhang, Jing; Safar, Kristina; Emami, Zahra; Ibrahim, George M.; Scratch, Shannon E.; da Costa, Leodante; Dunkley, Benjamin T.			Local and large-scale beta oscillatory dysfunction in males with mild traumatic brain injury	JOURNAL OF NEUROPHYSIOLOGY			English	Article						beta oscillations; concussion; machine learning; neural activity; magnetoencephalography		Mild traumatic brain injury (mTBI) is impossible to detect with standard neuroradiological assessment such as structural magnetic resonance imaging (MRI). Injury does, however, disrupt the dynamic repertoire of neural activity indexed by neural oscillations. In particular, beta oscillations are reliable predictors of cognitive, perceptual, and motor system functioning, as well as correlating highly with underlying myelin architecture and brain connectivity-all factors particularly susceptible to dysregulation after mTBI. We measured local and large-scale neural circuit function by magnetoencephalography (MEG) with a data-driven model fit approach using the fitting oscillations and one-over f algorithm in a group of young adult men with mTBI and a matched healthy control group. We quantified band-limited regional power and functional connectivity between brain regions. We found reduced regional power and deficits in functional connectivity across brain areas, which pointed to the well-characterized thalamocortical dysconnectivity associated with mTBI. Furthermore, our results suggested that beta functional connectivity data reached the best mTBI classification performance compared with regional power and symptom severity [measured with Sport Concussion Assessment Tool 2 (SCAT2)]. The present study reveals the relevance of beta oscillations as a window into neurophysiological dysfunction in mTBI and also highlights the reliability of neural synchrony biomarkers in disorder classification. NEW & NOTEWORTHY Mild traumatic brain injury (mTBI) disrupts the dynamic repertoire of neural oscillations, but so far beta activity has not been studied. In mTBI, we found reductions in frontal beta and large-scale beta networks, indicative of thalamocortical dysconnectivity and disrupted information flow through cortico-basal ganglia-thalamic circuits. Relatively, connectivity more accurately classifies individual mTBI cases compared with regional power. We show the relevance of beta oscillations in mTBI and the reliability of these markers in classification.	[Zhang, Jing; Safar, Kristina; Emami, Zahra; Dunkley, Benjamin T.] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON, Canada; [Zhang, Jing; Safar, Kristina; Emami, Zahra; Ibrahim, George M.; Dunkley, Benjamin T.] SickKids Res Inst, Neurosci & Mental Hlth, Toronto, ON, Canada; [Ibrahim, George M.; da Costa, Leodante] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Ibrahim, George M.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Ibrahim, George M.] Hosp Sick Children, Dept Neurosurg, Toronto, ON, Canada; [Scratch, Shannon E.] Bloorview Res Inst, Toronto, ON, Canada; [Scratch, Shannon E.] Holland Bloorview Rehabil Hosp, Toronto, ON, Canada; [Scratch, Shannon E.] Univ Toronto, Dept Paediat, Toronto, ON, Canada; [Scratch, Shannon E.] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [da Costa, Leodante] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Dunkley, Benjamin T.] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada		Dunkley, BT (corresponding author), Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON, Canada.; Dunkley, BT (corresponding author), SickKids Res Inst, Neurosci & Mental Hlth, Toronto, ON, Canada.; Dunkley, BT (corresponding author), Univ Toronto, Dept Med Imaging, Toronto, ON, Canada.	ben.dunkley@sickkids.ca			Defence Research and Development Canada (DRDC); Canadian Institute for Military and Veteran Health Research (CIMVHR); Innovation for Defence Excellence and Security (IDEaS) Program	This study was funded by grants from Defence Research and Development Canada (DRDC), the Canadian Institute for Military and Veteran Health Research (CIMVHR), and the Innovation for Defence Excellence and Security (IDEaS) Program.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alitto HJ, 2003, CURR OPIN NEUROBIOL, V13, P440, DOI 10.1016/S0959-4388(03)00096-5; Antonakakis M, 2017, NEUROSCIENCE, V356, P275, DOI 10.1016/j.neuroscience.2017.05.032; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Babiloni C, 2004, BEHAV NEUROSCI, V118, P687, DOI 10.1037/0735-7044.118.4.687; Baillet S, 2017, NAT NEUROSCI, V20, P327, DOI 10.1038/nn.4504; Bardouille T, 2010, EUR J NEUROSCI, V31, P761, DOI 10.1111/j.1460-9568.2010.07094.x; Bonaiuto JJ, 2018, ELIFE, V7, DOI 10.7554/eLife.33977; Briggs F, 2008, CURR OPIN NEUROBIOL, V18, P403, DOI 10.1016/j.conb.2008.09.002; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Buschman TJ, 2012, NEURON, V76, P838, DOI 10.1016/j.neuron.2012.09.029; Colclough GL, 2016, NEUROIMAGE, V138, P284, DOI 10.1016/j.neuroimage.2016.05.070; Dell'Acqua ML, 2010, HUM BRAIN MAPP, V31, P1588, DOI 10.1002/hbm.20961; Douw L, 2018, HUM BRAIN MAPP, V39, P104, DOI 10.1002/hbm.23827; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Dunkley BT, 2014, NEUROIMAGE-CLIN, V5, P377, DOI 10.1016/j.nicl.2014.07.017; Dunkley BT, 2015, HUM BRAIN MAPP, V36, P5220, DOI 10.1002/hbm.23006; Dunkley BT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123541; Dunkley BT, 2013, HUM BRAIN MAPP, V34, P837, DOI 10.1002/hbm.21478; Engel AK, 2013, NEURON, V80, P867, DOI 10.1016/j.neuron.2013.09.038; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Gaetz W, 2011, NEUROIMAGE, V55, P616, DOI 10.1016/j.neuroimage.2010.12.077; Galea OA, 2018, NEUROREHAB NEURAL RE, V32, P115, DOI 10.1177/1545968318760728; Gatev P, 2006, MOVEMENT DISORD, V21, P1566, DOI 10.1002/mds.21033; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; HajiHosseini A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13021; Haller M, 299859 BIORXIV, P201; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Hunt BAE, 2016, P NATL ACAD SCI USA, V113, P13510, DOI 10.1073/pnas.1608587113; Ibrahim GM, 2014, BRAIN, V137, P2690, DOI 10.1093/brain/awu214; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Kim JA, 2019, PAIN, V160, P187, DOI 10.1097/j.pain.0000000000001391; Little S, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000479; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; McFarland NR, 2002, J NEUROSCI, V22, P8117; Merritt VC, 2019, CLIN NEUROPSYCHOL, V33, P1016, DOI 10.1080/13854046.2018.1508616; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; Muthukumaraswamy SD, 2013, NEUROIMAGE, V66, P36, DOI 10.1016/j.neuroimage.2012.10.054; Othmer S, 2013, SEMIN PEDIATR NEUROL, V20, P246, DOI 10.1016/j.spen.2013.10.006; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Pusil S, 2019, BRAIN, V142, P3936, DOI 10.1093/brain/awz320; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Sacchet MD, 2015, J NEUROSCI, V35, P2074, DOI 10.1523/JNEUROSCI.1292-14.2015; Scheeringa R, 2011, NEURON, V69, P572, DOI 10.1016/j.neuron.2010.11.044; Schmid Kara E, 2012, Front Neurol, V3, P90, DOI 10.3389/fneur.2012.00090; Seedat ZA, 2020, NEUROIMAGE, V209, DOI 10.1016/j.neuroimage.2020.116537; Sherman MA, 2016, P NATL ACAD SCI USA, V113, pE4885, DOI 10.1073/pnas.1604135113; Swann NC, 2012, NEUROIMAGE, V59, P2860, DOI 10.1016/j.neuroimage.2011.09.049; Tewarie P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069318; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Wu W, 2016, IEEE SIGNAL PROC MAG, V33, P14, DOI 10.1109/MSP.2015.2481559; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Zamrini Edward, 2011, Int J Alzheimers Dis, V2011, P280289, DOI 10.4061/2011/280289; Zhang J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62713-5; Zhang J, 2016, J INTEGR BIOINFORMAT, V13, DOI 10.2390/biecoll-jib-2016-306	62	5	5	0	1	AMER PHYSIOLOGICAL SOC	Rockville	6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	DEC	2020	124	6					1948	1958		10.1152/jn.00333.2020			11	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	RC3LS	WOS:000632705900019	33052746				2022-02-06	
J	Miller, LE; Urban, JE; Davenport, EM; Powers, AK; Whitlow, CT; Maldjian, JA; Stitzel, JD				Miller, Logan E.; Urban, Jillian E.; Davenport, Elizabeth M.; Powers, Alexander K.; Whitlow, Christopher T.; Maldjian, Joseph A.; Stitzel, Joel D.			Brain Strain: Computational Model-Based Metrics for Head Impact Exposure and Injury Correlation	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Subconcussive head impacts; Head impact exposure; Brain injury; Finite element model; Strain; Youth football; HITS	DIFFUSE AXONAL INJURY; LIFE COGNITIVE IMPAIRMENT; MAXIMUM PRINCIPAL STRAIN; CORPUS-CALLOSUM; 1ST EXPOSURE; FOOTBALL; ACCELERATION; CONCUSSION; DAMAGE; MILD	Athletes participating in contact sports are exposed to repetitive subconcussive head impacts that may have long-term neurological consequences. To better understand these impacts and their effects, head impacts are often measured during football to characterize head impact exposure and estimate injury risk. Despite widespread use of kinematic-based metrics, it remains unclear whether any single metric derived from head kinematics is well-correlated with measurable changes in the brain. This shortcoming has motivated the increasing use of finite element (FE)-based metrics, which quantify local brain deformations. Additionally, quantifying cumulative exposure is of increased interest to examine the relationship to brain changes over time. The current study uses the atlas-based brain model (ABM) to predict the strain response to impacts sustained by 116 youth football athletes and proposes 36 new, or derivative, cumulative strain-based metrics that quantify the combined burden of head impacts over the course of a season. The strain-based metrics developed and evaluated for FE modeling and presented in the current study present potential for improved analytics over existing kinematically-based and cumulative metrics. Additionally, the findings highlight the importance of accounting for directional dependence and expand the techniques to explore spatial distribution of the strain response throughout the brain.	[Miller, Logan E.; Urban, Jillian E.; Powers, Alexander K.; Whitlow, Christopher T.; Stitzel, Joel D.] Wake Forest Sch Med, Dept Biomed Engn, 575 N Patterson Ave,Suite 530, Winston Salem, NC 27101 USA; [Miller, Logan E.; Urban, Jillian E.; Stitzel, Joel D.] Virginia Tech Wake Forest Univ, Sch Biomed Engn & Sci, 575 N Patterson Ave,Suite 530, Winston Salem, NC 27101 USA; [Davenport, Elizabeth M.; Maldjian, Joseph A.] Univ Texas Dallas, Southwestern Med Sch, Dept Radiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Powers, Alexander K.] Wake Forest Sch Med, Dept Neurosurg, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Dept Radiol, Med Ctr Blvd, Winston Salem, NC 27157 USA		Miller, LE (corresponding author), Wake Forest Sch Med, Dept Biomed Engn, 575 N Patterson Ave,Suite 530, Winston Salem, NC 27101 USA.	logmille@wakehealth.edu		Miller, Logan/0000-0002-6348-7536	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410, R01NS082453]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Numbers R01NS094410 and R01NS082453.	Abel J, 1978, SAE TECH PAP; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Amen DG, 2011, J PSYCHOACTIVE DRUGS, V43, P1, DOI 10.1080/02791072.2011.566489; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Atabaki SM, 2007, PEDIATR REV, V28, P215, DOI 10.1542/pir.28-6-215; Bandak F. A, 1994, SAE TECHNICAL PAPER; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Benavidez DA, 1999, CORTEX, V35, P315, DOI 10.1016/S0010-9452(08)70803-7; Bhatoe HS, 1999, ACTA NEUROCHIR, V141, P515, DOI 10.1007/s007010050333; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Casper ST, 2018, HEADACHE, V58, P795, DOI 10.1111/head.13288; Chatelin Simon, 2013, Journal of Biorheology, V27, P26, DOI 10.1007/s12573-012-0055-6; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eppinger R, 1999, DEV IMPROVED INJURY, P1; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gadd C, 1966, SAE TECH PAP; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GURDJIAN ES, 1961, J NEUROSURG, V18, P58, DOI 10.3171/jns.1961.18.1.0058; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Holbourn AHS, 1943, LANCET, V2, P438; Hrapko M, 2008, BIORHEOLOGY, V45, P663, DOI 10.3233/BIR-2008-0512; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; King A. I, 2003, IS HEAD INJURY CAUSE; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kmush BL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.4442; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lauret C, 2009, MED ENG PHYS, V31, P392, DOI 10.1016/j.medengphy.2008.05.004; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller Logan E., 2019, New Developments on Computational Methods and Imaging in Biomechanics and Biomedical Engineering. Lecture Notes in Computational Vision and Biomechanics (LNCVB 33), P121, DOI 10.1007/978-3-030-23073-9_8; Miller LE, 2019, J NEUROTRAUM, V36, P1561, DOI 10.1089/neu.2018.6037; Miller LE, 2017, COMPUT METHOD BIOMEC, V20, P1273, DOI 10.1080/10255842.2017.1340462; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Shatsky S. A, 1974, SAE T, P3707; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith TA, 2015, SPORTS ENG, V18, P165, DOI 10.1007/s12283-015-0175-5; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stegun I. A., 1965, HDB MATH FUNCTIONS; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Takhounts E. G, 2011, KINEMATIC ROTATIONAL; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; THOMAS LM, 1967, J NEUROSURG, V26, P316, DOI 10.3171/jns.1967.26.3.0316; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Versace J, 1971, SAE TECHNICAL PAPER; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Withnall, 2017, NFL LINEAR IMPACTOR; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Zanetti K, 2013, IDENTIFYING INJURY C; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhao W, 2015, PARAMETRIC INVESTIGA; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239	88	5	5	2	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	MAR	2021	49	3					1083	1096		10.1007/s10439-020-02685-9		NOV 2020	14	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	QV2UK	WOS:000594827400002	33258089				2022-02-06	
J	Kim, M; Lee, S; Ko, DR; Kim, DH; Huh, JK; Kim, JY				Kim, Minsik; Lee, Soyeon; Ko, Dong Ryul; Kim, Dae-Hoon; Huh, Jong-Ki; Kim, Jae-Young			Craniofacial and dental injuries associated with stand-up electric scooters	DENTAL TRAUMATOLOGY			English	Article						craniocerebral trauma; dento&#8208; alveolar trauma; facial injuries	HELMET USE	Background/Aim With the recent increased share of stand-up electric scooters (e-scooters), it is common to see people riding e-scooters on the roads in Korea. The aim of this study was to investigate traumatic injuries to the craniofacial region related to e-scooter accidents and to determine the role of dentists (especially oral and maxillofacial surgeons) in the evaluation of patients with trauma at the emergency department due to an e-scooter accident. Materials and Methods This retrospective study investigated the medical records of patients who visited the Gangnam Severance Hospital Emergency Care Center for trauma related to e-scooter use from January 1, 2017 to March 31, 2020. Medical records were reviewed to determine the injuries sustained to the craniofacial region related to e-scooter use, including location of the injury (eg, cranium, craniofacial bone, teeth, soft tissue) and the type of trauma (eg, fracture, laceration, abrasion, contusion, concussion). Result A total of 256 patients' medical records were evaluated. Among them, 125 patients (48.8% of all patients) had sustained craniofacial trauma. Laceration (n = 56, 44.8%) was the most common type of craniofacial injury, followed by cerebral concussion (n = 49, 39.2%), dental injury (n = 27, 21.6%), and craniofacial bone fracture (n = 16, 12.8%). Conclusion Dentists should always consider the possibility of brain trauma and perform a complete craniofacial and oral examination when assessing patients after e-scooter accidents as outlined by the International Association of Dental Traumatology guidelines. Additionally, it is necessary to educate e-scooter riders about the importance of wearing protective devices, such as helmets, to reduce the risk of injuries to the craniofacial region.	[Kim, Minsik; Lee, Soyeon; Kim, Dae-Hoon; Huh, Jong-Ki; Kim, Jae-Young] Yonsei Univ, Coll Dent, Gangnam Severance Hosp, Dept Oral & Maxillofacial Surg, 211 Eonju Ro, Seoul 06273, South Korea; [Ko, Dong Ryul] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Emergency Med, Seoul, South Korea		Kim, JY (corresponding author), Yonsei Univ, Coll Dent, Gangnam Severance Hosp, Dept Oral & Maxillofacial Surg, 211 Eonju Ro, Seoul 06273, South Korea.	kjy810927@yuhs.ac		Huh, Jong-Ki/0000-0002-7381-3972; Kim, Minsik/0000-0002-0275-7299; Kim, Dae-Hoon/0000-0001-8778-4095; Kim, Jae-Young/0000-0002-9423-438X	Yonsei University College of Dentistry [2020-32-0015]	Yonsei University College of Dentistry, Grant/Award Number: 2020-32-0015	[Anonymous], JOONANG DAILY; [Anonymous], DIGITAL TODAY; Daverio M, 2018, BRAIN INJURY, V32, P335, DOI 10.1080/02699052.2018.1426107; Day PF, 2020, DENT TRAUMATOL, V36, P343, DOI 10.1111/edt.12576; Din-Lovinescu C, 2020, J ORAL MAXIL SURG, V78, DOI 10.1016/j.joms.2019.08.006; Faraji F, 2020, LARYNGOSCOPE INVEST, V5, P390, DOI 10.1002/lio2.380; Lin S, 2008, DENT TRAUMATOL, V24, P370, DOI 10.1111/j.1600-9657.2007.00530.x; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Pagadala S, 2015, IAIM, V2, P157; Samsung Traffic Safety Research Institute, TRAFF ACC STAT STAND; SCHATZ JP, 1995, ENDOD DENT TRAUMATOL, V11, P235; Trivedi B, 2019, J ORAL MAXIL SURG, V77, P2292, DOI 10.1016/j.joms.2019.07.014; Trivedi TK, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7381; Yarmohammadi A, 2020, OPHTHALMOLOGY, V127, P988, DOI 10.1016/j.ophtha.2020.02.007	14	5	5	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	APR	2021	37	2					229	233		10.1111/edt.12620		NOV 2020	5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	QT5TK	WOS:000591997500001	33184996				2022-02-06	
J	Caccese, JB; Houck, Z; Kaminski, TW; Clugston, JR; Iverson, GL; Bryk, KN; Oldham, JR; Pasquina, PF; Broglio, SP; McAllister, TW; McCrea, M; Hoy, AM; Hazzard, JB; Kelly, LA; Ortega, JD; Port, N; Putukian, M; Langford, TD; Giza, CC; Goldman, JT; Benjamin, HJ; Schmidt, JD; Feigenbaum, LA; Eckner, JT; Mihalik, JP; Miles, JD; Anderson, S; Master, CL; Collins, MW; Kontos, AP; Chrisman, SPD; Brooks, A; Jackson, JC; McGinty, G; Cameron, KL; Susmarski, A; O'Donnell, PG; Duma, S; Rowson, S; Miles, CM; Bullers, CT; Dykhuizen, BH; Lintner, L; Buckley, TA				Caccese, Jaclyn B.; Houck, Zac; Kaminski, Thomas W.; Clugston, James R.; Iverson, Grant L.; Bryk, Kelsey N.; Oldham, Jessie R.; Pasquina, Paul F.; Broglio, Steven P.; McAllister, Thomas W.; McCrea, Michael; Hoy, April Marie (Reed); Hazzard, Joseph B., Jr.; Kelly, Louise A.; Ortega, Justus D.; Port, Nicholas; Putukian, Margot; Langford, T. Dianne; Giza, Christopher C.; Goldman, Joshua T.; Benjamin, Holly J.; Schmidt, Julianne D.; Feigenbaum, Luis A.; Eckner, James T.; Mihalik, Jason P.; Miles, Jessica Dysart; Anderson, Scott; Master, Christina L.; Collins, Micky W.; Kontos, Anthony P.; Chrisman, Sara P. D.; Brooks, Alison; Jackson, Jonathan C.; McGinty, Gerald; Cameron, Kenneth L.; Susmarski, Adam; O'Donnell, Patrick G.; Duma, Stefan; Rowson, Steve; Miles, Christopher M.; Bullers, Christopher T.; Dykhuizen, Brian H.; Lintner, Laura; Buckley, Thomas A.		CARE Consortium Investigators	Estimated age of first exposure to American football and outcome from concussion	NEUROLOGY			English	Article							COGNITIVE RESERVE; LATER-LIFE; EPIDEMIOLOGY; IMPAIRMENT; EXERCISE; SPORTS	Objective To examine the association between estimated age at first exposure (eAFE) to American football and clinical measures throughout recovery following concussion. Methods Participants were recruited across 30 colleges and universities as part of the National Collegiate Athletic Association (NCAA)-Department of Defense Concussion Assessment, Research and Education Consortium. There were 294 NCAA American football players (age 19 +/- 1 years) evaluated 24-48 hours following concussion with valid baseline data and 327 (age 19 +/- 1 years) evaluated at the time they were asymptomatic with valid baseline data. Participants sustained a medically diagnosed concussion between baseline testing and postconcussion assessments. Outcome measures included the number of days until asymptomatic, Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) composite scores, Balance Error Scoring System (BESS) total score, and Brief Symptom Inventory 18 (BSI-18) subscores. The eAFE was defined as participant's age at the time of assessment minus self-reported number of years playing football. Results In unadjusted regression models, younger eAFE was associated with lower (worse) ImPACT Visual Motor Speed (R-2 = 0.031, p = 0.012) at 24-48 hours following injury and lower (better) BSI-18 Somatization subscores (R-2 = 0.014, p = 0.038) when the athletes were asymptomatic. The effect sizes were very small. The eAFE was not associated with the number of days until asymptomatic, other ImPACT composite scores, BESS total score, or other BSI-18 subscores. Conclusion Earlier eAFE to American football was not associated with longer symptom recovery, worse balance, worse cognitive performance, or greater psychological distress following concussion. In these NCAA football players, longer duration of exposure to football during childhood and adolescence appears to be unrelated to clinical recovery following concussion.	[Caccese, Jaclyn B.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Houck, Zac; Clugston, James R.] Univ Florida, Gainesville, FL USA; [Kaminski, Thomas W.; Bryk, Kelsey N.; Buckley, Thomas A.] Univ Delaware, Newark, DE 19716 USA; [Iverson, Grant L.] Harvard Med Sch, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.] MassGen Hosp Children, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Home Base, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [Oldham, Jessie R.] Boston Childrens Hosp, Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Pasquina, Paul F.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Pasquina, Paul F.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Broglio, Steven P.; Eckner, James T.] Univ Michigan, Ann Arbor, MI 48109 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [McCrea, Michael] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Hoy, April Marie (Reed)] Azusa Pacific Univ, Azusa, CA 91702 USA; [Hazzard, Joseph B., Jr.] Bloomsburg Univ, Bloomsburg, PA USA; [Kelly, Louise A.] Calif Lutheran Univ, Thousand Oaks, CA USA; [Ortega, Justus D.] Humboldt State Univ, Arcata, CA 95521 USA; [Port, Nicholas] Indiana Univ, Bloomington, IN USA; [Putukian, Margot] Princeton Univ, Princeton, NJ 08544 USA; [Langford, T. Dianne] Temple Univ, Philadelphia, PA 19122 USA; [Giza, Christopher C.; Goldman, Joshua T.] Univ Calif Los Angeles, Los Angeles, CA USA; [Benjamin, Holly J.] Univ Chicago, Chicago, IL 60637 USA; [Schmidt, Julianne D.] Univ Georgia, Athens, GA 30602 USA; [Feigenbaum, Luis A.] Univ Miami, Coral Gables, FL 33124 USA; [Mihalik, Jason P.] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Miles, Jessica Dysart] Univ North Georgia, Dahlonega, GA USA; [Anderson, Scott] Univ Oklahoma, Norman, OK 73019 USA; [Master, Christina L.] Univ Penn, Philadelphia, PA 19104 USA; [Collins, Micky W.; Kontos, Anthony P.] Univ Pittsburgh, Pittsburgh, PA USA; [Chrisman, Sara P. D.] Univ Washington, Seattle, WA 98195 USA; [Brooks, Alison] Univ Wisconsin Madison, Madison, WI USA; [Jackson, Jonathan C.; McGinty, Gerald] US Air Force Acad, Colorado Springs, CO 80840 USA; [Cameron, Kenneth L.] US Mil Acad, West Point, NY 10996 USA; [Susmarski, Adam] US Naval Acad, Annapolis, MD 21402 USA; [O'Donnell, Patrick G.] US Coast Guard Acad, New London, CT USA; [Duma, Stefan; Rowson, Steve] Virginia Tech, Blacksburg, VA USA; [Miles, Christopher M.; Bullers, Christopher T.] Wake Forest Univ, Winston Salem, NC 27101 USA; [Dykhuizen, Brian H.] Wilmington Coll, Wilmington, OH USA; [Lintner, Laura] Winston Salem Univ, Winston Salem, NC USA		Buckley, TA (corresponding author), Univ Delaware, Newark, DE 19716 USA.	tbuckley@udel.edu	Buckley, Thomas A/B-7525-2016; Caccese, Jaclyn B./AAH-4571-2020	Buckley, Thomas A/0000-0002-0515-0150; Caccese, Jaclyn B./0000-0003-2329-3603; Bryk, Kelsey/0000-0003-3926-230X; Clugston, James/0000-0002-2103-1039; Oldham, Jessie/0000-0003-2801-2110; Chrisman, Sara/0000-0001-5373-7223	Grand Alliance CARE Consortium - NCAA; Department of DefenseUnited States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; USAMRAA, Ford Detrick, MD; Department of Defense (DHP funds)United States Department of Defense	This publication was made possible, in part, with support from the Grand Alliance CARE Consortium, funded by the NCAA and the Department of Defense. The USAMRAA, Ford Detrick, MD, is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under award W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (DHP funds).	Alosco ML, 2019, SEMIN PEDIATR NEUROL, V30, P107, DOI 10.1016/j.spen.2019.03.016; Alosco ML, 2017, J NEUROPSYCH CLIN N, V29, P6, DOI 10.1176/appi.neuropsych.16030043; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Broe GA, 1998, AUST NZ J PUBL HEAL, V22, P621, DOI 10.1111/j.1467-842X.1998.tb01449.x; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Caccese JB, 2020, J NEUROTRAUM, V37, P334, DOI 10.1089/neu.2019.6571; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Houck ZM, 2020, CLIN NEUROPSYCHOL, V34, P561, DOI 10.1080/13854046.2019.1666923; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; Scarmeas N, 2003, J CLIN EXP NEUROPSYC, V25, P625, DOI 10.1076/jcen.25.5.625.14576; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, P112, DOI 10.1097/01.wad.0000213815.20177.19; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stone Arthur A., 1999, SCI SELF REPORT IMPL; van Uffelen JGZ, 2008, CLIN J SPORT MED, V18, P486, DOI 10.1097/JSM.0b013e3181845f0b; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	32	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	NOV 24	2020	95	21					E2935	E2944		10.1212/WNL.0000000000010672			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QI9DO	WOS:000619288500010	32907967	Bronze, Green Published			2022-02-06	
J	Foote, WE; Goodman-Delahunty, J; Young, G				Foote, William E.; Goodman-Delahunty, Jane; Young, Gerald			Civil Forensic Evaluation in Psychological Injury and Law: Legal, Professional, and Ethical Considerations	PSYCHOLOGICAL INJURY & LAW			English	Article						Forensic assessment; Litigation; Civil rights; Tort cases; Ethics; Professional issues	POSTTRAUMATIC-STRESS-DISORDER; PERSONALITY-ASSESSMENT INVENTORY; WORKPLACE SEXUAL-HARASSMENT; MENTAL STATUS EXAMINATION; ABUSE DEFENSE; SELF-REPORT; TARASOFF; GUIDELINES; INTERNET; IMPACT	Psychologists who work as therapists or administrators, or who engage in forensic practice in criminal justice settings, find it daunting to transition into practice in civil cases involving personal injury, namely psychological injury from the psychological perspective. In civil cases, psychological injury arises from allegedly deliberate or negligent acts of the defendant(s) that the plaintiff contends caused psychological conditions to appear. These alleged acts are disputed in courts and other tribunals. Conditions considered in psychological injury cases include posttraumatic stress disorder, depression, chronic pain conditions, and sequelae of traumatic brain injury. This article outlines a detailed case sequence from referral through the end of expert testimony to guide the practitioner to work effectively in this field of practice. It addresses the rules and regulations that govern admissibility of expert evidence in court. The article provides ethical and professional guidance throughout, including best practices in assessment and testing, and emphasizes evidence-based forensic practice.	[Foote, William E.] Univ New Mexico, Albuquerque, NM 87131 USA; [Goodman-Delahunty, Jane] Charles Sturt Univ, Manly, Australia; [Young, Gerald] York Univ, Glendon Coll, Toronto, ON, Canada		Foote, WE (corresponding author), Univ New Mexico, Albuquerque, NM 87131 USA.	forNpsych@aol.com		Goodman-Delahunty, Jane/0000-0003-4409-0063			Adkins JW, 2008, J ANXIETY DISORD, V22, P1393, DOI 10.1016/j.janxdis.2008.02.002; American Psychological Association, 2020, ETH COD TASK FORC IN; American Psychological Association, 2002, ETH PRINC PSYCH COD; APPELBAUM PS, 1985, AM J PSYCHIAT, V142, P425; Atwood Denise A, 2011, JONAS Healthc Law Ethics Regul, V13, P21, DOI 10.1097/NHL.0b013e31820b5cfa; Baker NL, 2013, HDB PSYCHOL, P225; Ben-Porath Y.S., 2020, MMPI 3 MANUAL ADM SC; Ben-Porath Y. S., 2020, MMPI 3 USERS GUIDE R; Ben-Porath Y.S., 2020, MMPI 3 TECHNICAL MAN; Bersoff DN, 2014, AM PSYCHOL, V69, P461, DOI 10.1037/a0037198; Binder DM, 2007, DISS ABSTR INT B, V67, P4757; Borkosky B, 2014, PSYCHOL INJ LAW, V7, P264, DOI 10.1007/s12207-014-9199-6; Brand BL, 2017, PSYCHOL INJ LAW, V10, P298, DOI 10.1007/s12207-017-9305-7; Brearly TW, 2017, NEUROPSYCHOL REV, V27, P174, DOI 10.1007/s11065-017-9349-1; Briere J., 2010, TRAUMA SYMPTOM INVEN, V2; Brodsky S. L., 1991, TESTIFYING COURT GUI; Brodsky S. L., 2016, EXPERT EXPERT WITNES; Brodsky S. L., 1999, EXPERT EXPERT WITNES; Bush S. S., 2020, ETHICAL PRACTICE FOR, DOI [10.1037/0000164-000, DOI 10.1037/0000164-000]; Cabaniss DL, 2013, PSYCHODYNAMIC FORMULATION, P213; Connell M. A., 2003, AM PSYCHOL LAW SOC N, V23, P16; Daley TT, 1996, CAN MED ASSOC J, V154, P573; DeBell C, 1997, PROF PSYCHOL-RES PR, V28, P559, DOI 10.1037/0735-7028.28.6.559; DeMier R. L, 2013, HDB PSYCHOL, P75; DeMier RL, 2017, INT PERSP FOREN MENT, P216; Donner MB, 2008, PROF PSYCHOL-RES PR, V39, P369, DOI 10.1037/0735-7028.39.3.369; Dostart Z., 2006, PEPP L REV, V33, P723; Drogin E. Y, 2019, ETHICAL CONFLICTS PS, P317, DOI [10.1037/0000125-006, DOI 10.1037/0000125-006]; Drogin E. Y., 2011, HDB FORENSIC ASSESSM, DOI [10.1002/9781118093399, DOI 10.1002/9781118093399]; Drogin E. Y, 2019, ETHICAL CONFLICTS PS, P245, DOI [10.1037/0000125-005, DOI 10.1037/0000125-005]; Drogin EY, 2020, INT J LAW PSYCHIAT, V71, DOI 10.1016/j.ijlp.2020.101595; Drogin EY, 2010, PROF PSYCHOL-RES PR, V41, P236, DOI 10.1037/a0019001; Faigman DL, 2014, U CHICAGO LAW REV, V81, P417; Faust D, 2010, ANNU REV CLIN PSYCHO, V6, P49, DOI 10.1146/annurev.clinpsy.3.022806.091523; FENNIG S, 1994, J NERV MENT DIS, V182, P20, DOI 10.1097/00005053-199401000-00005; First M., 2015, STRUCTURED CLIN INTE; Fitzgerald LF, 1999, MIL PSYCHOL, V11, P243, DOI 10.1207/s15327876mp1103_3; Fitzgerald LF, 1999, PSYCHOL PUBLIC POL L, V5, P730, DOI 10.1037/1076-8971.5.3.730; Fitzgerald LF, 1995, BASIC APPL SOC PSYCH, V17, P425, DOI 10.1207/s15324834basp1704_2; Flaks MK, 2014, J PSYCHIATR RES, V48, P32, DOI 10.1016/j.jpsychires.2013.10.009; Fokas KF, 2020, PSYCHOL INJ LAW, V13, P370, DOI 10.1007/s12207-020-09393-8; Foote W. E, 2020, ASSESSING TRAUMA FOR; Foote W. E., UNDERSTANDING SEXUAL; Foote WE, 2013, HDB PSYCHOL, P172; Foote WE, 2006, PROF PSYCHOL-RES PR, V37, P437, DOI 10.1037/0735-7028.37.5.437; Foote WE, 2016, PSYCHOL INJ LAW, V9, P253, DOI 10.1007/s12207-016-9266-2; Freckelton I., 2016, EXPERT EVIDENCE CRIM; FULLER RK, 1988, ALCOHOL CLIN EXP RES, V12, P201, DOI 10.1111/j.1530-0277.1988.tb00180.x; Gass CS, 2017, APPL NEUROPSYCH-ADUL, V24, P357, DOI 10.1080/23279095.2016.1185427; GLADSJO JA, 1992, ADDICT BEHAV, V17, P347, DOI 10.1016/0306-4603(92)90040-3; Glancy Graham D, 2015, J Am Acad Psychiatry Law, V43, pS3; Glassman JB, 1998, PROF PSYCHOL-RES PR, V29, P121, DOI 10.1037/0735-7028.29.2.121; Glick P, 2018, J SOC ISSUES, V74, P449, DOI 10.1111/josi.12280; Gold L. H., 2011, HDB FORENSIC ASSESSM, P303; Gold LH, 2004, SEXUAL HARASSMENT PS; GOODMAN J, 1989, BEHAV SCI L, V7, P227, DOI DOI 10.1002/bsl.2370070207; Goodman-Delahunty J, 1999, PERSPECTIVES PSYCHOL, P277; Goodman-Delahunty J., 2011, WORKPLACE DISCRIMINA; Goodman-Delahunty J, 2013, PSYCHOL INJ LAW, V6, P92, DOI 10.1007/s12207-013-9154-y; Goodman-Delahunty J, 2013, AUST PSYCHOL, V48, P32, DOI 10.1111/j.1742-9544.2012.00082.x; GOODMANDELAHUNTY J, 1995, BEHAV SCI LAW, V13, P183, DOI 10.1002/bsl.2370130204; Greenberg SA, 1997, PROF PSYCHOL-RES PR, V28, P50, DOI 10.1037/0735-7028.28.1.50; Greenberg SA, 2003, ASSESSMENT, V10, P411, DOI 10.1177/1073191103259532; Greene R. L, 2011, MMPI 2 MMPI 2RF INTE; Hall SR, 2006, J FORENSIC PSYCHOL P, V6, P55, DOI 10.1300/J158v06n04_04; Halphen JM, 2020, J ELDER ABUSE NEGL, V32, P121, DOI 10.1080/08946566.2020.1740127; HEILBRUN K, 1992, LAW HUMAN BEHAV, V16, P257, DOI 10.1007/BF01044769; Heilbrun K, 1994, Bull Am Acad Psychiatry Law, V22, P399; Heilbrun K., 2014, FORENSIC MENTAL HLTH, DOI [10.1093/med:psych/9780199941551.001.0001, DOI 10.1093/MED:PSYCH/9780199941551.001.0001]; Heilbrun K., 2001, PRINCIPLES FORENSIC; Hekele A, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.54; HELLKAMP DT, 1995, CONSULTING PSYCHOL J, V47, P150, DOI DOI 10.1037/1061-4087.47.3.150; HERSCH PD, 1990, J CLIN PSYCHOL, V46, P795, DOI 10.1002/1097-4679(199011)46:6<795::AID-JCLP2270460617>3.0.CO;2-K; JENSVOLD MF, 1993, PSYCHIAT ANN, V23, P438, DOI 10.3928/0048-5713-19930801-09; Kalichman S. C, 1993, MANDATED REPORTING S; Kane A. W., 2011, BEST PRACTICES FOREN, DOI [10.1093/med:psych/9780195326079.001.0001, DOI 10.1093/MED:PSYCH/9780195326079.001.0001]; Kapoor R, 2010, J AM ACAD PSYCHIATRY, V38, P49; Karson M., 2013, FORENSIC PRACTICE PS, P145, DOI [10.1037/14182-011, DOI 10.1037/14182-011]; Kerig P. K., 2020, PSYCHOL INJURY LAW, P13; Knapp DE, 2016, EMPLOY RESPONSIB RIG, V28, P1, DOI 10.1007/s10672-015-9269-2; Kohutis E. A., 2020, PSYCHOL INJURY LAW, P13; LaDuke C., 2017, ETHICAL PRACTICE FOR, P159, DOI [10.1093/acprof:oso/9780190258542.003.0006, DOI 10.1093/ACPROF:OSO/9780190258542.003.0006]; Lannin DG, 2013, PROF PSYCHOL-RES PR, V44, P135, DOI 10.1037/a0031794; Lareau CR, 2016, PSYCHOL INJ LAW, V9, P206, DOI 10.1007/s12207-016-9268-0; Lareau CR, 2015, INT J LAW PSYCHIAT, V42-43, P43, DOI 10.1016/j.ijlp.2015.08.006; Lawson AK, 2016, PSYCHOL INJ LAW, V9, P216, DOI 10.1007/s12207-016-9269-z; Levine M., 1995, IMPACT MANDATED REPO; Lexcen FJ, 2006, PSYCHIAT SERV, V57, P713, DOI 10.1176/appi.ps.57.5.713; Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693; Luxton DD, 2019, CURR PSYCHIAT REP, V21, DOI 10.1007/s11920-019-1037-9; Luxton DD, 2018, PROF PSYCHOL-RES PR, V49, P124, DOI 10.1037/pro0000179; Luxton DD, 2015, BEHAV TELEHEALTH, P203, DOI 10.1007/978-3-319-08765-8_9; Manguno-Mire GM, 2007, J AM ACAD PSYCHIATRY, V35, P481; Matarazzo J. D., 1987, CLIN NEUROPSYCHOL, V1, P307; Melton GB, 2018, PSYCHOL EVALUATIONS, VThird; Metzner JL, 2010, J AM ACAD PSYCHIATRY, V38, P27; Mitrevski JP, 2006, J AM ACAD PSYCHIATRY, V34, P245; MONAHAN J, 1993, AM PSYCHOL, V48, P242, DOI 10.1037/0003-066X.48.3.242; Morey, 1991, PERSONALITY ASSESSME; Neimark G, 2006, AM J PSYCHIAT, V163, P1842, DOI 10.1176/appi.ajp.163.10.1842; Nelson LD, 2015, USING MMPI 2 FORENSI; Olley J. G, 2014, FORENSIC MENTAL HLTH, P146; Otto R.K., 2014, FORENSIC REPORTS TES; Packer I. K., 2013, HDB PSYCHOL, P16; PAETZOLD RL, 1994, STAT DISCRIMINATION; PFOHL B, 1982, STRUCTURED INTERVIEW; Pirelli G., 2017, ETHICAL PRACTICE FOR, DOI [10.1093/acprof:oso/9780190258542.001.0001, DOI 10.1093/ACPROF:OSO/9780190258542.001.0001]; Pirelli G, 2016, PROF PSYCHOL-RES PR, V47, P12, DOI 10.1037/pro0000061; Pope K.S., 2006, MMPI MMPI 2 MMPI A C; Recupero PR, 2010, J AM ACAD PSYCHIATRY, V38, P15; Recupero PR, 2008, J AM ACAD PSYCHIATRY, V36, P505; Reed ME, 2016, PSYCHOL INJ LAW, V9, P230, DOI 10.1007/s12207-016-9267-1; ROGERS R, 1994, LAW HUMAN BEHAV, V18, P543, DOI 10.1007/BF01499173; Rogers R, 1997, CLIN ASSESSMENT MALI, P301; Rogers R., 2018, CLIN ASSESSMENT MALI; Rogers R., 1992, STRUCTURED INTERVIEW; Rogers R., 2018, CLIN ASSESSMENT MALI, P592; Rogers R, 2020, PSYCHOL INJ LAW, V13, P275, DOI 10.1007/s12207-020-09379-6; Rogers Richard, 1987, Behav Sci Law, V5, P149, DOI 10.1002/bsl.2370050207; Sales CP, 2018, J FORENSIC PSYCHI PS, V29, P387, DOI 10.1080/14789949.2017.1396487; Scheibe S, 2001, PSYCHOL ASSESSMENT, V13, P369, DOI 10.1037/1040-3590.13.3.369; Sherman EMS, 2020, ARCH CLIN NEUROPSYCH, V35, P735, DOI 10.1093/arclin/acaa019; Shuman D. W, 2000, PSYCHIAT PSYCHOL EVI; Shuman DW, 1998, BEHAV SCI LAW, V16, P509, DOI 10.1002/(SICI)1099-0798(199823)16:4<509::AID-BSL324>3.0.CO;2-Y; Shuman DW, 2003, PROF PSYCHOL-RES PR, V34, P219, DOI 10.1037/0735-7028.34.3.219; Shuman DW, 1999, PROF PSYCHOL-RES PR, V30, P479, DOI 10.1037/0735-7028.30.5.479; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spizzirri R, 2017, ETHICAL PRACTICE FOR, P99, DOI [10.1093/acprof:oso/9780190258542.003.0004, DOI 10.1093/ACPROF:OSO/9780190258542.003.0004]; Stadnik RD, 2013, J TRAUMA DISSOCIATIO, V14, P546, DOI 10.1080/15299732.2013.792310; Stangl, 1989, STRUCTURED INTERVIEW; Tellegen, 2008, MINNESOTA MULTIPHASI; Tellegen A., 2003, MMPI 2 RESTRUCTURED; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; TREADWAY J, 1990, HOSP COMMUNITY PSYCH, V41, P88; Turvey C, 2013, TELEMED E-HEALTH, V19, P722, DOI 10.1089/tmj.2013.9989; Tylicki JL, 2021, PSYCHOL ASSESSMENT, V33, P71, DOI 10.1037/pas0000968; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Wechsler, 2008, WAIS 4 ADM SCORING M; Weiner IB, 2014, HDB FORENSIC PSYCHOL, p[3, 711]; Whitman MR, 2021, PSYCHOL ASSESSMENT, V33, P142, DOI 10.1037/pas0000969; Williger SD, 1995, CONSULTING PSYCHOL J, V47, P141, DOI [10.1037/1061-4087.47.3.141, DOI 10.1037/1061-4087.47.3.141]; Winick Bruce J, 1996, Univ Miami Law Rev, V50, P249; Wooley CN, 2015, ASSESSMENT, V22, P449, DOI 10.1177/1073191114552076; Wright CV, 2009, LAW HUMAN BEHAV, V33, P265, DOI 10.1007/s10979-008-9156-6; WULSIN LR, 1983, AM J PSYCHIAT, V140, P601; Wygant DB, 2015, PSYCHOL INJ LAW, V8, P11, DOI 10.1007/s12207-015-9220-8; Young G, 2014, INT LIBR ETH LAW NEW, V56, P1, DOI 10.1007/978-94-007-7899-3; Young G., 2017, REVISING APA ETHICS, DOI [10.1007/978-3-319-60002-4, DOI 10.1007/978-3-319-60002-4]; Young G., 2020, INTEGRATED SCI GLOBA, V9, pXX; Young G., 2019, ETHICS MED PUBLIC HL, V10, P93, DOI DOI 10.1016/j.jemep.2019.100407; Young G, 2007, CAUSALITY PSYCHOL IN, DOI [10.1007/978-0-387-36445-2, DOI 10.1007/978-0-387-36445-2]; Young G, 2020, PSYCHOL INJURY LAW, P13; Young G, 2014, MENTAL HLTH LAW POLI, V3, P373; Young G, 2019, PSYCHOL INJ LAW, V12, P225, DOI 10.1007/s12207-019-09360-y; Young G, 2016, PSYCHOL INJ LAW, V9, P278, DOI 10.1007/s12207-016-9264-4; Young G, 2015, PSYCHOL INJ LAW, V8, P169, DOI 10.1007/s12207-015-9226-2; Young G, 2017, INT J LAW PSYCHIAT, V52, P81, DOI 10.1016/j.ijlp.2017.03.001; Young G, 2015, PSYCHOL INJ LAW, V8, P188, DOI 10.1007/s12207-015-9232-4; Young Gerald, 2016, Int J Law Psychiatry, V49, P214, DOI 10.1016/j.ijlp.2016.10.008; Young Gerald, 2016, Int J Law Psychiatry, V49, P161, DOI 10.1016/j.ijlp.2016.11.001; Young G, 2008, PSYCHOL INJ LAW, V1, P78, DOI 10.1007/s12207-008-9008-1; Young Glendon., 2020, ETHICS MED PUBLIC HL, V15, P100590, DOI 10.1016/j.jemep.2020.100590; Younggren JN, 2008, J CLIN PSYCHOL, V64, P589, DOI 10.1002/jclp.20480	163	5	5	3	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	DEC	2020	13	4			SI		327	353		10.1007/s12207-020-09398-3		NOV 2020	27	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	PE4KT	WOS:000591976600001	33250954	Green Published			2022-02-06	
J	Zhang, T; Wang, F; Li, K; Lv, CW; Gao, K; Lv, CL				Zhang, Tao; Wang, Fang; Li, Kang; Lv, Chengwei; Gao, Kai; Lv, Chaoliang			Therapeutic effect of metformin on inflammation and apoptosis after spinal cord injury in rats through the Wnt/beta-catenin signaling pathway	NEUROSCIENCE LETTERS			English	Article						Spinal cord injury; Metformin; Wnt/beta-catenin signaling pathway; Inflammation; Neuroprotection		Objective: To verify the effect of metformin on spinal cord injury (SCI) through Wnt/beta-catenin signaling pathway. Background: SCI is a serious traumatic disease of the central nervous system. Wnt/beta-catenin signaling pathway plays important roles in SCI. Metformin has been reported to exert neuroprotective effects in the central nervous system. Whether metformin could improve SCI through Wnt/beta-catenin signaling pathway remains unclear. Methods: Rats were divided into sham group, SCI group, SCI + metformin group, metformin + XAV939 group (XAV939 is an effective inhibitor of the Wnt/beta-catenin signaling pathway), and methylprednisolone group. BBB scores were used to detect motor function recovery at different time points (0, 1, 3, 7, 14, 21, and 28 days) in SCI rats. Western blot analysis, immunofluorescence, TUNEL, HE and Nissl staining were used to observe the morphological characteristics of spinal cord tissue and the expression of inflammation and apoptosis in spinal cord neurons. Results: Metformin(50 mg/kg) promoted motor functional recovery in rats after SCI, increased the expressions of beta-catenin and brain derived neurotrophic factor (BDNF), inhibited neuron apoptosis and inflammatory response, and improved the recovery of pathological morphology at the injury site by activating the Wnt/beta-catenin signaling pathway. Conclusion: We found a possible mechanism that metformin could reduce inflammation and apoptosis, and promote functional recovery of SCI rats through activating Wnt/beta-catenin signaling pathway.	[Zhang, Tao] Jining Med Univ, Sch Clin Med, Jining, Peoples R China; [Zhang, Tao; Li, Kang; Lv, Chengwei; Gao, Kai; Lv, Chaoliang] Jining 1 Peoples Hosp, Dept Orthoped, Jining, Peoples R China; [Wang, Fang] Jining 1 Peoples Hosp, Dept Sci & Educ, Jining, Peoples R China		Gao, K; Lv, CL (corresponding author), Jining 1 Peoples Hosp, Dept Orthoped, Jining, Peoples R China.	gaohaikai88@126.com; lvchaolianggk@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801906]; Natural Science Foundation of Shandong ProvinceNatural Science Foundation of Shandong Province [ZR2018PH024]	This work was supported by grants from the National Natural Science Foundation of China, No. 81801906 and the Natural Science Foundation of Shandong Province, No. ZR2018PH024.	Afshari K, 2018, SPINAL CORD, V56, P1032, DOI 10.1038/s41393-018-0168-x; Amable G, 2019, INT J BIOCHEM CELL B, V112, P88, DOI 10.1016/j.biocel.2019.05.004; [Anonymous], 2019, EXP NEUROL, V320, P112965; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bem J, 2019, FEBS LETT, V593, P1654, DOI 10.1002/1873-3468.13502; Chen X., 2018, INT J MOL SCI, V19; Dai J, 2018, EUR REV MED PHARMACO, V22, P6609, DOI 10.26355/eurrev_201810_16135; Santo CCD, 2019, BRAIN BEHAV IMMUN, V78, P91, DOI 10.1016/j.bbi.2019.01.012; Evaniew N, 2016, J NEUROTRAUM, V33, P468, DOI 10.1089/neu.2015.4192; Fehlings MG, 2017, GLOB SPINE J, V7, p203S, DOI 10.1177/2192568217703085; Fehlings Michael G, 2014, Neurosurgery, V61 Suppl 1, P36, DOI 10.1227/NEU.0000000000000412; Gaudet AD, 2018, NEUROTHERAPEUTICS, V15, P554, DOI 10.1007/s13311-018-0630-7; Ge AQ, 2018, MOL MED REP, V17, P5229, DOI 10.3892/mmr.2018.8541; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; He ZJ, 2019, INT J NANOMED, V14, P721, DOI 10.2147/IJN.S187854; Kertmen H, 2018, ARCH MED SCI, V14, P1459, DOI 10.5114/aoms.2017.65650; Kleene R., 2019, RESTOR NEUROL NEUROS; Leech T, 2019, PHARMACOL RES, V146, DOI 10.1016/j.phrs.2019.104261; Lemmens S, 2020, J NEUROTRAUM, V37, P564, DOI 10.1089/neu.2018.6211; Li JL, 2019, BIOCHEM BIOPH RES CO, V516, P991, DOI 10.1016/j.bbrc.2019.06.118; Li Z., 2019, CURR DEV NUTR; Libro R, 2016, NEUROREPORT, V27, P1086, DOI 10.1097/WNR.0000000000000663; Liu WN, 2019, J AFFECT DISORDERS, V246, P486, DOI 10.1016/j.jad.2018.12.112; Lotan I, 2016, INT CLIN PSYCHOPHARM, V31, P224, DOI 10.1097/YIC.0000000000000122; Lu GB, 2016, NEURAL REGEN RES, V11, P1816, DOI 10.4103/1673-5374.194753; Lv ZC, 2019, EUR REV MED PHARMACO, V23, P4558, DOI 10.26355/eurrev_201906_18031; Ma J, 2018, EUR REV MED PHARMACO, V22, P7962, DOI 10.26355/eurrev_201811_16424; Mercieca K, 2007, J CATARACT REFR SURG, V33, P815, DOI 10.1016/j.jcrs.2007.01.029; Pan F, 2018, ONCOL LETT, V16, P1953, DOI 10.3892/ol.2018.8790; Saker D, 2019, NEUROL RES, V41, P991, DOI 10.1080/01616412.2019.1652014; Samano C, 2019, NEUROCHEM RES, V44, P200, DOI 10.1007/s11064-017-2459-6; Snigdha S, 2012, NEUROSCI BULL, V28, P14, DOI 10.1007/s12264-012-1057-5; Su YL, 2019, FASEB J, V33, P10859, DOI 10.1096/fj.201900743R; Tao L, 2019, EUR J PHARMACOL, V858, DOI 10.1016/j.ejphar.2019.172476; Wang C, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1630-1; Wang C, 2016, BIOCHEM BIOPH RES CO, V477, P534, DOI 10.1016/j.bbrc.2016.05.148; Wang HL, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/9741369; Yuan YM, 2013, NEUROSCI BULL, V29, P421, DOI 10.1007/s12264-013-1358-3; Zhang D, 2017, MOL NEUROBIOL, V54, P3327, DOI 10.1007/s12035-016-9895-1	39	5	5	3	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 20	2020	739								135440	10.1016/j.neulet.2020.135440			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PA8JE	WOS:000595874900006	33132177				2022-02-06	
J	Li, L; Chopp, M; Ding, GL; Davoodi-Bojd, E; Zhang, L; Li, QJ; Zhang, YL; Xiong, Y; Jiang, Q				Li, Lian; Chopp, Michael; Ding, Guangliang; Davoodi-Bojd, Esmaeil; Zhang, Li; Li, Qingjiang; Zhang, Yanlu; Xiong, Ye; Jiang, Quan			MRI detection of impairment of glymphatic function in rat after mild traumatic brain injury	BRAIN RESEARCH			English	Article						Glymphatic function; Mild traumatic brain injury; Contrast agent; Kinetic parameter; CE-MRI	OLFACTORY DYSFUNCTION; CEREBROSPINAL-FLUID; PATHWAY; TRANSPORT; MODEL; SPECTROSCOPY; PERFUSION; SYMPTOMS; SYSTEM	We investigated the effect of mild traumatic brain injury (mTBI) on the glymphatic pathway using contrast enhanced magnetic resonance imaging (CE-MRI) and quantified with kinetic parameters obtained from an advanced two-compartment model. mTBI was induced in male Wistar rats using a closed head impact. Animals with and without mTBI (n = 7/group) underwent the identical MRI protocol 10-weeks post-injury, including T2 weighted imaging and 3D T1-weighted imaging with intra-cisterna magna injection of contrast agent (GdDTPA). The parameters of infusion rate, clearance rate and clearance time constant, characterizing the kinetic features of glymphatic tracer transport in a living brain, were quantified in multiple brain tissue regions. In the majority of examined regions, our quantification demonstrated significantly reduced infusion and clearance rates, and significantly increased clearance time constant in the mTBI animals compared to the healthy controls. These data indicate that mTBI induces chronic changes in influx and efflux of contrast agent and glymphatic pathway dysfunction. While the reduced efficiency of glymphatic function after mTBI was apparent in brain, regional evaluation revealed heterogeneous glymphatic effects of the mTBI in different anatomical regions. The suppression of glymphatic function, rather than the presence of focal lesions, indicates a persistent injury of the brain after mTBI. Thus, dynamic CE-MRI in conjunction with advanced kinetic analysis may offer a useful methodology for an objective assessment and confirmatory diagnosis of mTBI.	[Li, Lian; Chopp, Michael; Ding, Guangliang; Davoodi-Bojd, Esmaeil; Zhang, Li; Li, Qingjiang; Jiang, Quan] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48309 USA; [Zhang, Yanlu; Xiong, Ye] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI 48208 USA; [Li, Lian; Chopp, Michael; Ding, Guangliang; Davoodi-Bojd, Esmaeil; Zhang, Li; Li, Qingjiang; Zhang, Yanlu; Xiong, Ye; Jiang, Quan] Henry Ford Hosp, Dept Neurol, B126,Educ & Res Bldg,2799 West Grand Blvd, Detroit, MI 48202 USA		Jiang, Q (corresponding author), Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA.; Jiang, Q (corresponding author), Henry Ford Hosp, Dept Neurol, B126,Educ & Res Bldg,2799 West Grand Blvd, Detroit, MI 48202 USA.	lli2@hfhs.org; MCHOPP1@hfhs.org; gding1@hfhs.org; EDAVOOD1@hfhs.org; LZhang3@hfhs.org; QLI1@hfhs.org; YZHANG2@hfhs.org; YXIONG1@hfhs.org; QJIANG1@hfhs.org		Li, Lian/0000-0003-0097-1184; Ding, Guangliang/0000-0003-1286-5901; jiang, quan/0000-0001-7908-4443	National Institutes of Health, United StatesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RF1 AG057494, RO1 NS108463]	This work was supported by National Institutes of Health, United States: RF1 AG057494 (Quan Jiang & Li Zhang), RO1 NS108463 (Quan Jiang).	Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Atighechi S, 2009, AM J RHINOL ALLERGY, V23, P409, DOI 10.2500/ajra.2009.23.3345; Benveniste H, 2019, GERONTOLOGY, V65, P106, DOI 10.1159/000490349; Benveniste H, 2017, ANESTHESIOLOGY, V127, P976, DOI 10.1097/ALN.0000000000001888; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Christensen J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63022-7; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Davoodi-Bojd E, 2019, NEUROIMAGE, V188, P616, DOI 10.1016/j.neuroimage.2018.12.039; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dillard C, 2017, DISABIL REHABIL, V39, P544, DOI 10.3109/09638288.2016.1152602; Ding GL, 2018, J NEUROSCI RES, V96, P1876, DOI 10.1002/jnr.24325; Ettenhofer ML, 2020, ANN CLIN TRANSL NEUR, V7, P507, DOI 10.1002/acn3.51020; Ettenhofer ML, 2016, J NEUROPSYCH CLIN N, V28, P223, DOI 10.1176/appi.neuropsych.15100243; Gaberel T, 2014, STROKE, V45, P3092, DOI 10.1161/STROKEAHA.114.006617; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hadjihambi A, 2019, J HEPATOL, V70, P40, DOI 10.1016/j.jhep.2018.08.021; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Jiang Q, 2017, J CEREBR BLOOD F MET, V37, P1326, DOI 10.1177/0271678X16654702; Johnston Miles, 2004, Cerebrospinal Fluid Res, V1, P2, DOI 10.1186/1743-8454-1-2; Kaminski M, 2012, J LEUKOCYTE BIOL, V92, P31, DOI 10.1189/jlb.0511241; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Lange RT, 2019, J CLIN EXP NEUROPSYC, V41, P497, DOI 10.1080/13803395.2019.1585518; Lee H, 2018, MAGN RESON MED, V79, P1568, DOI 10.1002/mrm.26779; Lee HD, 2015, J NEUROSCI, V35, P11034, DOI 10.1523/JNEUROSCI.1625-15.2015; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Mestre H, 2020, SCIENCE, V367, P1211, DOI 10.1126/science.aax7171; Nagra G, 2006, AM J PHYSIOL-REG I, V291, pR1383, DOI 10.1152/ajpregu.00235.2006; Norwood JN, 2019, ELIFE, V8, DOI 10.7554/eLife.44278; Peng WG, 2016, NEUROBIOL DIS, V93, P215, DOI 10.1016/j.nbd.2016.05.015; Piantino J, 2019, CURR PAIN HEADACHE R, V23, DOI 10.1007/s11916-019-0799-4; Plog BA, 2018, ANNU REV PATHOL-MECH, V13, P379, DOI 10.1146/annurev-pathol-051217-111018; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Proskynitopoulos Phileas J, 2016, Surg Neurol Int, V7, pS263, DOI 10.4103/2152-7806.181981; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shetty T, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00836; Swann IJ, 2006, EMERG MED J, V23, P618, DOI 10.1136/emj.2005.029017; Wang MH, 2017, J NEUROSCI, V37, P2870, DOI 10.1523/JNEUROSCI.2112-16.2017; Yousem DM, 1999, ACAD RADIOL, V6, P264, DOI 10.1016/S1076-6332(99)80449-8; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhang YL, 2018, J NEUROSURG, V129, P1295, DOI 10.3171/2017.6.JNS171007; Zhang YL, 2019, NEUROREHAB NEURAL RE, V33, P15, DOI 10.1177/1545968318809916	50	5	5	2	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 15	2020	1747								147062	10.1016/j.brainres.2020.147062			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NR3EY	WOS:000571446800002	32818526				2022-02-06	
J	Howe, EI; Fure, SCR; Lovstad, M; Enehaug, H; Sagstad, K; Hellstrom, T; Brunborg, C; Roe, C; Nordenmark, TH; Soberg, HL; Twamley, E; Lu, J; Andelic, N				Howe, Emilie Isager; Fure, Silje C. R.; Lovstad, Marianne; Enehaug, Heidi; Sagstad, Kjersti; Hellstrom, Torgeir; Brunborg, Cathrine; Roe, Cecilie; Nordenmark, Tonje Haug; Soberg, Helene L.; Twamley, Elizabeth; Lu, Juan; Andelic, Nada			Effectiveness of Combining Compensatory Cognitive Training and Vocational Intervention vs. Treatment as Usual on Return to Work Following Mild-to-Moderate Traumatic Brain Injury: Interim Analysis at 3 and 6 Month Follow-Up	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; randomized controlled trial; return to work; cognitive remediation; vocational rehabilitation	HEAD-INJURY; EMPLOYMENT; PEOPLE; PREDICTORS; DISABILITY; VETERANS; COGSMART	Aims: Knowledge regarding the most effective return to work (RTW) approaches after traumatic brain injury (TBI) is lacking. This trial aimed to compare the effectiveness of a combined cognitive and vocational intervention to treatment as usual (TAU) on RTW and work stability after TBI. Methods: We performed a parallel-group randomized controlled trial (RCT) at a TBI outpatient clinic at Oslo University Hospital (OUH), Norway. Patients with a history of mild-to-moderate TBI (n = 116) aged 18-60 were randomized (1:1) by an independent investigator to receive group-based compensatory cognitive training (CCT) and supported employment (SE) (n = 60) or TAU consisting of individualized multidisciplinary treatment (n = 56). Participants were enrolled 2-3 months post-injury. The nature of the intervention prevented blinding of patients and therapists, however, outcome assessors were blinded to group allocation. The primary outcome measure was RTW at 3 and 6 months following study inclusion. Secondary outcomes were work percentage, stability, and productivity. The present study provides results from an interim analysis from the first two planned follow ups, while subsequent publications will present results up to 12 months following study inclusion. Results: Mixed effects models showed no between-group differences in the RTW proportion, work percentage, and hours worked between CCT-SE and TAU from baseline to 6 months. A significantly higher proportion of participants in CCT-SE had returned to work at 3 months when adjusting for baseline differences. The majority of participants who were employed at 3 and 6 months were stably employed. There was a statistically significant within-group improvement on RTW proportion, hours worked and work percentage in both groups. Conclusion: The results revealed no difference between CCT-SE and TAU on work-related outcomes from baseline to 6 months. However, there was a higher RTW proportion in the CCT-SE group compared to TAU at 3 months. Future publications will assess the effectiveness of CCT-SE vs. TAU up to 12 months.	[Howe, Emilie Isager; Fure, Silje C. R.; Hellstrom, Torgeir; Roe, Cecilie; Nordenmark, Tonje Haug; Soberg, Helene L.; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Howe, Emilie Isager; Roe, Cecilie] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Fure, Silje C. R.; Lu, Juan; Andelic, Nada] Univ Oslo, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Oslo, Norway; [Lovstad, Marianne] Sunnaas Rehabil Hosp Trust, Dept Res, Nesoddtangen, Norway; [Lovstad, Marianne; Nordenmark, Tonje Haug] Univ Oslo, Dept Psychol, Oslo, Norway; [Enehaug, Heidi] Oslo Metropolitan Univ, Work Res Inst, Oslo, Norway; [Sagstad, Kjersti] Norwegian Labour & Welf Adm, Dept Vocat Rehabil, Oslo, Norway; [Brunborg, Cathrine] Oslo Univ Hosp, Res Support Serv, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Soberg, Helene L.] Oslo Metropolitan Univ, Fac Hlth Sci, Oslo, Norway; [Twamley, Elizabeth] Vet Affairs VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Twamley, Elizabeth] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Lu, Juan] Virginia Commonwealth Univ, Div Epidemiol, Dept Family Med & Populat Hlth, Richmond, VA USA		Howe, EI (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.; Howe, EI (corresponding author), Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway.	emilie.howe@medisin.uio.no	Hellstrom, Torgeir/AAW-4301-2021; Hellstrom, Torgeir/AAY-6043-2021	Hellstrom, Torgeir/0000-0003-0831-3274; Fure, Silje Christine Reistad/0000-0001-7926-6298; Lu, Juan/0000-0002-5389-7603	Research Council of NorwayResearch Council of Norway [256689/H10]	This research was funded by The Research Council of Norway, Grant No. 256689/H10.	Alves DE, 2020, OCCUP ENVIRON MED, V77, P122, DOI 10.1136/oemed-2019-106102; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Becker D. R., 2003, WORKING LIFE PEOPLE; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; de Koning ME, 2017, NEUROLOGY, V89, P1908, DOI 10.1212/WNL.0000000000004604; Graham CW., 2016, CAMPBELL SYST REV, V12, DOI [10.4073/csr.2016.6, DOI 10.4073/CSR.2016.6]; Holm I, 2003, SPINE, V28, P828, DOI 10.1097/00007632-200304150-00017; HOWE EI, 2019, COGENT MED, P00001, DOI DOI 10.1080/2331205X.2019.1565614; Howe EI, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2218-7; Johansson P, 2005, J PUBLIC ECON, V89, P1879, DOI 10.1016/j.jpubeco.2004.11.007; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Man DWK, 2013, BRAIN INJURY, V27, P1016, DOI 10.3109/02699052.2013.794969; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Orman JA, 2011, TXB TRAUMATIC BRAIN, V2nd, P3; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Reme SE, 2019, SCAND J WORK ENV HEA, V45, P33, DOI 10.5271/sjweh.3753; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Scaratti C, 2017, DISABIL REHABIL, V39, P847, DOI 10.3109/09638288.2016.1162854; Scheenen ME, 2017, J NEUROTRAUM, V34, P2713, DOI 10.1089/neu.2016.4885; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Silverberg ND, 2018, ARCH PHYS MED REHAB, V99, P250, DOI 10.1016/j.apmr.2017.07.006; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Twamley EW, 2015, J HEAD TRAUMA REHAB, V30, P391, DOI 10.1097/HTR.0000000000000076; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2016, DISABIL REHABIL, V38, P62, DOI 10.3109/09638288.2015.1017057; Vikane E, 2017, BRAIN INJURY, V31, P475, DOI 10.1080/02699052.2017.1280852; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wehman PH, 2017, PHYS MED REH CLIN N, V28, P351, DOI 10.1016/j.pmr.2016.12.010; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Winter L, 2016, BRAIN INJURY, V30, P373, DOI 10.3109/02699052.2016.1144080	47	5	5	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 10	2020	11								561400	10.3389/fneur.2020.561400			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OU8ZN	WOS:000591813200001	33240196	gold, Green Published			2022-02-06	
J	Zhang, YZ; Xu, CB; Nan, Y; Nan, SJ				Zhang, Yizhi; Xu, Chengbi; Nan, Yi; Nan, Shanji			Microglia-Derived Extracellular Vesicles Carrying miR-711 Alleviate Neurodegeneration in a Murine Alzheimer's Disease Model by Binding to Itpkb	FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY			English	Article						extracellular vesicles; microRNA-711; Alzheimer&#8217; s disease; Itpkb; Tau; microglia	ASSOCIATION; EXPRESSION; BRAIN	Neurodegeneration in Alzheimer's disease (AD) results in microglial activation, which may participate in the inflammatory cascade accelerating tissue damage. In this study, we sought to characterize the alleviatory role of microRNA-711 (miR-711) encapsulated in microglia-derived extracellular vesicles (EVs) in a model of AD. Ultracentrifugation was employed to extract EVs from microglia (BV2 cells), which were identified using Western blot analysis of the EVs marker proteins Alix and CD63. A repetitive mild traumatic brain injury (rmTBI) mouse model was induced by controlled cortical impact. After overexpressing miR-711 or 1,4,5-trisphosphate 3-kinase B (Itpkb) in BV2 cells, we evaluated the inflammation in BV2 cells and the ratio of microglia M2/M1. Further, we injected BV2 cell-secreted EVs with overexpressed miR-711 or Itpkb into rmTBI mice through a tail vein to investigate the inflammation markers in mouse serum and, the M2/M1 phenotype ratio of microglia in brain tissues, and to evaluate neurological deficit and cognitive function. The EVs obtained by ultracentrifugation were verified by the presence of Alix and CD63 expression. Mechanistic studies suggested that miR-711 targeted and inhibited Itpkb, thereby repressing Tau phosphorylation and increasing the ratio of M2/M1. Furthermore, miR-711-containing EVs reduced the score of neurological deficits and improved cognitive function in rmTBI mice. The administration of microglia-derived EVs loaded with miR-711, which mediated the hyperphosphorylation of Tau protein in the Itpkb pathway, effectively alleviated neurodegenerative changes and cognitive dysfunction in AD.	[Zhang, Yizhi; Nan, Shanji] Second Hosp Jilin Univ, Dept Neurol, Changchun, Peoples R China; [Xu, Chengbi] Second Hosp Jilin Univ, Dept Otolaryngol Head & Neck Surg, Changchun, Peoples R China; [Nan, Yi] Ningxia Med Univ, Coll Tradit Chinese Med, Yinchuan, Ningxia, Peoples R China		Nan, SJ (corresponding author), Second Hosp Jilin Univ, Dept Neurol, Changchun, Peoples R China.	nanshanji@126.com					Andrews SJ, 2020, LANCET NEUROL, V19, P326, DOI 10.1016/S1474-4422(19)30435-1; Brites D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00476; Chen O, 2020, CURR OPIN NEUROBIOL, V62, P17, DOI 10.1016/j.conb.2019.11.006; Cortes-Canteli M, 2020, J AM COLL CARDIOL, V75, P942, DOI 10.1016/j.jacc.2019.10.062; Crehan Helen, 1800, Int J Alzheimers Dis, V2012, P983640, DOI 10.1155/2012/983640; Franzmeier N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14159-1; Freilich RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079416; Gate D, 2020, NATURE, V577, P399, DOI 10.1038/s41586-019-1895-7; Ge XT, 2020, MOL THER, V28, P503, DOI 10.1016/j.ymthe.2019.11.017; Guedes JR, 2014, HUM MOL GENET, V23, P6286, DOI 10.1093/hmg/ddu348; Hill AF, 2019, J NEUROSCI, V39, P9269, DOI 10.1523/JNEUROSCI.0147-18.2019; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Muraoka S, 2020, ALZHEIMERS DEMENT, V16, P896, DOI 10.1002/alz.12089; Paolicelli RC, 2019, NEUROSCIENCE, V405, P148, DOI 10.1016/j.neuroscience.2018.04.003; Perrotte M, 2020, NEUROBIOL AGING, V86, P102, DOI 10.1016/j.neurobiolaging.2019.10.010; Plastira I, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0701-9; Rawlinson C, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10030159; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Saetre P, 2011, SYNAPSE, V65, P971, DOI 10.1002/syn.20933; Salta E, 2016, EMBO MOL MED, V8, P1005, DOI 10.15252/emmm.201606520; Semba RD, 2020, ADV NUTR, V11, P760, DOI 10.1093/advances/nmaa024; Stygelbout V, 2014, BRAIN, V137, P537, DOI 10.1093/brain/awt344; Surgucheva I, 2012, BIOCHEMISTRY-US, V51, P4743, DOI 10.1021/bi300478w; Tesovnik T, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00202; Uddin MS, 2020, AGEING RES REV, V60, DOI 10.1016/j.arr.2020.101046; Upadhya R, 2020, J CONTROL RELEASE, V323, P225, DOI 10.1016/j.jconrel.2020.04.017; Xia CJ, 2017, JAMA NEUROL, V74, P427, DOI 10.1001/jamaneurol.2016.5755; Yang YY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1204-7; Zheng J, 2020, CELL STEM CELL, V26, P331, DOI 10.1016/j.stem.2019.12.015	30	5	5	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-634X			FRONT CELL DEV BIOL	Front. Cell. Dev. Biol.	NOV 6	2020	8								566530	10.3389/fcell.2020.566530			12	Cell Biology; Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Developmental Biology	OT0DS	WOS:000590525900001	33240878	gold, Green Published			2022-02-06	
J	Sawant-Pokam, PA; Vail, TJ; Metcalf, CS; Maguire, JL; McKean, TO; McKean, NO; Brennan, KC				Sawant-Pokam, Punam A.; Vail, Tyler J.; Metcalf, Cameron S.; Maguire, Jamie L.; McKean, Thomas O.; McKean, Nick O.; Brennan, K. C.			Preventing neuronal edema increases network excitability after traumatic brain injury	JOURNAL OF CLINICAL INVESTIGATION			English	Article							CORTICAL SPREADING DEPRESSION; CATION-CHLORIDE COTRANSPORTERS; CEREBRAL EDEMA; EPILEPTIFORM ACTIVITY; PYRAMIDAL NEURONS; UP-REGULATION; SEIZURES; MODEL; MECHANISMS; DEPOLARIZATION	Edema is an important target for clinical intervention after traumatic brain injury (TBI). We used in vivo cellular resolution imaging and electrophysiological recording to examine the ionic mechanisms underlying neuronal edema and their effects on neuronal and network excitability after controlled cortical impact (CCI) in mice. Unexpectedly, we found that neuronal edema 48 hours after CCI was associated with reduced cellular and network excitability, concurrent with an increase in the expression ratio of the cation-chloride cotransporters (CCCs) NKCC1 and KCC2. Treatment with the CCC blocker bumetanide prevented neuronal swelling via a reversal in the NKCC1/KCC2 expression ratio, identifying altered chloride flux as the mechanism of neuronal edema. Importantly, bumetanide treatment was associated with increased neuronal and network excitability after injury, including increased susceptibility to spreading depolarizations (Os) and seizures, known agents of clinical worsening after TBI. Treatment with mannitol, a first-line edema treatment in clinical practice, was also associated with increased susceptibility to SDs and seizures after CCI, showing that neuronal volume reduction, regardless of mechanism, was associated with an excitability increase. Finally, we observed an increase in excitability when neuronal edema normalized by 1 week after CCI. We conclude that neuronal swelling may exert protective effects against damaging excitability in the aftermath of TBI and that treatment of edema has the potential to reverse these effects.	[Sawant-Pokam, Punam A.; Vail, Tyler J.; McKean, Thomas O.; McKean, Nick O.; Brennan, K. C.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Metcalf, Cameron S.] Univ Utah, Coll Pharm, Dept Pharmacol & Toxicol, Anticonvulst Drug Dev Program, Salt Lake City, UT USA; [Maguire, Jamie L.] Tufts Univ, Sch Med, Neurosci Dept, Boston, MA 02111 USA		Sawant-Pokam, PA; Brennan, KC (corresponding author), Dept Neurol, 383 Colorow Dr Room 280A, Salt Lake City, UT 84108 USA.	punam.pokam@utah.edu; k.c.brennan@hsc.utah.edu		Vail, Tyler/0000-0003-1706-9533; Brennan, K.C./0000-0003-4193-5841	United States Department of DefenseUnited States Department of Defense [CDMRP PR 130373]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS085413]	We would like to thank our laboratory colleagues for valuable comments and suggestions. This work was supported by the United States Department of Defense (CDMRP PR 130373) and the NIH (R01NS085413).	AVOLI M, 1991, ANN NEUROL, V30, P589, DOI 10.1002/ana.410300412; Bahari F, 2018, POSTED BIORXIV, DOI [10.1101/455519., DOI 10.1101/455519]; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Brandt C, 2010, J NEUROSCI, V30, P8602, DOI 10.1523/JNEUROSCI.0633-10.2010; Brennan KC, 2007, ANN NEUROL, V61, P603, DOI 10.1002/ana.21138; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chamma I, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00005; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; DUDEK FE, 1990, NEUROSCI LETT, V120, P267, DOI 10.1016/0304-3940(90)90056-F; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Glykys J, 2019, NEUROBIOL DIS, V125, P163, DOI 10.1016/j.nbd.2019.01.024; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; Glykys J, 2017, TRENDS NEUROSCI, V40, P276, DOI 10.1016/j.tins.2017.03.006; Gorji A, 2004, EUR J NEUROSCI, V19, P3371, DOI 10.1111/j.0953-816X.2004.03436.x; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Halabisky B, 2010, J NEUROPHYSIOL, V104, P2214, DOI 10.1152/jn.00147.2010; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hanell A, 2015, J NEUROTRAUM, V32, P1590, DOI 10.1089/neu.2014.3592; Hartings JA, 2017, CURR OPIN CRIT CARE, V23, P94, DOI 10.1097/MCC.0000000000000395; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; Hui H, 2016, NEUROCHEM INT, V94, P23, DOI 10.1016/j.neuint.2016.02.002; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; Jha S K, 2003, Med J Armed Forces India, V59, P326, DOI 10.1016/S0377-1237(03)80147-8; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kaufmann D, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00294; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Khoshkhoo S, 2017, NEURON, V93, P291, DOI 10.1016/j.neuron.2016.11.043; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; KOROLEVA VI, 1983, EXP BRAIN RES, V51, P291, DOI 10.1007/BF00237205; Kourdougli N, 2017, ANN NEUROL, V81, P251, DOI 10.1002/ana.24870; Lafrenaye AD, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020330; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Loscher W, 2013, NEUROPHARMACOLOGY, V69, P62, DOI 10.1016/j.neuropharm.2012.05.045; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Lu KT, 2006, EUR J PHARMACOL, V548, P99, DOI 10.1016/j.ejphar.2006.07.048; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; MacAulay N, 2010, NEUROSCIENCE, V168, P941, DOI 10.1016/j.neuroscience.2009.09.016; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; Mongiat LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005320; Neske GT, 2016, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00088; Neske GT, 2015, J NEUROSCI, V35, P1089, DOI 10.1523/JNEUROSCI.2279-14.2015; Otto JF, 2009, EPILEPSIA, V50, P1752, DOI 10.1111/j.1528-1167.2009.02100.x; Otto JE, 2004, EPILEPSIA, V45, P1009, DOI 10.1111/j.0013-9580.2004.65703.x; Petersen CCH, 2013, NEURON, V78, P28, DOI 10.1016/j.neuron.2013.03.020; Pietrobon D, 2014, NAT REV NEUROSCI, V15, P379, DOI 10.1038/nrn3770; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Pratt J, 1999, NEUROSCI LETT, V272, P143, DOI 10.1016/S0304-3940(99)00005-1; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Rao VR, 2015, SEMIN NEUROL, V35, P57, DOI 10.1055/s-0035-1544239; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Sanchez-Vives MV, 2010, J NEUROPHYSIOL, V104, P1314, DOI 10.1152/jn.00178.2010; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sawant-Pokam PM, 2017, CEREB CORTEX, V27, P1311, DOI 10.1093/cercor/bhv328; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scholl EA, 2013, NEUROSCIENCE, V252, P45, DOI 10.1016/j.neuroscience.2013.07.045; Shah S, 2016, SEMIN NEUROL, V36, P502, DOI 10.1055/s-0036-1592109; Sivakumaran S, 2016, EPILEPSIA, V57, P222, DOI 10.1111/epi.13270; Sooksawate T, 2005, NEUROSCI RES, V52, P174, DOI 10.1016/j.neures.2005.03.007; STERIADE M, 1993, J NEUROSCI, V13, P3284; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Theriot JJ, 2012, J NEUROSCI, V32, P15252, DOI 10.1523/JNEUROSCI.2092-12.2012; Topfer M, 2014, EUR J NEUROSCI, V39, P673, DOI 10.1111/ejn.12424; VANHARREVELD A, 1953, J NEUROPHYSIOL, V16, P352, DOI 10.1152/jn.1953.16.4.352; Vella J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00108; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; Wang FS, 2017, BRAIN STRUCT FUNCT, V222, P1543, DOI 10.1007/s00429-016-1292-z; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Watts LT, 2013, J NEUROTRAUM, V30, P55, DOI 10.1089/neu.2012.2488; Wilson Charles, 2008, Scholarpedia J, V3, P1410; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	87	5	5	2	3	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	NOV 2	2020	130	11					6005	6020		10.1172/JCI134793			16	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	OO5JD	WOS:000587413700036	33044227	Green Published, Bronze			2022-02-06	
J	Carroll, EL; Manktelow, AE; Outtrim, JG; Chatfield, D; Forsyth, F; Hutchinson, PJA; Tenovuo, O; Posti, JP; Wilson, L; Sahakian, BJ; Menon, DK; Newcombe, VFJ				Carroll, Ellen L.; Manktelow, Anne E.; Outtrim, Joanne G.; Chatfield, Doris; Forsyth, Faye; Hutchinson, Peter J. A.; Tenovuo, Olli; Posti, Jussi P.; Wilson, Lindsay; Sahakian, Barbara J.; Menon, David K.; Newcombe, Virginia F. J.			Influence of Concomitant Extracranial Injury on Functional and Cognitive Recovery From Mild Versus Moderate to Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury severity; depression; extracranial injury; GOSE; multiple trauma; neurocognitive function; quality of life; traumatic brain injury	HEAD-INJURY; IMPAIRMENTS	Objective: To determine the effect of extracranial injury (ECI) on 6-month outcome in patients with mild traumatic brain injury (TBI) versus moderate-to-severe TBI. Participants/Setting: Patients with TBI (n = 135) or isolated orthopedic injury (n = 25) admitted to a UK major trauma center and healthy volunteers (n = 99). Design: Case-control observational study. Main Measures: Primary outcomes: (a) Glasgow Outcome Scale Extended (GOSE), (b) depression, (c) quality of life (QOL), and (d) cognitive impairment including verbal fluency, episodic memory, short-term recognition memory, working memory, sustained attention, and attentional flexibility. Results: Outcome was influenced by both TBI severity and concomitant ECI. The influence of ECI was restricted to mild TBI; GOSE, QOL, and depression outcomes were significantly poorer following moderate-to-severe TBI than after isolated mild TBI (but not relative to mild TBI plus ECI). Cognitive impairment was driven solely by TBI severity. General health, bodily pain, semantic verbal fluency, spatial recognition memory, working memory span, and attentional flexibility were unaffected by TBI severity and additional ECI. Conclusion: The presence of concomitant ECI ought to be considered alongside brain injury severity when characterizing the functional and neurocognitive effects of TBI, with each presenting challenges to recovery.	[Carroll, Ellen L.; Manktelow, Anne E.; Outtrim, Joanne G.; Chatfield, Doris; Forsyth, Faye; Menon, David K.; Newcombe, Virginia F. J.] Univ Cambridge, Univ Div Anaesthesia, Dept Med, Cambridge, England; [Hutchinson, Peter J. A.] Univ Cambridge, Acad Dept Neurosurg, Dept Clin Neurosci, Cambridge, England; [Sahakian, Barbara J.; Menon, David K.; Newcombe, Virginia F. J.] Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge, England; [Sahakian, Barbara J.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Sahakian, Barbara J.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Tenovuo, Olli; Posti, Jussi P.] Univ Turku, Turku Brain Injury Ctr, Turku, Finland; [Tenovuo, Olli; Posti, Jussi P.] Turku Univ Hosp, Turku, Finland; [Posti, Jussi P.] Turku Univ Hosp, Dept Neurosurg, Turku, Finland; [Wilson, Lindsay] Univ Stirling, Div Psychol, Stirling, Scotland		Newcombe, VFJ (corresponding author), Addenbrookes Hosp, Div Anaesthesia, Box 93,Hills Rd, Cambridge CB2 0QQ, England.	vfjn2@cam.ac.uk	Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193; Newcombe, Virginia/0000-0001-6044-9035; Forsyth, Faye/0000-0003-2107-3690	Medical Research Council (MRC, United Kingdom) Program Grant (Acute Brain Injury: Heterogeneity of Mechanisms, Therapeutic Targets) [G9439390 ID 65883]; European CommissionEuropean CommissionEuropean Commission Joint Research Centre [FP7-270259-TBIcare]; UK National Institute of Health Research (NIHR) Biomedical Research Centre at Cambridge; UK Department of Health; Engineering and Physical Sciences Research Council (EPSRC, United Kingdom) Pathways to Impact award; Academy of Finland-grantAcademy of Finland [17379]; Emil Aaltonen Foundation; Finnish Brain Foundation; Maire Taponen Foundation; NIHR Brain Injury MedTech Co-operative, Cambridge; NIHR Cambridge Biomedical Research Centre (Mental Health Theme); NIHR through the NIHR Cambridge Biomedical Research Centre grant - Health Foundation/Academy of Medical Sciences Clinician Scientist Fellowship; UK National Institute of Health Research (NIHR) Biomedical Research Centre at Cambridge, the Technology Platform; NIHRNational Institute for Health Research (NIHR); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390] Funding Source: UKRI	This work was partially funded by aMedical Research Council (MRC, United Kingdom) Program Grant (Acute Brain Injury: Heterogeneity of Mechanisms, Therapeutic Targets and Outcome Effects [G9439390 ID 65883]), the European Commission under the 7th Framework Programme (FP7-270259-TBIcare), the UK National Institute of Health Research (NIHR) Biomedical Research Centre at Cambridge, the Technology Platform funding provided by the UK Department of Health, and an Engineering and Physical Sciences Research Council (EPSRC, United Kingdom) Pathways to Impact award. P.J.A.H. was supported by theNIHR (Research Professorship and Cambridge BRC). J.P.P. received funding from Academy of Finland-grant #17379, Government's Special Financial Transfer tied to academic research in Health Sciences (Finland), the Emil Aaltonen Foundation, the Finnish Brain Foundation, and the Maire Taponen Foundation. B.J.S. receives funding from the NIHR Brain Injury MedTech Co-operative, Cambridge, and the NIHR Cambridge Biomedical Research Centre (Mental Health Theme). D.K.M. was supported by the NIHR through the NIHR Cambridge Biomedical Research Centre grant and a Senior Investigator Award. V.F.J.N. was funded by a Health Foundation/Academy of Medical Sciences Clinician Scientist Fellowship.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BECHTOLDT HP, 1962, PSYCHOL REC, V12, P147, DOI 10.1007/BF03393452; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Findler M, 2009, BRAIN INJURY, V15, P715; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas Andrew I R, 2012, Front Neurol, V3, P173, DOI 10.3389/fneur.2012.00173; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; Sun MJ, 2018, BRAIN BEHAV IMMUN, V69, P618, DOI 10.1016/j.bbi.2018.01.007; TEASDALE G, 1974, LANCET, V2, P81; TOMBAUGH TN, 1999, ARCH CLIN NEUROPSYCO, V14, P2; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Weckbach S, 2013, J TRAUMA ACUTE CARE, V74, P489, DOI 10.1097/TA.0b013e31827d5f1b; Wilde EA, 2019, J NEUROTRAUM, V36, P239, DOI 10.1089/neu.2017.5513; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	36	5	5	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2020	35	6			SI		E513	E523		10.1097/HTR.0000000000000575			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OP5PJ	WOS:000588138300014	32472833				2022-02-06	
J	Forcione, M; Yakoub, KM; Chiarelli, AM; Perpetuini, D; Merla, A; Sun, RS; Sawosz, P; Belli, A; Davies, DJ				Forcione, Mario; Yakoub, Kamal Makram; Chiarelli, Antonio Maria; Perpetuini, David; Merla, Arcangelo; Sun, Rosa; Sawosz, Piotr; Belli, Antonio; Davies, David James			Dynamic contrast-enhanced near-infrared spectroscopy using indocyanine green on moderate and severe traumatic brain injury: a prospective observational study	QUANTITATIVE IMAGING IN MEDICINE AND SURGERY			English	Article						Near-infrared spectroscopy (NIRS); traumatic brain injury (TBI); indocyanine green (ICG); cerebral perfusion; blood-brain barrier (BBB)	ACUTE ISCHEMIC-STROKE; CEREBRAL PERFUSION; DECOMPRESSIVE CRANIECTOMY; SPECTRAL STABILIZATION; TOMOGRAPHY; VALUES; TRIAL; BOLUS; ICG	Background: The care given to moderate and severe traumatic brain injury (TBI) patients may be hampered by the inability to tailor their treatments according to their neurological status. Contrast-enhanced near-infrared spectroscopy (NIRS) with indocyanine green (ICG) could be a suitable neuromonitoring tool. Methods: Monitoring the effective attenuation coefficients (EAC), we compared the ICG kinetics between five TBI and five extracranial trauma patients, following a venous-injection of 5 mL of 1 mg/mL ICG, using two commercially available NIRS devices. Results: A significantly slower passage of the dye through the brain of the TBI group was observed in two parameters related to the first ICG inflow into the brain (P=0.04; P=0.01). This is likely related to the reduction of cerebral perfusion following TBI. Significant changes in ICG optical properties minutes after injection (P=0.04) were registered. The acquisition of valid optical data in a clinical environment was challenging. Conclusions: Future research should analyze abnormalities in the ICG kinetic following brain trauma, test how these values can enhance care in TBI, and adapt the current optical devices to clinical settings. Also, studies on the pattern in changes of ICG optical properties after venous injection can improve the accuracy of the values detected.	[Forcione, Mario; Yakoub, Kamal Makram; Sun, Rosa; Belli, Antonio; Davies, David James] Univ Hosp Birmingham NHS Fdn Trust, Natl Inst Hlth Res Surg Reconstruct & Microbiol R, Mindelsohn Way, Birmingham, W Midlands, England; [Forcione, Mario; Belli, Antonio; Davies, David James] Univ Birmingham, Neurosci & Ophthalmol Res Grp, Inst Inflammat & Ageing, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Chiarelli, Antonio Maria; Perpetuini, David; Merla, Arcangelo] Univ G dAnnunzio, Inst Adv Biomed Technol, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Sawosz, Piotr] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Trojdena 4, Warsaw, Poland		Forcione, M (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Mindelsohn Way, Birmingham B15 2TH, W Midlands, England.	mxf610@student.bham.ac.uk	Belli, Antonio/I-3799-2015	Belli, Antonio/0000-0002-3211-9933; Sawosz, Piotr/0000-0002-0697-3036	project "Brain Injury and Trauma Monitoring Using Advanced Photonics" - European Union Horizon 2020 Research and Innovation Program, under the National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR SRMRC) [675332]; Polish National Science Centre, Poland [2016/21/D/ST7/03454]	This article presents independent research funded by the project "Brain Injury and Trauma Monitoring Using Advanced Photonics", financed by the European Union Horizon 2020 Research and Innovation Program, under grant agreement 675332, through the National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR SRMRC), partnership between University Hospitals Birmingham NHS Foundation Trust, the University of Birmingham, and the Royal Centre for Defence Medicine. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. This work was also partially supported by Polish National Science Centre, Poland within the project number 2016/21/D/ST7/03454.	Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bigio IJ, 2016, CAMBRIDGE TEXTS BIOM; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chiarelli AM, 2019, PHOTONICS-BASEL, V6, DOI 10.3390/photonics6030079; Chiarelli AM, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.2.021103; Chiarelli AM, 2019, NEUROPHOTONICS, V6, DOI 10.1117/1.NPh.6.3.035005; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cuenod C A, 2013, Diagn Interv Imaging, V94, P1187, DOI 10.1016/j.diii.2013.10.010; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Desmettre T, 2000, SURV OPHTHALMOL, V45, P15, DOI 10.1016/S0039-6257(00)00123-5; Ergin A, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.057008; FANTINI S, 1994, APPL OPTICS, V33, P5204, DOI 10.1364/AO.33.005204; Forcione M, 2020, J CEREBR BLOOD F MET, V40, P1586, DOI 10.1177/0271678X20921973; Ganau Laura, 2018, Medicines (Basel), V5, DOI 10.3390/medicines5010022; Ganau M, 2013, MINERVA ANESTESIOL, V79, P310; Ganau Mario, 2018, Medicines (Basel), V5, DOI 10.3390/medicines5010019; GENEVE J, 1990, BRIT J CLIN PHARMACO, V30, P297, DOI 10.1111/j.1365-2125.1990.tb03779.x; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hazeldine J, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002338; HOPEROSS M, 1994, OPHTHALMOLOGY, V101, P529; Hopton P, 1999, J APPL PHYSIOL, V87, P1981, DOI 10.1152/jappl.1999.87.5.1981; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Katzung B. G., 2015, BASIC CLIN PHARM; LANDSMAN MLJ, 1976, J APPL PHYSIOL, V40, P575, DOI 10.1152/jappl.1976.40.4.575; Lee SS, 2020, QUANT IMAG MED SURG, V10, P779, DOI 10.21037/qims.2020.02.24; Liebert A, 2005, NEUROIMAGE, V24, P426, DOI 10.1016/j.neuroimage.2004.08.046; Liebert A, 2013, IEEE ENG MED BIO, P3040, DOI 10.1109/EMBC.2013.6610181; Milej D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01922-x; Moore EE, 2017, TRAUMA; MUCKLE TJ, 1976, BIOCHEM MED METAB B, V15, P17, DOI 10.1016/0006-2944(76)90069-7; Mudra R, 2008, OPTO-ELECTRON REV, V16, P297, DOI 10.2478/s11772-008-0027-y; O'Connor JPB, 2011, BRIT J RADIOL, V84, pS112, DOI 10.1259/bjr/55166688; Prisco L, 2012, J NEUROSURG SCI, V56, P131; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Scholkmann F, 2018, ADV EXP MED BIOL, V1072, P325, DOI 10.1007/978-3-319-91287-5_52; Shu X, 2019, QUANT IMAG MED SURG, V9, P769, DOI 10.21037/qims.2019.05.01; Steinkellner O, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3505009; Suzuki S, 1999, BIOS 99 INT BIOM OPT; Terborg C, 2004, J NEUROL NEUROSUR PS, V75, P38; Terborg C, 2009, EUR NEUROL, V62, P338, DOI 10.1159/000239794; TRIPP MR, 1973, P SOC EXP BIOL MED, V143, P879; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vos JJ, 2014, ANAESTHESIA, V69, P1364, DOI 10.1111/anae.12755; Wang YG, 2013, QUANT IMAG MED SURG, V3, P132, DOI 10.3978/j.issn.2223-4292.2013.06.03; Wang YH, 2019, QUANT IMAG MED SURG, V9, P799, DOI 10.21037/qims.2019.05.02; Weigl W, 2014, NEUROIMAGE, V85, P555, DOI 10.1016/j.neuroimage.2013.06.065; Zhou JF, 1994, OE LASE 94	49	5	5	2	2	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2223-4292	2223-4306		QUANT IMAG MED SURG	Quant. Imaging Med. Surg.	NOV	2020	10	11					2085	2097		10.21037/qims-20-742			13	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	NT7GS	WOS:000573105100002	33139989	Green Published, gold			2022-02-06	
J	Garcia, GGP; Yang, J; Lavieri, MS; McAllister, TW; McCrea, MA; Broglio, SP				Garcia, Gian-Gabriel P.; Yang, Jing; Lavieri, Mariel S.; McAllister, Thomas W.; McCrea, Michael A.; Broglio, Steven P.		CARE Consortium Investigators	Optimizing Components of the Sport Concussion Assessment Tool for Acute Concussion Assessment	NEUROSURGERY			English	Article						Sports-related concussion; Sideline assessment	SEX-DIFFERENCES; HIGH-SCHOOL; SUBSET-SELECTION; NORMATIVE DATA; SYMPTOMS; BASE; CARE; RELIABILITY; REGRESSION; EDUCATION	BACKGROUND: The Sport Concussion Assessment Tool (SCAT) could be improved by identifying critical subsets that maximize diagnostic accuracy and eliminate low information elements. OBJECTIVE: To identify optimal SCAT subsets for acute concussion assessment. METHODS: Using Concussion Assessment, Research, and Education (CARE) Consortium data, we compared student-athletes' and cadets' preinjury baselines (n = 2178) with postinjury assessments within 6 h (n = 1456) and 24 to 48 h (n = 2394) by considering demographics, symptoms, Standard Assessment of Concussion (SAC), and Balance Error Scoring System (BESS) scores. We divided data into training/testing (60%/40%) sets. Using training data, we integrated logistic regression with an engineering methodology-mixed integer programming-to optimize models with <= 4, 8, 12, and 16 variables (Opt-k). We also created models including only raw scores (Opt-RS-k) and symptom, SAC, and BESS composite scores (summary scores). We evaluated models using testing data. RESULTS: At < 6 h and 24 to 48 h, most Opt-k and Opt-RS-k models included the following symptoms: do not feel right, headache, dizziness, sensitivity to noise, and whether physical or mental activity worsens symptoms. Opt-k models included SAC concentration and delayed recall change scores. Opt-k models had lower Brier scores (BS) and greater area under the curve (AUC) (<6 h: BS = 0.072-0.089, AUC = 0.95-0.96; 24-48 h: BS = 0.085-0.093, AUC = 0.94-0.95) than Opt-RS-k (< 6 h: BS = 0.082-0.087, AUC = 0.93-0.95; 24-48 h: BS = 0.095-0.099, AUC = 0.92-0.93) and summary score models (<6 h: BS = 0.14, AUC = 0.89; 24-48 h: BS = 0.15, AUC = 0.87). CONCLUSION: We identified SCAT subsets that accurately assess acute concussion and improve administration time over the complete battery, highlighting the importance of eliminating "noisy" elements. These findings can direct clinicians to the SCAT components that are most sensitive to acute concussion.	[Garcia, Gian-Gabriel P.; Yang, Jing; Lavieri, Mariel S.] Univ Michigan, Dept Ind & Operat Engn, 1205 Beal Ave, Ann Arbor, MI 48109 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg & Neurol, Milwaukee, WI 53226 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Sch Kinesiol, Ann Arbor, MI 48109 USA		Garcia, GGP (corresponding author), Univ Michigan, Dept Ind & Operat Engn, 1205 Beal Ave, Ann Arbor, MI 48109 USA.	garciagg@umich.edu		Chrisman, Sara/0000-0001-5373-7223			Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Ayvaci MUS, 2012, M&SOM-MANUF SERV OP, V14, P600, DOI 10.1287/msom.1110.0371; Bertsimas D, 2016, OPER RES, V64, P2, DOI 10.1287/opre.2015.1436; Bertsimas D, 2016, ANN STAT, V44, P813, DOI 10.1214/15-AOS1388; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown GG, 2010, INFORMS T ED, V7, P153; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Cevik M, 2018, PROD OPER MANAG, V27, P949, DOI 10.1111/poms.12842; Chen QS, 2018, OPER RES, V66, P673, DOI 10.1287/opre.2017.1706; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Deo S, 2015, OPER RES, V63, P287, DOI 10.1287/opre.2015.1353; Downey RI, 2018, BRAIN INJURY, V32, P1345, DOI 10.1080/02699052.2018.1484166; Echemendia RJ, 2017, BRIT J SPORT MED, V51, DOI DOI 10.1136/BJSPORTS-2017-097506; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Efron B., 1993, INTRO BOOTSTRAP; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Garcia GGP, 2019, J NEUROTRAUM, V36, P1571, DOI 10.1089/neu.2018.6098; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Lee EK, 2003, ANN OPER RES, V119, P165, DOI 10.1023/A:1022938707934; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Makdissi Michael, 2015, Neurol Clin Pract, V5, P2, DOI 10.1212/CPJ.0000000000000061; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2004, JAMA-J AM MED ASSOC, V290, P2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Newman Alexandra M., 2013, INFORMS Transactions on Education, V14, P26, DOI 10.1287/ited.2013.0115; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Putukian M, 2013, BRIT J SPORT MED, V47, P285, DOI 10.1136/bjsports-2013-092158; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Royston P, 2004, STATA J, V4, P224; Sato T, 2016, COMPUT OPTIM APPL, V64, P865, DOI 10.1007/s10589-016-9832-2; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	51	5	5	2	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	NOV	2020	87	5					971	981		10.1093/neuros/nyaa150			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	OW8HS	WOS:000593121200046	32433732				2022-02-06	
J	Kletzel, SL; Aaronson, AL; Guernon, A; Carbone, C; Chaudhry, N; Walsh, E; Conneely, M; Patil, V; Roth, E; Steiner, M; Pacheco, M; Rosenow, J; Pape, TLB				Kletzel, Sandra L.; Aaronson, Alexandra L.; Guernon, Ann; Carbone, Christina; Chaudhry, Noor; Walsh, Elyse; Conneely, Mark; Patil, Vijaya; Roth, Elliott; Steiner, Monica; Pacheco, Marilyn; Rosenow, Joshua; Pape, Theresa L. Bender			Safety Considerations for the Use of Transcranial Magnetic Stimulation as Treatment for Coma Recovery in People With Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						amantadine; disorders of consciousness; seizure; severe traumatic brain injury; transcranial magnetic stimulation	AMANTADINE; CORTEX; STATE; RTMS	Objective: For persons in states of disordered consciousness (DoC) after severe traumatic brain injury (sTBI), we report cumulative findings from safety examinations, including serious adverse events (AEs) of a repetitive transcranial magnetic stimulation (rTMS) parameter protocol in 2 different studies. Participants: Seven persons in states of DoC after sTBI with widespread neuropathology, but no large lesions in proximity to the site of rTMS. One participant had a ventriculoperitoneal shunt with programmable valve. Methods: Two clinical trials each providing 30 rTMS sessions to the right or left dorsolateral prefrontal cortex, involving 300 to 600 pulses over 1 or 2 sessions daily. One study provided concomitant amantadine. Safety indicators monitored related to sleep, temperature, blood pressure, skin integrity, sweating, weight loss, infections, and seizure. Results: Average changes for monitored indicators were of mild severity, with 75 nonserious AEs and 1 serious AE (seizure). The participant incurring a seizure resumed rTMS while taking antieplieptics without further seizure activity. Conclusions: Considering elevated risks for this patient population and conservative patient selection, findings indicate a relatively safe profile for the specified rTMS protocols; however, potential for seizure induction must be monitored. Future research for this population can be broadened to include patients previously excluded on the basis of profiles raising safety concerns.	[Kletzel, Sandra L.; Aaronson, Alexandra L.; Guernon, Ann; Chaudhry, Noor; Walsh, Elyse; Patil, Vijaya; Steiner, Monica; Pacheco, Marilyn; Pape, Theresa L. Bender] Edward Hines Jr VA Hosp, Dept Vet Affairs VA, Res Serv, Hines, IL USA; [Aaronson, Alexandra L.] Hines VA, Dept Vet Affairs Mental Hlth Serv Line, Hines, IL USA; [Guernon, Ann; Pape, Theresa L. Bender] Marianjoy Rehabil Hosp, Northwestern Med, Wheaton, IL USA; [Carbone, Christina] Battle Creek VA Med Ctr, Kalamazoo, MI USA; [Roth, Elliott; Rosenow, Joshua; Pape, Theresa L. Bender] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Rosenow, Joshua] Northwestern Univ, Feinberg Sch Med, Dept Neurosurg, Chicago, IL 60611 USA; [Rosenow, Joshua] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Aaronson, Alexandra L.; Pacheco, Marilyn] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Conneely, Mark] Rosalind Franklin Univ Sci & Med, Chicago Med Sch, N Chicago, IL USA; [Patil, Vijaya; Steiner, Monica] Loyola Univ, Stritch Sch Med, Maywood, IL 60153 USA; [Chaudhry, Noor] Univ Illinois, Chicago, IL USA		Pape, TLB (corresponding author), US Dept Vet Affairs, Rehabil Res & Dev Serv, MC 151H POB 5000, Hines, IL 60141 USA.	Theresa.BenderPape@va.gov			RRD VA [IK1 RX003082] Funding Source: Medline		Abbasivash R, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069518824851; American Academy of Neurology, 1995, PRACT PAR ASS MAN PA; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Pape TBL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.01027; Cincotta M, 2015, CORTEX, V71, P368, DOI 10.1016/j.cortex.2015.07.027; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Ghalaenovi H, 2018, BRAIN INJURY, V32, P1050, DOI 10.1080/02699052.2018.1476733; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Lefranc M, 2010, ACTA NEUROCHIR, V152, P689, DOI 10.1007/s00701-009-0564-2; Legostaeva L, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9050103; Loggini A, 2020, CLIN NEUROL NEUROSUR, V194, DOI 10.1016/j.clineuro.2020.105815; Ma HM, 2020, BRAIN INJURY, V34, P299, DOI 10.1080/02699052.2020.1723697; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Pape TLB, 2006, J HEAD TRAUMA REHAB, V21, P437, DOI 10.1097/00001199-200609000-00063; Pape TLB, 2014, BRAIN STIMUL, V7, P620, DOI 10.1016/j.brs.2014.03.007; Pape TLB, 2009, BRAIN STIMUL, V2, P22, DOI 10.1016/j.brs.2008.09.004; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Xia XY, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00182	21	5	5	3	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2020	35	6			SI		430	438		10.1097/HTR.0000000000000636			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OP5PJ	WOS:000588138300006	33165155	hybrid			2022-02-06	
J	Lu, H; Zhan, YF; Ai, L; Chen, HX; Chen, JQ				Lu, Hong; Zhan, Yuefu; Ai, Li; Chen, Haixia; Chen, Jianqiang			AQP4-siRNA alleviates traumatic brain edema by altering post-traumatic AQP4 polarity reversal in TBI rats	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						AQP4; Traumatic brain injury; Astrocyte; Polarity reversal; Cerebral edema		The spatial and temporal distribution of aquaporin-4 (AQP4) expression in rat brain following brain trauma and AQP4-siRNA treatment, as well as corresponding pathological changes, were studied to explore the mechanism underlying the effect of AQP4-siRNA treatment on traumatic brain injury (TBI). The rats in the sham operation group had normal structure, with AQP4 located in the perivascular end-foot membranes and astrocytic membranes in a polarized pattern. The accelerated polarity reversal was observed in the TBI group in 1-12 h after TBI. During this period, AQP4 abundance on the astrocytic membrane is gradually increased, while AQP4 abundance on the perivascular end-foot membrane declined rapidly. Twelve hours after TBI, AQP4 expression was depolarized, showing a shift from the perivascular end-foot membrane to the astrocytic membrane. Pathological observation showed that vasogenic edema occurred immediately after TBI, at which time the extracellular space was expanded, leading to severe intracellular edema. AQP4-siRNA reduced the polarity reversal index at the early stage of TBI recovery and reduced edema, demonstrating the potential benefit of reduced AQP4 expression during recovery from TBI. (C) 2020 Elsevier Ltd. All rights reserved.	[Lu, Hong; Ai, Li; Chen, Haixia] Chongqing Seventh Peoples Hosp, Dept Radiol, Chongqing, Peoples R China; [Zhan, Yuefu] Hainan Women & Childrens Med Ctr, Dept Radiol, 15,Long Kun Nan Rd, Haikou 572500, Hainan, Peoples R China; [Chen, Jianqiang] Cent South Univ, Affiliated Haikou Hosp, Xiangya Sch Med, Dept Radiol, Haikou 570208, Hainan, Peoples R China		Zhan, YF (corresponding author), Hainan Women & Childrens Med Ctr, Dept Radiol, 15,Long Kun Nan Rd, Haikou 572500, Hainan, Peoples R China.; Chen, JQ (corresponding author), Cent South Univ, Affiliated Haikou Hosp, Xiangya Sch Med, Dept Radiol, Haikou 570208, Hainan, Peoples R China.	zyfradiology@163.com; hnchenjq@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81160181]; Chongqing Municipal Commission of Health and Family Planning Key Project [2016ZDXM040]; Scientific Research Foundation of Haikou Municipal Science and Technology Information Industry Bureau [2014-079, 2013-72]; Natural Science Foundation of ChongqingNatural Science Foundation of Chongqing [cstc2019jcyj-msxmX0353]; Banan District Science and Technology Commission Project [2018-1]	This project was supported the National Natural Science Foundation of China (No. 81160181); the Chongqing Municipal Commission of Health and Family Planning Key Project (No.2016ZDXM040), the Scientific Research Foundation of Haikou Municipal Science and Technology Information Industry Bureau (No.2013-72 and 2014-079). Natural Science Foundation of Chongqing (No.cstc2019jcyj-msxmX0353), Banan District Science and Technology Commission Project (No.2018-1).	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Aoyama M, 2012, J NEUROSCI RES, V90, P2272, DOI 10.1002/jnr.23117; Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; Badaut J, 2011, J CEREBR BLOOD F MET, V31, P819, DOI 10.1038/jcbfm.2010.163; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Hadaczek P, 2006, MOL THER, V14, P69, DOI 10.1016/j.ymthe.2006.02.018; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Iliff JJ, 2013, STROKE, V44, pS93, DOI 10.1161/STROKEAHA.112.678698; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ke CS, 2002, EXP NEUROL, V178, P194, DOI 10.1006/exnr.2002.8037; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Lopez NE, 2012, J NEUROTRAUM, V29, P385, DOI 10.1089/neu.2011.2053; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Marmarou A, 2006, ACTA NEUROCHIR SUPPL, V96, P24; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2003, ACT NEUR S, V86, P7; Marmarou A, 1997, ACT NEUR S, V70, P68; MARMAROU A, 1994, AM J PHYSIOL, V267, pH514, DOI 10.1152/ajpheart.1994.267.2.H514; MARMAROU A, 1994, ACTA NEUROCHIR, P421; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Mori K, 2002, J NEUROTRAUM, V19, P1261, DOI 10.1089/08977150260338047; Nielsen S, 1997, J NEUROSCI, V17, P171; Oliva AA, 2011, NEUROSCIENCE, V180, P272, DOI 10.1016/j.neuroscience.2011.02.020; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Steiner E, 2012, GLIA, V60, P1646, DOI 10.1002/glia.22383; Strohschein S, 2011, GLIA, V59, P973, DOI 10.1002/glia.21169; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Verkman AS, 1996, AM J PHYSIOL-CELL PH, V270, pC12, DOI 10.1152/ajpcell.1996.270.1.C12; Walz Thomas, 2009, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-540-79885-9_2; Yang BX, 1996, J BIOL CHEM, V271, P4577; Zhang CC, 2015, MOL MED REP, V12, P7351, DOI 10.3892/mmr.2015.4372; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	39	5	6	6	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2020	81						113	119		10.1016/j.jocn.2020.09.015			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PC7AG	WOS:000597149000026	33222898				2022-02-06	
J	Sherer, M; Katz, DI; Bodien, YG; Arciniegas, DB; Block, C; Blum, S; Doiron, M; Frey, K; Giacino, JT; Graf, MJP; Greenwald, B; Hammond, FM; Kalmar, K; Kean, J; Kraus, MF; Nakase-Richardson, R; Pavawalla, S; Rosenbaum, A; Stuss, DT; Yablon, SA				Sherer, Mark; Katz, Douglas, I; Bodien, Yelena G.; Arciniegas, David B.; Block, Cady; Blum, Sonja; Doiron, Matt; Frey, Kim; Giacino, Joseph T.; Graf, Min Jeong P.; Greenwald, Brian; Hammond, Flora M.; Kalmar, Kathleen; Kean, Jacob; Kraus, Marilyn F.; Nakase-Richardson, Risa; Pavawalla, Shital; Rosenbaum, Amy; Stuss, Donald T.; Yablon, Stuart A.			Post-traumatic Confusional State: A Case Definition and Diagnostic Criteria	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain Injuries; traumatic; Confusion; Delirium; Rehabilitation	TRAUMATIC BRAIN-INJURY; GALVESTON ORIENTATION; COGNITIVE IMPAIRMENT; AMNESIA TEST; RECOVERY; DISORDERS; MEMORY; CONSCIOUSNESS; SCALE; REHABILITATION	In response to the need to better define the natural history of emerging consciousness after traumatic brain injury and to better describe the characteristics of the condition commonly labeled posttraumatic amnesia, a case definition and diagnostic criteria for the posttraumatic confusional state (PTCS) were developed. This project was completed by the ConfusionWorkgroup of the American Congress of Rehabilitation Medicine Brain Injury Interdisciplinary Special Interest group. The case definition was informed by an exhaustive literature review and expert opinion of workgroup members from multiple disciplines. The workgroup reviewed 2466 abstracts and extracted evidence from 44 articles. Consensus was reached through teleconferences, face-to-face meetings, and 3 rounds of modified Delphi voting. The case definition provides detailed description of PTCS (1) core neurobehavioral features, (2) associated neurobehavioral features, (3) functional implications, (4) exclusion criteria, (5) lower boundary, and (6) criteria for emergence. Core neurobehavioral features include disturbances of attention, orientation, and memory as well as excessive fluctuation. Associated neurobehavioral features include emotional and behavioral disturbances, sleep-wake cycle disturbance, delusions, perceptual disturbances, and confabulation. The lower boundary distinguishes PTCS from the minimally conscious state, while upper boundary is marked by significant improvement in the 4 core and 5 associated features. Key research goals are establishment of cutoffs on assessment instruments and determination of levels of behavioral function that distinguish persons in PTCS from those who have emerged to the period of continued recovery. (C) 2020 Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Katz, Douglas, I] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Bodien, Yelena G.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Arciniegas, David B.] Univ Colorado, Sch Med, Marcus Inst Brain Hlth, Aurora, CO USA; [Block, Cady] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA; [Blum, Sonja] New York Univ Langone, Dept Neurol, New York, NY USA; [Doiron, Matt; Giacino, Joseph T.] Spaulding Rehabil Hosp, Boston, MA USA; [Frey, Kim] Craig Hosp, Dept Speech Language Pathol, Englewood, CO USA; [Graf, Min Jeong P.] Hennepin Healthcare, Minneapolis, MN USA; [Greenwald, Brian; Kalmar, Kathleen] JFK Johnson Rehabil Inst, Edison, NJ USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Kean, Jacob] Univ Utah, Dept Populat Hlth, Salt Lake City, UT USA; [Kraus, Marilyn F.] George Washington Univ, Med Ctr, Washington, DC 20037 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Pavawalla, Shital] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Rosenbaum, Amy] Pk Terrace Care Ctr, Rego Pk, New York, NY USA; [Stuss, Donald T.] Rotman Res Inst, N York, ON, Canada; [Yablon, Stuart A.] Mary Free Bed Rehabil Hosp, Grand Rapids, MI USA		Sherer, M (corresponding author), Research, TIRR Mem Hermann St,1333 Moursund, Houston, TX 77030 USA.	Mark.Sherer@memorialhermann.org	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698	CARF International; Paradigm; National Institute of Disability, Independent Living, and Rehabilitation Research grant [90DPTB0016]	This case definition was developed under the ACRM Evidence and Practice Committee (ACRM EPC), which is supported by unrestricted grants from CARF International and Paradigm. Neither CARF International nor Paradigm were involved in any phase of the development of this case definition. Preparation of this article was partially supported by National Institute of Disability, Independent Living, and Rehabilitation Research grant no. 90DPTB0016. NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, or HHS, and you should not assume endorsement by the Federal Government. This Case Definition is in the public domain: it may be copied, published, or shared without permission from ACRM.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Baird A, 2005, BRAIN INJURY, V19, P811, DOI 10.1080/02699050500149213; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Bodien YG, 2020, NEUROREHABILITATION, V46, P65, DOI 10.3233/NRE-192860; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; FRANCIS J, 1992, J AM GERIATR SOC, V40, P601, DOI 10.1111/j.1532-5415.1992.tb02111.x; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; Giacino JT, 2018, NEUROLOGY, V91, P461, DOI 10.1212/WNL.0000000000005928; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, NEUROREHABILITATION, V19, P293; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Glisky EL, 1996, J HEAD TRAUMA REHAB, V11, P31, DOI 10.1097/00001199-199604000-00004; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jorm AF, 2015, AUST NZ J PSYCHIAT, V49, P887, DOI 10.1177/0004867415600891; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Nakase-Richardson R, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.127795; Nakase-Richardson R, 2014, HDB NEUROPSYCHOLOGY, P157; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Salluh JIF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2538; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Sherer M, 2014, HDB NEUROPSYCHOLOGY, P49; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Silva MA, 2012, AM J PHYS MED REHAB, V91, P890, DOI 10.1097/PHM.0b013e31825a1648; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Symonds C P, 1937, Proc R Soc Med, V30, P1081; Symonds CP, 1943, LANCET, V1, P7; Trevena-Peters J, 2018, ARCH PHYS MED REHAB, V99, P329, DOI 10.1016/j.apmr.2017.08.486; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684	38	5	5	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2020	101	11					2041	2050		10.1016/j.apmr.2020.06.021			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	OH7DM	WOS:000582754600023	32738198	Green Submitted, hybrid			2022-02-06	
J	Hummel, R; Ulbrich, S; Appel, D; Li, SL; Hirnet, T; Zander, S; Bobkiewicz, W; Golz, C; Schafer, MKE				Hummel, Regina; Ulbrich, Sebastian; Appel, Dominik; Li, Shuailong; Hirnet, Tobias; Zander, Sonja; Bobkiewicz, Wieslawa; Goelz, Christina; Schaefer, Michael K. E.			Administration of all-trans retinoic acid after experimental traumatic brain injury is brain protective	BRITISH JOURNAL OF PHARMACOLOGY			English	Article						all&#8208; trans retinoic acid; apoptosis; astrogliosis; axonal injury; hippocampus; neuroinflammation; traumatic brain injury	CONCISE GUIDE; CELL-DEATH; EXPRESSION; RAT; NEUROINFLAMMATION; NEUROPROTECTION; ACTIVATION; ASTROCYTES; NEURODEGENERATION; PROGRANULIN	Background and Purpose All-trans retinoic acid (ATRA) is a vitamin A metabolite, important in the developing and mature brain. Pre-injury ATRA administration ameliorates ischaemic brain insults in rodents. This study examined the effects of post-traumatic ATRA treatment in experimental traumatic brain injury (TBI). Experimental Approach Male adult mice were subjected to the controlled cortical impact model of TBI or sham procedure and killed at 7 or 30 days post-injury (dpi). ATRA (10 mg kg-1, i.p.) was given immediately after the injury and 1, 2 and 3 dpi. Neurological function and sensorimotor coordination were evaluated. Brains were processed for (immuno-) histological, mRNA and protein analyses (qPCR and western blot). Key Results ATRA treatment reduced brain lesion size, reactive astrogliosis and axonal injury at 7 dpi, and hippocampal granule cell layer (GCL) integrity was protected at 7 and 30 dpi, independent of cell proliferation in neurogenic niches and blood-brain barrier damage. Neurological and motor deficits over time and the brain tissue loss at 30 dpi were not affected by ATRA treatment. ATRA decreased gene expression of markers for damage-associated molecular pattern (HMGB1), apoptosis (caspase-3 and Bax), activated microglia (TSPO), and reactive astrogliosis (GFAP, SerpinA3N) at 7 dpi and a subset of markers at 30 dpi (TSPO, GFAP). Conclusion and Implications In experimental TBI, post-traumatic ATRA administration exerted brain protective effects, including long-term protection of GCL integrity, but did not affect neurological and motor deficits. Further investigations are required to optimize treatment regimens to enhance ATRA's brain protective effects and improve outcomes.	[Hummel, Regina; Ulbrich, Sebastian; Appel, Dominik; Li, Shuailong; Hirnet, Tobias; Zander, Sonja; Bobkiewicz, Wieslawa; Goelz, Christina; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1,Bld 505, D-55131 Mainz, Germany; [Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, Mainz, Germany; [Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Res Ctr Immunotherapy, Mainz, Germany		Schafer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1,Bld 505, D-55131 Mainz, Germany.	michael.schaefer@unimedizin-mainz.de	Shuailong, Li/O-8207-2014; Schaefer, Michael K.E./S-1715-2019	Shuailong, Li/0000-0003-1693-2024; Schaefer, Michael K.E./0000-0001-6055-6244	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SCHA1261/4-3]; China Scholarship CouncilChina Scholarship Council	Deutsche Forschungsgemeinschaft, Grant/Award Number: SCHA1261/4-3; China Scholarship Council	Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS297, DOI 10.1111/bph.14752; Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS229, DOI 10.1111/bph.14750; Alexander SPH, 2018, BRIT J PHARMACOL, V175, P407, DOI 10.1111/bph.14112; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Beckers L, 2018, MOL IMAGING BIOL, V20, P94, DOI 10.1007/s11307-017-1099-1; Behairi N, 2016, J NEUROIMMUNOL, V300, P21, DOI 10.1016/j.jneuroim.2016.10.004; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Cai W, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1557-6; Choi BK, 2009, EXP BRAIN RES, V193, P581, DOI 10.1007/s00221-008-1660-x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Corcoran J, 2002, J CELL SCI, V115, P4735, DOI 10.1242/jcs.00169; Curtis MJ, 2018, BRIT J PHARMACOL, V175, P987, DOI 10.1111/bph.14153; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Dheen ST, 2005, GLIA, V50, P21, DOI 10.1002/glia.20153; du Sert NP, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000410; Duprey-Diaz MV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162626; Esteves M, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00020; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Golz C, 2019, J NEUROCHEM, V150, P173, DOI 10.1111/jnc.14678; Goncalves MB, 2015, J NEUROSCI, V35, P15731, DOI 10.1523/JNEUROSCI.1339-15.2015; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Hellmann-Regen J, 2013, J NEUROIMMUNOL, V256, P1, DOI 10.1016/j.jneuroim.2012.11.005; Israel I, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0604-9; Janesick A, 2015, CELL MOL LIFE SCI, V72, P1559, DOI 10.1007/s00018-014-1815-9; Jiang W, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0360-0; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kayser S, 2018, LEUKEMIA, V32, P1277, DOI 10.1038/s41375-018-0139-4; Kelly KK, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0284-5; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kim JH, 2013, NEUROCHEM RES, V38, P2604, DOI 10.1007/s11064-013-1178-x; Kim JB, 2008, J NEUROSCI RES, V86, P1125, DOI 10.1002/jnr.21555; Kong L, 2015, PHARMACOL RES, V99, P125, DOI 10.1016/j.phrs.2015.05.014; Kramer T, 2017, J NEUROCHEM, V143, P523, DOI 10.1111/jnc.14220; Kramer TJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1550-0; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Le Doze O, 2000, DRUG METAB DISPOS, V28, P205; Li MH, 2018, NEUROCHEM RES, V43, P1283, DOI 10.1007/s11064-018-2545-4; Li Y, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431X20175561, 10.1590/1414-431x20175561]; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lilley E, 2020, BRIT J PHARMACOL, V177, P3611, DOI 10.1111/bph.15178; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Menzel L, 2017, GLIA, V65, P278, DOI 10.1002/glia.23091; Mishra S, 2018, STEM CELL REP, V10, P1705, DOI 10.1016/j.stemcr.2018.04.024; Mohamadpour M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00007; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Park E, 2018, J NEUROSCI, V38, pS277, DOI 10.1523/JNEUROSCI.3028-17.2018; Piao CS, 2012, NEUROBIOL DIS, V46, P745, DOI 10.1016/j.nbd.2012.03.018; Pottker B, 2017, BRAIN STRUCT FUNCT, V222, P4005, DOI 10.1007/s00429-017-1452-9; Sakamoto K, 2010, EUR J PHARMACOL, V635, P56, DOI 10.1016/j.ejphar.2010.03.001; Schafer MKE, 2018, MATRIX BIOL, V68-69, P571, DOI 10.1016/j.matbio.2017.10.002; Schafer M, 2014, CELL TISSUE RES, V357, P395, DOI 10.1007/s00441-014-1807-y; Sebastiani A, 2015, J NEUROTRAUM, V32, P1599, DOI 10.1089/neu.2014.3751; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sun Q, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-106; Takamura R, 2017, J NEUROSCI RES, V95, P897, DOI 10.1002/jnr.23843; Theus MH, 2017, J HISTOCHEM CYTOCHEM, V65, P69, DOI 10.1369/0022155416679638; Timaru-Kast R, 2015, J NEUROTRAUM, V32, P1777, DOI 10.1089/neu.2014.3784; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Toklu HZ, 2015, BRAIN NEUROTRAUMA MO; van Neerven S, 2010, J NEUROCHEM, V114, P1511, DOI 10.1111/j.1471-4159.2010.06867.x; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang RS, 2015, J BIOL CHEM, V290, P22532, DOI 10.1074/jbc.M115.662908; WUARIN L, 1990, INT J DEV NEUROSCI, V8, P317, DOI 10.1016/0736-5748(90)90038-4; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu HH, 2006, J NEUROIMMUNOL, V171, P135, DOI 10.1016/j.jneuroim.2005.10.004; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yakovlev Alexander G, 2004, NeuroRx, V1, P5, DOI 10.1602/neurorx.1.1.5; Yu SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04048-2; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z	76	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	NOV	2020	177	22					5208	5223		10.1111/bph.15259		OCT 2020	16	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	OJ2ET	WOS:000581136800001	32964418	Green Published, Bronze			2022-02-06	
J	Faroqi, AH; Lim, MJ; Kee, EC; Lee, JH; Burgess, JD; Chen, RD; Di Virgilio, F; Delenclos, M; McLean, PJ				Faroqi, Ayman H.; Lim, Melina J.; Kee, Emma C.; Lee, Jannifer H.; Burgess, Jeremy D.; Chen, Ridong; Di Virgilio, Francesco; Delenclos, Marion; McLean, Pamela J.			In VivoDetection of Extracellular Adenosine Triphosphate in a Mouse Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						CCI; extracellular ATP; in vivoImaging; pmeLUC; TBI	CEREBRAL CONCUSSION; BIOENERGETIC STATE; IMPROVES RECOVERY; ATP; RISK; PATHOPHYSIOLOGY; INFLAMMATION; CONSEQUENCES; HIPPOCAMPUS; EXPRESSION	Traumatic brain injury (TBI) is traditionally characterized by primary and secondary injury phases, both contributing to pathological and morphological changes. The mechanisms of damage and chronic consequences of TBI remain to be fully elucidated, but synaptic homeostasis disturbances and impaired energy metabolism are proposed to be a major contributor. It has been proposed that an increase of extracellular (eATP) adenosine triphosphate (ATP) in the area immediately surrounding impact may play a pivotal role in this sequence of events. After tissue injury, rupture of cell membranes allows release of intracellular ATP into the extracellular space, triggering a cascade of toxic events and inflammation. ATP is a ubiquitous messenger; however, simple and reliable techniques to measure its concentration have proven elusive. Here, we integrate a sensitive bioluminescent eATP sensor known as pmeLUC, with a controlled cortical impact mouse model to monitor eATP changes in a living animal after injury. Using the pmeLUC probe, a rapid increase of eATP is observed proximal to the point of impact within minutes of the injury. This event is significantly attenuated when animals are pretreated with an ATP hydrolyzing agent (apyrase) before surgery, confirming the contribution of eATP. This new eATP reporter could be useful for understanding the role of eATP in the pathogenesis in TBI and may identify a window of opportunity for therapeutic intervention.	[Faroqi, Ayman H.; Lim, Melina J.; Kee, Emma C.; Lee, Jannifer H.; Burgess, Jeremy D.; Delenclos, Marion; McLean, Pamela J.] Mayo Clin, Coll Med, Dept Neurosci, Grad Sch Biomed Sci, Jacksonville, FL 32224 USA; [Faroqi, Ayman H.; Lee, Jannifer H.; Burgess, Jeremy D.; McLean, Pamela J.] Mayo Clin, Coll Med, Neurosci PhD Program, Grad Sch Biomed Sci, Jacksonville, FL 32224 USA; [Chen, Ridong] APT Therapeut Inc, St Louis, MO USA; [Di Virgilio, Francesco] Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy		McLean, PJ (corresponding author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	mclean.pamela@mayo.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS094908-01A1]; Mayo Medical Foundation	This work was funded, in part, by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R21 NS094908-01A1 and the Mayo Medical Foundation.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abrahamson EE, 2020, EXP NEUROL, V328, DOI 10.1016/j.expneurol.2020.113257; Apolloni S, 2009, FEBS J, V276, P354, DOI 10.1111/j.1742-4658.2008.06796.x; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Buczek M, 2002, METAB BRAIN DIS, V17, P153, DOI 10.1023/A:1019973921217; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Cauwels A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.70; Chan KY, 2017, NAT NEUROSCI, V20, P1172, DOI 10.1038/nn.4593; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Choo AM, 2013, BRAIN, V136, P65, DOI 10.1093/brain/aws286; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; De Marchi E, 2019, ONCOGENE, V38, P3636, DOI 10.1038/s41388-019-0684-y; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Delenclos M, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0455-3; Di Virgilio F, 2016, METHODS MOL BIOL, V1417, P115, DOI 10.1007/978-1-4939-3566-6_7; Dosch M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041222; Falzoni S, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0101; Folbergrova J, 1997, EXP BRAIN RES, V114, P44, DOI 10.1007/PL00005622; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Ge XT, 2018, J NEUROSCI METH, V308, P162, DOI 10.1016/j.jneumeth.2018.07.021; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Hellal F, 2004, NEUROSCI LETT, V357, P21, DOI 10.1016/j.neulet.2003.12.036; Jamnia N, 2017, J NEUROTRAUM, V34, P1351, DOI 10.1089/neu.2016.4517; Ji Y, 2017, J THROMB HAEMOST, V15, P814, DOI 10.1111/jth.13621; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lee KH, 2003, NUCL MED COMMUN, V24, P1003, DOI 10.1097/00006231-200309000-00009; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marklund N, 2006, NEUROCHEM RES, V31, P1085, DOI 10.1007/s11064-006-9120-0; Medina C, 2006, J PHARMACOL EXP THER, V317, P739, DOI 10.1124/jpet.105.098384; Moeckel D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009246; Morabito G, 2017, MOL THER, V25, P2727, DOI 10.1016/j.ymthe.2017.08.004; Nguyen K. V., 2019, J BIOCH BIOTECH, V2, P1; Nguyen TP, 2018, J ALZHEIMERS DIS, V66, P717, DOI 10.3233/JAD-180586; Oliveira Carla Oliveira de, 2008, Rev Bras Ter Intensiva, V20, P411; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Prasai P, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-90; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rajendran M, 2016, BIOL BULL-US, V231, P73, DOI 10.1086/689592; Riggio S, 2010, PSYCHIAT CLIN N AM, V33, P807, DOI 10.1016/j.psc.2010.08.004; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Sperlagh B, 2011, CURR TOP MED CHEM, V11, P1034, DOI 10.2174/156802611795347564; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; St Martin JL, 2007, J NEUROCHEM, V100, P1449, DOI 10.1111/j.1471-4159.2006.04310.x; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; Wang C, 2013, BIOSENS BIOELECTRON, V43, P355, DOI 10.1016/j.bios.2012.12.027; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	62	5	5	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2021	38	5					655	664		10.1089/neu.2020.7226		OCT 2020	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QP9GR	WOS:000581641500001	32935624	hybrid, Green Published			2022-02-06	
J	Tian, J; Yang, L; Wang, PF; Yang, LJ; Fan, ZZ				Tian, Jun; Yang, Lei; Wang, Pengfei; Yang, Lijun; Fan, Zhenzeng			Exogenous CGRP Regulates Apoptosis and Autophagy to Alleviate Traumatic Brain Injury Through Akt/mTOR Signalling Pathway	NEUROCHEMICAL RESEARCH			English	Article						TBI; CGRP; Signal transduction; Neurons; Cognition	GENE-RELATED PEPTIDE; DEFICITS; PROTEIN; GROWTH; MODEL; BETA; RNA	With millions of traumatic brain injury (TBI) patients every year, TBI is regarded as one of the leading causes of human death and disability. Calcitonin gene-related peptide (CGRP) has been domenstrated to be a potential therapeutic target for TBI. However, the detailed effect and underlying mechanism of CGRP on the injured brain after TBI has hardly been investigated. In this work, we established TBI models of mice and injected CGRP before and after modelling to study its effects on the brain lesion, neurological functions and behaviours, neuron apoptosis and autophagy after TBI. Impacts of introduced CGRP on the activation of Akt/mTOR signalling in the cortical tissues surrounding injured areas after TBI were also evaluated. It was found that CGRP was reduced after TBI, and gradually restored over time. CGRP administration significantly restored the brain lesion induced by TBI. The permeability of blood-brain barrier and brain edema was increased dramatically after TBI, which was ameliorated by exogenous CGRP. Moreover, several neurological behaviour tests were performed, showing that CGRP introduction also relieved the cognitive abilities of mice which were impaired after TBI. Enhancing apoptosis and autophagy of neurons in the cortical tissues of injury sites following TBI were also alleviated by CGRP administration. Besides, CGRP-treated brain cortical tissues showed increased activation of Akt/mTOR signalling after TBI. Therefore, the results suggest that exogenous CGRP plays a neuroprotective role in the injuryed brain after TBI, to relieve cell apoptosis and autophagy, at least partially through Akt/mTOR signalling pathway. This finding also provides more evidence for the treatment of TBI through introducing exogenous CGRP or its related drugs.	[Tian, Jun; Yang, Lijun; Fan, Zhenzeng] Hebei Med Univ, Dept Neurosurg, Shijiazhuang, Hebei, Peoples R China; [Yang, Lijun; Fan, Zhenzeng] Hebei Med Univ, Hosp 2, Dept Neurosurg, 215 Heping Rd, Shijiazhuang 050000, Hebei, Peoples R China; [Tian, Jun] Shijiazhuang First Hosp, Dept Neurosurg, Shijiazhuang, Hebei, Peoples R China; [Yang, Lei] Hebei Med Univ, Dept Epidemiol & Stat, Sch Publ Hlth, Hebei Key Lab Environm & Human Hlth, Shijiazhuang, Hebei, Peoples R China; [Wang, Pengfei] Hebei Gen Hosp, Dept Neurosurg, Shijiazhuang, Hebei, Peoples R China		Yang, LJ; Fan, ZZ (corresponding author), Hebei Med Univ, Dept Neurosurg, Shijiazhuang, Hebei, Peoples R China.; Yang, LJ; Fan, ZZ (corresponding author), Hebei Med Univ, Hosp 2, Dept Neurosurg, 215 Heping Rd, Shijiazhuang 050000, Hebei, Peoples R China.	yanglijun1981@163.com; Fanzhenzeng@126.com			Natural Science Foundation of Hebei Province, ChinaNatural Science Foundation of Hebei Province [H2018206325]; foundation of 2017 clinical medicine training program of Hebei Province; Hebei Medical Science Research Project [20150631]	This project was supported by Natural Science Foundation of Hebei Province, China. (Grant No. H2018206325), foundation of 2017 clinical medicine training program of Hebei Province, and Hebei Medical Science Research Project (No. 20150631).	Akamatsu Y, 2020, NEUROTHERAPEUTICS, V17, P446, DOI 10.1007/s13311-020-00840-7; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Chen LX, 2018, NEURAL REGEN RES, V13, P1782, DOI 10.4103/1673-5374.238619; Chung AM, 2018, REV NEUROSCIENCE, V29, P369, DOI 10.1515/revneuro-2017-0060; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Duan JX, 2017, MOL IMMUNOL, V91, P105, DOI 10.1016/j.molimm.2017.08.020; Edvinsson L, 2017, HEADACHE, V57, P47, DOI 10.1111/head.13081; Favoni V, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-0979-y; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Jalin AMAA, 2019, EXP NEUROL, V314, P20, DOI 10.1016/j.expneurol.2019.01.002; Jean-Richard-Dit-Bressel P, 2015, LEARN MEMORY, V22, P128, DOI 10.1101/lm.035907.114; KAMEYAMA T, 1986, J PHARMACOL METHOD, V16, P39, DOI 10.1016/0160-5402(86)90027-6; Khalin I, 2016, NEURAL REGEN RES, V11, P630, DOI 10.4103/1673-5374.180749; Leong YQ, 2020, METAB BRAIN DIS, V35, P11, DOI 10.1007/s11011-019-00516-y; Lewejohann L, 2004, BEHAV BRAIN RES, V154, P273, DOI 10.1016/j.bbr.2004.02.015; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Machado J, 2016, INT J BIOCHEM CELL B, V72, P40, DOI 10.1016/j.biocel.2015.12.011; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mrak E, 2010, J CELL PHYSIOL, V225, P701, DOI 10.1002/jcp.22266; National Research Council, 2010, GUIDE CARE USE LAB A, V8th ed.; Navratilova E, 2019, CEPHALALGIA, V39, P1762, DOI 10.1177/0333102419877662; Nirmala JG, 2020, CELL BIOL TOXICOL, V36, P145, DOI 10.1007/s10565-019-09496-2; Rubio-Beltran E, 2019, HANDB EXP PHARMACOL, V255, P131, DOI 10.1007/164_2019_204; Sorby-Adams AJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081788; Sun LQ, 2018, BEHAV BRAIN RES, V337, P271, DOI 10.1016/j.bbr.2017.08.042; Umoh Nsini A, 2014, Ann Clin Exp Hypertens, V2, P1007; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Voss JL, 2017, TRENDS COGN SCI, V21, P577, DOI 10.1016/j.tics.2017.05.008; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wang ZF, 2019, NEUROBIOL LEARN MEM, V161, P12, DOI 10.1016/j.nlm.2019.03.002; Xiao S, 2018, DNA CELL BIOL, V37, P117, DOI 10.1089/dna.2017.3941; Xu YQ, 2019, EUR REV MED PHARMACO, V23, P5040, DOI 10.26355/eurrev_201906_18167; Zhang L, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00190	35	5	5	1	6	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	DEC	2020	45	12					2926	2938		10.1007/s11064-020-03141-9		OCT 2020	13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Neurosciences & Neurology	OV4JV	WOS:000577977700002	33063244				2022-02-06	
J	Zimmerman, A; Fox, S; Griffin, RD; Nelp, T; Thomaz, EBAF; Mvungi, M; Mmbaga, BT; Sakita, F; Gerardo, CJ; Vissoci, JRN; Staton, CA				Zimmerman, Armand; Fox, Samara; Griffin, Randi; Nelp, Taylor; Thomaz, Erika Barbara Abreu Fonseca; Mvungi, Mark; Mmbaga, Blandina T.; Sakita, Francis; Gerardo, Charles J.; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.			An analysis of emergency care delays experienced by traumatic brain injury patients presenting to a regional referral hospital in a low-income country	PLOS ONE			English	Article							ADJUSTED LIFE YEARS; TRIAGE SCORE SATS; GLOBAL BURDEN; OUTCOMES; EPIDEMIOLOGY; DISABILITY; QUALITY; SYSTEMS; AFRICA; TIME	Background Trauma is a leading cause of death and disability worldwide. In low- and middle-income countries (LMICs), trauma patients have a higher risk of experiencing delays to care due to limited hospital resources and difficulties in reaching a health facility. Reducing delays to care is an effective method for improving trauma outcomes. However, few studies have investigated the variety of care delays experienced by trauma patients in LMICs. The objective of this study was to describe the prevalence of pre- and in-hospital delays to care, and their association with poor outcomes among trauma patients in a low-income setting. Methods We used a prospective traumatic brain injury (TBI) registry from Kilimanjaro Christian Medical Center in Moshi, Tanzania to model nine unique delays to care. Multiple regression was used to identify delays significantly associated with poor in-hospital outcomes. Results Our analysis included 3209 TBI patients. The most common delay from injury occurrence to hospital arrival was 1.1 to 4.0 hours (31.9%). Most patients were evaluated by a physician within 15.0 minutes of arrival (69.2%). Nearly all severely injured patients needed and did not receive a brain computed tomography scan (95.0%). A majority of severely injured patients needed and did not receive oxygen (80.8%). Predictors of a poor outcome included delays to lab tests, fluids, oxygen, and non-TBI surgery. Conclusions Time to care data is informative, easy to collect, and available in any setting. Our time to care data revealed significant constraints to non-personnel related hospital resources. Severely injured patients with the greatest need for care lacked access to medical imaging, oxygen, and surgery. Insights from our study and future studies will help optimize resource allocation in low-income hospitals thereby reducing delays to care and improving trauma outcomes in LMICs.	[Zimmerman, Armand; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Fox, Samara] Yale Sch Med, New Haven, CT USA; [Griffin, Randi] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA; [Nelp, Taylor; Gerardo, Charles J.; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.] Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Durham, NC 27710 USA; [Thomaz, Erika Barbara Abreu Fonseca] Univ Fed Maranhao, Sao Luis, Maranhao, Brazil; [Mvungi, Mark; Mmbaga, Blandina T.; Sakita, Francis] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Mmbaga, Blandina T.] Kilimanjaro Clin Res Inst, Moshi, Tanzania; [Mmbaga, Blandina T.; Sakita, Francis] Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania		Staton, CA (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.; Staton, CA (corresponding author), Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Durham, NC 27710 USA.	catherine.staton@duke.edu	THOMAZ, ERIKA/AAU-7752-2021; THOMAZ, ERIKA/AAU-7762-2021; Mmbaga, Blandina Theophil/AAR-8707-2021	THOMAZ, ERIKA/0000-0003-4156-4067; Mmbaga, Blandina Theophil/0000-0002-5550-1916; Staton, Catherine/0000-0002-6468-2894; Zimmerman, Armand/0000-0002-1216-581X	KCMC MEPI [T84HA21123-02]; U.S. National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Duke Division of Emergency Medicine; NSF Graduate Research FellowshipNational Science Foundation (NSF); e Fogarty International Center [K01 TW010000-01A1]	This project was made possible by the Mentored Research Training Program in collaboration with the HRSA-funded KCMC MEPI grant #T84HA21123-02; U.S. National Institutes of Health and the Duke Division of Emergency Medicine. Randi Griffin would like to cknowledge support from the NSF Graduate Research Fellowship. Dr. Staton would like to acknowledge salary support funding from the Fogarty International Center (Staton, dK01 TW010000-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgadir J, 2017, WORLD NEUROSURG, V102, P526, DOI 10.1016/j.wneu.2017.03.019; Alibhai A, 2019, AFR J EMERG MED, V9, pS38, DOI 10.1016/j.afjem.2019.01.004; Amu H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201833; [Anonymous], 2014, INJURIES AND VIOLENC; Anonymous, 2012, MMWR-MORBID MORTAL W, V59, P1, DOI DOI 10.3791/3636; [Anonymous], 2015, HAINAN TODAY; [Anonymous], 2017, HEART LUNG CIRC, V26, pe125; Baker T, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-140; Beavogui Kezely, 2015, J Vasc Interv Neurol, V8, P30; Berg LM, 2019, ANN EMERG MED, V74, P345, DOI 10.1016/j.annemergmed.2019.04.012; Bruijns SR, 2008, EMERG MED J, V25, P398, DOI 10.1136/emj.2007.051177; Carney N, GUIDELINES MANAGEMEN, P244; Carter EJ, 2014, J NURS SCHOLARSHIP, V46, P106, DOI 10.1111/jnu.12055; Casalino E, 2013, EMERG MED J, V30, P638, DOI 10.1136/emermed-2012-201404; Cavallaro FL, 2013, ACTA OBSTET GYN SCAN, V92, P496, DOI 10.1111/aogs.12071; Dalwai MK, 2014, SAMJ S AFR MED J, V104, P372, DOI [10.7196/SAMJ.7604, 10.7196/samj.7604]; Dalwai M, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000160; de Andrade L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103577; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Diamond MB, 2018, INJURY PREV, V24, P272, DOI 10.1136/injuryprev-2016-042254; Eaton J, 2017, WORLD NEUROSURG, V108, P650, DOI 10.1016/j.wneu.2017.09.084; Georgoff P, 2010, WORLD NEUROSURG, V74, P331, DOI 10.1016/j.wneu.2010.03.025; Gottschalk SB, 2006, EMERG MED J, V23, P149, DOI 10.1136/emj.2005.028332; Groenland CN, 2019, CRIT CARE MED, V47, P1564, DOI 10.1097/CCM.0000000000003957; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Haglund MM, 2019, J NEUROSURG, V131, P993, DOI 10.3171/2019.4.JNS181747; Hansmann A, 2017, AFR J EMERG MED, V7, pS10, DOI 10.1016/j.afjem.2017.10.001; Hashmi ZG, 2013, J TRAUMA ACUTE CARE, V75, P60, DOI 10.1097/TA.0b013e31829880a0; Horwitz LI, 2010, ANN EMERG MED, V55, P133, DOI 10.1016/j.annemergmed.2009.07.023; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johnson KD, 2011, ADV EMERG NURS J, V33, P39, DOI 10.1097/TME.0b013e318207e86a; Kawooya MG, 2012, J CLIN IMAG SCI, V2, DOI 10.4103/2156-7514.97747; Kawooya MG, 2011, J CLIN IMAG SCI, V1, DOI 10.4103/2156-7514.90035; Khan BA, 2016, J PAK MED ASSOC, V66, P509; Kobusingye OC, 2005, B WORLD HEALTH ORGAN, V83, P626; Krebs E, 2017, WORLD NEUROSURG, V102, P571, DOI 10.1016/j.wneu.2017.03.001; London JA, 2001, J TRAUMA, V51, P747, DOI 10.1097/00005373-200110000-00021; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; McKenna P, 2019, CLIN EXP EMERG MED, V6, P189, DOI 10.15441/ceem.18.022; McQueen K, 2016, WORLD J SURG, V40, P249, DOI 10.1007/s00268-015-3284-1; Morley C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203316; Mould-Millman NK, 2017, PREHOSP DISASTER MED, V32, P273, DOI 10.1017/S1049023X17000061; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ngoya PS, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.2016.25.99.9736; Nielsen K, 2012, PREHOSP EMERG CARE, V16, P381, DOI 10.3109/10903127.2012.664245; Obermeyer Z, 2015, B WORLD HEALTH ORGAN, V93, P577, DOI 10.2471/BLT.14.148338; Ormond DR, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18239; Peden, 2004, GUIDELINES ESSENTIAL; Rocha TAH, 2020, J NEUROSURG, V132, P1961, DOI 10.3171/2019.2.JNS182098; Rominski S, 2014, AFR J EMERG MED, V4, P71, DOI 10.1016/j.afjem.2013.11.001; Rosedale K, 2011, SAMJ S AFR MED J, V101, P537; Rosseau G, 2020, J NEUROSURG, V132, P1256, DOI 10.3171/2019.11.JNS191823; Sasser SM, 2006, B WORLD HEALTH ORGAN, V84, P507, DOI 10.2471/BLT.06.033605; Schuur JD, 2013, HEALTH AFFAIR, V32, P2129, DOI 10.1377/hlthaff.2013.0730; Singer AJ, 2011, ACAD EMERG MED, V18, P1324, DOI 10.1111/j.1553-2712.2011.01236.x; Smart LR, 2017, WORLD NEUROSURG, V105, P238, DOI 10.1016/j.wneu.2017.05.101; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Sunyoto T, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0531-3; Twomey M, 2012, EMERG MED J, V29, P650, DOI 10.1136/emermed-2011-200503; Wangara AA, 2019, INT J EMERG MED, V12, DOI 10.1186/s12245-019-0221-3; Wllper AP, 2008, HEALTH AFFAIR, V27, pW84, DOI 10.1377/hlthaff.27.2.w84; Wong JC, 2016, EUR J NEUROL, V23, P382, DOI 10.1111/ene.12877; Yeboah D, 2014, WORLD J SURG, V38, P1707, DOI 10.1007/s00268-014-2452-z	64	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240528	10.1371/journal.pone.0240528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3TU	WOS:000581811700044	33045030	gold, Green Published			2022-02-06	
J	Navaratnam, AV; Hariri, A; Ho, C; Machin, JT; Briggs, TWR; Marshall, A				Navaratnam, Annakan Victor; Hariri, Ahmad; Ho, Cherrie; Machin, John T.; Briggs, Tim W. R.; Marshall, Andrew			Otorhinolaryngology litigation in England: 727 clinical negligence cases against the National Health Service	CLINICAL OTOLARYNGOLOGY			English	Article						clinical negligence claims; informed consent; litigation; malpractice; otolaryngology	MEDICAL MALPRACTICE; TONSILLECTOMY	Introduction Litigation against the National Health Service (NHS) in England is rising. The aim of this study was to determine the incidence and characteristics of otorhinolaryngology clinical negligence claims in England. Methods A retrospective review was undertaken of all clinical negligence claims in England held by NHS Resolution relating to otorhinolaryngology between April 2013 and April 2018. Analysis was performed using information for cause, patient injury and claim cost. Where claim information was adequately detailed, the authors categorised claims by subspecialty, diagnosis and surgery. Results A total number of 727 claims were identified with an estimated potential cost of 108 pound million. Out of these, 463 were closed claims. Including open claim reserves, the mean cost of a claim was 148 pound 923. Head and neck surgery was the subspecialty with the highest number of claims (n = 313, 43%) and highest cost (51.5 pound million) followed by otology (n = 171, 24.5 pound million) and rhinology (n = 171, 13.6 pound million). Over half of claims were associated with an operation (n = 429, 59%) where mastoid surgery (n = 46) and endoscopic sinus surgery (n = 46) were equally associated with the greatest number of claims. The most frequent causes for clinical negligence claims included failure or delay to diagnose (n = 178, 25%), failure or delay to treat (n = 136, 19%), intra-operative complications (n = 130, 18%) and failure of the consent process (n = 107, 15%). Discussion Clinical negligence claims in otorhinolaryngology are related to several different components of patient management and are not limited to postoperative complications. This study highlights the importance of robust pathways in out-patient diagnostics and the consenting process in order to deliver better patient care and reduce the impact of litigation. Keywords informed consent, malpractice, clinical negligence claims, litigation, otolaryngology	[Navaratnam, Annakan Victor; Ho, Cherrie; Machin, John T.; Briggs, Tim W. R.; Marshall, Andrew] NHS England, Getting It Right First Time Programme, 5th Floor,Area D,Skipton House,22 London Rd, London SE1 6JW, England; [Navaratnam, Annakan Victor; Ho, Cherrie; Machin, John T.] NHS Improvement, 5th Floor,Area D,Skipton House,22 London Rd, London, England; [Hariri, Ahmad] Univ Coll London Healthcare NHS Trust, Royal Natl Throat Nose & Ear Hosp, London, England; [Briggs, Tim W. R.] Royal Natl Orthopaed Hosp, NHS Improvement, London, England; [Marshall, Andrew] Nottingham Univ Hosp NHS Trust, NHS Improvement, London, England		Navaratnam, AV (corresponding author), NHS England, Getting It Right First Time Programme, 5th Floor,Area D,Skipton House,22 London Rd, London SE1 6JW, England.; Navaratnam, AV (corresponding author), NHS Improvement, 5th Floor,Area D,Skipton House,22 London Rd, London, England.	annakan.navaratnam@nhs.net		Navaratnam, Annakan/0000-0001-7387-9464			Albano GD, 2019, CURR PHARM BIOTECHNO, V20, P653, DOI 10.2174/1389201020666190408102221; [Anonymous], CLIN NEGL LIT; Beckett Heather, 2016, Pract Midwife, V19, P27; Choudry Mohsin I, 2016, Future Hosp J, V3, P109, DOI 10.7861/futurehosp.3-2-109; Dent PC, 2017, BRIT J HOSP MED, V78, P213, DOI 10.12968/hmed.2017.78.4.213; Gao C, 2019, J LARYNGOL OTOL, V133, P704, DOI 10.1017/S002221511900149X; Gollnick I, 2013, HNO, V61, P495, DOI 10.1007/s00106-012-2668-x; Harris AS, 2014, AM J RHINOL ALLERGY, V129, P244; Islam SMS, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000033; Kim JS, 2017, OTOLARYNG HEAD NECK, V157, P178, DOI 10.1177/0194599817700374; Light A, 2019, SURG-J R COLL SURG E, V17, P193, DOI 10.1016/j.surge.2018.06.001; London NR, 2016, ADV OTO-RHINO-LARYNG, V79, P1, DOI 10.1159/000444957; Machin JT, 2019, GIRFT BHS BOA NHS RE; Mahalingam Sridhayan, 2014, Qual Prim Care, V22, P251; Marshall A., 2019, EAR NOSE THROAT SURG; Mathew R, 2012, ANN OTO RHINOL LARYN, V121, P337, DOI 10.1177/000348941212100509; NHS England Elective Care Transformation Programme, 2019, TRANSF EL CAR SERV E; NHS Resolution, GUID NOT UND NHS RES; NHS Resolution, NHS RES ANN REP ACC; Nicopoullos J D M, 2003, J Obstet Gynaecol, V23, P381; Patel A, 2020, SURG-J R COLL SURG E, V18, P75, DOI 10.1016/j.surge.2019.06.001; Pfaltz CR, 1985, ACTA OTORHINOLARYNGO, V39, P197; Ruhl DS, 2015, CURR OPIN OTOLARYNGO, V23, P348, DOI 10.1097/MOO.0000000000000182; Ruhl DS, 2014, OTOLARYNG HEAD NECK, V151, P431, DOI 10.1177/0194599814536850; Siau D, 2010, CLIN OTOLARYNGOL, V35, P503, DOI 10.1111/j.1749-4486.2010.02227.x; Smith ME, 2013, EUR ARCH OTO-RHINO-L, V270, P2551, DOI 10.1007/s00405-013-2464-6; The Committee of Public Accounts, 2017, MAN COSTS CLIN NEGL; The Royal College of Surgeons, 2014, GOOD SURG PRACT; Thomson DR, 2016, INT J SURG, V27, P17, DOI 10.1016/j.ijsu.2016.01.037	29	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1749-4478	1749-4486		CLIN OTOLARYNGOL	Clin. Otolaryngol.	JAN	2021	46	1					9	15		10.1111/coa.13646		OCT 2020	7	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	PL9QB	WOS:000574167000001	32869463				2022-02-06	
J	Campbell, KR; Marshall, SW; Luck, JF; Pinton, GF; Stitzel, JD; Boone, JS; Guskiewicz, KM; Mihalik, JP				Campbell, Kody R.; Marshall, Stephen W.; Luck, Jason F.; Pinton, Gianmarco F.; Stitzel, Joel D.; Boone, Joshua S.; Guskiewicz, Kevin M.; Mihalik, Jason P.			Head Impact Telemetry System's Video-based Impact Detection and Location Accuracy	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						HEAD INJURIES; CONCUSSION; AMERICAN FOOTBALL; INJURY PREVENTION; HEAD IMPACTS	SPORT-RELATED CONCUSSIONS; HIGH-SCHOOL; HYBRID III; FOOTBALL; INJURY; YOUTH; EPIDEMIOLOGY; RELIABILITY; VALIDATION; SEVERITY	Purpose This study aimed to quantify the Head Impact Telemetry (HIT) System's impact detection and location measurement accuracy using an impact biomechanics data set paired with video of high school football special teams plays. Methods The head impact biomechanics data set and video were collected from 22 high school football players, wearing HIT System instrumented helmets, competing in 218 special teams plays over a single high school football season. We used two separate video analysis approaches. To quantify the impact detection accuracy, we evaluated the video for head impacts independently of the impact data collection triggers collected by the HIT System. Video-observed impacts matched to valid and invalid head impacts by the HIT System algorithm were categorized as true positives, false positives, false negatives, and true negatives. To quantify impact location accuracy, we analyzed video-synchronized head impacts for impact location independent of the HIT System's impact location measurement and quantified the estimated percent agreement of impact location between the HIT System recorded impact location and the impact location observed on video. Results The HIT System's impact-filtering algorithm had 69% sensitivity, 72% specificity, and 70% accuracy in categorizing true and non-head impact data collection triggers. The HIT System agreed with video-observed impact locations on 64% of the 129 impacts we analyzed (unweightedk= 0.43, 95% confidence interval = 0.31-0.54). Conclusion This work provides data on the HIT System's impact detection and location accuracy during high school football special teams plays using game video analysis that has not been previously published. Based on our data, we believe that the HIT System is useful for estimating population-based impact location distributions for special teams plays.	[Campbell, Kody R.; Boone, Joshua S.; Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Campbell, Kody R.; Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Dept Allied Hlth Sci, Sch Med, Curriculum Human Movement Sci, Chapel Hill, NC 27515 USA; [Campbell, Kody R.] Oregon Hlth & Sci Univ, Dept Neurol, Balance Disorders Lab, Portland, OR 97201 USA; [Marshall, Stephen W.; Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA; [Luck, Jason F.] Duke Univ, Dept Biomed Engn, Injury Biomech Lab, Durham, NC 27706 USA; [Pinton, Gianmarco F.] Univ North Carolina Chapel Hill & North Carolina, Joint Dept Biomed Engn, Chapel Hill, NC USA; [Stitzel, Joel D.] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC 27101 USA; [Stitzel, Joel D.] Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Winston Salem, NC USA		Mihalik, JP (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 2201 Stallings Evans Sports Med Complex, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE0042479]	The acquisition of video and the head impact data used for this study were partially supported by an award to the UNC Injury Prevention Research Center (R49/CE0042479) from the Centers for Disease Control and Prevention. The authors would also like to acknowledge Adrian J. Boltz, MS, the academic faculty, the research staff, and the trainees in the Matthew Gfeller Center at UNC-Chapel Hill and the research staff at Duke University for their assistancewith various aspects of this project.; Dr. Stitzel is a coinventor for a mouthpiece-based head impact kinematic measurement technology that is patent pending. Riddell has previously sponsored the Matthew Gfeller Neurotrauma Symposium at the University of North Carolina at Chapel Hill (in 2017 and 2019). The remaining authors have no conflicts to disclose. The results of the present study do not constitute endorsement by the American College of Sports Medicine. The results of the study are presented clearly, honestly, and without fabrication or inappropriate data manipulation.	Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Biomechanical Devices in TBI Working Group, 2018, TRAUM BRAIN INJ COMM; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Cobb BR, 2015, P I MECH ENG P-J SPO, V229, P39, DOI 10.1177/1754337114548245; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Joodaki H, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4043038; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Lynall RC, 2017, J NEUROTRAUM, V34, P2684, DOI 10.1089/neu.2017.5032; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; National Federation of State High School Associations, 2020, 2018 2019 HIGH SCH A; Nevins D, 2018, P I MECH ENG P-J SPO, V232, P242, DOI 10.1177/1754337117739458; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P25; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Ruestow PS, 2015, J OCCUP ENVIRON HYG, V12, P875, DOI 10.1080/15459624.2015.1072632; Schmidt JD, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4231; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Trotta A, 2018, J BIOMECH, V75, P28, DOI 10.1016/j.jbiomech.2018.05.003; Urban JE, 2019, J NEUROSURG-PEDIATR, V24, P190, DOI 10.3171/2019.2.PEDS18558; Viera AJ, 2005, FAM MED, V37, P360; Wu LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17864-3; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Yard EE, 2009, RES SPORTS MED, V17, P35, DOI 10.1080/15438620802678495; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	42	5	4	2	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	OCT	2020	52	10					2198	2206		10.1249/MSS.0000000000002371			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	NS0RY	WOS:000571968600016	32936594	Green Accepted			2022-02-06	
J	Cardim, D; Robba, C; Czosnyka, M; Savo, D; Mazeraud, A; Iaquaniello, C; Banzato, E; Rebora, P; Citerio, G				Cardim, Danilo; Robba, Chiara; Czosnyka, Marek; Savo, Davide; Mazeraud, Aurelien; Iaquaniello, Carolina; Banzato, Erika; Rebora, Paola; Citerio, Giuseppe			Noninvasive Intracranial Pressure Estimation With Transcranial Doppler: A Prospective Observational Study	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						intracranial hypertension; intracranial pressure; transcranial Doppler	CEREBRAL PERFUSION-PRESSURE; PULSATILITY INDEX; VENTRICULOSTOMY PLACEMENT; HEMORRHAGIC COMPLICATIONS; ULTRASONOGRAPHY; POSITION; MODERATE; ICP	Background: Transcranial Doppler (TCD) ultrasonography has been described for the noninvasive assessment of intracranial pressure (ICP). This study investigates the relationship between standard, invasive intracranial pressure monitoring (ICPi) and noninvasive ICP assessment using a simple formula based on TCD-derived flow velocity (FV) and mean arterial blood pressure values (ICPTCD). Material and Methods: We performed a prospective observational study on 100 consecutive traumatic brain injury patients requiring invasive ICP monitoring, admitted to the Neurosciences and Trauma Critical Care Unit of Addenbrooke's Hospital, Cambridge, UK. ICP(i)was compared with ICP(TCD)using a method based on the "diastolic velocity-derived estimator" (FVd), which was initially described for the noninvasive estimation of cerebral perfusion pressure but subsequently utilized for ICP assessment. Results: Median ICP(i)was 13 mm Hg (interquartile range: 10, 17.25 mm Hg). There was no correlation between ICP(i)and ICPTCD(R=-0.17; 95% confidence interval [CI]: -0.35, 0.03;P=0.097). Bland-Altman analysis demonstrated wide 95% limits of agreement between ICP(i)and ICPTCD(-27.58, 30.10; SD, 14.42). ICP(TCD)was not able to detect intracranial hypertension (ICPi>20 mm Hg); the area under the receiver operating characteristic curve for prediction was 34.5% (95% CI, 23.1%-45.9%) with 0% sensitivity and 74.4% specificity for ICP(TCD)to detect ICPi>20 mm Hg. Conclusions: Using a formula based on diastolic FV, TCD is an insufficiently accurate method for the noninvasive assessment of ICP. Further studies are warranted to confirm these results in a broader patient cohort.	[Cardim, Danilo] Univ Cambridge, Brain Phys Lab, Dept Clin Neurosci, Addenbrookes Hosp,Div Neurosurg, Cambridge Biomed Campus, Cambridge, England; [Robba, Chiara] Cambridge Univ Hosp Trust, Neurocrit Care Unit, Addenbrookes Hosp, Cambridge, England; [Czosnyka, Marek] Univ Cambridge, Brain Phys Lab, Dept Clin Neurosci, Addenbrookes Hosp,Div Neurosurg, Cambridge Biomed Campus, Cambridge, England; [Robba, Chiara] IRCCS Oncol & Neurosci, San Martino Hosp, Anesthesia & Intens Care, Genoa, Italy; [Savo, Davide; Mazeraud, Aurelien; Citerio, Giuseppe] San Gerardo Hosp, Neurointens Care Unit, Monza, Italy; [Iaquaniello, Carolina; Banzato, Erika; Rebora, Paola; Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy; [Mazeraud, Aurelien] Paris Descartes Univ, Neurointens Care, Ctr Hosp St Anne, Paris, France		Robba, C (corresponding author), Cambridge Univ Hosp Trust, Neurocrit Care Unit, Addenbrookes Hosp, Cambridge, England.; Robba, C (corresponding author), IRCCS Oncol & Neurosci, San Martino Hosp, Anesthesia & Intens Care, Genoa, Italy.	kiarobba@gmail.com	; REBORA, PAOLA/M-9098-2016	Cardim, Danilo/0000-0002-9261-1321; REBORA, PAOLA/0000-0003-0606-5852	NIHR Brain Injury Healthcare Technology Co-operative, Cambridge, UK; Italian Ministry of Education, University and ResearchMinistry of Education, Universities and Research (MIUR) [SIR RBSI14LOVD]	D.C. and M.C. are partially supported by NIHR Brain Injury Healthcare Technology Co-operative, Cambridge, UK. P.R. and E.B. are partially supported by the grant SIR RBSI14LOVD of the Italian Ministry of Education, University and Research. G.C. is a member of the speakers' bureau of Integra-Codman, and he received funding for educational activities. The remaining authors have no conflicts of interest to disclose.	Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bauer DF, 2011, NEUROSURGERY, V69, P255, DOI 10.1227/NEU.0b013e31821a45ba; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carstensen B., 2010, COMP CLIN MEASUREMEN; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; Dimitriou J, 2016, WORLD NEUROSURG, V89, P641, DOI 10.1016/j.wneu.2015.11.037; Fanelli A, 2017, P ANN INT IEEE EMBS, P4001, DOI 10.1109/EMBC.2017.8037733; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; Rasulo FA, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1632-2; Robba C, 2016, BRIT J ANAESTH, V117, P783, DOI 10.1093/bja/aew356; Robba C, 2016, ACTA NEUROL SCAND, V134, P4, DOI 10.1111/ane.12527; Robba C, 2019, INTENSIVE CARE MED; Robba C, 2018, J NEUROSCI RES, V96, P720, DOI 10.1002/jnr.24148; Robba C, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002356; Robba C, 2017, J NEUROSURG ANESTH, V29, P243, DOI 10.1097/ANA.0000000000000295; Robba C, 2015, NEUROCRIT CARE, V23, P419, DOI 10.1007/s12028-015-0163-4; Shafe M, 2004, ACAD EMERG MED, V11, P774, DOI 10.1197/j.aem.2004.02.518; Splavski B, 2006, BRIT J NEUROSURG, V20, P386, DOI 10.1080/02688690601048104; Trabold F, 2004, INTENS CARE MED, V30, P108, DOI 10.1007/s00134-003-2057-8; Varsos GV, 2015, J NEUROSURG, V123, P638, DOI 10.3171/2014.10.JNS14613; Zweifel C, 2012, NEUROSURGERY, V71, P853, DOI 10.1227/NEU.0b013e3182675b42	28	5	6	2	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	2020	32	4					349	353		10.1097/ANA.0000000000000622			5	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	NY6QL	WOS:000576511300012	31306262				2022-02-06	
J	Chatelle, C; Rosenthal, ES; Bodien, YG; Spencer-Salmon, CA; Giacino, JT; Edlow, BL				Chatelle, Camille; Rosenthal, Eric S.; Bodien, Yelena G.; Spencer-Salmon, Camille A.; Giacino, Joseph T.; Edlow, Brian L.			EEG Correlates of Language Function in Traumatic Disorders of Consciousness	NEUROCRITICAL CARE			English	Article						Electroencephalography; Consciousness disorder; Language; Traumatic brain injury; Intensive care unit	VEGETATIVE STATE; IMPAIRED CONSCIOUSNESS; BRAIN; COMA; AWARENESS; RECOVERY; N400; MISDIAGNOSIS; VALIDATION; DIAGNOSIS	Background/Objective Behavioral examinations may fail to detect language function in patients with severe traumatic brain injury (TBI) due to confounds such as having an endotracheal tube. We investigated whether resting and stimulus-evoked electroencephalography (EEG) methods detect the presence of language function in patients with severe TBI. Methods Four EEG measures were assessed: (1) resting background (applying Forgacs' criteria), (2) reactivity to speech, (3) background and reactivity (applying Synek's criteria); and (4) an automated support vector machine (classifier for speech versus rest). Cohen's kappa measured agreement between the four EEG measures and evidence of language function on a behavioral coma recovery scale-revised (CRS-R) and composite (CRS-R or functional MRI) reference standard. Sensitivity and specificity of each EEG measure were calculated against the reference standards. Results We enrolled 17 adult patients with severe TBI (mean +/- SD age 27.0 +/- 7.0 years; median [range] 11.5 [2-1173] days post-injury) and 16 healthy subjects (age 28.5 +/- 7.8 years). The classifier, followed by Forgacs' criteria for resting background, demonstrated the highest agreement with the behavioral reference standard. Only Synek's criteria for background and reactivity showed significant agreement with the composite reference standard. The classifier and resting background showed balanced sensitivity and specificity for behavioral (sensitivity = 84.6% and 80.8%; specificity = 57.1% for both) and composite reference standards (sensitivity = 79.3% and 75.9%, specificity = 50% for both). Conclusions Methods applying an automated classifier, resting background, or resting background with reactivity may identify severe TBI patients with preserved language function. Automated classifier methods may enable unbiased and efficient assessment of larger populations or serial timepoints, while qualitative visual methods may be practical in community settings.	[Chatelle, Camille] Univ Liege, Coma Sci Grp, GIGA Consciousness, Ave Hop,11, B-4000 Liege, Belgium; [Chatelle, Camille; Rosenthal, Eric S.; Bodien, Yelena G.; Spencer-Salmon, Camille A.; Edlow, Brian L.] Massachusetts Gen Hosp, Ctr Neurotechnol & Neurorecovery, Boston, MA 02114 USA; [Rosenthal, Eric S.] Harvard Med Sch, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Rosenthal, Eric S.] Massachusetts Gen Hosp, Clin Data Animat Ctr, Boston, MA 02114 USA; [Bodien, Yelena G.; Giacino, Joseph T.] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Edlow, Brian L.] Harvard Med Sch, Athinoula A Martinos Ctr Biomed Imaging, Massachusetts Gen Hosp, Boston, MA 02115 USA		Chatelle, C (corresponding author), Univ Liege, Coma Sci Grp, GIGA Consciousness, Ave Hop,11, B-4000 Liege, Belgium.; Chatelle, C (corresponding author), Massachusetts Gen Hosp, Ctr Neurotechnol & Neurorecovery, Boston, MA 02114 USA.	camillechatelle@gmail.com	Giacino, Joseph/AAF-1952-2021; Rosenthal, Eric/A-2085-2017	Giacino, Joseph/0000-0002-7916-9698; Rosenthal, Eric/0000-0003-3900-356X	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [DP2 HD101400] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS105950, R21 NS109627, K23 NS094538, RF1 NS115268] Funding Source: Medline		Alberg AJ, 2004, J GEN INTERN MED, V19, P460, DOI 10.1111/j.1525-1497.2004.30091.x; American Clinical Neurophysiology Society, 2006, J Clin Neurophysiol, V23, P118; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; Balconi M, 2013, J NEUROPSYCH CLIN N, V25, P237, DOI 10.1176/appi.neuropsych.12090227; Beukema S, 2016, NEUROIMAGE-CLIN, V12, P359, DOI 10.1016/j.nicl.2016.08.003; Bodien YG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00688; Bodien YG, 2016, ARCH PHYS MED REHAB, V97, P490, DOI 10.1016/j.apmr.2015.08.422; Bodien YG, 2019, CORTEX; Braiman C, 2018, CURR BIOL, V28, P3833, DOI 10.1016/j.cub.2018.10.057; Claassen J, 2019, NEW ENGL J MED, V380, P2497, DOI 10.1056/NEJMoa1812757; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Cruse D, 2012, NEUROLOGY, V78, P816, DOI 10.1212/WNL.0b013e318249f764; Cruse D, 2014, NEUROIMAGE-CLIN, V4, P788, DOI 10.1016/j.nicl.2014.05.001; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Curley WH, 2018, BRAIN, V141, P1404, DOI 10.1093/brain/awy070; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Engemann DA, 2018, BRAIN, V141, P3179, DOI 10.1093/brain/awy251; Erlbeck H, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00654; Erler KS, 2018, J HEAD TRAUMA REHAB, V33, P257, DOI 10.1097/HTR.0000000000000383; Forgacs PB, 2014, ANN NEUROL, V76, P869, DOI 10.1002/ana.24283; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 1997, J HEAD TRAUMA REHABI, V12; Gill-Thwaites H, 2006, BRAIN INJURY, V20, P1321, DOI 10.1080/02699050601081802; Gosseries O, 2014, BRAIN INJURY, V28, P1141, DOI 10.3109/02699052.2014.920522; Kirsch M, 2017, ANESTHESIA ANALGESIA; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Noirhomme Q, 2017, NEUROIMAGE, V145, P288, DOI 10.1016/j.neuroimage.2015.12.006; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Piarulli A, 2016, J NEUROL, V263, P1746, DOI 10.1007/s00415-016-8196-y; Rohaut B, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2370-4; Rohaut B, 2015, NEUROPSYCHOLOGIA, V66, P279, DOI 10.1016/j.neuropsychologia.2014.10.014; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2016, NEUROLOGY CONCIOUSNE; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Stender J, 2016, CURR BIOL, V26, P1494, DOI 10.1016/j.cub.2016.04.024; Stender J, 2015, J CEREBR BLOOD F MET, V35, P58, DOI 10.1038/jcbfm.2014.169; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Steppacher I, 2013, ANN NEUROL, V73, P594, DOI 10.1002/ana.23835; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; SYNEK VM, 1988, J CLIN NEUROPHYSIOL, V5, P161, DOI 10.1097/00004691-198804000-00003; TEASDALE G, 1974, LANCET, V2, P81; Threlkeld ZD, 2018, CORTEX, V106, P299, DOI 10.1016/j.cortex.2018.05.004; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611	48	5	5	1	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2020	33	2					449	457		10.1007/s12028-019-00904-3			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NS0NU	WOS:000571957800016	31900883	Green Accepted			2022-02-06	
J	Hicks, SD; Onks, C; Kim, RY; Zhen, KJ; Loeffert, J; Loeffert, AC; Olympia, RP; Fedorchak, G; DeVita, S; Rangnekar, A; Leddy, J; Haider, MN; Gagnon, Z; McLoughlin, CD; Badia, M; Randall, J; Madeira, M; Yengo-Kahn, AM; Wenzel, J; Heller, M; Zwibel, H; Roberts, A; Johnson, S; Monteith, C; Dretsch, MN; Campbell, TR; Mannix, R; Neville, C; Middleton, F				Hicks, Steven D.; Onks, Cayce; Kim, Raymond Y.; Zhen, Kevin J.; Loeffert, Jayson; Loeffert, Andrea C.; Olympia, Robert P.; Fedorchak, Gregory; DeVita, Samantha; Rangnekar, Aakanksha; Leddy, John; Haider, Mohammad N.; Gagnon, Zofia; McLoughlin, Callan D.; Badia, Matthew; Randall, Jason; Madeira, Miguel; Yengo-Kahn, Aaron M.; Wenzel, Justin; Heller, Matthew; Zwibel, Hallie; Roberts, Aaron; Johnson, Samantha; Monteith, Chuck; Dretsch, Michael N.; Campbell, Thomas R.; Mannix, Rebekah; Neville, Christopher; Middleton, Frank			Diagnosing mild traumatic brain injury using saliva RNA compared to cognitive and balance testing	CLINICAL AND TRANSLATIONAL MEDICINE			English	Article						balance; biomarker; concussion; diagnosis; neurocognition; RNA; saliva; traumatic brain injury	CONCUSSION; MICRORNA; BIOMARKERS; SYMPTOMS; SERUM; MARKERS; IMPACT	Background Early, accurate diagnosis of mild traumatic brain injury (mTBI) can improve clinical outcomes for patients, but mTBI remains difficult to diagnose because of reliance on subjective symptom reports. An objective biomarker could increase diagnostic accuracy and improve clinical outcomes. The aim of this study was to assess the ability of salivary noncoding RNA (ncRNA) to serve as a diagnostic adjunct to current clinical tools. We hypothesized that saliva ncRNA levels would demonstrate comparable accuracy for identifying mTBI as measures of symptom burden, neurocognition, and balance. Methods This case-control study involved 538 individuals. Participants included 251 individuals with mTBI, enrolled <= 14 days postinjury, from 11 clinical sites. Saliva samples (n = 679) were collected at five time points (<= 3, 4-7, 8-14, 15-30, and 31-60 days post-mTBI). Levels of ncRNAs (microRNAs, small nucleolar RNAs, and piwi-interacting RNAs) were quantified within each sample using RNA sequencing. The first sample from each mTBI participant was compared to saliva samples from 287 controls. Samples were divided into testing (n = 430; mTBI = 201 and control = 239) and training sets (n = 108; mTBI = 50 and control = 58). The test set was used to identify ncRNA diagnostic candidates and create a diagnostic model. Model accuracy was assessed in the naive test set. Results A model utilizing seven ncRNA ratios, along with participant age and chronic headache status, differentiated mTBI and control participants with a cross-validated area under the curve (AUC) of .857 in the training set (95% CI, .816-.903) and .823 in the naive test set. In a subset of participants (n = 321; mTBI = 176 and control = 145) assessed for symptom burden (Post-Concussion Symptom Scale), as well as neurocognition and balance (ClearEdge System), these clinical measures yielded cross-validated AUC of .835 (95% CI, .782-.880) and .853 (95% CI, .803-.899), respectively. A model employing symptom burden and four neurocognitive measures identified mTBI participants with similar AUC (.888; CI, .845-.925) as symptom burden and four ncRNAs (.932; 95% CI, .890-.965). Conclusion Salivary ncRNA levels represent a noninvasive, biologic measure that can aid objective, accurate diagnosis of mTBI.	[Hicks, Steven D.; Zhen, Kevin J.; Loeffert, Andrea C.] Penn State Coll Med, Dept Pediat, 500 Univ Dr, Hershey, PA 17033 USA; [Onks, Cayce; Loeffert, Jayson] Penn State Coll Med, Dept Family Med, Hershey, PA USA; [Kim, Raymond Y.] Penn State Coll Med, Dept Orthoped & Rehabil, Hershey, PA USA; [Olympia, Robert P.] Penn State Coll Med, Dept Emergency Med, Hershey, PA USA; [Fedorchak, Gregory; DeVita, Samantha; Rangnekar, Aakanksha] Quadrant Biosci, Syracuse, NY USA; [Leddy, John; Haider, Mohammad N.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, UBMD Orthoped & Sports Med, Buffalo, NY USA; [Gagnon, Zofia; McLoughlin, Callan D.; Badia, Matthew] Marist Coll, Dept Biomed Sci, Poughkeepsie, NY USA; [Randall, Jason] Marist Coll, Sch Sci, Dept Environm Sci, Poughkeepsie, NY USA; [Madeira, Miguel] Marist Coll, Sch Sci, Dept Biol, Poughkeepsie, NY USA; [Yengo-Kahn, Aaron M.; Wenzel, Justin] Vanderbilt Univ, Med Ctr, Vanderbilt Sports Concuss Ctr, Nashville, TN USA; [Heller, Matthew; Zwibel, Hallie] New York Inst Technol, Coll Osteopath Med, Dept Family Med, Old Westbury, NY 11568 USA; [Roberts, Aaron; Johnson, Samantha] Adena Reg Med Ctr, Adena Bone & Joint Ctr, Chillicothe, OH USA; [Monteith, Chuck] Colgate Univ, Athlet Training Dept, Hamilton, NY 13346 USA; [Dretsch, Michael N.] US Army, Med Res Directorate West, Walter Reed Army Inst Res, Joint Base Lewis McChord, Washington, DC USA; [Campbell, Thomas R.] Old Domin Univ, Athlet Training Dept, Norfolk, VA USA; [Mannix, Rebekah] Harvard Med Sch, Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Neville, Christopher] SUNY Upstate Med Univ, Dept PT Educ Orthoped & Neurosci, Syracuse, NY 13210 USA; [Middleton, Frank] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA		Hicks, SD (corresponding author), Penn State Coll Med, Dept Pediat, 500 Univ Dr, Hershey, PA 17033 USA.	Shicks1@pennstatehealth.psu.edu		Kim, Raymond/0000-0003-4229-904X; DeVita, Samantha/0000-0002-4843-7709; Hicks, Steven/0000-0002-9579-6798	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR002015, UL1 TR002014] Funding Source: Medline		Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; [Anonymous], 2015, C TRAUM BRAIN INJ US; Atif H, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519832286; Bahn JH, 2015, CLIN CHEM, V61, P221, DOI 10.1373/clinchem.2014.230433; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bhomia M, 2016, SCI REP, V6, P12; Bitsko RH, 2018, J DEV BEHAV PEDIATR, V39, P395, DOI 10.1097/DBP.0000000000000571; Boutis K, 2015, J PEDIATR-US, V166, P1214, DOI 10.1016/j.jpeds.2015.02.013; Brooks BL, 2016, J INT NEUROPSYCH SOC, V22, P379, DOI 10.1017/S1355617715001368; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Charek DB, 2020, J HEAD TRAUMA REHAB, V35, P85, DOI 10.1097/HTR.0000000000000476; Chen Rui, 2009, Fa Yi Xue Za Zhi, V25, P249; Choi G, 2018, BIOSENS BIOELECTRON, V115, P83, DOI 10.1016/j.bios.2018.05.019; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Cole WR, 2018, J INT NEUROPSYCH SOC, V24, P156, DOI 10.1017/S1355617717001187; Dadas Aaron, 2018, Concussion, V3, pCNC53, DOI 10.2217/cnc-2017-0019; Davies SC, 2015, J CLIN SPORT PSYCHOL, V9, P101, DOI 10.1123/jcsp.2014-0037; Di Pietro V, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00290; Di Pietro V, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00429; Dretsch MN, 2019, BRAIN INJURY, V33, P1646, DOI 10.1080/02699052.2019.1658226; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Faul M, 2010, TRAUMATIC BRAIN INJU; Follert P, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00005; Gardner A, 2012, APPL NEUROPSYCH-ADUL, V19, P90, DOI 10.1080/09084282.2011.643945; Goreth MB, 2017, CRIT CARE NURS CLIN, V29, P157, DOI 10.1016/j.cnc.2017.01.003; Guan W, 2015, ACS CATAL, V5, P1, DOI 10.1021/cs501653s; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hicks SD, 2018, J NEUROTRAUM, V35, P64, DOI 10.1089/neu.2017.5111; Higgins KL, 2017, ARCH CLIN NEUROPSYCH, V32, P259, DOI 10.1093/arclin/acw108; Hobbs JG, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15617; Johnson JJ, 2018, JAMA PEDIATR, V172, P65, DOI 10.1001/jamapediatrics.2017.3884; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LaRocca D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0207785; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; LUMBABROWN A, 2018, JAMA PEDIAT, V172; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDonald T, 2016, J TRAUMA NURS, V23, P241, DOI 10.1097/JTN.0000000000000227; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Neville C, 2015, MED DEVICES-EVID RES, V8, P447, DOI 10.2147/MDER.S91719; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; Papa L, 2019, J NEUROTRAUM, V36, P1343, DOI 10.1089/neu.2018.6072; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Pape TLB, 2013, PM&R, V5, P856, DOI 10.1016/j.pmrj.2013.06.007; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Prada I, 2018, ACTA NEUROPATHOL, V135, P529, DOI 10.1007/s00401-017-1803-x; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Rozbacher A, 2017, J NEUROTRAUM, V34, P2195, DOI 10.1089/neu.2016.4765; Sarmiento K, 2018, BRAIN INJURY, V32, P889, DOI 10.1080/02699052.2018.1466197; Shahjouei S, 2018, BRAIN INJURY, V32, P1, DOI 10.1080/02699052.2017.1382717; Smith TE, 2016, JNP-J NURSE PRACT, V12, P47, DOI 10.1016/j.nurpra.2015.08.011; VanNostrand M, 2019, BRAIN INJURY, V33, P941, DOI 10.1080/02699052.2019.1619094; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Williams MR, 2017, BIOMED MICRODEVICES, V19, DOI 10.1007/s10544-017-0191-2	65	5	5	3	4	JOHN WILEY & SONS LTD	CHICHESTER	THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND	2001-1326			CLIN TRANSL MED	Clin. Transl. Med.	OCT	2020	10	6							e197	10.1002/ctm2.197			20	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology; Research & Experimental Medicine	OP4OP	WOS:000588061700007	33135344	Green Published, gold			2022-02-06	
J	Hoffman, H; Bunch, KM; Furst, T; Chin, LS				Hoffman, Haydn; Bunch, Katherine M.; Furst, Taylor; Chin, Lawrence S.			Use of Intracranial Pressure Monitoring in Patients with Severe Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Guidelines; Intracranial pressure monitoring; Severe traumatic brain injury	GUIDELINES; MORTALITY; OUTCOMES; IMPACT; MANAGEMENT	OBJECTIVE: The Brain Trauma Foundation (BTF) recommends intracranial pressure (ICP) monitoring for all salvageable patients with an abnormal computed tomography (CT) scan and a Glasgow Coma Scale <9. Studies have shown that compliance with this recommendation is low. We sought to obtain contemporary national rates of ICP monitor placement in patients with severe traumatic brain injury (TBI). METHODS: Patients from the National Trauma Data Bank from 2013 to 2017 who met BTF criteria for ICP monitoring were included. Placement of an intraparenchymal ICP monitor or an external ventricular drain was queried. Binary logistic regression was used to determine factors that influenced the placement of an ICP monitor. RESULTS: A total of 21,374 patients with severe TBI and an abnormal CT scan were included in the study. An ICP monitor was placed in 6543 patients (30.6%). ICP monitor placement increased modestly from 28.6% in 2013 to 32.8% in 2017. The pooled odds of ICP monitor placement between 2014 and 2017 were not different from 2013 (odds ratio, 1.04; 95% confidence interval, 0.99-1.09), but the adjusted odds of ICP monitor placement in 2017 were significantly greater (odds ratio, 1.18; 95% confidence interval, 1.06-1.30). Treatment at a teaching hospital, subdural hematoma, multiple intracranial abnormalities on CT, and greater Injury Severity Score were associated with ICP monitor placement, whereas older age was negatively associated with ICP monitor placement. CONCLUSIONS: The rate of ICP monitoring in patients with severe TBI who meet BTF criteria is low and increased only slightly from 2013 to 2017.	[Hoffman, Haydn; Bunch, Katherine M.; Furst, Taylor; Chin, Lawrence S.] SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA		Hoffman, H (corresponding author), SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA.	hoffmanh@upstate.edu.cell		Furst, Taylor/0000-0002-1588-5230; Hoffman, Haydn/0000-0002-2967-6528			Agrawal D, 2016, J NEUROTRAUM, V33, P853, DOI 10.1089/neu.2015.4015; Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Al Saiegh F, 2020, WORLD NEUROSURG, V136, pE535, DOI 10.1016/j.wneu.2020.01.070; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Alice P, 2017, INJURY, V48, P1944, DOI 10.1016/j.injury.2017.04.033; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balakrishnan B, 2018, PEDIATR NEUROSURG, V53, P379, DOI 10.1159/000494028; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dawes AJ, 2015, JAMA SURG, V150, P965, DOI 10.1001/jamasurg.2015.1678; Dimitriou J, 2016, WORLD NEUROSURG, V89, P641, DOI 10.1016/j.wneu.2015.11.037; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Haddad S, 2011, ANAESTH INTENS CARE, V39, P1043, DOI 10.1177/0310057X1103900610; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; MacLaughlin BW, 2015, AM J SURG, V210, P1082, DOI 10.1016/j.amjsurg.2015.08.007; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Ronning P, 2019, J NEUROSURG, V131, P1896, DOI 10.3171/2018.7.JNS18270; Schupper AJ, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000306; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; Shen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168901; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Volovici V, 2019, J NEUROTRAUM, V36, P988, DOI 10.1089/neu.2018.6086; You WD, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0199-9; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460	29	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2020	142						E385	E395		10.1016/j.wneu.2020.07.022			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NY5WL	WOS:000576459300048	32668331				2022-02-06	
J	Yi, HJ; Lee, JE; Lee, DH; Kim, YI; Cho, CB; Kim, I; Sung, JH; Yang, SH				Yi, Ho Jun; Lee, Jung Eun; Lee, Dong Hoon; Kim, Young Il; Cho, Chul Bum; Kim, Il Sup; Sung, Jae Hoon; Yang, Seung Ho			The role of NLRP3 in traumatic brain injury and its regulation by pioglitazone	JOURNAL OF NEUROSURGERY			English	Article						astrocytes; inflammasome; microglia; NLRP3; pioglitazone; traumatic brain injury	NF-KAPPA-B; INFLAMMASOME ACTIVATION; CEREBROSPINAL-FLUID; PROTEIN; EDEMA; MICE; ULTRASOUND; MICROGLIA; MICROBUBBLES; MODEL	OBJECTIVE Perilesional edema is a predominant mechanism underlying secondary brain injury after traumatic brain injury (TBI). Perilesional edema is characterized by inflammation, production of proinflammatory cytokines, and migration of peripheral immune cells into the brain. The nucleotide-binding domain and leucine-rich repeat (NLR) family pyrin domain- containing 3 protein (NLRP3) is a key component of secondary injury. Pioglitazone regulates NLRP3 and other inflammatory cytokines. In the present study, the role of NLRP3 and the pharmacological effects of pioglitazone were investigated in animal TBI models. METHODS Brain contusion was induced in a weight drop model involving 3 groups of mice: C57 BL/6 (sham group), NLRP3 knockout (K/O group), and pioglitazone-treated mice (treatment group). The percentage of brain water content of the 3 groups of mice was compared over a period of time. Western blot, immunohistochemistry, and immunofluorescence analyses were conducted to investigate NLRP3-related inflammasomes and the effects of pioglitazone in the TBI models. RESULTS Brain edema was the highest on day 3 after TBI in the sham group. Brain edema in both the K/O and the treatment groups was lower than in the sham group. In Western blot, the expression of inflammasomes was higher after TBI in the sham group, but the expression of interleukin-1 beta, caspase-1, and NLRP3 was decreased significantly following treatment with pioglitazone. The expression of GFAP (glial fibrillary acidic protein) and Iba1 was decreased in both the K/O and treatment groups. In addition, confocal microscopy revealed a decrease in microglial cell and astrocyte activation following pioglitazone therapy. CONCLUSIONS The inflammasome NLRP3 plays a pivotal role in regulating cerebral edema and secondary inflammation. Interestingly, pioglitazone reduced cerebral edema and immune response after TBI by downregulating the effects of NLRP3. These results suggest that the clinical application of pioglitazone may be a neuroprotective strategy in TBI.	[Yi, Ho Jun; Lee, Jung Eun; Lee, Dong Hoon; Kim, Young Il; Cho, Chul Bum; Kim, Il Sup; Sung, Jae Hoon; Yang, Seung Ho] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Neurosurg, Seoul, South Korea; [Yang, Seung Ho] Catholic Univ Korea, Coll Med, Cell Death Dis Res Ctr, St Vincents Hosp,Dept Neurosurg, Seoul, South Korea		Yang, SH (corresponding author), Catholic Univ Korea, Coll Med, Cell Death Dis Res Ctr, St Vincents Hosp, Gyeonggi Do, South Korea.	72ysh@catholic.ac.kr		Cho, Chul Bum/0000-0002-2665-7364	St. Vincent's Hospital, Research Institute of the Medical Science Foundation [SVHR-2017-03]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2019R1F1A1041197]	We thank Professor Ki Up Lee for providing the NLRP3 knockout mice for our TBI experiments. We also acknowledge the financial support of St. Vincent's Hospital, Research Institute of the Medical Science Foundation (SVHR-2017-03). This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2019R1F1A1041197).	Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; D'Espessailles A, 2018, J CELL PHYSIOL, V233, P6232, DOI 10.1002/jcp.26490; Esen F, 2003, J NEUROSURG ANESTH, V15, P119, DOI 10.1097/00008506-200304000-00009; Fann DYW, 2018, MOL NEUROBIOL, V55, P1082, DOI 10.1007/s12035-017-0394-9; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Karve Ila P, 2016, Br J Pharmacol, V173, P692, DOI 10.1111/bph.13125; Kernan WN, 2016, NEW ENGL J MED, V374, P1321, DOI 10.1056/NEJMoa1506930; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Liu M, 2017, J NEUROTRAUM, V34, P414, DOI 10.1089/neu.2015.4361; Liu MD, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fincel.2015.00168, 10.3389/fncel.2015.00168]; Ma J, 2016, INFLAMMATION, V39, P2094, DOI 10.1007/s10753-016-0446-8; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meairs S, 2007, PROG BIOPHYS MOL BIO, V93, P354, DOI 10.1016/j.pbiomolbio.2006.07.019; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Park S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15489; Qian HH, 2017, MOL MED REP, V16, P3922, DOI 10.3892/mmr.2017.7079; Qiu J, 2016, INT IMMUNOPHARMACOL, V40, P492, DOI 10.1016/j.intimp.2016.09.024; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Stutz A, 2017, J EXP MED, V214, P1725, DOI 10.1084/jem.20160933; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Thal SC, 2011, J NEUROTRAUM, V28, P983, DOI 10.1089/neu.2010.1685; Wallisch JS, 2017, NEUROCRIT CARE, V27, P44, DOI 10.1007/s12028-017-0378-7; Wang Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181248; Wei X, 2016, J HUAZHONG U SCI-MED, V36, P576, DOI 10.1007/s11596-016-1628-1; Yan YP, 2009, BRAIN RES, V1288, P116, DOI 10.1016/j.brainres.2009.06.073; Yang FY, 2008, ULTRASON SONOCHEM, V15, P636, DOI 10.1016/j.ultsonch.2007.08.003; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Yoo JY, 2012, J NEURO-ONCOL, V109, P219, DOI 10.1007/s11060-012-0890-8; Yoon SH, 2012, PEDIATR NEUROSURG, V48, P102, DOI 10.1159/000343011; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zou P, 2018, MOL MED REP, V17, P3212, DOI 10.3892/mmr.2017.8241	44	5	5	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2020	133	4					1083	1091		10.3171/2019.6.JNS1954			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OM5UM	WOS:000586089500019	31561220				2022-02-06	
J	Bromberg, CE; Condon, AM; Ridgway, SW; Krishna, G; Garcia-Filion, PC; Adelson, PD; Rowe, RK; Thomas, TC				Bromberg, Caitlin E.; Condon, Andrew M.; Ridgway, Samantha W.; Krishna, Gokul; Garcia-Filion, Pamela C.; Adelson, P. David; Rowe, Rachel K.; Thomas, Theresa Currier			Sex-Dependent Pathology in the HPA Axis at a Sub-acute Period After Experimental Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						hypothalamic-pituitary-adrenal axis; diffuse traumatic brain injury; sex-differences; glucocorticoid receptors; neuroinflammation; astrocytosis; microglia; diffuse axonal injury	GONADAL HORMONE REPLACEMENT; RAT ADRENAL-CORTEX; ADRENOCORTICAL STRUCTURE; STRESS-RESPONSE; POSTPUBERTAL GONADECTOMY; GLUCOCORTICOID-RECEPTOR; PLASMA-CORTICOSTERONE; MICROGLIA; NEUROENDOCRINE; EXPRESSION	Over 2.8 million traumatic brain injuries (TBIs) are reported in the United States annually, of which, over 75% are mild TBIs with diffuse axonal injury (DAI) as the primary pathology. TBI instigates a stress response that stimulates the hypothalamic-pituitary-adrenal (HPA) axis concurrently with DAI in brain regions responsible for feedback regulation. While the incidence of affective symptoms is high in both men and women, presentation is more prevalent and severe in women. Few studies have longitudinally evaluated the etiology underlying late-onset affective symptoms after mild TBI and even fewer have included females in the experimental design. In the experimental TBI model employed in this study, evidence of chronic HPA dysregulation has been reported at 2 months post-injury in male rats, with peak neuropathology in other regions of the brain at 7 days post-injury (DPI). We predicted that mechanisms leading to dysregulation of the HPA axis in male and female rats would be most evident at 7 DPI, the sub-acute time point. Young adult age-matched male and naturally cycling female Sprague Dawley rats were subjected to midline fluid percussion injury (mFPI) or sham surgery. Corticotropin releasing hormone, gliosis, and glucocorticoid receptor (GR) levels were evaluated in the hypothalamus and hippocampus, along with baseline plasma adrenocorticotropic hormone (ACTH) and adrenal gland weights. Microglial response in the paraventricular nucleus of the hypothalamus indicated mild neuroinflammation in males compared to sex-matched shams, but not females. Evidence of microglia activation in the dentate gyrus of the hippocampus was robust in both sexes compared with uninjured shams and there was evidence of a significant interaction between sex and injury regarding microglial cell count. GFAP intensity and astrocyte numbers increased as a function of injury, indicative of astrocytosis. GR protein levels were elevated 30% in the hippocampus of females in comparison to sex-matched shams. These data indicate sex-differences in sub-acute pathophysiology following DAI that precede late-onset HPA axis dysregulation. Further understanding of the etiology leading up to late-onset HPA axis dysregulation following DAI could identify targets to stabilize feedback, attenuate symptoms, and improve efficacy of rehabilitation and overall recovery.	[Bromberg, Caitlin E.; Krishna, Gokul; Adelson, P. David; Rowe, Rachel K.; Thomas, Theresa Currier] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85016 USA; [Bromberg, Caitlin E.; Condon, Andrew M.; Ridgway, Samantha W.; Krishna, Gokul; Adelson, P. David; Rowe, Rachel K.; Thomas, Theresa Currier] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85004 USA; [Condon, Andrew M.] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Ridgway, Samantha W.] Arizona State Univ, Dept Biol, Sch Life Sci, Tempe, AZ USA; [Garcia-Filion, Pamela C.] Univ Arizona, Dept Biomed Informat, Coll Med Phoenix, Phoenix, AZ USA; [Adelson, P. David] Mayo Clin, Dept Neurosurg, Sch Med, Phoenix, AZ USA; [Adelson, P. David] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA; [Rowe, Rachel K.; Thomas, Theresa Currier] Phoenix VA Hlth Care Syst, Phoenix, AZ 85012 USA		Thomas, TC (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85016 USA.; Thomas, TC (corresponding author), Phoenix VA Hlth Care Syst, Phoenix, AZ 85012 USA.	theresathomas@email.arizona.edu	; Gokul, Krishna/H-3365-2019	Rowe, Rachel/0000-0002-9034-3159; Gokul, Krishna/0000-0001-5869-2204; Thomas, Theresa/0000-0002-9619-7666	Valley Research Partnership [VRP P1201706]; Arizona Biomedical Research Commission through Arizona Department of Health Services [ADHS14-00003606]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS100793]; Phoenix Children's Hospital Mission Support	This project was funded, in part, by Valley Research Partnership (VRP P1201706), Arizona Biomedical Research Commission through Arizona Department of Health Services (ADHS14-00003606), and National Institutes of Health (R01NS100793) to TCT, and Phoenix Children's Hospital Mission Support. This content was solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, ADHS, or Phoenix VA Healthcare System.	Andreollo NA, 2012, ABCD-ARQ BRAS CIR DI, V25, P49, DOI 10.1590/S0102-67202012000100011; Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Ataka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081744; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Becerra-Calixto A, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00088; Beitchman JA, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01434; Bollinger JL, 2019, J NEUROENDOCRINOL, V31, DOI 10.1111/jne.12762; Brett CE, 2017, NEUROPSYCHOL REHABIL, V27, P959, DOI 10.1080/09602011.2015.1090459; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Bukovsky Antonin, 2003, Reprod Biol Endocrinol, V1, P46, DOI 10.1186/1477-7827-1-46; Centers for Disease Control and Prevention, 2013, INJ PREV CONTR TRAUM; Chatterjee S, 2014, J NEUROCHEM, V128, P476, DOI 10.1111/jnc.12478; Chen C, 2017, FRONT NEUROENDOCRIN, V44, P83, DOI 10.1016/j.yfrne.2016.12.001; Chen X, 2014, J NEUROL SCI, V342, P93, DOI 10.1016/j.jns.2014.04.032; Cope EC, 2018, J NEUROSCI, V38, P8889, DOI 10.1523/JNEUROSCI.0789-18.2018; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; De Koning ME, 2018, BRAIN INJURY, V32, P540, DOI 10.1080/02699052.2018.1431844; Koning ME, 2017, J NEUROTRAUM, V34, P257, DOI 10.1089/neu.2015.4377; de la Tremblaye PB, 2018, NEUROSCI BIOBEHAV R, V85, P160, DOI 10.1016/j.neubiorev.2017.05.022; de la Tremblaye PB, 2014, HORM BEHAV, V65, P273, DOI 10.1016/j.yhbeh.2014.01.003; Erler KS, 2018, J HEAD TRAUMA REHAB, V33, P257, DOI 10.1097/HTR.0000000000000383; Fakhoury M, 2018, CURR NEUROPHARMACOL, V16, P508, DOI 10.2174/1570159X15666170720095240; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Frank MG, 2012, BRAIN BEHAV IMMUN, V26, P337, DOI 10.1016/j.bbi.2011.10.005; Garcia-Ovejero D, 2002, J COMP NEUROL, V450, P256, DOI 10.1002/cne.10325; Gefen T, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00094; Goel N, 2014, COMPR PHYSIOL, V4, P1121, DOI 10.1002/cphy.c130054; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Griesbach GS, 2014, J NEUROTRAUM, V31, P674, DOI 10.1089/neu.2013.3151; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Guaraldi F, 2015, J CLIN MED, V4, P1025, DOI 10.3390/jcm4051025; Hailer NP, 1999, EUR J NEUROSCI, V11, P3359, DOI 10.1046/j.1460-9568.1999.00808.x; Hannibal KE, 2014, PHYS THER, V94, P1816, DOI 10.2522/ptj.20130597; Harrison JL, 2016, NEURAL REGEN RES, V11, P77, DOI 10.4103/1673-5374.175046; Hoffman AN, 2017, J NEUROTRAUM, V34, P213, DOI 10.1089/neu.2015.4339; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Ilie G, 2015, J PSYCHIATR RES, V69, P174, DOI 10.1016/j.jpsychires.2015.08.004; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Joels M, 2007, PROG BRAIN RES, V163, P355, DOI 10.1016/S0079-6123(07)63021-0; Johann S, 2013, J STEROID BIOCHEM, V137, P71, DOI 10.1016/j.jsbmb.2012.11.006; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; KASPRZAK A, 1986, EXP CLIN ENDOCRINOL, V87, P26, DOI 10.1055/s-0029-1210518; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; KING LR, 1970, ANN SURG, V172, P975, DOI 10.1097/00000658-197012000-00008; Kodama L, 2019, TRENDS MOL MED, V25, P741, DOI 10.1016/j.molmed.2019.05.001; Korosi A, 2008, EUR J PHARMACOL, V583, P204, DOI 10.1016/j.ejphar.2007.11.066; Kraft AD, 2011, INT J ENV RES PUB HE, V8, P2980, DOI 10.3390/ijerph8072980; Krishna G, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00749; Krishna G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020588; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Li TJ, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00840; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Liossi C, 2009, J NEUROPSYCH CLIN N, V21, P43, DOI 10.1176/appi.neuropsych.21.1.43; Lisembee AM, 2010, J NEUROTRAUM, V27, pA29, DOI [10.1089/neu.2010.9950, DOI 10.1089/NEU.2010.9950]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAJCHRZAK M, 1983, CELL TISSUE RES, V232, P457, DOI 10.1007/BF00213800; MALENDOWICZ LK, 1974, CELL TISSUE RES, V151, P525, DOI 10.1007/BF00222997; MALENDOWICZ LK, 1974, CELL TISSUE RES, V151, P537, DOI 10.1007/BF00222998; Maras PM, 2012, TRENDS NEUROSCI, V35, P315, DOI 10.1016/j.tins.2012.01.005; Marquardt N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203793; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Meffre D, 2013, NEUROSCIENCE, V231, P111, DOI 10.1016/j.neuroscience.2012.11.039; Meijer OC, 1998, CRIT REV NEUROBIOL, V12, P1; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Munoz MJ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00044; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; National Women's Health Network, 2017, DOM AB BRAIN INJ WOM; Oyesanya TO, 2016, HEALTH CARE WOMEN IN, V37, P45, DOI 10.1080/07399332.2015.1005307; Oyola MG, 2017, STRESS, V20, P476, DOI 10.1080/10253890.2017.1369523; Paretkar T, 2018, NEUROSCIENCE, V390, P187, DOI 10.1016/j.neuroscience.2018.08.019; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Piao Y, 2013, J TOXICOL PATHOL, V26, P29, DOI 10.1293/tox.26.29; Pietrobelli A, 2002, INT J OBESITY, V26, P1339, DOI 10.1038/sj.ijo.0802065; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Popescu C, 2015, J Med Life, V8, P272; Popovich PG, 2009, ENCY NEUROSCI, P853, DOI [10.1016/B978-008045046-9.00018-8, DOI 10.1016/B978-008045046-9.00018-8]; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ranganathan P, 2016, BRAIN INJURY, V30, P452, DOI 10.3109/02699052.2016.1144081; Ridgway S, 2019, THESIS; Roe SY, 1998, EUR J NEUROSCI, V10, P553, DOI 10.1046/j.1460-9568.1998.00064.x; ROLLS BJ, 1979, PHYSIOL BEHAV, V23, P241, DOI 10.1016/0031-9384(79)90361-5; Rowe RK, 2016, METHODS MOL BIOL, V1462, P211, DOI 10.1007/978-1-4939-3816-2_13; Rowe RK, 2016, ENDOCR CONNECT, V5, P152, DOI 10.1530/EC-16-0031; Russell AL, 2018, NEUROSCIENCE, V392, P1, DOI 10.1016/j.neuroscience.2018.09.014; Russell AL, 2018, ENDOCRINOLOGY, V159, P2363, DOI 10.1210/en.2018-00203; Saber M, 2020, EUR J NEUROSCI, V52, P2791, DOI 10.1111/ejn.14611; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Shi P, 2010, HYPERTENSION, V56, P297, DOI 10.1161/HYPERTENSIONAHA.110.150409; SLOB AK, 1975, PHYSIOL BEHAV, V14, P353, DOI 10.1016/0031-9384(75)90044-X; Sophie Su Y, 2016, TRANSLATIONAL RES TR; STEINBEHRENS B, 1994, J NEUROSCI, V14, P5373; Tapp ZM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00345; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2018, J NEUROTRAUM, V35, P630, DOI 10.1089/neu.2017.5238; Taylor AN, 2013, J NEUROTRAUM, V30, P1250, DOI 10.1089/neu.2012.2847; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Taylor AN, 2006, J NEUROTRAUM, V23, P1802, DOI 10.1089/neu.2006.23.1802; Taylor SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097096; Thomas TC, 2015, BRAIN NEUROTRAUMA MO, P531, DOI [10.1201/b18126-43, DOI 10.1201/B18126-43]; Thomas TC, 2018, BEHAV BRAIN RES, V340, P137, DOI 10.1016/j.bbr.2016.12.038; Thomas TC, 2017, RESTOR NEUROL NEUROS, V35, P611, DOI 10.3233/RNN-170753; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Toninato J, 2018, CONT CLIN TRIAL COMM, V11, P102, DOI 10.1016/j.conctc.2018.06.007; Trejter M, 2015, INT J MOL MED, V35, P702, DOI 10.3892/ijmm.2015.2064; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Ulrich-Lai YM, 2006, AM J PHYSIOL-ENDOC M, V291, pE965, DOI 10.1152/ajpendo.00070.2006; Vahl TP, 2005, AM J PHYSIOL-ENDOC M, V289, pE823, DOI 10.1152/ajpendo.00122.2005; van der Horn HJ, 2016, BRAIN IMAGING BEHAV, V10, P1243, DOI 10.1007/s11682-015-9489-y; van der Horn HJ, 2020, J NEUROL, V267, P2497, DOI 10.1007/s00415-019-09335-8; Villa A, 2016, ENDOCR REV, V37, P372, DOI 10.1210/er.2016-1007; Villa RF, 2018, PHARMACOL THERAPEUT, V184, P131, DOI 10.1016/j.pharmthera.2017.11.005; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Wang CC, 2009, SYNAPSE, V63, P745, DOI 10.1002/syn.20654; Wang Q, 2013, NEUROBIOL AGING, V34, P1662, DOI 10.1016/j.neurobiolaging.2012.11.019; Wang ZJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09442; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027; Wohleb ES, 2012, PSYCHONEUROENDOCRINO, V37, P1491, DOI 10.1016/j.psyneuen.2012.02.003; Wohleb ES, 2011, J NEUROSCI, V31, P6277, DOI 10.1523/JNEUROSCI.0450-11.2011; Wu XY, 2015, PHYSIOL BEHAV, V145, P118, DOI 10.1016/j.physbeh.2015.04.003; Young K, 2018, JOVE-J VIS EXP, DOI 10.3791/57648; Yuan FF, 2019, MOLECULES, V24, DOI 10.3390/molecules24193517; Zardooz H, 2010, PHYSIOL RES, V59, P973, DOI 10.33549/physiolres.931896; Ziebell JM, 2017, NEUROSCIENCE, V359, P209, DOI 10.1016/j.neuroscience.2017.07.027	132	5	5	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 30	2020	11								946	10.3389/fneur.2020.00946			19	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OC3SA	WOS:000579077200001	33101162	Green Published, gold			2022-02-06	
J	Gravesteijn, BY; Sewalt, CA; Stocchetti, N; Citerio, G; Ercole, A; Lingsma, HF; von Steinbuchel, N; Steyerberg, EW; Wilson, L; Maas, AIR; Menon, DK; Lecky, FE				Gravesteijn, Benjamin Yael; Sewalt, Charlie Aletta; Stocchetti, Nino; Citerio, Giuseppe; Ercole, Ari; Lingsma, Hester Floor; von Steinbuchel, Nicole; Steyerberg, Ewout Willem; Wilson, Lindsay; Maas, Andrew I. R.; Menon, David K.; Lecky, Fiona Elizabeth		CENTER-TBI Collaborators	Prehospital Management of Traumatic Brain Injury across Europe: A CENTER-TBI Study	PREHOSPITAL EMERGENCY CARE			English	Article						traumatic brain injury; prospective; guidelines; practice; prehospital care	RAPID-SEQUENCE INTUBATION; EPIDEMIOLOGY; SCOOP; STAY; PLAY; CARE	Background Prehospital care for traumatic brain injury (TBI) is important to prevent secondary brain injury. We aim to compare prehospital care systems within Europe and investigate the association of system characteristics with the stability of patients at hospital arrival. Methods We studied TBI patients who were transported to CENTER-TBI centers, a pan-European, prospective TBI cohort study, by emergency medical services between 2014 and 2017. The association of demographic factors, injury severity, situational factors, and interventions associated with on-scene time was assessed using linear regression. We used mixed effects models to investigate the case mix adjusted variation between countries in prehospital times and interventions. The case mix adjusted impact of on-scene time and interventions on hypoxia (oxygen saturation <90%) and hypotension (systolic blood pressure <100mmHg) at hospital arrival was analyzed with logistic regression. Results Among 3878 patients, the greatest driver of longer on-scene time was intubation (+8.3 min, 95% CI: 5.6-11.1). Secondary referral was associated with shorter on-scene time (-5.0 min 95% CI: -6.2- -3.8). Between countries, there was a large variation in response (range: 12-25 min), on-scene (range: 16-36 min) and travel time (range: 15-32 min) and in prehospital interventions. These variations were not explained by patient factors such as conscious level or severity of injury (expected OR between countries: 1.8 for intubation, 1.8 for IV fluids, 2.0 for helicopter). On-scene time was not associated with the regional EMS policy (p= 0.58). Hypotension and/or hypoxia were seen in 180 (6%) and 97 (3%) patients in the overall cohort and in 13% and 7% of patients with severe TBI (GCS <8). The largest association with secondary insults at hospital arrival was with major extracranial injury: the OR was 3.6 (95% CI: 2.6-5.0) for hypotension and 4.4 (95% CI: 2.9-6.7) for hypoxia. Discussion Hypoxia and hypotension continue to occur in patients who suffer a TBI, and remain relatively common in severe TBI. Substantial variation in prehospital care exists for patients after TBI in Europe, which is only partially explained by patient factors.	[Gravesteijn, Benjamin Yael; Sewalt, Charlie Aletta; Lingsma, Hester Floor; Steyerberg, Ewout Willem] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Stocchetti, Nino] Milan Univ, Dept Pathophysiol & Transplantat, Milan, Italy; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Antwerp, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Antwerp, Belgium; [Ercole, Ari; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [von Steinbuchel, Nicole] Univ Med Gottingen, Inst Med Psychol & Med Sociol, Gottingen, Germany; [Steyerberg, Ewout Willem] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands; [Wilson, Lindsay] Univ Stirling, Div Physiol, Stirling, Scotland; [Lecky, Fiona Elizabeth] Univ Sheffield, Sch Hlth & Related Res, Hlth Serv Res Sect, Ctr Urgent & Emergency Care Res, Sheffield, S Yorkshire, England; [Lecky, Fiona Elizabeth] Salford Royal Hosp, Emergency Dept, Salford, Lancs, England		Gravesteijn, BY (corresponding author), Na Bldg,Room Na-2318,Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.	b.gravesteijn@erasmusmc.nl	Posti, Jussi P./Y-2908-2019; Ercole, Ari/B-6288-2009; Maas, Andrew I.R./C-5584-2013; Steyerberg, Ewout/C-1509-2018	Posti, Jussi P./0000-0002-5925-5193; Ercole, Ari/0000-0001-8350-8093; Maas, Andrew I.R./0000-0003-1612-1264; Gravesteijn, Benjamin/0000-0001-8096-5803; Steyerberg, Ewout/0000-0002-7787-0122; Radoi, Andreea/0000-0002-0677-3544	European Union 7th Framework Program (EC) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	This work was supported by the European Union 7th Framework Program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), OneMind (USA) and the Integra LifeSciences Corporation (USA). The funders had no role in the study design, enrollment, collection of data, writing or publication decisions.	Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Cnossen MC, 2019, J NEUROTRAUM, V36, P176, DOI 10.1089/neu.2018.5712; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Cnossen MC, 2016, J NEUROTRAUM; Cudnik MT, 2007, PREHOSP EMERG CARE, V11, P224, DOI 10.1080/10903120701205208; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Ebben RHA, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-9; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Gravesteijn BY, 2020, ANAESTHESIA, V75, P45, DOI 10.1111/anae.14838; King Steven G, 2003, JEMS, V28, P14; Little R., 1991, J EDUC STAT, V16, P150; Lodwick G, 2017, BRIT J HOSP MED, V78, P118, DOI 10.12968/hmed.2017.78.2.118; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Neeraj Badjatia A, 2006, PREHOSPITAL GUIDELIN; Nirula R, 2010, J TRAUMA, V69, P595, DOI 10.1097/TA.0b013e3181ee6e32; Raj R, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-67; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; Smith RM, 2009, INJURY, V40, pS23, DOI 10.1016/j.injury.2009.10.033; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]	26	5	5	1	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	AUG 31	2021	25	5					629	643		10.1080/10903127.2020.1817210		SEP 2020	15	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	UK6ZS	WOS:000574195800001	32877267	Green Submitted, hybrid, Green Published			2022-02-06	
J	Jones, KF; Pryor, J; Care-Unger, C; Simpson, G				Jones, Kate Fiona; Pryor, Julie; Care-Unger, Candice; Simpson, Grahame			"Spirituality is everybody's business": an exploration of the impact of spiritual care training upon the perceptions and practice of rehabilitation professionals	DISABILITY AND REHABILITATION			English	Article; Early Access						Spirituality; spiritual care; training; evaluation; health professionals; spinal cord injury; traumatic brain injury; rehabilitation	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; RESILIENCE; ADJUSTMENT; PROGRAM; NURSES; DEPRESSION; LIFE	Purpose This study explored the impact of a brief spiritual care training program upon the perceptions and self-reported practice of rehabilitation professionals working in traumatic injury. Methodology and methods A qualitative study. Semi-structured interviews were held with staff from a rehabilitation hospital in Sydney, Australia, between six and eight weeks after participation in spiritual care training. A thematic analysis was conducted. Results Of the 41 rehabilitation professionals who attended the training (1 h online, 1.5 h face to face), 16 agreed to be interviewed. The majority worked in spinal cord injury and were female. Half reported holding a Christian affiliation. One overarching theme and six sub-themes were identified from the qualitative data. The overarching theme was "spirituality is everybody's business". The six sub-themes were: (i) increased awareness of the nature of spirituality, (ii) realisation of the importance of spirituality to clients, (iii) a desire to keep spirituality on the radar, (iv) identifying barriers to providing spiritual care (v) incorporating spirituality into practice, and, (vi) recognising spirituality as personally meaningful. Conclusions A brief spiritual care training program can impact positively upon perceptions and practice of rehabilitation professionals. Ongoing training is needed to ensure that staff retain what was learnt.	[Jones, Kate Fiona; Pryor, Julie; Care-Unger, Candice] Royal Rehab, Sydney, NSW, Australia; [Jones, Kate Fiona; Simpson, Grahame] Griffith Univ, Sch Human Serv & Social Work, Brisbane, Qld, Australia; [Jones, Kate Fiona] Univ Notre Dame, Inst Eth & Soc, Sydney, NSW, Australia; [Pryor, Julie] Univ Sydney, Susan Wakil Sch Nursing & Midwifery, Sydney, NSW, Australia; [Simpson, Grahame] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Sydney, NSW, Australia		Jones, KF (corresponding author), Univ Notre Dame, Inst Eth & Soc, POB 944, Broadway, NSW 2007, Australia.	kate.jones1@nd.edu.au	Jones, Kate/AAV-7641-2021	Simpson, Grahame/0000-0001-8156-9060; Pryor, Julie/0000-0003-4907-8530; Jones, Kate/0000-0002-5964-3479	Community of Christ	This project was funded by a grant from Community of Christ.	Agyemang A, 2017, ARCH PHYS MED REHABI, V98, pe81, DOI 10.1016/j.apmr.2016.12.016; Anandarajah G, 2016, J PAIN SYMPTOM MANAG, V52, P859, DOI 10.1016/j.jpainsymman.2016.06.006; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Bandini JI, 2019, J PALLIAT MED, V22, P1236, DOI 10.1089/jpm.2018.0616; Bar-Sela G, 2019, PALLIAT SUPPORT CARE, V17, P345, DOI 10.1017/S147895151800055X; Best M, 2016, J CLIN MED, V5, DOI 10.3390/jcm5090077; Best M, 2016, SUPPORT CARE CANCER, V24, P3295, DOI 10.1007/s00520-016-3135-0; Biro AL, 2012, J NURS MANAGE, V20, P1002, DOI 10.1111/j.1365-2834.2012.01444.x; Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cerra A, 2008, J CHRIST NURS, V25, P204, DOI 10.1097/01.CNJ.0000337006.04272.d1; Chun S, 2013, DISABIL REHABIL, V35, P11, DOI 10.3109/09638288.2012.687026; Cobb Mark, 2012, OXFORD TXB SPIRITUAL; Davis DE, 2015, J COUNS PSYCHOL, V62, P503, DOI 10.1037/cou0000082; DeSanto-Madeya S, 2006, WESTERN J NURS RES, V28, P265, DOI 10.1177/0193945905283178; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Dryden DM, 2005, NEUROEPIDEMIOLOGY, V25, P55, DOI 10.1159/000086284; Gowri ANANDARAJAH, 2001, AM FAM PHYSICIAN, V63, P1; Hodge DR, 2013, SOC WORK, V58, P223, DOI 10.1093/sw/swt019; Hubbell SL, 2017, J CONTIN EDUC NURS, V48, P358, DOI 10.3928/00220124-20170712-07; Johnstone B, 2007, DISABIL REHABIL, V29, P1153, DOI 10.1080/09638280600955693; Jones K, 2016, DISABIL REHABIL, V38, P921, DOI 10.3109/09638288.2015.1066884; Jones KF, 2018, BRAIN INJURY, V32, P1612, DOI 10.1080/02699052.2018.1511066; Jones KF, 2019, CLIN REHABIL, V33, P1503, DOI 10.1177/0269215519845034; Jones KF, 2018, REHABIL PSYCHOL, V63, P521, DOI 10.1037/rep0000229; Jones Kate Fiona, 2018, Spinal Cord Ser Cases, V4, P54, DOI 10.1038/s41394-018-0078-3; Jones K, 2020, PROF DEV EDUC, V46, P1, DOI 10.1080/19415257.2020.1694187; Kennedy P, 2009, PSYCHOL HEALTH MED, V14, P17, DOI 10.1080/13548500802001801; Kirshblum S., 2009, SPINAL CORD INJURIES, P1, DOI DOI 10.1016/B978-032300699-6.10001-2; Koenig Harold G, 2012, ISRN Psychiatry, V2012, P278730, DOI 10.5402/2012/278730; Lind B, 2011, CRIT CARE NURSE, V31, P87, DOI 10.4037/ccn2011372; McSherry W., 2010, RCN SPIRITUALITY SUR; Meredith P, 2012, J RELIG HEALTH, V51, P879, DOI 10.1007/s10943-010-9399-7; Middleton JW, 2014, ARCH PHYS MED REHAB, V95, P1312, DOI 10.1016/j.apmr.2014.03.017; Minichiello V., 2008, IN DEPTH INTERVIEWIN; Monden KR, 2014, SPINAL CORD, V52, P197, DOI 10.1038/sc.2013.159; Nas K, 2015, WORLD J ORTHOP, V6, P1, DOI 10.5312/wjo.v6.i1.1; NHS Education for Scotland, 2013, SPIRITUAL CARE; O'Brien MR, 2019, J CLIN NURS, V28, P182, DOI 10.1111/jocn.14648; Paal P, 2015, J PASTOR CARE COUNS, V69, P19, DOI 10.1177/1542305015572955; Pearce MJ, 2019, SPIRITUAL CLIN PRACT, V6, P73, DOI 10.1037/scp0000195; Pollard C, 2007, BRIT J HEALTH PSYCH, V12, P347, DOI 10.1348/135910707X197046; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Puchalski C, 2000, J Palliat Med, V3, P129, DOI 10.1089/jpm.2000.3.129; Puchalski C, 2009, J PALLIAT MED, V12, P10; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Schonherr MC, 2005, SPINAL CORD, V43, P241, DOI 10.1038/sj.sc.3101683; Simpson GK, 2020, NEUROREHABILITATION, V46, P3, DOI 10.3233/NRE-192945; Simpson R., 2013, Nature & Faune, V27, P4; Sulmasy Daniel P, 2002, Gerontologist, V42 Spec No 3, P24; Webb JR, 2010, DISABIL REHABIL, V32, P360, DOI 10.3109/09638280903166360; White B, 2010, REHABIL PSYCHOL, V55, P23, DOI 10.1037/a0018451; Yang GM, 2017, PALLIAT SUPPORT CARE, V15, P434, DOI 10.1017/S1478951516000894	53	5	5	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2020.1820586		SEP 2020	10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	NT7GZ	WOS:000573105800001	32976734	Green Submitted			2022-02-06	
J	Torres-Esquivel, C; Montiel, T; Flores-Mendez, M; Massieu, L				Torres-Esquivel, Carmen; Montiel, Teresa; Flores-Mendez, Marco; Massieu, Lourdes			Effect of beta-Hydroxybutyrate on Autophagy Dynamics During Severe Hypoglycemia and the Hypoglycemic Coma	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						hypoglycemia; ketone bodies; neuronal death; autophagy; AMPK	FUNCTION IMPROVING AGENT; TRAUMATIC BRAIN-INJURY; PROTECTS RAT-BRAIN; NEURONAL DEATH; KETONE-BODIES; ISCHEMIA; GLUCOSE; EXPRESSION; METABOLISM; HYPOXIA	Glucose supply from blood is mandatory for brain functioning and its interruption during acute hypoglycemia or cerebral ischemia leads to brain injury. Alternative substrates to glucose such as the ketone bodies (KB), acetoacetate (AcAc), and beta-hydroxybutyrate (BHB), can be used as energy fuels in the brain during hypoglycemia and prevent neuronal death, but the mechanisms involved are still not well understood. During glucose deprivation adaptive cell responses can be activated such as autophagy, a lysosomal-dependent degradation process, to support cell survival. However, impaired or excessive autophagy can lead to cell dysfunction. We have previously shown that impaired autophagy contributes to neuronal death induced by glucose deprivation in cortical neurons and that D isomer of BHB (D-BHB) reestablishes the autophagic flux increasing viability. Here, we aimed to investigate autophagy dynamics in the brain of rats subjected to severe hypoglycemia (SH) without glucose infusion (GI), severe hypoglycemia followed by GI (SH + GI), and a brief period of hypoglycemic coma followed by GI (Coma). The effect of D-BHB administration after the coma was also tested (Coma + BHB). The transformation of LC3-I to LC3-II and the abundance of autophagy proteins, Beclin 1 (BECN1), ATG7, and ATG12-ATG5 conjugate, were analyzed as an index of autophagosome formation, and the levels of sequestrosome1/p62 (SQSTM1/p62) were determined as a hallmark of autophagic degradation. Data suggest that autophagosomes accumulate in the cortex and the hippocampus of rats after SH, likely due to impaired autophagic degradation. In the cortex, autophagosome accumulation persisted at 6 h after GI in animals exposed to SH but recovered basal levels at 24 h, while in the hippocampus no significant effect was observed. In animals subjected to coma, autophagosome accumulation was observed at 24 h after GI in both regions. D-BHB treatment reduced LC3-II and SQSTM1/p62 content and reduced ULK1 phosphorylation by AMPK, suggesting it stimulates the autophagic flux and decreases AMPK activity reducing autophagy initiation. D-BHB also reduced the number of degenerating cells. Together, data suggest different autophagy dynamics after GI in rats subjected to SH or the hypoglycemic coma and support that D-BHB treatment can modulate autophagy dynamics favoring the autophagic flux.	[Torres-Esquivel, Carmen; Montiel, Teresa; Flores-Mendez, Marco; Massieu, Lourdes] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Dept Neuropatol Mol, Mexico City, DF, Mexico; [Flores-Mendez, Marco] Childrens Hosp Philadelphia, Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA		Massieu, L (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Dept Neuropatol Mol, Mexico City, DF, Mexico.	lmassieu@ifc.unam.mx			PAPIIT-UNAMPrograma de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico [IN204919]; CONACyTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [A1S-17357]; CONACyT fellowshipConsejo Nacional de Ciencia y Tecnologia (CONACyT) [573885]	The present work was supported by PAPIIT-UNAM grant IN204919 and CONACyT grant A1S-17357 to LM. CT-E is a doctoral student from the Programa de Doctorado en Ciencias Biomedicas, at the Universidad Nacional Autonoma de Mexico (UNAM) and she was a recipient of CONACyT fellowship (573885).	Amador-Alvarado L, 2014, METAB BRAIN DIS, V29, P711, DOI 10.1007/s11011-014-9508-5; AUER RN, 1984, ACTA NEUROPATHOL, V64, P177, DOI 10.1007/BF00688108; Camberos-Luna L, 2020, NEUROCHEM INT, V133, DOI 10.1016/j.neuint.2019.104614; Camberos-Luna L, 2016, NEUROCHEM RES, V41, P600, DOI 10.1007/s11064-015-1700-4; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Cryer PE, 2005, DIABETES, V54, P3592, DOI 10.2337/diabetes.54.12.3592; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; FERRENDELLI JA, 1973, ARCH NEUROL-CHICAGO, V28, P173, DOI 10.1001/archneur.1973.00490210053006; Fu L, 2016, BRAIN RES, V1650, P103, DOI 10.1016/j.brainres.2016.08.035; Gao ZH, 2010, AUTOPHAGY, V6, P126, DOI 10.4161/auto.6.1.10928; Geronimo-Olvera C, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.299; Haces ML, 2010, NEUROSCIENCE, V165, P28, DOI 10.1016/j.neuroscience.2009.10.003; Haces ML, 2008, EXP NEUROL, V211, P85, DOI 10.1016/j.expneurol.2007.12.029; Julio-Amilpas A, 2015, J CEREBR BLOOD F MET, V35, P851, DOI 10.1038/jcbfm.2015.1; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Languren G, 2019, J CEREBR BLOOD F MET, V39, DOI 10.1177/0271678X17733640; LEWIS LD, 1974, J NEUROCHEM, V23, P673, DOI 10.1111/j.1471-4159.1974.tb04390.x; Li J, 2007, STROKE, V38, P2992, DOI 10.1161/STROKEAHA.107.490904; Li L, 2013, CELL SIGNAL, V25, P50, DOI 10.1016/j.cellsig.2012.09.020; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Marosi K, 2016, J NEUROCHEM, V139, P769, DOI 10.1111/jnc.13868; Masuda R, 2005, J NEUROSCI RES, V80, P501, DOI 10.1002/jnr.20464; Melo TM, 2006, NEUROCHEM INT, V48, P498, DOI 10.1016/j.neuint.2005.12.037; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Montiel T, 2020, CURR PHARM DESIGN, V26, P1377, DOI 10.2174/1381612826666200115103646; Moreira TJTP, 2009, J CEREBR BLOOD F MET, V29, P1273, DOI 10.1038/jcbfm.2009.50; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; Prins ML, 2006, DEV NEUROSCI-BASEL, V28, P447, DOI 10.1159/000094170; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Puchowicz MA, 2008, J CEREBR BLOOD F MET, V28, P1907, DOI 10.1038/jcbfm.2008.79; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Sheng R, 2012, AUTOPHAGY, V8, P310, DOI 10.4161/auto.18673; Shi RY, 2012, CNS NEUROSCI THER, V18, P250, DOI 10.1111/j.1755-5949.2012.00295.x; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2003, J NEUROSCI, V23, P10681; Sun F, 2016, TUMOR BIOL, V37, P15467, DOI 10.1007/s13277-016-5353-y; Sun YL, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01022; Suzuki M, 2002, JPN J PHARMACOL, V89, P36, DOI 10.1254/jjp.89.36; Suzuki M, 2001, JPN J PHARMACOL, V87, P143, DOI 10.1254/jjp.87.143; Tseng MT, 2003, NEUROL RES, V25, P83, DOI 10.1179/016164103101200978; Uddin MM, 2020, MOL CELL BIOCHEM, V473, P39, DOI 10.1007/s11010-020-03806-7; Wang JF, 2018, NEURAL REGEN RES, V13, P989, DOI 10.4103/1673-5374.233441; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Xia GH, 2018, MOL MED REP, V18, P2744, DOI 10.3892/mmr.2018.9248; Yin ZY, 2016, MICROB CELL, V3, P457, DOI 10.15698/mic2016.12.546; Zhang F, 2005, J NEUROSCI RES, V79, P139, DOI 10.1002/jnr.20312	54	5	5	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	SEP 23	2020	14								547215	10.3389/fncel.2020.547215			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NX1SC	WOS:000575495800001	33173467	Green Published, gold			2022-02-06	
J	Orefice, NS; Guillemot-Legris, O; Capasso, R; Bottemanne, P; Hantraye, P; Caraglia, M; Orefice, G; Alhouayek , M; Muccioli , GG				Orefice, Nicola S.; Guillemot-Legris, Owein; Capasso, Rosanna; Bottemanne, Pauline; Hantraye, Philippe; Caraglia, Michele; Orefice, Giuseppe; Alhouayek, Mireille; Muccioli, Giulio G.			miRNA profile is altered in a modified EAE mouse model of multiple sclerosis featuring cortical lesions	ELIFE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PRO-INFLAMMATORY CYTOKINES; TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; DEMYELINATION; PATHOGENESIS; TARGETS; DIFFERENTIATION; WIDESPREAD; MECHANISMS	Cortical lesions represent a hallmark of multiple sclerosis and are proposed as a predictor of disease severity. microRNAs are suggested to be important players in the disease pathogenesis and the experimental autoimmune encephalomyelitis animal model. We implemented a mouse model recapitulating more closely the human pathology as it is characterized by both an autoimmune heterogeneity and the presence of cortical lesions, two parameters missing in experimental autoimmune encephalomyelitis. In our model, mice clustered in two groups displaying high or low clinical scores. Upon cortical cytokine injection, lesions appeared with a specific topography while cortical miRNA profiles were altered. These two features differed according to disease severity. We evidenced changes in miRNA regulators and targets suggesting that miRNA alteration had functional repercussions that could explain the differences in cortical lesions. This model represents a crucial tool for the study of both miRNA involvement and cortical lesion formation in disease pathogenesis.	[Orefice, Nicola S.; Hantraye, Philippe] Mol Imaging Res Ctr MIRCen, Fundamental Res Div DRF, Inst Biol Francois Jacob, CEA, Fontenay Aux Roses, France; [Guillemot-Legris, Owein; Bottemanne, Pauline; Alhouayek, Mireille; Muccioli, Giulio G.] Catholic Univ Louvain, Louvain Drug Res Inst, UCLouvain, Bioanal & Pharmacol Bioact Lipids Res Grp, Brussels, Belgium; [Capasso, Rosanna; Caraglia, Michele] Univ Campania Luigi Vanvitelli, Dept Precis Med, Sch Med & Surg, Naples, Italy; [Orefice, Giuseppe] Federico II Univ Naples, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy; [Orefice, Nicola S.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA		Orefice, NS (corresponding author), Mol Imaging Res Ctr MIRCen, Fundamental Res Div DRF, Inst Biol Francois Jacob, CEA, Fontenay Aux Roses, France.; Orefice, NS (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	nicolaorefice819@gmail.com	Orefice, Nicola S/AAB-3869-2021; Alhouayek, Mireille/R-5058-2018	Orefice, Nicola S/0000-0001-8135-3737; Guillemot-Legris, Owein/0000-0003-3738-3423; Muccioli, Giulio/0000-0002-1600-9259; Alhouayek, Mireille/0000-0002-9193-0718; Bottemanne, Pauline/0000-0003-0414-4127	Fondation Charcot; Fonds De La Recherche Scientifique - FNRSFonds de la Recherche Scientifique - FNRS; Fonds pour la Formation a la Recherche dans l'Industrie et dans l'AgricultureFonds de la Recherche Scientifique - FNRS	Fondation Charcot Giulio G Muccioli; Fonds De La Recherche Scientifique - FNRS Owein Guillemot-Legris Mireille Alhouayek; Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture Pauline Bottemanne; The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; Benoit ME, 2011, J NEUROSCI, V31, P3459, DOI 10.1523/JNEUROSCI.3932-10.2011; Cantoni C, 2017, ACTA NEUROPATHOL, V133, P61, DOI 10.1007/s00401-016-1621-6; Chen C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01256; Chen K, 2018, PHYSIOL GENOMICS, V50, P144, DOI 10.1152/physiolgenomics.00045.2017; Escobar TM, 2014, IMMUNITY, V40, P865, DOI 10.1016/j.immuni.2014.03.014; Fenoglio C, 2012, INT J MOL SCI, V13, P13227, DOI 10.3390/ijms131013227; Filippi M, 2010, NEUROLOGY, V75, P1988, DOI 10.1212/WNL.0b013e3181ff96f6; Filippi M, 2019, RADIOLOGY, V291, P750, DOI 10.1148/radiol.2019190398; Fischer MT, 2013, BRAIN, V136, P1799, DOI 10.1093/brain/awt110; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gardner C, 2013, BRAIN, V136, P3596, DOI 10.1093/brain/awt279; Guillemot-Legris O, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0666-8; Haneklaus M, 2013, J INTERN MED, V274, P215, DOI 10.1111/joim.12099; He Y, 2019, HEPATOLOGY, V70, P1150, DOI 10.1002/hep.30645; Hou HQ, 2017, NEUROCHEM RES, V42, P2831, DOI 10.1007/s11064-017-2296-7; Howell OW, 2011, BRAIN, V134, P2755, DOI 10.1093/brain/awr182; Irizar H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1396-5; Jagot F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00129; Jovicic A, 2013, J NEUROSCI, V33, P5127, DOI 10.1523/JNEUROSCI.0600-12.2013; Juarez B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02365-8; Junker A, 2011, NAT REV NEUROL, V7, P56, DOI 10.1038/nrneurol.2010.179; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Keller A, 2014, MULT SCLER J, V20, P295, DOI 10.1177/1352458513496343; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lassmann H, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03116; Lassmann H, 2012, BRAIN, V135, P2904, DOI 10.1093/brain/aws260; Liu DM, 2016, CELL PHYSIOL BIOCHEM, V39, P303, DOI 10.1159/000445625; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Lv JF, 2018, BRAIN RES, V1685, P91, DOI 10.1016/j.brainres.2018.01.032; Marty V, 2016, HUM MOL GENET, V25, P728, DOI 10.1093/hmg/ddv510; Merkler D, 2006, BRAIN, V129, P1972, DOI 10.1093/brain/awl135; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; Ni JS, 2015, BRAIN BEHAV IMMUN, V49, P75, DOI 10.1016/j.bbi.2015.04.014; Noorbakhsh F, 2011, BRAIN, V134, P2703, DOI 10.1093/brain/awr200; Perdaens O, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000673; Popescu BFG, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-11; Ruther BJ, 2017, GLIA, V65, P1900, DOI 10.1002/glia.23202; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Soldan MMP, 2002, J INFECT DIS, V186, pS248, DOI 10.1086/344283; Srivastava T, 2018, J CLIN INVEST, V128, P2025, DOI 10.1172/JCI94158; Stassart RM, 2016, BRAIN PATHOL, V26, P452, DOI 10.1111/bpa.12292; Stefanetti Renae J, 2018, F1000Res, V7, DOI 10.12688/f1000research.15258.1; Stienne C, 2016, IMMUNITY, V45, P774, DOI 10.1016/j.immuni.2016.09.010; Thamilarasan M, 2012, AUTOIMMUN REV, V11, P174, DOI 10.1016/j.autrev.2011.05.009; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2; Treaba CA, 2019, RADIOLOGY, V291, P740, DOI 10.1148/radiol.2019181719; Ucal M, 2017, EXP NEUROL, V294, P32, DOI 10.1016/j.expneurol.2017.04.014; Vakhitov V. A., 2020, Human Physiology, V46, P104, DOI 10.1134/S0362119720010144; Victorio SCS, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-77; Watkins LM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0611-x; Wolstenholme JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021100; Wu DS, 2015, J CEREBR BLOOD F MET, V35, P412, DOI 10.1038/jcbfm.2014.207; Yu JH, 2016, ASIAN PAC J TROP MED, V9, P69, DOI 10.1016/j.apjtm.2015.12.015; Zhang J, 2014, J NEUROIMMUNOL, V266, P56, DOI 10.1016/j.jneuroim.2013.09.019; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	59	5	5	0	4	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	SEP 17	2020	9								e56916	10.7554/eLife.56916			25	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	NU1EG	WOS:000573382800001	32940597	gold, Green Published			2022-02-06	
J	McAvoy, K; Eagan-Johnson, B; Dymacek, R; Hooper, S; McCart, M; Tyler, J				McAvoy, Karen; Eagan-Johnson, Brenda; Dymacek, Rosalie; Hooper, Stephen; McCart, Melissa; Tyler, Janet			Establishing Consensus for Essential Elements in Returning to Learn Following a Concussion	JOURNAL OF SCHOOL HEALTH			English	Article						concussion; traumatic brain injury; return to learn; return to play; interdisciplinary team; section 504; individual health care plan	BUILDING STATEWIDE INFRASTRUCTURE; TRAUMATIC BRAIN-INJURY; US HIGH-SCHOOL; STUDENTS; CHILDREN; KNOWLEDGE; SYMPTOMS; REST; TBI	BACKGROUND: Returning to learn following a concussion is the process of managing a student's recovery during the school day by implementation of academic supports with varying intensity. Due to a lack of consensus or even guidance on Return to Learn, this paper set out to establish cross discipline consensus on some essential elements of Return to Learn using a Delphi method. METHODS: Sixteen national organizations participated in a Delphi process to reach consensus on overarching themes of Return to Learn focused on: returning a student to school, composition of the school-based concussion management team, progress-monitoring, educational safeguards, neuropsychological testing, and legislation. Two rounds of questionnaires were disseminated via email using a Delphi process. Consensus was established during round 2. RESULTS: Twelve national organizations were able to reach consensus and endorse 13 essential elements of Return to Learn following a concussion. CONCLUSIONS: There continues to be limited research on concussion Return to Learn leading to confusion in the field. In this paper, we demonstrate consensus on a number of essential elements, from a wide variety of professional disciplines who participate in the care of students following a concussion, as a starting place for some guidance on Return to Learn.	[McAvoy, Karen] Ctr Concuss Rocky Mt Hosp Children, 10107 RidgeGate Pkwy,Suite 310, Lone Tree, CO 80124 USA; [Eagan-Johnson, Brenda] BrainSTEPS Brain Injury Sch Consulting Program, 1891 Old State Rd, New Castle, PA 16101 USA; [Dymacek, Rosalie] Nebraska Dept Edcu, Lincoln, NE USA; [Hooper, Stephen] Univ N Carolina, Dept Allied Hlth Sci, 333 S Columbia St,Suite 304, Chapel Hill, NC 27514 USA; [McCart, Melissa] Ctr Brain Injury Res & Training, Rainier Bldg,1244 Walnut St,Suite 220, Eugene, OR 97403 USA; [Tyler, Janet] Colorado Dept Educ, Hlth & Wellness, 201 East Colfax Ave, Denver, CO 80203 USA		Eagan-Johnson, B (corresponding author), BrainSTEPS Brain Injury Sch Consulting Program, 1891 Old State Rd, New Castle, PA 16101 USA.	karenmcavoy11@gmail.com; b.eagan.johnson@gmail.com; stephen_hooper@med.unc.edu; mmcart@uoregon.edu; tyler_j@cde.state.co.us		Eagan-Johnson, Brenda/0000-0002-6091-9639			Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Baker JG, 2014, INT J CLIN PRACT, V68, P1286, DOI 10.1111/ijcp.12517; BrainSTEPS and Pennsylvania Department of Education, 2017, RET LEARN CONC REC P; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Carzoo SA., 2015, ATHL TRAIN SPORTS HL, V7, P144; Coelho R. F., 2015, EVOLUTIONARY ALGORIT, P1; Colorado Department of Education, MULT SYST SUPP MTSS; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; DeMatteo C, 2015, DISABIL REHABIL, V37, P1107, DOI 10.3109/09638288.2014.952452; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Dreer LE, 2017, HEALTH PROMOT PRACT, V18, P428, DOI 10.1177/1524839916650865; Ettel D, 2011, EXCEPTIONALITY ED IN, V26, P1; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Gioia GA, 2016, J HEAD TRAUMA REHAB, V31, P397, DOI 10.1097/HTR.0000000000000205; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Green P, 1982, C NW DISTR ASS AM AL; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Hsu C., 2007, PRACTICAL ASSESSMENT, V12, P1, DOI DOI 10.1016/S0169-2070(99)00018-7; Hunt T, 2017, J ATHL TRAINING, V12, P26; Janson IA, 2019, J HEAD TRAUMA REHAB, V34, pE10, DOI 10.1097/HTR.0000000000000396; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; Lowrey KM., 2015, J BUS TECHNOL LAW, V10, P61; Lowry R, 2019, AM J PREV MED, V57, P733, DOI 10.1016/j.amepre.2019.08.016; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McAvoy K, 2018, NEUROREHABILITATION, V42, P325, DOI 10.3233/NRE-172381; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Myers RK, 2018, CLIN PEDIATR, V57, P645, DOI 10.1177/0009922817732146; National Association of School Nurses, 2020, US IND HEALTHC PLANS; O'Neill JA, 2017, REHABIL PSYCHOL, V62, P300, DOI 10.1037/rep0000155; Oregon Concussion and Management Program, 2011, CONC MAN POL RES HDB; Roscigno CI, 2015, DISABIL REHABIL, V37, P523, DOI 10.3109/09638288.2014.933896; Russell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165116; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Salisbury David, 2017, Proc (Bayl Univ Med Cent), V30, P33; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Thompson LL, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2151; US Department of Education, 2004, IND DIS ED ACT IDEA; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475; Zirkel PA, 2015, J SCH NURS, V31, P99, DOI 10.1177/1059840514521465	46	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4391	1746-1561		J SCHOOL HEALTH	J. Sch. Health	NOV	2020	90	11					849	858		10.1111/josh.12949		SEP 2020	10	Education & Educational Research; Education, Scientific Disciplines; Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Health Care Sciences & Services; Public, Environmental & Occupational Health	NX6AV	WOS:000569519300001	32939780				2022-02-06	
J	Sanchez, CM; Titus, DJ; Wilson, NM; Freund, JE; Atkins, CM				Sanchez, Chantal M.; Titus, David J.; Wilson, Nicole M.; Freund, Julie E.; Atkins, Coleen M.			Early Life Stress Exacerbates Outcome after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						corticosterone; early life stress; fluid-percussion brain injury; learning and memory; traumatic brain injury	NEONATAL MATERNAL SEPARATION; CONTROLLED CORTICAL IMPACT; GLUCOCORTICOID-RECEPTOR; COGNITIVE DEFICITS; SYNAPTIC PLASTICITY; REARING CONDITIONS; MAJOR DEPRESSION; FEAR EXTINCTION; CONTEXTUAL FEAR; GENE-EXPRESSION	The neurocognitive impairments associated with mild traumatic brain injury (TBI) often resolve within 1-2 weeks; however, a subset of people exhibit persistent cognitive dysfunction for weeks to months after injury. The factors that contribute to these persistent deficits are unknown. One potential risk factor for worsened outcome after TBI is a history of stress experienced by a person early in life. Early life stress (ELS) includes maltreatment such as neglect, and interferes with the normal construction of cortical and hippocampal circuits. We hypothesized that a history of ELS contributes to persistent learning and memory dysfunction following a TBI. To explore this interaction, we modeled ELS by separating Sprague Dawley pups from their nursing mothers from post-natal days 2-14 for 3 h daily. At 2 months of age, male rats received sham surgery or mild to moderate parasagittal fluid-percussion brain injury. We found that the combination of ELS with TBI in adulthood impaired hippocampal-dependent learning, as assessed with contextual fear conditioning, the water maze task, and spatial working memory. Cortical atrophy was significantly exacerbated in TBI animals exposed to ELS compared with normal-reared TBI animals. Changes in corticosterone in response to restraint stress were prolonged in TBI animals that received ELS compared with TBI animals that were normally reared or sham animals that received ELS. Our findings indicate that ELS is a risk factor for worsened outcome after TBI, and results in persistent learning and memory deficits, worsened cortical pathology, and an exacerbation of the hormonal stress response.	[Sanchez, Chantal M.; Titus, David J.; Wilson, Nicole M.; Freund, Julie E.; Atkins, Coleen M.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, 1095 NW 14th Terrace, Miami, FL 33136 USA		Atkins, CM (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, 1095 NW 14th Terrace, Miami, FL 33136 USA.	catkins@med.miami.edu			Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [I21RX003017]; Miami Project to Cure Paralysis; Buoniconti Fund	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service (I21RX003017), The Miami Project to Cure Paralysis, and the Buoniconti Fund.	Abercrombie HC, 2003, BEHAV NEUROSCI, V117, P505, DOI 10.1037/0735-7044.117.3.505; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Alfarez DN, 2003, EUR J NEUROSCI, V17, P1928, DOI 10.1046/j.1460-9568.2003.02622.x; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Batalha VL, 2013, MOL PSYCHIATR, V18, P320, DOI 10.1038/mp.2012.8; Bellavance MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00136; BODNOFF SR, 1995, J NEUROSCI, V15, P61; Brunson KL, 2005, J NEUROSCI, V25, P9328, DOI 10.1523/JNEUROSCI.2281-05.2005; Buchanan TW, 2001, PSYCHONEUROENDOCRINO, V26, P307, DOI 10.1016/S0306-4530(00)00058-5; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Callaghan BL, 2011, BEHAV NEUROSCI, V125, P20, DOI 10.1037/a0022008; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chen YH, 2019, BRAIN RES, V1710, P163, DOI 10.1016/j.brainres.2019.01.005; Chocyk A, 2014, BEHAV BRAIN RES, V264, P161, DOI 10.1016/j.bbr.2014.01.040; Choe MC, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0573-9; Cnossen MC, 2017, J NEUROPSYCH CLIN N, V29, P206, DOI 10.1176/appi.neuropsych.16090165; Coelho R, 2014, ACTA PSYCHIAT SCAND, V129, P180, DOI 10.1111/acps.12217; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Davies DR, 2016, FRONT BEHAV NEUROSCI, V10, DOI [10.3389/fnbeh.2016.00071, 10.3339/fnbeh.2015.00071]; de Quervain D, 2017, NAT REV NEUROSCI, V18, P7, DOI 10.1038/nrn.2016.155; Delpech JC, 2016, BRAIN BEHAV IMMUN, V57, P79, DOI 10.1016/j.bbi.2016.06.006; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Doom JR, 2013, DEV PSYCHOPATHOL, V25, P1359, DOI 10.1017/S0954579413000667; Fagundes CP, 2013, BRAIN BEHAV IMMUN, V27, P8, DOI 10.1016/j.bbi.2012.06.014; Frank MG, 2015, BRAIN BEHAV IMMUN, V48, P1, DOI 10.1016/j.bbi.2015.03.010; Franklin TC, 2018, BIOL PSYCHIAT, V83, P50, DOI 10.1016/j.biopsych.2017.06.034; Frankola KA, 2010, NEUROBIOL LEARN MEM, V94, P91, DOI 10.1016/j.nlm.2010.04.005; Ganguly P, 2015, DEV COGN NEUROS-NETH, V11, P18, DOI 10.1016/j.dcn.2014.07.001; Gjerstad JK, 2018, STRESS, V21, P403, DOI 10.1080/10253890.2018.1470238; Goldman-Mellor S, 2012, PSYCHONEUROENDOCRINO, V37, P1755, DOI 10.1016/j.psyneuen.2012.03.010; Greenberg M., 2014, CHILD MALTREATMENT 2; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; GUILLET R, 1980, ENDOCRINOLOGY, V106, P991, DOI 10.1210/endo-106-3-991; Guinn AS, 2019, INJURY PREV, V25, P514, DOI 10.1136/injuryprev-2018-042927; Heim C, 2008, BIOL PSYCHIAT, V63, P398, DOI 10.1016/j.biopsych.2007.07.002; Hoeijmakers L, 2017, BRAIN BEHAV IMMUN, V63, P160, DOI 10.1016/j.bbi.2016.12.023; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Hui JJ, 2011, BEHAV BRAIN RES, V217, P122, DOI 10.1016/j.bbr.2010.10.014; Huot RL, 2001, PSYCHOPHARMACOLOGY, V158, P366, DOI 10.1007/s002130100701; Huot RL, 2002, BRAIN RES, V950, P52, DOI 10.1016/S0006-8993(02)02985-2; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Ivy AS, 2010, J NEUROSCI, V30, P13005, DOI 10.1523/JNEUROSCI.1784-10.2010; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; Johnson FK, 2018, BRAIN BEHAV IMMUN, V69, P18, DOI 10.1016/j.bbi.2017.06.008; Kalinichev M, 2002, PHARMACOL BIOCHEM BE, V73, P131, DOI 10.1016/S0091-3057(02)00781-5; Klein RC, 2016, J NEUROSCI RES, V94, P579, DOI 10.1002/jnr.23702; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Kosten TA, 2006, BRAIN RES, V1087, P142, DOI 10.1016/j.brainres.2006.03.009; Kosten TA, 2012, NEUROSCI BIOBEHAV R, V36, P1985, DOI 10.1016/j.neubiorev.2012.07.003; Krugers Harmen J, 2010, Front Synaptic Neurosci, V2, P24, DOI 10.3389/fnsyn.2010.00024; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lajud N, 2012, PSYCHONEUROENDOCRINO, V37, P410, DOI 10.1016/j.psyneuen.2011.07.011; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lee R, 2005, AM J PSYCHIAT, V162, P995, DOI 10.1176/appi.ajp.162.5.995; Lehmann J, 1999, PHARMACOL BIOCHEM BE, V64, P705, DOI 10.1016/S0091-3057(99)00150-1; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lovic V, 2001, DEV PSYCHOBIOL, V39, P19, DOI 10.1002/dev.1024; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Madruga C, 2006, BEHAV BRAIN RES, V166, P241, DOI 10.1016/j.bbr.2005.08.005; Masson M, 2015, CLIN NEUROPSYCHOL, V29, P573, DOI 10.1080/13854046.2015.1061057; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Nugent NR, 2011, PSYCHOPHARMACOLOGY, V214, P175, DOI 10.1007/s00213-010-2151-x; Nusslock R, 2016, BIOL PSYCHIAT, V80, P23, DOI 10.1016/j.biopsych.2015.05.017; Ogier M, 2017, J NEUROTRAUM, V34, P1645, DOI 10.1089/neu.2016.4741; Ohta K, 2014, INT J DEV NEUROSCI, V33, P15, DOI 10.1016/j.ijdevneu.2013.10.007; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Park SW, 2017, NEUROSCI LETT, V650, P38, DOI 10.1016/j.neulet.2017.04.024; Pavlides C, 2002, HIPPOCAMPUS, V12, P245, DOI 10.1002/hipo.1116; Peterson AB, 2019, SURVEILLANCE REPORT; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Reid MW, 2018, J NEUROTRAUM, V35, P1146, DOI 10.1089/neu.2017.5424; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Roozendaal B, 1999, EUR J NEUROSCI, V11, P1317, DOI 10.1046/j.1460-9568.1999.00537.x; Roque S, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00192; Rowe RK, 2016, DEV NEUROSCI-BASEL, V38, P195, DOI 10.1159/000446773; Schmidt M, 2003, INT J DEV NEUROSCI, V21, P125, DOI 10.1016/S0736-5748(03)00030-3; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Sierra-Mercado D, 2015, BRAIN RES, V1606, P133, DOI 10.1016/j.brainres.2015.02.031; Smyth K, 2014, DEV MED CHILD NEUROL, V56, P73, DOI 10.1111/dmcn.12263; Stiller AL, 2011, PSYCHONEUROENDOCRINO, V36, P1383, DOI 10.1016/j.psyneuen.2011.03.012; Takatsuru Y, 2015, J PHYSIOL SCI, V65, P187, DOI 10.1007/s12576-015-0361-z; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Titus DJ, 2013, NEUROSCIENCE, V231, P182, DOI 10.1016/j.neuroscience.2012.12.002; Titus DJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223180; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Titus DJ, 2015, CURR PHARM DESIGN, V21, P332; Titus DJ, 2015, EXP NEUROL, V263, P254, DOI 10.1016/j.expneurol.2014.10.020; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; van Bodegom M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00087; van der Doelen RHA, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00355; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Weaver ICG, 2004, ANN NY ACAD SCI, V1024, P182, DOI 10.1196/annals.1321.099; Weber MD, 2015, J NEUROSCI, V35, P316, DOI 10.1523/JNEUROSCI.3561-14.2015; Wei L, 2012, NEUROPSYCHOPHARMACOL, V37, P567, DOI 10.1038/npp.2011.239; Wei L, 2010, HORM BEHAV, V57, P396, DOI 10.1016/j.yhbeh.2010.01.007; Wildeman C, 2014, JAMA PEDIATR, V168, P706, DOI 10.1001/jamapediatrics.2014.410; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Xiong GJ, 2014, BEHAV BRAIN RES, V269, P75, DOI 10.1016/j.bbr.2014.04.015; Yamakawa GR, 2017, EXP NEUROL, V295, P55, DOI 10.1016/j.expneurol.2017.06.001; Young ES, 2019, PSYCHOL SCI, V30, P739, DOI 10.1177/0956797619833664; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zhu LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097689; Zhu YZ, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0782-5; Zoicas I, 2016, BEHAV BRAIN RES, V297, P323, DOI 10.1016/j.bbr.2015.10.034	117	5	5	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2021	38	5					555	565		10.1089/neu.2020.7267		SEP 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	QP9GR	WOS:000570969100001	32862765				2022-02-06	
J	Sergio, LE; Gorbet, DJ; Adams, MS; Dobney, DM				Sergio, Lauren E.; Gorbet, Diana J.; Adams, Meaghan S.; Dobney, Danielle M.			The Effects of Mild Traumatic Brain Injury on Cognitive-Motor Integration for Skilled Performance	FRONTIERS IN NEUROLOGY			English	Article						movement; cognition; eye-hand coordination; sensorimotor integration; concussion; blast exposure; neuroimaging; motor psychophysics	LEVEL BLAST EXPOSURE; SEX-DIFFERENCES; PREMOTOR CORTEX; ARM MOVEMENTS; OPTIC ATAXIA; EYE; CONCUSSION; DISCONNECTION; SUPPLEMENTARY; COORDINATION	Adults exposed to blast and blunt impact often experience mild traumatic brain injury, affecting neural functions related to sensory, cognitive, and motor function. In this perspective article, we will review the effects of impact and blast exposure on functional performance that requires the integration of these sensory, cognitive, and motor control systems. We describe cognitive-motor integration and how it relates to successfully navigating skilled activities crucial for work, duty, sport, and even daily life. We review our research on the behavioral effects of traumatic impact and blast exposure on cognitive-motor integration in both younger and older adults, and the neural networks that are involved in these types of skills. Overall, we have observed impairments in rule-based skilled performance as a function of both physical impact and blast exposure. The extent of these impairments depended on the age at injury and the sex of the individual. It appears, however, that cognitive-motor integration deficits can be mitigated by the level of skill expertise of the affected individual, suggesting that such experience imparts resiliency in the brain networks that underly the control of complex visuomotor performance. Finally, we discuss the next steps needed to comprehensively understand the impact of trauma and blast exposure on functional movement control.	[Sergio, Lauren E.; Gorbet, Diana J.; Adams, Meaghan S.; Dobney, Danielle M.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada; [Sergio, Lauren E.; Gorbet, Diana J.] York Univ, Ctr Vis Res, Toronto, ON, Canada; [Adams, Meaghan S.; Dobney, Danielle M.] York Univ, Vis Sci Applicat VISTA Program, Toronto, ON, Canada; [Adams, Meaghan S.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada		Sergio, LE (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada.; Sergio, LE (corresponding author), York Univ, Ctr Vis Res, Toronto, ON, Canada.	lsergio@yorku.ca			Donald Sanderson Memorial Fund; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; Department of National Defence (DND); Canadian Forces Health Services; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-125915]; VISTA Program, Canada First Research Excellence Fund; Canada First Research Excellence Fund	The authors acknowledge the operating funding support from the Donald Sanderson Memorial Fund (LS), the Natural Sciences and Engineering Research Council of Canada (LS), the Department of National Defence (DND) and the Canadian Forces Health Services, and the Canadian Institutes of Health Research (MOP-125915, LS). Postdoctoral funding support provided by the VISTA Program, Canada First Research Excellence Fund (MA and DD). This research was undertaken as part of the Vision: Science to Applications program, thanks in part to funding from the Canada First Research Excellence Fund.	Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Battaglia-Mayer A, 2002, BRAIN, V125, P225, DOI 10.1093/brain/awf034; BEDFORD FL, 1993, J EXP PSYCHOL HUMAN, V19, P517, DOI 10.1037/0096-1523.19.3.517; Bock O, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00081; Bolouri H, 2015, BRAIN NEUROTRAUMA MO, P1; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Brown JA, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0019-4; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buxbaum LJ, 1997, NEUROCASE, V3, P159, DOI 10.1080/13554799708404050; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Choe MC, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0573-9; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Clements AM, 2006, BRAIN LANG, V98, P150, DOI 10.1016/j.bandl.2006.04.007; Clower DM, 2000, J NEUROPHYSIOL, V84, P2703, DOI 10.1152/jn.2000.84.5.2703; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Craik FIM, 2010, NEUROLOGY, V75, P1726, DOI 10.1212/WNL.0b013e3181fc2a1c; Crawford JD, 2004, J NEUROPHYSIOL, V92, P10, DOI 10.1152/jn.00117.2004; Crutcher MD, 2004, EXP BRAIN RES, V158, P278, DOI 10.1007/s00221-004-1895-0; Dalecki M, 2019, EUR J SPORT SCI, V19, P1257, DOI 10.1080/17461391.2019.1584249; Dalecki Marc, 2016, Concussion, V1, pCNC14, DOI 10.2217/cnc-2016-0001; de Boer C, 2018, DEMENT GER COGN D EX, V8, P248, DOI 10.1159/000490173; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Denise Y, 2012, J MOTOR BEHAV, V44:6, P435, DOI [10.1080/00222895.2012.659232, DOI 10.1080/00222895.2012.659232]; Echlin HV, 2020, CAN GERIATR J, V23, P190, DOI 10.5770/cgj.23.394; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Flores-Gutierrez EO, 2009, INT J PSYCHOPHYSIOL, V71, P43, DOI 10.1016/j.ijpsycho.2008.07.007; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; GIELEN CCAM, 1984, EXP BRAIN RES, V56, P154, DOI 10.1007/BF00237452; Giza CC, 2015, NEUROSURGERY, V75, pS24, DOI DOI 10.1227/NEU.0000000000000505; Goldstein K, 1942, EFFECTS BRAIN INJURY; Gorbet DJ, 2016, BEHAV BRAIN RES, V298, P229, DOI 10.1016/j.bbr.2015.11.012; Gorbet DJ, 2007, EUR J NEUROSCI, V25, P1228, DOI 10.1111/j.1460-9568.2007.05358.x; Gorbet DJ, 2019, EXP BRAIN RES, V237, P57, DOI 10.1007/s00221-018-5395-z; Gorbet DJ, 2011, EXP BRAIN RES, V212, P315, DOI 10.1007/s00221-011-2731-y; Gorbet DJ, 2010, EXP BRAIN RES, V202, P633, DOI 10.1007/s00221-010-2170-1; Gorbet DJ, 2004, NEUROIMAGE, V23, P1100, DOI 10.1016/j.neuroimage.2004.07.043; Granek JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0086138; Granek JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046619; Hall GBC, 2004, NEUROREPORT, V15, P219, DOI 10.1097/00001756-200402090-00001; HERMAN R, 1981, EXP BRAIN RES, V42, P392; Hristopulos DT, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00419; Hurtubise J, 2015, SOC NEUR ANN M CHIC; Hurtubise Johanna, 2016, Concussion, V1, pCNC17, DOI 10.2217/cnc-2016-0006; Hurtubise JM, 2020, J NEUROTRAUM, V37, P1528, DOI 10.1089/neu.2019.6765; Jackson SR, 2009, NEUROPSYCHOLOGIA, V47, P1397, DOI 10.1016/j.neuropsychologia.2009.01.035; JAKOBSON LS, 1991, NEUROPSYCHOLOGIA, V29, P803, DOI 10.1016/0028-3932(91)90073-H; Karnath HO, 2005, CEREB CORTEX, V15, P1561, DOI 10.1093/cercor/bhi034; Kaushal M, 2019, HUM BRAIN MAPP, V40, P1211, DOI 10.1002/hbm.24440; Kis Mihaly, 2020, J Funct Morphol Kinesiol, V5, DOI 10.3390/jfmk5010013; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Lackner JR, 2005, CURR OPIN NEUROBIOL, V15, P653, DOI 10.1016/j.conb.2005.10.012; Lee H, 2015, BRIT J SPORT MED, V49, P500, DOI 10.1136/bjsports-2013-092930; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGrath SP, 2018, AMIA ANN S P, V2017, P1282; Murdaugh DL, 2018, J INT NEUROPSYCH SOC, V24, P781, DOI 10.1017/S1355617718000413; Mushiake H, 1996, J NEUROPHYSIOL, V75, P2187, DOI 10.1152/jn.1996.75.5.2187; Passarelli L, 2011, J NEUROSCI, V31, P1790, DOI 10.1523/JNEUROSCI.4784-10.2011; Pellijeff A, 2006, NEUROPSYCHOLOGIA, V44, P2685, DOI 10.1016/j.neuropsychologia.2006.01.009; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; PRABLANC C, 1979, BIOL CYBERN, V35, P113, DOI 10.1007/BF00337436; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Reyes-Puerta V, 2010, J NEUROPHYSIOL, V103, P3153, DOI 10.1152/jn.00989.2009; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0; Shepherd HA, 2020, CLIN J SPORT MED, V30, pe88, DOI [10.1097/JSM.0000000000000844, DOI 10.1097/JSM.0000000000000844]; Soldan A, 2020, CLIN GERIATR MED, V36, P247, DOI 10.1016/j.cger.2019.11.006; Stoodley Catherine J, 2018, Handb Clin Neurol, V154, P59, DOI 10.1016/B978-0-444-63956-1.00004-7; Tenn C, 2000, SOC NEUR ANN M SAN D; Thies SB, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-2; van Donkelaar P, 2006, EXERC SPORT SCI REV, V34, P77, DOI 10.1249/00003677-200604000-00007; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Williams LM, 2005, NEUROIMAGE, V28, P618, DOI 10.1016/j.neuroimage.2005.06.035; Wise SP, 1996, CAN J PHYSIOL PHARM, V74, P469, DOI 10.1139/cjpp-74-4-469; Wright DK, 2021, J NEUROTRAUM, V38, P983, DOI 10.1089/neu.2019.6886; Yang SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179352	80	5	5	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 16	2020	11								541630	10.3389/fneur.2020.541630			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NY3BW	WOS:000576270500001	33041992	Green Published, gold			2022-02-06	
J	Ding, K; Tarumi, T; Tomoto, T; Mccolloster, M; Le, T; Dieppa, M; Diaz-Arrastia, R; Bell, K; Madden, C; Cullum, CM; Zhang, R				Ding, Kan; Tarumi, Takashi; Tomoto, Tsubasa; Mccolloster, Max; Le, Tran; Dieppa, Marisara; Diaz-Arrastia, Ramon; Bell, Kathleen; Madden, Christopher; Cullum, C. Munro; Zhang, Rong			Impaired cerebral blood flow regulation in chronic traumatic brain injury	BRAIN RESEARCH			English	Article						Baroreflex; Dynamic cerebral autoregulation; Cognition; Traumatic brain injury	HEART-RATE-VARIABILITY; BAROREFLEX SENSITIVITY; AUTOREGULATION; PRESSURE; HEMODYNAMICS; CONSEQUENCES; PERFUSION; ADULT; REST	Baroreflex sensitivity (BRS) and cerebral autoregulation (CA) play an important role in maintaining constant cerebral blood flow (CBF) during systemic changes in blood pressure (BP). Impaired BRS and CA have been reported in acute traumatic brain injury (TBI) which may also contribute to secondary injury and poorer recovery after acute TBI; however, their status during chronic stages remains elusive. Thus, the goal of this study is to determine whether cardiac BRS and dynamic CA (dCA) were impaired during the chronic stage in patients with single TBI and persistent neurological symptoms. Twenty-two subjects with blunt head TBI >= 6 months prior to the study (13 mild and 9 moderate to severe TBI) and persistent symptoms on Rivermead Post-Concussion Symptoms Questionnaire at enrollment were compared to 22 age/sex/fitness level-matched healthy control subjects. Beat-to-beat changes in heart rate, BP, and CBF velocity were measured at rest and during a repeated sit-stand maneuver. Hemodynamic variability, dCA, and cardiac BRS were calculated using spectral and transfer function analyses. We found dCA phase in low frequency (LF) range of 0.07-0.20 Hz was lower in subjects with TBI than in control subjects (0.51 +/- 0.19 vs. 0.63 +/- 0.26, p = 0.043) during the resting condition. Among subjects with TBI, the lower dCA phase in LF was correlated with poorer performance on measures of cognitive function (all p < 0.05). These findings suggested that subjects with chronic TBI showed impaired dCA which may contribute to persistent cognitive impairment. Cerebrovascular measures may provide a physiological measure to evaluate interventions for chronic TBI and accompanying functional deficits.	[Ding, Kan; Tarumi, Takashi; Mccolloster, Max; Le, Tran; Dieppa, Marisara; Cullum, C. Munro; Zhang, Rong] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Tarumi, Takashi; Tomoto, Tsubasa; Zhang, Rong] Texas Hlth Presbyterian Hosp Dallas, Inst Exercise & Environm Med, 8200 Walnut Hill Ln, Dallas, TX 75231 USA; [Tarumi, Takashi] Natl Inst Adv Ind Sci & Technol, Human Informat Res Inst, Tsukuba, Ibaraki, Japan; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, 51 North 39th St, Philadelphia, PA 19104 USA; [Bell, Kathleen] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Madden, Christopher; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosurg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA		Ding, K (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	kan.ding@utsouthwestern.edu	Tarumi, Takashi/M-9976-2018	Tarumi, Takashi/0000-0001-7061-8867; , Kan/0000-0003-3485-8200; Dieppa, Marisara/0000-0002-4532-0601; Le, Tran/0000-0002-0030-2266	Darrell Royal Research Foundation; Texas Institute for Brain Injury and Repair	The authors thank all of our study participants, technical support from staff at IEEM cerebrovascular lab, and grant support from the Darrell Royal Research Foundation and the Texas Institute for Brain Injury and Repair.	Aengevaeren VL, 2013, J APPL PHYSIOL, V114, P195, DOI 10.1152/japplphysiol.00402.2012; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Claassen JAHR, 2009, J APPL PHYSIOL, V106, P153, DOI 10.1152/japplphysiol.90822.2008; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Dawson SL, 2000, STROKE, V31, P463, DOI 10.1161/01.STR.31.2.463; Department of Veterans Affairs D.o.D., 2016, VA DOD CLIN PRACT GU; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; El-Menyar A, 2017, CARDIOL REV, V25, P279, DOI 10.1097/CRD.0000000000000167; Fadel PJ, 2008, MED SCI SPORT EXER, V40, P2055, DOI 10.1249/MSS.0b013e318180bc80; Flechet M, 2018, ACTA NEUROCHIR SUPPL, V126, P291, DOI 10.1007/978-3-319-65798-1_57; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Gershon RC, 2013, MONOGR SOC RES CHILD, V78, P49, DOI 10.1111/mono.12034; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Henden PL, 2014, J NEUROSURG ANESTH, V26, P50, DOI 10.1097/ANA.0b013e3182a47b62; Highton D, 2015, ANESTH ANALG, V121, P198, DOI 10.1213/ANE.0000000000000790; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Horsman HM, 2014, AM J PHYSIOL-REG I, V307, pR1345, DOI 10.1152/ajpregu.00376.2014; Iwasaki KI, 2000, AM J PHYSIOL-REG I, V279, pR2189, DOI 10.1152/ajpregu.2000.279.6.R2189; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Ko Y, 2010, STROKE, V41, P2512, DOI 10.1161/STROKEAHA.110.595561; La Rovere MT, 1998, LANCET, V351, P478; Lok J, 2015, CNS NEUROSCI THER, V21, P304, DOI 10.1111/cns.12359; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Ogoh S, 2010, J PHYSIOL-LONDON, V588, P365, DOI 10.1113/jphysiol.2009.180844; PAULSON OB, 1988, CIRCULATION, V77, P55; Preiksaitis A., 2015, NEUROSURGERY; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Selassie AW, 2014, J HEAD TRAUMA REHAB, V29, pE8, DOI 10.1097/HTR.0b013e3182976ad3; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Tarumi T, 2014, J ALZHEIMERS DIS, V41, P765, DOI 10.3233/JAD-132018; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tzeng YC, 2014, EUR J APPL PHYSIOL, V114, P545, DOI 10.1007/s00421-013-2667-y; Tzeng YC, 2010, J APPL PHYSIOL, V108, P1162, DOI 10.1152/japplphysiol.01390.2009; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Xing CY, 2017, HYPERTENSION, V69, P712, DOI 10.1161/HYPERTENSIONAHA.116.08986; Yang DX, 2016, J ULTRAS MED, V35, P1907, DOI 10.7863/ultra.15.10040; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Zhang R, 2002, J PHYSIOL-LONDON, V543, P337, DOI 10.1113/jphysiol.2001.013398; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE	44	5	5	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 15	2020	1743								146924	10.1016/j.brainres.2020.146924			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LZ5HS	WOS:000541255600008	32505751				2022-02-06	
J	Longo, MGF; Tan, CO; Chan, ST; Welt, J; Avesta, A; Ratai, E; Mercaldo, ND; Yendiki, A; Namati, J; Chico-Calero, I; Parry, BA; Drake, L; Anderson, R; Rauch, T; Diaz-Arrastia, R; Lev, M; Lee, J; Hamblin, M; Vakoc, B; Gupta, R				Figueiro Longo, Maria Gabriela; Tan, Can Ozan; Chan, Suk-tak; Welt, Jonathan; Avesta, Arman; Ratai, Eva; Mercaldo, Nathaniel David; Yendiki, Anastasia; Namati, Jacqueline; Chico-Calero, Isabel; Parry, Blair A.; Drake, Lynn; Anderson, Rox; Rauch, Terry; Diaz-Arrastia, Ramon; Lev, Michael; Lee, Jarone; Hamblin, Michael; Vakoc, Benjamin; Gupta, Rajiv			Effect of Transcranial Low-Level Light Therapy vs Sham Therapy Among Patients With Moderate Traumatic Brain Injury A Randomized Clinical Trial	JAMA NETWORK OPEN			English	Article							LASER THERAPY; NEUROTHERA EFFECTIVENESS; ISCHEMIC-STROKE; HEAD-INJURY; DIFFUSION; SAFETY; PHOTOBIOMODULATION; MRI	IMPORTANCE Preclinical studies have shown that transcranial near-infrared low-level light therapy (LLLT) administered after traumatic brain injury (TBI) confers a neuroprotective response. OBJECTIVES To assess the feasibility and safety of LLLT administered acutely after a moderate TBI and the neuroreactivity to LLLT through quantitative magnetic resonance imaging metrics and neurocognitive assessment. DESIGN, SETTING, AND PARTICIPANTS A randomized, single-center, prospective, double-blind, placebo-controlled parallel-group trial was conducted from November 27, 2015, through July 11, 2019. Participants included 68 men and women with acute, nonpenetrating, moderate TBI who were randomized to LLLT or sham treatment. Analysis of the response-evaluable population was conducted. INTERVENTIONS Transcranial LLLT was administered using a custom-built helmet starting within 72 hours after the trauma. Magnetic resonance imaging was performed in the acute (within 72 hours), early subacute (2-3 weeks), and late subacute (approximately 3 months) stages of recovery. Clinical assessments were performed concomitantly and at 6 months via the Rivermead Post-Concussion Questionnaire (RPQ), a 16-item questionnaire with each item assessed on a 5-point scale ranging from 0 (no problem) to 4 (severe problem). MAIN OUTCOMES AND MEASURES The number of participants to successfully and safely complete LLLT without any adverse events within the first 7 days after the therapy was the primary outcome measure. Secondary outcomes were the differential effect of LLLT on MR brain diffusion parameters and RPQ scores compared with the sham group. RESULTS Of the 68 patients who were randomized (33 to LLLT and 35 to sham therapy), 28 completed at least 1 LLLT session. No adverse events referable to LLLT were reported. Forty-three patients (22 men [51.2%]; mean [SD] age, 50.49 [17.44] years]) completed the study with at least 1 magnetic resonance imaging scan: 19 individuals in the LLLT group and 24 in the sham treatment group. Radial diffusivity (RD), mean diffusivity (MD), and fractional anisotropy (FA) showed significant time and treatment interaction at 3-month time point (RD: 0.013; 95% CI, 0.006 to 0.019; P < .001; MD: 0.008; 95% CI, 0.001 to 0.015; P = .03; FA: -0.018; 95% CI, -0.026 to -0.010; P < .001).The LLLT group had lower RPQ scores, but this effect did not reach statistical significance (time effect P = .39, treatment effect P = .61, and time x treatment effect P = .91). CONCLUSIONS AND RELEVANCE In this randomized clinical trial, LLLT was feasible in all patients and did not exhibit any adverse events. Light therapy altered multiple diffusion tensor parameters in a statistically significant manner in the late subacute stage. This study provides the first human evidence to date that light therapy engages neural substrates that play a role in the pathophysiologic factors of moderate TBI and also suggests diffusion imaging as the biomarker of therapeutic response.	[Figueiro Longo, Maria Gabriela; Tan, Can Ozan; Ratai, Eva; Mercaldo, Nathaniel David; Namati, Jacqueline; Chico-Calero, Isabel; Parry, Blair A.; Drake, Lynn; Anderson, Rox; Lev, Michael; Lee, Jarone; Hamblin, Michael; Vakoc, Benjamin; Gupta, Rajiv] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA; [Tan, Can Ozan] Spaulding Rehabil Hosp, Boston, MA USA; [Chan, Suk-tak; Yendiki, Anastasia] Athinoula Martinos Ctr Biomed Imaging, Boston, MA USA; [Welt, Jonathan] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Avesta, Arman] Yale Sch Med, Dept Radiol, New Haven, CT USA; [Rauch, Terry] Dept Def, Off Secretary Def, Washington, DC USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA		Longo, MGF (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Div Emergency Radiol, 55 Fruit St,Blk SB Rm 0029A, Boston, MA 02114 USA.	mfigueirolongo@mgh.harvard.edu	Tan, Can Ozan/E-2598-2016	Tan, Can Ozan/0000-0001-9673-9907; Mercaldo, Nathaniel/0000-0003-1658-6598	Air Force [FA8650-17-C-9113]; Army USAMRAA Joint Warfighter Medical Research Program [W81XWH-15-C-0052]; Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-13-2-0067]	This research fund was partially supported by grants from Air Force contract FA8650-17-C-9113; Army USAMRAA Joint Warfighter Medical Research Program, contract W81XWH-15-C-0052; and Congressionally Directed Medical Research Program W81XWH-13-2-0067.	Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Aung Wint Yan, 2013, Imaging Med, V5, P427; Bossini PS, 2009, LASER MED SCI, V24, P209, DOI 10.1007/s10103-008-0551-5; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; Centers for Disease Control and Prevention, 2014, SURV REP TRAUM BRAIN; Corazza AV, 2007, PHOTOMED LASER SURG, V25, P102, DOI 10.1089/pho.2006.2011; Defense and Veterans Brain Injury Center, 2019, DOD TBI WORLDW NUMB; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; FAZEKAS F, 1987, AM J NEURORADIOL, V8, P421; Hacke W, 2014, STROKE, V45, P3187, DOI 10.1161/STROKEAHA.114.005795; Hemvani N, 2005, PHOTOMED LASER SURG, V23, P571, DOI 10.1089/pho.2005.23.571; Huisa BN, 2013, INT J STROKE, V8, P315, DOI 10.1111/j.1747-4949.2011.00754.x; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Liang HL, 2006, NEUROSCIENCE, V139, P639, DOI 10.1016/j.neuroscience.2005.12.047; Marr A., 2004, CENTRAL NERVOUS SYST; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Sommer AP, 2001, J CLIN LASER MED SUR, V19, P29, DOI 10.1089/104454701750066910; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Thunshelle C, 2016, PHOTOMED LASER SURG, V34, P587, DOI 10.1089/pho.2015.4051; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Yano R, 2018, NEUROCHEM INT, V119, P151, DOI 10.1016/j.neuint.2017.10.004; Yendiki A, 2016, NEUROIMAGE, V127, P277, DOI 10.1016/j.neuroimage.2015.12.003; Zhang R, 2009, J MOL CELL CARDIOL, V46, P4, DOI 10.1016/j.yjmcc.2008.09.707; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	31	5	5	3	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	SEP 14	2020	3	9							e2017337	10.1001/jamanetworkopen.2020.17337			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NU7XD	WOS:000573851900005	32926117	gold, Green Published			2022-02-06	
J	Hart, T; Vaccaro, M; Collier, G; Chervoneva, I; Fann, JR				Hart, Tessa; Vaccaro, Monica; Collier, George; Chervoneva, Inna; Fann, Jesse R.			Promoting mental health in traumatic brain injury using single-session Behavioural Activation and SMS messaging: A randomized controlled trial	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injuries; Behavioural Activation; implementation intentions; depression treatment; anxiety treatment	IMPLEMENTATION INTENTIONS; DEPRESSION; THERAPY; REHABILITATION; ANXIETY; MEMORY; SCALE; PARTICIPATION; METAANALYSIS; DISORDER	We compared two treatments for depression and/ or anxiety in chronic moderate to severe traumatic brain injury (TBI) (Clinicaltrials.gov NCT02061553). Fifty-nine participants were randomized 2:1 to a single session of Behavioural Activation followed by 8 weeks of daily SMS (text) messages in the form of implementation intentions supporting individualized goals for increased rewarding/ meaningful activities (INT), or a single (attention control) session focused on the importance of motivation followed by 8 weeks of motivational SMS messages (MOT). Both conditions resulted in modestly improved emotional status. The INT condition led to more exposure to environmental reward and greater productivity. Gains in both conditions were of questionable clinical significance but suggested different mechanisms of action, which should be confirmed by further research. The delivery of frequent text messages proved to be a very feasible means of supporting treatment in this population.	[Hart, Tessa; Vaccaro, Monica] Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA; [Collier, George] Sixth Wave Technol LLC, Asheville, NC USA; [Chervoneva, Inna] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Fann, Jesse R.] Univ Washington, Sch Med, Seattle, WA USA		Hart, T (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	thart@einstein.edu					Armento MEA, 2007, BEHAV THER, V38, P107, DOI 10.1016/j.beth.2006.05.003; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brown I, 2009, EPILEPSY BEHAV, V16, P634, DOI 10.1016/j.yebeh.2009.09.014; Burgess P.W., 1997, HAYLING BRIXTON TEST; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Culley C, 2010, NEUROPSYCHOL REHABIL, V20, P103, DOI 10.1080/09602010902906926; Derogatis L.R., 2000, BRIEF SYMPTOM INVENT; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Gawrysiak M, 2009, J COUNS PSYCHOL, V56, P468, DOI 10.1037/a0016383; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Gollwitzer PM, 2014, MOTIV EMOTION, V38, P305, DOI 10.1007/s11031-014-9416-3; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hart T, 2017, J HEAD TRAUMA REHAB, V32, P319, DOI 10.1097/HTR.0000000000000316; Hart T, 2017, BRAIN INJURY, V31, P297, DOI 10.1080/02699052.2016.1251612; Hart T, 2016, ARCH PHYS MED REHAB, V97, P701, DOI 10.1016/j.apmr.2015.08.436; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hart T, 2010, J VOCAT REHABIL, V32, P135, DOI 10.3233/JVR-2010-0505; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hopko DR, 2011, J CONSULT CLIN PSYCH, V79, P834, DOI 10.1037/a0025450; Hopko DR, 2016, CLIN CASE STUD, V3, P37, DOI [10.1177/1534650103258969, DOI 10.1177/1534650103258969]; Jacobson NS, 1996, J CONSULT CLIN PSYCH, V64, P295, DOI 10.1037/0022-006X.64.2.295; Kanter JW, 2007, J PSYCHOPATHOL BEHAV, V29, P191, DOI 10.1007/s10862-006-9038-5; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Marquardt MK, 2017, REHABIL PSYCHOL, V62, P580, DOI 10.1037/rep0000104; Mazzucchelli T, 2009, CLIN PSYCHOL-SCI PR, V16, P383, DOI 10.1111/j.1468-2850.2009.01178.x; Mioni G, 2015, J INT NEUROPSYCH SOC, V21, P305, DOI 10.1017/S1355617715000211; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Prestwich A, 2009, PSYCHOL HEALTH, V24, P677, DOI 10.1080/08870440802040715; Prestwich A, 2010, HEALTH PSYCHOL, V29, P40, DOI 10.1037/a0016993; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Reitan R, 1985, HALSTEAD REITAN NEUR; Reuter T, 2009, REHABIL PSYCHOL, V54, P363, DOI 10.1037/a0017830; Richard NM, 2018, NEUROPSYCHOLOGY, V32, P541, DOI 10.1037/neu0000442; Schmidt M., 1996, REY AUDITORY VERBAL; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Sniehotta FF, 2006, BRIT J HEALTH PSYCH, V11, P23, DOI 10.1348/135910705X43804; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Wechsler D., 2011, WECHSLER ABBREVIATED; Weinstock LM, 2011, BEHAV MODIF, V35, P403, DOI 10.1177/0145445511405646; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wieber F, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00395; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Ziegelmann JP, 2007, REHABIL PSYCHOL, V52, P97, DOI 10.1037/0090-5550.52.1.97	51	5	5	2	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	SEP 13	2020	30	8					1523	1542		10.1080/09602011.2019.1592761			20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	MT6UM	WOS:000555107800006	30870102				2022-02-06	
J	Koohbor, B; Blourchian, A; Uddin, KZ; Youssef, G				Koohbor, Behrad; Blourchian, Aryan; Uddin, Kazi Zahir; Youssef, George			Characterization of Energy Absorption and Strain Rate Sensitivity of a Novel Elastomeric Polyurea Foam	ADVANCED ENGINEERING MATERIALS			English	Article						energy absorption; impact mitigations; polyurea foams; semi-closed cell foams; strain-rate sensitivity	LOAD-COMPRESSION BEHAVIOR; DYNAMIC TENSILE-STRENGTH; FOOTBALL; HELMET; CONCUSSION; FAILURE; MODEL	Elastomeric polymer foams are widely used in sports and other protective padding applications due to their unique properties, such as excellent cushioning and relatively high-energy absorption to weight ratio. This work investigates the mechanical and energy absorption performance of an elastomeric hybrid structure polyurea foam in response to low-velocity impact. The examined polyurea foams are synthesized using a novel self-foaming process that leads to the development of a semi-closed cellular structure. The quasi-static response of the foam is first characterized by measuring the global stress-strain and energy absorption characteristics. The evolution of the foam's Poisson's ratio is also characterized by in situ digital image correlation (DIC) measurements. The same properties are also studied in dynamic loading conditions by subjecting the foam samples to controlled impact tests. A strain-dependent rate sensitivity parameter is used to quantify differences between the quasi-static and dynamic strength and energy absorption responses of the foam. The examined foam shows significant enhancement in strength at increased strain rates while retaining its excellent energy absorption capacity. This unique characteristic of the examined foam is discussed in terms of the concurrent effects of entrapped gas and the rate sensitivity of the parent polymer.	[Koohbor, Behrad; Uddin, Kazi Zahir] Rowan Univ, Dept Mech Engn, 201 Mull Hill Rd, Glassboro, NJ 08028 USA; [Blourchian, Aryan; Youssef, George] San Diego State Univ, Dept Mech Engn, Expt Mech Lab, 5500 Campanile Dr, San Diego, CA 92182 USA		Youssef, G (corresponding author), San Diego State Univ, Dept Mech Engn, Expt Mech Lab, 5500 Campanile Dr, San Diego, CA 92182 USA.	gyoussef@sdsu.edu	Koohbor, Behrad/F-9771-2015	Koohbor, Behrad/0000-0002-5787-4644; Youssef, George/0000-0003-2029-7692; Uddin, Kazi Zahir/0000-0001-5486-5024	United States Department of DefenseUnited States Department of Defense [W911NF-14-1-0039, W911NF-18-10477]; Office of Naval ResearchOffice of Naval Research; San Diego State University	Some of the research leading to these results was supported in part by the United States Department of Defense under Grant Agreement No. W911NF-14-1-0039 and W911NF-18-10477. The researchers from the Experimental Mechanics Laboratory are grateful to the guidance of Dr. Roshdy Barsoum of the Office of Naval Research. The research was also in part supported by internal funds from San Diego State University. The authors also wish to acknowledge Mr. Nathan Reed and Ms. Brooke Rosenow for their help.	Amirkhizi AV, 2006, PHILOS MAG, V86, P5847, DOI 10.1080/14786430600833198; Avalle M, 2001, INT J IMPACT ENG, V25, P455, DOI 10.1016/S0734-743X(00)00060-9; Avalle M, 2019, ADV ENG MATER, V21, DOI 10.1002/adem.201800457; Barsoum RGS., 2015, ELASTOMERIC POLYM HI; Belda R, 2020, INT J MECH SCI, V165, DOI 10.1016/j.ijmecsci.2019.105213; Bouix R, 2009, INT J IMPACT ENG, V36, P329, DOI 10.1016/j.ijimpeng.2007.11.007; Bustamante MC, 2019, J DYNAM BEHAV MAT, V5, P117, DOI 10.1007/s40870-019-00189-9; Deshpande VS, 2000, INT J IMPACT ENG, V24, P277, DOI 10.1016/S0734-743X(99)00153-0; Do S., 2020, J APPL SCI UNPUB; Felten M, 2020, ADV ENG MATER, V22, DOI 10.1002/adem.201901589; Gibson L. J., 1999, CELLULAR SOLIDS STRU; GRUENBAUM G, 1983, J APPL POLYM SCI, V28, P135, DOI 10.1002/app.1983.070280112; Grujicic A, 2012, J MATER ENG PERFORM, V21, P1562, DOI 10.1007/s11665-011-0065-3; Grujicic M, 2012, MULTIDISCIP MODEL MA, V8, P297, DOI 10.1108/15736101211269122; Grujicic M, 2010, MATER DESIGN, V31, P4050, DOI 10.1016/j.matdes.2010.05.002; Gupta B. J., 2017, J APPL PHYS, V121, P225107; Gupta V, 2014, EXP MECH, V54, P1133, DOI 10.1007/s11340-014-9854-6; Gupta V., 2016, U.S. Patent Application, Patent No. [14/827,120, 14827120]; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Jain A, 2013, J ADHES SCI TECHNOL, V27, P403, DOI 10.1080/01694243.2012.705545; Kim H, 2012, MECH MATER, V45, P10, DOI 10.1016/j.mechmat.2011.08.017; Koohbor B, 2020, INT J MECH SCI, V181, DOI 10.1016/j.ijmecsci.2020.105679; Koohbor B, 2018, MECH MATER, V116, P67, DOI 10.1016/j.mechmat.2017.03.017; Koohbor B, 2016, INT J IMPACT ENG, V98, P62, DOI 10.1016/j.ijimpeng.2016.08.006; Koohbor B, 2016, INT J IMPACT ENG, V91, P170, DOI 10.1016/j.ijimpeng.2016.01.007; Koohbor B, 2015, POLYM TEST, V44, P112, DOI 10.1016/j.polymertesting.2015.03.016; Koumlis S, 2019, EXP MECH, V59, P1087, DOI 10.1007/s11340-019-00521-3; Li QM, 2006, J CELL PLAST, V42, P371, DOI 10.1177/0021955X06063519; Lindholm US., 1974, J CELL PLAST, V10, P127, DOI DOI 10.1177/0021955X7401000306; Mills NJ, 2007, POLYMER FOAMS HANDBOOK: ENGINEERING AND BIOMECHANICS APPLICATIONS AND DESIGN GUIDE, P1; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Ramirez BJ, 2018, MATER DESIGN, V137, P298, DOI 10.1016/j.matdes.2017.10.037; Reed N, 2020, J APPL POLYM SCI, V137, DOI 10.1002/app.48839; RUSCH KC, 1970, J APPL POLYM SCI, V14, P1433, DOI 10.1002/app.1970.070140603; RUSCH KC, 1969, J APPL POLYM SCI, V13, P2297, DOI 10.1002/app.1969.070131106; RUSCH KC, 1970, J APPL POLYM SCI, V14, P1263, DOI 10.1002/app.1970.070140514; Sun Y, 2016, ACTA MATER, V110, P161, DOI 10.1016/j.actamat.2016.03.003; Sun YL, 2015, INT J SOLIDS STRUCT, V63, P50, DOI 10.1016/j.ijsolstr.2015.02.034; Tripathi M, 2020, POLYM TEST, V86, DOI 10.1016/j.polymertesting.2020.106488; Uddin KZ, 2020, J BIOMECH, V109, DOI 10.1016/j.jbiomech.2020.109950; Youssef G, 2013, EXP MECH, V53, P145, DOI 10.1007/s11340-012-9613-5; Youssef G., 2017, U.S Provisional Patent, Patent No. 62553120; Youssef G, 2020, MECH MATER, V148, DOI 10.1016/j.mechmat.2020.103432; Youssef G, 2012, MECH TIME-DEPEND MAT, V16, P317, DOI 10.1007/s11043-011-9164-7; Youssef G, 2012, J MATER RES, V27, P494, DOI 10.1557/jmr.2011.405	45	5	5	8	27	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1438-1656	1527-2648		ADV ENG MATER	Adv. Eng. Mater.	JAN	2021	23	1							2000797	10.1002/adem.202000797		SEP 2020	11	Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	QE9FA	WOS:000567179500001		Bronze			2022-02-06	
J	Carmichael, JJ; Gould, KR; Hicks, AJ; Feeney, TJ; Ponsford, JL				Carmichael, Jai Jason; Gould, Kate Rachel; Hicks, Amelia J.; Feeney, Timothy J.; Ponsford, Jennie Louise			Understanding Australian Community ABI Therapists' Preferences for Training in and Implementing Behaviour Interventions: A Focus on Positive Behaviour Support	BRAIN IMPAIRMENT			English	Article						acquired brain injury; challenging behaviours; Positive Behaviour Support; training; implementation	TRAUMATIC BRAIN-INJURY; CHALLENGING BEHAVIOR; INDIVIDUALS; MANAGEMENT; ADULTS; TBI; SENSITIVITY; CHOICE; ADOLESCENTS; IMPAIRMENT	Objective: Individuals with acquired brain injury (ABI) may experience persistent and distressing challenging behaviours (CB), and therefore, effective delivery of behaviour interventions is crucial. This study aimed to investigate community ABI therapists' experiences of using, training in and implementing behaviour interventions with a focus on Positive Behaviour Support (PBS). Methods: A sample of Australian community ABI therapists (n= 136) completed an online survey about their experiences with behaviour interventions, including PBS. Data from open-ended questions were analysed using content analysis. Frequency and descriptive statistics were computed, and a multiple regression was performed to determine factors predicting readiness to learn and implement new behaviour interventions. Rank-based non-parametric tests were conducted to investigate the influence of clinical role on experiences with behaviour interventions and training preferences. Results: Consistent with PBS, participants indicated that the following were important in addressing CB: teamwork and collaboration, person-centred practice, working with antecedents, environmental modification, improving quality of life and skill-building. Despite a high level of desire and readiness, 80% of participants reported facing barriers to learning and implementing new behaviour interventions (e.g., lack of time). Participants' confidence in using behaviour interventions (beta = 0.31;p= 0.002) and the number of barriers faced (beta = -0.30;p= 0.002) predicted their readiness to learn and implement new behaviour interventions. Confidence, duration of past training in behaviour interventions and preferred duration of future training did not differ based on clinical role. Conclusion: Implications for the development of training in behaviour interventions such as PBS and implementation into community practice are discussed.	[Carmichael, Jai Jason; Gould, Kate Rachel; Hicks, Amelia J.; Ponsford, Jennie Louise] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Carmichael, Jai Jason; Gould, Kate Rachel; Hicks, Amelia J.; Ponsford, Jennie Louise] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Clayton, Vic, Australia; [Feeney, Timothy J.] Belvedere Hlth Serv, Essex Jct, VT USA; [Feeney, Timothy J.] Mill Sch, Essex Jct, VT USA		Carmichael, JJ (corresponding author), Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia.; Carmichael, JJ (corresponding author), Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Clayton, Vic, Australia.	jai.carmichael@monash.edu	Gould, Kate Rachel/AAA-5511-2020	Gould, Kate Rachel/0000-0002-3564-7408; Carmichael, Jai/0000-0002-3796-9240	Transport Accident Commission through the Institute for Safety Compensation and Recovery Research [135]	This work was supported by the Transport Accident Commission through the Institute for Safety Compensation and Recovery Research (grant number 135).	Adams AS, 1999, INT J QUAL HEALTH C, V11, P187, DOI 10.1093/intqhc/11.3.187; Allen D., 2011, INT J POSITIVE BEHAV, V1, P14; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; [Anonymous], 2018, QUALTRICS COMPUTER S; Arco L, 2009, BRAIN IMPAIR, V10, P307, DOI 10.1375/brim.10.3.307; Australian Government Department of Human Services, 2013, NAT FRAM RED EL US R; Barbour RS, 1998, QUAL HEALTH RES, V8, P352, DOI 10.1177/104973239800800306; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Berger T, 2004, J CLIN PSYCHOL, V60, P301, DOI 10.1002/jclp.10265; Bradshaw CP, 2010, J POSIT BEHAV INTERV, V12, P133, DOI 10.1177/1098300709334798; Braine ME, 2011, J NEUROSCI NURS, V43, P156, DOI 10.1097/JNN.0b013e3182135bb2; Carnevale GJ, 2006, ARCH PHYS MED REHAB, V87, P1289, DOI 10.1016/j.apmr.2006.06.010; Carnevale GJ, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199602000-00005; Carr EG, 2002, J POSIT BEHAV INTERV, V4, P4, DOI 10.1177/109830070200400102; Cashwell T.H., 2001, CLIN SUPERV, V20, P39, DOI 10.1300/J001v20n01_03; Cochrane LJ, 2007, J CONTIN EDUC HEALTH, V27, P94, DOI 10.1002/chp.106; Crabtree B. F., 1999, DOING QUALITATIVE RE; Curtin M, 2007, AUST OCCUP THER J, V54, P88, DOI 10.1111/j.1440-1630.2007.00661.x; Dopson S, 2003, HEALTH, V7, P311, DOI 10.1177/1363459303007003004; Fairburn CG, 2011, BEHAV RES THER, V49, P373, DOI 10.1016/j.brat.2011.03.005; Feeney TJ, 2014, NEUROREHABILITATION, V34, P709, DOI 10.3233/NRE-141088; Feeney Timothy J., 2010, Seminars in Speech and Language, V31, P145, DOI 10.1055/s-0030-1257531; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Feeney TJ, 2001, J HEAD TRAUMA REHAB, V16, P61, DOI 10.1097/00001199-200102000-00008; Field A., 2018, DISCOVERING STAT USI; Fisher A, 2017, BRAIN IMPAIR, V18, P211, DOI 10.1017/BrImp.2016.36; Fleming J., 1995, BRIT J OCCUPATIONAL, V58, P55, DOI [https://doi.org/10.1177/030802269505800204, DOI 10.1177/030802269505800204]; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Gardner RM, 2003, J HEAD TRAUMA REHAB, V18, P52, DOI 10.1097/00001199-200301000-00007; Gore, 2013, INT J POSITIVE BEHAV, V3, P14; Gould KR, 2019, NEUROPSYCHOL REHABIL, V29, P376, DOI 10.1080/09602011.2017.1307767; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hassiotis A, 2018, BRIT J PSYCHIAT, V212, P161, DOI 10.1192/bjp.2017.34; Hicks AJ, 2017, BRAIN INJURY, V31, P1312, DOI 10.1080/02699052.2017.1317361; Holt DT, 2010, J GEN INTERN MED, V25, P50, DOI 10.1007/s11606-009-1112-8; Holt DT, 2007, RES ORGAN CHAN DEV, V16, P289, DOI 10.1016/S0897-3016(06)16009-7; Hoofien D, 2001, BRAIN INJURY, V15, P189; IBM Corp, 2017, SPSS STAT WIND; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; Krippendorff Klaus, 2018, CONTENT ANAL INTRO I; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P615, DOI 10.1017/S1355617707070762; Lowe K, 2005, TIZARD LEARN DISABIL, V10, P34, DOI 10.1108/13595474200500019; Neimeyer GJ, 2012, PROF PSYCHOL-RES PR, V43, P364, DOI 10.1037/a0028698; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; *QSR INT, 2018, NVIVO VERS 12 COMP S; Rahman B, 2010, NEUROPSYCHOL REHABIL, V20, P212, DOI 10.1080/09602010903021097; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Schlund MW, 2002, BRAIN INJURY, V16, P347, DOI 10.1080/02699050110103977; Schlund MW, 2002, BRAIN INJURY, V16, P527, DOI 10.1080/02699050110113679; Schlund MW, 2000, BEHAV INTERVENT, V15, P155, DOI 10.1002/1099-078X(200007/09)15:3<155::AID-BIN53>3.0.CO;2-F; Shea CM, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-7; Stewart RE, 2012, J CLIN PSYCHOL, V68, P8, DOI 10.1002/jclp.20832; Storkholm MH, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0769-y; Tabachnick B.G., 2013, USING MULTIVARIATE S; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Viera AJ, 2005, FAM MED, V37, P360; Weiner BJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-67; Willis TJ, 2003, J HEAD TRAUMA REHAB, V18, P75, DOI 10.1097/00001199-200301000-00008; Wong D, 2014, AUST PSYCHOL, V49, P209, DOI 10.1111/ap.12061; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	62	5	5	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2020	21	2					191	207	PII S1443964619000329	10.1017/BrImp.2019.32			17	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	OA1UW	WOS:000577580500004					2022-02-06	
J	Hoffman, H; Furst, T; Jalal, MS; Chin, LS				Hoffman, Haydn; Furst, Taylor; Jalal, Muhammad S.; Chin, Lawrence S.			Costs and predictors of 30-day readmissions after craniotomy for traumatic brain injury: a nationwide analysis	JOURNAL OF NEUROSURGERY			English	Article						craniotomy; traumatic brain injury; readmission; predictors	HOSPITAL READMISSIONS; UNITED-STATES; REHOSPITALIZATION; CARE; REHABILITATION; BURDEN; HEALTH; TBI	OBJECTIVE There is increasing interest in the use of 30-day readmission (30dRA) as a quality metric to represent hospital and provider performance. Data regarding the incidence and risk factors for 30dRA after traumatic brain injury (TBI) are sparse. The authors sought to characterize these variables using a national database. METHODS The Nationwide Readmissions Database was used to identify patients with a primary diagnosis of TBI who underwent craniotomy or craniectomy between 2010 and 2014. Our primary outcome of interest was 30dRA. Binary logistic regression was used to identify variables related to patient demographics, comorbidities, and index hospital admission that were associated with 30dRA. RESULTS A total of 25,354 patients met the inclusion criteria. The 30dRA rate during the entire study period was 15.5%. In 2010 the 30dRA rate was 16.8% and in 2014 it decreased to 15.1% (pooled OR 0.90, 95% CI 0.87-0.94). The mean cost associated with a 30dRA increased slightly but significantly, from $9999 in 2010 to $10,114 in 2014 (p = 0.021). Factors associated with increased odds of 30dRA in the binary logistic regression included increased age, greater comorbidity burden, more severe injury, tracheostomy, gastrostomy, sodium abnormality, and venous thromboembolism. In order of decreasing frequency, the most common causes for 30dRA were neurological, injury/iatrogenic, cardiovascular/cerebrovascular, infectious, and respiratory. CONCLUSIONS The incidence of 30dRA after craniotomy for TBI decreased slightly from 2010 to 2014. This study identified several variables associated with 30dRA that require confirmation in a prospective study, which could direct attempts to prevent readmissions.	[Hoffman, Haydn; Furst, Taylor; Jalal, Muhammad S.; Chin, Lawrence S.] SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA		Hoffman, H (corresponding author), SUNY Upstate Med Univ, Syracuse, NY 13210 USA.	hoffmanh@upstate.edu		Hoffman, Haydn/0000-0002-2967-6528			Canner JK, 2016, BRAIN INJURY, V30, P1570, DOI 10.1080/02699052.2016.1199898; Centers for Medicare and Medicaid, 2017, 2015 QRURS 2017 VAL; Chen W, 2017, NEUROPSYCH DIS TREAT, V13, P2301, DOI 10.2147/NDT.S141486; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cucchiara BL, 2004, CRIT CARE MED, V32, P241, DOI 10.1097/01.CCM.0000104113.36384.81; Dams-O'Connor K, 2017, J HEAD TRAUMA REHAB, V32, P147, DOI 10.1097/HTR.0000000000000263; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dhakar MB, 2015, SEIZURE-EUR J EPILEP, V32, P16, DOI 10.1016/j.seizure.2015.08.005; Ding J, 2014, ARQ NEURO-PSIQUIAT, V72, P715, DOI 10.1590/0004-282X20140106; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS293, DOI 10.1016/j.apmr.2014.08.026; Hoffman H, 2018, WORLD NEUROSURG, V118, pE880, DOI 10.1016/j.wneu.2018.07.089; Hsia RY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022297; Kayani NA, 2009, PUBLIC HEALTH REP, V124, P551, DOI 10.1177/003335490912400412; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; Kripalani S, 2014, ANNU REV MED, V65, P471, DOI 10.1146/annurev-med-022613-090415; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leppin AL, 2014, JAMA INTERN MED, V174, P1095, DOI 10.1001/jamainternmed.2014.1608; Li CY, 2018, ARCH PHYS MED REHAB, V99, P1279, DOI 10.1016/j.apmr.2017.12.006; Marin JR, 2017, BRAIN INJURY, V31, P24, DOI 10.1080/02699052.2016.1217351; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; McCutcheon BA, 2015, J NEUROSURG, V123, P406, DOI 10.3171/2015.3.JNS131356; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1884, DOI 10.1016/j.apmr.2012.11.054; Onukwugha E, 2018, JCO CLIN CANCER INFO, V2, DOI 10.1200/CCI.17.00075; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Pretz CR, 2017, ARCH PHYS MED REHAB, V98, P997, DOI 10.1016/j.apmr.2016.12.012; Salisbury DB, 2017, ARCH PHYS MED REHAB, V98, P425, DOI 10.1016/j.apmr.2016.09.117; Sanches Jose Eduardo Arantes, 2012, Open Orthop J, V6, P590, DOI 10.2174/1874325001206010590; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Tran J, 2017, J HEAD TRAUMA REHAB, V32, P264, DOI 10.1097/HTR.0000000000000296; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0	31	5	5	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2020	133	3					875	883		10.3171/2019.5.JNS19459			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	OM5UA	WOS:000586088300034	31398707				2022-02-06	
J	Ioncoli, M; Berardi, A; Tofani, M; Panuccio, F; Servadio, A; Valente, D; Galeoto, G				Ioncoli, Melissa; Berardi, Anna; Tofani, Marco; Panuccio, Francescaroberta; Servadio, Annamaria; Valente, Donatella; Galeoto, Giovanni			Crosscultural Validation of the Community Integration Questionnaire-Revised in an Italian Population	OCCUPATIONAL THERAPY INTERNATIONAL			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; QUALITY-OF-LIFE; HAND FUNCTION-TEST; PSYCHOMETRIC PROPERTIES; CONCURRENT VALIDITY; SATISFACTION; OUTCOMES; ADULTS; INDIVIDUALS	Objective.The aims of this study are the translation, cultural adaptation, and validation of the Community Integration Questionnaire-Revised (CIQ-R) in Italian in a group of individuals with no clinical evidence of disability.Methods. The test's internal consistency and validity were assessed by following international guidelines. The test's internal consistency was examined using Cronbach's alpha (alpha) coefficient. Pearson's correlation coefficient was calculated to assess the test's concurrent validity compared with the Short Form-12 (SF-12) health survey.Results. The CIQ-R was administrated to 400 people with no clinical evidence of disease, impairment, or disability, aged between 18 and 64. Cronbach's alpha reported a value of 0.82 in the home integration subscale. The test also showed a good test-retest reliability, with an Intraclass Correlation Coefficient of 0.78, and a significant correlation between the total score of the CIQ-R and the Physical Component Summary (PCS) of the SF-12 (r=0.118), between the "social integration" subscale's score and PCS12 (r=0.121) and between the "Electronic Social Networking integration" subscale's score and PCS12 (r=0.184), with p < 0.05.Conclusion. This is the first study to report the results of the translation and validation of the CIQ-R in Italian. The CIQ-R is an important tool for Italian professionals and can be useful in both clinical practice and research for measuring the level of community integration among the healthy population.	[Ioncoli, Melissa; Panuccio, Francescaroberta] Sapienza Univ Rome, Rome, Italy; [Berardi, Anna; Valente, Donatella; Galeoto, Giovanni] Sapienza Univ Rome, Dept Human Neurosci, Rome, Italy; [Tofani, Marco] Bambino Gesu Pediat Hosp, Dept Neurosci & Neurorehabil, Neurorehabil Unit, Rome, Italy; [Servadio, Annamaria] Tor Vergata Hosp Rome, Dept Hlth Profess, Rome, Italy; [Valente, Donatella] IRCSS Neuromed, Via Atinense 18, I-86077 Pozzilli, Italy		Galeoto, G (corresponding author), Sapienza Univ Rome, Dept Human Neurosci, Rome, Italy.	melissa.ioncoli@gmail.com; aberardi96@gmail.com; marco.tofani@uniroma1.it; francesca.panucciovg@gmail.com; servadio@med.uniroma2.it; donatella.valente@uniroma1.it; giovanni.galeoto@uniroma1.it	TOFANI, Marco/L-9720-2019; Galeoto, Giovanni/M-4922-2016	TOFANI, Marco/0000-0003-2071-4513; Galeoto, Giovanni/0000-0002-9043-5686; Berardi, Anna/0000-0003-0670-5303			Ahmed N, 2018, DISABIL REHABIL, V40, P1033, DOI 10.1080/09638288.2017.1283713; Berardi A., 2020, ADV INTELLIGENT SYST, DOI [10.1007/978-3-030-23884-1_8, DOI 10.1007/978-3-030-23884-1_8]; Berardi A, 2019, NEUROREHABILITATION, V45, P331, DOI 10.3233/NRE-192867; Berardi A, 2019, SPINAL CORD SER CASE, V5, DOI 10.1038/s41394-019-0196-6; Berardi A, 2019, SPINAL CORD, V57, P339, DOI 10.1038/s41393-018-0226-4; Berardi A, 2018, FUNCT NEUROL, V33, P229; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Callaway L, 2017, AUST OCCUP THER J, V64, P226, DOI 10.1111/1440-1630.12350; Callaway L, 2016, AUST OCCUP THER J, V63, P143, DOI 10.1111/1440-1630.12284; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Constant CR, 2008, J SHOULDER ELB SURG, V17, P355, DOI 10.1016/j.jse.2007.06.022; Dalemans RJ, 2010, ARCH PHYS MED REHAB, V91, P395, DOI 10.1016/j.apmr.2009.10.021; Dattoli S, 2020, J SPINAL CORD MED, V43, P185, DOI 10.1080/10790268.2018.1456768; Esselman PC, 2007, ARCH PHYS MED REHAB, V88, pS3, DOI 10.1016/j.apmr.2007.09.020; Galeoto G, 2020, ANN IG MED PREV COMU, V32, P16, DOI 10.7416/ai.2020.2326; Galeoto G, 2018, CLIN TER, V169, pE184, DOI 10.7417/T.2018.2076; Galeoto G, 2021, CRANIO, V39, P326, DOI 10.1080/08869634.2019.1627067; Galeoto G, 2019, TOP STROKE REHABIL, V26, P236, DOI 10.1080/10749357.2019.1574060; Gerber GJ, 2016, BRAIN INJURY, V30, P1552, DOI 10.1080/02699052.2016.1199896; Gontkovsky ST, 2009, NEUROREHABILITATION, V24, P185, DOI 10.3233/NRE-2009-0467; Hall K., 2005, TOPICS SPINAL CORD I, V4, P16; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hirsh AT, 2011, ARCH PHYS MED REHAB, V92, P1602, DOI 10.1016/j.apmr.2011.05.004; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Kaplan CP, 2000, AM J PHYS MED REHAB, V79, P243, DOI 10.1097/00002060-200005000-00005; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Kratz AL, 2015, J SPINAL CORD MED, V38, P446, DOI 10.1179/2045772313Y.0000000182; Lee H, 2015, YONSEI MED J, V56, P1694, DOI 10.3349/ymj.2015.56.6.1694; Lombardi F., 1997, GIORNALE ITALIANO ME, V1, P23; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Migliorini C, 2016, BRAIN INJURY, V30, P1201, DOI 10.1080/02699052.2016.1175666; Mollayeva T, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0432-z; Negahban H, 2013, DISABIL REHABIL, V35, P1453, DOI 10.3109/09638288.2012.741653; Nobilia M, 2019, AM J OCCUP THER, V73, DOI 10.5014/ajot.2019.030080; Puledda F, 2015, NEUROL SCI, V36, P1417, DOI 10.1007/s10072-015-2173-6; Reistetter TA, 2005, NEUROREHABILITATION, V20, P139; Ritchie L, 2014, ARCH PHYS MED REHAB, V95, P163, DOI 10.1016/j.apmr.2013.08.237; Ruggieri M, 2018, PHYS OCCUP THER GERI, V36, P331, DOI 10.1080/02703181.2018.1520381; Saeki S, 2006, J REHABIL MED, V38, P333, DOI 10.1080/16501970600780245; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Savona A, 2019, HAND THER, V24, P48, DOI 10.1177/1758998319843554; Tate R, 2012, AUST PSYCHOL, V47, P20, DOI 10.1111/j.1742-9544.2011.00060.x; Tofani M, 2019, CLIN TER, V170, pE460, DOI 10.7417/CT.2019.2176; Tomaszewski R, 2016, DISABIL REHABIL, V38, P1016, DOI 10.3109/09638288.2015.1070296; Trsinski D, 2019, DISABIL REHABIL, V41, P1711, DOI 10.1080/09638288.2018.1443349; Venderbos LDF, 2015, PSYCHO-ONCOLOGY, V24, P348, DOI 10.1002/pon.3657; Ware J. E., 1995, HOW TO SCORE THE SF1; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Winkler D, 2011, BRAIN INJURY, V25, P153, DOI 10.3109/02699052.2010.541403	52	5	5	0	0	WILEY-HINDAWI	LONDON	ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND	0966-7903	1557-0703		OCCUP THER INT	Occup. Ther. Int.	SEP 1	2020	2020								8916541	10.1155/2020/8916541			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	NS6AV	WOS:000572342800002	32934614	Green Published, gold			2022-02-06	
J	Nasution, RA; Islam, AA; Hatta, M; Prihantono; Kaelan, C; Poniman, J; Wangi, H				Nasution, Rizha Anshori; Islam, Andi Assadul; Hatta, Mochammad; Prihantono; Kaelan, Cahyono; Poniman, Jeni; Wangi, Harakati			Modification of the Marmarou model in developing countries	ANNALS OF MEDICINE AND SURGERY			English	Article						Traumatic brain injury; Marmarou model; Modification; Limited facilities	TRAUMATIC BRAIN-INJURY; RATS	Introduction: Head injury is an injury or wound of the brain tissue due to external forces; it can cause a decrease or change in the status of consciousness. Many head injury models have used mice as experimental animals; the Marmarou model is the most famous and the most widely-used diffuse brain injury model. In this study, we slightly modified the Marmarou model. The purpose of this study is to help researchers examining head injuries in mice, especially those in developing countries who have limited facilities and infrastructure. Methods: This experimental research uses animals models (Rattus novergicus, strain Sprague Dawley) that fit several criteria, including male, aged 10-12 weeks, and body weight of 200-300 g. This study involves a slight modification on the tube used, with a 20 cm-long weight of 20 g. The blood samples for the following assays of ELISA and brain tissue samples were collected at 24 h and 4, 5, 6, and 7 days post-trauma. Results: A significant effect on the brain was seen with the Marmarou model modification, at a mass weight of 20 g and height of 20 cm, with 0.04 J energy produced. Changes were also seen in the histological features of brain tissue and the serum levels of AQP-4, F2 IsoPs, MPO, and VEGF from 24 h until 7 days after trauma. Conclusion: This report describes the development of an experimental head injury approach modifying the Marmarou model that is able to produce a diffuse brain injury model in mice.	[Nasution, Rizha Anshori] Pelamonia Hosp, Dept Neurosurg, Jalan Jend Sudirman 27, Makassar 90157, Indonesia; [Nasution, Rizha Anshori] Hasanuddin Univ, Fac Med, Doctoral Program Biomed Sci, Makassar, Indonesia; [Islam, Andi Assadul] Hasanuddin Univ, Fac Med, Dept Neurosurg, Makassar, Indonesia; [Hatta, Mochammad] Hasanuddin Univ, Fac Med, Clin Microbiologist Program, Makassar, Indonesia; [Prihantono] Hasanuddin Univ, Fac Med, Dept Surg, Makassar, Indonesia; [Kaelan, Cahyono; Poniman, Jeni] Hasanuddin Univ, Fac Med, Dept Pathol Anat, Makassar, Indonesia; [Wangi, Harakati] Pelamonia Hosp, Dept Internal Med, Makassar, Indonesia		Nasution, RA (corresponding author), Pelamonia Hosp, Dept Neurosurg, Jalan Jend Sudirman 27, Makassar 90157, Indonesia.	rizha_nst@yahoo.com; andiasadul@yahoo.com; hattaram@yahoo.com; prihantono.md@gmail.com; cakaelan@yahoo.com; jeni.poniman@gmail.com; gizha_lubis@yahoo.com	Hatta, Mochammad/D-3742-2019; , prihantono/AAK-2259-2020	Hatta, Mochammad/0000-0002-8456-4203; , prihantono/0000-0002-8247-0457			Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Branton, 2017, INT J CLIN DEV ANAT, V3, P9, DOI [10.11648/j.ijcda.20170303.11, DOI 10.11648/J.IJCDA.20170303.11]; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cheng Z, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1153-1; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Darakchiev BJ, 1997, ACT NEUR S, V70, P98; Eakin K., 2015, MODELING FLUID PERCU; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kawa L, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00479; Keep RF., 2017, PRIMER CEREBROVASCUL, P145, DOI [10.1016/B978-0-12-803058-5.00029-1, DOI 10.1016/B978-0-12-803058-5.00029-1]; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Melincovici CS, 2018, ROM J MORPHOL EMBRYO, V59, P455; Nasution RA, 2020, ANN MED SURG, V54, P89, DOI 10.1016/j.amsu.2020.04.015; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Sempere L, 2019, MED INTENSIVA, V43, P362, DOI 10.1016/j.medin.2018.04.012; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Yen HC, 2015, FREE RADICAL RES, V49, P861, DOI 10.3109/10715762.2015.1014812; Zhang CC, 2015, MOL MED REP, V12, P7351, DOI 10.3892/mmr.2015.4372	26	5	5	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2049-0801			ANN MED SURG	Ann. Med. Surg.	SEP	2020	57						109	113		10.1016/j.amsu.2020.07.029			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	NO4BQ	WOS:000569430900025	32742649	gold, Green Published			2022-02-06	
J	Shwartz, SK; Roper, BL; Arentsen, TJ; Crouse, EM; Adler, MC				Shwartz, Susan K.; Roper, Brad L.; Arentsen, Timothy J.; Crouse, Ellen M.; Adler, Marcy C.			The Behavior Rating Inventory of Executive Function (R)-Adult Version is Related to Emotional Distress, Not Executive Dysfunction, in a Veteran Sample	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						BRIEF-A; Executive functions; MMPI-2; Response bias	TRAUMATIC BRAIN-INJURY; SUBJECTIVE COGNITIVE COMPLAINTS; NEUROPSYCHOLOGICAL ASSESSMENT; VALIDITY SCALES; RESPONSE BIAS; OLDER-ADULTS; MILD; MMPI-2-RF; SCORES; PERFORMANCE	Objective: In three studies, we explore the impact of response bias, symptom validity, and psychological factors on the self-report form of the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) and the relationship between self-reported executive functioning (EF) and objective performance. Method: Each study pulled from a sample of 123 veterans who were administered a BRIEF-A and Minnesota Multiphasic Personality Inventory-2 (MMPI-2) during a neuropsychological evaluation. Participants were primarily middle-aged, and half carried a mood disorder diagnosis. Study 1 examined group differences in BRIEF-A ratings among valid, invalid, and indeterminate MMPI-2 responders. Analyses were conducted to determine the optimal cut-score for the BRIEF-A Negativity Validity scale. In Study 2, relationships were explored among MMPI-2-RF (restructured form) Restructured Clinical (RC) scales, somatic/cognitive scales, and the BRIEF-A Metacognition Index (MI); hierarchical analyses were performed to predictMI using MMPI-2-RF Demoralization (RCd) and specific RC scales. Study 3 correlated BRIEF-A clinical scales and indices with RCd and an EF composite score from neuropsychological testing. Hierarchical analyses were conducted to predict BRIEF-A clinical scales. Results: Invalid performance on the MMPI-2 resulted in significantly elevated scores on the BRIEF-A compared to those with valid responding. A more stringent cut-score of >= 4 for the BRIEF-A Negativity scale is more effective at identifying invalid symptom reporting. The BRIEF-A MI is most strongly correlated with demoralization. BRIEF-A indices and scales are largely unrelated to objective EF performance. Conclusions: In a veteran sample, responses on the BRIEF-A are most representative of generalized emotional distress and response bias, not actual EF abilities.	[Shwartz, Susan K.; Roper, Brad L.; Arentsen, Timothy J.; Crouse, Ellen M.; Adler, Marcy C.] Dept Vet Affairs Med Ctr, Memphis, TN 38104 USA; [Roper, Brad L.] Univ Tennessee, Dept Psychiat, Coll Med, Memphis, TN 38103 USA; [Shwartz, Susan K.] Shepherd Ctr, Dept Psychol, Atlanta, GA USA		Roper, BL (corresponding author), Dept Vet Affairs Med Ctr, Memphis, TN 38104 USA.; Roper, BL (corresponding author), Univ Tennessee, Dept Psychiat, Coll Med, Memphis, TN 38103 USA.; Roper, BL (corresponding author), Univ Tennessee, Dept Neurol, Coll Med, Memphis, TN 38103 USA.	Brad.Roper@va.gov	Adler, Marcy/AAN-9597-2021; tan, janie/AAH-9283-2021				Allen L., 1997, CARB 97 MANUAL COMPU; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Ben-Porath YS., 2008, MMPI 2 RF MANUAL ADM; Bolinger E, 2014, ARCH CLIN NEUROPSYCH, V29, P7, DOI 10.1093/arclin/act082; Brookes RL, 2014, NEUROPSYCHOLOGY, V28, P247, DOI 10.1037/neu0000015; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butcher J.N., 1989, MANUAL RESTANDARDIZE; Crumley JJ, 2014, PSYCHOL AGING, V29, P250, DOI 10.1037/a0035908; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Delis D.C., 2001, D KEFS EXAMINERS MAN; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Donders J, 2015, J HEAD TRAUMA REHAB, V30, pE30, DOI 10.1097/HTR.0000000000000120; Donders J, 2010, J NEUROPSYCHOL, V4, P197, DOI 10.1348/174866409X478970; Dufouil C, 2005, J AM GERIATR SOC, V53, P616, DOI 10.1111/j.1532-5415.2005.53209.x; Forbey JD, 2013, ASSESSMENT, V20, P448, DOI 10.1177/1073191113478154; Garcia-Molina A, 2012, BRAIN INJURY, V26, P864, DOI 10.3109/02699052.2012.655362; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Golden CJ, 1978, STROOP COLOR WORD TE; Green P., 2003, WORD MEMORY TEST WIN; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Hamster K., 1983, MULTILINGUAL APHASIA; Hart Robert P, 2003, Curr Pain Headache Rep, V7, P116, DOI 10.1007/s11916-003-0021-5; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Kinsinger SW, 2010, NEUROPSYCHOLOGY, V24, P573, DOI 10.1037/a0019222; Lovstad M, 2016, J INT NEUROPSYCH SOC, V22, P682, DOI 10.1017/S135561771600031X; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; McClintock SA, 2010, NEUROPSYCHOLOGY, V24, P9, DOI 10.1037/a0017336; McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nelson NW, 2010, CLIN NEUROPSYCHOL, V24, P701, DOI 10.1080/13854040903482863; Okon-Singer H, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00058; Pearson, 2009, ADV CLIN SOLUTIONS W; Perrotin A, 2007, NEUROPSYCHOLOGIA, V45, P2811, DOI 10.1016/j.neuropsychologia.2007.05.003; Rabin LA, 2017, ANNU REV CLIN PSYCHO, V13, P369, DOI 10.1146/annurev-clinpsy-032816-045136; Riccio CA, 2011, APPL NEUROPSYCHOL, V18, P1, DOI 10.1080/09084282.2010.525143; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Russo A., 2013, PSYCHOL INJURY LAW, V4, P187; Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2; Schwartz CE, 1996, ANN BEHAV MED, V18, P177, DOI 10.1007/BF02883395; SEIDENBERG M, 1994, ARCH CLIN NEUROPSYCH, V9, P353, DOI 10.1016/0887-6177(94)90023-X; Sellbom M, 2012, PSYCHIAT RES, V197, P295, DOI 10.1016/j.psychres.2011.12.043; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Slavin MJ, 2010, AM J GERIAT PSYCHIAT, V18, P701, DOI 10.1097/JGP.0b013e3181df49fb; Smart CM, 2017, NEUROPSYCHOL REV, V27, P245, DOI 10.1007/s11065-017-9342-8; Spencer A, 2010, TABLOID TERRORIST: THE PREDICATIVE CONSTRUCTION OF NEW TERRORISM IN THE MEDIA, P8; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Thames AD, 2011, CLIN NEUROPSYCHOL, V25, P224, DOI 10.1080/13854046.2010.539577; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Vytal K, 2012, PSYCHOPHYSIOLOGY, V49, P842, DOI 10.1111/j.1469-8986.2012.01358.x; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Wechsler D., 1997, WECHSLER MEMORY SCAL; White BA, 2013, J PSYCHOPATHOL BEHAV, V35, P1, DOI 10.1007/s10862-012-9310-9; Whiteside Douglas M, 2016, Appl Neuropsychol Adult, V23, P29, DOI 10.1080/23279095.2015.1004574; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Wolfson, 1993, HALSTEAD REITAN NEUR; Worthen MD, 2011, PSYCHOL INJ LAW, V4, P187, DOI 10.1007/s12207-011-9115-2; Wygant DB, 2007, ARCH CLIN NEUROPSYCH, V22, P489, DOI 10.1016/j.acn.2007.01.027; Wygant DB, 2009, ARCH CLIN NEUROPSYCH, V24, P671, DOI 10.1093/arclin/acp073; Yehyawi N. T., 2011, 39 ANN M INT NEUR SO; Young G, 2015, PSYCHOL INJ LAW, V8, P200, DOI 10.1007/s12207-015-9230-6; Young JC, 2012, ARCH CLIN NEUROPSYCH, V27, P159, DOI 10.1093/arclin/acr109	70	5	6	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	SEP	2020	35	6					701	716		10.1093/arclin/acaa024			16	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	OW5NS	WOS:000592933700006	32380529	hybrid			2022-02-06	
J	Wade, SL; Kaizar, EE; Narad, ME; Zang, HY; Kurowski, BG; Miley, AE; Moscato, EL; Aguilar, JM; Yeates, KO; Taylor, HG; Zhang, NH				Wade, Shari L.; Kaizar, Eloise E.; Narad, Megan E.; Zang, Huaiyu; Kurowski, Brad G.; Miley, Aimee E.; Moscato, Emily L.; Aguilar, Jessica M.; Yeates, Keith Owen; Taylor, H. Gerry; Zhang, Nanhua			Behavior Problems Following Childhood TBI: The Role of Sex, Age, and Time Since Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						age; behavioral problems; gender; pediatric brain injury; time since injury	TRAUMATIC BRAIN-INJURY; DEFICIT HYPERACTIVITY DISORDER; 1ST 6 MONTHS; LONG-TERM; SOCIAL COMPETENCE; PSYCHIATRIC-DISORDERS; PARENT RATINGS; HEAD-INJURY; CHILDREN; OUTCOMES	Objective: To examine the frequency of behavioral problems after childhood traumatic brain injury (TBI) and their associations with injury severity, sex, and social environmental factors. Setting: Children's hospitals in the Midwestern/Western United States. Participants: 381 boys and 210 girls with moderate (n= 359) and severe (n= 227) TBI, with an average age at injury of 11.7 years (range 0.3-18) who were injured <= 3 years ago. Design: Secondary data analysis of a multistudy cohort. Main Measures: Child Behavior Checklist (CBCL) administered pretreatment. Results: Thirty-seven percent had borderline/clinical elevations on the CBCL Total Problem Scale, with comparable rates of Internalizing and Externalizing problems (33% and 31%, respectively). Less parental education was associated with higher rates of internalizing, externalizing, and total problems. Time since injury had a linear association with internalizing symptoms, with greater symptoms at longer postinjury intervals. Younger boys had significantly higher levels of oppositional defiant symptoms than girls, whereas older girls had significantly greater attention-deficit hyperactivity disorder symptoms than boys. Conclusions: Pediatric TBI is associated with high rates of behavior problems, with lower socioeconomic status predicting substantially elevated risk. Associations of higher levels of internalizing symptoms with greater time since injury highlight the importance of tracking children over time.	[Wade, Shari L.; Narad, Megan E.; Zang, Huaiyu; Zhang, Nanhua] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Wade, Shari L.; Moscato, Emily L.] Univ Cincinnati, Coll Arts & Sci, Cincinnati, OH USA; [Wade, Shari L.; Miley, Aimee E.; Moscato, Emily L.; Aguilar, Jessica M.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, Cincinnati, OH USA; [Narad, Megan E.] Cincinnati Childrens Hosp Med Ctr, Behav Med & Clin Psychol, Cincinnati, OH USA; [Zang, Huaiyu; Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Biostat & Epidemiol, Cincinnati, OH USA; [Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, Phys Med & Rehabil, Cincinnati, OH USA; [Kaizar, Eloise E.] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Kurowski, Brad G.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Dept Neurol, Cincinnati, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Dept Rehabil Med, Cincinnati, OH USA; [Yeates, Keith Owen] Alberta Childrens Hosp Res Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Hotchkiss Brain Inst, Dept Psychol, Calgary, AB, Canada; [Taylor, H. Gerry] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Biobehav Hlth, Columbus, OH USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	Shari.Wade@cchmc.org	Zang, Huaiyu/AAY-6603-2021; Yeates, Keith/AAJ-4223-2020		National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21HD089076-01]	Funding for this study was provided by the National Institutes of Health (NIH grant 1R21HD089076-01).	Abo-Zaid G, 2013, J CLIN EPIDEMIOL, V66, P865, DOI 10.1016/j.jclinepi.2012.12.017; Abo-Zaid G, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-56; Acerini CL, 2007, HORM RES, V68, P14, DOI 10.1159/000110465; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Avenevoli S, 2015, J AM ACAD CHILD PSY, V54, P37, DOI 10.1016/j.jaac.2014.10.010; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Birmaher B, 1996, J AM ACAD CHILD PSY, V35, P1427, DOI 10.1097/00004583-199611000-00011; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chapman S.B., 2006, BRAIN INJ PROF, V3, P10; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Gagnon I, 2017, BRIT J SPORT MED, V51, P11, DOI [10.1136/bjsports-2016-097270.91, DOI 10.1136/BJSPORTS-2016-097270.91]; Gamino JF, 2009, TOP LANG DISORD, V29, P224, DOI 10.1097/TLD.0b013e3181b531da; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gauvin-Lepage J, 2010, BRAIN INJURY, V24, P1087, DOI 10.3109/02699052.2010.494593; Gerring JP, 2012, J NEUROTRAUM, V29, P621, DOI 10.1089/neu.2011.2234; Gerring JP, 2009, BRAIN INJURY, V23, P944, DOI 10.3109/02699050903285531; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Karver CL, 2014, ARCH PHYS MED REHAB, V95, P1556, DOI 10.1016/j.apmr.2014.03.030; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Kurowski BG, 2013, PM&R, V5, P1026, DOI 10.1016/j.pmrj.2013.08.589; Kurowski BG, 2013, ARCH PHYS MED REHAB, V94, P543, DOI 10.1016/j.apmr.2012.10.029; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Martinez W, 2011, J PEDIATR PSYCHOL, V36, P878, DOI 10.1093/jpepsy/jsr035; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Merrell KM., 2002, HOME COMMUNITY SOCIA; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Narad ME, 2015, J DEV BEHAV PEDIATR, V36, P700, DOI 10.1097/DBP.0000000000000208; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Raj SP, 2015, J HEAD TRAUMA REHAB, V30, P347, DOI 10.1097/HTR.0000000000000052; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Team RC R Core Team, 2019, R LANG ENV STAT COMP; Thompson A, 2009, EUR J EPIDEMIOL, V24, P727, DOI 10.1007/s10654-009-9412-1; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Walz NC, 2009, J PEDIATR REHAB MED, V2, P285, DOI 10.3233/PRM-2009-0094; Wetherington CE, 2010, J PEDIATR PSYCHOL, V35, P662, DOI 10.1093/jpepsy/jsp081; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734	67	5	5	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2020	35	5			SI		E393	E404		10.1097/HTR.0000000000000567			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NP5SO	WOS:000570236100010	32108717	Green Accepted			2022-02-06	
J	Williams, J; Roberts, I; Shakur-Still, H; Lecky, FE; Chaudhri, R; Miners, A				Williams, Jack; Roberts, Ian; Shakur-Still, Haleema; Lecky, Fiona E.; Chaudhri, Rizwana; Miners, Alec			Cost-effectiveness analysis of tranexamic acid for the treatment of traumatic brain injury, based on the results of the CRASH-3 randomised trial: a decision modelling approach	BMJ GLOBAL HEALTH			English	Article						health economics; public health; injury	POSTPARTUM HEMORRHAGE; HEAD-INJURY; ADULTS; SCALE; WOMEN; WOMAN	Introduction An estimated 69 million traumatic brain injuries (TBI) occur each year worldwide, with most in low-income and middle-income countries. The CRASH-3 randomised trial found that intravenous administration of tranexamic acid within 3 hours of injury reduces head injury deaths in patients sustaining a mild or moderate TBI. We examined the cost-effectiveness of tranexamic acid treatment for TBI. Methods A Markov decision model was developed to assess the cost-effectiveness of treatment with and without tranexamic acid, in addition to current practice. We modelled the decision in the UK and Pakistan from a health service perspective, over a lifetime time horizon. We used data from the CRASH-3 trial for the risk of death during the trial period (28 days) and patient quality of life, and data from the literature to estimate costs and long-term outcomes post-TBI. We present outcomes as quality-adjusted life years (QALYs) and 2018 costs in pounds for the UK, and US dollars for Pakistan. Incremental cost-effectiveness ratios (ICER) per QALY gained were estimated, and compared with country specific cost-effective thresholds. Deterministic and probabilistic sensitivity analyses were also performed. Results Tranexamic acid was highly cost-effective for patients with mild TBI and intracranial bleeding or patients with moderate TBI, at 4288 pound per QALY in the UK, and US$24 per QALY in Pakistan. Tranexamic acid was 99% and 98% cost-effective at the cost-effectiveness thresholds for the UK and Pakistan, respectively, and remained cost-effective across all deterministic sensitivity analyses. Tranexamic acid was even more cost-effective with earlier treatment administration. The cost-effectiveness for those with severe TBI was uncertain. Conclusion Early administration of tranexamic acid is highly cost-effective for patients with mild or moderate TBI in the UK and Pakistan, relative to the cost-effectiveness thresholds used. The estimated ICERs suggest treatment is likely to be cost-effective across all income settings globally.	[Williams, Jack; Miners, Alec] London Sch Hyg & Trop Med, Hlth Serv Res & Policy, London, England; [Roberts, Ian; Shakur-Still, Haleema] London Sch Hyg & Trop Med, Clin Trials Unit, London, England; [Lecky, Fiona E.] Univ Sheffield, Sch Hlth & Related Res, Ctr Urgent & Emergency Care Res, Sheffield, S Yorkshire, England; [Lecky, Fiona E.] Salford Royal Hosp NHS Fdn Trust, Emergency Dept, Salford, Lancs, England; [Chaudhri, Rizwana] Rawalpindi Med Univ, Holy Family Hosp, Rawalpindi, Pakistan		Williams, J (corresponding author), London Sch Hyg & Trop Med, Hlth Serv Res & Policy, London, England.	Jack.Williams@lshtm.ac.uk		Williams, Jack/0000-0002-1331-387X	JP Moulton Charitable Trust; National Institute for Health ResearchNational Institute for Health Research (NIHR); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; Department for International Development; Wellcome TrustWellcome TrustEuropean Commission; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/M009211/1] Funding Source: UKRI	JP Moulton Charitable Trust, National Institute for Health Research, Joint Global Health Trials (Medical Research Council, Department for International Development, Wellcome Trust).	Beecham J, 2009, BRAIN INJURY, V23, P30, DOI 10.1080/02699050802590338; Born K, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0966-z; Curtis LA, 2018, UNIT COSTS HLTH SOCI; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Dziekan G, 2003, B WORLD HEALTH ORGAN, V81, P277; Fuller GW, 2017, VALUE HEALTH, V20, P141, DOI 10.1016/j.jval.2016.09.2398; Guerriero C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018987; Guerriero Carla, 2010, Cost Eff Resour Alloc, V8, P1, DOI 10.1186/1478-7547-8-1; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kind P, 1999, UK POPULATION NORMS; Lecky F, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20010; Li B, 2018, LANCET GLOB HEALTH, V6, pE222, DOI 10.1016/S2214-109X(17)30467-9; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; National Health Service (NHS), 2018, NAT SCHED REF COSTS; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; National Institute for Health and Care Excellence, 2014, COST STAT NEEDL SYR; National Institute for Health and Care Excellence, 2018, QS166 NAT I HLTH CAR; Ochalek J, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000964; Office for national statistics, 2019, NAT LIF TABL UK; Roberts I, 2020, HLTH TECHNOL ASSESS; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Shakur H, 2017, LANCET, V389, P2105, DOI 10.1016/S0140-6736(17)30638-4; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; WHO, 2018, GLOB HLTH OBS DAT RE; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015; Woods B, 2016, VALUE HEALTH, V19, P929, DOI 10.1016/j.jval.2016.02.017; World Bank, 2019, GDP PER CAP PAK; World Health Organisation, WHO CHOIC PAK	31	5	5	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2059-7908			BMJ GLOB HEALTH	BMJ Glob. Health	SEP	2020	5	9							e002716	10.1136/bmjgh-2020-002716			10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	NQ6EK	WOS:000570963200001	32878899	gold, Green Published, Green Accepted			2022-02-06	
J	Zhang, J; Yi, TL; Cheng, SX; Zhang, S				Zhang, Jun; Yi, Tailong; Cheng, Shixiang; Zhang, Sai			Glucagon-like peptide-1 receptor agonist Exendin-4 improves neurological outcomes by attenuating TBI- induced inflammatory responses and MAPK activation in rats	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Traumatic brain injury; Glucagon-like peptide-1; Exendin-4; Inflammation; Neurological outcomes; Animal models	TRAUMATIC BRAIN-INJURY; GLP-1; MECHANISMS; ASSOCIATION; SEVERITY; DEFICITS; MODELS; SEX	Traumatic brain injury (TBI) can be exacerbated and prolonged for months or even years by chronic inflammatory processes with long-term consequences on neurodegeneration and neurological impairment. However, there are no clear pharmacological therapies of benefit to manage neurological dysfunctions, which, relating to the molecular mechanisms underlying the behavioral deficits after TBI, have yet to be fully identified. Recently, a glucagon-like peptide 1 (GLP-1) agonist, Exendin-4, was approved not only for the treatment of type 2 diabetes mellitus, but it also played a neurotrophic role in various CNS neurological diseases. In this study, we evaluated the neuroprotective effects of Exendin-4 on neurological outcome, cerebral blood flow, neurodegeneration, and inflammatory responses by utilizing a cortical contusion impact injury (CCI) model in rats. We found that TBI rats displayed neurological impairments, neurodegeneration, reduction of cerebral blood flow, and inflammatory responses, while Exendin-4 promoted neurological, cognitive, and cerebral blood flow recovery and attenuated neural degeneration and inflammatory cytokines after TBI. Furthermore, Exendin-4 treatment significantly diminished the TBI-induced overexpression of TNF alpha and IL-1 beta, as well as phosphorylation of p38 and ERK1/2. These data suggest a strong beneficial action of the glucagon-like peptide-1 receptor agonist Exendin-4 in improving neurological outcomes by attenuating inflammatory responses induced by traumatic brain injury, which is of therapeutic potential for TBI.	[Zhang, Jun] Tianjin Med Univ, Grad Sch, Tianjin 300070, Peoples R China; [Yi, Tailong; Cheng, Shixiang; Zhang, Sai] Characterist Med Ctr Chinese Peoples Armed Police, Tianjin Key Lab Neurotrauma Repair, Inst Neurotrauma Repair, Tianjin 300162, Peoples R China		Cheng, SX; Zhang, S (corresponding author), Characterist Med Ctr Chinese Peoples Armed Police, Tianjin Key Lab Neurotrauma Repair, Inst Neurotrauma Repair, Tianjin 300162, Peoples R China.	shixiangcheng_tj@163.com; zhangsai718_tj@163.com			National Natural Science Foundation Major Program of ChinaNational Natural Science Foundation of China (NSFC) [81891003, 81891004]; Technology Research Projects of PAL [AWS15J001]	This study is supporting by the National Natural Science Foundation Major Program of China (81891003, 81891004) and the Technology Research Projects of PAL (AWS15J001).	Armstead WM, 2017, J NEUROTRAUM, V34, P1666, DOI 10.1089/neu.2016.4770; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Banerjee A, 2016, TRENDS NEUROSCI, V39, P26, DOI 10.1016/j.tins.2015.11.001; Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Chen H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29430-6; de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101; Drucker DJ, 2018, CELL METAB, V27, P740, DOI 10.1016/j.cmet.2018.03.001; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Gallwitz B, 2011, DRUGS, V71, P1675, DOI 10.2165/11592810-000000000-00000; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Harkavyi A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-19; Holscher C, 2012, CNS DRUGS, V26, P871, DOI 10.2165/11635890-000000000-00000; Holscher Christian, 2010, Recent Pat CNS Drug Discov, V5, P109; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kinder HA, 2019, J NEUROTRAUM, V36, P2810, DOI 10.1089/neu.2019.6405; Li YZ, 2020, EXP NEUROL, V324, DOI 10.1016/j.expneurol.2019.113113; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032008; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Livny A, 2017, J NEUROTRAUM, V34, P1466, DOI 10.1089/neu.2016.4598; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Lu KT, 2011, J NEUROTRAUM, V28, P441, DOI 10.1089/neu.2010.1473; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Olsen A, 2015, CEREB CORTEX, V25, P2170, DOI 10.1093/cercor/bhu023; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Reiner DJ, 2018, NEUROPSYCHOPHARMACOL, V43, P627, DOI 10.1038/npp.2017.225; Rigon A, 2020, J CLIN EXP NEUROPSYC, V42, P14, DOI 10.1080/13803395.2019.1659755; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Skaper SD, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00072; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Stocchetti N, 2014, LANCET NEUROL, V13, P14, DOI 10.1016/S1474-4422(13)70280-1; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Varin EM, 2020, CAN J DIABETES, V44, P68, DOI 10.1016/j.jcjd.2019.08.011; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5	41	5	5	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	SEP	2020	86								106715	10.1016/j.intimp.2020.106715			7	Immunology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy	NH7AJ	WOS:000564818600010	32570036				2022-02-06	
